PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Buslepp, J; Wang, HC; Biddison, WE; Appella, E; Collins, EJ				Buslepp, J; Wang, HC; Biddison, WE; Appella, E; Collins, EJ			A correlation between TCR V alpha docking on MHC and CD8 dependence: Implications for T cell selection	IMMUNITY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; HIGH-AFFINITY; RECEPTOR RECOGNITION; CYTOPLASMIC DOMAINS; CORECEPTOR FUNCTION; MAXIMUM-LIKELIHOOD; CLASS-II; COMPLEX; PEPTIDE	T cell receptors (TCR) adopt a similar orientation when binding with major histocompatibility complex (MHC) molecules, yet the biological mechanism that generates this similar TCR orientation remains obscure. We show here the cocrystallographic structure of a mouse TCR bound to a human MHC molecule not seen by the TCR during thymic development. The orientation of this xenoreactive murine TCR atop human MHC deviates from the typical orientation more than any previously determined TCR/MHC structure. This unique orientation is solely due to the placement of the TCR Valpha domain on the MHC. In light of new information provided by this structure, we have reanalyzed the existing TCR/MHC cocrystal structures and discovered unique features of TCR Valpha domain position on class I MHC that correlate with CD8 dependence. Finally, we propose that the orientation seen in TCR recognition of MHC is a consequence of selection during T cell development.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Natl Inst Neurol Disorders & Stroke, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Collins, EJ (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.				NATIONAL CANCER INSTITUTE [Z01BC003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002603] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Bachmann MF, 1998, EUR J IMMUNOL, V28, P2571, DOI 10.1002/(SICI)1521-4141(199808)28:08<2571::AID-IMMU2571>3.0.CO;2-T; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Bankovich AJ, 2003, IMMUNITY, V18, P7, DOI 10.1016/S1074-7613(02)00517-4; Buslepp J, 2003, J IMMUNOL, V170, P373, DOI 10.4049/jimmunol.170.1.373; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CROOKS MEC, 1994, IMMUNITY, V1, P277; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; ENGELHARD VH, 1982, J IMMUNOL, V129, P2621; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; HENDERSON RA, 1993, P NATL ACAD SCI USA, V90, P10275, DOI 10.1073/pnas.90.21.10275; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lawson TM, 2001, INT IMMUNOL, V13, P1383, DOI 10.1093/intimm/13.11.1383; Lin RS, 1998, J BIOL CHEM, V273, P32878, DOI 10.1074/jbc.273.49.32878; Loftus DJ, 1997, J IMMUNOL, V158, P3651; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Moss DJ, 2001, PHILOS T ROY SOC B, V356, P475, DOI 10.1098/rstb.2000.0784; MOSS PAH, 1995, P NATL ACAD SCI USA, V92, P5773, DOI 10.1073/pnas.92.13.5773; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1997, MACROMOLECULAR CRY A, P581; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; RAMSDELL F, 1989, J IMMUNOL, V143, P1467; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rotzschke O, 1997, P NATL ACAD SCI USA, V94, P14642, DOI 10.1073/pnas.94.26.14642; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sewell AK, 1999, NAT MED, V5, P399, DOI 10.1038/7398; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHERMAN LA, 1992, SCIENCE, V258, P815, DOI 10.1126/science.1439792; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Wang ZC, 2002, J IMMUNOL, V169, P3146, DOI 10.4049/jimmunol.169.6.3146; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	69	84	85	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					595	606		10.1016/S1074-7613(03)00269-3	http://dx.doi.org/10.1016/S1074-7613(03)00269-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563323	Bronze			2022-12-18	WOS:000186051900015
J	Pashine, A; Busch, R; Belmares, MP; Munning, JN; Doebele, RC; Buckingham, M; Nolan, GP; Mellins, ED				Pashine, A; Busch, R; Belmares, MP; Munning, JN; Doebele, RC; Buckingham, M; Nolan, GP; Mellins, ED			Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN-PRESENTING CELLS; CLASS-II MOLECULES; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; LYSOSOMAL PH; IN-VIVO; B-CELLS; ALPHA; DISSOCIATION	HLA-DM (DM) edits major histocompatibility complex class II (MHCII)-bound peptides in endocytic compartments and stabilizes empty MHCII molecules. Crystal structures of DM have revealed similarity to MHCII but not how DM and MHCII interact. We used mutagenesis to map a MHCII-interacting surface on DM. Mutations on this surface impair DM action on HLA-DR and -DP in cells and DM-dependent peptide loading in vitro. The orientation of DM and MHCII predicted by these studies guided design of soluble DM and DR molecules fused to leucine zippers via their beta chains, resulting in stable DM/DR complexes. Peptide release from the complexes was fast and only weakly sequence dependent, arguing that DM diminishes the selectivity of the MHCII groove. Analysis of soluble DM action on soluble DR/peptide complexes corroborates this conclusion.	Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Mellins, ED (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.		Doebele, Robert C./I-8230-2019; Nolan, Garry/AAE-7903-2019	Doebele, Robert C./0000-0001-6728-6857; Busch, Robert/0000-0002-4132-0751; Nolan, Garry/0000-0002-8862-9043; Mellins, Elizabeth/0000-0003-2577-139X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028809] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI28809] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; Busch R, 2002, J IMMUNOL METHODS, V263, P111, DOI 10.1016/S0022-1759(02)00034-0; Busch R, 1996, CURR OPIN IMMUNOL, V8, P51, DOI 10.1016/S0952-7915(96)80105-1; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Faubert A, 2002, J BIOL CHEM, V277, P2750, DOI 10.1074/jbc.M110300200; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Glazier KS, 2002, J EXP MED, V195, P1063, DOI 10.1084/jem.20012059; Guerra CB, 1998, J IMMUNOL, V160, P4289; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kropshofer H, 1998, EMBO J, V17, P2971, DOI 10.1093/emboj/17.11.2971; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LAMB JR, 1982, J IMMUNOL, V128, P1428; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Liljedahl M, 1996, EMBO J, V15, P4817, DOI 10.1002/j.1460-2075.1996.tb00862.x; MARSH EW, 1992, J EXP MED, V175, P425, DOI 10.1084/jem.175.2.425; McFarland BH, 2002, BEHAV HEALTHC TOM, V11, P22; MELLINS E, 1991, J EXP MED, V174, P1607, DOI 10.1084/jem.174.6.1607; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Raddrizzani L, 1999, EUR J IMMUNOL, V29, P660, DOI 10.1002/(SICI)1521-4141(199902)29:02<660::AID-IMMU660>3.0.CO;2-I; Ramachandra L, 1996, J IMMUNOL, V156, P2196; ROBBINS PA, 1987, HUM IMMUNOL, V18, P301, DOI 10.1016/0198-8859(87)90077-2; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; Schafer PH, 1996, J IMMUNOL, V157, P5487; Siklodi B, 1998, HUM IMMUNOL, V59, P463, DOI 10.1016/S0198-8859(98)00038-X; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; Weber DA, 2001, J IMMUNOL, V167, P5167, DOI 10.4049/jimmunol.167.9.5167; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398	46	84	87	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					183	192		10.1016/S1074-7613(03)00200-0	http://dx.doi.org/10.1016/S1074-7613(03)00200-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932352	Bronze			2022-12-18	WOS:000184929000006
J	Gongora, R; Stephan, RP; Zhang, ZX; Cooper, MD				Gongora, R; Stephan, RP; Zhang, ZX; Cooper, MD			An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons	IMMUNITY			English	Article							LEUKEMIA PROTEIN PML; BONE-MARROW; CELL DEVELOPMENT; SIGNAL-TRANSDUCTION; TARGETED DISRUPTION; APOPTOTIC PATHWAYS; LINEAGE-CELLS; ACTIVATION; EXPRESSION; GROWTH	Interferon-alpha and -beta inhibit the interleukin-7-mediated growth and survival of T and B lymphoid progenitors via an unknown, STAT1-independent pathway. Gene expression profile analysis of interferon-beta -treated progenitor B cells revealed enhanced Daxx expression, with concomitant Daxx protein increase and nuclear body translocation. The interferon effects included downregulation of cell cycle regulating genes and cell cycle arrest, followed by Bcl-2 downregulation and apoptosis. Daxx antisense oligonucleotides rescued the interferon-treated pro-B cells from growth arrest and apoptosis in parallel with the reduction of nuclear Daxx. These findings implicate the gene repressor function of Daxx in interferon-induced apoptosis of lymphoid progenitors.	Univ Alabama, Div Dev & Clin Immunol, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama, Howard Hughes Med Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham	Cooper, MD (corresponding author), Univ Alabama, Div Dev & Clin Immunol, Dept Med, Birmingham, AL 35294 USA.		Gongora, Rafael/M-4891-2018	Gongora, Rafael/0000-0002-8046-4301	NIAID NIH HHS [T32 AI007051, AII39816] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039816, R01AI039816, T32AI007051] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASAI A, 1994, ONCOGENE, V9, P2345; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; BORZILLO GV, 1992, ONCOGENE, V7, P869; Conley ME, 1998, CURR OPIN IMMUNOL, V10, P399, DOI 10.1016/S0952-7915(98)80112-X; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DELMAZO J, 1987, CHROMOSOMA, V96, P55, DOI 10.1007/BF00285884; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Everett RD, 1999, J CELL SCI, V112, P3443; FOXWELL BMJ, 1995, EUR J IMMUNOL, V25, P3041, DOI 10.1002/eji.1830251109; Gongora C, 2000, NUCLEIC ACIDS RES, V28, P2333, DOI 10.1093/nar/28.12.2333; Gongora C, 1997, J BIOL CHEM, V272, P19457, DOI 10.1074/jbc.272.31.19457; Gongora R, 2000, J IMMUNOL, V165, P2362, DOI 10.4049/jimmunol.165.5.2362; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Grotzinger T, 1996, EUR J BIOCHEM, V238, P554, DOI 10.1111/j.1432-1033.1996.0554z.x; GULDNER HH, 1992, J IMMUNOL, V149, P4067; Haque SJ, 1998, SEMIN ONCOL, V25, P14; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hess JL, 1998, NAT GENET, V20, P220, DOI 10.1038/3014; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KINCADE PW, 1994, P NATL ACAD SCI USA, V91, P2888, DOI 10.1073/pnas.91.8.2888; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; MANDIK L, 1995, EUR J IMMUNOL, V25, P3148, DOI 10.1002/eji.1830251124; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; OGAWA M, 1989, LEUKEMIA, V3, P282; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Silvio Gutkind J., 2000, SIGNALING NETWORKS C; Stadler M, 1995, ONCOGENE, V11, P2565; Su DM, 1997, IMMUNOLOGY, V90, P543, DOI 10.1046/j.1365-2567.1997.00205.x; Su L, 1999, J IMMUNOL, V162, P6317; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Vasconcellos R, 1999, INT IMMUNOL, V11, P279, DOI 10.1093/intimm/11.2.279; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WANG JY, 1995, IMMUNITY, V3, P475, DOI 10.1016/1074-7613(95)90176-0; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	58	84	87	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					727	737		10.1016/S1074-7613(01)00152-2	http://dx.doi.org/10.1016/S1074-7613(01)00152-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420043	Bronze			2022-12-18	WOS:000169495100009
J	Garrett-Sinha, LA; Su, GH; Rao, S; Kabak, S; Hao, ZP; Clark, MR; Simon, MC				Garrett-Sinha, LA; Su, GH; Rao, S; Kabak, S; Hao, ZP; Clark, MR; Simon, MC			PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction	IMMUNITY			English	Article							TRANSCRIPTION FACTOR PU.1; TYROSINE-PHOSPHATASE 1C; ANTIGEN RECEPTOR; CHAIN GENE; PHOSPHOLIPASE C-GAMMA-1; TARGETED DISRUPTION; CROSS-LINKING; MICE LACKING; PROTEIN; IMMUNOGLOBULIN	PU.1 and Spi-B have previously been implicated in the regulation of genes encoding B cell receptor (BCR) signaling components. Spi-B-/- B lymphocytes respond poorly to BCR stimulation; PU.1(-/-) mice, however, lack B cells, precluding an analysis of BCR responses. We now show that PU.1(+/-)Spi-B-/- B cells exhibit more extensive defects than Spi-B-/- B cells, indicating that both PU.1 and Spi-B are required for normal BCR signaling. Strikingly, BCR cross-linking results in substantially reduced protein tyrosine phosphorylation in mutant B cells. Further analysis shows that Ig alpha is phosphorylated and syk is recruited and becomes phosphorylated but that BLNK and PLC gamma phosphorylation are defective in mutant cells. Our data support the existence of a novel component coupling syk to downstream targets.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Simon, MC (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Simon, Celeste/AAG-3941-2021; Garrett-Sinha, Lee Ann/K-5911-2019	Garrett-Sinha, Lee Ann/0000-0001-7806-4352; Su, Gloria/0000-0002-5158-6019	PHS HHS [52094] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P1; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; FELDHAUS AL, 1992, MOL CELL BIOL, V12, P1126, DOI 10.1128/MCB.12.3.1126; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LANKESTER AC, 1994, EUR J IMMUNOL, V24, P2818, DOI 10.1002/eji.1830241136; Law CL, 1996, MOL CELL BIOL, V16, P1305; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LIN JJ, 1992, J IMMUNOL, V149, P1548; LIN YH, 1995, J BIOL CHEM, V270, P25968, DOI 10.1074/jbc.270.43.25968; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Muller S, 1996, ONCOGENE, V13, P1955; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NOVAK EJ, 1994, CYTOMETRY, V17, p13P5; OMORI SA, 1993, P NATL ACAD SCI USA, V90, P11723, DOI 10.1073/pnas.90.24.11723; Pao LI, 1997, J IMMUNOL, V158, P1116; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Sambrook J, 1989, MOL CLONING LAB MANU; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SIDERAS P, 1994, J IMMUNOL, V153, P5607; SMIT L, 1994, J BIOL CHEM, V269, P20209; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; SU HT, 1997, EMBO J, V16, P7118; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; TORRES RM, 1996, SCIENCE, V272, P1802; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Vilen BJ, 1997, J IMMUNOL, V159, P231; VOSO MT, 1994, P NATL ACAD SCI USA, V91, P7932, DOI 10.1073/pnas.91.17.7932; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791	54	84	86	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					399	408		10.1016/S1074-7613(00)80040-0	http://dx.doi.org/10.1016/S1074-7613(00)80040-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229183	Bronze			2022-12-18	WOS:000079989600001
J	Ozga, AJ; Chow, MT; Luster, AD				Ozga, Aleksandra J.; Chow, Melvyn T.; Luster, Andrew D.			Chemokines and the immune response to cancer	IMMUNITY			English	Review							T-CELL INFILTRATION; ANTIGEN-PRESENTING CELLS; TUMOR MICROENVIRONMENT; DENDRITIC CELLS; COLON-CANCER; EXPRESSION; TRAFFICKING; RECRUITMENT; RESISTANCE; INFLAMMATION	Chemokines are chemotactic cytokines that regulate the migration of immune cells. Chemokines function as cues for the coordinated recruitment of immune cells into and out of tissue and also guide the spatial organization and cellular interactions of immune cells within tissues. Chemokines are critical in directing immune cell migration necessary to mount and then deliver an effective anti-tumor immune response; however, chemokines also participate in the generation and recruitment of immune cells that contribute to a pro-tumorigenic microenvironment. Here, we review the role of the chemokine system in anti-tumor and pro-tumor immune responses and discuss how malignant cells and the tumor microenvironment regulate the overall chemokine landscape to shape the type and outcome of immune responses to cancer and cancer treatment.	[Ozga, Aleksandra J.; Chow, Melvyn T.; Luster, Andrew D.] Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Luster, AD (corresponding author), Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Boston, MA 02114 USA.	aluster@mgh.harvard.edu						Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Arwert EN, 2018, CELL REP, V23, P1239, DOI 10.1016/j.celrep.2018.04.007; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Barsheshet Y, 2017, P NATL ACAD SCI USA, V114, P6086, DOI 10.1073/pnas.1621280114; Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bonecchi R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00224; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bronger H, 2016, BRIT J CANCER, V115, P553, DOI 10.1038/bjc.2016.172; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Bryce SA, 2016, J IMMUNOL, V196, P3341, DOI 10.4049/jimmunol.1501542; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chang KP, 2013, ORAL ONCOL, V49, P802, DOI 10.1016/j.oraloncology.2013.05.006; Chao T, 2016, CANCER IMMUNOL RES, V4, P968, DOI 10.1158/2326-6066.CIR-16-0188; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Chen WL, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005869; Chiodoni C, 2020, CANCER RES, V80, P484, DOI 10.1158/0008-5472.CAN-19-1425; Chiu DKC, 2016, HEPATOLOGY, V64, P797, DOI 10.1002/hep.28655; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Chow MT, 2014, CANCER IMMUNOL RES, V2, P1125, DOI 10.1158/2326-6066.CIR-14-0160; Connolly KA, 2016, ONCOTARGET, V7, P86522, DOI 10.18632/oncotarget.13287; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Dangaj D, 2019, CANCER CELL, V35, P885, DOI 10.1016/j.ccell.2019.05.004; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Di Pilato M, 2019, NATURE, V570, P112, DOI 10.1038/s41586-019-1215-2; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Faget J, 2017, CELL REP, V21, P3190, DOI 10.1016/j.celrep.2017.11.052; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Frankenberger C, 2015, CANCER RES, V75, P4063, DOI 10.1158/0008-5472.CAN-14-3394; Galon J, 2020, IMMUNITY, V52, P55, DOI 10.1016/j.immuni.2019.12.018; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Giese MA, 2019, BLOOD, V133, P2159, DOI 10.1182/blood-2018-11-844548; Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gubin MM, 2018, CELL, V175, P1443, DOI 10.1016/j.cell.2018.11.003; Halama N, 2016, CANCER CELL, V29, P587, DOI 10.1016/j.ccell.2016.03.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Hsin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080052; Hua YC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02178; Idorn M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1450715; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Jin LC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11869-4; Juric V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207255; Kalbasi A, 2017, CLIN CANCER RES, V23, P137, DOI 10.1158/1078-0432.CCR-16-0870; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Kerdidani D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09370-z; Kim IS, 2019, NAT CELL BIOL, V21, P1113, DOI 10.1038/s41556-019-0373-7; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lesch S, 2019, EUR J CANCER, V110, pS25, DOI 10.1016/j.ejca.2019.01.080; Li A, 2019, CELL REP, V29, P2998, DOI 10.1016/j.celrep.2019.10.120; Li L, 2017, NEOPLASMA, V64, P778, DOI 10.4149/neo_2017_517; Lian J, 2015, CURR OPIN CELL BIOL, V36, P1, DOI 10.1016/j.ceb.2015.05.003; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01566-5; Liao WT, 2019, CANCER CELL, V35, P559, DOI 10.1016/j.ccell.2019.02.008; Lieber S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1424672; Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7; Liu B, 2017, EXP CELL RES, V360, P105, DOI 10.1016/j.yexcr.2017.08.031; Liu WS, 2016, ONCOTARGET, V7, P13976, DOI 10.18632/oncotarget.7468; Lugade AA, 2008, J IMMUNOL, V180, P3132, DOI 10.4049/jimmunol.180.5.3132; Ma YT, 2014, CANCER RES, V74, P436, DOI 10.1158/0008-5472.CAN-13-1265; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Maurice NJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12980-2; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mlecnik B, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx123; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Mondini M, 2019, CANCER IMMUNOL RES, V7, P376, DOI 10.1158/2326-6066.CIR-18-0633; Moran CJ, 2002, CLIN CANCER RES, V8, P3803; Mortezaee K, 2020, LIFE SCI, V249, DOI 10.1016/j.lfs.2020.117534; Mukaida N, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/170381; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Nagarsheth N, 2016, CANCER RES, V76, P275, DOI 10.1158/0008-5472.CAN-15-1938; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Peng WY, 2010, CLIN CANCER RES, V16, P5458, DOI 10.1158/1078-0432.CCR-10-0712; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Qian L, 2019, PANCREATOLOGY, V19, P340, DOI 10.1016/j.pan.2019.01.015; Rafat M, 2018, CANCER RES, V78, P4241, DOI 10.1158/0008-5472.CAN-17-3623; Rapp M, 2019, J EXP MED, V216, P1170, DOI 10.1084/jem.20170277; Rapp M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1105428; Riedel A, 2016, NAT IMMUNOL, V17, P1118, DOI 10.1038/ni.3492; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Salmon H, 2019, NAT REV CANCER, V19, P215, DOI 10.1038/s41568-019-0125-9; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shabaneh TB, 2018, CANCER RES, V78, P5038, DOI 10.1158/0008-5472.CAN-18-0365; Sharma MD, 2018, IMMUNITY, V48, P91, DOI 10.1016/j.immuni.2017.12.014; Shen H, 2006, FASEB J, V20, P59, DOI 10.1096/fj.05-4764com; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Siddiqui I, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0125-1; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Steinberg SM, 2017, CANCER RES, V77, P1599, DOI 10.1158/0008-5472.CAN-16-1755; Sun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35855; Tang HD, 2016, CANCER CELL, V29, P285, DOI 10.1016/j.ccell.2016.02.004; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Thompson S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081692; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Vergani E, 2016, ONCOTARGET, V7, P4428, DOI 10.18632/oncotarget.6599; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Walens A, 2019, ELIFE, V8, DOI 10.7554/eLife.43653; Wang D, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0701-2; Wang L, 2019, NAT IMMUNOL, V20, P1220, DOI 10.1038/s41590-019-0429-7; Wing JB, 2019, IMMUNITY, V50, P302, DOI 10.1016/j.immuni.2019.01.020; Wu QC, 2019, HEPATOLOGY, V70, P198, DOI 10.1002/hep.30593; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020282; Yang JM, 2021, CANCER IMMUNOL RES, V9, P200, DOI 10.1158/2326-6066.CIR-20-0312; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang CY, 2015, BIOMED PHARMACOTHER, V69, P242, DOI 10.1016/j.biopha.2014.12.008; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003	143	83	84	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					859	874		10.1016/j.immuni.2021.01.012	http://dx.doi.org/10.1016/j.immuni.2021.01.012		MAY 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33838745	Green Accepted, Bronze			2022-12-18	WOS:000652019500006
J	Bunders, MJ; Altfeld, M				Bunders, Madeleine J.; Altfeld, Marcus			Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions	IMMUNITY			English	Review							PLASMACYTOID DENDRITIC CELLS; IFN-ALPHA PRODUCTION; REGULATORY T-CELLS; TISSUE REGENERATION; GENDER-DIFFERENCES; MEDIATED RESPONSE; CORONAVIRUS; ESTROGEN; INFECTION; VIRUS	Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently understood. However, studies from other viral infections have shown that females can mount stronger immune responses against viruses than males. Emerging knowledge on the basic biological pathways that underlie differences in immune responses between women and men needs to be incorporated into research efforts on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions aimed at enhancing antiviral immune function and lung airway resilience while reducing pathogenic inflammation in COVID-19.	[Bunders, Madeleine J.; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Altfeld, Marcus] Univ Med Ctr Hamburg Eppendorf UKE, Inst Immunol, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bunders, MJ; Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.; Altfeld, M (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Immunol, Hamburg, Germany.	madeleine.bunders@leibniz-hpi.de; m.altfeld@uke.de	Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997				[Anonymous], 2020, EUR HEART J, DOI DOI 10.1093/eurheartj/ehaa373; Atyeo C, 2020, IMMUNITY, V53, P524, DOI 10.1016/j.immuni.2020.07.020; Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Dimitrijevic M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58127-y; Docherty A. B., 2020, JS NGUYEN VAN TAM, DOI [10.1101/2020.04.23.20076042v1, DOI 10.1101/2020.04.23.20076042, 10.1136/bmj.m1985]; Egarnes B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00132; Fink AL, 2018, P NATL ACAD SCI USA, V115, P12477, DOI 10.1073/pnas.1805268115; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Fuseini H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02740; Fuseini H, 2018, J IMMUNOL, V201, P1843, DOI 10.4049/jimmunol.1800293; Gabriel G, 2014, J INFECT DIS, V209, pS93, DOI 10.1093/infdis/jiu020; Gause WC, 2020, NAT REV IMMUNOL, V20, P603, DOI 10.1038/s41577-020-0301-x; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grishina I, 2014, AGING DIS, V5, P160, DOI 10.14336/AD.2014.0500160; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001; HAYASHI M, 1977, AM REV RESPIR DIS, V115, P595; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; JOSEPH J, 1965, NATURE, V208, P599, DOI 10.1038/208599a0; Kadel S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01653; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Klein SL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008570; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kolosowska N, 2019, NEUROTHERAPEUTICS, V16, P1304, DOI 10.1007/s13311-019-00761-0; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Kuperman DA, 2005, J IMMUNOL, V175, P3746, DOI 10.4049/jimmunol.175.6.3746; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laffont S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01069; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Laffont S, 2014, J IMMUNOL, V193, P5444, DOI 10.4049/jimmunol.1303400; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Li Y, 2013, MICROBES INFECT, V15, P88, DOI 10.1016/j.micinf.2012.10.008; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Liu Jun, 2010, Biol Sex Differ, V1, P6, DOI 10.1186/2042-6410-1-6; Liu W, 2006, J INFECT DIS, V193, P792, DOI 10.1086/500469; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lupia T, 2020, J GLOB ANTIMICROB RE, V21, P22, DOI 10.1016/j.jgar.2020.02.021; Mangalmurti N, 2020, IMMUNITY, V53, P19, DOI 10.1016/j.immuni.2020.06.017; Mantlo Emily, 2020, bioRxiv, DOI 10.1101/2020.04.02.022764; Marquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9; Mateen S, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105675; Mathew Divij, 2020, bioRxiv, DOI 10.1101/2020.05.20.106401; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Moni MA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-333; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Montopoli M, 2020, ANN ONCOL, V31, P1040, DOI 10.1016/j.annonc.2020.04.479; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315; Newcomb DC, 2015, J ALLERGY CLIN IMMUN, V136, P1025, DOI 10.1016/j.jaci.2015.05.046; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; O'Brien TR, 2020, CLIN INFECT DIS, V71, P1410, DOI 10.1093/cid/ciaa453; Oliphant S, 2015, VIRAL IMMUNOL, V28, P580, DOI 10.1089/vim.2015.0039; OUDIT GY, 2020, EUR HEART J, V41, P1818, DOI DOI 10.1093/EURHEARTJ/EHAA414; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Peters MC, 2020, AM J RESP CRIT CARE, V202, P83, DOI 10.1164/rccm.202003-0821OC; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791; Sankaran-Walters S, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-10; Scheuplein VA, 2015, J VIROL, V89, P3859, DOI 10.1128/JVI.03607-14; Schultheiss C, 2020, IMMUNITY, V53, P442, DOI 10.1016/j.immuni.2020.06.024; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831; Shah SC, 2018, GASTROENTEROLOGY, V155, P1079, DOI 10.1053/j.gastro.2018.06.043; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Shen L, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1766382; Souyris M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8855; Stanelle-Bertram S, 2018, NAT MICROBIOL, V3, P1161, DOI 10.1038/s41564-018-0236-1; Stopsack KH, 2020, CANCER DISCOV, V10, P779, DOI 10.1158/2159-8290.CD-20-0451; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; van Lunzen J, 2014, J INFECT DIS, V209, pS79, DOI 10.1093/infdis/jiu159; Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vermillion MS, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0184-8; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; vom Steeg LG, 2019, SEMIN IMMUNOPATHOL, V41, P189, DOI 10.1007/s00281-018-0718-5; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wambier CG, 2020, DRUG DEVELOP RES, V81, P771, DOI 10.1002/ddr.21688; Wambier CG, 2020, J AM ACAD DERMATOL, V83, P308, DOI 10.1016/j.jaad.2020.04.032; Wang N, 2020, CELL HOST MICROBE, V28, P455, DOI 10.1016/j.chom.2020.07.005; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xu KJ, 2020, CLIN INFECT DIS, V71, P799, DOI 10.1093/cid/ciaa351; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zhang XD, 2020, NEW ENGL J MED, V382, P1869, DOI 10.1056/NEJMc2005157; Zhang ZQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111901; ZHAO J, 2020, CLIN INFECT DIS, DOI [DOI 10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]; Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Ziegler SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01224	137	83	85	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					487	495		10.1016/j.immuni.2020.08.003	http://dx.doi.org/10.1016/j.immuni.2020.08.003			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32853545	Bronze, Green Published			2022-12-18	WOS:000569806100007
J	Castro-Dopico, T; Dennison, TW; Ferdinand, JR; Mathews, RJ; Fleming, A; Clift, D; Stewart, BJ; Jing, CZ; Strongili, K; Labzin, LI; Monk, EJM; Saeb-Parsy, K; Bryant, CE; Clare, S; Parkes, M; Clatworthy, MR				Castro-Dopico, Tomas; Dennison, Thomas W.; Ferdinand, John R.; Mathews, Rebeccah J.; Fleming, Aaron; Clift, Dean; Stewart, Benjamin J.; Jing, Chenzhi; Strongili, Konstantina; Labzin, Larisa I.; Monk, Edward J. M.; Saeb-Parsy, Kourosh; Bryant, Clare E.; Clare, Simon; Parkes, Miles; Clatworthy, Menna R.			Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis	IMMUNITY			English	Article							FC-GAMMA RECEPTORS; BOWEL-DISEASE; MAINTENANCE THERAPY; T(H)17 CELLS; IL-1-BETA; AUTOIMMUNITY; RIIB; INTERLEUKIN-1; CONSEQUENCES; PATHOGENESIS	Inflammatory bowel disease is a chronic, relapsing condition with two subtypes, Crohn's disease (CD) and ulcerative colitis (UC). Genome-wide association studies (GWASs) in UC implicate a FCGR2A variant that alters the binding affinity of the antibody receptor it encodes, Fc gamma RIIA, for immunoglobulin G (IgG). Here, we aimed to understand the mechanisms whereby changes in Fc gamma RIIA affinity would affect inflammation in an IgA-dominated organ. We found a profound induction of anti-commensal IgG and a concomitant increase in activating Fc gamma R signaling in the colonic mucosa of UC patients. Commensal-IgG immune complexes engaged gut-resident Fc gamma R-expressing macrophages, inducing NLRP3-and reactive-oxygen-species-dependent production of interleukin-1 beta (IL-1 beta) and neutrophil-recruiting chemokines. These responses were modulated by the FCGR2A genotype. In vivo manipulation of macrophage Fc gamma R signal strength in a mouse model of UC determined the magnitude of intestinal inflammation and IL-1 beta-dependent type 17 immunity. The identification of an important contribution of IgG-Fc gamma R-dependent inflammation to UC has therapeutic implications.	[Castro-Dopico, Tomas; Dennison, Thomas W.; Ferdinand, John R.; Mathews, Rebeccah J.; Fleming, Aaron; Stewart, Benjamin J.; Jing, Chenzhi; Monk, Edward J. M.; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, Cambridge CB2 0QH, England; [Clift, Dean; Labzin, Larisa I.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [Strongili, Konstantina; Parkes, Miles] Cambridge Univ NHS Fdn Trust, Div Gastroenterol, Cambridge CB2 0QQ, England; [Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England; [Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Clare, Simon] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Clatworthy, Menna R.] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cellular Genet, Hinxton CB10 1SA, England	University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute	Clatworthy, MR (corresponding author), Univ Cambridge, Dept Med, Mol Immun Unit, Cambridge CB2 0QH, England.; Clatworthy, MR (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cellular Genet, Hinxton CB10 1SA, England.	mrc38@cam.ac.uk	Labzin, Larisa/AAC-8618-2020; Jing, Chenzhi/AAY-9690-2020; Castro-Dopico, Tomas/AAN-2643-2021	Labzin, Larisa/0000-0001-9098-4493; Stewart, Benjamin J/0000-0003-4522-0085; Parkes, Miles/0000-0002-6467-0631; Ferdinand, John Robert/0000-0003-0936-0128; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Castro-Dopico, Tomas/0000-0002-6964-5478; Clift, Dean/0000-0001-8141-7817; Clatworthy, Menna/0000-0002-3340-9828; Mathews, Rebeccah/0000-0002-3834-4744; Monk, Edward/0000-0001-9546-9650	Wellcome Trust Infection, Immunity, and Inflammation Programme PhD fellowship; Wellcome Trust PhD Fellowship [216366/Z/19/Z]; China Scholarship Council [201408060241]; Medical Research Council (UK) [U105181010]; EMBO Long-Term Fellowship [1487-2015]; Australian National Health Medical Research Council CJ Martin Fellowship [GNT1124612]; National Institute of Health Research (NIHR); Cambridge Biomedical Research Centre; NIHR Blood and Transplant Research Unit [NIHR BTRU-2014-10027]; Medical Research Council New Investigator Research Grant [MR/N024907/1]; NIHR [RP-2017-08-ST2-002]; MRC [MR/N024907/1, MC_U105181010] Funding Source: UKRI	Wellcome Trust Infection, Immunity, and Inflammation Programme PhD fellowship; Wellcome Trust PhD Fellowship(Wellcome Trust); China Scholarship Council(China Scholarship Council); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Australian National Health Medical Research Council CJ Martin Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); NIHR Blood and Transplant Research Unit; Medical Research Council New Investigator Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Arthur Kaser, Ken Smith, and Leo James for helpful discussions; the NIHR Cambridge BCR Cell Phenotyping Hub; and all donors and their families. The Molecular Immunity Unit is within the MRC Laboratory of Molecular Biology, and the authors are grateful for the use of the core facilities. T.C.D. was supported by a Wellcome Trust Infection, Immunity, and Inflammation Programme PhD fellowship. B.J.S. was supported by a Wellcome Trust PhD Fellowship (216366/Z/19/Z). C.J. was funded by the China Scholarship Council (201408060241). D.C. is supported by the Medical Research Council (UK; U105181010). L.I.L. is supported by an EMBO Long-Term Fellowship (1487-2015) and an Australian National Health Medical Research Council CJ Martin Fellowship (GNT1124612). J.R.F., R.J.M., and M.R.C. were supported by the National Institute of Health Research (NIHR), the Cambridge Biomedical Research Centre, and the NIHR Blood and Transplant Research Unit (NIHR BTRU-2014-10027). M.R.C. and T.W.D. were supported by a Medical Research Council New Investigator Research Grant (MR/N024907/1), and M.R.C. is also supported by an NIHR Research Professorship (RP-2017-08-ST2-002).	Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BAKLIEN K, 1975, CLIN EXP IMMUNOL, V22, P197; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bosques CJ, 2016, AUTOIMMUN REV, V15, P1081, DOI 10.1016/j.autrev.2016.07.035; Breynaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068876; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Catana CS, 2015, WORLD J GASTROENTERO, V21, P5823, DOI 10.3748/wjg.v21.i19.5823; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Clatworthy MR, 2014, ANTIBODY FC: LINKING ADAPTIVE AND INNATE IMMUNITY, P217; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; Clift D, 2017, CELL, V171, P1692, DOI 10.1016/j.cell.2017.10.033; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Leiper K, 2011, GUT, V60, P1520, DOI 10.1136/gut.2010.225482; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Ma TKW, 2017, NEPHROL DIAL TRANSPL, V32, P129, DOI 10.1093/ndt/gfw336; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Masuda A, 2008, INFECT IMMUN, V76, P1728, DOI 10.1128/IAI.01493-07; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Planell N, 2013, GUT, V62, P967, DOI 10.1136/gutjnl-2012-303333; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; SHAFIR M, 1986, EUR J SURG ONCOL, V12, P351; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Uo M, 2013, GUT, V62, P1734, DOI 10.1136/gutjnl-2012-303063; Vanhove W, 2015, INFLAMM BOWEL DIS, V21, P2673, DOI 10.1097/MIB.0000000000000535; Vennik J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022643; Weersma RK, 2010, INFLAMM BOWEL DIS, V16, P2080, DOI 10.1002/ibd.21342; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Yang SK, 2011, DIGEST LIVER DIS, V43, P856, DOI 10.1016/j.dld.2011.07.006; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	57	83	85	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1099	+		10.1016/j.immuni.2019.02.006	http://dx.doi.org/10.1016/j.immuni.2019.02.006			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30876876	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000464660800025
J	Yang, DP; Chen, X; Wang, JJ; Lou, Q; Lou, YW; Li, L; Wang, HL; Chen, JY; Wu, M; Song, XY; Qian, YC				Yang, Daping; Chen, Xi; Wang, Jingjing; Lou, Qi; Lou, Yunwei; Li, Li; Wang, Honglin; Chen, Jiangye; Wu, Meng; Song, Xinyang; Qian, Youcun			Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles	IMMUNITY			English	Article							AIRWAY INFLAMMATION; IL-17; CELLS; GUT; MICROBIOME; RECEPTOR; BIOGENESIS; MECHANISMS; EXPRESSION; BLEOMYCIN	Idiopathic pulmonary fibrosis (IPF) is a severe form of lung fibrosis with a high mortality rate. However, the etiology of IPF remains unknown. Here, we report that alterations in lung microbiota critically promote pulmonary fibrosis pathogenesis. We found that lung microbiota was dysregulated, and the dysregulated microbiota in turn induced production of interleukin-17B (IL-17B) during bleomycin-induced mouse lung fibrosis. Either lung-microbiota depletion or IL-17B deficiency ameliorated the disease progression. IL-17B cooperated with tumor necrosis factor-a to induce expression of neutrophil-recruiting genes and T helper 17 (Th17)-cell-promoting genes. Three pulmonary commensal microbes, which belong to the genera Bacteroides and Prevotella, were identified to promote fibrotic pathogenesis through IL-17R signaling. We further defined that the outer membrane vesicles (OMVs) that were derived from the identified commensal microbes induced IL-17B production through Toll-like receptor-Myd88 adaptor signaling. Together our data demonstrate that specific pulmonary symbiotic commensals can promote lung fibrosis by regulating a profibrotic inflammatory cytokine network.	[Yang, Daping; Wang, Jingjing; Lou, Qi; Lou, Yunwei; Qian, Youcun] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci,CAS Ctr Excellence Mol Cel, Shanghai Inst Nutr & Hlth,CAS Key Lab Tissue Micr, Shanghai 200031, Peoples R China; [Qian, Youcun] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Chen, Xi] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China; [Li, Li] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Resp Dis, Baoshan Branch, Shanghai 201900, Peoples R China; [Li, Li] Baoshan Dist Hosp Integrated Tradit Chinese & Wes, Dept Resp Dis, Shanghai 201900, Peoples R China; [Wang, Honglin; Wu, Meng] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Inst Med Sci, Sch Med, Shanghai 200025, Peoples R China; [Chen, Jiangye] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Song, Xinyang] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard Medical School	Qian, YC (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci,CAS Ctr Excellence Mol Cel, Shanghai Inst Nutr & Hlth,CAS Key Lab Tissue Micr, Shanghai 200031, Peoples R China.; Qian, YC (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China.	ycqian@sibs.ac.cn	Wu, Meng/P-9657-2019; Song, Xinyang/AAL-7495-2021; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022; wang, jing/GVT-8700-2022; WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927; Song, Xinyang/0000-0002-3422-6927	National Natural Science Foundation of China [91842306, 81430036, 81830018, 91429307, 91542119, 31500707]; National Key R&D Program of China [2018YFA0507402]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (91842306, 81430036, 81830018, 91429307, 91542119, and 31500707), National Key R&D Program of China (2018YFA0507402), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Atkins CP, 2014, RESP MED, V108, P376, DOI 10.1016/j.rmed.2013.11.007; Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chen K, 2016, CELL HOST MICROBE, V20, P596, DOI 10.1016/j.chom.2016.10.003; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Hammond M, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2453-6; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kim D, 2016, NAT MED, V22, P524, DOI 10.1038/nm.4075; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Li L, 2018, ONCOL LETT, V16, P2490, DOI 10.3892/ol.2018.8903; Liang JR, 2016, NAT MED, V22, P1285, DOI 10.1038/nm.4192; Macaluso C, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00628-2018; Molyneaux PL, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0511-3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Song XY, 2014, IMMUNITY, V40, P140, DOI 10.1016/j.immuni.2013.11.018; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Wang L, 2017, J IMMUNOL, V198, P4772, DOI 10.4049/jimmunol.1700030; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287	46	83	85	13	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					692	+		10.1016/j.immuni.2019.02.001	http://dx.doi.org/10.1016/j.immuni.2019.02.001			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30824326	Bronze			2022-12-18	WOS:000461660500019
J	Zhou, J; Peng, H; Li, K; Qu, K; Wang, BH; Wu, YZ; Ye, LL; Dong, ZJ; Wei, HM; Sun, R; Tian, ZG				Zhou, Jing; Peng, Hui; Li, Kun; Qu, Kun; Wang, Baohui; Wu, Yuzhang; Ye, Lilin; Dong, Zhongjun; Wei, Haiming; Sun, Rui; Tian, Zhigang			Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; INNATE LYMPHOID-CELLS; TISSUE-RESIDENT; IFN-GAMMA; INFECTION; IMMUNITY; RECEPTOR; RESPONSES; ANTIGEN; ACCUMULATION	The tolerogenic microenvironment of the liver is associated with impaired hepatic T cell function. Here, we examined the contribution of liver-resident natural killer (LrNK) cells, a prominent hepatic NK cell compartment, to T cell antiviral responses in the liver. The number of virus-specific T cells increased in LrNK-cell-deficient mice during both acute and chronic lymphocytic choriomeningitis virus infection. Upon infection with adenovirus, hepatic T cells from these mice produced more cytokines, which was accompanied by reduced viral loads. Transfer of LrNK cells into LrNK-cell-deficient or wild-type mice inhibited hepatic T cell function, resulting in impaired viral clearance, whereas transfer of conventional NK cells promoted T cell antiviral responses. LrNK-cell-mediated inhibition of T cell function was dependent on the PD-1-PD-L1 axis. Our findings reveal a role for LrNK cells in the regulation of T cell immunity and provide insight into the mechanisms of immune tolerance in the liver.	[Zhou, Jing; Peng, Hui; Li, Kun; Qu, Kun; Wang, Baohui; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Div Mol Med,Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Zhou, Jing; Peng, Hui; Wang, Baohui; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Inst Immunol, Hefei 230027, Anhui, Peoples R China; [Wu, Yuzhang; Ye, Lilin] Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China; [Dong, Zhongjun] Tsinghua Univ, Sch Med, Beijing 100086, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Army Medical University; Tsinghua University	Peng, H; Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Div Mol Med,Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Peng, H; Tian, ZG (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei 230027, Anhui, Peoples R China.	huipeng@mail.ustc.edu.cn; tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013	Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China [81788101, 91642105, 81571522, 91542114, 81761128013, 91542000]; Chinese Academy of Sciences [XDB29030000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Prof. Rafi Ahmed (Emory University School of Medicine, GA, USA) for providing the LCMV strains and the National Institutes of Health Tetramer Core Facility at Emory University for providing the anti-LCMV gp66 tetramer. This work was supported by the National Natural Science Foundation of China (81788101, 91642105, 81571522, 91542114, 81761128013, and 91542000) and the Chinese Academy of Sciences (XDB29030000).	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bauche D, 2018, IMMUNITY, V49, P342, DOI 10.1016/j.immuni.2018.07.007; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crome SQ, 2017, NAT MED, V23, P368, DOI 10.1038/nm.4278; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; Cuff AO, 2016, J IMMUNOL, V197, P4283, DOI 10.4049/jimmunol.1601424; Cunningham EC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/419692; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110; Gao B, 2016, CELL MOL IMMUNOL, V13, P265, DOI 10.1038/cmi.2016.09; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gu J, 2017, CELL MOL IMMUNOL, V14, P521, DOI 10.1038/cmi.2016.30; Harmon C, 2016, EUR J IMMUNOL, V46, P2111, DOI 10.1002/eji.201646559; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Krueger PD, 2017, J LEUKOCYTE BIOL, V101, P329, DOI 10.1189/jlb.3A0516-225R; Lam VC, 2017, CURR OPIN IMMUNOL, V44, P43, DOI 10.1016/j.coi.2016.11.003; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Li FL, 2013, CELL MOL IMMUNOL, V10, P292, DOI 10.1038/cmi.2013.7; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Liang YJ, 2015, EUR J IMMUNOL, V45, P3052, DOI 10.1002/eji.201545696; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu ZX, 2000, J IMMUNOL, V164, P6480, DOI 10.4049/jimmunol.164.12.6480; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; MCINTYRE KW, 1986, J EXP MED, V164, P1667, DOI 10.1084/jem.164.5.1667; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Peng H, 2017, CELL MOL IMMUNOL, V14, P890, DOI 10.1038/cmi.2017.72; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Peng H, 2016, CELL MOL IMMUNOL, V13, P328, DOI 10.1038/cmi.2015.96; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Raziorrouh B, 2011, GASTROENTEROLOGY, V141, P1422, DOI 10.1053/j.gastro.2011.07.004; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Schuster IS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00235; Schuster IS, 2014, IMMUNITY, V41, P646, DOI 10.1016/j.immuni.2014.09.013; Schwartz C, 2017, J EXP MED, V214, P2507, DOI 10.1084/jem.20170051; Seillet C, 2016, CURR TOP MICROBIOL, V395, P37, DOI 10.1007/82_2015_474; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Stegmann KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26157; Tang L, 2016, J AUTOIMMUN, V67, P29, DOI 10.1016/j.jaut.2015.09.004; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Urbani S, 2008, J HEPATOL, V48, P548, DOI 10.1016/j.jhep.2007.12.014; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang YS, 2017, J IMMUNOL, V199, P1012, DOI 10.4049/jimmunol.1601430; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; WELSH RM, 1991, J EXP MED, V173, P1053, DOI 10.1084/jem.173.5.1053; Yeang HXA, 2017, J IMMUNOL, V198, P1417, DOI 10.4049/jimmunol.1601818; Zhang C, 2006, CELL MOL IMMUNOL, V3, P241; Zhang LH, 2016, J EXP MED, V213, P2249, DOI 10.1084/jem.20151998; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037	80	83	87	8	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					403	+		10.1016/j.immuni.2018.12.024	http://dx.doi.org/10.1016/j.immuni.2018.12.024			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30709740	Bronze			2022-12-18	WOS:000459006700015
J	Pan, W; Zhu, S; Qu, K; Meeth, K; Cheng, JJ; He, KX; Ma, HD; Liao, Y; Wen, XZ; Roden, C; Tobiasova, Z; Wei, Z; Zhao, J; Liu, J; Zheng, J; Guo, B; Khan, SA; Bosenberg, M; Flavell, RA; Lu, J				Pan, Wen; Zhu, Shu; Qu, Kun; Meeth, Katrina; Cheng, Jijun; He, Kaixin; Ma, Hongdi; Liao, Yan; Wen, Xizhi; Roden, Christine; Tobiasova, Zuzana; Wei, Zheng; Zhao, Jun; Liu, Jun; Zheng, Ji; Guo, Bo; Khan, Sajid A.; Bosenberg, Marcus; Flavell, Richard A.; Lu, Jun			The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; CLONAL HEMATOPOIESIS; SUPPRESSOR-CELLS; ARGINASE-I; MUTATIONS; 5-METHYLCYTOSINE; CANCER; IL-1; MICROENVIRONMENT; DIFFERENTIATION	Ten-Eleven-Translocation-2 (Tet2) is a DNA methylcytosine dioxygenase that functions as a tumor suppressor in hematopoietic malignancies. We examined the role of Tet2 in tumor-tissue myeloid cells and found that Tet2 sustains the immunosuppressive function of these cells. We found that Tet2 expression is increased in intratumoral myeloid cells both in mouse models of melanoma and in melanoma patients and that this increased expression is dependent on an IL-1R-MyD88 pathway. Ablation of Tet2 in myeloid cells suppressed melanoma growth in vivo and shifted the immunosuppressive gene expression program in tumor-associated macrophages to a proinflammatory one, with a concomitant reduction of the immunosuppressive function. This resulted in increased numbers of effector T cells in the tumor, and T cell depletion abolished the reduced tumor growth observed upon myeloid-specific deletion of Tet2. Our findings reveal a non-cell-intrinsic, tumor-promoting function for Tet2 and suggest that Tet2 may present a therapeutic target for the treatment of non-hematologic malignancies.	[Roden, Christine; Liu, Jun; Flavell, Richard A.; Lu, Jun] Yale Univ Sch Med, Dept Genet, New Haven, CT 06520 USA; [He, Kaixin; Ma, Hongdi; Wen, Xizhi; Wei, Zheng; Zhao, Jun] Yale Univ, Yale Stem Cell Ctr, Yale Canc Ctr, Yale Cooperat Ctr Excellence Hematol, New Haven, CT 06520 USA; [Zhu, Shu; Wei, Zheng; Zheng, Ji] Yale Univ Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cheng, Jijun; Wei, Zheng; Zheng, Ji; Khan, Sajid A.] Univ Sci & Technol China, Inst Immunol, Hefei 230027, Peoples R China; [Ma, Hongdi; Wen, Xizhi; Tobiasova, Zuzana; Zheng, Ji] Univ Sci & Technol China, Sch Life Sci & Med Ctr, CAS Key Lab Innate Immun & Chron Dis, Hefei 230027, Peoples R China; [He, Kaixin; Ma, Hongdi; Wen, Xizhi; Wei, Zheng; Khan, Sajid A.] Yale Univ Sch Med, Dept Pathol, New Haven, CT 06519 USA; [Liao, Yan; Tobiasova, Zuzana; Liu, Jun] Yale Univ Sch Med, Dept Dermatol, New Haven, CT 06519 USA; [Cheng, Jijun; Wen, Xizhi; Tobiasova, Zuzana; Zhao, Jun; Flavell, Richard A.] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Key Lab Stem Cells & Tissue Engn, Minist Educ, Guangzhou 510060, Peoples R China; [Liao, Yan; Wei, Zheng; Zheng, Ji; Khan, Sajid A.] Sun Yat Sen Univ, Biotherapy Ctr, Guangzhou 510060, Peoples R China	Yale University; Yale University; Yale University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yale University; Yale University; Sun Yat Sen University; Sun Yat Sen University	Lu, J (corresponding author), Yale Univ Sch Med, Dept Genet, New Haven, CT 06520 USA.	jun.lu@yale.edu	Zhu, Shu/P-6163-2018; Qu, Kun/G-3359-2012; khan, sajid/HGE-2406-2022; Zhao, Jun/AAT-2086-2021	Zhu, Shu/0000-0002-8163-0869; 	Connecticut Regenerative Medicine Research Fund (RMRF); Li Ka Shing Foundation; NIH [R01CA149109]; Connecticut RMRF [15-RMB-YALE-06]; DoD [0011014192]; Developmental Research Award from Yale SPORE in Skin Cancer; Leukemia and Lymphoma Society Fellowship [5338-15]; Helen Hay Whitney Foundation-Howard Hughes Medical Institute; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA149109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER	Connecticut Regenerative Medicine Research Fund (RMRF); Li Ka Shing Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut RMRF; DoD(United States Department of Defense); Developmental Research Award from Yale SPORE in Skin Cancer; Leukemia and Lymphoma Society Fellowship(Leukemia and Lymphoma Society); Helen Hay Whitney Foundation-Howard Hughes Medical Institute(Howard Hughes Medical Institute); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Susan Kaech, Carla Rothlin, Shangqin Guo, Tae Kon Kim, Yi Yang, and Anna Baccei for helpful discussions, technical expertise, or critical review of this manuscript. We thank Mei Zhong from Yale Stem Cell Center Genomics Core for assistance with deep sequencing, which was supported by the Connecticut Regenerative Medicine Research Fund (RMRF) and the Li Ka Shing Foundation. We thank the assistance from the cores of Yale Cooperative Center of Excellence in Hematology. This work is supported in part by NIH grant R01CA149109 (to J. Lu), Connecticut RMRF grant 15-RMB-YALE-06 (to J. Lu), DoD grant 0011014192 (to J. Lu), a Developmental Research Award from Yale SPORE in Skin Cancer (to J. Lu), Leukemia and Lymphoma Society Fellowship No. 5338-15 (to W.P.), a fellowship from Helen Hay Whitney Foundation-Howard Hughes Medical Institute (to S.Z.), and a grant from the Strategic Priority Research Program of the Chinese Academy of Sciences No. XDPB03 (to S.Z.).	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Bhatia S, 2014, LANCET, V384, P1078, DOI 10.1016/S0140-6736(14)61140-5; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Callahan MK, 2016, CANCER J, V22, P73, DOI 10.1097/PPO.0000000000000183; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Church SE, 2015, IMMUNITY, V43, P631, DOI 10.1016/j.immuni.2015.10.004; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cullen SM, 2015, CELL CYCLE, V14, P693, DOI 10.1080/15384101.2015.1006558; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Andrade LF, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.998119; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rawal S, 2011, BLOOD, V118, P349; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Xue SJ, 2016, CELL REP, V16, P1096, DOI 10.1016/j.celrep.2016.06.068; Yadav M, 2016, SCIENCE, V352, P1275, DOI 10.1126/science.aag1547; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	61	83	86	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					284	+		10.1016/j.immuni.2017.07.020	http://dx.doi.org/10.1016/j.immuni.2017.07.020			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813659	Bronze, Green Accepted			2022-12-18	WOS:000407788300014
J	Thomas, GD; Hanna, RN; Vasudevan, NT; Hamers, AA; Romanoski, CE; McArdle, S; Ross, KD; Blatchley, A; Yoakum, D; Hamilton, BA; Mikulski, Z; Jain, MK; Glass, CK; Hedrick, CC				Thomas, Graham D.; Hanna, Richard N.; Vasudevan, Neelakatan T.; Hamers, Anouk A.; Romanoski, Casey E.; McArdle, Sara; Ross, Kevin D.; Blatchley, Amy; Yoakum, Deborah; Hamilton, Bruce A.; Mikulski, Zbigniew; Jain, Mukesh K.; Glass, Christopher K.; Hedrick, Catherine C.			Deleting an Nr4a1 Super-Enhancer Subdomain Ablates Ly6C(low) Monocytes while Preserving Macrophage Gene Function	IMMUNITY			English	Article							TRANSCRIPTION FACTOR NR4A1; PPAR-GAMMA; CELL IDENTITY; IN-VIVO; DIFFERENTIATION; ACTIVATION; POLARIZATION; HOMEOSTASIS; GENOME; NUR77	Mononuclear phagocytes are a heterogeneous family that occupy all tissues and assume numerous roles to support tissue function and systemic homeostasis. Our ability to dissect the roles of individual subsets is limited by a lack of technologies that ablate gene function within specificmononuclear phagocyte sub-populations. Using Nr4a1-dependent Ly6C(low) monocytes, we present a proof-of-principle approach that addresses these limitations. Combining ChIP-seq and molecular approaches we identified a single, conserved, sub-domain within the Nr4a1 enhancer that was essential for Ly6C(low) monocyte development. Mice lacking this enhancer lacked Ly6C(low) monocytes but retained Nr4a1 gene expression in macrophages during steady state and in response to LPS. Because Nr4a1 regulates inflammatory gene expression and differentiation of Ly6C(low) monocytes, decoupling these processes allows Ly6C(low) monocytes to be studied independently.	[Thomas, Graham D.; Hanna, Richard N.; Hamers, Anouk A.; McArdle, Sara; Blatchley, Amy; Yoakum, Deborah; Mikulski, Zbigniew; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Vasudevan, Neelakatan T.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med, Cleveland, OH 44106 USA; [Romanoski, Casey E.] Keating Biores Bldg, 1657 E Helen St, Tucson, AZ 85721 USA; [Ross, Kevin D.; Hamilton, Bruce A.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; Case Western Reserve University; Case Western Reserve University Hospital; University of California System; University of California San Diego	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.	hedrick@lji.org	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Romanoski, Casey/0000-0002-0149-225X; Thomas, Graham/0000-0001-9778-8874; Hamilton, Bruce/0000-0001-5599-9139	AHA Fellowships [16POST27630002, 12DG12070005]; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Grant, from National Institute of General Medical Sciences [T32 GM008666];  [R01HL134236];  [R01HL118765];  [R01CA202987];  [R01HL112039];  [R01DK091183];  [R01CA17390];  [R01HL088093];  [R00HL123485];  [R01GM086912];  [R01HL086548];  [R01075427]; NATIONAL CANCER INSTITUTE [R01CA202987, P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118765, R01HL086548, R01HL134236, R00HL123485, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P01DK074868, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, R01GM086912] Funding Source: NIH RePORTER	AHA Fellowships(American Heart Association); Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Grant, from National Institute of General Medical Sciences; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Joseph Miano (University of Rochester) for helpful advice with CRISPR design. We would like to acknowledge the LJI flow cytometry core and sequencing core facilities as well as the UCSD transgenic core facility. Funding sources: R01HL134236; R01HL118765, R01CA202987, and R01HL112039 to C.C.H.; R01DK091183, R01CA17390, and R01HL088093 to C.K.G.; R00HL123485 to C.E.R.; R01GM086912 to B.A.H.; R01HL086548 and R01075427 to M.K.J. AHA Fellowships 16POST27630002 to G.D.T. and 12DG12070005 to R.N.H. K.D.R. was supported in part by a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Grant, T32 GM008666, from the National Institute of General Medical Sciences.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Concepcion D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005123; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gilfillan GD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-645; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jacob A, 2007, BBA-MOL BASIS DIS, V1772, P766, DOI 10.1016/j.bbadis.2007.03.010; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tacke R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10055; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	49	83	83	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					975	987		10.1016/j.immuni.2016.10.011	http://dx.doi.org/10.1016/j.immuni.2016.10.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27814941	Bronze, Green Accepted			2022-12-18	WOS:000389473500010
J	van Unen, V; Li, N; Molendijk, I; Temurhan, M; Hollt, T; van der Meulen-de Jong, AE; Verspaget, HW; Mearin, ML; Mulder, CJ; van Bergen, J; Lelieveldt, BPF; Koning, F				van Unen, Vincent; Li, Na; Molendijk, Ilse; Temurhan, Mine; Hollt, Thomas; van der Meulen-de Jong, Andrea E.; Verspaget, Hein W.; Mearin, M. Luisa; Mulder, Chris J.; van Bergen, Jeroen; Lelieveldt, Boudewijn P. F.; Koning, Frits			Mass Cytometry of the Human Mucosal Immune System Identifies Tissue- and Disease-Associated Immune Subsets	IMMUNITY			English	Article							FISTULIZING CROHNS-DISEASE; REFRACTORY CELIAC-DISEASE; INNATE LYMPHOID-CELLS; PREVALENCE; EXPRESSION; RESPONSES	Inflammatory intestinal diseases are characterized by abnormal immune responses and affect distinct locations of the gastrointestinal tract. Although the role of several immune subsets in driving intestinal pathology has been studied, a system-wide approach that simultaneously interrogates all major lineages on a single-cell basis is lacking. We used high-dimensional mass cytometry to generate a system-wide view of the human mucosal immune system in health and disease. We distinguished 142 immune subsets and through computational applications found distinct immune subsets in peripheral blood mononuclear cells and intestinal biopsies that distinguished patients from controls. In addition, mucosal lymphoid malignancies were readily detected as well as precursors from which these likely derived. These findings indicate that an integrated high-dimensional analysis of the entire immune system can identify immune subsets associated with the pathogenesis of complex intestinal disorders. This might have implications for diagnostic procedures, immune-monitoring, and treatment of intestinal diseases and mucosal malignancies.	[van Unen, Vincent; Li, Na; van Bergen, Jeroen; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Molendijk, Ilse; van der Meulen-de Jong, Andrea E.; Verspaget, Hein W.] Leiden Univ, Med Ctr, Dept Gastroenterol, NL-2333 ZA Leiden, Netherlands; [Temurhan, Mine] Leiden Univ, Med Ctr, Dept Ctr Prote, NL-2333 ZA Leiden, Netherlands; [Mearin, M. Luisa] Leiden Univ, Med Ctr, Dept Pediat, NL-2333 ZA Leiden, Netherlands; [Lelieveldt, Boudewijn P. F.] Leiden Univ, Med Ctr, Dept LKEB Radiol, NL-2333 ZA Leiden, Netherlands; [Mulder, Chris J.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol, NL-1081 HZ Amsterdam, Netherlands; [Hollt, Thomas; Lelieveldt, Boudewijn P. F.] Delft Univ Technol, Dept Pattern Recognit, NL-2600 GA Delft, Netherlands; [Hollt, Thomas; Lelieveldt, Boudewijn P. F.] Delft Univ Technol, Bioinformat Grp, NL-2600 GA Delft, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Delft University of Technology; Delft University of Technology	Koning, F (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands.	f.koning@lumc.nl	Li, Na/AAO-8117-2020; van Unen, Vincent/L-9105-2019; van der Meulen, Andrea/AAU-9430-2020; Lelieveldt, Boudewijn/B-6501-2008	Li, Na/0000-0001-5380-8554; van Unen, Vincent/0000-0001-9339-8430; van der Meulen, Andrea/0000-0001-9353-5431; Lelieveldt, Boudewijn/0000-0001-8269-7603; Koning, Frits/0000-0002-4007-5715; /0000-0001-8125-1650	Leiden University Medical Center; Netherlands Organization for Scientific Research (ZonMW) [91112008]; World Wide Cancer Research grant [14-0245]; European Union [604102]; Dutch Technology Foundation STW [12720]; DigestScience Foundation; Worldwide Cancer Research [14-0245] Funding Source: researchfish	Leiden University Medical Center; Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); World Wide Cancer Research grant; European Union(European Commission); Dutch Technology Foundation STW(Technologiestichting STW); DigestScience Foundation; Worldwide Cancer Research	We thank the patients and their families. The research leading to these results has received funding from the Leiden University Medical Center, the Netherlands Organization for Scientific Research (ZonMW grant 91112008), a World Wide Cancer Research grant (14-0245), the European Union Seventh Framework Programme (FP7/2007-2013, grant agreement no. 604102), the Dutch Technology Foundation STW (project 12720: "VANPIRE" under the STW IMAGENE perspective program), and DigestScience Foundation. We thank Drs. F.J.T. Staal, F.A. Ossendorp, M.W. Schilham, M. Yazdanbakhsh, and W.E. Fibbe for critical review of the manuscript.	Al-Toma A, 2007, GUT, V56, P1373, DOI 10.1136/gut.2006.114512; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kamm MA, 2008, CLIN GASTROENTEROL H, V6, P7, DOI 10.1016/j.cgh.2007.10.010; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Molendijk I, 2014, INFLAMM BOWEL DIS, V20, P2022, DOI 10.1097/MIB.0000000000000148; Ornatsky OI, 2008, J ANAL ATOM SPECTROM, V23, P463, DOI 10.1039/b710510j; Pascual V, 2014, WORLD J GASTROENTERO, V20, P4846, DOI 10.3748/wjg.v20.i17.4846; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Randall CW, 2015, THER ADV GASTROENTER, V8, P143, DOI 10.1177/1756283X15576462; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Schmitz F, 2013, GUT, V62, P509, DOI 10.1136/gutjnl-2012-302265; Schwartz DA, 2002, GASTROENTEROLOGY, V122, P875, DOI 10.1053/gast.2002.32362; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; SPENCER J, 1989, EUR J IMMUNOL, V19, P1335, DOI 10.1002/eji.1830190728; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Verbeek WHM, 2008, CLIN IMMUNOL, V126, P48, DOI 10.1016/j.clim.2007.09.002	27	83	83	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1227	1239		10.1016/j.immuni.2016.04.014	http://dx.doi.org/10.1016/j.immuni.2016.04.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27178470	Green Published, Bronze			2022-12-18	WOS:000376478500025
J	Wendland, M; Willenzon, S; Kocks, J; Davalos-Misslitz, AC; Hammerschmidt, SI; Schumann, K; Kremmer, E; Sixt, M; Hoffmeyer, A; Pabst, O; Forstert, R				Wendland, Meike; Willenzon, Stefanie; Kocks, Jessica; Davalos-Misslitz, Ana Clara; Hammerschmidt, Swantje I.; Schumann, Kathrin; Kremmer, Elisabeth; Sixt, Michael; Hoffmeyer, Angelika; Pabst, Oliver; Foerstert, Reinhold			Lymph Node T Cell Homeostasis Relies on Steady State Homing of Dendritic Cells	IMMUNITY			English	Article							MIGRATION; CCR7; ORGANS; SPHINGOSINE-1-PHOSPHATE; CHEMOKINES; RECEPTORS; TOLERANCE; MOTILITY; EGRESS; ENTRY	Little is known about mechanisms determining the homeostasis of lymphocytes within lymphoid organs. Applying different mouse models, including conditionally proficient Ccr7 gene-targeted mice, we now show that semimature steady state dendritic cells (sDCs) constitutively trafficking into lymph nodes (LNs) were essential contributors to T cell homeostasis in these organs. sDCs provided vascular endothelial growth factor known to support high endothelial venule formation, thus facilitating enhanced homing of T cells to LNs. The presence of sDCs led to increased CCL21 production in T-zone fibroblastic reticular cells. CCL21 is a ligand for CCR7 known to regulate homing as well as retention of T cells in LNs. In addition, we provide evidence that CCL21 binds to the surface of DCs via its heparin-binding domain, further explaining why T cells leave LNs more rapidly in the absence of sDCs. Together, these data reveal multiple roles for sDCs in regulating T cell homeostasis in LNs.	[Wendland, Meike; Willenzon, Stefanie; Kocks, Jessica; Davalos-Misslitz, Ana Clara; Hammerschmidt, Swantje I.; Pabst, Oliver; Foerstert, Reinhold] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Schumann, Kathrin; Sixt, Michael] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Hoffmeyer, Angelika] Nycomed GmbH, D-78467 Constance, Germany	Hannover Medical School; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Nycomed GmbH	Forstert, R (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	foerster.reinhold@mh-hannover.de	Pabst, Oliver/H-5014-2016	Pabst, Oliver/0000-0002-5533-883X; Schumann, Kathrin/0000-0002-0993-3910; Sixt, Michael/0000-0002-6620-9179; Forster, Reinhold/0000-0001-6190-7923	Deutsche Forschungsgemeinschafts [SFB621-A1, SFB587-B3]	Deutsche Forschungsgemeinschafts	We thank I. Prinz for scientific discussions and G. Bernhardt for critically reading the manuscript. We thank W. Muller, Manchester, and B. Reizis, New York City, for providing Cd4-cre and Cd11c-cre mice, respectively. This work was supported by a Deutsche Forschungsgemeinschafts grants SFB621-A1 and SFB587-B3 to R.F. and Nycomed GmbH. A.H. is employee of Nycomed GmbH (Konstanz, Germany).	Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lohr J, 2005, IMMUNOL REV, V204, P116, DOI 10.1111/j.0105-2896.2005.00241.x; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	32	83	87	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					945	957		10.1016/j.immuni.2011.10.017	http://dx.doi.org/10.1016/j.immuni.2011.10.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195748	Bronze			2022-12-18	WOS:000298777300013
J	Browne, CD; Del Nagro, CJ; Cato, MH; Dengler, HS; Rickert, RC				Browne, Cecille D.; Del Nagro, Christopher J.; Cato, Matthew H.; Dengler, Hart S.; Rickert, Robert C.			Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell Anergy	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; MARGINAL ZONE; SELF-TOLERANCE; RECEPTOR; CD19; LYMPHOCYTES; ACTIVATION; REQUIRES; PTEN; IGM	Anergy is a critical physiologic mechanism to censor self-reactive B cells. However, a biochemical understanding of how anergy is achieved and maintained is lacking. Herein, we investigated the role of the phosphoinositide 3-kinase (PI3K) lipid product PI(3,4,5)P-3 in B cell anergy. We found reduced generation of PI(3,4,5)P-3 in anergic B cells, which was attributable to reduced phosphorylation of the PI3K membrane adaptor CD19, as well as increased expression of the inositol phosphatase II Sustained production of PI(3,4,5)P3 in B cells, achieved through conditional deletion of Pten, resulted in failed tolerance induction and abundant autoantibody production. In contrast to wild-type immature B cells, B cell receptor engagement of PTEN-deficient immature B cells resulted in activation and proliferation, indicating a central defect in early B cell responsiveness. These findings establish repression of the PI3K signaling pathway as a necessary condition to avert the generation, activation, and persistence of self-reactive B cells.	[Browne, Cecille D.; Del Nagro, Christopher J.; Cato, Matthew H.; Dengler, Hart S.; Rickert, Robert C.] Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Browne, Cecille D.; Del Nagro, Christopher J.; Cato, Matthew H.; Dengler, Hart S.; Rickert, Robert C.] Burnham Inst Med Res, Program Signal Transduct, Ctr Canc, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Rickert, RC (corresponding author), Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	robert@burnham.org			National Institutes of Health [A1041649]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Rickert lab for discussions and critical reading of the manuscript, J. Cambier for helpful discussions, E. Schuman for administrative assistance, J. Browne for assistance with the figures, and the BIMR animal facility for animal husbandry. This work was supported by National Institutes of Health grant A1041649.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Buhl AM, 2000, IMMUNOL REV, V176, P141; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Carter RH, 1997, J IMMUNOL, V158, P3062; CHANG TL, 1991, J IMMUNOL, V147, P750; Cook MC, 1997, J EXP MED, V186, P631, DOI 10.1084/jem.186.5.631; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Diamant E, 2005, BLOOD, V105, P3247, DOI 10.1182/blood-2004-08-3165; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hasegawa M, 2001, J IMMUNOL, V167, P3190, DOI 10.4049/jimmunol.167.6.3190; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lyubchenko T, 2007, J IMMUNOL, V179, P2695, DOI 10.4049/jimmunol.179.5.2695; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rui LX, 2006, J IMMUNOL, V177, P5337, DOI 10.4049/jimmunol.177.8.5337; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Schmidt KN, 1999, J IMMUNOL, V162, P284; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; YELLEN AJ, 1991, J IMMUNOL, V146, P1446	51	83	85	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					749	760		10.1016/j.immuni.2009.08.026	http://dx.doi.org/10.1016/j.immuni.2009.08.026			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19896393	Green Accepted, Bronze			2022-12-18	WOS:000272097900010
J	Mallevaey, T; Scott-Browne, JP; Matsuda, JL; Young, MH; Pellicci, DG; Patel, O; Thakur, M; Kjer-Nielsen, L; Richardson, SK; Cerundolo, V; Howell, AR; McCluskey, J; Godfrey, DI; Rossjohn, J; Marrack, P; Gapin, L				Mallevaey, Thierry; Scott-Browne, James P.; Matsuda, Jennifer L.; Young, Mary H.; Pellicci, Daniel G.; Patel, Onisha; Thakur, Meena; Kjer-Nielsen, Lars; Richardson, Stewart K.; Cerundolo, Vincenzo; Howell, Amy R.; McCluskey, James; Godfrey, Dale I.; Rossjohn, Jamie; Marrack, Philippa; Gapin, Laurent			T Cell Receptor CDR2 beta and CDR3 beta Loops Collaborate Functionally to Shape the iNKT Cell Repertoire	IMMUNITY			English	Article							INVARIANT NKT CELLS; V-BETA DOMAIN; ALPHA-CHAIN; ANTIGEN PRESENTATION; GLYCOLIPID ANTIGENS; CD1D TETRAMERS; CUTTING EDGE; MOUSE THYMUS; AMINO-ACIDS; RECOGNITION	Mouse type I natural killer T cell receptors (iNKT TCRs) use a single V alpha 14-J alpha 18 sequence and V beta s that are almost always V beta 8.2, V beta 7, or V beta 2, although the basis of this differential usage is unclear. We showed that the V beta bias occurred as a consequence of the CDR2 beta loops determining the affinity of the iNKT TCR for CD1d-glycolipids, thus controlling positive selection. Within a conserved iNKT-TCR-CD1d docking framework, these inherent V beta-CD1d affinities are further modulated by the hypervariable CDR3 beta loop, thereby defining a functional interplay between the two iNKT TCR CDR beta loops. These V beta biases revealed a broadly hierarchical response in which V beta 8.2>V beta 7>V beta 2 in the recognition of diverse CD1d ligands. This restriction of the iNKT TCR repertoire during thymic selection paradoxically ensures that each peripheral iNKT cell recognizes a similar spectrum of antigens.	[Mallevaey, Thierry; Scott-Browne, James P.; Matsuda, Jennifer L.; Young, Mary H.; Marrack, Philippa; Gapin, Laurent] Univ Colorado, Dept Immunol, Denver, CO 80206 USA; [Mallevaey, Thierry; Scott-Browne, James P.; Matsuda, Jennifer L.; Young, Mary H.; Marrack, Philippa; Gapin, Laurent] Natl Jewish Hlth, Denver, CO 80206 USA; [Marrack, Philippa] Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80220 USA; [Marrack, Philippa] Univ Colorado, Sch Med, Dept Med, Denver, CO 80220 USA; [Marrack, Philippa] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80220 USA; [Cerundolo, Vincenzo] John Radcliffe Hosp, Weatherall Inst Mol Med, Tumour Immunol Grp, Oxford OX3 9DS, England; [Thakur, Meena; Richardson, Stewart K.; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Pellicci, Daniel G.; Kjer-Nielsen, Lars; McCluskey, James; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Patel, Onisha; Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia	University of Colorado System; University of Colorado Denver; National Jewish Health; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oxford; University of Connecticut; University of Melbourne; Monash University	Gapin, L (corresponding author), Univ Colorado, Dept Immunol, Denver, CO 80206 USA.	gapinl@njhealth.org	Rossjohn, Jamie/F-9032-2013; Marrack, Philippa/AHE-6316-2022; Mallevaey, Thierry/AAH-4499-2020; McCluskey, James/A-1291-2007; Pellicci, Daniel/AAX-8539-2020	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Marrack, Philippa/0000-0003-1883-3687; Cerundolo, Vincenzo/0000-0003-0040-3793; Howell, Amy/0000-0003-1958-6411; Pellicci, Daniel/0000-0001-5305-2398; Godfrey, Dale/0000-0002-3009-5472; Patel, Onisha/0000-0001-6701-7139	National Institute of Health [AI057485, A1076463, A1078246, 8785, A1057519, T32 A107405]; Howard Hughes Medical Institute; Australian Research Council Federation Fellowship; National Health and Medical Research Council (NHMRC) Research Fellowship; MRC [MC_U137884181] Funding Source: UKRI; Cancer Research UK [11331] Funding Source: researchfish; Medical Research Council [MC_U137884181] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057485, R37AI018785, R21AI076463, P01AI022295, R56AI018785, R01AI018785, R01AI057519, R56AI078246, T32AI007405] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Research Council Federation Fellowship(Australian Research Council); National Health and Medical Research Council (NHMRC) Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Cambier and R. Torres for thoughtful discussion and critical comments on the manuscript. We also thank NJH and UCD flow cytometry facilities for assistance with cell sorting and the NIH core facility for CD1d tetramers and the GSL-1' compound. Supported by National Institute of Health (AI057485, A1076463, and A1078246 to L.G., All 8785 to P.M. and A1057519 to A.H.); NIH training grant T32 A107405 to J.P.S.-B.; the Howard Hughes Medical Institute (P.M.); the Australian Research Council Federation Fellowship (to J.R.); the National Health and Medical Research Council (NHMRC) Research Fellowship to D.I.G., NHMRC Program grants to D.I.G. and J.M.; and the Cancer Council of Victoria grant (to J.M. and J.R.). T.M., J.P.S.-B., J.L.M., M.H.Y., and L.G. designed, did the experimental work, analyzed the experiments, and prepared the manuscript. V.C., S.K.R., M.T., and A.R.H. provided reagents. D.G.P., O.P., L.K.-N., J.M., D.G., and J.R. provided intellectual insight and crystallographic data. T.M., J.P.S.-B., P.M., and L.G. devised the project. T.M., J.P.S.-B., D.I.G., J.R., P.M., and L.G. wrote the manuscript.	Behar SM, 1999, J IMMUNOL, V162, P161; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Dao T, 2004, EUR J IMMUNOL, V34, P3542, DOI 10.1002/eji.200425546; Degermann S, 1999, J EXP MED, V190, P1357, DOI 10.1084/jem.190.9.1357; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Gui M, 2001, J IMMUNOL, V167, P6239, DOI 10.4049/jimmunol.167.11.6239; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; KOSEKI H, 1990, P NATL ACAD SCI USA, V87, P5248, DOI 10.1073/pnas.87.14.5248; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Li YS, 2008, GLYCOBIOLOGY, V18, P158, DOI 10.1093/glycob/cwm129; Li YS, 2009, J PROTEOME RES, V8, P2740, DOI 10.1021/pr801040h; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Ohteki T, 1996, J EXP MED, V183, P1277, DOI 10.1084/jem.183.3.1277; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Silk JD, 2008, J IMMUNOL, V180, P6452, DOI 10.4049/jimmunol.180.10.6452; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Stanic AK, 2003, J IMMUNOL, V171, P4539, DOI 10.4049/jimmunol.171.9.4539; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	49	83	88	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					60	71		10.1016/j.immuni.2009.05.010	http://dx.doi.org/10.1016/j.immuni.2009.05.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19592274	Green Accepted, Bronze			2022-12-18	WOS:000268219900012
J	Voigt, S; Mesci, A; Ettinger, J; Fine, JH; Chen, P; Chou, W; Carlyle, JR				Voigt, Sebastian; Mesci, Aruz; Ettinger, Jakob; Fine, Jason H.; Chen, Peter; Chou, Wayne; Carlyle, James R.			Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1 B : Clr-b missing-self axis	IMMUNITY			English	Article							NATURAL-KILLER-CELL; C-TYPE LECTIN; NK CELLS; RAT CYTOMEGALOVIRUS; CUTTING EDGE; RECEPTOR; RECOGNITION; GENE; LIGANDS; CLONING	Cytomegaloviruses are known to encode several gene products that function to subvert MHC-dependent immune recognition. Here we characterize a rat cytomegalovirus (RCMV) C-type lectin-like (RCTL) gene product with homology to the Clr ligands for the NKR-P1 receptors. RCMV infection rapidly extinguished host Clr-b expression, thereby sensitizing infected cells to killing by natural killer (NK) cells. However, the RCTL protein functioned as a decoy ligand to protect infected cells from NK killing via direct interaction with the NKR-P1 B inhibitory receptor. In vivo, an RCTL mutant virus displayed diminished virulence in an NK-dependent and strain-specific manner, suggesting that host NKR-P1 polymorphisms have evolved to avert the viral decoy mechanism while maintaining Clr-b recognition to preserve self tolerance. These findings reveal a unique strategy adopted by cytomegaloviruses to evade MHC-independent self-nonself discrimination. The existence of lectin-like genes in several poxviruses suggests that this may represent a common theme for viral evasion of innate immunity.	Robert Koch Inst, Div Viral Infect, D-13353 Berlin, Germany; Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada	Robert Koch Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Voigt, S (corresponding author), Robert Koch Inst, Div Viral Infect, Nordufer 20, D-13353 Berlin, Germany.	voigts@rki.de; james.carlyle@utoronto.ca	Carlyle, James R/A-1224-2008; Voigt, Sebastian/W-8594-2019	Voigt, Sebastian/0000-0003-1544-9903; Carlyle, James/0000-0002-3579-0300				Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; Brocchieri L, 2005, J VIROL, V79, P7570, DOI 10.1128/JVI.79.12.7570-7596.2005; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Carlton JT., 1999, BIOL INVASIONS, V1, P1, DOI 10.1023/A:1010026510194; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; GLIMCHER L, 1977, J EXP MED, V145, P1, DOI 10.1084/jem.145.1.1; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4; Hassink GC, 2005, VIRAL IMMUNOL, V18, P607, DOI 10.1089/vim.2005.18.607; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KELLER R, 1983, EXP CELL BIOL, V51, P158; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Kung SKP, 1999, J IMMUNOL, V162, P5876; Kveberg L, 2006, J IMMUNOL, V176, P4133, DOI 10.4049/jimmunol.176.7.4133; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lenac T, 2006, J EXP MED, V203, P1843, DOI 10.1084/jem.20060514; Li J, 2003, INT IMMUNOL, V15, P411, DOI 10.1093/intimm/dxg046; Liu JX, 2000, J IMMUNOL, V164, P1793, DOI 10.4049/jimmunol.164.4.1793; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mesci A, 2007, J IMMUNOL METHODS, V323, P78, DOI 10.1016/j.jim.2007.02.007; Mesci A, 2006, IMMUNOL RES, V35, P13, DOI 10.1385/IR:35:1:13; Plougastel B, 2001, IMMUNOGENETICS, V53, P592, DOI 10.1007/s002510100367; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Voigt S, 2001, J VIROL, V75, P603, DOI 10.1128/JVI.75.2.603-611.2001; Wills MR, 2005, J IMMUNOL, V175, P7457, DOI 10.4049/jimmunol.175.11.7457; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200	43	83	98	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					617	627		10.1016/j.immuni.2007.03.013	http://dx.doi.org/10.1016/j.immuni.2007.03.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17462921	Bronze			2022-12-18	WOS:000246895900014
J	Janssen, E; Tabeta, K; Barnes, MJ; Rutschmann, S; McBride, S; Bahjat, KS; Schoenberger, SP; Theofilopoulos, AN; Beutler, B; Hoebe, K				Janssen, Edith; Tabeta, Koichi; Barnes, Michael J.; Rutschmann, Sophie; McBride, Sara; Bahjat, Keith S.; Schoenberger, Stephen P.; Theofilopoulos, Argyrios N.; Beutler, Bruce; Hoebe, Kasper			Efficient T cell activation via a Toll-interleukin 1 Receptor-independent pathway	IMMUNITY			English	Article							MHC CLASS-I; CD8-ALPHA(+) DENDRITIC CELLS; APOPTOTIC CELLS; B-CELLS; RIG-I; ANTIGEN; INDUCTION; CD8(+); INTERFERONS; COMPLEXES	Here, we describe a previously unrecognized pathway for activation of antigen-specific adaptive immune responses that was independent of Toll-Interleukin 1 Receptor signaling and directed toward detection of antigens expressed by apoptotic cells. This pathway is represented within Flt-3 Ligand-derived dendritic cells (DCs) that represent immature lymphoid DCs, but not within GM-CSF-treated bone marrow-derived dendritic cells. Exposure of these DCs to apoptotic cells resulted in production of type I interferon and favored the development of cytotoxic T cell responses. The N-Ethyl-N-Nitrosourea-induced germline mutation 3d (Unc3b1(3d/3d)) abolished both MHC class I and 11 responses elicited by this pathway, whereas a null allele of Cd36 selectively abolished class 11 responses. We propose that this mode of adaptive immune activation evolved to permit the sensitive detection of intracellular microbial infections, particularly viral infections, which frequently induce apoptotic cell death, but may also be important in transplantation, autoimmunity, and vaccine development.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Dept Dev Immunol, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, San Diego, CA 92121 USA; Cerus Corp, Concord, CA 94520 USA	Scripps Research Institute; La Jolla Institute for Immunology; La Jolla Institute for Immunology; Cerus Corporation	Hoebe, K (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	khoebe@scripps.edu	TABTA, KOICHI/AAG-6481-2020	TABTA, KOICHI/0000-0002-7019-1872; Rutschmann, Sophie/0000-0003-3932-1162; Barnes, Michael/0000-0003-0846-3352; Hoebe, Kasper/0000-0002-3626-8098	NIAID NIH HHS [AI 054523] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dennert G, 2002, CRIT REV IMMUNOL, V22, P1; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; FINBERG R, 1979, J IMMUNOL, V123, P1205; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; GORLA R, 1994, AIDS RES HUM RETROV, V10, P1097, DOI 10.1089/aid.1994.10.1097; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin DA, 2005, J EXP MED, V202, P1465, DOI 10.1084/jem.20052228; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Ronchetti A, 1999, J IMMUNOL, V163, P130; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith L, 2003, ATHLET THER TODAY, V8, P1; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	56	83	84	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					787	799		10.1016/j.immuni.2006.03.024	http://dx.doi.org/10.1016/j.immuni.2006.03.024			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782034	Bronze			2022-12-18	WOS:000238592200016
J	Tourigny, MR; Ursini-Siegel, J; Lee, H; Toellner, KM; Cunningham, AF; Franklin, DS; Ely, S; Chen, MH; Qin, XF; Xiong, Y; MacLennan, ICM; Chen-Kiang, S				Tourigny, MR; Ursini-Siegel, J; Lee, H; Toellner, KM; Cunningham, AF; Franklin, DS; Ely, S; Chen, MH; Qin, XF; Xiong, Y; MacLennan, ICM; Chen-Kiang, S			CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; B-LYMPHOCYTES; CYCLIN-D; BLIMP-I; DIFFERENTIATION; INDUCTION; PROTEINS; PROLIFERATION; (4-HYDROXY-3-NITROPHENYL)ACETYL; MATURATION	B cell terminal differentiation is associated with the onset of high-level antibody secretion and cell cycle arrest. Here the cyclin-dependent kinase (CDK) inhibitor p18(INK4c) is shown to be required within B cells for both terminating cell proliferation and differentiation of functional plasma cells. In its absence, B cells hyperproliferate in germinal centers and extrafollicular foci in response to T-dependent antigens but serum antibody titers are severely reduced, despite unimpaired germinal center formation, class switch recombination, variable region-directed hypermutation, and differentiation to antibody-containing plasmacytoid cells. The novel link between cell cycle control and plasma cell differentiation may, at least in part, relate to p18(INK4c) inhibition of CDK6. Cell cycle arrest mediated by p18(INK4c) is therefore requisite for the generation of functional plasma cells.	Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Univ Birmingham, Sch Med, Birmingham, W Midlands, England; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Cornell University; Cornell University; University of Birmingham; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rockefeller University; University of North Carolina; University of North Carolina Chapel Hill	Chen-Kiang, S (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol, 1300 York Ave, New York, NY 10021 USA.	sckiang@mail.med.cornell.edu	Toellner, Kai-Michael/F-1519-2011	Toellner, Kai-Michael/0000-0001-8404-645X; Cunningham, Adam/0000-0003-0248-964X; QIN, FRANK XIAOFENG/0000-0002-5395-0304	NATIONAL CANCER INSTITUTE [R01CA080204] Funding Source: NIH RePORTER; NCI NIH HHS [CA80204] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Guan KL, 1996, MOL BIOL CELL, V7, P57, DOI 10.1091/mbc.7.1.57; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kabat EA, 1991, SEQUENCES PROTEINS I; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; LEE AS, 1981, P NATL ACAD SCI-BIOL, V78, P4922, DOI 10.1073/pnas.78.8.4922; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Starborg M, 1996, J CELL SCI, V109, P143; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tanguay DA, 1996, J IMMUNOL, V156, P539; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	42	83	84	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2002	17	2					179	189		10.1016/S1074-7613(02)00364-3	http://dx.doi.org/10.1016/S1074-7613(02)00364-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196289	Bronze, Green Published			2022-12-18	WOS:000177669400006
J	Li, PW; McDermott, G; Strong, RK				Li, PW; McDermott, G; Strong, RK			Crystal structures of RAE-1 beta and its complex with the activating immunoreceptor NKG2D	IMMUNITY			English	Article							CELL-SURFACE PROTEINS; INDUCIBLE CDNA-CLONES; F9 CELLS; NK CELLS; T-CELLS; RECEPTOR; LIGANDS; FAMILY; RAE1; RECOGNITION	Induced by retinoic acid and implicated in playing a role in development, rodent RAE-1 proteins are ligands for the activating immunoreceptor NKG2D, widely expressed on natural killer cells, T cells, and macrophages. RAE-1 proteins (alpha, beta, gamma, and delta) are distant major histocompatibility complex (MHC) class I homologs, comprising isolated alpha1alpha2 platform domains. The crystal structure of RAE-1beta was distorted from other MHC homologs and displayed noncanonical disulfide bonds. The loss of any remnant of a peptide binding groove was facilitated by the close approach of the groove-defining helices through a hydrophobic, leucine-rich interface. The RAE-1beta-murine NKG2D complex structure resembled the human NKG2D-MICA receptor-ligand complex and further demonstrated the promiscuity of the NKG2D ligand binding site.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Fred Hutchinson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Strong, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	rstrong@fhcrc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048675] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48675] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bahram S, 1996, IMMUNOGENETICS, V43, P230, DOI 10.1007/BF00587305; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakker ABH, 2000, HUM IMMUNOL, V61, P18, DOI 10.1016/S0198-8859(99)00160-3; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	47	83	92	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2002	16	1					77	86		10.1016/S1074-7613(02)00258-3	http://dx.doi.org/10.1016/S1074-7613(02)00258-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825567	Bronze			2022-12-18	WOS:000173575700008
J	Benedict, CA; Banks, TA; Senderowicz, L; Ko, M; Britt, WJ; Angulo, A; Ghazal, P; Ware, CF				Benedict, CA; Banks, TA; Senderowicz, L; Ko, M; Britt, WJ; Angulo, A; Ghazal, P; Ware, CF			Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente	IMMUNITY			English	Article							NECROSIS-FACTOR RECEPTOR; NF-KAPPA-B; ALPHA-DEFICIENT MICE; CELL-DEATH; MEMBRANE LYMPHOTOXIN; TUMOR; INFECTION; ACTIVATION; EXPRESSION; APOPTOSIS	Tumor necrosis factor (TNF)-related cytokines regulate cell death and survival and provide strong selective pressures for viruses, such as cytomegalovirus (CMV), to evolve counterstrategies in order to persist in immune-competent hosts. Signaling by the lymphotoxin (LT)-beta receptor or TNF receptor-1, but not Fas or TRAIL receptors, inhibits the cytopathicity and replication of human CMV by a nonapoptotic, reversible process that requires nuclear factor kappaB (NF-kappaB)dependent induction of interferon-beta (IFN-beta). Efficient induction of IFN-beta requires virus infection and LT signaling, demonstrating the need for both host and viral factors in the curtailment of viral replication without cellular elimination. LT alpha -deficient mice and LT betaR-Fc transgenic mice were profoundly susceptible to murine CMV infection. Together, these results reveal an essential and conserved role for LTs in establishing host defense to CMV.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; Allimmune Inc, San Diego, CA 92121 USA; Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35294 USA; Scripps Res Inst, Dept Immunol, Div Virol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, Div Virol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; University of Alabama System; University of Alabama Birmingham; Scripps Research Institute; Scripps Research Institute	Ware, CF (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.	carl_ware@liai.org		Angulo, Ana/0000-0002-5792-1164	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035602, R21AI044851, R29AI030627, R37AI033068, R43AI047644, R01AI048073, R01AI033068, R01AI030627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000252] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NIAID NIH HHS [AI30627, AI35602, AI48073, AI33068, AI47644, AI44851] Funding Source: Medline; NIA NIH HHS [T32AG00252] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BANKS TA, 1995, J IMMUNOL, V155, P1685; Benedict CA, 1999, J IMMUNOL, V162, P6967; Berger DP, 1999, VIROLOGY, V260, P136, DOI 10.1006/viro.1999.9811; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Browning JL, 1996, J BIOL CHEM, V271, P8618, DOI 10.1074/jbc.271.15.8618; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; Elewaut D, 2000, J IMMUNOL, V165, P671, DOI 10.4049/jimmunol.165.2.671; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Farrell PJ, 1998, TRENDS MICROBIOL, V6, P175, DOI 10.1016/S0966-842X(98)01262-1; Fleck M, 1998, J CLIN INVEST, V102, P1431, DOI 10.1172/JCI3248; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Force WR, 2000, J BIOL CHEM, V275, P11121, DOI 10.1074/jbc.275.15.11121; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Iizuka K, 1999, P NATL ACAD SCI USA, V96, P6336, DOI 10.1073/pnas.96.11.6336; Kerry JA, 1997, J VIROL, V71, P981, DOI 10.1128/JVI.71.2.981-987.1997; KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879; Kumaraguru U, 2001, J IMMUNOL, V166, P1066, DOI 10.4049/jimmunol.166.2.1066; Lee BJ, 2000, J VIROL, V74, P2786, DOI 10.1128/JVI.74.6.2786-2792.2000; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Miller DM, 1999, J IMMUNOL, V162, P6107; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Orange JS, 1996, J IMMUNOL, V156, P4746; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; REIS LFL, 1989, J BIOL CHEM, V264, P16351; Rooney I, 2000, METHOD ENZYMOL, V322, P345; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; SAMBUCETTI LC, 1989, EMBO J, V8, P4251, DOI 10.1002/j.1460-2075.1989.tb08610.x; Sanchez V, 1998, J VIROL, V72, P3321, DOI 10.1128/JVI.72.4.3321-3329.1998; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; SMITH AL, 1993, J WILDLIFE DIS, V29, P219, DOI 10.7589/0090-3558-29.2.219; Soderberg-Naucler C, 1997, J CLIN INVEST, V100, P3154, DOI 10.1172/JCI119871; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Sweet C, 1999, FEMS MICROBIOL REV, V23, P457, DOI 10.1111/j.1574-6976.1999.tb00408.x; Tamada K, 2000, NAT MED, V6, P283; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WilliamsAbbott L, 1997, J BIOL CHEM, V272, P19451, DOI 10.1074/jbc.272.31.19451; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997	49	83	85	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					617	626		10.1016/S1074-7613(01)00222-9	http://dx.doi.org/10.1016/S1074-7613(01)00222-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672543	Bronze, Green Published			2022-12-18	WOS:000171757800012
J	Zhang, YH; Boesen, CC; Radaev, S; Brooks, AG; Fridman, WH; Sautes-Fridman, C; Sun, PD				Zhang, YH; Boesen, CC; Radaev, S; Brooks, AG; Fridman, WH; Sautes-Fridman, C; Sun, PD			Crystal structure of the exctracellular domain of a human Fc gamma RIII	IMMUNITY			English	Article							LOW-AFFINITY RECEPTOR; INHIBITORY RECEPTOR; EPSILON-RI; PROTEIN STRUCTURES; BINDING-SITE; CLASS-I; IGE; IDENTIFICATION; ACTIVATION; COMPLEX	Fc receptors play a major role in immune defenses against pathogens and in inflammatory processes. The crystal structure of a human immunoglobulin receptor, Fc gamma RIIIb, has been determined to 1.8 Angstrom resolution. The overall fold consists of two immunoglobulinlike domains with an acute interdomain hinge angle of approximately 50 degrees. Trp-113, wedged between the N-terminal D1 and the C-terminal D2 domains, appears to further restrict the hinge angle. The putative Pc binding region of the receptor carries a net positive charge complementary to the negative-charged receptor binding regions on Fc. A1:1 binding stoichiometry between the receptor and Fc was measured by both the equilibrium and nonequilibrium size-exclusion chromatography. Two separate parallel dimers are observed in the crystal lattice, offering intriguing models for receptor aggregation.	NIAID, Struct Biol Sect, NIH, Rockville, MD 20852 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; Inst Curie, Lab Cellular & Clin Immunol, INSERM, U255, F-75005 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Medical Branch Galveston; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Sun, PD (corresponding author), NIAID, Struct Biol Sect, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov		Brooks, Andrew/0000-0002-4085-9683; sautes-fridman, catherine/0000-0003-1735-8722; fridman, wolf herman/0000-0002-1332-0973	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000853, ZIAAI000853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Galon J, 1996, J IMMUNOL, V157, P1184; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; Hulett MD, 1999, J BIOL CHEM, V274, P13345, DOI 10.1074/jbc.274.19.13345; HULETT MD, 1994, J BIOL CHEM, V269, P15287; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; KIMBERLY RP, 1990, J EXP MED, V171, P1239, DOI 10.1084/jem.171.4.1239; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1994, ACTA CRYSTALLOGR D, V50, P760; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Sun PD, 2000, ACTA CRYSTALLOGR D, V56, P161, DOI 10.1107/S0907444999015188; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3	33	83	86	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2000	13	3					387	395		10.1016/S1074-7613(00)00038-8	http://dx.doi.org/10.1016/S1074-7613(00)00038-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021536	Bronze			2022-12-18	WOS:000089616400011
J	Fremont, DH; Crawford, F; Marrack, P; Hendrickson, WA; Kappler, J				Fremont, DH; Crawford, F; Marrack, P; Hendrickson, WA; Kappler, J			Crystal structure of mouse H2-M	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II MOLECULES; BOUND SINGLE PEPTIDES; HLA-DR MOLECULES; ANTIGEN PRESENTATION; INVARIANT CHAIN; GENOMIC ORGANIZATION; IN-VIVO; DM; CELLS	H2-M (HLA-DM in humans) resides in an acidic endosomal compartment, where it facilitates the loading of antigenic peptides into the peptide-binding groove of class II MHC. The crystal structure of a soluble form of H2-M has been solved to 3.1 Angstrom resolution, revealing a heterodimer with structural similarities to the MHC family of proteins. In contrast to its antigen-presenting cousins, the membrane distal alpha helices of H2-M pack closely together, occluding most of the binding groove except for a single large pocket near the center. The structure of H2-M has several unique features that may play a role in its function as a molecular chaperone and peptide exchange factor.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Dept Pathol,Ctr Immunol, St Louis, MO 63110 USA; Natl Jewish Med & Res Ctr, Zuckerman Family Canyon Ranch Crystallog Lab, Dept Med, Div Basic Immunol,Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biophys Biochem & Genet, Denver, CO 80262 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Biomol Struct, Denver, CO 80262 USA	Washington University (WUSTL); Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Columbia University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Dept Pathol,Ctr Immunol, St Louis, MO 63110 USA.	fremont@immunology.wustl.edu	Marrack, Philippa/AHE-6316-2022	Fremont, Daved/0000-0002-8544-2689; Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI-17134, AI-18785, AI-22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018785, R37AI017134, P01AI022295, R37AI018785, R01AI017134] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Albert LJ, 1996, J IMMUNOL, V157, P2247; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertolino P, 1996, CRIT REV IMMUNOL, V16, P359; BROOKS AG, 1994, J IMMUNOL, V153, P5382; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Busch R, 1996, CURR OPIN IMMUNOL, V8, P51, DOI 10.1016/S0952-7915(96)80105-1; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Copier J, 1996, J IMMUNOL, V157, P1017; Cuthbert JA, 1997, J INVEST MED, V45, P518; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Green J M, 1996, Int Rev Immunol, V13, P209, DOI 10.3109/08830189609061748; Guerra CB, 1998, J IMMUNOL, V160, P4289; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KELLY A, 1994, INT ARCH ALLERGY IMM, V103, P11, DOI 10.1159/000236599; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; LINDSTEDT R, 1995, IMMUNITY, V3, P561, DOI 10.1016/1074-7613(95)90127-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK SJ, 1995, P NATL ACAD SCI USA, V92, P11289, DOI 10.1073/pnas.92.24.11289; Peleraux A, 1996, IMMUNOGENETICS, V43, P204, DOI 10.1007/BF00587301; RADLEY E, 1994, J BIOL CHEM, V269, P18834; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SMITH GP, 1994, INT IMMUNOL, V6, P1917, DOI 10.1093/intimm/6.12.1917; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; UNANUE ER, 1992, CURR OPIN IMMUNOL, V4, P63, DOI 10.1016/0952-7915(92)90127-Z; Weenink SM, 1997, IMMUNOL CELL BIOL, V75, P69, DOI 10.1038/icb.1997.11; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	52	83	84	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					385	393		10.1016/S1074-7613(00)80621-4	http://dx.doi.org/10.1016/S1074-7613(00)80621-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768758	Bronze			2022-12-18	WOS:000076202300011
J	ERNST, P; SMALE, ST				ERNST, P; SMALE, ST			COMBINATORIAL REGULATION OF TRANSCRIPTION .1. GENERAL-ASPECTS OF TRANSCRIPTIONAL CONTROL	IMMUNITY			English	Review							DNA-BINDING PROTEIN; T-CELL DEVELOPMENT; ACTIVATION DOMAIN; CRYSTAL-STRUCTURE; FACTOR-TFIIB; POU-DOMAIN; REPRESSION; ENHANCER; RECOGNITION; YEAST				ERNST, P (corresponding author), CALIF STATE UNIV LOS ANGELES,HOWARD HUGHES MED INST,INST MOLEC BIOL,SCH MED,LOS ANGELES,CA 90095, USA.			Ernst, Patricia/0000-0001-7638-2939	NCI NIH HHS [CA09120] Funding Source: Medline; NIDDK NIH HHS [DK43726] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043726, R01DK043726] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; CARCAMO J, 1991, P NATL ACAD SCI USA, V88, P8052, DOI 10.1073/pnas.88.18.8052; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CLEVERS HC, 1993, IMMUNOL TODAY, V14, P591, DOI 10.1016/0167-5699(93)90198-T; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; COOPER JP, 1994, GENE DEV, V8, P1400, DOI 10.1101/gad.8.12.1400; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Drapkin R, 1993, CURR OPIN CELL BIOL, V5, P469, DOI 10.1016/0955-0674(93)90013-G; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEORGIEV GP, 1969, J THEOR BIOL, V25, P473, DOI 10.1016/S0022-5193(69)80034-2; GHOSH S, 1995, IN PRESS IMMUNOGLOBU; GIERER A, 1973, COLD SPRING HARB SYM, V38, P951, DOI 10.1101/SQB.1974.038.01.097; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; GRILLI M, 1993, INT REV CYTOL, V143, P1; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; HAGMAN J, 1994, CURR OPIN IMMUNOL, V6, P220; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cellbio.9.1.479; HORI R, 1994, CURR OPIN GENET DEV, V4, P236, DOI 10.1016/S0959-437X(05)80050-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; ISRAEL A, 1994, NATURE, V369, P443, DOI 10.1038/369443a0; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kerppola TK, 1991, CURR OPIN STRUC BIOL, V1, P71, DOI 10.1016/0959-440X(91)90014-K; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KOLLMAR R, 1993, P SOC EXP BIOL MED, V203, P127; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LEIDEN JM, 1994, CURR OPIN IMMUNOL, V6, P231, DOI 10.1016/0952-7915(94)90096-5; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LEWIN B, 1994, CELL, V79, P397, DOI 10.1016/0092-8674(94)90249-6; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; MCKNIGHT RA, 1992, P NATL ACAD SCI USA, V89, P6943, DOI 10.1073/pnas.89.15.6943; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; NELSEN B, 1992, INT REV CYTOL, V133, P121, DOI 10.1016/S0074-7696(08)61859-8; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; Paro R, 1993, CURR OPIN CELL BIOL, V5, P999, DOI 10.1016/0955-0674(93)90084-4; PHIVAN L, 1990, PROG MOL SUBCELL BIO, V11, P1; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; RICHARDFOY H, 1994, NATURE, V370, P417, DOI 10.1038/370417a0; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; ROY AL, 1993, NATURE, V365, P355, DOI 10.1038/365355a0; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHEUERMANN RH, 1989, GENE DEV, V3, P1255, DOI 10.1101/gad.3.8.1255; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SMALE S.T., 1994, TRANSCRIPTION MECHAN, P63; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; THOMPSON JS, 1993, COLD SPRING HARB SYM, V58, P247, DOI 10.1101/SQB.1993.058.01.029; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; van Holde KE., 1989, SPRINGER SERIES MOL; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1991, CURR OPIN IMMUNOL, V3, P199, DOI 10.1016/0952-7915(91)90050-B; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	97	83	83	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					311	319		10.1016/1074-7613(95)90139-6	http://dx.doi.org/10.1016/1074-7613(95)90139-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719936	Bronze			2022-12-18	WOS:A1995QU61600001
J	DAY, PM; ESQUIVEL, F; LUKSZO, J; BENNINK, JR; YEWDELL, JW				DAY, PM; ESQUIVEL, F; LUKSZO, J; BENNINK, JR; YEWDELL, JW			EFFECT OF TAP ON THE GENERATION AND INTRACELLULAR TRAFFICKING OF PEPTIDE-RECEPTIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES	IMMUNITY			English	Article							RMA-S CELLS; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; HEAVY-CHAINS; VIRAL PEPTIDES; T-CELLS; MHC; BETA-2-MICROGLOBULIN; BINDING; ANTIGENS	Using a fluorescein-conjugated antigenic peptide, peptide-receptive H-2K(b) MHC class I molecules were found throughout the secretory pathways of RMA cells and peptide transporter (TAP)-deficient derivative cells (RMA/S). RMA/S cells displayed higher levels of intracellular peptide-receptive molecules, while, surprisingly, RMA cells expressed 3- to 5-fold more cell surface peptide-receptive molecules. Metabolic radiolabeling of K-b-associated oligosaccharides with [1-H-3]galactose demonstrated that despite a large difference in the fraction of K-b molecules in native conformation in detergent extracts, K-b transport rates from the trans-Golgi complex to the surfaces of RMA and RMA/S cells were similar. Thus, although considerable numbers of class I alpha chains reach the RM AIS cell surface, they are a less productive source of peptide-receptive molecules than class I molecules synthesized by TAP-expressing RMA cells, suggesting paradoxically that TAP functions to increase the amount of peptide-receptive molecules at the cell surface.	NIAID,BIOL RESOURCES BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	DAY, PM (corresponding author), NIAID,VIRAL DIS LAB,BETHESDA,MD 20892, USA.		yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Esquivel, Fernando/0000-0002-2962-0428				ALLEN H, 1984, NATURE, V309, P279, DOI 10.1038/309279a0; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; ELLIOTT T, 1991, IMMUNOL TODAY, V12, P386; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GONATAS JO, 1989, J BIOL CHEM, V264, P646; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HASENKRUG KJ, 1987, IMMUNOGENETICS, V25, P136, DOI 10.1007/BF00364282; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; JOYCE S, 1994, P NATL ACAD SCI USA, V91, P4145, DOI 10.1073/pnas.91.10.4145; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPHAM CK, 1993, J EXP MED, V177, P1633, DOI 10.1084/jem.177.6.1633; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; LIPPINCOTTSCHWARTZ, 1989, CELL, V56, P801; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1989, J IMMUNOL, V142, P2911; LOKEN MR, 1982, J IMMUNOL METHODS, V50, pR85, DOI 10.1016/0022-1759(82)90161-2; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MELIMAN I, 1992, CELL, V68, P829; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MOTAL UMA, 1993, EUR J IMMUNOL, V23, P3224, DOI 10.1002/eji.1830231227; NEEFJES JJ, 1992, EUR J IMMUNOL, V22, P1609, DOI 10.1002/eji.1830220639; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; OTTEN GR, 1992, J IMMUNOL, V148, P3723; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; OZATO K, 1981, J IMMUNOL, V126, P317; ROCK KL, 1992, J IMMUNOL, V148, P1451; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; ROCK KL, 1991, CELL, V65, P611, DOI 10.1016/0092-8674(91)90093-E; ROCK KL, 1991, P NATL ACAD SCI USA, V88, P4200, DOI 10.1073/pnas.88.10.4200; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SMITH MH, 1990, MOL IMMUNOL, V27, P169, DOI 10.1016/0161-5890(90)90112-D; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; Townsend A, 1993, Semin Cell Biol, V4, P53, DOI 10.1006/scel.1993.1007; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; TSE DB, 1984, J EXP MED, V159, P193, DOI 10.1084/jem.159.1.193; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002; YANG Y, 1992, J BIOL CHEM, V267, P11669; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	58	83	83	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1995	2	2					137	147		10.1016/S1074-7613(95)80014-X	http://dx.doi.org/10.1016/S1074-7613(95)80014-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895170	Bronze			2022-12-18	WOS:A1995QH13200002
J	Takeda, A; Hollmen, M; Dermadi, D; Pan, JL; Brulois, KF; Kaukonen, R; Lonnberg, T; Bostrom, P; Koskivuo, I; Irjala, H; Miyasaka, M; Salmi, M; Butcher, EC; Jalkanen, S				Takeda, Akira; Hollmen, Maija; Dermadi, Denis; Pan, Junliang; Brulois, Kevin Francis; Kaukonen, Riina; Lonnberg, Tapio; Bostrom, Pia; Koskivuo, Ilkka; Irjala, Heikki; Miyasaka, Masayuki; Salmi, Marko; Butcher, Eugene C.; Jalkanen, Sirpa			Single-Cell Survey of Human Lymphatics Unveils Marked Endothelial Cell Heterogeneity and Mechanisms of Homing for Neutrophils	IMMUNITY			English	Article							FIBROBLASTIC RETICULAR CELLS; DC-SIGN; GENE-EXPRESSION; LYMPHANGIOGENESIS; NODES; RECEPTOR; CONNEXIN37; MIGRATION; BINDING; INNATE	Lymphatic vessels form a critical component in the regulation of human health and disease. While their functional significance is increasingly being recognized, the comprehensive heterogeneity of lymphatics remains uncharacterized. Here, we report the profiling of 33,000 lymphatic endothelial cells (LECs) in human lymph nodes (LNs) by single-cell RNA sequencing. Unbiased clustering revealed six major types of human LECs. LECs lining the subcapsular sinus (SCS) of LNs abundantly expressed neutrophil chemoattractants, whereas LECs lining the medullary sinus (MS) expressed a C-type lectin CD209. Binding of a carbohydrate Lewis X (CD15) to CD209 mediated neutrophil binding to the MS. The neutrophil-selective homing by MS LECs may retain neutrophils in the LN medulla and allow lymph-borne pathogens to clear, preventing their spread through LNs in humans. Our study provides a comprehensive characterization of LEC heterogeneity and unveils a previously undefined role for medullary LECs in human immunity.	[Takeda, Akira; Hollmen, Maija; Miyasaka, Masayuki; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, MediCity Res Lab, Turku, Finland; [Takeda, Akira; Hollmen, Maija; Miyasaka, Masayuki; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Inst Biomed, Turku, Finland; [Dermadi, Denis; Pan, Junliang; Brulois, Kevin Francis; Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; [Pan, Junliang; Butcher, Eugene C.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Pan, Junliang; Butcher, Eugene C.] Palo Alto Vet Inst Res, Palo Alto, CA USA; [Kaukonen, Riina; Lonnberg, Tapio] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Bostrom, Pia] Turku Univ Hosp, Dept Pathol, Turku, Finland; [Koskivuo, Ilkka] Turku Univ Hosp, Dept Plast & Gen Surg, Turku, Finland; [Irjala, Heikki] Turku Univ Hosp, Dept Otorhinolaryngol, Turku, Finland; [Irjala, Heikki] Univ Turku, Turku, Finland; [Miyasaka, Masayuki] Osaka Univ, Inst Acad Initiatives, Interdisciplinary Program Biomed Sci, Suita, Osaka, Japan	University of Turku; University of Turku; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Osaka University	Jalkanen, S (corresponding author), Univ Turku, MediCity Res Lab, Turku, Finland.; Jalkanen, S (corresponding author), Univ Turku, Inst Biomed, Turku, Finland.	sirjal@utu.fi	Miyasaka, Masayuki/AAM-6343-2020; Koskivuo, Ilkka/ADS-3873-2022; Takeda, Akira/AAH-7892-2019; Hollmén, Maija/B-5831-2017	Takeda, Akira/0000-0003-4748-4543; Hollmén, Maija/0000-0002-3250-7653; Salmi, Marko/0000-0002-1913-7408; Dermadi Bebek, Denis/0000-0001-6268-4178; Irjala, Heikki/0000-0003-3054-4677	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Foundation; Jane and Aatos Erkko Foundation; NIH [AI130471, CA228019]; US Department of Veterans Affairs, Biomedical Laboratory Research and Development Service [BX-0914-001, 1U54CA209971]; NIH individual fellowship; Finnish Functional Genomics Centre and Medical Bioinformatics Centre, University of Turku; Abo Academy University; Biocenter Finland; NATIONAL CANCER INSTITUTE [U54CA209971] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundation; Jane and Aatos Erkko Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); NIH individual fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Functional Genomics Centre and Medical Bioinformatics Centre, University of Turku; Abo Academy University; Biocenter Finland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Academy of Finland (A.T. and S.J.), the Sigrid Juselius Foundation (M.H. and S.J.), the Finnish Cancer Foundation (S.J.), the Jane and Aatos Erkko Foundation (S.J.), the NIH (grants AI130471 and CA228019), the US Department of Veterans Affairs, Biomedical Laboratory Research and Development Service (merit review award BX-0914-001 and a pilot award under 1U54CA209971 to E.C.B.), and an NIH individual fellowship (K.F.B.). We thank Professor van Kooyk for kindly providing us with anti-CD209 antibody (AZN-D1). We also thank S. M_ aki for technical assistance and D. Eichin for preparing human DCs. Microscopic and flow cytometric analyses were performed at the Cell Imaging Core in the Turku Centre for Biotechnology in Finland. scRNA-seq analysis was supported by Finnish Functional Genomics Centre and Medical Bioinformatics Centre, University of Turku, Abo Academy University, and Biocenter Finland. Murine stromal cell RNA-seq data were obtained from data assembled by the ImmGen consortium.	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; BAILEY RP, 1975, AM J ANAT, V142, P15, DOI 10.1002/aja.1001420103; Bazigou E, 2013, CELL MOL LIFE SCI, V70, P1055, DOI 10.1007/s00018-012-1110-6; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Bogoslowski A, 2018, P NATL ACAD SCI USA, V115, P2449, DOI 10.1073/pnas.1715756115; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cohen JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087740; Dermadi D, 2018, BIORXIV, DOI [10.1101/336313, DOI 10.1101/336313]; Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gorlino CV, 2014, J IMMUNOL, V193, P1966, DOI 10.4049/jimmunol.1301791; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hampton HR, 2016, SEMIN IMMUNOL, V28, P129, DOI 10.1016/j.smim.2016.03.008; Hampton HR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8139; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Iftakhar-E-Khuda I, 2016, P NATL ACAD SCI USA, V113, P10643, DOI 10.1073/pnas.1602357113; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Kanady JD, 2011, DEV BIOL, V354, P253, DOI 10.1016/j.ydbio.2011.04.004; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lane RS, 2018, J EXP MED, V215, P3057, DOI 10.1084/jem.20180654; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Maksimow M, 2014, CRIT CARE MED, V42, P2556, DOI 10.1097/CCM.0000000000000550; McInnes L., 2018, ARXIV180203426; Mendoza A, 2017, NATURE, V546, P158, DOI 10.1038/nature22352; Mondal N, 2018, J BIOL CHEM, V293, P7300, DOI 10.1074/jbc.RA117.000775; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Park SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094781; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Riedel A, 2016, NAT IMMUNOL, V17, P1118, DOI 10.1038/ni.3492; Rigby DA, 2015, J LEUKOCYTE BIOL, V98, P897, DOI 10.1189/jlb.1HI0415-149R; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Tewalt EF, 2012, BLOOD, V120, P4772, DOI 10.1182/blood-2012-04-427013; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Zhang Y, 2016, ELIFE, V5, DOI 10.7554/eLife.18156; Zheng W, 2014, GENE DEV, V28, P1592, DOI 10.1101/gad.237677.114	56	82	83	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					561	+		10.1016/j.immuni.2019.06.027	http://dx.doi.org/10.1016/j.immuni.2019.06.027			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31402260	Bronze			2022-12-18	WOS:000486184600017
J	Xu, W; Cherrier, DE; Chea, S; Vosshenrich, C; Serafini, N; Petit, M; Liu, PT; Golub, R; Di Santo, JP				Xu, Wei; Cherrier, Dylan E.; Chea, Sylvestre; Vosshenrich, Christian; Serafini, Nicolas; Petit, Maxime; Liu, Pentao; Golub, Rachel; Di Santo, James P.			An Id2(RFP)-Reporter Mouse Redefines Innate Lymphoid Cell Precursor Potentials	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR BCL11B; TISSUE-INDUCER CELL; T-CELLS; NK; IDENTIFICATION; PROGENITOR; FETAL; DIFFERENTIATION; EXPRESSION	Innate lymphoid cell (ILC) development proposes that ILC precursors (ILCPs) segregate along natural killer (NK) cell versus helper cell (ILC1, ILC2, ILC3) pathways, the latter depending on expression of 1d2, Zbtb16, and Gata3. We have developed an Id2-reporter strain expressing red fluorescent protein (RFP) in the context of normal Id2 expression to re-examine ILCP phenotype and function. We show that bone-marrow ILCPs were heterogeneous and harbored extensive NK-cell potential in vivo and in vitro. By multiplexing Id2(RFP) with Zbtb16(Cre)(GFP) and Bcl11b(tdTomato) strains, we made a single-cell dissection of the ILCP compartment. In contrast with the current model, we have demonstrated that Id2(+)Zbtb16(+) ILCPs included multi-potent ILCPs that retained NK-cell potential. Late-stage ILC2P and ILC3P compartments could be defined by differential Zbtb16 and Bcl11b expression. We suggest a revised model for ILC differentiation that redefines the cell-fate potential of helper-ILC-restricted Zbtb16(+) ILCPs.	[Xu, Wei; Cherrier, Dylan E.; Vosshenrich, Christian; Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Xu, Wei; Cherrier, Dylan E.; Chea, Sylvestre; Vosshenrich, Christian; Serafini, Nicolas; Petit, Maxime; Golub, Rachel; Di Santo, James P.] Inst Pasteur, INSERM, U1223, F-75724 Paris, France; [Xu, Wei] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China; [Cherrier, Dylan E.; Petit, Maxime] Paris Diderot Univ, Sorbonne Paris Cite, F-75013 Paris, France; [Chea, Sylvestre; Petit, Maxime; Golub, Rachel] Inst Pasteur, Lymphopoiesis Unit, F-75724 Paris, France; [Liu, Pentao] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Fudan University; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Hong Kong	Xu, W; Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, F-75724 Paris, France.; Xu, W; Di Santo, JP (corresponding author), Inst Pasteur, INSERM, U1223, F-75724 Paris, France.; Xu, W (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China.	wei_xuxx@fudan.edu.cn; james.di-santo@pasteur.fr	Vosshenrich, Christian AJ/M-6523-2014; GOLUB, rachel/X-8717-2019; Xu, Wei/AAG-2857-2019; Rachel, GOLUB/M-7188-2014; Di Santo, James P/M-4298-2014; SERAFINI, nicolas/S-5675-2019	Vosshenrich, Christian AJ/0000-0002-4407-8649; GOLUB, rachel/0000-0002-2306-5363; Rachel, GOLUB/0000-0002-2306-5363; Di Santo, James P/0000-0002-7146-1862; SERAFINI, nicolas/0000-0002-7440-4353; Cherrier, Dylan E./0000-0002-9324-8763	French Ministry of Higher Education, Research and Innovation; Institut National de la Sante et de la Recherche Medicale (INSERM); Institut Pasteur; Agence National pour le Recherche (ANR); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [695467 - ILC_REACTIVITY]	French Ministry of Higher Education, Research and Innovation; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Agence National pour le Recherche (ANR)(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	We thank Albert Bendelac for providing Zbtb16<SUP>GFPGre</SUP> mice, Andreas Diefenbach for providing Id2<SUP>GFP</SUP> mice, and Ana Cumano for providing OP9 and OP9-DL4 cells. We are grateful to Francina Langa-Vives and Franck Bourgade for their help with the generation of Id2<SUP>RFP</SUP> mice and the CB-UTechS platform for cytometry support. We thank all the members of the Innate Immunity Unit for helpful discussions. D.E.C. is supported by the French Ministry of Higher Education, Research and Innovation. The Innate Immunity Unit is supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Pasteur, the Agence National pour le Recherche (ANR), and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (695467 - ILC_REACTIVITY).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chea S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/368427; Cherrier DE, 2018, IMMUNITY, V48, P1091, DOI 10.1016/j.immuni.2018.05.010; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Colucci F, 1999, J IMMUNOL, V162, P2761; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cording S, 2014, FEBS LETT, V588, P4176, DOI 10.1016/j.febslet.2014.03.034; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yang Q, 2016, CURR OPIN IMMUNOL, V39, P114, DOI 10.1016/j.coi.2016.01.006; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	49	82	85	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1054	+		10.1016/j.immuni.2019.02.022	http://dx.doi.org/10.1016/j.immuni.2019.02.022			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30926235	Green Published, hybrid			2022-12-18	WOS:000464660800022
J	Bauche, D; Joyce-Shaikh, B; Jain, R; Grein, J; Ku, KS; Blumenschein, WM; Ganal-Vonarburg, SC; Wilson, DC; McClanahan, TK; Malefyt, RDW; Macpherson, AJ; Annamalai, L; Yearley, JH; Cua, DJ				Bauche, David; Joyce-Shaikh, Barbara; Jain, Renu; Grein, Jeff; Ku, Karin S.; Blumenschein, Wendy M.; Ganal-Vonarburg, Stephanie C.; Wilson, Douglas C.; McClanahan, Terrill K.; Malefyt, Rene de Waal; Macpherson, Andrew J.; Annamalai, Lakshmanan; Yearley, Jennifer H.; Cua, Daniel J.			LAG3(+) Regulatory T Cells Restrain Interleukin-23 Producing CX3CR1(+) Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis	IMMUNITY			English	Article							GENOME-WIDE ASSOCIATION; CLASS-II ENGAGEMENT; DENDRITIC CELLS; ORAL TOLERANCE; LAG-3; EXPRESSION; INFLAMMATION; HOMEOSTASIS; LIGAND; IL-22	Interleukin-22 (IL-22)-producing group 3 innate lymphoid cells (ILC3) maintains gut homeostasis but can also promote inflammatory bowel disease (IBD). The regulation of ILC3-dependent colitis remains to be elucidated. Here we show that Foxp3(+) regulatory T cells (Treg cells) prevented ILC3-mediated colitis in an IL-10-independent manner. Treg cells inhibited IL-23 and IL-1 beta production from intestinal-resident CX3CR1(+) macrophages but not CD103(+) dendritic cells. Moreover, Treg cells restrained ILC3 production of IL-22 through suppression of CX3CR1(+) macrophage production of IL-23 and IL-1b. This suppression was contact dependent and was mediated by latent activation gene-3 (LAG-3)-an immune checkpoint receptor-expressed on Treg cells. Engagement of LAG-3 on MHC class II drove profound immunosuppression of CX3CR1(+) tissue-resident macrophages. Our study reveals that the health of the intestinal mucosa is maintained by an axis driven by Treg cells communication with resident macrophages that withhold inflammatory stimuli required for ILC3 function.	[Bauche, David; Joyce-Shaikh, Barbara; Jain, Renu; Grein, Jeff; Ku, Karin S.; Blumenschein, Wendy M.; Wilson, Douglas C.; McClanahan, Terrill K.; Malefyt, Rene de Waal; Annamalai, Lakshmanan; Yearley, Jennifer H.; Cua, Daniel J.] Merck & Co Inc, MRL, Palo Alto, CA 94304 USA; [Ganal-Vonarburg, Stephanie C.; Macpherson, Andrew J.] Univ Bern, Univ Klin Viszerale Chirurg & Med, Inselspital, Maurice Muller Labs DKF, Murtenstr 35, CH-3008 Bern, Switzerland	Merck & Company; University of Bern; University Hospital of Bern	Cua, DJ (corresponding author), Merck & Co Inc, MRL, Palo Alto, CA 94304 USA.	daniel.cua@merck.com	bauche, david/M-2409-2019; Ganal-Vonarburg, Stephanie C./AAE-5705-2019	Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; de Waal Malefyt, Rene/0000-0002-2663-383X				Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Aychek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7525; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Buisson S, 2003, VACCINE, V21, P862, DOI 10.1016/S0264-410X(02)00533-9; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Castelli C, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.967146; Chang SY, 2013, IMMUNITY, V38, P153, DOI 10.1016/j.immuni.2012.09.018; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00124; Koscso B, 2016, J IMMUNOL METHODS, V432, P13, DOI 10.1016/j.jim.2015.12.009; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Li LJ, 2014, WORLD J GASTROENTERO, V20, P18177, DOI 10.3748/wjg.v20.i48.18177; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Loftus Edward V Jr, 2004, Curr Gastroenterol Rep, V6, P506, DOI 10.1007/s11894-004-0073-7; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parks OB, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00085; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rossini V, 2014, MUCOSAL IMMUNOL, V7, P533, DOI 10.1038/mi.2013.70; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Silberger DJ, 2017, MUCOSAL IMMUNOL, V10, P1108, DOI 10.1038/mi.2017.47; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	59	82	86	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					342	+		10.1016/j.immuni.2018.07.007	http://dx.doi.org/10.1016/j.immuni.2018.07.007			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30097293	Bronze			2022-12-18	WOS:000442354500018
J	Bantug, GR; Fischer, M; Grahlert, J; Balmer, ML; Unterstab, G; Develioglu, L; Steiner, R; Zhang, LJ; Costa, ASH; Gubser, PM; Burgener, AV; Sauder, U; Loliger, J; Belle, R; Dimeloe, S; Lotscher, J; Jauch, A; Recher, M; Honger, G; Hall, MN; Romero, P; Frezza, C; Hess, C				Bantug, Glenn R.; Fischer, Marco; Grahlert, Jasmin; Balmer, Maria L.; Unterstab, Gunhild; Develioglu, Leyla; Steiner, Rebekah; Zhang, Lianjun; Costa, Ana S. H.; Gubser, Patrick M.; Burgener, Anne-Valerie; Sauder, Ursula; Loliger, Jordan; Belle, Reka; Dimeloe, Sarah; Lotscher, Jonas; Jauch, Annaise; Recher, Mike; Honger, Gideon; Hall, Michael N.; Romero, Pedro; Frezza, Christian; Hess, Christoph			Mitochondria-Endoplasmic Reticulum Contact Sites Function as Immunometabolic Hubs that Orchestrate the Rapid Recall Response of Memory CD8(+) T Cells	IMMUNITY			English	Article							MEMBRANE MAM; HEXOKINASE; DIFFERENTIATION; LYMPHOCYTES; MAINTENANCE; METABOLISM; SUBSETS; STRESS	Glycolysis is linked to the rapid response of memory CD8(+) T cells, but the molecular and subcellular structural elements enabling enhanced glucose metabolism in nascent activated memory CD8(+) T cells are unknown. We found that rapid activation of protein kinase B (PKB or AKT) by mammalian target of rapamycin complex 2 (mTORC2) led to inhibition of glycogen synthase kinase 3b (GSK3 beta) at mito-chondria-endoplasmic reticulum (ER) junctions. This enabled recruitment of hexokinase I (HK-I) to the voltage-dependent anion channel (VDAC) on mitochondria. Binding of HK-I to VDAC promoted respiration by facilitating metabolite flux into mitochondria. Glucose tracing pinpointed pyruvate oxidation in mitochondria, which was the metabolic requirement for rapid generation of interferon-gamma (IFN-gamma) in memory T cells. Subcellular organization of mTORC2-AKTGSK3 beta at mitochondria-ER contact sites, promoting HK-I recruitment to VDAC, thus underpins the metabolic reprogramming needed for memory CD8(+) T cells to rapidly acquire effector function.	[Bantug, Glenn R.; Fischer, Marco; Grahlert, Jasmin; Balmer, Maria L.; Unterstab, Gunhild; Develioglu, Leyla; Steiner, Rebekah; Gubser, Patrick M.; Burgener, Anne-Valerie; Loliger, Jordan; Belle, Reka; Dimeloe, Sarah; Lotscher, Jonas; Honger, Gideon; Hess, Christoph] Univ Basel, Dept Biomed, Immunobiol Lab, 20 Hebelstr, CH-4031 Basel, Switzerland; [Bantug, Glenn R.; Fischer, Marco; Grahlert, Jasmin; Balmer, Maria L.; Unterstab, Gunhild; Develioglu, Leyla; Steiner, Rebekah; Gubser, Patrick M.; Burgener, Anne-Valerie; Loliger, Jordan; Belle, Reka; Dimeloe, Sarah; Lotscher, Jonas; Jauch, Annaise; Recher, Mike; Honger, Gideon; Hess, Christoph] Univ Hosp Basel, 20 Hebelstr, CH-4031 Basel, Switzerland; [Zhang, Lianjun; Romero, Pedro] Univ Lausanne, Ludwig Ctr Canc Res, 155 Chemin Boveresses, CH-1066 Epalinges, Vaud, Switzerland; [Costa, Ana S. H.; Frezza, Christian] Univ Cambridge, Hutchison MRC Res Ctr, Canc Unit, MRC, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England; [Sauder, Ursula] Univ Basel, Electron Microscopy Core Facil, Biozentrum, 70 Klingelbergstr, CH-4056 Basel, Switzerland; [Jauch, Annaise; Recher, Mike] Univ Basel, Dept Biomed, Immunodeficiency Lab, 20 Hebelstr, CH-4031 Basel, Switzerland; [Hall, Michael N.] Univ Basel, Biozentrum, 70 Klingelbergstr, CH-4056 Basel, Switzerland	University of Basel; University of Basel; University of Lausanne; University of Cambridge; University of Basel; University of Basel; University of Basel	Hess, C (corresponding author), Univ Basel, Dept Biomed, Immunobiol Lab, 20 Hebelstr, CH-4031 Basel, Switzerland.; Hess, C (corresponding author), Univ Hosp Basel, 20 Hebelstr, CH-4031 Basel, Switzerland.	chess@uhbs.ch	Zhang, Lianjun/AAE-6795-2020; Costa, Ana/HDL-9297-2022; Balmer, Maria L/A-8546-2013; Romero, Pedro/S-6015-2017; Costa, Ana SH/H-2852-2012; Coll, Lluis Fajas/C-8567-2014; Balmer, Maria Luisa/AAB-8993-2021; Frezza, Christian/G-2174-2010	Romero, Pedro/0000-0002-9688-2882; Costa, Ana SH/0000-0001-8932-6370; Balmer, Maria Luisa/0000-0003-0356-6352; Frezza, Christian/0000-0002-3293-7397; Fischer, Marco/0000-0002-2704-7912; Dimeloe, Sarah/0000-0002-4598-6518; Steiner, Rebekah/0000-0001-8921-3202; Hall, Michael N/0000-0002-2998-0757; Bantug, Glenn Robert/0000-0003-2253-6028; Recher, Mike/0000-0002-9121-6936	SNSF [31003A_172848, CRSII3_160766, 323530_139181, PP00P3_144863]; Basel University; MRC [MC_UU_12022/6] Funding Source: UKRI	SNSF(Swiss National Science Foundation (SNSF)); Basel University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the flow sorting team of the Department of Biomedicine at Basel University. Funding: C.H., SNSF 31003A_172848 and CRSII3_160766; M.F., SNSF 323530_139181; M.L.B., S.D., and P.M.G., Basel University Young Investigator grants; and M.R., SNSF PP00P3_144863.	Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Farber DL, 2009, SEMIN IMMUNOL, V21, P84, DOI 10.1016/j.smim.2009.02.003; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; Lim S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155689; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Theurey P, 2017, TRENDS ENDOCRIN MET, V28, P32, DOI 10.1016/j.tem.2016.09.002; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Zhang LJ, 2016, CELL REP, V14, P1206, DOI 10.1016/j.celrep.2015.12.095; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	37	82	83	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					542	+		10.1016/j.immuni.2018.02.012	http://dx.doi.org/10.1016/j.immuni.2018.02.012			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29523440	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000427916900014
J	Shimba, A; Cui, GW; Tani-ichi, S; Ogawa, M; Abe, S; Okazaki, F; Kitano, S; Miyachi, H; Yamada, H; Hara, T; Yoshikai, Y; Nagasawa, T; Schutz, G; Ikuta, K				Shimba, Akihiro; Cui, Guangwei; Tani-ichi, Shizue; Ogawa, Makoto; Abe, Shinya; Okazaki, Fumie; Kitano, Satsuki; Miyachi, Hitoshi; Yamada, Hisakata; Hara, Takahiro; Yoshikai, Yasunobu; Nagasawa, Takashi; Schuetz, Gunther; Ikuta, Koichi			Glucocorticoids Drive Diurnal Oscillations in T Cell Distribution and Responses by Inducing Interleukin-7 Receptor and CXCR4	IMMUNITY			English	Article							CIRCADIAN CLOCK; IN-VIVO; IL-7 RECEPTOR; THYMOCYTE SUBPOPULATIONS; IMMUNE-RESPONSE; EXPRESSION; HOMEOSTASIS; ACTIVATION; INHIBITION; DIFFERENTIATION	Glucocorticoids are steroid hormones with strong anti-inflammatory and immunosuppressive effects that are produced in a diurnal fashion. Although glucocorticoids have the potential to induce inter-leukin-7 receptor (IL-7R) expression in T cells, whether they control T cell homeostasis and responses at physiological concentrations remains unclear. We found that glucocorticoid receptor signaling induces IL-7R expression in mouse T cells by binding to an enhancer of the IL-7R alpha locus, with a peak at midnight and a trough at midday. This diurnal induction of IL-7R supported the survival of T cells and their redistribution between lymph nodes, spleen, and blood by controlling expression of the chemokine receptor CXCR4. In mice, T cell accumulation in the spleen at night enhanced immune responses against soluble antigens and systemic bacterial infection. Our results reveal the immunoenhancing role of glucocorticoids in adaptive immunity and provide insight into how immune function is regulated by the diurnal rhythm.	[Shimba, Akihiro; Cui, Guangwei; Tani-ichi, Shizue; Ogawa, Makoto; Abe, Shinya; Okazaki, Fumie; Hara, Takahiro; Ikuta, Koichi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Immune Regulat, Kyoto 6068507, Japan; [Shimba, Akihiro; Ogawa, Makoto; Abe, Shinya; Okazaki, Fumie] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Tani-ichi, Shizue] Kyoto Univ, Grad Sch Med, Lab Biol Chem, Human Hlth Sci, Kyoto 6068507, Japan; [Kitano, Satsuki; Miyachi, Hitoshi] Kyoto Univ, Inst Frontier Life & Med Sci, Reprod Engn Team, Kyoto 6068507, Japan; [Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Network Ctr Infect Dis, Med Inst Bioregulat, Div Host Def, Fukuoka 8128582, Japan; [Nagasawa, Takashi] Osaka Univ, Grad Sch Frontier Biosci, Lab Stem Cell Biol & Dev Immunol, Osaka 5650871, Japan; [Nagasawa, Takashi] Osaka Univ, Grad Sch Med, Osaka 5650871, Japan; [Schuetz, Gunther] German Canc Res Ctr, Dept Mol Biol Cell 1, D-69120 Heidelberg, Germany	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyushu University; Osaka University; Osaka University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ikuta, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Immune Regulat, Kyoto 6068507, Japan.	ikuta.koichi.6c@kyoto-u.ac.jp	Ogawa, Makoto/AAE-6161-2021	Hara, Takahiro/0000-0002-3845-8434; Ikuta, Koichi/0000-0003-1319-1021; Nagasawa, Takashi/0000-0002-1085-0960	JSPS KAKENHI [16K15288, 16H05172, 15H01153, 26460572, 16K08835]; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University; Kyoto University Research Coordination Alliance; Japan Society for the Promotion of Science (JSPS); TUBITAK; Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University; Kyoto University Research Coordination Alliance; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	We would like to acknowledge Drs. J. Takeda, K. Yusa, and G. Kondoh for providing the KY1.1 ES line and targeting system and Dr. Batu Erman and members of the K. Ikuta laboratory for discussion. This work was supported by JSPS KAKENHI grant numbers 16K15288, 16H05172, and 15H01153 (K.I.), 26460572 (S.T.), and 16K08835 (T.H.), by the Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University, by the Future Developmental Funding Program of Kyoto University Research Coordination Alliance, and by the Japan Society for the Promotion of Science (JSPS) and TUBITAK Joint Research Project. A.S. was supported by the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED). G.C. was an International Research Fellow of the Japan Society for the Promotion of Science.	Abe A, 2015, J IMMUNOL, V195, P3129, DOI 10.4049/jimmunol.1302447; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cui GW, 2014, P NATL ACAD SCI USA, V111, P1915, DOI 10.1073/pnas.1318281111; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dimitrov S, 2009, BLOOD, V113, P5134, DOI 10.1182/blood-2008-11-190769; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Fortier EE, 2011, J IMMUNOL, V187, P6291, DOI 10.4049/jimmunol.1004030; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Franchimont D, 2000, J IMMUNOL, V164, P1768, DOI 10.4049/jimmunol.164.4.1768; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gilmore W, 1997, J IMMUNOL, V158, P446; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hata K, 2016, FEBS LETT, V590, P1200, DOI 10.1002/1873-3468.12161; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lee HC, 2005, J IMMUNOL, V174, P7800, DOI 10.4049/jimmunol.174.12.7800; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Purton JF, 2000, IMMUNITY, V13, P179, DOI 10.1016/S1074-7613(00)00018-2; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCREPANTI I, 1989, J IMMUNOL, V142, P3378; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Tani-ichi S, 2013, P NATL ACAD SCI USA, V110, P612, DOI 10.1073/pnas.1219242110; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Yajima T, 2005, J IMMUNOL, V174, P3590, DOI 10.4049/jimmunol.174.6.3590	45	82	83	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					286	+		10.1016/j.immuni.2018.01.004	http://dx.doi.org/10.1016/j.immuni.2018.01.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29396162	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000425507800014
J	Oyler-Yaniv, A; Oyler-Yaniv, J; Whitlock, BM; Liu, ZD; Germain, RN; Huse, M; Altan-Bonnet, G; Krichevsky, O				Oyler-Yaniv, Alon; Oyler-Yaniv, Jennifer; Whitlock, Benjamin M.; Liu, Zhiduo; Germain, Ronald N.; Huse, Morgan; Altan-Bonnet, Gregoire; Krichevsky, Oleg			A Tunable Diffusion-Consumption Mechanism of Cytokine Propagation Enables Plasticity in Cell-to-Cell Communication in the Immune System	IMMUNITY			English	Article							IN-VIVO; PRO-B; IL-2; DIFFERENTIATION; EFFECTOR; HELPER; INTERLEUKIN-2; EXPRESSION; LYMPHOCYTES; MODULATION	Immune cells communicate by exchanging cytokines to achieve a context-appropriate response, but the distances over which such communication happens are not known. Here, we used theoretical considerations and experimental models of immune responses in vitro and in vivo to quantify the spatial extent of cytokine communications in dense tissues. We established that competition between cytokine diffusion and consumption generated spatial niches of high cytokine concentrations with sharp boundaries. The size of these self-assembled niches scaled with the density of cytokine-consuming cells, a parameter that gets tuned during immune responses. In vivo, we measured interactions on length scales of 80-120 mm, which resulted in a high degree of cell-to-cell variance in cytokine exposure. Such heterogeneous distributions of cytokines were a source of non-genetic cell-to-cell variability that is often overlooked in single-cell studies. Our findings thus provide a basis for understanding variability in the patterning of immune responses by diffusible factors.	[Oyler-Yaniv, Alon; Krichevsky, Oleg] Ben Gurion Univ Negev, Phys Dept, IL-84105 Beer Sheva, Israel; [Oyler-Yaniv, Alon; Oyler-Yaniv, Jennifer; Altan-Bonnet, Gregoire] NCI, ImmunoDynam Grp, Canc & Inflammat Program, Ctr Canc Res,NIH, Bethesda, MD 21701 USA; [Oyler-Yaniv, Alon; Oyler-Yaniv, Jennifer; Whitlock, Benjamin M.; Altan-Bonnet, Gregoire; Krichevsky, Oleg] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Oyler-Yaniv, Alon; Oyler-Yaniv, Jennifer; Whitlock, Benjamin M.; Huse, Morgan; Altan-Bonnet, Gregoire; Krichevsky, Oleg] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Oyler-Yaniv, Jennifer] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Whitlock, Benjamin M.] Weill Cornell Med Coll, Biochem & Mol Biol Grad Program, New York, NY 10065 USA; [Liu, Zhiduo; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Krichevsky, Oleg] Ben Gurion Univ Negev, Ilse Kats Ctr Nanosci, IL-84105 Beer Sheva, Israel	Ben Gurion University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Ben Gurion University	Krichevsky, O (corresponding author), Ben Gurion Univ Negev, Phys Dept, IL-84105 Beer Sheva, Israel.; Altan-Bonnet, G (corresponding author), NCI, ImmunoDynam Grp, Canc & Inflammat Program, Ctr Canc Res,NIH, Bethesda, MD 21701 USA.; Altan-Bonnet, G; Krichevsky, O (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA.; Altan-Bonnet, G; Krichevsky, O (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Krichevsky, O (corresponding author), Ben Gurion Univ Negev, Ilse Kats Ctr Nanosci, IL-84105 Beer Sheva, Israel.	gregoire.altan-bonnet@nih.gov; okrichev@bgu.ac.il	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Altan-Bonnet, Gregoire/0000-0002-7283-3162; Oyler-Yaniv, Jennifer/0000-0001-8937-8592; Krichevsky, Oleg/0000-0002-6856-7551	U.S.-Israel Binational Science Foundation [2012327]; US National Institutes of Health [R01-AI083408, R01-AI087644]; Intramural Research programs of the Center for Cancer Research, NCI; Intramural Research programs of the NIAID, NIH; NATIONAL CANCER INSTITUTE [ZIABC011726, ZIABC011728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087644, R56AI116863, R01AI083408, R56AI083408, ZIAAI000545] Funding Source: NIH RePORTER	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research programs of the Center for Cancer Research, NCI; Intramural Research programs of the NIAID, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Molecular Cytology Core Facility at MSKCC for help with histology and imaging. A.O.-Y. and O.K. are grateful to Professor Noah Isakov, Margalit Krup, and Gad Afek for help in setting up experiments at Ben-Gurion University. This work was supported in part by the U.S.-Israel Binational Science Foundation (#2012327 to G.A.-B. and O.K.), by the US National Institutes of Health (R01-AI083408 to G.A.-B. and M.H., and R01-AI087644 to M.H.), by the Intramural Research programs of the Center for Cancer Research, NCI, and by the Intramural Research programs of the NIAID, NIH.	Amado IF, 2013, J EXP MED, V210, P2707, DOI 10.1084/jem.20122759; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Carmona-Fontaine C, 2013, P NATL ACAD SCI USA, V110, P19402, DOI 10.1073/pnas.1311939110; DUPREZ V, 1991, J BIOL CHEM, V266, P1497; Economopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027508; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; Helmstetter C, 2015, IMMUNITY, V42, P108, DOI 10.1016/j.immuni.2014.12.018; Heltemes-Harris LM, 2011, ANN NY ACAD SCI, V1217, P18, DOI 10.1111/j.1749-6632.2010.05907.x; Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Huang J., 2013, IMMUNITY; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Thurley K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004206; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Yarilin D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09534; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	44	82	83	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					609	620		10.1016/j.immuni.2017.03.011	http://dx.doi.org/10.1016/j.immuni.2017.03.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28389069	Bronze, Green Accepted			2022-12-18	WOS:000399451100014
J	Stephen, TL; Payne, KK; Chaurio, RA; Allegrezza, MJ; Zhu, HR; Perez-Sanz, J; Perales-Puchalt, A; Nguyen, JM; Vara-Ailor, AE; Eruslanov, EB; Borowsky, ME; Zhang, RG; Laufer, TM; Conejo-Garcia, JR				Stephen, Tom L.; Payne, Kyle K.; Chaurio, Ricardo A.; Allegrezza, Michael J.; Zhu, Hengrui; Perez-Sanz, Jairo; Perales-Puchalt, Alfredo; Nguyen, Jenny M.; Vara-Ailor, Ana E.; Eruslanov, Evgeniy B.; Borowsky, Mark E.; Zhang, Rugang; Laufer, Terri M.; Conejo-Garcia, Jose R.			SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; PERSISTENT VIRAL-INFECTION; TGF-BETA; ANTI-PD-1 ANTIBODY; EFFECTOR FUNCTION; IMMUNE-RESPONSE; BINDING PROTEIN; DENDRITIC CELLS; OVARIAN-CANCER; BLOCKADE	Despite the importance of programmed cell death-1 (PD-1) in inhibiting T cell effector activity, the mechanisms regulating its expression remain poorly defined. We found that the chromatin organizer specialAT-rich sequence-binding protein-1 (Satb1) restrains PD-1 expression induced upon T cell activation by recruiting a nucleosome remodeling deacetylase (NuRD) complex to Pdcd1 regulatory regions. Satb1 deficienct T cells exhibited a 40-fold increase in PD-1 expression. Tumor-derived transforming growth factor beta (Tgf-beta) decreased Satb1 expression through binding of Smad proteins to the Satb1 promoter. Smad proteins also competed with the Satb1-NuRD complex for binding to Pdcd1 enhancers, releasing Pdcd1 expression from Satb1-mediated repression, Satb1-deficient tumor-reactive T cells lost effector activity more rapidly than wild-type lymphocytes at tumor beds expressing PD-1 ligand (CD274), and these differences were abrogated by sustained CD274 blockade. Our findings suggest that Satb1 functions to prevent premature T cell exhaustion by regulating Pdcd1 expression upon T cell activation. Dysregulation of this pathway in tumor-infiltrating T cells results in diminished anti-tumor immunity.	[Stephen, Tom L.; Payne, Kyle K.; Chaurio, Ricardo A.; Allegrezza, Michael J.; Perez-Sanz, Jairo; Perales-Puchalt, Alfredo; Nguyen, Jenny M.; Vara-Ailor, Ana E.; Conejo-Garcia, Jose R.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Zhu, Hengrui; Zhang, Rugang] Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Eruslanov, Evgeniy B.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Laufer, Terri M.] Univ Penn, Dept Rheumatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Borowsky, Mark E.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, 4701 Ogletown Stanton Rd, Newark, DE 19713 USA; [Stephen, Tom L.] AstraZeneca Pharmaceut PLC, Oncol Biosci, 35 Gatehouse Dr, Waltham, MA 02451 USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; AstraZeneca	Conejo-Garcia, JR (corresponding author), Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	jose.conejo-garcia@moffitt.org	Payne, Kyle/AAL-6614-2020; Eruslanov, Evgeniy/AAS-1277-2020; Blanco, Leire/O-5114-2017; Conejo-Garcia, Jose R/V-1897-2019	Conejo-Garcia, Jose R/0000-0001-6431-4074; Payne, Kyle/0000-0002-6531-9835; Perez Sanz, Jairo/0000-0003-4786-8379	Cancer Center Support [CA010815]; Jayne Koskinas & Ted Giovanis Breast Cancer Research Consortium at Wistar [R01CA157664, R01CA124515, R01CA178687, CA187392]; Ovarian Cancer Research Fund Program Project Development awards; Department of Defense Ovarian Cancer Academy; Ann Schreiber Mentored Investigator Award (OCRF);  [T32CA009171];  [T32CA009140-39]; NATIONAL CANCER INSTITUTE [T32CA009140, R01CA202919, R01CA160331, P30CA010815, R01CA124515, R01CA187392, R01CA163377, T32CA009171, R01CA178687, R01CA157664] Funding Source: NIH RePORTER	Cancer Center Support; Jayne Koskinas & Ted Giovanis Breast Cancer Research Consortium at Wistar; Ovarian Cancer Research Fund Program Project Development awards; Department of Defense Ovarian Cancer Academy; Ann Schreiber Mentored Investigator Award (OCRF); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for Shared Resources was provided by Cancer Center Support Grant CA010815 to The Wistar Institute. This study was supported by R01CA157664, R01CA124515, R01CA178687, CA187392, The Jayne Koskinas & Ted Giovanis Breast Cancer Research Consortium at Wistar, Ovarian Cancer Research Fund Program Project Development awards, and the Department of Defense Ovarian Cancer Academy. M.J.A. was supported by T32CA009171. K.K.P. was supported by T32CA009140-39. A.P.-P. was supported by the Ann Schreiber Mentored Investigator Award (OCRF).	Ahmadzadeh M, 2005, J IMMUNOL, V174, P5215, DOI 10.4049/jimmunol.174.9.5215; Alvarez JD, 2000, GENE DEV, V14, P521; Austin JW, 2014, J IMMUNOL, V192, P4876, DOI 10.4049/jimmunol.1302750; Avram D, 2014, J IMMUNOL, V193, P2059, DOI 10.4049/jimmunol.1400930; Baas M, 2016, ELIFE, V5, DOI 10.7554/eLife.08133; Bally APR, 2016, J IMMUNOL, V196, P2431, DOI 10.4049/jimmunol.1502643; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Cui T.X., 2013, IMMUNITY; Dege C, 2014, IMMUNOL REV, V261, P126, DOI 10.1111/imr.12209; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Furuya Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005180; Gaillard Stephanie L, 2016, Gynecol Oncol Res Pract, V3, P11; Garidou L, 2012, J VIROL, V86, P7060, DOI 10.1128/JVI.00164-12; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Lewis GM, 2015, J VIROL, V89, P3343, DOI 10.1128/JVI.03076-14; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McPherson RC, 2014, ELIFE, V3, DOI 10.7554/eLife.03416; Nesbeth Y, 2009, CANCER RES, V69, P6331, DOI 10.1158/0008-5472.CAN-08-4329; Nesbeth YC, 2010, J IMMUNOL, V184, P5654, DOI 10.4049/jimmunol.0903247; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Park BV, 2016, CANC DISCOV; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Stephen TL, 2014, IMMUNITY, V41, P427, DOI 10.1016/j.immuni.2014.08.012; Tesone AJ, 2016, CELL REP, V14, P1774, DOI 10.1016/j.celrep.2016.01.056; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tserel L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13107; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Woods DM, 2015, CANCER IMMUNOL RES, V3, P1375, DOI 10.1158/2326-6066.CIR-15-0077-T; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	51	82	89	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					51	64		10.1016/j.immuni.2016.12.015	http://dx.doi.org/10.1016/j.immuni.2016.12.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099864	Green Accepted, Bronze			2022-12-18	WOS:000392918300010
J	Ettersperger, J; Montcuquet, N; Malamut, G; Guegan, N; Lopez-Lastra, S; Gayraud, S; Reimann, C; Vidal, E; Cagnard, N; Villarese, P; Andre-Schmutz, I; Domingues, RG; Godinho-Silva, C; Veiga-Fernandes, H; Lhermitte, L; Asnafi, V; Macintyre, E; Cellier, C; Beldjord, K; Di Santo, JP; Cerf-Bensussan, N; Meresse, B				Ettersperger, Julien; Montcuquet, Nicolas; Malamut, Georgia; Guegan, Nicolas; Lopez-Lastra, Silvia; Gayraud, Segolene; Reimann, Christian; Vidal, Elodie; Cagnard, Nicolas; Villarese, Patrick; Andre-Schmutz, Isabelle; Domingues, Rita Gomes; Godinho-Silva, Cristina; Veiga-Fernandes, Henrique; Lhermitte, Ludovic; Asnafi, Vahid; Macintyre, Elizabeth; Cellier, Christophe; Beldjord, Kheira; Di Santo, James P.; Cerf-Bensussan, Nadine; Meresse, Bertrand			Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease	IMMUNITY			English	Article							NATURAL-KILLER; ALPHA-BETA; TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; GUT; PROGENITOR; LINEAGE; DELTA; IDENTIFICATION; INFLAMMATION	The nature of gut intraepithelial lymphocytes (IELs) lacking antigen receptors remains controversial. Herein we showed that, in humans and in mice, innate intestinal IELs expressing intracellular CD3 (iCD3(+)) differentiate along an Id2 transcription factor (TF)independent pathway in response to TF NOTCH1, interleukin-15 (IL-15), and Granzyme B signals. In NOTCH1-activated human hematopoietic precursors, IL-15 induced Granzyme B, which cleaved NOTCH1 into a peptide lacking transcriptional activity. As a result, NOTCH1 target genes indispensable for T cell differentiation were silenced and precursors were reprogrammed into innate cells with T cell marks including intracellular CD3 and T cell rearrangements. In the intraepithelial lymphoma complicating celiac disease, iCD3(+) innate IELs acquired gain-of-function mutations in Janus kinase 1 or Signal transducer and activator of transcription 3, which enhanced their response to IL-15. Overall we characterized gut T cell-like innate IELs, deciphered their pathway of differentiation and showed their malignant transformation in celiac disease.	[Ettersperger, Julien; Montcuquet, Nicolas; Malamut, Georgia; Guegan, Nicolas; Gayraud, Segolene; Cellier, Christophe; Cerf-Bensussan, Nadine; Meresse, Bertrand] INSERM UMR1163, Inst Imagine, Lab Intestinal Immun, F-75015 Paris, France; [Ettersperger, Julien; Montcuquet, Nicolas; Malamut, Georgia; Guegan, Nicolas; Gayraud, Segolene; Reimann, Christian; Andre-Schmutz, Isabelle; Cellier, Christophe; Cerf-Bensussan, Nadine; Meresse, Bertrand] Univ Paris 05, Sorbonne Paris Cite, F-75015 Paris, France; [Ettersperger, Julien; Montcuquet, Nicolas; Malamut, Georgia; Guegan, Nicolas; Gayraud, Segolene; Reimann, Christian; Andre-Schmutz, Isabelle; Cellier, Christophe; Cerf-Bensussan, Nadine; Meresse, Bertrand] Inst Imagine, F-75015 Paris, France; [Malamut, Georgia] Hop Europe Georges Pompidou, AP HP, Dept Gastroenterol, F-75015 Paris, France; [Lopez-Lastra, Silvia; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75015 Paris, France; [Lopez-Lastra, Silvia; Di Santo, James P.] INSERM U 668, F-75015 Paris, France; [Reimann, Christian; Andre-Schmutz, Isabelle] INSERM UMR1163, Lab Human Lymphohematopoiesis, F-75015 Paris, France; [Vidal, Elodie; Villarese, Patrick; Lhermitte, Ludovic; Asnafi, Vahid; Macintyre, Elizabeth; Beldjord, Kheira] Univ Paris 05, Sorbonne Paris Cite, Inst Necker Enfants Malades, AP HP Necker Enfants Malades,INSERM & Biol Hemato, F-75015 Paris, France; [Cagnard, Nicolas] Paris Descartes Bioinformat Platform, F-75015 Paris, France; [Domingues, Rita Gomes; Godinho-Silva, Cristina; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; [Beldjord, Kheira] Hop St Louis, Inst Univ Hematol, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidade de Lisboa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Cerf-Bensussan, N; Meresse, B (corresponding author), INSERM UMR1163, Inst Imagine, Lab Intestinal Immun, F-75015 Paris, France.; Cerf-Bensussan, N; Meresse, B (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75015 Paris, France.; Cerf-Bensussan, N; Meresse, B (corresponding author), Inst Imagine, F-75015 Paris, France.	nadine.cerf-bensussan@inserm.fr; bertrand.meresse@inserm.fr	GUEGAN, Nicolas/H-9484-2017; Meresse, Bertrand/N-6325-2017; Cerf-Bensussan, nadine/H-9505-2017; Andre-Schmutz, Isabelle/M-1279-2016; Di Santo, James P/M-4298-2014; Cellier, Christophe JP/I-8386-2017; Andre, Isabelle/F-6263-2013; Cagnard, Nicolas/K-2754-2014	GUEGAN, Nicolas/0000-0003-2434-4564; Meresse, Bertrand/0000-0002-8978-8636; Cerf-Bensussan, nadine/0000-0003-0665-1245; Di Santo, James P/0000-0002-7146-1862; Andre, Isabelle/0000-0002-3905-9910; Malamut, Georgia/0000-0003-4030-3025; christophe, Cellier/0000-0003-0784-2318; Lopez Lastra, Silvia/0000-0003-2391-6858; Godinho-Silva, Cristina/0000-0002-0300-8839; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493; Cagnard, Nicolas/0000-0002-9051-1896	INSERM; grant Equipe Ligue Nationale Contre le Cancer (LNCC); Canceropole Ile-de-France; LNCC; Association Francaise des Intolerants au gluten	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); grant Equipe Ligue Nationale Contre le Cancer (LNCC); Canceropole Ile-de-France(Region Ile-de-France); LNCC; Association Francaise des Intolerants au gluten	This work was supported by INSERM, by a grant Equipe Ligue Nationale Contre le Cancer (LNCC). J.E. was supported by Canceropole Ile-de-France and LNCC and N.M. by LNCC and Association Francaise des Intolerants au gluten. The authors thank Prs P. Wind and S. Sarnacki for providing surgical intestinal samples, Dr. V. Parietti for providing purified CD34<SUP>+</SUP> cells, the cytometry platforms of SFR-Necker for help with cell sorting, IMAGINE genomic core facilities, and the ProfileXpert platform (SFR Sante Lyon Est) for transcriptome studies and Institut Universitaire d'Hematologie (Hopital Saint Louis) for Genescan study. B.M. and N.C.-B. have benefited of "AP-HP Contrat d'Interface.''	Carnevalli LS, 2014, J EXP MED, V211, P769, DOI 10.1084/jem.20131072; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chea S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2223; Crescenzo R, 2015, CANCER CELL, V27, P516, DOI 10.1016/j.ccell.2015.03.006; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; De Smedt M, 2007, BLOOD, V110, P2696, DOI 10.1182/blood-2007-03-082206; Eiras P, 2000, SCAND J IMMUNOL, V52, P1; Fronkova E, 2005, J IMMUNOL, V175, P2495, DOI 10.4049/jimmunol.175.4.2495; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; GuyGrand D, 1996, EUR J IMMUNOL, V26, P2248, DOI 10.1002/eji.1830260942; Howie D, 1998, J IMMUNOL, V161, P5862; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Leon F, 2003, GASTROENTEROLOGY, V125, P345, DOI 10.1016/S0016-5085(03)00886-2; LIN T, 1994, EUR J IMMUNOL, V24, P1080, DOI 10.1002/eji.1830240511; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; Malamut G, 2012, SEMIN IMMUNOPATHOL, V34, P601, DOI 10.1007/s00281-012-0322-z; Malamut G, 2010, J CLIN INVEST, V120, P2131, DOI 10.1172/JCI41344; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Park Y, 2016, BMB REP, V49, P11, DOI 10.5483/BMBRep.2016.49.1.242; Peaudecerf L, 2011, MUCOSAL IMMUNOL, V4, P93, DOI 10.1038/mi.2010.47; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Schmitz F, 2016, GUT, V65, P1269, DOI 10.1136/gutjnl-2014-308153; Schmitz F, 2013, GUT, V62, P509, DOI 10.1136/gutjnl-2012-302265; Schotte R, 2010, J IMMUNOL, V184, P6670, DOI 10.4049/jimmunol.0901508; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tack GJ, 2012, MOL IMMUNOL, V50, P262, DOI 10.1016/j.molimm.2012.01.014; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Van Kaer L, 2014, IMMUNITY, V41, P451, DOI 10.1016/j.immuni.2014.08.010; van Tetering G, 2011, BIOCHEM J, V437, P313, DOI 10.1042/BJ20110226; Vosshenrich CAJ, 2013, CURR OPIN IMMUNOL, V25, P130, DOI 10.1016/j.coi.2013.02.002; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927	47	82	84	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					610	625		10.1016/j.immuni.2016.07.018	http://dx.doi.org/10.1016/j.immuni.2016.07.018			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27612641	Bronze			2022-12-18	WOS:000388454300017
J	Sekai, M; Hamazaki, Y; Minato, N				Sekai, Miho; Hamazaki, Yoko; Minato, Nagahiro			Medullary Thymic Epithelial Stem Cells Maintain a Functional Thymus to Ensure Lifelong Central T Cell Tolerance	IMMUNITY			English	Article							KERATINOCYTE GROWTH-FACTOR; PROGENITOR CELLS; SELF-TOLERANCE; ADULT THYMUS; MICE; DIFFERENTIATION; THYMOPOIESIS; REGENERATION; RENEWAL; MICROENVIRONMENT	Medullary thymic epithelial cells (mTECs) are crucial for central T cell self-tolerance. Although progenitors of mTECs have been demonstrated in thymic organogenesis, the mechanism for postnatal mTEC maintenance remains elusive. We demonstrate that implantation of embryonic TECs expressing claudin-3 and claudin-4 (Cld3,4) in a medulla-defective thymic microenvironment restores medulla formation and suppresses multiorgan autoimmunity throughout life. A minor SSEA-1(+) fraction within the embryonic Cld3,4(hi) TECs contained self-renewable clonogenic TECs, capable of preferentially generating mature mTECs in vivo. Adult SSEA-1(+)Cld3,4(hi) TECs retained mTEC reconstitution potential, although the activity decreased. The clonogenicity of TECs also declined rapidly after birth in wild-type mice, whereas it persisted in Rag2(-/-) adult mice with defective thymopoiesis. The results suggest that unipotent mTEC-restricted stem cells that develop in the embryo have the capacity to functionally reconstitute the thymic medulla long-term, thus ensuring lifelong central T cell self-tolerance.	[Sekai, Miho; Hamazaki, Yoko; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Sekai, Miho] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Hamazaki, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	hamazaki@imm.med.kyoto-u.ac.jp	Hamazaki, Y*/Q-3076-2019	Hamazaki, Y*/0000-0001-5866-7340	JSPS Research Fellowship for Young Scientists; JSPS KAKENHI [20200069, 24590580, 25111505, 24111008]; Takeda Science Foundation; Hayashi Memorial Foundation for Female Natural Scientists; Grants-in-Aid for Scientific Research [24111008] Funding Source: KAKEN	JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all members of our laboratory for helpful discussions. We are also grateful to H. Fujita, H. Tanaka, Y. Xu, A. Kurogi, J. Wang, Y. Zhao, and M. Hikida for technical assistance, to Y. Shohab for proofreading, and to M. Matsumoto for providing the anti-Aire antibody. M.S. was supported by a grant-in-aid from JSPS Research Fellowship for Young Scientists. This work was supported by JSPS KAKENHI grant numbers 20200069, 24590580, 25111505 (to Y.H.), and 24111008 (to N.M.), and by grants from Takeda Science Foundation and Hayashi Memorial Foundation for Female Natural Scientists (to Y.H.).	Akiyama T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00278; Alpdogan O, 2006, BLOOD, V107, P2453, DOI 10.1182/blood-2005-07-2831; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Dumont-Lagace M, 2014, J IMMUNOL, V192, P2219, DOI 10.4049/jimmunol.1302961; Fletcher AL, 2009, J IMMUNOL, V183, P823, DOI 10.4049/jimmunol.0900225; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI22492; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Jenkinson WE, 2008, J IMMUNOL, V181, P6101, DOI 10.4049/jimmunol.181.9.6101; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kelly RM, 2008, BLOOD, V111, P5734, DOI 10.1182/blood-2008-01-136531; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Mouri Y, 2011, J IMMUNOL, V186, P5047, DOI 10.4049/jimmunol.1003533; Ohigashi I, 2013, P NATL ACAD SCI USA, V110, P9885, DOI 10.1073/pnas.1301799110; Peterson P, 2013, EUR J IMMUNOL, V43, P580, DOI 10.1002/eji.201343323; Rode I, 2012, P NATL ACAD SCI USA, V109, P3463, DOI 10.1073/pnas.1118823109; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Shortman K, 1990, Semin Immunol, V2, P3; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Swann JB, 2007, EUR J IMMUNOL, V37, P2364, DOI 10.1002/eji.200737709; Tsubata R, 1996, EUR J IMMUNOL, V26, P2742, DOI 10.1002/eji.1830261129; Ucar A, 2014, IMMUNITY, V41, P257, DOI 10.1016/j.immuni.2014.07.005; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046	47	82	83	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					753	761		10.1016/j.immuni.2014.10.011	http://dx.doi.org/10.1016/j.immuni.2014.10.011			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25464854	Bronze			2022-12-18	WOS:000345504900012
J	Calantone, N; Wu, F; Klase, Z; Deleage, C; Perkins, M; Matsuda, K; Thompson, EA; Ortiz, AM; Vinton, CL; Ourmanov, I; Lore, K; Douek, DC; Estes, JD; Hirsch, VM; Brenchley, JM				Calantone, Nina; Wu, Fan; Klase, Zachary; Deleage, Claire; Perkins, Molly; Matsuda, Kenta; Thompson, Elizabeth A.; Ortiz, Alexandra M.; Vinton, Carol L.; Ourmanov, Ilnour; Lore, Karin; Douek, Daniel C.; Estes, Jacob D.; Hirsch, Vanessa M.; Brenchley, Jason M.			Tissue Myeloid Cells in SIV-Infected Primates Acquire Viral DNA through Phagocytosis of Infected T Cells	IMMUNITY			English	Article							RESTRICTION FACTOR SAMHD1; GASTROINTESTINAL-TRACT; HIV-1 INFECTION; RHESUS MACAQUES; VIRUS; MACROPHAGES; VPX; DEPLETION; RESERVOIRS; DISEASE	The viral accessory protein Vpx, expressed by certain simian and human immunodeficiency viruses (SIVs and HIVs), is thought to improve viral infectivity of myeloid cells. We infected 35 Asian macaques and African green monkeys with viruses that do or do not express Vpx and examined viral targeting of cells in vivo. While lack of Vpx expression affected viral dynamics in vivo, with decreased viral loads and infection of CD4(+) T cells, Vpx expression had no detectable effect on infectivity of myeloid cells. Moreover, viral DNA was observed only within myeloid cells in tissues not massively depleted of CD4(+) T cells. Myeloid cells containing viral DNA also showed evidence of T cell phagocytosis in vivo, suggesting that their viral DNA may be attributed to phagocytosis of SIV-infected T cells. These data suggest that myeloid cells are not a major source of SIV in vivo, irrespective of Vpx expression.	[Calantone, Nina; Wu, Fan; Klase, Zachary; Perkins, Molly; Matsuda, Kenta; Ortiz, Alexandra M.; Vinton, Carol L.; Ourmanov, Ilnour; Hirsch, Vanessa M.; Brenchley, Jason M.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Deleage, Claire; Estes, Jacob D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Ft Detrick, MD 21702 USA; [Thompson, Elizabeth A.; Lore, Karin; Douek, Daniel C.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Thompson, Elizabeth A.; Lore, Karin] Karolinska Inst, Dept Med, S-171 Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet	Brenchley, JM (corresponding author), NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA.	jbrenchl@mail.nih.gov	Thompson, Elizabeth A/M-4898-2017; Brenchley, Jason/AAC-5085-2019; WU, FAN/GRX-1654-2022	Thompson, Elizabeth A/0000-0001-8464-9904; Brenchley, Jason/0000-0001-8357-2984; Calantone Lund, Nina/0000-0001-7491-7071; Wu, Fan/0000-0003-4741-3948	Division of Intramural Research/NIAID/NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005066, ZIAAI001194, ZIAAI001029, ZIAAI000370, ZIAAI005033] Funding Source: NIH RePORTER	Division of Intramural Research/NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to acknowledge H. Cronise, J. Swerczek, R. Herbert, and all the veterinary staff at the NIH animal center. We would like to thank CLIC/BBC for advice and helpful discussions. Funding for this study was provided in part by the Division of Intramural Research/NIAID/NIH. The content of this publication does not necessarily reflect the views or policies of DHHS, nor does the mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berger G, 2012, J BIOL CHEM, V287, P41210, DOI 10.1074/jbc.M112.403816; Bloch N, 2014, AIDS RES HUM RETROV, V30, P195, DOI [10.1089/AID.2013.0119, 10.1089/aid.2013.0119]; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Cline AN, 2005, J MED PRIMATOL, V34, P303; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Dai L, 2013, J EXP MED, V210, P517, DOI 10.1084/jem.20120572; Dang Q, 2012, J VIROL, V86, P13795, DOI 10.1128/JVI.02174-12; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fregoso OI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003496; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Mejia ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2413, DOI 10.2741/3387; Gonzalez-Perez MP, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-20; Greter M, 2013, GLIA, V61, P121, DOI 10.1002/glia.22408; Heeregrave EJ, 2009, VIROLOGY, V393, P24, DOI 10.1016/j.virol.2009.07.011; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Igarashi T, 2003, J LEUKOCYTE BIOL, V74, P772, DOI 10.1189/jlb.0503196; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Ortiz AM, 2011, J CLIN INVEST, V121, P4433, DOI 10.1172/JCI46023; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; Spits H, 2002, NAT REV IMMUNOL, V2, P760, DOI 10.1038/nri913; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; van Furth R, 1989, Curr Top Pathol, V79, P125; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Westmoreland SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084463; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yao R, 2007, LEUKEMIA LYMPHOMA, V48, P837, DOI 10.1080/10428190601187729	48	82	82	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					493	502		10.1016/j.immuni.2014.08.014	http://dx.doi.org/10.1016/j.immuni.2014.08.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238099	Bronze, Green Accepted			2022-12-18	WOS:000342626500018
J	Klose, CSN; Blatz, K; d'Hargues, Y; Hernandez, PP; Kofoed-Nielsen, M; Ripka, JF; Ebert, K; Arnold, SJ; Diefenbach, A; Palmer, E; Tanriver, Y				Klose, Christoph S. N.; Blatz, Katharina; d'Hargues, Yannick; Hernandez, Pedro P.; Kofoed-Nielsen, Michael; Ripka, Juliane F.; Ebert, Karolina; Arnold, Sebastian J.; Diefenbach, Andreas; Palmer, Ed; Tanriver, Yakup			The Transcription Factor T-bet Is Induced by IL-15 and Thymic Agonist Selection and Controls CD8 alpha alpha(+) Intraepithelial Lymphocyte Development	IMMUNITY			English	Article							CELL-RECEPTOR; CUTTING EDGE; ALPHA-BETA; DIFFERENTIATION; HOMEOSTASIS; PRECURSORS; EXPRESSION; FATE; EOMESODERMIN; REPERTOIRE	CD8 alpha alpha(+) intraepithelial lymphocytes (IELs) are instrumental in maintaining the epithelial barrier in the intestine. Similar to natural killer cells and other innate lymphoid cells, CD8 alpha alpha(+) IELs constitutively express the T-box transcription factor T-bet. However, the precise role of T-bet for the differentiation or function of IELs is unknown. Here we show that mice genetically deficient for T-bet lacked both TCR alpha beta(+) and TCR gamma delta(+) CD8 alpha alpha(+) IELs and thus are more susceptible to chemically induced colitis. Although T-bet was induced in thymic IEL precursors (IELPs) as a result of agonist selection and interleukin-15 (IL-15) receptor signaling, it was dispensable for the generation of IELPs. Subsequently, T-bet was required for the IL-15-dependent activation, differentiation, and expansion of IELPs in the periphery. Our study reveals a function of T-bet as a central transcriptional regulator linking agonist selection and IL-15 signaling with the emergence of CD8 alpha alpha(+) IELs.	[Klose, Christoph S. N.; Blatz, Katharina; d'Hargues, Yannick; Hernandez, Pedro P.; Kofoed-Nielsen, Michael; Ripka, Juliane F.; Ebert, Karolina; Tanriver, Yakup] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Klose, Christoph S. N.; Blatz, Katharina; d'Hargues, Yannick; Ripka, Juliane F.; Ebert, Karolina; Arnold, Sebastian J.; Tanriver, Yakup] Univ Freiburg, Med Ctr, Dept Internal Med 4, D-79106 Freiburg, Germany; [Hernandez, Pedro P.; Kofoed-Nielsen, Michael; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Kofoed-Nielsen, Michael] Int Max Planck Res Sch Mol & Cellular Biol, D-79108 Freiburg, Germany; [Ebert, Karolina] Fac Biol, D-79104 Freiburg, Germany; [Arnold, Sebastian J.] BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Palmer, Ed] Univ Basel Hosp, Dept Biomed, Lab Transplantat Immunol, CH-4031 Basel, Switzerland; [Palmer, Ed] Univ Basel Hosp, Dept Nephrol, Lab Transplantat Immunol, CH-4031 Basel, Switzerland	University of Freiburg; University of Freiburg; Johannes Gutenberg University of Mainz; Max Planck Society; University of Basel; University of Basel	Tanriver, Y (corresponding author), Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany.	yakup.tanriver@uniklinik-freiburg.de	Hernandez, Pedro P/K-4783-2015; Klose, Christoph/ABE-6396-2020; Tanriver, Yakup/AAU-7064-2020; Hernandez, Pedro/X-2121-2019; Diefenbach, Andreas/T-2589-2018	Hernandez, Pedro P/0000-0002-2873-4298; Hernandez, Pedro/0000-0002-2873-4298; Diefenbach, Andreas/0000-0002-9176-9530; Tanriver, Yakup/0000-0002-4806-2548	Deutsche Forschungsgemeinschaft [SFB992, AR732/1-1, TA436/2-1, TA436/3-1]; German Federal Ministry of Education and Research, BMBF [01 EO 0803]; SNF [310030B_133131/1]; EU; ERC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); SNF; EU(European Commission); ERC(European Research Council (ERC)European Commission)	We thank G. Hacker and G. Walz for support; the members of the Diefenbach laboratory for discussions; H. Pircher for comments on the manuscript; and I. Prinz and P. Pereira for providing the clone F2.67. We are grateful to M. Follo and D. Herchenbach for cell sorting; K. Oberle and C. Fabiunke for technical assistance. Work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB992 to A.D., AR732/1-1 to S.J.A., and TA436/2-1, TA436/3-1 to Y.T.), the German Federal Ministry of Education and Research, BMBF 01 EO 0803 (to A.D.), the SNF (310030B_133131/1 to E.P.), the EU FP7 (Sybilla to E.P.), and the ERC (NutrImmune to A.D. and TerraIncognita to E.P.).	Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Grange M, 2013, J IMMUNOL, V191, P3712, DOI 10.4049/jimmunol.1300319; Huss DJ, 2010, J IMMUNOL, V184, P5628, DOI 10.4049/jimmunol.1000288; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Lai YG, 2008, J IMMUNOL, V180, P3757, DOI 10.4049/jimmunol.180.6.3757; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Ma LJ, 2009, J IMMUNOL, V183, P1044, DOI 10.4049/jimmunol.0900420; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muller S, 2000, J IMMUNOL, V164, P1986, DOI 10.4049/jimmunol.164.4.1986; Nakazato K, 2007, J IMMUNOL, V178, P757, DOI 10.4049/jimmunol.178.2.757; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yu QS, 2006, J IMMUNOL, V176, P6180, DOI 10.4049/jimmunol.176.10.6180	48	82	84	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					230	243		10.1016/j.immuni.2014.06.018	http://dx.doi.org/10.1016/j.immuni.2014.06.018			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148024	Bronze			2022-12-18	WOS:000341455300011
J	Jin, J; Hu, HB; Li, HYS; Yu, JY; Xiao, YC; Brittain, GC; Zou, Q; Cheng, XH; Mallette, FA; Watowich, SS; Sun, SC				Jin, Jin; Hu, Hongbo; Li, Haiyan S.; Yu, Jiayi; Xiao, Yichuan; Brittain, George C.; Zou, Qiang; Cheng, Xuhong; Mallette, Frederick A.; Watowich, Stephanie S.; Sun, Shao-Cong			Noncanonical NF-kappa B Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity	IMMUNITY			English	Article							GENE-EXPRESSION; IFN-BETA; KINASE; ACTIVATION; ALPHA; TRAF3; INDUCTION; COMPLEX; UBIQUITINATION; METHYLATION	Production of type I interferons (IFN-I) is a crucial innate immune mechanism against viral infections. IFN-I induction is subject to negative regulation by both viral and cellular factors, but the underlying mechanism remains unclear. We report that the noncanonical NF-kappa B pathway was stimulated along with innate immune cell differentiation and viral infections and had a vital role in negatively regulating IFN-I induction. Genetic deficiencies in major components of the noncanonical NF-kappa B pathway caused IFN-I hyperinduction and rendered cells and mice substantially more resistant to viral infection. Noncanonical NF-kappa B suppressed signal-induced histone modifications at the Ifnb promoter, an action that involved attenuated recruitment of the transcription factor RelA and a histone demethylase, JMJD2A. These findings reveal an unexpected function of the noncanonical NF-kappa B pathway and highlight an important mechanism regulating antiviral innate immunity.	[Jin, Jin; Hu, Hongbo; Li, Haiyan S.; Yu, Jiayi; Xiao, Yichuan; Brittain, George C.; Zou, Qiang; Cheng, Xuhong; Watowich, Stephanie S.; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Mallette, Frederick A.] Univ Montreal, Dept Med, Montreal, PQ H1T 2M4, Canada; [Watowich, Stephanie S.; Sun, Shao-Cong] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Universite de Montreal	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Hu, Hongbo/J-8059-2016; Mallette, Frédérick A./J-6646-2019; Yu, Jiayi/I-5923-2014	Hu, Hongbo/0000-0002-8177-7641; Mallette, Frédérick A./0000-0001-7932-0338; Zou, Qiang/0000-0002-1362-2007; Watowich, Stephanie/0000-0003-1969-659X; Jin, Jin/0000-0001-7887-5972	NIH/NCI [P30CA016672]; National Institutes of Health [AI057555, AI064639, AI104519, GM84459]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064639, R01AI057555, R01AI104519, R01AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Amgen, Bristol-Myers Squibb Pharmaceutical Research Institute, R Starr, and Walter Eliza Hall Institute of Medical Research for mutant mice; L. Schmitz (Justus-Liebig-University), H.J. Kung (University of California, Davis), J. Pagano (University of North Carolina), and D. Thanos (Academy of Athens) for plasmid vectors; L. F. Chen (University of Illinois) and P. Chiao (MD Anderson Cancer Center) for Rela<SUP>-/-</SUP> MEFs; and G. Barber (University of Miami) and J. Bell (University of Ottawa) for VSV viruses. We also thank the personnel from the NIH/NCI-supported resources (Flow Cytometry, DNA Analysis, and Genetically Engineered Mouse core facilities) under award number P30CA016672 at The MD Anderson Cancer Center. This study was supported by grants from National Institutes of Health (AI057555, AI064639, AI104519, and GM84459).	ASANO M, 1990, VIROLOGY, V176, P30, DOI 10.1016/0042-6822(90)90227-I; Bartlett NW, 2012, EMBO MOL MED, V4, P1244, DOI 10.1002/emmm.201201650; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Manches O, 2012, P NATL ACAD SCI USA, V109, P14122, DOI 10.1073/pnas.1204032109; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Miosge LA, 2002, J EXP MED, V196, P1113, DOI 10.1084/jem.20020959; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Ruckle A, 2012, J VIROL, V86, P10211, DOI 10.1128/JVI.00323-12; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	45	82	86	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					342	354		10.1016/j.immuni.2014.02.006	http://dx.doi.org/10.1016/j.immuni.2014.02.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656046	Green Accepted, Bronze			2022-12-18	WOS:000333422300008
J	Baghdadi, M; Yoneda, A; Yamashina, T; Nagao, H; Komohara, Y; Nagai, S; Akiba, H; Foretz, M; Yoshiyama, H; Kinoshita, I; Dosaka-Akita, H; Takeya, M; Viollet, B; Yagita, H; Jinushi, M				Baghdadi, Muhammad; Yoneda, Akihiro; Yamashina, Tsunaki; Nagao, Hiroko; Komohara, Yoshihiro; Nagai, Shigenori; Akiba, Hisaya; Foretz, Marc; Yoshiyama, Hironori; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Takeya, Motohiro; Viollet, Benoit; Yagita, Hideo; Jinushi, Masahisa			TIM-4 Glycoprotein-Mediated Degradation of Dying Tumor Cells by Autophagy Leads to Reduced Antigen Presentation and Increased Immune Tolerance	IMMUNITY			English	Article							CANCER; MACROPHAGES; CLEARANCE; AMPK; PHOSPHATIDYLSERINE; PHOSPHORYLATION; AUTOIMMUNITY; METABOLISM; DEATH	Phagocytosis of apoptotic cells by myeloid cells has been implicated in the maintenance of immune homeostasis. In this study, we found that T cell immunoglobulin-and mucin domain-containing molecule-4 (TIM-4) repressed tumor-specific immunity triggered by chemotherapy-induced tumor cell death. TIM-4 was found to be highly expressed on tumor-associated myeloid cells such as macrophages (TAMs) and dendritic cells (TADCs) and danger-associated molecular patterns (DAMPs) released from chemotherapy-damaged tumor cells induced TIM-4 on tumor-associated myeloid cells recruited from bone marrow-derived precursors. TIM-4 directly interacted with AMPK alpha 1 and activated autophagy-mediated degradation of ingested tumors, leading to reduced antigen presentation and impaired CTL responses. Consistently, blockade of the TIM-4-AMPK alpha 1-autophagy pathway augmented the antitumor effect of chemotherapeutics by enhancing tumor-specific CTL responses. Our finding provides insight into the immune tolerance mediated by phagocytosis of dying cells, and targeting of the TIM-4-AMPK alpha 1 interaction constitutes a unique strategy for augmenting antitumor immunity and improving cancer chemotherapy.	[Baghdadi, Muhammad; Yoneda, Akihiro; Yamashina, Tsunaki; Nagao, Hiroko; Yoshiyama, Hironori; Jinushi, Masahisa] Hokkaido Univ, Inst Med Genet, Res Ctr Infect Associated Canc, Sapporo, Hokkaido 0600815, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; [Nagai, Shigenori] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo 1138549, Japan; [Akiba, Hisaya] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Foretz, Marc; Viollet, Benoit] INSERM, Inst Cochin, U1016, Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 0600815, Japan	Hokkaido University; Kumamoto University; Tokyo Medical & Dental University (TMDU); Juntendo University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hokkaido University	Jinushi, M (corresponding author), Hokkaido Univ, Inst Med Genet, Res Ctr Infect Associated Canc, Sapporo, Hokkaido 0600815, Japan.	jinushi@igm.hokudai.ac.jp	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Yoshiyama, Hironori/H-5674-2019; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Yoshiyama, Hironori/0000-0001-7588-278X; FORETZ, Marc/0000-0001-7017-9032; Baghdadi, Muhammad/0000-0002-2347-8889; Nagai, Shigenori/0000-0002-5018-5942	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [25112701, 25461503] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Wang and W. Ouyang (Genentech) for providing TIM-4 knockout mice, N. Mizushima (University of Tokyo) for Atg-5flox/flox mice and LC3-GFP transgenic mice, Y. Morioka (Hokkaido University) and M. Okabe (Osaka University) for GFP-transgenic mice, and R. DePinho (University of Texas MD Anderson Cancer Center) for LKB1<SUP>flox/flox</SUP> mice. We also extend appreciation to K. Akashi (Kyusyu University) and G. Dranoff (Harvard Medical School) for giving valuable comments and advice on the manuscript. This study is partially supported by a Grant-in-Aid for Scientific Research and Scientific Research for Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Ministry of Health, Labour and Welfare (M.J.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Griffith TS, 2011, IMMUNITY, V35, P456, DOI 10.1016/j.immuni.2011.08.011; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peggs KS, 2007, CANCER CELL, V12, P192, DOI 10.1016/j.ccr.2007.08.023; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang Z., 2010, J BIOL CHEM, V285, P1892	32	82	84	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1070	1081		10.1016/j.immuni.2013.09.014	http://dx.doi.org/10.1016/j.immuni.2013.09.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24315994	Bronze			2022-12-18	WOS:000330951000013
J	Blanco-Melo, D; Venkatesh, S; Bieniasz, PD				Blanco-Melo, Daniel; Venkatesh, Siddarth; Bieniasz, Paul D.			Intrinsic Cellular Defenses against Human Immunodeficiency Viruses	IMMUNITY			English	Review							RESTRICTION FACTOR SAMHD1; SMALL-MOLECULE INHIBITION; RETROVIRAL RESTRICTION; HIV-1 INFECTION; TRIM5-ALPHA RESTRICTION; ANTIRETROVIRAL ACTIVITY; APOBEC3B DELETION; TYPE-1 INFECTION; IN-VITRO; GENE	Viral infections are often detrimental to host survival and reproduction. Consequently, hosts have evolved a variety of mechanisms to defend themselves against viruses. A component of this arsenal is a set of proteins, termed restriction factors, which exhibit direct antiviral activity. Among these are several classes of proteins (APOBEC3, TRIM5, Tetherin, and SAMHD1) that inhibit the replication of human and simian immunodeficiency viruses. Here, we outline the features, mechanisms, and evolution of these defense mechanisms. We also speculate on how restriction factors arose, how they might interact with the conventional innate and adaptive immune systems, and how an understanding of these intrinsic cellular defenses might be usefully exploited.	[Blanco-Melo, Daniel; Venkatesh, Siddarth; Bieniasz, Paul D.] Rockefeller Univ, Howard Hughes Med Inst, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University	Bieniasz, PD (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	pbienias@adarc.org	Blanco-Melo, Daniel/AAG-3682-2020	Blanco-Melo, Daniel/0000-0002-0256-5019	NIH [R01AI050111, R37AI0664003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064003, R01AI050111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We apologize to those investigators whose work was not cited due to space constraints. We are grateful to V. Chandrasekaran and W. Sundquist for providing the high-resolution image of HIV-1 capsid. Work in our laboratory on restriction factors is supported by the NIH (grants R01AI050111 and R37AI0664003). P.D.B. is an Investigator of the Howard Hughes Medical Institute.	An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Autore F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011515; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bizinoto MC, 2011, AIDS RES HUM RETROV, V27, P137, DOI 10.1089/aid.2010.0146; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Do H, 2005, J INFECT DIS, V191, P159, DOI 10.1086/426826; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Gaddis NC, 2004, J VIROL, V78, P12041, DOI 10.1128/JVI.78.21.12041-12046.2004; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goldstone DC, 2010, CELL HOST MICROBE, V8, P248, DOI 10.1016/j.chom.2010.08.006; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Itaya S, 2010, J INFECT DIS, V202, P815, DOI 10.1086/655227; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kratovac Z, 2008, J VIROL, V82, P6772, DOI 10.1128/JVI.00410-08; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lee YN, 2008, J VIROL, V82, P8762, DOI 10.1128/JVI.00751-08; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Liu FL, 2011, JAIDS-J ACQ IMM DEF, V56, P306, DOI 10.1097/QAI.0b013e318205a59b; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Meyerson NR, 2011, TRENDS MICROBIOL, V19, P286, DOI 10.1016/j.tim.2011.03.006; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Perez-Caballero D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000181; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Sastri J, 2011, AIDS RES HUM RETROV, V27, P231, DOI [10.1089/aid.2010.0367, 10.1089/AID.2010.0367]; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.cub.2005.11.045; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stoye JP, 2008, P NATL ACAD SCI USA, V105, P3177, DOI 10.1073/pnas.0800667105; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Torimiro JN, 2009, VIROLOGY, V391, P140, DOI 10.1016/j.virol.2009.05.038; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Manen D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040018; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Weissenhorn W, 2012, CURR HIV RES, V10, P298, DOI 10.2174/157016212800792487; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2006, J VIROL, V80, P4061, DOI 10.1128/JVI.80.8.4061-4067.2006; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002039; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	106	82	88	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					399	411		10.1016/j.immuni.2012.08.013	http://dx.doi.org/10.1016/j.immuni.2012.08.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999946	Green Accepted, Bronze			2022-12-18	WOS:000309199000003
J	Endo, Y; Iwamura, C; Kuwahara, M; Suzuki, A; Sugaya, K; Tumes, DJ; Tokoyoda, K; Hosokawa, H; Yamashita, M; Nakayama, T				Endo, Yusuke; Iwamura, Chiaki; Kuwahara, Makoto; Suzuki, Akane; Sugaya, Kaoru; Tumes, Damon J.; Tokoyoda, Koji; Hosokawa, Hiroyuki; Yamashita, Masakatsu; Nakayama, Toshinori			Eomesodermin Controls Interleukin-5 Production in Memory T Helper 2 Cells through Inhibition of Activity of the Transcription Factor GATA3	IMMUNITY			English	Article							T-CELL; VIRAL-INFECTION; HELPER-CELLS; GENE LOCUS; DIFFERENTIATION; EFFECTOR; CD4(+); MAINTENANCE; EXPRESSION; CYTOKINE	The regulation of memory CD4(+) helper T (Th) cell function, such as polarized cytokine production, remains unclear. Here we show that memory T helper 2 (Th2) cells are divided into four subpopulations by CD62L and CXCR3 expression. All four subpopulations produced interleukin-4 (IL-4) and IL-13, whereas only the CD62L(lo)CXCR3(lo) population produced IL-5 accompanied by increased H3-K4 methylation at the 115 gene locus. The transcription factor Eomesodermin (encoded by Eomes) was highly expressed in memory Th2 cells, whereas its expression was selectively downregulated in the IL-5-producing cells. 115 expression was enhanced in Eomes-deficient cells, and Eomesodermin was shown to interact with the transcription factor GATA3, preventing GATA3 binding to the 115 promoter. Memory Th2 cell-dependent airway inflammation was attenuated in the absence of the CD62L(lo)CXCR3(lo) population but was enhanced by Eomes-deficient memory Th2 cells. Thus, IL-5 production in memory Th2 cells is regulated by Eomesodermin via the inhibition of GATA3 activity.	[Endo, Yusuke; Iwamura, Chiaki; Kuwahara, Makoto; Suzuki, Akane; Sugaya, Kaoru; Tumes, Damon J.; Tokoyoda, Koji; Hosokawa, Hiroyuki; Yamashita, Masakatsu; Nakayama, Toshinori] Chiba Univ, Dept Immunol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Nakayama, Toshinori] JST, CREST, Chuo Ku, Chiba 2608670, Japan	Chiba University; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Dept Immunol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Tumes, Damon J/B-9917-2009; Nakayama, Toshinori/E-1067-2017	Tumes, Damon J/0000-0001-5709-857X; Nakayama, Toshinori/0000-0002-1434-2007; Hosokawa, Hiroyuki/0000-0002-9592-2889; Sugaya, Kiminobu/0000-0002-2788-5457; Tokoyoda, Koji/0000-0001-6101-4826	Global Center for Education and Research in Immune System Regulation and Treatment; MEXT (Japan); Ministry of Education, Culture, Sports, Science and Technology (Japan) [17016010, 20060003, 22021011, 21390147, 22790452]; JSPS [21.09747]; Grants-in-Aid for Scientific Research [22021008, 22689014] Funding Source: KAKEN	Global Center for Education and Research in Immune System Regulation and Treatment; MEXT (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to R. Kubo for his helpful comments and constructive criticisms in the preparation of the manuscript. We thank H. Asou, M. Kato, and T. Ito for their excellent technical assistance. This work was supported by Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), City Area Program (Kazusa/Chiba Area) MEXT (Japan), and by grants from the Ministry of Education, Culture, Sports, Science and Technology (Japan) (Grants-in-Aid: for Scientific Research on Priority Areas #17016010, #20060003, #22021011; Scientific Research [B] #21390147, Young Scientists [B] #22790452, and [JSPS fellows] #21.09747).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	48	82	82	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					733	745		10.1016/j.immuni.2011.08.017	http://dx.doi.org/10.1016/j.immuni.2011.08.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118525	Bronze			2022-12-18	WOS:000297390800013
J	Nolz, JC; Harty, JT				Nolz, Jeffrey C.; Harty, John T.			Protective Capacity of Memory CD8(+) T Cells Is Dictated by Antigen Exposure History and Nature of the Infection	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; SELECTIN-DEFICIENT MICE; PERIPHERAL LYMPHOID ORGANS; IMMUNE-SYSTEM; EXHAUSTION; RESPONSES; VACCINE; DISEASE; VIRUS; DIFFERENTIATION	Infection or vaccination confers heightened resistance to pathogen rechallenge because of quantitative and qualitative differences between naive and primary memory T cells. Herein, we show that secondary (boosted) memory CD8(+) T cells were better than primary memory CD8(+) T cells in controlling some, but not all acute infections with diverse pathogens. However, secondary memory CD8(+) T cells were less efficient than an equal number of primary memory cells at preventing chronic LCMV infection and are more susceptible to functional exhaustion. Importantly, localization of memory CD8(+) T cells within lymph nodes, which is reduced by antigen restimulation, was critical for both viral control in lymph nodes and for the sustained CD8(+) T cell response required to prevent chronic LCMV infection. Thus, repeated antigen stimulation shapes memory CD8(+) T cell populations to either enhance or decrease per cell protective immunity in a pathogen-specific manner, a concept of importance in vaccine design against specific diseases.	[Nolz, Jeffrey C.; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		Harty, John/0000-0001-7266-2802	National Institutes of Health [AI42767, AI46653, AI50073, AI59752]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042767, R01AI046653, R01AI042767, R01AI059752, R01AI050073, R21AI042767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI42767, AI46653, AI50073, and AI59752; J.T.H.) and a Career Development Award from The Leukemia and Lymphoma Society (J.C.N.). The authors would like to thank members of the Harty Lab for helpful discussions and V. Badovinac, S. Perlman, and S. Varga for critical review of the manuscript. We thank S. Perlman and J. Netland for reagents and technical assistance with MHV and L. Epping, L. Hancox and J. Hoang for technical assistance. J.C.N. designed and performed experiments, analyzed data, and wrote the paper. J.T.H. designed experiments, analyzed data, and wrote the paper.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; BANKS TA, 1995, J IMMUNOL, V155, P1685; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Chen G, 2001, BLOOD, V98, P156, DOI 10.1182/blood.V98.1.156; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Quadros CA, 2002, MED MICROBIOL IMMUN, V191, P75, DOI 10.1007/s00430-002-0120-7; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim TS, 2003, J IMMUNOL, V171, P2006, DOI 10.4049/jimmunol.171.4.2006; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Steeber DA, 1996, J IMMUNOL, V157, P1096; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Xu JC, 1996, J EXP MED, V183, P589, DOI 10.1084/jem.183.2.589	41	82	85	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					781	793		10.1016/j.immuni.2011.03.020	http://dx.doi.org/10.1016/j.immuni.2011.03.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21549619	Bronze, Green Accepted			2022-12-18	WOS:000291456500016
J	Ehrlich, LIR; Oh, DY; Weissman, IL; Lewis, RS				Ehrlich, Lauren I. Richie; Oh, David Y.; Weissman, Irving L.; Lewis, Richard S.			Differential Contribution of Chemotaxis and Substrate Restriction to Segregation of Immature and Mature Thymocytes	IMMUNITY			English	Article							COMMON LYMPHOID PROGENITORS; PROMISCUOUS GENE-EXPRESSION; THYMIC EPITHELIAL-CELLS; POSITIVELY SELECTED THYMOCYTES; PERTUSSIS TOXIN; CCR7 LIGANDS; BONE-MARROW; NEGATIVE SELECTION; MEDULLA MIGRATION; CENTRAL TOLERANCE	T cell development requires sequential localization of thymocyte subsets to distinct thymic microenvironments. To address mechanisms governing this segregation, we used two-photon microscopy to visualize migration of purified thymocyte subsets in defined microenvironments within thymic slices. Double-negative (CD4(-)8) and double-positive (CD4(+)8(+)) thymocytes were confined to cortex where they moved slowly without directional bias. DP cells accumulated and migrated more rapidly in a specialized inner-cortical microenvironment, but were unable to migrate on medullary substrates. In contrast, CD4 single positive (SIP) thymocytes migrated directionally toward the medulla, where they accumulated and moved very rapidly. Our results revealed a requisite two-step process governing CD4 SP cell medullary localization: the chemokine receptor CCR7 mediated chemotaxis of CD4 SIP cells towards medulla, whereas a distinct pertussis-toxin sensitive pathway was required for medullary entry. These findings suggest that developmentally regulated responses to both chemotactic signals and specific migratory substrates guide thymocytes to specific locations in the thymus.	[Ehrlich, Lauren I. Richie; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Oh, David Y.; Lewis, Richard S.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	irv@stanford.edu; rslewis@stanford.edu		Ehrlich, Lauren/0000-0002-1697-1755; Lewis, Richard/0000-0002-6010-7403	Leukemia and Lymphoma Society; NIGMS; Institute of Stem Cell Biology and Regenerative Medicine; Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institute of Stem Cell Biology and Regenerative Medicine; Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S Hestrin for use of his microscope, R Tsien for use of his vibratome, T. Serwold for providing LN3 beta x Rag2 <SUP>/</SUP> mice, and J Cyster for sharing Ccr7 <SUP>/</SUP> mice This work was supported by a Special Fellow Career Development award from the Leukemia and Lymphoma Society (L I R E), a Medical Scientist Training Program grant from NIGMS (D Y O.), general funds of the Institute of Stem Cell Biology and Regenerative Medicine (I L W), and the Mathers Charitable Foundation and an R01 grant from NIGMS (R S L)	Alfano M, 1999, J EXP MED, V190, P597, DOI 10.1084/jem.190.5.597; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; BRAHIM F, 1970, ANAT REC, V168, P139, DOI 10.1002/ar.1091680202; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; FARR AG, 1985, J IMMUNOL, V134, P2971; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Ladi E, 2008, J IMMUNOL, V181, P7014, DOI 10.4049/jimmunol.181.10.7014; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Misslitz A, 2006, IMMUNOL REV, V209, P115, DOI 10.1111/j.0105-2896.2006.00351.x; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Prockop SE, 2002, J IMMUNOL, V169, P4354, DOI 10.4049/jimmunol.169.8.4354; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Serwold T, 2009, BLOOD, V113, P807, DOI 10.1182/blood-2008-08-173682; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STRNAD CF, 1987, FEBS LETT, V225, P16, DOI 10.1016/0014-5793(87)81123-7; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018; Uehara S, 2006, J IMMUNOL, V176, P75, DOI 10.4049/jimmunol.176.1.75; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Witt CM, 2005, SEMIN IMMUNOL, V17, P95, DOI 10.1016/j.smim.2004.09.008; Wong WSF, 1996, CAN J PHYSIOL PHARM, V74, P559, DOI 10.1139/cjpp-74-5-559; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	56	82	82	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					986	998		10.1016/j.immuni.2009.09.020	http://dx.doi.org/10.1016/j.immuni.2009.09.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	19962328	Green Accepted, Bronze			2022-12-18	WOS:000273616400018
J	Zhou, J; Cheng, PY; Youn, JI; Cotter, MJ; Gabrilovich, DI				Zhou, Jie; Cheng, Pingyan; Youn, Je-In; Cotter, Matthew J.; Gabrilovich, Dmitry I.			Notch and Wingless Signaling Cooperate in Regulation of Dendritic Cell Differentiation	IMMUNITY			English	Article							BONE-MARROW STROMA; BETA-CATENIN; LIGAND DELTA-1; T-CELLS; WNT; EXPRESSION; MONOCYTES; PATHWAY; LYMPHOPOIESIS; HEMATOPOIESIS	Dendritic cell (DC) differentiation is regulated by stroma via a network of soluble and cell-bound factors. Notch is one of the major elements of this network. Its role in DC differentiation, however, is controversial. Here, we demonstrate that activation of Notch signaling in hematopoietic progenitor cells (HPCs) promoted differentiation of conventional DCs via activation of the canonical Wingless (Wnt) pathway. Inhibition of the Wnt pathway abrogated the effect of Notch on DC differentiation. The fact that activation of the Wnt pathway in Notch-1-deficient embryonic stem cells restored DC differentiation indicates that Wnt signaling is downstream of the Notch pathway in regulating DC differentiation. Notch signaling activated the Wnt pathway in HPCs via expression of multiple members of the Frizzled family of Wnt receptors, which was directly regulated by the CSL (RPB-J kappa) transcription factor. Thus, these data suggest a model of DC differentiation via cooperation between Wnt and Notch pathways.	[Zhou, Jie; Cheng, Pingyan; Youn, Je-In; Cotter, Matthew J.; Gabrilovich, Dmitry I.] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Gabrilovich, Dmitry I.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Gabrilovich, Dmitry I.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Gabrilovich, DI (corresponding author), Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	dmitry.gabrilovich@moffitt.org	Gabrilovich, Dmitry/ABE-7122-2020		NATIONAL CANCER INSTITUTE [R01CA100062] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100062-05, R01 CA100062] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Aoyama K, 2007, STEM CELLS, V25, P2488, DOI 10.1634/stemcells.2007-0102; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Cheng PY, 2007, BLOOD, V109, P507, DOI 10.1182/blood-2006-05-025601; Cheng PY, 2003, BLOOD, V102, P3980, DOI 10.1182/blood-2003-04-1034; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; De Smedt M, 2005, BLOOD, V106, P3498, DOI 10.1182/blood-2005-02-0496; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ferrero I, 2002, BLOOD, V100, P2852, DOI 10.1182/blood-2002-01-0214; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Heinz LX, 2006, BLOOD, V107, P1445, DOI 10.1182/blood-2005-04-1721; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hoshino N, 2005, J LEUKOCYTE BIOL, V78, P921, DOI 10.1189/jlb.1204746; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mizutani K, 2000, CELL STRUCT FUNCT, V25, P21, DOI 10.1247/csf.25.21; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2008, BLOOD, V111, P2220, DOI 10.1182/blood-2007-07-102632; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Olivier A, 2006, BLOOD, V107, P2694, DOI 10.1182/blood-2005-03-0970; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158	44	82	90	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					845	859		10.1016/j.immuni.2009.03.021	http://dx.doi.org/10.1016/j.immuni.2009.03.021			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19523851	Green Accepted, Bronze			2022-12-18	WOS:000267270700012
J	Tassi, I; Cella, M; Gilfillan, S; Turnbull, I; Diacovo, TG; Penninger, JM; Colonna, M				Tassi, Ilaria; Cella, Marina; Gilfillan, Susan; Turnbull, Isaiah; Diacovo, Thomas G.; Penninger, Josef M.; Colonna, Marco			p110 gamma and p110 delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; B-CELL; GRANULE RELEASE; CUTTING EDGE; T-CELLS; ACTIVATION; CYTOTOXICITY; KINASE; PI3K-GAMMA	Phosphoinositide 3-kinases (PI-3Ks) are key enzymes for cell development, activation, and survival. Here we showed that PI-3K class IB and class IA catalytic subunits, p110 gamma and p110 delta, played a crucial role in the development and functions of murine NK cells. p110 gamma deficiency and impairment of G protein-coupled receptor (GPRC) signaling prevented full NK cell maturation. Concomitant loss of p110 gamma and p110 delta exacerbated this defect, resulting in a very small population of NK cells with a highly immature phenotype in the bone marrow and periphery. Moreover, combined p110 gamma and p110 delta signals were required for cytotoxicity and activation of the kinase ERK during NK cell-target cell interaction. p110 gamma played a major role in receptor-induced interferon-gamma (IFN-gamma) production through a pathway that involved the kinase ERK and 5-Lipoxigenase, which most likely generates lipid mediators activating GPRCs. Conversely, P13Ks negatively regulated interleukin-12 (IL-12) and IL-18-induced IFN-gamma by modulating p38 kinase activation. Our data shed light on the multiple intersecting pathways through which P13Ks; control NK cell-mediated innate responses.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Columbia Presbyterian Med Ctr, Dept Pathol, Dept Pediat, New York, NY 10032 USA; Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria	Washington University (WUSTL); Columbia University; NewYork-Presbyterian Hospital; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/ABA-8564-2020; Penninger, Josef M/I-6860-2013; Cella, Marina/G-8850-2011	Penninger, Josef M/0000-0002-8194-3777; tassi, ilaria/0000-0002-5803-9499; Cella, Marina/0000-0003-1230-1313; Colonna, Marco/0000-0001-5222-4987	NHLBI NIH HHS [HL75805-2] Funding Source: Medline; NIAID NIH HHS [R01AI056139] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056139] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Cerboni C, 1998, EUR J IMMUNOL, V28, P1005, DOI 10.1002/(SICI)1521-4141(199803)28:03<1005::AID-IMMU1005>3.0.CO;2-O; Cifone MG, 1997, J IMMUNOL, V159, P309; CIFONE MG, 1993, CELL IMMUNOL, V148, P247, DOI 10.1006/cimm.1993.1109; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Curnock AP, 2003, J IMMUNOL, V170, P4021, DOI 10.4049/jimmunol.170.8.4021; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Egerton M, 1996, EUR J IMMUNOL, V26, P2279, DOI 10.1002/eji.1830261002; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lian RH, 2004, EUR J IMMUNOL, V34, P2699, DOI 10.1002/eji.200425394; Lian RH, 2002, SEMIN IMMUNOL, V14, P453, DOI 10.1016/S1044532302000805; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ortaldo JR, 2006, BLOOD, V107, P1468, DOI 10.1182/blood-2005-04-1579; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Saudemont A, 2007, BIOCHEM SOC T, V35, P183, DOI 10.1042/BST0350183; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Swat W, 2006, BLOOD, V107, P2415, DOI 10.1182/blood-2005-08-3300; Trotta R, 1998, J IMMUNOL, V161, P6648; Trotta R, 2000, J IMMUNOL, V165, P1782, DOI 10.4049/jimmunol.165.4.1782; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Young SM, 2006, CELL SIGNAL, V18, P608, DOI 10.1016/j.cellsig.2005.06.005; Zhong B, 2002, IMMUNOBIOLOGY, V205, P74, DOI 10.1078/0171-2985-00112; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	54	82	85	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					214	227		10.1016/j.immuni.2007.07.014	http://dx.doi.org/10.1016/j.immuni.2007.07.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723215	Bronze			2022-12-18	WOS:000249056300009
J	Saleh, A; Davies, GE; Pascal, V; Wright, PW; Hodge, DL; Cho, EH; Lockett, SJ; Abshari, M; Anderson, SK				Saleh, A; Davies, GE; Pascal, V; Wright, PW; Hodge, DL; Cho, EH; Lockett, SJ; Abshari, M; Anderson, SK			Identification of probabilistic transcriptional switches in the Ly49 gene cluster: A eukaryotic mechanism for selective gene activation	IMMUNITY			English	Article							NK CELL-RECEPTOR; REGULATORY ELEMENT; C57BL/6 MICE; BONE-MARROW; IN-VITRO; EXPRESSION; FAMILY; REPERTOIRE; DNA; PROMOTER	Murine natural killer cells selectively express members of the Ly49 family of class I MHC receptors; however, the molecular mechanism controlling probabilistic expression of Ly49 proteins has not been defined. A pair of overlapping, divergent promoters discovered in the Ly49g gene functions as a molecular switch that can produce a forward transcript containing the coding region of the gene (on position) or a noncoding transcript in the opposite direction (off position), and this element maintains transcription in the chosen direction. Competition of C/EBP and TBP transcription factors for overlapping binding sites determines the relative strength of the competing promoters and the probability of transcription in a given direction. Similar elements precede all Ly49 family members, and the relative strength of the forward promoter in each inhibitory Ly49 gene correlates with the percentage of natural killer cells that express a given receptor, supporting a promoter competition model of selective gene activation.	NCI, Basic Res Program, Sci Applicat Int Corp, Frederick, MD 21702 USA; NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21702 USA; NCI, Image Anal Lab, Sci Applicat Int Corp, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Anderson, SK (corresponding author), NCI, Basic Res Program, Sci Applicat Int Corp, Frederick, MD 21702 USA.	andersn@ncifcrf.gov	Anderson, Stephen K/B-1727-2012; Cho, Edward/B-3727-2012	Anderson, Stephen K/0000-0002-7856-4266; Cho, Edward/0000-0002-0278-334X; Abshari, Mehrnoosh/0000-0003-4217-0625	NATIONAL CANCER INSTITUTE [Z01BC010013] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson SK, 2001, IMMUNOL REV, V181, P79, DOI 10.1034/j.1600-065X.2001.1810106.x; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Fraser KP, 2002, EUR J IMMUNOL, V32, P868, DOI 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Gosselin P, 2000, IMMUNOGENETICS, V51, P326, DOI 10.1007/s002510050626; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Held W, 1998, EUR J IMMUNOL, V28, P2407, DOI 10.1002/(SICI)1521-4141(199808)28:08&lt;2407::AID-IMMU2407&gt;3.0.CO;2-D; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Kubo S, 1999, BBA-GENE STRUCT EXPR, V1444, P191, DOI 10.1016/S0167-4781(98)00284-X; Kuboto A, 1999, J IMMUNOL, V163, P212; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; McQueen KL, 2001, IMMUNOGENETICS, V52, P212; MEYERHOF GG, 1993, P INT S LIM STAT DES, V1, P1; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Montmayeur JP, 2002, CURR OPIN NEUROBIOL, V12, P366, DOI 10.1016/S0959-4388(02)00345-8; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Osada S, 1996, J BIOL CHEM, V271, P3891; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Tanamachi DM, 2004, J IMMUNOL, V172, P1074, DOI 10.4049/jimmunol.172.2.1074; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Wilhelm BT, 2002, GENOMICS, V80, P646, DOI 10.1006/geno.2002.7004; Williams NS, 2000, EUR J IMMUNOL, V30, P2074, DOI 10.1002/1521-4141(200007)30:7<2074::AID-IMMU2074>3.0.CO;2-#	36	82	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					55	66		10.1016/j.immuni.2004.06.005	http://dx.doi.org/10.1016/j.immuni.2004.06.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345220	Bronze			2022-12-18	WOS:000222975500008
J	MacAry, PA; Javid, B; Floto, RA; Smith, KGC; Oehlmann, W; Singh, M; Lehner, PJ				MacAry, PA; Javid, B; Floto, RA; Smith, KGC; Oehlmann, W; Singh, M; Lehner, PJ			HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation	IMMUNITY			English	Article							HEAT-SHOCK PROTEINS; CLASS-I MOLECULES; RECEPTOR-MEDIATED ENDOCYTOSIS; CROSS-PRESENTATION; SUBSTRATE-BINDING; FUSION PROTEINS; T-CELLS; HEAT-SHOCK-PROTEIN-70; COMPLEXES; CHAPERONE	Microbial heat shock proteins (HSPs) have been implicated in the induction of both the innate and adaptive arms of the immune response. We now show that human dendritic cells (DC) pulsed with peptide-loaded mycobacterial HSP70 complexes generate potent antigen-specific cytotoxic lymphocyte (CTL) responses, which are dependent on an HSP70-stimulated calcium signaling cascade. From the calculated peptide binding affinity of mycobacterial HSP70 (K-D = 14 muM) we show that 120 pM HSP70 bound peptide is sufficient to generate a peptide-specific CTL response that is up to four orders of magnitude more efficient than peptide alone. The minimal 136 amino acid, mycobacterial HSP70 peptide binding domain can generate CTL responses, and a single amino acid mutant HSP70 designed to prevent peptide binding but retain stimulatory capacity has allowed us to separate antigen delivery from DC immunostimulation.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Div Immunol, Cambridge CB2 2XY, England; Lionex Diagnost & Therapeut GmbH, D-38124 Braunschweig, Germany	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Lionex Diagnostics & Therapeutics GmbH	Lehner, PJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Div Immunol, Hills Rd, Cambridge CB2 2XY, England.	pjl30@cam.ac.uk		Javid, Babak/0000-0002-6354-6305; MacAry, Paul/0000-0002-1139-8996; Lehner, Paul Joseph/0000-0001-9383-1054; Smith, Kenneth/0000-0003-3829-4326	MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; AZERN A, 1997, J BIOL CHEM, V272, P20901; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Belli F, 2002, J CLIN ONCOL, V20, P4169, DOI 10.1200/JCO.2002.09.134; Berwin B, 2002, TRAFFIC, V3, P358, DOI 10.1034/j.1600-0854.2002.30505.x; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Cho BK, 2000, IMMUNITY, V12, P263, DOI 10.1016/S1074-7613(00)80179-X; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; CZEMIECKI BJ, 1997, J IMMUNOL, V159, P3823; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Huang Q, 2000, J EXP MED, V191, P403, DOI 10.1084/jem.191.2.403; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lipsker D, 2002, EUR J IMMUNOL, V32, P322, DOI 10.1002/1521-4141(200202)32:2<322::AID-IMMU322>3.0.CO;2-0; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Menoret A, 1999, BIOCHEM BIOPH RES CO, V262, P813, DOI 10.1006/bbrc.1999.1306; Moroi Y, 2000, P NATL ACAD SCI USA, V97, P3485, DOI 10.1073/pnas.070550797; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wang YF, 2002, J IMMUNOL, V169, P2422, DOI 10.4049/jimmunol.169.5.2422; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	34	82	90	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					95	106		10.1016/S1074-7613(03)00357-1	http://dx.doi.org/10.1016/S1074-7613(03)00357-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738768	Bronze			2022-12-18	WOS:000221442200010
J	Santori, FR; Kieper, WC; Brown, SM; Lu, Y; Neubert, TA; Johnson, KL; Naylor, S; Vukmanovic, S; Hogquist, KA; Jameson, SC				Santori, FR; Kieper, WC; Brown, SM; Lu, Y; Neubert, TA; Johnson, KL; Naylor, S; Vukmanovic, S; Hogquist, KA; Jameson, SC			Rare, structurally homologous self-peptides promote thymocyte positive selection	IMMUNITY			English	Article							T-CELL SELECTION; DIFFERENTIAL AVIDITY MODEL; THYMIC SELECTION; NEGATIVE SELECTION; MASS-SPECTROMETRY; IN-VIVO; MHC; LIGAND; COMPLEX; SPECIFICITY	Although it is clear that positive selection of T cells involves recognition of specific self-peptide/MHC complexes, the nature of these self-ligands and their relationship to the cognate antigen are controversial. Here we used two complementary strategies to identify naturally occurring self-peptides able to induce positive selection of T cells bearing a specific T cell receptor, OT-I. Both the bioassay- and bioinformatics-based strategies identified the same self-peptides, derived from F-actin capping protein and beta-catenin. These peptides displayed charge conservation at two key TCR contact residues. The biological activity of 43 other self-peptides and of complex peptide libraries directly correlated to the extent of conservation at TCR contact residues. These results demonstrate that selecting self-peptides are rare and can be identified by homology-based search strategies.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Biomed Mass Spectrometry & Funct Proteom Facil, Rochester, MN 55905 USA	New York University; New York University; New York University; New York University; New York University; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Vukmanovic, S (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave, New York, NY 10016 USA.	vukmas01@med.nyu.edu; hogqu001@umn.edu; james024@umn.edu	Santori, Fabio/GRF-1002-2022; Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Santori, Fabio/0000-0002-0220-8935; Hogquist, Kristin/0000-0001-9963-5687; Vukmanovic, Stanislav/0000-0003-3547-8349	NCI NIH HHS [5P30 CA16087] Funding Source: Medline; NIAID NIH HHS [AI41573, AI38903, AI39560] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039560, R01AI041573, R29AI038903, R01AI039560, R37AI038903, R29AI039560, R01AI038903] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Baldwin KK, 1999, J EXP MED, V189, P13, DOI 10.1084/jem.189.1.13; Basu D, 1998, P NATL ACAD SCI USA, V95, P14332, DOI 10.1073/pnas.95.24.14332; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Chiu NM, 1999, J EXP MED, V190, P1869, DOI 10.1084/jem.190.12.1869; Cook JR, 1997, IMMUNITY, V7, P233, DOI 10.1016/S1074-7613(00)80526-9; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GASCOIGNE NRJ, 2001, EXP REV MOL MED; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Girao C, 1997, J IMMUNOL, V159, P4205; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hogquist KA, 2000, METH MOL B, V156, P219; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ignatowicz L, 1997, IMMUNITY, V7, P179, DOI 10.1016/S1074-7613(00)80521-X; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; KELLY BD, 1993, BIOTECHNOLOGY, V3, P23; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Kraj P, 2001, J EXP MED, V194, P407, DOI 10.1084/jem.194.4.407; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Ober BT, 2000, INT IMMUNOL, V12, P1353, DOI 10.1093/intimm/12.9.1353; Ohteki T, 1999, EUR J IMMUNOL, V29, P2886, DOI 10.1002/(SICI)1521-4141(199909)29:09<2886::AID-IMMU2886>3.0.CO;2-A; Pacholczyk R, 2001, J IMMUNOL, V166, P2357, DOI 10.4049/jimmunol.166.4.2357; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; Poland GA, 2001, VACCINE, V19, P2692, DOI 10.1016/S0264-410X(00)00505-3; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Santori FR, 2001, J IMMUNOL, V167, P6092, DOI 10.4049/jimmunol.167.11.6092; Sasada T, 2001, J EXP MED, V194, P883, DOI 10.1084/jem.194.7.883; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Smyth LA, 1998, P NATL ACAD SCI USA, V95, P8193, DOI 10.1073/pnas.95.14.8193; SPAIN LM, 1994, J IMMUNOL, V152, P1709; Stefanski HE, 2001, J IMMUNOL, V166, P6602, DOI 10.4049/jimmunol.166.11.6602; Stefanski HE, 2000, J IMMUNOL, V164, P3519, DOI 10.4049/jimmunol.164.7.3519; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; Tomlinson AJ, 1997, J AM SOC MASS SPECTR, V8, P15, DOI 10.1016/S1044-0305(96)00133-X; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Viret C, 2000, J IMMUNOL, V165, P6183, DOI 10.4049/jimmunol.165.11.6183; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305	57	82	82	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2002	17	2					131	142		10.1016/S1074-7613(02)00361-8	http://dx.doi.org/10.1016/S1074-7613(02)00361-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196285	Bronze			2022-12-18	WOS:000177669400002
J	Slifka, MK; Whitton, JL				Slifka, MK; Whitton, JL			Antigen-specific regulation of T cell-mediated cytokine production	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MESSENGER-RNA STABILITY; NATURAL-KILLER-CELLS; HUMAN MXA PROTEIN; INTERFERON-GAMMA; VIRAL-INFECTION; MICE LACKING; TNF-ALPHA; TYROSINE PHOSPHORYLATION		Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute	Whitton, JL (corresponding author), Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027028, R21AI027028] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-27028, R01 AI027028] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALON R, 1994, J IMMUNOL, V152, P1304; ANDO K, 1994, J IMMUNOL, V153, P482; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; BAUMGARTNER JD, 1993, IMMUNOBIOLOGY, V187, P464, DOI 10.1016/S0171-2985(11)80357-8; Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; BOULEY DM, 1995, J IMMUNOL, V155, P3964; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; CAHALON L, 1994, CELL ADHES COMMUN, V2, P269, DOI 10.3109/15419069409004447; Carson WE, 1999, J IMMUNOL, V162, P4943; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cross AS, 1999, VACCINE, V17, pS13, DOI 10.1016/S0264-410X(99)00230-3; DEMETRI GD, 1989, J CLIN ONCOL, V7, P1545, DOI 10.1200/JCO.1989.7.10.1545; Dinarello CA, 1996, CURR TOP MICROBIOL, V216, P133; Ehl S, 1997, EUR J IMMUNOL, V27, P3404, DOI 10.1002/eji.1830271240; ESSANI K, 1994, MICROB PATHOGENESIS, V17, P347, DOI 10.1006/mpat.1994.1080; Estcourt MJ, 1998, CURR OPIN MICROBIOL, V1, P411, DOI 10.1016/S1369-5274(98)80058-1; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; FINKE D, 1995, J VIROL, V69, P5469, DOI 10.1128/JVI.69.9.5469-5474.1995; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Gebhard JR, 1998, AM J PATHOL, V153, P417, DOI 10.1016/S0002-9440(10)65585-X; Gilat D, 1996, IMMUNOL TODAY, V17, P16, DOI 10.1016/0167-5699(96)80563-9; Guidotti LG, 1996, CURR OPIN IMMUNOL, V8, P478, DOI 10.1016/S0952-7915(96)80034-3; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; HERSHKOVIZ R, 1994, J IMMUNOL, V153, P554; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; JONES AL, 1989, CANCER SURV, V8, P817; Kagi D, 1996, J EXP MED, V183, P2143, DOI 10.1084/jem.183.5.2143; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kalvakolanu DV, 1999, TRENDS MICROBIOL, V7, P166, DOI 10.1016/S0966-842X(99)01476-6; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; KUMAR R, 1988, J VIROL, V62, P3175, DOI 10.1128/JVI.62.9.3175-3181.1988; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Leonard JP, 1997, BLOOD, V90, P2541; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Marie-Cardine A, 1999, J EXP MED, V189, P1181, DOI 10.1084/jem.189.8.1181; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; MESTAN J, 1986, NATURE, V323, P816, DOI 10.1038/323816a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Mossman K, 1996, VIROLOGY, V215, P17, DOI 10.1006/viro.1996.0003; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Nash P, 1999, IMMUNOL REV, V168, P103, DOI 10.1111/j.1600-065X.1999.tb01286.x; Nguyen KB, 1999, J IMMUNOL, V162, P5238; OZMEN L, 1994, J EXP MED, V180, P907, DOI 10.1084/jem.180.3.907; Puglielli MT, 1999, NAT MED, V5, P1370; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; RAMSDEN L, 1992, EUR J IMMUNOL, V22, P3027, DOI 10.1002/eji.1830221139; Ramshaw IA, 1997, IMMUNOL REV, V159, P119, DOI 10.1111/j.1600-065X.1997.tb01011.x; Rebouillat D, 1999, J INTERF CYTOK RES, V19, P295, DOI 10.1089/107999099313992; Rellahan BL, 1997, J BIOL CHEM, V272, P30806, DOI 10.1074/jbc.272.49.30806; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Schraven B, 1999, IMMUNOL TODAY, V20, P431, DOI 10.1016/S0167-5699(99)01519-4; Selin LK, 1997, J IMMUNOL, V158, P5366; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; SLIFKA MK, 1999, RAPID CYCLING CYTOKI; SLIFKA MK, 2000, IN PRESS J MOL MED; Smith GL, 1996, CURR OPIN IMMUNOL, V8, P467, DOI 10.1016/S0952-7915(96)80032-X; SPRIGGS MK, 1994, CURR OPIN IMMUNOL, V6, P526, DOI 10.1016/0952-7915(94)90136-8; STAEHELI P, 1991, J VIROL, V65, P4498, DOI 10.1128/JVI.65.8.4498-4501.1991; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; TARTOUR E, 1992, BIOMED PHARMACOTHER, V46, P473, DOI 10.1016/0753-3322(92)90005-R; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Topham DJ, 1996, J VIROL, V70, P1288, DOI 10.1128/JVI.70.2.1288-1291.1996; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Viola A, 1999, APMIS, V107, P615, DOI 10.1111/j.1699-0463.1999.tb01450.x; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	89	82	84	2	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2000	12	5					451	457		10.1016/S1074-7613(00)80197-1	http://dx.doi.org/10.1016/S1074-7613(00)80197-1			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843378	Bronze			2022-12-18	WOS:000087356400001
J	Mainiero, F; Soriani, A; Strippoli, R; Jacobelli, J; Gismondi, A; Piccoli, M; Frati, L; Santoni, A				Mainiero, F; Soriani, A; Strippoli, R; Jacobelli, J; Gismondi, A; Piccoli, M; Frati, L; Santoni, A			RAC1/P38 MAPK signaling pathway controls beta 1 integrin-induced interleukin-8 production in human natural killer cells	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; GENE-EXPRESSION; CROSS-LINKING; ALPHA(6)BETA(4) INTEGRIN; SELECTIVE ACTIVATION; T-LYMPHOCYTES; TNF-ALPHA; P38	The MAP kinase (MAPK) p38 plays a key role in regulating inflammatory responses. Here, we demonstrate that beta 1 integrin ligation on human NK cells results in the activation of the p38 MAPK signaling pathway, which is required for integrin-triggered IL-8 production. In addition, we identified some of the upstream events accompanying the beta 1 integrin-mediated p38 MAPK activation, namely, the activation of the Rac guanine nucleotide exchange factor (GEF) p95 Vav, the small G protein Rac1, and the cytoplasmic kinases Pak1 and MKK3. Finally, we provide direct evidence that p95 Vav and Rac control the activation of p38 MAPK triggered by beta 1 integrins.	Univ Rome La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Expt Med & Pathol, I-00161 Rome, Italy; Regina Elena Inst Canc Res, Lab Pathophysiol, I-00158 Rome, Italy; Mediterranean Inst Neursci Neuromed, I-86077 Pozzilli, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Neuromed	Mainiero, F (corresponding author), Univ Rome La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Expt Med & Pathol, Piazzale Aldo Moro 5, I-00161 Rome, Italy.		Strippoli, Raffaele/J-2129-2018; Frati, Luigi/ABI-7437-2020; santoni, angela/K-8997-2016	Strippoli, Raffaele/0000-0003-3483-8381; santoni, angela/0000-0003-1206-7731; Mainiero, Fabrizio/0000-0002-7136-9839; SORIANI, Alessandra/0000-0001-5461-9026				ALLAVENA P, 1991, J EXP MED, V173, P439, DOI 10.1084/jem.173.2.439; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Cichowski K, 1996, J BIOL CHEM, V271, P7544, DOI 10.1074/jbc.271.13.7544; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Craxton A, 1998, J IMMUNOL, V161, P3225; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; DEFILIPPI P, 1997, LANDES BIOSCIENCE; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fogler WE, 1996, J IMMUNOL, V156, P4707; Galandrini R, 1999, J IMMUNOL, V162, P3148; GIANCOTTI FG, 1994, BBA-REV CANCER, V1198, P47, DOI 10.1016/0304-419X(94)90005-1; GISMONDI A, 1995, J IMMUNOL, V154, P3128; GISMONDI A, 1991, J IMMUNOL, V146, P384; Gismondi A, 1997, J IMMUNOL, V159, P4729; Gotoh A, 1997, CELL GROWTH DIFFER, V8, P721; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; MAINIERO F, 1994, J IMMUNOL, V152, P446; Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; PALMIERI G, 1995, J IMMUNOL, V155, P5314; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rudel T, 1998, J IMMUNOL, V160, P7; SAITOH A, 1994, J CLIN LAB ANAL, V8, P200, DOI 10.1002/jcla.1860080404; Salmon RA, 1997, J IMMUNOL, V159, P5309; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; SOMERSALO K, 1994, EUR J IMMUNOL, V24, P2957, DOI 10.1002/eji.1830241206; SOMERSALO K, 1991, EUR J IMMUNOL, V21, P35, DOI 10.1002/eji.1830210107; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WARY KK, 1996, CELL, V87, P1; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763; Zhang J, 1999, J IMMUNOL, V162, P3819; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zu YL, 1998, J IMMUNOL, V160, P1982	60	82	83	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					7	16		10.1016/S1074-7613(00)80154-5	http://dx.doi.org/10.1016/S1074-7613(00)80154-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661401	Bronze			2022-12-18	WOS:000085011900002
J	Zhang, DF; Jin, WW; Wu, RQ; Li, J; Park, SA; Tu, E; Zanyit, P; Xu, JJ; Liu, OS; Cain, A; Chen, WJ				Zhang, Dunfang; Jin, Wenwen; Wu, Ruiqing; Li, Jia; Park, Sang-A; Tu, Eric; Zanyit, Peter; Xu, Junji; Liu, Ousheng; Cain, Alexander; Chen, WanJun			High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-beta Cytokine Activation	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; SUGAR-SWEETENED BEVERAGES; T(H)17; INDUCTION; DIFFERENTIATION; SUSCEPTIBILITY; SUPPRESSION; PATHWAYS; FRUCTOSE	Diet has been suggested to be a potential environmental risk factor for the increasing incidence of autoimmune diseases, yet the underlying mechanisms remain elusive. Here, we show that high glucose intake exacerbated autoimmunity in mouse models of colitis and experimental autoimmune encephalomyelitis (EAE). We elucidated that high amounts of glucose specifically promoted T helper-17 (Th17) cell differentiation by activating transforming growth factor-beta (TGF-beta) from its latent form through upregulation of reactive oxygen species (ROS) in T cells. We further determined that mitochondrial ROS (mtROS) are key for high glucose-induced TGF-beta activation and Th17 cell generation. We have thus revealed a previously unrecognized mechanism underlying the adverse effects of high glucose intake in the pathogenesis of autoimmunity and inflammation.	[Zhang, Dunfang; Jin, Wenwen; Wu, Ruiqing; Li, Jia; Park, Sang-A; Tu, Eric; Zanyit, Peter; Xu, Junji; Liu, Ousheng; Cain, Alexander; Chen, WanJun] NIDCD, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Chen, WJ (corresponding author), NIDCD, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA.	wchen@mail.nih.gov	liu, ousheng/C-6772-2008	Zhang, Dunfang/0000-0001-7545-9930; , liu ou sheng/0000-0003-3293-9824	Intramural Research Program of the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), United States	Intramural Research Program of the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), United States	This research was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), United States. We thank Dr. Yoichiro Iwakura (Research Institute for Biomedical Sciences, Tokyo University of Science, Tokyo, Japan) for providing the Il17<SUP>-/-</SUP> mice strain; the Combined Technical Research Core and Veterinary Resources Core at NIDCR for service; and Dr. J.E. Konkel, H. Nakatsukasa, and T. Gauthier for technical expertise. This manuscript is dedicated to Dr. Sang-A Park, who passed away suddenly on January 22, 2018.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Cao GC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.20; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Edwards JP, 2014, J IMMUNOL, V193, P2843, DOI 10.4049/jimmunol.1401102; Goncalves MD, 2019, SCIENCE, V363, P1345, DOI 10.1126/science.aat8515; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Hu CM, 2019, CELL METAB, V29, P1334, DOI 10.1016/j.cmet.2019.02.005; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Konkel JE, 2017, IMMUNITY, V46, P660, DOI 10.1016/j.immuni.2017.03.015; Lerner A, 2015, AUTOIMMUN REV, V14, P479, DOI 10.1016/j.autrev.2015.01.009; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Malik VS, 2019, CIRCULATION, V139, P2113, DOI 10.1161/CIRCULATIONAHA.118.037401; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manzel A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0404-6; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakatsukasa H, 2015, NAT IMMUNOL, V16, P1077, DOI 10.1038/ni.3252; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rees F, 2016, ANN RHEUM DIS, V75, P136, DOI 10.1136/annrheumdis-2014-206334; Selmi C, 2010, AUTOIMMUN REV, V9, pA247, DOI 10.1016/j.autrev.2010.02.004; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tu E, 2018, IMMUNITY, V48, P745, DOI 10.1016/j.immuni.2018.03.025; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zhang CP, 2014, HUM IMMUNOL, V75, P289, DOI 10.1016/j.humimm.2014.02.007; Zhang DF, 2017, NAT MED, V23, P1036, DOI 10.1038/nm.4375	47	81	86	4	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					671	+		10.1016/j.immuni.2019.08.001	http://dx.doi.org/10.1016/j.immuni.2019.08.001			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31451397	Bronze			2022-12-18	WOS:000490141700013
J	Zhang, FH; Li, RR; Yang, YS; Shi, CH; Shen, YY; Lu, CJ; Chen, YH; Zhou, W; Lin, AF; Yu, L; Zhang, WJ; Xue, ZW; Wang, JL; Cai, ZJ				Zhang, Fanghui; Li, Rongrong; Yang, Yunshan; Shi, Chunhui; Shen, Yingying; Lu, Chaojie; Chen, Yinghu; Zhou, Wu; Lin, Aifu; Yu, Lei; Zhang, Wanjing; Xue, Zhenwei; Wang, Jianli; Cai, Zhijian			Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8(+) T Cell Responses	IMMUNITY			English	Article							ADENOSINE; CANCER; CD73; LYMPHOCYTES; GENERATION; PROTECTS; EXOSOMES; CD39	Systemic immunosuppression greatly affects the chemotherapeutic antitumor effect. Here, we showed that CD19(+) extracellular vesicles (EVs) from B cells through CD39 and CD73 vesicle-incorporated proteins hydrolyzed ATP from chemotherapy-treated tumor cells into adenosine, thus impairing CD8(+) T cell responses. Serum CD19(+) EVs were increased in tumor-bearing mice and patients. Patients with fewer serum CD19+ EVs had a better prognosis after chemotherapy. Upregulated hypoxia-inducible factor-1 alpha (HIF-1 alpha) promoted B cells to release CD19(+) EVs by inducing Rab27a mRNA transcription. Rab27a or HIF-1 alpha deficiency in B cells inhibited CD19(+) EV production and improved the chemotherapeutic antitumor effect. Silencing of Rab27a in B cells by inactivated Epstein-Barr viruses carrying Rab27a siRNA greatly improved chemotherapeutic efficacy in humanized immunocompromised NOD Prkdc(scid) Il2rg(-/-) mice. Thus, decreasing CD19(+) EVs holds high potential to improve the chemotherapeutic antitumor effect.	[Zhang, Fanghui; Li, Rongrong; Shen, Yingying; Lu, Chaojie; Zhang, Wanjing; Xue, Zhenwei; Cai, Zhijian] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Fanghui; Li, Rongrong; Shen, Yingying; Lu, Chaojie; Zhang, Wanjing; Xue, Zhenwei; Cai, Zhijian] Zhejiang Univ, Dept Orthopaed, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Fanghui; Wang, Jianli] Zhejiang Univ, Inst Immunol, Sch Med, Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Fanghui; Wang, Jianli] Zhejiang Univ, Bone Marrow Transplantat Ctr, Sch Med, Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Fanghui; Wang, Jianli] Zhejiang Univ, Inst Hematol, Hangzhou 310006, Zhejiang, Peoples R China; [Zhang, Fanghui; Wang, Jianli] Zhejiang Engn Lab Stem Cell & Immunotherapy, Hangzhou 310006, Zhejiang, Peoples R China; [Yang, Yunshan] Zhejiang Canc Hosp, Dept Chemotherapy, Hangzhou 310022, Zhejiang, Peoples R China; [Shi, Chunhui] Yuhuan Hosp Tradit Chinese Med, Dept Gynaecol & Obstet, Taizhou 317600, Peoples R China; [Chen, Yinghu] Zhejiang Univ, Childrens Hosp, Div Infect Dis, Zhejiang Key Lab Neonatal Dis,Sch Med, Hangzhou 310006, Zhejiang, Peoples R China; [Zhou, Wu] Lishui Univ, Coll Med & Hlth, Dept Med, Lishui 323000, Peoples R China; [Lin, Aifu] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Lei] Zhejiang Univ, Sir Run Run Shaw Hosp, Lab Canc Biol, Key Lab Biotherapy Zhejiang,Med Sch, Hangzhou 310020, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; Zhejiang University; Lishui University; Zhejiang University; Zhejiang University	Cai, ZJ (corresponding author), Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China.; Cai, ZJ (corresponding author), Zhejiang Univ, Dept Orthopaed, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China.; Wang, JL (corresponding author), Zhejiang Univ, Inst Immunol, Sch Med, Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, JL (corresponding author), Zhejiang Univ, Bone Marrow Transplantat Ctr, Sch Med, Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, JL (corresponding author), Zhejiang Univ, Inst Hematol, Hangzhou 310006, Zhejiang, Peoples R China.; Wang, JL (corresponding author), Zhejiang Engn Lab Stem Cell & Immunotherapy, Hangzhou 310006, Zhejiang, Peoples R China.	jlwang@zju.edu.cn; caizj@zju.edu.cn		zhou, wu/0000-0003-3105-8064	National Key R&D Program of China [2016YFA0501800]; National Key Basic Research Program of China [2015CB943301]; National Natural Science Foundation of China [31770951, 31670877, 81572879]	National Key R&D Program of China; National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key R&D Program of China (2016YFA0501800), National Key Basic Research Program of China (2015CB943301), and National Natural Science Foundation of China (31770951, 31670877, and 81572879).	Benevento I, 2017, CHEMOTHERAPY, V62, P314, DOI 10.1159/000476056; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Caserta S, 2012, CRIT REV IMMUNOL, V32, P97, DOI 10.1615/CritRevImmunol.v32.i2.10; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Ghiringhelli F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/473712; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Jiang LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13045; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kuo CW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061220; Lakhal S, 2011, BIOESSAYS, V33, P737, DOI 10.1002/bies.201100076; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Menard C, 2008, CANCER IMMUNOL IMMUN, V57, P1579, DOI 10.1007/s00262-008-0505-6; Menna P, 2017, CHEMOTHERAPY, V62, P159, DOI 10.1159/000455823; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PATTENGALE PK, 1973, LANCET, V2, P93; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; RASMUSSEN L, 1982, ENVIRON HEALTH PERSP, V43, P21, DOI 10.2307/3429163; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Saze Z, 2013, BLOOD, V122, P9, DOI 10.1182/blood-2013-02-482406; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wang RF, 2017, CELL RES, V27, P1, DOI 10.1038/cr.2017.1; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wen C, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1400370; Zhang W, 2017, AM J PHYSIOL-RENAL, V313, pF906, DOI 10.1152/ajprenal.00178.2017	32	81	84	5	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					738	+		10.1016/j.immuni.2019.01.010	http://dx.doi.org/10.1016/j.immuni.2019.01.010			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30770248	Bronze			2022-12-18	WOS:000461660500022
J	Triller, G; Scally, SW; Costa, G; Pissarev, M; Kreschel, C; Bosch, A; Marois, E; Sack, BK; Murugan, R; Salman, AM; Janse, CJ; Khan, SM; Kappe, SHI; Adegnika, AA; Mordmuller, B; Levashina, EA; Julien, JP; Wardemann, H				Triller, Gianna; Scally, Stephen W.; Costa, Giulia; Pissarev, Maria; Kreschel, Cornelia; Bosch, Alexandre; Marois, Eric; Sack, Brandon K.; Murugan, Rajagopal; Salman, Ahmed M.; Janse, Chris J.; Khan, Shahid M.; Kappe, Stefan H. I.; Adegnika, Ayola A.; Mordmueller, Benjamin; Levashina, Elena A.; Julien, Jean-Philippe; Wardemann, Hedda			Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies	IMMUNITY			English	Article							PLASMODIUM-FALCIPARUM SPOROZOITES; MEMORY B-CELLS; CIRCUMSPOROZOITE PROTEIN; MONOCLONAL-ANTIBODIES; HUMAN MALARIA; RESPONSES; IMMUNITY; STAGE; SYSTEM; TRANSMISSION	Antibodies against the NANP repeat of circumsporozoite protein (CSP), the major surface antigen of Plasmodium falciparum (Pf) sporozoites, can protect from malaria in animal models but protective humoral immunity is difficult to induce in humans. Here we cloned and characterized rare affinity-matured human NANP-reactive memory B cell antibodies elicited by natural Pf exposure that potently inhibited parasite transmission and development in vivo. We unveiled the molecular details of antibody binding to two distinct protective epitopes within the NANP repeat. NANP repeat recognition was largely mediated by germline encoded and immunoglobulin (Ig) heavy-chain complementarity determining region 3 (HCDR3) residues, whereas affinity maturation contributed predominantly to stabilizing the antigen-binding site conformation. Combined, our findings illustrate the power of exploring human anti-CSP antibody responses to develop tools for malaria control in the mammalian and the mosquito vector and provide a molecular basis for the structure-based design of next-generation CSP malaria vaccines.	[Triller, Gianna; Murugan, Rajagopal; Wardemann, Hedda] German Canc Res Ctr, B Cell Immunol, D-69120 Heidelberg, Germany; [Scally, Stephen W.; Bosch, Alexandre; Julien, Jean-Philippe] Hosp Sick Children Res Inst, Program Mol Med, Toronto, ON M5G 1X8, Canada; [Costa, Giulia; Pissarev, Maria; Kreschel, Cornelia; Levashina, Elena A.] Max Planck Inst Infect Biol, Vector Biol Unit, D-10117 Berlin, Germany; [Marois, Eric] Univ Strasbourg, CNRS UPR9022, INSERM, U963, F-67000 Strasbourg, France; [Sack, Brandon K.; Kappe, Stefan H. I.] Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA; [Salman, Ahmed M.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford OX3 7DQ, England; [Salman, Ahmed M.; Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden Malaria Res Grp,Parasitol, NL-2333 ZA Leiden, Netherlands; [Adegnika, Ayola A.] Ctr Rech Med Lambarene, Lambarene 242, Gabon; [Adegnika, Ayola A.; Mordmueller, Benjamin] Univ Tubingen, Partner Site Tubingen, Inst Trop Med, D-72074 Tubingen, Germany; [Adegnika, Ayola A.; Mordmueller, Benjamin] Univ Tubingen, German Ctr Infect Res, Partner Site Tubingen, D-72074 Tubingen, Germany; [Adegnika, Ayola A.] LUMC, NL-2333 ZA Leiden, Netherlands; [Julien, Jean-Philippe] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON M5G 0A4, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Center for Infectious Disease Research; University of Oxford; Jenner Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; German Center for Infection Research; University of Toronto; University of Toronto	Wardemann, H (corresponding author), German Canc Res Ctr, B Cell Immunol, D-69120 Heidelberg, Germany.; Julien, JP (corresponding author), Hosp Sick Children Res Inst, Program Mol Med, Toronto, ON M5G 1X8, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5G 0A4, Canada.	jean-philippe.julien@sickkids.ca; h.wardemann@dkfz-heidelberg.de	Mordmüller, Benjamin/A-5749-2010; Marois, Eric/H-9246-2016; ADEGNIKA, Ayola Akim/AAK-7307-2020	Mordmüller, Benjamin/0000-0001-9101-2768; Marois, Eric/0000-0003-4147-3747; salman, ahmed/0000-0002-5634-2726; Khan, Shahid/0000-0002-0533-4670; Levashina, Elena/0000-0003-4605-906X; Salman, Ahmed/0000-0002-9259-7339; Scally, Stephen/0000-0002-4264-7772; Wardemann, Hedda/0000-0003-3921-5933; Murugan, Rajagopal/0000-0002-0336-7268; Julien, Jean-Philippe/0000-0001-7602-3995; Janse, Chris J/0000-0002-6410-6205	Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research (CIHR); DOE Office of Science [DE-AC02-06CH11357]; NIH [F32 AI114113]; CNRS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI114113] Funding Source: NIH RePORTER	Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to all study participants and thank P.G. Kremsner, B. Lell, M. Massinga Loembe , E. Askani, and members of the Albert Schweitzer Hospital and CERMEL for their support. Further, they thank Christian Busse (German Cancer Research Center, Heidelberg), Peter Sehr (EMBL-DKFZ Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany), Hanne Kruger, Dana Tschierske, Liane Spohr, Daniel Eyermann, and Manuela Andres (MPIIB, Berlin) for technical assistance. G.T. was supported by the International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI) and the German National Academic Foundation. X-ray diffraction experiments were performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research (CIHR). SAXS experiments were performed at beamline 18-ID of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Part of this work was funded by NIH grant #F32 AI114113 and by CNRS in the frame of the LIA "REL2 and resistance to malaria''. The following reagents were obtained through BEI Resources, NIAID, NIH: Hybridoma 2A10 Anti-Plasmodium falciparum Circumsporozoite Protein (CSP), MRA-183, contributed by Elizabeth Nardin and HC-04, Hepatocyte (human), MRA-975, contributed by Jetsumon Sattabongkot Prachumsri.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AIKAWA M, 1981, J IMMUNOL, V126, P2494; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Boyington J.C., 2013, SCIENCE, V342, P592; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Dups JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00625; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ikpa T. F., 2011, International Journal of Tropical Medicine, V6, P100; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; John CC, 2008, J INFECT DIS, V197, P519, DOI 10.1086/526787; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keitany GJ, 2016, CELL REP, V17, P3193, DOI 10.1016/j.celrep.2016.11.060; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Noland GS, 2015, ACTA TROP, V142, P47, DOI 10.1016/j.actatropica.2014.10.011; Offeddu V, 2012, INT J PARASITOL, V42, P535, DOI 10.1016/j.ijpara.2012.03.011; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Pompon J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002255; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sack BK, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0028-2; Salman AM, 2015, METHODS MOL BIOL, V1325, P257, DOI 10.1007/978-1-4939-2815-6_21; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Sumitani M, 2013, INSECT MOL BIOL, V22, P41, DOI 10.1111/j.1365-2583.2012.01168.x; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Volohonsky G, 2015, G3-GENES GENOM GENET, V5, P1151, DOI 10.1534/g3.115.016808; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; Yoshida S, 2006, INSECT MOL BIOL, V15, P403, DOI 10.1111/j.1365-2583.2006.00645.x; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947	75	81	85	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1197	+		10.1016/j.immuni.2017.11.007	http://dx.doi.org/10.1016/j.immuni.2017.11.007			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29195810	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000418486500021
J	Chae, WJ; Ehrlich, AK; Chan, PY; Teixeira, AM; Henegariu, O; Hao, LM; Shin, JH; Park, JH; Tang, WH; Kim, ST; Maher, SE; Goldsmith-Pestana, K; Shan, PY; Hwa, J; Lee, PJ; Krause, DS; Rothlin, CV; McMahon-Pratt, D; Bothwell, ALM				Chae, Wook-Jin; Ehrlich, Allison K.; Chan, Pamela Y.; Teixeira, Alexandra M.; Henegariu, Octavian; Hao, Liming; Shin, Jae Hun; Park, Jong-Hyun; Tang, Wai Ho; Kim, Sang-Taek; Maher, Stephen E.; Goldsmith-Pestana, Karen; Shan, Peiying; Hwa, John; Lee, Patty J.; Krause, Diane S.; Rothlin, Carla V.; McMahon-Pratt, Diane; Bothwell, Alfred L. M.			The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation	IMMUNITY			English	Article							LEISHMANIA-MAJOR; MURINE MODEL; C-MAF; PLATELETS; INFECTION; IMMUNE; DIFFERENTIATION; EXPRESSION; PROTEIN; INTERLEUKIN-4	Exposure to a plethora of environmental challenges commonly triggers pathological type 2 cell-mediated inflammation. Here we report the pathological role of the Wnt antagonist Dickkopf-1 (Dkk-1) upon allergen challenge or non-healing parasitic infection. The increased circulating amounts of Dkk-1 polarized T cells to T helper 2 (Th2) cells, stimulating a marked simultaneous induction of the transcription factors c-Maf and Gata-3, mediated by the kinases p38 MAPK and SGK-1, resulting in Th2 cell cytokine production. Circulating Dkk-1 was primarily from platelets, and the increase of Dkk-1 resulted in formation of leukocyte-platelet aggregates (LPA) that facilitated leukocyte infiltration to the affected tissue. Functional inhibition of Dkk-1 impaired Th2 cell cytokine production and leukocyte infiltration, protecting mice from house dust mite (HDM)-induced asthma or Leishmania major infection. These results highlight that Dkk-1 from thrombocytes is an important regulator of leukocyte infiltration and polarization of immune responses in pathological type 2 cell-mediated inflammation.	[Chae, Wook-Jin; Chan, Pamela Y.; Shin, Jae Hun; Park, Jong-Hyun; Maher, Stephen E.; Rothlin, Carla V.; Bothwell, Alfred L. M.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Ehrlich, Allison K.; Goldsmith-Pestana, Karen; McMahon-Pratt, Diane] Yale Univ, Sch Med, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 333 Cedar St, New Haven, CT 06520 USA; [Teixeira, Alexandra M.; Hao, Liming; Krause, Diane S.] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA; [Henegariu, Octavian] Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA; [Tang, Wai Ho; Hwa, John] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Tang, Wai Ho; Hwa, John] Yale Univ, Sch Med, Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06520 USA; [Kim, Sang-Taek] Yale Univ, Sch Med, Dept Rheumatol, 333 Cedar St, New Haven, CT 06520 USA; [Shan, Peiying; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, 333 Cedar St, New Haven, CT 06520 USA; [Krause, Diane S.] Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA; [Krause, Diane S.] Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Bothwell, ALM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	alfred.bothwell@yale.edu		Ehrlich, Allison/0000-0002-0994-6471	NIH [1R21AI107957-01, 1R01CA168670-01, AI093775, R01 AI089824, T32 AI007019]; Shared Instrument Grant [1-S10-RR-026526-01]; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA168670] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026526] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115247, R01HL122815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093775, T32AI007019, R01AI089824, R21AI107957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrument Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Gouzel Tokmulina and Tom Taylor for cell sorting and Christine Cote for technical help in AMNIS operation. This work was supported by NIH 1R21AI107957-01 and NIH 1R01CA168670-01 (both awarded to A.L.M.B.), AI093775 (D.M.-P.), R01 AI089824 (C.V.R.), and T32 AI007019 (P.Y.C.). AMNIS work was supported by the Shared Instrument Grant (1-S10-RR-026526-01).	Abbas AK, 2000, CELL, V100, P129, DOI 10.1016/S0092-8674(00)81689-X; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; BUTLER J, 1995, LANCET, V346, P841, DOI 10.1016/S0140-6736(95)91653-9; Carvalho LP, 2012, J IMMUNOL, V188, P1394, DOI 10.4049/jimmunol.1101018; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cines Douglas B, 2014, Presse Med, V43, pe49, DOI 10.1016/j.lpm.2014.01.010; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; de la Rosa CM, 2013, J PHARMACOL EXP THER, V345, P15, DOI 10.1124/jpet.112.200881; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Divekar R, 2015, CURR OPIN ALLERGY CL, V15, P98, DOI 10.1097/ACI.0000000000000133; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Hebenstreit D, 2008, J BIOL CHEM, V283, P22490, DOI 10.1074/jbc.M804096200; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hsu AC, 2007, J IMMUNOL, V179, P8200, DOI 10.4049/jimmunol.179.12.8200; Jenne CN, 2015, PLATELETS, V26, P286, DOI 10.3109/09537104.2015.1010441; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kim H, 2013, J BIOL CHEM, V288, P34352, DOI 10.1074/jbc.M113.459750; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Conglei, 2012, Adv Hematol, V2012, P384685; Li N, 1997, BRIT J HAEMATOL, V99, P808, DOI 10.1046/j.1365-2141.1997.4993305.x; Maier E, 2011, J BIOL CHEM, V286, P919, DOI 10.1074/jbc.M110.144949; McGrath B, 2011, BIOMECH MODEL MECHAN, V10, P473, DOI 10.1007/s10237-010-0248-0; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Pelletier JC, 2009, J MED CHEM, V52, P6962, DOI 10.1021/jm9014197; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Redpath SA, 2014, PARASITE IMMUNOL, V36, P233, DOI 10.1111/pim.12113; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rondina MT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00653; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; SCOTT P, 1991, J IMMUNOL, V147, P3149; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shi GF, 2014, J CLIN INVEST, V124, P543, DOI 10.1172/JCI71858; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tacchini-Cottier F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00032; Tamagawa-Mineoka R, 2007, AM J PATHOL, V170, P2019, DOI 10.2353/ajpath.2007.060881; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Trikalinos NA, 2009, BRIT J HAEMATOL, V145, P262, DOI 10.1111/j.1365-2141.2009.07586.x; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Wang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084852; Whyte JL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008078; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang W, 2009, BLOOD, V113, P4086, DOI 10.1182/blood-2008-09-181073	63	81	85	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					246	258		10.1016/j.immuni.2016.01.008	http://dx.doi.org/10.1016/j.immuni.2016.01.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26872695	Bronze, Green Accepted			2022-12-18	WOS:000370294000009
J	Yuk, JM; Kim, TS; Kim, SY; Lee, HM; Han, J; Dufour, CR; Kim, JK; Jin, HS; Yang, CS; Park, KS; Lee, CH; Kim, JM; Kweon, GR; Choi, HS; Vanacker, JM; Moore, DD; Giguere, V; Jo, EK				Yuk, Jae-Min; Kim, Tae Sung; Kim, Soo Yeon; Lee, Hye-Mi; Han, Jeongsu; Dufour, Catherine Rosa; Kim, Jin Kyung; Jin, Hyo Sun; Yang, Chul-Su; Park, Ki-Sun; Lee, Chul-Ho; Kim, Jin-Man; Kweon, Gi Ryang; Choi, Hueng-Sik; Vanacker, Jean-Marc; Moore, David D.; Giguere, Vincent; Jo, Eun-Kyeong			Orphan Nuclear Receptor ERR alpha Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation	IMMUNITY			English	Article							NF-KAPPA-B; ESTROGEN-RELATED RECEPTOR; FATTY-ACID OXIDATION; POSTTRANSLATIONAL MODIFICATIONS; SIRTUIN 1; CANCER; ENZYME; ACTIVATION; SUPPRESSOR; INFECTION	The orphan nuclear receptor estrogen-related receptor alpha (ERR alpha; NR3B1) is a key metabolic regulator, but its function in regulating inflammation remains largely unknown. Here, we demonstrate that ERRa negatively regulates Toll-like receptor (TLR)-induced inflammation by promoting Tnfaip3 transcription and fine-tuning of metabolic reprogramming in macrophages. ERR alpha-deficient (Esrra(-/-)) mice showed increased susceptibility to endo-toxin-induced septic shock, leading to more severe pro-inflammatory responses than control mice. ERR alpha regulated macrophage inflammatory responses by directly binding the promoter region of Tnfaip3, a deubiquitinating enzyme in TLR signaling. In addition, Esrra(-/-) macrophages showed an increased glycolysis, but impaired mitochondrial respiratory function and biogenesis. Further, ERR alpha was required for the regulation of NF-kappa B signaling by controlling p65 acetylation via maintenance of NAD(+) levels and sirtuin 1 activation. These findings unravel a previously unappreciated role for ERR alpha as a negative regulator of TLR-induced inflammatory responses through inducing Tnfaip3 transcription and controlling the metabolic reprogramming.	[Yuk, Jae-Min; Kim, Tae Sung; Kim, Soo Yeon; Lee, Hye-Mi; Kim, Jin Kyung; Jin, Hyo Sun; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon 301747, South Korea; [Han, Jeongsu; Kweon, Gi Ryang] Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon 301747, South Korea; [Kim, Jin-Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon 301747, South Korea; [Yuk, Jae-Min] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon 301747, South Korea; [Yuk, Jae-Min; Kim, Tae Sung; Kim, Soo Yeon; Lee, Hye-Mi; Han, Jeongsu; Kim, Jin Kyung; Jin, Hyo Sun; Kim, Jin-Man; Kweon, Gi Ryang; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon 301747, South Korea; [Dufour, Catherine Rosa; Giguere, Vincent] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Yang, Chul-Su] Hanyang Univ, Coll Sci & Technol, Dept Mol & Life Sci, Ansan 426791, South Korea; [Park, Ki-Sun] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Lab Anim Resource Ctr, Taejon 305806, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Gwangju 500757, South Korea; [Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69364 Lyon 07, France; [Moore, David D.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA	Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University; McGill University; Hanyang University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Chonnam National University; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Baylor College of Medicine	Jo, EK (corresponding author), Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon 301747, South Korea.	hayoungj@cnu.ac.kr		Giguere, Vincent/0000-0001-9567-3694; Yuk, Jae-Min/0000-0002-0630-9194; Han, Jeongsu/0000-0001-6524-9841; KIM, JIN MAN/0000-0003-0905-9730; Eun-Kyeong, Jo/0000-0001-7191-0587	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2007-0054932]; KRIBB Research Initiative Program [KGM4541521]; NRF - Korean government (MSIP) [2011-0030049]; Basic Science Research Program through the NRF - Ministry of Education [NRF-2014R1A6A1029617]; National Creative Research Initiatives Grant through the NRF - Korean government (Ministry of Science, ICT & Future Planning) [20110018305]; Canadian Institutes for Health Research [MOP-111144]	National Research Foundation of Korea (NRF) - Korea government (MSIP); KRIBB Research Initiative Program; NRF - Korean government (MSIP); Basic Science Research Program through the NRF - Ministry of Education; National Creative Research Initiatives Grant through the NRF - Korean government (Ministry of Science, ICT & Future Planning); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank Drs. J.-S. Kim and H. Kim for critical reading of manuscript; Drs. J.-J. Kim (Konyang University) and J.-W. Chang for excellent technical assistance. We thank Dr. S.-H. Koo (Korea University) for Flag-pcDNA3-hPGC1 alpha and Dr. S. Akira (Osaka University) for MyD88- or TRIF-deficient mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2007-0054932) at Chungnam National University, by a grant of KRIBB Research Initiative Program (KGM4541521), by the NRF grant funded by the Korean government (MSIP) (No. 2011-0030049) at Hanyang University, Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2014R1A6A1029617), and by a National Creative Research Initiatives Grant (20110018305) through the NRF funded by the Korean government (Ministry of Science, ICT & Future Planning) to H.-S.C. and by a Canadian Institutes for Health Research grant (MOP-111144) to V.G.	Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Deblois G, 2011, BBA-MOL BASIS DIS, V1812, P1032, DOI 10.1016/j.bbadis.2010.12.009; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hong EJ, 2013, P NATL ACAD SCI USA, V110, P17975, DOI 10.1073/pnas.1315319110; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim DK, 2014, NAT MED, V20, P419, DOI 10.1038/nm.3483; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Martinez J, 2013, CELL METAB, V17, P895, DOI 10.1016/j.cmet.2013.05.012; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064	45	81	88	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					80	91		10.1016/j.immuni.2015.07.003	http://dx.doi.org/10.1016/j.immuni.2015.07.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200012	Bronze			2022-12-18	WOS:000360101100012
J	Sathe, P; Metcalf, D; Vremec, D; Naik, SH; Langdon, WY; Huntington, ND; Wu, L; Shortman, K				Sathe, Priyanka; Metcalf, Donald; Vremec, David; Naik, Shalin H.; Langdon, Wallace Y.; Huntington, Nicholas D.; Wu, Li; Shortman, Ken			Lymphoid Tissue and Plasmacytoid Dendritic Cells and Macrophages Do Not Share a Common Macrophage-Dendritic Cell-Restricted Progenitor	IMMUNITY			English	Article							BONE-MARROW; IN-VIVO; GM-CSF; HEMATOPOIETIC STEM; CROSS-PRESENTATION; CD8 EXPRESSION; MOUSE THYMUS; FLT3 LIGAND; MONOCYTES; SPLEEN	The relationship between dendritic cells (DCs) and macrophages is often debated. Here we ask whether steady-state, lymphoid-tissue-resident conventional DCs (cDCs), plasmacytoid DCs (pDCs), and macrophages share a common macrophage-DC-restricted precursor (MDP). Using new clonal culture assays combined with adoptive transfer, we found that MDP fractions isolated by previous strategies are dominated by precursors of macrophages and monocytes, include some multipotent precursors of other hematopoietic lineages, but contain few precursors of resident cDCs and pDCs and no detectable common precursors restricted to these DC types and macrophages. Overall we find no evidence for a common restricted MDP leading to both macrophages and FL-dependent, resident cDCs and pDCs.	[Sathe, Priyanka; Metcalf, Donald; Vremec, David; Naik, Shalin H.; Huntington, Nicholas D.; Shortman, Ken] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Sathe, Priyanka; Metcalf, Donald; Vremec, David; Naik, Shalin H.; Huntington, Nicholas D.; Shortman, Ken] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Naik, Shalin H.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Wu, Li] Tsinghua Univ, Sch Med, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Shortman, Ken] Burnet Inst, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Netherlands Cancer Institute; University of Western Australia; Tsinghua University; Burnet Institute	Sathe, P (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	sathe@wehi.edu.au; shortman@wehi.edu.au	Huntington, NICHOLAS/AAV-4704-2020; Naik, Shalin/AFD-5605-2022	Huntington, NICHOLAS/0000-0002-5267-7211; Shortman, Ken/0000-0002-9107-3007; Naik, Shalin/0000-0003-0299-3301	NHMRC Australia; University of Melbourne	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	This work was supported by the NHMRC Australia and the University of Melbourne. It was made possible through the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; del Rio ML, 2008, J IMMUNOL, V181, P6178, DOI 10.4049/jimmunol.181.9.6178; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKinstry WJ, 1997, BLOOD, V89, P65, DOI 10.1182/blood.V89.1.65.65_65_71; Metcalf D, 2002, STEM CELLS, V20, P552, DOI 10.1002/stem.200552; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540	41	81	81	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					104	115		10.1016/j.immuni.2014.05.020	http://dx.doi.org/10.1016/j.immuni.2014.05.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035955	Bronze			2022-12-18	WOS:000341444200014
J	Venkatesh, D; Ernandez, T; Rosetti, F; Batal, I; Cullere, X; Luscinskas, FW; Zhang, YZ; Stavrakis, G; Garcia-Cardena, G; Horwitz, BH; Mayadas, TN				Venkatesh, Deepak; Ernandez, Thomas; Rosetti, Florencia; Batal, Ibrahim; Cullere, Xavier; Luscinskas, Francis W.; Zhang, Yuzhi; Stavrakis, George; Garcia-Cardena, Guillermo; Horwitz, Bruce H.; Mayadas, Tanya N.			Endothelial TNF Receptor 2 Induces IRF1 Transcription Factor-Dependent Interferon-beta Autocrine Signaling to Promote Monocyte Recruitment	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; PERIPHERAL-BLOOD; RHEUMATOID-ARTHRITIS; VASCULAR ENDOTHELIUM; INDUCIBLE PROTEIN-10; GENE-EXPRESSION; T-LYMPHOCYTES; IN-VITRO; ALPHA	Endothelial-dependent mechanisms of mononuclear cell influx are not well understood. We showed that acute stimulation of murine microvascular endothelial cells expressing the tumor necrosis factor receptors TNFR1 and TNFR2 with the soluble cytokine TNF led to CXCR3 chemokine generation. The TNF receptors signaled through interferon regulatory factor-1 (IRF1) to induce interferon-beta (IFN-beta) and subsequent autocrine signaling via the type I IFN receptor and the transcription factor STAT1. Both TNFR2 and TNFR1 were required for IRF1-IFN beta signaling and, in human endothelial cells TNFR2 expression alone induced IFN-beta signaling and monocyte recruitment. In vivo, TNFR1 was required for acute renal neutrophil and monocyte influx after systemic TNF treatment, whereas the TNFR2-IRF1-IFN-beta autocrine loop was essential only for macrophage accumulation. In a chronic model of proliferative nephritis, IRF1 and renal-expressed TNFR2 were essential for sustained macrophage accumulation. Thus, our data identify a pathway in endothelial cells that selectively recruits monocytes during a TNF-induced inflammatory response.	[Venkatesh, Deepak; Ernandez, Thomas; Rosetti, Florencia; Batal, Ibrahim; Cullere, Xavier; Luscinskas, Francis W.; Zhang, Yuzhi; Stavrakis, George; Garcia-Cardena, Guillermo; Horwitz, Bruce H.; Mayadas, Tanya N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rosetti, Florencia] Harvard Univ, Harvard Grad Sch Arts & Sci, Sch Med, Immunol Grad Program,Div Med Sci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Mayadas, TN (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	tmayadas@rics.bwh.harvard.edu	Rosetti, Florencia/AFO-5427-2022; Garcia-Cardena, Guillermo/Q-6649-2019	Luscinskas, Francis/0000-0001-7100-4103	National Institutes of Health [RO1 DK51643, HL65095, PO1HL036028, RO1 AI52667, KO1 AR54984]; Novartis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036028, R01HL065095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Foundation(Novartis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health RO1 DK51643, HL65095, and PO1HL036028 (to T.N.M.), RO1 AI52667 (to B. H. H.), KO1 AR54984 (to X. C.), and a scholarship from the Novartis Foundation (formerly Ciba-Geigy-Jubilee Foundation, to T.E.).	Akassoglou K, 2003, P NATL ACAD SCI USA, V100, P709, DOI 10.1073/pnas.0236046100; Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Douni E, 1998, J EXP MED, V188, P1343, DOI 10.1084/jem.188.7.1343; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Fairhurst AM, 2009, J IMMUNOL, V183, P6831, DOI 10.4049/jimmunol.0900742; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hoffmann U, 2009, AM J TRANSPLANT, V9, P675, DOI 10.1111/j.1600-6143.2008.02536.x; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; LEEUWENBERG JFM, 1987, J EXP MED, V166, P1180, DOI 10.1084/jem.166.4.1180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas R, 1997, EUR J IMMUNOL, V27, P1719, DOI 10.1002/eji.1830270719; Luscinskas FW, 1996, J IMMUNOL, V157, P326; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; OHMORI Y, 1993, AM J PATHOL, V142, P861; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Santee SM, 1996, J BIOL CHEM, V271, P21151, DOI 10.1074/jbc.271.35.21151; Satchell SC, 2007, J AM SOC NEPHROL, V18, P2875, DOI 10.1681/ASN.2006101104; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Taub DD, 1996, BLOOD, V87, P1423, DOI 10.1182/blood.V87.4.1423.bloodjournal8741423; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Tliba O, 2003, J BIOL CHEM, V278, P50615, DOI 10.1074/jbc.M303680200; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wright HL, 2011, ANN RHEUM DIS, V70, P537, DOI 10.1136/ard.2010.138065; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098	48	81	83	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					1025	1037		10.1016/j.immuni.2013.01.012	http://dx.doi.org/10.1016/j.immuni.2013.01.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23623383	Green Accepted, Bronze			2022-12-18	WOS:000330942500019
J	Coquet, JM; Middendorp, S; van der Horst, G; Kind, J; Veraar, EAM; Xiao, YL; Jacobs, H; Borst, J				Coquet, Jonathan M.; Middendorp, Sabine; van der Horst, Gerda; Kind, Jop; Veraar, Elise A. M.; Xiao, Yanling; Jacobs, Heinz; Borst, Jannie			The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity	IMMUNITY			English	Article							DENDRITIC CELLS; DNA METHYLATION; IFN-GAMMA; TGF-BETA; DIFFERENTIATION; PROTEIN; T(H)17; GENERATION; EXPRESSION; PROLIFERATION	T helper 17 (Th17) cells protect against infection but also promote inflammation and autoimmunity. Therefore, the factors that govern Th17 cell differentiation are of special interest. The CD27 and CD70 costimulatory pathway impeded Th17 effector cell differentiation and associated autoimmunity in a mouse model of multiple sclerosis. CD27 or CD70 deficiency exacerbated disease, whereas constitutive CD27 signaling strongly reduced disease incidence and severity. CD27 signaling did not impact master regulators of T helper cell lineage commitment but selectively repressed transcription of the key effector molecules interleukin-17 (IL-17) and the chemokine receptor CCR6 in differentiating Th17 cells. CD27 mediated this repression at least in part via the c-Jun N-terminal kinase (JNK) pathway that restrained IL-17 and CCR6 expression in differentiating Th17 cells. CD27 signaling also resulted in epigenetic silencing of the II17a gene. Thus, CD27 costimulation via JNK signaling, transcriptional, and epigenetic effects suppresses Th17 effector cell function and associated pathological consequences.	[Coquet, Jonathan M.; Middendorp, Sabine; van der Horst, Gerda; Veraar, Elise A. M.; Xiao, Yanling; Borst, Jannie] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Kind, Jop] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Jacobs, Heinz] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Biol Stress Responses, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Coquet, JM (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, B-9000 Ghent, Belgium.	jonathanc@dmbr.ugent.be; j.borst@nki.nl	Middendorp, Sabine/J-8205-2012; Middendorp, Sabine/B-8357-2013; Coquet, Jonathan M/A-5551-2015	Middendorp, Sabine/0000-0002-0925-0095; Middendorp, Sabine/0000-0002-0925-0095; Coquet, Jonathan M/0000-0002-5967-4857; Jacobs, Heinz/0000-0001-6227-9850; Borst, Jannie/0000-0002-8043-5009; Xiao, Yanling/0000-0003-1755-1709	Dutch Cancer Society (KWF) [NKI 2004-3078, NKI 2008-4028]; Rubicon fellowship (NWO); EMBO long-term fellowship; VENI	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Rubicon fellowship (NWO); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); VENI(Netherlands Organization for Scientific Research (NWO))	The authors thank the following colleagues at the Netherlands Cancer Institute: V. Peperzak for help with experiments, A. Velds for help with bioinformatics analysis, J.-Y. Song for mouse pathology, R. bin Ali for blastocyst injections, M. Snoek for help with speed congenics, and personnel of the experimental animal, histology, and flow cytometry facilities for excellent services. We also thank S. Chakravarti (University of Melbourne, Australia) for sharing expertise regarding the EAE model, N. Toni and A. Oxenius (ETHZ, Zuerich, Switzerland), K. Murphy (Washington University School of Medicine, St. Louis MO), and R. Mebius (Free University Amsterdam, The Netherlands) for advise and reagents. This work was supported by grants NKI 2004-3078 and NKI 2008-4028 from the Dutch Cancer Society (KWF) to J.B., a Rubicon fellowship (NWO), and an EMBO long-term fellowship to J.M.C. as well as an EMBO long-term fellowship and a VENI grant (NWO) to J.K.	Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Guikema JEJ, 2004, BRIT J HAEMATOL, V124, P299, DOI 10.1046/j.1365-2141.2003.04783.x; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hermann-Kleiter N, 2008, IMMUNITY, V29, P205, DOI 10.1016/j.immuni.2008.06.008; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Keller AM, 2008, IMMUNITY, V29, P934, DOI 10.1016/j.immuni.2008.10.009; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee WW, 2007, J IMMUNOL, V179, P2609, DOI 10.4049/jimmunol.179.4.2609; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nakajima A, 2000, J NEUROIMMUNOL, V109, P188, DOI 10.1016/S0165-5728(00)00324-6; Oelke K, 2004, ARTHRITIS RHEUM-US, V50, P1850, DOI 10.1002/art.20255; Peperzak V, 2010, J CLIN INVEST, V120, P168, DOI 10.1172/JCI40178; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; So T, 2008, CYTOKINE GROWTH F R, V19, P253, DOI 10.1016/j.cytogfr.2008.04.003; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; van Osterk MF, 2007, INT IMMUNOL, V19, P713, DOI 10.1093/intimm/dxm033; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xiao YL, 2008, J IMMUNOL, V181, P1071, DOI 10.4049/jimmunol.181.2.1071; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	50	81	86	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					53	65		10.1016/j.immuni.2012.09.009	http://dx.doi.org/10.1016/j.immuni.2012.09.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23159439	Bronze			2022-12-18	WOS:000314195500009
J	McGuire, HM; Vogelzang, A; Ma, CS; Hughes, WE; Silveira, PA; Tangye, SG; Christ, D; Fulcher, D; Falcone, M; King, C				McGuire, Helen M.; Vogelzang, Alexis; Ma, Cindy S.; Hughes, William E.; Silveira, Pablo A.; Tangye, Stuart G.; Christ, Daniel; Fulcher, David; Falcone, Marika; King, Cecile			A Subset of Interleukin-21(+) Chemokine Receptor CCR9(+) T Helper Cells Target Accessory Organs of the Digestive System in Autoimmunity	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; TERTIARY LYMPHOID STRUCTURES; DENDRITIC CELLS; NOD MICE; IMMUNE-SYSTEM; B-LYMPHOCYTES; IL-21; MOUSE; DIFFERENTIATION; EXPRESSION	This study describes a CD4(+) T helper (Th) cell subset marked by coexpression of the cytokine interleukin 21 (IL-21) and the gut-homing chemokine receptor CCR9. Although CCR9(+) Th cells were observed in healthy mice and humans, they were enriched in the inflamed pancreas and salivary glands of NOD mice and in the circulation of Sjogren's syndrome patients. CCR9+ Th cells expressed large amounts of IL-21, inducible T cell costimulator (ICOS), and the transcription factors Bcl6 and Maf, and also supported antibody production from B cells, thereby resembling T follicular B helper (Tfh) cells. However, in contrast to Tfh cells, CCR9(+) Th cells displayed limited expression of CXCR5 and the targets of CCR9(+) Th cells were CD8(+) T cells whose responsiveness to IL-21 was necessary for the development of diabetes. Thus, CCR9(+) Th cells are a subset of IL-21-producing T helper cells that influence regional specification of autoimmune diseases that affect accessory organs of the digestive system.	[McGuire, Helen M.; Vogelzang, Alexis; Ma, Cindy S.; Hughes, William E.; Silveira, Pablo A.; Tangye, Stuart G.; Christ, Daniel; King, Cecile] St Vincents Hosp, Garvan Inst Med Res, Dept Immunol, Darlinghurst, NSW 2010, Australia; [McGuire, Helen M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Vogelzang, Alexis; Ma, Cindy S.; Hughes, William E.; Silveira, Pablo A.; Tangye, Stuart G.; Christ, Daniel; King, Cecile] Univ NSW, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Fulcher, David] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Immunol, Westmead, NSW 2145, Australia; [Falcone, Marika] Ist Sci San Raffaele, Div Immunol, Expt Diabet Unit, I-20132 Milan, Italy	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	King, C (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Dept Immunol, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	c.king@garvan.org.au	Christ, Daniel/C-1861-2018; McGuire, Helen/L-6877-2019; Tangye, Stuart G/H-4023-2014; King, Cecile/Q-9794-2019; Falcone, Marika/AAC-2146-2019; S, Cindy/B-2340-2012; Silveira, Pablo A/A-7560-2008; Vogelzang, Alexis/C-5440-2017	Christ, Daniel/0000-0002-7313-3977; McGuire, Helen/0000-0003-2047-6543; Tangye, Stuart G/0000-0002-5360-5180; King, Cecile/0000-0003-2193-2563; Falcone, Marika/0000-0001-6080-5351; S, Cindy/0000-0001-5387-8413; Silveira, Pablo A/0000-0001-5074-8824; Vogelzang, Alexis/0000-0002-2921-1755; Hughes, William/0000-0002-7149-3987	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank K. Kyparissoudis and D. Godfrey for the CD1d tetramer, C. Brownlee for performing the cell sorting, A. Chan for performing the qPCRs on human tonsils, and the Australian Cancer Research Fund (ACRF) Unit for the Molecular Genetics of Cancer for use of ABI Prism 7900 HT Sequence Detection System. This study was supported by grants from the National Health and Medical Research Council of Australia.	Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Bach JF, 1997, RES IMMUNOL, V148, P285, DOI 10.1016/S0923-2494(97)87235-5; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Datta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003118; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; FAVEEUW C, 1995, J IMMUNOL METHODS, V187, P163, DOI 10.1016/0022-1759(95)00180-I; GOILLOT E, 1991, CLIN IMMUNOL IMMUNOP, V59, P462, DOI 10.1016/0090-1229(91)90041-8; Graewin SJ, 2004, J GASTROINTEST SURG, V8, P824, DOI 10.1016/j.gassur.2004.06.014; Hanninen A, 1998, J IMMUNOL, V160, P6018; Hawiger D, 2008, J IMMUNOL, V180, P3140, DOI 10.4049/jimmunol.180.5.3140; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jaakkola I, 2003, EUR J IMMUNOL, V33, P3255, DOI 10.1002/eji.200324405; JANSEN A, 1993, AUTOIMMUNITY, V15, P31, DOI 10.3109/08916939309004836; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kendall PL, 2007, J IMMUNOL, V178, P5643, DOI 10.4049/jimmunol.178.9.5643; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koarada S, 2004, J IMMUNOL, V173, P2315, DOI 10.4049/jimmunol.173.4.2315; Koenecke C, 2009, EXPERT OPIN THER TAR, V13, P297, DOI [10.1517/14728220902762928, 10.1517/14728220902762928 ]; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; McGuire HM, 2009, P NATL ACAD SCI USA, V106, P19438, DOI 10.1073/pnas.0903561106; Monteleone Giovanni, 2009, Discov Med, V8, P113; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Papadakis KA, 2003, J IMMUNOL, V171, P159, DOI 10.4049/jimmunol.171.1.159; Phillips JM, 2005, IMMUNOLOGY, V116, P525, DOI 10.1111/j.1365-2567.2005.02254.x; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Sondergaard H, 2009, TISSUE ANTIGENS, V74, P467, DOI 10.1111/j.1399-0039.2009.01382.x; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vaarala O, 2002, ANN NY ACAD SCI, V958, P39; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	56	81	83	3	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					602	615		10.1016/j.immuni.2011.01.021	http://dx.doi.org/10.1016/j.immuni.2011.01.021			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511186	Bronze			2022-12-18	WOS:000290367300018
J	Raab, M; Wang, HY; Lu, YN; Smith, X; Wu, ZL; Strebhardt, K; Ladbury, JE; Rudd, CE				Raab, Monika; Wang, Hongyan; Lu, Yuning; Smith, Xin; Wu, Zhonglin; Strebhardt, Klaus; Ladbury, John E.; Rudd, Christopher E.			T Cell Receptor "Inside-Out" Pathway via Signaling Module SKAP1-RapL Regulates T Cell Motility and Interactions in Lymph Nodes	IMMUNITY			English	Article							MEDIATES RAP1-INDUCED ADHESION; PROMOTING ADAPTER PROTEIN; INTEGRIN ACTIVATION; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; UP-REGULATION; STOP-SIGNAL; INTERLEUKIN-2 PRODUCTION; IMMUNOLOGICAL SYNAPSE; INTERACTIONS DEFINE	Although essential for T cell function, the identity of the T cell receptor "inside-out" pathway for lymphocyte function-associated antigen 1 (LFA-1) adhesion has proved elusive. Here, we define the "inside-out" pathway mediated by N-terminal SKAP1 (SKAP-55) domain binding to the C-terminal SARAH domain of RapL. TcR induced Rap1-RapL complex formation and LFA-1 binding failed to occur in Skap1(-/-) primary T cells. SKAP1 generated a SKAP1-RapL-Rap1 complex that bound to LFA-1, whereas a RapL mutation (L224A) that abrogated SKAP1 binding without affecting MST1 disrupted component colocalization in vesicles as well as T cell-dendritic cell (DC) conjugation. RapL expression also "slowed" T cell motility in D011.10 transgenic T cells in lymph nodes (LNs), an effect reversed by the L224A mutation with reduced dwell times between T cells and DCs. Overall, our findings define a TCR "inside-out" pathway via N-SKAP1-C-RapL that regulates T cell adhesion, motility, and arrest times with DCs in LNs.	[Raab, Monika; Wang, Hongyan; Wu, Zhonglin; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signaling Sect, Cambridge CB2 1Q, England; [Wang, Hongyan; Lu, Yuning; Smith, Xin; Rudd, Christopher E.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Strebhardt, Klaus] Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynaecol, D-60590 Frankfurt, Germany; [Ladbury, John E.] UCL, Dept Biol Mol & Struct, London WC1E 6BT, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Goethe University Frankfurt; University of London; University College London	Rudd, CE (corresponding author), Univ Cambridge, Dept Pathol, Cell Signaling Sect, Tennis Court Rd, Cambridge CB2 1Q, England.		Strebhardt, Klaus/E-8765-2011; hongyan, wang/GWQ-6360-2022; Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019; Ladbury, John/0000-0002-6328-7200; Strebhardt, Klaus/0000-0003-2173-9763	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a programme grant from the Wellcome Trust C E R is the recipient of a Wellcome Trust Principal Research Fellowship, and J E L was the recipient of a Wellcome Trust Senior Research Fellowship We thank H Schneider (Cambridge University) for reviewing the manuscript and R George (University College, London) for his help with the ITC experiments	Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Collins TL, 1997, IMMUNOL TODAY, V18, P221; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Duke-Cohan JS, 2006, J BIOL CHEM, V281, P13743, DOI 10.1074/jbc.M508774200; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Geng LP, 1999, J IMMUNOL, V163, P5753; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Huang YP, 2005, J BIOL CHEM, V280, P23576, DOI 10.1074/jbc.M413201200; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Kupfer A, 2006, IMMUNITY, V25, P11, DOI 10.1016/j.immuni.2006.07.005; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Mueller KL, 2007, J IMMUNOL, V179, P3559, DOI 10.4049/jimmunol.179.6.3559; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Pawson T, 2000, GENE DEV, V14, P1027; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Raab M, 2001, IMMUNITY, V15, P921, DOI 10.1016/S1074-7613(01)00248-5; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sarantos MR, 2005, J BIOL CHEM, V280, P28290, DOI 10.1074/jbc.M501662200; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2008, EUR J IMMUNOL, V38, P40, DOI 10.1002/eji.200737423; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; Swanson KD, 2008, MOL CELL, V32, P564, DOI 10.1016/j.molcel.2008.09.022; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wang H, 2007, MOL CELL BIOL, V27, P6863, DOI 10.1128/MCB.00556-07; Wang HY, 2010, IMMUNOL LETT, V128, P148, DOI 10.1016/j.imlet.2009.10.010; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	80	81	85	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					541	556		10.1016/j.immuni.2010.03.007	http://dx.doi.org/10.1016/j.immuni.2010.03.007			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20346707	Bronze, Green Accepted			2022-12-18	WOS:000277171900013
J	Sinha, RK; Park, C; Hwang, IY; Davis, MD; Kehrl, JH				Sinha, Rajesh K.; Park, Chung; Hwang, Il-Young; Davis, Michael D.; Kehrl, John H.			B Lymphocytes Exit Lymph Nodes through Cortical Lymphatic Sinusoids by a Mechanism Independent of Sphingosine-1-Phosphate-Mediated Chemotaxis	IMMUNITY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; IMMUNOSUPPRESSANT FTY720; THYMOCYTE EMIGRATION; ENDOTHELIAL-CELLS; T-CELLS; IN-VIVO; MIGRATION; EGRESS; INHIBITION; MOTILITY	Sphingosine-1-phosphate (S1P) helps mediate lymphocyte egress from lymph nodes, yet many mechanistic questions remain. Here, we show the presence of B lymphocyte egress sites located in the lymph node cortex close to lymph node follicles. B cells exited lymph nodes by squeezing through apparent portals in the lymphatic endothelium of these sinusoids. Treatment with the S1P receptor agonist FTY720 emptied the cortical sinusoids of lymphocytes, blocked lymphatic endothelial penetration, and displaced B lymphocytes into the T cell zone. Slpr3(-/-) B cells, which lack chemoattractant responses to S1P, transited lymph nodes normally, whereas Gnai2(-/-) B cells, which have impaired responses to chemokines and S1P, transited more rapidly than did wild-type cells. This study identifies a major site of B lymphocyte lymph node egress, shows that FTY720 treatment blocks passage through the cortical lymphatic endothelium, and argues against a functional role for S1P chemotaxis in B lymphocyte egress.	[Sinha, Rajesh K.; Park, Chung; Hwang, Il-Young; Davis, Michael D.; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739, Z01AI000739, K11AI000739] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like thank M. Rust for her editorial assistance; A.S. Fauci for his continued support, and 0. Schwartz, M. Czapiga, and J. a at o t e Research Technology Branch of the National Institutes of Allergy and Infectious Diseases for their help in the acquisition and analysis of the TP-LSM data. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Akiyama T, 2008, J MOL HISTOL, V39, P527, DOI 10.1007/s10735-008-9193-y; Alfonso C, 2006, EUR J IMMUNOL, V36, P149, DOI 10.1002/eji.200535127; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; ANDERSON AO, 1975, AM J PATHOL, V80, P387; AZZALI G, 1990, CELL TISSUE RES, V262, P191, DOI 10.1007/BF00327761; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; GOWANS JL, 1957, BRIT J EXP PATHOL, V38, P67; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; HALL JG, 1965, J EXP MED, V121, P901, DOI 10.1084/jem.121.6.901; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; HE Y, 1985, ARCH HISTOL JAPON, V48, P1, DOI 10.1679/aohc.48.1; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Kehrl JH, 2006, IMMUNOL RES, V34, P211, DOI 10.1385/IR:34:3:211; KUROKAWA T, 1980, ACTA ANAT, V107, P439; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; LEPAULT F, 1994, EUR J IMMUNOL, V24, P3106, DOI 10.1002/eji.1830241229; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Ohtani O, 2008, ARCH HISTOL CYTOL, V71, P69, DOI 10.1679/aohc.71.69; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; SODERSTROM N, 1969, SCAND J HAEMATOL, V6, P186; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163	41	81	81	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					434	446		10.1016/j.immuni.2008.12.018	http://dx.doi.org/10.1016/j.immuni.2008.12.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19230723	Bronze, Green Accepted			2022-12-18	WOS:000264405500015
J	Gras, S; Burrows, SR; Kjer-Nielsen, L; Clements, CS; Liu, YC; Sullivan, LC; Bell, MJ; Brooks, AG; Purcell, AW; McCluskey, J; Rossjohn, J				Gras, Stephanie; Burrows, Scott R.; Kjer-Nielsen, Lars; Clements, Craig S.; Liu, Yu Chih; Sullivan, Lucy C.; Bell, Melissa J.; Brooks, Andrew G.; Purcell, Anthony W.; McCluskey, James; Rossjohn, Jamie			The Shaping of T Cell Receptor Recognition by Self-Tolerance	IMMUNITY			English	Article							HISTOCOMPATIBILITY COMPLEX BINDING; PEPTIDE-MHC; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; POSITIVE SELECTION; EPITOPE; BIAS; CRYSTALLIZATION; ALLORESPONSE; LYMPHOCYTES	During selection of the T cell repertoire, the immune system navigates the subtle distinction between self-restriction and self-tolerance, yet how this is achieved is unclear. Here we describe how self-tolerance toward atrans-HLA (human leukocyte antigen) allotype shapes T cell receptor (TCR) recognition of an Epstein-Barr virus (EBV) determinant (FLRGRAYGL). The recognition of HLA-B8-FLRGRAYGL by two archetypal TCRs was compared. One was a publicly selected TCR, LC13, that is alloreactive with HLA-B44; the other, CF34, lacks HLA-B44 reactivity because it arises when HLA-B44 is coinherited in trans with HLA-B8. Whereas the alloreactive LC13 TCR docked at the C terminus of HLA-B8-FLRGRAYGL, the CF34 TCR docked at the N terminus of HLA-B8-FLRGRAYGL, which coincided with a polymorphic region between HLA-B8 and HLA-B44. The markedly contrasting footprints of the LC13 and CF34 TCRs provided a portrait of how self-tolerance shapes the specificity of TCRs selected into the immune repertoire.	[Kjer-Nielsen, Lars; Sullivan, Lucy C.; Brooks, Andrew G.; McCluskey, James; Rossjohn, Jamie] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Burrows, Scott R.; Bell, Melissa J.] Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; [Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Gras, Stephanie; Clements, Craig S.; Liu, Yu Chih] Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia	University of Melbourne; QIMR Berghofer Medical Research Institute; University of Melbourne; University of Melbourne; Monash University	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	Purcell, Anthony/AAH-1942-2019; Rossjohn, Jamie/F-9032-2013; gras, stephanie/C-8307-2013; McCluskey, James/A-1291-2007; Burrows, Scott/G-2050-2011	Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Burrows, Scott/0000-0002-1430-0472; Sullivan, Lucy/0000-0003-2907-4989; Brooks, Andrew/0000-0002-4085-9683; gras, stephanie/0000-0001-7416-038X	National Health and Medical Research Council (NHMRC) of Australia; Roche Organ Transplantation Research Foundation; Australian Research Council (ARC); ARC Federation Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Roche Organ Transplantation Research Foundation; Australian Research Council (ARC)(Australian Research Council); ARC Federation Fellowship(Australian Research Council)	We thank the staff at the Australian synchrotron for assistance with data collection. The National Health and Medical Research Council (NHMRC) of Australia, Roche Organ Transplantation Research Foundation, and the Australian Research Council (ARC) supported this research. S.R.B. and A.W.P. are supported by NHMRC Senior Research Fellowships, and J.R. is supported by an ARC Federation Fellowship.	Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; BURROWS SR, 1990, J EXP MED, V171, P345, DOI 10.1084/jem.171.1.345; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Callan MFC, 1998, EUR J IMMUNOL, V28, P4382, DOI 10.1002/(SICI)1521-4141(199812)28:12<4382::AID-IMMU4382>3.3.CO;2-Q; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DeLano W. L, 2002, PYMOL MOL GENETICS G; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Ely LK, 2005, J IMMUNOL, V174, P5593, DOI 10.4049/jimmunol.174.9.5593; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; MCCLUSKEY J, 1986, J IMMUNOL, V137, P3881; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Nicholson MJ, 2005, IMMUNITY, V23, P351, DOI 10.1016/j.immuni.2005.09.009; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reid SW, 1996, FEBS LETT, V383, P119, DOI 10.1016/0014-5793(96)00226-8; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rossjohn J, 2007, CELL, V129, P19, DOI 10.1016/j.cell.2007.03.018; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	54	81	84	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					193	203		10.1016/j.immuni.2008.11.011	http://dx.doi.org/10.1016/j.immuni.2008.11.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19167249	Bronze			2022-12-18	WOS:000263710500007
J	Jordan, MS; Smith, JE; Burns, JC; Austin, JET; Nichols, KE; Aschenbrenner, AC; Koretzky, GA				Jordan, Martha S.; Smith, Jennifer E.; Burns, Jeremy C.; Austin, Jessica-Elise T.; Nichols, Kim E.; Aschenbrenner, Anna C.; Koretzky, Gary A.			Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76	IMMUNITY			English	Article							T-CELL-RECEPTOR; PROTEIN SLP-76; TCR SIGNALS; PHOSPHOLIPASE C-GAMMA-1; NEGATIVE SELECTION; SH2 DOMAIN; ITK; ACTIVATION; VAV; REQUIREMENT	The adaptor protein SLP76 directs signaling downstream of the T cell receptor (TCR) and is essential for thymocyte development. SLP76 contains three N-terminal tyrosines that are critical for its function. To define the role of these residues in thymocyte development, we generated two lines of "knock-in" mice, one expressing a mutation in tyrosine 145 (Y145F) and a second harboring two point mutations at tyrosines 112 and 128 (Y112-128F). We show here that although thymocyte development requires both Y145- and Y112-128-generated signals, selection was more dependent upon Y145. Although several proximal TCR signaling events were defective in both mutant mice, phosphorylation of the guanine nucleotide exchange factor, Vav1, and activation of Itk-dependent pathways were differentially affected by mutations at Y112-128 and Y145, respectively. Analysis of mice expressing one Y145F and one Y112-128F allele revealed that these mutants could complement one another in trans, demonstrating cooperativity between two or more SLP76 molecules. Thus, the N-terminal tyrosines of SLP76 are required for thymocyte selection but can function on separate molecules to support TCR signaling.	[Jordan, Martha S.; Smith, Jennifer E.; Burns, Jeremy C.; Austin, Jessica-Elise T.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Nichols, Kim E.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Aschenbrenner, Anna C.] Univ Bonn, D-53115 Bonn, Germany; [Koretzky, Gary A.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Bonn; University of Pennsylvania	Koretzky, GA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, 427 BRB2-3, Philadelphia, PA 19104 USA.	koretzky@mail.med.upenn.edu	Nichols, Kim/AAP-8592-2020; Koretzky, Gary/AAU-5381-2021; Nichols, Kim/E-9353-2016	Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555; Aschenbrenner, Anna/0000-0002-9429-5457; Burns, Jeremy/0000-0003-3853-0237	NCI NIH HHS [P01 CA093615, P01 CA093615-06] Funding Source: Medline; NCRR NIH HHS [T32-RR07063, T32 RR007063] Funding Source: Medline; NIAID NIH HHS [R01 AI061039, R01 AI061039-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM053256, R01 GM053256-12] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053256] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Cho HJ, 2003, J IMMUNOL, V170, P10, DOI 10.4049/jimmunol.170.1.10; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; CRISPE IN, 1987, J IMMUNOL, V138, P2013; Cunningham NR, 2006, J IMMUNOL, V177, P6660, DOI 10.4049/jimmunol.177.10.6660; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; DUPLAY P, 1989, J IMMUNOL, V142, P2998; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gadue P, 2002, J IMMUNOL, V169, P2397, DOI 10.4049/jimmunol.169.5.2397; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISHIMOTO H, 1995, J EXP MED, V181, P649, DOI 10.1084/jem.181.2.649; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kumar L, 2002, P NATL ACAD SCI USA, V99, P884, DOI 10.1073/pnas.022619199; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; McGargill MA, 1999, J IMMUNOL, V162, P1237; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Musci MA, 1997, J IMMUNOL, V159, P1639; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; PETERSON DO, 1985, J VIROL, V54, P525, DOI 10.1128/JVI.54.2.525-531.1985; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pletneva EV, 2006, J MOL BIOL, V357, P550, DOI 10.1016/j.jmb.2005.12.073; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; SALINAS J, 1987, NUCLEIC ACIDS RES, V15, P3009, DOI 10.1093/nar/15.7.3009; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	50	81	81	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					359	369		10.1016/j.immuni.2008.01.010	http://dx.doi.org/10.1016/j.immuni.2008.01.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342008	Green Accepted, Bronze			2022-12-18	WOS:000254142500013
J	Aiba, Y; Yamazaki, T; Okada, T; Gotoh, K; Sanjo, H; Ogata, M; Kurosaki, T				Aiba, Y; Yamazaki, T; Okada, T; Gotoh, K; Sanjo, H; Ogata, M; Kurosaki, T			BANK negatively regulates Akt activation and subsequent B cell responses	IMMUNITY			English	Article							CD40 LIGAND; SIGNAL-TRANSDUCTION; CD40-DEFICIENT MICE; AUTOIMMUNE-DISEASE; RECEPTOR; INFLAMMATION; SURVIVAL; PHOSPHORYLATION; IMMUNOGLOBULIN; PROTEINS	BANK is an adaptor protein that is highly expressed in B cells. To investigate its physiological role, we generated BANK-deficient mice. BANK-deficient mice displayed enhanced germinal center formation and IgM production in response to T-dependent antigens, whereas this phenotype was blocked in CD40-BANK double knockout mice. Involvement of BANK in CD40 signaling was further demonstrated by in vitro analysis. CD40-mediated proliferation and survival were significantly increased in BANK-deficient B cells, with enhanced Akt activation, whereas introduction of dominant-negative Akt into BANK-deficient B cells suppressed the augmented CD40-mediated responses. Together, our findings suggest that BANK attenuates CD40-mediated Akt activation, thereby preventing hyperactive B cell responses.	RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Kansai Med Univ, Dept Mol Genet, Inst Liver Res, Moriguchi, Osaka 5708506, Japan; Mie Univ, Sch Med, Dept Biochem, Tsu, Mie 5148507, Japan	RIKEN; Kansai Medical University; Mie University	Kurosaki, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	kurosaki@rcai.riken.jp	Okada, Takaharu/N-7931-2015; Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Battersby A, 2003, J MOL BIOL, V329, P479, DOI 10.1016/S0022-2836(03)00489-3; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Calderhead DM, 2000, CURR TOP MICROBIOL, V245, P73; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Clark EA, 2003, IMMUNITY, V18, P724, DOI 10.1016/S1074-7613(03)00146-8; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Doronin S, 2002, J BIOL CHEM, V277, P15124, DOI 10.1074/jbc.M108771200; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; Flavell RA, 2002, CURR TOP MICROBIOL, V266, P1; FULEIHAN R, 1993, CURR OPIN IMMUNOL, V5, P963, DOI 10.1016/0952-7915(93)90113-7; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Grammer A C, 2000, Adv Immunol, V76, P61; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawamura T, 2004, J IMMUNOL, V172, P6388, DOI 10.4049/jimmunol.172.10.6388; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Laurencikiene J, 2001, J IMMUNOL, V167, P3257, DOI 10.4049/jimmunol.167.6.3257; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; ROY T, 1993, J EXP MED, V178, P1567; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Strom L, 1999, SCAND J IMMUNOL, V49, P523; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; VONKOOTEN C, 1997, CURR OPIN CELL BIOL, V9, P330; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Wiley JA, 1997, J IMMUNOL, V158, P2932; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yamazaki T, 2003, NAT IMMUNOL, V4, P780, DOI 10.1038/ni949; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83	46	81	87	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					259	268		10.1016/j.immuni.2006.01.002	http://dx.doi.org/10.1016/j.immuni.2006.01.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546095	Bronze			2022-12-18	WOS:000236504500007
J	Faria, AMC; Levay, A; Wang, Y; Kamphorst, AO; Rosa, MLP; Nussenzveig, DR; Balkan, W; Chook, YM; Levy, DE; Fontoura, BMA				Faria, AMC; Levay, A; Wang, Y; Kamphorst, AO; Rosa, MLP; Nussenzveig, DR; Balkan, W; Chook, YM; Levy, DE; Fontoura, BMA			The nucleoporin Nup96 is required for proper expression of interferon-regulated proteins and functions	IMMUNITY			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE; BIOGENESIS PATHWAY; NUP107-160 COMPLEX; GENE-EXPRESSION; GERMINAL CENTER; TRANSPORT; DIFFERENTIATION; COSTIMULATION; KINETOCHORES	Nup98 and Nup96 are components of the nuclear transport machinery and are induced by interferons (IFN). Nup98 is a constituent of an mRNA export pathway that is targeted by viruses and regulated by IFN. However, the role of Nup96 in IFN-related mechanisms has not been established. To investigate the function of Nup96 in vivo, we generated Nup86(+/-) mice that express low levels of Nup96, as Nup96(-/-) mice are lethal. The Nup96(+/-) mice presented selective alterations of the immune system, which resulted in downregulation and impaired IFN alpha- and gamma-mediated induction of MHC I and IFN gamma induction of MHC II, ICAM-1, and other proteins. Frequency of TCR alpha beta+ and CD4+ T cells, which depends on MHC function, is reduced in NUP96(+/-) mice. Upon immunization, Nup96(+/-) mice showed impaired antigen presentation and T cell proliferation. Nup96(+/-) cells and mice were highly susceptible to viral infection, demonstrating a role for Nup96 in innate and adaptive immunity.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Miami; Universidade Federal de Minas Gerais; New York University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Fontoura, BMA (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	beatriz.fontoura@utsouthwestern.edu	Levy, David/AAG-6202-2019; Chook, Yuh Min/AAA-9549-2019; Levy, David/GPS-4945-2022; Levay, Agata/R-5392-2019; Faria, Ana Maria/AAK-8688-2021	Levy, David/0000-0002-7320-7788; Kamphorst, Alice/0000-0002-9230-9501; Levay, Agata/0000-0001-9404-4503; Faria, Ana Maria/0000-0002-0604-8510	NIAID NIH HHS [AI28900] Funding Source: Medline; NIGMS NIH HHS [R01 GM067159-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067159] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chook YM, 2002, BIOCHEMISTRY-US, V41, P6955, DOI 10.1021/bi012122p; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; Dockendorff TC, 1997, MOL CELL BIOL, V17, P906, DOI 10.1128/MCB.17.2.906; Emtage JLT, 1997, J CELL SCI, V110, P911; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; Hegde NR, 2003, TRENDS IMMUNOL, V24, P278, DOI 10.1016/S1471-4906(03)00099-1; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; McAdam AJ, 1998, IMMUNOL REV, V165, P231; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; Natarajan K, 1999, Rev Immunogenet, V1, P32; OGARRA A, 1986, P NATL ACAD SCI USA, V83, P5228, DOI 10.1073/pnas.83.14.5228; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REYNOLDS DS, 1987, J IMMUNOL, V139, P767; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Stavnezer J, 2000, SCIENCE, V288, P984, DOI 10.1126/science.288.5468.984; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Woodland RT, 2005, SEMIN IMMUNOL, V17, P209, DOI 10.1016/j.smim.2005.02.006; Yu X, 2000, J IMMUNOL, V164, P3543, DOI 10.4049/jimmunol.164.7.3543; Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926; Zuckerman LA, 1998, J IMMUNOL, V160, P3259	45	81	85	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					295	304		10.1016/j.immuni.2006.01.014	http://dx.doi.org/10.1016/j.immuni.2006.01.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546098	Bronze			2022-12-18	WOS:000236504500010
J	Baba, Y; Garrett, KP; Kincade, PW				Baba, Y; Garrett, KP; Kincade, PW			Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; CHROMATIN-REMODELING COMPLEXES; B-LYMPHOCYTE; TRANSCRIPTIONAL COACTIVATORS; MACROPHAGE PROGENITORS; LINEAGE SWITCH; SELF-RENEWAL; PHD-FINGER; CONVERSION; LEUKEMIA	beta-catenin-mediated Wnt signaling may contribute to the self-renewal of hematopoietic stem cells and proliferation in some malignancies. We now show that expression of constitutively active P-catenin in normal lymphoid or myeloid progenitors generated uncommitted cells with multilineage differentiation potential. Inappropriate gene expression occurred in cells destined to produce either cell type and caused corresponding changes in their characteristics. For example, forced activation of beta-catenin quickly increased C/EBP alpha while reducing EBF and Pax-5 in lymphoid progenitors that then generated myeloid cells. Inversely, EBF dramatically increased in transduced myeloid progenitors and lymphocytes were produced. The results indicate that ectopic activation of beta-catenin destabilizes lineage fate decisions and confers some, but not all, stem cell properties on committed progenitors.	Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI058162, R01AI020069] Funding Source: NIH RePORTER; NCRR NIH HHS [P20-RR15577, P20 RR015577] Funding Source: Medline; NIAID NIH HHS [AI20069, AI58162, R01 AI020069, R01 AI058162] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; BOGGS DR, 1974, BLOOD, V44, P449, DOI 10.1182/blood.V44.3.449.449; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703, DOI 10.1128/MCB.10.6.2703; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; Cellot S, 2005, TRENDS IMMUNOL, V26, P68, DOI 10.1016/j.it.2004.12.005; CHENG GY, 1986, J EXP MED, V163, P414, DOI 10.1084/jem.163.2.414; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; HERSHFIELD MS, 1984, P NATL ACAD SCI-BIOL, V81, P253, DOI 10.1073/pnas.81.1.253; HUANG J, 2005, IN PRESS J IMMUNOL; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; McNagny KM, 2003, BLOOD, V101, P1103, DOI 10.1182/blood-2002-04-1050; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; NOSAKA T, 1988, J CLIN INVEST, V81, P1824, DOI 10.1172/JCI113526; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Parker DS, 2002, DEVELOPMENT, V129, P2565; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schmidt C A, 2001, Int Rev Immunol, V20, P107, DOI 10.3109/08830180109056725; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Serinsoz E, 2004, BRIT J HAEMATOL, V126, P313, DOI 10.1111/j.1365-2141.2004.05049.x; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; SMITH LJ, 1983, BLOOD, V61, P1138; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; STASS S, 1984, BLOOD, V64, P701; Sustar A, 2005, CELL, V120, P383, DOI 10.1016/j.cell.2004.12.008; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	70	81	93	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					599	609		10.1016/j.immuni.2005.10.009	http://dx.doi.org/10.1016/j.immuni.2005.10.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356858	Green Accepted, Bronze			2022-12-18	WOS:000234316900007
J	Rupec, RA; Jundt, F; Rebholz, B; Eckelt, B; Weindl, G; Herzinger, T; Flaig, MJ; Moosmann, S; Plewig, G; Dorken, B; Forster, I; Huss, R; Pfeffer, K				Rupec, RA; Jundt, F; Rebholz, B; Eckelt, B; Weindl, G; Herzinger, T; Flaig, MJ; Moosmann, S; Plewig, G; Dorken, B; Forster, I; Huss, R; Pfeffer, K			Stroma-mediated dysregulation of myelopolesis in mice lackingk l kappa B alpha	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; NOTCH SIGNALING PATHWAY; ACUTE MYELOID LEUKEMIAS; TRANSCRIPTION FACTORS; MARROW STROMA; IN-VIVO; EXPRESSION; DIFFERENTIATION; PROGENITOR; DEFICIENT	Hematopoiesis occurs in the liver and the bone marrow (BM) during murine development. Newborn mice with a ubiquitous deletion of I kappa B alpha develop a severe hematological disorder characterized by an increase of granulocyte/erythroid/monocyte/macrophage colony-forming units (CFU-GEMM) and hypergranulopoiesis. Here, we report that this particular myeloproliferative disturbance is mediated by continuously deregulated perinatal expression of Jagged1 in I kappa B alpha deficient hepatocytes. The result is a permanent activation of Notch1 in neutrophils. In contrast, in mice with a conditional deletion of I kappa B alpha only in the myeloid lineage (Ikba(flox/flox) x LysM-Cre) and in fetal liver cell chimeras (ikba(FL Delta/FL Delta)), a cell-autonomous induction of the myeloproliferative disease was not observed. Coculture of I kappa B alpha-deficient hepatocytes with wildtype (wt) BM cells induced a Jagged1-dependent increase in CFUs. In summary, we show that cell-fate decisions leading to a premalignant hematopoietic disorder can be initiated by nonhematopoietic cells with inactive I kappa B alpha.	Univ Munich, Dept Dermatol, D-80337 Munich, Germany; Max Delbruck Ctr Mol Med & Charite, D-13353 Berlin, Germany; Univ Munich, Inst Pathol, D-80337 Munich, Germany; Univ Dusseldorf, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany	University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Rupec, RA (corresponding author), Univ Munich, Dept Dermatol, Frauenlobstr 9-11, D-80337 Munich, Germany.	rudolf.rupec@med.uni-muenchen.de; pfeffer@uni-duesseldorf.de	Förster, Irmgard/P-8545-2016; Jundt, Franziska/E-9748-2014; Weindl, Günther/B-6161-2011	Förster, Irmgard/0000-0002-7644-5642; Jundt, Franziska/0000-0002-8661-7110; Weindl, Günther/0000-0002-4493-7597; Pfeffer, Klaus/0000-0002-5652-6330				Aizawa S, 1999, LEUKEMIA RES, V23, P239, DOI 10.1016/S0145-2126(98)00163-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BENTLEY SA, 1981, EXP HEMATOL, V9, P308; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Deeg HJ, 2000, LEUKEMIA LYMPHOMA, V37, P405, DOI 10.3109/10428190009089441; Deeg HJ, 2002, LEUKEMIA RES, V26, P687, DOI 10.1016/S0145-2126(02)00015-2; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Friedman AD, 2002, INT J HEMATOL, V75, P466, DOI 10.1007/BF02982108; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; INOUE T, 1994, LEUKEMIA, V8, pS202; Jaffe ES, 2001, WHO CLASSIFICATION T; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; JENNINGS B, 1995, DEVELOPMENT, V121, P3745; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Kuprash DV, 2002, MOL CELL BIOL, V22, P8626, DOI 10.1128/MCB.22.24.8626-8634.2002; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pyatt DW, 1999, BLOOD, V93, P3302, DOI 10.1182/blood.V93.10.3302.410a38_3302_3308; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rupec RA, 1999, IMMUNOGENETICS, V49, P395, DOI 10.1007/s002510050512; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Siebenlist U., 1997, BIOCHIMICA BIOPHYSIC, V1332, P7; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tan-Pertel HT, 2000, J IMMUNOL, V165, P4428, DOI 10.4049/jimmunol.165.8.4428; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tohda S, 2001, LEUKEMIA LYMPHOMA, V42, P467, DOI 10.3109/10428190109064603; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Walker L, 1999, STEM CELLS, V17, P162, DOI 10.1002/stem.170162; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	57	81	82	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					479	491		10.1016/j.immuni.2005.02.009	http://dx.doi.org/10.1016/j.immuni.2005.02.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845452	Bronze			2022-12-18	WOS:000228909600009
J	Selin, LK; Welsh, RM				Selin, LK; Welsh, RM			Plasticity of T cell memory responses to viruses	IMMUNITY			English	Review							HETEROLOGOUS ANTIVIRAL IMMUNITY; CROSS-REACTIVITY; IN-VIVO; HOMEOSTATIC PROLIFERATION; IMMUNOLOGICAL MEMORY; PROTECTIVE IMMUNITY; MOLECULAR MIMICRY; EFFECTOR FUNCTION; ANTIGEN; MICE	Virus-specific memory T cell populations demonstrate plasticity in antigenic and functional phenotype, in recognition of antigen, and in their ability to accommodate new memory T cell populations. The adaptability of complex antigen-specific T cell repertoires allows the host to respond to a diverse array of pathogens and accommodate memory pools to many pathogens in a finite immune system. This is in part accounted for by crossreactive memory T cells, which can be employed in immune responses and mediate protective immunity or life-threatening immunopathology.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Welsh, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA.	raymond.welsh@umassmed.edu		Selin, Liisa/0000-0002-6993-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017672, R01AI017672, R01AI046578, P01AI046629, P01AI049320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI049320, AI17672, AI46578, P01 AI046629, R01 AI017672, R01 AI046578, AI49320, AI46629, R37 AI017672] Funding Source: Medline; NIAMS NIH HHS [AR35506, R01 AR035506] Funding Source: Medline; NIDDK NIH HHS [P30 DK032520, DK32520] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alam SM, 1998, J IMMUNOL, V160, P3883; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bachmann MF, 1997, J VIROL, V71, P5764, DOI 10.1128/JVI.71.8.5764-5768.1997; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; BOLOGNIA J, 1992, HARRISONS PRINCIPLES, P290; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Brehm MA, 2003, J IMMUNOL, V170, P4077, DOI 10.4049/jimmunol.170.8.4077; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; Cameron TO, 2002, IMMUNOGENETICS, V54, P611, DOI 10.1007/s00251-002-0508-y; Catalina MD, 2002, J IMMUNOL, V168, P4184, DOI 10.4049/jimmunol.168.8.4184; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen HD, 2003, AM J PATHOL, V163, P1341, DOI 10.1016/S0002-9440(10)63493-1; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Cohen GB, 2002, VIROLOGY, V304, P474, DOI 10.1006/viro.2002.1743; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; DeMaria A, 1997, P NATL ACAD SCI USA, V94, P10285, DOI 10.1073/pnas.94.19.10285; DESTGROTH SF, 1966, J EXP MED, V124, P347, DOI 10.1084/jem.124.3.347; DIGIUSTO CA, 1986, LANCET, V2, P1042; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Edinger JW, 1999, J IMMUNOL, V162, P3694; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Evans CF, 1996, J EXP MED, V184, P2371, DOI 10.1084/jem.184.6.2371; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; GASTON JSH, 1985, IMMUNOL TODAY, V6, P237, DOI 10.1016/0167-5699(85)90010-6; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Jiang J, 2003, J IMMUNOL, V171, P3353, DOI 10.4049/jimmunol.171.7.3353; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim SK, 2002, J IMMUNOL, V169, P90, DOI 10.4049/jimmunol.169.1.90; KIM SK, 2004, IN PRESS J IMMUNOL, V172; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Liu HY, 2003, J VIROL, V77, P7756, DOI 10.1128/JVI.77.14.7756-7763.2003; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Maryanski JL, 1999, MOL IMMUNOL, V36, P745, DOI 10.1016/S0161-5890(99)00088-7; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Misko IS, 1999, P NATL ACAD SCI USA, V96, P2279, DOI 10.1073/pnas.96.5.2279; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Moser JM, 2001, J EXP MED, V193, P595, DOI 10.1084/jem.193.5.595; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; NAHILL SR, 1993, J EXP MED, V177, P317, DOI 10.1084/jem.177.2.317; Naumov YN, 2003, J IMMUNOL, V170, P3994, DOI 10.4049/jimmunol.170.8.3994; NETTESHEIM P, 1972, LAB INVEST, V26, P210; Nilges K, 2003, J VIROL, V77, P5464, DOI 10.1128/JVI.77.9.5464-5474.2003; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; Olsen JK, 2001, J CLIN INVEST, V108, P311; Ostler T, 2003, EUR J IMMUNOL, V33, P1839, DOI 10.1002/eji.200323460; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Pewe L, 1999, J IMMUNOL, V163, P6106; PFIZENMAIER K, 1977, J IMMUNOL, V119, P939; RAZVI ES, 1995, J IMMUNOL, V154, P620; RAZVI ES, 1995, AM J PATHOL, V147, P79; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; ROUSE BT, 1986, REV INFECT DIS, V8, P850; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schlesinger C, 1998, Ann Diagn Pathol, V2, P321, DOI 10.1016/S1092-9134(98)80026-9; Selin Liisa K., 2000, P327; Selin LK, 1997, J IMMUNOL, V158, P5366; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; SHIMOJO N, 1989, J IMMUNOL, V143, P2939; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Smith DK, 2002, J IMMUNOL, V169, P1197, DOI 10.4049/jimmunol.169.3.1197; Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Theil DJ, 2001, J NEUROVIROL, V7, P220; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; TRIPP RA, 1995, J IMMUNOL, V154, P5870; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vely F, 2001, J IMMUNOL, V166, P2487, DOI 10.4049/jimmunol.166.4.2487; Walzl G, 2000, J EXP MED, V192, P1317, DOI 10.1084/jem.192.9.1317; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; WEINSTEIN L, 1956, ARCH INTERN MED, V98, P91, DOI 10.1001/archinte.1956.00250250097013; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Welsh RM, 2000, J VIROL, V74, P2210, DOI 10.1128/JVI.74.5.2210-2218.2000; WELSH RM, 2004, IN PRESS ANN REV IMM, V22; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455; Xiong YL, 2001, J VIROL, V75, P3028, DOI 10.1128/JVI.75.6.3028-3033.2001; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	112	81	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					5	16		10.1016/S1074-7613(03)00356-X	http://dx.doi.org/10.1016/S1074-7613(03)00356-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738760	Green Published, Bronze			2022-12-18	WOS:000221442200003
J	Bhandoola, A; Tai, XG; Eckhaus, M; Auchincloss, H; Mason, K; Rubin, SA; Carbone, KM; Grossman, Z; Rosenberg, AS; Singer, A				Bhandoola, A; Tai, XG; Eckhaus, M; Auchincloss, H; Mason, K; Rubin, SA; Carbone, KM; Grossman, Z; Rosenberg, AS; Singer, A			Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: Evidence from a lymphopenic T cell model	IMMUNITY			English	Article							POSITIVE SELECTION; HOMEOSTATIC PROLIFERATION; ACTIVATION THRESHOLD; PEPTIDE LIGANDS; SURVIVAL; THYMUS; COMPLEX; MOLECULES; ANTIGENS; MOUSE	While intrathymic MHC expression influences the specificity of developing thymocytes, we considered that peripheral MHC expression might influence the reactivity of postthymic T cells. We now report for CD4(+) T cells that peripheral MHC-II expression does influence their reactivity and self-tolerance. Upon transfer into MHC-II-deficient lymphopenic hosts, mature CD4(+) T cells were found to acquire an activated memory phenotype and to become: (1) autoreactive against syngeneic MHC-II+ skin grafts, (2) hyperreactive against third-party MHC-II+ skin grafts, and (3) functionally dysregulated, resulting in a lymphoproliferative disorder characterized by intraepithelial infiltrations. Peripheral MHC-II expression appeared to influence CD4+ T cell reactivity by two complementary mechanisms: maintenance of CD4(+)CD25(+) regulatory T cells ("suppression") and direct dampening of CD4(+) T cell reactivity ("tuning").	NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; NIH, Vet Resources Program, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Transplantat Unit, Boston, MA 02114 USA; US FDA, Div Therapeut Prot, Bethesda, MD 20892 USA; US FDA, Lab Pediat & Resp Viral Dis, Bethesda, MD 20892 USA; Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; NIAID, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Harvard University; Massachusetts General Hospital; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bldg 10, Bethesda, MD 20892 USA.		Grossman, Zvi/A-9643-2008					Auchincloss Hugh Jr., 1993, P1099; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; MCKENZIE IFC, 1979, J EXP MED, V150, P1323, DOI 10.1084/jem.150.6.1323; MCKENZIE IFC, 1984, IMMUNOGENETICS, V20, P475, DOI 10.1007/BF00364350; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nicholson LB, 2000, INT IMMUNOL, V12, P205, DOI 10.1093/intimm/12.2.205; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Singer A., 1986, PROG IMMUNOL, V6, P60; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Trobonjaca Z, 2001, J IMMUNOL, V166, P3804, DOI 10.4049/jimmunol.166.6.3804; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737; Zinkernagel RM, 1997, IMMUNOL TODAY, V18, P14, DOI 10.1016/S0167-5699(97)80008-4; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882; ZINKERNAGEL RM, 1978, J EXP MED, V147, P897, DOI 10.1084/jem.147.3.897	40	81	84	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					425	436		10.1016/S1074-7613(02)00417-X	http://dx.doi.org/10.1016/S1074-7613(02)00417-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387737	Bronze			2022-12-18	WOS:000178667100004
J	Stetson, DB; Mohrs, M; Mallet-Designe, V; Teyton, L; Locksley, RM				Stetson, DB; Mohrs, M; Mallet-Designe, V; Teyton, L; Locksley, RM			Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo	IMMUNITY			English	Article							MURINE LEISHMANIASIS; ANTIGEN; RESISTANCE; PLASTICITY; SUSCEPTIBILITY; INDUCTION; INSTRUCTS; RESPONSES; IMMUNITY; MOUSE	CD4 T cells are pivotal for effective immunity, yet their initial differentiation into effector subsets after infection remains poorly defined. We examined CD4 T cells specific for the immunodominant Leishmania major LACK antigen using MHC/peptide tetramers and IL-4 reporter mice. Comprising similar to15 cells/lymph node in naive mice, LACK-specific T cells expanded over 100-fold, and 70% acquired IL-4 expression by 96 hr. Despite their pathogenic role in susceptible mice, LACK-specific precursor frequency, expansion, and IL-4 expression were comparable between susceptible and resistant mice. When injected with unrelated antigen, Leishmania efficiently activated IL-4 expression from naive antigen-specific T cells. CD4 subset polarization in this highly characterized model occurs independently from IL-4 expression by naive T cells, which is activated indiscriminately after parasitism.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Scripps Research Institute	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			NIAID NIH HHS [AI26918] Funding Source: Medline; NIA NIH HHS [AG04322] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004322] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Julia V, 2000, J IMMUNOL, V165, P5637, DOI 10.4049/jimmunol.165.10.5637; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Malhotra V, 2000, J AM SOC ECHOCARDIOG, V13, P771, DOI 10.1067/mje.2000.106078; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MORRIS L, 1992, J IMMUNOL, V149, P2715; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NobenTrauth N, 1996, SCIENCE, V271, P987, DOI 10.1126/science.271.5251.987; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Pingel S, 1999, J EXP MED, V189, P1111, DOI 10.1084/jem.189.7.1111; Prina E, 1996, J IMMUNOL, V156, P4318; Reiner SL, 1998, J IMMUNOL, V160, P884; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; SADICK MD, 1991, INFECT IMMUN, V59, P4710, DOI 10.1128/IAI.59.12.4710-4714.1991; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schuler T, 2001, J EXP MED, V194, P1767, DOI 10.1084/jem.194.12.1767; Schuler T, 1999, J EXP MED, V189, P803, DOI 10.1084/jem.189.5.803; Scott CA, 1998, PROTEIN SCI, V7, P413; Sommer F, 1998, INT IMMUNOL, V10, P1853, DOI 10.1093/intimm/10.12.1853; Sousa CRE, 2001, IMMUNITY, V14, P495; Topham DJ, 1998, J IMMUNOL, V161, P4530; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998	43	81	86	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2002	17	2					191	200		10.1016/S1074-7613(02)00363-1	http://dx.doi.org/10.1016/S1074-7613(02)00363-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196290	Bronze			2022-12-18	WOS:000177669400007
J	Sano, S; Takahama, Y; Sugawara, T; Kosaka, H; Itami, S; Yoshikawa, K; Miyazaki, J; van Ewijk, W; Takeda, J				Sano, S; Takahama, Y; Sugawara, T; Kosaka, H; Itami, S; Yoshikawa, K; Miyazaki, J; van Ewijk, W; Takeda, J			Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival	IMMUNITY			English	Article							EPIDERMAL GROWTH-FACTOR; TRANSCRIPTION FACTORS; NEU ONCOGENE; IN-VIVO; MICE; DIFFERENTIATION; INVOLUTION; APOPTOSIS; PROTEIN; SIGNALS	This study describes abnormalities of the thymus in mice in which the Stat3 gene has been specifically disrupted behind the keratin 5 promoter. In these mice, virtually all of the thymic epithelial cells (TEC) were deficient for Stat3 activation. Adult mutant mice developed severe thymic hypoplasia, which included alterations in the cortical TEC architecture that coincided with the loss of thymocytes. Even during the asymptomatic period of preadolescence, these mice exhibited a higher susceptibility of the thymus to suboptimal doses of dexamethasone or gamma -irradiation, while their thymocytes per se were no more sensitive than controls. These results indicate that Stat3 in TEC plays an essential role in maintaining thymic architecture and thymocyte survival.	Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Social Environm Med, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Physiol Chem & Nutr, Suita, Osaka 5650871, Japan; Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands	Osaka University; Osaka University; Osaka University; Tokushima University; Erasmus University Rotterdam	Sano, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Takahama, Yousuke/A-5863-2010; Miyazaki, Jun-ichi/N-1976-2015; Sugawara, Takehiko/K-2906-2012	Takahama, Yousuke/0000-0002-4992-9174; Miyazaki, Jun-ichi/0000-0003-2475-589X; Sugawara, Takehiko/0000-0002-9925-3619				Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Bol D, 1998, MOL CARCINOGEN, V21, P2, DOI 10.1002/(SICI)1098-2744(199801)21:1<2::AID-MC2>3.3.CO;2-7; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; BRUNELLI R, 1992, ANN NY ACAD SCI, V673, P252, DOI 10.1111/j.1749-6632.1992.tb27460.x; Capone M, 2001, BLOOD, V97, P1336, DOI 10.1182/blood.V97.5.1336; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cohen J J, 1992, Semin Immunol, V4, P363; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cellbio.11.1.123; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; George AJT, 1996, IMMUNOL TODAY, V17, P267, DOI 10.1016/0167-5699(96)80543-3; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; HENNING SJ, 1978, AM J PHYSIOL, V235, P451; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; HIROKAWA K, 1975, J IMMUNOL, V114, P1659; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; HUGO P, 1993, IMMUNOL REV, V135, P133, DOI 10.1111/j.1600-065X.1993.tb00647.x; IMAIZUMI A, 1993, CELL IMMUNOL, V150, P81, DOI 10.1006/cimm.1993.1180; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levin SD, 1999, J IMMUNOL, V162, P677; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Mackall CL, 1997, IMMUNOL REV, V160, P91, DOI 10.1111/j.1600-065X.1997.tb01030.x; Mackall CL, 1998, EUR J IMMUNOL, V28, P1886, DOI 10.1002/(SICI)1521-4141(199806)28:06<1886::AID-IMMU1886>3.0.CO;2-M; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Pazirandeh A, 1999, FASEB J, V13, P893, DOI 10.1096/fasebj.13.8.893; Purton JF, 2000, IMMUNITY, V13, P179, DOI 10.1016/S1074-7613(00)00018-2; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; ROPKE C, 1995, DEV IMMUNOL, V4, P149, DOI 10.1155/1995/23168; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Sano S, 2000, P NATL ACAD SCI USA, V97, P13824, DOI 10.1073/pnas.240303097; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; SPRENT J, 1995, J IMMUNOL, V154, P1198; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tibbetts TA, 1999, P NATL ACAD SCI USA, V96, P12021, DOI 10.1073/pnas.96.21.12021; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VANEWLIJK W, 2000, DEVELOPMENT, V127, P1283; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Windmill KF, 1999, J REPROD IMMUNOL, V44, P29, DOI 10.1016/S0165-0378(99)00006-6; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	55	81	86	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					261	273		10.1016/S1074-7613(01)00180-7	http://dx.doi.org/10.1016/S1074-7613(01)00180-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520461	Bronze			2022-12-18	WOS:000170717200008
J	Wiesmann, A; Phillips, RL; Mojica, M; Pierce, LJ; Searles, AE; Spangrude, GJ; Lemischka, I				Wiesmann, A; Phillips, RL; Mojica, M; Pierce, LJ; Searles, AE; Spangrude, GJ; Lemischka, I			Expression of CD27 on murine hematopoietic stem and progenitor cells	IMMUNITY			English	Article							FACTOR RECEPTOR FAMILY; TUMOR-NECROSIS-FACTOR; BONE-MARROW; DIFFERENTIATION; COSTIMULATION; HETEROGENEITY; ACTIVATION; DIVISIONS; RECOVERY; DEFINES	Hematopoietic stem cells (HSC) are defined by self-renewal and multilineage differentiation potentials. In order to uncover the genetic program of HSC, we utilized high-density arrays to compare gene expression in highly purified mouse HSC and their mature progeny. One molecule specifically expressed in immature cells is CD27, a member of the TNF receptor family previously shown to play roles in lymphoid proliferation, differentiation, and apoptosis. We show here that the CD27 protein is expressed by about 90% of cells in a purified HSC population. Interestingly, the CD27(pos) cells are enriched for cells with short-term hematopoietic activities (colony forming potential in vivo and in vitro), while the minority CD27(neg) population is more effective in clonal long-term transplantation.	Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84132 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84132 USA; Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; Univ Utah, Dept Med, Div Hematol, Salt Lake City, UT 84132 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Princeton University	Lemischka, I (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84132 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049219, R01DK042989] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL56857] Funding Source: Medline; NIDDK NIH HHS [P50 DK49219, R01 DK42989] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; Gothot A, 1998, EXP HEMATOL, V26, P562; GRAVESTEIN LA, 1993, EUR J IMMUNOL, V23, P943, DOI 10.1002/eji.1830230427; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; Jordan CT, 1996, EXP HEMATOL, V24, P1347; KOBATA T, 1994, J IMMUNOL, V153, P5422; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KRAUSE DS, 1994, BLOOD, V84, P691; Lansdorp PM, 1995, LEUCOCYTE TYPING, P1030; LI CL, 1992, J EXP MED, V175, P1443, DOI 10.1084/jem.175.6.1443; Morel F, 1998, EXP HEMATOL, V26, P440; MORELAND K, 1996, AM STUD INT, V34, P88; Nibley WE, 1998, BONE MARROW TRANSPL, V21, P345, DOI 10.1038/sj.bmt.1701097; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Sitnicka E, 1996, BLOOD, V88, P82; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SUGITA K, 1991, J IMMUNOL, V147, P1477; Uchida N, 1996, EXP HEMATOL, V24, P649; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; VANLIER RAW, 1987, J IMMUNOL, V139, P1589	33	81	82	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					193	199		10.1016/S1074-7613(00)80172-7	http://dx.doi.org/10.1016/S1074-7613(00)80172-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714685	Bronze			2022-12-18	WOS:000085621400009
J	Iritani, BM; Alberola-Ila, J; Forbush, KA; Perlmutter, RM				Iritani, BM; Alberola-Ila, J; Forbush, KA; Perlmutter, RM			Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors	IMMUNITY			English	Article							T-CELL-RECEPTOR; LYN-DEFICIENT MICE; IMMUNOGLOBULIN HEAVY-CHAIN; PROTEIN-TYROSINE KINASES; SURROGATE LIGHT-CHAIN; MOUSE BONE-MARROW; TCR-ZETA SUBUNIT; THYMOCYTE DEVELOPMENT; V(D)J RECOMBINATION; C-MYC	Successful in-frame rearrangement of immunoglobulin heavy chain genes or T cell antigen receptor (TCR) beta chain genes in lymphocyte progenitors results in formation of pre-BCR and pre-TCR complexes. These complexes signal progenitor cells to mature, expand in cell number, and suppress further rearrangements at the immunoglobulin heavy chain or TCR beta chain loci, thereby ensuring allelic exclusion. We used transgenic expression of a constitutively active form of c-Raf-1 (Raf-CAAX) to demonstrate that activation of the Map kinase pathway can stimulate both maturation and expansion of B and T lymphocytes, even in the absence of pre-TCR or pre-BCR formation. However, the same Raf signal did not mediate allelic exclusion. We conclude that maturation of lymphocyte progenitors and allelic exclusion require distinct signals.	Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Comparat Med, Seattle, WA 98195 USA; CALTECH, Div Biol, Pasadena, CA 92115 USA; Merck Res Labs, Rahway, NJ 07065 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; California Institute of Technology; Merck & Company	Perlmutter, RM (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA.			alberola-ila, Jose/0000-0003-2439-553X; Iritani, Brian/0000-0003-1903-7850	NCRR NIH HHS [T32 RR007019, T32 RR07019] Funding Source: Medline; NIAID NIH HHS [K08 AI001445-05, K08 AI001445-06, K08 AI001445-04] Funding Source: Medline; PHS HHS [1 K08 AJ01445-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001445] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; AIFANTIS I, 1997, IMMUNITY, V7; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; BroussardDiehl C, 1996, J IMMUNOL, V156, P3141; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; Chen L, 1997, J I ENERGY, V70, P2; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Farrar MA, 1998, BBA-REV CANCER, V1377, pF35, DOI 10.1016/S0304-419X(97)00038-3; FEDER JN, 1990, J CELL BIOL, V111, P2693, DOI 10.1083/jcb.111.6.2693; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Henning SW, 1998, J EXP MED, V188, P931, DOI 10.1084/jem.188.5.931; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Kawauchi K, 1996, MOL IMMUNOL, V33, P287, DOI 10.1016/0161-5890(95)00134-4; Kerkhoff E, 1998, ONCOGENE, V16, P211, DOI 10.1038/sj.onc.1201520; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Melchers F, 1997, CURR TOP MICROBIOL, V224, P19; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; PERLMUTTER RM, 1985, SCIENCE, V227, P1597, DOI 10.1126/science.3975629; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SEGER R, 1994, J BIOL CHEM, V269, P25699; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; tenBoekel E, 1997, IMMUNITY, V7, P357; TONEGAWA S, 1988, BIOSCIENCE REP, V8, P3, DOI 10.1007/BF01128968; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zou XM, 1997, GENE DEV, V11, P654, DOI 10.1101/gad.11.5.654	82	81	81	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					713	722		10.1016/S1074-7613(00)80070-9	http://dx.doi.org/10.1016/S1074-7613(00)80070-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403646	Bronze, Green Accepted			2022-12-18	WOS:000081209600009
J	Aifantis, L; Azogui, O; Feinberg, J; Saint-Ruf, C; Buer, J; von Boehmer, H				Aifantis, L; Azogui, O; Feinberg, J; Saint-Ruf, C; Buer, J; von Boehmer, H			On the role of the pre T cell receptor in alpha beta versus gamma delta T lineage commitment	IMMUNITY			English	Article							GENE RECOMBINATION; ALLELIC EXCLUSION; TRANSGENIC MICE; EXPRESSION; CHAIN; REARRANGEMENT; THYMOCYTES; REPERTOIRE; SELECTION; IMMATURE	The role of the pre-T cell receptor (TCR) in lineage commitment to the gamma delta versus cup lineage of T cells was addressed by analyzing TCR beta chain rearrangements in gamma delta T cells from wild-type and pre-TCR-deficient mice by single cell polymerase chain reaction. Results show that the pre-TCR selects against gamma delta T cells containing rearranged V beta genes and that gamma delta T cell precursors but not gamma delta T cells express the pre-TCR alpha protein. Furthermore, pre-TCR-induced proliferation could not be detected in gamma delta T cells. We propose that the pre-TCR commits developing T cells to the cup lineage by an instructive mechanism that has largely replaced an evolutionary more ancient stochastic mechanism of lineage commitment.	Fac Med Necker Enfants Malad, INSERM, U373, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	von Boehmer, H (corresponding author), Fac Med Necker Enfants Malad, INSERM, U373, 156 Rue Vaugirard, F-75730 Paris 15, France.	vonboehm@infobiogen.fr		Buer, Jan/0000-0002-7602-1698				Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Berger MA, 1997, J EXP MED, V186, P1461, DOI 10.1084/jem.186.9.1461; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Burtrum DB, 1996, J IMMUNOL, V157, P4293; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; Mertsching E, 1997, EUR J IMMUNOL, V27, P389, DOI 10.1002/eji.1830270208; PARAMITHIOTIS E, 1995, J EXP MED, V181, P105, DOI 10.1084/jem.181.1.105; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SARUKHAN A, 1994, EUR J IMMUNOL, V24, P1750, DOI 10.1002/eji.1830240805; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SNODGRASS HR, 1985, NATURE, V315, P232, DOI 10.1038/315232a0; ten Boekel E, 1998, IMMUNITY, V8, P199; von Boehmer H, 1998, IMMUNOL REV, V165, P111; VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729, DOI 10.1073/pnas.85.24.9729; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7	32	81	81	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					649	655		10.1016/S1074-7613(00)80662-7	http://dx.doi.org/10.1016/S1074-7613(00)80662-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846486	Bronze			2022-12-18	WOS:000077298300007
J	Mendoza, LM; Paz, P; Zuberi, A; Christianson, G; Roopenian, D; Shastri, N				Mendoza, LM; Paz, P; Zuberi, A; Christianson, G; Roopenian, D; Shastri, N			Minors held by majors: The H13 minor histocompatibility locus defined as a peptide MHC class I complex	IMMUNITY			English	Article							CYTOTOXIC T-LYMPHOCYTES; VERSUS-HOST DISEASE; MOUSE Y-CHROMOSOME; POSITIVE SELECTION; H-Y; CELL RESPONSE; ANTIGEN; GENE; IDENTIFICATION; MOLECULE	The products of minor histocompatibility (H) loci are serious barriers to tissue transplantation even among major histocompatibility complex (MHC) identical individuals, frequently causing chronic graft rejection and graft versus host disease. Over 50 minor H loci map to mouse autosomal chromosomes but none are known at the molecular level. By expression cloning, we identified the H13 locus, a classical minor H locus first detected 30 years ago by the trait of graft rejection. The H13(a) allele is located on chromosome 2 and encodes a novel protein that yields the rare naturally processed nonapeptide SSVVGVWYL (SVL9) for presentation by the D-b MHC class I molecule. The SVL9 peptide binds Db MHC despite the absence of the consensus binding motif, and a conservative methyl group substitution (Valine 4 <--> Isoleucine) explains why reciprocal T cell responses are elicited in H13(a) and H13(b) congenic strains.	UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,DIV IMMUNOL,LSA 421,BERKELEY,CA 94720; JACKSON LAB,BAR HARBOR,ME 04609	University of California System; University of California Berkeley; Jackson Laboratory				Christianson, Gregory/0000-0001-5532-342X				ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; Auchincloss H, 1996, CURR OPIN IMMUNOL, V8, P681, DOI 10.1016/S0952-7915(96)80086-0; BEVAN MJ, 1975, NATURE, V256, P419, DOI 10.1038/256419a0; Bhuyan PK, 1997, J IMMUNOL, V158, P3753; Brusic V, 1996, NUCLEIC ACIDS RES, V24, P242, DOI 10.1093/nar/24.1.242; Cariappa A, 1996, EUR J IMMUNOL, V26, P2215, DOI 10.1002/eji.1830260938; CEROTTINI JC, 1974, J EXP MED, V140, P703, DOI 10.1084/jem.140.3.703; Dabhi VM, 1996, IMMUNOGENETICS, V45, P65, DOI 10.1007/s002510050168; DENHAAN JMM, 1995, SCIENCE, P20479; DOOLITTLE DP, 1996, GENETIC VARIANTS STR, P17; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; Goulmy E, 1996, CURR OPIN IMMUNOL, V8, P75, DOI 10.1016/S0952-7915(96)80108-7; GRAFF RJ, 1977, IMMUNOGENETICS, V7, P413; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KING TR, 1994, GENOMICS, V24, P159, DOI 10.1006/geno.1994.1593; LILL NL, 1992, J EXP MED, V176, P449, DOI 10.1084/jem.176.2.449; LINDAHL KF, 1991, TRENDS GENET, V7, P219, DOI 10.1016/0168-9525(91)90368-Z; Little C C, 1914, Science, V40, P904, DOI 10.1126/science.40.1042.904; LITTLE CC, 1941, BIOL LABORATORY MOUS, P279; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; LOVELAND BE, 1991, ANTIGEN PROCESSING R, P173; MALARKANNAN S, 1995, J EXP MED, V182, P1739, DOI 10.1084/jem.182.6.1739; Malarkannan S, 1996, P NATL ACAD SCI USA, V93, P13991, DOI 10.1073/pnas.93.24.13991; Malarkannan S, 1996, J IMMUNOL, V157, P4464; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; MCKENZIE IF, 1985, TRANSPLANT P, V18, P754; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Morse MC, 1996, J IMMUNOL, V156, P3301; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; Perreault C, 1996, J CLIN INVEST, V98, P622, DOI 10.1172/JCI118832; ROOPENIAN DC, 1992, IMMUNOL TODAY, V13, P7, DOI 10.1016/0167-5699(92)90197-F; ROOPENIAN DC, 1989, IMMUNOGENETICS, V30, P335, DOI 10.1007/BF02425273; ROOPENIAN DC, 1993, J IMMUNOL, V151, P4595; ROOPENIAN DC, 1983, J IMMUNOL, V131, P2135; ROTZSCHKE O, 1990, SCIENCE, V249, P283, DOI 10.1126/science.1695760; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Shastri N, 1996, CURR OPIN IMMUNOL, V8, P271, DOI 10.1016/S0952-7915(96)80067-7; SHASTRI N, 1993, J IMMUNOL, V150, P2724; SHASTRI N, 1985, P NATL ACAD SCI USA, V82, P5885, DOI 10.1073/pnas.82.17.5885; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; SNELL GEORGE D., 1967, TRANSPLANTATION, V5, P492, DOI 10.1097/00007890-196705000-00011; VANBLEEK GM, 1990, NATURE, V348, P213; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594; WALLNY HJ, 1990, NATURE, V343, P275, DOI 10.1038/343275a0; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; WETTSTEIN PJ, 1986, J IMMUNOL, V137, P2073; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6	65	81	82	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					461	472		10.1016/S1074-7613(00)80368-4	http://dx.doi.org/10.1016/S1074-7613(00)80368-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354467	Bronze			2022-12-18	WOS:A1997YD59300003
J	Hu, QH; Walker, CRB; Girao, C; Opferman, JT; Sun, JL; Shabanowitz, J; Hunt, DF; AshtonRickardt, PG				Hu, QH; Walker, CRB; Girao, C; Opferman, JT; Sun, JL; Shabanowitz, J; Hunt, DF; AshtonRickardt, PG			Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; HISTOCOMPATIBILITY COMPLEX ANTIGENS; CELL MEMORY; RIBONUCLEOTIDE REDUCTASE; MASS-SPECTROMETRY; IN-VITRO; TOLERANCE; CLONES; VIRUS; PROLIFERATION	To understand how thymic selection gives rise to T cells that are capable of major histocompatibility complex (MHC)-restricted recognition of antigen but are tolerant of self, we directly examined how peptide/MHC ligands expressed on thymic epithelial cells trigger the positive selection of immature thymocytes. We demonstrate that abundant self-peptides, purified from the H-2D(b) molecules of thymic epithelial cells, are specifically recognized during the positive selection of CD8(+) T cells, implying that positive selection generates a repertoire of T cells that is weakly self-reactive. We also found that this recognition is somewhat cross-reactive, thereby providing an explanation for how the specific recognition of a limited repertoire of thymic self-peptides can select a diverse repertoire of T cells.	UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637; UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637; UNIV CHICAGO,COMM DEV BIOL,CHICAGO,IL 60637; UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22903; UNIV VIRGINIA,DEPT PATHOL,CHARLOTTESVILLE,VA 22903	University of Chicago; University of Chicago; University of Chicago; University of Virginia; University of Virginia	Hu, QH (corresponding author), UNIV CHICAGO,GWEN KNAPP CTR LUPUS & IMMUNOL RES,CHICAGO,IL 60637, USA.		Hunt, Donald F/I-6936-2012; Bazemore-Walker, Carthene/I-1879-2013; Opferman, Joseph T/M-5331-2018	Hunt, Donald F/0000-0003-2815-6368; Opferman, Joseph T/0000-0002-1147-5621; Bazemore-Walker, Carthene/0000-0001-5157-4440	NIAID NIH HHS [AI 33993] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033993, R37AI033993] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; ASHTONRICKARDT PG, 1993, THYMUS, V22, P111; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BRINSTER RL, 1984, CELL, V37, P36; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; CEREDIG R, 1982, J EXP MED, V155, P617, DOI 10.1084/jem.155.2.617; FAAS SJ, 1993, EUR J IMMUNOL, V23, P1201, DOI 10.1002/eji.1830230602; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FECKER L, 1990, MOL CELL BIOL, V10, P2848, DOI 10.1128/MCB.10.6.2848; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOGQUIST KA, 1993, J EXP MED, V177, P1464; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OWEN JA, 1984, CELL IMMUNOL, V84, P403, DOI 10.1016/0008-8749(84)90112-6; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PIRCHER H, 1987, EUR J IMMUNOL, V17, P159, DOI 10.1002/eji.1830170202; PRICHER HP, 1990, NATURE, V346, P624; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SIGAL LJ, 1995, MOL IMMUNOL, V32, P623, DOI 10.1016/0161-5890(95)00031-9; THELANDER L, 1986, MOL CELL BIOL, V6, P3433, DOI 10.1128/MCB.6.10.3433; THELANDER L, 1980, J BIOL CHEM, V255, P7426; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VANSANTEN HM, 1995, J EXP MED, V181, P757; VONBOEHMER H, 1984, EUR J IMMUNOL, V14, P1048, DOI 10.1002/eji.1830141116; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	47	81	81	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					221	231		10.1016/S1074-7613(00)80525-7	http://dx.doi.org/10.1016/S1074-7613(00)80525-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285407	Bronze			2022-12-18	WOS:A1997XT49200006
J	Levelt, CN; Eichmann, K				Levelt, CN; Eichmann, K			Receptors and signals in early thymic selection	IMMUNITY			English	Review							T-CELL-RECEPTOR; BETA-CHAIN; THYMOCYTE DEVELOPMENT; ANTIGEN RECEPTOR; MICE LACKING; MUTANT MICE; SCID MICE; TRANSGENIC MICE; ALPHA-CHAIN; ZETA-CHAIN				Levelt, CN (corresponding author), MAX PLANCK INST IMMUNBIOL,STUBEWEG 51,POSTFACH 1169,D-79108 FREIBURG,GERMANY.							ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; DAVIS CB, 1993, CELL, V73, P236; FEHLING JJ, 1995, NATURE, V375, P795; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; HABU S, 1987, EUR J IMMUNOL, V17, P1467, DOI 10.1002/eji.1830171013; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; HU Q, 1995, J BIOL CHEM, V270, P1928, DOI 10.1074/jbc.270.4.1928; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KAPPES D, 1994, 12TH EUR IMM M BARC; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; LEVELT CN, 1995, IMMUNITY, V3, P215, DOI 10.1016/1074-7613(95)90091-8; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; LEVELT CN, 1993, J EXP MED, V178, P1867, DOI 10.1084/jem.178.6.1867; LEVELT CN, 1993, IMMUNOLOGIST, V1, P151; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LEY SC, 1989, EUR J IMMUNOL, V19, P2309, DOI 10.1002/eji.1830191220; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1995, P NATL ACAD SCI USA, V92, P7420, DOI 10.1073/pnas.92.16.7420; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; PUNT JA, 1991, J EXP MED, V174, P775, DOI 10.1084/jem.174.4.775; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SHINKAI Y, 1995, IMMUNITY, V2, P391; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SHORES EW, 1990, EUR J IMMUNOL, V20, P69, DOI 10.1002/eji.1830200111; SOMMERS CL, 1995, ONCOGENE, V11, P245; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; TIMON M, 1993, EUR J IMMUNOL, V23, P1440, DOI 10.1002/eji.1830230706; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WANG BP, 1995, INT IMMUNOL, V7, P435, DOI 10.1093/intimm/7.3.435; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; WIEST DL, 1994, J EXP MED, V180, P1375, DOI 10.1084/jem.180.4.1375; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; ZUNIGAPFLUCKER JC, 1994, J EXP MED, V180, P1517, DOI 10.1084/jem.180.4.1517	69	81	82	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					667	672		10.1016/1074-7613(95)90056-X	http://dx.doi.org/10.1016/1074-7613(95)90056-X			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777712	Bronze			2022-12-18	WOS:A1995TM02300001
J	Minutti, CM; Modak, RV; Macdonald, F; Li, FQ; Smyth, DJ; Dorward, DA; Blair, N; Husovsky, C; Muir, A; Giampazolias, E; Dobie, R; Maizels, RM; Kendall, TJ; Griggs, DW; Kopf, M; Henderson, NC; Zaiss, DM				Minutti, Carlos M.; Modak, Rucha, V; Macdonald, Felicity; Li, Fengqi; Smyth, Danielle J.; Dorward, David A.; Blair, Natalie; Husovsky, Connor; Muir, Andrew; Giampazolias, Evangelos; Dobie, Ross; Maizels, Rick M.; Kendall, Timothy J.; Griggs, David W.; Kopf, Manfred; Henderson, Neil C.; Zaiss, Dietmar M.			A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation	IMMUNITY			English	Article							REGULATORY T-CELLS; EGF RECEPTOR; TGF-BETA; LATENT TGF-BETA-1; EXPRESSION; HOMEOSTASIS; DIFFERENTIATION; INFLAMMATION; EPIREGULIN; CARCINOMA	The epidermal growth factor receptor ligand Amphiregulin has a well-documented role in the restoration of tissue homeostasis after injury; however, the mechanism by which Amphiregulin contributes to wound repair remains unknown. Here we show that Amphiregulin functioned by releasing bioactive transforming growth factor beta (TGF-beta) from latent complexes via integrin-alpha(v) activation. Using acute injury models in two different tissues, we found that by inducing TGF-beta activation on mesenchymal stromal cells (pericytes), Amphiregulin induced their differentiation into myofibroblasts, thereby selectively contributing to the restoration of vascular barrier function within injured tissue. Furthermore, we identified macrophages as a critical source of Amphiregulin, revealing a direct effector mechanism by which these cells contribute to tissue restoration after acute injury. Combined, these observations expose a so far under-appreciated mechanism of how cells of the immune system selectively control the differentiation of tissue progenitor cells during tissue repair and inflammation.	[Minutti, Carlos M.; Modak, Rucha, V; Macdonald, Felicity; Blair, Natalie; Husovsky, Connor; Muir, Andrew; Zaiss, Dietmar M.] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh EH9 3FL, Midlothian, Scotland; [Minutti, Carlos M.; Giampazolias, Evangelos] Francis Crick Inst, Immunobiol Lab, 1 Midland Rd, London NW1 1AT, England; [Li, Fengqi; Kopf, Manfred] Swiss Fed Inst Technol Zurich, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Smyth, Danielle J.; Maizels, Rick M.] Univ Glasgow, Wellcome Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Dorward, David A.; Dobie, Ross; Kendall, Timothy J.; Henderson, Neil C.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [Dorward, David A.; Kendall, Timothy J.] Univ Edinburgh, Div Pathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Griggs, David W.] St Louis Univ, Edward A Doisy Res Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	University of Edinburgh; Francis Crick Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Glasgow; University of Edinburgh; University of Edinburgh; Saint Louis University	Minutti, CM; Zaiss, DM (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh EH9 3FL, Midlothian, Scotland.	carlos.minutti@crick.ac.uk; dietmar.zaiss@ed.ac.uk	Kendall, Tim/H-2698-2019; Kopf, Manfred/B-6907-2009	Kendall, Tim/0000-0002-4174-2786; Kopf, Manfred/0000-0002-0628-7140; Minutti, Carlos/0000-0002-9663-1928; Zaiss, Dietmar M.W./0000-0003-3596-7062	Medical Research Council [MR/M011755/1]; European Union [CIG-631413]; Wellcome Trust [103749, 095898/Z/11/Z]; MRC [MR/M011755/1, MC_PC_18048] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to C. Reis e Sousa for allowing C.M.M. to perform some experiments in his laboratory. We thank M. Waterfall and the Francis Crick Flow Facility for expertise with flow cytometry, G. Goodman for essential advice on the optimization of oxygen saturation measurements, the Crick Research Illustration and Graphics Team for assistance with the design of our graphical abstract, R. Zamoyska and J.E. Allen for critical evaluation of the manuscript, N. Logan and A. Fulton for excellent technical assistance, and support staff from the Francis Crick Institute and the University of Edinburgh for excellent animal husbandry. D.M.Z. has been supported by the Medical Research Council grant MR/M011755/1 and the European Union grant CIG-631413 (''EGF-R for Immunity''). N.C.H has been supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (103749) and T.J.K. by a Wellcome Trust Intermediate Clinical Fellowship (095898/Z/11/Z').	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Goto H, 2010, AM J RESP CRIT CARE, V181, P1336, DOI 10.1164/rccm.200907-1002OC; Graham John M, 2002, ScientificWorldJournal, V2, P1347; Gurevich DB, 2018, EMBO J, V37, DOI 10.15252/embj.201797786; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Henderson NC, 2013, BBA-MOL BASIS DIS, V1832, P891, DOI 10.1016/j.bbadis.2012.10.005; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li XD, 2010, ONKOLOGIE, V33, P353, DOI 10.1159/000315380; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Minutti CM, 2017, IMMUNITY, V47, P710, DOI 10.1016/j.immuni.2017.09.013; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nieves W, 2016, J IMMUNOL, V196, P4632, DOI 10.4049/jimmunol.1502218; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Robertson IB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021907; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Tinhofer I, 2011, CLIN CANCER RES, V17, P5197, DOI 10.1158/1078-0432.CCR-10-3338; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	53	80	81	9	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					645	+		10.1016/j.immuni.2019.01.008	http://dx.doi.org/10.1016/j.immuni.2019.01.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30770250	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000461660500015
J	Essig, K; Hu, DS; Guimaraes, JC; Alterauge, D; Edelmann, S; Raj, T; Kranich, J; Behrens, G; Heiseke, A; Floess, S; Klein, J; Maiser, A; Marschall, S; de Angelis, MH; Leonhardt, H; Calkhoven, CF; Noessner, E; Brocker, T; Huehn, J; Krug, AB; Zavolan, M; Baumjohann, D; Heissmeyer, V				Essig, Katharina; Hu, Desheng; Guimaraes, Joao C.; Alterauge, Dominik; Edelmann, Stephanie; Raj, Timsse; Kranich, Jan; Behrens, Gesine; Heiseke, Alexander; Floess, Stefan; Klein, Juliane; Maiser, Andreas; Marschall, Susan; de Angelis, Martin Hrabe; Leonhardt, Heinrich; Calkhoven, Cornelis F.; Noessner, Elfriede; Brocker, Thomas; Huehn, Jochen; Krug, Anne B.; Zavolan, Mihaela; Baumjohann, Dirk; Heissmeyer, Vigo			Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells	IMMUNITY			English	Article							MESSENGER-RNA DECAY; TH17 DIFFERENTIATION; EFFECTOR LINEAGE; EXPRESSION; MTOR; KINASE; FOXP3; AUTOIMMUNITY; RECEPTOR; FOXO1	Roquin proteins preclude spontaneous T cell activation and aberrant differentiation of T follicular helper (Tfh) or T helper 17 (Th17) cells. Here we showed that deletion of Roquin-encoding alleles specifically in regulatory T (Treg) cells also caused the activation of conventional T cells. Roquin-deficient Treg cells downregulated CD25, acquired a follicular Treg (Tfr) cell phenotype, and suppressed germinal center reactions but could not protect from colitis. Roquin inhibited the PI3K-mTOR signaling pathway by upregulation of Pten through interfering with miR-17 similar to 92 binding to an overlapping cis-element in the Pten 3' UTR, and downregulated the Foxo1-specific E3 ubiquitin ligase Itch. Loss of Roquin enhanced Akt-mTOR signaling and protein synthesis, whereas inhibition of PI3K or mTOR in Roquin-deficient T cells corrected enhanced Tfh and Th17 or reduced iTreg cell differentiation. Thereby, Roquin-mediated control of PI3K-mTOR signaling prevents autoimmunity by restraining activation and differentiation of conventional T cells and specialization of Treg cells.	[Essig, Katharina; Hu, Desheng; Alterauge, Dominik; Raj, Timsse; Kranich, Jan; Behrens, Gesine; Heiseke, Alexander; Klein, Juliane; Brocker, Thomas; Krug, Anne B.; Baumjohann, Dirk; Heissmeyer, Vigo] Ludwig Maximilians Univ Munchen, Inst Immunol, Biomed Ctr, D-82152 Planegg Martinsried, Germany; [Guimaraes, Joao C.; Zavolan, Mihaela] Univ Basel, Computat & Syst Biol, Biozentrum, CH-4056 Basel, Switzerland; [Edelmann, Stephanie; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, D-81377 Munich, Germany; [Floess, Stefan; Huehn, Jochen] Helmholtz Ctr Infect Res, Expt Immunol, D-38124 Braunschweig, Germany; [Maiser, Andreas; Leonhardt, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol, Ctr Integrated Prot Sci, D-82152 Planegg Martinsried, Germany; [Marschall, Susan; de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Marschall, Susan; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Marschall, Susan; de Angelis, Martin Hrabe] Tech Univ Munich, Sch Life Sci Weihenstephan, Chair Expt Genet, D-85353 Freising Weihenstephan, Germany; [Calkhoven, Cornelis F.] Univ Groningen, Univ Med Ctr Groningen, ERIBA, NL-9700 AD Groningen, Netherlands; [Noessner, Elfriede] Helmholtz Zentrum Munchen, Immunoanalyt Core Facil, D-81377 Munich, Germany; [Hu, Desheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Integrated Tradit Chinese & Western Med, Union Hosp, Wuhan 430022, Hubei, Peoples R China	University of Munich; University of Basel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center for Infection Research; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Huazhong University of Science & Technology	Hu, DS; Heissmeyer, V (corresponding author), Ludwig Maximilians Univ Munchen, Inst Immunol, Biomed Ctr, D-82152 Planegg Martinsried, Germany.; Heissmeyer, V (corresponding author), Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, D-81377 Munich, Germany.; Hu, DS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Integrated Tradit Chinese & Western Med, Union Hosp, Wuhan 430022, Hubei, Peoples R China.	desheng_hu@126.com; vigo.heissmeyer@med.uni-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Baumjohann, Dirk/C-9047-2009; Leonhardt, Heinrich/B-2791-2014; Zavolan, Mihaela/S-3888-2016; Guimaraes, Joao C/A-8572-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Baumjohann, Dirk/0000-0001-8385-8288; Maiser, Andreas/0000-0002-2349-5822; Guimaraes, Joao C/0000-0002-1664-472X; Essig, Katharina/0000-0001-5928-6013; Krug, Anne/0000-0002-9556-7207; Calkhoven, Cornelis/0000-0001-6318-7210; Brocker, Thomas/0000-0001-7060-5433; Alterauge, Dominik/0000-0001-8164-3734; Heissmeyer, Vigo/0000-0002-2263-8545; Kranich, Jan/0000-0002-9928-4132	SystemsX.ch Transitional Postdoctoral Fellowship; DFG [HE3359/4-1, KR2199/3-2, KR2199/9-1, SFB 1243, SFB 854, SPP-1935, SFB-1054, BA 5132/1-1]; Friedrich-Baur foundation; Erich and Gertrud Roggenbuck Foundation [218-15]; European Research Council ERC-StG [281666 Rc3h1/2-Specificity]; Fritz Thyssen foundation [10.16.1.021MN]; ElseFresenius-Kroner foundation [2015_A158]	SystemsX.ch Transitional Postdoctoral Fellowship; DFG(German Research Foundation (DFG)); Friedrich-Baur foundation; Erich and Gertrud Roggenbuck Foundation; European Research Council ERC-StG(European Research Council (ERC)); Fritz Thyssen foundation; ElseFresenius-Kroner foundation	We thank Frank Dahlstrom, Claudia Lohs, Desiree Argiriu, and Barbara Mosetter for technical assistance and Kai Hofig for advice. For the provision of mice, we thank Thorsten Buch (Cd4-Cre-ERT2), Marc Schmidt-Supprian (Rc3h1<SUP>fl</SUP>), Wolfgang Wurst (Rc3h2<SUP>fl</SUP>), Alexander Y. Rudensky (Foxp3-IRES-YFP-Cre), Tim Sparwasser (DEREG), and Christopher Wilson (Cd4-Cre). J.C.G. was supported by a SystemsX.ch Transitional Postdoctoral Fellowship and D.B. by the Emmy Noether Programme of the DFG (BA 5132/1-1). The work was supported by the DFG grants HE3359/4-1 to V.H. and KR2199/3-2 and KR2199/9-1 to A.B.K., SFB 1243 project A01 to H.L., SFB 854 project B16 to J.H., SPP-1935 to V.H., the SFB-1054 projects A03 and Z02 to V.H., A06 to A.B.K., B03 to T.B., B12 to D.B., as well as by Friedrich-Baur foundation grants to D.H. and A.H., and an Erich and Gertrud Roggenbuck Foundation grant (218-15) to E.N. as well as by an European Research Council ERC-StG (no. 281666 Rc3h1/2-Specificity), a Fritz Thyssen foundation (10.16.1.021MN), and an ElseFresenius-Kroner foundation grant (2015_A158) to V.H.	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Annemann M, 2015, J IMMUNOL, V194, P2888, DOI 10.4049/jimmunol.1401964; Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Drees C, 2017, J IMMUNOL, V198, P2747, DOI 10.4049/jimmunol.1601732; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gewies A, 2014, CELL REP, V9, P1292, DOI 10.1016/j.celrep.2014.10.044; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Janowski R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11032; Jeltsch KM, 2016, CURR OPIN IMMUNOL, V39, P127, DOI 10.1016/j.coi.2016.01.011; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Laine A, 2015, J IMMUNOL, V195, P1791, DOI 10.4049/jimmunol.1500849; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Olshen AB, 2013, BIOINFORMATICS, V29, P2995, DOI 10.1093/bioinformatics/btt533; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Ramiscal RR, 2015, ELIFE, V4, DOI 10.7554/eLife.08698; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schlundt A, 2014, NAT STRUCT MOL BIOL, V21, P671, DOI 10.1038/nsmb.2855; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu JH, 2014, J CLIN INVEST, V124, P1685, DOI 10.1172/JCI69780; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang J., 2016, ELIFE, V5, P5, DOI DOI 10.1155/2016/1690896; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhu JY, 2010, J VIROL, V84, P10266, DOI 10.1128/JVI.01119-10	60	80	89	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1067	+		10.1016/j.immuni.2017.11.008	http://dx.doi.org/10.1016/j.immuni.2017.11.008			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29246441	Bronze			2022-12-18	WOS:000418486500012
J	Kuroda, E; Ozasa, K; Temizoz, B; Ohata, K; Koo, CX; Kanuma, T; Kusakabe, T; Kobari, S; Horie, M; Morimoto, Y; Nakajima, S; Kabashima, K; Ziegler, SF; Iwakura, Y; Ise, W; Kurosaki, T; Nagatake, T; Kunisawa, J; Takemura, N; Uematsu, S; Hayashi, M; Aoshi, T; Kobiyama, K; Coban, C; Ishii, KJ				Kuroda, Etsushi; Ozasa, Koji; Temizoz, Burcu; Ohata, Keiichi; Koo, Christine X.; Kanuma, Tomohiro; Kusakabe, Takato; Kobari, Shingo; Horie, Masanori; Morimoto, Yasuo; Nakajima, Saeko; Kabashima, Kenji; Ziegler, Steven F.; Iwakura, Yoichiro; Ise, Wataru; Kurosaki, Tomohiro; Nagatake, Takahiro; Kunisawa, Jun; Takemura, Naoki; Uematsu, Satoshi; Hayashi, Masayuki; Aoshi, Taiki; Kobiyama, Kouji; Coban, Cevayir; Ishii, Ken J.			Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1 alpha Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation	IMMUNITY			English	Article							ADAPTIVE IMMUNE-RESPONSES; HELPER T-CELLS; NALP3 INFLAMMASOME; STERILE INFLAMMATION; ADJUVANT ACTIVITY; DENDRITIC CELLS; SILICA CRYSTALS; IGE PRODUCTION; TH2 CELL; ASTHMA	Particulate pollution is thought to function as an adjuvant that can induce allergic responses. However, the exact cell types and immunological factors that initiate the lung-specific immune responses are unclear. We found that upon intratracheal instillation, particulates such as aluminum salts and silica killed alveolar macrophages (AMs), which then released interleukin-1 alpha (IL-1 alpha) and caused inducible bronchus-associated lymphoid tissue (iBALT) formation in the lung. IL-1 alpha release continued for up to 2 weeks after particulate exposure, and type-2 allergic immune responses were induced by the inhalation of antigen during IL-1 alpha release and iBALT formation, even long after particulate instillation. Recombinant IL-1 alpha was sufficient to induce iBALTs, which coincided with subsequent immunoglobulin E responses, and IL-1-receptor-deficient mice failed to induce iBALT formation. Therefore, the AM-IL-1 alpha-iBALT axis might be a therapeutic target for particulate-induced allergic inflammation.	[Kuroda, Etsushi; Temizoz, Burcu; Ohata, Keiichi; Kanuma, Tomohiro; Kusakabe, Takato; Hayashi, Masayuki; Kobiyama, Kouji; Ishii, Ken J.] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Vaccine Sci, Osaka 5650871, Japan; [Kuroda, Etsushi; Ozasa, Koji; Ishii, Ken J.] Natl Inst Biomed Innovat, Ctr Drug Design Res, Lab Vaccine Design, Osaka 5670085, Japan; [Kuroda, Etsushi; Koo, Christine X.; Kanuma, Tomohiro; Kusakabe, Takato; Kobari, Shingo; Aoshi, Taiki; Ishii, Ken J.] Natl Inst Biomed Innovat Hlth & Nutr, Lab Adjuvant Innovat, Osaka 5670085, Japan; [Ozasa, Koji; Kobari, Shingo] Yokohama City Univ, Grad Sch Med, Dept Pediat, Yokohama, Kanagawa 2360004, Japan; [Koo, Christine X.] Natl Univ Singapore, Ctr Life Sci, Immunol Programme, Singapore 117456, Singapore; [Koo, Christine X.] Natl Univ Singapore, Ctr Life Sci, Dept Microbiol, Singapore 117456, Singapore; [Horie, Masanori] Natl Univ Singapore, NUS Grad Sch Integrated Sci & Engn, Singapore 117456, Singapore; [Morimoto, Yasuo] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Kagawa 7610395, Japan; [Nakajima, Saeko; Kabashima, Kenji] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Fukuoka 8078555, Japan; [Ziegler, Steven F.] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068317, Japan; [Iwakura, Yoichiro] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Ise, Wataru; Kurosaki, Tomohiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba 2780222, Japan; [Nagatake, Takahiro; Kunisawa, Jun] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650871, Japan; [Takemura, Naoki; Uematsu, Satoshi] Natl Inst Biomed Innovat Hlth & Nutr, Vaccine Mat, Osaka 5670085, Japan; [Takemura, Naoki; Uematsu, Satoshi] Chiba Univ, Sch Med, Dept Mucosal Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Hayashi, Masayuki] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Div Innate Immune Regulat, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Aoshi, Taiki] Mitsubishi Tanabe Pharma Corp, Sohyaku Innovat Res Div, Adv Drug Res Labs, Vaccine Res Dev Off, Mitsubishi, Kanagawa 2270033, Japan; [Kobiyama, Kouji] Microbial Dis Res Inst, BIKEN Innovat Vaccine Res Alliance Labs, Vaccine Dynam Project, Osaka 5650871, Japan; [Coban, Cevayir] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Coban, Cevayir] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Malaria Immunol, Osaka 5650871, Japan	Osaka University; National Institute of Health Sciences - Japan; Yokohama City University; National University of Singapore; National University of Singapore; National University of Singapore; National Institute of Advanced Industrial Science & Technology (AIST); University of Occupational & Environmental Health - Japan; Kyoto University; Benaroya Research Institute; Tokyo University of Science; Osaka University; Chiba University; University of Tokyo; Mitsubishi Tanabe Pharma Corporation; La Jolla Institute for Immunology; Osaka University	Kuroda, E; Ishii, KJ (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Vaccine Sci, Osaka 5650871, Japan.; Kuroda, E; Ishii, KJ (corresponding author), Natl Inst Biomed Innovat, Ctr Drug Design Res, Lab Vaccine Design, Osaka 5670085, Japan.; Kuroda, E; Ishii, KJ (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Adjuvant Innovat, Osaka 5670085, Japan.	kuroetu@ifrec.osaka-u.ac.jp; kenishii@biken.osaka-u.ac.jp	COBAN, Cevayir/P-1928-2019; Iwakura, Yoichiro/E-5457-2011; Horie, Masanori/K-5582-2016; Ishii, Ken J/B-1685-2012; Nakajima, Saeko/AAB-1577-2021; Nagatake, Takahiro/AAL-1995-2020; Coban, Cevayir/B-2129-2012; Kabashima, Kenji/G-2521-2014	COBAN, Cevayir/0000-0002-4467-7799; Iwakura, Yoichiro/0000-0002-9934-5775; Horie, Masanori/0000-0001-9640-9350; Ishii, Ken J/0000-0002-6728-3872; Kabashima, Kenji/0000-0002-0773-0554; Nakajima, Saeko/0000-0003-0831-1447; Ohata, Keiichi/0000-0002-5635-4292	Regional Innovation Strategy Support Program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) (MEXT/JSPS KAKENHI grant) [JP24591145, JP16H05256]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Research on Development of New Drugs from the Japan Agency for Medical Research and development (AMED); Grants-in-Aid for Scientific Research [15H05790] Funding Source: KAKEN	Regional Innovation Strategy Support Program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) (MEXT/JSPS KAKENHI grant); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Research on Development of New Drugs from the Japan Agency for Medical Research and development (AMED); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Carl F. Ware (Sanford-Burnham Medical Research Institute). E.K. was supported in part by the Regional Innovation Strategy Support Program, a Grant-in Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Society for the Promotion of Science (JSPS) (MEXT/JSPS KAKENHI grant numbers JP24591145 and JP16H05256), the Takeda Science Foundation, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research. K.J.I., C.C., J.K., and S.U. were supported by the Research on Development of New Drugs from the Japan Agency for Medical Research and development (AMED).	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Chvatchko Y, 1996, J EXP MED, V184, P2353, DOI 10.1084/jem.184.6.2353; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Dagvadorj J, 2015, IMMUNITY, V42, P640, DOI 10.1016/j.immuni.2015.03.007; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elliot JG, 2004, AM J RESP CRIT CARE, V169, P712, DOI 10.1164/rccm.200308-1167OC; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Granum B, 2002, TOXICOL SCI, V65, P7, DOI 10.1093/toxsci/65.1.7; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI [10.1080/08958370801935133, 10.1080/08958370801935133 ]; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Lovik M, 1997, TOXICOLOGY, V121, P165, DOI 10.1016/S0300-483X(97)00075-9; MANCINO D, 1983, INT ARCH ALLER A IMM, V71, P279, DOI 10.1159/000233404; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Matsushita K, 2014, J IMMUNOL, V193, P5791, DOI 10.4049/jimmunol.1401768; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Moriwaki K, 2016, J BIOL CHEM, V291, P5948, DOI 10.1074/jbc.M115.700997; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Onishi M, 2015, J IMMUNOL, V194, P2673, DOI 10.4049/jimmunol.1402027; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SCHWARTZ J, 1993, AM REV RESPIR DIS, V147, P826, DOI 10.1164/ajrccm/147.4.826; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tonti E, 2013, CELL REP, V5, P323, DOI 10.1016/j.celrep.2013.09.004; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	50	80	82	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1299	1310		10.1016/j.immuni.2016.11.010	http://dx.doi.org/10.1016/j.immuni.2016.11.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002730	Bronze			2022-12-18	WOS:000392918100015
J	Yu, X; Cai, BW; Wang, MJ; Tan, P; Ding, XL; Wu, J; Li, J; Li, QT; Liu, PH; Xing, CS; Wang, HY; Su, XZ; Wang, RF				Yu, Xiao; Cai, Baowei; Wang, Mingjun; Tan, Peng; Ding, Xilai; Wu, Jian; Li, Jian; Li, Qingtian; Liu, Pinghua; Xing, Changsheng; Wang, Helen Y.; Su, Xin-zhuan; Wang, Rong-Fu			Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality	IMMUNITY			English	Article							CEREBRAL MALARIA; INNATE; RECOGNITION; RESPONSES; BLOCKADE; INSIGHTS	Type I interferon (IFN) is critical for controlling pathogen infection; however, its regulatory mechanisms in plasmacytoid cells (pDCs) still remain unclear. Here, we have shown that nucleic acid sensors cGAS-, STING-, MDA5-, MAVS-, or transcription factor IRF3-deficient mice produced high amounts of type I IFN-alpha and IFN-beta (IFN-a/b) in the serum and were resistant to lethal plasmodium yoelii YM infection. Robust IFN-alpha/beta production was abolished when gene encoding nucleic acid sensor TLR7, signaling adaptor MyD88, or transcription factor IRF7 was ablated or pDCs were depleted. Further, we identified SOCS1 as a key negative regulator to inhibit MyD88-dependent type I IFN signaling in pDCs. Finally, we have demonstrated that pDCs, cDCs, and macrophages were required for generating IFN-alpha/beta-induced subsequent protective immunity. Thus, our findings have identified a critical regulatory mechanism of type I IFN signaling in pDCs and stage-specific function of immune cells in generating potent immunity against lethal YM infection.	[Yu, Xiao] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mingjun] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao; Cai, Baowei; Wang, Mingjun; Tan, Peng; Ding, Xilai; Li, Qingtian; Liu, Pinghua; Xing, Changsheng; Wang, Helen Y.; Wang, Rong-Fu] Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Cai, Baowei; Li, Jian; Su, Xin-zhuan] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Wu, Jian; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Wang, Rong-Fu] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA; [Tan, Peng; Wang, Rong-Fu] Texas A&M Univ, Coll Med, Inst Biosci & Technol, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; The Methodist Hospital System; The Methodist Hospital - Houston; Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cornell University; Texas A&M University System	Wang, RF (corresponding author), Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA.; Su, XZ (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.; Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Wang, RF (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA.; Wang, RF (corresponding author), Texas A&M Univ, Coll Med, Inst Biosci & Technol, Houston, TX 77030 USA.	xsu@niaid.nih.gov; rwang3@houstonmethodist.org	Wu, Jian/K-2038-2015; Tan, Peng/HGD-6812-2022; Tan, Peng/P-3825-2015; Tan, Peng/ABD-8190-2020	Wu, Jian/0000-0001-8011-9551; Tan, Peng/0000-0002-7005-1896; Yu, Xiao/0000-0003-2491-9110; Su, Xinzhuan/0000-0003-3246-3248; WANG, MINGJUN/0000-0002-5848-0444; Tan, Peng/0000-0001-6992-9000; Xing, Changsheng/0000-0001-6582-9037	China Scholar Council; NCI, NIH [R01CA101795, DA030338]; NIDA, NIH [R01CA101795, DA030338]; Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL CANCER INSTITUTE [R01CA101795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892] Funding Source: NIH RePORTER	China Scholar Council; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Marco Colonna (Washington University School of Medicine) for providing Tlr9<SUP>-/-</SUP> mice, Richard A. Flavell (Yale University) for Tlr7<SUP>-/-</SUP> mice, Kate Fitzgerald (University of Massachusetts Medical School) and Tadatsugo Taniguchi (The University of Tokyo) for Irf3<SUP>-/-</SUP>:Irf7<SUP>-/-</SUP> mice, Michael Gale (University of Washington) and Wenxin Wu (University of Oklahoma Health Science Center) for Ddx58<SUP>-/-</SUP> mice, and Skip Virgin (Washington University at St. Louis) for Mb21d1<SUP>-/-</SUP> mice, Bo Ning for art drawing, and Jana S. Burchfield for editing the manuscript. X.Y. and B.C. were partially supported by the China Scholar Council. This work was supported, in part, by grants (R01CA101795 and DA030338) from the NCI and NIDA, NIH to R.-F.W. and by the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID).	Baccarella A, 2013, INFECT IMMUN, V81, P4431, DOI 10.1128/IAI.00923-13; Ball EA, 2013, J IMMUNOL, V190, P5118, DOI 10.4049/jimmunol.1300114; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Gun SY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/243713; Haque A, 2014, J CLIN INVEST, V124, P2483, DOI 10.1172/JCI70698; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Li J, 2011, P NATL ACAD SCI USA, V108, pE374, DOI 10.1073/pnas.1102261108; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JL, 2014, CELL REP, V7, P436, DOI 10.1016/j.celrep.2014.03.018; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Palomo J, 2013, EUR J IMMUNOL, V43, P2683, DOI 10.1002/eji.201343327; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Sharma S, 2015, P NATL ACAD SCI USA, V112, pE710, DOI 10.1073/pnas.1420217112; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wu J, 2014, P NATL ACAD SCI USA, V111, pE511, DOI 10.1073/pnas.1316467111; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824	37	80	84	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1093	1107		10.1016/j.immuni.2016.10.001	http://dx.doi.org/10.1016/j.immuni.2016.10.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27793594	Green Published, Bronze			2022-12-18	WOS:000389473500019
J	Bunting, KL; Soong, TD; Singh, R; Jiang, YW; Beguelin, W; Poloway, DW; Swed, BL; Hatzi, K; Reisacher, W; Teater, M; Elemento, O; Melnick, AM				Bunting, Karen L.; Soong, T. David; Singh, Rajat; Jiang, Yanwen; Beguelin, Wendy; Poloway, David W.; Swed, Brandon L.; Hatzi, Katerina; Reisacher, William; Teater, Matt; Elemento, Olivier; Melnick, Ari M.			Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region	IMMUNITY			English	Article							CHROMATIN INTERACTIONS; FUNCTIONAL-ORGANIZATION; MAMMALIAN GENOMES; BINDING PROTEIN; MOUSE GENOME; GENE LOOPS; RNA-SEQ; TRANSCRIPTION; ARCHITECTURE; DIFFERENTIATION	During the humoral immune response, B cells undergo a dramatic change in phenotype to enable antibody affinity maturation in germinal centers (GCs). Using genome-wide chromosomal conformation capture (Hi-C), we found that GC B cells undergo massive reorganization of the genomic architecture that encodes the GC B cell transcriptome. Coordinate expression of genes that specify the GC B cell phenotype-most prominently BCL6-was achieved through amultilayered chromatin reorganization process involving (1) increased promoter connectivity, (2) formation of enhancer networks, (3) 50 to 30 gene looping, and (4) merging of gene neighborhoods that share active epigenetic marks. BCL6 was an anchor point for the formation of GC-specific gene and enhancer loops on chromosome 3. Deletion of a GC-specific, highly interactive locus control region upstream of Bcl6 abrogated GC formation in mice. Thus, large-scale and multi-tiered genomic three-dimensional reorganization is required for coordinate expression of phenotype-driving gene sets that determine the unique characteristics of GC B cells.	[Bunting, Karen L.; Singh, Rajat; Jiang, Yanwen; Beguelin, Wendy; Poloway, David W.; Swed, Brandon L.; Hatzi, Katerina; Teater, Matt; Melnick, Ari M.] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA; [Bunting, Karen L.; Melnick, Ari M.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Soong, T. David; Jiang, Yanwen; Teater, Matt; Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Singh, Rajat] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Jiang, Yanwen] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Reisacher, William] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Otorhinolaryngol, New York, NY 10065 USA; [Bunting, Karen L.] New York Genome Ctr, New York, NY 10013 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Melnick, AM (corresponding author), Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA.; Melnick, AM (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.; Elemento, O (corresponding author), Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA.	ole2001@med.cornell.edu; amm2014@med.cornell.edu	Melnick, Ari/AAA-5763-2020	Singh, Rajat/0000-0002-9542-1929	NCI [R01 CA104348, R01 CA194547]; US National Science Foundation CAREER grant [1054964]; American Society of Hematology Scholar Award; NATIONAL CANCER INSTITUTE [R01CA104348, R01CA187109, R01CA194547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Science Foundation CAREER grant(National Science Foundation (NSF)); American Society of Hematology Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Epigenomics Core Facility (WCMC); the Dekker lab and Nynke van-Berkum for advice on Hi-C; Jiao Maria and Dr. Sebastien Monette from the WCMC and MSKCC lab of comparative pathology; Dr. John Schimenti from Cornell University (Ithaca); the Cornell Stem Cell and Transgenic Core facility; and Hao Shen. A.M.M. and O.E. are funded through NCI R01 CA104348. O.E. is funded by a US National Science Foundation CAREER grant 1054964 and NCI R01 CA194547. K.L.B. was supported by an American Society of Hematology Scholar Award.	Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Bai YC, 2005, J IMMUNOL, V175, P5160, DOI 10.4049/jimmunol.175.8.5160; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fabre PJ, 2015, P NATL ACAD SCI USA, V112, P13964, DOI 10.1073/pnas.1517972112; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hakim O, 2013, GENOME RES, V23, P462, DOI 10.1101/gr.147652.112; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Majumder P, 2011, J IMMUNOL, V187, P4236, DOI 10.4049/jimmunol.1100688; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Yamamoto H, 2002, CELL GROWTH DIFFER, V13, P69; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	80	81	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					497	512		10.1016/j.immuni.2016.08.012	http://dx.doi.org/10.1016/j.immuni.2016.08.012			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27637145	Green Accepted, Bronze			2022-12-18	WOS:000388454300009
J	Delconte, RB; Shi, W; Sathe, P; Ushiki, T; Seillet, C; Minnich, M; Kolesnik, TB; Rankin, LC; Mielke, LA; Zhang, JG; Busslinger, M; Smyth, MJ; Hutchinson, DS; Nutt, SL; Nicholson, SE; Alexander, WS; Corcoran, LM; Vivier, E; Belz, GT; Carotta, S; Huntington, ND				Delconte, Rebecca B.; Shi, Wei; Sathe, Priyanka; Ushiki, Takashi; Seillet, Cyril; Minnich, Martina; Kolesnik, Tatiana B.; Rankin, Lucille C.; Mielke, Lisa A.; Zhang, Jian-Guo; Busslinger, Meinrad; Smyth, Mark J.; Hutchinson, Dana S.; Nutt, Stephen L.; Nicholson, Sandra E.; Alexander, Warren S.; Corcoran, Lynn M.; Vivier, Eric; Belz, Gabrielle T.; Carotta, Sebastian; Huntington, Nicholas D.			The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15	IMMUNITY			English	Article							NATURAL-KILLER-CELL; TRANSCRIPTIONAL REGULATOR ID2; INNATE LYMPHOID-CELLS; IMMUNOGLOBULIN ENHANCER; EXPRESSION; CYTOKINE; SURVIVAL; IL-15; NFIL3; MAINTENANCE	The inhibitor of DNA binding 2 (Id2) is essential for natural killer (NK) cell development with its canonical role being to antagonize E-protein function and alternate lineage fate. Here we have identified a key role for Id2 in regulating interleukin-15 (IL-15) receptor signaling and homeostasis of NK cells by repressing multiple E-protein target genes including Socs3. Id2 deletion in mature NK cells was incompatible with their homeostasis due to impaired IL-15 receptor signaling and metabolic function and this could be rescued by strong IL-15 receptor stimulation or genetic ablation of Socs3. During NK cell maturation, we observed an inverse correlation between E-protein target genes and Id2. These results shift the current paradigm on the role of ID2, indicating that it is required not only to antagonize E-proteins during NK cell commitment, but constantly required to titrate E-protein activity to regulate NK cell fitness and responsiveness to IL-15.	[Delconte, Rebecca B.; Shi, Wei; Sathe, Priyanka; Ushiki, Takashi; Seillet, Cyril; Kolesnik, Tatiana B.; Rankin, Lucille C.; Mielke, Lisa A.; Zhang, Jian-Guo; Nutt, Stephen L.; Nicholson, Sandra E.; Alexander, Warren S.; Corcoran, Lynn M.; Belz, Gabrielle T.; Carotta, Sebastian; Huntington, Nicholas D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Delconte, Rebecca B.; Shi, Wei; Sathe, Priyanka; Ushiki, Takashi; Seillet, Cyril; Kolesnik, Tatiana B.; Rankin, Lucille C.; Mielke, Lisa A.; Zhang, Jian-Guo; Nutt, Stephen L.; Nicholson, Sandra E.; Alexander, Warren S.; Corcoran, Lynn M.; Belz, Gabrielle T.; Carotta, Sebastian; Huntington, Nicholas D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic 3010, Australia; [Minnich, Martina; Busslinger, Meinrad] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Smyth, Mark J.] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia; [Hutchinson, Dana S.] Monash Inst Pharmacol Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Vivier, Eric] Aix Marseille Univ UM2, INSERM, U1104, Ctr Immunol Marseille Luminy,CNRS,UMR7280, F-13288 Marseille, France; [Vivier, Eric] Hop Comception, AP HM, Immunol, F-13385 Marseille, France	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); QIMR Berghofer Medical Research Institute; University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	belz@wehi.edu.au; huntington@wehi.edu.au	Huntington, NICHOLAS/AAV-4704-2020; Vivier, Eric/F-8939-2010; Smyth, Mark J/H-8709-2014; Busslinger, Meinrad J./J-1249-2016; Belz, Gabrielle T/C-9350-2013; Nutt, Stephen L/C-9256-2013; Seillet, Cyril/AAF-1888-2019	Huntington, NICHOLAS/0000-0002-5267-7211; Vivier, Eric/0000-0001-7022-8287; Smyth, Mark J/0000-0001-7098-7240; Busslinger, Meinrad J./0000-0002-9111-9351; Belz, Gabrielle T/0000-0002-9660-9587; Nutt, Stephen L/0000-0002-0020-6637; Seillet, Cyril/0000-0002-0941-8679; Hutchinson, Dana/0000-0001-9947-0106; Mielke, Lisa/0000-0002-9522-9320; , Sandra/0000-0002-1314-2134; Rankin, Lucille/0000-0002-3699-1569; Delconte, Rebecca/0000-0002-3066-4014	National Health and Medical Research Council (NH&MRC) of Australia [1027472, 1047903, 1016647, 1049407, 1066770, 1057852]; National Health and Medical Research Council of Australia [GNT0461276, 1058344, 545952]; Australian Research Council; Cancer Australia; Menzies Foundation; Leukaemia Foundation scholarship; European Research Council (THINK Advanced Grant); INSERM; CNRS; Aix Marseille; Boehringer Ingelheim; ERC Advanced Grant (Lymphocyte Control) from the European Community's Seventh Framework Program [291740];  [628623]	National Health and Medical Research Council (NH&MRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Australia; Menzies Foundation; Leukaemia Foundation scholarship; European Research Council (THINK Advanced Grant); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix Marseille; Boehringer Ingelheim(Boehringer Ingelheim); ERC Advanced Grant (Lymphocyte Control) from the European Community's Seventh Framework Program; 	We wish to thank Tobias Kratina, Tania Camilleri, Pradnya Gangatirkar, Hesham Abdulla, Cathy Quillici, and Mary Camilleri for technical assistance and Andreas Strasser, Ross Dickins, and Philippe Bouillet for reagents and helpful discussion. We thank the staff of the WEHI Animal Services, monoclonal antibody facility, the flow cytometry facility, and Clinical Translational Centre. This work is supported by program and project grants from the National Health and Medical Research Council (NH&MRC) of Australia (1027472 to S.C., N.D.H., and G.T.B.; 1047903 to G.T.B. and L.A.M.; 1016647 to J.-G.Z., S.E.N., and W.S.A.; 1049407, 1066770, 1057852 to N.D.H.). This work is supported by fellowships from the National Health and Medical Research Council of Australia (GNT0461276 to N.D.H.; 1058344 to W.S.A.; 545952 to D.S.H.; Dora Lush Training Scholarship to L.C.R.), the Australian Research Council (S.C., G.T.B., S.L.N.), Australia Fellowship (628623) to M.J.S., Cancer Australia (L.A.M.), and The Menzies Foundation (N.D.H.). R.B.D. is supported by a Leukaemia Foundation scholarship. The E.V. lab is supported by the European Research Council (THINK Advanced Grant) and by institutional grants from INSERM, CNRS, and Aix Marseille to CIML. E.V. is a scholar of the Institut Universitaire de France. The M.B. group was supported by Boehringer Ingelheim and an ERC Advanced Grant (291740 - Lymphocyte Control) from the European Community's Seventh Framework Program. This study was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; Herold MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.409; Holmes ML, 2014, EMBO J, V33, P2721, DOI 10.15252/embj.201487900; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Klose CSN, 2014, CURR TOP MICROBIOL, V381, P215, DOI 10.1007/82_2014_381; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lin YY, 2012, J IMMUNOL, V189, P1400, DOI 10.4049/jimmunol.1200491; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Masson F, 2014, BLOOD, V123, P3420, DOI 10.1182/blood-2014-03-561456; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang MX, 2015, J EXP MED, V212, P253, DOI 10.1084/jem.20141703; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zheng XD, 2008, MOL IMMUNOL, V45, P2559, DOI 10.1016/j.molimm.2008.01.001	51	80	85	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					103	115		10.1016/j.immuni.2015.12.007	http://dx.doi.org/10.1016/j.immuni.2015.12.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795246	Bronze			2022-12-18	WOS:000368347000016
J	Oh-hora, M; Komatsu, N; Pishyareh, M; Feske, S; Hori, S; Taniguchi, M; Rao, A; Takayanagi, H				Oh-hora, Masatsugu; Komatsu, Noriko; Pishyareh, Mojgan; Feske, Stefan; Hori, Shohei; Taniguchi, Masaru; Rao, Anjana; Takayanagi, Hiroshi			Agonist-Selected T Cell Development Requires Strong T Cell Receptor Signaling and Store-Operated Calcium Entry	IMMUNITY			English	Article							NEGATIVE SELECTION; POSITIVE SELECTION; CA2+ ENTRY; TGF-BETA; IN-VIVO; INTRAEPITHELIAL LYMPHOCYTES; CD4+8+ THYMOCYTES; CHANNEL FUNCTION; TRANSGENIC MICE; NKT CELLS	T cell receptor (TCR) signaling driven by interaction of the TCR with specific complexes of self-peptide and the major histocompatibility complex determines T cell fate in thymic development. However, the signaling pathway through which TCR signal strength regulates distinct T cell lineages remains unknown. Here we have used mice lacking the endoplasmic reticulum Ca2+ sensors stromal interaction molecule 1 (STIM1) and STIM2 to show that STIM-induced store-operated Ca2+ entry is not essential for thymic development of conventional TCR alpha beta(+) T cells but is specifically required for the development of agonist-selected T cells (regulatory T cells, invariant natural killer T cells, and TCR alpha beta(+) CD8 alpha alpha(+) intestinal intraepithelial lymphocytes). The severe impairment of agonist-selected T cell development is mainly due to a defect in interleukin-2 (IL-2) or IL-15 signaling. Thus, STIM1 and STIM2-mediated store-operated Ca2+ influx, leading to efficient activation of NFAT (nuclear factor of activated T cells), is critical for the postselection maturation of agonist-selected T cells.	[Oh-hora, Masatsugu; Komatsu, Noriko; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Oh-hora, Masatsugu; Pishyareh, Mojgan; Rao, Anjana] Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol,Immune Dis Inst, Boston, MA 02115 USA; [Oh-hora, Masatsugu; Pishyareh, Mojgan; Rao, Anjana] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Oh-hora, Masatsugu; Komatsu, Noriko; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo 1138549, Japan; [Oh-hora, Masatsugu] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO Progr, Bunkyo Ku, Tokyo 1138549, Japan; [Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Hori, Shohei] RIKEN, Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Taniguchi, Masaru] RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Takayanagi, Hiroshi] Japan Sci & Technol Agcy JST, Explorat Res Adv Technol ERATO Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1138549, Japan	Tokyo Medical & Dental University (TMDU); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Japan Science & Technology Agency (JST); New York University; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Oh-hora, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	ohora.gcoe@tmd.ac.jp; arao@liai.org	Hori, Shohei/O-6163-2019; Feske, stefan/ABB-3554-2021; Taniguchi, Masaru/N-7932-2015	Hori, Shohei/0000-0001-8770-4593; Feske, stefan/0000-0001-5431-8178; Taniguchi, Masaru/0000-0001-7821-7179	Japan Society for the Promotion of Science (JSPS); PRESTO from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan; ERATO; Takayanagi Osteonetwork Project from the JST; NIH [AI 066128, AI40127, AI84167]; Takeda Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; JSPS Research Fellowships for Young Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084167, R01AI097302, R01AI040127, R01AI066128] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO(Japan Science & Technology Agency (JST)); Takayanagi Osteonetwork Project from the JST; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; JSPS Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Kitamura (The University of Tokyo) for providing Plat-E packaging cell lines, as well as K. Okamoto, M. Guerrini, A. Terashima, Y. Muratani, and T. Kato for discussion and assistance. This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas from the Japan Society for the Promotion of Science (JSPS), PRESTO from the Japan Science and Technology Agency (JST) (to M.O.), Grants-in-Aid for GCOE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.O. and H. T.), ERATO, Takayanagi Osteonetwork Project from the JST (to H. T.) and NIH grants to S. F. (AI 066128) and A. R. (AI40127 and AI84167). M.O. was also supported by grants from Takeda Life Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research. N.K. is supported by JSPS Research Fellowships for Young Scientists. S. F. and A. R. are scientific founders of CalciMedica, a company that seeks to identify novel treatments for immune-related diseases.	Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Beyersdorf N, 2009, J IMMUNOL, V182, P3390, DOI 10.4049/jimmunol.0802888; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cante-Barrett K, 2006, J IMMUNOL, V176, P2299, DOI 10.4049/jimmunol.176.4.2299; Cante-Barrett K, 2007, J IMMUNOL, V179, P103, DOI 10.4049/jimmunol.179.1.103; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; NAKAYAMA T, 1992, SCIENCE, V257, P96, DOI 10.1126/science.1621102; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zullo AJ, 2007, J IMMUNOL, V178, P58, DOI 10.4049/jimmunol.178.1.58	60	80	83	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					881	895		10.1016/j.immuni.2013.02.008	http://dx.doi.org/10.1016/j.immuni.2013.02.008			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23499491	Bronze, Green Accepted			2022-12-18	WOS:000330942500008
J	Cheng, LE; Hartmann, K; Roers, A; Krummel, MF; Locksley, RM				Cheng, Laurence E.; Hartmann, Karin; Roers, Axel; Krummel, Matthew F.; Locksley, Richard M.			Perivascular Mast Cells Dynamically Probe Cutaneous Blood Vessels to Capture Immunoglobulin E	IMMUNITY			English	Article							FC-EPSILON-RI; IN-VIVO; B-CELLS; DENDRITIC CELLS; PLASMA-CELLS; IGE; EXPRESSION; EFFECTOR; ALLERGY; ASTHMA	Mast cells are tissue-resident immune cells that play a central role in allergic disease. These contributions are largely dependent on the acquisition of antigen-specific immunoglobulin E (IgE). Despite this requirement, studies of mast cell and IgE interactions have overlooked the mechanism by which mast cells acquire IgE from the blood. To address this gap, we developed reporter IgE molecules and employed imaging techniques to study mast cell function in situ. Our data demonstrate that skin mast cells exhibit selective uptake of IgE based on perivascular positioning. Furthermore, perivascular mast cells acquire IgE by extending cell processes across the vessel wall to capture lumina! IgE. These data demonstrate how tissue mast cells acquire IgE and reveal a strategy by which extravascular cells monitor blood contents to capture molecules central to cellular function.	[Cheng, Laurence E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Hartmann, Karin] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, D-01307 Dresden, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Cologne; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Hartmann, Karin/N-4865-2015	Hartmann, Karin/0000-0002-4595-8226	Howard Hughes Medical Institute, NIH [AI026918, AI30663, AI078869]; SABRE Center at UCSF; NIH [HD044331, AI095319]; AAAAI-GSK Career Development Award; A.P. Giannini Medical Research Foundation; German Research Council (DFG) [CRC/SFB832]; German-Israeli Foundation for Scientific Research and Development [993/2008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918, T32AI007334, P01AI078869, K08AI095319, R01AI030663, R01AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SABRE Center at UCSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAAAI-GSK Career Development Award; A.P. Giannini Medical Research Foundation; German Research Council (DFG)(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following grants to R.M.L.: the Howard Hughes Medical Institute, NIH AI026918, AI30663, AI078869, and SABRE Center at UCSF; the following grants to L.E.C.: NIH T32 (HD044331), AAAAI-GSK Career Development Award, the A.P. Giannini Medical Research Foundation, and NIH AI095319; and the following grants to K.H.: the German Research Council (DFG; CRC/SFB832, project A14) and the German-Israeli Foundation for Scientific Research and Development(993/2008). We thank C. Allen and G. Caughey for providing mice and the Biological Imaging Development Center for assistance with microscopy. We thank members of the Locksley laboratory, C. Allen, J. Cyster, and S. Coughlin for thoughtful discussions and/or review of the manuscript. We also thank P. Kubes for sharing experimental protocols.	Cheng LE, 2010, J IMMUNOL, V185, P5040, DOI 10.4049/jimmunol.1001900; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Dawicki W, 2010, J IMMUNOL, V184, P2116, DOI 10.4049/jimmunol.0803894; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Fifadara NH, 2010, INT IMMUNOL, V22, P113, DOI 10.1093/intimm/dxp118; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCMENAMIN C, 1992, IMMUNOLOGY, V77, P592; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	33	80	81	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					166	175		10.1016/j.immuni.2012.09.022	http://dx.doi.org/10.1016/j.immuni.2012.09.022			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23290520	Bronze, Green Accepted			2022-12-18	WOS:000314195500018
J	Hu, W; Troutman, TD; Edukulla, R; Pasare, C				Hu, Wei; Troutman, Ty Dale; Edukulla, Ramakrishna; Pasare, Chandrashekhar			Priming Microenvironments Dictate Cytokine Requirements for T Helper 17 Cell Lineage Commitment	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; ROR-GAMMA-T; PATTERN-RECOGNITION RECEPTORS; CD103(+) DENDRITIC CELLS; TOLL-LIKE RECEPTORS; TGF-BETA; IMMUNE-RESPONSES; TRANSGENIC MICE; RETINOIC-ACID; T(H)17 CELLS	Activation of pattern recognition receptors on dendritic cells (DCs) and macrophages leads to secretion of cytokines that control differentiation of CD4(+) T cells. The current understanding is that interleukin-6 (IL-6) in combination with transforming growth factor-beta (TGF-beta) leads to generation of T helper 17 (Th17) lineage cells. Here, we have discovered that the cytokine requirements for Th17 cell polarization depend on the site of priming. Although IL-6 played a critical role in Th17 cell lineage priming in the skin and mucosal tissues, it was not required for Th17 cell priming in the spleen. In contrast, IL-1 played an irreplaceable role for priming of Th17 lineage cells in all tissues. Importantly, we have demonstrated that IL-6-independent and -dependent pathways of Th17 cell differentiation are guided by DCs residing in various tissues. These results reveal fundamental differences by which the systemic, mucosa!, and cutaneous immune systems guide Th17 cell lineage commitment.	[Hu, Wei; Troutman, Ty Dale; Edukulla, Ramakrishna; Pasare, Chandrashekhar] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Pasare, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chandrashekhar.pasare@utsouthwestern.edu	Hu, Wei/ABH-1470-2021	Hu, Wei/0000-0002-0392-6939; Troutman, Ty/0000-0001-8925-8080	National Institutes of Health [AI082265]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Forman, R. Medzhitov, S. Rath, A. Unni. and C. Wuelfing for helpful comments on the manuscript. This work was supported by National Institutes of Health grant AI082265 to C.P.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumanogoh A, 1997, P NATL ACAD SCI USA, V94, P2478, DOI 10.1073/pnas.94.6.2478; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	49	80	81	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					1010	1022		10.1016/j.immuni.2011.10.013	http://dx.doi.org/10.1016/j.immuni.2011.10.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22137454	Green Accepted, Bronze			2022-12-18	WOS:000298777300018
J	Johnson, S; Zhan, YF; Sutherland, RM; Mount, AM; Bedoui, S; Brady, JL; Carrington, EM; Brown, LE; Belz, GT; Heath, WR; Lew, AM				Johnson, Susan; Zhan, Yifan; Sutherland, Robyn M.; Mount, Adele M.; Bedoui, Sammy; Brady, Jamie L.; Carrington, Emma M.; Brown, Lorena E.; Belz, Gabrielle T.; Heath, William R.; Lew, Andrew M.			Selected Toll-like Receptor Ligands and Viruses Promote Helper-Independent Cytotoxic T Cell Priming by Upregulating CD40L on Dendritic Cells	IMMUNITY			English	Article							CROSS-PRESENTATION; CUTTING EDGE; LYMPH-NODE; EXPRESSION; MICE; INDUCTION; ACTIVATION; ANTIGEN; MEMORY; REQUIREMENT	CD40L (CD154) on CD4(+) T cells has been shown to license dendritic cells (DCs) via CD40 to prime cytotoxic T lymphocyte (CTL) responses. We found that the converse (CD40L on DCs) was also important. Anti-CD40L treatment decreased endogenous CTL responses to both ovalbumin and influenza infection even in the absence of CD4(+) T cells. DCs expressed CD40L upon stimulation with agonists to Toll-like receptor 3 (TLR3) and TLR9. Moreover, influenza infection, which stimulates CTLs without help, upregulated CD40L on DCs, but herpes simplex infection, which elicits CTLs through help, did not. CD40L-deficient (Cd40lg(-/-)) DCs are suboptimal both in vivo in bone marrow chimera experiments and in vitro in mixed lymphocyte reactions. In contrast, Cd40lg(-/-)CD8(+) T cells killed as effectively as wild-type cells. Thus, CD40L upregulation on DCs promoted optimal priming of CD8(+) T cells without CD4(+) T cells, providing a mechanism by which pathogens may elicit helper-independent CTL immunity.	[Johnson, Susan; Zhan, Yifan; Sutherland, Robyn M.; Brady, Jamie L.; Carrington, Emma M.; Lew, Andrew M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3050, Australia; [Mount, Adele M.; Bedoui, Sammy; Belz, Gabrielle T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Johnson, Susan; Mount, Adele M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Brown, Lorena E.; Heath, William R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Lew, AM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3050, Australia.	lew@wehi.edu.au	Lew, Andrew M/C-7248-2013; Belz, Gabrielle T/C-9350-2013	Lew, Andrew M/0000-0002-2198-8164; Belz, Gabrielle T/0000-0002-9660-9587; Zhan, Yifan/0000-0001-6974-0486; BEDOUI, SAMMY/0000-0002-7443-0543; Brown, Lorena/0000-0001-9342-909X; Heath, William/0000-0001-9670-259X	National Health and Medical Research Council of Australia; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043347] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A Melbourne Research Scholarship, provided by the University of Melbourne, supports S.J. This work was supported by grants from the National Health and Medical Research Council of Australia and Juvenile Diabetes Research Foundation.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; ALLAN W, 1990, J IMMUNOL, V144, P3980; Andreasen SO, 2000, J IMMUNOL, V164, P3689, DOI 10.4049/jimmunol.164.7.3689; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Bagenstose LM, 2005, J IMMUNOL, V175, P124, DOI 10.4049/jimmunol.175.1.124; Behrens G, 2004, IMMUNOL CELL BIOL, V82, P84, DOI 10.1111/j.1440-1711.2004.01211.x; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bereta M, 2004, CANCER GENE THER, V11, P808, DOI 10.1038/sj.cgt.7700762; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bucher P, 2005, TRANSPLANTATION, V79, P1545, DOI 10.1097/01.TP.0000163505.63159.69; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Dotti G, 2001, EXP HEMATOL, V29, P952, DOI 10.1016/S0301-472X(01)00668-3; Ford ML, 2007, J EXP MED, V204, P299, DOI 10.1084/jem.20062319; Gray D, 1994, Semin Immunol, V6, P303, DOI 10.1006/smim.1994.1039; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Hamilton SE, 2001, J IMMUNOL, V167, P5603, DOI 10.4049/jimmunol.167.10.5603; Hanninen A, 2002, J CLIN INVEST, V109, P261; Harui A, 2006, J LEUKOCYTE BIOL, V79, P1271, DOI 10.1189/jlb.1105694; Hernandez MGH, 2007, J IMMUNOL, V178, P2844, DOI 10.4049/jimmunol.178.5.2844; Ito H, 2006, TRANSPLANTATION, V82, P251, DOI 10.1097/01.tp.0000226147.69877.6f; Jain P, 2007, J LEUKOCYTE BIOL, V82, P44, DOI 10.1189/jlb.1006641; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Komura K, 2008, ANN RHEUM DIS, V67, P867, DOI 10.1136/ard.2007.073387; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Lee BO, 2002, J EXP MED, V196, P693, DOI 10.1084/jem.20020845; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Masten BJ, 1997, AM J RESP CELL MOL, V16, P335, DOI 10.1165/ajrcmb.16.3.9070619; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Mintern JD, 2006, J IMMUNOL, V177, P8422, DOI 10.4049/jimmunol.177.12.8422; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Montoya M, 2005, J IMMUNOL, V174, P1851, DOI 10.4049/jimmunol.174.4.1851; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Ortiz-Sanchez E, 2007, INT J GYNECOL CANCER, V17, P571, DOI 10.1111/j.1525-1438.2007.00904.x; Ostrowski MA, 2000, J IMMUNOL, V165, P6133, DOI 10.4049/jimmunol.165.11.6133; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Salgado CG, 1999, J LEUKOCYTE BIOL, V66, P281, DOI 10.1002/jlb.66.2.281; Saurwein-Teissl M, 1998, CLIN EXP IMMUNOL, V114, P271; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tomihara K, 2008, GENE THER, V15, P203, DOI 10.1038/sj.gt.3303056; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; TRIPP RA, 1995, J IMMUNOL, V155, P2955; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; VANKOOTEN C, 1994, EUR J IMMUNOL, V24, P787, DOI 10.1002/eji.1830240402; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Wang B, 2001, J IMMUNOL, V167, P1283, DOI 10.4049/jimmunol.167.3.1283; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; WU Y, 1994, CURR BIOL, V4, P499, DOI 10.1016/S0960-9822(00)00110-X; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335; Zhan YF, 2000, J IMMUNOL, V165, P3612, DOI 10.4049/jimmunol.165.7.3612; Zhan YF, 2004, IMMUNOL RES, V30, P1, DOI 10.1385/IR:30:1:001; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	75	80	88	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					218	227		10.1016/j.immuni.2008.11.015	http://dx.doi.org/10.1016/j.immuni.2008.11.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19200758	Green Accepted, Bronze			2022-12-18	WOS:000263710500009
J	Agata, Y; Tamaki, N; Sakamoto, S; Ikawa, T; Masuda, K; Kawamoto, H; Murre, C				Agata, Yasutoshi; Tamaki, Nobuyuki; Sakamoto, Shuji; Ikawa, Tomokatsu; Masuda, Kyoko; Kawamoto, Hiroshi; Murre, Cornelis			Regulation of T cell receptor beta gene rearrangements and allelic exclusion by the helix-loop-helix protein, E47	IMMUNITY			English	Article							V(D)J RECOMBINATION; B-CELLS; CD3-EPSILON-MEDIATED SIGNALS; TRANSCRIPTIONAL REGULATION; THYMOCYTE DIFFERENTIATION; LYMPHOCYTE DEVELOPMENT; CHAIN EXPRESSION; LOCUS; E2A; MICE	Allelic exclusion of antigen-receptor genes is ensured primarily by monoallelic locus activation upon rearrangement and subsequently by feedback inhibition of continued rearrangement. Here, we demonstrated that the basic helix-loop-helix protein, E47, promoted T cell receptor beta (TCR beta) gene rearrangement by directly binding to target gene segments to increase chromatin accessibility in a dosage-sensitive manner. Feedback signaling abrogated E47 binding, leading to a decline in accessibility. Conversely, enforced expression of E47 induced TCR beta gene rearrangement by antagonizing feedback inhibition. Thus, the abundance of E47 is rate limiting in locus activation, and feedback signaling downregulates E47 activity to ensure allelic exclusion.	[Agata, Yasutoshi; Ikawa, Tomokatsu; Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ikawa, Tomokatsu; Masuda, Kyoko; Kawamoto, Hiroshi] Rikagaku Kenkyusho Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Agata, Yasutoshi; Tamaki, Nobuyuki; Sakamoto, Shuji] Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Kyoto 6068501, Japan	University of California System; University of California San Diego; RIKEN; Kyoto University	Agata, Y (corresponding author), Osaka Med Ctr Maternal & Child Hlth, Dept Dev Med, Res Inst, Osaka 5941101, Japan.	yagata@mch.pref.osaka.jp; murre@biomail.ucsd.edu		Agata, Yasutoshi/0000-0001-9642-6994				Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200; Chattopadhyay S, 1998, J IMMUNOL, V160, P1256; Chen F, 2001, J IMMUNOL, V166, P1771, DOI 10.4049/jimmunol.166.3.1771; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; KODAMA H, 1994, EXP HEMATOL, V22, P979; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Mathieu N, 2003, J BIOL CHEM, V278, P18101, DOI 10.1074/jbc.M212647200; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Senoo M, 1998, INT IMMUNOL, V10, P553, DOI 10.1093/intimm/10.5.553; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Tripathi RK, 2000, MOL CELL BIOL, V20, P42, DOI 10.1128/MCB.20.1.42-53.2000; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; WATANABE Y, 1992, CELL IMMUNOL, V142, P385, DOI 10.1016/0008-8749(92)90299-5	37	80	81	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	2007	27	6					871	884		10.1016/j.immuni.2007.11.015	http://dx.doi.org/10.1016/j.immuni.2007.11.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093539	Bronze			2022-12-18	WOS:000251907300008
J	Horai, R; Mueller, KL; Handon, RA; Cannons, JL; Anderson, SM; Kirby, MR; Schwartzberg, PL				Horai, Reiko; Mueller, Kristen L.; Handon, Robin A.; Cannons, Jennifer L.; Anderson, Stacie M.; Kirby, Martha R.; Schwartzberg, Pamela L.			Requirements for selection of conventional and innate T lymphocyte lineages	IMMUNITY			English	Article							NKT-CELL-DEVELOPMENT; TEC FAMILY KINASES; NF-KAPPA-B; POSITIVE SELECTION; NEGATIVE SELECTION; CUTTING EDGE; CD4(+)CD8(+) THYMOCYTES; PERIPHERAL HOMEOSTASIS; HEMATOPOIETIC-CELLS; THYMIC SELECTION	Mice deficient in the Tec kinase Itk develop a large population of CD8(+) T cells with properties, including expression of memory markers, rapid production of cytokines, and dependence on Interleukin-15, resembling NKT and other innate T cell lineages. Like NKT cells, these CD8(+) T cells can be selected on hematopoietic cells' We demonstrate that these CD8(+) T cell phenotypes resulted from selection on hematopoietic cells-forcing selection on the thymic stroma reduced the number and innate phenotypes of mature ltk-deficient CD8(+) T cells. We further show that, similar to NKT cells, selection of innate-type CD8(+) T cells in Itk(-/-) mice required the adaptor SAP. Acquisition of their innate characteristics, however, required CD28. Our results suggest that SAP and Itk reciprocally regulate selection of innate and conventional CD8(+) T cells on hematopoietic cells and thymic epithelium, respectively, whereas CD28 regulates development of innate phenotypes resulting from selection on hematopoietic cells.	NIH, NHGRI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schwartzberg, PL (corresponding author), NIH, NHGRI, Bethesda, MD 20892 USA.	pams@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200350, Z01HG000123] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000123-10] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amsen D, 1996, INT IMMUNOL, V8, P1927, DOI 10.1093/intimm/8.12.1927; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Buhlmann JE, 2003, J IMMUNOL, V170, P5421, DOI 10.4049/jimmunol.170.11.5421; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Eberl G, 1999, J IMMUNOL, V163, P4091; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Li W, 2007, J EXP MED, V204, P2145, DOI 10.1084/jem.20070321; Li WL, 2005, MICROSYST TECHNOL, V11, P23, DOI 10.1007/s00542-004-0462-8; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Teh HS, 2001, CELL IMMUNOL, V207, P100, DOI 10.1006/cimm.2000.1757; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Vacchio MS, 2005, EUR J IMMUNOL, V35, P418, DOI 10.1002/eji.200424918; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	56	80	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					775	785		10.1016/j.immuni.2007.09.012	http://dx.doi.org/10.1016/j.immuni.2007.09.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031697	Green Accepted, Bronze			2022-12-18	WOS:000251269000011
J	Sen, R				Sen, Ranjan			Control of B lymphocyte apoptosis by the transcription factor Nk-kappa B	IMMUNITY			English	Review							BRUTONS TYROSINE KINASE; CELL ANTIGEN RECEPTOR; FLICE-INHIBITORY PROTEIN; FAS-MEDIATED APOPTOSIS; FAMILY-MEMBER BIM; CUTTING EDGE; NEGATIVE SELECTION; POSITIVE SELECTION; GERMINAL-CENTERS; MARGINAL ZONE	B cells maintain homeostasis by balancing cell viability and cell death. B lymphocytes are susceptible to mitochondria- and receptor-initiated cell death at various stages of peripheral differentiation and during immune responses. The inducible transcription factor NF-kappa B enhances cell viability by activating genes that counteract both cell-death pathways. This review uses characteristic features of NF-kappa B activation and down-regulation to provide insight into the regulation of B cell apoptosis in the periphery. In particular, the temporal patterns of NF-kappa B induction, differences between Rel family members, and the intersection between canonical and noncanonical signaling pathways in keeping B cells alive are discussed.	NIA, Lab Cellular & Mol Biol, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, R (corresponding author), NIA, Lab Cellular & Mol Biol, Baltimore, MD 21224 USA.	rs465z@nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000383, Z01AG000383] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Amanna IJ, 2003, J IMMUNOL, V170, P4593, DOI 10.4049/jimmunol.170.9.4593; Amin RH, 2005, IMMUNITY, V22, P401, DOI 10.1016/j.immuni.2005.04.002; Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Banerjee Daliya, 2006, P41; Barrington RA, 2005, J IMMUNOL, V175, P2859, DOI 10.4049/jimmunol.175.5.2859; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Calderhead DM, 2000, CURR TOP MICROBIOL, V245, P73; Cancro MP, 2004, J IMMUNOL, V173, P15, DOI 10.4049/jimmunol.173.1.15; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Chen C, 2006, J IMMUNOL, V176, P5183, DOI 10.4049/jimmunol.176.9.5183; Cheng SH, 2003, ONCOGENE, V22, P8472, DOI 10.1038/sj.onc.1206917; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; Chung JB, 2001, J IMMUNOL, V166, P736, DOI 10.4049/jimmunol.166.2.736; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Crowley JE, 2005, SEMIN IMMUNOL, V17, P193, DOI 10.1016/j.smim.2005.02.001; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Feng B, 2004, CELL IMMUNOL, V232, P9, DOI 10.1016/j.cellimm.2005.01.006; Foote LC, 1998, J EXP MED, V187, P847, DOI 10.1084/jem.187.6.847; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Fujimoto M, 2002, J IMMUNOL, V168, P5465, DOI 10.4049/jimmunol.168.11.5465; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Gerondakis S, 2003, SEMIN IMMUNOL, V15, P159, DOI 10.1016/S1044-5323(03)00036-8; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GROSS TM, 2000, DIABETES TECHNOL THE, V2, P19, DOI DOI 10.1089/15209150050214087; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hennino A, 2001, J EXP MED, V193, P447, DOI 10.1084/jem.193.4.447; Hennino A, 2000, J IMMUNOL, V165, P3023, DOI 10.4049/jimmunol.165.6.3023; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; King LB, 1999, J IMMUNOL, V162, P2655; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuo P, 1997, MOL IMMUNOL, V34, P1011, DOI 10.1016/S0161-5890(97)00117-X; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Louzoun Y, 2002, SEMIN IMMUNOL, V14, P169, DOI 10.1016/S1044-5323(02)00041-6; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Meffre E, 2002, P NATL ACAD SCI USA, V99, P11334, DOI 10.1073/pnas.172369999; Mittal A, 2006, J IMMUNOL, V176, P2183, DOI 10.4049/jimmunol.176.4.2183; Mizuno T, 2003, APOPTOSIS, V8, P451, DOI 10.1023/A:1025534223168; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Moore CR, 2005, J IMMUNOL, V175, P3780, DOI 10.4049/jimmunol.175.6.3780; Narayan P, 2006, MOL CELL BIOL, V26, P2327, DOI 10.1128/MCB.26.6.2327-2336.2006; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Oliver PM, 2006, J EXP MED, V203, P731, DOI 10.1084/jem.20051407; Otero DC, 2001, J BIOL CHEM, V276, P1474, DOI 10.1074/jbc.M003918200; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schmitz ML, 2006, CELL DEATH DIFFER, V13, P834, DOI 10.1038/sj.cdd.4401845; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shapiro-Shelef M, 2004, CURR OPIN IMMUNOL, V16, P226, DOI 10.1016/j.coi.2004.02.001; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Thomas MD, 2006, CELL IMMUNOL, V239, P92, DOI 10.1016/j.cellimm.2006.04.007; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; van Eijk M, 2001, J IMMUNOL, V166, P6473, DOI 10.4049/jimmunol.166.11.6473; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Vora KA, 2003, J IMMUNOL, V171, P547, DOI 10.4049/jimmunol.171.2.547; Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; William J, 2006, J IMMUNOL, V176, P2142, DOI 10.4049/jimmunol.176.4.2142; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamazaki T, 2003, NAT IMMUNOL, V4, P780, DOI 10.1038/ni949; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	133	80	84	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					871	883		10.1016/j.immuni.2006.12.003	http://dx.doi.org/10.1016/j.immuni.2006.12.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174931	Bronze			2022-12-18	WOS:000243087500007
J	Su, YW; Jumaa, H				Su, YW; Jumaa, H			LAT links the Pre-BCR to calcium signaling	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; ADAPTER PROTEIN SLP-65; TEC FAMILY KINASES; MATURE B-CELLS; TYROSINE KINASE; T-CELLS; SURFACE-IMMUNOGLOBULIN; MEDIATED ACTIVATION; MOLECULAR-CLONING; BONE-MARROW	SLP-65(-/-) mice display a partial block at the pre-B cell stage of development. Here, we show that LAT is required for the differentiation of SLP-65(-/-) pre-B cells. We show that LAT and SLP-76 are recruited to the pre-BCR and associated with Ig-alpha upon pre-BCR engagement, whereas LAT interaction with SLP-76 is already detected in untreated pre-B cells. Reconstitution of LAT or SLP-65 expression in SLP-65/LAT(-/-) pre-B cells restored their calcium (Ca2+) mobilization capacity, led to downregulation of surface pre-BCR, and induced differentiation to BCR+ cells. Together, our results suggest that the adaptor proteins LAT and SLP-76 are involved in pre-BCR signaling, thereby rescuing arrested murine SLP-65(-/-) pre-B cells.	Univ Freiburg, Inst Biol 3, D-7800 Freiburg, Germany; Max Planck Inst Immunbiol, D-7800 Freiburg, Germany	University of Freiburg; Max Planck Society	Jumaa, H (corresponding author), Univ Freiburg, Inst Biol 3, Hugstetter Str 55, D-7800 Freiburg, Germany.		Su, Yu-Wen/E-8804-2010					Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Buhl AM, 2000, IMMUNOL REV, V176, P141; Clements JL, 1998, J IMMUNOL, V161, P3880; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; EDERY I, 1983, J BIOL CHEM, V258, P1398; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Facchetti F, 1999, AM J PATHOL, V154, P1037, DOI 10.1016/S0002-9440(10)65356-4; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Ishiai M, 2000, J EXP MED, V192, P847, DOI 10.1084/jem.192.6.847; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Leo A, 2001, CURR OPIN IMMUNOL, V13, P307, DOI 10.1016/S0952-7915(00)00220-X; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 2000, CURR OPIN IMMUNOL, V12, P173, DOI 10.1016/S0952-7915(99)00068-0; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Wong J, 2000, J BIOL CHEM, V275, P33116, DOI 10.1074/jbc.M004467200; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	51	80	83	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					295	305		10.1016/S1074-7613(03)00202-4	http://dx.doi.org/10.1016/S1074-7613(03)00202-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932362	Bronze			2022-12-18	WOS:000184929000016
J	Held, W; Kunz, B; Lowin-Kropf, B; van de Wetering, M; Clevers, H				Held, W; Kunz, B; Lowin-Kropf, B; van de Wetering, M; Clevers, H			Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; LY-49 MULTIGENE FAMILY; MHC CLASS-I; BETA-CATENIN; TRANSCRIPTION FACTOR; HMG-BOX; GENE-EXPRESSION; COMPLEX; LEF-1; MICE	Families of clonally expressed major histocompatibility complex (MHC) class I-specific receptors provide specificity to and regulate the function of natural killer (NK) cells. One of these receptors, mouse Ly49A, is expressed by 20% of NK cells and inhibits the killing of H-2D(d) but not D-b-expressing target cells. Here, we show that the trans-acting factor TCF-1 binds to two sites in the Ly49A promoter and regulates its activity. Moreover, we find that TCF-1 determines the size of the Ly49A NK cell subset in vivo in a dosage-dependent manner. We propose that clonal Ly49A acquisition during NK cell development is regulated by TCF-1.	Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Univ Utrecht Hosp, Dept Immunol, NL-3584 CX Utrecht, Netherlands	Ludwig Institute for Cancer Research; University of Lausanne; Utrecht University; Utrecht University Medical Center	Held, W (corresponding author), Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, 155 Chemin Boveresses, CH-1066 Epalinges, Switzerland.	wheld@isrec.unil.ch						Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HELD W, 1993, J EXP MED, V177, P359, DOI 10.1084/jem.177.2.359; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Held W, 1998, EUR J IMMUNOL, V28, P2407, DOI 10.1002/(SICI)1521-4141(199808)28:08&lt;2407::AID-IMMU2407&gt;3.0.CO;2-D; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HELD W, 1999, IN PRESS SEM IMMUNOL; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; KUBO S, 1993, GENE, V136, P329; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; McQueen KL, 1998, IMMUNOGENETICS, V48, P174, DOI 10.1007/s002510050421; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moore TA, 1996, IMMUNOL RES, V15, P151, DOI 10.1007/BF02918504; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; NAKAMURA MC, 1997, J EXP MED, V147, P3244; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Ohteki T, 1996, EUR J IMMUNOL, V26, P351, DOI 10.1002/eji.1830260213; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Schilham MW, 1998, J IMMUNOL, V161, P3984; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SMITH HRC, 1994, J IMMUNOL, V153, P1068; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Williams NS, 1998, IMMUNOL REV, V165, P47, DOI 10.1111/j.1600-065X.1998.tb01229.x; WONG S, 1991, J IMMUNOL, V147, P1417	56	80	81	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1999	11	4					433	442		10.1016/S1074-7613(00)80118-1	http://dx.doi.org/10.1016/S1074-7613(00)80118-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549625	Bronze			2022-12-18	WOS:000083343100005
J	Sant'Angelo, DB; Lucas, B; Waterbury, PG; Cohen, B; Brabb, T; Goverman, J; Germain, RN; Janeway, CA				Sant'Angelo, DB; Lucas, B; Waterbury, PG; Cohen, B; Brabb, T; Goverman, J; Germain, RN; Janeway, CA			A molecular map of T cell development	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENT; POSITIVE SELECTION; MATURATION PATHWAY; INTERMEDIATE STEPS; THYMOCYTES; DIFFERENTIATION; RECOMBINATION; COMMITMENT; LINEAGES; THYMUS	Using a sensitive molecular marker for positive selection, the appearance of a particular functional TCR alpha chain sequence in cells from mice bearing a transgenic beta chain, we address several aspects of intrathymic T cell development. First, by examining specific TCR prior to and after maturation, we demonstrate how a restricted TCR repertoire is positively selected from a highly diverse immature TCR repertoire. Second, since this molecular marker is enriched in cells progressing toward the CD4 lineage and depleted in cells progressing toward the CD8 lineage, a map of the developmental pathway of alpha beta thymocytes can be inferred. Third, the first cells that show clear signs of positive intrathymic selection are identified.	Yale Univ, Howard Hughes Med Inst, Sch Med, Immunol Sect, New Haven, CT 06520 USA; National Institute Allergy & Infectious Diseases, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Washington, Sch Med, Dept Mol Biotechnol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Lucas, B (corresponding author), Yale Univ, Howard Hughes Med Inst, Sch Med, Immunol Sect, New Haven, CT 06520 USA.	derek.santangelo@yale.edu	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Goverman, Joan/0000-0002-7361-9424; LUCAS, Bruno/0000-0002-0322-3977	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014579, R37AI014579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035126] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-14579] Funding Source: Medline; NINDS NIH HHS [NS35126-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; Barthlott T, 1997, EUR J IMMUNOL, V27, P2024, DOI 10.1002/eji.1830270829; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; FERGUSON SE, 1994, MOL CELL BIOL, V14, P7298, DOI 10.1128/MCB.14.11.7298; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KYDD R, 1995, J IMMUNOL, V155, P3806; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; LUNDBERG K, 1994, J EXP MED, V179, P1475, DOI 10.1084/jem.179.5.1475; Page D M, 1996, Semin Immunol, V8, P69, DOI 10.1006/smim.1996.0010; Penit C, 1997, J IMMUNOL, V159, P4848; PETRIE HT, 1993, J IMMUNOL, V151, P1273; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1994, EUR J IMMUNOL, V24, P1010, DOI 10.1002/eji.1830240436; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1	33	80	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					179	186		10.1016/S1074-7613(00)80600-7	http://dx.doi.org/10.1016/S1074-7613(00)80600-7			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729038	Bronze			2022-12-18	WOS:000075610300004
J	Daniel, C; Horvath, S; Allen, PM				Daniel, C; Horvath, S; Allen, PM			A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR	IMMUNITY			English	Article							T-CELL RECEPTOR; AMINO-ACID CHANGES; MOLECULAR-BASIS; ENDOGENOUS PEPTIDES; SELF PEPTIDES; COMPLEX; LIGAND; LYMPHOCYTES; SPECIFICITY; ALLORECOGNITION	The high frequency of alloreactive T cells is a major hindrance for transplantation; however, the molecular basis for alloreactivity remains elusive. We examined the I-E-rho alloreactivity of a well-characterized Hb(64-76)/I-E-k-specific murine T cell. Using a combinatorial peptide library approach, we identified a highly stimulatory alloepitope mimic and observed that the recognition of the central TCR contact residues (P3 and P5) was much more flexible than that seen with Hb(64-76)/I-E-k, but still specific. Therefore, alloreactive T cells can recognize a self-peptide/MHC surface; however, the allogeneic MHC molecule changes the recognition requirements for the central region of the peptide, allowing a more diverse repertoire of ligands to be recognized.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.							ALLEN PM, 1987, MONOCLONAL ANTIBODY, P25; Ausubel LJ, 1997, J IMMUNOL, V159, P2502; Ausubel LJ, 1996, P NATL ACAD SCI USA, V93, P15317, DOI 10.1073/pnas.93.26.15317; BILL J, 1989, J EXP MED, V169, P115, DOI 10.1084/jem.169.1.115; Blake J, 1996, J EXP MED, V184, P121, DOI 10.1084/jem.184.1.121; BLUESTONE JA, 1992, J EXP MED, V176, P1757, DOI 10.1084/jem.176.6.1757; BRAUNSTEIN NS, 1990, J IMMUNOL, V145, P1635; Brock R, 1996, P NATL ACAD SCI USA, V93, P13108, DOI 10.1073/pnas.93.23.13108; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; CATIPOVIC B, 1992, J EXP MED, V176, P1611, DOI 10.1084/jem.176.6.1611; CHATTOPADHYAY S, 1994, J EXP MED, V179, P213, DOI 10.1084/jem.179.1.213; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; COPPIN HL, 1993, EUR J IMMUNOL, V23, P343, DOI 10.1002/eji.1830230207; CRUMPACKER DB, 1992, J IMMUNOL, V148, P3004; Daniel C, 1998, J IMMUNOL, V160, P3244; DELLABONA P, 1991, EUR J IMMUNOL, V21, P209, DOI 10.1002/eji.1830210131; EVAVOLD BD, 1994, P NATL ACAD SCI USA, V91, P2300, DOI 10.1073/pnas.91.6.2300; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Frelinger JA, 1996, IMMUNOL REV, V154, P45, DOI 10.1111/j.1600-065X.1996.tb00929.x; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GRANDEA AG, 1992, P NATL ACAD SCI USA, V89, P2794, DOI 10.1073/pnas.89.7.2794; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hong SC, 1997, J IMMUNOL, V159, P4395; Hsu BL, 1996, J IMMUNOL, V157, P2291; HSU BL, 1995, J EXP MED, V181, P805, DOI 10.1084/jem.181.2.805; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Janeway CA., 2021, IMMUNOBIOLOGY IMMUNE; Joyce S, 1996, IMMUNOL REV, V154, P59, DOI 10.1111/j.1600-065X.1996.tb00930.x; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KUZUSHIMA K, 1995, J IMMUNOL, V155, P594; LOMBARDI G, 1989, P NATL ACAD SCI USA, V86, P4190, DOI 10.1073/pnas.86.11.4190; LORENZ RG, 1988, P NATL ACAD SCI USA, V85, P5220, DOI 10.1073/pnas.85.14.5220; LOTUS DJ, 1997, J IMMUNOL, V158, P3651; MATIS LA, 1987, CELL, V51, P59, DOI 10.1016/0092-8674(87)90010-9; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MCKENZIE IFC, 1979, J EXP MED, V150, P1323, DOI 10.1084/jem.150.6.1323; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; PANINABORDIGNON P, 1991, SCIENCE, V252, P1548, DOI 10.1126/science.1710827; PEASE LR, 1993, J IMMUNOL, V150, P3375; Penzotti JE, 1996, J AUTOIMMUN, V9, P287, DOI 10.1006/jaut.1996.0037; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; RACIOPPI L, 1991, J IMMUNOL, V147, P3718; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROTZSCHKE O, 1991, J EXP MED, V174, P1059, DOI 10.1084/jem.174.5.1059; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Schild H, 1995, INT IMMUNOL, V7, P1957, DOI 10.1093/intimm/7.12.1957; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Sim BC, 1997, J IMMUNOL, V159, P3322; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; TALLQUIST MD, 1995, J IMMUNOL, V155, P2419; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Vella JP, 1997, TRANSPLANTATION, V64, P795, DOI 10.1097/00007890-199709270-00001; Wang W, 1998, J IMMUNOL, V160, P1091; Wei BY, 1996, IMMUNOGENETICS, V44, P231; Wen R, 1996, J EXP MED, V183, P1083, DOI 10.1084/jem.183.3.1083; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219	66	80	82	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					543	552		10.1016/S1074-7613(00)80559-2	http://dx.doi.org/10.1016/S1074-7613(00)80559-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620675	Bronze			2022-12-18	WOS:000073885400002
J	Pewe, L; Wu, GF; Barnett, EM; Castro, RF; Perlman, S				Pewe, L; Wu, GF; Barnett, EM; Castro, RF; Perlman, S			Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease	IMMUNITY			English	Article							MOUSE HEPATITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; CLASS-I MOLECULES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NEUROTROPIC CORONAVIRUS; MURINE CORONAVIRUS; CHRONIC INFECTION; LETHAL INFECTION; IMMUNE-RESPONSE; SPINAL-CORD	C57BI/6 mice infected with mouse hepatitis virus, strain JHM (MHV-JHM) develop a chronic demyelinating encephalomyelitis. Infectious virus can be isolated only from symptomatic mice. In C57BI/6 mice, two CD8(+) T cell epitopes within the MHV-JHM surface glycoprotein were previously identified. Here, we show that mutations in the RNA encoding the immunodominant of the epitopes are present in nearly all virus samples isolated from these mice. Mutations are not present in sequences flanking this epitope or in other CD8(+) or CD4(+) T cell epitopes. Furthermore, analysis of five peptides corresponding to variant epitopes in direct ex vivo cytotoxicity assays showed that each mutation caused a loss of epitope recognition. These results suggest that escape from CD8(+) T cell recognition is necessary for enhanced virus replication and development of clinical disease in these MHV-JHM-infected mice.	UNIV IOWA,DEPT MICROBIOL,IOWA CITY,IA 52242; UNIV IOWA,NEUROSCI PROGRAM,IOWA CITY,IA 52242	University of Iowa; University of Iowa	Pewe, L (corresponding author), UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242, USA.			Perlman, Stanley/0000-0003-4213-2354	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024401] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 24401] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMI C, 1995, VIROLOGY, V209, P337, DOI 10.1006/viro.1995.1265; ARMSTRONG J, 1984, NATURE, V308, P751, DOI 10.1038/308751a0; BANNER LR, 1990, VIROLOGY, V175, P548, DOI 10.1016/0042-6822(90)90439-X; BERGMANN C, 1993, J VIROL, V67, P7041, DOI 10.1128/JVI.67.12.7041-7049.1993; Bergmann CC, 1996, J GEN VIROL, V77, P315, DOI 10.1099/0022-1317-77-2-315; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BUCHMEIER MJ, 1984, VIROLOGY, V132, P261, DOI 10.1016/0042-6822(84)90033-3; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; CASTRO RF, 1995, J VIROL, V69, P8127, DOI 10.1128/JVI.69.12.8127-8131.1995; CASTRO RF, 1994, VIROLOGY, V200, P733, DOI 10.1006/viro.1994.1237; COUILLIN I, 1994, J EXP MED, V180, P1129, DOI 10.1084/jem.180.3.1129; DALZIEL RG, 1986, J VIROL, V59, P463, DOI 10.1128/JVI.59.2.463-471.1986; EISENLOHR LC, 1992, J EXP MED, V175, P481, DOI 10.1084/jem.175.2.481; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FLEMING JO, 1989, VIROLOGY, V168, P162, DOI 10.1016/0042-6822(89)90415-7; FRANCO A, 1995, CURR OPIN IMMUNOL, V7, P524, DOI 10.1016/0952-7915(95)80098-0; GAIRIN JE, 1992, J VIROL, V66, P6755, DOI 10.1128/JVI.66.11.6755-6762.1992; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; GOMBOLD JL, 1995, MICROB PATHOGENESIS, V18, P211, DOI 10.1016/S0882-4010(95)90058-6; HASPEL MV, 1978, P NATL ACAD SCI USA, V75, P4033, DOI 10.1073/pnas.75.8.4033; Hingorani R, 1996, J IMMUNOL, V156, P852; JACOBSEN G, 1990, ADV EXP MED BIOL, V276, P573; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KNOBLER RL, 1982, NATURE, V298, P279, DOI 10.1038/298279a0; KORNER H, 1991, J IMMUNOL, V147, P2317; KYUWA S, 1990, SEMINARS VIROLOGY, V1, P273; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; LEWICKI HA, 1995, VIROLOGY, V211, P443, DOI 10.1006/viro.1995.1426; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Miedema F, 1996, SCIENCE, V272, P505, DOI 10.1126/science.272.5261.505; MORRIS VL, 1989, VIROLOGY, V169, P127, DOI 10.1016/0042-6822(89)90048-2; MOSKOPHIDIS D, 1995, J VIROL, V69, P2187, DOI 10.1128/JVI.69.4.2187-2193.1995; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PARKER SE, 1989, VIROLOGY, V173, P664, DOI 10.1016/0042-6822(89)90579-5; PEARCE BD, 1994, J VIROL, V68, P5483, DOI 10.1128/JVI.68.9.5483-5495.1994; PERLMAN S, 1990, VIROLOGY, V175, P418, DOI 10.1016/0042-6822(90)90426-R; PERLMAN S, 1987, MICROB PATHOGENESIS, V2, P185, DOI 10.1016/0882-4010(87)90020-9; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; REHERMANN B, 1995, J CLIN INVEST, V96, P1527, DOI 10.1172/JCI118191; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SORENSEN O, 1980, ARCH NEUROL-CHICAGO, V37, P478, DOI 10.1001/archneur.1980.00500570026003; STOHLMAN SA, 1995, J VIROL, V69, P684, DOI 10.1128/JVI.69.2.684-694.1995; STOHLMAN SA, 1986, J IMMUNOL, V136, P3052; SUN N, 1995, J VIROL, V69, P633, DOI 10.1128/JVI.69.2.633-641.1995; WATANABE R, 1987, LAB INVEST, V57, P375; WEGE H, 1995, SPRINGER SEMIN IMMUN, V17, P133; WILLIAMSON JSP, 1990, J VIROL, V64, P4589, DOI 10.1128/JVI.64.9.4589-4592.1990; WILLIAMSON JSP, 1991, J NEUROIMMUNOL, V32, P199, DOI 10.1016/0165-5728(91)90189-E; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; XUE SR, 1995, VIROLOGY, V208, P173, DOI 10.1006/viro.1995.1140; YAMAGUCHI K, 1991, J NEUROIMMUNOL, V32, P1, DOI 10.1016/0165-5728(91)90065-F; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	61	80	83	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1996	5	3					253	262		10.1016/S1074-7613(00)80320-9	http://dx.doi.org/10.1016/S1074-7613(00)80320-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808680	Bronze			2022-12-18	WOS:A1996VJ79700007
J	Wilson, A; deVillartay, JP; MacDonald, HR				Wilson, A; deVillartay, JP; MacDonald, HR			T cell receptor delta gene rearrangement and T early alpha (TEA) expression in immature alpha beta lineage thymocytes: Implications for alpha beta/gamma delta lineage commitment	IMMUNITY			English	Article							GAMMA-DELTA; TCR-ALPHA; ALPHA/DELTA-LOCUS; ANTIGEN RECEPTOR; TRANSGENIC MICE; PRECURSOR CELLS; CD4; THYMUS; RECOMBINATION; DELETION	Mature T cells comprise two mutually exclusive lineages expressing heterodimeric alpha beta or gamma delta antigen receptors. During development, beta, gamma, and delta genes rearrange before alpha, and mature gamma delta cells arise in the thymus prior to alpha beta cells. The mechanism underlying commitment of immature T cells to the alpha beta or gamma delta lineage is controversial. Since the delta locus is located within the alpha locus, rearrangement of alpha genes leads to deletion of delta. We have examined the rearrangement status of the delta locus immediately prior to alpha rearrangement. We find that many thymic precursors of alpha beta cells undergo VDJ delta rearrangements. Furthermore, the same cells frequently coexpress sterile T early alpha (TEA) transcripts originating 3' of C delta and 5' of the most upstream J alpha, thus implying that individual alpha beta lineage cells undergo sequential VDJ delta and VJ alpha rearrangements. Finally, VDJ delta rearrangements in immature alpha beta cells appear to be random, supporting models in which alpha beta lineage commitment is determined independently of the rearrangement status at the TCR delta locus.	HOP NECKER ENFANTS MALAD, INSERM, U429, PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Wilson, A (corresponding author), UNIV LAUSANNE, LUDWIG INST CANC RES, CH-1066 EPALINGES, SWITZERLAND.		Wilson, Anne/A-7131-2011; de Villartay, jean pierre/H-9353-2017	de Villartay, jean pierre/0000-0001-5987-0463				ARDEN B, 1992, EUR J IMMUNOL, V22, P1287, DOI 10.1002/eji.1830220525; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BORN W, 1988, IMMUNOL RES, V7, P279, DOI 10.1007/BF02935533; BORST J, 1993, IMMUNOL REV, V132, P49, DOI 10.1111/j.1600-065X.1993.tb00837.x; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Casanova J L, 1993, Methods Mol Biol, V23, P191; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CROMPTON T, 1992, J EXP MED, V176, P903, DOI 10.1084/jem.176.3.903; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; DEVILLARTAY JP, 1990, RES IMMUNOL, V141, P618, DOI 10.1016/0923-2494(90)90069-B; DEVILLARTAY JP, 1987, P NATL ACAD SCI USA, V84, P8608; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; EGERTON M, 1990, INT IMMUNOL, V2, P501, DOI 10.1093/intimm/2.6.501; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; HAAS W, 1992, CURR OPIN IMMUNOL, V4, P147, DOI 10.1016/0952-7915(92)90004-X; HEID W, 1990, EUR J IMMUNOL, V20, P2133; Hugo P, 1992, ADV MOL CELL BIOL, V5, P37, DOI [DOI 10.1016/S1569-2558(08)60187-3, 10.1016/s1569-2558(08)60187-3]; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; KRUISBEEK AM, 1993, CURR OPIN IMMUNOL, V5, P227, DOI 10.1016/0952-7915(93)90009-H; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; MACDONALD HR, 1988, EUR J IMMUNOL, V18, P519, DOI 10.1002/eji.1830180405; MACDONALD HR, 1990, EUR J IMMUNOL, V20, P927; MAGUIRE JE, 1990, FASEB J, V4, P3131, DOI 10.1096/fasebj.4.13.1698681; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NIKOLICZUGIC J, 1991, IMMUNOL TODAY, V12, P65, DOI 10.1016/0167-5699(91)90160-U; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P1957, DOI 10.1002/eji.1830191030; OHASHI PS, 1990, EUR J IMMUNOL, V20, P517, DOI 10.1002/eji.1830200309; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PATERSON DJ, 1987, J EXP MED, V166, P1603, DOI 10.1084/jem.166.5.1603; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SCOLLAY R, 1991, CURR OPIN IMMUNOL, V3, P204, DOI 10.1016/0952-7915(91)90051-2; SHIMIZU T, 1993, INT IMMUNOL, V5, P155, DOI 10.1093/intimm/5.2.155; SHORTMAN K, 1991, CURR TOP MICROBIOL, V173, P71; SHORTMAN K, 1988, CELL IMMUNOL, V113, P462, DOI 10.1016/0008-8749(88)90042-1; SHORTMAN K, 1992, CURR OPIN IMMUNOL, V4, P140, DOI 10.1016/0952-7915(92)90003-W; SIM GK, 1995, J IMMUNOL, V154, P5821; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; WILSON A, 1988, J IMMUNOL, V140, P1461; Wilson A, 1989, Int Immunol, V1, P605, DOI 10.1093/intimm/1.6.605; Wilson A, 1992, Dev Immunol, V2, P85, DOI 10.1155/1992/45150; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1991, CURR OPIN IMMUNOL, V3, P199, DOI 10.1016/0952-7915(91)90050-B; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011	63	80	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1996	4	1					37	45		10.1016/S1074-7613(00)80296-4	http://dx.doi.org/10.1016/S1074-7613(00)80296-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574850	Bronze			2022-12-18	WOS:A1996TT31900004
J	BISWAS, P; SMITH, CA; GOLETTI, D; HARDY, EC; JACKSON, RW; FAUCI, AS				BISWAS, P; SMITH, CA; GOLETTI, D; HARDY, EC; JACKSON, RW; FAUCI, AS			CROSS-LINKING OF CD30 INDUCES HIV EXPRESSION IN CHRONICALLY INFECTED T-CELLS	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW TRANSPLANTATION; LONG TERMINAL REPEAT; STERNBERG-REED CELLS; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; HODGKINS-DISEASE; FACTOR RECEPTOR; KAPPA-B	CD30, a member of the tumor necrosis factor (TNF) receptor family, is expressed constitutively on the surface of the human T cell line ACH-2, which is chronically infected with human immunodeficiency virus type-1 (HIV)-1. We demonstrate that cross-linking CD30 with an anti-CD30-specific monoclonal antibody, which mimics the described biological activities of the CD30 ligand (CD30L), results in HIV expression. CD30 cross-linking does not alter proliferation of ACH-2 cells and the induction of HIV expression is not mediated by endogenous TNF alpha/beta. Furthermore, cross-linking of CD30 leads to NF-kappa B activation and enhanced HIV transcription. Thus, CD30-CD30L interactions mediate the induction of HIV expression by a kappa B-dependent pathway that is independent of TNF. This mechanism may be important in the activation of HIV expression from latently infected CD4(+) T cells, especially in lymphoid organs where cell to cell contact is conducive to receptor-ligand Interactions.	NIAID,IMMUNOREGULAT LAB,BETHESDA,MD 20892; IMMUNEX RES & DEV CORP,SEATTLE,WA 98101	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			goletti, delia/AAM-6577-2020	Goletti, Delia/0000-0001-8360-4376				ANDREESEN R, BLOOD, V63, P1299; ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; BAUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141; BERTINI R, 1993, EUR CYTOKINE NETW, V4, P39; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BIANCO JA, 1991, BLOOD, V78, P1205; BISWAS P, 1992, J EXP MED, V176, P739, DOI 10.1084/jem.176.3.739; BISWAS P, 1994, J VIROL, V68, P2598, DOI 10.1128/JVI.68.4.2598-2604.1994; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BRESSLER P, 1993, AIDS RES HUM RETROV, V9, P547, DOI 10.1089/aid.1993.9.547; BRESSLER P, 1991, J IMMUNOL, V147, P2290; CLOUSE KA, 1989, J IMMUNOL, V142, P431; DEZUBE BJ, 1993, J ACQ IMMUN DEF SYND, V6, P787; DEZUBE BJ, 1990, LANCET, V335, P662, DOI 10.1016/0140-6736(90)90450-J; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ELLIS TM, 1993, J IMMUNOL, V151, P2380; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1994, J EXP MED, V180, P1445, DOI 10.1084/jem.180.4.1445; FROESE P, 1987, J IMMUNOL, V139, P2081; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GRILLI M, 1993, INT REV CYTOL, V148, P1; GRUSS HJ, 1994, BLOOD, V83, P2045; HANSEN H, 1990, RES IMMUNOL, V141, P13, DOI 10.1016/0923-2494(90)90098-J; HOLLER E, 1990, BLOOD, V75, P1011; ISRAEL N, 1989, J IMMUNOL, V143, P3956; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; KOBAYASHI N, 1990, P NATL ACAD SCI USA, V87, P9620, DOI 10.1073/pnas.87.24.9620; LESSLAUER W, 1991, EUR J IMMUNOL, V21, P2883, DOI 10.1002/eji.1830211134; MANETTI R, 1994, J EXP MED, V180, P2407, DOI 10.1084/jem.180.6.2407; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MICHIHIKO S, 1989, LANCET, V1, P1206; MOHLER KM, 1993, J IMMUNOL, V151, P1548; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; NAWROCKI JF, 1988, J IMMUNOL, V141, P672; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PFREUNDSCHUH M, 1988, ANTICANCER RES, V8, P217; PIZZOLO G, 1994, AIDS, V8, P741, DOI 10.1097/00002030-199406000-00003; Poli G, 1993, Semin Immunol, V5, P165, DOI 10.1006/smim.1993.1020; POLI G, 1990, P NATL ACAD SCI USA, V87, P782, DOI 10.1073/pnas.87.2.782; SAMPAIO EP, 1992, J EXP MED, V175, P1729, DOI 10.1084/jem.175.6.1729; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; SCHWARTING R, 1989, BLOOD, V74, P1678; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STEIN H, 1982, INT J CANCER, V30, P445, DOI 10.1002/ijc.2910300411; STEIN H, 1985, BLOOD, V66, P848; STREITER RM, 1988, BIOCHEM BIOPH RES CO, V155, P1230; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988	58	80	80	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					587	596						10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7540942				2022-12-18	WOS:A1995RE53800004
J	Chu, C; Artis, D; Chiu, IM				Chu, Coco; Artis, David; Chiu, Isaac M.			Neuro-immune Interactions in the Tissues	IMMUNITY			English	Review							VAGUS NERVE-STIMULATION; INNATE LYMPHOID-CELLS; SENSORY NEURONS; CAENORHABDITIS-ELEGANS; MUSCULARIS MACROPHAGES; NEGATIVE REGULATION; HOST-DEFENSE; RECEPTOR; RESPONSES; PATHWAY	The ability of the nervous system to sense environmental stimuli and to relay these signals to immune cells via neurotransmitters and neuropeptides is indispensable for effective immunity and tissue homeostasis. Depending on the tissue microenvironment and distinct drivers of a certain immune response, the same neuronal populations and neuro-mediators can exert opposing effects, promoting or inhibiting tissue immunity. Here, we review the current understanding of the mechanisms that underlie the complex interactions between the immune and the nervous systems in different tissues and contexts. We outline current gaps in knowledge and argue for the importance of considering infectious and inflammatory disease within a conceptual framework that integrates neuro-immune circuits both local and systemic, so as to better understand effective immunity to develop improved approaches to treat inflammation and disease.	[Chu, Coco; Artis, David] Cornell Univ, Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Artis, David] Cornell Univ, Joan & Sanford I Weill Dept Med, Friedman Ctr Nutr & Inflammat, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA; [Chiu, Isaac M.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Cornell University; Cornell University; Harvard University; Harvard Medical School	Artis, D (corresponding author), Cornell Univ, Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.; Artis, D (corresponding author), Cornell Univ, Joan & Sanford I Weill Dept Med, Friedman Ctr Nutr & Inflammat, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA.; Chiu, IM (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	dartis@med.cornell.edu; isaac_chiu@hms.harvard.edu	Chu, Coco/HGC-0804-2022	Chu, Coco/0000-0002-5466-7252; Artis, David/0000-0002-1753-4100	National Institutes of Health [DP2AT009499, R01AI130019, AI074878, AI095466, AI095608, AI102942]; Burroughs Wellcome Fund; Crohn's and Colitis Foundation; Rosanne H. Silbermann Family Foundation; GSK; Chan-Zuckerberg Initiative; Allergan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's and Colitis Foundation; Rosanne H. Silbermann Family Foundation; GSK(GlaxoSmithKline); Chan-Zuckerberg Initiative; Allergan(AbbVieAllergan)	We thank the members of the Artis lab and the Chiu lab for critical reading of the manuscript. Research in the Artis lab is supported by the National Institutes of Health (AI074878, AI095466, AI095608, and AI102942), the Burroughs Wellcome Fund, the Crohn's and Colitis Foundation, and the Rosanne H. Silbermann Family Foundation. Research in the Chiu lab is supported by the National Institutes of Health (DP2AT009499, R01AI130019), sponsored research support from GSK and Allergan, the Burroughs Wellcome Fund, and the Chan-Zuckerberg Initiative.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Baral P, 2019, NAT REV IMMUNOL, V19, P433, DOI 10.1038/s41577-019-0147-2; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Blake KJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02448-6; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bruchfeld A, 2010, J INTERN MED, V268, P94, DOI 10.1111/j.1365-2796.2010.02226.x; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Furness JB, 2016, ADV EXP MED BIOL, V891, P159, DOI 10.1007/978-3-319-27592-5_16; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Godinho-Silva C, 2019, NATURE, V574, P254, DOI 10.1038/s41586-019-1579-3; Godinho-Silva C, 2019, ANNU REV IMMUNOL, V37, P19, DOI 10.1146/annurev-immunol-042718-041812; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Huh J.R., 2019, NAT REV IMMUNOL, DOI [10.1038/s41577-019-0247-z, DOI 10.1038/S41577-019-0247-Z.]; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Jarret A, 2020, CELL, V180, P50, DOI 10.1016/j.cell.2019.12.016; Jocken JWE, 2008, PHYSIOL BEHAV, V94, P219, DOI 10.1016/j.physbeh.2008.01.002; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Klose CSN, 2019, CURR OPIN IMMUNOL, V56, P94, DOI 10.1016/j.coi.2018.11.002; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Labed SA, 2018, IMMUNITY, V48, P963, DOI 10.1016/j.immuni.2018.04.017; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Levine YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104530; LIND CD, 1991, GASTROENTEROL CLIN N, V20, P279; LINDGREN S, 1993, SCAND J GASTROENTERO, V28, P638, DOI 10.3109/00365529309096103; Makhijani K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15990; Maruyama K, 2018, ISCIENCE, V6, P306, DOI 10.1016/j.isci.2018.08.007; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pahwa R, 2020, STATPEARLS; Pavlov VA, 2018, ANNU REV IMMUNOL, V36, P783, DOI 10.1146/annurev-immunol-042617-053158; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rochlitzer S, 2011, CLIN EXP ALLERGY, V41, P1609, DOI 10.1111/j.1365-2222.2011.03822.x; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rose N.R., 2019, AUTOIMMUNE DIS; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Sepahi A, 2019, P NATL ACAD SCI USA, V116, P12428, DOI 10.1073/pnas.1900083116; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tarnawski L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02648; Teng F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1215; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Umans BD, 2018, TRENDS NEUROSCI, V41, P911, DOI 10.1016/j.tins.2018.07.008; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang QL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay7501; Wani K.A., 2019, CURR OPIN NEUROBIOL, V62, P1; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Xu HP, 2019, IMMUNITY, V51, P696, DOI 10.1016/j.immuni.2019.09.004; Zanos TP, 2018, P NATL ACAD SCI USA, V115, pE4843, DOI 10.1073/pnas.1719083115; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700; [No title captured]; [No title captured]	96	79	80	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					464	474		10.1016/j.immuni.2020.02.017	http://dx.doi.org/10.1016/j.immuni.2020.02.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187517	Bronze			2022-12-18	WOS:000520600200009
J	Liu, XY; Nemeth, DP; McKim, DB; Zhu, L; DiSabato, DJ; Berdysz, O; Gorantla, G; Oliver, B; Witcher, KG; Wang, YF; Negray, CE; Vegesna, RS; Sheridan, JF; Godbout, JP; Robson, MJ; Blakely, RD; Popovich, PG; Bilbo, SD; Quan, N				Liu, Xiaoyu; Nemeth, Daniel P.; McKim, Daniel B.; Zhu, Ling; DiSabato, Damon J.; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G.; Wang, Yufen; Negray, Christina E.; Vegesna, Rekha S.; Sheridan, John F.; Godbout, Jonathan P.; Robson, Matthew J.; Blakely, Randy D.; Popovich, Phillip G.; Bilbo, Staci D.; Quan, Ning			Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities	IMMUNITY			English	Article							INDUCED SICKNESS BEHAVIOR; INFLAMMATORY CYTOKINES; MESSENGER-RNA; RAT-BRAIN; IL-1; EXPRESSION; IL-1-BETA; ACTIVATION; MECHANISMS; DEPRESSION	Interleukin-1 (IL-1) signaling is important for multiple potentially pathogenic processes in the central nervous system (CNS), but the cell-type-specific roles of IL-1 signaling are unclear. We used a genetic knockin reporter system in mice to track and reciprocally delete or express IL-1 receptor 1 (IL-1R1) in specific cell types, including endothelial cells, ventricular cells, peripheral myeloid cells, microglia, astrocytes, and neurons. We found that endothelial IL-1R1 was necessary and sufficient for mediating sickness behavior and drove leukocyte recruitment to the CNS and impaired neurogenesis, whereas ventricular IL-1R1 was critical for monocyte recruitment to the CNS. Although microglia did not express IL1R1, IL-1 stimulation of endothelial cells led to the induction of IL-1 in microglia. Together, these findings describe the structure and functions of the brain's IL-1R1-expressing system and lay a foundation for the dissection and identification of IL-1R1 signaling pathways in the pathogenesis of CNS diseases.	[Liu, Xiaoyu; Nemeth, Daniel P.; McKim, Daniel B.; DiSabato, Damon J.; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G.; Wang, Yufen; Negray, Christina E.; Vegesna, Rekha S.; Sheridan, John F.; Godbout, Jonathan P.; Quan, Ning] Ohio State Univ, Coll Med, Inst Behav Med Res, Columbus, OH 43210 USA; [Nemeth, Daniel P.; DiSabato, Damon J.; Wang, Yufen; Sheridan, John F.; Quan, Ning] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [McKim, Daniel B.; DiSabato, Damon J.; Witcher, Kristina G.; Sheridan, John F.; Godbout, Jonathan P.; Popovich, Phillip G.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [McKim, Daniel B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Zhu, Ling] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Sichuan, Peoples R China; [Godbout, Jonathan P.; Popovich, Phillip G.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Wexner Med Ctr, Columbus, OH 43210 USA; [Robson, Matthew J.] Univ Cincinnati, James L Winkle Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA; [Blakely, Randy D.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Jupiter, FL 33458 USA; [Blakely, Randy D.] Florida Atlantic Univ, Brain Inst, Jupiter, FL 33458 USA; [Bilbo, Staci D.] Harvard Med Sch, Lurie Ctr Autism, Massachusetts Gen Hosp Children, Pediat & Neurosci, Boston, MA 02126 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; Sichuan University; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; Harvard University; Harvard Medical School	Quan, N (corresponding author), Ohio State Univ, Coll Med, Inst Behav Med Res, Columbus, OH 43210 USA.; Quan, N (corresponding author), Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA.	quan.14@osu.edu		Nemeth, Daniel/0000-0002-0693-343X; Liu, Xiaoyu/0000-0002-4971-0164	National Institute of Mental Health [R01-MH-109165]; National Institute of Dental and Craniofacial Research training grant [2T32DE01432016]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109165] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research training grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Institute of Mental Health grant R01-MH-109165 to N.Q. and National Institute of Dental and Craniofacial Research training grant 2T32DE01432016 to D.J.D. We gratefully acknowledge the contribution of Tamara N. Kolli for help with in situ hybridization.	Aguliar-Valles A, 2014, MOL PSYCHIATR, V19, P599, DOI 10.1038/mp.2013.137; An Y, 2014, J NEUROSCI RES, V92, P486, DOI 10.1002/jnr.23317; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bluthe RM, 2000, EUR J NEUROSCI, V12, P4447, DOI 10.1046/j.1460-9568.2000.01348.x; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Chen Q, 2009, J BIOL CHEM, V284, P8694, DOI 10.1074/jbc.M808261200; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Ching S, 2005, BRAIN BEHAV IMMUN, V19, P127, DOI 10.1016/j.bbi.2004.06.001; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; CUNNINGHAM ET, 1993, IMMUNOL TODAY, V14, P171; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davis CN, 2006, J NEUROCHEM, V98, P1379, DOI 10.1111/j.1471-4159.2006.03951.x; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; Eyre HA, 2015, JAMA PSYCHIAT, V72, P511, DOI 10.1001/jamapsychiatry.2014.3128; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; French RA, 1999, J NEUROIMMUNOL, V93, P194, DOI 10.1016/S0165-5728(98)00224-0; Huang YY, 2011, J NEUROSCI, V31, P18048, DOI 10.1523/JNEUROSCI.4067-11.2011; Hutson LW, 2017, BRAIN BEHAV IMMUN, V62, P171, DOI 10.1016/j.bbi.2017.01.017; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Khairova RA, 2009, INT J NEUROPSYCHOPH, V12, P561, DOI 10.1017/S1461145709009924; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Konsman JP, 2004, J COMP NEUROL, V472, P113, DOI 10.1002/cne.20052; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, CURR OPIN INVEST DR, V10, P664; Krasnow SM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0908-4; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Liu XY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00008; Liu XY, 2016, BRAIN BEHAV IMMUN, V54, P140, DOI 10.1016/j.bbi.2016.01.018; Liu XY, 2015, J NEUROSCI, V35, P2860, DOI 10.1523/JNEUROSCI.3199-14.2015; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; Monif M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0621-8; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pare A, 2017, BRAIN BEHAV IMMUN, V62, P1, DOI 10.1016/j.bbi.2016.07.146; Parker LC, 2002, BRIT J PHARMACOL, V136, P312, DOI 10.1038/sj.bjp.0704715; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Proescholdt MG, 2002, NEUROSCIENCE, V112, P731, DOI 10.1016/S0306-4522(02)00048-9; Quan N, 2008, MOL NEUROBIOL, V37, P142, DOI 10.1007/s12035-008-8026-z; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Robson MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150068; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; TOBLER I, 1984, EUR J PHARMACOL, V104, P191, DOI 10.1016/0014-2999(84)90391-1; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Wingren AG, 1996, CELL IMMUNOL, V169, P226, DOI 10.1006/cimm.1996.0113; Wu MD, 2013, BRAIN BEHAV IMMUN, V32, P9, DOI 10.1016/j.bbi.2013.03.003; YABUUCHI K, 1994, MOL BRAIN RES, V27, P27, DOI 10.1016/0169-328X(94)90180-5; Zhu CB, 2010, NEUROPSYCHOPHARMACOL, V35, P2510, DOI 10.1038/npp.2010.116	56	79	80	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					317	+		10.1016/j.immuni.2018.12.012	http://dx.doi.org/10.1016/j.immuni.2018.12.012			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30893590	Bronze, Green Accepted			2022-12-18	WOS:000459006700009
J	Glasner, A; Levi, A; Enk, J; Isaacson, B; Viukov, S; Orlanski, S; Scope, A; Neuman, T; Enk, CD; Hanna, JH; Sexl, V; Jonjic, S; Seliger, B; Zitvogel, L; Mandelboim, O				Glasner, Ariella; Levi, Assi; Enk, Jonatan; Isaacson, Batya; Viukov, Sergey; Orlanski, Shari; Scope, Alon; Neuman, Tzahi; Enk, Claes D.; Hanna, Jacob H.; Sexl, Veronika; Jonjic, Stipan; Seliger, Barbara; Zitvogel, Laurence; Mandelboim, Ofer			NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis	IMMUNITY			English	Article							IN-VIVO; NK CELLS; INFLUENZA INFECTION; MELANOMA; RECOGNITION; CANCER; GENE; NEURAMINIDASE; CYTOTOXICITY; PROGRESSION	Natural killer (NK) cells are innate lymphoid cells, and their presence within human tumors correlates with better prognosis. However, the mechanisms by which NK cells control tumors in vivo are unclear. Here, we used reflectance confocal microscopy (RCM) imaging in humans and in mice to visualize tumor architecture in vivo. We demonstrated that signaling via the NK cell receptor NKp46 (human) and Ncr1 (mouse) induced interferon-gamma (IFN-gamma) secretion from intratumoral NK cells. NKp46-and Ncr1-mediated IFN-gamma production led to the increased expression of the extracellular matrix protein fibronectin 1 (FN1) in the tumors, which altered primary tumor architecture and resulted in decreased metastases formation. Injection of IFN-gamma into tumor-bearing mice or transgenic overexpression of Ncr1 in NK cells in mice resulted in decreased metastasis formation. Thus, we have defined a mechanism of NK cell-mediated control of metastases in vivo that may help develop NK cell-dependent cancer therapies.	[Glasner, Ariella; Enk, Jonatan; Isaacson, Batya; Mandelboim, Ofer] Hebrew Univ Jerusalem, Dept Immunol & Canc Res, Lautenberg Ctr Gen & Tumor Immunol, IMRIC,Med Sch,Fac Med, Jerusalem, Israel; [Levi, Assi] Rabin Med Ctr, Dept Dermatol, Photodermatosis Clin, Petah Tiqwa, Israel; [Levi, Assi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Viukov, Sergey; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel; [Orlanski, Shari] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Med Sch, Jerusalem, Israel; [Scope, Alon] Tel Aviv Univ, Med Screening Inst, Sheba Med Ctr, Tel Aviv, Israel; [Scope, Alon] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Neuman, Tzahi] Hebrew Univ Jerusalem, Dept Pathol, Hadassah Med Org, Med Ctr, Jerusalem, Israel; [Enk, Claes D.] Hadassah Hebrew Univ, Dept Dermatol, Med Sch, Jerusalem, Israel; [Sexl, Veronika] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria; [Jonjic, Stipan] Univ Rijeka, Dept Histol, Fac Med, Rijeka, Croatia; [Jonjic, Stipan] Univ Rijeka, Embryol Ctr Prot, Fac Med, Rijeka, Croatia; [Seliger, Barbara] Martin Luther Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Germany; [Zitvogel, Laurence] Univ Paris Saclay, Ctr Clin Invest, Gustave Roussy Canc Campus, Villejuif Grand Paris, France; [Zitvogel, Laurence] Univ Paris Saclay, INSERM U1015, Gustave Roussy Canc Campus, Villejuif Grand Paris, France	Hebrew University of Jerusalem; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Veterinary Medicine Vienna; University of Rijeka; University of Rijeka; Martin Luther University Halle Wittenberg; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Dept Immunol & Canc Res, Lautenberg Ctr Gen & Tumor Immunol, IMRIC,Med Sch,Fac Med, Jerusalem, Israel.	oferm@ekmd.huji.ac.il	Glasner, Ari/HHC-5411-2022; Hanna, Jacob/K-1339-2012; Jonjic, Stipan/C-5657-2016; levi, assi/AAM-1613-2021	Hanna, Jacob/0000-0003-2042-9974; Jonjic, Stipan/0000-0001-5003-3108; Mandelboim, Ofer/0000-0002-9354-1855; Seliger, Barbara/0000-0002-5544-4958; ZITVOGEL, laurence/0000-0003-1596-0998	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant [320473-BacNK]; Hebrew University; Hadassah Medical Center; PLBIO INCA; Cancer Aid grants [31113557, 34102500]; ICRF professorship grant; Israel Science Foundation; GIF foundation; Rosetrees Trust; Helmhultz foundation;  [SFB-61];  [GRK1591]	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant(European Research Council (ERC)); Hebrew University; Hadassah Medical Center; PLBIO INCA; Cancer Aid grants; ICRF professorship grant; Israel Science Foundation(Israel Science Foundation); GIF foundation(German-Israeli Foundation for Scientific Research and Development); Rosetrees Trust(Rosetrees Trust); Helmhultz foundation; ; 	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement number 320473-BacNK. Further support came from the Israel Science Foundation, the GIF foundation (to O.M. and B.S.), the ICRF professorship grant, the Helmhultz foundation, and the Rosetrees Trust (all to O.M.). O.M. is a Crown Professor of Molecular Immunology. A. G. and A.L. were supported by a grant from the joint research fund of the Hebrew University and Hadassah Medical Center. J.H.H. is a New York Stem Cell Foundation (NYSCF)-Robertson Investigator. V.S. is supported by SFB-61. L.Z. is supported by PLBIO INCA 2016. B.S. is supported by the GRK1591 grant and the Cancer Aid grants #31113557 and #34102500.	Arnold M, 2014, J EUR ACAD DERMATOL, V28, P1170, DOI 10.1111/jdv.12236; Bar-On Y, 2014, J INFECT DIS, V210, P410, DOI 10.1093/infdis/jiu094; Bar-On Y, 2013, CELL REP, V3, P1044, DOI 10.1016/j.celrep.2013.03.034; Breunis WB, 2008, J IMMUNOTHER, V31, P586, DOI 10.1097/CJI.0b013e31817fd8f3; Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601; Chernyavskiy O, 2009, MICROSC RES TECHNIQ, V72, P411, DOI 10.1002/jemt.20687; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Degenhardt Y, 2010, GENE CHROMOSOME CANC, V49, P144, DOI 10.1002/gcc.20728; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Desbois M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00395; Diab M, 2017, EUR J IMMUNOL, V47, P692, DOI 10.1002/eji.201646756; Diab M, 2016, ONCOTARGET, V7, P66468, DOI 10.18632/oncotarget.11979; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; EISENBACH L, 1983, J CELL BIOL, V97, P1412, DOI 10.1083/jcb.97.5.1412; Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fuertes MB, 2008, J IMMUNOL, V180, P4606, DOI 10.4049/jimmunol.180.7.4606; Garber K, 2016, NAT BIOTECHNOL, V34, P219, DOI 10.1038/nbt0316-219; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Ghadially H, 2014, CELL REP, V7, P1809, DOI 10.1016/j.celrep.2014.05.011; Ghadially H, 2013, EUR J IMMUNOL, V43, P3006, DOI 10.1002/eji.201343388; Glasner A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12998-w; Glasner A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.36; Glasner A, 2015, J IMMUNOL, V195, P3959, DOI 10.4049/jimmunol.1501234; Glasner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036837; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Gur C, 2013, CELL HOST MICROBE, V14, P664, DOI 10.1016/j.chom.2013.11.004; Gur C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074033; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Guy GP, 2011, PHARMACOECONOMICS, V29, P863, DOI 10.2165/11589300-000000000-00000; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li YY, 2005, J INVEST DERMATOL, V125, P798, DOI 10.1111/j.0022-202X.2005.23786.x; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Parakh S, 2017, BRIT J CANCER, V116, P1558, DOI 10.1038/bjc.2017.142; Park J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3394301; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; PORGADOR A, 1989, J IMMUNOGENET, V16, P291; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Seidel E, 2012, CELL MOL LIFE SCI, V69, P3911, DOI 10.1007/s00018-012-1001-x; Sengupta S, 2010, NEOPLASIA, V12, P837, DOI 10.1593/neo.10662; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Vitenshtein A, 2016, CELL HOST MICROBE, V20, P527, DOI 10.1016/j.chom.2016.09.008; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wisco OJ, 2012, DERMATOL CLIN, V30, P469, DOI 10.1016/j.det.2012.04.008; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	61	79	81	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					107	+		10.1016/j.immuni.2017.12.007	http://dx.doi.org/10.1016/j.immuni.2017.12.007			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29329948	Bronze			2022-12-18	WOS:000422751600014
J	Oh, KS; Patel, H; Gottschalk, RA; Lee, WS; Baek, S; Fraser, IDC; Hager, GL; Sung, MH				Oh, Kyu-Seon; Patel, Heta; Gottschalk, Rachel A.; Lee, Wai Shing; Baek, Songjoon; Fraser, Iain D. C.; Hager, Gordon L.; Sung, Myong-Hee			Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action	IMMUNITY			English	Article							SOLUBLE P-SELECTIN; KAPPA-B; PAPA SYNDROME; INFLAMMATORY RESPONSES; REGULATORY ELEMENTS; DNA-BINDING; MACROPHAGE; CLEC5A; ACCESSIBILITY; ARCHITECTURE	Despite the widespread use of glucocorticoids (GCs), their anti-inflammatory effects are not understood mechanistically. Numerous investigations have examined the effects of glucocorticoid receptor (GR) activation prior to inflammatory challenges. However, clinical situations are emulated by a GC intervention initiated in the midst of rampant inflammatory responses. To characterize the effects of a late GC treatment, we profiled macrophage transcriptional and chromatinscapes with Dexamethasone (Dex) treatment before or after stimulation by lipopolysaccharide (LPS). The late activation of GR had a similar gene-expression profile as from GR pre-activation, while ameliorating the disruption of metabolic genes. Chromatin occupancy of GR was not predictive of Dex-regulated gene expression, contradicting the "trans-repression by tethering'' model. Rather, GR activation resulted in genome-wide blockade of NF-kappa B interaction with chromatin and directly induced inhibitors of NF-kappa B and AP-1. Our investigation using GC treatments with clinically relevant timing highlights mechanisms underlying GR actions for modulating the "inflamed epigenome.''	[Oh, Kyu-Seon; Patel, Heta; Gottschalk, Rachel A.; Lee, Wai Shing; Baek, Songjoon; Fraser, Iain D. C.; Hager, Gordon L.; Sung, Myong-Hee] Natl Inst Aging, Natl Inst Hlth, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Lee, Wai Shing; Hager, Gordon L.; Sung, Myong-Hee] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Lab Syst Biol, Bethesda, MD 20892 USA; [Gottschalk, Rachel A.; Hager, Gordon L.] Natl Canc Inst, Natl Inst Hlth, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sung, MH (corresponding author), Natl Inst Aging, Natl Inst Hlth, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA.	sungm@mail.nih.gov	Fraser, Iain DC/L-4735-2017; Sung, Myong-Hee/AAC-7316-2020	Fraser, Iain DC/0000-0003-2272-3907; Sung, Myong-Hee/0000-0002-9739-8558; Patel, Heta/0000-0002-1618-951X	National Institutes of Health Intramural Research Program at the National Cancer Institute, National Institute of Allergy and Infectious Diseases; National Institute on Aging; NATIONAL CANCER INSTITUTE [ZIABC010027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001106, ZIAAI001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000390] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program at the National Cancer Institute, National Institute of Allergy and Infectious Diseases; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lars Grontved, R. Louis Schiltz, and Erik Martin for technical help and Sohyoung Kim for handling shipment and tracking of all the chromatin and RNA samples. All high throughput sequencing was performed at the NCI Center for Cancer Research sequencing facility, Frederick, Maryland. We thank Diego Presman, Ville Paakinaho, and members of the Sung laboratory for critical reading of the manuscript. This research was supported by the National Institutes of Health Intramural Research Program at the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and the National Institute on Aging.	Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Baek S, 2016, METHODS MOL BIOL, V1418, P225, DOI 10.1007/978-1-4939-3578-9_12; Baek S, 2012, METHODS MOL BIOL, V833, P433, DOI 10.1007/978-1-61779-477-3_26; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Chinenov Y, 2012, P NATL ACAD SCI USA, V109, P11776, DOI 10.1073/pnas.1206059109; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gonzalez-Dominguez E, 2015, J LEUKOCYTE BIOL, V98, P453, DOI 10.1189/jlb.3HI1114-531R; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hakim O, 2013, GENOME RES, V23, P462, DOI 10.1101/gr.147652.112; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Hui WL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/248492; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Miranda TB, 2013, CANCER RES, V73, P5130, DOI 10.1158/0008-5472.CAN-13-0742; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; Presman DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001813; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Smith EJ, 2010, CURR GENOMICS, V11, P519, DOI 10.2174/138920210793175921; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Sung MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004764; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weiss JM, 2016, ONCOTARGET, V7, P7550, DOI 10.18632/oncotarget.6885; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Woollard KJ, 2008, CIRC RES, V103, P1128, DOI 10.1161/CIRCRESAHA.108.180273; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Zeeli T, 2015, CLIN EXP DERMATOL, V40, P367, DOI 10.1111/ced.12585	50	79	82	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					298	+		10.1016/j.immuni.2017.07.012	http://dx.doi.org/10.1016/j.immuni.2017.07.012			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28801231	Bronze, Green Accepted			2022-12-18	WOS:000407788300015
J	Hess, C; Kemper, C				Hess, Christoph; Kemper, Claudia			Complement-Mediated Regulation of Metabolism and Basic Cellular Processes	IMMUNITY			English	Review							NLRP3 INFLAMMASOME ACTIVATION; ADIPOSE-TISSUE INFLAMMATION; TOLL-LIKE RECEPTORS; CD4(+) T-CELLS; INSULIN-RESISTANCE; GLYCOLYTIC SWITCH; INDUCED APOPTOSIS; HUMAN MONOCYTES; INDUCED INJURY; GLUCOSE-UPTAKE	Complement is well appreciated as a critical arm of innate immunity. It is required for the removal of invading pathogens and works by directly destroying them through the activation of innate and adaptive immune cells. However, complement activation and function is not confined to the extracellular space but also occurs within cells. Recent work indicates that complement activation regulates key metabolic pathways and thus can impact fundamental cellular processes, such as survival, proliferation, and autophagy. Newly identified functions of complement include a key role in shaping metabolic reprogramming, which underlies T cell effector differentiation, and a role as a nexus for interactions with other effector systems, in particular the inflammasome and Notch transcription-factor networks. This review focuses on the contributions of complement to basic processes of the cell, in particular the integration of complement with cellular metabolism and the potential implications in infection and other disease settings.	[Hess, Christoph] Univ Basel, Dept Biomed, Immunobiol, 20 Hebelstr, CH-4031 Basel, Switzerland; [Kemper, Claudia] Kings Coll London, Guys Hosp, Div Transplant Immunol & Mucosal Biol, Med Res Council,Ctr Transplantat, London SE1 9RT, England; [Kemper, Claudia] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Kemper, Claudia] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA	University of Basel; Guy's & St Thomas' NHS Foundation Trust; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hess, C (corresponding author), Univ Basel, Dept Biomed, Immunobiol, 20 Hebelstr, CH-4031 Basel, Switzerland.; Kemper, C (corresponding author), Kings Coll London, Guys Hosp, Div Transplant Immunol & Mucosal Biol, Med Res Council,Ctr Transplantat, London SE1 9RT, England.; Kemper, C (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.; Kemper, C (corresponding author), NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA.	chess@uhbs.ch; claudia.kemper@kcl.ac.uk		Kemper, Claudia/0000-0003-4196-1417	MRC Centre grant [MR/J006742/1]; EU-funded Innovative Medicines Initiative BTCURE; Wellcome Trust Investigator Award; King's Bioscience Institute at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Division of Intramural Research of the National Heart, Lung, and Blood Institute at the NIH; intramural research program of NIAID, NIH; Swiss National Science Foundation [310030_154059, CRSII_160766]; Gebert-Ruf Foundation [GER-058/14]; Swiss Cancer League [KFS-3773-08-2015]; Medical Research Council [MR/J006742/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006223] Funding Source: NIH RePORTER	MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-funded Innovative Medicines Initiative BTCURE; Wellcome Trust Investigator Award(Wellcome Trust); King's Bioscience Institute at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Division of Intramural Research of the National Heart, Lung, and Blood Institute at the NIH; intramural research program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert-Ruf Foundation; Swiss Cancer League; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work in the Hess and Kemper laboratories is supported by MRC Centre grant MR/J006742/1, an EU-funded Innovative Medicines Initiative BTCURE (C.K.), a Wellcome Trust Investigator Award (C.K.), the King's Bioscience Institute at King's College London (G.A.), the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, the Division of Intramural Research of the National Heart, Lung, and Blood Institute at the NIH, the intramural research program of NIAID, NIH, the Swiss National Science Foundation (310030_154059 and CRSII_160766) (C.H.), the Gebert-Ruf Foundation (GER-058/14), and the Swiss Cancer League (KFS-3773-08-2015).	Alexander JJ, 2005, J IMMUNOL, V175, P8312, DOI 10.4049/jimmunol.175.12.8312; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Amsen D, 2015, TRENDS IMMUNOL, V36, P802, DOI 10.1016/j.it.2015.10.007; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Baudino L, 2014, P NATL ACAD SCI USA, V111, P1503, DOI 10.1073/pnas.1316877111; Bloomfield PS, 2016, AM J PSYCHIAT, V173, P44, DOI 10.1176/appi.ajp.2015.14101358; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bordet J., 1909, STUDIES IMMUNITY COL; Bosmann M, 2012, J IMMUNOL, V188, P5086, DOI 10.4049/jimmunol.1102914; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; CIANFLONE K, 1988, CLIN INVEST MED, V11, P99; CIANFLONE KM, 1990, J CLIN INVEST, V85, P722, DOI 10.1172/JCI114497; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Coll RC, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.19; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Croker D.E., 2016, IMMUNOL CELL BIOL; Cudrici C, 2006, J IMMUNOL, V176, P3173, DOI 10.4049/jimmunol.176.5.3173; Cui W, 2007, AM J PHYSIOL-ENDOC M, V293, pE1482, DOI 10.1152/ajpendo.00565.2006; Cumpelik A, 2016, ANN RHEUM DIS, V75, P1236, DOI 10.1136/annrheumdis-2015-207338; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Gassart A, 2015, IMMUNITY, V43, P835, DOI 10.1016/j.immuni.2015.10.024; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Faraj M, 2004, J LIPID RES, V45, P657, DOI 10.1194/jlr.M300299-JLR200; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fico A, 2004, CELL DEATH DIFFER, V11, P823, DOI 10.1038/sj.cdd.4401420; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hsia CCW, 2013, COMPR PHYSIOL, V3, P849, DOI 10.1002/cphy.c120003; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Ingersoll SA, 2010, MOL IMMUNOL, V48, P219, DOI 10.1016/j.molimm.2010.08.007; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; KATZ Y, 1994, EUR J IMMUNOL, V24, P1517, DOI 10.1002/eji.1830240709; Keating GM, 2013, DRUGS, V73, P2053, DOI 10.1007/s40265-013-0147-7; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krus U, 2014, CELL METAB, V19, P883, DOI 10.1016/j.cmet.2014.03.001; Kurihara R, 2010, INFLAMM RES, V59, P659, DOI 10.1007/s00011-010-0178-4; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Le Friec G, 2009, ARCH IMMUNOL THER EX, V57, P393, DOI 10.1007/s00005-009-0047-4; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Li K, 2012, IMMUNOBIOLOGY, V217, P65, DOI 10.1016/j.imbio.2011.07.033; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo Y, 2005, J IMMUNOL, V174, P7226, DOI 10.4049/jimmunol.174.11.7226; Lv QY, 2016, EXP CELL RES, V341, P132, DOI 10.1016/j.yexcr.2016.02.009; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Macor P, 2007, IMMUNOL LETT, V111, P6, DOI 10.1016/j.imlet.2007.04.014; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Niyonzima N, 2015, J IMMUNOL, V195, P257, DOI 10.4049/jimmunol.1403044; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Okroj M, 2013, CANCER TREAT REV, V39, P632, DOI 10.1016/j.ctrv.2012.10.008; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Pavlovski D, 2012, FASEB J, V26, P3680, DOI 10.1096/fj.11-202382; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Perez-Alcazar M, 2014, EXP NEUROL, V253, P154, DOI 10.1016/j.expneurol.2013.12.013; Phieler J, 2013, J IMMUNOL, V191, P4367, DOI 10.4049/jimmunol.1300038; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Richardson VR, 2013, IMMUNOBIOLOGY, V218, P1497, DOI 10.1016/j.imbio.2013.05.002; Richetta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003599; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Roy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057494; Rus HG, 2001, IMMUNOL REV, V180, P49, DOI 10.1034/j.1600-065X.2001.1800104.x; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Schejbel L, 2013, IMMUNOBIOLOGY, V218, P1304, DOI 10.1016/j.imbio.2013.04.021; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Slaninova V, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150155; Soane L, 1999, J IMMUNOL, V163, P6132; Song WC, 2012, TOXICOL PATHOL, V40, P174, DOI 10.1177/0192623311428478; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Sullivan Kathleen E., 1998, Current Opinion in Pediatrics, V10, P600; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tam JCH, 2014, SCIENCE, V345, P1134, DOI 10.1126/science.1256070; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Triantafilou M, 2016, IMMUNOLOGY, V147, P152, DOI 10.1111/imm.12556; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang YT, 2012, IMMUNOLOGY, V136, P78, DOI 10.1111/j.1365-2567.2012.03561.x; Wang Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-24; WARBURG O, 1956, SCIENCE, V124, P269; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wiens M, 2007, MOL BIOL EVOL, V24, P792, DOI 10.1093/molbev/msl208; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xu J, 2015, ONCOTARGET, V6, P19942, DOI 10.18632/oncotarget.4651; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Yamamoto H, 2013, INT J BIOCHEM CELL B, V45, P2808, DOI 10.1016/j.biocel.2013.09.016; Yuen B, 2014, MOL BIOL EVOL, V31, P106, DOI 10.1093/molbev/mst174; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Ziporen L, 2009, J IMMUNOL, V182, P515, DOI 10.4049/jimmunol.182.1.515; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	150	79	81	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					240	254		10.1016/j.immuni.2016.08.003	http://dx.doi.org/10.1016/j.immuni.2016.08.003			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533012	Green Accepted, Bronze			2022-12-18	WOS:000382267300008
J	de Almeida, L; Khare, S; Misharin, AV; Patel, R; Ratsimandresy, RA; Wallin, MC; Perlman, H; Greaves, DR; Hoffman, HM; Dorfleutner, A; Stehlik, C				de Almeida, Lucia; Khare, Sonal; Misharin, Alexander V.; Patel, Rajul; Ratsimandresy, Rojo A.; Wallin, Melissa C.; Perlman, Harris; Greaves, David R.; Hoffman, Hal M.; Dorfleutner, Andrea; Stehlik, Christian			The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease	IMMUNITY			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME; ADAPTER ASC; ACTIVATION; HMGB1; EXPRESSION; DEUBIQUITINATION; TRANSDUCTION; RECOGNITION; RECRUITMENT	In response to infections and tissue damage, ASC-containing inflammasome protein complexes are assembled that promote caspase-1 activation, IL-1 beta and IL-18 processing and release, pyroptosis, and the release of ASC particles. However, excessive or persistent activation of the inflammasome causes inflammatory diseases. Therefore, a well-balanced inflammasome response is crucial for the maintenance of homeostasis. We show that the PYD-only protein POP1 inhibited ASC-dependent inflammasome assembly by preventing inflammasome nucleation, and consequently interfered with caspase-1 activation, IL-1 beta and IL-18 release, pyroptosis, and the release of ASC particles. There is no mouse ortholog for POP1, but transgenic expression of human POP1 in monocytes, macrophages, and dendritic cells protected mice from systemic inflammation triggered by molecular PAMPs, inflammasome component NLRP3 mutation, and ASC danger particles. POP1 expression was regulated by TLR and IL-1R signaling, and we propose that POP1 provides a regulatory feedback loop that shuts down excessive inflammatory responses and thereby prevents systemic inflammation.	[de Almeida, Lucia; Khare, Sonal; Misharin, Alexander V.; Patel, Rajul; Ratsimandresy, Rojo A.; Wallin, Melissa C.; Perlman, Harris; Dorfleutner, Andrea; Stehlik, Christian] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Hoffman, Hal M.] Univ Calif San Diego, Sch Med, Dept Pediat, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Hoffman, Hal M.] Ludwig Inst Canc Res, San Diego Branch, La Jolla, CA 92093 USA; [Stehlik, Christian] Northwestern Univ, Interdept Immunobiol Ctr, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Stehlik, Christian] Northwestern Univ, Feinberg Sch Med, Skin Dis Res Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Oxford; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Dorfleutner, A (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA.	a-dorfleutner@northwestern.edu; c-stehlik@northwestern.edu	Misharin, Alexander/AAD-6456-2019; Stehlik, Christian/AAG-2132-2021; Dorfleutner, Andrea/AAG-5504-2021	Stehlik, Christian/0000-0002-3782-2484; Dorfleutner, Andrea/0000-0003-4406-2986; Greaves, David/0000-0003-2856-9410	NIH [GM071723, HL097183, AI082406, AI099009, AI120625, AR064349, AR057532, AR066739, AR050250, AR054796, AI092490, HL108795, AR061593, AI52430, T32AR007611]; Cancer Center Support Grant [CA060553]; Skin Disease Research Center [AR057216]; American Heart Association [13GRNT17110117, 11POST585000]; ATS/Scleroderma Foundation; British Heart Foundation [RG/10/15/28578]; Solovy/Arthritis Research Society; Northwestern University Transgenic and Targeted Mutagenesis Laboratory; Mouse Histology and Phenotyping Laboratory; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097183, P01HL108795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099009, R21AI082406, R21AI092490, R01AI052430, R01AI120625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057532, K01AR066739, R01AR050250, T32AR007611, R03AR061593, R01AR054796, P30AR057216, R01AR064349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Skin Disease Research Center; American Heart Association(American Heart Association); ATS/Scleroderma Foundation; British Heart Foundation(British Heart Foundation); Solovy/Arthritis Research Society; Northwestern University Transgenic and Targeted Mutagenesis Laboratory; Mouse Histology and Phenotyping Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (GM071723, HL097183, AI092490, AI082406, AI099009, AI120625, and AR064349 to C.S.; AR057532 and AR066739 to A.D.; AR050250, AR054796, AI092490, and HL108795 to H.P.; AR061593 to A.V.M.; and AI52430 to H.M.H.), a Cancer Center Support Grant (CA060553), the Skin Disease Research Center (AR057216), and the American Heart Association (13GRNT17110117) to C.S., an ATS/Scleroderma Foundation Grant to A.V.M., and The British Heart Foundation (RG/10/15/28578) to D.R.G.S.K. was an Arthritis Foundation fellow (AF161715), L.d.A. was supported by the American Heart Association (11POST585000) and the NIH (T32AR007611), and H.P. was supported by funds provided by the Solovy/Arthritis Research Society Professor. Plasmids pMD2.G and psPAX2 were kindly provided by Didier Trono (Ecole Polytechnique Federale de Lausanne), Nlrp3 A350V KI mice by H.M.H. (University of California at San Diego), and Pycard<SUP>-/-</SUP> and Nlrp3<SUP>-/-</SUP> mice by Vishva M. Dixit (Genentech). This work was supported by the Northwestern University Transgenic and Targeted Mutagenesis Laboratory, Mouse Histology and Phenotyping Laboratory, and flow cytometry facility. We thank Dr. C.M. Cuda for support with flow cytometry.	Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chu LH, 2015, APOPTOSIS, V20, P157, DOI 10.1007/s10495-014-1065-1; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Dorfleutner A, 2015, IMMUNOL REV, V265, P205, DOI 10.1111/imr.12290; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Iqbal AJ, 2014, BLOOD, V124, pE33, DOI 10.1182/blood-2014-04-568691; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Khare S, 2010, CRIT REV IMMUNOL, V30, P463, DOI 10.1615/CritRevImmunol.v30.i5.50; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Lin Y.-C., 2015, J LEUKOC BI IN PRESS; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662	55	79	81	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					264	276		10.1016/j.immuni.2015.07.018	http://dx.doi.org/10.1016/j.immuni.2015.07.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26275995	Green Accepted, Bronze			2022-12-18	WOS:000360101200010
J	Carnevale, D; Pallante, F; Fardella, V; Fardella, S; Iacobucci, R; Federici, M; Cifelli, G; De Lucia, M; Lembo, G				Carnevale, Daniela; Pallante, Fabio; Fardella, Valentina; Fardella, Stefania; Iacobucci, Roberta; Federici, Massimo; Cifelli, Giuseppe; De Lucia, Massimiliano; Lembo, Giuseppe			The Angiogenic Factor PlGF Mediates a Neuroimmune Interaction in the Spleen to Allow the Onset of Hypertension	IMMUNITY			English	Article							PLACENTAL GROWTH-FACTOR; II-INDUCED HYPERTENSION; REGULATE BLOOD-PRESSURE; T-CELL COSTIMULATION; TISSUE INHIBITOR; VASCULAR INFLAMMATION; CARDIAC INFLAMMATION; SALT HYPERTENSION; ANGIOTENSIN; ATHEROSCLEROSIS	Hypertension is a health problem affecting over 1 billion people worldwide. How the immune system gets activated under hypertensive stimuli to contribute to blood pressure elevation is a fascinating enigma. Here we showed a splenic role for placental growth factor (PlGF), which accounts for the onset of hypertension, through immune system modulation. PlGF repressed the expression of the protein Timp3 (tissue inhibitor of metalloproteinases 3), through the transcriptional Sirt1-p53 axis. Timp3 repression allowed costimulation of T cells and their deployment toward classical organs involved in hypertension. We showed that the spleen is an essential organ for the development of hypertension through a noradrenergic drive mediated by the celiac ganglion efferent. Overall, we demonstrate that PlGF mediates the neuroimmune interaction in the spleen, organizing a unique and nonredundant response that allows the onset of hypertension.	[Carnevale, Daniela; Pallante, Fabio; Fardella, Valentina; Fardella, Stefania; Iacobucci, Roberta; Cifelli, Giuseppe; De Lucia, Massimiliano; Lembo, Giuseppe] IRCCS Neuromed, Dept Angiocardioneurol & Translat Med, Neuro & Cardiovasc Pathophysiol Res Unit, I-86077 Pozzilli, Italy; [Carnevale, Daniela; Lembo, Giuseppe] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy; [Federici, Massimo] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy	IRCCS Neuromed; Sapienza University Rome; University of Rome Tor Vergata	Lembo, G (corresponding author), IRCCS Neuromed, Dept Angiocardioneurol & Translat Med, Neuro & Cardiovasc Pathophysiol Res Unit, I-86077 Pozzilli, Italy.	lembo@neuromed.it	Pallante, Fabio/AAA-7738-2021; Fardella, Valentina/AAC-7476-2022; Carnevale, Daniela/AAE-6319-2020; Federici, Massimo/G-9940-2012; Lembo, Giuseppe/AAE-8096-2020; De Lucia, Massimiliano/AAA-7372-2021; Fardella, Stefania/AAB-3107-2021; Fardella, Valentina/AAC-3210-2021; Cifelli, Giuseppe/AAB-6938-2019	Fardella, Valentina/0000-0001-5005-3459; Carnevale, Daniela/0000-0002-5016-3161; Federici, Massimo/0000-0003-4989-5194; Lembo, Giuseppe/0000-0002-3510-223X; De Lucia, Massimiliano/0000-0002-3320-9324; Cifelli, Giuseppe/0000-0002-6417-7185	MIUR (Italian Ministry of University and Research) [PON01_00829, PON01_01227]; MOH (Italian Ministry of Health); SIIA (Italian Society of Hypertension); Pasteur Institute - Fondazione Cenci Bolognetti	MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); MOH (Italian Ministry of Health); SIIA (Italian Society of Hypertension); Pasteur Institute - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by the following grants: PON01_00829 and PON01_01227 by MIUR (Italian Ministry of University and Research) to G.L.; "Ricerca corrente" by MOH (Italian Ministry of Health) to G.L.; research grant from SIIA (Italian Society of Hypertension) to G.L.; and Pasteur Institute - Fondazione Cenci Bolognetti to D.C.	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; Carnevale D, 2012, TRENDS CARDIOVAS MED, V22, P209, DOI 10.1016/j.tcm.2012.07.022; Carnevale D, 2012, CARDIOVASC RES, V93, P200, DOI 10.1093/cvr/cvr288; Carnevale D, 2011, CIRCULATION, V124, P1337, DOI 10.1161/CIRCULATIONAHA.111.050500; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Gigante B, 2006, FASEB J, V20, P970, DOI 10.1096/fj.05-4481fje; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Harrison DG, 2013, J AM SOC HYPERTENS, V7, P68, DOI 10.1016/j.jash.2012.11.007; Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Kim S, 2000, PHARMACOL REV, V52, P11; King AJ, 2007, HYPERTENSION, V50, P547, DOI 10.1161/HYPERTENSIONAHA.107.090696; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li HP, 2011, AM J PHYSIOL-REG I, V301, pR1067, DOI 10.1152/ajpregu.00124.2011; Loging WT, 1999, ONCOGENE, V18, P7608, DOI 10.1038/sj.onc.1203135; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Madhur MS, 2012, CIRC RES, V111, P1113, DOI 10.1161/CIRCRESAHA.112.278408; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Pan PX, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-36; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Shao QQ, 2012, BLOOD, V119, P4636, DOI 10.1182/blood-2011-08-376418; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Steinberg G, 2009, THROMB RES, V123, pS93, DOI 10.1016/S0049-3848(09)70020-9; SVENDSEN UG, 1976, ACTA PATH MICRO IM A, V84, P523; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; ZIGMOND RE, 1977, P NATL ACAD SCI USA, V74, P3078, DOI 10.1073/pnas.74.7.3078	41	79	82	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					737	752		10.1016/j.immuni.2014.11.002	http://dx.doi.org/10.1016/j.immuni.2014.11.002			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517614	Bronze			2022-12-18	WOS:000345504900011
J	Stephen, TL; Rutkowski, MR; Allegrezza, MJ; Perales-Puchalt, A; Tesone, AJ; Svoronos, N; Nguyen, JM; Sarmin, F; Borowsky, ME; Tchou, J; Conejo-Garcia, JR				Stephen, Tom L.; Rutkowski, Melanie R.; Allegrezza, Michael J.; Perales-Puchalt, Alfredo; Tesone, Amelia J.; Svoronos, Nikolaos; Nguyen, Jenny M.; Sarmin, Fahmida; Borowsky, Mark E.; Tchou, Julia; Conejo-Garcia, Jose R.			Transforming Growth Factor beta-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression	IMMUNITY			English	Article							TGF-BETA; OVARIAN-CANCER; TUMOR MICROENVIRONMENT; DENDRITIC CELLS; IN-VIVO; C-MYC; EXHAUSTION; TGF-BETA-1; IMMUNOTHERAPY; PROLIFERATION	Tumor-reactive T cells become unresponsive in advanced tumors. Here we have characterized a common mechanism of T cell unresponsiveness in cancer driven by the upregulation of the transcription factor Forkhead box protein P1 (Foxp1), which prevents CD8(+) T cells from proliferating and upregulating Granzyme-B and interferon-gamma in response to tumor antigens. Accordingly, Foxp1-deficient lymphocytes induced rejection of incurable tumors and promoted protection against tumor rechallenge. Mechanistically, Foxp1 interacted with the transcription factors Smad2 and Smad3 in preactivated CD8(+) T cells in response to microenvironmental transforming growth factor-beta (TGF-beta), and was essential for its suppressive activity. Therefore, Smad2 and Smad3mediated c-Myc repression requires Foxp1 expression in T cells. Furthermore, Foxp1 directly mediated TGF-beta-induced c-Jun transcriptional repression, which abrogated T cell activity. Our results unveil a fundamental mechanism of T cell unresponsiveness different from anergy or exhaustion, driven by TGF-beta signaling on tumor-associated lymphocytes undergoing Foxp1-dependent transcriptional regulation.	[Stephen, Tom L.; Rutkowski, Melanie R.; Allegrezza, Michael J.; Perales-Puchalt, Alfredo; Tesone, Amelia J.; Svoronos, Nikolaos; Nguyen, Jenny M.; Sarmin, Fahmida; Conejo-Garcia, Jose R.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Borowsky, Mark E.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Tchou, Julia] Univ Penn, Dept Surg, Div Endocrine & Oncol Surg, Philadelphia, PA 19104 USA; [Tchou, Julia] Univ Penn, Rena Rowan Breast Ctr, Philadelphia, PA 19104 USA; [Tchou, Julia] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA	The Wistar Institute; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Conejo-Garcia, JR (corresponding author), Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	jrconejo@wistar.org	Conejo-Garcia, Jose R/V-1897-2019	Conejo-Garcia, Jose R/0000-0001-6431-4074; PERALES-PUCHALT, ALFREDO/0000-0003-4904-5050; Rutkowski, Melanie/0000-0001-8604-815X; Svoronos, Nikolaos/0000-0003-2556-3793	Cancer Center Support Grant (CCSG) [CA010815]; Breast Cancer Alliance; Ovarian Cancer Research Fund; Fundacion Alfonso Martin Escudero; DoD grant [OC100059];  [R01CA157664];  [R01CA124515];  [R01CA178687];  [U54CA151662];  [P30CA10815];  [T32CA009171]; NATIONAL CANCER INSTITUTE [T32CA009171, P30CA010815, R01CA157664, U54CA151662, R01CA124515, R01CA178687] Funding Source: NIH RePORTER	Cancer Center Support Grant (CCSG); Breast Cancer Alliance; Ovarian Cancer Research Fund; Fundacion Alfonso Martin Escudero; DoD grant; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for Shared Resources utilized in this study was provided by Cancer Center Support Grant (CCSG) CA010815 to The Wistar Institute. We thank H. Wang and H. Hu for providing transgenic models, antibodies, and technical support, and Y. Yashiro-Ohtani (Pear Laboratory) for support with ChIP experiments. This study was supported by R01CA157664, R01CA124515, R01CA178687, U54CA151662, P30CA10815, and awards from the Breast Cancer Alliance (J.T.) and the Ovarian Cancer Research Fund (J.R.C.-G.). M.J.A. was supported by T32CA009171. A.P.-P. was supported by Fundacion Alfonso Martin Escudero. A.J.T. was a nested Teal Scholar in DoD grant OC100059.	Ahmadzadeh M, 2005, J IMMUNOL, V174, P5215, DOI 10.4049/jimmunol.174.9.5215; Baitsch L, 2012, TRENDS IMMUNOL, V33, P364, DOI 10.1016/j.it.2012.02.006; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Cubillos-Ruiz JR, 2012, CANCER RES, V72, P1683, DOI 10.1158/0008-5472.CAN-11-3160; Cubillos-Ruiz JR, 2010, ONCOTARGET, V1, P329, DOI 10.18632/oncotarget.165; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hamilton SE, 2012, TRENDS IMMUNOL, V33, P224, DOI 10.1016/j.it.2012.01.007; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Nesbeth Y, 2009, CANCER RES, V69, P6331, DOI 10.1158/0008-5472.CAN-08-4329; Nesbeth YC, 2010, J IMMUNOL, V184, P5654, DOI 10.4049/jimmunol.0903247; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; Wang W, 2006, CANCER RES, V66, P6826, DOI 10.1158/0008-5472.CAN-05-3529; Watkins SK, 2011, J CLIN INVEST, V121, P1361, DOI 10.1172/JCI44325; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342; Zhu ZQ, 2013, CANCER RES, V73, P595, DOI 10.1158/0008-5472.CAN-12-1123; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	44	79	83	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					427	439		10.1016/j.immuni.2014.08.012	http://dx.doi.org/10.1016/j.immuni.2014.08.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238097	Green Accepted, Bronze			2022-12-18	WOS:000342626500013
J	Reis, BS; van Konijnenburg, DPH; Grivennikov, SI; Mucida, D				Reis, Bernardo S.; van Konijnenburg, David P. Hoytema; Grivennikov, Sergei I.; Mucida, Daniel			Transcription Factor T-bet Regulates Intraepithelial Lymphocyte Functional Maturation	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CELIAC-DISEASE; RETINOIC ACID; CELL FATE; TGF-BETA; DIFFERENTIATION; RESPONSES; CD8-ALPHA-ALPHA; HOMEOSTASIS; ACTIVATION	The intestinal epithelium harbors large populations of activated and memory lymphocytes, yet these cells do not cause tissue damage in the steady state. We investigated how intestinal T cell effector differentiation is regulated upon migration to the intestinal epithelium. Using gene loss-and gain-of-function strategies, as well as reporter approaches, we showed that cooperation between the transcription factors T-bet and Runx3 resulted in suppression of conventional CD4(+) T helper functions and induction of an intraepithelial lymphocyte (IEL) program that included expression of IEL markers such as CD8 alpha alpha homodimers. Interferon-gamma sensing and T-bet expression by CD4(+) T cells were both required for this program, which was distinct from conventional T helper differentiation but shared by other IEL populations, including TCR alpha beta(+)CD8 alpha alpha(+) IELs. We conclude that the gut environment provides cues for IEL maturation through the interplay between T-bet and Runx3, allowing tissue-specific adaptation of mature T lymphocytes.	[Reis, Bernardo S.; van Konijnenburg, David P. Hoytema; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA	Rockefeller University; Fox Chase Cancer Center	Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA.	mucida@rockefeller.edu	van Konijnenburg, David Hoytema/AAN-8626-2021; Grivennikov, Sergei/AAE-7365-2019; Sgarbi Reis, Bernardo/E-3448-2012	van Konijnenburg, David Hoytema/0000-0001-5198-9718; Grivennikov, Sergei/0000-0003-2987-0555; Sgarbi Reis, Bernardo/0000-0002-6841-116X	Ellison Medical Foundation New Scholar Award in Aging; Irma T. Hirschl Award; Crohn's & Colitis Foundation of America Senior Research Award; National Institutes of Health NIH [R01 DK093674-02]; Leona M. and Harry B. Helmsley Charitable Trust; Dutch Digestive Foundation; NIH [R00DK088589]; FCCC-Temple University Nodal grant; Pew Scholar in Biomedical Sciences Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093674, R00DK088589] Funding Source: NIH RePORTER	Ellison Medical Foundation New Scholar Award in Aging; Irma T. Hirschl Award; Crohn's & Colitis Foundation of America Senior Research Award; National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Dutch Digestive Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCCC-Temple University Nodal grant; Pew Scholar in Biomedical Sciences Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to K. Velinzon and Y. Shatalina for sorting cells and members of the Nussenzweig laboratory and The Rockefeller University employees for continuous assistance. We thank L. Glimcher (Cornell) and I. Taniuchi (Riken-RCAI) for vectors and H. Cheroutre (LIAI) for TL-tetramers. We especially thank A. Rogoz for outstanding technical support, Y. Gultenkin for help with in vitro assays, and V. Hou (FCCC) for help with mouse breeding and IL-27R alpha ex vivo analysis. We thank G. Kim (LIAI) and members of our laboratory, particularly V. Pedicord and D. Esterhazy, for discussions, critical reading, and editing of the manuscript. D.M. is supported by an Ellison Medical Foundation New Scholar Award in Aging, an Irma T. Hirschl Award, a Crohn's & Colitis Foundation of America Senior Research Award, and a National Institutes of Health NIH R01 DK093674-02 grant. B.S.R. is supported by the Leona M. and Harry B. Helmsley Charitable Trust. D.P.H.v.K. is supported by the Dutch Digestive Foundation. S.I.G. is supported by a NIH R00DK088589, a FCCC-Temple University Nodal grant, and by the Pew Scholar in Biomedical Sciences Program.	Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; GUYGRAND D, 1991, J EXP MED, V173, P1549, DOI 10.1084/jem.173.6.1549; Huang YJ, 2011, NAT IMMUNOL, V12, P1086, DOI 10.1038/ni.2106; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shi MJ, 1998, J IMMUNOL, V161, P6751; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Troy AE, 2009, J IMMUNOL, V183, P2037, DOI 10.4049/jimmunol.0802918; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	34	79	81	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					244	256		10.1016/j.immuni.2014.06.017	http://dx.doi.org/10.1016/j.immuni.2014.06.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148025	Green Accepted, Bronze			2022-12-18	WOS:000341455300012
J	Nakamura, Y; Franchi, L; Kambe, N; Meng, GX; Strober, W; Nunez, G				Nakamura, Yuumi; Franchi, Luigi; Kambe, Naotomo; Meng, Guangxun; Strober, Warren; Nunez, Gabriel			Critical Role for Mast Cells in Interleukin-1 beta-Driven Skin Inflammation Associated with an Activating Mutation in the NIrp3 Protein	IMMUNITY			English	Article							COLD AUTOINFLAMMATORY SYNDROME; NLRP3 INFLAMMASOME; CIAS1 MUTATIONS; CINCA/NOMID SYNDROME; PATTERN-RECOGNITION; HOST-DEFENSE; SUBSTANCE-P; PYRIN; RECEPTORS; MODEL	Cryopyrin-associated periodic syndromes (CAPS) are caused by aberrant interleukin-1 beta (IL-1 beta) production induced by mutations in the NLRP3 protein in humans, but the mechanisms involved remain poorly understood. Using a mouse model, we show a role for the indigenous microbiota and mast cells (MCs) in skin disease associated with mutant NIrp3 protein. Unlike normal cells, MCs expressing mutant NIrp3 produced IL-1 beta in response to lipopolysaccharide or tumor necrosis factor-alpha (TNF-alpha). In neonatal mice, the microbiota induced TNF-alpha and IL-1 beta and promoted skin disease. MC deficiency greatly reduced disease in NIrp3 mutant mice, and reconstitution of MC-deficient mice with mutant MCs restored skin disease, which required the expression of IL-1 beta in MCs. Surprisingly, neutralization of TNF-alpha abrogated IL-1 beta production and skin disease in neonatal NIrp3 mutant mice, but not in affected adult mice. Thus, the microbiota and MCs initiate cellular events leading to dysregulated IL-1 beta production and skin inflammation in neonatal mice with the CAPS-associated NIrp3 mutation.	[Nakamura, Yuumi; Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nakamura, Yuumi; Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Kambe, Naotomo] Chiba Univ, Grad Sch Med, Dept Dermatol, Chuo Ku, Chiba 2608670, Japan; [Meng, Guangxun] Chinese Acad Sci, Unit Innate Immun, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai,Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Strober, Warren] NIAID, Mucosal Immun Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chiba University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014; Kambe, Naotomo/H-3987-2017; Nakamura, Yuumi/H-8459-2017	Kambe, Naotomo/0000-0001-9610-4952; Nakamura, Yuumi/0000-0001-6256-8302; 孟, 广勋/0000-0002-4253-9675	NIH [R01AR059688, R01AI06331]; University of Michigan's Cancer Center Support Grant; Chiba University Global COE Program; Cell Science Research Foundation; Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, ZIAAI000432, ZIAAI000354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059688] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390280] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center Support Grant; Chiba University Global COE Program; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Koonse for animal husbandry, J. Whitfield for ELISAs, and Y. Iwakura for the generous gift of mice. This work was supported by NIH grants R01AR059688 and R01AI06331, and funds to the Michigan Comprehensive Cancer Center Immunology Monitoring Core from the University of Michigan's Cancer Center Support Grant. Y.N. was supported by fellowships from Chiba University Global COE Program, the Cell Science Research Foundation, and the Kanae Foundation for the Promotion of Medical Science.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Ebrahimi-Fakhari D, 2010, J RHEUMATOL, V37, P2196, DOI 10.3899/jrheum.100290; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Federico G, 2003, SCAND J RHEUMATOL, V32, P312, DOI 10.1080/03009740310003974; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Gunduz Z, 2008, RHEUMATOL INT, V28, P379, DOI 10.1007/s00296-007-0432-4; Hasegawa M, 2010, INFECT IMMUN, V78, P639, DOI 10.1128/IAI.01043-09; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Kallinich T, 2005, SCAND J RHEUMATOL, V34, P246, DOI 10.1080/03009740410010236; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Maurer M, 2006, FASEB J, V20, P2460, DOI 10.1096/fj.06-5860com; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; MOUSLI M, 1990, FEBS LETT, V259, P260, DOI 10.1016/0014-5793(90)80023-C; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamada N, 2003, J INVEST DERMATOL, V121, P1425, DOI 10.1046/j.1523-1747.2003.12613.x; Zhu GF, 1996, J NEUROSCI, V16, P3745	42	79	79	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					85	95		10.1016/j.immuni.2012.04.013	http://dx.doi.org/10.1016/j.immuni.2012.04.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22819042	Green Accepted, Bronze			2022-12-18	WOS:000307133200012
J	Wang, XH; Zhang, YB; Yang, XXO; Nurieva, RI; Chang, SH; Ojeda, SS; Kang, HS; Schluns, KS; Gui, JF; Jetten, AM; Dong, C				Wang, Xiaohu; Zhang, Yibing; Yang, Xuexian O.; Nurieva, Roza I.; Chang, Seon Hee; Ojeda, Sandra S.; Kang, Hong S.; Schluns, Kimberly S.; Gui, Jianfang; Jetten, Anton M.; Dong, Chen			Transcription of Il17 and Il17f Is Controlled by Conserved Noncoding Sequence 2	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RANGE INTRACHROMOSOMAL INTERACTIONS; CD4(+) T-CELLS; ROR-GAMMA-T; NUCLEAR RECEPTORS; GENE-EXPRESSION; DIFFERENTIATION; CYTOKINE; LOCUS; LINEAGE	T helper 17 (Th17) cells specifically transcribe the Il17 and Il17f genes, which are localized in the same chromosome region, but the underlying mechanism is unclear. Here, we report a cis element that we previously named conserved noncoding sequence 2 (CNS2) physically interacted with both Il17 and Il17f gene promoters and was sufficient for regulating their selective transcription in Th17 cells. Targeted deletion of CNS2 resulted in impaired retinoic acid-related orphan receptor gammat (ROR gamma t)-driven IL-17 expression in vitro. CNS2-deficient T cells also produced substantially decreased amounts of IL-17F. These cytokine defects were associated with defective chromatin remodeling in the Ild17-Il17f gene locus, possibly because of effects on CNS2-mediated recruitment of histone-modifying enzymes p300 and JmjC domain-containing protein 3 (JMJD3). CNS2-deficient animals were also shown to be resistant to experimental autoimmune encephalomyelitis (EAE). Our results thus suggest that CNS2 is sufficient and necessary for Il17 and optimal Il17f gene transcription in Th17 cells.	[Wang, Xiaohu; Zhang, Yibing; Yang, Xuexian O.; Nurieva, Roza I.; Chang, Seon Hee; Ojeda, Sandra S.; Schluns, Kimberly S.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Zhang, Yibing; Gui, Jianfang] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Kang, Hong S.; Jetten, Anton M.] NIEHS, Cell Biol Sect, LRB, NIH, Res Triangle Pk, NC 27709 USA	University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009; Schluns, Kimberly/R-5635-2019; Yang, Xuexian/Y-2472-2019; Chang, Seon Hee/AAQ-9521-2020; Jetten, Anton/C-3736-2019	dong, chen/0000-0002-0084-9130; Yang, Xuexian/0000-0001-6816-7024; Chang, Seon Hee/0000-0002-9389-508X; Jetten, Anton/0000-0003-0954-4445	NIH; American Heart Association; 973 National Basic Research Program of China [2010CB126301]; National Multiple Sclerosis Society; Chinese Academy of Sciences; MD Anderson Cancer Center; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR059010, R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); 973 National Basic Research Program of China(National Basic Research Program of China); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Chinese Academy of Sciences(Chinese Academy of Sciences); MD Anderson Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the C.D. laboratory members for their help. The work is supported by research grants from NIH (to C.D. and R.I.N.), American Heart Association (to X.O.Y.), and 973 National Basic Research Program of China (2010CB126301). X.W. receives a postdoctoral fellowship from the National Multiple Sclerosis Society, Y.Z. was supported by a fellowship from Chinese Academy of Sciences, and C.D. receives a Research Trust Fellowship from MD Anderson Cancer Center and is a Leukemia and Lymphoma Society Scholar. C.D. and X.W. designed the research and analyzed the data. X.W., Y.Z., X.O.Y., RN., S.H.C., S.S.O., and H.S.K. performed the experiments, and X.W., J.G., K.S.S., A.M.J., and C.D. prepared the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Laky K, 1997, J IMMUNOL, V158, P1417; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nakamura T, 1997, J IMMUNOL, V158, P1085; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	37	79	86	3	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					23	31		10.1016/j.immuni.2011.10.019	http://dx.doi.org/10.1016/j.immuni.2011.10.019			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22244845	Green Accepted, Bronze			2022-12-18	WOS:000299766000007
J	Xu, DK; Holko, M; Sadler, AJ; Scott, B; Higashiyama, S; Berkofsky-Fessler, W; McConnell, MJ; Pandolfi, PP; Licht, JD; Williams, BRG				Xu, Dakang; Holko, Michelle; Sadler, Anthony J.; Scott, Bernadette; Higashiyama, Shigeki; Berkofsky-Fessler, Windy; McConnell, Melanie J.; Pandolfi, Pier Paolo; Licht, Jonathan D.; Williams, Bryan R. G.			Promyelocytic Leukemia Zinc Finger Protein Regulates Interferon-Mediated Innate Immunity	IMMUNITY			English	Article							STIMULATED GENE-EXPRESSION; RENAL-CELL CARCINOMA; TRANSCRIPTIONAL REPRESSION; ANTIVIRAL RESPONSES; SUPPRESSOR GENE; NUCLEAR-BODIES; PLZF PROTEIN; GRANZYME-B; NK CELLS; ALPHA	Interferons (IFNs) direct innate and acquired immune responses and, accordingly, are used therapeutically to treat a number of diseases, yet the diverse effects they elicit are not fully understood. Here, we identified the promyelocytic leukemia zinc finger (PLZF) protein as a previously unrecognized component of the IFN response. IFN stimulated an association of PLZF with promyelocytic leukemia protein (PML) and histone deacetylase 1 (HDAC1) to induce a decisive subset of IFN-stimulated genes (ISGs). Consequently, PLZF-deficient mice had a specific ISG expression defect and as a result were more susceptible to viral infection. This susceptibility correlated with a marked decrease in the expression of the key antiviral mediators and an impaired IFN-mediated induction of natural killer cell function. These results provide new insights into the regulatory mechanisms of IFN signaling and the induction of innate antiviral immunity.	[Xu, Dakang; Sadler, Anthony J.; Scott, Bernadette; Williams, Bryan R. G.] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Holko, Michelle] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, To On, Ehime 7910295, Japan; [Berkofsky-Fessler, Windy; McConnell, Melanie J.; Licht, Jonathan D.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol & Med, Boston, MA 02215 USA	Monash University; Northwestern University; Ehime University; Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Williams, BRG (corresponding author), Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	bryan.williams@med.monash.edu.au	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019; Williams, Bryan R. G./A-5021-2009; sadler, anthony/ABA-5572-2020	Licht, Jonathan/0000-0002-3942-1369; Williams, Bryan R. G./0000-0002-4969-1151; sadler, anthony/0000-0002-7970-8030; Xu, Dakang/0000-0003-2415-4920; McConnell, Melanie J./0000-0003-3840-1347	National Health and Medical Research Council of Australia [436814]; National Institutes of Health [P01 CA062220, R01 A1034039]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Fitzgerald for the RASD2-luc constructs, P. Hertzog and P. Fitzgerald-Bocarsly for helpful advice, and N. de Weerd, S. Samarajiwa, and J. Gould for mouse IFN alpha, and SFV virus. We thank I. Harper, S. Firth, and C. Lo (Monash Micro Imaging) for the confocal microscopic analysis and M. Gantier, D. Wang, D. Wu, and J. Ou for technical assistance. We also thank F. Cribbin for critical reading and preparation of the manuscript. This work was supported by grants from the National Health and Medical Research Council of Australia (436814 to B.R.G.W.) and the National Institutes of Health (P01 CA062220 and R01 A1034039 to B.R.G.W.).	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Ball HJ, 1999, NUCLEIC ACIDS RES, V27, P4106, DOI 10.1093/nar/27.20.4106; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chauchereau A, 2004, ONCOGENE, V23, P8777, DOI 10.1038/sj.onc.1208128; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Haque SJ, 1998, SEMIN ONCOL, V25, P14; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, pW213, DOI 10.1093/nar/gkh402; Holko M, 2006, J INTERF CYTOK RES, V26, P534, DOI 10.1089/jir.2006.26.534; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.bi.56.070187.003455; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shey Michael R., 2008, V447, P259, DOI 10.1007/978-1-59745-242-7_18; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Stadler M, 1995, ONCOGENE, V11, P2565; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Walsh KB, 2007, J IMMUNOL, V179, P1155, DOI 10.4049/jimmunol.179.2.1155; Zimmerer JM, 2007, CANCER IMMUNOL IMMUN, V56, P1845, DOI 10.1007/s00262-007-0329-9; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	54	79	82	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					802	816		10.1016/j.immuni.2009.04.013	http://dx.doi.org/10.1016/j.immuni.2009.04.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19523849	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000267270700009
J	Gourzi, P; Leonova, T; Papavasiliou, FN				Gourzi, Polyxeni; Leonova, Tatyana; Papavasiliou, F. Nina			A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; RNA EDITING ENZYME; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; HIV-1 INFECTION; AID; GENE; IMMUNOGLOBULIN; VIRUS	Activation-induced cytidine deaminase (AID) is specifically expressed in the germinal centers of lymphoid organs, where it initiates targeted hypermutation of variable regions of immunoglobulin genes in response to stimulation by antigen. Ectopic expression of AID, however, mediates generalized hypermutation in eukaryotes and prokaryotes. Here, we present evidence that AID is induced outside the germinal center in response to infection by the Abelson murine leukemia virus. The genotoxic activity of virally induced AID resulted in checkpoint kinase-1 (chk1) phosphorylation and ultimately restricted the proliferation of the infected cell. At the same time, it induced NKG2D ligand upregulation, which alerts the immune system to the presence of virally transformed cells. Hence, in addition to its known function in immunoglobulin diversification, AID is active in innate defense against a transforming retrovirus.	Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA	Rockefeller University	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, 1230 York Ave, New York, NY 10021 USA.	papavasiliou@rockefeller.edu			NIAID NIH HHS [R01 AI071029] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071029] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABELSON HT, 1970, CANCER RES, V30, P2213; Anant S, 2003, PROG NUCLEIC ACID RE, V75, P1, DOI 10.1016/S0079-6603(03)75001-6; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Goff SP, 2003, CELL, V114, P281, DOI 10.1016/S0092-8674(03)00602-0; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; ROSENBERG N, 1976, J EXP MED, V143, P1453, DOI 10.1084/jem.143.6.1453; ROSENBERG N, 1994, SEMIN CANCER BIOL, V5, P95; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	28	79	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					779	786		10.1016/j.immuni.2006.03.021	http://dx.doi.org/10.1016/j.immuni.2006.03.021			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782033	Bronze			2022-12-18	WOS:000238592200015
J	Haddad, R; Guimiot, F; Six, E; Jourquin, F; Setterblad, N; Kahn, E; Yagello, M; Schiffer, C; Andre-Schmutz, I; Cavazzana-Calvo, M; Gluckman, JC; Delezoide, AL; Pflumio, F; Canque, B				Haddad, R; Guimiot, F; Six, E; Jourquin, F; Setterblad, N; Kahn, E; Yagello, M; Schiffer, C; Andre-Schmutz, I; Cavazzana-Calvo, M; Gluckman, JC; Delezoide, AL; Pflumio, F; Canque, B			Dynamics of thymus-colonizing cells during human development	IMMUNITY			English	Article							HUMAN FETAL THYMUS; T-CELL; NATURAL-KILLER; STEM-CELLS; PROGENITOR CELLS; DENDRITIC CELLS; BONE-MARROW; CORD BLOOD; FUNCTIONAL-ANALYSIS; EARLY EVENTS	Here, we identify fetal bone marrow (BM)-derived CD34(hi)CD45RA(hi)CD7(+) hematopoietic progenitors as thymus-colonizing cells. This population, virtually absent from the fetal liver (FL), emerges in the BM by development weeks 8-9, where it accumulates throughout the second trimester, to finally decline around birth. Based on phenotypic, molecular, and functional criteria, we demonstrate that CD34(hi)CD45RA(hi)CD7(+) cells represent the direct precursors of the most immature CD34(hi)CD1a(-) fetal thymocytes that follow a similar dynamics pattern during fetal and early postnatal development. Histological analysis of fetal thymuses further reveals that early immigrants predominantly localize in the perivascular areas of the cortex, where they form a lymphostromal complex with thymic epithelial cells (TECs) driving their rapid specification toward the T lineage. Finally, using an ex vivo xenogeneic thymus-colonization assay, we show that BM-derived CD34(hi)CD45RA(hi)CD7(+) progenitors are selectively recruited into the thymus parenchyma in the absence of exogenous cytokines, where they adopt a definitive T cell fate.	Univ Paris 07, Ecole Prat Hautes Etud, Lab Immunol Cellulaire & Immunopathol, F-75221 Paris 05, France; Univ Paris 07, CNRS, UMR 7151, F-75221 Paris 05, France; Univ Paris, Hop St Louis, Inst Hematol, Serv Commun Imagerie Cellulaire & Mol, Paris, France; Hop Robert Debre, AP HP, Serv Biol Dev, F-75019 Paris, France; INSERM, U768, Biotherapy Dept, Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Paris, France; CHU Pitie Salpetriere, UPMC, INSERM, U678,UMRS, Paris, France; CNRS, UMR 8104, INSERM, U567,Inst Cochin,Dept Hematol, Paris, France; Univ Paris 05, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Canque, B (corresponding author), Univ Paris 07, Ecole Prat Hautes Etud, Lab Immunol Cellulaire & Immunopathol, F-75221 Paris 05, France.	bruno.canque@paris7.jussieu.fr	Andre, Isabelle/F-6263-2013; Andre-Schmutz, Isabelle/M-1279-2016; setterblad, niclas/GSN-1756-2022; Pflumio, Francoise/E-2074-2017; Six, Emmanuelle/H-7891-2017; canque, Bruno/F-2743-2019	Andre, Isabelle/0000-0002-3905-9910; Six, Emmanuelle/0000-0001-7806-0968; Pflumio, Francoise/0000-0001-8995-596X; canque, Bruno/0000-0003-0892-2811; Haddad, Rima/0000-0001-7040-843X				ABE J, 1989, CLIN IMMUNOL IMMUNOP, V51, P13, DOI 10.1016/0090-1229(89)90202-X; BARCENA A, 1994, J EXP MED, V180, P123, DOI 10.1084/jem.180.1.123; BARCENA A, 1993, BLOOD, V82, P3401; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Blom B, 1998, CRIT REV IMMUNOL, V18, P371, DOI 10.1615/CritRevImmunol.v18.i4.50; Blom B, 1997, J IMMUNOL, V158, P3571; CAMPANA D, 1989, J IMMUNOL, V142, P57; Canque B, 2000, BLOOD, V96, P3748, DOI 10.1182/blood.V96.12.3748.h8003748_3748_3756; Charbord P, 1996, BLOOD, V87, P4109, DOI 10.1182/blood.V87.10.4109.bloodjournal87104109; Dalloul AH, 1999, J IMMUNOL, V162, P5821; De Smedt M, 2004, BLOOD CELL MOL DIS, V33, P227, DOI 10.1016/j.bcmd.2004.08.007; Douagi I, 2002, BLOOD, V99, P463, DOI 10.1182/blood.V99.2.463; Dunon D, 1993, Curr Top Microbiol Immunol, V184, P139; GALY A, 1993, J EXP MED, V178, P391, DOI 10.1084/jem.178.2.391; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GALY AHM, 1993, THYMUS, V22, P13; HAAR JL, 1974, ANAT REC, V179, P463, DOI 10.1002/ar.1091790406; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; HAYNES BF, 1989, IMMUNOL TODAY, V10, P87, DOI 10.1016/0167-5699(89)90232-6; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; HAYNES BF, 1988, J IMMUNOL, V141, P3776; HOFMAN FM, 1984, J IMMUNOL, V133, P1197; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaleco AC, 1997, J IMMUNOL, V159, P694; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; KYEWSKI BA, 1987, J EXP MED, V166, P520, DOI 10.1084/jem.166.2.520; LEDOUARIN NM, 1984, AM J ANAT, V170, P261, DOI 10.1002/aja.1001700305; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; LOBACH DF, 1985, J IMMUNOL, V135, P1752; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; MOTTEMOHS RN, 2005, BLOOD, V105, P1431; Norris E. H., 1938, CONTRIB EMBRYOL CARN, V27, P193; Peault B, 2003, ANN NY ACAD SCI, V996, P132, DOI 10.1111/j.1749-6632.2003.tb03241.x; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; RAVIOLA E, 1972, J EXP MED, V136, P466, DOI 10.1084/jem.136.3.466; Res P, 1996, BLOOD, V87, P5196, DOI 10.1182/blood.V87.12.5196.bloodjournal87125196; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; SANCHEZ MJ, 1993, J EXP MED, V177, P19, DOI 10.1084/jem.177.1.19; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Spits H, 2002, NAT REV IMMUNOL, V2, P760, DOI 10.1038/nri913; Suniara RK, 1999, EUR J IMMUNOL, V29, P75, DOI 10.1002/(SICI)1521-4141(199901)29:01<75::AID-IMMU75>3.3.CO;2-3; TERSTAPPEN LWMM, 1992, BLOOD, V79, P666; von Gaudecker B, 1979, Adv Exp Med Biol, V114, P19	50	79	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					217	230		10.1016/j.immuni.2006.01.008	http://dx.doi.org/10.1016/j.immuni.2006.01.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473833	Bronze			2022-12-18	WOS:000235479000012
J	Catalfamo, M; Karpova, T; McNally, J; Costes, SV; Lockett, SJ; Bos, E; Peters, PJ; Henkart, PA				Catalfamo, M; Karpova, T; McNally, J; Costes, SV; Lockett, SJ; Bos, E; Peters, PJ; Henkart, PA			Human CD8(+) T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation	IMMUNITY			English	Article							BETA-CHEMOKINES; LYMPHOCYTES; GRANULES; EFFECTOR; INTERFERON; PATHWAYS	The chemokine RANTES is secreted rapidly after activation of human CD8(+) T cells, with a cycloheximide-resistant burst during the first hour. This pattern was observed in purified memory and effector phenotype CD8+ cells from blood as well as in blasts. In contrast, secretion of other chemokines and interferon-gamma by these cells was sensitive to cycloheximide and detectable only after a lag. Immunofluorescence microscopy of CD8(+) memory and effector cells and blasts showed RANTES present in intracellular vesicles that do not significantly colocalize with cytotoxic granule markers or other markers of defined cytoplasmic compartments. Immunoelectron microscopy confirmed that RANTES is stored in small vesicles distinct from the lysosomal secretory granules. RANTES(+) vesicles polarize rapidly in response to TcR engagement and are more rapidly depleted from the cytoplasm. These results show that CD8+ T cells have two distinct TcRregulated secretory compartments characterized by different mobilization kinetics, effector molecules, and biological function.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; NCI, SAIC Frederick, Microscopy & Image Anal Lab, Frederick, MD 21702 USA; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Netherlands Cancer Institute	Henkart, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	henkartp@mail.nih.gov	Costes, Sylvain V/D-2522-2013	Costes, Sylvain V/0000-0002-8542-2389; Karpova, Tatiana/0000-0001-6025-2128	DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010381] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010571, Z01BC009255, ZICBC010571, ZICBC009255] Funding Source: NIH RePORTER	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; CONLON K, 1995, EUR J IMMUNOL, V25, P751, DOI 10.1002/eji.1830250319; FORTIER AH, 1989, CELL IMMUNOL, V124, P64, DOI 10.1016/0008-8749(89)90112-3; GREENBERG AH, 1986, J IMMUNOL, V137, P3224; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Lacy P, 1999, BLOOD, V94, P23, DOI 10.1182/blood.V94.1.23.413k13_23_32; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Peters PJ, 2001, METHOD ENZYMOL, V329, P210; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; ROBINSON E, 1995, CLIN EXP IMMUNOL, V101, P398; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Swanson BJ, 2002, IMMUNITY, V17, P605, DOI 10.1016/S1074-7613(02)00456-9; Taub DD, 1996, J LEUKOCYTE BIOL, V59, P81, DOI 10.1002/jlb.59.1.81; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Walzer T, 2003, J IMMUNOL, V170, P1615, DOI 10.4049/jimmunol.170.4.1615; WINSLOW CM, 1982, FED PROC, V41, P22; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	20	79	81	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					219	230		10.1016/S1074-7613(04)00027-5	http://dx.doi.org/10.1016/S1074-7613(04)00027-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975243	Bronze			2022-12-18	WOS:000221442400010
J	Mamane, Y; Sharma, S; Petropoulos, L; Lin, RT; Hiscott, J				Mamane, Y; Sharma, S; Petropoulos, L; Lin, RT; Hiscott, J			Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52	IMMUNITY			English	Article							HEAT-SHOCK PROTEIN; T-CELL LEUKEMIA; TROPICAL SPASTIC PARAPARESIS; STEROID-RECEPTOR COMPLEXES; VIRUS TYPE-I; CYCLOSPORINE-A; TRANSCRIPTION FACTOR; FK506-BINDING PROTEIN; FACTOR FAMILY; TAX PROTEIN	Interferon regulatory factor-4 (IRF-4) plays an important role in immunoregulatory gene expression in B and T lymphocytes and is also highly expressed in human T cell leukemia virus type 1 infected cells. In this study, we characterize a novel interaction between IRF-4 and the FK506-binding protein 52 (FKBP52), a 59 kDa member of the immunophilin family with peptidyl-prolyl isomerase activity (PPlase). IRF-4-FKBP52 association inhibited IRF4-PU.1 binding to the immunoglobulin light chain enhancer Elambda 2-4 as well as IRF-4-PU. 1 transactivation, effects that were dependent on functional PPlase activity. FKBP52 association also resulted in a structural modification of IRF-4, detectable by immunoblot analysis and by IRF-4 partial proteolysis. These results demonstrate a novel posttranslational mechanism of transcriptional control, mediated through the interaction of an immunophilin with a transcriptional regulator.	McGill Univ, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Hiscott, J (corresponding author), McGill Univ, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.		Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503				Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Burysek L, 1999, J VIROL, V73, P7334; CZAR MJ, 1994, MOL ENDOCRINOL, V8, P1731, DOI 10.1210/me.8.12.1731; DADDARIO M, 1992, J IMMUNOL, V148, P1222; DAENKE S, 1990, J VIROL, V64, P1278, DOI 10.1128/JVI.64.3.1278-1282.1990; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GESSAIN A, 1985, LANCET, V2, P407; GONDA T, 1998, INT J BIOCHEM CELL B, V30, P517; GONDA TJ, 1989, EMBO J, V8, P1767, DOI 10.1002/j.1460-2075.1989.tb03570.x; HISCOTT J, 1995, VIROLOGY, V214, P3, DOI 10.1006/viro.1995.9960; Hunter T, 1998, CELL, V92, P141, DOI 10.1016/S0092-8674(00)80906-X; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Jeang KT, 1997, J VIROL, V71, P6277, DOI 10.1128/JVI.71.9.6277-6278.1997; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; KOROMILAS AE, 1995, J BIOL CHEM, V270, P25426, DOI 10.1074/jbc.270.43.25426; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lipsick JS, 1996, ONCOGENE, V13, P223; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; Mattila PS, 1996, BIOCHEM SOC T, V24, P45, DOI 10.1042/bst0240045; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; MORRIS R, 1994, TRANSPLANT P, V26, P3272; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Ortiz MA, 1999, P NATL ACAD SCI USA, V96, P2740, DOI 10.1073/pnas.96.6.2740; PAHL A, 1992, J BACTERIOL, V174, P5888, DOI 10.1128/jb.174.18.5888-5894.1992; PAIGE CJ, 1981, NATURE, V292, P631, DOI 10.1038/292631a0; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; PERROTAPPLANAT M, 1995, J CELL SCI, V108, P2037; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	43	79	81	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					129	140		10.1016/S1074-7613(00)80166-1	http://dx.doi.org/10.1016/S1074-7613(00)80166-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714679	Bronze			2022-12-18	WOS:000085621400003
J	Yang, XF; Weber, GF; Cantor, H				Yang, XF; Weber, GF; Cantor, H			A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells	IMMUNITY			English	Article							TRANSGENIC MICE; DEFICIENT MICE; DNA-BINDING; DEATH; SURVIVAL; BCL-X(L); GENE; SUPERANTIGEN; EXPRESSION; TOLERANCE	We define a novel Bcl-x isoform, Bcl-x gamma, that is generated by alternative splicing and characterized by a unique 47 amino acid C-terminus. Bcl-x gamma is expressed primarily in thymocytes, where it may depend on an interaction between the TCR and host MHC products, and in mature T cells, where its expression is associated with ligation of the T cell receptor. Overexpression of Bcl-x gamma in T cells inhibits activation-induced apoptosis; inhibition of Bcl-x gamma, after stable expression of Bcl-x gamma antisense cDNA, enhances activation-induced apoptosis. In contrast to other Bcl-x isoforms, cells that fail to express Bcl-x gamma after CD3 ligation undergo programmed cell death, while activated T cells that express Bcl-x gamma are spared. Identification of Bcl-x gamma helps provide a molecular explanation of T cell activation and death after antigen engagement.	HARVARD UNIV,SCH MED,DEPT CANC IMMUNOL & AIDS,DANA FARBER CANC INST,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School					NIAID NIH HHS [AI13600, P01 AI037833, AI37833, AI12184, R37 AI012184, R01 AI013600] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012184, P01AI037833, R01AI012184, R01AI013600] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKBAR AN, 1993, IMMUNOL TODAY, V14, P526, DOI 10.1016/0167-5699(93)90181-J; Bailey G S, 1994, Methods Mol Biol, V32, P381; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BROOME HE, 1995, J IMMUNOL, V155, P2311; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; CLARKE MF, 1995, P NATL ACAD SCI USA, V92, P11024, DOI 10.1073/pnas.92.24.11024; COEN DM, 1994, CURRENT PROTOCOLS MO, V2; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; FANG W, 1994, J IMMUNOL, V153, P4388; FRIEDMAN S, 1987, IMMUNOGENETICS, V26, P193, DOI 10.1007/BF00346512; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOCKENBERY DM, 1995, BIOESSAYS, V17, P631, DOI 10.1002/bies.950170709; IGNATOWICZ L, 1992, J EXP MED, V175, P917, DOI 10.1084/jem.175.4.917; JACOBS KA, 1988, NUCLEIC ACIDS RES, V16, P4637, DOI 10.1093/nar/16.10.4637; Kincade P W, 1993, Curr Top Microbiol Immunol, V184, P215; KLEIN ES, 1993, GENE DEV, V7, P55, DOI 10.1101/gad.7.1.55; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; MOORE NC, 1994, IMMUNOLOGY, V81, P115; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Mueller DL, 1996, J IMMUNOL, V156, P1764; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; NUNEZ G, 1994, IMMUNOL TODAY, V15, P582, DOI 10.1016/0167-5699(94)90221-6; ORMEROD MG, 1993, CYTOMETRY, V14, P595, DOI 10.1002/cyto.990140603; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; ROBINSONBENION C, 1995, METHOD ENZYMOL, V254, P3; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SPINELLA DG, 1987, J IMMUNOL, V138, P3991; Takahashi T, 1997, CELL DEATH DIFFER, V4, P159, DOI 10.1038/sj.cdd.4400214; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WEBER GF, 1995, IMMUNITY, V2, P363, DOI 10.1016/1074-7613(95)90144-2; Weber GF, 1997, CYTOMETRY, V27, P136, DOI 10.1002/(SICI)1097-0320(19970201)27:2<136::AID-CYTO5>3.0.CO;2-E; WEBER GF, 1994, J IMMUNOL, V152, P4433; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; WEIN J, 1965, CANCER RES, V25, P1753; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; YANG XF, 1995, BIOCHEM J, V312, P99, DOI 10.1042/bj3120099; ZHANG L, 1994, J IMMUNOL, V152, P2222; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZINKERNAGEL RM, 1993, IMMUNOL REV, V131, P199	53	79	81	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					629	639		10.1016/S1074-7613(00)80384-2	http://dx.doi.org/10.1016/S1074-7613(00)80384-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390687	Green Accepted, Bronze			2022-12-18	WOS:A1997YH55400006
J	Wiest, DL; Ashe, JM; Abe, R; Bolen, JB; Singer, A				Wiest, DL; Ashe, JM; Abe, R; Bolen, JB; Singer, A			TCR activation of ZAP70 is impaired in CD4(+)CD8(+) thymocytes as a consequence of intrathymic interactions that diminish available p56(lck)	IMMUNITY			English	Article							T-CELL RECEPTOR; TYROSINE-PROTEIN-KINASE; IMMATURE CD4+CD8+ THYMOCYTES; ANTIGEN RECEPTOR; MICE LACKING; MONOCLONAL-ANTIBODY; ZETA-CHAIN; LYMPHOCYTES-T; CD8 LINEAGE; EXPRESSION	The fate of developing CD4(+)CD8(+) thymocytes is determined by signals transduced through surface TCR complexes. Here, we report that cross-linking of TCR on CD4(+)CD8(+) thymocytes fails to activate ZAP70 protein tyrosine kinase and fails to initiate downstream signaling events, unless the TCR are coaggregated with surface coreceptor molecules. TCR signaling in CD4(+)CD8(+) thymocytes is impaired because the number of available p56(lck) molecules is diminished by intrathymic CD4-1a interactions that initially activate p56(lck) molecules, which are subsequently degraded. As a consequence of intrathymic CD4-1a interactions, TCR zeta chains are initially phosphorylated to recruit ZAP70 molecules, but the recruited ZAP70 molecules are not subsequently phosphorylated, resulting in TCR complexes that are stably associated with inactive ZAP70 molecules. Thus, intrathymic interactions that diminish p56(lck) regulate TCR signaling thresholds and affect TCR structure in developing CD4(+)CD8(+) thymocytes.	USN, MED RES INST, IMMUNE CELL BIOL DEPT, BETHESDA, MD 20889 USA; DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT CELLULAR SIGNALING, PALO ALTO, CA 94304 USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Wiest, DL (corresponding author), NCI, EXPTL IMMUNOL BRANCH, NIH, BLDG 10, BETHESDA, MD 20892 USA.			Wiest, David/0000-0002-0792-3188				APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BOLEN JB, 1991, ADV CANCER RES, V57, P103; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; COULIE PG, 1991, EUR J IMMUNOL, V21, P1703, DOI 10.1002/eji.1830210718; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FINKEL TH, 1987, NATURE, V330, P179, DOI 10.1038/330179a0; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KEARSE KP, 1993, P NATL ACAD SCI USA, V90, P2438, DOI 10.1073/pnas.90.6.2438; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; VANEWIJK W, 1980, J HISTOCHEM CYTOCHEM, V28, P1089, DOI 10.1177/28.10.6999083; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WANGE RL, 1995, J BIOL CHEM, V270, P944, DOI 10.1074/jbc.270.2.944; WATTS JD, 1994, J BIOL CHEM, V269, P29520; WEIL R, 1995, J BIOL CHEM, V270, P2791, DOI 10.1074/jbc.270.6.2791; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; WIEST DL, 1994, J EXP MED, V180, P1375, DOI 10.1084/jem.180.4.1375; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	56	79	80	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1996	4	5					495	504		10.1016/S1074-7613(00)80415-X	http://dx.doi.org/10.1016/S1074-7613(00)80415-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630734	Bronze			2022-12-18	WOS:A1996UM67800008
J	Hegde, S; Leader, AM; Merad, M				Hegde, Samarth; Leader, Andrew M.; Merad, Miriam			MDSC: Markers, development, states, and unaddressed complexity	IMMUNITY			English	Review							T-CELL-ACTIVATION; SUPPRESSOR-CELLS; MYELOID CELLS; HEMATOPOIETIC STEM; IMMUNE SUPPRESSION; MASS CYTOMETRY; IMMUNOSUPPRESSION; MONOCYTE; PROGENITORS; NEUTROPHILS	Myeloid-derived suppressor cells (MDSCs) are one of the most discussed biological entities in immunology. While the context and classification of this group of cells has evolved, MDSCs most commonly describe cells arising during chronic inflammation, especially late-stage cancers, and are defined by their T cell immunosuppressive functions. This MDSC concept has helped explain myeloid phenomena associated with disease outcome, but currently lacks clear definitions and a unifying framework across pathologies. Here, we propose such a framework to classify MDSCs as discrete cell states based on activation signals in myeloid populations leading to suppressive modes characterized by specific, measurable effects. Developing this level of knowledge of myeloid states across pathological conditions may ultimately transform how disparate diseases are grouped and treated.	[Hegde, Samarth; Leader, Andrew M.; Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Hegde, Samarth; Leader, Andrew M.; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Hegde, Samarth; Leader, Andrew M.; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA.	miriam.merad@mssm.edu		Hegde, Samarth/0000-0001-6319-0372	National Cancer Institute [K00 CA223043, R01 CA190400, U19 AI128949, R01 CA154947]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Merad lab for providing feedback on this manuscript. S.H. was supported by National Cancer Institute predoctoral-to-postdoctoral fellowship K00 CA223043. M.M. is funded by R01 CA190400, U19 AI128949, and R01 CA154947.	Aarts CEM, 2019, BLOOD ADV, V3, P3562, DOI 10.1182/bloodadvances.2019031609; Ahl PJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1027-9; Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Al Sayed MF, 2019, CANCER RES, V79, P346, DOI 10.1158/0008-5472.CAN-17-3026; Almand B, 2000, CLIN CANCER RES, V6, P1755; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Alshetaiwi H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay6017; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Becht E., 2020, INFINITY FLOW HIGH T, DOI [10.1101/2020.06.17.152926, DOI 10.1101/2020.06.17.152926]; BENNETT JA, 1978, P NATL ACAD SCI USA, V75, P5142, DOI 10.1073/pnas.75.10.5142; Bernard V, 2019, CLIN CANCER RES, V25, P2194, DOI 10.1158/1078-0432.CCR-18-1955; Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004; Bowling S, 2020, CELL, V181, P1410, DOI 10.1016/j.cell.2020.04.048; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Cassetta L, 2019, CANCER IMMUNOL IMMUN, V68, P687, DOI 10.1007/s00262-019-02302-2; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Cirovic B, 2017, STEM CELL REP, V8, P346, DOI 10.1016/j.stemcr.2016.12.015; Clements DR, 2017, J PROTEOME RES, V16, P3391, DOI 10.1021/acs.jproteome.7b00425; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Faget J., 2018, EFFICIENT SPECIFIC L, DOI [10.1101/498881, DOI 10.1101/498881]; Fleming V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00398; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Giles AJ, 2016, CANCER RES, V76, P1335, DOI 10.1158/0008-5472.CAN-15-0204; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Halaby MJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8189; Hartmann FJ, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0651-8; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Ikeda N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat0207; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Kalhor R, 2018, SCIENCE, V361, P893, DOI 10.1126/science.aat9804; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Kempkes RWM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02839; Kitamura T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.02004; Knier B, 2018, NAT IMMUNOL, V19, P1341, DOI 10.1038/s41590-018-0237-5; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Laughney AM, 2020, NAT MED, V26, P259, DOI 10.1038/s41591-019-0750-6; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Lu ZH, 2020, NATURE, V579, P284, DOI 10.1038/s41586-020-2054-x; Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022; Mackert JR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12968-2; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Mandruzzato S, 2016, CANCER IMMUNOL IMMUN, V65, P161, DOI 10.1007/s00262-015-1782-5; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Mastio J, 2019, J EXP MED, V216, P2150, DOI 10.1084/jem.20181952; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Millrud CR, 2017, ONCOTARGET, V8, P3649, DOI 10.18632/oncotarget.12278; Mimitou EP, 2019, NAT METHODS, V16, P409, DOI 10.1038/s41592-019-0392-0; Mohamed E, 2020, IMMUNITY, V52, P668, DOI 10.1016/j.immuni.2020.03.004; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Muench DE, 2020, NATURE, V582, P109, DOI 10.1038/s41586-020-2227-7; Nagata DED, 2019, CELL REP, V27, P269, DOI 10.1016/j.celrep.2019.03.008; Neamah WH, 2019, J IMMUNOL, V203, P1830, DOI 10.4049/jimmunol.1900291; Netherby CS, 2017, J IMMUNOL, V198, P4129, DOI 10.4049/jimmunol.1601722; Newson J, 2017, CELL REP, V20, P3162, DOI 10.1016/j.celrep.2017.08.098; Oliveira LD, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3067126; Orsini M, 2019, CELL DEATH DIFFER, V26, P1796, DOI 10.1038/s41418-018-0245-x; Ostendorf BN, 2020, NAT MED, V26, P1048, DOI 10.1038/s41591-020-0879-3; Pan W, 2017, IMMUNITY, V47, P284, DOI 10.1016/j.immuni.2017.07.020; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pu SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23115; Pundhir S, 2018, CELL REP, V23, P2744, DOI 10.1016/j.celrep.2018.05.012; Ribechini E, 2017, BLOOD ADV, V1, P947, DOI 10.1182/bloodadvances.2017006858; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Rodriguez-Ubreva J, 2017, CELL REP, V21, P154, DOI 10.1016/j.celrep.2017.09.018; Roussel M, 2017, J LEUKOCYTE BIOL, V102, P437, DOI 10.1189/jlb.5MA1116-457R; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schouppe E, 2013, EUR J IMMUNOL, V43, P2930, DOI 10.1002/eji.201343349; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Si Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw9159; Singel KL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122311; Sippel TR, 2011, CLIN CANCER RES, V17, P6992, DOI 10.1158/1078-0432.CCR-11-1107; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stromnes IM, 2014, GUT, V63, P1769, DOI 10.1136/gutjnl-2013-306271; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vitale I, 2019, CELL METAB, V30, P36, DOI 10.1016/j.cmet.2019.06.001; Weiss JM, 2018, J CLIN INVEST, V128, P3794, DOI 10.1172/JCI99169; Wesolowski R, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-10; Wistuba-Hamprecht K, 2017, J IMMUNOL, V198, P927, DOI 10.4049/jimmunol.1600875; Wroblewska A, 2018, CELL, V175, P1141, DOI 10.1016/j.cell.2018.09.022; Xing YF, 2016, ANN RHEUM DIS, V75, pE49, DOI 10.1136/annrheumdis-2016-209786; Xu J, 2019, ELIFE, V8, DOI 10.7554/eLife.45105; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yanez A, 2015, BLOOD, V125, P1452, DOI 10.1182/blood-2014-09-600833; Yang SH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01192; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x; Zhao LT, 2018, NAT MED, V24, P1536, DOI 10.1038/s41591-018-0205-5; Zhou Q, 2017, CANCER IMMUNOL RES, V5, P547, DOI 10.1158/2326-6066.CIR-16-0259; Zhou ZP, 2010, STEM CELLS, V28, P620, DOI 10.1002/stem.301; Zhu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00784-1	109	78	79	10	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					875	884		10.1016/j.immuni.2021.04.004	http://dx.doi.org/10.1016/j.immuni.2021.04.004		MAY 2021	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979585	Green Accepted, Bronze			2022-12-18	WOS:000652019500007
J	Schwarzer, R; Jiao, HP; Wachsmuth, L; Tresch, A; Pasparakis, M				Schwarzer, Robin; Jiao, Huipeng; Wachsmuth, Laurens; Tresch, Achim; Pasparakis, Manolis			FADD and Caspase-8 Regulate Gut Homeostasis and Inflammation by Controlling MLKL- and GSDMD-Mediated Death of Intestinal Epithelial Cells	IMMUNITY			English	Article							NF-KAPPA-B; INNATE IMMUNITY; CROHNS-DISEASE; CD95 FAS/APO-1; CUTTING EDGE; NECROPTOSIS; RIPK3; APOPTOSIS; NECROSIS; ADAPTER	Pathways controlling intestinal epithelial cell (IEC) death regulate gut immune homeostasis and contribute to the pathogenesis of inflammatory bowel diseases. Here, we show that caspase-8 and its adapter FADD act in IECs to regulate intestinal inflammation downstream of Z-DNA binding protein 1 (ZBP1)- and tumor necrosis factor receptor-1 (TNFR1)-mediated receptor interacting protein kinase 1 (RIPK1) and RIPK3 signaling. Mice with IEC-specific FADD or caspase-8 deficiency developed colitis dependent on mixed lineage kinase-like (MLKL)-mediated epithelial cell necroptosis. However, MLKL deficiency fully prevented ileitis caused by epithelial caspase-8 ablation, but only partially ameliorated ileitis in mice lacking FADD in IECs. Our genetic studies revealed that caspase-8 and gasdermin-D (GSDMD) were both required for the development of MLKL-independent ileitis in mice with epithelial FADD deficiency. Therefore, FADD prevents intestinal inflammation downstream of ZBP1 and TNFR1 by inhibiting both MLKL-induced necroptosis and caspase-8-GSDMD-dependent pyroptosis-like death of epithelial cells.	[Schwarzer, Robin; Jiao, Huipeng; Wachsmuth, Laurens; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Schwarzer, Robin; Jiao, Huipeng; Wachsmuth, Laurens; Tresch, Achim; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Tresch, Achim] Univ Cologne, Fac Med, Inst Med Stat & Computat Biol, Bachemer Str 86, D-50931 Cologne, Germany; [Tresch, Achim] Univ Cologne, Ctr Data & Simulat Sci CDS, Cologne, Germany; [Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, D-50674 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany.	pasparakis@uni-koeln.de	Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Wachsmuth, Laurens/0000-0003-1701-9384; Jiao, Huipeng/0000-0001-9632-6176	European Research Council [323040, 787826]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB1403, 414786233, PA 1476/8-1, 411102043, SFB1218, 269925409, 390661388]; International Graduate School in Development, Health and Disease at the University of Cologne	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); International Graduate School in Development, Health and Disease at the University of Cologne	We thank J. Kuth, C. Uthoff-Hachenberg, E. Stade, B. K_uhnel and E. Gareus for technical assistance; P. Wagle and H. Nolte for help on microarray data analysis; and B. Zevnik and the CECAD Transgenic Core Facility for CRISPR/Cas9assisted generation of Gsdmd~/~ mice. We also thank K. Newton for Ripk3fl/fl, G. Kollias for Tnfr1fl/fl, S. Hedrick for Casp8 fl/fl and J. Tschopp for Ascfl/fl mice. Research reported in this publication was supported by funding from the European Research Council (grant agreements no. 323040 and 787826) and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; projects SFB1403 [project no. 414786233], PA 1476/8-1 [project no. 411102043], SFB1218 [project no. 269925409], and CECAD [project no. 390661388]). R.S. was supported by a PhD fellowship from the International Graduate School in Development, Health and Disease at the University of Cologne.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Eftychi C, 2019, IMMUNITY, V51, P367, DOI 10.1016/j.immuni.2019.06.008; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Jiao HP, 2020, NATURE, V580, P391, DOI 10.1038/s41586-020-2129-8; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21998-3; Lehle AS, 2019, GASTROENTEROLOGY, V156, P275, DOI 10.1053/j.gastro.2018.09.041; Lin J, 2016, NATURE, V540, P124, DOI 10.1038/nature20558; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Moriwaki K, 2017, CELL REP, V18, P2441, DOI 10.1016/j.celrep.2017.02.015; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Nolte H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31154-6; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Scott NE, 2017, J BIOL CHEM, V292, P17337, DOI 10.1074/jbc.M117.805036; Stolzer I, 2020, INFLAMM BOWEL DIS, V26, P66, DOI 10.1093/ibd/izz142; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Van Hauwermeiren F, 2013, J CLIN INVEST, V123, P2590, DOI 10.1172/JCI65624; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wittkopf N, 2013, GASTROENTEROLOGY, V145, P1369, DOI 10.1053/j.gastro.2013.08.059; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	53	78	83	6	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					978	+		10.1016/j.immuni.2020.04.002	http://dx.doi.org/10.1016/j.immuni.2020.04.002			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32362323	Bronze, Green Accepted			2022-12-18	WOS:000541890000013
J	McGinty, JW; Ting, HA; Billipp, TE; Nadjsombati, MS; Khan, DM; Barrett, NA; Liang, HE; Matsumoto, I; von Moltke, J				McGinty, John W.; Ting, Hung-An; Billipp, Tyler E.; Nadjsombati, Marija S.; Khan, Danish M.; Barrett, Nora A.; Liang, Hong-Erh; Matsumoto, Ichiro; von Moltke, Jakob			Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; GENE DISRUPTION REVEALS; VASCULAR-PERMEABILITY; TYPE-2 IMMUNITY; RECEPTOR; TISSUE; TRPM5; 5-LIPOXYGENASE; ACCUMULATION; ACTIVATION	Helminths, allergens, and certain protists induce type 2 immune responses, but the underlying mechanisms of immune activation remain poorly understood. In the small intestine, chemosensing by epithelial tuft cells results in the activation of group 2 innate lymphoid cells (ILC2s), which subsequently drive increased tuft cell frequency. This feedforward circuit is essential for intestinal remodeling and helminth clearance. ILC2 activation requires tuft-cell-derived interleukin-25 (IL-25), but whether additional signals regulate the circuit is unclear. Here, we show that tuft cells secrete cysteinyl leukotrienes (cysLTs) to rapidly activate type 2 immunity following chemosensing of helminth infection. CysLTs cooperate with IL-25 to activate ILC2s, and tuft-cell-specific ablation of leukotriene synthesis attenuates type 2 immunity and delays helminth clearance. Conversely, cysLTs are dispensable for the tuft cell response induced by intestinal protists. Our findings identify an additional tuft cell effector function and suggest context-specific regulation of tuft-ILC2 circuits within the small intestine.	[McGinty, John W.; Ting, Hung-An; Billipp, Tyler E.; Nadjsombati, Marija S.; Khan, Danish M.; von Moltke, Jakob] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA; [Barrett, Nora A.] Harvard Med Sch, Brigham & Womens Hosp, Jeff & Penny Vinik Ctr Allerg Dis Res, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Barrett, Nora A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Liang, Hong-Erh] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Liang, Hong-Erh] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Matsumoto, Ichiro] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Monell Chemical Senses Center	von Moltke, J (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA.	jmoltke@uw.edu		Nadjsombati, Marija/0000-0001-6632-8381; Ting, Hung-An/0000-0001-9125-8944	University of Washington [T32 AI106677]; UW Immunology Department Titus Fellowship; NIH [1DP2 OD024087, R01 DC015491, R01 DC017503, R01 AI026918]; Kenneth Rainin Foundation Synergy Award; UCSF Diabetes Research Center	University of Washington(University of Washington); UW Immunology Department Titus Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation Synergy Award; UCSF Diabetes Research Center	We thank D. Hailey and the Garvey Cell Imaging Lab in the Institute for Stem Cell & Regenerative Medicine for microscopy support; M. Black and the UW Cell Analysis Facility for flow cytometry support; the mouse husbandry staff in the UW SLU vivarium; Northwest BioSpecimen for human tissue samples; V. Gersuk, M. Rosasco, and the Benaroya Research Institute Genomics Core for help with RNA sequencing; V. Kuchroo at Brigham and Women's Hospital for mice; and M. Fontana for helpful comments on the manuscript. J.W.M. was supported by a University of Washington Immunology Training Grant T32 AI106677. M.S.N. was supported by the UW Immunology Department Titus Fellowship. J.v.M. is a Searle Scholar. Work at the University of Washington was supported by NIH 1DP2 OD024087 and a Kenneth Rainin Foundation Synergy Award. The Pou2f3-Cre<SUP>ERT2</SUP>-ires-EGFP strain was generated at the Monell Chemical Senses Center with funding support from NIH R01 DC015491 and R01 DC017503. The Alox5-flox strain was generated at the University of California, San Francisco with generous funding support from R. Locksley (NIH R01 AI026918, UCSF Diabetes Research Center, and Sandler Asthma Basic Research Center at UCSF for support of H.-E.L., targeting, and mouse costs).	Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Deckmann K, 2018, FASEB J, V32, P2903, DOI 10.1096/fj.201700582R; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Escalante NK, 2016, J EXP MED, V213, P2841, DOI 10.1084/jem.20161776; FALLON PG, 2006, J EXP MED, V203, P1105, DOI DOI 10.1084/JEM.20051615; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Johnston C.J.C., 2015, JOVE-J VIS EXP, V98, P52412; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; KEPPLER D, 1989, ADV ENZYME REGUL, V28, P307, DOI 10.1016/0065-2571(89)90078-2; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liu Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0036-z; Lund SJ, 2017, J IMMUNOL, V199, P1096, DOI 10.4049/jimmunol.1601569; Luo XC, 2019, P NATL ACAD SCI USA, V116, P5564, DOI 10.1073/pnas.1812901116; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2002, J BIOL CHEM, V277, P20820, DOI 10.1074/jbc.M203163200; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; McGinty J.W., 2019, CURR OPIN IMMUNOL, V62, P15; McKinley ET, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93487; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pelly VS, 2016, MUCOSAL IMMUNOL, V9, P1407, DOI 10.1038/mi.2016.4; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; ROUZER CA, 1988, J BIOL CHEM, V263, P10980; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Schutz B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53997-3; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Thorne CA, 2018, DEV CELL, V44, P624, DOI 10.1016/j.devcel.2018.01.024; Ualiyeva S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax7224; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; WONG A, 1988, BIOCHEMISTRY-US, V27, P6763, DOI 10.1021/bi00418a018; Wong CK, 2005, AM J RESP CELL MOL, V33, P186, DOI 10.1165/rcmb.2005-0034OC; Wunder F, 2010, BRIT J PHARMACOL, V160, P399, DOI 10.1111/j.1476-5381.2010.00730.x	60	78	80	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					528	+		10.1016/j.immuni.2020.02.005	http://dx.doi.org/10.1016/j.immuni.2020.02.005			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32160525	Green Accepted, Bronze			2022-12-18	WOS:000520600200014
J	Evavold, CL; Kagan, JC				Evavold, Charles L.; Kagan, Jonathan C.			Inflammasomes: Threat-Assessment Organelles of the Innate Immune System	IMMUNITY			English	Review							INDUCED CELL-DEATH; NF-KAPPA-B; NLRP3 INFLAMMASOME; GASDERMIN-D; AIM2 INFLAMMASOME; PATTERN-RECOGNITION; DIFFERENTIAL REQUIREMENT; ACTIVATION; PROTEIN; CASPASE-11	Inflammasomes are supramolecular organizing centers that operate to drive interleukin-1 (IL-1)-dependent inflammation. Depending on context, inflammatory caspases act upstream or downstream of inflammasome assembly, serving as the principal enzymes that control activities of these organelles. In this review, we discuss mechanisms of inflammasome assembly and signaling. We posit that upstream regulatory proteins, classically known as pattern-recognition receptors, operate to assess infectious and non-infectious threats to the host. Threat assessment is achieved through two general strategies: (1) direct binding of receptors to microbial or host-derived ligands or (2) indirect detection of changes in cellular homeostasis. Upon activation, these upstream regulatory factors seed the assembly of inflmmasomes, leading to IL-1 family cytokine release from living (hyperactive) or dead (pyroptotic) cells. The molecular and physiological consequences of these distinct cell fate decisions are discussed.	[Evavold, Charles L.; Kagan, Jonathan C.] Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Evavold, Charles L.; Kagan, Jonathan C.] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Kagan, JC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Harvard Med Sch, Program Immunol, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu		Evavold, Charles/0000-0003-3913-5626	NIH [AI133524, AI093589, AI116550, P30DK34854, AI138369]; Burroughs Wellcome Fund; Harvard Herchel Smith and Landry Cancer Biology Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R01AI116550, U19AI133524, F31AI138369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Herchel Smith and Landry Cancer Biology Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Kagan lab for helpful discussions and Isabella Fraschilla for thoughtful reading of the manuscript. We apologize to members of the community whose studies were not cited herein because of space constraints. This study was supported by NIH grants AI133524, AI093589, AI116550, and P30DK34854 (to J.C.K.) and grant AI138369 (to C.L.E.). J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. C.L.E. is supported by the Harvard Herchel Smith and Landry Cancer Biology Fellowships.	Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; AYALA JM, 1994, J IMMUNOL, V153, P2592; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Baum R, 2015, J IMMUNOL, V194, P873, DOI 10.4049/jimmunol.1402573; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Bryant CE, 2015, CRIT REV BIOCHEM MOL, V50, P359, DOI 10.3109/10409238.2015.1033511; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Carty M, 2019, IMMUNITY, V50, P1412, DOI 10.1016/j.immuni.2019.04.005; Case CL, 2011, MBIO, V2, DOI 10.1128/mBio.00117-11; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chavarria-Smith J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006052; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Chen KW, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6676; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Cheng TC, 2016, ELIFE, V5, DOI 10.7554/eLife.17755; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; de Carvalho RVH, 2019, CELL REP, V26, P429, DOI 10.1016/j.celrep.2018.12.047; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Elliott EI, 2018, J IMMUNOL, V200, P3047, DOI 10.4049/jimmunol.1701723; Erlich Z, 2019, NAT IMMUNOL, V20, P397, DOI 10.1038/s41590-019-0313-5; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Evavold CL, 2018, J MOL BIOL, V430, P217, DOI 10.1016/j.jmb.2017.09.019; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Freigang S, 2016, EUR J IMMUNOL, V46, P1818, DOI 10.1002/eji.201545676; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hafner-Bratkovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07573-4; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jakobs C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131702; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jeru I, 2005, ARTHRITIS RHEUM-US, V52, P1848, DOI 10.1002/art.21050; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Koch SC, 2018, ANNU REV PHYSIOL, V80, P189, DOI 10.1146/annurev-physiol-022516-034303; Kortmann J, 2015, J IMMUNOL, V195, P815, DOI 10.4049/jimmunol.1403100; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li XH, 2017, Int J Nurs Sci, V4, P3, DOI 10.1016/j.ijnss.2017.01.004; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.13; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nagar A, 2019, J IMMUNOL, V202, P1003, DOI 10.4049/jimmunol.1800973; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Rayamajhi M, 2013, J IMMUNOL, V191, P3986, DOI 10.4049/jimmunol.1301549; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ru H, 2013, CELL RES, V23, P855, DOI 10.1038/cr.2013.52; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Ruiz VMR, 2017, P NATL ACAD SCI USA, V114, P13242, DOI 10.1073/pnas.1710433114; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Stoecklein VM, 2015, J IMMUNOL, V194, P1178, DOI 10.4049/jimmunol.1303051; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tan YH, 2017, TRAFFIC, V18, P6, DOI 10.1111/tra.12454; Tzeng TC, 2016, CELL REP, V16, P571, DOI 10.1016/j.celrep.2016.06.011; Vajjhala PR, 2015, J BIOL CHEM, V290, P29217, DOI 10.1074/jbc.M115.687731; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Wang PH, 2018, EMBO REP, V19, DOI 10.15252/embr.201845737; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yeon SH, 2017, J LEUKOCYTE BIOL, V101, P205, DOI 10.1189/jlb.3VMA1215-579RR; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967	157	78	84	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					609	624		10.1016/j.immuni.2019.08.005	http://dx.doi.org/10.1016/j.immuni.2019.08.005			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31473100	Bronze, Green Accepted			2022-12-18	WOS:000490141700009
J	Li, CF; Zhu, BB; Son, YM; Wang, Z; Jiang, L; Xiang, M; Ye, ZQ; Beckermann, KE; Wu, Y; Jenkins, JW; Siska, PJ; Vincent, BG; Prakash, YS; Peikert, T; Edelson, BT; Taneja, R; Kaplan, MH; Rathmell, JC; Dong, HD; Hitosugi, T; Sun, J				Li, Chaofan; Zhu, Bibo; Son, Young Min; Wang, Zheng; Jiang, Li; Xiang, Min; Ye, Zhenqing; Beckermann, Kathryn E.; Wu, Yue; Jenkins, James W.; Siska, Peter J.; Vincent, Benjamin G.; Prakash, Y. S.; Peikert, Tobias; Edelson, Brian T.; Taneja, Reshma; Kaplan, Mark H.; Rathmell, Jeffrey C.; Dong, Haidong; Hitosugi, Taro; Sun, Jie			The Transcription Factor Bhlhe40 Programs Mitochondria! Regulation of Resident CD8(+) T Cell Fitness and Functionality	IMMUNITY			English	Article							TISSUE-RESIDENT; TUMOR MICROENVIRONMENT; DENDRITIC CELLS; MEMORY; INFECTION; PD-L1; ACTIVATION; IMMUNITY; SUPPRESSION; DYSFUNCTION	Tissue-resident memory CD8(+) T (Trm) cells share core residency gene programs with tumor-infiltrating lymphocytes (TILs). However, the transcriptional, metabolic, and epigenetic regulation of Trm cell and TIL development and function is largely undefined. Here, we found that the transcription factor Bhlhe40 was specifically required for Trm cell and TIL development and polyfunctionality. Local PD-1 signaling inhibited TIL Bhlhe40 expression, and Bhlhe40 was critical for TIL reinvigoration following anti-PD-L1 blockade. Mechanistically, Bhlhe40 sustained Trm cell and TIL mitochondria! fitness and a functional epigenetic state. Building on these findings, we identified an epigenetic and metabolic regimen that promoted Trm cell and TIL gene signatures associated with tissue residency and polyfunctionality. This regimen empowered the anti-tumor activity of CD8(+) T cells and possessed therapeutic potential even at an advanced tumor stage in mouse models. Our results provide mechanistic insights into the local regulation of Trm cell and TIL function.	[Li, Chaofan; Zhu, Bibo; Son, Young Min; Wang, Zheng; Jiang, Li; Xiang, Min; Peikert, Tobias; Sun, Jie] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Ye, Zhenqing] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Beckermann, Kathryn E.] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN 37232 USA; [Wu, Yue; Jenkins, James W.; Dong, Haidong; Sun, Jie] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Siska, Peter J.] Univ Hosp Regensburg, Internal Med 3, D-93042 Regensburg, Germany; [Siska, Peter J.; Rathmell, Jeffrey C.] Vanderbilt Univ, Ctr Immunobiol, Med Ctr, Nashville, TN 37232 USA; [Vincent, Benjamin G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Edelson, Brian T.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Taneja, Reshma] Natl Univ Singapore, Dept Physiol, Singapore 117593, Singapore; [Kaplan, Mark H.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hitosugi, Taro] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Vanderbilt University; Mayo Clinic; University of Regensburg; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Washington University (WUSTL); National University of Singapore; Indiana University System; Indiana University Bloomington; Mayo Clinic	Sun, J (corresponding author), Mayo Clin, Dept Med, Rochester, MN 55905 USA.; Sun, J (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	sun.jie@mayo.edu	Ye, Zhenqing/ABF-1433-2020; Taneja, Reshma/F-9658-2014; Li, Chaofan/GMX-4943-2022	Taneja, Reshma/0000-0002-2151-2094; Li, Chaofan/0000-0002-5426-1498; Reshma, Taneja/0000-0001-6214-6177; Prakash, Y S/0000-0002-2968-224X; ZHU, BIBO/0000-0002-1187-4526; Edelson, Brian/0000-0003-2856-7650; Jenkins, James/0000-0001-5694-9707; Siska, Peter/0000-0002-1521-6213	NIH [R01 AI112844, R01 AG047156, R01 HL126647, R01 HL056470, R01 HL126451, R01 AI057459, R01 CA217987, R01 AI113118, R01 AI132653]; Merck-Cancer Research Institute Irvington post-doctoral fellowship; Else Kroner-Fresenius-Stiftung Foundation; NATIONAL CANCER INSTITUTE [R01CA217987] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126451, R01HL056470, R01HL126647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113118, R01AI057459, R01AI112844, R01AI132653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck-Cancer Research Institute Irvington post-doctoral fellowship; Else Kroner-Fresenius-Stiftung Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	thank the NIH tetramer core for the tetramers and H. Zhang for the scRNA-seq analysis. This study was funded by the NIH R01 AI112844, R01 AG047156, and R01 HL126647 (to J.S.); R01 HL056470 and R01 HL126451 (to P.K.S.); R01 AI057459 (to M.H.K.); R01 CA217987 (to J.C.R.); and R01 AI113118 and R01 AI132653 (to B.T.E.). K.H.B. receives funding from the Merck-Cancer Research Institute Irvington post-doctoral fellowship. P.J.S. is supported by the Else Kroner-Fresenius-Stiftung Foundation.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bantug GR, 2018, IMMUNITY, V48, P542, DOI 10.1016/j.immuni.2018.02.012; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Colgan SP, 2016, ANNU REV PATHOL-MECH, V11, P77, DOI 10.1146/annurev-pathol-012615-044231; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dronca RS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86014; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hamieh M, 2019, NATURE, V568, P112, DOI 10.1038/s41586-019-1054-1; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lienlaf M, 2016, MOL ONCOL, V10, P735, DOI 10.1016/j.molonc.2015.12.012; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Ma WS, 2013, ONCOL REP, V30, P2957, DOI 10.3892/or.2013.2774; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Nunez-Andrade N, 2016, J CELL SCI, V129, P1305, DOI 10.1242/jcs.180885; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Qiu J, 2019, CELL REP, V27, P2063, DOI 10.1016/j.celrep.2019.04.022; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Sun J, 2007, J IMMUNOL, V178, P1635, DOI 10.4049/jimmunol.178.3.1635; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yao S, 2015, MUCOSAL IMMUNOL, V8, P746, DOI 10.1038/mi.2014.106; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	75	78	79	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					491	+		10.1016/j.immuni.2019.08.013	http://dx.doi.org/10.1016/j.immuni.2019.08.013			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533057	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000486184600012
J	Tinoco, R; Carrette, F; Barraza, ML; Otero, DC; Magana, J; Bosenberg, MW; Swain, SL; Bradley, LM				Tinoco, Roberto; Carrette, Florent; Barraza, Monique L.; Otero, Dennis C.; Magana, Jonathan; Bosenberg, Marcus W.; Swain, Susan L.; Bradley, Linda M.			PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; SELECTIN GLYCOPROTEIN LIGAND-1; PERSISTENCE IN-VIVO; P-SELECTIN; MALIGNANT-MELANOMA; PD-1; RESPONSES; DELETION; MICE; PROLIFERATION	Chronic viruses and cancers thwart immune responses in humans by inducing T cell dysfunction. Using a murine chronic virus that models human infections, we investigated the function of the adhesion molecule, P-selectin glycoprotein ligand-1 (PSGL-1), that is upregulated on responding T cells. PSGL-1-deficient mice cleared the virus due to increased intrinsic survival of multifunctional effector T cells that had downregulated PD-1 as well as other inhibitory receptors. Notably, this response resulted in CD4(+)-T-cell-dependent immunopathology. Mechanistically, PSGL-1 ligation on exhausted CD8(+) T cells inhibited T cell receptor (TCR) and interleukin-2 (IL-2) signaling and upregulated PD-1, leading to diminished survival with TCR stimulation. In models of melanoma cancer in which T cell dysfunction occurs, PSGL-1 deficiency led to PD-1 downregulation, improved T cell responses, and tumor control. Thus, PSGL-1 plays a fundamental role in balancing viral control and immunopathology and also functions to regulate T cell responses in the tumor microenvironment.	[Tinoco, Roberto; Carrette, Florent; Barraza, Monique L.; Otero, Dennis C.; Magana, Jonathan; Bradley, Linda M.] Sanford Burnham Prebys Med Discovery Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Tinoco, Roberto; Carrette, Florent; Barraza, Monique L.; Otero, Dennis C.; Magana, Jonathan; Bradley, Linda M.] Sanford Burnham Prebys Med Discovery Res Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA; [Tinoco, Roberto] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA; [Swain, Susan L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Yale University; University of Massachusetts System; University of Massachusetts Worcester	Bradley, LM (corresponding author), Sanford Burnham Prebys Med Discovery Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.; Bradley, LM (corresponding author), Sanford Burnham Prebys Med Discovery Res Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA.	lbradley@sbpdiscovery.org		Tinoco, Roberto/0000-0001-5420-9692; Henriquez, Monique/0000-0001-5684-5959	NIH Institutional Research and Academic Career Development Award (IRACDA) [K12 GM068524]; UCSD; NIH [P01-AI046530, R01-AI106895]; Melanoma Research Foundation [322189]; NCI Cancer Center [P30 CA030199]; NATIONAL CANCER INSTITUTE [R21CA209627, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118820, R03AI119990, R01AI106895, P01AI046530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	NIH Institutional Research and Academic Career Development Award (IRACDA); UCSD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Monica Macal, Robert Rickert, and Carl Ware for critical review of the manuscript, Dr. Denise M. Malicki, UCSD Rady Children's Hospital for pathology analysis, and Miguel Reina Campos for assistance with RNA-seq analysis. R.T is supported by the NIH Institutional Research and Academic Career Development Award (IRACDA) K12 GM068524 fellowship and the UCSD Chancellor's Postdoctoral Fellowship. This work was supported by NIH grants P01-AI046530 to S.L.S and L.M.B. and R01-AI106895 and Melanoma Research Foundation grant 322189 to L.M.B. This work was also supported by NCI Cancer Center grant P30 CA030199, which supports the animal, flow cytometry, and histology cores at the La Jolla campus.	Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Borges E, 1997, BLOOD, V90, P1934, DOI 10.1182/blood.V90.5.1934; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Engelhardt B, 2005, J IMMUNOL, V175, P1267, DOI 10.4049/jimmunol.175.2.1267; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Haddad W, 2003, J EXP MED, V198, P369, DOI 10.1084/jem.20020691; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Matsumoto M, 2009, J IMMUNOL, V183, P7204, DOI 10.4049/jimmunol.0902173; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Sullivan JA, 2012, J VIROL, V86, P9025, DOI 10.1128/JVI.00942-12; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Urzainqui A, 2007, J IMMUNOL, V179, P7457, DOI 10.4049/jimmunol.179.11.7457; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; Veerman KM, 2012, J IMMUNOL, V188, P1638, DOI 10.4049/jimmunol.1103026; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zarbock A, 2009, J LEUKOCYTE BIOL, V86, P1119, DOI 10.1189/jlb.0209117; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	47	78	85	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1190	1203		10.1016/j.immuni.2016.04.015	http://dx.doi.org/10.1016/j.immuni.2016.04.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192578	Green Accepted, Bronze			2022-12-18	WOS:000376478500022
J	Dagvadorj, J; Shimada, K; Chen, S; Jones, HD; Tumurkhuu, G; Zhang, WX; Wawrowsky, KA; Crother, TR; Arditi, M				Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Jones, Heather D.; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Wawrowsky, Kolja A.; Crother, Timothy R.; Arditi, Moshe			Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1 alpha Release	IMMUNITY			English	Article							ACUTE LUNG INJURY; INFLAMMATORY RESPONSE; BACTERIAL LIPOPOLYSACCHARIDE; ENDOTHELIAL-CELLS; MOUSE MODEL; IN-VIVO; STERILE INFLAMMATION; SIGNALING PATHWAY; P2X(7) RECEPTORS; ALPHA PRODUCTION	Acute lung injury (ALI) remains a serious health issue with little improvement in our understanding of the pathophysiology and therapeutic approaches. We investigated the mechanism that lipopolysaccharide (LPS) induces early neutrophil recruitment to lungs and increases pulmonary vascular permeability during ALI. Intratracheal LPS induced release of pro-interleukin-1 alpha (IL-1 alpha) from necrotic alveolar macrophages (AM), which activated endothelial cells (EC) to induce vascular leakage via loss of vascular endothelial (VE)-cadherin. LPS triggered the AM purinergic receptor P2X7(R) to induce Ca2+ influx and ATP depletion, which led to necrosis. P2X7R deficiency significantly reduced necrotic death of AM and release of pro-IL-1 alpha into the lung. CD14 was required for LPS binding to P2X7R, as CD14 neutralization significantly diminished LPS induced necrotic death of AM and pro-IL-1 alpha release. These results demonstrate a key role for pro-IL-1 alpha from necrotic alveolar macrophages in LPS-mediated ALI, as a critical initiator of increased vascular permeability and early neutrophil infiltration.	[Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis, Los Angeles, CA 90048 USA; [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Div Immunol, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Chen, Shuang; Jones, Heather D.; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Los Angeles, CA 90048 USA; [Jones, Heather D.] Cedars Sinai Med Ctr, Div Pulm & Crit Care Med, Los Angeles, CA 90048 USA; [Wawrowsky, Kolja A.] Cedars Sinai Med Ctr, Confocal Core, Los Angeles, CA 90048 USA; [Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Arditi, M (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.	moshe.arditi@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health (NIH) [RO1AI-067995, 2R56AI067995-06]; American Heart Association [13BGIA17220050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067995, R01AI067995] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants RO1AI-067995 and 2R56AI067995-06 to M.A. K.S. is supported by the American Heart Association 13BGIA17220050. The authors would like to thank Ganghua Huang and Polly Sun for technical support and Bill Parks for his help in the editing of this manuscript.	Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brunn GJ, 2008, CIRC RES, V102, P823, DOI 10.1161/CIRCRESAHA.107.165332; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han JL, 2013, THROMB RES, V132, pE42, DOI 10.1016/j.thromres.2013.03.010; HARMSEN AG, 1988, INFECT IMMUN, V56, P1858, DOI 10.1128/IAI.56.8.1858-1863.1988; Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kitchens RL, 1998, J IMMUNOL, V161, P5534; Kitchens RL, 1998, J IMMUNOL, V160, P1920; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Leiva-Salcedo E, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/152625; Lemaire I, 2003, DRUG DEVELOP RES, V59, P118, DOI 10.1002/ddr.10209; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Mishra A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-26; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Myrtek D, 2008, J IMMUNOL, V181, P2181, DOI 10.4049/jimmunol.181.3.2181; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399; SALGADO A, 1994, HAEMOSTASIS, V24, P132; Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a; Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615, DOI 10.1002/jlb.64.5.615; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Tanabe M, 2005, J MED MICROBIOL, V54, P7, DOI 10.1099/jmm.0.45736-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741; ULICH TR, 1991, AM J PATHOL, V138, P521; ULICH TR, 1991, AM J PATHOL, V138, P1097; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Xing JJ, 2012, MICROVASC RES, V83, P194, DOI 10.1016/j.mvr.2011.09.012; Zanoni I, 2010, IMMUNOBIOLOGY, V215, P709, DOI 10.1016/j.imbio.2010.05.026; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	69	78	82	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					640	653		10.1016/j.immuni.2015.03.007	http://dx.doi.org/10.1016/j.immuni.2015.03.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25862090	Green Accepted, Bronze			2022-12-18	WOS:000353347500011
J	Kobayashi, T; Shimabukuro-Demoto, S; Yoshida-Sugitani, R; Furuyama-Tanaka, K; Karyu, H; Sugiura, Y; Shimizu, Y; Hosaka, T; Goto, M; Kato, N; Okamura, T; Suematsu, M; Yokoyama, S; Toyama-Sorimachi, N				Kobayashi, Toshihiko; Shimabukuro-Demoto, Shiho; Yoshida-Sugitani, Reiko; Furuyama-Tanaka, Kaori; Karyu, Hitomi; Sugiura, Yuki; Shimizu, Yukiko; Hosaka, Toshiaki; Goto, Motohito; Kato, Norihiro; Okamura, Tadashi; Suematsu, Makoto; Yokoyama, Shigeyuki; Toyama-Sorimachi, Noriko			The Histidine Transporter SLC15A4 Coordinates mTOR-Dependent Inflammatory Responses and Pathogenic Antibody Production	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; I INTERFERON; T-BET; INDUCTION; RECOGNITION; ACTIVATION; EXPRESSION; REGULATOR	SLC15A4 is a lysosome-resident, proton-coupled amino-acid transporter that moves histidine and oligopeptides from inside the lysosome to the cytosol of eukaryotic cells. SLC15A4 is required for Toll-like receptor 7 (TLR7)-and TLR9-mediated type I interferon (IFN-I) productions in plasmacytoid dendritic cells (pDCs) and is involved in the pathogenesis of certain diseases including lupus-like autoimmunity. How SLC15A4 contributes to diseases is largely unknown. Here we have shown that B cell SLC15A4 was crucial for TLR7-triggered IFN-I and autoantibody productions in a mouse lupus model. SLC15A4 loss disturbed the endolysosomal pH regulation and probably the v-ATPase integrity, and these changes were associated with disruption of the mTOR pathway, leading to failure of the IFN regulatory factor 7 (IRF7)-IFN-I regulatory circuit. Importantly, SLC15A4' s transporter activity was necessary for the TLR-triggered cytokine production. Our findings revealed that SLC15A4-mediated optimization of the endolysosomal state is integral to a TLR7-triggered, mTOR-dependent IRF7-IFN-I circuit that leads to autoantibody production.	[Kobayashi, Toshihiko; Shimabukuro-Demoto, Shiho; Yoshida-Sugitani, Reiko; Furuyama-Tanaka, Kaori; Karyu, Hitomi; Toyama-Sorimachi, Noriko] Natl Ctr Global Hlth & Med, Dept Mol Immunol & Inflammat, Res Inst, Shinjuku Ku, Toyama, Tokyo 1, Japan; [Sugiura, Yuki; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo 1608582, Japan; [Sugiura, Yuki] JST Precursory Res Embryon Sci & Technol PRESTO P, Kawaguchi, Saitama 3320012, Japan; [Shimizu, Yukiko; Goto, Motohito; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Infect Dis, Shinjuku Ku, Tokyo 1628655, Japan; [Hosaka, Toshiaki; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Shinjuku Ku, Tokyo 1628655, Japan; [Suematsu, Makoto] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO Suematsu Gas Bi, Tokyo 1608582, Japan	National Center for Global Health & Medicine - Japan; Keio University; National Center for Global Health & Medicine - Japan; RIKEN; National Center for Global Health & Medicine - Japan; Japan Science & Technology Agency (JST)	Kobayashi, T (corresponding author), Natl Ctr Global Hlth & Med, Dept Mol Immunol & Inflammat, Res Inst, Shinjuku Ku, 1-21-1 Toyama, Toyama, Tokyo 1, Japan.	tkobayashi@ri.ncgm.go.jp; nsorima@ri.ncgm.go.jp	Suematsu, Makoto/O-5762-2018; Yokoyama, Shigeyuki/N-6911-2015; Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336; Yokoyama, Shigeyuki/0000-0003-3133-7338; Suematsu, Makoto/0000-0002-7165-6336; Kobayashi, Toshihiko/0000-0002-3238-1544; Sugiura, Yuki/0000-0002-6983-8958; yuan ren, hou teng/0000-0001-6288-4583	Funding Program for Next Generation World-Leading Researchers (Next Program) [LS134]; Ministry of Education, Science, Sports and Culture of Japan [21390123, 25871165]; National Center for Global Health and Medicine [23S001]; Grants-in-Aid for Scientific Research [25871165] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (Next Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Tamura-Nakano (National Center for Global Health and Medicine) for technical assistance with the electron microscopy; P.M. Pitha (Johns Hopkins University) for the human IRF3-GFP and IRF7-GFP expression vectors; S. Takaki (National Center for Global Health and Medicine) for the mu MT mice; T. Taniguchi (University of Tokyo) for the Irf7<SUP>-/-</SUP> mice; and Y. Wada (Osaka University) and G.H. Sun-Wada (Doshisha Women's College) for the anti-V0a2 antibody. We also thank H. Karasuyama and Y. Kawano (Tokyo Medical and Dental University), K. Miyake (University of Tokyo), L.A. Miglietta, and G.E. Gray for critical reading of this manuscript; T. Maeda (University of Tokyo) for advice regarding the mTOR pathway; and M. Shirouzu, T. Kimura-Someya, S. Saito, N. Tanimura, and H. Sorimachi for helpful discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers (Next Program; for N.T.-S., LS134), grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (for N.T.-S., 21390123, for T.K., 25871165), and a grant from the National Center for Global Health and Medicine (for N.T.-S., 23S001).	Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Nguyen HV, 2012, BLOOD, V119, P4174, DOI 10.1182/blood-2011-09-378182; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Nephritis L, 2008, AM J PATHOL, V172, P275, DOI 10.2353/ajpath.2008.070563; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Sakai H, 2006, J PHYSIOL-LONDON, V576, P417, DOI 10.1113/jphysiol.2006.117176; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Takeuchi F, 2008, J HUM GENET, V53, P314, DOI 10.1007/s10038-008-0254-6; Wang C, 2013, EUR J HUM GENET, V21, P994, DOI 10.1038/ejhg.2012.277; Xu LY, 2009, PHARM RES-DORDR, V26, P2358, DOI 10.1007/s11095-009-9952-9; Xu WF, 2005, J IMMUNOL, V175, P7419, DOI 10.4049/jimmunol.175.11.7419; Xu Y, 2012, J IMMUNOL, V188, P4113, DOI 10.4049/jimmunol.1103113; Yamashita T, 1997, J BIOL CHEM, V272, P10205; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	78	84	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					375	388		10.1016/j.immuni.2014.08.011	http://dx.doi.org/10.1016/j.immuni.2014.08.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238095	Bronze			2022-12-18	WOS:000342626500009
J	Garin, A; Meyer-Hermann, M; Contie, M; Figge, MT; Buatois, V; Gunzer, M; Toellner, KM; Elson, G; Kosco-Vilbois, MH				Garin, Alexandre; Meyer-Hermann, Michael; Contie, Mathias; Figge, Marc Thilo; Buatois, Vanessa; Gunzer, Matthias; Toellner, Kai-Michael; Elson, Greg; Kosco-Vilbois, Marie H.			Toll-like Receptor 4 Signaling by Follicular Dendritic Cells Is Pivotal for Germinal Center Onset and Affinity Maturation	IMMUNITY			English	Article							LOW-DENSITY-LIPOPROTEIN; CENTER B-CELLS; ANTIBODY-RESPONSES; IMMUNITY; LYMPHOTOXIN; INNATE; PATHWAYS; ADHESION; MICE; PROLIFERATION	Germinal centers (GCs) are specialized microenvironments where antigen-activated B cells undergo proliferation, immunoglobulin (Ig) class switch recombination, somatic hypermutation (SHM), and affinity maturation. Within GCs, follicular dendritic cells (FDCs) are key players in driving these events via direct interaction with GC B cells. Here, we provide in vivo evidence that FDCs express and upregulate Toll-like-receptor (TLR) 4 in situ during germinal center reactions, confirm that their maturation is driven by TLR4, and associate the role of FDC-expressed TLR4 with quantitative and qualitative affects of GC biology. In iterative cycles of predictions by in silico modeling subsequently verified by in vivo experiments, we demonstrated that TLR4 signaling modulates FDC activation, strongly impacting SHM and generation of Ig class-switched high-affinity plasma and memory B cells. Thus, our data place TLR4 in the heart of adaptive humoral immunity, providing further insight into mechanisms driving GCs arising in both health and disease.	[Garin, Alexandre; Contie, Mathias; Buatois, Vanessa; Elson, Greg; Kosco-Vilbois, Marie H.] NovImmune SA, CH-1228 Plan Les Ouates, Switzerland; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res HZI, Dept Syst Immunol, D-38124 Braunschweig, Germany; [Meyer-Hermann, Michael; Figge, Marc Thilo] FIAS, D-60438 Frankfurt, Germany; [Gunzer, Matthias] Otto Von Guericke Univ, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany; [Toellner, Kai-Michael] Univ Birmingham, Coll Med & Dent Sci, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	NovImmune SA; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; University of Birmingham	Kosco-Vilbois, MH (corresponding author), NovImmune SA, 14 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland.	mkosco-vilbois@novimmune.com	Gunzer, Matthias/AAW-7026-2021; Toellner, Kai-Michael/F-1519-2011; Figge, Marc Thilo/J-7547-2017	Gunzer, Matthias/0000-0002-5534-6055; Toellner, Kai-Michael/0000-0001-8404-645X; Figge, Marc Thilo/0000-0002-4044-9166	EU; ALTANA AG; Medical Research Council [G9818340B] Funding Source: researchfish	EU(European Commission); ALTANA AG; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors want to thank J.L. Witztum for providing us with the EO6 Ab and B. Huard for technical assistance. This research was supported by the EU within the NEST project MAMOCELL. MM-H. is supported by ALTANA AG. V.B., G.E., and M.H.K.-V. are employees and shareholders of Novlmmune SA.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aydar Y, 2005, J IMMUNOL, V174, P5358, DOI 10.4049/jimmunol.174.9.5358; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; El Shikh MEM, 2007, J IMMUNOL, V179, P4444, DOI 10.4049/jimmunol.179.7.4444; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; Furtado GC, 2007, P NATL ACAD SCI USA, V104, P5026, DOI 10.1073/pnas.0606697104; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; HUMPHREY JH, 1984, EUR J IMMUNOL, V14, P859, DOI 10.1002/eji.1830140916; Husson H, 2000, CELL IMMUNOL, V203, P134, DOI 10.1006/cimm.2000.1688; Hwang IY, 2009, J EXP MED, V206, P2641, DOI 10.1084/jem.20091982; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwamura C, 2008, CURR ALLERGY ASTHM R, V8, P7, DOI 10.1007/s11882-008-0003-0; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; KOSCO MH, 1992, J IMMUNOL, V148, P2331; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; LINDHOUT E, 1993, CLIN EXP IMMUNOL, V91, P330; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Meyer-Hermann M, 2001, J THEOR BIOL, V210, P265, DOI 10.1006/jtbi.2001.2297; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Park CS, 2004, J IMMUNOL, V173, P6676, DOI 10.4049/jimmunol.173.11.6676; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; PHIPPS RP, 1981, CELL IMMUNOL, V57, P505, DOI 10.1016/0008-8749(81)90108-8; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; VAN OR, 1994, EUR J IMMUNOL, V24, P1396; Wheeler DS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-31; Wu YZ, 2008, J IMMUNOL, V180, P281, DOI 10.4049/jimmunol.180.1.281	42	78	79	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					84	95		10.1016/j.immuni.2010.07.005	http://dx.doi.org/10.1016/j.immuni.2010.07.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643339	Bronze			2022-12-18	WOS:000280418100012
J	Calame, K				Calame, Kathryn			MicroRNA-155 function in B cells	IMMUNITY			English	Editorial Material							LYMPHOMAS; RNA	Vigorito et al. (2007) report (in this issue of Immunity) that B cells require microRNA (miR)-155 for normal production of isotype-switched, high-affinity antibodies and for a memory response. They identify transcriptional regulator Pu.1 as a functionally important target of miR-155 in B cells.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Calame, K (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	klc1@columbia.edu						Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Singh H, 2007, ADV EXP MED BIOL, V596, P57; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009	10	78	80	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					825	827		10.1016/j.immuni.2007.11.010	http://dx.doi.org/10.1016/j.immuni.2007.11.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093533	Bronze			2022-12-18	WOS:000251907300001
J	Blonska, M; Pappu, BP; Matsumoto, R; Li, HX; Su, B; Wang, DM; Lin, X				Blonska, Marzenna; Pappu, Bhanu P.; Matsumoto, Reiko; Li, Hongxiu; Su, Bing; Wang, Demin; Lin, Xin			The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway	IMMUNITY			English	Article							NF-KAPPA-B; POSITIVE REGULATOR; MICE LACKING; PHOSPHORYLATION; LYMPHOCYTE; ACTIVATION; BCL10; REQUIREMENT; RECRUITMENT; APOPTOSIS	Members of the c-Jun NH2-terminal kinase (JNK) family play crucial roles in cell activation, differentiation, and apoptosis. Although many studies have indicated that JNK1 and JNK2 have functional differences and redundancy, the upstream signaling pathway that selectively activates JNK1 or JNK2 remains unknown. In this study, we have revealed a selective mechanism of JNK activation, in which JNK2, but not JNK1, was regulated by CARMA1, a scaffold molecule, after stimulation of the T cell receptor (TCR). This CARMA1-dependent regulation of JNK2 worked through the scaffold molecule Bcl10, which was inducibly associated with JNK2 and served as a JNK-interacting protein (JIP)-like scaffold to assemble the kinases JNK2, MKK7, and TAK1. Finally, we showed that CARMA1- and Bcl10-mediated JNK2 activation had a critical role in regulating the amount of c-Jun protein. Together, our studies provide genetic evidence that JNK1 and JNK2 are differentially regulated in the TCR-signaling pathway and play different functions.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Lin, X (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	xllin@mdanderson.org	Blonska, Marzenna/U-7751-2019; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795; Blonska, Marzenna/0000-0001-5237-8732	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899, R56GM065899] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL073284] Funding Source: Medline; NIAID NIH HHS [R56 AI050848, R01 AI050848, AI050848] Funding Source: Medline; NIGMS NIH HHS [GM065899, R56 GM065899, R01 GM065899] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	36	78	82	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					55	66		10.1016/j.immuni.2006.11.008	http://dx.doi.org/10.1016/j.immuni.2006.11.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17189706	Bronze, Green Accepted			2022-12-18	WOS:000243959000009
J	Khaled, AR; Li, WQ; Huang, JQ; Fry, TJ; Khaled, AS; Mackall, CL; Muegge, K; Young, HA; Durum, SK				Khaled, AR; Li, WQ; Huang, JQ; Fry, TJ; Khaled, AS; Mackall, CL; Muegge, K; Young, HA; Durum, SK			Bax deficiency partially corrects interleukin-7 receptor alpha deficiency	IMMUNITY			English	Article							BCL-2 FAMILY MEMBERS; T-CELL DEVELOPMENT; FORKHEAD TRANSCRIPTION FACTOR; GAMMA GENE REARRANGEMENT; THYMOCYTE DEVELOPMENT; INTRACELLULAR PH; IL-7 RECEPTOR; IN-VIVO; MICE; SURVIVAL	The requirement for cytokines in hematopoiesis is partly attributable to the protection of cells from apoptosis. Since IL-7 is required for normal T cell development, we evaluated the role of Bax in vivo by generating mice deficient in both Bax and the IL-7 receptor a chain (IL-7R). Starting at birth, we observed complete recovery of all stages of (3 thymocyte development up to 4 weeks of age. However, by 12 weeks of age, thymic cellularity had reverted to that of mice deficient in IL-7R alone. The BH3 only proteins, Bad and Bim, were also part of the death pathway repressed by IL-7. Thus, in young mice, Bax emerges as an essential protein in the death pathway induced by IL-7 deficiency.	NCI, Mol Immunoregulat Lab, Canc Res Ctr, Frederick, MD 21702 USA; NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; Univ Miami, Dept Pathol, Miami, FL 33136 USA; SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA; NCI, Expt Immunol Lab, Canc Res Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Durum, SK (corresponding author), NCI, Mol Immunoregulat Lab, Canc Res Ctr, Frederick, MD 21702 USA.		Huang, Jiaqiang/C-2375-2011; Young, Howard/A-6350-2008	Huang, Jiaqiang/0000-0002-6610-8159; Young, Howard/0000-0002-3118-5111; durum, scott/0000-0003-1307-9582				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Candeias S, 1997, IMMUNOL LETT, V57, P9, DOI 10.1016/S0165-2478(97)00062-X; Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; delPeso L, 1997, SCIENCE, V278, P687; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Khaled AR, 2001, J BIOL CHEM, V276, P6453, DOI 10.1074/jbc.M006391200; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim K, 1998, J IMMUNOL, V160, P5735; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Lee CK, 2001, BLOOD, V97, P1360, DOI 10.1182/blood.V97.5.1360; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Makino K, 1996, COLLOID SURFACE B, V8, P93, DOI 10.1016/S0927-7765(96)01313-6; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; Matsuzaki Y, 1997, BLOOD, V89, P853, DOI 10.1182/blood.V89.3.853; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Nakajima H, 1999, J IMMUNOL, V162, P782; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Vacchio MS, 2000, SEMIN IMMUNOL, V12, P475, DOI 10.1006/smim.2000.0265; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wen RR, 2001, MOL CELL BIOL, V21, P678, DOI 10.1128/MCB.21.2.678-689.2001; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	48	78	78	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					561	573		10.1016/S1074-7613(02)00450-8	http://dx.doi.org/10.1016/S1074-7613(02)00450-8			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433363	Bronze			2022-12-18	WOS:000179335100003
J	Baldwin, WM; Larsen, CP; Fairchild, RL				Baldwin, WM; Larsen, CP; Fairchild, RL			Innate immune responses to transplants: A significant variable with cadaver donors	IMMUNITY			English	Review							NATURAL-KILLER-CELLS; C-REACTIVE PROTEIN; P-SELECTIN; ISCHEMIA/REPERFUSION INJURY; ADHESION MOLECULES; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; ACUTE REJECTION; TISSUE FACTOR; IN-VIVO		Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Emory Univ, Atlanta, GA 30322 USA; Cleveland Clin Fdn, Inst Urol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA	Johns Hopkins University; Johns Hopkins Medicine; Emory University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Baldwin, WM (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	wbaldwin@jhmi.edu	Larsen, Christian P./B-6906-2012	Larsen, Christian P./0000-0001-6573-2649	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040519, R01AI042387, R37AI040519, R21AI042387, R01AI040459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050762] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56091] Funding Source: Medline; NIAID NIH HHS [AI40459, R01 AI040459, AI40519, AI42387] Funding Source: Medline; NIAMS NIH HHS [AR42687] Funding Source: Medline; NIDDK NIH HHS [DK50762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNAOUT MA, 1984, J CLIN INVEST, V74, P1291, DOI 10.1172/JCI111539; Ayalon O, 1998, P NATL ACAD SCI USA, V95, P2435, DOI 10.1073/pnas.95.5.2435; Bajtay Z, 2000, EUR J IMMUNOL, V30, P1706, DOI 10.1002/1521-4141(200006)30:6<1706::AID-IMMU1706>3.0.CO;2-2; Baldwin WM, 1999, TRANSPLANTATION, V68, P894, DOI 10.1097/00007890-199909270-00024; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bingaman AW, 2000, J IMMUNOL, V164, P3065, DOI 10.4049/jimmunol.164.6.3065; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BLAKELY ML, 1994, TRANSPLANTATION, V58, P1059, DOI 10.1097/00007890-199411270-00001; BLANCHO G, 1992, TRANSPLANTATION, V53, P1242, DOI 10.1097/00007890-199206000-00014; BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; Chandraker A, 1997, KIDNEY INT, V52, P1678, DOI 10.1038/ki.1997.502; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Collinge M, 1998, J IMMUNOL, V161, P1589; D'Alessandro AM, 1998, SURGERY, V124, P604, DOI 10.1067/msy.1998.91482; DiScipio RG, 1999, J IMMUNOL, V162, P1127; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; EMBER JA, 1994, AM J PATHOL, V144, P393; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; FOREMAN KE, 1994, J CLIN INVEST, V94, P1147, DOI 10.1172/JCI117430; Gourlay WA, 1998, TRANSPLANTATION, V65, P727, DOI 10.1097/00007890-199803150-00021; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; HALLORAN PF, 1992, J IMMUNOL, V148, P3837; Harris KR, 1996, TRANSPLANTATION, V61, P1593, DOI 10.1097/00007890-199606150-00008; HATTORI R, 1989, J BIOL CHEM, V264, P9053; HEIDECKE CD, 1985, TRANSPLANTATION, V40, P441; Kilgore KS, 1996, AM J PATHOL, V149, P953; Kondo T, 2000, TRANSPLANTATION, V69, P969; KUMMER JA, 1995, KIDNEY INT, V47, P70, DOI 10.1038/ki.1995.8; LACHMANN PJ, 1991, IMMUNOL TODAY, V12, P312, DOI 10.1016/0167-5699(91)90005-E; Lanier LL, 1998, CELL, V92, P705, DOI 10.1016/S0092-8674(00)81398-7; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lovik G, 2000, EUR J IMMUNOL, V30, P3355, DOI 10.1002/1521-4141(2000012)30:12<3355::AID-IMMU3355>3.0.CO;2-1; Manilay JO, 1998, CURR OPIN IMMUNOL, V10, P532, DOI 10.1016/S0952-7915(98)80219-7; MARKUS PM, 1991, TRANSPL P, V23, P178; McDouall RM, 1997, TRANSPLANTATION, V64, P1175, DOI 10.1097/00007890-199710270-00016; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Nataf S, 1999, J IMMUNOL, V162, P4018; NEMLANDER A, 1983, EUR J IMMUNOL, V13, P348, DOI 10.1002/eji.1830130415; Petersson E, 1997, CELL IMMUNOL, V175, P25, DOI 10.1006/cimm.1996.1031; Pratt JR, 2000, AM J PATHOL, V157, P825, DOI 10.1016/S0002-9440(10)64596-8; Qian ZP, 1999, AM J PATHOL, V155, P1293, DOI 10.1016/S0002-9440(10)65231-5; Rovere P, 2000, BLOOD, V96, P4300; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I; Szalai AJ, 2000, J IMMUNOL, V165, P1030, DOI 10.4049/jimmunol.165.2.1030; Takada M, 1997, J CLIN INVEST, V99, P2682, DOI 10.1172/JCI119457; TAUB DD, 1995, J IMMUNOL, V155, P3877; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; Timonen T, 1997, J LEUKOCYTE BIOL, V62, P693, DOI 10.1002/jlb.62.6.693; TIMONEN T, 1988, J IMMUNOL, V141, P1041; Tsuji RF, 2000, J IMMUNOL, V165, P1588, DOI 10.4049/jimmunol.165.3.1588; Van Loo AA, 1998, J AM SOC NEPHROL, V9, P473; WATSON CA, 1995, J IMMUNOL, V154, P3222; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; Wilhelm MJ, 2000, CIRCULATION, V102, P2426, DOI 10.1161/01.CIR.102.19.2426; Wolbink GJ, 1996, J IMMUNOL, V157, P473; Yoneda O, 2000, J IMMUNOL, V164, P4055, DOI 10.4049/jimmunol.164.8.4055; ZHU W, 1994, BIOCHEM BIOPH RES CO, V200, P389, DOI 10.1006/bbrc.1994.1461	62	78	79	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2001	14	4					369	376		10.1016/S1074-7613(01)00117-0	http://dx.doi.org/10.1016/S1074-7613(01)00117-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336682	Bronze			2022-12-18	WOS:000168246700004
J	Huseby, ES; Sather, B; Huseby, PG; Goverman, J				Huseby, ES; Sather, B; Huseby, PG; Goverman, J			Age-dependent T cell tolerance and autoimmunity to myelin basic protein	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; DEVELOPMENTAL REGULATION; GENE-EXPRESSION; HUMAN THYMUS; MOUSE-BRAIN; IN-VIVO; TRANSCRIPTION; REPERTOIRE; THYMOCYTES; ANTIGENS	Experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, is induced by activating a subset of myelin basic protein (MBP)-specific T cells that have escaped tolerance induction. Here, we define the tolerance mechanisms that eliminate the majority of MBP-specific T cells from the periphery. We show that MBP-specific T cells undergo central tolerance mediated by bone marrow-derived antigen-presenting cells presenting exogenously derived MBP epitopes. The efficiency of tolerance is age dependent, reflecting the developmentally regulated expression of MBP. Dependence of tolerance on the amount of MBP expressed in vivo results in an age window of susceptibility to EAE in mice that peaks during puberty. These results suggest that facto rs regulating expression of self-antigens in vivo can influence susceptibility to autoimmunity.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goverman, J (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.			Goverman, Joan/0000-0002-7361-9424	NCI NIH HHS [CA09537-13] Funding Source: Medline; NIA NIH HHS [P30AG13280] Funding Source: Medline; NINDS NIH HHS [R01NS35126] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013280] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; BARBARESE E, 1978, J NEUROCHEM, V31, P779, DOI 10.1111/j.1471-4159.1978.tb00110.x; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; DUPOUEY P, 1979, NEUROSCI LETT, V12, P113, DOI 10.1016/0304-3940(79)91490-3; FRITZ RB, 1995, J NEUROIMMUNOL, V57, P93, DOI 10.1016/0165-5728(94)00167-M; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Huseby ES, 1999, J IMMUNOL, V163, P1115; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; KURTZKE JF, 1997, MULTIPLE SCLEROSIS C, P91; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Landry CF, 1996, J NEUROSCI, V16, P2452; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; MASON K, 1995, J IMMUNOL, V154, P5216; MATHISEN PM, 1993, P NATL ACAD SCI USA, V90, P10125, DOI 10.1073/pnas.90.21.10125; MCFARLAND HF, 1997, MULTIPLE SCLEROSIS C, P205; Miller JFAP, 1998, IMMUNOL REV, V165, P267, DOI 10.1111/j.1600-065X.1998.tb01244.x; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PEREIRA RA, 1994, J EXP MED, V180, P841, DOI 10.1084/jem.180.3.841; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; Singer A, 1999, SEMIN IMMUNOL, V11, P273, DOI 10.1006/smim.1999.0183; SPAIN LM, 1992, J EXP MED, V176, P213, DOI 10.1084/jem.176.1.213; Stockinger B, 1999, Adv Immunol, V71, P229; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Van Parijs L, 1998, SCIENCE, V280, P243; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	44	78	78	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					471	481		10.1016/S1074-7613(01)00127-3	http://dx.doi.org/10.1016/S1074-7613(01)00127-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336692	Bronze			2022-12-18	WOS:000168246700014
J	Reich-Zeliger, S; Zhao, Y; Krauthgamer, R; Bachar-Lustig, E; Reisner, Y				Reich-Zeliger, S; Zhao, Y; Krauthgamer, R; Bachar-Lustig, E; Reisner, Y			Anti-third party CD8(+) CTLs as potent veto cells: Coexpression of CD8 and FasL is a prerequisite	IMMUNITY			English	Article							BONE-MARROW TRANSPLANTATION; VERSUS-HOST DISEASE; SUBLETHALLY IRRADIATED MICE; LYMPHOID RADIATION CHIMERAS; CYTOTOXIC T-LYMPHOCYTES; CYTO-TOXIC RESPONSES; CLASS-I MHC; PROGENITOR CELLS; STEM-CELLS; TOLERANCE INDUCTION	Several bone marrow cells and lymphocyte subpopulations, known as "veto cells," were shown to induce transplantation tolerance across major histocompatibility antigens. Recently, it has been suggested that anti-third party CTLs depleted of alloreactivity are endowed with marked veto activity and therefore might potentially facilitate bone marrow allografting without graft versus host disease (GVHD). The veto mechanism is still obscure. While early studies emphasized the role of CD8-mediated apoptosis, more recent evidence indicates a role for Fas-FasL. In the present study we show, by using blocking anti-CD8 antibody, by generating CTLs from FasL or perforin mutated mice, and by gene transfer of FasL, that the veto activity of anti-third party CD8(+) CTLs is dependent upon the simultaneous expression of both CD8 and FasL.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reisner, Y (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.		Reisner, Yair/AAA-4772-2019	Reisner, Yair/0000-0002-3354-6945				Asiedu C, 1999, TRANSPLANTATION, V67, P372, DOI 10.1097/00007890-199902150-00006; AUPHAN N, 1992, INT IMMUNOL, V4, P1419, DOI 10.1093/intimm/4.12.1419; AVERSA F, 1994, BLOOD, V84, P3948, DOI 10.1182/blood.V84.11.3948.bloodjournal84113948; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bachar-Lustig E, 1999, BLOOD, V94, P3212, DOI 10.1182/blood.V94.9.3212.421k29_3212_3221; BACHARLUSTIG E, 1995, NAT MED, V1, P1268, DOI 10.1038/nm1295-1268; BACHERLUSTIG E, 2000, IN PRESS TRANSPLANT; Bergenthal A, 1998, EUR J IMMUNOL, V28, P1911, DOI 10.1002/(SICI)1521-4141(199806)28:06<1911::AID-IMMU1911>3.0.CO;2-N; Berke G, 1997, HUM IMMUNOL, V54, P1, DOI 10.1016/S0198-8859(97)00009-8; CASSELL DJ, 1990, J IMMUNOL, V144, P4075; CAVAZZANACALVO M, 1994, BLOOD, V83, P288; CLAESSON MH, 1987, CELL IMMUNOL, V109, P360, DOI 10.1016/0008-8749(87)90319-4; CLAESSON MH, 1984, J EXP MED, V160, P1702, DOI 10.1084/jem.160.6.1702; CLAESSON MH, 1989, SCAND J IMMUNOL, V29, P493, DOI 10.1111/j.1365-3083.1989.tb01150.x; COBBOLD SP, 1986, NATURE, V323, P164, DOI 10.1038/323164a0; FAKTOROWICH Y, 1993, BONE MARROW TRANSPL, V12, P15; FINK PJ, 1984, J IMMUNOL, V133, P1775; FINK PJ, 1988, ANNU REV IMMUNOL, V6, P115; FINK PJ, 1984, J IMMUNOL, V133, P1769; George JF, 1998, NAT MED, V4, P333, DOI 10.1038/nm0398-333; Green WR, 1999, IMMUNOL REV, V168, P271, DOI 10.1111/j.1600-065X.1999.tb01298.x; Gribben JG, 1996, BLOOD, V87, P4887, DOI 10.1182/blood.V87.11.4887.bloodjournal87114887; HIRUMA K, 1992, J EXP MED, V175, P863, DOI 10.1084/jem.175.3.863; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KAUFMAN CL, 1994, BLOOD, V84, P2436; KIKUYA S, 1988, P NATL ACAD SCI USA, V85, P4824; KIYOSHI H, 1992, J EXP MED, V175, P863; Korb LC, 1999, J IMMUNOL, V162, P6401; LAPIDOT T, 1990, P NATL ACAD SCI USA, V87, P4595, DOI 10.1073/pnas.87.12.4595; LAPIDOT T, 1988, J IMMUNOL, V141, P2619; LAPIDOT T, 1992, BLOOD, V80, P2406; Li JH, 1998, J IMMUNOL, V161, P3943; MILLER AD, 1993, METHOD ENZYMOL, V217, P271; MILLER RG, 1980, NATURE, V287, P544, DOI 10.1038/287544a0; PIERCE GE, 1993, TRANSPLANTATION, V55, P882, DOI 10.1097/00007890-199304000-00037; PIERCE GE, 1993, TRANSPLANT P, V25, P331; Qi Y, 1996, J EXP MED, V183, P1973, DOI 10.1084/jem.183.5.1973; Rachamim N, 1998, TRANSPLANTATION, V65, P1386, DOI 10.1097/00007890-199805270-00017; RAMMENSEE HG, 1984, J IMMUNOL, V133, P2390; Reisner Y, 1999, ANN NY ACAD SCI, V872, P336, DOI 10.1111/j.1749-6632.1999.tb08478.x; REISNER Y, 1995, IMMUNOL TODAY, V16, P437, DOI 10.1016/0167-5699(95)80021-2; Rich RF, 1999, J VIROL, V73, P3826, DOI 10.1128/JVI.73.5.3826-3834.1999; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; SAMBHARA SR, 1994, J IMMUNOL, V152, P1103; SAMBHARA SR, 1991, SCIENCE, V252, P1424; STROBER S, 1987, J IMMUNOL, V138, P699; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; Sykes M, 1997, NAT MED, V3, P783, DOI 10.1038/nm0797-783; TSCHERNING T, 1993, EXP CLIN IMMUNOGENET, V10, P179; TSCHERNING T, 1991, IMMUNOL LETT, V29, P223, DOI 10.1016/0165-2478(91)90174-9; UHAREK L, 1992, BLOOD, V79, P1612; Woodward JE, 1996, TRANSPLANTATION, V62, P1011, DOI 10.1097/00007890-199610150-00021; YANAGIE H, 1993, TRANSPL P, V25, P350; ZHANG L, 1994, J IMMUNOL, V152, P2222	55	78	86	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					507	515		10.1016/S1074-7613(00)00050-9	http://dx.doi.org/10.1016/S1074-7613(00)00050-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070169	Bronze			2022-12-18	WOS:000090079100010
J	Zhu, Y; Herndon, JM; Sojka, DK; Kim, KW; Knolhoff, BL; Zuo, C; Cullinan, DR; Luo, JQ; Bearden, AR; Lavine, KJ; Yokoyama, WM; Hawkins, WG; Fields, RC; Randolph, GJ; DeNardo, DG				Zhu, Yu; Herndon, John M.; Sojka, Dorothy K.; Kim, Ki-Wook; Knolhoff, Brett L.; Zuo, Chong; Cullinan, Darren R.; Luo, Jingqin; Bearden, Audrey R.; Lavine, Kory J.; Yokoyama, Wayne M.; Hawkins, William G.; Fields, Ryan C.; Randolph, Gwendalyn J.; DeNardo, David G.			Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression (vol 47, pg 323, 2017)	IMMUNITY			English	Correction												ddenardo@wustl.edu			NATIONAL CANCER INSTITUTE [T32CA009621, R01CA203890, R01CA177670] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138466, K08HL123519] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009621, R01 CA203890, R01 CA177670] Funding Source: Medline; NHLBI NIH HHS [R01 HL138466, K08 HL123519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	1	77	80	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					597	597		10.1016/j.immuni.2017.08.018	http://dx.doi.org/10.1016/j.immuni.2017.08.018			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930665	Bronze, Green Accepted			2022-12-18	WOS:000411128200021
J	Abram, CL; Roberge, GL; Pao, LI; Neel, BG; Lowell, CA				Abram, Clare L.; Roberge, Gray L.; Pao, Lily I.; Neel, Benjamin G.; Lowell, Clifford A.			Distinct Roles for Neutrophils and Dendritic Cells in Inflammation and Autoimmunity in motheaten Mice	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SYSTEMIC AUTOIMMUNITY; SIGNAL-TRANSDUCTION; VIABLE MOTHEATEN; T-CELLS; SHP-1; MACROPHAGES; KINASE; DISEASE; DEFICIENCY	The motheaten mouse has long served as a paradigm for complex autoimmune and inflammatory disease. Null mutations in Ptpn6, which encodes the nonreceptor protein-tyrosine phosphatase Shp1, cause the motheaten phenotype. However, Shp1 regulates multiple signaling pathways in different hematopoietic cell types, so the cellular and molecular mechanism of autoimmunity and inflammation in the motheaten mouse has remained unclear. By using floxed Ptpn6 mice, we dissected the contribution of innate immune cells to the motheaten phenotype. Ptpn6 deletion in neutrophils resulted in cutaneous inflammation, but not autoimmunity, providing an animal model of human neutrophilic dermatoses. By contrast, dendritic cell deletion caused severe autoimmunity, without inflammation. Genetic and biochemical analysis showed that inflammation was caused by enhanced neutrophil integrin signaling through Src-family and Syk kinases, whereas autoimmunity resulted from exaggerated MyD88-dependent signaling in dendritic cells. Our data demonstrate that disruption of distinct Shp1-regulated pathways in different cell types combine to cause motheaten disease.	[Abram, Clare L.; Roberge, Gray L.; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Abram, Clare L.; Roberge, Gray L.; Lowell, Clifford A.] Univ Calif San Francisco, Program Immunol, San Francisco, CA 94143 USA; [Pao, Lily I.; Neel, Benjamin G.] HMS, Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol,Canc Biol Program, Boston, MA 02215 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Neel, BG (corresponding author), Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Campbell Family Canc Res Inst,Ontario Canc Inst, Toronto, ON MG5 1L7, Canada.	bneel@uhnresearch.ca; clifford.lowell@ucsf.edu			US National Institutes of Health [AI065495, AI068150, AI078869, RO1CA114945, R37CA49152]; Ontario Ministry of Health and Long Term Care; Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA114945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065495, P01AI078869, R01AI068150] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Yongmei Hu for help with animal husbandry and genotyping; and Chrystelle Lamagna for help with FACS sorting. Supported by the US National Institutes of Health (AI065495, AI068150 and AI078869 to C. A. L., RO1CA114945 and R37CA49152 to B.G.N.). B.G.N. is a Canada Research Chair, Tier I, and is partially supported by the Ontario Ministry of Health and Long Term Care and the Princess Margaret Hospital Foundation.	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Fowler CC, 2010, J IMMUNOL, V185, P3256, DOI 10.4049/jimmunol.1001362; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hardin AO, 2006, BIOCHEM BIOPH RES CO, V342, P547, DOI 10.1016/j.bbrc.2006.02.005; Jiao HY, 1997, EXP HEMATOL, V25, P592; Kaneko T, 2012, J IMMUNOL, V188, P5397, DOI 10.4049/jimmunol.1103210; KOO GC, 1993, J IMMUNOL, V151, P6733; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; KUNTZ L, 1990, J AUTOIMMUN, V3, P329, DOI 10.1016/0896-8411(90)90151-H; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Lorenz U, 1996, J EXP MED, V184, P1111, DOI 10.1084/jem.184.3.1111; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nesterovitch AB, 2011, AM J PATHOL, V178, P1701, DOI 10.1016/j.ajpath.2010.12.053; Nesterovitch AB, 2011, AM J PATHOL, V178, P1434, DOI 10.1016/j.ajpath.2010.12.035; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Ramachandran IR, 2011, J IMMUNOL, V186, P3934, DOI 10.4049/jimmunol.1001675; Rego D, 2011, J IMMUNOL, V186, P5443, DOI 10.4049/jimmunol.1003551; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; SHULTZ LD, 1984, AM J PATHOL, V116, P179; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Siemsen Daniel W., 2007, V412, P21, DOI 10.1007/978-1-59745-467-4_3; Suen PW, 1999, J CELL SCI, V112, P4067; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tsui FWL, 2006, IMMUNOL RES, V35, P127, DOI 10.1385/IR:35:1:127; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang L, 2010, J IMMUNOL, V184, P1180, DOI 10.4049/jimmunol.0901972; Zhou DL, 2010, J LEUKOCYTE BIOL, V87, P845, DOI 10.1189/jlb.0409289	42	77	78	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					489	501		10.1016/j.immuni.2013.02.018	http://dx.doi.org/10.1016/j.immuni.2013.02.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521885	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000330941500014
J	Good, MF; Doolan, DL				Good, Michael F.; Doolan, Denise L.			Malaria Vaccine Design: Immunological Considerations	IMMUNITY			English	Review							BLOOD-STAGE MALARIA; T-CELL RESPONSES; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM MALARIA; CD8-ALPHA(+) DENDRITIC CELLS; APICAL MEMBRANE ANTIGEN-1; CROSS-SPECIES REGULATION; CIRCUMSPOROZOITE PROTEIN; LIVER STAGES; IN-VITRO	The concept of a malaria vaccine has sparked great interest for decades, however, the challenge is proving to be a difficult one Immune dysregulation by Plasmodium and the ability of the parasite to mutate critical epitopes in surface antigens have proved to be strong defense weapons This has led to reconsideration of polyvalent and whole parasite strategies and ways to enhance cellular immunity to malaria that may be more likely to target conserved antigens and an expanded repertoire of antigens These and other concepts will be discussed in this review	[Good, Michael F.; Doolan, Denise L.] Queensland Inst Med Res, Div Immunol, Brisbane, Qld 4006, Australia; [Good, Michael F.] Griffith Univ, Inst Glyc, Gold Coast, Qld 4222, Australia	QIMR Berghofer Medical Research Institute; Griffith University	Good, MF (corresponding author), Queensland Inst Med Res, Div Immunol, Brisbane, Qld 4006, Australia.		Doolan, Denise L/F-1969-2015	Doolan, Denise/0000-0001-7354-8817	National Health and Medical Research Council (Australia); National Institutes of Health (USA); Pfizer Australia	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Australia(PfizerPfizer Australia)	We gratefully acknowledge the efforts of our many colleagues whose work is referred to herein Our work is supported by program and project grants from the National Health and Medical Research Council (Australia) and the National Institutes of Health (USA) and a grant from Rotarians against Malaria M F G is supported by a NHMRC Australia Fellowship D L D is supported by a Pfizer Australia Senior Research Fellowship	Amante FH, 1997, PARASITE IMMUNOL, V19, P111, DOI 10.1046/j.1365-3024.1997.d01-187.x; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; BALLOU WR, 1987, LANCET, V1, P1277; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bongfen SE, 2008, PARASITE IMMUNOL, V30, P375, DOI 10.1111/j.1365-3024.2008.01032.x; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; BRAKE DA, 1986, J IMMUNOL, V137, P345; Bruce MC, 2002, CURR OPIN MICROBIOL, V5, P431, DOI 10.1016/S1369-5274(02)00348-X; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Bruder JT, 2010, HUM VACCINES, V6, P54, DOI 10.4161/hv.6.1.10463; Casares S, 2009, CURR OPIN IMMUNOL, V21, P321, DOI 10.1016/j.coi.2009.05.015; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chattopadhyay R, 2009, INDIAN J EXP BIOL, V47, P527; Chung Y, 2007, EUR J IMMUNOL, V37, P1453, DOI 10.1002/eji.200636544; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Cohen S, 1978, Curr Top Microbiol Immunol, V80, P97; Coler RN, 2009, PARASITE IMMUNOL, V31, P520, DOI 10.1111/j.1365-3024.2009.01142.x; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Coppens I, 2010, TRENDS PARASITOL, V26, P305, DOI 10.1016/j.pt.2010.03.007; COUTINHO AIV, 2010, MEM I O CRUZ, V105, P1; COX FEG, 1970, B WORLD HEALTH ORGAN, V43, P325; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 2001, INT J PARASITOL, V31, P753, DOI 10.1016/S0020-7519(01)00184-9; Doolan DL, 1996, J BIOL CHEM, V271, P17861, DOI 10.1074/jbc.271.30.17861; Doolan DL, 1997, PARASITOL TODAY, V13, P171, DOI 10.1016/S0169-4758(97)01040-5; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Ejigiri I, 2009, CURR OPIN MICROBIOL, V12, P401, DOI 10.1016/j.mib.2009.06.006; Elliott SR, 2005, INFECT IMMUN, V73, P2478, DOI 10.1128/IAI.73.4.2478-2485.2005; ELLIS J, 1983, NATURE, V302, P536, DOI 10.1038/302536a0; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; FAVILA CL, 1996, PARASITE IMMUNOL, V18, P325; FELL AH, 1994, PARASITE IMMUNOL, V16, P579, DOI 10.1111/j.1365-3024.1994.tb00313.x; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; GOOD MF, 1988, IMMUNOL TODAY, V9, P351, DOI 10.1016/0167-5699(88)91336-9; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Good MF, 2007, NAT MED, V13, P1023, DOI 10.1038/nm0907-1023; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; GRUN JL, 1983, INFECT IMMUN, V41, P1197, DOI 10.1128/IAI.41.3.1197-1204.1983; GUAZZI M, 1963, Riv Malariol, V42, P55; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hirunpetcharat C, 1998, P NATL ACAD SCI USA, V95, P1715, DOI 10.1073/pnas.95.4.1715; Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; KEMP DJ, 1983, P NATL ACAD SCI-BIOL, V80, P3787, DOI 10.1073/pnas.80.12.3787; Kemp K, 2002, CLIN EXP IMMUNOL, V127, P151, DOI 10.1046/j.1365-2249.2002.01714.x; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; KUMAR S, 1988, NATURE, V334, P258, DOI 10.1038/334258a0; Langhorne J, 1989, Int Immunol, V1, P416, DOI 10.1093/intimm/1.4.416; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Le Hesran JY, 2006, ACTA TROP, V98, P261, DOI 10.1016/j.actatropica.2006.05.010; Limbach KJ, 2009, PARASITE IMMUNOL, V31, P501, DOI 10.1111/j.1365-3024.2009.01141.x; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Lynette B, 2006, J IMMUNOL, V177, P2518, DOI 10.4049/jimmunol.177.4.2518; Makobongo MO, 2003, P NATL ACAD SCI USA, V100, P2628, DOI 10.1073/pnas.0337629100; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; MCCOLM AA, 1983, ANN TROP MED PARASIT, V77, P355, DOI 10.1080/00034983.1983.11811724; Mikolajczak SA, 2010, J INFECT DIS, V201, P1270, DOI 10.1086/651279; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Minigo G, 2007, TRENDS PARASITOL, V23, P341, DOI 10.1016/j.pt.2007.06.006; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Olugbile S, 2010, CURR OPIN MOL THER, V12, P64; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; OWUSU AS, 2001, AM J TROP MED HYG, V65, P197; Pierce SK, 2009, IMMUNOL RES, V43, P85, DOI 10.1007/s12026-008-8052-y; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; RENIA L, 1994, IMMUNOLOGY, V82, P164; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Richie T, 2006, PARASITOLOGY, V133, pS113, DOI 10.1017/S0031182006001843; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; SIDDIQUI WA, 1978, SCIENCE, V201, P1236; Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Snounou G, 2004, TRENDS PARASITOL, V20, P262, DOI 10.1016/j.pt.2004.03.008; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Ssewanyana I, 2008, J TROP PEDIATRICS, V54, P6, DOI 10.1093/tropej/fmm061; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Su Z, 2003, INFECT IMMUN, V71, P5178, DOI 10.1128/IAI.71.9.5178-5187.2003; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuji M, 2010, EXP PARASITOL, V126, P421, DOI 10.1016/j.exppara.2009.11.009; Vaughan AM, 2008, CELL HOST MICROBE, V4, P209, DOI 10.1016/j.chom.2008.08.010; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; WEISS L, 1986, AM J ANAT, V176, P251, DOI 10.1002/aja.1001760303; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wipasa J, 2007, EXPERT OPIN BIOL TH, V7, P1841, DOI 10.1517/14712598.7.12.1841; Wykes M, 2006, PARASITE IMMUNOL, V28, P31, DOI 10.1111/j.1365-3024.2006.00768.x; Wykes MN, 2009, EUR J IMMUNOL, V39, P2004, DOI 10.1002/eji.200939552; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x; ZEVERING Y, 1994, P NATL ACAD SCI USA, V91, P6118, DOI 10.1073/pnas.91.13.6118	141	77	84	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					555	566		10.1016/j.immuni.2010.10.005	http://dx.doi.org/10.1016/j.immuni.2010.10.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029965	Bronze			2022-12-18	WOS:000284300200011
J	Siegmund, B				Siegmund, Britta			Interleukin-18 in Intestinal Inflammation: Friend and Foe?	IMMUNITY			English	Editorial Material							CROHNS-DISEASE		Charite, Med Klin 1, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Siegmund, B (corresponding author), Charite, Med Klin 1, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	britta.siegmund@charite.de	Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X				Dinarello CA, 2004, IMMUNITY, V20, P243, DOI 10.1016/S1074-7613(04)00055-X; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Kanai T, 2001, GASTROENTEROLOGY, V121, P875, DOI 10.1053/gast.2001.28021; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	9	77	81	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 26	2010	32	3					300	302		10.1016/j.immuni.2010.03.010	http://dx.doi.org/10.1016/j.immuni.2010.03.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20346770	Bronze			2022-12-18	WOS:000276125400003
J	Lin, KBL; Freeman, SA; Zabetian, S; Brugger, H; Weber, M; Lei, V; Dang-Lawson, M; Tse, KWK; Santamaria, R; Batista, FD; Gold, MR				Lin, Kevin B. L.; Freeman, Spencer A.; Zabetian, Saba; Brugger, Hayley; Weber, Michele; Lei, Victor; Dang-Lawson, May; Tse, Kathy W. K.; Santamaria, Rene; Batista, Facundo D.; Gold, Michael R.			The Rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands	IMMUNITY			English	Article							MEDIATES RAP1-INDUCED ADHESION; PYK2 TYROSINE PHOSPHORYLATION; IMMUNOLOGICAL SYNAPSE; ACTIN POLYMERIZATION; INTEGRIN ACTIVATION; ADAPTER PROTEIN; DENDRITIC CELLS; ANTIGEN; LYMPHOCYTES; MIGRATION	B lymphocytes spread and extend membrane processes when searching for antigens and form immune synapses upon contacting cells that display antigens on their surface. Although these dynamic morphological changes facilitate B cell activation the signaling pathways underlying these processes are not fully understood. We found that activation of the Rap GTPases was essential for these changes in B cell morphology. Rap activation was important for B cell receptor (BCR)- and lymphocyte-function-associated antigen-1 (LFA-1)-induced spreading, for BCR-induced immune-synapse formation, and for particulate BCR ligands to induce localized F-actin assembly and membrane-process extension. Rap activation and F-actin assembly were also required for optimal BCR signaling in response to particulate antigens but not soluble antigens. Thus by controlling B cell morphology and cytoskeletal organization, Rap might play a key role in the activation of B cells by particulate and cell-associated antigens.	[Lin, Kevin B. L.; Freeman, Spencer A.; Zabetian, Saba; Brugger, Hayley; Lei, Victor; Dang-Lawson, May; Tse, Kathy W. K.; Santamaria, Rene; Gold, Michael R.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Weber, Michele; Batista, Facundo D.] Univ British Columbia, Inst Life Sci, CELL Res Grp, Vancouver, BC V6T 1Z3, Canada; Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, London WC2A 3PX, England	University of British Columbia; University of British Columbia; Cancer Research UK	Gold, MR (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	mgold@interchange.ubc.ca	Gold, Michael/AAF-2081-2021	Gold, Michael/0000-0003-1222-3191; Weber, Michele/0000-0003-2056-3751				Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Huang NN, 2005, J IMMUNOL, V175, P7125, DOI 10.4049/jimmunol.175.11.7125; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; Kang PJ, 2001, SCIENCE, V292, P1376, DOI 10.1126/science.1060360; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Miertzschke M, 2007, J BIOL CHEM, V282, P30629, DOI 10.1074/jbc.M704361200; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; POLAKIS PG, 1991, P NATL ACAD SCI USA, V88, P239, DOI 10.1073/pnas.88.1.239; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Vidard L, 1996, J IMMUNOL, V156, P2809	48	77	79	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2008	28	1					75	87		10.1016/j.immuni.2007.11.019	http://dx.doi.org/10.1016/j.immuni.2007.11.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18191594	Bronze			2022-12-18	WOS:000252627300012
J	Rothenberg, EV				Rothenberg, Ellen V.			Negotiation of the T lineage fate decision by transcription-factor interplay and microenvironmental signals	IMMUNITY			English	Review							NATURAL-KILLER-CELL; PLASMACYTOID DENDRITIC CELL; COMMON LYMPHOID PROGENITORS; COLONY-STIMULATING FACTOR; FACTOR SPI-B; NK-CELL; GENE-EXPRESSION; ALPHA-BETA; HEMATOPOIETIC PROGENITORS; THYMOCYTE DEVELOPMENT	Notch-Delta signaling of hematopoietic precursors sets in motion a train of events that activates expression of T lineage genes. Even so, through many cell generations the pro-T cells remain uncommitted to the T cell fate, preserving alternative potentials as divergent as monocyte or dendritic cell fates. This plasticity can be explained by the tenacious expression of stem- and progenitor-associated regulatory genes in the cells, and by the combinatorial coding of T cell identity by factors that are not intrinsically T lineage specific in their spectra of activity. T lineage developmental success depends on precise temporal and quantitative regulation of these factors and on the continuing modulating influence of Notch-Delta signals that buffer the cells against mechanisms promoting non-T outcomes. An additional mechanism, still not fully defined, is required just prior to T cell receptor-mediated selection to end plasticity and make T lineage commitment irreversible.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X	NCI NIH HHS [CA90233, CA98925] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090233, R01CA098925] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Blom B, 1999, EMBO J, V18, P2793, DOI 10.1093/emboj/18.10.2793; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Carotta S, 2006, EUR J IMMUNOL, V36, P3294, DOI 10.1002/eji.200636325; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dallas MH, 2005, J EXP MED, V201, P1361, DOI 10.1084/jem.20042450; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; De Smedt M, 2005, BLOOD, V106, P3498, DOI 10.1182/blood-2005-02-0496; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dionne CJ, 2005, DEV BIOL, V280, P448, DOI 10.1016/j.ydbio.2005.01.027; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Fukuchi Y, 2006, EMBO J, V25, P3398, DOI 10.1038/sj.emboj.7601199; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Harman BC, 2003, J IMMUNOL, V170, P1299, DOI 10.4049/jimmunol.170.3.1299; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Kamimura K, 2007, BIOCHEM BIOPH RES CO, V355, P538, DOI 10.1016/j.bbrc.2007.02.003; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2003, EUR J IMMUNOL, V33, P606, DOI 10.1002/eji.200323461; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lee CK, 2001, J IMMUNOL, V166, P5964, DOI 10.4049/jimmunol.166.10.5964; Lefebvre JM, 2005, J IMMUNOL, V174, P6184, DOI 10.4049/jimmunol.174.10.6184; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Lian RH, 2002, SEMIN IMMUNOL, V14, P453, DOI 10.1016/S1044532302000805; Lucas K, 1998, DEV COMP IMMUNOL, V22, P339, DOI 10.1016/S0145-305X(98)00012-3; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Mohtashami M, 2006, J IMMUNOL, V176, P730, DOI 10.4049/jimmunol.176.2.730; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okazuka K, 2005, BIOCHEM BIOPH RES CO, V328, P545, DOI 10.1016/j.bbrc.2005.01.013; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 2006, IMMUNOL LETT, V107, P50, DOI 10.1016/j.imlet.2006.07.005; Rothenberg EV, 2007, CURR OPIN HEMATOL, V14, P322, DOI 10.1097/MOH.0b013e3281de72a8; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Schotte R, 2003, BLOOD, V101, P1015, DOI 10.1182/blood-2002-02-0438; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shen HQ, 2003, J IMMUNOL, V171, P3401, DOI 10.4049/jimmunol.171.7.3401; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Smith EMK, 2005, BLOOD, V106, P1995, DOI 10.1182/blood-2004-12-4744; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Spain LM, 1999, J IMMUNOL, V163, P2681; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Staal FJT, 2001, STEM CELLS, V19, P165, DOI 10.1634/stemcells.19-3-165; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; TAGHON T, IN PRESS NAT IMMUNOL; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; TYDELL CC, IN PRESS J IMMUNOL; van den Brandt J, 2004, EUR J IMMUNOL, V34, P1405, DOI 10.1002/eji.200324735; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang DC, 2006, J IMMUNOL, V177, P109, DOI 10.4049/jimmunol.177.1.109; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Yokota T, 2003, IMMUNITY, V19, P365, DOI 10.1016/S1074-7613(03)00231-0; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	118	77	79	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					690	702		10.1016/j.immuni.2007.06.005	http://dx.doi.org/10.1016/j.immuni.2007.06.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582342	Bronze			2022-12-18	WOS:000247646900004
J	Grumont, R; Lock, P; Mollinari, M; Shannon, FM; Moore, A; Gerondakis, S				Grumont, R; Lock, P; Mollinari, M; Shannon, FM; Moore, A; Gerondakis, S			The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-kappa B-dependent c-myc expression	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTORS; NUCLEAR-FACTOR; LYMPHOCYTE-PROLIFERATION; EXHIBIT DEFECTS; APOPTOSIS; PROTEINS; PROMOTER; GROWTH; THETA	Cell growth during the G1 stage of the cell cycle is partly controlled by inducing c-myc expression, which in B cells is regulated by the NF-kappaB1 and c-Rel transcription factors. Here, we show that c-myc-dependent growth during T cell activation requires c-Rel and ReIA and that blocking this growth by inhibiting protein kinase C theta (PKCtheta) coincides with a failure to upregulate c-myc due to impaired ReIA nuclear import and inhibition of NFAT-dependent c-rel transcription. These results demonstrate that different Rel/NF-kappa dimers regulate the mitogenic growth of mature T and B cells, with a signaling pathway incorporating PKCtheta and NFAT controlling c-Rel/ReIA-induced c-myc expression in activated T cells.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Surg, Melbourne, Vic 3050, Australia; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Australian National University; John Curtin School of Medical Research	Gerondakis, S (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	gerondakis@wehi.edu.au		Lock, Peter/0000-0003-4421-3609				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; GRUMONT RJ, 1990, CELL GROWTH DIFFER, V1, P345; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Gugasyan R, 2002, J CELL BIOL, V158, P115, DOI 10.1083/jcb.200112066; Halloran PF, 1998, TRANSPLANT P, V30, P2167, DOI 10.1016/S0041-1345(98)00577-6; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Iritani BM, 2002, EMBO J, V21, P4820, DOI 10.1093/emboj/cdf492; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; Onai N, 2000, BLOOD, V96, P2074; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shang C, 1999, INT IMMUNOL, V11, P1945, DOI 10.1093/intimm/11.12.1945; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; WOO J, 1990, SCAND J IMMUNOL, V31, P297, DOI 10.1111/j.1365-3083.1990.tb02772.x; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	48	77	89	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					19	30		10.1016/j.immuni.2004.06.004	http://dx.doi.org/10.1016/j.immuni.2004.06.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345217	Bronze			2022-12-18	WOS:000222975500005
J	Rose-John, S; Neurath, MF				Rose-John, S; Neurath, MF			IL-6 trans-signaling: The heat is on	IMMUNITY			English	Editorial Material							INFLAMMATION; BLOCKADE; DISEASE; GP130	The molecular consequence of the fever response has been illuminated by a recent study showing that a temperature shift to 40degreesC resulted in increased leukocyte adhesion to tissue sections, which was mediated by L-selectin activation in lymphocytes. This L-selectin activation during heat responses was dependent on IL-6 trans-signaling via the soluble IL-6R.	Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; Univ Mainz, Med Clin 1, D-55131 Mainz, Germany	University of Kiel; Johannes Gutenberg University of Mainz	Rose-John, S (corresponding author), Univ Kiel, Dept Biochem, Olshausenstr 40, D-24098 Kiel, Germany.		Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279				Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; *CDCP, 2003, MMWR-MORBID MORTAL W, V51, P1197; Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; DING C, 2003, CURR OPIN MOL THER, V9, P295; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Ito H, 2003, CURR PHARM DESIGN, V9, P295, DOI 10.2174/1381612033391900; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797	10	77	81	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2004	20	1					2	4		10.1016/S1074-7613(04)00003-2	http://dx.doi.org/10.1016/S1074-7613(04)00003-2			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738759	Bronze			2022-12-18	WOS:000221442200002
J	Woo, CJ; Martin, A; Scharff, MD				Woo, CJ; Martin, A; Scharff, MD			Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin	IMMUNITY			English	Article							CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; HISTONE ACETYLATION; IN-VITRO; B-CELLS; DNA; ACTIVATION; GENE; SEQUENCES; PROMOTER	Somatic hypermutation (SHM) requires selective targeting of the mutational machinery to the variable region of the immunoglobulin heavy chain gene. The induction of SHM in the BL2 cell line upon costimulation is associated with hyperacetylation of the chromatin at the variable region but not at the constant region. The V region-restricted histone hyperacetylation resulting from costimulation occurs independent of AID expression and mutation. Interestingly, costimulation in the presence of Trichostatin A causes hyperacetylation of histones associated with the constant region and extends mutations to the constant region. Under this condition, promoter proximal mutations are observed in the variable region as well. The overexpression of AID results in a similar deregulation of mutational targeting. Our results indicate that the stimulation of SHM in BL2 cells activates two independent pathways resulting in histone modifications that permit induced levels of AID to selectively target the variable region for mutation.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave,Chanin 403, Bronx, NY 10461 USA.	scharff@aecom.yu.edu	Martin, Alberto/B-1421-2008	Martin, Alberto/0000-0002-0795-0418	NCI NIH HHS [CA 72649] Funding Source: Medline; NIAID NIH HHS [AI 53362] Funding Source: Medline; NIGMS NIH HHS [T32 GM 07491] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gao CF, 1999, BIOCHEM BIOPH RES CO, V264, P860, DOI 10.1006/bbrc.1999.1611; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kohge T, 1998, BIOCHEM PHARMACOL, V56, P1359, DOI 10.1016/S0006-2952(98)00183-X; Kong QZ, 2001, GENETICS, V158, P369; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Lorincz MC, 2000, MOL CELL BIOL, V20, P842, DOI 10.1128/MCB.20.3.842-850.2000; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Michael N, 2002, IMMUNITY, V16, P123, DOI 10.1016/S1074-7613(02)00261-3; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Poltoratsky V, 2001, P NATL ACAD SCI USA, V98, P7976, DOI 10.1073/pnas.141222198; Przylepa J, 1998, CURR TOP MICROBIOL, V229, P85; Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744; Siino JS, 2002, BIOCHEM BIOPH RES CO, V297, P1318, DOI 10.1016/S0006-291X(02)02383-5; SISKIND GREGORY W., 1965, J IMMUNOL, V95, P436; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Storb U, 2001, PHILOS T ROY SOC B, V356, P13, DOI 10.1098/rstb.2000.0743; Storb U, 1999, COLD SPRING HARB SYM, V64, P227, DOI 10.1101/sqb.1999.64.227; Takahashi Y, 2000, GENE DEV, V14, P804; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zan H, 1999, J IMMUNOL, V162, P3437	54	77	78	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					479	489		10.1016/S1074-7613(03)00261-9	http://dx.doi.org/10.1016/S1074-7613(03)00261-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563313	Bronze			2022-12-18	WOS:000186051900005
J	Coste, A; Dubourdeau, M; Linas, MD; Cassaing, S; Lepert, JC; Balard, P; Chalmeton, S; Bernad, J; Orfila, C; Seguela, JP; Pipy, B				Coste, A; Dubourdeau, M; Linas, MD; Cassaing, S; Lepert, JC; Balard, P; Chalmeton, S; Bernad, J; Orfila, C; Seguela, JP; Pipy, B			PPAR gamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13	IMMUNITY			English	Article							MOUSE PERITONEAL-MACROPHAGES; ARACHIDONIC-ACID; INTERFERON-GAMMA; MEDIATED PHAGOCYTOSIS; DENDRITIC CELLS; DOWN-REGULATION; OXIDIZED LDL; IFN-GAMMA; ACTIVATION; PROTEIN	Macrophage mannose receptor (MMR) is an important component of the innate immune system implicated in host defense against microbial infections such as candidiasis and in antigen presentation. We demonstrate here that the MMR expression is induced in mouse peritoneal macrophages following exposure to PPARgamma ligands or to interleukine-13 (IL-13) via a PPARgamma signaling pathway. Ligand activation of the PPARgamma in macrophages promotes uptake, killing of Candida albicans, and reactive oxygen intermediates production triggered by the yeasts through MMR overexpression. We also show that MMR induction by IL-13 via PPARgamma is dependent on phopholipase A2 activation and that IL-13 induces 15d-PGJ2 production and nuclear localization. These results reveal a novel signaling pathway controlling the MMR surface expression and suggest that endogenous PPARgamma ligand produced by phospholipase A2 activation may be an important regulator of MMR expression by IL-13.	Univ Toulouse 3, Lab Macrophages Mediateurs Inflammat & Interact C, INSERM, Hop Rangueil,Ea 2405,IFR 31, F-31403 Toulouse 4, France; Ctr Hosp Univ, Dept Parasitol & Mycol, Hop Rangueil, F-31403 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Pipy, B (corresponding author), Univ Toulouse 3, Lab Macrophages Mediateurs Inflammat & Interact C, INSERM, Hop Rangueil,Ea 2405,IFR 31, F-31403 Toulouse 4, France.		Agnès, Coste/AAK-9408-2020	Coste, Agnes/0000-0001-7781-3323; Pipy, Bernard/0000-0001-8060-7029; Cassaing, Sophie/0000-0003-0055-0136				BERTON G, 1983, IMMUNOLOGY, V49, P705; BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324; Bogdan C, 1997, J IMMUNOL, V159, P4506; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; CLOHISY DR, 1987, J BIOL CHEM, V262, P15922; Coste A, 2002, J ANTIMICROB CHEMOTH, V49, P731, DOI 10.1093/jac/dkf011; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; Escoubet-Lozach L, 2001, CLIN EXP ALLERGY, V31, P1094, DOI 10.1046/j.1365-2222.2001.01121.x; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; EZEKOWITZ RAB, 1986, BIOCHEM BIOPH RES CO, V136, P737; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995; LARKIN M, 1989, AIDS, V3, P793, DOI 10.1097/00002030-198912000-00003; Lefkowitz DL, 1997, IMMUNOL CELL BIOL, V75, P136, DOI 10.1038/icb.1997.18; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Minty A, 1997, EUR CYTOKINE NETW, V8, P189; Montaner LJ, 1999, J IMMUNOL, V162, P4606; MRini C, 1997, BBA-MOL CELL RES, V1357, P319, DOI 10.1016/S0167-4889(97)00042-6; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Raveh D, 1998, J LEUKOCYTE BIOL, V64, P108, DOI 10.1002/jlb.64.1.108; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Rey A, 1998, BBA-LIPID LIPID MET, V1393, P244, DOI 10.1016/S0005-2760(98)00080-0; Rey A, 1999, BBA-MOL CELL BIOL L, V1440, P183, DOI 10.1016/S1388-1981(99)00121-3; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SCHREIBER S, 1993, J IMMUNOL, V151, P4973; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Shibata Y, 1997, J IMMUNOL, V159, P2462; SOZZANI P, 1995, J BIOL CHEM, V270, P5084, DOI 10.1074/jbc.270.10.5084; STAHL P, 1982, J CELL BIOL, V93, P49, DOI 10.1083/jcb.93.1.49; STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997	42	77	80	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					329	339		10.1016/S1074-7613(03)00229-2	http://dx.doi.org/10.1016/S1074-7613(03)00229-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499109	Bronze			2022-12-18	WOS:000185499800005
J	Zan, H; Wu, XP; Komori, A; Holloman, WK; Casali, P				Zan, H; Wu, XP; Komori, A; Holloman, WK; Casali, P			AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; HUMAN B-CELLS; IMMUNOGLOBULIN GENES; VARIABLE REGION; GERMINAL CENTER; CD40 LIGAND; T-CELLS; ACTIVATION; IG; REPAIR	Somatic hypermutation (SHM) of immunoglobulin (Ig) genes appears to involve the generation of double-strand DNA breaks (DSBs) and their error-prone repair. Here we show that DSBs occur at a high frequency in unrearranged (germline) Ig variable M genes, BCL6 and c-MYC. These DSBs are blunt, target the mutational RGYW/RGY hotspot, and would be resolved through nonhomologous end-joining, as indicated by the presence of Ku70/Ku86 on these DNA ends. Upon CD40-induced expression of activation-induced cytidine deaminase (AID), DSBs increase in frequency and are resected to yield 5'- and X-protruding ends in hypermutating rearranged V genes, BCL6 and translocated c-MYC. 3'-protruding ends would direct DSB repair through homologous recombination, as indicated by their exclusive presence in S/G2 and recruitment of Rad52/Rad51, leading to SHM, upon mispair by error-prone DNA polymerases modulated by cross-linking of the B cell receptor for antigen.	Cornell Univ, Joan & Sanford I Weill Med Coll, Div Mol Immunol, Dept Pathol & Lab Med, New York, NY 10021 USA; Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA; Univ Calif Irvine, Sch Biol Sci, Ctr Immunol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Irvine, CA 92697 USA	Cornell University; Cornell University; Cornell University; University of California System; University of California Irvine; University of California System; University of California Irvine	Casali, P (corresponding author), Cornell Univ, Joan & Sanford I Weill Med Coll, Div Mol Immunol, Dept Pathol & Lab Med, New York, NY 10021 USA.		Casali, Paolo/F-6579-2010		NIAID NIH HHS [AI 07621, R01 AI045011, R56 AI045011, T32 AI007621, AI 45011] Funding Source: Medline; NIAMS NIH HHS [AR 40908, R01 AR040908] Funding Source: Medline; NIA NIH HHS [AG 13910] Funding Source: Medline; NIGMS NIH HHS [R01 GM042482, GM 42482] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045011, R01AI045011, T32AI007621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013910] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAER R, 1988, J EXP MED, V167, P2011, DOI 10.1084/jem.167.6.2011; Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; BERMAN JE, 1991, J EXP MED, V173, P1529, DOI 10.1084/jem.173.6.1529; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CAYRE Y, 1981, P NATL ACAD SCI-BIOL, V78, P3814, DOI 10.1073/pnas.78.6.3814; Cerutti A, 1998, IMMUNITY, V9, P247, DOI 10.1016/S1074-7613(00)80607-X; Cerutti A, 1998, J IMMUNOL, V160, P2145; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Diaz M, 2002, CURR OPIN IMMUNOL, V14, P235, DOI 10.1016/S0952-7915(02)00327-8; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gurrieri C, 2002, J EXP MED, V196, P629, DOI 10.1084/jem.20011693; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Koenig N, 1997, MOL IMMUNOL, V34, P333, DOI 10.1016/S0161-5890(97)00023-0; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; PICARD D, 1984, EMBO J, V3, P3031, DOI 10.1002/j.1460-2075.1984.tb02250.x; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Schaffer A, 1999, J IMMUNOL, V162, P5327; Schaffer A, 2003, J BIOL CHEM, V278, P23141, DOI 10.1074/jbc.M212952200; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Storb U, 2001, PHILOS T ROY SOC B, V356, P13, DOI 10.1098/rstb.2000.0743; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zan H, 2000, J IMMUNOL, V165, P830, DOI 10.4049/jimmunol.165.2.830; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zan H, 1998, J IMMUNOL, V161, P5217	47	77	77	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					727	738		10.1016/S1074-7613(03)00151-1	http://dx.doi.org/10.1016/S1074-7613(03)00151-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818155	Green Accepted, Bronze			2022-12-18	WOS:000183767700004
J	Liu, YW; Xiong, Y; Naidenko, OV; Liu, JH; Zhang, R; Joachimiak, A; Kronenberg, M; Cheroutre, H; Reinherz, EL; Wang, JH				Liu, YW; Xiong, Y; Naidenko, OV; Liu, JH; Zhang, R; Joachimiak, A; Kronenberg, M; Cheroutre, H; Reinherz, EL; Wang, JH			The crystal structure of a TL/CD8 alpha alpha complex at 2.1 angstrom resolution: Implications for modulation of T cell activation and memory	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; THYMUS-LEUKEMIA ANTIGEN; CLASS-I MOLECULE; NONCLASSICAL MHC; MICE LACKING; MOUSE CD1; PEPTIDE; RECEPTOR; BINDING; CD8-ALPHA-ALPHA	TL is a nonclassical MHC class I molecule that modulates T cell activation through relatively high-affinity interaction with CD8alphaalpha. To investigate how the TL/CD8alphaalpha interaction influences TCR signaling, we characterized the structure of the TL/CD8alphaalpha complex using X-ray crystallography. Unlike antigen-presenting molecules, the TL antigen-binding groove is occluded by specific conformational changes. This feature eliminates antigen presentation, severely hampers direct TCR recognition, and prevents TL from participating in the TCR activation complex. At the same time, the TL/CD8alphaalpha interaction is strengthened through subtle structure changes in the TL alpha3 domain. Thus, TL functions to sequester and redirect CD8alphaalpha away from the TCR, modifying lck-dependent signaling.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; La Jolla Institute for Immunology; United States Department of Energy (DOE); Argonne National Laboratory	Wang, JH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	jwang@red.dfci.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045022, R01AI045022, R21AI045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056008] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45022, AI50263] Funding Source: Medline; NIGMS NIH HHS [GM56008] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CHEN YT, 1985, J EXP MED, V162, P1134, DOI 10.1084/jem.162.4.1134; CHEROUTRE H, 1995, IMMUNOL REV, V147, P31, DOI 10.1111/j.1600-065X.1995.tb00086.x; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Devine L, 2002, J IMMUNOL, V168, P3881, DOI 10.4049/jimmunol.168.8.3881; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; He XL, 2001, STRUCTURE, V9, P1213, DOI 10.1016/S0969-2126(01)00689-X; HOLCOMBE HR, 1995, J EXP MED, V181, P1433, DOI 10.1084/jem.181.4.1433; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; KRULIS P, 1991, J APPL CRYSTALLOGR, V24, P924; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kulski JK, 2001, J MOL EVOL, V53, P642, DOI 10.1007/s002390010251; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; MASHIMO H, 1992, IMMUNOGENETICS, V36, P326, DOI 10.1007/BF00215662; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OBATA Y, 1994, P NATL ACAD SCI USA, V91, P6589, DOI 10.1073/pnas.91.14.6589; OLD LJ, 1963, JNCI-J NATL CANCER I, V31, P977; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PONTAROTTI PA, 1986, P NATL ACAD SCI USA, V83, P1782, DOI 10.1073/pnas.83.6.1782; RODGERS JR, 1995, EUR J IMMUNOL, V25, P1001, DOI 10.1002/eji.1830250421; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Sharma P, 1996, J IMMUNOL, V156, P987; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STROYNOWSKI I, 1994, CURR OPIN IMMUNOL, V6, P38, DOI 10.1016/0952-7915(94)90031-0; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; TEITELL M, 1994, CRIT REV IMMUNOL, V14, P1; TEITELL M, 1991, J EXP MED, V174, P1131, DOI 10.1084/jem.174.5.1131; TEITELL M, 1993, J EXP MED, V178, P2139, DOI 10.1084/jem.178.6.2139; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Weber DA, 2002, J IMMUNOL, V169, P5708, DOI 10.4049/jimmunol.169.10.5708; WEINTRAUB BC, 1994, J IMMUNOL, V153, P3051; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310; YAO L, 1990, IMMUNOL LETT, V24, P267, DOI 10.1016/0165-2478(90)90011-E; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	59	77	78	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2003	18	2					205	215		10.1016/S1074-7613(03)00027-X	http://dx.doi.org/10.1016/S1074-7613(03)00027-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594948	Bronze			2022-12-18	WOS:000181138100005
J	Yolcu, ES; Askenasy, N; Singh, NP; Cherradi, SEL; Shirwan, H				Yolcu, ES; Askenasy, N; Singh, NP; Cherradi, SEL; Shirwan, H			Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection	IMMUNITY			English	Article							CONFER IMMUNE PRIVILEGE; GENE-THERAPY; T-CELLS; DOWN-REGULATION; LIGAND; EXPRESSION; ALLOGRAFTS; SURFACE; STREPTAVIDIN; LYMPHOCYTES	Long-term display of exogenous proteins on the cell surface may have important research and therapeutic implications. We report a novel method for the cell-surface display of proteins that involves generation of a chimeric protein with core streptavidin, biotinylation of cells, and "decoration" with the protein. A chimeric protein with the extracellular portions of FasL (SA-FasL) was efficiently displayed on the cell surface within 2 hr without detectable cellular toxicity. Biotin and SA-FasL persisted on the cell surface for weeks in vitro and in vivo. Immunomodulation with SA-FasL-decorated splenocytes effectively blocked alloreactive responses in naive and presensitized rodents and prevented the rejection of allogeneic pancreatic islets. This approach may serve as an alternative to gene transfer-based expression with broad research and therapeutic applications.	Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA; Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA; Carnegie Mellon Univ, Ctr Light Microscope Imaging & Biotechnol, Pittsburgh, PA 15213 USA	University of Louisville; University of Louisville; Carnegie Mellon University	Shirwan, H (corresponding author), Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK061333] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI47864] Funding Source: Medline; NIDDK NIH HHS [R21 DK61333] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison J, 1997, P NATL ACAD SCI USA, V94, P3943, DOI 10.1073/pnas.94.8.3943; Anderson WF, 1998, NATURE, V392, P25; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chen AS, 2000, J IMMUNOL, V164, P705, DOI 10.4049/jimmunol.164.2.705; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; HARE JF, 1994, J BIOL CHEM, V269, P5981; Kang SM, 1997, NAT MED, V3, P738, DOI 10.1038/nm0797-738; Lau HT, 1996, SCIENCE, V273, P109, DOI 10.1126/science.273.5271.109; Matsue H, 1999, NAT MED, V5, P930, DOI 10.1038/11375; Ottonello L, 1999, J IMMUNOL, V162, P3601; PAHLER A, 1987, J BIOL CHEM, V262, P13933; PARIJS LV, 1996, IMMUNITY, V4, P321; RAUB TJ, 1986, EXP CELL RES, V165, P73, DOI 10.1016/0014-4827(86)90534-3; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Seino K, 1998, J IMMUNOL, V161, P4484; Shirwan H, 1997, IMMUNOLOGY, V90, P572, DOI 10.1046/j.1365-2567.1997.00187.x; STEIGER J, 1995, J IMMUNOL, V155, P489; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Takeda Y, 1998, DIABETOLOGIA, V41, P315, DOI 10.1007/s001250050909; Takeuchi T, 1999, J IMMUNOL, V162, P518; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; van Broekhoven CL, 2000, J IMMUNOL, V164, P2433, DOI 10.4049/jimmunol.164.5.2433; Wahlsten JL, 1998, J IMMUNOL, V161, P6761; Watanabe T, 2002, J IMMUNOL, V168, P2188, DOI 10.4049/jimmunol.168.5.2188; Wierda WG, 2000, BLOOD, V96, P2917; WU JG, 1994, P NATL ACAD SCI USA, V91, P2344, DOI 10.1073/pnas.91.6.2344; ZHANG F, 1992, P NATL ACAD SCI USA, V89, P5231, DOI 10.1073/pnas.89.12.5231; Zhang H, 1999, J IMMUNOL, V162, P1423; Zhang HD, 1997, J CLIN INVEST, V100, P1951, DOI 10.1172/JCI119726	38	77	93	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					795	808		10.1016/S1074-7613(02)00482-X	http://dx.doi.org/10.1016/S1074-7613(02)00482-X			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479825	Bronze			2022-12-18	WOS:000179985500011
J	Whitehurst, CE; Schlissel, MS; Chen, JZ				Whitehurst, CE; Schlissel, MS; Chen, JZ			Deletion of germline promoter PD beta 1 from the TCR beta locus causes hypermethylation that impairs D beta 1 recombination by multiple mechanisms	IMMUNITY			English	Article							CELL-SPECIFIC DEMETHYLATION; V(D)J RECOMBINATION; DNA METHYLATION; B-CELL; DEVELOPMENTAL REGULATION; GENE REARRANGEMENT; TARGETED DELETION; CHAIN ENHANCER; ACCESSIBILITY; TRANSCRIPTION	The role of the germline transcriptional promoter, PD beta1, in V(D)J recombination at the T cell receptor beta locus was investigated. Deletion of PD beta1 caused reduced germline transcription and DNA hypermethylation in the D beta1-J beta1 region and decreased D beta1 rearrangement Analyses of methylation levels surrounding recombination signal sequences (RSS) before, during, and after recombination revealed that under physiological conditions cleavage of hypomethylated alleles was preferred over hypermethylated alleles. Methylation of a specific CpG site within the heptamer of the 3' D beta1 RSS was incompatible with cleavage by the V(D)J recombinase. These findings suggest that methylation can regulate V(D)J recombination both at a general level by influencing regional chromatin accessibility and specifically by blocking RSS recognition or cleavage by the V(D)J recombinase.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Chen, JZ (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	jchen@mit.edu		Whitehurst, Charles/0000-0003-3112-5458	NIAID NIH HHS [R01 AI40227, AI40146] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040146, R01AI040227] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; Bjorklund S, 1999, CELL, V96, P759, DOI 10.1016/S0092-8674(00)80586-3; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Cedar H, 1999, CURR OPIN IMMUNOL, V11, P64, DOI 10.1016/S0952-7915(99)80012-0; Chattopadhyay S, 1998, J IMMUNOL, V160, P1256; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DeGuerra A, 1997, MOL IMMUNOL, V34, P653, DOI 10.1016/S0161-5890(97)00061-8; Demengeot J, 1995, INT IMMUNOL, V7, P1995, DOI 10.1093/intimm/7.12.1995; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Forrester WC, 1999, GENE DEV, V13, P3003, DOI 10.1101/gad.13.22.3003; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; Hozumi K, 1996, INT IMMUNOL, V8, P1473, DOI 10.1093/intimm/8.10.1473; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Mostoslavsky R, 1997, BBA-REV CANCER, V1333, pF29, DOI 10.1016/S0304-419X(97)00010-3; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sikes ML, 1998, J IMMUNOL, V161, P1399; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Whitelaw CBA, 1999, CYTOTECHNOLOGY, V31, P3, DOI 10.1023/A:1008044517150; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Yi M, 1999, J IMMUNOL, V162, P6029	47	77	77	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					703	714		10.1016/S1074-7613(00)00069-8	http://dx.doi.org/10.1016/S1074-7613(00)00069-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114382	Bronze			2022-12-18	WOS:000165598500012
J	Vilen, BJ; Nakamura, T; Cambier, JC				Vilen, BJ; Nakamura, T; Cambier, JC			Antigen-stimulated dissociation of BCR mig from Ig-alpha/Ig-beta: Implications for receptor desensitization	IMMUNITY			English	Article							LYMPHOCYTE CYTOSKELETAL MATRIX; TYROSINE KINASE ACTIVATION; LIGAND-INDUCED ASSOCIATION; REACTIVE B-CELLS; MOLECULAR MECHANISMS; MEMBRANE-PROTEINS; TCR-CD3 COMPLEX; SELF-TOLERANCE; T-CELLS; IMMUNOGLOBULIN	B cell antigen receptor (BCR) ligation leads to receptor desensitization wherein BCR remain competent to bind antigen and yet fail to transduce signals. Desensitized BCR exhibit a defect at the most proximal level of signal transduction, consistent with failed transmission of signals through the receptor complex. We report that antigen stimulation leads to dissociation or destabilization of the BCR reflected by inability to coimmunoprecipitate Ig-alpha/Ig-beta with mIg. This destabilization is temporally correlated with desensitization and occurs in BCR containing mIgM and mIgD. Induction of BCR destabilization requires tyrosine kinase activation but is not induced by phosphatase inhibitors. BCR destabilization occurs at the cell surface and "dissociated" Ig-alpha/Ig-beta complexes remain responsive to anti-Ig-beta stimulation, suggesting that mIg-transducer uncoupling may mediate receptor desensitization.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA; Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Minato Ku, Tokyo 108, Japan	National Jewish Health; University of Tokyo	Cambier, JC (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA.			Cambier, John/0000-0002-7803-242X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI001756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013983] Funding Source: NIH RePORTER; NIAID NIH HHS [K22 AI001756] Funding Source: Medline; NIA NIH HHS [R01 AG013983, AG13983] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBRECHT DL, 1988, J IMMUNOL, V141, P3915; BRAUN J, 1982, J IMMUNOL, V128, P1198; BRUNSWICK M, 1994, CELL IMMUNOL, V156, P240, DOI 10.1006/cimm.1994.1168; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1990, J IMMUNOL, V145, P13; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Jugloff LS, 1997, J IMMUNOL, V159, P1096; KIM KJ, 1979, J IMMUNOL, V122, P549; KIM KM, 1993, IMMUNOL REV, V132, P125, DOI 10.1111/j.1600-065X.1993.tb00840.x; KISHIMOTO H, 1995, J EXP MED, V182, P1997, DOI 10.1084/jem.182.6.1997; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; PAO L, 1997, LYMPHOCYTE SIGNALLIN, P3; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SPARKS AB, 1995, METHOD ENZYMOL, V255, P498; Vilen BJ, 1997, J IMMUNOL, V159, P231; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WODA BA, 1983, J IMMUNOL, V131, P1917; WODA BA, 1984, J IMMUNOL, V133, P2767; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	40	77	78	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					239	248		10.1016/S1074-7613(00)80024-2	http://dx.doi.org/10.1016/S1074-7613(00)80024-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072076	Bronze, Green Accepted			2022-12-18	WOS:000078972200011
J	DIGHE, AS; CAMPBELL, D; HSIEH, CS; CLARKE, S; GREAVES, DR; GORDON, S; MURPHY, KM; SCHREIBER, RD				DIGHE, AS; CAMPBELL, D; HSIEH, CS; CLARKE, S; GREAVES, DR; GORDON, S; MURPHY, KM; SCHREIBER, RD			TISSUE-SPECIFIC TARGETING OF CYTOKINE UNRESPONSIVENESS IN TRANSGENIC MICE	IMMUNITY			English	Article							INTERFERON-GAMMA RECEPTOR; CD4+ T-CELLS; IFN-GAMMA; MACROPHAGE ACTIVATION; MONOCLONAL-ANTIBODIES; PHENOTYPE DEVELOPMENT; ANTIVIRAL ACTIVITY; TH1; ANTIGEN; ALPHA	The ubiquitous cellular distribution of certain cytokine receptors has hampered attempts to define the physiologically important cell-specific functions of cytokines in vivo. Herein, we report the generation of transgenic mice that express a dominant-negative lFN gamma receptor alpha chain mutant under the control of either the human lysozyme promoter or the murine lck proximal promoter, which display tissue-specific unresponsiveness in the macrophage or T cell compartments, respectively, to the pleiotropic cytokine, IFN gamma. We utilize these mice to identify previously undefined cellular targets of IFN gamma, action in the development of a murine antimicrobial response and the mixed lymphocyte reaction, Moreover, we identify the macrophage as a critical responsive cell in manifesting the effects of IFN gamma in regulating CD4(+) T helper subset development. These studies thus represent a novel approach to studying the cell-specific actions of an endogenously produced pleiotropic cytokine in vivo.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,OXFORD OX1 3RE,ENGLAND	Washington University (WUSTL); University of Oxford	DIGHE, AS (corresponding author), WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63110, USA.		Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019; Dighe, Anand/AAP-9640-2020	Schreiber, Robert D/0000-0001-6311-0432; Greaves, David/0000-0003-2856-9410; Schreiber, Robert/0000-0003-1590-2341; Dighe, Anand/0000-0003-4130-0758				AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; BUCY RP, 1988, J IMMUNOL, V140, P1148; COOK JR, 1992, P NATL ACAD SCI USA, V89, P11317, DOI 10.1073/pnas.89.23.11317; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FARRAR MA, 1991, J BIOL CHEM, V266, P19626; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; Hogan B., 1986, MANIPULATING MOUSE E; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1993, INT IMMUNOL, V5, P371; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; MARRACK P, 1983, J EXP MED, V158, P1635, DOI 10.1084/jem.158.5.1635; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; SAMBRTOOK J, 1989, MOL CLONING LABORATO; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; SCOTT P, 1991, J IMMUNOL, V147, P3149; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; TRIPP CS, 1994, J IMMUNOL, V152, P1883; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367	39	77	79	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					657	666		10.1016/1074-7613(95)90136-1	http://dx.doi.org/10.1016/1074-7613(95)90136-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584155	Bronze			2022-12-18	WOS:A1995TG28100013
J	ONO, S; OHNO, H; SAITO, T				ONO, S; OHNO, H; SAITO, T			RAPID TURNOVER OF THE CD3-ZETA CHAIN INDEPENDENT OF THE TCR-CD3 COMPLEX IN NORMAL T-CELLS	IMMUNITY			English	Article							ANTIGEN RECEPTOR COMPLEX; PRE-GOLGI DEGRADATION; ZETA-CHAIN; ENDOPLASMIC-RETICULUM; SIGNAL TRANSDUCTION; MICE LACKING; CD3 COMPLEX; GAMMA-CHAIN; ETA-CHAIN; EXPRESSION	The function of CD3 zeta in the assembly and transport of the T cell receptor (TCR)-CD3 complex was analyzed in normal T cells. The zeta chain, but not other chains in the surface TCR complex, rapidly exchanged with newly synthesized zeta. Because zeta was expressed independently from the complex, the ICR complex may be transported to the surface along the zeta turnover pathway by association with zeta. These data suggest the dynamic nature of zeta metabolism and provide the evidence that a single component in a multisubunit receptor exhibits independent metabolism from the rest of the complex.			ONO, S (corresponding author), CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOLEC GENET,CHUO KU,1-8-1 INOHANA,CHIBA 260,JAPAN.		Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547				ALARCON B, 1988, J BIOL CHEM, V263, P2953; AOE T, 1994, INT IMMUNOL, V6, P1671, DOI 10.1093/intimm/6.11.1671; AOE T, 1995, J EXP MED, V181, P1881, DOI 10.1084/jem.181.5.1881; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; BAUER A, 1991, P NATL ACAD SCI USA, V88, P3842, DOI 10.1073/pnas.88.9.3842; BONIFACINO JS, 1988, J BIOL CHEM, V263, P8965; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; FINKE JH, 1993, CANCER RES, V53, P5613; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GUNJI Y, 1994, JPN J CANCER RES, V85, P1189, DOI 10.1111/j.1349-7006.1994.tb02927.x; GUNTER KC, 1987, NATURE, V326, P505, DOI 10.1038/326505a0; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KOYASU S, 1992, J EXP MED, V175, P203, DOI 10.1084/jem.175.1.203; KRANGEL MS, 1987, J EXP MED, V165, P1141, DOI 10.1084/jem.165.4.1141; LIPPINCOTTSCHWA.J, 1988, CELL, V54, P209; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; LUTON F, 1994, J IMMUNOL, V153, P63; MALISSEN B, 1993, CURR OPIN IMMUNOL, V5, P324, DOI 10.1016/0952-7915(93)90049-X; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; NAKAGOMI H, 1993, CANCER RES, V53, P5610; NAKANO H, 1994, MOL CELL BIOL, V14, P1213, DOI 10.1128/MCB.14.2.1213; OETTGEN HC, 1986, NATURE, V320, P272, DOI 10.1038/320272a0; OHNO H, 1993, INT IMMUNOL, V5, P1403, DOI 10.1093/intimm/5.11.1403; OHNO H, 1994, J EXP MED, V179, P365, DOI 10.1084/jem.179.1.365; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; SAITO T, 1987, J IMMUNOL, V139, P625; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973	43	77	77	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					639	644		10.1016/1074-7613(95)90008-X	http://dx.doi.org/10.1016/1074-7613(95)90008-X			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796297	Bronze			2022-12-18	WOS:A1995RE53800009
J	Kolter, J; Feuerstein, R; Zeis, P; Hagemeyer, N; Paterson, N; d'Errico, P; Baasch, S; Amann, L; Masuda, T; Losslein, A; Gharun, K; Meyer-Luehmann, M; Waskow, C; Franzke, CW; Grun, D; Lammermann, T; Prinz, M; Henneke, P				Kolter, Julia; Feuerstein, Reinhild; Zeis, Patrice; Hagemeyer, Nora; Paterson, Neil; d'Errico, Paolo; Baasch, Sebastian; Amann, Lukas; Masuda, Takahiro; Loesslein, Anne; Gharun, Kourosh; Meyer-Luehmann, Melanie; Waskow, Claudia; Franzke, Claus-Werner; Gruen, Dominic; Lammermann, Tim; Prinz, Marco; Henneke, Philipp			A Subset of Skin Macrophages Contributes to the Surveillance and Regeneration of Local Nerves	IMMUNITY			English	Article							TISSUE MACROPHAGES; MYELOID CELLS; MONOCYTES; MICROGLIA; PRECURSORS; LINEAGE; FATE; DEGENERATION; RESPONSES; IDENTITY	The skin comprises tissue macrophages as the most abundant resident immune cell type. Their diverse tasks including resistance against invading pathogens, attraction of bypassing immune cells from vessels, and tissue repair require dynamic specification. Here, we delineated the postnatal development of dermal macrophages and their differentiation into subsets by adapting single-cell transcriptomics, fate mapping, and imaging. Thereby we identified a phenotypically and transcriptionally distinct subset of prenatally seeded dermal macrophages that self-maintained with very low postnatal exchange by he-matopoietic stem cells. These macrophages specifically interacted with sensory nerves and surveilled and trimmed the myelin sheath. Overall, resident dermal macrophages contributed to axon sprouting after mechanical injury. In summary, our data show long-lasting functional specification of macrophages in the dermis that is driven by stepwise adaptation to guiding structures and ensures codevelopment of ontogenetically distinct cells within the same compartment.	[Kolter, Julia; Feuerstein, Reinhild; Baasch, Sebastian; Loesslein, Anne; Gharun, Kourosh; Henneke, Philipp] Univ Freiburg, Inst Immunodeficiency, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany; [Kolter, Julia; Feuerstein, Reinhild; Hagemeyer, Nora; d'Errico, Paolo; Baasch, Sebastian; Amann, Lukas; Masuda, Takahiro; Loesslein, Anne; Gharun, Kourosh; Meyer-Luehmann, Melanie; Prinz, Marco; Henneke, Philipp] Univ Freiburg, Fac Med, Freiburg, Germany; [Kolter, Julia; Zeis, Patrice; Paterson, Neil; Amann, Lukas] Univ Freiburg, Fac Biol, Freiburg, Germany; [Zeis, Patrice; Paterson, Neil; Gruen, Dominic; Lammermann, Tim] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Zeis, Patrice; Paterson, Neil] Int Max Planck Res Sch Mol & Cell Biol, Freiburg, Germany; [Hagemeyer, Nora; Amann, Lukas; Masuda, Takahiro; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Med Ctr, Freiburg, Germany; [d'Errico, Paolo; Meyer-Luehmann, Melanie] Univ Freiburg, Dept Neurol, Med Ctr, Freiburg, Germany; [Waskow, Claudia] Tech Univ Dresden, Inst Immunol, Regenerat Hematopoiesis, Dresden, Germany; [Franzke, Claus-Werner] Univ Freiburg, Dept Dermatol, Med Ctr, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany; [Gruen, Dominic; Prinz, Marco] Univ Freiburg, CIBSS, Freiburg, Germany; [Henneke, Philipp] Univ Freiburg, Ctr Pediat & Adolescent Med, Med Ctr, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; Technische Universitat Dresden; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Henneke, P (corresponding author), Univ Freiburg, Inst Immunodeficiency, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany.; Henneke, P (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.; Henneke, P (corresponding author), Univ Freiburg, Ctr Pediat & Adolescent Med, Med Ctr, Freiburg, Germany.	philipp.henneke@uniklinik-freiburg.de	Masuda, Takahiro/AAY-6719-2021; Lämmermann, Tim/AAD-7453-2022; Waskow, Claudia/F-8146-2010	Masuda, Takahiro/0000-0003-3687-452X; Waskow, Claudia/0000-0003-3261-0922; Losslein, Anne Kathrin/0000-0002-0570-5902; Zeis, Patrice/0000-0001-7615-2201; Kolter, Julia/0000-0002-3268-8124; Amann, Lukas/0000-0002-8363-373X	Else Kroner-Fresenius Foundation; German Ministry of Education and Research [01EO0803, 01GL1746A, 01EK1602A]; German Ministry of Education and Research (KKNMS-network); German Research Council [HE3127/9-1, HE3127/12-1, SFB/TRR167, SFB 992, SFB1160, GR4980/1, CIBSS - EXC-2189, 390939984]; Sobek Foundation; Ernst-Jung Foundation; Ministry of Science, Research and Arts, Baden-Wuerttemberg; Max Planck Society	Else Kroner-Fresenius Foundation; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research (KKNMS-network); German Research Council(German Research Foundation (DFG)); Sobek Foundation; Ernst-Jung Foundation; Ministry of Science, Research and Arts, Baden-Wuerttemberg; Max Planck Society(Max Planck Society)	We are indebted to Anita Imm, Bernhard Kremer, Juna Leppert, the deep sequencing facility of the Max Planck Institute, and the Lighthouse facility of the University Medical Center Freiburg for their outstanding technical expertise; to Peter Wieghofer (Freiburg), Kathy McCoy (Canada), and Steffen Jung (Israel) for provision of mice; and to Katrin Kierdorf (Freiburg) for critical discussions. BLZ945 was provided by Novartis. Funding was provided by the Else Kroner-Fresenius Foundation (to A.L. and P.H.); the German Ministry of Education and Research (grants 01EO0803, 01GL1746A, and 01EK1602A to P.H. and via the KKNMS-network to M.P.); the German Research Council (grants HE3127/9-1 and HE3127/12-1 to P.H.; grant SFB/TRR167 to P.H., M.P., and T.L.; grants SFB 992, SFB1160, SFB/TRR167, and Reinhart-Koselleck-Grant to M.P.; grant GR4980/1 to P.Z.; and CIBSS - EXC-2189 - Project ID390939984 to M.P. and D.G.); the Sobek Foundation, the Ernst-Jung Foundation, and the Ministry of Science, Research and Arts, Baden-Wuerttemberg (all to M.P.); and the Max Planck Society (to T.L., D.G., and P.Z.).	Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Baranska A, 2018, J EXP MED, V215, P1115, DOI 10.1084/jem.20171608; Barreiro O, 2016, ELIFE, V5, DOI 10.7554/eLife.15251; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Buckley G, 2012, J ANAT, V220, P3, DOI 10.1111/j.1469-7580.2011.01452.x; Buckley G, 2011, J ANAT, V218, P163, DOI 10.1111/j.1469-7580.2010.01313.x; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chen PW, 2015, ACTA NEUROPATHOL, V130, P605, DOI 10.1007/s00401-015-1482-4; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Feuerstein R, 2015, J IMMUNOL, V194, P2735, DOI 10.4049/jimmunol.1402566; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; James JM, 2011, SEMIN CELL DEV BIOL, V22, P1019, DOI 10.1016/j.semcdb.2011.09.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kolter J, 2016, J IMMUNOL, V196, P2733, DOI 10.4049/jimmunol.1501014; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OLDFORS A, 1980, ACTA NEUROPATHOL, V49, P43, DOI 10.1007/BF00692218; PERRY VH, 1992, BIOESSAYS, V14, P401, DOI 10.1002/bies.950140610; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	56	76	80	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1482	+		10.1016/j.immuni.2019.05.009	http://dx.doi.org/10.1016/j.immuni.2019.05.009			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31201094	Bronze			2022-12-18	WOS:000471876100018
J	McCarthy, KR; Watanabe, A; Kuraoka, M; Do, KT; Mcgee, CE; Sempowski, GD; Kepler, TB; Schmidt, AG; Kelsoe, G; Harrison, SC				McCarthy, Kevin R.; Watanabe, Akiko; Kuraoka, Masayuki; Do, Khoi T.; Mcgee, Charles E.; Sempowski, Gregory D.; Kepler, Thomas B.; Schmidt, Aaron G.; Kelsoe, Garnett; Harrison, Stephen C.			Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires	IMMUNITY			English	Article							RECEPTOR-BINDING; AFFINITY MATURATION; CLONAL SELECTION; PLASMA-CELLS; ANTIBODY; ANTIGEN; NEUTRALIZATION; GENERATION; EVOLUTION; SYSTEM	Human B cell antigen-receptor (BCR) repertoires reflect repeated exposures to evolving influenza viruses; new exposures update the previously generated B cell memory (Bmem) population. Despite structural similarity of hemagglutinins (HAs) from the two groups of influenza A viruses, cross-reacting antibodies (Abs) are uncommon. We analyzed Bmem compartments in three unrelated, adult donors and found frequent cross-group BCRs, both HA-head directed and non-head directed. Members of a clonal lineage from one donor had a BCR structure similar to that of a previously described Ab, encoded by different gene segments. Comparison showed that both Abs contacted the HA receptor-binding site through long heavy-chain third complementarity determining regions. Affinities of the clonal-lineage BCRs for historical influenza-virus HAs from both group 1 and group 2 viruses suggested that serial responses to seasonal influenza exposures had elicited the lineage and driven affinity maturation. We propose that appropriate immunization regimens might elicit a comparably broad response.	[McCarthy, Kevin R.; Do, Khoi T.; Schmidt, Aaron G.; Harrison, Stephen C.] Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Boston, MA 02115 USA; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Watanabe, Akiko; Kuraoka, Masayuki; Kelsoe, Garnett] Duke Univ, Dept Immunol, Durham, NC 27710 USA; [Mcgee, Charles E.; Sempowski, Gregory D.; Kelsoe, Garnett] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Schmidt, Aaron G.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Schmidt, Aaron G.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Duke University; Duke University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	Harrison, SC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Boston, MA 02115 USA.; Harrison, SC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.; Kelsoe, G (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27710 USA.; Kelsoe, G (corresponding author), Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA.	ghkelsoe@duke.edu; harrison@crystal.harvard.edu		Sempowski, Gregory/0000-0003-0391-6594; Kelsoe, Garnett/0000-0002-8770-040X	National Institutes of Health and National Institute of Allergy and Infectious Diseases [UC6-AI058607]; NIH [P41 GM103403, P01 AI089618, U19 AI117892, R01 AI128832]; Pilatus 6M detector on 24-ID-C by NIHORIP HEI grant [S10-RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607, P01AI089618, R01AI128832, U19AI117892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health and National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilatus 6M detector on 24-ID-C by NIHORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Goran Bajic, Simon Jenni, Tim Caradonna, and Lindsey RobinsonMcCarthy for advice, discussion, and instruction; Allan Parelli (BCH), Xiaoyan Nie and Xiaoe Liang (Duke Immunology), and Ariel K. Mason and Christopher Sample (Duke RBL) for technical assistance; Kevin Wiehe and Amy Wang for a preliminary clonal lineage analysis. Affinity measurements were carried out in the Harvard Medical School Center for Macromolecular Interactions, directed by Dr. Kelly Arnett. X-ray diffraction data were recorded at beamline 8.2.2 (operated by the Berkeley Center for Structural Biology and the Howard Hughes Medical Institute) at the Advanced Light Source (ALS, Lawrence Berkeley Laboratory) and at beamline ID-24-C (operated by the Notheast Collaborative Access team: NE-CAT) at the Advanced Photon Source (APS, Argonne National Laboratory). We thank the staff members at both beamlines for advice and assistance in data collection. Influenza stock propagation and microneutralization assays were performed in the Virology Unit of the Duke Regional Biocontainment Laboratory (RBL), managed by C.E.M. and directed by G.D.S. The Duke RBL received partial support for construction from the National Institutes of Health and National Institute of Allergy and Infectious Diseases (UC6-AI058607). The following reagents were obtained through BEI Resources, NIAID, NIH: Kilbourne F165: A/Chile/1/1983 (HA, NA) x A/Puerto Rico/8/1934 (H1N1), Reassortant X-83, NR-3585; Kilbourne F178: A/Shanghai/11/1987 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), High Yield, Reassortant X-99a, NR-3505; Kilbourne F86: A/Johannesburg/33/1994 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), Reassortant X-123a, NR-3580; Influenza A Virus, A/California/07/2009 (H1N1) pdm09 Egg Isolate (Produced in Eggs), NR-13663; and Ferret Hyperimmune Sera to Influenza A/California/07/2009 (H1N1) pdm09, NR-19261; and Monoclonal Anti-Influenza A Virus Nucleoprotein (NP), Clones A1 and A3 (ascites blend, Mouse), NR-4282. The following reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Ferret Hyperimmune Sera to Influenza A/Solomon Islands/3/2006 (H1N1), NR-19262. Influenza A Virus, A/Wisconsin/67/2005 (H3N2), FR-397; Influenza A Virus, A/Solomon Islands/3/2006 (H1N1), FR-331; Influenza A Virus, A/Texas/50/2012 (H3N2), FR1210; Ferret Antisera to Influenza A Virus, A/USSR/90/1977 (H1N1), FR-953; Ferret Antisera to Influenza A Virus, A/Fujian/411/2002 (H3N2), FR-1264; Ferret Antisera to Influenza A Virus, A/Texas/50/2012 (H3N2), FR-1263; and MadinDarby Canine Kidney (MDCK) Cells, London Line, FR-58, was obtained through the Influenza Reagent Resource, Influenza Division, WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, GA, USA. NE-CAT is funded by NIH grant P41 GM103403 and the Pilatus 6M detector on 24-ID-C by NIHORIP HEI grant S10-RR029205. APS is operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. The research was supported by NIH grants P01 AI089618 (to S.C.H.), U19 AI117892 (to G.K. and T.B.K.), and R01 AI128832 (to G.K.). S.C.H. is an Investigator in the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; CDC, 2007, INFLUENZA VIRUS MICR; CDC, 2009, INFL VIR MICR ASS H1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISH S, 1989, J EXP MED, V170, P1191, DOI 10.1084/jem.170.4.1191; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Raymond DD, 2016, NAT MED, V22, P1465, DOI 10.1038/nm.4223; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Schmidt AG, 2015, CELL REP, V13, P2842, DOI 10.1016/j.celrep.2015.11.063; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Su KY, 2016, J IMMUNOL, V197, P4163, DOI 10.4049/jimmunol.1502193; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Willis JR, 2016, P NATL ACAD SCI USA, V113, P4446, DOI 10.1073/pnas.1518405113; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2010, SER DIAGN INFL MICR; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu HF, 2015, PROTEINS, V83, P771, DOI 10.1002/prot.24745; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	76	76	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					174	+		10.1016/j.immuni.2017.12.009	http://dx.doi.org/10.1016/j.immuni.2017.12.009			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343437	Green Accepted, Bronze			2022-12-18	WOS:000422751600019
J	Xu, LF; Huang, QZ; Wang, HQ; Hao, YX; Bai, Q; Hu, JJ; Li, YD; Wang, PC; Chen, XY; He, R; Li, BS; Yang, X; Zhao, TT; Zhang, YY; Wang, YF; Ou, JJ; Liang, HJ; Wu, YZ; Zhou, XY; Ye, LL				Xu, Lifan; Huang, Qizhao; Wang, Haoqiang; Hao, Yaxing; Bai, Qiang; Hu, Jianjun; Li, Yiding; Wang, Pengcheng; Chen, Xiangyu; He, Ran; Li, Bingshou; Yang, Xia; Zhao, Tingting; Zhang, Yanyan; Wang, Yifei; Ou, Juanjuan; Liang, Houjie; Wu, Yuzhang; Zhou, Xinyuan; Ye, Lilin			The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells	IMMUNITY			English	Article							GERMINAL CENTER REACTIONS; IMMUNE-RESPONSES; AKT-MTOR; DIFFERENTIATION; HELPER; METABOLISM; EXPRESSION; ACTIVATION; MEMORY; TCF-1	Follicular regulatory T (Tfr) cells differentiate from conventional regulatory T (Treg) cells and suppress excessive germinal center (GC) responses by acting on both GC B cells and T follicular helper (Tfh) cells. Here, we examined the impact of mTOR, a serine/threonine protein kinase that senses and integrates diverse environmental cues, on the differentiation and functional competency of Tfr cells in response to protein immunization or viral infection. By genetically deleting Rptor or Rictor, essential components for mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), respectively, we found that mTORC1 but not mTORC2 is essential for Tfr differentiation. Mechanistically, mTORC1-mediated phosphorylation of the transcription factor STAT3 induced the expression of the transcription factor TCF-1 by promoting STAT3 binding to the Tcf7 50-regulatory region. Subsequently, TCF-1 bound to the Bcl6 promoter to induce Bcl6 expression, which launched the Tfr cell differentiation program. Thus, mTORC1 initiates Tfr cell differentiation by activating the TCF-1-Bcl-6 axis during immunization or infection.	[Xu, Lifan; Huang, Qizhao; Wang, Haoqiang; Hao, Yaxing; Bai, Qiang; Hu, Jianjun; Li, Yiding; Wang, Pengcheng; Chen, Xiangyu; He, Ran; Li, Bingshou; Yang, Xia; Zhao, Tingting; Zhang, Yanyan; Wang, Yifei; Wu, Yuzhang; Zhou, Xinyuan; Ye, Lilin] Third Mil Med Univ, Southwest Hosp, Inst Immunol, Chongqing 400038, Peoples R China; [Ou, Juanjuan; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Ye, LL (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Immunol, Chongqing 400038, Peoples R China.	yelilinlcmv@tmmu.edu.cn	Zhou, Xinyuan/AFS-9817-2022; BAI, Qiang/O-1069-2019; Zhang, Yanyan/P-9931-2018	BAI, Qiang/0000-0001-7423-0712; Zhang, Yanyan/0000-0002-6037-5918; Chen, Xiangyu/0000-0001-7947-3211; Zhou, Xinyuan/0000-0002-1374-8240; Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China [31500710, 81471624]; National Basic Research Program of China (973 Program) [2013CB531500]; National Key Research Development Plan [2016YFA0502202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Research Development Plan	We thank the Institute Clinique de la Souris (part of the International Knockout Mouse Consortium) for permission to use the Tcf7 conditional knockout mice. We thank CapitalBio Corporation (Beijing, China) for performing microarray experiments and data analysis, and we thank the core facility center of Third Military Medical University for cell sorting. This study was supported by grants from the National Natural Science Foundation of China (no. 31500710 to X.Y.), the National Basic Research Program of China (973 Program, no. 2013CB531500 to L.Y.), the National Key Research Development Plan (no. 2016YFA0502202 to L.Y.), and the National Natural Science Foundation of China (no. 81471624 to L.Y.).	Alexander CM, 2011, IMMUNOLOGY, V133, P452, DOI 10.1111/j.1365-2567.2011.03456.x; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Chang JH, 2014, J EXP MED, V211, P137, DOI 10.1084/jem.20131019; Chapman NM, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00686; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eri R, 2012, METHODS MOL BIOL, V844, P261, DOI 10.1007/978-1-61779-527-5_19; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaeth M, 2014, J EXP MED, V211, P545, DOI 10.1084/jem.20130604; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Xie DL, 2012, P NATL ACAD SCI USA, V109, P14152, DOI 10.1073/pnas.1119744109; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	76	87	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					538	+		10.1016/j.immuni.2017.08.011	http://dx.doi.org/10.1016/j.immuni.2017.08.011			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930662	Bronze			2022-12-18	WOS:000411128200017
J	Zhivaki, D; Lemoine, S; Lim, A; Morva, A; Vidalain, PO; Schandene, L; Casartelli, N; Rameix-Welti, MA; Herve, PL; Deriaud, E; Beitz, B; Ripaux-Lefevre, M; Miatello, J; Lemercier, B; Lorin, V; Descamps, D; Fix, J; Eleouet, JF; Riffault, S; Schwartz, O; Porcheray, F; Mascart, F; Mouquet, H; Zhang, XM; Tissieres, P; Lo-Man, R				Zhivaki, Dania; Lemoine, Sebastien; Lim, Annick; Morva, Ahsen; Vidalain, Pierre-Olivier; Schandene, Liliane; Casartelli, Nicoletta; Rameix-Welti, Marie-Anne; Herve, Pierre-Louis; Deriaud, Edith; Beitz, Benoit; Ripaux-Lefevre, Maryline; Miatello, Jordi; Lemercier, Brigitte; Lorin, Valerie; Descamps, Delphyne; Fix, Jenna; Eleouet, Jean-Francois; Riffault, Sabine; Schwartz, Olivier; Porcheray, Fabrice; Mascart, Francoise; Mouquet, Hugo; Zhang, Xiaoming; Tissieres, Pierre; Lo-Man, Richard			Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; FUSION GLYCOPROTEIN; INFLUENZA-VIRUS; EARLY-LIFE; B-1 CELLS; RESPONSES; IMMUNITY; BRONCHIOLITIS; INTERLEUKIN-10; ANTIBODY	Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infections in infants and is characterized by pulmonary infiltration of B cells in fatal cases. We analyzed the B cell compartment in human newborns and identified a population of neonatal regulatory B lymphocytes (nBreg cells) that produced interleukin 10 (IL-10) in response to RSV infection. The polyreactive B cell receptor of nBreg cells interacted with RSV protein F and induced upregulation of chemokine receptor CX3CR1. CX3CR1 interacted with RSV glycoprotein G, leading to nBreg cell infection and IL-10 production that dampened T helper 1 (Th1) cytokine production. In the respiratory tract of neonates with severe RSV-induced acute bronchiolitis, RSV-infected nBreg cell frequencies correlated with increased viral load and decreased blood memory Th1 cell frequencies. Thus, the frequency of nBreg cells is predictive of the severity of acute bronchiolitis disease and nBreg cell activity may constitute an early-life host response that favors microbial pathogenesis.	[Zhivaki, Dania; Morva, Ahsen; Lo-Man, Richard] Inst Pasteur, Neonatal Immun Grp Human Histopathol & Anim Model, F-75724 Paris, France; [Zhivaki, Dania] Paris 7 Diderot Univ, F-75724 Paris, France; [Lemoine, Sebastien; Deriaud, Edith] Inst Pasteur, Regulat Immunitaire & Vaccinol, F-75724 Paris, France; [Lemoine, Sebastien; Deriaud, Edith] INSERM U1041, F-75724 Paris, France; [Lim, Annick] Inst Pasteur, Dept Immunol, F-75724 Paris, France; [Vidalain, Pierre-Olivier] Inst Pasteur, Unite Genom Virale & Vaccinat, F-75724 Paris, France; [Schandene, Liliane; Mascart, Francoise] Hop Erasme, Immunobiol Clin, B-1070 Brussels, Belgium; [Casartelli, Nicoletta; Schwartz, Olivier] Inst Pasteur, Virus & Immunite, F-75724 Paris, France; [Casartelli, Nicoletta; Schwartz, Olivier] CNRS, UMR 3568, F-75724 Paris, France; [Rameix-Welti, Marie-Anne] Versailles St Quentin Univ, INSERM U1173, F-78180 Versailles, France; [Rameix-Welti, Marie-Anne] Hop Ambroise Pare, AP HP, Lab Microbiol, F-92100 Boulogne, France; [Herve, Pierre-Louis; Descamps, Delphyne; Fix, Jenna; Eleouet, Jean-Francois; Riffault, Sabine] Univ Paris Saclay, INRA, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Ripaux-Lefevre, Maryline; Porcheray, Fabrice] Bioaster Microbiol Technol Inst, F-75015 Paris, France; [Miatello, Jordi; Tissieres, Pierre] Paris South Univ Hosp, APHP, Pediat ICU & Neonatal Med, F-94270 Le Kremlin Bicetre, France; [Miatello, Jordi; Tissieres, Pierre] Paris South Univ, Sch Med, F-94270 Le Kremlin Bicetre, France; [Miatello, Jordi; Tissieres, Pierre] Paris Saclay Univ, Inst Integrat Biol Cell, UMR 9196, F-91190 Gif Sur Yvette, France; [Lorin, Valerie; Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, F-75724 Paris, France; [Lorin, Valerie; Mouquet, Hugo] INSERM U1222, F-75724 Paris, France; [Mascart, Francoise] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, B-1070 Brussels, Belgium; [Zhang, Xiaoming] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Innate Def & Immune Modulat, Shanghai 200031, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Libre de Bruxelles; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Libre de Bruxelles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Lo-Man, R (corresponding author), Inst Pasteur, Neonatal Immun Grp Human Histopathol & Anim Model, F-75724 Paris, France.	richard.lo-man@pasteur.fr	morva, ahsen/GYU-3126-2022; Mouquet, Hugo/M-2750-2014; Casartelli, Nicoletta/AAD-5583-2021; Rameix-Welti, Marie-Anne/H-7526-2019; Eléouët, Jean-François/AAD-1994-2019; Hervé, Pierre-Louis/M-9935-2017; Schwartz, Olivier/AAZ-3765-2021; Vidalain, Pierre-Olivier/F-9778-2019	Mouquet, Hugo/0000-0002-4230-610X; Hervé, Pierre-Louis/0000-0002-6015-4154; Schwartz, Olivier/0000-0002-0729-1475; Vidalain, Pierre-Olivier/0000-0003-3082-7407; Miatello, Jordi/0000-0001-5649-8635; , Ahsen/0000-0002-0766-768X; Rameix-Welti, Marie-Anne/0000-0002-5901-3856; ELeouet, Jean-Francois/0000-0002-7361-4885	ANR [ANR 13-BSV3-0016]; Fondation pour la Recherche Medicale [DEQ20120323719]; French Government's Investissement d'Avenir program; Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; ANR; European Commission [HEALTH-F4-2011-280873]; Major Basic Research Project of Shanghai Science and Technology Commission [13JC1405600]; National Natural Science Foundation of China [31270961, 31470879]; Interdisciplinary Innovation Team and External Cooperation Program [GJHZ201312]; Chinese Academy of Sciences; DIM Malinf of Region IdF; ANRS; Sidaction; Fondation Areva; Center for Human Immunology at Institut Pasteur	ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Government's Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"; ANR(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Major Basic Research Project of Shanghai Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Interdisciplinary Innovation Team and External Cooperation Program; Chinese Academy of Sciences(Chinese Academy of Sciences); DIM Malinf of Region IdF; ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Fondation Areva; Center for Human Immunology at Institut Pasteur	We are very grateful to T. Domet (Therapie Cellulaire, Hopital Saint-Louis) for the cord blood sample collection and M. Lucas-Hourani for some viral preparation. We thank F. Huetz for helpful discussion about B lymphocytes. This work was supported by an ANR grant (ANR 13-BSV3-0016) and by the Fondation pour la Recherche Medicale (grant no. DEQ20120323719). This study also received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant no. ANR-10-LABX-62-IBEID). X.Z. and S.L. were supported by ANR and by the European Commission FP7 ADITEC program (HEALTH-F4-2011-280873). X.Z. was also partially supported by the Major Basic Research Project of Shanghai Science and Technology Commission (no. 13JC1405600); National Natural Science Foundation of China (31270961, 31470879); Interdisciplinary Innovation Team and External Cooperation Program (no. GJHZ201312); and Chinese Academy of Sciences. D.Z. was supported by DIM Malinf of Region IdF. Work in the O.S. lab is also supported by ANRS, Sidaction and Fondation Areva. We acknowledge the Center for Human Immunology at Institut Pasteur for support in conducting these studies.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; Castro M, 2008, J ALLERGY CLIN IMMUN, V122, P726, DOI 10.1016/j.jaci.2008.07.010; Chirkova T, 2015, J GEN VIROL, V96, P2543, DOI 10.1099/vir.0.000218; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Dougan SK, 2013, NATURE, V503, P406, DOI 10.1038/nature12637; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Jeong KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130517; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lemoine S, 2011, J AUTOIMMUN, V36, P228, DOI 10.1016/j.jaut.2011.01.005; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Nothelfer K, 2015, NAT REV MICROBIOL, V13, P173, DOI 10.1038/nrmicro3415; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104; Reed JL, 2009, J INFECT DIS, V199, P1128, DOI 10.1086/597386; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Sewald X, 2015, SCIENCE, V350, P563, DOI 10.1126/science.aab2749; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stein Renato T, 2009, Paediatr Respir Rev, V10 Suppl 1, P29, DOI 10.1016/S1526-0542(09)70013-2; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013; Zhang XM, 2014, J INFECT DIS, V210, P424, DOI 10.1093/infdis/jiu103; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748	43	76	81	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					301	314		10.1016/j.immuni.2017.01.010	http://dx.doi.org/10.1016/j.immuni.2017.01.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228284	Green Published, Bronze			2022-12-18	WOS:000396410900017
J	Terashima, A; Okamoto, K; Nakashima, T; Akira, S; Ikuta, K; Takayanagi, H				Terashima, Asuka; Okamoto, Kazuo; Nakashima, Tomoki; Akira, Shizuo; Ikuta, Koichi; Takayanagi, Hiroshi			Sepsis-Induced Osteoblast Ablation Causes Immunodeficiency	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-FORMATION; DIFFERENTIATION; PROGENITORS; MAINTENANCE; NICHE; MICE; IL-7; IMMUNOSUPPRESSION; IDENTIFICATION	Sepsis is a host inflammatory response to severe infection associated with high mortality that is caused by lymphopenia-associated immunodeficiency. However, it is unknown how lymphopenia persists after the accelerated lymphocyte apoptosis subsides. Here we show that sepsis rapidly ablated osteoblasts, which reduced the number of common lymphoid progenitors (CLPs). Osteoblast ablation or inducible deletion of interleukin-7 (IL-7) in osteoblasts recapitulated the lymphopenic phenotype together with a lower CLP number without affecting hematopoietic stem cells (HSCs). Pharmacological activation of osteoblasts improved sepsis-induced lymphopenia. This study demonstrates a reciprocal interaction between the immune and bone systems, in which acute inflammation induces a defect in bone cells resulting in lymphopenia-associated immunodeficiency, indicating that bone cells comprise a therapeutic target in certain life-threatening immune reactions.	[Terashima, Asuka; Okamoto, Kazuo; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Terashima, Asuka; Okamoto, Kazuo; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Terashima, Asuka; Okamoto, Kazuo] Univ Tokyo, Grad Sch Med, Dept Osteoimmunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Nakashima, Tomoki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan; [Nakashima, Tomoki] JST, Precursory Res Embryon Sci & Technol PRESTO, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan; [Nakashima, Tomoki] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Host Def Lab, Yamada Oka 3-1, Suita, Osaka 5650871, Japan; [Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect,Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Osaka University; Kyoto University	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.; Takayanagi, H (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	takayana@m.u-tokyo.ac.jp	Akira, Shizuo/C-3134-2009	Ikuta, Koichi/0000-0003-1319-1021	Japan Society for Promotion of Science(JSPS) [15H05703]; JSPS [15H05653]; JST; Japan Agency for Medical Research and Development [15ek0109106]; Chugai Pharmaceutical Co., LTD.; AYUMI Pharmaceutical Corporation; Noevir Co., Ltd.; JSPS Research Fellowship for Young Scientists;  [23.2656]	Japan Society for Promotion of Science(JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Chugai Pharmaceutical Co., LTD.; AYUMI Pharmaceutical Corporation; Noevir Co., Ltd.; JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	We are grateful to T. Nagasawa(Kyoto University) for discussion and advice. We are also grateful to J. Miyazaki (Osaka University) for providing CAG-CAT-EGFP transgenic mice. We thank T. Negishi-Koga, M. Shinohara, M. Oh-hora, S. Sawa, M. Hayashi, N. Komatsu, M. Guerrini, L. Danks, E. Sumiya, C. Tsuda, Y. Ogiwara, N. Otsuka, A. Suematsu, Y. Kunisawa, T. Ando, and K. Kusubata for discussion and assistance. This work was supported in part by Grant-in-Aid for Specially Promoted Research from the Japan Society for Promotion of Science(JSPS) (15H05703); Grant-in-Aid for Young Scientists A from JSPS (15H05653); Grant-in-Aid for JSPS Fellows (23 center dot 2656); grants for the ERATO, Takayanagi Osteonetwork Project and PRESTO from JST; and a grant for Practical Research Project for Rare/Intractable Diseases (15ek0109106) from Japan Agency for Medical Research and Development. Department of Osteoimmunology is an endowment department, supported with an unrestricted grant from Chugai Pharmaceutical Co., LTD., AYUMI Pharmaceutical Corporation and Noevir Co., Ltd. A. T. was supported by JSPS Research Fellowship for Young Scientists.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen YT, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh158; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Liang BF, 2012, J IMMUNOL, V189, P4444, DOI 10.4049/jimmunol.1201181; Martin T John, 2014, J Bone Metab, V21, P8, DOI 10.11005/jbm.2014.21.1.8; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	47	76	82	4	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1434	1443		10.1016/j.immuni.2016.05.012	http://dx.doi.org/10.1016/j.immuni.2016.05.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27317262	Bronze			2022-12-18	WOS:000378341200020
J	Ahern, PP; Faith, JJ; Gordon, JI				Ahern, Philip P.; Faith, Jeremiah J.; Gordon, Jeffrey I.			Mining the Human Gut Microbiota for Effector Strains that Shape the Immune System	IMMUNITY			English	Review							REGULATORY T-CELLS; TOLERANCE; INDUCTION; DIFFERENTIATION; METABOLITES; BACTERIA; RECEPTOR; MUCOSA	The gut microbiota codevelops with the immune system beginning at birth. Mining the microbiota for bacterial strains responsible for shaping the structure and dynamic operations of the innate and adaptive arms of the immune system represents a formidable combinatorial problem but one that needs to be overcome to advance mechanistic understanding of microbial community and immune system coregulation and to develop new diagnostic and therapeutic approaches that promote health. Here, we discuss a scalable, less biased approach for identifying effector strains in complex microbial communities that impact immune function. The approach begins by identifying uncultured human fecal microbiota samples that transmit immune phenotypes to germ-free mice. Clonally arrayed sequenced collections of bacterial strains are constructed from representative donor microbiota. If the collection transmits phenotypes, effector strains are identified by testing randomly generated subsets with overlapping membership in individually housed germ-free animals. Detailed mechanistic studies of effector strain-host interactions can then be performed.	[Ahern, Philip P.; Faith, Jeremiah J.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Faith, Jeremiah J.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Faith, Jeremiah J.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA	Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu			NIH [DK30292, DK70977]; Crohn's and Colitis Foundation of America; Henry Wellcome Postdoctoral Fellowship [096100]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R37DK030292, R01DK070977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Henry Wellcome Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the NIH (DK30292, DK70977) and the Crohn's and Colitis Foundation of America to J.I.G, and a Henry Wellcome Postdoctoral Fellowship (096100) to P.P.A. J.I.G. is the cofounder of Matutu, Inc., a company that is characterizing the role of diet-by-microbiota interactions in defining health.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bilate AB, 2011, IMMUNITY, V35, P6, DOI 10.1016/j.immuni.2011.07.003; Box G. E. P., 2005, WILEY SERIES PROBABI, pxvii; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Hastie T, 2009, ELEMENTS STAT LEARNI; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	36	76	81	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					815	823		10.1016/j.immuni.2014.05.012	http://dx.doi.org/10.1016/j.immuni.2014.05.012			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950201	Green Accepted, Bronze			2022-12-18	WOS:000341440200001
J	Shin, HM; Kapoor, VN; Guan, TX; Kaech, SM; Welsh, RM; Berg, LJ				Shin, Hyun Mu; Kapoor, Varun N.; Guan, Tianxia; Kaech, Susan M.; Welsh, Raymond M.; Berg, Leslie J.			Epigenetic Modifications Induced by Blimp-1 Regulate CD8(+) T Cell Memory Progression during Acute Virus Infection	IMMUNITY			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; METHYLTRANSFERASE G9A; CD27; EXPRESSION; EFFECTOR; IL-2; HOMEOSTASIS; ACTIVATION; SIGNALS; INTERLEUKIN-2	The transcription factor Blimp-1 regulates the overall accumulation of virus-specific CD8(+) T cells during acute viral infections. We found that increased proliferation and survival of Blimp-1-deficient CD8(+) T cells resulted from sustained expression of CD25 and CD27 and persistent cytokine responsiveness. Silencing of Il2ra and Cd27 reduced the Blimp-1-deficient CD8(+) T cell response. Genome-wide chromatin immunoprecipitation (ChIP) sequencing analysis identified Il2ra and Cd27 as direct targets of Blimp-1. At the peak of the antiviral response, but not earlier, Blimp-1 recruited the histone-modifying enzymes G9a and HDAC2 to the Il2ra and Cd27 loci, thereby repressing expression of these genes. In the absence of Blimp-1, Il2ra and Cd27 exhibited enhanced histone H3 acetylation and reduced histone H3K9 trimethylation. These data elucidate a central mechanism by which Blimp-1 acts as an epigenetic regulator and enhances the numbers of short-lived effector cells while suppressing the development of memory-precursor CD8(+) T cells.	[Shin, Hyun Mu; Kapoor, Varun N.; Welsh, Raymond M.; Berg, Leslie J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Guan, Tianxia; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Guan, Tianxia; Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; Yale University; Howard Hughes Medical Institute	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	leslie.berg@umassmed.edu	KAPOOR, VARUN/E-1239-2016; Guan, Tianxia/B-5559-2017	Guan, Tianxia/0000-0001-6187-5431	NIH [AI084987, AI017672, AI081675, AI074699]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101048, R01AI017672, R01AI084987, R01AI074699, R37AI017672, R01AI081675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Tarakhovsky for Prdm1 floxed mice, S. L. Nutt for Blimp-1-GFP mice, and R. T. Woodland for the contribution of mice. We thank members of the Berg and Welsh labs for technical assistance and helpful discussions. We thank O.H. Cho and R. Rohatgi for helpful discussions and critical reading of the manuscript. We also thank Flow Cytometry Core Lab and Deep Sequencing Core facility at UMMS. This work was supported by NIH grants AI084987 (L.J.B.), AI017672 (R. M. W.) and AI081675 (R. M. W.), AI074699 (S. M. K.), and HHMI (S.M.K.).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Collins R, 2010, NUCLEIC ACIDS RES, V38, P3503, DOI 10.1093/nar/gkq081; DEJONG R, 1991, J IMMUNOL, V146, P2488; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dolfi DV, 2008, J IMMUNOL, V180, P2912, DOI 10.4049/jimmunol.180.5.2912; Duttagupta PA, 2009, CRIT REV IMMUNOL, V29, P469, DOI 10.1615/CritRevImmunol.v29.i6.20; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; HINTZEN RQ, 1994, J IMMUNOL, V152, P1762; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Peperzak V, 2010, J IMMUNOL, V185, P6670, DOI 10.4049/jimmunol.1000159; Peperzak V, 2010, J CLIN INVEST, V120, P168, DOI 10.1172/JCI40178; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; RAZVI ES, 1995, AM J PATHOL, V147, P79; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Thomas LR, 2008, J IMMUNOL, V181, P485, DOI 10.4049/jimmunol.181.1.485; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	45	76	79	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					661	675		10.1016/j.immuni.2013.08.032	http://dx.doi.org/10.1016/j.immuni.2013.08.032			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24120360	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000330950000008
J	Wan, CK; Oh, J; Li, P; West, EE; Wong, EA; Andraski, AB; Spolski, R; Yu, ZX; He, JP; Kelsall, BL; Leonard, WJ				Wan, Chi-Keung; Oh, Jangsuk; Li, Peng; West, Erin E.; Wong, Elizabeth A.; Andraski, Allison B.; Spolski, Rosanne; Yu, Zu-Xi; He, Jianping; Kelsall, Brian L.; Leonard, Warren J.			The Cytokines IL-21 and GM-CSF Have Opposing Regulatory Roles in the Apoptosis of Conventional Dendritic Cells	IMMUNITY			English	Article							T-CELLS; NEGATIVE REGULATOR; STEADY-STATE; INTERLEUKIN-21; ACTIVATION; REVEALS; GENERATION; AUTOIMMUNE; RESPONSES; DISTINCT	Interleukin-21 (IL-21) has broad actions on T and B cells, but its actions in innate immunity are poorly understood. Here we show that IL-21 induced apoptosis of conventional dendritic cells (cDCs) via STAT3 and Bim, and this was inhibited by granulocyte-macrophage colony-stimulating factor (GM-CSF). ChIP-Seq analysis revealed genome-wide binding competition between GM-CSF-induced STAT5 and IL-21-induced STAT3. Expression of IL-21 in vivo decreased cDC numbers, and this was prevented by GM-CSF. Moreover, repetitive alpha-galactosylceramide injection of mice induced IL-21 but decreased GM-CSF production by natural killer T (NKT) cells, correlating with decreased cDC numbers. Furthermore, adoptive transfer of wild-type CD4(+) T cells caused more severe colitis with increased DCs and interferon-gamma (IFN-gamma)-producing CD4(+) T cells in Il21r(-/-)Rag2(-/-) mice (which lack T cells and have IL-21-unresponsive DCs) than in Rag2(-/-) mice. Thus, IL-21 and GM-CSF exhibit cross-regulatory actions on gene regulation and apoptosis, regulating cDC numbers and thereby the magnitude of the immune response.	[Wan, Chi-Keung; Oh, Jangsuk; Li, Peng; West, Erin E.; Wong, Elizabeth A.; Andraski, Allison B.; Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Wan, Chi-Keung; Oh, Jangsuk; Li, Peng; West, Erin E.; Wong, Elizabeth A.; Andraski, Allison B.; Spolski, Rosanne; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Yu, Zu-Xi] NHLBI, Pathol Core, NIH, Bethesda, MD 20892 USA; [He, Jianping; Kelsall, Brian L.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022	Wan, Edwin/0000-0003-4783-3029	Intramural Research Program, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZICHL005904, ZIAHL005402, ZIGHL006020, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000833] Funding Source: NIH RePORTER	Intramural Research Program, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.X. Lin, NHLBI and R. Schwartz, NIAID, for critical comments, H. Young for the Csf2 and control expression plasmids, L. Hennighausen and G. Robinson for Stat5a<SUP>-/-</SUP> mice, and NHLBI Flow Cytometry Core Facility for cell sorting and sample analysis. This work was supported by the Intramural Research Program, National Heart, Lung, and Blood Institute, NIH. R.S. and W.J.L. are inventors on patents related to IL-21.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Debierre-Grockiego F, 2004, APOPTOSIS, V9, P717, DOI 10.1023/B:APPT.0000045785.65546.a2; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Gelebart P, 2009, LEUKEMIA, V23, P1836, DOI 10.1038/leu.2009.100; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Kojo S, 2005, J IMMUNOL, V175, P3648, DOI 10.4049/jimmunol.175.6.3648; Konforte D, 2006, J IMMUNOL, V177, P8381, DOI 10.4049/jimmunol.177.12.8381; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Ma HL, 2003, J IMMUNOL, V171, P608, DOI 10.4049/jimmunol.171.2.608; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2012, J IMMUNOL, V188, P1924, DOI 10.4049/jimmunol.1100767; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang G, 2003, CANCER RES, V63, P9016; Wang L, 2011, P NATL ACAD SCI USA, V108, P9542, DOI 10.1073/pnas.1018182108; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	59	76	85	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					514	527		10.1016/j.immuni.2013.02.011	http://dx.doi.org/10.1016/j.immuni.2013.02.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23453633	Green Accepted, Bronze			2022-12-18	WOS:000330941500016
J	Tikhonova, AN; Van Laethem, F; Hanada, K; Lu, JH; Pobezinsky, LA; Hong, CW; Guinter, TI; Jeurling, SK; Bernhardt, G; Park, JH; Yang, JC; Sun, PD; Singer, A				Tikhonova, Anastasia N.; Van Laethem, Francois; Hanada, Ken-ichi; Lu, Jinghua; Pobezinsky, Leonid A.; Hong, Changwan; Guinter, Terry I.; Jeurling, Susanna K.; Bernhardt, Guenter; Park, Jung-Hyun; Yang, James C.; Sun, Peter D.; Singer, Alfred			alpha beta T Cell Receptors that Do Not Undergo Major Histocompatibility Complex-Specific Thymic Selection Possess Antibody-like Recognition Specificities	IMMUNITY			English	Article							NECTIN-LIKE MOLECULES; CLASS-I; IMMUNOGLOBULIN SUPERFAMILY; CRYSTAL-STRUCTURE; MHC INTERACTION; AMINO-ACIDS; PEPTIDE; ANTIGEN; BINDING; CD4	Major histocompatibility complex (MHC) restriction is the cardinal feature of T cell antigen recognition and is thought to be intrinsic to alpha beta T cell receptor (TCR) structure because of germline-encoded residues that impose MHC specificity. Here, we analyzed alpha beta TCRs from T cells that had not undergone MHC-specific thymic selection. Instead of recognizing peptide-MHC complexes, the two alpha beta TCRs studied here resembled antibodies in recognizing glycosylation-dependent conformational epitopes on a native self-protein, CD155, and they did so with high affinity independently of MHC molecules. Ligand recognition was via the alpha beta TCR combining site and involved the identical germline-encoded residues that have been thought to uniquely impose MHC specificity, demonstrating that these residues do not only promote MHC binding. This study demonstrates that, without MHC-specific thymic selection, alpha beta TCRs can resemble antibodies in recognizing conformational epitopes on MHC-independent ligands.	[Tikhonova, Anastasia N.; Van Laethem, Francois; Pobezinsky, Leonid A.; Hong, Changwan; Guinter, Terry I.; Jeurling, Susanna K.; Park, Jung-Hyun; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Hanada, Ken-ichi; Yang, James C.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Tikhonova, Anastasia N.] Univ Penn, Sch Med, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Lu, Jinghua; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hannover Medical School	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov	Hong, Changwan/AAO-2460-2020; Hanada, Kenichi/L-2481-2013; Bernhardt, Günter/F-6946-2012; lu, jinghua/G-5872-2012; Tikhonova, Anastasia/F-1186-2015; Hong, Changwan/R-5683-2019; Park, Jung Hyun/B-5712-2015	Hong, Changwan/0000-0003-2567-2973; Hanada, Kenichi/0000-0003-2959-1257; Bernhardt, Günter/0000-0002-0510-2853; Park, Jung Hyun/0000-0002-9547-9055	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011214, ZIABC011116, ZIABC011113, ZIABC011106, ZIABC009273, ZIABC011114, ZIABC011111, ZIABC011117, ZIABC011112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Bosselut, W. Pear, and A. Chervonsky for providing reagents and N. Taylor, J. Di Santo, M. Kimura, T. McCaughtry, X. Tai, and D. Margulies for critically reading the manuscript. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Chadeneau C, 1996, MAMM GENOME, V7, P636, DOI 10.1007/s003359900194; Chadeneau C, 1996, INT J CANCER, V68, P817; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Frankel TL, 2010, J IMMUNOL, V184, P5988, DOI 10.4049/jimmunol.1000189; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; LEE WH, 1994, INT IMMUNOL, V6, P1307, DOI 10.1093/intimm/6.9.1307; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Manning TC, 1999, IMMUNOL TODAY, V20, P417, DOI 10.1016/S0167-5699(99)01508-X; Margulies DH, 1997, CURR OPIN IMMUNOL, V9, P390, DOI 10.1016/S0952-7915(97)80086-6; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Miyoshi J, 2007, AM J NEPHROL, V27, P590, DOI 10.1159/000108103; RAO A, 1984, CELL, V36, P879, DOI 10.1016/0092-8674(84)90037-0; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SCHWARTZ RH, 1976, J IMMUNOL, V117, P531; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SILICIANO RF, 1985, J IMMUNOL, V135, P906; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	37	76	78	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					79	91		10.1016/j.immuni.2011.11.013	http://dx.doi.org/10.1016/j.immuni.2011.11.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22209676	Green Accepted, Bronze			2022-12-18	WOS:000299766000012
J	Malherbe, L; Mark, L; Fazilleau, N; McHeyzer-Williams, LJ; McHeyzer-Williams, MG				Malherbe, Laurent; Mark, Linda; Fazilleau, Nicolas; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.			Vaccine adjuvants alter TCR-based selection thresholds	IMMUNITY			English	Article							DENDRITIC CELL-INTERACTIONS; T-HELPER-CELLS; IN-VIVO; IMMUNE-RESPONSE; CLASS-II; REPERTOIRE SELECTION; INNATE IMMUNITY; LYMPH-NODES; ANTIGEN; MEMORY	How T cell receptor (TCR) specificity evolves in vivo after protein vaccination is central to the development of helper T (Th) cell function. Most models of clonal selection in the Th cell compartment favor TCR affinity-based thresholds. Here, we demonstrated that depot-forming vaccine adjuvants did not require Toll-like receptor (TLR) agonists; to induce clonal dominance in antigen-specific Th cell responses. However, readily dispersible adjuvants using TLR-9 and TLR-4 agonists skewed TCR repertoire usage by increasing TCR selection thresholds and enhancing antigen-specific clonal expansion. In this manner, vaccine adjuvants control the local accumulation of Th cells expressing TCR with the highest peptide MHC class II binding. Clonal composition was altered by mechanisms that blocked the local propagation of clonotypes independently of antigen dose and not as a consequence of interclonal competition. This capacity of adjuvants to modify antigen-specific Th cell clonal composition has fundamental implications for the design of future protein subunit vaccines.	[Malherbe, Laurent; Mark, Linda; Fazilleau, Nicolas; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Fazilleau, Nicolas/J-9883-2014	Fazilleau, Nicolas/0000-0002-3574-5614	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059475, R01AI040215, R01AI071182] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI059475-05, AI071182, AI040215, R01 AI040215, R01 AI059475, R01 AI040215-12, AI059475, R01 AI071182, R01 AI071182-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Falta MT, 2005, ARTHRITIS RHEUM-US, V52, P1885, DOI 10.1002/ART.21098; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Glenn GM, 2007, EXPERT REV VACCINES, V6, P651, DOI 10.1586/14760584.6.5.651; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Klinman DM, 2006, INT REV IMMUNOL, V25, P135, DOI 10.1080/08830180600743057; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2004, IMMUNITY, V20, P231, DOI 10.1016/S1074-7613(04)00028-7; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001	53	76	81	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					698	709		10.1016/j.immuni.2008.03.014	http://dx.doi.org/10.1016/j.immuni.2008.03.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18450485	Green Accepted, Bronze			2022-12-18	WOS:000256003900016
J	Park, B; Lee, S; Kim, E; Chang, S; Jin, M; Ahn, K				Park, B; Lee, S; Kim, E; Chang, S; Jin, M; Ahn, K			The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments	IMMUNITY			English	Article							CLASS-I MOLECULES; NATURAL-KILLER-CELLS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; GOLGI-APPARATUS; INTERMEDIATE COMPARTMENT; MEMBRANE-PROTEIN; COMPLEX; RECEPTOR; PEPTIDE	In contrast to the current model of MHC class I trafficking, which predicts that once a MHC class I molecule leaves the ER, it moves to the cell surface by bulk flow, we show that HLA-G that is loaded with suboptimal peptides is retrieved from post-ER compartments to the ER. Loading of HLA-G with high-affinity peptides abrogates this retrieval due to the lack of binding affinity to coatomer. Moreover, the loss of the endocytosis motif in the truncated cytoplasmic tail results in the prolonged half-life of HLA-G on the cell surface. Our findings reveal that surface expression of HLA-G can be further regulated in post-ER compartments and that the truncated cytoplasmic tail plays a critical role in such quality-control mechanisms.	Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea	Korea University	Ahn, K (corresponding author), Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea.		Lee, Sungwook/K-3697-2013					Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; Davis DM, 1997, EUR J IMMUNOL, V27, P2714, DOI 10.1002/eji.1830271035; Diehl M, 1996, CURR BIOL, V6, P305, DOI 10.1016/S0960-9822(02)00481-5; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HOWELL DN, 1986, HUM IMMUNOL, V17, P443, DOI 10.1016/0198-8859(86)90303-4; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jun Y, 2000, J IMMUNOL, V164, P805, DOI 10.4049/jimmunol.164.2.805; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Munz C, 1997, J EXP MED, V185, P385, DOI 10.1084/jem.185.3.385; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; RAPOSO G, 1995, J CELL BIOL, V131, P1403, DOI 10.1083/jcb.131.6.1403; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; SCHWARTZ AL, 1984, J CELL BIOL, V98, P732, DOI 10.1083/jcb.98.2.732; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; White S, 1998, J BIOL CHEM, V273, P14355, DOI 10.1074/jbc.273.23.14355; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	35	76	82	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					213	224		10.1016/S1074-7613(01)00179-0	http://dx.doi.org/10.1016/S1074-7613(01)00179-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520457	Bronze			2022-12-18	WOS:000170717200004
J	WANG, JY; LIN, Q; LANGSTON, H; COOPER, MD				WANG, JY; LIN, Q; LANGSTON, H; COOPER, MD			RESIDENT BONE-MARROW MACROPHAGES PRODUCE TYPE-1 INTERFERONS THAT CAN SELECTIVELY INHIBIT INTERLEUKIN-7-DRIVEN GROWTH OF B-LINEAGE-CELLS	IMMUNITY			English	Article							RECEPTOR GAMMA-CHAIN; FACTOR-I; IMMUNOGLOBULIN HEAVY; FUNCTIONAL COMPONENT; LYMPHOCYTES-B; PRO-B; MURINE; DIFFERENTIATION; PROLIFERATION; LYMPHOPOIESIS	Type 1 interferons alpha and beta are found to be potent inhibitors of IL-7-induced growth of early B lineage cells, while having no effect on cell growth induced by IL-2, IL-3, IL-4, or autogenous factors. The combination of IL-7 and interferons alpha/beta induces bcl-2 down-regulation and cell death by apoptosis. These conclusions were derived initially from experiments employing exogenous cytokines, but functional type 1 interferons are also shown to be produced by resident bone marrow macrophages. As physiological modulators of IL-7-driven proliferation and cell survival, interferons alpha/beta may cooperate with other homeostatic factors to maintain the balanced production of normal B lineage cells.	UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT MED,DIV DEV & CLIN IMMUNOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT PEDIAT,DIV DEV & CLIN IMMUNOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT MICROBIOL,DIV DEV & CLIN IMMUNOL,BIRMINGHAM,AL 35294	Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030879] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30879] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; ARMITAGE RJ, 1990, J IMMUNOL, V144, P938; BILLIPS LG, 1992, BLOOD, V79, P1185; BILLIPS LG, 1990, BLOOD, V75, P611; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CONLON PJ, 1989, BLOOD, V74, P1368; COOPER MD, 1986, NATURE, V321, P616, DOI 10.1038/321616a0; COOPER MD, 1990, IMMUNOGLOBULIN GENES, P1; DESIDERIO S, 1994, CURR OPIN IMMUNOL, V6, P248, DOI 10.1016/0952-7915(94)90098-1; DORSHKIND K, 1988, J IMMUNOL, V141, P531; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GARVY BA, 1994, IMMUNOLOGY, V81, P381; GIBSON LF, 1993, BLOOD, V82, P3005; GIMBLE JM, 1993, EXP HEMATOL, V21, P224; GRABSTEIN KH, 1990, J IMMUNOL, V144, P3015; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; GRAWUNDER U, 1993, EUR J IMMUNOL, V23, P544, DOI 10.1002/eji.1830230237; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAYASHI S, 1989, BLOOD, V74, P1711; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HIRAYAMA F, 1994, P NATL ACAD SCI USA, V91, P469, DOI 10.1073/pnas.91.2.469; HUGHES TK, 1994, J INTERFERON RES, V14, P117, DOI 10.1089/jir.1994.14.117; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KINCADE PW, 1994, IMMUNOL TODAY, V15, P539, DOI 10.1016/0167-5699(94)90211-9; KINCADE PW, 1994, P NATL ACAD SCI USA, V91, P2888, DOI 10.1073/pnas.91.8.2888; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEE G, 1989, J IMMUNOL, V142, P3875; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; MEDINA KL, 1993, J EXP MED, V178, P1507, DOI 10.1084/jem.178.5.1507; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MORRISSEY PJ, 1989, J EXP MED, V169, P707, DOI 10.1084/jem.169.3.707; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OSMOND DG, 1994, IMMUNOL REV, V142, P208; PELLEGRINI S, 1993, TRENDS BIOCHEM SCI, V18, P338, DOI 10.1016/0968-0004(93)90070-4; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; RAJEWSKY K, 1992, CURR OPIN IMMUNOL, V4, P171, DOI 10.1016/0952-7915(92)90008-3; RENNICK D, 1987, P NATL ACAD SCI USA, V84, P6889, DOI 10.1073/pnas.84.19.6889; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; ROLINK A, 1991, EUR J IMMUNOL, V21, P2609, DOI 10.1002/eji.1830211044; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; STANLEY ER, 1981, J IMMUNOL METHODS, V445, P253; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; TONEGAWA S, 1983, NATURE, V308, P575; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; YAMADA G, 1991, P NATL ACAD SCI USA, V88, P532, DOI 10.1073/pnas.88.2.532	61	76	76	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					475	484		10.1016/1074-7613(95)90176-0	http://dx.doi.org/10.1016/1074-7613(95)90176-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584138	Bronze			2022-12-18	WOS:A1995TB60800008
J	Johnson, JL; Rosenthal, RL; Knox, JJ; Myles, A; Naradikian, MS; Madej, J; Kostiv, M; Rosenfeld, AM; Meng, WZ; Christensen, SR; Hensley, SE; Yewdell, J; Canaday, DH; Zhu, J; McDermott, AB; Dori, Y; Itkin, M; Wherry, EJ; Pardi, N; Weissman, D; Naji, A; Prak, ETL; Betts, MR; Cancro, MP				Johnson, John L.; Rosenthal, Rebecca L.; Knox, James J.; Myles, Arpita; Naradikian, Martin S.; Madej, Joanna; Kostiv, Mariya; Rosenfeld, Aaron M.; Meng, Wenzhao; Christensen, Shannon R.; Hensley, Scott E.; Yewdell, Jonathan; Canaday, David H.; Zhu, Jinfang; McDermott, Adrian B.; Dori, Yoav; Itkin, Max; Wherry, E. John; Pardi, Norbert; Weissman, Drew; Naji, Ali; Prak, Eline T. Luning; Betts, Michael R.; Cancro, Michael P.			The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans	IMMUNITY			English	Article							INFLUENZA-VIRUS; EXPRESSION; DIFFERENTIATION; HEMAGGLUTININ; REPERTOIRE; INFECTION; RESPONSES; PATTERNS; PROGRAM; VACCINE	B cell subsets expressing the transcription factor T-bet are associated with humoral immune responses and autoimmunity. Here, we examined the anatomic distribution, clonal relationships, and functional properties of T-bet(+) and T-bet(-) memory B cells (MBCs) in the context of the influenza-specific immune response. In mice, both T-bet(-) and T-bet(+) hemagglutinin (HA)-specific B cells arose in germinal centers, acquired memory B cell markers, and persisted indefinitely. Lineage tracing and IgH repertoire analyses revealed minimal interconversion between T-bet(-) and T-bet(+) MBCs, and parabionts showed differential tissue residency and recirculation properties. T-bet(+) MBCs could be subdivided into recirculating T-bet(lo) MBCs and spleen-resident T-bet(hi) MBCs. Human MBCs displayed similar features. Conditional gene deletion studies revealed that T-bet expression in B cells was required for nearly all HA stalk-specific IgG2c antibodies and for durable neutralizing titers to influenza. Thus, T-bet expression distinguishes MBC subsets that have profoundly different homing, residency, and functional properties, and mediate distinct aspects of humoral immune memory.	[Johnson, John L.; Rosenthal, Rebecca L.; Knox, James J.; Myles, Arpita; Madej, Joanna; Kostiv, Mariya; Rosenfeld, Aaron M.; Meng, Wenzhao; Prak, Eline T. Luning; Cancro, Michael P.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Naradikian, Martin S.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Christensen, Shannon R.; Hensley, Scott E.; Betts, Michael R.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Yewdell, Jonathan] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Canaday, David H.] Case Western Reserve Univ, Sch Med, Div Infect Dis, Cleveland, OH 45106 USA; [Canaday, David H.] Cleveland VA Hosp, Cleveland, OH 45106 USA; [Zhu, Jinfang] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dori, Yoav] Childrens Hosp Philadelphia, Ctr Lymphat Imaging & Intervent, Philadelphia, PA 19104 USA; [Itkin, Max] Hosp Univ Penn, Dept Radiol, Div Intervent Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Inst Immunol, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Pardi, Norbert; Weissman, Drew] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Naji, Ali] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA	University of Pennsylvania; La Jolla Institute for Immunology; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cancro, MP (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	cancro@pennmedicine.upenn.edu	Wherry, John/ABI-1280-2020; Naradikian, Martin Souren/HHD-2348-2022; McDermott, Adrian B/E-7306-2011; Rosenfeld, Aaron/ABB-9927-2020; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745; McDermott, Adrian/0000-0003-0616-9117; Cancro, Michael/0000-0002-8659-3227	National Institute of Allergy and Infectious Diseases [1R01AI118694, 1UC4-DK-112217]; Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH-14-1-0305]; National Institutes of Health (NIH) [R01-AI-118691, P01-AI106697, P30-CA016520, R21-AI-133998]; Division of Intramural Research of the NIAID, NIH;  [T32 HL07954];  [T32 AI-055428];  [T32 AR-007442];  [T32 AI055428]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; 	We thank Barney Graham and his laboratory and the Vaccine Research Center (National Institute of Allergy and Infectious Disease, National Institutes of Health) for sharing plasmids expressing recombinant HA protein (HA probe) used in flow cytometry-based detection of influenza-binding B cells and Florian Krammer (Mt. Sinai) for sharing plasmids expressing recombinant H6/H1 protein that was used in this paper. This work was supported by National Institute of Allergy and Infectious Diseases 1R01AI118694 (M.R.B.) and 1UC4-DK-112217 (A.N.); Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, award no. W81XWH-14-1-0305 (M.P.C.); and National Institutes of Health (NIH) award no. R01-AI-118691 (M.P.C.), P01-AI106697 (E.L.P.), P30-CA016520 (E.L.P.), and R21-AI-133998 (M.P.C.). J.Z. is supported by the Division of Intramural Research of the NIAID, NIH. J.J.K. was supported in part by training grant T32 HL07954. R.L.R. was supported in part by training grant T32 AI-055428. J.L.J. was supported in party by training grant T32 AR-007442 and T32 AI055428.	Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Andrews SF, 2019, IMMUNITY, V51, P398, DOI 10.1016/j.immuni.2019.06.024; Austin JW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax0904; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Bell P, 2007, J HISTOCHEM CYTOCHEM, V55, P931, DOI 10.1369/jhc.7A7180.2007; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Boyden AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040733; Branch Alicia, 2012, Morbidity and Mortality Weekly Report, V61, P237; CANCRO MP, 1978, J EXP MED, V147, P776, DOI 10.1084/jem.147.3.776; Chang LY, 2017, J VIRAL HEPATITIS, V24, P389, DOI 10.1111/jvh.12659; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; de Jong J C, 2003, Dev Biol (Basel), V115, P63; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; FAZEKAS G, 1994, EUR J IMMUNOL, V24, P3063, DOI 10.1002/eji.1830241222; Frank GM, 2015, MBIO, V6, DOI 10.1128/mBio.01156-15; Gerth AJ, 2003, INT IMMUNOL, V15, P937, DOI 10.1093/intimm/dxg093; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOCART MJ, 1989, J GEN VIROL, V70, P809, DOI 10.1099/0022-1317-70-4-809; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johrens K, 2006, HISTOPATHOLOGY, V48, P343, DOI 10.1111/j.1365-2559.2005.02305.x; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kenderes KJ, 2018, CELL REP, V24, P824, DOI 10.1016/j.celrep.2018.06.074; Knode LMR, 2017, J IMMUNOL, V198, P1921, DOI 10.4049/jimmunol.1601106; Knox JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92943; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; Meng WZ, 2017, NAT BIOTECHNOL, V35, P879, DOI 10.1038/nbt.3942; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Obeng-Adjei N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006576; Pardi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05482-0; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Piovesan D, 2017, CELL REP, V19, P461, DOI 10.1016/j.celrep.2017.03.060; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02107; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01472; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sheikh AA, 2019, CELL REP, V28, P1758, DOI 10.1016/j.celrep.2019.07.034; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Turner DL, 2013, J VIROL, V87, P4496, DOI 10.1128/JVI.03413-12; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	68	75	77	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					842	+		10.1016/j.immuni.2020.03.020	http://dx.doi.org/10.1016/j.immuni.2020.03.020			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32353250	Bronze, Green Accepted			2022-12-18	WOS:000535371100016
J	Milner, JJ; Toma, C; He, ZR; Kurd, NS; Nguyen, QP; McDonald, B; Quezada, L; Widjaja, CE; Witherden, DA; Crowl, JT; Shaw, LA; Yeo, GW; Chang, JT; Omilusik, KD; Goldrath, AW				Milner, J. Justin; Toma, Clara; He, Zhaoren; Kurd, Nadia S.; Nguyen, Quynh P.; McDonald, Bryan; Quezada, Lauren; Widjaja, Christella E.; Witherden, Deborah A.; Crowl, John T.; Shaw, Laura A.; Yeo, Gene W.; Chang, John T.; Omilusik, Kyla D.; Goldrath, Ananda W.			Heterogenous Populations of Tissue-Resident CD8(+) T Cells Are Generated in Response to Infection and Malignancy	IMMUNITY			English	Article							TERMINAL DIFFERENTIATION; CUTTING EDGE; NONLYMPHOID TISSUES; MEMORY; EFFECTOR; ID3; MAINTENANCE; PATHWAY; ZEB2; ESTABLISHMENT	Tissue-resident memory CD8(+) T cells (Trm) provide host protection through continuous surveillance of non-lymphoid tissues. Using single-cell RNA-sequencing (scRNA-seq) and genetic reporter mice, we identified discrete lineages of intestinal antigen-specific CD8(+) T cells, including a Blimp1(hi)Id3(lo) tissue-resident effector cell population most prominent in the early phase of acute viral and bacterial infections and a molecularly distinct Blimp1(lo)Id3(hi) tissue-resident memory population that subsequently accumulated at later infection time points. These Trm populations exhibited distinct cytokine production, secondary memory potential, and transcriptional programs including differential roles for transcriptional regulators Blimp1, T-bet, Id2, and Id3 in supporting and maintaining intestinal Trm. Extending our analysis to malignant tissue, we also identified discrete populations of effector-like and memory-like CD8(+) T cell populations with tissue-resident gene-expression signatures that shared features of terminally exhausted and progenitor-exhausted T cells, respectively. Our findings provide insight into the development and functional heterogeneity of Trm cells, which has implications for enhancing vaccination and immunotherapy approaches.	[Milner, J. Justin; Toma, Clara; Nguyen, Quynh P.; McDonald, Bryan; Witherden, Deborah A.; Crowl, John T.; Shaw, Laura A.; Omilusik, Kyla D.; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [He, Zhaoren; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kurd, Nadia S.; Quezada, Lauren; Widjaja, Christella E.; Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Omilusik, KD; Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	komilusik@ucsd.edu; agoldrath@ucsd.edu	Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Omilusik, Kyla/0000-0003-3675-048X; Shaw, Laura/0000-0001-6595-1673; Chang, John/0000-0003-0873-6218; Goldrath, Ananda/0000-0002-5900-508X; McDonald, Bryan/0000-0003-1744-3433	NIH [AI132122, K99 CA234430-01];  [P30KC063491];  [P30CA023100]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	We thank the Flow Cytometry Core at the La Jolla Institute for Allergy and Immunology for their assistance with cell sorting, and the Chang and Goldrath laboratories for technical advice, helpful discussion, and critical reading of the manuscript. Single-cell RNA-sequencing using the 10X Genomics platform was conducted at the IGM Genomics Center, University of California, San Diego, La Jolla, CA and supported by grants P30KC063491 and P30CA023100. This work was funded by the NIH (AI132122 to A.W.G., G.W. Y., and J.T. Chang and K99 CA234430-01 to J.J.M.).	Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Bergsbaken T, 2017, CELL REP, V19, P114, DOI 10.1016/j.celrep.2017.03.031; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chen Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02826; Clarke J, 2019, J EXP MED, V216, P2128, DOI 10.1084/jem.20190249; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Davies B, 2017, J IMMUNOL, V198, P2233, DOI 10.4049/jimmunol.1601367; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Guan TX, 2018, J EXP MED, V215, P1153, DOI 10.1084/jem.20171352; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Ho AW, 2019, NAT REV IMMUNOL, V19, P490, DOI 10.1038/s41577-019-0162-3; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kakaradov B, 2017, NAT IMMUNOL, V18, P422, DOI 10.1038/ni.3688; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Knell J, 2013, J IMMUNOL, V190, P1501, DOI 10.4049/jimmunol.1200750; Kumar BV, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123568; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Milner JJ, 2018, CURR OPIN IMMUNOL, V51, P162, DOI 10.1016/j.coi.2018.03.017; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Mollo SB, 2014, J LEUKOCYTE BIOL, V95, P705, DOI 10.1189/jlb.0813429; Nguyen QP, 2019, IMMUNOLOGY, V157, P3, DOI 10.1111/imm.13059; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Omilusik KD, 2018, J EXP MED, V215, P773, DOI 10.1084/jem.20171584; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	71	75	77	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					808	+		10.1016/j.immuni.2020.04.007	http://dx.doi.org/10.1016/j.immuni.2020.04.007			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433949	Bronze, Green Accepted			2022-12-18	WOS:000535371100014
J	McGinley, AM; Sutton, CE; Edwards, SC; Leane, CM; DeCourcey, J; Teijeiro, A; Hamilton, JA; Boon, L; Djouder, N; Mills, KHG				McGinley, Aoife M.; Sutton, Caroline E.; Edwards, Sarah C.; Leane, Charlotte M.; DeCourcey, Joseph; Teijeiro, Ana; Hamilton, John A.; Boon, Louis; Djouder, Nabil; Mills, Kingston H. G.			Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1 beta-Producing Myeloid Cells that Promote Pathogenic T Cells	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; GAMMA-DELTA; IL-17 PRODUCTION; EFFECTOR PHASE; T(H)17 CELLS; TH17 CELLS; TNF-ALPHA; GM-CSF; DIFFERENTIATION; RECEPTOR	Interleukin-17A (IL-17A) is a major mediator of tissue inflammation in many autoimmune diseases. Anti-IL-17A is an effective treatment for psoriasis and is showing promise in clinical trials in multiple sclerosis. In this study, we find that IL-17A-defective mice or mice treated with anti-IL-17A at induction of experimental autoimmune encephalomyelitis (EAE) are resistant to disease and have defective priming of IL-17-secreting gamma delta T (gamma delta T-17) cells and Th17 cells. However, T cells from Il17a(-/-) mice induce EAE in wild-type mice following in vitro culture with autoantigen, IL-1 beta, and IL-23. Furthermore, treatment with IL-1 beta or IL-17A at induction of EAE restores disease in Il17a(-/-) mice. Importantly, mobilization of IL-1 beta-producing neutrophils and inflammatory monocytes and activation of gamma delta T17 cells is reduced in Il17a(-/-) mice. Our findings demonstrate that a key function of IL-17A in central nervous system (CNS) autoimmunity is to recruit IL-1 beta-secreting myeloid cells that prime pathogenic gamma delta T17 and Th17 cells.	[McGinley, Aoife M.; Sutton, Caroline E.; Edwards, Sarah C.; Leane, Charlotte M.; DeCourcey, Joseph; Mills, Kingston H. G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin 2, Ireland; [Teijeiro, Ana; Djouder, Nabil] CNIO, Growth Factors Nutrients & Canc Grp, Mol Oncol Programme, Madrid 28029, Spain; [Hamilton, John A.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Boon, Louis] Bioceros, Utrecht, Netherlands	Trinity College Dublin; Centro Nacional de Investigaciones Oncologicas (CNIO); Royal Melbourne Hospital; University of Melbourne	Mills, KHG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin 2, Ireland.	kingston.mills@tcd.ie	Boon, Laurence/HCI-3629-2022; Djouder, Nabil/E-4135-2015; Mills, Kingston H/F-5684-2013; Teijeiro, Ana/G-2788-2016	Djouder, Nabil/0000-0001-8423-1030; Mills, Kingston H/0000-0003-3646-8222; Edwards, Sarah C./0000-0003-4618-037X; Boon, Louis/0000-0002-0937-9171; Leane, Charlotte/0000-0003-2230-1587; Teijeiro, Ana/0000-0003-2276-7950; deCourcey, Joseph/0000-0002-8627-0129	Science Foundation Ireland [11/PI/1036, 16/IA/4468, 12/RI/2340]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants from Science Foundation Ireland (11/PI/1036, 16/IA/4468, and 12/RI/2340).	Allen AC, 2018, MUCOSAL IMMUNOL, V11, P1763, DOI 10.1038/s41385-018-0080-x; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aube B, 2014, J IMMUNOL, V193, P2438, DOI 10.4049/jimmunol.1400401; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bot J, 2003, PATHOL RES PRACT, V199, P341, DOI 10.1078/0344-0338-00427; Campa M, 2016, DERMATOLOGY THER, V6, P1, DOI 10.1007/s13555-015-0092-3; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dungan LS, 2014, EUR J IMMUNOL, V44, P2903, DOI 10.1002/eji.201444612; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Havrdova E, 2016, J NEUROL, V263, P1287, DOI 10.1007/s00415-016-8128-x; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones S.A., 2012, J IMMUNOL, V13, P1022; Jones Sarah A, 2012, Nat Immunol, V13, P1022, DOI 10.1038/ni.2450; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Levesque S.A., 2016, IMMUNITY, V52, P342; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Papotto PH, 2017, EMBO REP, V18, P1957, DOI 10.15252/embr.201744200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; Rei M, 2014, P NATL ACAD SCI USA, V111, pE3562, DOI 10.1073/pnas.1403424111; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Ronchi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11541; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Steinbach K, 2013, J IMMUNOL, V191, P4531, DOI 10.4049/jimmunol.1202613; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	59	75	82	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					342	+		10.1016/j.immuni.2020.01.002	http://dx.doi.org/10.1016/j.immuni.2020.01.002			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32023490	Green Published, Bronze			2022-12-18	WOS:000515082000015
J	Liu, ZH; Wang, CP; Yang, J; Zhou, BW; Yang, R; Ramachandran, R; Abbott, DW; Xiao, TS				Liu, Zhonghua; Wang, Chuanping; Yang, Jie; Zhou, Bowen; Yang, Rui; Ramachandran, Rajesh; Abbott, Derek W.; Xiao, Tsan Sam			Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization	IMMUNITY			English	Article							PYROPTOSIS; GSDMD; PORE; CASPASE-11; CLEAVAGE; SYSTEM	Gasdermin D (GSDMD) is an effector molecule for pyroptosis downstream of canonical and non-canonical inflammasome signaling pathways. Cleavage of GSDMD by inflammatory caspases triggers the oligomerization and lipid binding by its N-terminal domain, which assembles membrane pores, whereas its C-terminal domain binds the N-terminal domain to inhibit pyroptosis. Despite recent progress in our understanding of the structure and function of the murine gasdermin A3 (mGSDMA3), the molecular mechanisms of GSDMD activation and regulation remain poorly characterized. Here, we report the crystal structures of the full-length murine and human GSDMDs, which reveal the architecture of the GSDMD N-terminal domains and demonstrate distinct and common features of autoinhibition among gasdermin family members utilizing their beta 1-beta 2 loops. Disruption of the intramolecular domain interface enhanced pyroptosis, whereas mutations at the predicted lipid-binding or oligomerization surface reduced cytolysis. Our study provides a framework for understanding the autoinhibition, lipid binding, and oligomerization of GSDMD by using overlapping interfaces.	[Liu, Zhonghua; Wang, Chuanping; Yang, Jie; Zhou, Bowen; Abbott, Derek W.; Xiao, Tsan Sam] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Yang, Jie; Ramachandran, Rajesh] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Yang, Rui] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Ramachandran, Rajesh; Xiao, Tsan Sam] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Xiao, TS (corresponding author), Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA.	tsx@case.edu	Xiao, Tsan Sam/A-8590-2010; Ramachandran, Rajesh/A-1337-2011	Xiao, Tsan Sam/0000-0001-9688-475X; Ramachandran, Rajesh/0000-0002-4645-2841; Zhou, Bowen/0000-0003-4421-9787; YANG, JIE/0000-0001-6662-4236	Careers in Immunology postdoctoral fellowship from the American Association of Immunologists; NIH [T32AI089474, R01GM121583, P01DK091222, R01GM086550, R21AR069908, R01GM127609, P41GM103311]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR069908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550, R01GM121583, P41GM103311, R01GM127609, T32GM007250] Funding Source: NIH RePORTER	Careers in Immunology postdoctoral fellowship from the American Association of Immunologists; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Z.L. is supported by a Careers in Immunology postdoctoral fellowship from the American Association of Immunologists. B.Z. is supported by NIH grant T32AI089474, R.R. is supported by NIH grant R01GM121583, D.W.A. is supported by NIH grants P01DK091222 and R01GM086550, and T.S.X. is supported by NIH grants R21AR069908 and R01GM127609. We are grateful for help from the Ramakrishnan lab on the use of the inducible expression system. We would like to thank the Xiao, Abbott, Dubyak, Ramakrishnan, and Adoro labs for insightful discussions. X-ray diffraction data were collected at the Advanced Photon Source (APS) SER-CAT beamline (supporting institutions can be found at http://www.ser-cat.org/members.html) and the GM/CA-CAT beamline, funded in whole or in part by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the APS, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Molecular graphics and analyses were performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH grant P41GM103311.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Chao KL, 2017, P NATL ACAD SCI USA, V114, pE1128, DOI 10.1073/pnas.1616783114; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kuang SY, 2017, P NATL ACAD SCI USA, V114, P10642, DOI 10.1073/pnas.1708194114; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu Z, 2018, STRUCTURE, V26, P778, DOI 10.1016/j.str.2018.03.002; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115	32	75	84	7	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					43	+		10.1016/j.immuni.2019.04.017	http://dx.doi.org/10.1016/j.immuni.2019.04.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31097341	Green Accepted, Bronze			2022-12-18	WOS:000475561000009
J	Castellanos, JG; Woo, V; Viladomiu, M; Putzel, G; Lima, S; Diehl, GE; Marderstein, AR; Gandara, J; Perez, AR; Withers, DR; Targan, SR; Shih, DQ; Scherl, EJ; Longman, RS				Castellanos, Jim G.; Woo, Viola; Viladomiu, Monica; Putzel, Gregory; Lima, Svetlana; Diehl, Gretchen E.; Marderstein, Andrew R.; Gandara, Jorge; Perez, Alexendar R.; Withers, David R.; Targan, Stephan R.; Shih, David Q.; Scherl, Ellen J.; Longman, Randy S.			Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis	IMMUNITY			English	Article							CYTOKINE TL1A; TNFSF15; DR3; HETEROGENEITY; EXPRESSION; PREDICTOR; SELECTION; IL-22	Inflammatory bowel disease (IBD) results from a dys-regulated interaction between the microbiota and a genetically susceptible host. Genetic studies have linked TNFSF15 polymorphisms and its protein TNF-like ligand 1A (TL1A) with IBD, but the functional role of TL1A is not known. Here, we found that adherent IBD-associated microbiota induced TL1A release from CX3CR1(+) mononuclear phagocytes (MNPs). Using cell-specific genetic deletion models, we identified an essential role for CX3CR1(+)MNP-derived TL1A in driving group 3 innate lymphoid cell (ILC3) production of interleukin-22 and mucosal healing during acute colitis. In contrast to this protective role in acute colitis, TL1A-dependent expression of co-stimulatory molecule OX40L in MHCII+ ILC3s during colitis led to co-stimulation of antigen-specific T cells that was required for chronic T cell colitis. These results identify a role for ILC3s in activating intestinal T cells and reveal a central role for TL1A in promoting ILC3 barrier immunity during colitis.	[Castellanos, Jim G.; Woo, Viola; Viladomiu, Monica; Putzel, Gregory; Lima, Svetlana; Marderstein, Andrew R.; Gandara, Jorge; Perez, Alexendar R.; Longman, Randy S.] Weill Cornell Med, Jill Roberts Inst Res IBD, New York, NY 10021 USA; [Diehl, Gretchen E.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Withers, David R.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Targan, Stephan R.; Shih, David Q.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunol Res Inst, F Widjaja Fdn, Los Angeles, CA 90048 USA; [Scherl, Ellen J.; Longman, Randy S.] Weill Cornell Med, Jill Roberts Ctr IBD, New York, NY 10021 USA	Cornell University; Baylor College of Medicine; University of Birmingham; Cedars Sinai Medical Center; Cornell University	Longman, RS (corresponding author), Weill Cornell Med, Jill Roberts Inst Res IBD, New York, NY 10021 USA.; Longman, RS (corresponding author), Weill Cornell Med, Jill Roberts Ctr IBD, New York, NY 10021 USA.	ral2006@med.cornell.edu	Viladomiu, Monica/GNM-6447-2022; Withers, David/C-7055-2015	Withers, David/0000-0003-3757-7594; Diehl, Gretchen/0000-0002-1841-2842	Crohn's and Colitis Foundation Senior Research Award; NIH [1R03DK111852, 1R01 DK114252]; USPHS [DK056328]; NIH Medical Scientist Training Program [T32GM07739]; F. Widjaja Foundation Inflammatory Bowel & Immunobiology Research Institute; NIH K08 Career Development Award [DK099381, DK093578];  [NIHR01AI125264]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056328, K08DK093578, K08DK099381, R03DK111852, R01DK114252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation Senior Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. Widjaja Foundation Inflammatory Bowel & Immunobiology Research Institute; NIH K08 Career Development Award; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge Timothy Vyse and Marina Botto (Tnfsf4<SUP>flox/flox</SUP>), Julie Blander (MyD88<SUP>-/-</SUP>),and Gregory Sonnenberg (H2-Ab1<SUP>flox/flox</SUP> Rorc-cre) for generously providing mice. Bioinformatics support was provided by the Jill Roberts Institute for Research in IBD and microbiome sequencing was performed by the Microbiome Core Lab at Weill Cornell Medicine. We would like to thank Gregory Sonnenberg for helpful comments and critical review of the manuscript. This work was supported by grants from the Crohn's and Colitis Foundation Senior Research Award (R.S.L.), NIH 1R03DK111852 and 1R01 DK114252 (R.S.L.), NIHR01AI125264 (G.E.D.), USPHS grant DK056328 (S.R.T.), NIH K08 Career Development Award DK099381 (R.S.L.) and DK093578 (D.Q.S.), NIH Medical Scientist Training Program grant T32GM07739 (J.G.C.) and the F. Widjaja Foundation Inflammatory Bowel & Immunobiology Research Institute (S.R.T. and D.Q.S.).	Ahn YO, 2015, EUR J IMMUNOL, V45, P2335, DOI 10.1002/eji.201445213; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2013, CURR OPIN GASTROEN, V29, P597, DOI 10.1097/MOG.0b013e328365d3a2; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cortini A, 2017, ANN RHEUM DIS, V76, P2095, DOI 10.1136/annrheumdis-2017-211499; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hedl M, 2014, P NATL ACAD SCI USA, V111, P13451, DOI 10.1073/pnas.1404178111; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jia LG, 2016, J IMMUNOL, V197, P377, DOI 10.4049/jimmunol.1502466; Kim M., 2018, CX3CR1 INTESTINAL MO; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Melo-Gonzalez F, 2017, IMMUNOLOGY, V150, P265, DOI 10.1111/imm.12697; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Richard AC, 2015, J LEUKOCYTE BIOL, V98, P333, DOI 10.1189/jlb.3RI0315-095R; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Shih DQ, 2014, MUCOSAL IMMUNOL, V7, P1492, DOI 10.1038/mi.2014.37; Shih DQ, 2009, EUR J IMMUNOL, V39, P3239, DOI 10.1002/eji.200839087; Siakavellas SI, 2015, INFLAMM BOWEL DIS, V21, P2441, DOI 10.1097/MIB.0000000000000492; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Tung CC, 2014, J GASTROEN HEPATOL, V29, P723, DOI 10.1111/jgh.12496; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; Yang DH, 2014, J CROHNS COLITIS, V8, P1315, DOI 10.1016/j.crohns.2014.04.002; Zheng L, 2013, EUR J MICROBIOL IMMU, V3, P11, DOI 10.1556/EuJMI.3.2013.1.2; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	42	75	77	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1077	+		10.1016/j.immuni.2018.10.014	http://dx.doi.org/10.1016/j.immuni.2018.10.014			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30552020	Green Accepted, Bronze			2022-12-18	WOS:000453556500013
J	Buchan, SL; Dou, L; Remer, M; Booth, SG; Dunn, SN; Lai, C; Semmrich, M; Teige, I; Martensson, L; Penfold, CA; Chan, HTC; Willoughby, JE; Mockridge, CI; Dahal, LN; Cleary, KLS; James, S; Rogel, A; Kannisto, P; Jernetz, M; Williams, EL; Healy, E; Verbeek, JS; Johnson, PWM; Frendeus, B; Cragg, MS; Glennie, MJ; Gray, JC; Al-Shamkhani, A; Beers, SA				Buchan, Sarah L.; Dou, Lang; Remer, Marcus; Booth, Steven G.; Dunn, Stuart N.; Lai, Chester; Semmrich, Monika; Teige, Ingrid; Martensson, Linda; Penfold, Christine A.; Chan, H. T. Claude; Willoughby, Jane E.; Mockridge, C. Ian; Dahal, Lekh N.; Cleary, Kirstie L. S.; James, Sonya; Rogel, Anne; Kannisto, Paivi; Jernetz, Mats; Williams, Emily L.; Healy, Eugene; Verbeek, J. Sjef; Johnson, Peter W. M.; Frendeus, Bjorn; Cragg, Mark S.; Glennie, Martin J.; Gray, Juliet C.; Al-Shamkhani, Aymen; Beers, Stephen A.			Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function	IMMUNITY			English	Article							FC-GAMMA-RIIB; CD40 ANTIBODY; EX-VIVO; LYMPHOMA; THERAPY; EXPRESSION; IMMUNOTHERAPY; ENGAGEMENT; CONTRIBUTE; EFFICACY	The costimulatory receptor 4-1 BB is expressed on activated immune cells, including activated T cells. Antibodies targeting 4-1 BB enhance the proliferation and survival of antigen-stimulated T cells in vitro and promote CD8 T cell-dependent anti-tumor immunity in pre-clinical cancer models. We found that T regulatory (Treg) cells infiltrating human or murine tumors expressed high amounts of 4-1 BB. Intra-tumoral Treg cells were preferentially depleted by anti-41 BB mAbs in vivo. Anti-4-1 BB mAbs also promoted effector T cell agonism to promote tumor rejection. These distinct mechanisms were competitive and dependent on antibody isotype and Fc gamma R availability. Administration of anti-4-1 BB IgG2a, which preferentially depletes Treg cells, followed by either agonistic anti-4-1 BB IgG1 or anti-PD-1 mAb augmented anti-tumor responses in multiple solid tumor models. An antibody engineered to optimize both Fc gamma R-dependent Treg cell depleting capacity and Fc gamma R-independent agonism delivered enhanced anti-tumor therapy. These insights into the effector mechanisms of anti-4-1 BB mAbs lay the groundwork for translation into the clinic.	[Buchan, Sarah L.; Dou, Lang; Remer, Marcus; Booth, Steven G.; Dunn, Stuart N.; Penfold, Christine A.; Chan, H. T. Claude; Willoughby, Jane E.; Mockridge, C. Ian; Dahal, Lekh N.; Cleary, Kirstie L. S.; James, Sonya; Rogel, Anne; Williams, Emily L.; Cragg, Mark S.; Glennie, Martin J.; Gray, Juliet C.; Al-Shamkhani, Aymen; Beers, Stephen A.] Univ Southampton, Fac Med, Ctr Canc Immunol, Antibody & Vaccine Grp, Southampton SO16 6YD, Hants, England; [Lai, Chester; Healy, Eugene] Univ Southampton, Dept Dermatopharmacol, Fac Med, Southampton SO16 6YD, Hants, England; [Lai, Chester; Healy, Eugene] Univ Hosp Southampton NHS Fdn Trust, Dept Dermatol, Southampton SO16 6YD, Hants, England; [Semmrich, Monika; Teige, Ingrid; Martensson, Linda; Frendeus, Bjorn] BioInvent Int AB, Solvegatan 41, S-22370 Lund, Sweden; [Kannisto, Paivi; Jernetz, Mats] Lund Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden; [Verbeek, J. Sjef] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Johnson, Peter W. M.] Univ Southampton, Canc Res UK Southampton Ctr, Ctr Canc Immunol, Fac Med, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Lund University; Skane University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Southampton	Gray, JC; Al-Shamkhani, A; Beers, SA (corresponding author), Univ Southampton, Fac Med, Ctr Canc Immunol, Antibody & Vaccine Grp, Southampton SO16 6YD, Hants, England.	j.c.gray@soton.ac.uk; a.al-shamkhani@soton.ac.uk; sab@soton.ac.uk	Johnson, Peter/L-2403-2018; Dahal, Lekh/AAB-1268-2021; Cragg, Mark S/E-5965-2010; Johnson, Peter/O-3529-2019; Buchan, Sarah/AGK-4217-2022	Johnson, Peter/0000-0003-2306-4974; Cragg, Mark S/0000-0003-2077-089X; Johnson, Peter/0000-0003-2306-4974; Kannisto, Paivi/0000-0002-5517-1494; Williams, Emily/0000-0003-3506-9668; Buchan, Sarah/0000-0003-0913-8826; Healy, Eugene/0000-0001-5591-6970; Lai, Chester/0000-0003-2282-5655; Rogel, Anne/0000-0002-8788-566X; Al-Shamkhani, Aymen/0000-0003-0727-4189; Willoughby, Jane/0000-0002-6326-4519; Gray, Juliet/0000-0002-5652-4722; Cleary, Kirstie/0000-0001-6200-4945; chan, claude/0000-0003-0530-9480; Beers, Stephen/0000-0002-3765-3342	Cancer Research UK [C34592/A12343, C1477/A10834, C8574/A11781, C34999A/A18087]; Bloodwise [12050, 12020]; FP6 Marie Curie Research Training Network Immune Deficient Mice Grant [MRTN-CT-2004-005632]	Cancer Research UK(Cancer Research UK); Bloodwise; FP6 Marie Curie Research Training Network Immune Deficient Mice Grant	We are grateful to Alison Tutt and the staff of the University of Southampton Biomedical Research facility for their technical support. We are grateful to Prof. Dieter Riethmacher for providing access to Flp delete mice (B6.129S4-Gt(ROSA) 26Sor<SUP>tm1(FLP1)Dym</SUP>/RainJ) and for technical help with genotyping. We also thank Leon Douglas and Patrick Duriez from the ECMC/CRUK Protein Core Facility for making SIINFEKL tetramers and human M-CSF respectively. This work was funded by Cancer Research UK (grants C34592/A12343, C1477/A10834, C8574/A11781, and C34999A/A18087), Bloodwise (12050 and 12020), and the FP6 Marie Curie Research Training Network Immune Deficient Mice Grant (MRTN-CT-2004-005632). C.L. is a Wellcome Trust Research Training Fellow.	Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beers SA, 2008, BLOOD, V112, P4170, DOI 10.1182/blood-2008-04-149161; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Buchan SL, 2018, CLIN CANCER RES, V24, P2383, DOI 10.1158/1078-0432.CCR-17-3057; Buchan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045244; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Dahal LN, 2017, CANCER RES, V77, P3619, DOI 10.1158/0008-5472.CAN-16-2784; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; French RR, 1999, NAT MED, V5, P548, DOI 10.1038/8426; Furness AJS, 2014, TRENDS IMMUNOL, V35, P290, DOI 10.1016/j.it.2014.05.002; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Haynes NM, 2010, J IMMUNOL, V185, P532, DOI 10.4049/jimmunol.0903624; Li FB, 2012, CELL CYCLE, V11, P3343, DOI 10.4161/cc.21842; Li FB, 2012, P NATL ACAD SCI USA, V109, P10966, DOI 10.1073/pnas.1208698109; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Melero I, 2013, CLIN CANCER RES, V19, P1044, DOI 10.1158/1078-0432.CCR-12-2065; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; Mimoto F, 2013, PROTEIN ENG DES SEL, V26, P589, DOI 10.1093/protein/gzt022; Minard-Colin V, 2008, BLOOD, V112, P1205, DOI 10.1182/blood-2008-01-135160; Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Segal NH, 2014, J CLIN ONCOL, V32; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Taraban VY, 2011, J CLIN INVEST, V121, P463, DOI 10.1172/JCI45832; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Tipton TRW, 2015, BLOOD, V126, P2643, DOI 10.1182/blood-2015-09-671339; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Vargas FA, 2017, IMMUNITY, V46, P577, DOI 10.1016/j.immuni.2017.03.013; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; White AL, 2014, CURR TOP MICROBIOL, V382, P355, DOI 10.1007/978-3-319-07911-0_16; White AL, 2014, J IMMUNOL, V193, P1828, DOI 10.4049/jimmunol.1303204; White AL, 2011, J IMMUNOL, V187, P1754, DOI 10.4049/jimmunol.1101135; Williams EL, 2013, CLIN CANCER RES, V19, P3545, DOI 10.1158/1078-0432.CCR-12-3226; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428	50	75	76	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					958	+		10.1016/j.immuni.2018.09.014	http://dx.doi.org/10.1016/j.immuni.2018.09.014			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30446386	Bronze, Green Accepted			2022-12-18	WOS:000450752200019
J	Mollaoglu, G; Jones, A; Wait, SJ; Mukhopadhyay, A; Jeong, S; Arya, R; Camolotto, SA; Mosbruger, TL; Stubben, CJ; Conley, CJ; Bhutkar, A; Vahrenkamp, JM; Berrett, KC; Cessna, MH; Lane, TE; Witt, BL; Salama, ME; Gertz, J; Jones, KB; Snyder, EL; Oliver, TG				Mollaoglu, Gurkan; Jones, Alex; Wait, Sarah J.; Mukhopadhyay, Anandaroop; Jeong, Sangmin; Arya, Rahul; Camolotto, Soledad A.; Mosbruger, Timothy L.; Stubben, Chris J.; Conley, Christopher J.; Bhutkar, Arjun; Vahrenkamp, Jeffery M.; Berrett, Kristofer C.; Cessna, Melissa H.; Lane, Thomas E.; Witt, Benjamin L.; Salama, Mohamed E.; Gertz, Jason; Jones, Kevin B.; Snyder, Eric L.; Oliver, Trudy G.			The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment	IMMUNITY			English	Article							MOUSE MODEL; STEM-CELLS; NEUTROPHILS; LKB1; P53; ADENOCARCINOMAS; IMMUNOTHERAPY; PROGRESSION; MECHANISMS; EXPRESSION	The major types of non-small-cell lung cancer (NSCLC) squamous cell carcinoma and adenocarcinoma have distinct immune microenvironments. We developed a genetic model of squamous NSCLC on the basis of overexpression of the transcription factor Sox2, which specifies lung basal cell fate, and loss of the tumor suppressor Lkb 1 (SL mice). SL tumors recapitulated gene-expression and immune infiltrate features of human squamous NSCLC; such features included enrichment of tumor-associated neutrophils (TANs) and decreased expression of NKX2-1, a transcriptional regulator that specifies alveolar cell fate. In Kras-driven adenocarcinomas, mis-expression of Sox2 or loss of Nkx2-1 led to TAN recruitment. TAN recruitment involved SOX2-mediated production of the chemokine CXCL5. Deletion of Nkx2-1 in SL mice (SNL) revealed that NKX2-1 suppresses SOX2-driven squamous tumorigenesis by repressing adeno-to-squamous transdifferentiation. Depletion of TANs in SNL mice reduced squamous tumors, suggesting that TANs foster squamous cell fate. Thus, lineage-defining transcription factors determine the tumor immune microenvironment, which in turn might impact the nature of the tumor.	[Mollaoglu, Gurkan; Wait, Sarah J.; Mukhopadhyay, Anandaroop; Jeong, Sangmin; Arya, Rahul; Vahrenkamp, Jeffery M.; Berrett, Kristofer C.; Gertz, Jason; Jones, Kevin B.; Snyder, Eric L.; Oliver, Trudy G.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, Alex; Camolotto, Soledad A.; Lane, Thomas E.; Witt, Benjamin L.; Salama, Mohamed E.; Snyder, Eric L.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Mosbruger, Timothy L.; Stubben, Chris J.; Conley, Christopher J.] Huntsman Canc Inst, Bioinformat Shared Resource, Salt Lake City, UT 84112 USA; [Bhutkar, Arjun] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cessna, Melissa H.] Intermt Healthcare, Intermt Biorepository, Salt Lake City, UT 84111 USA; [Witt, Benjamin L.; Salama, Mohamed E.] Univ Utah, ARUP Labs, Salt Lake City, UT 84108 USA; [Jones, Kevin B.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Massachusetts Institute of Technology (MIT); Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Oliver, TG (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	trudy.oliver@hci.utah.edu	Mollaoglu, Gurkan/L-7051-2019; Wait, Sarah/L-2922-2019	Mollaoglu, Gurkan/0000-0003-0679-7463; Stubben, Chris/0000-0002-3390-4888; Oliver, Trudy/0000-0003-2082-2397; Gertz, Jason/0000-0001-7568-6789; Wait, Sarah/0000-0001-5660-2391; Arya, Rahul/0000-0003-0867-6585	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [P30CA042014]; Biorepository and Molecular Pathology, High Throughput Genomics and Bioinformatics Analysis, and Flow Cytometry Shared Resources; Immunology, Inflammation, and Infectious Diseases Initiative; NIH NCI [F99CA223015, R01CA187457]; Burroughs Wellcome Fund; NIH [R01CA212415]; Damon Runyon Cancer Research Foundation [DRR-26-13]; American Cancer Society [RSG-13-300-01-TBG]; NATIONAL CANCER INSTITUTE [R01CA187457, P30CA042014, R01CA212415, F99CA223015] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biorepository and Molecular Pathology, High Throughput Genomics and Bioinformatics Analysis, and Flow Cytometry Shared Resources; Immunology, Inflammation, and Infectious Diseases Initiative; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the T. Jacks laboratory for lentiviral constructs and KP mice and M. Van Brocklin for HEK293T reporter cells. Thanks to excellent core facilities, specifically to J. O'Shea, B. Anderson, and K. Gligorich for histological services; J. Marvin for flow cytometry; and B. Dalley for bioinformatics support. We are grateful to members of the Oliver, Snyder, and McMahon laboratories for technical assistance and feedback; specifically, we thank P. Ballieu, D. Hansen, R. Olsen, and R. Dahlgren. We acknowledge support from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award P30CA042014 awarded to Huntsman Cancer Institute for the use of core facilities, including the Biorepository and Molecular Pathology, High Throughput Genomics and Bioinformatics Analysis, and Flow Cytometry Shared Resources, and we acknowledge internal funding from the Immunology, Inflammation, and Infectious Diseases Initiative. G.M. is supported by the NIH NCI (F99CA223015). E.L.S. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and the NIH (R01CA212415). T.G.O. was supported in part by the Damon Runyon Cancer Research Foundation (DRR-26-13), American Cancer Society (Research Scholar Award no. RSG-13-300-01-TBG) and the NIH NCI (R01CA187457).	Asselin-Labat ML, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120094; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bezzi M, 2018, NAT MED, V24, P165, DOI 10.1038/nm.4463; Busch SE, 2016, J IMMUNOL, V197, P4493, DOI 10.4049/jimmunol.1600576; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hou SD, 2016, TRENDS CANCER, V2, P463, DOI 10.1016/j.trecan.2016.08.002; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kargl J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14381; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327; Langer CJ, 2016, J THORAC ONCOL, V11, P2066, DOI 10.1016/j.jtho.2016.08.138; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Li FM, 2015, CANCER CELL, V27, P698, DOI 10.1016/j.ccell.2015.04.001; Li J, 2018, IMMUNITY, V48, P185, DOI 10.1016/j.immuni.2018.02.004; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mukhopadhyay A, 2014, CELL REP, V8, P40, DOI 10.1016/j.celrep.2014.05.036; Nagaraj AS, 2017, CELL REP, V18, P673, DOI 10.1016/j.celrep.2016.12.059; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tata PR, 2018, DEV CELL, V44, P679, DOI 10.1016/j.devcel.2018.02.024; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Van de Laar Emily, 2014, Respir Res, V15, P160, DOI 10.1186/s12931-014-0160-8; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545; Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	52	75	77	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					764	+		10.1016/j.immuni.2018.09.020	http://dx.doi.org/10.1016/j.immuni.2018.09.020			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332632	Green Accepted, Bronze			2022-12-18	WOS:000447386700020
J	Ganesh, K; Massague, J				Ganesh, Karuna; Massague, Joan			TGF-beta Inhibition and Immunotherapy: Checkmate	IMMUNITY			English	Editorial Material							TUMOR MICROENVIRONMENT; CANCER; BLOCKADE	Immune checkpoint therapy can induce durable remissions, but many tumors demonstrate resistance. In a recent issue of Nature, Mariathasan et al. (2018) and Tauriello et al. (2018) identify stromal TGF-beta signaling as a determinant of immune exclusion. Combination TGF-beta inhibition and immunotherapy induces complete responses in mouse models.	[Ganesh, Karuna; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10065 USA; [Ganesh, Karuna] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Med, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10065 USA.	massaguj@mskcc.org		Massague, Joan/0000-0001-9324-8408	American Cancer Society; Shulamit Katzman Endowed Fellowships; Stand Up to Cancer Colorectal Cancer Dream Team [SU2C-AACR-DT22-17]; NIH [CA34610]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA034610] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Shulamit Katzman Endowed Fellowships; Stand Up to Cancer Colorectal Cancer Dream Team; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K.G. is supported by American Cancer Society and Shulamit Katzman Endowed Fellowships and is an Investigator of the Stand Up to Cancer Colorectal Cancer Dream Team (SU2C-AACR-DT22-17). J.M. is supported by NIH grant CA34610.	Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Gajewski TF, 2015, SEMIN ONCOL, V42, P663, DOI 10.1053/j.seminoncol.2015.05.011; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Ott PA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0218-5; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492	10	75	78	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					626	628		10.1016/j.immuni.2018.03.037	http://dx.doi.org/10.1016/j.immuni.2018.03.037			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669246	Green Accepted, Bronze			2022-12-18	WOS:000430198900010
J	Karunarathne, DS; Horne-Debets, JM; Huang, JX; Faleiro, R; Leow, CY; Amante, F; Watkins, TS; Miles, JJ; Dwyer, PJ; Stacey, KJ; Yarski, M; Poh, CM; Lee, JS; Cooper, MA; Renia, L; Richard, D; McCarthy, JS; Sharpe, AH; Wykes, MN				Karunarathne, Deshapriya S.; Horne-Debets, Joshua M.; Huang, Johnny X.; Faleiro, Rebecca; Leow, Chiuan Yee; Amante, Fiona; Watkins, Thomas S.; Miles, John J.; Dwyer, Patrick J.; Stacey, Katryn J.; Yarski, Michael; Poh, Chek Meng; Lee, Jason S.; Cooper, Matthew A.; Renia, Laurent; Richard, Derek; McCarthy, James S.; Sharpe, Arlene H.; Wykes, Michelle N.			Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity	IMMUNITY			English	Article							PLASMODIUM-FALCIPARUM; DENDRITIC CELLS; MALARIA; RECEPTOR; ACTIVATION; EXHAUSTION; INFECTION; BLOCKADE; ENGAGEMENT; EXPRESSION	Many pathogens, including Plasmodiumspp., exploit the interaction of programmed death-1 (PD-1) with PD-1-ligand-1 (PD-L1) to "deactivate'' T cell functions, but the role of PD-L2 remains unclear. We studied malarial infections to understand the contribution of PD-L2 to immunity. Here we have shown that higher PD-L2 expression on blood dendritic cells, from Plasmodium falciparum-infected individuals, correlated with lower parasitemia. Mechanistic studies in mice showed that PD-L2 was indispensable for establishing effective CD4(+) T cell immunity against malaria, because it not only inhibited PD-L1 to PD-1 activity but also increased CD3 and inducible co-stimulator (ICOS) expression on T cells. Importantly, administration of soluble multimeric PD-L2 to mice with lethal malaria was sufficient to dramatically improve immunity and survival. These studies show immuno-regulation by PD-L2, which has the potential to be translated into an effective treatment for malaria and other diseases where T cell immunity is ineffective or short-lived due to PD-1-mediated signaling.	[Karunarathne, Deshapriya S.; Horne-Debets, Joshua M.; Faleiro, Rebecca; Leow, Chiuan Yee; Amante, Fiona; Watkins, Thomas S.; Miles, John J.; Lee, Jason S.; McCarthy, James S.; Wykes, Michelle N.] IQIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Huang, Johnny X.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Dwyer, Patrick J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Stacey, Katryn J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Yarski, Michael] Millennium Sci, 4 Miles St, Mulgrave, Vic 3170, Australia; [Poh, Chek Meng; Renia, Laurent] ASTAR, Singapore Immunol Network, Singapore 136648, Singapore; [Poh, Chek Meng; Renia, Laurent] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Richard, Derek] Queensland Univ Technol, Sch Biomed Res, Brisbane, Qld 4102, Australia; [Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	QIMR Berghofer Medical Research Institute; University of Queensland; Queensland University of Technology (QUT); University of Queensland; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Queensland University of Technology (QUT); Harvard University; Harvard Medical School	Wykes, MN (corresponding author), IQIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia.	michelle.wykes@qimrberghofer.edu.au	Cooper, Matthew A./C-7988-2009; Wykes, Michelle N/G-6272-2013; Renia, Laurent/E-2117-2011; Huang, Johnny X/A-4041-2012; Lee, Jason/M-7522-2016; Miles, John J/ABC-1105-2020; Huang, Johnny/X-6916-2019; Richard, Derek/J-1338-2012; Faleiro, Rebecca/AAX-5674-2021	Cooper, Matthew A./0000-0003-3147-3460; Wykes, Michelle N/0000-0002-7956-0144; Renia, Laurent/0000-0003-0349-1557; Lee, Jason/0000-0003-0879-934X; Miles, John J/0000-0001-5506-6304; Huang, Johnny/0000-0003-3595-208X; Richard, Derek/0000-0002-4839-8471; Faleiro, Rebecca/0000-0003-2151-6199; McCarthy, James/0000-0001-6596-9718; Leow, Chiuan Yee/0000-0002-6919-5921; Stacey, Katryn/0000-0002-3992-7802	NHMRC (Australia); ARC Future Fellowship; NHMRC Practitioner Fellowship; Queensland Health Research Fellowship; Australian Post-Graduate Award through University of Queensland, School of Medicine; NHMRC Senior Research Fellowship; Singapore's A*STAR; NRF Singapore [NRF2007NRF-RF001-226]; Yong Loo Lin School of Medicine, National University of Singapore; NIH grant [P01 AI56299]; Medicines for Malaria Venture	NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Queensland Health Research Fellowship; Australian Post-Graduate Award through University of Queensland, School of Medicine; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Singapore's A*STAR(Agency for Science Technology & Research (A*STAR)); NRF Singapore(National Research Foundation, Singapore); Yong Loo Lin School of Medicine, National University of Singapore(National University of Singapore); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicines for Malaria Venture	We sincerely thank the seven volunteers who agreed to participate in our study. We most sincerely thank Professor J. Sprent (Garvan Institute, Australia), Dr. R. Ahmed (Emory Vaccine Development Center, USA), Dr. J.L. Ferrara (USA), and Dr. G. Freeman (Dana-Farber Cancer Institute, USA) for critical discussion or reading of the manuscript. The authors acknowledge support from NHMRC (Australia). M.N.W. was supported by ARC Future Fellowship; J.S.M. by NHMRC Practitioner and Queensland Health Research Fellowships; J.M.H.-D. by Australian Post-Graduate Award through University of Queensland, School of Medicine; J.J.M. by NHMRC CDF; and K.J.S. by NHMRC Senior Research Fellowship. L.R. was supported by Singapore's A*STAR and NRF Singapore (NRF2007NRF-RF001-226). C.M.P. was supported by Post-Graduate scholarship from the Yong Loo Lin School of Medicine, National University of Singapore. A.H.S. is supported by NIH grant P01 AI56299. We thank the animal and flow cytometry facilities for their assistance with the study. The clinical trial was funded by the Medicines for Malaria Venture. We also thank the volunteers, Dr Silvana Sekuloski, and Staff of Q-Pharm Pty Ltd for their assistance in sample collection in the clinical trial.	Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Haque A, 2014, J CLIN INVEST, V124, P2483, DOI 10.1172/JCI70698; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lau LS, 2011, J INFECT DIS, V204, P1989, DOI 10.1093/infdis/jir656; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Liu XL, 2003, J EXP MED, V197, P1721, DOI 10.1084/jem.20022089; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021914, 10.1371/journal.pone.0024413]; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Rockett RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-48; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; World Health Organization, 2015, WORLD MAL REP 2015; Wykes MN, 2008, NAT REV MICROBIOL, V6, P864, DOI 10.1038/nrmicro1988; Wykes MN, 2007, PLOS PATHOG, V3, P904, DOI 10.1371/journal.ppat.0030096; Xiao YP, 2014, J EXP MED, V211, P943, DOI 10.1084/jem.20130790; Yadava A, 1996, P NATL ACAD SCI USA, V93, P4595, DOI 10.1073/pnas.93.10.4595; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9	35	75	82	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					333	345		10.1016/j.immuni.2016.07.017	http://dx.doi.org/10.1016/j.immuni.2016.07.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533014	Bronze			2022-12-18	WOS:000382267300015
J	Kawalekar, OU; Connor, RSO; Fraietta, JA; Guo, LL; McGettigan, SE; Posey, AD; Patel, PR; Guedan, S; Scholler, J; Keith, B; Snyder, NW; Blair, IA; Milone, MC; June, CH				Kawalekar, Omkar U.; Connor, Roddy S. O'; Fraietta, Joseph A.; Guo, Lili; McGettigan, Shannon E.; Posey, Avery D., Jr.; Patel, Prachi R.; Guedan, Sonia; Scholler, John; Keith, Brian; Snyder, Nathaniel W.; Blair, Ian A.; Milone, Michael C.; June, Carl H.			Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells (vol 44, pg 380, 2016)	IMMUNITY			English	Correction												cjune@exchange.upenn.edu	patel, prachi/GRY-0386-2022; Guedan, Sonia/O-9645-2018	Guedan, Sonia/0000-0002-9605-0760				Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021	1	75	80	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					712	712		10.1016/j.immuni.2016.02.023	http://dx.doi.org/10.1016/j.immuni.2016.02.023			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	28843072	Bronze			2022-12-18	WOS:000372784200027
J	Zhang, YW; Li, Q; Rao, EY; Sun, YW; Grossmann, ME; Morris, RJ; Cleary, MP; Li, B				Zhang, Yuwen; Li, Qiang; Rao, Enyu; Sun, Yanwen; Grossmann, Michael E.; Morris, Rebecca J.; Cleary, Margot P.; Li, Bing			Epidermal Fatty Acid Binding Protein Promotes Skin Inflammation Induced by High-Fat Diet	IMMUNITY			English	Article							NLRP3 INFLAMMASOME; ULCERATIVE DERMATITIS; INSULIN-RESISTANCE; C57BL/6 MICE; OBESITY; ACTIVATION; MACROPHAGES; DIFFERENTIATION; SENSITIVITY; MECHANISMS	Defining specific cellular and molecular mechanisms in most obesity-related diseases remains an important challenge. Here we report a serendipitous finding that consumption of a high-fat diet (HFD) greatly increased the occurrence of skin lesions in C57BL/6 mice. We demonstrated that HFD induced the accumulation of a specific type of CD11c(+) macrophages in skin preceding detectable lesions. These cells primed skin to induce IL-1 beta and IL-18 signaling, which further promoted the cytokines IFN-gamma-and IL-17-mediated skin inflammation. Mechanistically, epidermal fatty acid binding protein (E-FABP) was significantly upregulated in skin of obese mice, which coupled lipid droplet formation and NLRP3 inflammasome activation. Deficiency of E-FABP in obese mice decreased recruitment of CD11c(+) macrophages in skin tissues, reduced production of IL-1b and IL-18, and consequently dampened activation of effector T cells. Furthermore, E-FABP-deficient mice are completely resistant to HFD-induced skin lesions. Collectively, E-FABP represents a molecular sensor triggering HFD-induced skin inflammation.	[Zhang, Yuwen; Li, Qiang; Rao, Enyu; Sun, Yanwen; Grossmann, Michael E.; Morris, Rebecca J.; Cleary, Margot P.; Li, Bing] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Li, Qiang] Shandong Univ, Shandong Prov Hosp Affiliated, Dept Burn & Plast Surg, Jinan 250021, Shandong, Peoples R China; [Sun, Yanwen] Mayo Clin Hlth Syst, Austin, MN 55912 USA	University of Minnesota System; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, B (corresponding author), Univ Minnesota, Hormel Inst, Austin, MN 55912 USA.	bli@hi.umn.edu	Rao, Enyu/S-9810-2017; Rao, Enyu/P-1726-2017; , Bing/A-7536-2016	, Bing/0000-0001-5363-7070	Hormel Foundation; Minnesota Obesity Center [5P30DK50456]; Career Transition Fellowship (NMSS) [TA3047-A-1]; NIH [CA18098601A1, CA17767901A1, CA157012]; NIDDK [U24DK100469]; NCATs [UL1TR000135]; NATIONAL CANCER INSTITUTE [R01CA180986, R01CA157012, R01CA177679] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469, P30DK050456] Funding Source: NIH RePORTER	Hormel Foundation; Minnesota Obesity Center; Career Transition Fellowship (NMSS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Jill Suttles for providing the E-FABP-deficient mice and Dr. Xuan-Mai T. Person and Dr. Michael D. Jensen for fat composition analysis with lipid mass spectrometry. This work was supported by the Hormel Foundation, Minnesota Obesity Center (5P30DK50456), Career Transition Fellowship (NMSS, TA3047-A-1), NIH R01 grants (CA18098601A1, CA17767901A1, CA157012), NIDDK (U24DK100469), and NCATs (UL1TR000135).	Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Duarte-Vogel SM, 2011, COMPARATIVE MED, V61, P13; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grau V, 2006, INT J BIOCHEM CELL B, V38, P279, DOI 10.1016/j.biocel.2005.09.010; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hayes CS, 2011, CARCINOGENESIS, V32, P1340, DOI 10.1093/carcin/bgr129; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P320, DOI 10.1002/art.27242; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; L'homme L, 2013, J LIPID RES, V54, P2998, DOI 10.1194/jlr.M037861; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Mathur A. N., 2011, ADOLESC MED STATE AR, V22, pix; Mathur Anubhav N, 2011, Adolesc Med State Art Rev, V22, P146; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mirmirani P, 2014, PEDIATR DERMATOL, V31, P183, DOI 10.1111/pde.12271; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Namatame I, 1999, J BIOCHEM-TOKYO, V125, P319, DOI 10.1093/oxfordjournals.jbchem.a022289; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Ogawa E, 2011, J INVEST DERMATOL, V131, P604, DOI 10.1038/jid.2010.342; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Scheinfeld NS, 2004, CLIN DERMATOL, V22, P303, DOI 10.1016/j.clindermatol.2004.01.001; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shipman AR, 2011, BRIT J DERMATOL, V165, P743, DOI 10.1111/j.1365-2133.2011.10393.x; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Sundberg JP, 2011, VET PATHOL, V48, P513, DOI 10.1177/0300985810379431; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang Y, 2013, PROTEIN CELL, V4, P425, DOI 10.1007/s13238-013-2113-2; Warden CH, 2008, CELL METAB, V7, P277, DOI 10.1016/j.cmet.2008.03.014; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Williams LK, 2012, COMPARATIVE MED, V62, P166; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Yosipovitch G, 2007, J AM ACAD DERMATOL, V56, P901, DOI 10.1016/j.jaad.2006.12.004; Zhang YW, 2014, CANCER RES, V74, P2986, DOI 10.1158/0008-5472.CAN-13-2689	48	75	76	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					953	964		10.1016/j.immuni.2015.04.016	http://dx.doi.org/10.1016/j.immuni.2015.04.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992864	Green Accepted, Bronze			2022-12-18	WOS:000354827400020
J	Boyer, L; Magoc, L; Dejardin, S; Cappillino, M; Paquette, N; Hinault, C; Charriere, GM; Ip, WKE; Fracchia, S; Hennessy, E; Erturk-Hasdemir, D; Reichhart, JM; Silverman, N; Lacy-Hulbert, A; Stuart, LM				Boyer, Laurent; Magoc, Lorin; Dejardin, Stephanie; Cappillino, Michael; Paquette, Nicholas; Hinault, Charlotte; Charriere, Guillaume M.; Ip, W. K. Eddie; Fracchia, Shannon; Hennessy, Elizabeth; Erturk-Hasdemir, Deniz; Reichhart, Jean-Marc; Silverman, Neal; Lacy-Hulbert, Adam; Stuart, Lynda M.			Pathogen-Derived Effectors Trigger Protective Immunity via Activation of the Rac2 Enzyme and the IMD or Rip Kinase Signaling Pathway	IMMUNITY			English	Article							NECROTIZING FACTOR-I; INNATE IMMUNITY; RHO-GTPASES; DROSOPHILA-MELANOGASTER; BACTERIAL EFFECTORS; FUNGAL-INFECTIONS; ESCHERICHIA-COLI; TOXINS; SYSTEM; COMPLEX	Although infections with virulent pathogens often induce a strong inflammatory reaction, what drives the increased immune response to pathogens compared to nonpathogenic microbes is poorly understood. One possibility is that the immune system senses the level of threat from a microorganism and augments the response accordingly. Here, focusing on cytotoxic necrotizing factor 1 (CNF1), an Escherichia coli-derived effector molecule, we showed the host indirectly sensed the pathogen by monitoring for the effector that modified RhoGTPases. CNF1 modified Rac2, which then interacted with the innate immune adaptors IMD and Rip1-Rip2 in flies and mammalian cells, respectively, to drive an immune response. This response was protective and increased the ability of the host to restrict pathogen growth, thus defining a mechanism of effector-triggered immunity that contributes to how metazoans defend against microbes with pathogenic potential.	[Boyer, Laurent; Magoc, Lorin; Dejardin, Stephanie; Cappillino, Michael; Paquette, Nicholas; Charriere, Guillaume M.; Ip, W. K. Eddie; Fracchia, Shannon; Hennessy, Elizabeth; Lacy-Hulbert, Adam; Stuart, Lynda M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hinault, Charlotte] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Hinault, Charlotte] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Erturk-Hasdemir, Deniz; Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA; [Reichhart, Jean-Marc] Univ Strasbourg, IBMC, UPR 9022, CNRS, F-67084 Strasbourg, France; [Stuart, Lynda M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Boyer, L (corresponding author), Ctr Mediterraneen Med Mol, INSERM, U895, C3M, F-06204 Nice 3, France.	boyerl@unice.fr; lstuart@partners.org	BOYER, Laurent/AAH-4543-2021; Ip, W. K. Eddie/C-3042-2012; Charriere, Guillaume M/O-8317-2014; Charriere, Guillaume/Z-1574-2019; Hennessy, Elizabeth/AAJ-4800-2021; Boyer, laurent/F-8921-2015; hinault, charlotte/P-6003-2016	BOYER, Laurent/0000-0002-1375-1706; Ip, W. K. Eddie/0000-0003-1953-972X; Charriere, Guillaume M/0000-0002-4796-1488; Charriere, Guillaume/0000-0002-4796-1488; Hennessy, Elizabeth/0000-0002-1231-5777; Boyer, laurent/0000-0002-1375-1706; Silverman, Neal/0000-0002-4259-456X; hinault, charlotte/0000-0002-3588-039X; Lacy-Hulbert, Adam/0000-0003-2162-0156; dejardin, stephanie/0000-0001-5328-1414	Fondation Recherche Medical; MGH ECOR Fund for Medical Discovery; Ligue Nationale Contre le Cancer; NIH/NIAID [PO1: A104420, RO1: A160025]; MGH ECOR; NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025, R01AI079198, P01AI044220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Fondation Recherche Medical; MGH ECOR Fund for Medical Discovery; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MGH ECOR; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank D. Ferrandon, J.L. Imler, and C. Kocks for sharing fly stocks, K. Fitzgerald, J. Tschopp, G. Gacon, and the Drosophila Genomics Resource Center for plasmids and E. Lemichez and G. Flatau for providing CNF1 and CNF1 mutant purified proteins and cDNA and anti-CNF1 antibody. We thank J. Dejardin, O. Visvikis, P. Leopold, M. Maddugoda, A. Mettouchi, B. Ferrua, P. Munro, and A. Doye for technical suggestions and F. Ausubel, A Ezekowitz, and E. Lemichez for critical discussion and reading the manuscript. Technical support was provided by the C3M Cell Imaging Facility (Francois Prodon) and the Taplin Mass Spectrometric Facility (Ross Tomaino). L.B. was supported by Fondation Recherche Medical, MGH ECOR Fund for Medical Discovery and Ligue Nationale Contre le Cancer. This work was supported by NIH/NIAID grants to J-M.R. (PO1: A104420) and N.S (RO1: A160025) and grants to L.S from MGH ECOR and NIH/NIAID. All experiments were designed and interpreted by L.B. and L.M.S. L.M.S. supervised the work with assistance from A.L-H. L.B. and L.M.S. wrote the manuscript with input from A.L.-H. and N.S. In vitro experiments were performed by L.B., S.D., C.H., G.M.C., EN., and W.K.I. Flies were generated and maintained by L.B., M.C., and L.M. In vivo experiments were performed by L.B., L.M., M.C., N.P., and S.F. IMD, Relish, Dorsal and PGRP-LC reagents (constructs antibodies, etc.) were generated and supplied by D.E.-H., J.M.R., and N.S.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Freche B, 2007, SEMIN IMMUNOPATHOL, V29, P249, DOI 10.1007/s00281-007-0085-0; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Munro P, 2004, J BIOL CHEM, V279, P35849, DOI 10.1074/jbc.M401580200; Raymond K, 2001, J BIOL CHEM, V276, P35909, DOI 10.1074/jbc.M105779200; Real JM, 2007, CYTOKINE, V37, P22, DOI 10.1016/j.cyto.2007.02.016; Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Shames SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001057; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Waterfield NR, 2002, TRENDS MICROBIOL, V10, P541, DOI 10.1016/S0966-842X(02)02463-0; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195	39	75	77	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					536	549		10.1016/j.immuni.2011.08.015	http://dx.doi.org/10.1016/j.immuni.2011.08.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22018470	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000296657700013
J	Griffith, TS; Ferguson, TA				Griffith, Thomas S.; Ferguson, Thomas A.			Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells	IMMUNITY			English	Review							CD8(+) T-CELLS; ANTIGEN-PRESENTING CELLS; IMMATURE DENDRITIC CELLS; APOPTOTIC CELLS; IN-VIVO; CROSS-PRESENTATION; IMMUNOLOGICAL-TOLERANCE; IMMUNE-RESPONSE; AUTOIMMUNE-DISEASE; SELF-ANTIGENS	The mammalian immune system continually faces death in the form of its own dead and dying cells that arise during normal tissue turnover, infections, cellular damage, and cancer. Complex decisions must then be made that will permit a protective response to pathogens, while at the same time destroying tumors but not attacking vital systems of the host that could lead to autoimmunity. By using an investigative technique termed the five Ws (who, what, when, where, and why), we will examine how the immune system responds to antigens generated via cell death. This analysis will give us a better understanding of the molecular differences fundamental to tolerogenic or immunogenic cell death, the cells that sense and react to the dead cells, and the consequences of these fundamental elements on the maintenance or abrogation of tolerance.	[Ferguson, Thomas A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Griffith, Thomas S.] Univ Minnesota, Dept Urol, Minneapolis, MN 55455 USA; [Griffith, Thomas S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ferguson, TA (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	tgriffit@umn.edu; ferguson@vision.wustl.edu	Griffith, Thomas/ABF-8225-2020		National Institutes of Health [AI077565, CA109446, EY06765, EY015570, EY02687]; University of Iowa Carver College of Medicine; Research to Prevent Blindness (New York, NY); NATIONAL CANCER INSTITUTE [R01CA109446] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006765, R01EY006765, P30EY002687, R01EY015570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Carver College of Medicine; Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants AI077565 (T.S.G.), CA109446 (T.S.G.), EY06765 (T.A.F.), EY015570 (T.A.F.), and EY02687 (Department of Ophthalmology and Visual Science Core Grant, Washington University, St. Louis, MO). Additional support was obtained from a University of Iowa Carver College of Medicine Medical Research Initiative Grant (T.S.G.) and a Department of Ophthalmology and Visual Science grant from Research to Prevent Blindness (New York, NY) (T.A.F.) and the Macular Vision Research Foundation (West Conshohocken, PA) (T.A.F.). The authors wish to express their sincere thanks to J. Choi and P. Gurung for designing the figures.	Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Barreiro R, 2004, J IMMUNOL, V173, P1519, DOI 10.4049/jimmunol.173.3.1519; BATTISTO JR, 1980, IMMUNOL REV, V50, P47, DOI 10.1111/j.1600-065X.1980.tb00307.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; CANTOR H, 1976, J EXP MED, V143, P1391, DOI 10.1084/jem.143.6.1391; Chaput N, 2007, J MOL MED, V85, P1069, DOI 10.1007/s00109-007-0214-1; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; CONLON PJ, 1980, J IMMUNOL, V125, P807; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dupont E, 2009, IMMUNOTHERAPY-UK, V1, P205, DOI 10.2217/1750743X.1.2.205; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Ferguson TA, 2011, IMMUNOL REV, V241, P77, DOI 10.1111/j.1600-065X.2011.01006.x; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gao YK, 1998, J EXP MED, V188, P887, DOI 10.1084/jem.188.5.887; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; GERSHON RK, 1972, J IMMUNOL, V108, P586; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; GREENE MI, 1980, IMMUNOL REV, V50, P163, DOI 10.1111/j.1600-065X.1980.tb00311.x; Griffith TS, 2007, J IMMUNOL, V178, P2679, DOI 10.4049/jimmunol.178.5.2679; Griffith TS, 2011, J IMMUNOL, V186, P791, DOI 10.4049/jimmunol.1002678; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Gurung P, 2010, J LEUKOCYTE BIOL, V88, P1217, DOI 10.1189/jlb.0610343; Gurung P, 2009, J IMMUNOL, V183, P6114, DOI 10.4049/jimmunol.0901676; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hannani D, 2010, TRANSPLANTATION, V90, P1232, DOI 10.1097/TP.0b013e3181fa4eb6; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hege KM, 2006, INT REV IMMUNOL, V25, P321, DOI 10.1080/08830180600992498; Herndon JM, 2005, J IMMUNOL, V174, P4098, DOI 10.4049/jimmunol.174.7.4098; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Ip WK, 2004, J IMMUNOL, V173, P189, DOI 10.4049/jimmunol.173.1.189; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Johansson U, 2007, J IMMUNOL, V179, P1711, DOI 10.4049/jimmunol.179.3.1711; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; Kleinclauss F, 2003, TRANSPLANTATION, V75, p43S, DOI 10.1097/01.TP.0000067951.90241.54; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Li A, 2006, CLIN DEV IMMUNOL, V13, P273, DOI 10.1080/17402520600834704; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Lin JS, 2005, J IMMUNOL, V174, P6282, DOI 10.4049/jimmunol.174.10.6282; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Marin-Gallen S, 2010, CLIN EXP IMMUNOL, V160, P207, DOI 10.1111/j.1365-2249.2009.04082.x; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McMenamin PG, 1999, BRIT J OPHTHALMOL, V83, P598, DOI 10.1136/bjo.83.5.598; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Rawson PM, 2007, NAT MED, V13, P1431, DOI 10.1038/nm1679; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Ronchetti A, 1999, J LEUKOCYTE BIOL, V66, P247, DOI 10.1002/jlb.66.2.247; Ronchetti A, 1999, J IMMUNOL, V163, P130; Roth E, 2004, CURR OPIN CLIN NUTR, V7, P161, DOI 10.1097/00075197-200403000-00010; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Smith CE, 2006, J AUTOIMMUN, V27, P218, DOI 10.1016/j.jaut.2006.12.002; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steptoe RJ, 2000, OCUL IMMUNOL INFLAMM, V8, P177, DOI 10.1076/0927-3948(200009)8:3;1-K;FT177; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Xie YF, 2009, CANCER RES, V69, P7756, DOI 10.1158/0008-5472.CAN-09-0496; Zitvogel L, 2004, ADV IMMUNOL, V84, P131, DOI 10.1016/S0065-2776(04)84004-5	118	75	77	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					456	466		10.1016/j.immuni.2011.08.011	http://dx.doi.org/10.1016/j.immuni.2011.08.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035838	Green Accepted, Bronze			2022-12-18	WOS:000296657700003
J	Kane, M; Case, LK; Wang, C; Yurkovetskiy, L; Dikiy, S; Golovkina, TV				Kane, Melissa; Case, Laure K.; Wang, Christine; Yurkovetskiy, Leonid; Dikiy, Stanislav; Golovkina, Tatyana V.			Innate Immune Sensing of Retroviral Infection via Toll-like Receptor 7 Occurs upon Viral Entry	IMMUNITY			English	Article							MAMMARY-TUMOR VIRUS; PLASMACYTOID DENDRITIC CELLS; MURINE LEUKEMIA VIRUSES; RESISTANCE GENE; INFLUENZA-VIRUS; STRANDED-RNA; I/LNJ MICE; T-CELLS; MOUSE; RECOGNITION	Innate immune sensors are required for induction of pathogen-specific immune responses. Retroviruses are notorious for their ability to evade immune defenses and establish long-term persistence in susceptible hosts. However, some infected animals are able to develop efficient virus-specific immune responses, and thus can be employed for identification of critical innate virus-sensing mechanisms. With mice from two inbred strains that control retroviruses via adaptive immune mechanisms, we found that of all steps in viral replication, the ability to enter the host cell was sufficient to induce antivirus humoral immune responses. Virus sensing occurred in endosomes via a MyD88-Toll-like receptor 7-dependent mechanism and stimulated virus-neutralizing immunity independently of type I interferons. Thus, efficient adaptive immunity to retroviruses is induced in vivo by innate sensing of the early stages of retroviral infection.	[Kane, Melissa; Case, Laure K.; Wang, Christine; Yurkovetskiy, Leonid; Dikiy, Stanislav; Golovkina, Tatyana V.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Golovkina, TV (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	tgolovki@bsd.uchicago.edu	Dikiy, Stanislav/GWR-2104-2022	Yurkovetskiy, Leonid/0000-0001-5078-493X; Dikiy, Stanislav/0000-0002-8287-6561; Kane, Melissa/0000-0002-4580-1210	PHS [CA134667];  [P30 CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599, R01CA134667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090084] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to the members of the T.V.G. laboratory, J. Bubeck-Wardenburg, and A. Chervonsky for helpful discussion. We are also thankful to A. Kozlova and The University of Chicago Light Microscopy director V. Bindokas for technical support. This work was supported by PHS grant CA134667 to T.V.G. and by a grant (P30 CA014599) to the University of Chicago.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ammann CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006105; Andreadis S, 2000, J VIROL, V74, P3431, DOI 10.1128/JVI.74.7.3431-3431.2000; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Boeke J. D., 1997, P343; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Buggiano V, 1999, SCAND J IMMUNOL, V49, P269; Case LK, 2008, J VIROL, V82, P1438, DOI 10.1128/JVI.01991-07; Case LK, 2005, J IMMUNOL, V175, P7543, DOI 10.4049/jimmunol.175.11.7543; CHESEBRO B, 1990, ANNU REV IMMUNOL, V8, P477, DOI 10.1146/annurev.immunol.8.1.477; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; CLOYD MW, 1980, J EXP MED, V151, P542, DOI 10.1084/jem.151.3.542; Coffin J. M., 1990, VIROLOGY, P1437; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Evans DT, 2001, IMMUNOL REV, V183, P141, DOI 10.1034/j.1600-065x.2001.1830112.x; Gerlach N, 2006, J VIROL, V80, P3438, DOI 10.1128/JVI.80.7.3438-3444.2006; GOLOVKINA TV, 1994, J EXP MED, V179, P439, DOI 10.1084/jem.179.2.439; Golovkina TV, 1997, J VIROL, V71, P3895, DOI 10.1128/JVI.71.5.3895-3903.1997; Golovkina TV, 2000, J VIROL, V74, P2752, DOI 10.1128/JVI.74.6.2752-2759.2000; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; HASENKRUG KJ, 1995, J VIROL, V69, P2617, DOI 10.1128/JVI.69.4.2617-2620.1995; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hook LM, 2002, J VIROL, V76, P12112, DOI 10.1128/JVI.76.23.12112-12122.2002; Hook LM, 2000, J VIROL, V74, P8876, DOI 10.1128/JVI.74.19.8876-8883.2000; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kane M, 2011, J VIROL, V85, P3415, DOI 10.1128/JVI.01768-10; Katen LJ, 2001, J VIROL, V75, P5018, DOI 10.1128/JVI.75.11.5018-5026.2001; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; MacDearmid CC, 2006, J VIROL, V80, P2206, DOI 10.1128/JVI.80.5.2206-2215.2006; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyazawa M, 2008, VACCINE, V26, P2981, DOI 10.1016/j.vaccine.2008.01.004; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; OGURA H, 1976, MED MICROBIOL IMMUN, V162, P175, DOI 10.1007/BF02120995; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; PIAZZON I, 1994, J IMMUNOL, V153, P1553; Purdy A, 2003, J EXP MED, V197, P233, DOI 10.1084/jem.20021499; RISSER R, 1983, ANNU REV GENET, V17, P85, DOI 10.1146/annurev.ge.17.120183.000505; Rosenberg N., 1997, RETROVIRUSES, P475; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Santiago ML, 2011, J VIROL, V85, P189, DOI 10.1128/JVI.01838-10; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider-Schaulies S, 2006, J GEN VIROL, V87, P1423, DOI 10.1099/vir.0.81713-0; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; STOYE JP, 1991, J VIROL, V65, P1273, DOI 10.1128/JVI.65.3.1273-1285.1991; Super HJ, 1999, J VIROL, V73, P7848, DOI 10.1128/JVI.73.9.7848-7852.1999; Tsuji-Kawahara S, 2010, J VIROL, V84, P6082, DOI 10.1128/JVI.02516-09; Wang EX, 2008, VIROLOGY, V381, P230, DOI 10.1016/j.virol.2008.08.013; Wrona T, 1996, J VIROL, V70, P1246, DOI 10.1128/JVI.70.2.1246-1249.1996; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	66	75	75	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 22	2011	35	1					135	145		10.1016/j.immuni.2011.05.011	http://dx.doi.org/10.1016/j.immuni.2011.05.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21723157	Bronze, Green Accepted			2022-12-18	WOS:000293107300016
J	Fang, M; Orr, MT; Spee, P; Egebjerg, T; Lanier, LL; Sigal, LJ				Fang, Min; Orr, Mark T.; Spee, Pieter; Egebjerg, Thomas; Lanier, Lewis L.; Sigal, Luis J.			CD94 Is Essential for NK Cell-Mediated Resistance to a Lethal Viral Disease	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTED CELLS; CD8(+) T-CELLS; ECTROMELIA VIRUS; GENE-COMPLEX; ACTIVATING RECEPTORS; CLASS-I; RECOGNITION; CYTOMEGALOVIRUS; IDENTIFICATION	It is well established that natural killer (NK) cells confer resistance to many viral diseases, but in only a few instances the molecular mechanisms whereby NK cells recognize virus-infected cells are known. Here we show that CD94, a molecule preferentially expressed by NK cells, is essential for the resistance of C57BL/6 mice to mousepox, a disease caused by the Orthopoxvirus ectromelia virus. Ectromelia virus-infected cells expressing the major histocompatibility complex (MHC) class lb molecule Qa-1(b) are specifically recognized by the activating receptor formed by CD94 and NKG2E. Because CD94-NKG2 receptors and their ligands are highly conserved in rodents and humans, a similar mechanism may exist during human infections with the smallpox and monkeypox viruses, which are highly homologous to ectromelia virus.	[Fang, Min; Sigal, Luis J.] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Fang, Min; Sigal, Luis J.] Fox Chase Canc Ctr, Host Def Program, Philadelphia, PA 19111 USA; [Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Spee, Pieter; Egebjerg, Thomas] Novo Nordisk AS, Dept NK Cell Biol, DK-2760 Malov, Denmark	Fox Chase Cancer Center; Fox Chase Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Novo Nordisk	Sigal, LJ (corresponding author), Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	luis.sigal@fccc.edu	Sigal, Luis/AAL-1849-2021; Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Fang, Min/0000-0002-5278-1430; Sigal, Luis/0000-0001-6642-5472; Orr, Mark/0000-0003-2684-4722	NIAID [R01AI048849, R21AI077021, R01AI065544]; NIH [AI066897]; NCI [CA006927]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065544, R37AI066897, R01AI068129, R21AI077021, R01AI048849] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the following FCCC core facilities: Laboratory Animal, Flow Cytometry, Sequencing, Cell Culture, Transgenic, and Hybridoma. We thank H. Gillin for secretarial support. This work was supported by NIAID grants R01AI048849, R21AI077021, and R01AI065544 to L.J.S., NIH grant AI066897 to L.L.L., and NCI grant CA006927 to FCCC. M.F. was partly supported by the William J. Avery Fellowship. M.T.O. was supported by a fellowship from the Cancer Research Institute. L.L.L. is an American Cancer Society Professor. Author contributions are as follows. L.J.S. and L.L.L. conceived the initial idea; M.F. performed most of the experiments; L.J.S. supervised the project; M.T.O. generated some of the reporter cells; P.S. and T.E. produced the CD94 blocking mAb; L.J.S. and L.L.L. contributed reagents and analytic tools; M.F., M.T.O., L.L.L., and L.J.S. discussed the general design and the analysis of experiments; M.F. and L.J.S. designed most of the experiments; L.J.S. wrote the manuscript with M.F. collaboration; and M.F. and L.J.S. prepared the figures. L.J.S. and L.L.L. should be considered senior authors. All the authors approved the final manuscript.	ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Brown MG, 2008, SEMIN IMMUNOL, V20, P361, DOI 10.1016/j.smim.2008.06.004; BROWNSTEIN DG, 1991, J VIROL, V65, P1946, DOI 10.1128/JVI.65.4.1946-1951.1991; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; DeCloux A, 1997, J IMMUNOL, V158, P2183; DELANO ML, 1995, J VIROL, V69, P5875, DOI 10.1128/JVI.69.9.5875-5877.1995; ELROYSTEIN O, 1990, P NATL ACAD SCI USA, V87, P6743, DOI 10.1073/pnas.87.17.6743; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; Fang M, 2006, J IMMUNOL, V177, P8027, DOI 10.4049/jimmunol.177.11.8027; Fang M, 2010, J EXP MED, V207, P2369, DOI 10.1084/jem.20100282; Fang M, 2010, METHODS MOL BIOL, V612, P411, DOI 10.1007/978-1-60761-362-6_28; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Gross E, 2003, ANN EMERG MED, V42, P660, DOI 10.1016/S0196-0644(03)00819-9; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Hooijberg E, 2000, BLOOD, V96, P459; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; JACOBY RO, 1989, ARCH VIROL, V108, P49, DOI 10.1007/BF01313742; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Larkin M, 2003, LANCET INFECT DIS, V3, P3, DOI 10.1016/S1473-3099(03)00499-7; Lee SH, 2010, EUR J IMMUNOL, V40, P923, DOI 10.1002/eji.201040304; Lu LR, 2006, IMMUNOL REV, V212, P51, DOI 10.1111/j.0105-2896.2006.00418.x; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Orr MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015184; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Shen ZH, 1997, J IMMUNOL, V158, P2723; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xu RH, 2007, P NATL ACAD SCI USA, V104, P10992, DOI 10.1073/pnas.0701822104; YOKOYAMA WM, 1991, J IMMUNOL, V147, P3229	40	75	80	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					579	589		10.1016/j.immuni.2011.02.015	http://dx.doi.org/10.1016/j.immuni.2011.02.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21439856	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000290367300016
J	Charles, N; Watford, WT; Ramos, HL; Hellman, L; Oettgen, HC; Gomez, G; Ryan, JJ; O'Shea, JJ; Rivera, J				Charles, Nicolas; Watford, Wendy T.; Ramos, Haydee L.; Hellman, Lars; Oettgen, Hans C.; Gomez, Gregorio; Ryan, John J.; O'Shea, John J.; Rivera, Juan			Lyn Kinase Controls Basophil GATA-3 Transcription Factor Expression and Induction of Th2 Cell Differentiation	IMMUNITY			English	Article							FC-EPSILON-RI; DEFICIENT MAST-CELLS; CYTOKINE PRODUCTION; NONRELEASER BASOPHILS; NEGATIVE REGULATION; AUTOIMMUNE-DISEASE; ALLERGIC RESPONSES; HISTAMINE-RELEASE; INTERFERON-GAMMA; GENETIC-EVIDENCE	T helper 1 (Th1)-Th2 cell balance is key to host defense and its dysregulation has pathophysiological consequences. Basophils are important in Th2 cell differentiation. However, the factors controlling the onset and extent of basophil-mediated Th2 cell differentiation are unknown. Here, we demonstrate that Lyn kinase dampened basophil expression of the transcription factor GATA-3 and the initiation and extent of Th2 cell differentiation. Lyn-deficient mice had a marked basophilia, a constitutive Th2 cell skewing that was exacerbated upon in vivo challenge of basophils, produced antibodies to a normally inert antigen, and failed to appropriately respond to a Th1 cell-inducing pathogen. The Th2 cell skewing was dependent on basophils, immunoglobulin E, and interleukin-4, but was independent of mast cells. Our findings demonstrate that basophil-expressed Lyn kinase exerts regulatory control on Th2 cell differentiation and function.	[Charles, Nicolas; Rivera, Juan] NIAMS, NIH, Lab Immune Cell Signaling, Bethesda, MD 20892 USA; [Watford, Wendy T.; Ramos, Haydee L.; O'Shea, John J.] NIAMS, NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Oettgen, Hans C.] Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat,Div Immunol, Boston, MA 02115 USA; [Gomez, Gregorio; Ryan, John J.] Virginia Commonwealth Univ, Div Rheumatol Allergy & Immunol, Dept Internal Med, Richmond, VA 23284 USA; [Gomez, Gregorio; Ryan, John J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Uppsala University; Harvard University; Boston Children's Hospital; Harvard Medical School; Virginia Commonwealth University; Virginia Commonwealth University	Rivera, J (corresponding author), NIAMS, NIH, Lab Immune Cell Signaling, Bethesda, MD 20892 USA.	juan_rivera@nih.gov	CHARLES, Nicolas/P-5430-2014; CHARLES, Nicolas/S-2214-2019	CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; Watford, Wendy/0000-0003-4261-5399	National Institutes of Health; Fondation pour la Recherche Medicale of France; MAID [R01-A1054471]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041156, ZIAAR041159, ZIAAR041155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale of France; MAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health. N.C. was supported in part by the Fondation pour la Recherche Medicale of France. H.C.O. is supported by MAID R01-A1054471. We thank D. Jankovic (NIAID) and J. Zhu (NIAID) for providing key reagents. We also thank the Laboratory Animal Care and Use Section, the Flow Cytometry Unit, and the Light Imaging Section of NIAMS for support of this work. We are grateful to H. Karasuyama (Tokyo Medical and Dental University) and R.L. Stevens (Harvard) for helpful discussions. The authors have no conflict of interest to declare.	Beavitt SJE, 2005, J IMMUNOL, V175, P1867, DOI 10.4049/jimmunol.175.3.1867; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Capron A, 2004, CLIN REV ALLERG IMMU, V26, P25, DOI 10.1385/CRIAI:26:1:25; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; DELISI C, 1979, J IMMUNOL, V122, P2286; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Flores-Borja F, 2005, ARTHRITIS RHEUM-US, V52, P3955, DOI 10.1002/art.21416; Gilmartin L, 2008, INT ARCH ALLERGY IMM, V145, P182, DOI 10.1159/000109287; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Hernandez-Hansen V, 2005, J IMMUNOL, V175, P7880, DOI 10.4049/jimmunol.175.12.7880; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Janas ML, 1999, J IMMUNOL, V163, P4192; Kawakami Kazuyoshi, 2003, Journal of Infection and Chemotherapy, V9, P201, DOI 10.1007/s10156-003-0263-5; Kepley CL, 1999, J ALLERGY CLIN IMMUN, V104, P279, DOI 10.1016/S0091-6749(99)70367-2; Lavens-Phillips SE, 2000, AM J RESP CELL MOL, V23, P566, DOI 10.1165/ajrcmb.23.4.4123; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; LIU FT, 1980, J IMMUNOL, V124, P2728; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Reschner A, 2008, CLIN EXP IMMUNOL, V152, P219, DOI 10.1111/j.1365-2249.2008.03624.x; Schroeder JT, 2001, ADV IMMUNOL, V77, P93, DOI 10.1016/S0065-2776(01)77015-0; SEGAL DM, 1977, P NATL ACAD SCI USA, V74, P2993, DOI 10.1073/pnas.74.7.2993; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Spiegl N, 2008, BLOOD, V112, P3762, DOI 10.1182/blood-2008-01-135251; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Youssef LA, 2007, J IMMUNOL, V178, P4584, DOI 10.4049/jimmunol.178.7.4584; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	41	75	78	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					533	543		10.1016/j.immuni.2009.02.008	http://dx.doi.org/10.1016/j.immuni.2009.02.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19362019	Bronze, Green Accepted			2022-12-18	WOS:000265319000010
J	Hammer, GE; Kanaseki, T; Shastri, N				Hammer, Gianna Elena; Kanaseki, Takayuki; Shastri, Nilabh			The final touches make perfect the peptide-MHC class I repertoire	IMMUNITY			English	Review							ANTIGEN-PROCESSING PATHWAY; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; LOADING COMPLEX; OXIDOREDUCTASE ERP57; AMINOPEPTIDASE ERAAP; PRESENTED PEPTIDES; CROSS-PRESENTATION; ER AMINOPEPTIDASE; IMMUNE-RESPONSES	Major histocompatibility complex (MHC) class I molecules present short, perfectly cleaved peptides on the cell surface for immune surveillance by CD8(+) T cells. The pathway for generating these peptides begins in the cytoplasm, and the peptide-MHC I (pMHC I) repertoire is finalized in the endoplasmic reticulum. Recent studies show that the peptides for MHC I are customized by the ER aminopeptidase associated with antigen processing and by dynamic interactions within the MHC peptide-loading complex. Failure to customize the pMHC I repertoire has profound immunological consequences.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	nshastri@berkeley.edu		Hammer, Gianna/0000-0001-6959-858X; Kanaseki, Takayuki/0000-0001-7294-6880				Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Green KJ, 2004, EUR J IMMUNOL, V34, P2510, DOI 10.1002/eji.200425193; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEISIG A, 1995, J IMMUNOL, V154, P1273; Ostrov DA, 2002, J IMMUNOL, V168, P283, DOI 10.4049/jimmunol.168.1.283; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Paulsson KM, 2004, CELL MOL LIFE SCI, V61, P2446, DOI 10.1007/s00018-004-4113-0; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; RAMMENSEEHG, 1997, MHC LIGANDS PEPTIDE; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	63	75	77	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					397	406		10.1016/j.immuni.2007.04.003	http://dx.doi.org/10.1016/j.immuni.2007.04.003			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17459809	Bronze			2022-12-18	WOS:000246126400006
J	Winslow, MM; Gallo, EM; Neilson, JR; Crabtree, GR				Winslow, MM; Gallo, EM; Neilson, JR; Crabtree, GR			The calcineurin phosphatase complex modulates immunogenic B cell responses	IMMUNITY			English	Article							ACTIVATED T-CELLS; CYCLOSPORINE-A; NUCLEAR-FACTOR; CYCLIN D2; KAPPA-B; NF-AT; EXPRESSION; LYMPHOCYTES; ANTIGEN; INDUCTION	A series of signal-directed transitions regulates the development of distinct populations of self-tolerant B cells and ultimately the production of antibody-producing plasma cells. We studied the role of calcineurin/NFAT signaling in B cells by deleting the regulatory b1 subunit of calcineurin specifically in B cells. Follicular (FO) and marginal zone (MZ) B cells develop normally in these mice, but B1 cell numbers are reduced. In vitro, calcineurin b1-deficient B cells have a cell-intrinsic proliferation defect downstream of the B cell receptor. These mice have higher total serum IgM despite the absence of B1 cells and have enhanced T cell-independent-1 responses. Conversely, mice with calcineurin b1-deficient B cells develop larger germinal centers and have reduced plasma cell development and antigen-specific antibody production during T cell-dependent immune responses. By several different criteria, calcineurin is dispensable for B cell tolerance, indicating that this phosphatase complex modulates immunogenic, but not tolerogenic, responses in vivo.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Winslow, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu		Neilson, Joel R./0000-0002-3408-608X				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Antony P, 2004, BIOCHEM SOC T, V32, P113, DOI 10.1042/BST0320113; Berland R, 2003, P NATL ACAD SCI USA, V100, P13459, DOI 10.1073/pnas.2233620100; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Glassford J, 2003, ONCOGENE, V22, P2248, DOI 10.1038/sj.onc.1206425; Glassford J, 2001, J BIOL CHEM, V276, P41040, DOI 10.1074/jbc.M105305200; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow C C, 1989, Semin Immunol, V1, P125; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; HIGHAM AD, 1986, IMMUNOLOGY, V59, P203; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; KEARNEY JF, 1981, EUR J IMMUNOL, V11, P877, DOI 10.1002/eji.1830111106; KENNY JJ, 1983, J IMMUNOL, V130, P2574; KINCAID RL, 1987, NATURE, V330, P176, DOI 10.1038/330176a0; KLAUS GGB, 1994, EUR J IMMUNOL, V24, P3229, DOI 10.1002/eji.1830241248; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUNKL A, 1980, J IMMUNOL, V125, P2526; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McHeyzer-Williams LJ, 2001, CURR OPIN HEMATOL, V8, P52, DOI 10.1097/00062752-200101000-00010; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; PRUDHOMME GJ, 1993, CLIN IMMUNOL IMMUNOP, V66, P185, DOI 10.1006/clin.1993.1024; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Timmerman LA, 1997, J IMMUNOL, V159, P2735; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; UEKI K, 1992, BIOCHEM BIOPH RES CO, V187, P537, DOI 10.1016/S0006-291X(05)81527-X; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413	57	75	77	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					141	152		10.1016/j.immuni.2005.12.013	http://dx.doi.org/10.1016/j.immuni.2005.12.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473827	Bronze			2022-12-18	WOS:000235479000006
J	Weber, JR; Freyer, D; Alexander, C; Schroder, NWJ; Reiss, A; Kuster, C; Pfeil, D; Tuomanen, EI; Schumann, RR				Weber, JR; Freyer, D; Alexander, C; Schroder, NWJ; Reiss, A; Kuster, C; Pfeil, D; Tuomanen, EI; Schumann, RR			Recognition of pneumococcal peptidoglycan: An expanded, pivotal role for LPS binding protein	IMMUNITY			English	Article							GRAM-POSITIVE BACTERIA; LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; NITRIC-OXIDE SYNTHASE; CELL-WALL COMPONENTS; NF-KAPPA-B; STREPTOCOCCUS-PNEUMONIAE; HUMAN MONOCYTES; TEICHOIC-ACID; SEVERE SEPSIS; SEPTIC SHOCK	Lipopolysaccharide binding protein (LBP) has a well-established role in LPS-induced immune responses. Here, we report that LBP also plays an essential role in the innate immune response to Gram-positive pneumococci, specifically to their major inflammatory component, pneumococcal cell wall (PCW). LBP was present in the CSF of patients with meningitis, and ILBP-deficient mice failed to develop meningeal inflammation. LBP enhanced PCW-induced cell signaling and TNF-alpha release. LBP bound specifically to PCW multimers, indicating novel lipid-independent binding capability for LBP. We propose the iterative anionic groups along the glycan backbone of the cell wall are a crucial structure for recognition by ILBP. Such a function for LBP expands its role to Gram-positive infections.	Humboldt Univ, Dept Neurol, Univ Klinikum Charite, D-10117 Berlin, Germany; Humboldt Univ, Dept Microbiol & Hyg, Univ Klinikum Charite, D-10117 Berlin, Germany; Res Ctr Borstel, Dept Immunochem & Biochem Microbiol, Ctr Med & Biosci, D-28845 Borstel, Germany; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel; St Jude Children's Research Hospital	Weber, JR (corresponding author), Humboldt Univ, Dept Neurol, Univ Klinikum Charite, D-10117 Berlin, Germany.	joerg.weber@charite.de	Tuomanen, Elaine I/N-3081-2018	Tuomanen, Elaine I/0000-0003-0349-8716	NCI NIH HHS [CA-21765] Funding Source: Medline; NIAID NIH HHS [AI 27913] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027913] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 1998, PROTEIN SCI, V7, P1643, DOI 10.1002/pro.5560070721; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Blairon L, 2003, J INFECT DIS, V187, P287, DOI 10.1086/346046; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Cauwels A, 1997, INFECT IMMUN, V65, P3255, DOI 10.1128/IAI.65.8.3255-3260.1997; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Dowell SF, 2000, NEW ENGL J MED, V342, P1399, DOI 10.1056/NEJM200005113421904; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Dziarski R, 2000, J ENDOTOXIN RES, V6, P401, DOI 10.1179/096805100101532243; Fan XL, 1999, INFECT IMMUN, V67, P2964, DOI 10.1128/IAI.67.6.2964-2968.1999; Ferguson AD, 2000, STRUCTURE, V8, P585; Fierer J, 2002, J IMMUNOL, V168, P6396, DOI 10.4049/jimmunol.168.12.6396; FISCHER H, 1984, J BACTERIOL, V157, P507, DOI 10.1128/JB.157.2.507-513.1984; Freyer D, 1999, J IMMUNOL, V163, P4308; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GARCIABUSTOS JF, 1987, J BIOL CHEM, V262, P15400; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; GAZZANOSANTORO H, 1995, INFECT IMMUN, V63, P2201, DOI 10.1128/IAI.63.6.2201-2205.1995; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamann L, 2000, EUR J IMMUNOL, V30, P211, DOI 10.1002/1521-4141(200001)30:1<211::AID-IMMU211>3.3.CO;2-F; Heinrich JM, 2001, J IMMUNOL, V167, P1624, DOI 10.4049/jimmunol.167.3.1624; Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P; HEUMANN D, 1994, INFECT IMMUN, V62, P2715, DOI 10.1128/IAI.62.7.2715-2721.1994; Hoffmann O, 2002, J CEREBR BLOOD F MET, V22, P988, DOI 10.1097/00004647-200208000-00010; HOLZER TJ, 1984, J IMMUNOL, V133, P1424; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lamping N, 1996, J IMMUNOL, V157, P4648; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Monier RM, 2002, J INFECT DIS, V185, P921, DOI 10.1086/339483; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Savedra R, 1996, J IMMUNOL, V157, P2549; Schneider O, 1999, NEUROLOGY, V53, P1584, DOI 10.1212/WNL.53.7.1584; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Schumann RR, 1998, GLIA, V22, P295, DOI 10.1002/(SICI)1098-1136(199803)22:3<295::AID-GLIA8>3.0.CO;2-4; Schumann RR, 1997, J IMMUNOL, V159, P5599; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Severin A, 1996, J BACTERIOL, V178, P168, DOI 10.1128/jb.178.1.168-174.1996; Spellerberg B, 1996, MICROB PATHOGENESIS, V20, P309, DOI 10.1006/mpat.1996.0029; Tang T, 1996, J CLIN INVEST, V97, P2485, DOI 10.1172/JCI118695; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; TOMASZ A, 1981, REV INFECT DIS, V3, P190; TOMASZ A, 1975, J SUPRAMOL STR CELL, V3, P1, DOI 10.1002/jss.400030102; TUOMANEN E, 1985, J INFECT DIS, V151, P859, DOI 10.1093/infdis/151.5.859; TUOMANEN E, 1987, J INFECT DIS, V155, P985, DOI 10.1093/infdis/155.5.985; TUOMANEN EI, 1989, J EXP MED, V170, P959, DOI 10.1084/jem.170.3.959; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vreugdenhil ACE, 2000, J IMMUNOL, V165, P4561, DOI 10.4049/jimmunol.165.8.4561; Weber JR, 1997, J CEREBR BLOOD F MET, V17, P1221, DOI 10.1097/00004647-199711000-00011; Weber JR, 1995, J NEUROIMMUNOL, V63, P63; WINKELSTEIN JA, 1978, J IMMUNOL, V120, P174; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475; Yoshimura A, 1999, J IMMUNOL, V163, P1; ZHANG Y, 1999, CRYST ENG, V2, P1; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	68	75	80	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					269	279		10.1016/S1074-7613(03)00205-X	http://dx.doi.org/10.1016/S1074-7613(03)00205-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932360	Bronze			2022-12-18	WOS:000184929000014
J	Semerad, CL; Poursine-Laurent, J; Liu, FL; Link, DC				Semerad, CL; Poursine-Laurent, J; Liu, FL; Link, DC			A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation	IMMUNITY			English	Article							COLONY-STIMULATING-FACTOR; SEVERE CONGENITAL NEUTROPENIA; ERYTHROPOIETIN RECEPTOR; CYTOPLASMIC DOMAIN; DEFICIENT MICE; PROGENITOR CELLS; DISTINCT REGIONS; MYELOID CELLS; C-MPL; GRANULOCYTE	To investigate the specificity of cytokine signals in hematopoietic differentiation, we generated mice with a targeted mutation of their G-CSF receptor (G-CSFR) such that the cytoplasmic (signaling) domain of the G-CSFR is replaced with the cytoplasmic domain of the erythropoietin receptor. In homozygous mutant mice, expression of this chimeric receptor had no apparent affect on lineage commitment and was able to support the production of morphologically mature neutrophils. However, mutant neutrophils displayed reduced chemotaxis, and G-CSF-stimulated mobilization of neutrophils and hematopoietic progenitors from the bone marrow to blood was markedly impaired. Thus, the G-CSFR is generating unique signals that are required for certain specialized hematopoietic cell functions but are not required for granulocytic differentiation or lineage commitment.	Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat & Stem Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat & Stem Cell Biol, St Louis, MO 63110 USA.	dlink@im.wustl.edu			NHLBI NIH HHS [T 32 HL 07088-23] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Betsuyaku T, 1999, J CLIN INVEST, V103, P825, DOI 10.1172/JCI5191; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; CarverMoore K, 1996, BLOOD, V88, P803; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DANDREA AD, 1994, CURR OPIN CELL BIOL, V6, P804, DOI 10.1016/0955-0674(94)90048-5; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Feger F, 1997, BLOOD, V89, P435, DOI 10.1182/blood.V89.2.435; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Jacob J, 1998, BLOOD, V92, P353, DOI 10.1182/blood.V92.2.353.414k37_353_361; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu FL, 1997, BLOOD, V90, P2522, DOI 10.1182/blood.V90.7.2522.2522_2522_2528; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; MCARTHUR GA, 1994, BLOOD, V83, P972; McKinstry WJ, 1997, BLOOD, V89, P65, DOI 10.1182/blood.V89.1.65.65_65_71; McLemore ML, 1998, J CLIN INVEST, V102, P483, DOI 10.1172/JCI3216; MOLINEUX G, 1990, BLOOD, V75, P563; MOLINEUX G, 1990, BLOOD, V76, P2153; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; NICOLA NA, 1985, J CELL PHYSIOL, V124, P313, DOI 10.1002/jcp.1041240222; Rodel JE, 1996, BLOOD, V87, P858, DOI 10.1182/blood.V87.3.858.bloodjournal873858; ROT A, 1991, CYTOKINE, V3, P21, DOI 10.1016/1043-4666(91)90006-Y; SCHMITZ FJ, 1986, CYTOMETRY, V7, P439, DOI 10.1002/cyto.990070508; Shimozaki K, 1997, J BIOL CHEM, V272, P25184, DOI 10.1074/jbc.272.40.25184; SHINJO K, 1995, BRIT J HAEMATOL, V91, P783, DOI 10.1111/j.1365-2141.1995.tb05390.x; Socolovsky M, 1997, J BIOL CHEM, V272, P14009, DOI 10.1074/jbc.272.22.14009; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Stoffel R, 1999, P NATL ACAD SCI USA, V96, P698, DOI 10.1073/pnas.96.2.698; TIAN SS, 1994, BLOOD, V84, P1760; WATANABE M, 1991, ANAL BIOCHEM, V195, P38, DOI 10.1016/0003-2697(91)90291-Z; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; YOSHIKAWA A, 1995, EMBO J, V14, P5288, DOI 10.1002/j.1460-2075.1995.tb00213.x; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	42	75	80	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					153	161		10.1016/S1074-7613(00)80090-4	http://dx.doi.org/10.1016/S1074-7613(00)80090-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485650	Bronze			2022-12-18	WOS:000082383400004
J	Lacaud, G; Carlsson, L; Keller, G				Lacaud, G; Carlsson, L; Keller, G			Identification of a fetal hematopoietic precursor with B cell, T cell, and macrophage potential	IMMUNITY			English	Article							STEM-CELLS; LEPTIN RECEPTOR; NATURAL-KILLER; BONE-MARROW; DEVELOPMENTAL RELATIONSHIP; LINEAGE COMMITMENT; DENDRITIC CELLS; PROGENITORS; THYMOCYTES; LIVER	Despite years of investigation, precursor-progeny relationships within the developing lymphoid lineages of the hematopoietic system remain poorly defined. We have characterized the potential of precursors found within a subpopulation of fetal liver defined by AA4.1 and Fc gamma RII/III expression and predominantly restricted to lymphoid and macrophage development When cultured in methylcellulose with appropriate cytokines, AA4.1(+)/Fc gamma R+ precursors generate colonies consisting of various lineages, including the combination of B cell, T cell, and macrophage. Retroviral marking studies showed that the lymphoid cells and macrophages within these colonies arise from a common precursor. These results demonstrate the presence of a common precursor with B cell-, T cell-, and macrophage-restricted potential and as such define an early restriction point within the fetal lymphoid system.	Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA	National Jewish Health; Umea University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Keller, G (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA.		lacaud, Georges/ABH-5215-2020	Lacaud, Georges/0000-0002-5630-2417; Keller, Gordon/0000-0001-9309-9297	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI22295] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BALL TC, 1995, BLOOD, V85, P3086, DOI 10.1182/blood.V85.11.3086.bloodjournal85113086; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703, DOI 10.1128/MCB.10.6.2703; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; CARLSSON L, 1995, EUR J IMMUNOL, V25, P2308, DOI 10.1002/eji.1830250829; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cioffi JA, 1996, NAT MED, V2, P585, DOI 10.1038/nm0596-585; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Hattori N, 1996, J EXP MED, V184, P1901, DOI 10.1084/jem.184.5.1901; HIRAYAMA F, 1994, BLOOD CELLS, V20, P341; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; KEE BL, 1994, INT IMMUNOL, V6, P401, DOI 10.1093/intimm/6.3.401; KELLER G, 1992, CURR OPIN IMMUNOL, V4, P133, DOI 10.1016/0952-7915(92)90002-V; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LANIER LL, 1992, IMMUNOL TODAY, V13, P392, DOI 10.1016/0167-5699(92)90087-N; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; METCALF D, 1977, RECENT RES CANCER, V61, P1; Mikhail AA, 1997, BLOOD, V89, P1507, DOI 10.1182/blood.V89.5.1507.1507_1507_1512; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; ORKIN SH, 1992, BLOOD, V80, P575; PEAULT B, 1994, EUR J IMMUNOL, V24, P781, DOI 10.1002/eji.1830240345; PRINCIPATO M, 1990, MOL CELL BIOL, V10, P3562, DOI 10.1128/MCB.10.7.3562; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903	42	75	76	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					827	838		10.1016/S1074-7613(00)80648-2	http://dx.doi.org/10.1016/S1074-7613(00)80648-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881973	Bronze			2022-12-18	WOS:000077836600008
J	Wang, DP; Diao, HT; Getzler, AJ; Rogal, W; Frederick, MA; Milner, J; Yu, BF; Crotty, S; Goldrath, AW; Pipkin, ME				Wang, Dapeng; Diao, Huitian; Getzler, Adam J.; Rogal, Walter; Frederick, Megan A.; Milner, Justin; Yu, Bingfei; Crotty, Shane; Goldrath, Ananda W.; Pipkin, Matthew E.			The Transcription Factor Runx3 Establishes-Chromatin Accessibility of cis-Regulatory Landscapes that Drive Memory Cytotoxic T Lymphocyte Formation	IMMUNITY			English	Article							CELL DIFFERENTIATION; TERMINAL DIFFERENTIATION; CLONAL EXPANSION; CD8(+) EFFECTOR; DNA RECOGNITION; BET; EXPRESSION; PROGRAMS; FATE; INFECTION	T cell receptor (TCR) stimulation of naive CD8(+) T cells initiates reprogramming of cis-regulatory landscapes that specify effector and memory cytotoxic T lymphocyte (CTL) differentiation. We mapped regions of hyper-accessible chromatin in naive cells during TCR stimulation and discovered that the transcription factor (TF) Runx3 promoted accessibility to memory CTL-specific cis-regulatory regions before the first cell division and was essential for memory CTL differentiation. Runx3 was specifically required for accessibility to regions highly enriched with IRF, bZIP and Prdm1-like TF motifs, upregulation of TFs Irf4 and Blimp1, and activation of fundamental CTL attributes in early effector and memory precursor cells. Runx3 ensured that nascent CTLs differentiated into memory CTLs by preventing high expression of the TF T-bet, slowing effector cell proliferation, and repressing terminal CTL differentiation. Runx3 overexpression enhanced memory CTL differentiation during iterative infections. Thus, Runx3 governs chromatin accessibility during TCR stimulation and enforces the memory CTL developmental program.	[Wang, Dapeng; Diao, Huitian; Getzler, Adam J.; Rogal, Walter; Frederick, Megan A.; Pipkin, Matthew E.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA; [Milner, Justin; Yu, Bingfei; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane] UCSD Sch Med, Dept Med, Div Infect Dis, La Jolla, CA USA	Scripps Research Institute; University of California System; University of California San Diego; La Jolla Institute for Immunology; University of California System; University of California San Diego	Pipkin, ME (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.	mpipkin@scripps.edu	Crotty, Shane/AAC-6703-2019; Wang, Dapeng/HGD-4818-2022; Crotty, Shane/AAE-8446-2019; Getzler, Adam/U-9845-2017	Crotty, Shane/0000-0002-6484-6262; Getzler, Adam/0000-0001-8091-3851; Frederick, Megan/0000-0002-3808-8744; Goldrath, Ananda/0000-0002-5900-508X; Pipkin, Matthew/0000-0002-9688-0190	NIH [R01 AI095634, U19 AI109976]; Frenchman's Creek Women for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109976, R01AI095634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frenchman's Creek Women for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI095634 to M.E.P. and NIH U19 AI109976 to S.C., A.W.G., and M.E.P. and the Frenchman's Creek Women for Cancer Research (D.W.). We would like to thank Drs. Mathias G. Lichtenheld, Kendall Nettles, Mark Sundrud, and Joseph Kissil for critically reading the manuscript.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; AHMED R, 1984, J VIROL, V51, P34, DOI 10.1128/JVI.51.1.34-41.1984; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bartfeld D, 2002, STRUCTURE, V10, P1395, DOI 10.1016/S0969-2126(02)00853-5; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Buchholz VR, 2016, ANNU REV IMMUNOL, V34, P65, DOI 10.1146/annurev-immunol-032414-112014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carroll TS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00075; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Gusmao EG, 2016, NAT METHODS, V13, P303, DOI [10.1038/NMETH.3772, 10.1038/nmeth.3772]; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Pipkin ME, 2007, IMMUNITY, V26, P29, DOI 10.1016/j.immuni.2006.11.009; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pipkin ME, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl006; Plumlee CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12264; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Scharer CD, 2017, J IMMUNOL, V198, P2238, DOI 10.4049/jimmunol.1602086; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Seo YJ, 2016, IMMUNITY, V45, P988, DOI 10.1016/j.immuni.2016.10.024; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	74	75	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					659	+		10.1016/j.immuni.2018.03.028	http://dx.doi.org/10.1016/j.immuni.2018.03.028			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669249	Green Accepted, Bronze			2022-12-18	WOS:000430198900014
J	Goodwin, E; Gilman, MSA; Wrapp, D; Chen, M; Ngwuta, JO; Moin, SM; Bai, P; Sivasubramanian, A; Connor, RI; Wright, PF; Graham, BS; McLellan, JS; Walker, LM				Goodwin, Eileen; Gilman, Morgan S. A.; Wrapp, Daniel; Chen, Man; Ngwuta, Joan O.; Moin, Syed M.; Bai, Patricia; Sivasubramanian, Arvind; Connor, Ruth I.; Wright, Peter F.; Graham, Barney S.; McLellan, Jason S.; Walker, Laura M.			Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation	IMMUNITY			English	Article							FUSION GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; CROSS-NEUTRALIZATION; STRUCTURAL BASIS; F-GLYCOPROTEIN; B-CELLS; RSV; CHILDREN; REINFECTION; INTERFACE	Respiratory syncytial virus (RSV) is a leading cause of infant mortality, and there are currently no licensed vaccines to protect this vulnerable population. A comprehensive understanding of infant antibody responses to natural RSV infection would facilitate vaccine development. Here, we isolated more than 450 RSV fusion glycoprotein (F)-specific antibodies from 7 RSV-infected infants and found that half of the antibodies recognized only two antigenic sites. Antibodies targeting both sites showed convergent sequence features, and structural studies revealed the molecular basis for their recognition of RSV F. A subset of antibodies targeting one of these sites displayed potent neutralizing activity despite lacking somatic mutations, and similar antibodies were detected in RSV-naive B cell repertoires, suggesting that expansion of these B cells in infants may be possible with suitably designed vaccine antigens. Collectively, our results provide fundamental insights into infant antibody responses and a framework for the rational design of age-specific RSV vaccines.	[Goodwin, Eileen; Sivasubramanian, Arvind; Walker, Laura M.] Adimab LLC, Lebanon, NH 03766 USA; [Gilman, Morgan S. A.; Wrapp, Daniel; McLellan, Jason S.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA; [Chen, Man; Ngwuta, Joan O.; Moin, Syed M.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bai, Patricia; Connor, Ruth I.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Wright, Peter F.] Geisel Sch Med Dartmouth, Dept Pediat, Hanover, NH 03755 USA	Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Dartmouth College; Dartmouth College	Walker, LM (corresponding author), Adimab LLC, Lebanon, NH 03766 USA.; McLellan, JS (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.	jason.s.mclellan@dartmouth.edu; laura.walker@adimab.com	Graham, Barney S./AAC-5898-2019; Wrapp, Daniel/HCH-3481-2022	Graham, Barney S./0000-0001-8112-0853; Wrapp, Daniel/0000-0002-0538-9647; McLellan, Jason/0000-0003-3991-542X; Moin, Syed/0000-0001-8789-9167	National Cancer Institute Cancer Center Support Grant [P30CA023108-37]; Immunology COBRE Grant from the National Institute of General Medical Sciences [P30GM103415-15]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Institute of General Medical Sciences of the NIH [T32GM008704, P20GM113132]; National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113132, P41GM103393, P30GM103415, T32GM008704] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Immunology COBRE Grant from the National Institute of General Medical Sciences; U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Emilie Shipman for assistance with protein production, members of the McLellan laboratory for critical reading of the manuscript, and Cody Williams for assistance preparing the graphical abstract. PBMC processing was carried out in DartLab, the Immune Monitoring and Flow Cytometry Shared Resource, supported by a National Cancer Institute Cancer Center Support Grant to the Norris Cotton Cancer Center (P30CA023108-37) and an Immunology COBRE Grant (P30GM103415-15) from the National Institute of General Medical Sciences. Results shown in this report are derived in part from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, as well as the Stanford Synchrotron Radiation Light-source, SLAC National Accelerator Laboratory. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract no. DE-AC02-06CH11357. The Stanford Synchrotron Radiation Light-source, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). Support for this work was provided by the National Institute of General Medical Sciences of the NIH awards T32GM008704 (M.S.A.G.) and P20GM113132 (J.S.M.) and by intramural funding from the National Institute of Allergy and Infectious Diseases to support work at the Vaccine Research Center (B.S.G.).	Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; ANDERSON LJ, 1986, J CLIN MICROBIOL, V23, P475, DOI 10.1128/JCM.23.3.475-480.1986; Bailey JR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92872; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chen M, 2010, J IMMUNOL METHODS, V362, P180, DOI 10.1016/j.jim.2010.08.005; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito S, 2016, HUM VACC IMMUNOTHER, V12, P1700, DOI 10.1080/21645515.2016.1145847; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554; GARCIABARRENO B, 1989, J VIROL, V63, P925; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012; Griffin MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01714-16, 10.1128/aac.01714-16]; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Homaira Nusrat, 2014, Int J Pediatr, V2014, P571609, DOI 10.1155/2014/571609; Huang K, 2010, J VIROL, V84, P8132, DOI 10.1128/JVI.02699-09; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Jans J, 2017, J ALLERGY CLIN IMMUN, V139, P1997, DOI 10.1016/j.jaci.2016.10.032; Kamal-Bahl S, 2002, ARCH PEDIAT ADOL MED, V156, P1034, DOI 10.1001/archpedi.156.10.1034; Killikelly AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34108; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mousa JJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.271; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Panda S, 2015, J IMMUNOL, V194, P13, DOI 10.4049/jimmunol.1400844; PATH, 2017, RSV VACC MAB SNAPSH; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rechavi E, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0072; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Ridings J, 1998, CLIN EXP IMMUNOL, V114, P33; Sande CJ, 2014, VACCINE, V32, P4726, DOI 10.1016/j.vaccine.2014.05.038; Sastre P, 2005, J MED VIROL, V76, P248, DOI 10.1002/jmv.20349; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wen XW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.272; Williams JV, 2009, MOL IMMUNOL, V47, P407, DOI 10.1016/j.molimm.2009.08.024; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0; Yeung YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13376; Zhu Q, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1928	66	74	79	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					339	+		10.1016/j.immuni.2018.01.005	http://dx.doi.org/10.1016/j.immuni.2018.01.005			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29396163	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000425507800018
J	Cambier, CJ; O'Leary, SM; O'Sullivan, MP; Keane, J; Ramakrishnan, L				Cambier, C. J.; O'Leary, Seonadh M.; O'Sullivan, Mary P.; Keane, Joseph; Ramakrishnan, Lalita			Phenolic Glycolipid Facilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages	IMMUNITY			English	Article							HUMAN ALVEOLAR MACROPHAGES; CYTOSOLIC SURVEILLANCE PATHWAY; TUBERCULOUS GRANULOMA; MARINUM INFECTION; GROWTH-INHIBITION; ZEBRAFISH; EXPRESSION; SUSCEPTIBILITY; RESISTANCE; MICROGLIA	Mycobacterium tuberculosis (Mtb) enters the host in aerosol droplets deposited in lung alveoli, where the bacteria first encounter lung-resident alveolar macrophages. We studied the earliest mycobacterium-macrophage interactions in the optically transparent zebrafish. First-responding resident macrophages phagocytosed and eradicated infecting mycobacteria, suggesting that to establish a successful infection, mycobacteria must escape out of the initially infected resident macrophage into growth-permissive monocytes. We defined a critical role for mycobacterial membrane phenolic glycolipid (PGL) in engineering this transition. PGL activated the STING cytosolic sensing pathway in resident macrophages, inducing the production of the chemokine CCL2, which in turn recruited circulating CCR2(+) monocytes toward infection. Transient fusion of infected macrophages with CCR2(+) monocytes enabled bacterial transfer and subsequent dissemination, and interrupting this transfer so as to prolong mycobacterial sojourn in resident macrophages promoted clearing of infection. Human alveolar macrophages produced CCL2 in a PGL-dependent fashion following infection, arguing for the potential of PGL-blocking interventions or PGL-targeting vaccine strategies in the prevention of tuberculosis.	[Cambier, C. J.; Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Cambier, C. J.; Ramakrishnan, Lalita] Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge CB2 0QH, England; [Cambier, C. J.] Stanford Univ, Dept Chem, Stamford, CT 94305 USA; [O'Leary, Seonadh M.; O'Sullivan, Mary P.; Keane, Joseph] Trinity Coll Dublin, Trin Translat Med Inst, Dept Clin Med, Dublin, Ireland; [Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; MRC Laboratory Molecular Biology; University of Cambridge; Stanford University; Trinity College Dublin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Ramakrishnan, L (corresponding author), Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge CB2 0QH, England.; Keane, J (corresponding author), Trinity Coll Dublin, Trin Translat Med Inst, Dept Clin Med, Dublin, Ireland.; Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Ramakrishnan, L (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	josephmk@tcd.ie; lr404@cam.ac.uk	Keane, Joseph/AAX-6658-2021; O'Sullivan, Mary P/C-9413-2012	Keane, Joseph/0000-0001-5313-385X; O'Sullivan, Mary P/0000-0002-6104-8943; O'Leary, Seonadh/0000-0002-7903-2325; Ramakrishnan, Lalita/0000-0003-0692-5533	NIH; NIH [R37AI054503, T32 AI55396]; Wellcome Trust; Damon Runyon Postdoctoral Fellowship; Health Research Board of Ireland; Royal City of Dublin Hospital Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Damon Runyon Postdoctoral Fellowship; Health Research Board of Ireland; Royal City of Dublin Hospital Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C.R. Bertozzi for providing space and resources to complete this project, D. Stetson for suggesting STING, A. Pagan for suggesting the human experiments to test the model, K. Urdahl for discussion and suggestions, S. Candel, J.M. Davis, P. Edelstein, S. Falkow, D. Tobin, and K. Urdahl for manuscript review, and J. Cameron, R. Keeble and N. Goodwin for zebrafish husbandry, and P. Margiotta for preparing the graphical abstract. For the human work, we thank F. O'Connell, A.M. McLaughlin, the research nurses of the Wellcome Trust-HRB Clinical Research Facility, and the staff and patients of the St. James's Hospital Bronchoscopy Clinic, Dublin, and K. Gogan for assistance in preparation of alveolar macrophages. This work was supported by the NIH Director's Pioneer Award, NIH grant R37AI054503, and a Wellcome Trust Principal Research Fellowship (L.R.), NIH training grant T32 AI55396 and a Damon Runyon Postdoctoral Fellowship (C.J.C.), the Health Research Board of Ireland (S.M.O., M.P.O., and J.K.), and The Royal City of Dublin Hospital Trust (J.K.).	Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; Aston C, 1998, AM J RESP CRIT CARE, V157, P1943, DOI 10.1164/ajrccm.157.6.9705028; Athman JJ, 2015, J IMMUNOL, V195, P1044, DOI 10.4049/jimmunol.1402894; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Brannon MK, 2009, CELL MICROBIOL, V11, P755, DOI 10.1111/j.1462-5822.2009.01288.x; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Cepok S, 2009, ARCH NEUROL-CHICAGO, V66, P1216, DOI 10.1001/archneurol.2009.138; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Conrady CD, 2013, MUCOSAL IMMUNOL, V6, P45, DOI 10.1038/mi.2012.46; Curto M, 2004, NEUROCHEM INT, V44, P381, DOI 10.1016/j.neuint.2003.08.012; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ge R, 2015, J VIROL, V89, P7696, DOI 10.1128/JVI.01049-15; Gleeson LE, 2016, J IMMUNOL, V196, P2444, DOI 10.4049/jimmunol.1501612; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; HIRSCH CS, 1994, J IMMUNOL, V152, P743; HOCKING WG, 1979, NEW ENGL J MED, V301, P639, DOI 10.1056/NEJM197909203011205; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Lauvau G, 2014, CELL IMMUNOL, V291, P32, DOI 10.1016/j.cellimm.2014.07.007; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Madigan CA, 2017, CELL, V170, P973, DOI 10.1016/j.cell.2017.07.030; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Pagan AJ, 2015, CELL HOST MICROBE, V18, P15, DOI 10.1016/j.chom.2015.06.008; Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Simeone R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004650; Spanos JP, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00182; Srivastava S, 2014, IMMUNOL REV, V262, P179, DOI 10.1111/imr.12217; Steele S, 2016, ELIFE, V5, DOI 10.7554/eLife.10625; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Urdahl KB, 2014, SEMIN IMMUNOL, V26, P578, DOI 10.1016/j.smim.2014.10.003; van Zyl-Smit RN, 2014, THORAX, V69, P363, DOI 10.1136/thoraxjnl-2013-204229; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; WELLS WF, 1948, AM J HYG, V47, P11, DOI 10.1093/oxfordjournals.aje.a119179; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009	62	74	75	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					552	+		10.1016/j.immuni.2017.08.003	http://dx.doi.org/10.1016/j.immuni.2017.08.003			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28844797	Green Published, hybrid			2022-12-18	WOS:000411128200018
J	Hayatsu, N; Miyao, T; Tachibana, M; Murakami, R; Kimura, A; Kato, T; Kawakami, E; Endo, TA; Setoguchi, R; Watarai, H; Nishikawa, T; Yasuda, T; Yoshida, H; Hori, S				Hayatsu, Norihito; Miyao, Takahisa; Tachibana, Masashi; Murakami, Ryuichi; Kimura, Akihiko; Kato, Takako; Kawakami, Eiryo; Endo, Takaho A.; Setoguchi, Ruka; Watarai, Hiroshi; Nishikawa, Takeshi; Yasuda, Takuwa; Yoshida, Hisahiro; Hori, Shohei			Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells	IMMUNITY			English	Article							X-LINKED SYNDROME; LYMPHOPROLIFERATIVE DISORDER; IMMUNE DYSREGULATION; ADIPOSE-TISSUE; TARGET GENES; COMPLEX; DNA; SPECIFICITY; ENTEROPATHY; EXPRESSION	Foxp3 controls the development and function of regulatory T (Treg) cells, but it remains elusive how Foxp3 functions in vivo. Here, we established mouse models harboring three unique missense Foxp3 mutations that were identified in patients with the autoimmune disease IPEX. The I363V and R397W mutations were loss-of-function mutations, causing multi-organ inflammation by globally compromising Treg cell physiology. By contrast, the A384T mutation induced a distinctive tissue-restricted inflammation by specifically impairing the ability of Treg cells to compete with pathogenic T cells in certain non-lymphoid tissues. Mechanistically, repressed BATF expression contributed to these A384T effects. At the molecular level, the A384T mutation altered Foxp3 interactions with its specific target genes including Batf by broadening its DNA-binding specificity. Our findings identify BATF as a critical regulator of tissue Treg cells and suggest that sequence-specific perturbations of Foxp3-DNA interactions can influence specific facets of Treg cell physiology and the immunopathologies they regulate.	[Hayatsu, Norihito; Miyao, Takahisa; Tachibana, Masashi; Murakami, Ryuichi; Hori, Shohei] RIKEN Ctr Integrat Med Sci, Lab Immune Homeostasis, Kanagawa 2300045, Japan; [Nishikawa, Takeshi] RIKEN Ctr Integrat Med Sci, Lab Dis Syst Modeling, Kanagawa 2300045, Japan	RIKEN; RIKEN	Hori, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Immune Homeostasis, Kanagawa 2300045, Japan.	shohei@mol.f.u-tokyo.ac.jp	Hori, Shohei/O-6163-2019	Hori, Shohei/0000-0001-8770-4593; Murakami, Ryuichi/0000-0001-8257-585X; Tachibana, Masashi/0000-0002-0376-508X	JST PRESTO; MEXT KAKENHI [17689021, 20689012, 15H04747]; Cell Science Research Foundation; Astellas Foundation for Research on Metabolic Disorders; Tokyo Biochemical Research Foundation; JSPS Research Fellowship for Young Scientists; Grants-in-Aid for Scientific Research [15H04747] Funding Source: KAKEN	JST PRESTO(Japan Science & Technology Agency (JST)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Astellas Foundation for Research on Metabolic Disorders; Tokyo Biochemical Research Foundation; JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Jochen Huehn and Peter Burrows for critical reading of the manuscript, Kenya Honda for helpful comments, Hirokazu Tanaka and Ichiro Taniuchi for advice on ChIP assays, the animal and FACS facilities at RIKEN IMS for technical assistance, Bernard Malissen and Jun-ichi Miyazaki for mice, and Herman Waldmann, Toshio Kitamura, Wataru Ise, and Kenneth M. Murphy for reagents. This work was supported in part by JST PRESTO, MEXT KAKENHI (17689021, 20689012, 15H04747), the Cell Science Research Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Tokyo Biochemical Research Foundation (S.H.), and JSPS Research Fellowship for Young Scientists (A.K.).	Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tsai KL, 2006, J BIOL CHEM, V281, P17400, DOI 10.1074/jbc.M600478200; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	59	74	74	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					268	+		10.1016/j.immuni.2017.07.008	http://dx.doi.org/10.1016/j.immuni.2017.07.008			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28778586	Bronze			2022-12-18	WOS:000407788300013
J	Lee, CS; Penberthy, KK; Wheeler, KM; Juncadella, IJ; Vandenabeele, P; Lysiak, JJ; Ravichandran, KS				Lee, Chang Sup; Penberthy, Kristen K.; Wheeler, Karen M.; Juncadella, Ignacio J.; Vandenabeele, Peter; Lysiak, Jeffrey J.; Ravichandran, Kodi S.			Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo	IMMUNITY			English	Article							ULCERATIVE-COLITIS; AUTOIMMUNE-DISEASE; GENE-EXPRESSION; CROHNS-DISEASE; MAMMARY-GLAND; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; RECEPTOR; NECROPTOSIS; ASSOCIATION	Few apoptotic corpses are seen even in tissues with high cellular turnover, leading to the notion that the capacity for engulfment in vivo is vast. Whether corpse clearance can be enhanced in vivo for potential benefit is not known. In a colonic inflammation model, we noted that the expression of the phagocytic receptor Bai1 was progressively downmodulated. Consistent with this, BAI1-deficient mice had more pronounced colitis and lower survival, with many uncleared apoptotic corpses and inflammatory cytokines within the colonic epithelium. When we engineered and tested transgenic mice overexpressing BAI1, these had fewer apoptotic cells, reduced inflammation, and attenuated disease. Boosting BAI1-mediated uptake by intestinal epithelial cells (rather than myeloid cells) was important in attenuating inflammation. A signaling-deficient BAI1 transgene could not provide a similar benefit. Collectively, these complementary genetic approaches showed that cell clearance could be boosted in vivo, with potential to regulate tissue inflammation in specific contexts.	[Lee, Chang Sup; Penberthy, Kristen K.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Immunol, Canc Biol, Charlottesville, VA 22908 USA; [Lee, Chang Sup; Penberthy, Kristen K.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Lee, Chang Sup; Penberthy, Kristen K.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Wheeler, Karen M.; Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Vandenabeele, Peter] VIB, IRC, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, B-9052 Ghent, Belgium	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol, Immunol, Canc Biol, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022	Vandenabeele, Peter/0000-0002-6669-8822; Ravichandran, Kodi/0000-0001-9049-1410; Penberthy, Kristen/0000-0003-3178-0524	NHLBI F30 award; Belgian grants [IAP 7/32]; Flemish grants; Methusalem grant [BOF09/01M00709]; VIB;  [GM064709];  [MH096484];  [HD074981];  [T32AI1007496]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL126385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107848, T32GM007267, R01GM064709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096484] Funding Source: NIH RePORTER	NHLBI F30 award; Belgian grants; Flemish grants; Methusalem grant; VIB; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Jim Casanova and Kate Owen for guidance on colitis studies, Changchun Xiao for the CTV plasmid, and the K.S.R. laboratory for many helpful discussions. This work was supported in part by GM064709 and MH096484 (K.S.R.) and HD074981 (J.J.L. and K.S.R.). K.K.P. has been supported via T32AI1007496 and an NHLBI F30 award. P.V. is supported by Belgian grants (IAP 7/32), Flemish grants, Methusalem grant (BOF09/01M00709), and the VIB.	Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Bagci H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.338; Bjerrum JT, 2010, INFLAMM BOWEL DIS, V16, P999, DOI 10.1002/ibd.21142; Brinkman BM, 2013, INFLAMM BOWEL DIS, V19, P2560, DOI 10.1097/MIB.0b013e3182a8759a; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Dassopoulos T, 2013, GASTROENTEROLOGY, V145, P1464, DOI 10.1053/j.gastro.2013.10.046; Devitt A, 2004, J CELL BIOL, V167, P1161, DOI 10.1083/jcb.200410057; Devkota S, 2013, CURR OPIN GASTROEN, V29, P603, DOI 10.1097/MOG.0b013e328365d38f; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gao YY, 2013, CARCINOGENESIS, V34, P1861, DOI 10.1093/carcin/bgt135; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hagiwara C, 2002, J GASTROEN HEPATOL, V17, P758, DOI 10.1046/j.1440-1746.2002.02791.x; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Iwamoto M, 1996, J PATHOL, V180, P152; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nielsen OH, 2013, NEW ENGL J MED, V369, P754, DOI 10.1056/NEJMct1209614; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Spencer SP, 2012, CURR OPIN IMMUNOL, V24, P379, DOI 10.1016/j.coi.2012.07.006; Suwara MI, 2014, MUCOSAL IMMUNOL, V7, P684, DOI 10.1038/mi.2013.87; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Swan C, 2013, GUT, V62, P985, DOI 10.1136/gutjnl-2011-301213; Targownik LE, 2013, AM J GASTROENTEROL, V108, P1835, DOI 10.1038/ajg.2013.294; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986	65	74	74	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					807	820		10.1016/j.immuni.2016.02.005	http://dx.doi.org/10.1016/j.immuni.2016.02.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27037190	Green Accepted, Bronze			2022-12-18	WOS:000374444300013
J	Long, LY; Deng, YZ; Yao, F; Guan, DX; Feng, YY; Jiang, H; Li, XB; Hu, PT; Lu, XC; Wang, H; Li, JJ; Gao, X; Xie, D				Long, Lingyun; Deng, Yuezhen; Yao, Fan; Guan, Dongxian; Feng, Yuanyuan; Jiang, Hao; Li, Xiaobin; Hu, Pingting; Lu, Xincheng; Wang, Hui; Li, Jingjing; Gao, Xiang; Xie, Dong			Recruitment of Phosphatase PP2A by RACK1 Adaptor Protein Deactivates Transcription Factor IRF3 and Limits Type I Interferon Signaling	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; REGULATORY FACTOR-3; NEGATIVE REGULATION; ANTIVIRAL RESPONSE; GENE-EXPRESSION; ENDOTOXIN-SHOCK; VIRUS-INFECTION; ACTIVATION; PATHWAY	The transcription factor IRF3 is a central regulator of type I interferon (IFN) signaling. The mechanisms underlying deactivation of IRF3 are poorly understood although many studies suggest that IRF3 activity is terminated through degradation after viral infection. Here we report that IRF3 is deactivated via dephosphorylation mediated by the serine and threonine phosphatase PP2A and its adaptor protein RACK1. The PP2A-RACK1 complex negatively regulated the IRF3 pathway after LPS or poly(I: C) stimulation or Sendai virus (SeV) infection. After challenge with LPS, poly(I: C), or low-titer SeV, activated IRF3 was dephosphorylated and returned to resting state without being degraded, although high-titer SeV infection triggered the degradation of IRF3. Furthermore, PP2A-deficient macrophages showed enhanced type I IFN signaling upon LPS, poly(I: C), and SeV challenge and protected mice from lethal vesicular stomatitis virus infection. Therefore, dephosphorylation of IRF3 is a deactivation mechanism that contributes to termination of IRF3-type I IFN signaling.	[Long, Lingyun; Deng, Yuezhen; Yao, Fan; Guan, Dongxian; Feng, Yuanyuan; Jiang, Hao; Li, Xiaobin; Hu, Pingting; Lu, Xincheng; Wang, Hui; Li, Jingjing; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Long, Lingyun; Deng, Yuezhen; Yao, Fan; Guan, Dongxian; Feng, Yuanyuan; Jiang, Hao; Li, Xiaobin; Hu, Pingting; Lu, Xincheng; Wang, Hui; Li, Jingjing; Xie, Dong] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Nanjing University	Xie, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	dxie@sibs.ac.cn	Long, Lingyun/C-2455-2019	Long, Lingyun/0000-0002-8565-4948; Xie, Dong/0000-0002-1150-8657; Xie, Dong/0000-0003-2804-8578	National Basic Research Program of China [2010CB912102]; Ministry of Science and Technology Key Program [2012ZX10002009-017]; National Natural Science Foundation of China [81230058, 81372289, 30930023, 31100551, 31201046, 81021002, 81070325]; CAS/SAFEA; Chief Scientist Program; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2012004]; Technology Commission of Shanghai Municipality [12XD1405600, 13QA1404000]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA(Chinese Academy of Sciences); Chief Scientist Program; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	We thank F. Wang for LysM Cre mice; Y. Liu for si-RACK1 Adenoviral system and Myc-PP2A-C alpha plasmid; J. Han for RIG-I, TRIF, TRAF3, MAVS, and TBK1 plasmids; C. Wang for 293-TLR3 and 293-TLR3-IFN beta cells; and K. Shuai, D. Li, Z.J. Chen, and Z. Liu for the critical reading of the manuscript and helpful discussion. This work was supported by National Basic Research Program of China (2010CB912102), Ministry of Science and Technology Key Program (2012ZX10002009-017), National Natural Science Foundation of China (81230058, 81372289, 30930023, 31100551, 31201046, 81021002, and 81070325), CAS/SAFEA International Partnership Program for Creative Research Teams, Chief Scientist Program, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2012004), and Technology Commission of Shanghai Municipality (12XD1405600, 13QA1404000).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Salloum R, 2011, TRANSL RES, V157, P326, DOI 10.1016/j.trsl.2011.01.006; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi S, 2012, J BIOL CHEM, V287, P7845, DOI 10.1074/jbc.M111.315416; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	36	74	78	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					515	529		10.1016/j.immuni.2014.01.015	http://dx.doi.org/10.1016/j.immuni.2014.01.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24726876	Bronze			2022-12-18	WOS:000334849400010
J	van den Boorn, JG; Hartmann, G				van den Boorn, Jasper G.; Hartmann, Gunther			Turning Tumors into Vaccines: Co-opting the Innate Immune System	IMMUNITY			English	Review							CD8(+) T-CELLS; COLORECTAL-CANCER PATIENTS; RESISTANT PROSTATE-CANCER; DOUBLE-STRANDED-RNA; RIG-I ACTIVATION; NF-KAPPA-B; SUPPRESSOR-CELLS; PHASE-II; NEGATIVE REGULATION; DENDRITIC CELLS	Immunotherapy of cancer must be effective in the pre-established disease; i.e., in the therapeutic rather than prophylactic setting. Here, we review novel immunotherapeutic approaches for targeting established cancers. In addition to novel checkpoint-blocking antibodies, recent insight into innate immune sensors may further improve cancer immunotherapy protocols and help to overcome the limitations of conventional therapeutic immunization strategies. Specifically, the local induction of IL-12 and IFN alpha turns the immunosuppressive tumor microenvironment into an immunosupportive tissue, which is attained, for example, by local Toll-like receptor or RIG-I-like receptor triggering. Notably, the latter are endogenously expressed in all tumor cells and have the advantage of turning tumors into tumor vaccines by inducing apoptosis and improving antigen presentation. Thus, immunostimulatory agents embody strong promise as a part of combinatorial cancer immunotherapies.	[van den Boorn, Jasper G.; Hartmann, Gunther] Univ Hosp Bonn, D-53127 Bonn, Germany	University of Bonn	van den Boorn, JG (corresponding author), Univ Hosp Bonn, D-53127 Bonn, Germany.	jvdboorn@uni-bonn.de	Hartmann, Gunther/P-7492-2017	Hartmann, Gunther/0000-0003-1021-2018				Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Cerullo V, 2012, MOL THER, V20, P2076, DOI 10.1038/mt.2012.137; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00153; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Ellermeier J, 2013, CANCER RES, V73, P1709, DOI 10.1158/0008-5472.CAN-11-3850; Fehleisen F., 1883, ETIOLOGIE ERYSIPELS; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forsbach A, 2012, J INTERF CYTOK RES, V32, P254, DOI 10.1089/jir.2011.0091; Fortin C, 2012, J IMMUNOL, V189, P1843, DOI 10.4049/jimmunol.1200584; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gajewski TF, 2012, MOL ONCOL, V6, P242, DOI 10.1016/j.molonc.2012.01.002; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hamid O, 2013, N ENGL J MED; Heit A, 2005, J IMMUNOL, V174, P4373, DOI 10.4049/jimmunol.174.7.4373; Hernandez-Alcoceba R, 2012, ONCOIMMUNOLOGY, V1, P97, DOI 10.4161/onci.1.1.17930; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Iyori M, 2011, J IMMUNOL, V187, P3087, DOI 10.4049/jimmunol.1003879; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Leffers N, 2012, INT J CANCER, V130, P105, DOI 10.1002/ijc.25980; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Luzhna L, 2013, INT J ONCOL, V42, P1692, DOI 10.3892/ijo.2013.1845; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Madar S, 2013, TRENDS MOL MED; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Mocellin S, 2004, LANCET ONCOL, V5, P681, DOI 10.1016/S1470-2045(04)01610-9; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; ORSINI F, 1977, CANCER RES, V37, P1719; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pili R, 2011, J CLIN ONCOL, V29, P4022, DOI 10.1200/JCO.2011.35.6295; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Quakkelaar ED, 2012, ADV IMMUNOL, V114, P77, DOI 10.1016/B978-0-12-396548-6.00004-4; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Scarlett UK, 2009, CANCER RES, V69, P7329, DOI 10.1158/0008-5472.CAN-09-0835; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schurich A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003208; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Steding CE, 2011, IMMUNOLOGY, V133, P221, DOI 10.1111/j.1365-2567.2011.03429.x; Sumida K, 2012, EUR J IMMUNOL, V42, P2060, DOI 10.1002/eji.201142335; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Vermeij R, 2012, INT J CANCER, V131, pE670, DOI 10.1002/ijc.27388; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Yang JC, 2007, J IMMUNOTHER, V30, P825, DOI 10.1097/CJI.0b013e318156e47e; Zeestraten ECM, 2013, INT J CANCER, V132, P1581, DOI 10.1002/ijc.27819; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zheng YS, 2013, MOL IMMUNOL, V54, P74, DOI 10.1016/j.molimm.2012.10.035; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672; Zom GGP, 2012, ADV IMMUNOL, V114, P177, DOI 10.1016/B978-0-12-396548-6.00007-X	107	74	76	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					27	37		10.1016/j.immuni.2013.07.011	http://dx.doi.org/10.1016/j.immuni.2013.07.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890061	Bronze			2022-12-18	WOS:000330948300003
J	Hundt, M; Tabata, H; Jeon, MS; Hayashi, K; Tanaka, Y; Krishna, R; De Giorgio, L; Liu, YC; Fukata, M; Altman, A				Hundt, Matthias; Tabata, Hiroki; Jeon, Myung-Shin; Hayashi, Keitaro; Tanaka, Yoshihiko; Krishna, Roma; De Giorgio, Lauren; Liu, Yun-Cai; Fukata, Masaki; Altman, Amnon			Impaired activation and localization of LAT in anergic T cells as a consequence of a selective palmitoylation defect	IMMUNITY			English	Article							REDOX BALANCE ALTERATIONS; PROTEIN-TYROSINE KINASES; E3 UBIQUITIN LIGASE; CLONAL ANERGY; SIGNAL-TRANSDUCTION; GENE-TRANSCRIPTION; ANTIGEN RECEPTOR; PLASMA-MEMBRANE; TRANSGENIC MICE; LIPID RAFTS	The molecular basis of T cell anergy is not completely understood. We show that in antigen-primed anergic murine CD4(+) T cells the linker for activation of T cells (LAT) is hypophosphorylated upon CD3/CD28 restimulation. Signaling events downstream of LAT (PLC gamma 1 phosphorylation and p85 [PI3-K] association) were impaired, whereas upstream events (CD3 zeta and ZAP-70 phosphorylation) remained intact. LAT recruitment to the immunological synapse and its localization in detergent-resistant membrane (DRM) fractions were defective in anergic T cells. These defects resulted from impaired palmitoylation of LAT and were selective since the DRM localization and palmitoylation of Fyn were intact. This LAT defect was independent of Cbl-b and did not reflect enhanced LAT degradation. These results identify LAT as the most upstream target of anergy induction; moreover, they suggest that regulation of the amount of LAT in the immunological synapse and DRM by posttranslational palmitoylation contributes to the induction of T cell anergy.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Natl Inst Longev Sci, Lab Genom & Proteom, Obu, Aichi 4748522, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	La Jolla Institute for Immunology; Japan Science & Technology Agency (JST)	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA.	amnon@liai.org	Hundt, Matthias/B-3558-2009; Fukata, Masaki/AAZ-2476-2021	Hundt, Matthias/0000-0002-5054-8037; Fukata, Masaki/0000-0001-5200-9806; TANAKA, Yoshihiko/0000-0002-6458-5082; LIU, YUN-CAI/0000-0002-0996-7109	NCI NIH HHS [CA35299] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Asai K, 2002, J IMMUNOL, V169, P4723, DOI 10.4049/jimmunol.169.9.4723; Balamuth F, 2004, J IMMUNOL, V172, P5887, DOI 10.4049/jimmunol.172.10.5887; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Boussiotis VA, 1996, J EXP MED, V184, P365, DOI 10.1084/jem.184.2.365; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Cherukuri A, 2004, J BIOL CHEM, V279, P31973, DOI 10.1074/jbc.M404410200; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; DeSilva DR, 1997, CELL IMMUNOL, V180, P116, DOI 10.1006/cimm.1997.1182; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Faith A, 1997, J IMMUNOL, V159, P53; Falb D, 1996, EUR J IMMUNOL, V26, P130, DOI 10.1002/eji.1830260120; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; GAJEWSKI TF, 1995, EUR J IMMUNOL, V25, P1836, DOI 10.1002/eji.1830250707; Gringhuis SI, 2002, MOL CELL BIOL, V22, P400, DOI 10.1128/MCB.22.2.400-411.2002; Gringhuis SI, 2000, J IMMUNOL, V164, P2170, DOI 10.4049/jimmunol.164.4.2170; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Ise W, 2005, J IMMUNOL, V175, P829, DOI 10.4049/jimmunol.175.2.829; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mondino A, 1996, J IMMUNOL, V157, P2048; Ouellet M, 2003, BIOCHEMISTRY-US, V42, P8260, DOI 10.1021/bi034013b; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; QUILL H, 1992, J IMMUNOL, V149, P2887; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Salojin K, 1997, J EXP MED, V186, P887, DOI 10.1084/jem.186.6.887; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; Sundstedt A, 1998, J IMMUNOL, V161, P5930; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; Tsuchida M, 1999, EUR J IMMUNOL, V29, P2354, DOI 10.1002/(SICI)1521-4141(199907)29:07<2354::AID-IMMU2354>3.0.CO;2-P; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Zeyda M, 2002, J BIOL CHEM, V277, P28418, DOI 10.1074/jbc.M203343200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	59	74	86	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					513	522		10.1016/j.immuni.2006.03.011	http://dx.doi.org/10.1016/j.immuni.2006.03.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713970	Bronze			2022-12-18	WOS:000237970100009
J	Strbo, N; Oizumi, S; Sotosek-Tokmadzic, V; Podack, ER				Strbo, N; Oizumi, S; Sotosek-Tokmadzic, V; Podack, ER			Perforin is required for innate and adaptive immunity induced by heat shock protein Gp96	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; HUMAN DENDRITIC CELLS; T-CELLS; NK CELLS; ANTITUMOR IMMUNITY; VIRAL-INFECTION; DOWN-REGULATION; CUTTING EDGE; IN-VIVO; MICE	Tumor-secreted gp96-Ig is highly immunogenic and triggers CD8 T cell-mediated tumor rejection. In vivo secreted gp96-Ig and gp96-myc cause NK activation and clonal expansion of specific CD8(+) CTL in wildtype and in Fas-ligand-deficient (gld) mice but not in perforin- (PKO) or IFN-gamma-deficient (GKO) mice. Transfer of perforin-competent NK cells restores the ability of PKO mice to clonally expand CD8 CTL in response to gp96-Ig. The data demonstrate an essential role for perforin-mediated functions in the activation of innate and adaptive immunity by heat shock protein gp96-peptide complexes. Crosspresentation of antigens by heat shock proteins seems to require a perforin-dependent positive feedback loop between NK and DC for both sustained NK activation and clonal CTL expansion. The studies also explain how depressed NK activity in patients with tumors or after viral infections could diminish CTL responses.	Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami	Podack, ER (corresponding author), Univ Rijeka, Dept Physiol & Immunol, HR-51000 Rijeka, Croatia.	epodack@miami.edu	Oizumi, Satoshi/G-6717-2012; Sotosek Tokmadzic, Vlatka/O-2359-2018	Sotosek Tokmadzic, Vlatka/0000-0003-2645-5364	NCI NIH HHS [R01 CA80228, CA 39201] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039201, R01CA080228] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Badovinac VP, 2000, J IMMUNOL, V164, P6444, DOI 10.4049/jimmunol.164.12.6444; Baker MB, 1996, J EXP MED, V183, P2645, DOI 10.1084/jem.183.6.2645; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Berwin B, 2002, J IMMUNOL, V168, P4282, DOI 10.4049/jimmunol.168.9.4282; Berwin B, 2001, J BIOL CHEM, V276, P21083, DOI 10.1074/jbc.M101836200; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1986, J IMMUNOL, V136, P2280; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Dalyot-Herman N, 2000, J IMMUNOL, V165, P6731, DOI 10.4049/jimmunol.165.12.6731; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; HENKART MP, 1982, ADV EXP MED BIOL, V146, P227; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KALLAND T, 1987, J IMMUNOL, V138, P3640; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Kotera Y, 2001, CANCER RES, V61, P8105; Lan FS, 2001, J IMMUNOL, V167, P2087, DOI 10.4049/jimmunol.167.4.2087; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Matsumoto G, 2000, EUR J IMMUNOL, V30, P3723, DOI 10.1002/1521-4141(200012)30:12<3723::AID-IMMU3723>3.0.CO;2-9; Multhoff G, 2000, INT J CANCER, V88, P791, DOI 10.1002/1097-0215(20001201)88:5<791::AID-IJC17>3.0.CO;2-I; Palliser D, 2001, CURR OPIN MOL THER, V3, P25; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Poggi A, 2002, J IMMUNOL, V168, P95, DOI 10.4049/jimmunol.168.1.95; Reich A, 2000, EUR J IMMUNOL, V30, P678, DOI 10.1002/1521-4141(200002)30:2<678::AID-IMMU678>3.3.CO;2-H; Schreiber R D, 1988, Adv Exp Med Biol, V239, P185; SCHREIBER RD, 1984, CONTEMP TOP IMMUNOBI, V13, P171; Singh-Jasuja H, 2001, BIOL CHEM, V382, P629, DOI 10.1515/BC.2001.074; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; SMYTH MJ, 1990, J EXP MED, V171, P1269, DOI 10.1084/jem.171.4.1269; Smyth MJ, 1999, J IMMUNOL, V162, P6658; Somersan S, 2001, J IMMUNOL, V167, P4844, DOI 10.4049/jimmunol.167.9.4844; Spielman J, 1998, J IMMUNOL, V161, P7063; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; Stepp SE, 2000, IMMUNOL TODAY, V21, P254, DOI 10.1016/S0167-5699(00)01622-4; Stremmel C, 2001, EUR J IMMUNOL, V31, P2818, DOI 10.1002/1521-4141(200109)31:9<2818::AID-IMMU2818>3.0.CO;2-1; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Wang MD, 1998, J IMMUNOL, V160, P1098; Wilson JL, 1999, J IMMUNOL, V163, P6365; Yamazaki K, 1999, J IMMUNOL, V163, P5178; YAMAZAKI K, 2002, CANCER RES, V43, pA4821; Zheng H, 2001, J IMMUNOL, V167, P6731, DOI 10.4049/jimmunol.167.12.6731	51	74	76	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					381	390		10.1016/S1074-7613(03)00056-6	http://dx.doi.org/10.1016/S1074-7613(03)00056-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648455	Bronze			2022-12-18	WOS:000181713700008
J	Wan, YSY; DeGregori, J				Wan, YSY; DeGregori, J			The survival of antigen-stimulated T cells requires NF kappa B-mediated inhibition of p73 expression	IMMUNITY			English	Article							CD28 COSTIMULATION; DNA-DAMAGE; LYMPHOCYTE-PROLIFERATION; P53-DEPENDENT APOPTOSIS; MOLECULAR MECHANISMS; GENE-EXPRESSION; TARGET GENES; FAS-LIGAND; IN-VIVO; C-MYC	We have explored the interactions between the NFkappaB and Cdk-Rb-E2F pathways in controlling T cell fate following antigen stimulation. The inhibition of NFkappaB in antigen-stimulated T cells results in apoptosis but does not inhibit E2F activation and S phase entry. IkappaB-induced apoptosis coincides with the superinduction of p73 expression and activity. G1 Cdk activity is required for IkappaB-induced apoptosis and the induction of p73. Importantly, p73 deficiency rescues activated T cells from the apoptosis resulting from the inhibition of NFkappaB. Thus, Cdk2 activation sends signals for both cell cycle progression and apoptosis, the latter of which must be blocked by NFkappaB to allow for proliferation.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	DeGregori, J (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.	james.degregori@uchsc.edu		DeGregori, James/0000-0002-1287-1976	NATIONAL CANCER INSTITUTE [P30CA046934, R01CA077314] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA077314-05, R01 CA077314-06, CA77314, 2 P30 CA 46934-09, R01 CA077314] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attardi LD, 2000, GENE DEV, V14, P704; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Ferreira V, 1999, J IMMUNOL, V162, P6442; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Grimison B, 2000, CELL GROWTH DIFFER, V11, P507; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; JIN XM, 1995, CANCER RES, V55, P3250; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kishimoto H, 1999, J IMMUNOL, V163, P1817; Klefstrom J, 1997, EMBO J, V16, P7382, DOI 10.1093/emboj/16.24.7382; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Noel PJ, 1996, J IMMUNOL, V157, P636; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Pinkoski MJ, 1999, CELL DEATH DIFFER, V6, P1174, DOI 10.1038/sj.cdd.4400611; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Soares MP, 1998, J IMMUNOL, V161, P4572; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949; Zhu JH, 1998, CANCER RES, V58, P5061; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	55	74	76	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					331	342		10.1016/S1074-7613(03)00053-0	http://dx.doi.org/10.1016/S1074-7613(03)00053-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648451	Bronze			2022-12-18	WOS:000181713700004
J	Matsumoto, N; Ribaudo, RK; Abastado, JP; Margulies, DH; Yokoyama, WM				Matsumoto, N; Ribaudo, RK; Abastado, JP; Margulies, DH; Yokoyama, WM			The lectin-like NK cell receptor Ly-49A recognizes a carbohydrate-independent epitope on its MHC class I ligand	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL-KILLER-CELLS; MONOCLONAL-ANTIBODIES; KD/DD RECOMBINANTS; ANIMAL LECTINS; BINDING-SITE; T-CELLS; MOLECULES; ANTIGEN; EXPRESSION	The mouse NK inhibitory Ly-49A receptor specifically interacts with a peptide-induced conformational determinant on its MHC class I ligand, H-2D(d). In addition, it binds the polysaccharide fucoidan, consistent with its C-type lectin homology and the hypothesis that Ly-49A interacts with carbohydrates on D-d. Herein, however, we demonstrate that Ly-49A recognizes D-d mutants lacking N-glycosylation. Fucoidan competes for binding with anti-Ly-49A antibodies that inhibit Ly-49A-D-d interaction, and blocks apparent Ly-49A binding to unglycosylated D-d. We confirm that Ly-49A recognizes the alpha 1 and amino-terminal alpha 2 domains of D-d by analysis of recombinant H-2K(d)-H-2D(d) molecules. These studies indicate that Ly-49A recognizes carbohydrate-independent epitope(s) on D-d and suggest that Ly-49A has two distinct ligands, carbohydrate and MHC class I.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA; NCI, Lab Immune Cell Biol, Bethesda, MD 20892 USA; Inst Pasteur, Dept Immunol, F-75724 Paris, France; Natl Inst Hlth, Immunol Lab, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA.	yokoyama@imgate.wustl.edu	Ribaudo, Randall/AAH-7094-2021	Margulies, David/0000-0001-8530-7375				ABASTADO JP, 1987, J EXP MED, V166, P327, DOI 10.1084/jem.166.2.327; ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; AUBRY JP, 1994, J IMMUNOL, V152, P5806; BETTLER B, 1989, P NATL ACAD SCI USA, V86, P7118, DOI 10.1073/pnas.86.18.7118; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; BRENNAN J, 1995, J BIOL CHEM, V270, P9691, DOI 10.1074/jbc.270.17.9691; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; CHAN PY, 1986, J IMMUNOL, V136, P1346; CHAN PY, 1989, J IMMUNOL, V142, P1727; Coligan J.E., 1996, CURRENT PROTOCOLS IM; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; CORR M, 1993, J EXP MED, V178, P1877, DOI 10.1084/jem.178.6.1877; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; GLABE CG, 1983, ANAL BIOCHEM, V130, P287, DOI 10.1016/0003-2697(83)90590-0; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Held W, 1996, J EXP MED, V184, P2037, DOI 10.1084/jem.184.5.2037; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Lazetic S, 1996, J IMMUNOL, V157, P4741; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Mandelboim O, 1997, IMMUNITY, V6, P341, DOI 10.1016/S1074-7613(00)80336-2; MARYANSKI JL, 1989, EUR J IMMUNOL, V19, P193, DOI 10.1002/eji.1830190131; MCCLUSKEY J, 1986, J IMMUNOL, V137, P3881; NAGASAWA R, 1987, J IMMUNOL, V138, P815; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; OTTEN GR, 1992, J IMMUNOL, V148, P3723; PARHAM P, 1997, IMMUNOL REV, V155, P1; PULLEN JK, 1992, J IMMUNOL, V148, P953; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; ROLAND J, 1992, INT IMMUNOL, V4, P699, DOI 10.1093/intimm/4.6.699; STORKUS WJ, 1991, P NATL ACAD SCI USA, V88, P5989, DOI 10.1073/pnas.88.14.5989; SUN YH, 1985, J EXP MED, V162, P1588, DOI 10.1084/jem.162.5.1588; SYKES M, 1993, J EXP MED, V178, P223, DOI 10.1084/jem.178.1.223; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; VERCELLI D, 1989, NATURE, V338, P649, DOI 10.1038/338649a0; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Yokoyama W M, 1995, Semin Immunol, V7, P89, DOI 10.1006/smim.1995.0013; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	55	74	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1998	8	2					245	254		10.1016/S1074-7613(00)80476-8	http://dx.doi.org/10.1016/S1074-7613(00)80476-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492005	Bronze			2022-12-18	WOS:000072201800011
J	Wang, WH; Tam, WF; Hughes, CCW; Rath, S; Sen, R				Wang, WH; Tam, WF; Hughes, CCW; Rath, S; Sen, R			c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation	IMMUNITY			English	Article							NF-KAPPA-B; INTERLEUKIN-2 RECEPTOR EXPRESSION; ALPHA-CHAIN GENE; I TAX GENE; TRANSCRIPTION FACTORS; ENDOTHELIAL-CELLS; CYCLOSPORINE-A; IMMUNOGLOBULIN-KAPPA; ANTIGEN RECEPTOR; BINDING-SITES	The possible clinical use of the methyl xanthine derivative, pentoxifylline (PF), for the treatment of T cell-dependent diseases is being noted with increasing interest. In this paper, we studied the molecular consequences of PF treatment during lymphocyte activation. We found that in T cells, anti-CD3-induced c-Rel expression was blocked by PF, whereas the induction of other NF-kappa B family members was not significantly affected. However, induction of NF-AT, which has the same signaling requirements as c-Rel induction, was not inhibited by PF. Among genes that respond to these transcription factors, IL-2 mRNA induction was suppressed by PF, whereas IL-2R alpha chain mRNA induction was not affected. These observations implicated c-Rel as an IL-2 promoter factor, for which experimental support was obtained from transient transfection experiments. In contrast with the observation in T cells, c-Rel induction was not blocked by PF in B cells. The greater selectivity of PF, compared with FK506, at both the molecular and cellular levels may prove advantageous in manipulating T cell responses in vivo.	BRANDEIS UNIV,ROSENSTIEL BASIC MED SCI RES CTR,WALTHAM,MA 02254; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; NATL INST IMMUNOL,NEW DELHI 110067,INDIA; UNIV CALIF IRVINE,DEPT MOL BIOL & BIOCHEM,IRVINE,CA 92717	Brandeis University; Brandeis University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of California System; University of California Irvine			Hughes, Christopher/F-7510-2010		NCI NIH HHS [CA66626] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066626] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLAS RE, 1995, J CLIN INVEST, V96, P2521, DOI 10.1172/JCI118313; BEMELMANS MHA, 1994, J IMMUNOL, V153, P499; BISWAS DK, 1993, P NATL ACAD SCI USA, V90, P11044, DOI 10.1073/pnas.90.23.11044; BISWAS DK, 1993, J ACQ IMMUN DEF SYND, V6, P778; CHEN D, 1994, J EXP MED, V179, P931, DOI 10.1084/jem.179.3.931; CROSS SL, 1989, SCIENCE, V244, P466, DOI 10.1126/science.2497520; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Hughes CCW, 1996, J BIOL CHEM, V271, P5369, DOI 10.1074/jbc.271.10.5369; KILEY PD, 1995, EUR J IMMUNOL, V25, P2899; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KOVACH NL, 1994, BLOOD, V84, P2234; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; MAUXION F, 1991, P NATL ACAD SCI USA, V88, P2141, DOI 10.1073/pnas.88.6.2141; MAUXION F, 1989, MOL CELL BIOL, V9, P3548, DOI 10.1128/MCB.9.8.3548; MILLER J, 1985, J IMMUNOL, V134, P4212; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; NELSEN B, 1990, MOL CELL BIOL, V10, P3145, DOI 10.1128/MCB.10.6.3145; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; PIERCE JW, 1995, J IMMUNOL, V155, P1972; RAO KMK, 1991, CELL IMMUNOL, V135, P314, DOI 10.1016/0008-8749(91)90276-H; ROTT O, 1993, EUR J IMMUNOL, V23, P1745, DOI 10.1002/eji.1830230802; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P959, DOI 10.1128/MCB.9.3.959; SINHA B, 1995, EUR J IMMUNOL, V25, P147, DOI 10.1002/eji.1830250125; STREITER RM, 1988, BIOCHEM BIOPH RES CO, V155, P1230; TAKAHASHI GW, 1994, INT J IMMUNOPHARMACO, V16, P723, DOI 10.1016/0192-0561(94)90092-2; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TOZAWA K, 1995, CANCER RES, V55, P4162; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; UTZ PJ, 1988, SCIENCE, V241, P202; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; YANG KD, 1995, BIOCHEM BIOPH RES CO, V211, P1006, DOI 10.1006/bbrc.1995.1911	42	74	75	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					165	174		10.1016/S1074-7613(00)80423-9	http://dx.doi.org/10.1016/S1074-7613(00)80423-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047238	Bronze			2022-12-18	WOS:A1997XC61600006
J	SHINKAI, Y; MA, A; CHENG, HL; ALT, FW				SHINKAI, Y; MA, A; CHENG, HL; ALT, FW			CD3-EPSILON AND CD3-XI CYTOPLASMIC DOMAINS CAN INDEPENDENTLY GENERATE SIGNALS FOR T-CELL DEVELOPMENT AND FUNCTION	IMMUNITY			English	Article							RECEPTOR ZETA-CHAIN; ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODIES; MUTANT MICE; B-CELLS; EXPRESSION; ACTIVATION; COMPLEX; LACKING; TAIL	To determine whether CD3 epsilon and CD3 zeta proteins have unique roles in TCR-dependent functions, chimeric genes encoding the extracellular and transmembrane domains of the human IL-2 receptor alpha chain (Tac) fused to a cytoplasmic domain of either the CD3 epsilon or CD3 zeta chain were introduced as transgenes into both normal and RAG2-deficient (RAG2(-/-)) mice. Developmental arrest of T lineage cells at the CD4, CD8 double-negative stage in the transgenic RAG2(-/-) thymus was released to the CD4, CD8 double-positive (DR) stage by in vivo cross-linking of TT epsilon or TT zeta with anti-Tac antibody. In TT epsilon(+) or TT zeta(+), RAG2(-/-) mice, in vitro cross-linking of TT epsilon and TT zeta induced DP thymocyte cell death and proliferation of mature single-positive T cells. Overall, no qualitative differences were observed between TT epsilon- and TT zeta-mediated functions, suggesting that different CD3 components deliver qualitatively similar signals in inducing TCR-dependent functions.	CHILDRENS HOSP,HOWARD HUGHES MED INST,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CTR BLOOD RES,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	SHINKAI, Y (corresponding author), CHILDRENS HOSP,HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115, USA.		Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	NATIONAL CANCER INSTITUTE [R01CA042335] Funding Source: NIH RePORTER; NCI NIH HHS [CA42335] Funding Source: Medline; PHS HHS [U01 A131541, A120047] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; FOX DA, 1985, J IMMUNOL, V134, P330; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOH DY, 1991, NEW BIOL, V3, P924; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; ORTEGA G, 1984, J IMMUNOL, V133, P1970; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VONBOEHMER H, 1981, IMMUNOL REV, V54, P27; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; YAGITA H, 1989, P NATL ACAD SCI USA, V86, P645, DOI 10.1073/pnas.86.2.645	39	74	75	1	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					401	411						11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719942	Bronze			2022-12-18	WOS:A1995QU61600010
J	CORBELLA, P; MOSKOPHIDIS, D; SPANOPOULOU, E; MAMALAKI, C; TOLAINI, M; ITANO, A; LANS, D; BALTIMORE, D; ROBEY, E; KIOUSSIS, D				CORBELLA, P; MOSKOPHIDIS, D; SPANOPOULOU, E; MAMALAKI, C; TOLAINI, M; ITANO, A; LANS, D; BALTIMORE, D; ROBEY, E; KIOUSSIS, D			FUNCTIONAL COMMITMENT TO HELPER T-CELL LINEAGE PRECEDES POSITIVE SELECTION AND IS INDEPENDENT OF T-CELL RECEPTOR MHC SPECIFICITY	IMMUNITY			English	Article								Thymocyte differentiation proceeds from double positive CD4(+)CD8(+) to single positive T cells. It has been proposed that this process occurs by an instructive or a stochastic mechanism. In this report, we show that in recombination-deficient mice (RAG-1(-1-)) constitutive expression of a CD8 transgene allows maturation of CD4(+)(CD8tg(+)) cells, which express mature levels of a transgenic class I-restricted T cell receptor, F5. Rescued F5(+)CD4(+)(CD8tg(+)) cells have equivalent levels of T cell receptor expression as CD8end(+) cells, respond to cognate antigen and, upon stimulation, they exhibit a phenotype characteristic of CD4(+) helper T cells. These data are consistent with a model of differentiation that predicts that thymocytes become functionally committed to a helper or cytotoxic lineage before the final step of positive selection and independently of MHC specificity of their T cell receptor.	ROCKEFELLER UNIV, NEW YORK, NY 10021 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV IMMUNOL, BERKELEY, CA 94720 USA	Rockefeller University; University of California System; University of California Berkeley	CORBELLA, P (corresponding author), NATL INST MED RES, MOLEC IMMUNOL LAB, THE RIDGEWAY, LONDON NW7 1AA, ENGLAND.			Itano, Andrea/0000-0002-4766-6876				BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHAYEN A, 1982, J IMMUNOL METHODS, V49, P17, DOI 10.1016/0022-1759(82)90362-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V182, P158; CROMPTON T, 1993, P NATL ACAD SCI USA, V90, P8982, DOI 10.1073/pnas.90.19.8982; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; HULI J, 1989, J IMMUNOL, V142, P800; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MATZINGER P, 1993, IMMUNOL REV, V135, P81, DOI 10.1111/j.1600-065X.1993.tb00645.x; MURRAY LJ, 1990, EUR J IMMUNOL, V20, P163, DOI 10.1002/eji.1830200124; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TANAKA Y, 1993, EUR J IMMUNOL, V23, P2614, DOI 10.1002/eji.1830231035; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TOMONARI K, 1988, IMMUNOGENETICS, V28, P445, DOI 10.1007/BF00355377; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333	27	74	74	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1994	1	4					269	276		10.1016/1074-7613(94)90078-7	http://dx.doi.org/10.1016/1074-7613(94)90078-7			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889414				2022-12-18	WOS:A1994PK16600004
J	Li, J; Turner, SJ				Li, Jasmine; Turner, Stephen J.			T Cell LEGO: Identifying the Master Builders and What They Do	IMMUNITY			English	Editorial Material							IDENTITY; GENOME	Understanding how cell fate decisions are made during cellular differentiation and the mechanisms that drive them is a holy grail of cell biology. In this issue of Immunity, Hu et al. (2018) and Johnson et al. (2018) demonstrate that key transcriptional regulators and global changes in nuclear architecture underlie differentiation decisions during T cell development.	[Li, Jasmine; Turner, Stephen J.] Monash Univ, Biomed Discovery Inst, Dept Microbiol, Clayton, Vic, Australia	Monash University	Turner, SJ (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Microbiol, Clayton, Vic, Australia.	stephen.j.turner@monash.edu	Turner, Stephen/GXM-4654-2022	Turner, Stephen/0000-0002-1002-0000	NATIONAL CANCER INSTITUTE [R01CA169123, P30CA016520, P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	11	73	73	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					185	187		10.1016/j.immuni.2018.02.004	http://dx.doi.org/10.1016/j.immuni.2018.02.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466746	Bronze			2022-12-18	WOS:000425507800001
J	Krishnamoorthy, V; Kannanganat, S; Maienschein-Cline, M; Cook, SL; Chen, JJ; Bahroos, N; Sievert, E; Corse, E; Chong, A; Sciammas, R				Krishnamoorthy, Veena; Kannanganat, Sunil; Maienschein-Cline, Mark; Cook, Sarah L.; Chen, Jianjun; Bahroos, Neil; Sievert, Evelyn; Corse, Emily; Chong, Anita; Sciammas, Roger			The IRF4 Gene Regulatory Module Functions as a Read-Write Integrator to Dynamically Coordinate T Helper Cell Fate	IMMUNITY			English	Article							TRANSCRIPTION FACTOR IRF4; DIFFERENTIAL EXPRESSION ANALYSIS; DISTINCT INFLUENCES; EFFECTOR FUNCTION; GENOMIC FEATURES; REPRESSOR BCI6; IN-VIVO; EXPANSION; BINDING; SPECIFICATION	Transcriptional regulation during CD4(+) T cell fate decisions enables their differentiation into distinct states, guiding immune responses toward antibody production via Tfh cells or inflammation by Teff cells. Tfh-Teff cell fate commitment is regulated by mutual antagonism between the transcription factors Bcl6 and Blimp-1. Here we examined how T cell receptor (TCR) signals establish and arbitrate Bcl6-Blimp-1 counter-antagonism. We found that the TCR-signal-induced transcription factor Irf4 is essential for the differentiation of Bcl6-expressing Tfh and Blimp1-expressing Teff cells. Increased TCR signaling raised Irf4 amounts and promoted Teff cell fates at the expense of Tfh ones. Importantly, orthogonal induction of Irf4 expression redirected Tfh cell fate trajectories toward those of Teff. Mechanistically, we linked greater Irf4 abundance with its recruitment toward low-affinity binding sites within Teff cell cis-regulatory elements, including those of Prdm1. We propose that the Irf4 locus functions as the "reader'' of TCR signal strength, and in turn, concentration-dependent activity of Irf4 "writes'' T helper fate choice.	[Krishnamoorthy, Veena; Kannanganat, Sunil; Cook, Sarah L.; Sciammas, Roger] Methodist Hosp, Res Inst, Dept Surg, Transplant Immunobiol Ctr, Houston, TX 77030 USA; [Maienschein-Cline, Mark; Bahroos, Neil] Univ Illinois, Res Resources Ctr, Ctr Res Informat, Chicago, IL 60612 USA; [Chen, Jianjun; Chong, Anita] Univ Chicago, Dept Surg, Chicago, IL 60612 USA; [Corse, Emily] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Krishnamoorthy, Veena; Cook, Sarah L.; Sievert, Evelyn; Sciammas, Roger] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Corse, Emily] Roche, Autoimmun Grp, Zurich, Switzerland	The Methodist Hospital System; The Methodist Hospital - Houston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; Roche Holding	Sciammas, R (corresponding author), Methodist Hosp, Res Inst, Dept Surg, Transplant Immunobiol Ctr, Houston, TX 77030 USA.; Sciammas, R (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	rsciammas@ucdavis.edu	Sidharthan, Sunil Kannanganat/V-4917-2019	Sidharthan, Sunil Kannanganat/0000-0003-4605-9799; Quackenbush, Sarah/0000-0002-0516-9388	NIH [1S10OD010786-01]; NCATS [UL1TR000050]; NIAID [R01AI113145]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050, UL1TR002003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113145] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010786] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to David Fooksman (Albert Einstein College of Medicine), Michael Kuhns (U of Arizona), and Marcus Clark (U of Chicago) for discussions. We thank Malay Mandal (U of Chicago) for help with ATAC-seq and Laurie Minze (THMRI) for help with retro-orbital injections. The NIAID/Taconic Repository graciously provided mice. We thank the TMHRI and UC Davis flow cytometry facility for cell sorting and the DNA Technologies and Expression Analysis Cores at the UC Davis Genome Center, supported by NIH Shared Instrumentation Grant 1S10OD010786-01. Research was supported by the NCATS grant UL1TR000050 (M.M.-C. and N.B.) and by NIAID grant R01AI113145 (R.S.).	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Corse E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000481; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dustin ML, 2014, MOL CELL, V54, P255, DOI 10.1016/j.molcel.2014.04.001; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; FORGY EW, 1965, BIOMETRICS, V21, P768; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gottschalk RA, 2012, P NATL ACAD SCI USA, V109, P881, DOI 10.1073/pnas.1119763109; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Keck S, 2014, P NATL ACAD SCI USA, V111, P14852, DOI 10.1073/pnas.1403271111; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mahnke J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35521; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Willis SN, 2014, J IMMUNOL, V192, P3200, DOI 10.4049/jimmunol.1303216; Wysocker A., 2013, PICARD TOOLS VERSION; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yenson V, 2014, METHODS MOL BIOL, V1190, P17, DOI 10.1007/978-1-4939-1161-5_2; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	55	73	73	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					481	+		10.1016/j.immuni.2017.09.001	http://dx.doi.org/10.1016/j.immuni.2017.09.001			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930660	Bronze, Green Accepted			2022-12-18	WOS:000411128200013
J	Nguyen, HN; Noss, EH; Mizoguchi, F; Huppertz, C; Wei, KS; Watts, GFM; Brenner, MB				Nguyen, Hung N.; Noss, Erika H.; Mizoguchi, Fumitaka; Huppertz, Christine; Wei, Kevin S.; Watts, Gerald F. M.; Brenner, Michael B.			Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators	IMMUNITY			English	Article							LEUKEMIA INHIBITORY FACTOR; SMOOTH-MUSCLE-CELLS; RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; RETICULAR CELLS; GENE-EXPRESSION; IFN-ALPHA; IN-VITRO; T-CELLS; INTERLEUKIN-6	Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1 alpha, and IL-1 beta. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes.	[Nguyen, Hung N.; Noss, Erika H.; Mizoguchi, Fumitaka; Wei, Kevin S.; Watts, Gerald F. M.; Brenner, Michael B.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nguyen, Hung N.; Noss, Erika H.; Mizoguchi, Fumitaka; Wei, Kevin S.; Watts, Gerald F. M.; Brenner, Michael B.] Harvard Med Sch, Boston, MA 02115 USA; [Mizoguchi, Fumitaka] Tokyo Med & Dent Univ, Dept Rheumatol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Huppertz, Christine] Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Noss, Erika H.] Univ Washington, Div Rheumatol, Seattle, WA 98109 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tokyo Medical & Dental University (TMDU); Novartis; University of Washington; University of Washington Seattle	Brenner, MB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.; Brenner, MB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mbrenner@research.bwh.harvard.edu	Mizoguchi, Fumitaka/Y-3271-2018; Nguyen, Hung/G-8827-2018	Mizoguchi, Fumitaka/0000-0002-3956-7122; Watts, Gerald/0000-0003-2276-1524	NIH [R01-AR063709, K08-AR063696]; Rheumatology Research Foundation New Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR063696, R01AR063709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation New Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the NIH (R01-AR063709). E.H.N. was supported by the Rheumatology Research Foundation New Investigator Award and NIH (K08-AR063696). We thank Dr. Brandon Earp, Dr. Philip Blazar, Dr. John Wright, Dr. Barry Simmons, and Dr. Peter Nigrovic for human and mouse specimen; Dr. Sook Kyung Chang and Dr. I-Cheng Ho for feedback and discussion; and the BWH Human Immunology Center Flow Cytometry Core for cell sorting assistance.	Agarwal S, 2008, J RHEUMATOL, V35, P515; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Cho SS, 1996, J IMMUNOL, V157, P4781; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Donlin LT, 2014, J IMMUNOL, V193, P2373, DOI 10.4049/jimmunol.1400486; Dumler I, 1998, J BIOL CHEM, V273, P315, DOI 10.1074/jbc.273.1.315; Dumler I, 1999, J BIOL CHEM, V274, P24059, DOI 10.1074/jbc.274.34.24059; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enomoto Hiroyuki, 2003, Mod Rheumatol, V13, P121, DOI 10.3109/s10165-002-0210-9; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fletcher AL, 2011, TRENDS IMMUNOL, V32, P12, DOI 10.1016/j.it.2010.11.002; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Fox DA, 2010, RHEUM DIS CLIN N AM, V36, P311, DOI 10.1016/j.rdc.2010.02.004; Galon J, 1999, J IMMUNOL, V162, P7256; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kushwah R, 2011, J IMMUNOL, V187, P4639, DOI 10.4049/jimmunol.1101967; Lally F, 2005, ARTHRITIS RHEUM-US, V52, P3460, DOI 10.1002/art.21394; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee YH, 2012, INFLAMM RES, V61, P665, DOI 10.1007/s00011-012-0459-1; Lefevre S, 2015, CURR PHARM DESIGN, V21, P130; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05714; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; MADHOK R, 1993, ANN RHEUM DIS, V52, P232, DOI 10.1136/ard.52.3.232; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Noss EH, 2015, P NATL ACAD SCI USA, V112, P14948, DOI 10.1073/pnas.1520861112; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Pitard V, 1997, J IMMUNOL METHODS, V205, P177, DOI 10.1016/S0022-1759(97)00074-4; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Suman P., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.25155; Tanaka T, 2014, SEMIN IMMUNOL, V26, P88, DOI 10.1016/j.smim.2014.01.009; Taupin JL, 2001, J BIOL CHEM, V276, P47975, DOI 10.1074/jbc.M105476200; Tyler DR, 2007, MOL IMMUNOL, V44, P1864, DOI 10.1016/j.molimm.2006.10.006; Upadhyay A, 2012, CLIN EXP IMMUNOL, V169, P71, DOI 10.1111/j.1365-2249.2012.04601.x; Villuendas G, 2002, J CLIN ENDOCR METAB, V87, P1134, DOI 10.1210/jc.87.3.1134; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	52	73	74	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					220	232		10.1016/j.immuni.2017.01.004	http://dx.doi.org/10.1016/j.immuni.2017.01.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228280	Bronze, Green Accepted			2022-12-18	WOS:000396410900011
J	Lassen, KG; McKenzie, CI; Mari, M; Murano, T; Begun, J; Baxt, LA; Goel, G; Villablanca, EJ; Kuo, SY; Huang, HL; Macia, L; Bhan, AK; Batten, M; Daly, MJ; Reggiori, F; Mackay, CR; Xavier, RJ				Lassen, Kara G.; McKenzie, Craig I.; Mari, Muriel; Murano, Tatsuro; Begun, Jakob; Baxt, Leigh A.; Goel, Gautam; Villablanca, Eduardo J.; Kuo, Szu-Yu; Huang, Hailiang; Macia, Laurence; Bhan, Atul K.; Batten, Marcel; Daly, Mark J.; Reggiori, Fulvio; Mackay, Charles R.; Xavier, Ramnik J.			Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis Risk	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; PEROXISOME BIOGENESIS; AMINO-ACIDS; AUTOPHAGY; ATG16L1; CELLS; MOUSE; ACIDIFICATION; PATHOGENESIS; ACTIVATION	Although numerous polymorphisms have been associated with inflammatory bowel disease (IBD), identifying the function of these genetic factors has proved challenging. Here we identified a role for nine genes in IBD susceptibility loci in antibacterial autophagy and characterized a role for one of these genes, GPR65, in maintaining lysosome function. Mice lacking Gpr65, a proton-sensing G protein-coupled receptor, showed increased susceptibly to bacteria- induced colitis. Epithelial cells and macrophages lacking GPR65 exhibited impaired clearance of intracellular bacteria and accumulation of aberrant lysosomes. Similarly, IBD patient cells and epithelial cells expressing an IBD-associated missense variant, GPR65 I231L, displayed aberrant lysosomal pH resulting in lysosomal dysfunction, impaired bacterial restriction, and altered lipid droplet formation. The GPR65 I231L polymorphism was sufficient to confer decreased GPR65 signaling. Collectively, these data establish a role for GPR65 in IBD susceptibility and identify lysosomal dysfunction as a potentially causative element in IBD pathogenesis with effects on cellular homeostasis and defense.	[Lassen, Kara G.; Murano, Tatsuro; Villablanca, Eduardo J.; Kuo, Szu-Yu; Huang, Hailiang; Daly, Mark J.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lassen, Kara G.; Murano, Tatsuro; Begun, Jakob; Baxt, Leigh A.; Goel, Gautam; Villablanca, Eduardo J.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [McKenzie, Craig I.; Macia, Laurence; Mackay, Charles R.] Monash Univ, Monash Biomed Discovery Inst, Melbourne, Vic 3800, Australia; [McKenzie, Craig I.; Macia, Laurence; Mackay, Charles R.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Mari, Muriel; Reggiori, Fulvio] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-3713 AV Groningen, Netherlands; [Mari, Muriel; Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3564 CX Utrecht, Netherlands; [Begun, Jakob; Villablanca, Eduardo J.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Begun, Jakob] Univ Queensland, Mater Res Inst, Brisbane, Qld 4101, Australia; [Begun, Jakob] Univ Queensland, Sch Med, Brisbane, Qld 4101, Australia; [Huang, Hailiang; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Bhan, Atul K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bhan, Atul K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Bhan, Atul K.; Daly, Mark J.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Batten, Marcel] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Batten, Marcel] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Monash University; Monash University; University of Groningen; Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts General Hospital; Mater Research; University of Queensland; University of Queensland; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Lassen, KG; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Lassen, KG; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.	klassen@broadinstitute.org; xavier@molbio.mgh.harvard.edu	Mackay, Charles R/A-9673-2008; Macia, laurence/D-5983-2016; Begun, Jakob/J-6793-2014; Daly, Mark J/B-2453-2017; Reggiori, Fulvio/U-8327-2019; Villablanca, Eduardo/E-1380-2016; Kuo, Szu-Yu/N-9605-2017	Mackay, Charles R/0000-0002-6338-7340; Macia, laurence/0000-0003-0835-851X; Begun, Jakob/0000-0001-5256-7672; Daly, Mark J/0000-0002-0949-8752; Reggiori, Fulvio/0000-0003-2652-2686; Baxt, Leigh/0000-0001-8286-3907; Villablanca, Eduardo/0000-0001-9522-9729; Batten, Marcel/0000-0002-3726-3790; Mari, Muriel/0000-0002-2677-6945; Kuo, Szu-Yu/0000-0001-9206-7824	Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Foundation of America; NIH [DK097485, AI109725]; ALW Open Program [822.02.014]; DFG-NWO cooperation [DN82-303]; SNF [CRSII3_154421]; ZonMW VICI [016.130.606]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK097485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALW Open Program; DFG-NWO cooperation; SNF; ZonMW VICI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Natalia Nedelsky for editorial assistance, Jenny Tam for help with the generation of DQ-BSA-conjugated beads, and Rushika C. Wirasinha for support with Gpr65<SUP>-/-</SUP> mice. We thank Skip Virgin and Beth Levine for comments. This work was supported by funding from The Leona M. and Harry B. Helmsley Charitable Trust, Crohn's and Colitis Foundation of America, and NIH grants DK097485 and AI109725 to R. J. X. F. R. is supported by ALW Open Program (822.02.014), DFG-NWO cooperation (DN82-303), SNF (CRSII3_154421), and ZonMW VICI (016.130.606) grants.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chen YQ, 2012, CELL RES, V22, P333, DOI 10.1038/cr.2011.134; Coffey EE, 2014, NEUROSCIENCE, V263, P111, DOI 10.1016/j.neuroscience.2014.01.001; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Deretic V, 2015, J CLIN INVEST, V125, P75, DOI 10.1172/JCI73945; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Hazzan D, 2006, COLORECTAL DIS, V8, P539, DOI 10.1111/j.1463-1318.2006.01046.x; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2011, CELL MOL LIFE SCI, V68, P3643, DOI 10.1007/s00018-011-0827-y; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kyaw H, 1998, DNA CELL BIOL, V17, P493, DOI 10.1089/dna.1998.17.493; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Maxwell M, 2003, MOL CELL BIOL, V23, P5947, DOI 10.1128/MCB.23.16.5947-5957.2003; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Qin BM, 2006, J BIOL CHEM, V281, P36891, DOI 10.1074/jbc.M608884200; Rahman N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00343; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Reis RCM, 1998, EUR J CELL BIOL, V75, P192, DOI 10.1016/S0171-9335(98)80061-7; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shaw SY, 2013, ACS CHEM BIOL, V8, P2724, DOI 10.1021/cb400352d; Shimozawa N, 1999, HUM MOL GENET, V8, P1077, DOI 10.1093/hmg/8.6.1077; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Song-Zhao GX, 2014, MUCOSAL IMMUNOL, V7, P763, DOI 10.1038/mi.2013.94; Terawaki S, 2015, J CELL BIOL, V210, P1133, DOI 10.1083/jcb.201501059; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045	60	73	77	4	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1392	1405		10.1016/j.immuni.2016.05.007	http://dx.doi.org/10.1016/j.immuni.2016.05.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27287411	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000378341200017
J	Vaeth, M; Eckstein, M; Shaw, PJ; Kozhaya, L; Yang, J; Berberich-Siebelt, F; Clancy, R; Unutmaz, D; Feske, S				Vaeth, Martin; Eckstein, Miriam; Shaw, Patrick J.; Kozhaya, Lina; Yang, Jun; Berberich-Siebelt, Friederike; Clancy, Robert; Unutmaz, Derya; Feske, Stefan			Store-Operated Ca2+ Entry in Follicular T Cells Controls Humoral Immune Responses and Autoimmunity	IMMUNITY			English	Article							TRANSCRIPTION FACTOR IRF4; CALCIUM SENSORS STIM1; HELPER-CELL; ION CHANNELS; NFAT; IMMUNODEFICIENCY; DIFFERENTIATION; DEFICIENCY; EXPRESSION; ORAI1	T follicular helper (Tfh) cells promote affinity maturation of B cells in germinal centers (GCs), whereas T follicular regulatory (Tfr) cells limit the GC reaction. Store-operated Ca2+ entry (SOCE) through Ca2+ release-activated Ca2+ (CRAC) channels mediated by STIM and ORAI proteins is a fundamental signaling pathway in T lymphocytes. Conditional deletion of Stim1 and Stim2 genes in T cells abolished SOCE and strongly reduced antibody-mediated immune responses following viral infection caused by impaired differentiation and function of Tfh cells. Conversely, aging Stim1Stim2-deficient mice developed humoral autoimmunity with spontaneous autoantibody production due to abolished Tfr cell differentiation in the presence of residual Tfh cells. Mechanistically, SOCE controlled Tfr and Tfh cell differentiation through NFAT-mediated IRF4, BATF, and Bcl-6 transcription- factor expression. SOCE had a dual role in controlling the GC reaction by regulating both Tfh and Tfr cell differentiation, thus enabling protective B cell responses and preventing humoral autoimmunity.	[Vaeth, Martin; Shaw, Patrick J.; Yang, Jun; Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Eckstein, Miriam] NYU, Coll Dent, New York, NY 10010 USA; [Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Kozhaya, Lina; Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Berberich-Siebelt, Friederike] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Clancy, Robert] NYU, Sch Med, Dept Med, New York, NY 10016 USA	New York University; New York University; New York University; Jackson Laboratory; University of Wurzburg; New York University	Feske, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	feskes01@nyumc.org	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Vaeth, Martin/0000-0001-8974-7052	NIH [AI097302, AI065303]; Fritz Thyssen Stiftung [10.13.2.215]; Deutsche Forschungsgemeinschaft [VA 882/1-1]; NIH grant from National Center for Advancing Translational Sciences [UL1 TR00038]; Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097302, R01AI065303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fritz Thyssen Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH grant from National Center for Advancing Translational Sciences; Laura and Isaac Perlmutter Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Kaech (Yale University) for providing SMARTA mice, A. Rudensky (Memorial Sloan Kettering Cancer Center) for Foxp3-YFPcre mice, and R. Ahmed (Emory University) for LCMV virus strains. We thank P. Schwartzberg (NIH) and Y.-C. Liu (LaJolla Institute for Allergy and Immunology) for sharing caNFAT2 and Bcl-6 RV vectors, respectively. I-A<SUP>b</SUP> GP<INF>66-77</INF> and CLIP tetramers were obtained from the NIH tetramer core facility. This work was funded by grants from the NIH (AI097302 to S.F. and AI065303 to D.U.), the Fritz Thyssen Stiftung (Az. 10.13.2.215 to M.V.), and the postdoctoral fellowship VA 882/1-1 by the Deutsche Forschungsgemeinschaft (to M. V.). NYU core facilities for genome technology, bioinformatics, histopathology, and cell sorting are supported by NIH grant UL1 TR00038 from the National Center for Advancing Translational Sciences and by a grant (P30CA016087) to the Laura and Isaac Perlmutter Cancer Center. S.F. is a cofounder of Calcimedica.	Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Cheng KT, 2012, P NATL ACAD SCI USA, V109, P14544, DOI 10.1073/pnas.1207354109; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Grimbacher Bodo, 2016, J Allergy Clin Immunol, V137, P3, DOI 10.1016/j.jaci.2015.11.004; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hock M, 2013, J IMMUNOL, V190, P2345, DOI 10.4049/jimmunol.1201591; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Mueller K, 2013, NUCLEIC ACIDS RES, V41, P2138, DOI 10.1093/nar/gks1349; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Shaw PJ, 2014, J CLIN INVEST, V124, P4549, DOI 10.1172/JCI76602; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Vaeth M, 2015, P NATL ACAD SCI USA, V112, P1125, DOI 10.1073/pnas.1409290112; Vaeth M, 2014, J EXP MED, V211, P545, DOI 10.1084/jem.20130604; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	44	73	76	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1350	1364		10.1016/j.immuni.2016.04.013	http://dx.doi.org/10.1016/j.immuni.2016.04.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27261277	Green Accepted, Bronze			2022-12-18	WOS:000378341200014
J	Prakash, MD; Munoz, MA; Jain, R; Tong, PL; Koskinen, A; Regner, M; Kleifeld, O; Ho, B; Olson, M; Turner, SJ; Mrass, P; Weninger, W; Bird, PI				Prakash, Monica D.; Munoz, Marcia A.; Jain, Rohit; Tong, Philip L.; Koskinen, Aulikki; Regner, Matthias; Kleifeld, Oded; Ho, Bosco; Olson, Matthew; Turner, Stephen J.; Mrass, Paulus; Weninger, Wolfgang; Bird, Phillip I.			Granzyme B Promotes Cytotoxic Lymphocyte Transmigration via Basement Membrane Remodeling	IMMUNITY			English	Article							EXTRACELLULAR-MATRIX; T-CELLS; MIGRATION; TUMOR; RECEPTOR; TOPOGRAPHY; MECHANISMS; EXOCYTOSIS; APOPTOSIS; CLEAVAGE	Granzyme B (GzmB) is a protease with a well-characterized intracellular role in targeted destruction of compromised cells by cytotoxic lymphocytes. However, GzmB also cleaves extracellular matrix components, suggesting that it influences the interplay between cytotoxic lymphocytes and their environment. Here, we show that GzmB-null effector T cells and natural killer (NK) cells exhibited a cell-autonomous homing deficit in mouse models of inflammation and Ectromelia virus infection. Intravital imaging of effector T cells in inflamed cremaster muscle venules revealed that GzmB-null cells adhered normally to the vessel wall and could extend lamellipodia through it but did not cross it efficiently. In vitro migration assays showed that active GzmB was released from migrating cytotoxic lymphocytes and enabled chemokine-driven movement through basement membranes. Finally, proteomic analysis demonstrated that GzmB cleaved basement membrane constituents. Our results highlight an important role for GzmB in expediting cytotoxic lymphocyte diapedesis via basement membrane remodeling.	[Prakash, Monica D.; Kleifeld, Oded; Ho, Bosco; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Munoz, Marcia A.; Jain, Rohit; Tong, Philip L.; Mrass, Paulus; Weninger, Wolfgang] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia; [Munoz, Marcia A.; Jain, Rohit; Tong, Philip L.; Weninger, Wolfgang] Univ Sydney, Sydney Med Sch, Discipline Dermatol, Sydney, NSW 2006, Australia; [Koskinen, Aulikki; Regner, Matthias] Australian Natl Univ, Coll Med Biol & Environm, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2600, Australia; [Olson, Matthew; Turner, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW 2050, Australia	Monash University; University of Sydney; Centenary Institute; University of Sydney; Australian National University; John Curtin School of Medical Research; University of Melbourne; University of Sydney	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia.	phil.bird@monash.edu	Turner, Stephen/GXM-4654-2022; Jain, Rohit/O-2015-2019; Prakash, Monica/AAK-1548-2021	Jain, Rohit/0000-0002-4905-462X; Olson, Matthew/0000-0003-2351-6002; Weninger, Wolfgang/0000-0003-3133-8699; Prakash, Monica/0000-0002-2814-7560; Turner, Stephen/0000-0002-1002-0000; Munoz, Marcia/0000-0001-7603-0351; Bird, Phillip/0000-0002-6695-606X	Australian National Health and Medical Research Council (NHMRC) [1007830]; University of Sydney; NHMRC; Australian Research Council; New South Wales Cancer Institute	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); New South Wales Cancer Institute	M.D.P. and P.I.B. were supported by a grant from Australian National Health and Medical Research Council (NHMRC) project no. 1007830. P.L.T. was supported by the Dean's Fellows Scholarship (University of Sydney) and an NHMRC Postgraduate Scholarship. W.W., P.M., M.M., and R.J. were supported by grants from the NHMRC and the Australian Research Council and a fellowship from the New South Wales Cancer Institute. W.W. and P.M. are fellows of the Cancer Institute New South Wales. We thank A. Matthews (Monash University) for recombinant GzmB, J. Clark (Monash University) for assistance with ultrastructural analysis, and M. Biro, B. Roediger, and M. Kuligowski (Centenary Institute) for help with imaging experiments.	Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Bird CH, 2010, BIOL CHEM, V391, P999, DOI 10.1515/BC.2010.099; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Buzza MS, 2008, J BIOL CHEM, V283, P22498, DOI 10.1074/jbc.M709080200; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Ferrell N, 2011, AM J PHYSIOL-RENAL, V300, pF86, DOI 10.1152/ajprenal.00484.2010; GASPARI AA, 1991, J IMMUNOL, V147, P4155; Hansen KC, 2009, MOL CELL PROTEOMICS, V8, P1648, DOI 10.1074/mcp.M900039-MCP200; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hendel A, 2010, CELL DEATH DIFFER, V17, P596, DOI 10.1038/cdd.2010.5; Hiebert PR, 2013, CELL DEATH DIFFER, V20, P1404, DOI 10.1038/cdd.2013.96; Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KRAMER MD, 1987, IMMUNOL TODAY, V8, P140, DOI 10.1016/0167-5699(87)90141-1; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Prakash MD, 2009, IMMUNOL CELL BIOL, V87, P249, DOI 10.1038/icb.2008.98; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; TAKAHASHI K, 1991, EUR J IMMUNOL, V21, P1559, DOI 10.1002/eji.1830210634; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Wallich R, 2001, VIRAL IMMUNOL, V14, P71, DOI 10.1089/08828240151061428; Weninger W, 2014, NAT REV IMMUNOL, V14, P232, DOI 10.1038/nri3641; Willoughby CA, 2002, BIOORG MED CHEM LETT, V12, P2197, DOI 10.1016/S0960-894X(02)00363-3; Xu DM, 2004, IMMUNOL CELL BIOL, V82, P462, DOI 10.1111/j.0818-9641.2004.01274.x; Zhang TQ, 2006, EUR J IMMUNOL, V36, P457, DOI 10.1002/eji.200526208	45	73	76	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					960	972		10.1016/j.immuni.2014.11.012	http://dx.doi.org/10.1016/j.immuni.2014.11.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526309	Bronze			2022-12-18	WOS:000346654100014
J	Hubbard-Lucey, VM; Shono, Y; Maurer, K; West, ML; Singer, NV; Ziegler, CGK; Lezcano, C; Motta, ACF; Schmid, K; Levi, SM; Murphy, GF; Liu, C; Winkler, JD; Amaravadi, RK; Rogler, G; Dickinson, AM; Holler, E; van den Brink, MRM; Cadwell, K				Hubbard-Lucey, Vanessa M.; Shono, Yusuke; Maurer, Katie; West, Mallory L.; Singer, Natalie V.; Ziegler, Carly G. K.; Lezcano, Cecilia; Motta, Ana Carolina Fragoso; Schmid, Karin; Levi, Samuel M.; Murphy, George F.; Liu, Chen; Winkler, Jeffrey D.; Amaravadi, Ravi K.; Rogler, Gerhard; Dickinson, Anne M.; Holler, Ernst; van den Brink, Marcel R. M.; Cadwell, Ken			Autophagy Gene Atg16l1 Prevents Lethal T Cell Alloreactivity Mediated by Dendritic Cells	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; TRANSMEMBRANE 5; STEM-CELL; PROTEIN; EXPRESSION; DEGRADATION; LAPTM5; TRANSPLANTATION; MECHANISMS; PHAGOSOMES	Atg16L1 mediates the cellular degradative process of autophagy and is considered a critical regulator of inflammation based on its genetic association with inflammatory bowel disease. Here we find that Atg16L1 deficiency leads to an exacerbated graft-versus-host disease (GVHD) in a mouse model of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Atg16L1-deficient allo-HSCT recipients with GVHD displayed increased T cell proliferation due to increased dendritic cell (DC) numbers and costimulatory molecule expression. Reduced autophagy within DCs was associated with lysosomal abnormalities and decreased amounts of A20, a negative regulator of DC activation. These results broaden the function of Atg16L1 and the autophagy pathway to include a role in limiting a DC-mediated response during inflammatory disease, such as GVHD.	[Hubbard-Lucey, Vanessa M.; Maurer, Katie; Cadwell, Ken] Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Hubbard-Lucey, Vanessa M.; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Shono, Yusuke; West, Mallory L.; Singer, Natalie V.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA; [Maurer, Katie] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA; [Ziegler, Carly G. K.] Mem Sloan Kettering Canc Ctr, Dept Computat Biol & Immunol, New York, NY 10065 USA; [Lezcano, Cecilia; Motta, Ana Carolina Fragoso; Murphy, George F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Program Dermatopathol, Boston, MA 02115 USA; [Schmid, Karin; Holler, Ernst] Univ Regensburg, Univ Med Ctr, Dept Haematol & Oncol, D-93053 Regensburg, Germany; [Levi, Samuel M.; Winkler, Jeffrey D.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Winkler, Jeffrey D.; Amaravadi, Ravi K.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Amaravadi, Ravi K.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Rogler, Gerhard] Univ Zurich Hosp, Dept Gastroenterol, CH-8006 Zurich, Switzerland; [Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	New York University; Memorial Sloan Kettering Cancer Center; New York University; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Regensburg; University of Pennsylvania; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Zurich; University Zurich Hospital; Newcastle University - UK; Memorial Sloan Kettering Cancer Center	van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA.	vandenbm@mskcc.org; ken.cadwell@med.nyu.edu	Rogler, Gerhard/O-5308-2015; van den Brink, Marcel R. M./HGB-9434-2022; Motta, Ana Carolina F/J-2683-2012	Rogler, Gerhard/0000-0002-1733-9188; Motta, Ana Carolina F/0000-0002-3887-9239; Levi, Samuel/0000-0003-0973-3991; Cadwell, Ken/0000-0002-5860-0661; Ziegler, Carly/0000-0002-8279-7150	US National Institute of Health (NIH) [R01 DK093668, R01 HL069929, P01 CA023766, P01-CA023766, R01 AI080455, AI100288, R01 AI101406, F32 HL115974, T32 AI007647, T32 AI100853, F30 DK098925, T32 GM0738]; Dale F. Frey Award from the Damon Runyon Cancer Research Foundation; Uehara Memorial Foundation; Lymphoma Research Foundation Post-Doctoral Fellowship Research Grant; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]; Swiss IBD Cohort Study [3347CO-108792]; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; European Union's Seventh Programme [602587]; NATIONAL CANCER INSTITUTE [P01CA033049, P30CA008748, P01CA114046, P30CA016087, P01CA023766] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, F32HL115974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853, R01AI100288, R01AI080455, T32AI007647, R01AI101406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093668, F30DK098925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dale F. Frey Award from the Damon Runyon Cancer Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Lymphoma Research Foundation Post-Doctoral Fellowship Research Grant; U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss IBD Cohort Study; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; European Union's Seventh Programme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Smita Srivastava for assistance with culturing DCs, Michael Cammer for assistance with imaging, Fiangxia Liang for assistance with TEM, Herbert W. Virgin for Atg16L1<SUP>flox/flox</SUP> mice, Boris Reizis and Ana Maria Cuervo for advice, NYUSoM Flow Cytometry and Cell Sorting Center (5P30CA016087-33), and NYUSoM Microcopy Core supported by RR023704-01A1. This work was supported by US National Institute of Health (NIH) grants R01 DK093668 (K.C.), R01 HL069929 (M.R.M.v.d.B.), P01 CA023766 (M.R.M.v.d.B.), Project 4 of P01-CA023766, R01 AI080455 (M.R.M.v.d.B.), AI100288 (M.R.M.v.d.B.), R01 AI101406 (M.R.M.v.d.B.), F32 HL115974 (V.M.H.-L.), T32 AI007647 (V.M.H.-L.), T32 AI100853 (K.M.), F30 DK098925 (K.M.), T32 GM0738 (K.M.); Dale F. Frey Award from the Damon Runyon Cancer Research Foundation (K.C.); The Uehara Memorial Foundation (Y.S.); Lymphoma Research Foundation Post-Doctoral Fellowship Research Grant (Y.S.); U.S. National Institute of Allergy and Infectious Diseases (NIAID Contract HHSN272200900059C) (M.R.M.v.d.B.); Swiss IBD Cohort Study: 3347CO-108792 (G.R.); The Lymphoma Foundation (M.R.M.v.d.B.); Susan and Peter Solomon Divisional Genomics Program (M.R.M.v.d.B.); and European Union's Seventh Programme for research, technological development and demonstration grant agreement No [602587] (M.R.M.v.d.B.).	Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Diab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082496; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P3, DOI 10.1053/j.seminhematol.2005.09.001; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Fong TC, 1996, J IMMUNOL, V157, P4442; FUJITA N, 2008, CELL, V19, P2092; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Glowacka WK, 2012, J BIOL CHEM, V287, P27691, DOI 10.1074/jbc.M112.355917; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hashimoto D, 2011, SEMIN IMMUNOL, V23, P50, DOI 10.1016/j.smim.2011.01.005; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Kawai Y, 2014, IMMUNOL CELL BIOL, V92, P527, DOI 10.1038/icb.2014.18; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Landfried K, 2010, CLIN EXP IMMUNOL, V159, P87, DOI 10.1111/j.1365-2249.2009.04049.x; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Reed M, 2013, J IMMUNOL, V191, P2526, DOI 10.4049/jimmunol.1300477; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Strisciuglio C, 2013, J CROHNS COLITIS, V7, P534, DOI 10.1016/j.crohns.2012.08.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takatsuka H, 2003, DRUGS, V63, P1, DOI 10.2165/00003495-200363010-00001; Tanabe T, 2011, INT J HEMATOL, V93, P771, DOI 10.1007/s12185-011-0860-5; Ullio C, 2012, J LIPID RES, V53, P1134, DOI 10.1194/jlr.M022384; Wildenberg ME, 2012, GASTROENTEROLOGY, V142, P1493, DOI 10.1053/j.gastro.2012.02.034; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383; Zhao JL, 1996, J EXP MED, V183, P777, DOI 10.1084/jem.183.3.777	52	73	77	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					579	591		10.1016/j.immuni.2014.09.011	http://dx.doi.org/10.1016/j.immuni.2014.09.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25308334	Green Accepted, Bronze			2022-12-18	WOS:000345504300012
J	Arora, P; Baena, A; Yu, KOA; Saini, NK; Kharkwal, SS; Goldberg, MF; Kunnath-Velayudhan, S; Carreno, LJ; Venkataswamy, MM; Kim, J; Lazar-Molnar, E; Lauvau, G; Chang, YT; Liu, Z; Bittman, R; Al-Shamkhani, A; Cox, LR; Jervis, PJ; Veerapen, N; Besra, GS; Porcelli, SA				Arora, Pooja; Baena, Andres; Yu, Karl O. A.; Saini, Neeraj K.; Kharkwal, Shalu S.; Goldberg, Michael F.; Kunnath-Velayudhan, Shajo; Carreno, Leandro J.; Venkataswamy, Manjunatha M.; Kim, John; Lazar-Molnar, Eszter; Lauvau, Gregoire; Chang, Young-tae; Liu, Zheng; Bittman, Robert; Al-Shamkhani, Aymen; Cox, Liam R.; Jervis, Peter J.; Veerapen, Natacha; Besra, Gurdyal S.; Porcelli, Steven A.			A Single Subset of Dendritic Cells Controls the Cytokine Bias of Natural Killer T Cell Responses to Diverse Glycolipid Antigens	IMMUNITY			English	Article							NKT CELLS; ACTIVATION; FLUORESCENCE; MECHANISM; VARIANTS; PATHWAYS	Many hematopoietic cell types express CD1d and are capable of presenting glycolipid antigens to invariant natural killer T cells (iNKT cells). However, the question of which cells are the principal presenters of glycolipid antigens in vivo remains controversial, and it has been suggested that this might vary depending on the structure of a particular glycolipid antigen. Here we have shown that a single type of cell, the CD8 alpha(+) DEC-205(+) dendritic cell, was mainly responsible for capturing and presenting a variety of different glycolipid antigens, including multiple forms of alpha-galactosylceramide that stimulate widely divergent cytokine responses. After glycolipid presentation, these dendritic cells rapidly altered their expression of various costimulatory and coinhibitory molecules in a manner that was dependent on the structure of the antigen. These findings show flexibility in the outcome of two-way communication between CD8 alpha(+) dendritic cells and iNKT cells, providing a mechanism for biasing toward either proinflammatory or anti-inflammatory responses.	[Arora, Pooja; Saini, Neeraj K.; Kharkwal, Shalu S.; Goldberg, Michael F.; Kunnath-Velayudhan, Shajo; Carreno, Leandro J.; Kim, John; Lazar-Molnar, Eszter; Lauvau, Gregoire; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Baena, Andres] Univ Antioquia UdeA, Fac Med, Grp Inmunol Celular & Inmunogenet GICIG, Dept Microbiol & Parasitol, Medellin 05001000, Colombia; [Yu, Karl O. A.] Univ Chicago, Comer Childrens Hosp, Chicago, IL 60637 USA; [Carreno, Leandro J.] Univ Chile, Fac Med, Millennium Inst Immunol & Immunotherapy, Santiago 8380453, Chile; [Venkataswamy, Manjunatha M.] Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India; [Chang, Young-tae] Natl Univ Singapore, Dept Chem, Biopolis 117543, Singapore; [Chang, Young-tae] Natl Univ Singapore, Med Chem Programme, Biopolis 117543, Singapore; [Chang, Young-tae] ASTAR, Singapore Bioimaging Consortium, Biopolis 117543, Singapore; [Liu, Zheng; Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; [Al-Shamkhani, Aymen] Univ Southampton, Canc Sci Acad Unit, Fac Med, Southampton SO16 6YD, Hants, England; [Cox, Liam R.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England; [Jervis, Peter J.; Veerapen, Natacha; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Universidad de Antioquia; University of Chicago; Universidad de Chile; National Institute of Mental Health & Neurosciences - India; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); City University of New York (CUNY) System; Queens College NY (CUNY); University of Southampton; University of Birmingham; University of Birmingham	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk; steven.porcelli@einstein.yu.edu	Jervis, Peter/AAD-6106-2020; Cox, Liam/AAG-9351-2020; Yu, Karl/ABC-4547-2020; Lazar-Molnar, Eszter/AAM-2657-2020; Chang, Young-Tae/B-2780-2010	Cox, Liam/0000-0001-7018-3904; Chang, Young-Tae/0000-0002-1927-3688; Baena, Andres/0000-0003-1309-1020; Jervis, Peter/0000-0002-5550-4535; Besra, Gurdyal/0000-0002-5605-0395; Al-Shamkhani, Aymen/0000-0003-0727-4189; sharma, shalu/0000-0003-0901-0259; arora, pooja/0000-0002-4037-7406	NIH/NIAID [AI45889]; Einstein Cancer Center [NIH/NCI CA013330]; Einstein Center for AIDS Research [NIH AI-51519]; Royal Society Wolfson Research Merit Award; Wellcome Trust [084923/B/08/7]; MRC [G1001750]; Programa Estrategia de Sostenibilidad, Universidad de Antioquia, Medellin, Colombia; Cancer Research UK [13211] Funding Source: researchfish; Medical Research Council [G1001750] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Einstein Cancer Center; Einstein Center for AIDS Research; Royal Society Wolfson Research Merit Award(Royal Society of London); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Programa Estrategia de Sostenibilidad, Universidad de Antioquia, Medellin, Colombia; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIAID grant AI45889 to S.A.P. Flow cytometry and imaging studies were carried out with analytical imaging and FACS core facilities supported by the Einstein Cancer Center (NIH/NCI CA013330) and the Einstein Center for AIDS Research (NIH AI-51519). S. pneumoniae URF918 was provided by M. Kronenberg (La Jolla Institute for Allergy & Immunology). G. S. B was supported by a Personal Research Chair from James Bardrick, a Royal Society Wolfson Research Merit Award, the Wellcome Trust (084923/B/08/7), and the MRC (G1001750). A. B. acknowledges support from Programa Estrategia de Sostenibilidad, Universidad de Antioquia, Medellin, Colombia. S. A. P. has served as paid consultants for Vaccinex, which has an interest in the commercial development of iNKT cell targeted therapeutics. We thank Olisambu Uche for help with FACS sorting.	Arora P, 2011, J AM CHEM SOC, V133, P5198, DOI 10.1021/ja200070u; Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Boldyrev IA, 2007, J LIPID RES, V48, P1518, DOI 10.1194/jlr.M600459-JLR200; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Bricard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014374; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brossay L, 1997, J IMMUNOL, V159, P1216; Carnaud C, 1999, J IMMUNOL, V163, P4647; Forestier C, 2007, J IMMUNOL, V178, P1415, DOI 10.4049/jimmunol.178.3.1415; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; King IL, 2013, J IMMUNOL, V191, P572, DOI 10.4049/jimmunol.1300299; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh AK, 2011, ALLERGY, V66, P155, DOI 10.1111/j.1398-9995.2010.02458.x; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taraban VY, 2008, J IMMUNOL, V180, P4615, DOI 10.4049/jimmunol.180.7.4615; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Wu TN, 2011, P NATL ACAD SCI USA, V108, P17275, DOI 10.1073/pnas.1114255108; Yu ED, 2012, J BIOL CHEM, V287, P1269, DOI 10.1074/jbc.M111.308783; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; zum Bueschenfelde COM, 2004, J IMMUNOL, V173, P6119, DOI 10.4049/jimmunol.173.10.6119	38	73	74	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					105	116		10.1016/j.immuni.2013.12.004	http://dx.doi.org/10.1016/j.immuni.2013.12.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412610	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000331476900013
J	Spence, S; Fitzsimons, A; Boyd, CR; Kessler, J; Fitzgerald, D; Elliott, J; Gabhann, JN; Smith, S; Sica, A; Hams, E; Saunders, SP; Jefferies, CA; Fallon, PG; McAuley, DF; Kissenpfennig, A; Johnston, JA				Spence, Shaun; Fitzsimons, Amy; Boyd, Caroline R.; Kessler, Julia; Fitzgerald, Denise; Elliott, Joanne; Gabhann, Joan Ni; Smith, Siobhan; Sica, Antonio; Hams, Emily; Saunders, Sean P.; Jefferies, Caroline A.; Fallon, Padraic G.; McAuley, Danny F.; Kissenpfennig, Adrien; Johnston, James A.			RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization (Retracted article. See vol. 40, pg. 1002, 2014)	IMMUNITY			English	Article; Retracted Publication							ALTERNATIVE ACTIVATION; T-CELLS; SOCS3; DIFFERENTIATION; INFLAMMATION; EXPRESSION; MONOCYTES; INNATE; CANCER; INHIBITOR	Suppressors of cytokine signaling (SOCS) are important regulators of lipopolysaccharide (LPS) and cytokine responses but their role in macrophage polarization is unknown. We have shown here that myeloid-restricted Socs3 deletion (Socs3(Lyz2cre)) resulted in resistance to LPS-induced endotoxic shock, whereas Socs2(-/-) mice were highly susceptible. We observed striking bias toward M2-like macrophages in Socs3(Lyz2cre) mice, whereas the M1-like population was enriched in Socs2-/- mice. Adoptive transfer experiments showed that responses to endotoxic shock and polymicrobial sepsis were transferable and macrophage dependent. Critically, this dichotomous response was associated with enhanced regulatory T (Treg) cell recruitment by Socs3(Lyz2cre) ells whereas Treg cell recruitment was absent in the presence of Socs2(-/-) macrophages. In addition, altered polarization coincided with enhanced interferon-gamma (IFN-gamma)-induced signal transducer and activator of transcription-1 (STAT1) activation in Socs2-/- macrophages and enhanced interleukin-4 (IL-4) plus IL-13-induced STAT6 phosphorylation in Socs3(Lyz2cre) macro-phages. SOCS, therefore, are essential controllers of macrophage polarization, regulating inflammatory responses.	[Spence, Shaun; Fitzsimons, Amy; Boyd, Caroline R.; Kessler, Julia; Fitzgerald, Denise; Elliott, Joanne; McAuley, Danny F.; Kissenpfennig, Adrien; Johnston, James A.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland; [Gabhann, Joan Ni; Smith, Siobhan; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, RSCI Res Inst, Dublin 2, Ireland; [Sica, Antonio] Humanitas Clin & Res Ctr, I-20089 Rozzano, Italy; [Sica, Antonio] Univ Piemonte Orientale, Dept Pharmaceut Sci, I-28100 Novara, Italy; [Hams, Emily; Saunders, Sean P.; Fallon, Padraic G.] Univ Dublin Trinity Coll, St Jamess Hosp, Inst Mol Med, Dublin 8, Ireland; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin 12, Ireland	Queens University Belfast; Royal College of Surgeons - Ireland; IRCCS Humanitas Research Hospital; University of Eastern Piedmont Amedeo Avogadro; Trinity College Dublin; Trinity College Dublin; National Children's Research Centre (NCRC)	Johnston, JA (corresponding author), Amgen Inc, Inflammat Res, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	jamesj03@amgen.com	Sica, Antonio/AAB-9546-2020; Jefferies, Caroline/AAI-1543-2021; Fallon, Padraic/Y-2711-2019	Jefferies, Caroline/0000-0002-8879-6722; Fallon, Padraic/0000-0002-8401-7293; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; McAuley, Daniel/0000-0002-3283-1947; , denise/0000-0002-8608-430X; Hams, Emily/0000-0002-9745-3246	Science Foundation Ireland; Wellcome Trust	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors would like to thank C. McFarlane, H. Carroll, and J. Burrows for helpful discussions and L. Hanna and other members of the Queens University of Belfast biological research unit for technical aid and expertise. P.G.F. was supported by Science Foundation Ireland and Wellcome Trust.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Hashimoto M, 2009, CANCER SCI, V100, P730, DOI 10.1111/j.1349-7006.2009.01098.x; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mantovani A., 2011, YIN YANG CANC RELATE; Mantovani A, 2011, NAT MED, V17, P285, DOI 10.1038/nm0311-285; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Matsumura Y, 2007, J IMMUNOL, V179, P2170, DOI 10.4049/jimmunol.179.4.2170; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; Quiding-Jarbrink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015018; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Soltys J, 2002, J IMMUNOL, V168, P1903, DOI 10.4049/jimmunol.168.4.1903; Stevenson NJ, 2009, J LEUKOCYTE BIOL, V85, P289, DOI 10.1189/jlb.0708394; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2004, J LEUKOCYTE BIOL, V75, P422, DOI 10.1189/jlb.0403194; Yoshimura Akihiko, 2009, Keio Journal of Medicine, V58, P73; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhao J, 2010, CLIN EXP IMMUNOL, V160, P479, DOI 10.1111/j.1365-2249.2010.04089.x; Zheng ZM, 1996, IMMUNOLOGY, V87, P544, DOI 10.1046/j.1365-2567.1996.513591.x; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	50	73	87	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					66	78		10.1016/j.immuni.2012.09.013	http://dx.doi.org/10.1016/j.immuni.2012.09.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23177319	Bronze			2022-12-18	WOS:000314195500010
J	Gomez-del Arco, P; Kashiwagi, M; Jackson, AF; Naito, T; Zhang, JW; Liu, FF; Kee, B; Vooijs, M; Radtke, F; Redondo, JM; Georgopoulos, K				Gomez-del Arco, Pablo; Kashiwagi, Mariko; Jackson, Audrey F.; Naito, Taku; Zhang, Jiangwen; Liu, Feifei; Kee, Barbara; Vooijs, Marc; Radtke, Freddy; Miguel Redondo, Juan; Georgopoulos, Katia			Alternative Promoter Usage at the Notch1 Locus Supports Ligand-Independent Signaling in T Cell Development and Leukemogenesis	IMMUNITY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; IKAROS GENE; GENOME-WIDE; C-MYC; CHROMATIN; MICE; FATE; DIFFERENTIATION; TRANSCRIPTION; MECHANISMS	Loss of the transcription factor Ikaros is correlated with Notch receptor activation in T cell acute lymphoblastic leukemia (T-ALL). However, the mechanism remains unknown. We identified promoters in Notch1 that drove the expression of Notch1 proteins in the absence of a ligand. Ikaros bound to both canonical and alternative Notch1 promoters and its loss increased permissive chromatin, facilitating recruitment of transcription regulators. At early stages of leukemogenesis, increased basal expression from the canonical and 5'-alternative promoters initiated a feedback loop, augmenting Notch1 signaling. Ikaros also repressed intragenic promoters for ligand-independent Notch1 proteins that are cryptic in wild-type cells, poised in preleukemic cells, and active in leukemic cells. Only ligand-independent Notch1 isoforms were required for Ikaros-mediated leukemogenesis. Notch1 alternative-promoter usage was observed during T cell development and T-ALL progression. Thus, a network of epigenetic and transcriptional regulators controls conventional and unconventional Notch signaling during normal development and leukemogenesis.	[Gomez-del Arco, Pablo; Kashiwagi, Mariko; Jackson, Audrey F.; Naito, Taku; Liu, Feifei; Georgopoulos, Katia] Harvard Univ, Sch Med, Mass Gen Hosp, CBRC, Boston, MA 02129 USA; [Gomez-del Arco, Pablo; Miguel Redondo, Juan] CNIC, Vasc Biol & Inflammat Dept, Madrid 28029, Spain; [Gomez-del Arco, Pablo] UAM, Dept Biol Mol, Madrid 28049, Spain; [Zhang, Jiangwen] Harvard Univ, Sch Med, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Kee, Barbara] Univ Chicago, Dept Pathol & Med, Chicago, IL 60637 USA; [Vooijs, Marc] Maastricht Univ, Med Ctr, Dept Radiat Oncol MAASTRO, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [Radtke, Freddy] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Harvard University; University of Chicago; Maastricht University; Ludwig Institute for Cancer Research; University of Lausanne	Georgopoulos, K (corresponding author), Harvard Univ, Sch Med, Mass Gen Hosp, CBRC, Boston, MA 02129 USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Arco, Pablo Gomez-del/ABG-3417-2020; Vooijs, Marc/K-3522-2019; Radtke, Freddy/Q-3198-2017; Redondo, Juan Miguel/H-6351-2015; Zhang, Jiangwen/A-7654-2013; Gomez-del Arco, Pablo/L-2728-2013	Radtke, Freddy/0000-0003-4315-4045; Redondo, Juan Miguel/0000-0001-5779-9122; Zhang, Jiangwen/0000-0002-2911-8446; Gomez-del Arco, Pablo/0000-0001-6748-7157; Liu, Feifei/0000-0002-4577-1744	European Research Council under the European Community [208259]; Spanish Ministry of Science and Innovation; Pro-CNIC Foundation; Ramon y Cajal Grant; NIH;  [NIH-R01-AI1 380342];  [SAF2009-.10708]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038342] Funding Source: NIH RePORTER	European Research Council under the European Community(European Research Council (ERC)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation; Ramon y Cajal Grant(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-R01-AI1 380342 to K.G and by SAF2009-.10708 to CNIC and J.M.R and by the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC Grant 208259 to M.V. The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. P.G.A. is supported by a Ramon y Cajal Grant and A.F.J. by an NIH training grant in Transplantation Biology. We thank T. Honjo, R. Kopan, A. Ferrando, W. Pear, M.L. Toribio, F. Gounari, and M. Dose for providing reagents used in this study and to B. Czyzewski for mouse husbandry. We also thank B. Morgan, M. Dose, I. Joshi and T. Yoshida for review of the manuscript.	Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chari S, 2008, J IMMUNOL, V181, P6265, DOI 10.4049/jimmunol.181.9.6265; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DE SB, 1999, NATURE, V398, P518; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2009, NEW ENGL J MED, V360, P524, DOI 10.1056/NEJMe0809819; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Laky K, 2008, CURR OPIN IMMUNOL, V20, P197, DOI 10.1016/j.coi.2008.03.004; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Mantha S, 2007, LEUKEMIA RES, V31, P321, DOI 10.1016/j.leukres.2006.06.009; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Mullighan C, 2008, LEUKEMIA LYMPHOMA, V49, P847, DOI 10.1080/10428190801947500; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reschly EJ, 2006, BLOOD, V107, P4115, DOI 10.1182/blood-2005-09-3551; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Sandelin A, 2007, NAT REV GENET, V8, P424, DOI 10.1038/nrg2026; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; von Boehmer H, 2009, IMMUNITY, V30, P5, DOI 10.1016/j.immuni.2008.12.008; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	73	73	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					685	698		10.1016/j.immuni.2010.11.008	http://dx.doi.org/10.1016/j.immuni.2010.11.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093322	Green Accepted, Bronze			2022-12-18	WOS:000286082600008
J	Krueger, A; von Boehmer, H				Krueger, Andreas; von Boehmer, Harald			Identification of a T lineage-committed progenitor in adult blood	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MURINE FETAL LIVER; COMMON LYMPHOID PROGENITORS; MOUSE BONE-MARROW; THYMIC PROGENITORS; PRECURSOR CELLS; B-LINEAGE; PT-ALPHA; NOTCH; COMMITMENT	With help of a hCD25 reporter controlled by pre-T cell receptor alpha (Ptcra) regulatory elements, T cell precursors were identified in peripheral blood. Sca-1(+)IL-7R alpha(+)Flt3(-) precursors that were c-kit(lo)Thy-1(hi) generated T lineage cells when cultured on OP9-DL1 stromal cells and upon transfer into Rag2(-/-)II2rg(-/-) mice. No B cells were generated in vivo and only few in vitro. These cells, which we call circulating T cell progenitors (CTP), were found at the same frequency in Foxn1(nu/n) thymus-deficient mice and wild-type mice, indicating that they were pre- rather than postthymic. Inhibition of Notch-dependent transcription in vivo reduced the frequency of intrathymic early T cell progenitors (ETP), but not CTP, indicating that the latter are less Notch dependent. Thus, CTP represent T lineage-committed T cell precursors linking extrathymic with intrathymic lymphopoiesis in adult mice.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu	Krueger, Andreas/M-9769-2019; Krueger, Andreas/B-9427-2009	Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334	NIAID NIH HHS [R01 AI045846, R01 AI051378, AI45846] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051378, R01AI045846] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Douagi I, 2002, BLOOD, V99, P463, DOI 10.1182/blood.V99.2.463; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Jenkinson EJ, 2006, NAT REV IMMUNOL, V6, P551, DOI 10.1038/nri1883; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krueger A, 2006, J EXP MED, V203, P1977, DOI 10.1084/jem.20060731; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; SPANGRUDE GJ, 1992, BLOOD, V80, P1957; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0	44	73	75	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2007	26	1					105	116		10.1016/j.immuni.2006.12.004	http://dx.doi.org/10.1016/j.immuni.2006.12.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17222572	Bronze, Green Accepted			2022-12-18	WOS:000243959000013
J	Nyholm, SV; Passegue, E; Ludington, WB; Voskoboynik, A; Mitchel, K; Weissman, IL; De Tomaso, AW				Nyholm, Spencer V.; Passegue, Emmanuelle; Ludington, William B.; Voskoboynik, Ayelet; Mitchel, Katrina; Weissman, Irving L.; De Tomaso, Anthony W.			fester, a Candidate allorecognition receptor from a primitive chordate	IMMUNITY			English	Article							STEM-CELLS; UROCHORDATE; VARIANTS	Histocompatibility in the primitive chordate, Botryllus schlosseri, is controlled by a single, highly polymorphic locus, the FuHC. By taking a forward genetic approach, we have identified a locus encoded near the FuHC, called fester, which is polymorphic, polygenic, and inherited in distinct haplotypes. Somatic diversification occurs through extensive alternative splicing, with each individual expressing a unique repertoire of splice forms, both membrane bound and potentially secreted, all expressed in tissues intimately associated with histocompatibility. Functional studies, via both siRNA-mediated knockdown and direct blocking by monoclonal antibodies raised against fester, were able to disrupt predicted histocompatibility outcomes. The genetic and somatic diversity, coupled to the expression and functional data, suggests that fester is a receptor involved in histocompatibility.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Hopkins Marine Stn, Dept Biol Sci, Pacific Grove, CA 93950 USA	Stanford University	De Tomaso, AW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	tdet@stanford.edu		Passegue, Emmanuelle/0000-0002-3516-297X	NIAID NIH HHS [AI04588] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Buss LW, 1987, EVOLUTION INDIVIDUAL; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Flajnik M.F., 2003, FUNDAMENTAL IMMUNOLO, V5th, P519; FRIEDMAN J, 1994, AM J PATHOL, V144, P1247; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Harlow E LD, 1988, ANTIBODIES LAB MANUA; Hirose E, 2003, ZOOL SCI, V20, P647, DOI 10.2108/zsj.20.647; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Laird DJ, 2005, DEV DYNAM, V234, P997, DOI 10.1002/dvdy.20583; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; OKA HIDEMITI, 1960, BULL MAR BIOL STA ASAMUSHI TOHOKU UNIV, V10, P153; Rabinovich B, 2006, IMMUNOGENETICS, V58, P81, DOI 10.1007/s00251-005-0078-x; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Rinkevich B, 2002, BIOESSAYS, V24, P730, DOI 10.1002/bies.10123; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1962, REND ACCAD NAZ LINCE, V32, P1031; SAITO Y, 1994, INT J DEV BIOL, V38, P237; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; TANAKA K, 1973, CELL IMMUNOL, V7, P427, DOI 10.1016/0008-8749(73)90207-4; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	30	73	78	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					163	173		10.1016/j.immuni.2006.04.011	http://dx.doi.org/10.1016/j.immuni.2006.04.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860765	Bronze			2022-12-18	WOS:000239713000019
J	Wang, Y; Carter, RH				Wang, Y; Carter, RH			CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; IMMUNE-RESPONSES; MARGINAL-ZONE; T-CELLS; IMMUNOGLOBULIN GENES; AFFINITY MATURATION; SOMATIC MUTATION; CR2(-/-) MICE; ANTIBODY; HYPERMUTATION	Mice with mutations in CD19 Y482/Y513 form germinal centers (GC) but fail to produce high-affinity antibodies. In these mice, GC B cell differentiation, proliferation, and class switching occur but are defective. Altered CD19 signaling results in retention of early GC B cells and reduced proliferation in the follicular dendritic cell (FDC) zone of GC, and causes failure to select for high-affinity mutations. In normal mice, the earliest detectable aggregates of GC B cells are in contact with FDC and IgM(+) cells are only found in the FDC zone, further evidence that the FDC zone is the site of initial GC B cell proliferation, differentiation, and class switching. Proliferation in the non-FDC zone and somatic mutation are not dependent on CD19, indicating separate signaling requirements for the two GC compartments, but these CD19-independent GC functions are not sufficient to generate high-affinity antibodies and B cell memory.	Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Birmingham VA Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Carter, RH (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.	rcarter@uab.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042265, T32AI007051] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42265, T32 AI007051] Funding Source: Medline; NIAMS NIH HHS [AR74315] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Balogh P, 2002, ANAT REC, V268, P160, DOI 10.1002/ar.10148; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; Berek Claudia, 2004, Methods Mol Biol, V271, P127; Bobbitt KR, 2000, J IMMUNOL, V165, P5588, DOI 10.4049/jimmunol.165.10.5588; Brachtel EF, 1996, SCAND J IMMUNOL, V43, P239; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; Chen ZB, 2000, J IMMUNOL, V164, P4522, DOI 10.4049/jimmunol.164.9.4522; Cyster JG, 2000, IMMUNOL REV, V176, P181; de Fougerolles AR, 2001, EUR J IMMUNOL, V31, P2189, DOI 10.1002/1521-4141(200107)31:7<2189::AID-IMMU2189>3.0.CO;2-V; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Donahue AC, 2003, J IMMUNOL, V170, P5851, DOI 10.4049/jimmunol.170.12.5851; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Gardby E, 2001, SCAND J IMMUNOL, V53, P13, DOI 10.1046/j.1365-3083.2001.00824.x; GulbransonJudge A, 1997, ANN NY ACAD SCI, V815, P199, DOI 10.1111/j.1749-6632.1997.tb52061.x; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; Hollowood K, 1998, J PATHOL, V185, P229, DOI 10.1002/(SICI)1096-9896(199807)185:3<229::AID-PATH86>3.0.CO;2-L; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kelsoe G, 2003, J CLIN INVEST, V112, P1480, DOI 10.1172/JCI200320371; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; KoscoVilbois MH, 1997, IMMUNOL REV, V156, P127, DOI 10.1111/j.1600-065X.1997.tb00964.x; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Liu YJ, 1997, CURR OPIN IMMUNOL, V9, P256, DOI 10.1016/S0952-7915(97)80145-8; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Piatelli MJ, 2004, J IMMUNOL, V172, P2753, DOI 10.4049/jimmunol.172.5.2753; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; Rossbacher J, 2003, J EXP MED, V198, P591, DOI 10.1084/jem.20022042; Schable KF, 1999, EUR J IMMUNOL, V29, P2082, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2082::AID-IMMU2082&gt;3.0.CO;2-C; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Wu XB, 2000, J IMMUNOL, V165, P3119, DOI 10.4049/jimmunol.165.6.3119	50	73	75	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					749	761		10.1016/j.immuni.2005.04.012	http://dx.doi.org/10.1016/j.immuni.2005.04.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963789	Bronze			2022-12-18	WOS:000230180300012
J	Kapadia, SB; Levine, B; Speck, SH; Virgin, HW				Kapadia, SB; Levine, B; Speck, SH; Virgin, HW			Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection	IMMUNITY			English	Article							MURINE GAMMAHERPESVIRUS INFECTION; TYPE-1 GLYCOPROTEIN GC; BACTERIAL ARTIFICIAL CHROMOSOME; EXTRACELLULAR ENVELOPED VIRUS; CELL-DEFICIENT MICE; CD8 T-CELLS; IMMUNE EVASION; CONTROL PROTEINS; IN-VIVO; B-CELLS	Several gamma-herpesviruses encode homologs of host regulators of complement activation (RCA) proteins, suggesting that they have evolved immune evasion strategies targeting complement. We evaluated the role of complement factor C3 (C3) and the murine gamma-herpesvirus 68 (gammaHV68) RCA protein in viral pathogenesis. Deletion of the gammaHV68 RCA protein decreased virulence during acute CNS infection, and this attenuation was specifically reversed by deletion of host C3. The gammaHV68 RCA protein was also important for persistent viral replication and virulence in IFNgammaR(-/-) mice. In addition, C3 played a role in regulating latency, but this was not counteracted by the gammaHV68 RCA protein. We conclude that complement is a key host defense against gamma-herpesvirus infection and that gamma-herpesviruses have evolved an immune evasion strategy that is effective against complement-mediated antiviral responses during acute but not latent infection.	Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Dept Microbiol & Immunol, Atlanta, GA 30329 USA	Washington University (WUSTL); Columbia University; Emory University	Speck, SH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.		Speck, Samuel/L-5893-2019	Virgin, Herbert/0000-0001-8580-7628	NCI NIH HHS [CA58524, CA87650, CA52004, CA43143] Funding Source: Medline; NIAID NIH HHS [R01 AI45019, R01 AI 44157] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087650, R01CA058524, R01CA052004, R01CA043143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044157, R01AI045019] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; ALBRECHT JC, 1992, J VIROL, V66, P3937, DOI 10.1128/JVI.66.6.3937-3940.1992; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Carroll M C, 2000, Adv Immunol, V74, P61; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Christensen JP, 1999, P NATL ACAD SCI USA, V96, P5135, DOI 10.1073/pnas.96.9.5135; Clambey ET, 2000, J VIROL, V74, P1973, DOI 10.1128/JVI.74.4.1973-1984.2000; Dal Canto Albert J., 1999, Current Opinion in Rheumatology, V11, P17, DOI 10.1097/00002281-199901000-00004; Dal Conto AJ, 2000, J VIROL, V74, P11304, DOI 10.1128/JVI.74.23.11304-11310.2000; DALCANT AJ, 2000, INT J CARDIOL S, V75, pS7; DavisPoynter NJ, 1996, IMMUNOL CELL BIOL, V74, P513, DOI 10.1038/icb.1996.84; DELMAR L, 1998, VIROLOGY, V252, P450; Dutia BM, 1999, VIROLOGY, V261, P173, DOI 10.1006/viro.1999.9834; Dutia BM, 1997, J VIROL, V71, P4278, DOI 10.1128/JVI.71.6.4278-4283.1997; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 1999, J IMMUNOL, V163, P3403; FODOR WL, 1995, J VIROL, V69, P3889, DOI 10.1128/JVI.69.6.3889-3892.1995; Friedman HM, 1996, J VIROL, V70, P4253, DOI 10.1128/JVI.70.7.4253-4260.1996; Gangappa S, 2002, J EXP MED, V195, P931, DOI 10.1084/jem.20011825; Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998; HICKS JT, 1978, J IMMUNOL, V121, P1437; HIRSCH RL, 1980, INFECT IMMUN, V30, P899; HIRSCH RL, 1980, J INFECT DIS, V141, P212, DOI 10.1093/infdis/141.2.212; Hoge AT, 2000, J VIROL, V74, P7016, DOI 10.1128/JVI.74.15.7016-7023.2000; ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628; ISAACS SN, 1992, J VIROL, V66, P7217, DOI 10.1128/JVI.66.12.7217-7224.1992; Johnston C, 2001, J VIROL, V75, P10431, DOI 10.1128/JVI.75.21.10431-10445.2001; Kapadia SB, 1999, J VIROL, V73, P7658, DOI 10.1128/JVI.73.9.7658-7670.1999; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Kulkarni AB, 1997, IN VIVO, V11, P281; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; LEDDY JP, 1977, J IMMUNOL, V118, P28; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; LEWIS RB, 1986, REV INFECT DIS, V8, pS434; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Lubinski J, 1999, J EXP MED, V190, P1637, DOI 10.1084/jem.190.11.1637; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; LUXEMBOURG AT, 1994, J IMMUNOL, V153, P4448; MARTINEZPOMARES L, 1993, J VIROL, V67, P5450, DOI 10.1128/JVI.67.9.5450-5462.1993; Mathew E, 1998, J VIROL, V72, P2429, DOI 10.1128/JVI.72.3.2429-2438.1998; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; MISTRIKOVA J, 1985, ACTA VIROL, V29, P312; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; RAJCANI J, 1985, ACTA VIROL, V29, P51; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; ROTHER RP, 1995, HUM GENE THER, V6, P429, DOI 10.1089/hum.1995.6.4-429; ROTHER RP, 1994, J VIROL, V68, P730, DOI 10.1128/JVI.68.2.730-737.1994; RUNDELL BB, 1982, J MED VIROL, V10, P109, DOI 10.1002/jmv.1890100205; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; SAIFUDDIN M, 1995, J EXP MED, V182, P501, DOI 10.1084/jem.182.2.501; Sambrook J, 1989, MOL CLONING LAB MANU; SEARS AE, 1991, P NATL ACAD SCI USA, V88, P5087, DOI 10.1073/pnas.88.12.5087; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; TAKAHASHINISHIMAKI F, 1991, VIROLOGY, V181, P158, DOI 10.1016/0042-6822(91)90480-Y; Takefman DM, 1998, VIROLOGY, V246, P370, DOI 10.1006/viro.1998.9205; Terry LA, 2000, J GEN VIROL, V81, P2635, DOI 10.1099/0022-1317-81-11-2635; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Topham DJ, 2001, J GEN VIROL, V82, P1971, DOI 10.1099/0022-1317-82-8-1971; Usherwood EJ, 2000, J EXP MED, V192, P943, DOI 10.1084/jem.192.7.943; Usherwood EJ, 1996, J GEN VIROL, V77, P2819, DOI 10.1099/0022-1317-77-11-2819; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Virgin HW, 1999, J VIROL, V73, P2321, DOI 10.1128/JVI.73.3.2321-2332.1999; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Weck KE, 1997, NAT MED, V3, P1346, DOI 10.1038/nm1297-1346; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; WOLFFE EJ, 1993, J VIROL, V67, P4732, DOI 10.1128/JVI.67.8.4732-4741.1993	84	73	81	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2002	17	2					143	155		10.1016/S1074-7613(02)00369-2	http://dx.doi.org/10.1016/S1074-7613(02)00369-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196286	Bronze			2022-12-18	WOS:000177669400003
J	Dalwadi, H; Wei, B; Kronenberg, M; Sutton, CL; Braun, J				Dalwadi, H; Wei, B; Kronenberg, M; Sutton, CL; Braun, J			The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN INTESTINAL-MUCOSA; ULCERATIVE-COLITIS; ESCHERICHIA-COLI; IFN-GAMMA; MICE; INTERLEUKIN-10; ANTIGENS; RESPONSES; IL-10	An aberrant T cell response to enteric bacteria is important in inflammatory bowel disease. However, the identity of relevant microbial antigens is unknown. Here, we report the presence of I2, a Crohn's disease-associated microbial gene, in the murine intestine. The I2 protein induced a proliferative and IL-10 response by CD4(+) T cells from unimmunized mice. The I2 response was dependent on MHC class I1-mediated recognition but did not require antigen processing. Selective activation was observed for the TCR-V beta5 subpopulation. These findings indicate that the I2 protein is a new class of T cell superantigen and suggest that colonization by the I2 microorganism in susceptible hosts may provide a superantigenic stimulus pertinent to Crohn's disease pathogenesis.	Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; La Jolla Institute for Immunology	Braun, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	jbraun@mednet.ucla.edu		Braun, Jonathan/0000-0003-1646-2974	NCI NIH HHS [P30 CA016042] Funding Source: Medline; NIAID NIH HHS [AI 07126-23] Funding Source: Medline; NIDDK NIH HHS [DK43026, DK46763, P01 DK046763] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, R01DK043026] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; Akolkar PN, 1997, AM J GASTROENTEROL, V92, P2241; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Assenmacher M, 1998, EUR J IMMUNOL, V28, P1534, DOI 10.1002/(SICI)1521-4141(199805)28:05<1534::AID-IMMU1534>3.0.CO;2-R; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; BLASER MJ, 1984, GASTROENTEROLOGY, V87, P888; Bos NA, 2000, CURR TOP MICROBIOL, V252, P211; BREESE E, 1993, IMMUNOLOGY, V78, P127; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; Byrnes HD, 1999, J IMMUNOL, V163, P4715; Camerini V, 1998, J IMMUNOL, V160, P2608; Cong YZ, 2000, J IMMUNOL, V165, P2173, DOI 10.4049/jimmunol.165.4.2173; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dalwadi HN, 2000, FASEB J, V14, pA975; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; DEWINTER H, 1999, AM J PHYSIOL, V276, pG1317; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; ELSAGHIER A, 1992, CLIN EXP IMMUNOL, V90, P503; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Gui GPH, 1997, J ANTIMICROB CHEMOTH, V39, P393, DOI 10.1093/jac/39.3.393; Hagenbaugh A, 1997, J EXP MED, V185, P2101, DOI 10.1084/jem.185.12.2101; HIROI T, 1995, EUR J IMMUNOL, V25, P2743, DOI 10.1002/eji.1830251005; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huber BT, 1996, MICROBIOL REV, V60, P473, DOI 10.1128/MMBR.60.3.473-482.1996; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Kakazu T, 1999, AM J GASTROENTEROL, V94, P2149; Khoo UY, 1997, J IMMUNOL, V158, P3626; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; MIYOSHIAKIYAMA T, 1995, J IMMUNOL, V154, P5228; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MULLIN GE, 1992, GASTROENTEROLOGY, V102, P1620, DOI 10.1016/0016-5085(92)91722-G; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Peeters M, 1997, GASTROENTEROLOGY, V113, P802, DOI 10.1016/S0016-5085(97)70174-4; PIATAK M, 1993, BIOTECHNIQUES, V14, P70; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Powell JD, 1999, J IMMUNOL, V162, P2775; Prantera C, 1996, AM J GASTROENTEROL, V91, P328; Rizzo LV, 1999, J IMMUNOL, V162, P2613; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P89; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Sutton CL, 2000, GASTROENTEROLOGY, V119, P23, DOI 10.1053/gast.2000.8519; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Takahashi I, 1999, J IMMUNOL, V162, P1843	60	73	78	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					149	158		10.1016/S1074-7613(01)00164-9	http://dx.doi.org/10.1016/S1074-7613(01)00164-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485746	Bronze			2022-12-18	WOS:000170153300015
J	Roman, CAJ; Cherry, SR; Baltimore, D				Roman, CAJ; Cherry, SR; Baltimore, D			Complementation of V(D)J recombination deficiency in RAG-1(-/-) B cells reveals a requirement for novel elements in the N-terminus of RAG-1	IMMUNITY			English	Article							STRAND-BREAK REPAIR; TRANSCRIPTION FACTOR; INTEGRASE PROTEIN; HIV-1 INTEGRASE; HUMAN HOMOLOG; DNA-BINDING; VIRUS; ZINC; DOMAINS; GENES	RAG-1 is an essential component of the site-specific V(D)J recombinase. A new assay system has revealed a significant contribution of the catalytically dispensible N-terminal region of RAG-1 to recombination activity. The foundation for this system is an Abelson virus-transformed cell line derived from RAG-1(-/-) mice that is dependent on the introduction of exogenous RAG-1 for rearrangement of either plasmid substrates or the endogenous immunoglobulin loci. Use of this line demonstrates that conserved and novel cysteine-containing elements in the N-terminal region are required for full RAG-1 activity when recombination activity is in a RAG-1 dose-responsive range. Our data suggest that the RAG-1 N-terminus enhances the formation of an active recombination complex that facilitates the rearrangement process.			Roman, CAJ (corresponding author), MIT,DEPT BIOL,77 MASSACHUSETTS AVE,CAMBRIDGE,MA 02139, USA.			cherry, sara/0000-0003-3956-6610	NCI NIH HHS [CA51462] Funding Source: Medline; NIGMS NIH HHS [5-T32-GM07287] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASLAND R, 1995, TRENDS BIOL, V20, P55; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BAKER TA, 1994, P NATL ACAD SCI USA, V91, P6654, DOI 10.1073/pnas.91.14.6654; BAKER TA, 1995, SEMIN VIROL, V6, P53, DOI 10.1016/S1044-5773(05)80009-5; Bernstein RM, 1996, P NATL ACAD SCI USA, V93, P9454, DOI 10.1073/pnas.93.18.9454; BURKE CJ, 1992, J BIOL CHEM, V267, P9639; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; CHEN HM, 1993, GENOMICS, V15, P621, DOI 10.1006/geno.1993.1116; Cortes P, 1996, P NATL ACAD SCI USA, V93, P14008, DOI 10.1073/pnas.93.24.14008; CORTES P, 1994, P NATL ACAD SCI USA, V91, P7633, DOI 10.1073/pnas.91.16.7633; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Donzella GA, 1996, J VIROL, V70, P3909, DOI 10.1128/JVI.70.6.3909-3921.1996; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; FUSCHIOTTI P, 1993, MOL IMMUNOL, V30, P1021, DOI 10.1016/0161-5890(93)90127-W; Gellert M, 1996, GENES CELLS, V1, P269, DOI 10.1046/j.1365-2443.1996.22023.x; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jonsson CB, 1996, J VIROL, V70, P4585, DOI 10.1128/JVI.70.7.4585-4597.1996; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; KHAN E, 1991, NUCLEIC ACIDS RES, V19, P851, DOI 10.1093/nar/19.4.851; Kirch SA, 1996, EUR J IMMUNOL, V26, P886, DOI 10.1002/eji.1830260425; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; MARCHALONIS JJ, 1977, IMMUNITY EVOLUTION; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MYERS G, 1993, HUMAN RETROVIRUSES A, V1; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Oettinger MA, 1996, CURR OPIN GENET DEV, V6, P141, DOI 10.1016/S0959-437X(96)80042-6; PASSANANTI C, 1989, P NATL ACAD SCI USA, V86, P9417, DOI 10.1073/pnas.86.23.9417; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; RATHBUN G, 1993, INT IMMUNOL, V5, P997, DOI 10.1093/intimm/5.8.997; Rodgers KK, 1996, J MOL BIOL, V260, P70, DOI 10.1006/jmbi.1996.0382; Roman CAJ, 1996, P NATL ACAD SCI USA, V93, P2333, DOI 10.1073/pnas.93.6.2333; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schwabe JWR, 1994, STRUCT BIOL, V1, P345; SCOTT ML, 1991, P NATL ACAD SCI USA, V88, P6506, DOI 10.1073/pnas.88.15.6506; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; SKALKA AM, 1993, GENE, V135, P175, DOI 10.1016/0378-1119(93)90063-9; Spanopoulou E, 1995, IMMUNITY, V3, P715, DOI 10.1016/1074-7613(95)90061-6; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; VINCENT KA, 1993, J VIROL, V67, P425, DOI 10.1128/JVI.67.1.425-437.1993; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; WEAVER DT, 1995, TRENDS GENET, V11, P388, DOI 10.1016/S0168-9525(00)89121-0; Willett CE, 1997, IMMUNOGENETICS, V45, P394, DOI 10.1007/s002510050221; WITZGALL R, 1993, MOL CELL BIOL, V13, P1933, DOI 10.1128/MCB.13.3.1933; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	70	73	74	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					13	24		10.1016/S1074-7613(00)80506-3	http://dx.doi.org/10.1016/S1074-7613(00)80506-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252116	Bronze			2022-12-18	WOS:A1997XN69300002
J	Wang, HY; Paul, WE; Keegan, AD				Wang, HY; Paul, WE; Keegan, AD			IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain	IMMUNITY			English	Article							HUMAN INTERLEUKIN-4 RECEPTOR; SIGNAL-TRANSDUCTION; HEMATOPOIETIC-CELLS; GAMMA-CHAIN; PROTEIN; PHOSPHORYLATION; SUPERFAMILY; ACTIVATION; PATHWAYS; CLONING	IL-4 binds to a cell surface receptor complex that consists of the IL-4-binding protein (IL-4R alpha) and the gamma chain of the IL-2 receptor complex (gamma c). The receptors for IL-4 and IL-2 have several features in common; both use the gamma c as a receptor component, and both activate the Janus kinases JAK-1 and JAK-3. In spite of these similarities, IL-4 evokes specific responses, including the tyrosine phosphorylation of 4PS/IRS-2 and the induction of CD23. To determine whether sequences within the cytoplasmic domain of the IL-4R alpha specify these IL-4-specific responses, we transplanted the insulin IL-4 receptor motif (14R motif) of the huIL-4R alpha to the cytoplasmic domain of a truncated IL-2R beta. In addition, we transplanted a region that contains peptide sequences shown to block State binding to DNA. We analyzed the ability of cells expressing these IL-2R-IL-4R chimeric constructs to respond to IL-2. We found that IL-4 function could be transplanted to the IL-2 receptor by these regions and that proliferative and differentiative functions can be induced by different receptor sequences.	NIAID,IMMUNOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wang, HY (corresponding author), AMER RED CROSS,JEROME H HOLLAND LAB,IMMUNOL LAB,15601 CRABBS BRANCH WAY,ROCKVILLE,MD 20855, USA.							BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; GALIZZI JP, 1990, INT IMMUNOL, V2, P669, DOI 10.1093/intimm/2.7.669; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOLDSMITH MA, 1994, J BIOL CHEM, V269, P14698; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; IVASHKIV LB, 1995, IMMUNITY, V3, P1, DOI 10.1016/1074-7613(95)90152-3; IZUHARA K, 1993, J BIOL CHEM, V268, P13097; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KEEGAN AD, 1994, IMMUNOL TODAY, V15, P423, DOI 10.1016/0167-5699(94)90272-0; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KOHLER I, 1993, EUR J IMMUNOL, V23, P3066, DOI 10.1002/eji.1830231204; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V257, P1877; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORIA AO, 1988, MOL CELL BIOL, V8, P2214; MYERS MG, 1994, J BIOL CHEM, V269, P28783; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OHARA J, 1987, J IMMUNOL, V139, P1127; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; PAUL WE, 1991, BLOOD, V77, P1859; PERNIS A, 1995, P NATL ACAD SCI USA, V92, P7971, DOI 10.1073/pnas.92.17.7971; PRUETT W, 1995, MOL CELL BIOL, V15, P1778; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; RICHARDS ML, 1994, J IMMUNOL, V152, P3453; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1180; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WELHAM MJ, 1992, J IMMUNOL, V149, P1683; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WHITE MF, 1994, J BIOL CHEM, V269, P1; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YIN TG, 1994, J BIOL CHEM, V269, P26614; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	57	73	73	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					113	121		10.1016/S1074-7613(00)80676-7	http://dx.doi.org/10.1016/S1074-7613(00)80676-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624802	Bronze			2022-12-18	WOS:A1996TX22500002
J	Ramaswamy, A; Brodsky, NN; Sumida, TS; Comi, M; Asashima, H; Hoehn, KB; Li, NS; Liu, YQ; Shah, A; Ravindra, NG; Bishai, J; Khan, A; Lau, W; Sellers, B; Bansal, N; Guerrerio, P; Unterman, A; Habet, V; Rice, AJ; Catanzaro, J; Chandnani, H; Lopez, M; Kaminski, N; Dela Cruz, CS; Tsang, JS; Wang, ZH; Yan, XT; Kleinstein, SH; van Dijk, D; Pierce, RW; Hafler, DA; Lucas, CL				Ramaswamy, Anjali; Brodsky, Nina N.; Sumida, Tomokazu S.; Comi, Michela; Asashima, Hiromitsu; Hoehn, Kenneth B.; Li, Ningshan; Liu, Yunqing; Shah, Aagam; Ravindra, Neal G.; Bishai, Jason; Khan, Alamzeb; Lau, William; Sellers, Brian; Bansal, Neha; Guerrerio, Pamela; Unterman, Avraham; Habet, Victoria; Rice, Andrew J.; Catanzaro, Jason; Chandnani, Harsha; Lopez, Merrick; Kaminski, Naftali; Dela Cruz, Charles S.; Tsang, John S.; Wang, Zuoheng; Yan, Xiting; Kleinstein, Steven H.; van Dijk, David; Pierce, Richard W.; Hafler, David A.; Lucas, Carrie L.			Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children	IMMUNITY			English	Article							CELL ACTIVATION; IMMUNOGLOBULIN; REPERTOIRE; INTERLEUKIN-1; RESPONSES; PROTEINS; COVID-19; SUBSET	Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV-2 infection. We profiled MIS-C, adult COVID-19, and healthy pediatric and adult individuals using single-cell RNA sequencing, flow cytometry, antigen receptor repertoire analysis, and unbiased serum proteomics, which collectively identified a signature in MIS-C patients that correlated with disease severity. Despite having no evidence of active infection, MIS-C patients had elevated S100A-family alarmins and decreased antigen presentation signatures, indicative of myeloid dysfunction. MIS-C patients showed elevated expression of cytotoxicity genes in NK and CD8(+) T cells and expansion of specific IgG-expressing plasmablasts. Clinically severe MIS-C patients displayed skewed memory T cell TCR repertoires and autoimmunity characterized by endothelium-reactive IgG. The alarmin, cytotoxicity, TCR repertoire, and plasmablast signatures we defined have potential for application in the clinic to better diagnose and potentially predict disease severity early in the course of MIS-C.	[Ramaswamy, Anjali; Brodsky, Nina N.; Sumida, Tomokazu S.; Comi, Michela; Asashima, Hiromitsu; Rice, Andrew J.; Hafler, David A.; Lucas, Carrie L.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06519 USA; [Brodsky, Nina N.; Khan, Alamzeb; Habet, Victoria; Catanzaro, Jason; Pierce, Richard W.] Yale Univ, Dept Pediat, Sch Med, New Haven, CT 06519 USA; [Sumida, Tomokazu S.; Comi, Michela; Asashima, Hiromitsu; Hafler, David A.] Yale Univ, Dept Neurol, Sch Med, New Haven, CT 06519 USA; [Hoehn, Kenneth B.; Kleinstein, Steven H.] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06519 USA; [Li, Ningshan; Liu, Yunqing; Wang, Zuoheng; Yan, Xiting] Yale Univ, Dept Biostat, Sch Med, New Haven, CT 06519 USA; [Shah, Aagam; Ravindra, Neal G.; Bishai, Jason; van Dijk, David] Yale Univ, Dept Internal Med Cardiol, Sch Med, New Haven, CT 06510 USA; [Shah, Aagam; Ravindra, Neal G.; Bishai, Jason; Yan, Xiting; van Dijk, David] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Lau, William; Sellers, Brian; Bansal, Neha; Tsang, John S.] NIAID, NIH Ctr Human Immunol CHI, NIH, Bethesda, MD 20892 USA; [Lau, William; Bansal, Neha; Tsang, John S.] NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Guerrerio, Pamela] NIAID, Food Allergy Res Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Unterman, Avraham; Kaminski, Naftali; Dela Cruz, Charles S.] Yale Univ, Sect Pulm Crit Care & Sleep Med, Sch Med, Haven, CT 06520 USA; [Chandnani, Harsha; Lopez, Merrick] Loma Linda Sch Med, Dept Pediat, Loma Linda, CA 92354 USA; [Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University; Loma Linda University; Yale University	Lucas, CL (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06519 USA.	carrie.lucas@yale.edu		Shah, Aagam/0000-0002-3248-3778; Ravindra, Neal/0000-0001-5558-3758; Kaminski, Naftali/0000-0001-5917-4601; COMI, MICHELA/0000-0002-0109-4868; Pierce, Richard/0000-0001-5941-8805	NIAID [R01AI104739, 3R21AI144315-01A1S1, 5T32AI007019]; Yale University; NHLBI [1K08HL136898-01A1]; NSF Graduate Research Fellowship; Division of Intramural Research, NIH	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Yale University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Division of Intramural Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank the patients and their families for participation. We are also grateful to the physicians, nurses, and hospital staff who helped care for the patients and obtain samples. The authors thank J. Pober and D. Jane-Wit for critical input, R. Montgomery for support, and G. Wang and C. Castaldi at Yale Center for Genome Analysis for 10x Genomics library preparation and sequencing services; K. Raddassi for processing scRNA-seq samples; J.L. Pappalardo for providing us the healthy adult scRNA-seq data; R. Sparks and L. Failla for assistance providing healthy pediatric samples for SomaLogic. We also thank Ms. M. Bucklin, Mr. D. Murdock, and Dr. JM. Carpier for feed-back and discussions. This research was supported by grants to C.L.L. from NIAID 3R21AI144315-01A1S1 and Yale University. R.W.P is supported by NHLBI 1K08HL136898-01A1. A.R. was supported by NIAID 5T32AI007019 and NSF Graduate Research Fellowship. S.H.K. and K.B.H. were funded in part by NIAID R01AI104739. P.G., W.L., B.S, N.B., J.S.T. are supported by the Division of Intramural Research, NIH.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Balazs Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16262-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cheng MH, 2020, P NATL ACAD SCI USA, V117, P25254, DOI 10.1073/pnas.2010722117; Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Franco LM, 2019, J EXP MED, V216, P384, DOI 10.1084/jem.20180595; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Grumann D, 2008, J IMMUNOL, V181, P5054, DOI 10.4049/jimmunol.181.7.5054; Guo TX, 2018, J IMMUNOL, V200, P500, DOI 10.4049/jimmunol.1700677; Gupta NT, 2017, J IMMUNOL, V198, P2489, DOI 10.4049/jimmunol.1601850; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hildebrand D, 2014, CELL REP, V9, P910, DOI 10.1016/j.celrep.2014.10.003; Kaneko N, 2020, CELL, V183, P143, DOI 10.1016/j.cell.2020.08.025; Klocperk A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01665; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; LEUNG DYM, 1989, LANCET, V2, P1298; LEUNG DYM, 1986, J CLIN INVEST, V77, P1428, DOI 10.1172/JCI112454; LEUNG DYM, 1989, T ASSOC AM PHYSICIAN, V102, P131; LEUNG DYM, 1986, J EXP MED, V164, P1958, DOI 10.1084/jem.164.6.1958; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lydon EC, 2019, EBIOMEDICINE, V48, P453, DOI 10.1016/j.ebiom.2019.09.040; Mimitou EP, 2019, NAT METHODS, V16, P409, DOI 10.1038/s41592-019-0392-0; Nielsen SCA, 2020, CELL HOST MICROBE, V28, P516, DOI 10.1016/j.chom.2020.09.002; Pappalardo JL, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb8786; R Core Team R, 2022, R LANG ENV STAT COMP; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Raredon MSB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw3851; Raredon MSB, 2021, BIORXIV; Rauf A, 2020, INDIAN J PEDIATR, V87, P745, DOI 10.1007/s12098-020-03357-1; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; The Yale IMPACT Research Team, 2020, YALE IMPACT RES TEAM; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Young LS, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P461; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	60	72	73	6	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					1083	+		10.1016/j.immuni.2021.04.003	http://dx.doi.org/10.1016/j.immuni.2021.04.003		MAY 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33891889	Green Published, Bronze			2022-12-18	WOS:000652019500021
J	Buechler, MB; Kim, KW; Onufer, EJ; Williams, JW; Little, CC; Dominguez, CX; Li, QL; Sandoval, W; Cooper, JE; Harris, CA; Junttila, MR; Randolph, GJ; Turley, SJ				Buechler, Matthew B.; Kim, Ki-Wook; Onufer, Emily J.; Williams, Jesse W.; Little, Christine C.; Dominguez, Claudia X.; Li, Qingling; Sandoval, Wendy; Cooper, Jonathan E.; Harris, Charles A.; Junttila, Melissa R.; Randolph, Gwendalyn J.; Turley, Shannon J.			A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages	IMMUNITY			English	Article							RETINOIC ACID; T-CELLS; TISSUE; DIFFERENTIATION; EPICARDIUM; INDUCTION; MONOCYTES; LINEAGE; ANTIGEN; ORGANS	Tissue-resident macrophages require specific milieus for the maintenance of defining gene-expression programs. Expression of the transcription factor GATA6 is required for the homeostasis, function and localization of peritoneal cavity-resident macrophages. Gata6 expression is maintained in a non-cell autonomous manner and is elicited by the vitamin A metabolite, retinoic acid. Here, we found that the GATA6 transcriptional program is a common feature of macrophages residing in all visceral body cavities. Retinoic acid-dependent and -independent hallmark genes of GATA6(+) macrophages were induced by mesothelial and fibroblastic stromal cells that express the transcription factor Wilms' Tumor 1 (WT1), which drives the expression of two rate-limiting enzymes in retinol metabolism. Depletion of Wt1(+) stromal cells reduced the frequency of GATA6(+) macrophages in the peritoneal, pleural and pericardial cavities. Thus, Wt1(+) mesothelial and fibroblastic stromal cells constitute essential niche components supporting the tissue-specifying transcriptional landscape and homeostasis of cavity-resident macrophages.	[Buechler, Matthew B.; Little, Christine C.; Dominguez, Claudia X.; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Li, Qingling; Sandoval, Wendy] Genentech Inc, Microchem & Prote, San Francisco, CA 94080 USA; [Cooper, Jonathan E.; Junttila, Melissa R.] Genentech Inc, Translat Oncol, San Francisco, CA 94080 USA; [Kim, Ki-Wook; Williams, Jesse W.; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Onufer, Emily J.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Harris, Charles A.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Kim, Ki-Wook] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Williams, Jesse W.] Univ Minnesota, Dept Integrat Biol & Physiol, Ctr Immunol, Minneapolis, MN 55455 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities	Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	turley.shannon@gene.com		Buechler, Matthew/0000-0003-1902-622X; /0000-0002-7207-4389; Little, Christine/0000-0002-9191-0282; Williams, Jesse/0000-0003-3815-0891	NIH grants [R37 AI049653, DP1DK109668, K99 HL138163, T32 DK077653]; Genentech; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL138163, K99HL138163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK077653, DP1DK109668] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech(Roche HoldingGenentech); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge members of the Turley and Randolph labs for their useful discussions and assistance in the laboratory. We thank facility staff at Genentech and Washington University in St. Louis for vivarium maintenance and core facility assistance and N.W. Lounsbury and S. Lianoglou for management of sequencing files. We express gratitude to A.M. Berkley for her careful review of this manuscript. We also acknowledge technical support from BioRender for the graphical abstract. This work was supported by Genentech, NIH grants R37 AI049653 and DP1DK109668 to G.J.R., K99 HL138163 to J.W.W., and T32 DK077653 to E.J.O.	Akilesh HM, 2019, SCIENCE, V363, P142, DOI 10.1126/science.aao5213; Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Buechler MB, 2018, SEMIN IMMUNOL, V35, P48, DOI 10.1016/j.smim.2017.11.001; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jing J, 2017, J PHARMACOL EXP THER, V361, P246, DOI 10.1124/jpet.117.240523; Kanamori-Katayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025391; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Klattig J, 2007, SEX DEV, V1, P238, DOI 10.1159/000104774; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McLarty JL, 2011, JOVE-J VIS EXP, DOI 10.3791/3020; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Mutsaers SE, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00113; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stevens SM, 2016, DEV BIOL, V413, P153, DOI 10.1016/j.ydbio.2016.03.014; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wu XB, 2018, J IMMUNOL, V200, P2786, DOI 10.4049/jimmunol.1701668; Zeng ZT, 2018, NAT IMMUNOL, V19, P1100, DOI 10.1038/s41590-018-0211-2; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	53	72	73	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					119	+		10.1016/j.immuni.2019.05.010	http://dx.doi.org/10.1016/j.immuni.2019.05.010			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31231034	Bronze, Green Accepted			2022-12-18	WOS:000475561000015
J	Bloch, Y; Bouchareychas, L; Merceron, R; Skladanowska, K; Van den Bossche, L; Detry, S; Govindarajan, S; Elewaut, D; Haerynck, F; Dullaers, M; Adamopoulos, IE; Savvides, SN				Bloch, Yehudi; Bouchareychas, Laura; Merceron, Romain; Skladanowska, Katarzyna; Van den Bossche, Lien; Detry, Sammy; Govindarajan, Srinath; Elewaut, Dirk; Haerynck, Filomeen; Dullaers, Melissa; Adamopoulos, Iannis E.; Savvides, Savvas N.			Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12R beta 1	IMMUNITY			English	Article							INTERLEUKIN 23 RECEPTOR; HETERODIMERIC CYTOKINE; PROTEIN; COMPLEX; PSORIASIS; VARIANTS; CELLS; IL-12; PROMOTES; IL23R	Interleukin-23 (IL-23), an IL-12 family cytokine, plays pivotal roles in pro-inflammatory T helper 17 cell responses linked to autoimmune and inflammatory diseases. Despite intense therapeutic targeting, structural and mechanistic insights into receptor complexes mediated by IL-23, and by IL-12 family members in general, have remained elusive. We determined a crystal structure of human IL-23 in complex with its cognate receptor, IL-23R, and revealed that IL-23R bound to IL-23 exclusively via its N-terminal immunoglobulin domain. The structural and functional hotspot of this interaction partially restructured the helical IL-23p19 subunit of IL-23 and restrained its IL-12p40 subunit to cooperatively bind the shared receptor IL-12Rb1 with high affinity. Together with structural insights from the interaction of IL-23 with the inhibitory antibody briakinumab and by leveraging additional IL-23: antibody complexes, we propose a mechanistic paradigm for IL-23 and IL-12 whereby cognate receptor binding to the helical cytokine subunits primes recruitment of the shared receptors via the IL-12p40 subunit.	[Bloch, Yehudi; Merceron, Romain; Skladanowska, Katarzyna; Detry, Sammy; Savvides, Savvas N.] Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn, B-9052 Ghent, Belgium; [Bloch, Yehudi; Merceron, Romain; Skladanowska, Katarzyna; Detry, Sammy; Govindarajan, Srinath; Elewaut, Dirk; Savvides, Savvas N.] VIB UGent Ctr Inflammat Res, B-9052 Ghent, Belgium; [Bouchareychas, Laura; Adamopoulos, Iannis E.] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Dept Internal Med, Davis, CA 95616 USA; [Bouchareychas, Laura; Adamopoulos, Iannis E.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA; [Van den Bossche, Lien; Haerynck, Filomeen; Dullaers, Melissa] Ghent Univ Hosp, Dept Pulm Med, Clin Immunol Res Lab, B-9000 Ghent, Belgium; [Van den Bossche, Lien; Haerynck, Filomeen; Dullaers, Melissa] Ghent Univ Hosp, Jeffrey Modell Diag & Res Ctr, Ctr Primary Immunodeficiency, B-9000 Ghent, Belgium; [Govindarajan, Srinath; Elewaut, Dirk; Dullaers, Melissa] Ghent Univ Hosp, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium; [Haerynck, Filomeen] Ghent Univ Hosp, Div Pediat Immunol & Pulmonol, Dept Pediat, B-9000 Ghent, Belgium; [Bouchareychas, Laura] Univ Calif San Francisco, Div Vasc & Endovasc Surg, Dept Surg, San Francisco, CA 94143 USA; [Bouchareychas, Laura] Vet Affairs Med Ctr, San Francisco, CA 94143 USA	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; University of California System; University of California Davis; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Savvides, SN (corresponding author), Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn, B-9052 Ghent, Belgium.; Savvides, SN (corresponding author), VIB UGent Ctr Inflammat Res, B-9052 Ghent, Belgium.	savvas.savvides@ugent.be	Haerynck, Filomeen/AAD-6761-2020; Detry, Sammy/AHA-4665-2022; Adamopoulos, Iannis/AAE-5624-2022; Adamopoulos, Iannis/L-1944-2019	Adamopoulos, Iannis/0000-0002-3708-2965; Bouchareychas, Laura/0000-0003-4962-9750; Haerynck, Filomeen/0000-0001-9161-7361; Elewaut, Dirk/0000-0002-7468-974X; Bloch, Yehudi/0000-0001-7924-3539	Flanders Agency for Innovation and Entrepreneurship (VLAIO-Flanders, Belgium); Research Foundation Flanders (FWO, Belgium); Ghent University Hospital Spearhead Initiative for Immunology Research; Jeffrey Modell Foundation; NIAMS/NIH [AR62173]; National Psoriasis Foundation Translational Research Grant; Research Foundation Flanders (FWO grant) [G0C2214N]; Hercules Foundation [AUGE-11-029]; VIB; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062173] Funding Source: NIH RePORTER	Flanders Agency for Innovation and Entrepreneurship (VLAIO-Flanders, Belgium); Research Foundation Flanders (FWO, Belgium)(FWO); Ghent University Hospital Spearhead Initiative for Immunology Research; Jeffrey Modell Foundation; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Psoriasis Foundation Translational Research Grant; Research Foundation Flanders (FWO grant)(FWO); Hercules Foundation; VIB; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the staff of beam lines P14 (PETRAIII) and Proxima2A (SOLEIL) for beam time allocation and excellent technical support. We further thank Veronique De Backer (Ghent University Hospital) for technical support. Y.B. and S.D. are supported by pre-doctoral fellowships from the Flanders Agency for Innovation and Entrepreneurship (VLAIO-Flanders, Belgium). S.G. is supported by a postdoctoral fellowship from Research Foundation Flanders (FWO, Belgium). L.V.d.B., F.H., and M.D. are supported by the Ghent University Hospital Spearhead Initiative for Immunology Research. F.H. is supported by the Jeffrey Modell Foundation. I.E.A. acknowledges support from the NIAMS/NIH (grant AR62173) and a National Psoriasis Foundation Translational Research Grant. S.N.S. acknowledges research support from Research Foundation Flanders (FWO grant G0C2214N), the Hercules Foundation (no. AUGE-11-029), and the VIB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arakawa A, 2016, JAMA DERMATOL, V152, P825, DOI 10.1001/jamadermatol.2016.0751; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Beyer BM, 2008, J MOL BIOL, V382, P942, DOI 10.1016/j.jmb.2008.08.001; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bricogne G., 2016, BUSTER V 2 10 3; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Desmet J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6237; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2016, NAT REV IMMUNOL, V16, P524, DOI 10.1038/nri.2016.75; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Feldmeyer L, 2017, JAMA DERMATOL, V153, P304, DOI 10.1001/jamadermatol.2016.5384; Felix J, 2015, STRUCTURE, V23, P1621, DOI 10.1016/j.str.2015.06.019; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Guo WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043322; Hasegawa H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00479; Hawkes JE, 2017, J ALLERGY CLIN IMMUN, V140, P645, DOI 10.1016/j.jaci.2017.07.004; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li J, 2017, ANAL CHEM, V89, P2250, DOI 10.1021/acs.analchem.6b03058; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Luo JQ, 2010, J MOL BIOL, V402, P797, DOI 10.1016/j.jmb.2010.07.046; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Moutsopoulos NM, 2017, NEW ENGL J MED, V376, P1141, DOI 10.1056/NEJMoa1612197; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Onodera K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137801; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Prescott NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004955; Ramamurthy V, 2012, STRUCTURE, V20, P259, DOI 10.1016/j.str.2011.11.016; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot3825, 10.1101/pdb.prot4027, 10.1101/pdb.prot3723, 10.1101/pdb.prot3871, 10.1101/pdb.prot4044, 10.1101/pdb.prot4050, 10.1101/pdb.prot4453, 10.1101/pdb.prot3972, 10.1101/pdb.prot4455, 10.1101/pdb.prot4056, 10.1101/pdb.prot4022]; Saunders M. J. S., 2009, European patent, Patent No. [EP 2 650 311 A2, 2650311]; Schroder J, 2015, J BIOL CHEM, V290, P359, DOI 10.1074/jbc.M114.617597; Shin HS, 2015, J IMMUNOL, V194, P316, DOI 10.4049/jimmunol.1401013; Shirouzono T, 2012, ACTA CRYSTALLOGR F, V68, P432, DOI 10.1107/S1744309112005295; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Sivanesan D, 2016, J BIOL CHEM, V291, P8673, DOI 10.1074/jbc.M116.715870; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Suzuki E, 2016, J IMMUNOL, V197, P4403, DOI 10.4049/jimmunol.1600383; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Verstraete K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14937; Verstraete K, 2014, NAT STRUCT MOL BIOL, V21, P375, DOI 10.1038/nsmb.2794; Verstraete K, 2011, ACTA CRYSTALLOGR F, V67, P325, DOI 10.1107/S1744309111003319; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang XQ, 2016, EUR J IMMUNOL, V46, P1343, DOI 10.1002/eji.201546095; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; WOLF SF, 1991, J IMMUNOL, V146, P3074; Zhang L, 2014, CARCINOGENESIS, V35, P1330, DOI 10.1093/carcin/bgu017; Zhao J, 2010, J MASS SPECTROM, V45, P1416, DOI 10.1002/jms.1858	74	72	74	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					45	+		10.1016/j.immuni.2017.12.008	http://dx.doi.org/10.1016/j.immuni.2017.12.008			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29287995	Bronze, Green Accepted			2022-12-18	WOS:000422751600010
J	Yi, TS; Li, JH; Chen, H; Wu, JX; An, JP; Xu, Y; Hu, YM; Lowell, CA; Cyster, JG				Yi, Tangsheng; Li, Jianhua; Chen, Hsin; Wu, Jiaxi; An, Jinping; Xu, Ying; Hu, Yongmei; Lowell, Clifford A.; Cyster, Jason G.			Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses	IMMUNITY			English	Article							REGULATORY PROTEIN-ALPHA; ADHESION MOLECULE ICAM-4; SIRP-ALPHA; T-CELL; APOPTOTIC CELLS; MARGINAL ZONE; SRC-FAMILY; LYMPH-NODE; B-CELLS; CD47	Sheep red blood cells (SRBCs) have long been used as a model antigen for eliciting systemic immune responses, yet the basis for their adjuvant activity has been unknown. Here, we show that SRBCs failed to engage the inhibitory mouse SIRPa receptor on splenic CD4(+) dendritic cells (DCs), and this failure led to DC activation. Removal of the SIRPa ligand, CD47, from self-RBCs was sufficient to convert them into an adjuvant for adaptive immune responses. DC capture of Cd47(-/-)RBCs and DC activation occurred within minutes in a Src-family-kinase- and CD18-in-tegrin- dependent manner. These findings provide an explanation for the adjuvant mechanism of SRBCs and reveal that splenic DCs survey blood cells for missing self-CD47, a process that might contribute to detecting and mountingimmune responses against pathogen-infected RBCs.	[Yi, Tangsheng; Li, Jianhua; Chen, Hsin; Wu, Jiaxi; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Yi, Tangsheng; Li, Jianhua; Chen, Hsin; Wu, Jiaxi; An, Jinping; Xu, Ying; Cyster, Jason G.] Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Hu, Yongmei; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Wu, Jiaxi/K-3322-2016	Wu, Jiaxi/0000-0002-6976-4784; Li, Jianhua/0000-0001-7329-5688	Cancer Research Institute; NIH [AI40098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI113272, R01AI065495, R01AI068150, R01AI040098] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Gregory Barton and Lewis Lanier for mice, Martin Bachmann for VLPs, Carl Gahmberg for 1A1 anti-ICAM4 antibody, Manikandan Subramanian, Ira Tabas, and Joachim Herz for Lrp1<SUP>fl/fl</SUP> Itgax-Cre<SUP>+</SUP> bone marrow, Neil Barclay, Lai Shan Kwong, and Chris Garcia for the B6 Sirp alpha reagents, and Robert Horton and Erick Lu for help with RNA-seq analysis and data deposition. T.Y. was a recipient of an Irvington postdoctoral fellowship from the Cancer Research Institute. J.G.C. is an investigator of the Howard Hughes Medical Institute. The work was supported in part by a grant from the NIH (AI40098).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; BAILLY P, 1994, P NATL ACAD SCI USA, V91, P5306, DOI 10.1073/pnas.91.12.5306; Bailly P, 1995, EUR J IMMUNOL, V25, P3316, DOI 10.1002/eji.1830251217; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Balkow S, 2010, BLOOD, V116, P1885, DOI 10.1182/blood-2009-05-224428; Banerjee R, 2015, P NATL ACAD SCI USA, V112, P3062, DOI 10.1073/pnas.1418144112; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Cartron JP, 2008, TRANSFUS CLIN BIOL, V15, P39, DOI 10.1016/j.tracli.2008.05.001; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; De Trez C, 2005, J IMMUNOL, V175, P839, DOI 10.4049/jimmunol.175.2.839; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gilson CR, 2009, TRANSFUSION, V49, P1546, DOI 10.1111/j.1537-2995.2009.02173.x; Hagnerud S, 2006, J IMMUNOL, V176, P5772, DOI 10.4049/jimmunol.176.10.5772; Hendrickson JE, 2010, TRANSFUSION, V50, P642, DOI 10.1111/j.1537-2995.2009.02481.x; Hunter P M, 1974, J Immunol, V113, P830; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; JERNE NK, 1963, SCIENCE, V140, P405, DOI 10.1126/science.140.3565.405; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; Kwong LS, 2014, IMMUNOLOGY, V143, P61, DOI 10.1111/imm.12290; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lee G, 2003, BLOOD, V101, P1790, DOI 10.1182/blood-2002-08-2529; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lv ZY, 2015, J IMMUNOL, V195, P661, DOI 10.4049/jimmunol.1401719; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Nilsson A, 2012, BIOCHEM BIOPH RES CO, V417, P1304, DOI 10.1016/j.bbrc.2011.12.137; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Scott CL, 2014, EUR J IMMUNOL, V44, P3658, DOI 10.1002/eji.201444859; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Stewart A, 2005, TRANSFUSION, V45, P1496, DOI 10.1111/j.1537-2995.2005.00564.x; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; TURNER L, 1995, J IMMUNOL, V155, P2437; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Washio K, 2015, GENES CELLS, V20, P451, DOI 10.1111/gtc.12238; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Zimring JC, 2008, CURR OPIN HEMATOL, V15, P631, DOI 10.1097/MOH.0b013e328313695e	68	72	74	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					764	775		10.1016/j.immuni.2015.08.021	http://dx.doi.org/10.1016/j.immuni.2015.08.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26453377	Green Accepted, Bronze			2022-12-18	WOS:000363478700018
J	Chen, RQ; Belanger, S; Frederick, MA; Li, B; Johnston, RJ; Xiao, NM; Liu, YC; Sharma, S; Peters, B; Rao, A; Crotty, S; Pipkin, ME				Chen, Runqiang; Belanger, Simon; Frederick, Megan A.; Li, Bin; Johnston, Robert J.; Xiao, Nengming; Liu, Yun-Cai; Sharma, Sonia; Peters, Bjoern; Rao, Anjana; Crotty, Shane; Pipkin, Matthew E.			In Vivo RNA Interference Screens Identify Regulators of Antiviral CD4(+) and CD8(+) T Cell Differentiation	IMMUNITY			English	Article							FOLLICULAR HELPER; TRANSCRIPTION FACTORS; IMMUNE-RESPONSES; VIRAL-INFECTION; P-TEFB; MEMORY; EXPRESSION; ELONGATION; EFFECTOR; GENES	Classical genetic approaches to examine the requirements of genes for T cell differentiation during infection are time consuming. Here we developed a pooled approach to screen 30-100+ genes individually in separate antigen-specific T cells during infection using short hairpin RNAs in a microRNA context (shRNAmir). Independent screens using T cell receptor (TCR)-transgenic CD4+ and CD8+ T cells responding to lymphocytic choriomeningitis virus (LCMV) identifiedmultiple genes that regulated development of follicular helper (Tfh) and T helper 1 (Th1) cells, and short-lived effector and memory precursor cytotoxic T lymphocytes (CTLs). Both screens revealed roles for the positive transcription elongation factor (P-TEFb) component Cyclin T1 (Ccnt1). Inhibiting expression of Cyclin T1, or its catalytic partner Cdk9, impaired development of Th1 cells and protective short-lived effector CTL and enhanced Tfh cell and memory precursor CTL formation in vivo. This pooled shRNA screening approach should have utility in numerous immunological studies.	[Chen, Runqiang; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Chen, Runqiang; Belanger, Simon; Li, Bin; Johnston, Robert J.; Peters, Bjoern; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Chen, Runqiang; Frederick, Megan A.; Pipkin, Matthew E.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Xiao, Nengming; Liu, Yun-Cai; Sharma, Sonia] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Scripps Research Institute; La Jolla Institute for Immunology	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@lji.org; mpipkin@scripps.edu	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; Pipkin, Matthew/0000-0002-9688-0190; Chen, Runqiang/0000-0002-6997-495X; Frederick, Megan/0000-0002-3808-8744; LIU, YUN-CAI/0000-0002-0996-7109	NIH [RC4 AI092763, R01 AI095634, R01 CA42471, R01 072543, U19 AI109976]; Frenchmen's Creek Women for Cancer Research; Fonds de la recherche sante Quebec; NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072543, R01AI063107, R01AI040127, R01AI109842, UM1AI100663, U19AI109976, R01AI095634, RC4AI092763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frenchmen's Creek Women for Cancer Research; Fonds de la recherche sante Quebec; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants RC4 AI092763 to M.E.P., R.C., S.S., B.P., and A.R.; NIH R01 AI095634 to M.E.P.; NIH R01 CA42471 to A.R.; NIH R01 072543 to S.C.; NIH U19 AI109976 to S.C. and M.E.P.; Frenchmen's Creek Women for Cancer Research to R.C.; and a Postdoctoral Training Award from the Fonds de la recherche sante Quebec to S.B. We thank G. Martinez for advice and assistance.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pipkin ME, 2009, CELL, V138, P606, DOI 10.1016/j.cell.2009.07.020; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Vahedi G, 2013, IMMUNOLOGY, V139, P294, DOI 10.1111/imm.12113; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	46	72	73	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					325	338		10.1016/j.immuni.2014.08.002	http://dx.doi.org/10.1016/j.immuni.2014.08.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148027	Green Accepted, Bronze			2022-12-18	WOS:000341455300018
J	Izawa, K; Yamanishi, Y; Maehara, A; Takahashi, M; Isobe, M; Ito, S; Kaitani, A; Matsukawa, T; Matsuoka, T; Nakahara, F; Oki, T; Kiyonari, H; Abe, T; Okumura, K; Kitamura, T; Kitaura, J				Izawa, Kumi; Yamanishi, Yoshinori; Maehara, Akie; Takahashi, Mariko; Isobe, Masamichi; Ito, Shinichi; Kaitani, Ayako; Matsukawa, Toshihiro; Matsuoka, Takayuki; Nakahara, Fumio; Oki, Toshihiko; Kiyonari, Hiroshi; Abe, Takaya; Okumura, Ko; Kitamura, Toshio; Kitaura, Jiro			The Receptor LMIR3 Negatively Regulates Mast Cell Activation and Allergic Responses by Binding to Extracellular Ceramide	IMMUNITY			English	Article							FC-EPSILON-RI; IMMUNOGLOBULIN-LIKE RECEPTORS; AFFINITY IGE RECEPTOR; CMRF-35-LIKE MOLECULE-1; INHIBITORY RECEPTORS; MOUSE; MICE; PHOSPHATIDYLSERINE; IDENTIFICATION; DEGRANULATION	Mast cells (MCs) are key effector cells in allergic reactions. However, the inhibitory mechanism that prevents excessive activation of MCs remains elusive. Here we show that leukocyte mono-immunoglobulin-like receptor 3 (LMIR3; also called CD300f) is a negative regulator of MC activation in vivo. LMIR3 deficiency exacerbated MC-dependent allergic responses in mice, including anaphylaxis, airway inflammation, and dermatitis. Both physical binding and functional reporter assays via an extracellular domain of LMIR3 showed that several extracellular lipids (including ceramide) and lipoproteins were possible ligands for LMIR3. Importantly, MCs were frequently surrounded by extracellular ceramide in vivo. Upon engagement of high-affinity immunoglobulin E receptor, extracellular ceramide-LMIR3 binding inhibited MC activation via immunoreceptor tyrosine-based inhibitory and switch motifs of LMIR3. Moreover, pretreatment with LMIR3-Fc fusion protein or antibody against either ceramide or LMIR3 interfered with this binding in vivo, thereby exacerbating passive cutaneous anaphylaxis. Thus, the interaction between extracellular ceramide and LMIR3 suppressed MC-dependent allergic responses.	[Izawa, Kumi; Yamanishi, Yoshinori; Maehara, Akie; Takahashi, Mariko; Isobe, Masamichi; Ito, Shinichi; Kaitani, Ayako; Matsukawa, Toshihiro; Matsuoka, Takayuki; Nakahara, Fumio; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Signaling,Minato Ku, Tokyo 1088639, Japan; [Izawa, Kumi; Okumura, Ko] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan	University of Tokyo; University of Tokyo; Juntendo University; RIKEN	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021; Kiyonari, Hiroshi/N-7936-2015; Matsukawa, Toshihiro/A-4194-2016	Nakahara, Fumio/0000-0003-1515-8284; Matsukawa, Toshihiro/0000-0003-2371-3778	Ministry of Education, Science, Technology, Sports and Culture, Japan	Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Arase (Osaka University) and N. Matsumoto (The University of Tokyo) for providing plasmids. We also thank S. Yamasaki and T. Saito (RIKEN Research Center for Allergy and Immunology) for providing the cell lines. We thank H. Kawahara for technical assistance (The University of Tokyo). We are grateful to D. Wylie for excellent language support. This study was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture, Japan.	BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Daheshia M, 2001, J EXP MED, V194, P227, DOI 10.1084/jem.194.2.227; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Heringdorf DMZ, 2002, BBA-MOL CELL BIOL L, V1582, P178, DOI 10.1016/S1388-1981(02)00154-3; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kang JS, 2007, INT IMMUNOPHARMACOL, V7, P1589, DOI 10.1016/j.intimp.2007.08.009; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Taube C, 2004, J IMMUNOL, V172, P6398, DOI 10.4049/jimmunol.172.10.6398; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Xi H, 2010, J EXP MED, V207, P7, DOI 10.1084/jem.20091508; Xiao WB, 2011, IMMUNITY, V34, P893, DOI 10.1016/j.immuni.2011.04.010; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	38	72	75	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					827	839		10.1016/j.immuni.2012.08.018	http://dx.doi.org/10.1016/j.immuni.2012.08.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23123064	Bronze			2022-12-18	WOS:000311460000010
J	Zikherman, J; Jenne, C; Watson, S; Doan, K; Raschke, W; Goodnow, CC; Weiss, A				Zikherman, Julie; Jenne, Craig; Watson, Susan; Doan, Kristin; Raschke, William; Goodnow, Christopher C.; Weiss, Arthur			CD45-Csk Phosphatase-Kinase Titration Uncouples Basal and Inducible T Cell Receptor Signaling during Thymic Development	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SRC-FAMILY KINASES; THYMOCYTE DEVELOPMENT; TCR-ZETA; CD4(+)CD8(+) THYMOCYTES; NEGATIVE REGULATION; ADAPTER PROTEIN; TRANSGENIC MICE; B-CELL; CD45-DEFICIENT MICE	The kinase-phosphatase pair Csk and CD45 reciprocally regulate phosphorylation of the inhibitory tyrosine of the Src family kinases Lck and Fyn. T cell receptor (TCR) signaling and thymic development require CD45 expression but proceed constitutively in the absence of Csk. Here, we show that relative titration of CD45 and Csk expression reveals distinct regulation of basal and inducible TCR signaling during thymic development. Low CD45 expression is sufficient to rescue inducible TCR signaling and positive selection, whereas high expression is required to reconstitute basal TCR signaling and beta selection. CD45 has a dual positive and negative regulatory role during inducible but not basal TCR signaling. By contrast, Csk titration regulates basal but not inducible signaling. High physiologic expression of CD45 is thus required for two reasons to downmodulate inducible TCR signaling during positive selection and to counteract Csk during basal TCR signaling.	[Zikherman, Julie; Doan, Kristin; Weiss, Arthur] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA; [Zikherman, Julie; Doan, Kristin; Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Zikherman, Julie; Doan, Kristin; Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Jenne, Craig; Watson, Susan] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Doan, Kristin; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Raschke, William] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Raschke, William] Virogenics Inc, San Diego, CA 92104 USA; [Goodnow, Christopher C.] Australian Natl Univ, John Curtin Sch Med Res, Australian Phen Facil, Canberra, ACT 2601, Australia	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Australian National University; John Curtin School of Medical Research	Weiss, A (corresponding author), Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155; Zikherman, Julie/0000-0002-0873-192X	Arthritis Foundation; ACR Rheumatology Investigator Award; National Institutes of Health (NIH) [RO1 AI174847, RO1 AI152127, P01 AI135297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847, P01AI035297, R01AI052127, U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR059723] Funding Source: NIH RePORTER	Arthritis Foundation; ACR Rheumatology Investigator Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank A. Roque for assistance with animal husbandry, N. Killeen and M. Hermiston for critical reading of the manuscript, and members of the Weiss lab for helpful discussions. We would like to thank P. Soriano and T. Mak for providing valuable mice used in these studies. We are grateful to of the lightning polymorphism. This work was supported by an Arthritis Foundation Postdoctoral Grant to J.Z.; an ACR Rheumatology Investigator Award to J.Z.; National Institutes of Health (NIH) RO1 AI174847 held by J. Oyster to C.J.; NIH RO1 AI152127 to C.G.; and NIH P01 AI135297 to A.W.	APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Becker AM, 2007, J IMMUNOL, V178, P4120, DOI 10.4049/jimmunol.178.7.4120; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CALNAN BJ, 1995, IMMUNITY, V3, P273; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Gomez M, 2001, IMMUNITY, V15, P703, DOI 10.1016/S1074-7613(01)00235-7; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2005, IMMUNITY, V23, P635, DOI 10.1016/j.immuni.2005.11.001; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kozieradzki I, 1997, J IMMUNOL, V158, P3130; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Mamchak AA, 2008, J IMMUNOL, V181, P5374, DOI 10.4049/jimmunol.181.8.5374; McNeill L, 2004, IMMUNOL LETT, V92, P125, DOI 10.1016/j.imlet.2003.10.018; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Panchal RG, 2009, CELL HOST MICROBE, V6, P162, DOI 10.1016/j.chom.2009.07.003; Panchal RG, 2009, J BIOL CHEM, V284, P12874, DOI 10.1074/jbc.M809633200; Pingel S, 1999, EUR J IMMUNOL, V29, P2376; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; Salmond RJ, 2008, INT IMMUNOL, V20, P819, DOI 10.1093/intimm/dxn040; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Seavitt JR, 1999, MOL CELL BIOL, V19, P4200; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Stone JD, 1997, J IMMUNOL, V158, P5773; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Virts EL, 2003, BLOOD, V101, P849, DOI 10.1182/blood-2002-07-1969; Wallace VA, 1997, J IMMUNOL, V158, P3205; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	60	72	73	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					342	354		10.1016/j.immuni.2010.03.006	http://dx.doi.org/10.1016/j.immuni.2010.03.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20346773	Bronze, Green Accepted			2022-12-18	WOS:000276125400008
J	Kuhns, MS; Davis, MM				Kuhns, Michael S.; Davis, Mark M.			Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling	IMMUNITY			English	Article							BETA FG LOOP; ANTIGEN RECEPTOR; CRYSTAL-STRUCTURE; SURFACE EXPRESSION; IMMUNOGLOBULIN FOLD; MONOCLONAL-ANTIBODY; LIGAND RECOGNITION; NEGATIVE SELECTION; STRUCTURAL BASIS; CLASS-II	The alpha beta T cell antigen receptor (TCR), in complex with the CD3 delta epsilon, gamma epsilon, and zeta zeta signaling subunits, is the chief determinant for specific CD4(+) and CD8(+) T cell responses to self and foreign antigens. Although transmembrane domain charge interactions are critical for the assembly of the complex, the location of extracellular contacts between the TCR and CD3 subunits and their contributions to stability and signal transduction have not been defined. Here we used mutagenesis to demonstrate that the CD3 delta epsilon and CD3 gamma epsilon, subunits interact with the TCR via adjacent C alpha DE and C beta CC' loops, respectively. The TCR-CD3 delta epsilon interactions helped stabilize CD3 gamma epsilon within the complex and were important for normal T cell and thymocyte responses to TCR engagement. These data demonstrate that extracellular TCR-CD3 subunit interactions contribute to the structural integrity and function of this multisubunit receptor.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu		Davis, Mark/0000-0001-6868-657X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Chatenoud L, 2005, CURR OPIN IMMUNOL, V17, P632, DOI 10.1016/j.coi.2005.09.011; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Karaivanova V, 1999, HYBRIDOMA, V18, P497; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; KUPFER A, 1988, P NATL ACAD SCI USA, V85, P8216, DOI 10.1073/pnas.85.21.8216; LEW AM, 1987, J IMMUNOL, V138, P807; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; MORLEY BJ, 1988, J EXP MED, V168, P1971, DOI 10.1084/jem.168.6.1971; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	72	76	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2007	26	3					357	369		10.1016/j.immuni.2007.01.015	http://dx.doi.org/10.1016/j.immuni.2007.01.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17368054	Bronze			2022-12-18	WOS:000245228100012
J	Datta, SK; Okamoto, S; Hayashi, T; Shin, SS; Mihajlov, I; Fermin, A; Guiney, DG; Fierer, J; Raz, E				Datta, Sandip K.; Okamoto, Sharon; Hayashi, Tomoko; Shin, Samuel S.; Mihajlov, Ivan; Fermin, Agnes; Guiney, Donald G.; Fierer, Joshua; Raz, Eyal			Vaccination with irradiated Listeria induces protective T cell immunity	IMMUNITY			English	Article							SCRUB TYPHUS IMMUNOGENS; MYELOID DIFFERENTIATION FACTOR-88; TOLL-LIKE RECEPTORS; CROSS-PRESENTATION; MEDIATED-IMMUNITY; DENDRITIC CELLS; MONOCYTOGENES INFECTION; BACTERIAL-INFECTION; CUTTING EDGE; BONE-MARROW	We evaluated gamma-irradiated Listeria monocytogenes as a killed bacterial vaccine, testing the hypothesis that irradiation preserves antigenic and adjuvant structures destroyed by traditional heat or chemical inactivation. Irradiated Listeria monocytogenes (I-M), unlike heat-killed LM, efficiently activated dendritic cells via Toll-like receptors and induced protective T cell responses in mice. Like live LM, irradiated LM induced Toll-like-receptor-independent T cell priming. Cross-presentation of irradiated listerial antigens to CD8(+) T cells involved TAP- and proteasome-dependent cytosolic antigen processing. These results establish that killed LM can induce protective T cell responses, previously thought to require live infection. gamma-irradiation may be potentially applied to numerous bacterial vaccine candidates, and irradiated bacteria could serve as a vaccine platform for recombinant antigens derived from other pathogens, allergens, or tumors.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; San Diego Vet Affairs Med Ctr, Dept Med, San Diego, CA 92161 USA	University of California System; University of California San Diego	Datta, SK (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sdatta@ucsd.edu	, jfierer/W-2823-2019	Datta, Sandip/0000-0003-0243-7815	NIAID NIH HHS [AI052406, AI040682, AI056453, AI058743] Funding Source: Medline; NIAMS NIH HHS [P30 AR47360] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI052406, R01AI058743, P01AI040682, U01AI056453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047360] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Bain RK, 1999, INT J PARASITOL, V29, P185, DOI 10.1016/S0020-7519(98)00187-8; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1023; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; EISENBERG GHG, 1978, INFECT IMMUN, V22, P80, DOI 10.1128/IAI.22.1.80-86.1978; EISENBERG GHG, 1979, INFECT IMMUN, V26, P131, DOI 10.1128/IAI.26.1.131-136.1979; Foster PL, 2005, MUTAT RES-FUND MOL M, V569, P3, DOI 10.1016/j.mrfmmm.2004.07.017; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; JERRELLS TR, 1983, INFECT IMMUN, V39, P262, DOI 10.1128/IAI.39.1.262-269.1983; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kursar M, 2004, J IMMUNOL, V172, P3167, DOI 10.4049/jimmunol.172.5.3167; Kursar M, 2004, INT IMMUNOL, V16, P415, DOI 10.1093/intimm/dxh047; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Posfay-Brabe KM, 2004, PEDIATR REV, V25, P151, DOI 10.1542/pir.25-5-151; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Stewart GR, 2004, CURR OPIN IMMUNOL, V16, P506, DOI 10.1016/j.coi.2004.05.007; Szalay G, 1995, P NATL ACAD SCI USA, V92, P12389, DOI 10.1073/pnas.92.26.12389; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vijh S, 1997, J IMMUNOL, V158, P3366; VONKOENIG CHW, 1982, NATURE, V297, P233, DOI 10.1038/297233a0; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533	40	72	79	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					143	152		10.1016/j.immuni.2006.05.013	http://dx.doi.org/10.1016/j.immuni.2006.05.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860763	Bronze			2022-12-18	WOS:000239713000017
J	Stork, B; Engelke, M; Frey, J; Horejsi, V; Hamm-Baarke, A; Schraven, B; Kurosaki, T; Wienands, J				Stork, B; Engelke, M; Frey, J; Horejsi, V; Hamm-Baarke, A; Schraven, B; Kurosaki, T; Wienands, J			Grb2 and the non-T cell activation linker NTAL constitute a Ca2+-regulating signal circuit in B lymphocytes	IMMUNITY			English	Article							ANTIGEN RECEPTOR; PHOSPHOLIPASE C-GAMMA-2; NEGATIVE REGULATION; TYROSINE KINASE; MEMBRANE RAFTS; SH2 DOMAIN; PROTEIN; BLNK; ADAPTERS; PHOSPHORYLATION	Activation of the B cell antigen receptor triggers phosphorylation of cytoplasmic and transmembrane adaptor proteins such as SLP-65 and NTAL, respectively. Specific phosphoacceptor sites in SLP-65 serve as docking sites for Ca2+-mobilizing enzymes Btk and PLC-gamma2. Phosphorylated NTAL recruits the Grb2 linker, but downstream signaling cascades are unclear. We now show that receptor-induced tyrosine phosphorylation of NTAL and concomitant Grb2 complex formation critically modulate the Ca2+ response without affecting SLP-65 and PLC-gamma2 phosphorylation. Grb2 turned out to play a negative regulatory role, which appears to be eliminated upon binding to NTAL. This allows for a sustained release of intracellular Ca2+ and is mandatory for subsequent entry of Ca2+ from extracellular sources. Thus, elevation of Ca2+ is regulated by at least two signaling modules, the B cell-specific Ca2+ initiation complex comprising SLP-65, Btk, and PLC-gamma2 and the more ubiquitously expressed NTAL/Grb2 complex, which acts as an amplifier by switching off inhibitory elements.	Univ Bielefeld, Dept Biochem 2, D-33615 Bielefeld, Germany; Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague 4, Czech Republic; Otto Von Guericke Univ, Inst Immunol, D-39120 Magdeburg, Germany; RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan; Univ Bielefeld, Dept Biol & Mol Immunol, D-33615 Bielefeld, Germany	University of Bielefeld; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Otto von Guericke University; RIKEN; Kansai Medical University; University of Bielefeld	Wienands, J (corresponding author), Univ Goetting, Dept Cellular & Mol Immunol, Kreuzbergring 57, D-37075 Goetting, Germany.	jwienan@uni-goettingen.de	Kurosaki, Tomohiro/D-1306-2009; Stork, Björn/C-2160-2011; Horejsi, Vaclav/G-3113-2014; Engelke, Michael/A-6612-2013	Kurosaki, Tomohiro/0000-0002-6352-304X; Stork, Björn/0000-0002-4167-7806; Horejsi, Vaclav/0000-0003-4925-0142; 				Adachi T, 2001, J BIOL CHEM, V276, P26648, DOI 10.1074/jbc.M100997200; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GOISUKA R, 1998, J IMMUNOL, V161, P5804; Harmer SL, 1999, J BIOL CHEM, V274, P12183, DOI 10.1074/jbc.274.17.12183; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Ishiai M, 1999, J IMMUNOL, V163, P1746; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Janssen E, 2004, J IMMUNOL, V172, P6810, DOI 10.4049/jimmunol.172.11.6810; Jefferson AB, 1997, J BIOL CHEM, V272, P5983, DOI 10.1074/jbc.272.9.5983; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; Kim CH, 1999, J CLIN INVEST, V104, P1751, DOI 10.1172/JCI7310; Koncz G, 2002, IMMUNOL LETT, V82, P41, DOI 10.1016/S0165-2478(02)00017-2; Koonpaew S, 2004, J BIOL CHEM, V279, P11229, DOI 10.1074/jbc.M311394200; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Leo A, 2002, J CLIN INVEST, V109, P301; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PENNELL CA, 1985, P NATL ACAD SCI USA, V82, P3799, DOI 10.1073/pnas.82.11.3799; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; VANDENHERIKOUDIJK IE, 1994, J IMMUNOL, V152, P574; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Yablonski D, 2001, ADV IMMUNOL, V79, P93, DOI 10.1016/S0065-2776(01)79003-7; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	45	72	77	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					681	691		10.1016/j.immuni.2004.09.007	http://dx.doi.org/10.1016/j.immuni.2004.09.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539154	Bronze			2022-12-18	WOS:000225365000009
J	Vines, CM; Potter, JW; Xu, Y; Geahlen, RL; Costello, PS; Tybulewicz, VL; Lowell, CA; Chang, PW; Gresham, HD; Willman, CL				Vines, CM; Potter, JW; Xu, Y; Geahlen, RL; Costello, PS; Tybulewicz, VL; Lowell, CA; Chang, PW; Gresham, HD; Willman, CL			Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; ACTIVATION LOOP TYROSINES; B-CELL DEVELOPMENT; C-FGR; ANTIGEN RECEPTOR; MEDIATED PHAGOCYTOSIS; VASCULAR ENDOTHELIUM; HUMAN NEUTROPHILS; IN-VIVO; PHOSPHORYLATION	While beta2 integrin ligand-receptor recognition interactions are well characterized, less is known about how these events trigger signal transduction cascades to regulate the transition from tethering to firm adhesion, spreading, and transendothelial migration. We have identified critical positive and negative regulatory components of this cascade in monocytes. Whereas the Syk tyrosine kinase is essential for beta2 integrin signaling and cell spreading, the Src family kinase Fgr is a negative regulator of this pathway. Fgr selectively inhibits beta2 but not beta1 integrin signaling and Syk kinase function via a direct association between the Fgr SH2 domain and Syk tyrosine Y342. The inhibitory effects of Fgr are independent of its kinase activity, are dose dependent, and can be overcome by chemokines and inflammatory mediators.	Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Canc Res Facil, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Natl Inst Med Res, London NW7 1AA, England; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of New Mexico; University of New Mexico; University of New Mexico; Purdue University System; Purdue University; Purdue University West Lafayette Campus; MRC National Institute for Medical Research; University of California System; University of California San Francisco	Willman, CL (corresponding author), Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA.			Tybulewicz, Victor/0000-0003-2439-0798; Geahlen, Robert/0000-0001-8400-2924	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043042, P01DK050267] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54467] Funding Source: Medline; NIDDK NIH HHS [DK50267, DK43042] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGARWAL A, 1993, J BIOL CHEM, V268, P15900; BERTON G, 1994, J CELL BIOL, V126, P1111, DOI 10.1083/jcb.126.4.1111; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; CORNALL R, 1997, IMMUNOLOGY, V8, P497; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; DARBY C, 1994, J IMMUNOL, V152, P5429; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; Gresham HD, 2000, J EXP MED, V191, P515, DOI 10.1084/jem.191.3.515; GUTKIND JS, 1989, P NATL ACAD SCI USA, V86, P8783, DOI 10.1073/pnas.86.22.8783; HAMADA F, 1993, P NATL ACAD SCI USA, V90, P6305, DOI 10.1073/pnas.90.13.6305; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; KIENER PA, 1993, J BIOL CHEM, V268, P24442; LIN TH, 1995, J BIOL CHEM, V270, P16189, DOI 10.1074/jbc.270.27.16189; LINK DC, 1995, BLOOD, V85, P472; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mocsai A, 1999, J IMMUNOL, V162, P1120; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Neeson PJ, 2000, J LEUKOCYTE BIOL, V67, P847, DOI 10.1002/jlb.67.6.847; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Suen PW, 1999, J CELL SCI, V112, P4067; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; WELDER CA, 1993, J IMMUNOL, V150, P2203; WILLMAN CL, 1987, P NATL ACAD SCI USA, V84, P4480, DOI 10.1073/pnas.84.13.4480; WILLMAN CL, 1991, BLOOD, V77, P726; Yan SR, 1997, J IMMUNOL, V158, P1902; YI TL, 1989, ONCOGENE, V4, P1081; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366	54	72	76	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					507	519		10.1016/S1074-7613(01)00221-7	http://dx.doi.org/10.1016/S1074-7613(01)00221-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672534	Bronze			2022-12-18	WOS:000171757800003
J	Galandrini, R; Henning, SW; Cantrell, DA				Galandrini, R; Henning, SW; Cantrell, DA			Different functions of the GTPase Rho in prothymocytes and late pre-T cells	IMMUNITY			English	Article							DEFECTIVE LYMPHOID DEVELOPMENT; RECEPTOR-GAMMA CHAIN; MICE LACKING JAK3; THYMOCYTE DIFFERENTIATION; INTERLEUKIN-7 RECEPTOR; NEGATIVE SELECTION; DEFICIENT MICE; CONTROL POINTS; ALPHA-BETA; EXPRESSION	Mice lacking thymic function of the GTPase Rho show severe defects in fetal and adult thymopoiesis. Rho(-) thymi are deficient in CD44(+)CD25(+) pro-T cells and CD44(-)CD25(+) early pre-T cells because Rho function is required for survival but not G1/S phase cell cycle progression in these populations. The selective apoptosis defect in Rho(-) prothymocytes can be rescued by expression of a bcl-2 transgene. A second function for Rho is seen in CD44(-)CD25(-) late pre-T cells: Rho regulates cell cycle progression but not survival of this population. These studies show that the critical processes of proliferation and survival are independently regulated during thymopoiesis and establish two different functions for Rho in the development of early thymic progenitors.	IMPERIAL CANC RES FUND, LYMPHOCYTE ACTIVAT LAB, LONDON WC2A 3PX, ENGLAND	Cancer Research UK								ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; AKTORIES K, 1994, MOL CELL BIOCHEM, V138, P167, DOI 10.1007/BF00928459; AKTORIES K, 1995, METHOD ENZYMOL, V256, P185; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHARLENELIAO X, 1995, IMMUNITY, V3, P757; Crompton T, 1997, EUR J IMMUNOL, V27, P100, DOI 10.1002/eji.1830270115; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Dutartre H, 1996, J CELL SCI, V109, P367; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FOXWELL BMJ, 1995, EUR J IMMUNOL, V25, P3041, DOI 10.1002/eji.1830251109; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lalli E, 1996, EMBO J, V15, P528, DOI 10.1002/j.1460-2075.1996.tb00385.x; LANG P, 1995, METHOD ENZYMOL, V256, P320; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Moorman JP, 1996, J IMMUNOL, V156, P4146; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Oosterwegel MA, 1997, IMMUNITY, V6, P351, DOI 10.1016/S1074-7613(00)80337-4; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; ROTHENBERG EV, 1993, J IMMUNOL, V151, P3530; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; VONBOEHMER H, 1992, IMMUNOL TODAY, V13, P454, DOI 10.1016/0167-5699(92)90075-I; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	62	72	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1997	7	1					163	174		10.1016/S1074-7613(00)80519-1	http://dx.doi.org/10.1016/S1074-7613(00)80519-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252129	Bronze			2022-12-18	WOS:A1997XN69300015
J	Shaffer, AL; Peng, A; Schlissel, MS				Shaffer, AL; Peng, A; Schlissel, MS			In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: A model for kappa locus activation	IMMUNITY			English	Article							IMMUNOGLOBULIN GENE-TRANSCRIPTION; LIGATION-MEDIATED PCR; HEAVY-CHAIN; 3'ALPHA ENHANCER; MICE LACKING; V(D)J RECOMBINATION; TARGETED DISRUPTION; PROTEIN-BINDING; CONSTANT REGION; NUCLEAR FACTOR	The immunoglobulin kappa light chain locus has two enhancer elements: the intronic enhancer, which lies between the J kappa cluster and the C kappa exon, and the 3'kappa enhancer, which is located downstream of C kappa. To address the contribution of these elements to the developmentally regulated activation of germline kappa locus transcription and rearrangement, we purified primary pro- and pre-B cells and determined by in vivo footprinting the sites within each enhancer that were occupied. We found that the kappa intronic enhancer NF-kappa B site is occupied in both pro- and pre-B cells, while CRE, BSAP, and PU.1/pip sites within the 3'kappa enhancer undergo changes in occupancy as cells progress from the pro-B to the pre-B cell stage. These findings suggest that regulation of the kappa locus in primary pre-B cells may be mediated by factors that bind the 3'kappa enhancer.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DEPT MOL BIOL & GENET,GRAD PROGRAM IMMUNOL,BALTIMORE,MD 21205	Johns Hopkins University					NHLBI NIH HHS [HL48702] Funding Source: Medline; NIAID NIH HHS [5T32 AI07247] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BLASQUEZ VC, 1993, J BIOL CHEM, V267, P23888; BUSSLINGER M, 1995, CURR OPIN GENET DEV, V5, P595, DOI 10.1016/0959-437X(95)80028-X; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; Costa MW, 1996, BIOCHEMISTRY-US, V35, P8662, DOI 10.1021/bi952801y; DESIDERIO S, 1996, CURR BIOL, V5, P605; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; EMORINE L, 1983, NATURE, V304, P447, DOI 10.1038/304447a0; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; GOODHARDT M, 1989, NUCLEIC ACIDS RES, V17, P7403, DOI 10.1093/nar/17.18.7403; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GRILLI M, 1993, INT REV CYTOL, V143, P1; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; HROMAS R, 1988, NUCLEIC ACIDS RES, V16, P953, DOI 10.1093/nar/16.3.953; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIOU HC, 1993, CURR OPIN CELL BIOL, V5, P447; MAX EE, 1981, J BIOL CHEM, V256, P5116; MEYER KB, 1990, NUCLEIC ACIDS RES, V18, P5609, DOI 10.1093/nar/18.19.5609; MEYER KB, 1994, NUCLEIC ACIDS RES, V22, P1576, DOI 10.1093/nar/22.9.1576; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NELSON KJ, 1985, P NATL ACAD SCI USA, V82, P5305, DOI 10.1073/pnas.82.16.5305; NELSON KJ, 1984, NUCLEIC ACIDS RES, V4, P1911; NEURATH MF, 1995, P NATL ACAD SCI USA, V92, P5336, DOI 10.1073/pnas.92.12.5336; NEURATH MF, 1994, J IMMUNOL, V153, P730; OLTZ EM, 1993, MOL CELL BIOL, V13, P6223, DOI 10.1128/MCB.13.10.6223; PARSLOW TG, 1982, NATURE, V299, P449, DOI 10.1038/299449a0; PICARD D, 1984, NATURE, V307, P80, DOI 10.1038/307080a0; PIERCE JW, 1991, MOL CELL BIOL, V11, P1431, DOI 10.1128/MCB.11.3.1431; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; Roque MC, 1996, MOL CELL BIOL, V16, P3138; SCHANKE JT, 1994, NUCLEIC ACIDS RES, V22, P5425, DOI 10.1093/nar/22.24.5425; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SPOLSKI R, 1988, EUR J IMMUNOL, V18, P295; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; STAUDT LM, 1988, SCIENCE, V241, P577, DOI 10.1126/science.3399892; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x; ZUNIGAPFLUCKER JC, 1993, J EXP MED, V178, P1139, DOI 10.1084/jem.178.4.1139; ZWOLLO P, 1994, J BIOL CHEM, V269, P15310	71	72	79	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					131	143		10.1016/S1074-7613(00)80420-3	http://dx.doi.org/10.1016/S1074-7613(00)80420-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047235	Bronze			2022-12-18	WOS:A1997XC61600003
J	GURISH, MF; PEAR, WS; STEVENS, RL; SCOTT, ML; SOKOL, K; GHILDYAL, N; WEBSTER, MJ; HU, XZ; AUSTEN, KF; BALTIMORE, D; FRIEND, DS				GURISH, MF; PEAR, WS; STEVENS, RL; SCOTT, ML; SOKOL, K; GHILDYAL, N; WEBSTER, MJ; HU, XZ; AUSTEN, KF; BALTIMORE, D; FRIEND, DS			TISSUE-REGULATED DIFFERENTIATION AND MATURATION OF A V-ABL-IMMORTALIZED MAST CELL-COMMITTED PROGENITOR	IMMUNITY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; C-KIT LIGAND; BONE-MARROW; MOLECULAR-CLONING; INFECTED MICE; SERINE PROTEASE; MESSENGER-RNA; SARCOMA-VIRUS; GROWTH-FACTOR; P-CELL	An immature v-abl-transformed mast cell line (VS-MG) was derived from a mouse that developed systemic mastocytosis after transplantation of v-abl-infected bone marrow cells. V3-MCs injected intravenously into adult BALB/c mice infiltrated the liver, spleen, and intestine by day 6 and underwent progressive differentiation and maturation, eventually resembling indigenous mast cells. in terms of their protease content, the V3-MCs that localized in the liver and spleen differed from those in the intestine, and both differed from the cultured V3-MCs. The acquired expression of certain proteases and the loss of expression of other proteases in these tissue V3-MCs defines particular phenotypes and indicates that the differentiation and maturation of mast cell-committed progenitor cells are primarily regulated by factors in the different tissue microenvironments.	BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; ROCKEFELLER UNIV,NEW YORK,NY 10021	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Rockefeller University	GURISH, MF (corresponding author), BRIGHAM & WOMENS HOSP,DEPT RHEUMATOL & IMMUNOL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022346, R01AI023483, R37AI022346, R01AI022531, R37AI022531] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22346, AI-22531, AI-23483] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKSTEAD JH, 1981, BLOOD, V57, P1088; BOENISH T, 1989, IMMUNOLOGICAL STAINI, P11; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DU T, 1994, FASEB J, V8, pA497; EKLUND KK, 1993, J IMMUNOL, V151, P4266; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FRIEND DS, 1995, IN PRESS P ANN M MIC, V53; GHILDYAL N, 1992, J IMMUNOL, V149, P2123; GHILDYAL N, 1992, J BIOL CHEM, V267, P8473; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; GHILDYAL N, 1993, J IMMUNOL, V151, P3206; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; GURISH MF, 1992, J ALLERGY CLIN IMMUN, V89, P309; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; HUNT JE, 1995, BIOLOGICAL AND MOLECULAR ASPECTS OF MAST CELL AND BASOPHIL DIFFERENTIATION AND FUNCTION, P149; HUNTLEY JF, 1990, PARASITE IMMUNOL, V12, P85, DOI 10.1111/j.1365-3024.1990.tb00938.x; IHLE JN, 1983, J IMMUNOL, V131, P282; IRANI AMA, 1994, ALLERGY PROC, V15, P303, DOI 10.2500/108854194778816472; JARBOE DL, 1989, J IMMUNOL, V142, P2405; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; LEFTWICH JA, 1992, J IMMUNOL, V148, P2894; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; MATIN R, 1992, J HISTOCHEM CYTOCHEM, V40, P781, DOI 10.1177/40.6.1588024; MCBRIDE P, 1988, J ALLERGY CLIN IMMUN, V82, P638, DOI 10.1016/0091-6749(88)90977-3; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; NAKAHATA T, 1982, BLOOD, V60, P352; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8396; PIERCE JH, 1985, CELL, V41, P685, DOI 10.1016/S0092-8674(85)80049-0; RAZIN E, 1984, J IMMUNOL, V132, P1479; REIN A, 1985, MOL CELL BIOL, V5, P2257, DOI 10.1128/MCB.5.9.2257; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; REYNOLDS DS, 1989, J BIOL CHEM, V264, P2094; SCHIFFMAKER L, 1986, J VIROL, V57, P1182, DOI 10.1128/JVI.57.3.1182-1186.1986; SCHRADER JW, 1981, P NATL ACAD SCI-BIOL, V78, P323, DOI 10.1073/pnas.78.1.323; SCOTT ML, 1991, P NATL ACAD SCI USA, V88, P6506, DOI 10.1073/pnas.88.15.6506; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SONODA T, 1982, J CELL PHYSIOL, V112, P136, DOI 10.1002/jcp.1041120120; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; Trong H Le, 1989, BIOCHEMISTRY-US, V28, P391, DOI 10.1021/BI00427A054; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; YUNG YP, 1983, J IMMUNOL, V130, P2843	51	72	73	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					175	186		10.1016/1074-7613(95)90087-X	http://dx.doi.org/10.1016/1074-7613(95)90087-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648391	Bronze			2022-12-18	WOS:A1995RR33900003
J	Bergamaschi, L; Mescia, F; Turner, L; Hanson, AL; Kotagiri, P; Dunmore, BJ; Ruffieux, H; De Sa, A; Huhn, O; Morgan, MD; Gerber, PP; Wills, MR; Baker, S; Calero-Nieto, FJ; Doffinger, R; Dougan, G; Elmer, A; Goodfellow, IG; Gupta, RK; Hosmillo, M; Hunter, K; Kingston, N; Lehner, PJ; Matheson, NJ; Nicholson, JK; Petrunkina, AM; Richardson, S; Saunders, C; Thaventhiran, JED; Toonen, EJM; Weekes, MP; Gottgens, B; Toshner, M; Hess, C; Bradley, JR; Lyons, PA; Smith, KGC				Bergamaschi, Laura; Mescia, Federica; Turner, Lorinda; Hanson, Aimee L.; Kotagiri, Prasanti; Dunmore, Benjamin J.; Ruffieux, Helene; De Sa, Aloka; Huhn, Oisin; Morgan, Michael D.; Gerber, Pehuen Pereyra; Wills, Mark R.; Baker, Stephen; Calero-Nieto, Fernando J.; Doffinger, Rainer; Dougan, Gordon; Elmer, Anne; Goodfellow, Ian G.; Gupta, Ravindra K.; Hosmillo, Myra; Hunter, Kelvin; Kingston, Nathalie; Lehner, Paul J.; Matheson, Nicholas J.; Nicholson, Jeremy K.; Petrunkina, Anna M.; Richardson, Sylvia; Saunders, Caroline; Thaventhiran, James E. D.; Toonen, Erik J. M.; Weekes, Michael P.; Gottgens, Berthold; Toshner, Mark; Hess, Christoph; Bradley, John R.; Lyons, Paul A.; Smith, Kenneth G. C.			Longitudinal analysis reveals that delayed bystander CD8(+) T cell activation and early immune pathology distinguish severe COVID-19 from mild disease	IMMUNITY			English	Article							ENRICHMENT ANALYSIS; INTERFERON; EXPRESSION; INNATE; PROLIFERATION; INDUCTION; INFECTION; RESPONSES; COGNATE; NKG2D	The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously assessed. Using immunophenotyping, RNA sequencing, and serum cytokine analysis, we analyzed serial samples from 207 SARS-CoV2-infected individuals with a range of disease severities over 12 weeks from symptom onset. An early robust bystander CD8(+) T cell immune response, without systemic inflammation, characterized asymptomatic or mild disease. Hospitalized individuals had delayed bystander responses and systemic inflammation that was already evident near symptom onset, indicating that immunopathology may be inevitable in some individuals. Viral load did not correlate with this early pathological response but did correlate with subsequent disease severity. Immune recovery is complex, with profound persistent cellular abnormalities in severe disease correlating with altered inflammatory responses, with signatures associated with increased oxidative phosphorylation replacing those driven by cytokines tumor necrosis factor (TNF) and interleukin (IL)-6. These late immunometabolic and immune defects may have clinical implications.	[Bergamaschi, Laura; Mescia, Federica; Turner, Lorinda; Hanson, Aimee L.; Kotagiri, Prasanti; De Sa, Aloka; Gerber, Pehuen Pereyra; Wills, Mark R.; Baker, Stephen; Dougan, Gordon; Gupta, Ravindra K.; Hunter, Kelvin; Lehner, Paul J.; Matheson, Nicholas J.; Petrunkina, Anna M.; Thaventhiran, James E. D.; Weekes, Michael P.; Hess, Christoph; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Jeffrey Cheah Biomed Ctr, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge CB2 0AW, England; [Bergamaschi, Laura; Mescia, Federica; Turner, Lorinda; Hanson, Aimee L.; Kotagiri, Prasanti; Dunmore, Benjamin J.; De Sa, Aloka; Huhn, Oisin; Gerber, Pehuen Pereyra; Wills, Mark R.; Baker, Stephen; Dougan, Gordon; Gupta, Ravindra K.; Hunter, Kelvin; Lehner, Paul J.; Matheson, Nicholas J.; Petrunkina, Anna M.; Thaventhiran, James E. D.; Toshner, Mark; Hess, Christoph; Bradley, John R.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Ruffieux, Helene; Richardson, Sylvia] Univ Cambridge, MRC Biostat Unit, Cambridge Biomed Campus, Cambridge CB2 0SR, England; [Morgan, Michael D.] Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Morgan, Michael D.] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England; [Calero-Nieto, Fernando J.; Gottgens, Berthold] Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge CB2 0AW, England; [Doffinger, Rainer] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge CB2 0QQ, England; [Elmer, Anne; Saunders, Caroline] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Clin Res Ctr, NIHR Clin Res Facil, Cambridge CB2 0QQ, England; [Goodfellow, Ian G.; Hosmillo, Myra] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 0QQ, England; [Kingston, Nathalie] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Kingston, Nathalie; Bradley, John R.] Cambridge Univ Hosp NHS Fdn, NIHR BioResource, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Matheson, Nicholas J.] NHS Blood & Transplant, Cambridge, England; [Nicholson, Jeremy K.] Murdoch Univ, Australian Natl Phenome Ctr, Ctr Computat & Syst Med, Hlth Futures Inst, Murdoch, WA 6150, Australia; [Thaventhiran, James E. D.] Univ Cambridge, Sch Biol Sci, MRC Toxicol Unit, Cambridge CB2 1QR, England; [Toonen, Erik J. M.] Hycult Biotech, R&D Dept, NL-5405 PD Uden, Netherlands; [Toshner, Mark] Heart & Lung Res Inst, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Toshner, Mark] Royal Papworth Hosp NHS Fdn Trust, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Hess, Christoph] Univ Basel, Dept Biomed, CH-4031 Basel, Switzerland; [Hess, Christoph] Univ Hosp Basel, CH-4031 Basel, Switzerland; [Hess, Christoph] Univ Basel, Botnar Res Ctr Child Hlth BRCCH, CH-4058 Basel, Switzerland; [Hess, Christoph] Swiss Fed Inst Technol, CH-4058 Basel, Switzerland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; European Molecular Biology Laboratory (EMBL); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Murdoch University; University of Cambridge; Papworth Hospital; University of Basel; University of Basel; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lyons, PA; Smith, KGC (corresponding author), Univ Cambridge, Jeffrey Cheah Biomed Ctr, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge CB2 0AW, England.; Lyons, PA; Smith, KGC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.	pal34@cam.ac.uk; kgcs2@cam.ac.uk	Bunclark, Katherine/GLN-3109-2022; Coudert, Jerome D/B-2628-2008; Toonen, Erik/G-7337-2015; Nicholson, Jeremy K/B-3395-2012; Summers, Charlotte/A-6973-2012; Morgan, Michael/A-4840-2015	Bunclark, Katherine/0000-0002-8785-0715; Coudert, Jerome D/0000-0001-6081-8494; Nicholson, Jeremy K/0000-0002-8123-8349; de Sa, Aloka/0000-0002-7714-8906; Summers, Charlotte/0000-0002-7269-2873; Ruffieux, Helene/0000-0002-7113-2540; Kingston, Nathalie/0000-0002-9190-2231; Walker, Neil/0000-0001-9796-7688; Kotagiri, Prasanti/0000-0002-9806-4349; Hanson, Aimee Lee/0000-0002-0231-8771; Morgan, Michael/0000-0003-0757-0711; Mescia, Federica/0000-0002-2759-4027	CVC Capital Partners, the Evelyn Trust [20/75]; Addenbrooke's Charitable Trust, Cambridge University Hospitals [12/20A]; NIHR Cambridge Biomedical Research Centre; UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC); Wellcome Investigator Award [200871/Z/16/Z]; Wellcome Senior Clinical Research Fellowship [108070/Z/15/Z]; Wellcome [207498/Z/17/Z]; Fondation Botnar; MRC (CSF) [MR/P008801/1]; NHSBT [WPA15-02]; Addenbrooke's Charitable Trust [900239]; Wellcome Senior Fellowship; Wellcome Trust Principal Research Fellowship [084957/Z/08/Z]; MRC [MR/V011561/1]; Spinnaker Healthcare Research Trust; McCusker Foundation, Australian National Phenome Centre; Jacquot Research Entry Scholarship of the Royal Australasian College of Physicians Foundation; MRC Clinical Infrastructure Award	CVC Capital Partners, the Evelyn Trust; Addenbrooke's Charitable Trust, Cambridge University Hospitals; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC)(UK Research & Innovation (UKRI)); Wellcome Investigator Award; Wellcome Senior Clinical Research Fellowship; Wellcome; Fondation Botnar; MRC (CSF)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHSBT; Addenbrooke's Charitable Trust; Wellcome Senior Fellowship; Wellcome Trust Principal Research Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spinnaker Healthcare Research Trust; McCusker Foundation, Australian National Phenome Centre; Jacquot Research Entry Scholarship of the Royal Australasian College of Physicians Foundation; MRC Clinical Infrastructure Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the patients and health care workers who consented to take part in this study. We are grateful to CVC Capital Partners, the Evelyn Trust (20/75), Addenbrooke's Charitable Trust, Cambridge University Hospitals (12/20A), the NIHR Cambridge Biomedical Research Centre, and the UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC) for their financial support. Further support: K.G.C.S.: Wellcome Investigator Award (200871/Z/16/Z); M.P.W.: Wellcome Senior Clinical Research Fellowship (108070/Z/15/Z); C.H.: Wellcome COVID-19 Rapid Response DCF and the Fondation Botnar; N.M.: MRC (CSF MR/P008801/1), NHSBT (WPA15-02), and Addenbrooke's Charitable Trust, (grant ref. to 900239 NJM); I.G.G.: Wellcome Senior Fellowship and Wellcome grant (Ref: 207498/Z/17/Z); P.J.L.: Wellcome Trust Principal Research Fellowship (084957/Z/08/Z) and MRC (MR/V011561/1); J.K.N.: The Spinnaker Healthcare Research Trust and the McCusker Foundation as part of Australian National Phenome Centre. P.K. is the recipient of a Jacquot Research Entry Scholarship of the Royal Australasian College of Physicians Foundation. We would like to thank the NIHR Cambridge Clinical Research Facility outreach team for enrollment of patients; the NIHR Cambridge Biomedical Research Centre Cell Phenotyping Hub and the CRUK Cambridge Institute flow cytometry core facility for flow and mass cytometry; and the Cambridge NIHR BRC Stratified Medicine Core Laboratory NGS Hub (supported by an MRC Clinical Infrastructure Award) for RNA sequencing.	Akbari P., 2020, GENETIC ANAL BLOOD C, DOI [10.1101/2020.01.30.927483, DOI 10.1101/2020.01.30.927483]; ANTIN JH, 1986, J IMMUNOL, V136, P505; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Banchereau R, 2017, ANNU REV IMMUNOL, V35, P337, DOI 10.1146/annurev-immunol-051116-052225; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Carissimo G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19080-6; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Cheng X, 2020, CELL METAB, V32, P537, DOI 10.1016/j.cmet.2020.08.013; Collier DA, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100062; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1101/2020.05.28.20115758, 10.1038/s41591-020-1051-9]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Espeli M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09434-0; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; HIRSCH RL, 1986, J INTERFERON RES, V6, P171, DOI 10.1089/jir.1986.6.171; Holzapfel KL, 2014, J IMMUNOL, V192, P5490, DOI 10.4049/jimmunol.1400722; Horns F, 2020, CELL REP, V30, P905, DOI 10.1016/j.celrep.2019.12.063; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025; Krummel MF, 2018, P NATL ACAD SCI USA, V115, P11585, DOI 10.1073/pnas.1804556115; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lichtner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019872; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Maurice NJ, 2021, J IMMUNOL, V206, P455, DOI 10.4049/jimmunol.2000937; Maurice NJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12980-2; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miles AL, 2017, ELIFE, V6, DOI 10.7554/eLife.22693; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mlcochova P, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100099; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Patterson Edward I, 2020, bioRxiv, DOI [10.1093/infdis/jiaa507, 10.1101/2020.05.21.108035]; Pereyra Gerber P., 2021, PROTEASE ACTIVATABLE; Pinheiro J., 2021, LINEAR NONLINEAR MIX; Prestes EB, 2020, J IMMUNOL, V205, P2795, DOI 10.4049/jimmunol.1900886; Pujadas E, 2020, LANCET RESP MED, V8, pE70, DOI 10.1016/S2213-2600(20)30354-4; R Development Core Team, 2018, R LANG ENV STAT COMP; Reynolds G., 2021, CELLULAR IMMUNE RESP, V2021; Ribeiro S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00015; Rivett L., 2020, CITIID NIHR COVID 19; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Russell CD, 2017, CLIN MICROBIOL REV, V30, P481, DOI 10.1128/CMR.00090-16; Sanderson NSR, 2017, P NATL ACAD SCI USA, V114, P734, DOI 10.1073/pnas.1614472114; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Soudja SM, 2014, IMMUNITY, V40, P974, DOI 10.1016/j.immuni.2014.05.005; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Ussher JE, 2018, IMMUNOL CELL BIOL, V96, P630, DOI 10.1111/imcb.12008; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Warnes GR, 2020, GENTLEMAN R R PACKAG; Wauters E, 2021, CELL RES, V31, P272, DOI 10.1038/s41422-020-00455-9; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Xiong X., NAT STRUCT MOL BIOL, V27, P934; Zafranskaya M, 2007, IMMUNOLOGY, V121, P29, DOI 10.1111/j.1365-2567.2006.02518.x; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	81	71	72	8	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1257	+		10.1016/j.immuni.2021.05.010	http://dx.doi.org/10.1016/j.immuni.2021.05.010		JUN 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34051148	Green Published, hybrid			2022-12-18	WOS:000659882900016
J	Hughes, TK; Wadsworth, MH; Gierahn, TM; Do, T; Weiss, D; Andrade, PR; Ma, FY; Silva, BJDA; Shao, S; Tsoi, LC; Ordovas-Montanes, J; Gudjonsson, JE; Modlin, RL; Love, JC; Shalek, AK				Hughes, Travis K.; Wadsworth, Marc H., II; Gierahn, Todd M.; Tran Do; Weiss, David; Andrade, Priscila R.; Ma, Feiyang; Silva, Bruno J. De Andrade; Shao, Shuai; Tsoi, Lam C.; Ordovas-Montanes, Jose; Gudjonsson, Johann E.; Modlin, Robert L.; Love, J. Christopher; Shalek, Alex K.			Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies	IMMUNITY			English	Article							DERMAL DENDRITIC CELLS; GENOME-WIDE EXPRESSION; RNA-SEQ; TRANSCRIPTOME ANALYSIS; LANGERHANS CELLS; SINGLE CELLS; DIFFERENTIATION; PSORIASIS; RECONSTRUCTION; SUBPOPULATION	High-throughput single-cell RNA-sequencing (scRNA-seq) methodologies enable characterization of complex biological samples by increasing the number of cells that can be profiled contemporaneously. Neverthe-less, these approaches recover less information per cell than low-throughput strategies. To accurately report the expression of key phenotypic features of cells, scRNA-seq platforms are needed that are both high fidelity and high throughput. To address this need, we created Seq-Well S-3 ("Second-Strand Synthesis"), a massively parallel scRNA-seq protocol that uses a randomly primed second-strand synthesis to recover complementary DNA (cDNA) molecules that were successfully reverse transcribed but to which a second oligonucleotide handle, necessary for subsequent whole transcriptome amplification, was not appended due to inefficient template switching. Seq-Well S-3 increased the efficiency of transcript capture and gene detection compared with that of previous iterations by up to 10- and 5-fold, respectively. We used Seq-Well S-3 to chart the transcriptional landscape of five human inflammatory skin diseases, thus providing a resource for the further study of human skin inflammation.	[Hughes, Travis K.; Wadsworth, Marc H., II; Shalek, Alex K.] MIT, Inst Med Engn & Sci IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hughes, Travis K.; Shalek, Alex K.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Ordovas-Montanes, Jose; Love, J. Christopher; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Love, J. Christopher; Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Hughes, Travis K.; Wadsworth, Marc H., II; Gierahn, Todd M.; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gierahn, Todd M.; Love, J. Christopher] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Tran Do; Weiss, David; Andrade, Priscila R.; Ma, Feiyang; Silva, Bruno J. De Andrade] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; [Shao, Shuai; Tsoi, Lam C.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Ordovas-Montanes, Jose; Modlin, Robert L.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Ordovas-Montanes, Jose] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.] Harvard Stem Cell Inst, Cambridge, MA 02139 USA; [Wadsworth, Marc H., II] MIT, Dept Chem, Cambridge, MA 02139 USA; [Tran Do; Weiss, David; Andrade, Priscila R.; Ma, Feiyang; Silva, Bruno J. De Andrade] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Biol, Los Angeles, CA 90095 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shalek, AK (corresponding author), MIT, Inst Med Engn & Sci IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Love, JC; Shalek, AK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Love, JC; Shalek, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Love, JC (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Love, JC (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02139 USA.	clove@mit.edu; shalek@mit.edu	Ma, Feiyang/GLN-6180-2022	Tsoi, Lam Cheung/0000-0003-1627-5722; Weiss, David/0000-0002-2068-7036	NIH [P30CA14051, 5P01AI039671, 1DP2GM1194192, U19AI0899922, R01HL0957911, U54CA2173772, P01AI 0396715, U24AI1186722, RM1HG0061931]; Koch Institute for Integrative Cancer Research at MIT; DanaFarber/Harvard Cancer Center; Food Allergy Science Initiative at the Broad Institute; Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars Program for Cancer Research; Sloan Fellowship in Chemistry; Bill and Melinda Gates Foundation [OPP1139972, OPP1202327, OPP1137006]; Taubman Medical Research Institute; Damon Runyon Cancer Research Foundation [DRG-2274-16]; Richard and Susan Smith Family Foundation;  [R33CA2028201];  [R01AI1385461];  [R01HL1265541];  [R01DA0462771];  [U2CCA23319501];  [5U19AI089992];  [R01A R060802];  [R01AI30025];  [P30AR075043];  [R01AI022553];  [R01AR040312];  [F30AI143160];  [R01AR074302]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute for Integrative Cancer Research at MIT; DanaFarber/Harvard Cancer Center; Food Allergy Science Initiative at the Broad Institute; Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars Program for Cancer Research; Sloan Fellowship in Chemistry; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Taubman Medical Research Institute; Damon Runyon Cancer Research Foundation; Richard and Susan Smith Family Foundation; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was supported in part by the NIH (P30CA14051, 5P01AI039671, 1DP2GM1194192, U19AI0899922, R01HL0957911, U54CA2173772, P01AI 0396715, U24AI1186722, RM1HG0061931, R33CA2028201, R01AI1385461, R01HL1265541, R01DA0462771, U2CCA23319501, 5U19AI089992, R01A R060802, R01AI30025, P30AR075043, R01AI022553, R01AR040312, F30AI143160, and R01AR074302), the Bridge Project (a partnership between the Koch Institute for Integrative Cancer Research at MIT and the DanaFarber/Harvard Cancer Center), and the Food Allergy Science Initiative at the Broad Institute. A.K.S. was supported by the Searle Scholars Program, the Beckman Young Investigator Program, the Pew-Stewart Scholars Program for Cancer Research, a Sloan Fellowship in Chemistry, and the Bill and Melinda Gates Foundation (OPP1139972, OPP1202327, OPP1137006, and OPP1202327). J.G was supported by the Taubman Medical Research Institute. J.O.-M. was supported by the Damon Runyon Cancer Research Foundation (Howard Hughes Medical Institute Fellow DRG-2274-16), and the Richard and Susan Smith Family Foundation.	Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Balin SJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7668; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Beylot C, 2014, J EUR ACAD DERMATOL, V28, P271, DOI 10.1111/jdv.12224; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bhattacharya R, 2012, BLOOD, V119, P4798, DOI 10.1182/blood-2011-11-392563; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cheng JB, 2018, CELL REP, V25, P871, DOI 10.1016/j.celrep.2018.09.006; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Di Rosa M, 2013, INFLAMMATION, V36, P482, DOI 10.1007/s10753-012-9569-8; Diani M, 2015, AUTOIMMUN REV, V14, P286, DOI 10.1016/j.autrev.2014.11.012; Ding J, 2020, NAT BIOTECHNOL, V38, P737, DOI 10.1038/s41587-020-0465-8; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Fu X, 2018, J CLIN INVEST, V128, P2127, DOI 10.1172/JCI98215; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hazell GGJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39553; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Holland DB, 2004, BRIT J DERMATOL, V150, P72, DOI 10.1111/j.1365-2133.2004.05749.x; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Huth S, 2015, EXP DERMATOL, V24, P663, DOI 10.1111/exd.12704; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; Kapteyn J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-413; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kim D, 2020, NAT MED, V26, P236, DOI 10.1038/s41591-019-0733-7; Kim TG, 2018, J INVEST DERMATOL, V138, P844, DOI 10.1016/j.jid.2017.11.003; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lopez D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4167-7; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; McGinnis CS, 2019, NAT METHODS, V16, P619, DOI 10.1038/s41592-019-0433-8; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Oakes T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01267; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Piette EW, 2016, J AM ACAD DERMATOL, V75, P457, DOI 10.1016/j.jaad.2015.03.054; Pinheiro RO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00518; Prakadan SM, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.15; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Reyes LI, 2008, CYTOKINE, V42, P170, DOI 10.1016/j.cyto.2007.12.005; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Sahmatova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07975-2; Saini C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004592; Saini C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002338; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schon MP, 2003, J INVEST DERMATOL, V121, P951, DOI 10.1046/j.1523-1747.2003.12563.x; Shao L, 2020, MOL IMMUNOL, V120, P23, DOI 10.1016/j.molimm.2020.01.024; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stutte S, 2010, P NATL ACAD SCI USA, V107, P8736, DOI 10.1073/pnas.0906126107; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Thiriot A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0381-7; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Tu AA, 2019, NAT IMMUNOL, V20, P1692, DOI 10.1038/s41590-019-0544-5; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Galen P, 2019, CELL, V176, P1265, DOI 10.1016/j.cell.2019.01.031; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Young M.D., 2018, BIORXIV; Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018; Zajac P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085270; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	95	71	72	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					878	+		10.1016/j.immuni.2020.09.015	http://dx.doi.org/10.1016/j.immuni.2020.09.015			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053333	Green Published, hybrid			2022-12-18	WOS:000581062800018
J	Cytlak, U; Resteu, A; Pagan, S; Green, K; Milne, P; Maisuria, S; McDonald, D; Hulme, G; Filby, A; Carpenter, B; Queen, R; Hambleton, S; Hague, R; Allen, HL; Thaventhiran, JED; Doody, G; Collin, M; Bigley, V				Cytlak, Urszula; Resteu, Anastasia; Pagan, Sarah; Green, Kile; Milne, Paul; Maisuria, Sheetal; McDonald, David; Hulme, Gillian; Filby, Andrew; Carpenter, Benjamin; Queen, Rachel; Hambleton, Sophie; Hague, Rosie; Allen, Hana Lango; Thaventhiran, James E. D.; Doody, Gina; Collin, Matthew; Bigley, Venetia			Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; RNA-SEQ DATA; LINEAGE COMMITMENT; DIFFUSION MAPS; PROGENITORS; EXPRESSION; NORMALIZATION; GENERATION; PHENOTYPE; SUBSETS	The formation of mammalian dendritic cells (DCs) is controlled by multiple hematopoietic transcription factors, including IRF8. Loss of IRF8 exerts a differential effect on DC subsets, including plasmacytoid DCs (pDCs) and the classical DC lineages cDC1 and cDC2. In humans, cDC2-related subsets have been described including AXL(+)SIGLEC6(+) pre-DC, DC2 and DC3. The origin of this heterogeneity is unknown. Using highdimensional analysis, in vitro differentiation, and an allelic series of human IRF8 deficiency, we demonstrated that cDC2 (CD1c +DC) heterogeneity originates from two distinct pathways of development. The lymphoid-primed IRF8hi pathway, marked by CD123 and BTLA, carried pDC, cDC1, and DC2 trajectories, while the common myeloid IRF8lo pathway, expressing SIRPA, formed DC3s and monocytes. We traced distinct trajectories through the granulocyte-macrophage progenitor (GMP) compartment showing that AXL(+)SIGLEC6(+) pre-DCs mapped exclusively to the DC2 pathway. In keeping with their lower requirement for IRF8, DC3s expand to replace DC2s in human partial IRF8 deficiency.	[Cytlak, Urszula; Resteu, Anastasia; Pagan, Sarah; Green, Kile; Milne, Paul; Hambleton, Sophie; Collin, Matthew; Bigley, Venetia] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Maisuria, Sheetal] Univ Leeds, Inst Rheumat & Musculoskeletal Med, Leeds LS9 7TF, W Yorkshire, England; [McDonald, David; Hulme, Gillian; Filby, Andrew; Queen, Rachel] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Carpenter, Benjamin] Univ Oxford, Nuffield Dept Med, Oxford Genom Ctr, Wellcome Ctr Human Genet, Oxford OX3 7BN, England; [Hambleton, Sophie] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hague, Rosie] Royal Hosp Children, Dept Paediat Immunol & Infect Dis, Glasgow G51 4TF, Lanark, Scotland; [Allen, Hana Lango] Univ Cambridge, Dept Haematol, Biomedical Campus, Cambridge CB2 0SP, England; [Allen, Hana Lango] Cambridge Univ Hosp, NIHR BioResource, Cambridge Biomed Campus, Cambridge CB2 0SP, England; [Thaventhiran, James E. D.] Univ Cambridge, Sch Biol Sci, MRC Toxicol Unit, Cambridge CB2 1QR, England; [Doody, Gina] Univ Leeds, Leeds Inst Med Res, Leeds LS9 7TF, W Yorkshire, England; [Collin, Matthew; Bigley, Venetia] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; University of Leeds; Newcastle University - UK; University of Oxford; Wellcome Centre for Human Genetics; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Cambridge; University of Cambridge; University of Cambridge; University of Leeds; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Bigley, V (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Bigley, V (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	venetia.bigley@ncl.ac.uk	Cytlak, Urszula/Y-2382-2019; Doody, Gina/AAN-8246-2021	Cytlak, Urszula/0000-0002-2536-6012; Doody, Gina/0000-0003-0665-6759; Resteu, Anastasia/0000-0002-3783-8806; Green, Kile/0000-0002-4777-5458; Bigley, Venetia/0000-0002-3017-2474	Wellcome Trust [101155/Z/13/Z]; CRUK [C30484/A21025]; NIHR Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals; Newcastle University Single Cell Unit	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); NIHR Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals; Newcastle University Single Cell Unit	We gratefully thank healthy donors, patients and their families for their participation. We thank NIHR BioResource volunteers for their participation, and we gratefully acknowledge the NIHR Bioresource Centre, NHS Trusts, and staff for their contribution. We thank the National Institute for Health Research, NHS Blood and Transplant, and Health Data Research UK as part of the Digital Innovation Hub Programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. We also thank staff at the Newcastle University Flow Cytometry Core Facility (FCCF) for assistance with the generation of flow cytometry data, as well as Lorna Witty and James Docker from the Oxford Genomics Centre (Wellcome Centre for Human Genetics, Oxford, UK). This work was supported by grants from the Wellcome Trust (101155/Z/13/Z to V.B. and U.C.), CRUK (C30484/A21025 to M.C.), Newcastle University Single Cell Unit, and the NIHR Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals.	Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; [Anonymous], 2019, BIORXIV, DOI [10.1101/507244, DOI 10.1101/507244]; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bigley V, 2018, J ALLERGY CLIN IMMUN, V141, P2234, DOI 10.1016/j.jaci.2017.08.044; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourdely P, 2020, IMMUNITY, V53, P335, DOI 10.1016/j.immuni.2020.06.002; Bryant C, 2016, IMMUNOL CELL BIOL, V94, P447, DOI 10.1038/icb.2015.116; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Cytlak U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02977-8; Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Granot T, 2017, IMMUNITY, V46, P504, DOI 10.1016/j.immuni.2017.02.019; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Helft J, 2017, CELL REP, V20, P529, DOI 10.1016/j.celrep.2017.06.075; Kirkling ME, 2018, CELL REP, V23, P3658, DOI 10.1016/j.celrep.2018.05.068; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Kong XF, 2018, NAT IMMUNOL, V19, P973, DOI 10.1038/s41590-018-0178-z; Korenfeld D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96101; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Salem S, 2014, BLOOD, V124, P1894, DOI 10.1182/blood-2014-04-570879; Satpathy AT, 2014, BLOOD, V123, P2968, DOI 10.1182/blood-2013-11-539643; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schroder M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157387; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Thaventhiran J.E.D., 2018, WHOLE GENOME SEQUENC, DOI [10.1101/499988., DOI 10.1101/499988]; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yin XY, 2017, J IMMUNOL, V198, P1553, DOI 10.4049/jimmunol.1600193	57	71	71	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					353	+		10.1016/j.immuni.2020.07.003	http://dx.doi.org/10.1016/j.immuni.2020.07.003			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32735845	hybrid, Green Published			2022-12-18	WOS:000561190600014
J	Egen, JG; Ouyang, WJ; Wu, LC				Egen, Jackson G.; Ouyang, Wenjun; Wu, Lawren C.			Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials	IMMUNITY			English	Review							CD8(+) T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; PD-1 BLOCKADE; CTLA-4 BLOCKADE; ANTI-CTLA-4 THERAPY; ACQUIRED-RESISTANCE; DENDRITIC CELL; PHASE 1B; TGF-BETA; CANCER	Therapeutics that target the T cell inhibitory checkpoint proteins CTLA-4 and PD(L)1 are efficacious across a broad range of cancers, resulting in reductions in tumor burden and increased long-term survival in subsets of patients. The significant and wide-ranging effects of these immunotherapies have prompted the clinical investigation of additional therapies that modulate anti-tumor immunity through effects on T cells, myeloid cells, and other cell types within the tumor microenvironment. The clinical activity of these newer investigational therapies has been mixed, with some therapeutics showing promise but others not exhibiting appreciable efficacy. In this review, we summarize the results of select recent clinical studies of cancer immunotherapies beyond anti-CTLA-4 and anti-PD(L)1 and discuss how these results are providing new insights into the regulation of human anti-tumor immunity.	[Egen, Jackson G.; Ouyang, Wenjun; Wu, Lawren C.] Amgen Inc, Amgen Res, Dept Inflammat & Oncol, San Francisco, CA 94080 USA	Amgen	Egen, JG; Wu, LC (corresponding author), Amgen Inc, Amgen Res, Dept Inflammat & Oncol, San Francisco, CA 94080 USA.	jegen@amgen.com; lawrenw@amgen.com	Ouyang, Wenjun/ABA-8763-2020	Egen, Jackson/0000-0003-2053-0837; Ouyang, Wenjun/0000-0002-1811-5864				Adusumilli PS, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2511; Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amin A, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.9555; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; ANDTBACKA RHI, 2015, J CLIN ONCOL, V33; Andtbacka RHI, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0623-z; Aznar MA, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0568-2; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Ascierto PB PA., 2017, ANN ONCOL, V28, pV605; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Bajor DL, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468956; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Bauwens Dirk, 2019, Herpetological Bulletin, P4, DOI 10.33256/hb147.48; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bentebibel SE, 2019, CANCER DISCOV, V9, P711, DOI 10.1158/2159-8290.CD-18-1495; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Broz ML, 2014, CANCER CELL, V26, P938, DOI 10.1016/j.ccell.2014.11.010; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Buchan SL, 2018, IMMUNITY, V49, P958, DOI 10.1016/j.immuni.2018.09.014; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; CALVO A, 2018, J CLIN ONCOL, V36; Cane S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01786; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Cassier PA, 2015, LANCET ONCOL, V16, P949, DOI 10.1016/S1470-2045(15)00132-1; Chandran SS, 2019, IMMUNOL REV, V290, P127, DOI 10.1111/imr.12772; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Chitu V, 2017, CURR TOP DEV BIOL, V123, P229, DOI 10.1016/bs.ctdb.2016.10.004; Chmielowski B, 2018, J IMMUNOTHER CANCER, V6, P1; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Curigliano G, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT183; Curti B, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-CT114; D'Angelo SP, 2018, CANCER DISCOV, V8, P944, DOI 10.1158/2159-8290.CD-17-1417; Dahan R, 2016, CANCER CELL, V29, P820, DOI 10.1016/j.ccell.2016.05.001; Damato B.E, 2019, CANCERS, V11, P11; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; DAUD A, 2018, J CLIN ONCOL, V36; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Emmerich J, 2012, CANCER RES, V72, P3570, DOI 10.1158/0008-5472.CAN-12-0721; Eng C, 2019, LANCET ONCOL, V20, P849, DOI 10.1016/S1470-2045(19)30027-0; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Floros T, 2015, SEMIN ONCOL, V42, P539, DOI 10.1053/j.seminoncol.2015.05.015; Fong L, 2018, J IMMUNOTHER CANC S1, V6, P115; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fransen MF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124507; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Giraldo NA, 2019, BRIT J CANCER, V120, P45, DOI 10.1038/s41416-018-0327-z; Golan T, 2018, J IMMUNOTHER CANCER, V6, P115; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Grothey A, 2018, ANN ONCOL, V29; Guedan S, 2019, ANNU REV IMMUNOL, V37, P145, DOI 10.1146/annurev-immunol-042718-041407; Haidar JN, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-2753; HARDING J, 2019, J CLIN ONCOL, V37; Harrington K.J, 2018, ANN ONCOL, V29; Harrington K, 2019, NAT REV DRUG DISCOV, V18, P689, DOI 10.1038/s41573-019-0029-0; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Hecht JR, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4119; Hegde PS, 2016, CLIN CANCER RES, V22, P1865, DOI 10.1158/1078-0432.CCR-15-1507; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2014, CANCER IMMUNOL RES, V2, P632, DOI 10.1158/2326-6066.CIR-14-0053; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Huang YH, 2018, NAT REV IMMUNOL, V18, P195, DOI 10.1038/nri.2017.145; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hummel HD, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.5034; Hurwitz ME, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2623; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Iwai Y, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0329-9; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jahchan NS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01611; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaufman HL, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0116-2; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Keenan TE, 2019, NAT MED, V25, P389, DOI 10.1038/s41591-019-0382-x; Khushalani NI, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.TPS9601; Kim A, 2019, J IMMUNOL, V203, P1076, DOI 10.4049/jimmunol.1801472; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Kvarnhammar AM, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0570-8; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Labadie BW, 2019, CLIN CANCER RES, V25, P1462, DOI 10.1158/1078-0432.CCR-18-2882; Lakhani N, 2018, J IMMUNOTHER CANC S1, V6, P115; Lan Y, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan5488; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le D, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-CT124; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Leone RD, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0360-8; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li J, 2018, CLIN CANCER RES, V24, P6447, DOI 10.1158/1078-0432.CCR-18-1139; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Long GV, 2019, LANCET ONCOL, V20, P1083, DOI 10.1016/S1470-2045(19)30274-8; Luke JJ, 2017, J IMMUNOTHER CANC SU, V5, P89, DOI DOI 10.1186/S40425-017-0297-3; LUKE JJ, 2019, J CLIN ONCOL, V37; Machiels JP, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0510-7; Majzner RG, 2019, NAT MED, V25, P1341, DOI 10.1038/s41591-019-0564-6; Mannino MH, 2015, CANCER LETT, V367, P103, DOI 10.1016/j.canlet.2015.07.009; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Marin-Acevedo JA, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0582-8; Rodas IM, 2018, ANN ONCOL, V29, P732; Martinez-Quintanilla J, 2019, J CLIN INVEST, V129, P1407, DOI 10.1172/JCI122287; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Matlung HL, 2017, IMMUNOL REV, V276, P145, DOI 10.1111/imr.12527; Mayes PA, 2018, NAT REV DRUG DISCOV, V17, P509, DOI 10.1038/nrd.2018.75; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meric-Bernstam F, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.7_suppl.549; Michea Paula, 2018, Nat Immunol, V19, P885, DOI 10.1038/s41590-018-0145-8; Middleton MR, 2018, ANN ONCOL, V29; MILHEM MM, 2019, J CLIN ONCOL, V37; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mitchell TC, 2018, J CLIN ONCOL, V36, P3223, DOI 10.1200/JCO.2018.78.9602; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Muller AJ, 2019, SEMIN IMMUNOPATHOL, V41, P41, DOI 10.1007/s00281-018-0702-0; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; Naing A, 2016, J CLIN ONCOL, V34, P3562, DOI 10.1200/JCO.2016.68.1106; Noel M, 2017, ANN ONCOL, V28; Noel MS, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.276; Nywening TM, 2016, LANCET ONCOL, V17, P651, DOI 10.1016/S1470-2045(16)00078-4; O'Hara MH, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT004; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Ouyang WJ, 2019, IMMUNITY, V50, P871, DOI 10.1016/j.immuni.2019.03.020; OVERMAN MJ, 2018, J CLIN ONCOL, V36; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Papadopoulos KP, 2017, CLIN CANCER RES, V23, P5703, DOI 10.1158/1078-0432.CCR-16-3261; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Paz-Ares L, 2018, ANN ONCOLOGY S8, V29; PAZARES LG, 2018, J CLIN ONCOL, V36; Platten M, 2019, NAT REV DRUG DISCOV, V18, P379, DOI 10.1038/s41573-019-0016-5; Prendergast GC, 2018, INT REV CEL MOL BIO, V336, P175, DOI 10.1016/bs.ircmb.2017.07.004; Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529; Rahma OE, 2019, CLIN CANCER RES, V25, P5449, DOI 10.1158/1078-0432.CCR-18-1543; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ribas A, 2018, CANCER DISCOV, V8, P1250, DOI 10.1158/2159-8290.CD-18-0280; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rini BI, 2019, LANCET, V393, P2404, DOI 10.1016/S0140-6736(19)30723-8; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Salmon H, 2019, NAT REV CANCER, V19, P215, DOI 10.1038/s41568-019-0125-9; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Segal NH, 2017, CLIN CANCER RES, V23, P1929, DOI 10.1158/1078-0432.CCR-16-1272; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Shrikant P, 1999, IMMUNITY, V11, P483, DOI 10.1016/S1074-7613(00)80123-5; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; SIKIC BI, 2018, J CLIN ONCOL, V36; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Singel KL, 2016, IMMUNOL REV, V273, P329, DOI 10.1111/imr.12459; Slaney CY, 2018, CANCER DISCOV, V8, P924, DOI 10.1158/2159-8290.CD-18-0297; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Solomon BL, 2018, CANCER IMMUNOL IMMUN, V67, P1659, DOI 10.1007/s00262-018-2246-5; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Stein A, 2019, DRUG SAFETY, V42, P587, DOI 10.1007/s40264-018-0760-1; Sucker A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15440; Sullivan RJ, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.3013; Tabernero J, 2017, P AN M AM SOC CLIN, V35, P3002, DOI DOI 10.1200/JC0.2017.35.15_SUPPL.3002;CITED; Tap WD, 2019, LANCET, V394, P478, DOI 10.1016/S0140-6736(19)30764-0; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Tetzlaff MT, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0323-0; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twumasi-Boateng K, 2018, NAT REV CANCER, V18, P419, DOI 10.1038/s41568-018-0009-4; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Montfoort N, 2018, CELL, V175, P1744, DOI 10.1016/j.cell.2018.10.028; Van Tine BA, 2019, ANN ONCOL, V30; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Vonderheide RH, 2020, ANNU REV MED, V71, P47, DOI 10.1146/annurev-med-062518-045435; Wainberg Z, 2017, J IMMUNOTHER CANCER, V5, P89, DOI [10.1186/s40425-017-0289-3, DOI 10.1186/S40425-017-0289-3]; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Wang-Gillam A, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.4_suppl.TPS465; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Willingham S, 2018, ANN ONCOL, V29; Xu F, 2014, CANCER RES, V74, P3418, DOI 10.1158/0008-5472.CAN-13-2690; Yarchoan M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126908; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Yu XJ, 2018, CANCER CELL, V33, P664, DOI 10.1016/j.ccell.2018.02.009; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zappasodi R, 2018, CANCER CELL, V33, P1017, DOI 10.1016/j.ccell.2018.05.009; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhan XB, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2509; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhukovsky EA, 2016, CURR OPIN IMMUNOL, V40, P24, DOI 10.1016/j.coi.2016.02.006; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	229	71	75	7	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					36	54		10.1016/j.immuni.2019.12.010	http://dx.doi.org/10.1016/j.immuni.2019.12.010			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940272	Bronze			2022-12-18	WOS:000507384600008
J	Deniset, JF; Belke, D; Lee, WY; Jorch, SK; Deppermann, C; Hassanabad, AF; Turnbull, JD; Teng, GQ; Rozich, I; Hudspeth, K; Kanno, Y; Brooks, SR; Hadjantonakis, AK; O'Shea, JJ; Weber, GF; Fedak, PWM; Kubes, P				Deniset, Justin F.; Belke, Darrell; Lee, Woo-Yong; Jorch, Selina K.; Deppermann, Carsten; Hassanabad, Ali Fatehi; Turnbull, Jeannine D.; Teng, Guoqi; Rozich, Isaiah; Hudspeth, Kelly; Kanno, Yuka; Brooks, Stephen R.; Hadjantonakis, Anna-Katerina; O'Shea, John J.; Weber, Georg F.; Fedak, Paul W. M.; Kubes, Paul			Gata6(+) Pericardial Cavity Macrophages Relocate to the Injured Heart and Prevent Cardiac Fibrosis	IMMUNITY			English	Article							STEADY-STATE; MONOCYTES; FLUID; RESERVOIR	Macrophages play an important role in structural cardiac remodeling and the transition to heart failure following myocardial infarction (MI). Previous research has focused on the impact of blood-derived monocytes on cardiac repair. Herewe examined the contribution of resident cavity macrophages located in the pericardial space adjacent to the site of injury. We found that disruption of the pericardial cavity accelerated maladaptive post-MI cardiac remodeling. Gata6(+) macrophages in mouse pericardial fluid contributed to the reparative immune response. Following experimental MI, these macrophages invaded the epicardium and lost Gata6 expression but continued to perform anti-fibrotic functions. Loss of this specialized macrophage population enhanced interstitial fibrosis after ischemic injury. Gata6(+) macrophages were present in human pericardial fluid, supporting the notion that this reparative function is relevant in human disease. Our findings uncover an immune cardioprotective role for the pericardial tissue compartment and argue for the reevaluation of surgical procedures that remove the pericardium.	[Deniset, Justin F.; Lee, Woo-Yong; Jorch, Selina K.; Deppermann, Carsten; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Kubes, Paul] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Deniset, Justin F.; Lee, Woo-Yong; Jorch, Selina K.; Deppermann, Carsten; Kubes, Paul] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada; [Belke, Darrell; Hassanabad, Ali Fatehi; Turnbull, Jeannine D.; Teng, Guoqi; Fedak, Paul W. M.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Sect Cardiac Surg,Dept Cardiac Sci, Calgary, AB T2N 1N4, Canada; [Rozich, Isaiah; Hudspeth, Kelly; Kanno, Yuka; O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Rockville, MD 20892 USA; [Brooks, Stephen R.] NIAMS, Biodata Min & Discovery Sect, Rockville, MD 20892 USA; [Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Weber, Georg F.] Friedrich Alexander Univ, Univ Klinikum Erlangen, Dept Surg, D-91054 Erlangen, Germany	University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Memorial Sloan Kettering Cancer Center; University of Erlangen Nuremberg	Kubes, P (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada.; Kubes, P (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada.; Kubes, P (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada.	pkubes@ucalgary.ca	Kanno, Yuka/B-5802-2013	Kanno, Yuka/0000-0001-5668-9319	Heart and Stroke Foundation of Canada [G-18-0020471]; Canadian Institutes of Health Research; Canada Research Chairs Program; National Institutes of Health; DFG [JO1497/2-1, DE2654/1-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIHAR041173, ZICAR041207] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Trecia Nussbaumer for the breeding of mice. We thank Dr. Karen Poon at the Nicole Perkins Microbial Communities Core Labs for assistance with flow cytometry. Next Generation Sequencing was performed by the NIAMS Sequencing Core This work utilized the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov).Funding: P.K. is supported by the Heart and Stroke Foundation of Canada G-18-0020471, Canadian Institutes of Health Research, and the Canada Research Chairs Program. P.W.M.F. is supported by Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research, and National Institutes of Health. J.F.D. is supported by a fellowship from Canadian Institutes of Health Research. S.K.J. is supported by a fellowship from the DFG (JO1497/2-1). C.D. is supported by a fellowship from the DFG (DE2654/1-1).	Beltrami C, 2017, MOL THER, V25, P679, DOI 10.1016/j.ymthe.2016.12.022; Butts B, 2017, CIRCULATION, V136, P2284, DOI 10.1161/CIRCULATIONAHA.117.029589; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Freyer L, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0086-5; Fujita M, 1998, Angiogenesis, V2, P105, DOI 10.1023/A:1009062712441; Fujita M, 1996, CIRCULATION, V94, P610, DOI 10.1161/01.CIR.94.4.610; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Horckmans M, 2018, CIRCULATION, V137, P948, DOI 10.1161/CIRCULATIONAHA.117.028833; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Jellis C, 2010, J AM COLL CARDIOL, V56, P89, DOI 10.1016/j.jacc.2010.02.047; Klingberg A, 2017, J AM SOC NEPHROL, V28, P452, DOI 10.1681/ASN.2016020232; Mewhort Holly E M, 2017, JACC Basic Transl Sci, V2, P450, DOI 10.1016/j.jacbts.2017.05.005; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakano H, 2015, J IMMUNOL, V194, P3808, DOI 10.4049/jimmunol.1402195; NAKATANI T, 1988, ANAT REC, V220, P132, DOI 10.1002/ar.1092200204; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Weber GF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0010-6; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	27	71	71	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					131	+		10.1016/j.immuni.2019.06.010	http://dx.doi.org/10.1016/j.immuni.2019.06.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315031	Bronze, Green Accepted			2022-12-18	WOS:000475561000016
J	Uchimura, Y; Fuhrer, T; Li, H; Lawson, MA; Zimmermann, M; Yilmaz, B; Zindel, J; Ronchi, F; Sorribas, M; Hapfelmeier, S; Ganal-Vonarburg, SC; de Aguero, MG; McCoy, KD; Sauer, U; Macpherson, AJ				Uchimura, Yasuhiro; Fuhrer, Tobias; Li, Hai; Lawson, Melissa A.; Zimmermann, Michael; Yilmaz, Bahtiyar; Zindel, Joel; Ronchi, Francesca; Sorribas, Marcel; Hapfelmeier, Siegfried; Ganal-Vonarburg, Stephanie C.; de Aguero, Mercedes Gomez; McCoy, Kathy D.; Sauer, Uwe; Macpherson, Andrew J.			Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response	IMMUNITY			English	Article							COMMENSAL BACTERIA; TARGETED DELETION; HIGH-THROUGHPUT; GUT MICROBIOTA; MICE; DYNAMICS; INNATE; ACID; COLONIZATION; EXPRESSION	Although the mammalian microbiota is well contained within the intestine, it profoundly shapes development and metabolism of almost every host organ. We questioned the range and depth of microbial metabolite penetration into the host, and how this is modulated by intestinal immunity. Chemically identical microbial and host metabolites were distinguished by stable isotope tracing from 13 C-labeled live non-replicating Escherichia coli, differentiating C-12 host isotopes with high-resolution mass spectrometry. Hundreds of endogenous microbial compounds penetrated 23 host tissues and fluids after intestinal exposure: subsequent C-12 host metabolome signatures included lipidemia, reduced glycolysis, and inflammation. Penetrant bacterial metabolites from the small intestine were rapidly cleared into the urine, whereas induced antibodies curtailed microbial metabolite exposure by accelerating intestinal bacterial transit into the colon where metabolite transport mechanisms are limiting. Pervasive penetration of microbial molecules can cause extensive host tissue responses: these are limited by immune and non-immune intestinal mucosal adaptations to the microbiota.	[Uchimura, Yasuhiro; Li, Hai; Lawson, Melissa A.; Yilmaz, Bahtiyar; Zindel, Joel; Ronchi, Francesca; Sorribas, Marcel; Ganal-Vonarburg, Stephanie C.; de Aguero, Mercedes Gomez; McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Maurice Muller Labs, Dept Biomed Res, Univ Klin Viszerale Chirurg & Med,Inselspital, Murtenstr 35, CH-3008 Bern, Switzerland; [Fuhrer, Tobias; Zimmermann, Michael; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Uchimura, Yasuhiro] Shiga Univ Med Sci, Dept Anat & Cell Biol, Otsu, Shiga 5202192, Japan	University of Bern; University Hospital of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Macpherson, AJ (corresponding author), Univ Bern, Maurice Muller Labs, Dept Biomed Res, Univ Klin Viszerale Chirurg & Med,Inselspital, Murtenstr 35, CH-3008 Bern, Switzerland.; Sauer, U (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	sauer@imsb.biol.ethz.ch; andrew.macpherson@insel.ch	McCoy, Kathy/ABD-5814-2021; Hapfelmeier, Siegfried/B-6005-2011; Sauer, Uwe/Y-3556-2019; Yilmaz, Bahtiyar/U-6646-2019; Ganal-Vonarburg, Stephanie C./AAE-5705-2019; Li, Hai/AAI-9163-2021	Hapfelmeier, Siegfried/0000-0002-6913-7932; Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; Lawson, Melissa/0000-0001-9882-8663; Yilmaz, Bahtiyar/0000-0003-1888-9226; Fuhrer, Tobias/0000-0001-5006-6874; Li, Hai/0000-0002-4762-9362; Zindel, Joel/0000-0003-3685-9338; Gomez de Aguero, Mercedes/0000-0002-7132-290X; Ronchi, Francesca/0000-0002-2035-6528; Zimmermann, Michael/0000-0002-5797-3589	Genaxen Foundation; Swiss National Science Foundation [SNSF 310030B_160262, SNF Sinergia CRSII3_136286, SNSF Sinergia CRSII3_154414]; Systems X program	Genaxen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Systems X program	We thank the staff of the clean mouse facility of the University of Bern and Professors Wolf Hardt and Christoph Mueller for their comments. We thank Jamie Macpherson, Dr. Irene Keller, Dr. Fabian Blank, and Carlos A. Wotzkow for assistance. The work was supported by the Genaxen Foundation, the Swiss National Science Foundation (SNSF 310030B_160262 and SNF Sinergia CRSII3_136286 to A.J.M. and SNSF Sinergia CRSII3_154414 to A.J.M. and U.S.), and the Systems X program (GutX A.J.M. and U.S.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; BEATTY DW, 1983, J CLIN LAB IMMUNOL, V12, P31; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COTRAN R, 1960, P SOC EXP BIOL MED, V104, P424; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; DAYMAN J, 1969, BIOCHEM J, V113, pP11, DOI 10.1042/bj1130011P; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Graaf AA, 2010, NMR BIOMED, V23, P2, DOI 10.1002/nbm.1418; Donowitz JR, 2016, MBIO, V7, DOI 10.1128/mBio.02102-15; El Aidy S, 2013, GUT, V62, P1306, DOI 10.1136/gutjnl-2011-301955; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fuhrer T, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167150; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jones HF, 2011, J PEDIATR GASTR NUTR, V52, P632, DOI 10.1097/MPG.0b013e31820d5c16; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Myhrvold C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10039; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Nicholls AW, 2003, CHEM RES TOXICOL, V16, P1395, DOI 10.1021/tx0340293; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Padmanabhan P, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-60; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Sajed T, 2016, NUCLEIC ACIDS RES, V44, pD495, DOI 10.1093/nar/gkv1060; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sevin DC, 2017, NAT METHODS, V14, P187, DOI [10.1038/NMETH.4103, 10.1038/nmeth.4103]; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tannock GW, 2014, APPL ENVIRON MICROB, V80, P2240, DOI 10.1128/AEM.03799-13; Uchimura Y., 2016, GENOME ANNOUNC, V4; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; VIANEYLIAUD C, 1987, J INHERIT METAB DIS, V10, P159, DOI 10.1007/BF01812855; Williams RE, 2002, XENOBIOTICA, V32, P783, DOI 10.1080/00498250210143047; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065	64	71	75	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					545	+		10.1016/j.immuni.2018.08.004	http://dx.doi.org/10.1016/j.immuni.2018.08.004			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30193848	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000444909600020
J	Stathopoulou, C; Gangaplara, A; Mallett, G; Flomerfelt, FA; Liniany, LP; Knight, D; Samsel, LA; Berlinguer-Palmini, R; Yim, JJ; Felizardo, TC; Eckhaus, MA; Edgington-Mitchell, L; Martinez-Fabregas, J; Zhu, JF; Fowler, DH; van Kasteren, SI; Laurence, A; Bogyo, M; Watts, C; Shevach, EM; Amarnath, S				Stathopoulou, Chaido; Gangaplara, Arunakumar; Mallett, Grace; Flomerfelt, Francis A.; Liniany, Lukasz P.; Knight, David; Samsel, Leigh A.; Berlinguer-Palmini, Rolando; Yim, Joshua J.; Felizardo, Tania C.; Eckhaus, Michael A.; Edgington-Mitchell, Laura; Martinez-Fabregas, Jonathan; Zhu, Jinfang; Fowler, Daniel H.; van Kasteren, Sander I.; Laurence, Arian; Bogyo, Matthew; Watts, Colin; Shevach, Ethan M.; Amarnath, Shoba			PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells	IMMUNITY			English	Article							INSTABILITY; PLASTICITY; LEGUMAIN; ANTIGEN; DIFFERENTIATION; FLEXIBILITY; COMMITMENT; GENERATION; EXPRESSION; INFECTION	CD4(+) T cell differentiation into multiple T helper (Th) cell lineages is critical for optimal adaptive immune responses. This report identifies an intrinsic mechanism by which programmed death-1 receptor (PD-1) signaling imparted regulatory phenotype to Foxp3(+) Th1 cells (denoted as Tbet(+) iTreg(PDL1) cells) and inducible regulatory T (iTreg) cells. Tbet(+) iTreg(PDL1) cells prevented inflammation in murine models of experimental colitis and experimental graft versus host disease (GvHD). Programmed death ligand-1 (PDL-1) binding to PD-1 imparted regulatory function to Tbet(+) iTreg(PDL1) cells and iTreg cells by specifically downregulating endolysosomal protease asparaginyl endopeptidase (AEP). AEP regulated Foxp3 stability and blocking AEP imparted regulatory function in Tbet(+) iTreg cells. Also, Aep(-/-) iTreg cells significantly inhibited GvHD and maintained Foxp3 expression. PD-1 mediated Foxp3 maintenance in Tbet(+) Th1 cells occurred both in tumor infiltrating lymphocytes (TILs) and during chronic viral infection. Collectively, this report has identified an intrinsic function for PD-1 in maintaining Foxp3 through proteolytic pathway.	[Stathopoulou, Chaido; Mallett, Grace; Liniany, Lukasz P.; Berlinguer-Palmini, Rolando; Laurence, Arian; Amarnath, Shoba] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Gangaplara, Arunakumar; Zhu, Jinfang; Shevach, Ethan M.] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Flomerfelt, Francis A.; Felizardo, Tania C.; Fowler, Daniel H.] NCI, Expt Transplantat Immunol Branch, NIH, Bethesda, MD 20892 USA; [Knight, David] Univ Manchester, Biol Mass Spectrometry Core, Manchester M13 9PL, Lancs, England; [Samsel, Leigh A.] NHLBI, Flow Cytometry Core, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yim, Joshua J.; Edgington-Mitchell, Laura; Bogyo, Matthew] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Eckhaus, Michael A.] NIH, Div Vet Resources, Off Res Serv, Bldg 10, Bethesda, MD 20892 USA; [Edgington-Mitchell, Laura] Monash Univ, Drug Discovery Biol, Melbourne, Vic 3800, Australia; [Martinez-Fabregas, Jonathan; Watts, Colin] Univ Dundee, Coll Life Sci, Dundee DD1 4HN, Scotland; [van Kasteren, Sander I.] Leiden Univ, Leiden Inst Chem, NL-2311 EZ Leiden, Netherlands; [van Kasteren, Sander I.] Leiden Univ, Inst Chem Immunol, NL-2311 EZ Leiden, Netherlands; [Laurence, Arian] Univ Oxford, John Radcliffe Hosp, Div Expt Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Laurence, Arian] Northern Ctr Canc Care, Dept Haematol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Manchester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University; National Institutes of Health (NIH) - USA; Monash University; University of Dundee; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Oxford	Amarnath, S (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	shoba.amarnath@newcastle.ac.uk	Martinez-Fabregas, Jonathan/A-5819-2019; Palmini, Rolando Berlinguer/K-8764-2013; amarnath, shoba/AAP-4391-2020; Zhu, Jinfang/B-7574-2012; Gangaplara, Arunakumar/K-5922-2019; Laurence, Arian/A-8770-2009	Martinez-Fabregas, Jonathan/0000-0001-5809-065X; Palmini, Rolando Berlinguer/0000-0002-1786-496X; Zhu, Jinfang/0000-0002-0117-4745; Gangaplara, Arunakumar/0000-0001-6307-9391; Edgington-Mitchell, Laura/0000-0002-6810-6149; Bogyo, Matthew/0000-0003-3753-4412; Yim, Joshua/0000-0002-9999-1566; Stathopoulou, Chaido/0000-0003-4760-1973; Laurence, Arian/0000-0003-0942-8292	Division of intramural research program of the NCI; NIAID, NIH, USA; Newcastle University Research Fellowship, Newcastle University; MRC-Newcastle University Single Cell Unit Award; Academy of Medical Sciences, Springboard [SBF003\1129]; MRC-DiMEN Doctoral Training Partnership program; Wellcome Trust; ERC [ER-StG-639005]; Crohn's and Colitis Foundation of America; MRC [1953078] Funding Source: UKRI	Division of intramural research program of the NCI; NIAID, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Newcastle University Research Fellowship, Newcastle University; MRC-Newcastle University Single Cell Unit Award; Academy of Medical Sciences, Springboard; MRC-DiMEN Doctoral Training Partnership program; Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Crohn's and Colitis Foundation of America; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Dr. Tsung-Ping and Dr. Shang-Yi Tsai, National Institute on Drug Abuse, NIH for sharing protocols on pulse chase experiments and analysis. We would like to thank Dr. William G. Telford for his valuable input on Amnis flow cytometry experiments and analysis. We would like to thank Dr. Billur Akkaya, NIAID, for providing us with B6. Tbx21ZsGreenFoxp3RFP mice for chronic LCMV experiments. We would like to thank Dr. Bishop Hague, NIAID, for his assistance in flow cytometry sorting of virus-infected cells. We would like to thank the core facilities at Newcastle University namely Bio-imaging, Comparative Biology Centre, and Flow cytometry. We would also like to thank Mr. Christopher Huggins for his technical expertise. The authors would also like to thank the NIH tetramer core facility for providing the tetramers used in this study. This research was funded by the Division of intramural research program of the NCI and NIAID, NIH, USA, Newcastle University Research Fellowship, Newcastle University, MRC-Newcastle University Single Cell Unit Award and the Academy of Medical Sciences, Springboard Award SBF003\1129; G.M. is supported by MRC-DiMEN Doctoral Training Partnership program; J.M.-F. and C.W. are supported by the Wellcome Trust, S.I.v.K. is supported by an ERC starter grant ER-StG-639005, and A.L. is supported by Crohn's and Colitis Foundation of America.	Adeeku E, 2008, P NATL ACAD SCI USA, V105, P9307, DOI 10.1073/pnas.0704807105; AHMED R, 1984, J VIROL, V51, P34, DOI 10.1128/JVI.51.1.34-41.1984; Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Brown CC, 2015, IMMUNITY, V42, P499, DOI 10.1016/j.immuni.2015.02.003; Burster T, 2004, J IMMUNOL, V172, P5495, DOI 10.4049/jimmunol.172.9.5495; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Dall E, 2016, BIOCHIMIE, V122, P126, DOI 10.1016/j.biochi.2015.09.022; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Edgington LE, 2013, J AM CHEM SOC, V135, P174, DOI 10.1021/ja307083b; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Haugen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052980; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Jacobs JFM, 2009, NEURO-ONCOLOGY, V11, P394, DOI 10.1215/15228517-2008-104; Johansen HT, 1999, ANAL BIOCHEM, V273, P278, DOI 10.1006/abio.1999.4221; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Lin YY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju012; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taylor JJ, 2006, J IMMUNOL, V176, P5839, DOI 10.4049/jimmunol.176.10.5839; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; van Kasteren SI, 2014, CURR OPIN CHEM BIOL, V23, P8, DOI 10.1016/j.cbpa.2014.08.011; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhao YX, 2015, J IMMUNOL, V194, P1639, DOI 10.4049/jimmunol.1402434; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	52	71	76	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					247	+		10.1016/j.immuni.2018.05.006	http://dx.doi.org/10.1016/j.immuni.2018.05.006			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30054205	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000442354500011
J	Kuo, HH; Ahmad, R; Lee, GQ; Gao, C; Chen, HR; Ouyang, ZY; Szucs, MJ; Kim, D; Tsibris, A; Chun, TW; Battivelli, E; Verdin, E; Rosenberg, ES; Carr, SA; Yu, XG; Lichterfeld, M				Kuo, Hsiao-Hsuan; Ahmad, Rushdy; Lee, Guinevere Q.; Gao, Ce; Chen, Hsiao-Rong; Ouyang, Zhengyu; Szucs, Matthew J.; Kim, Dhohyung; Tsibris, Athe; Chun, Tae-Wook; Battivelli, Emilie; Verdin, Eric; Rosenberg, Eric S.; Carr, Steven A.; Yu, Xu G.; Lichterfeld, Mathias			Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4(+) T Cells	IMMUNITY			English	Article							PROGNOSTIC MARKER; LATENT RESERVOIR; HIV-1; EXPRESSION; INFECTION; DEATH; OX40; PROLIFERATION; PERSISTENCE; MULTICENTER	HIV-1 infection of CD4(+) T cells leads to cytopathic effects and cell demise, which is counter to the observation that certain HIV-1-infected cells possess a remarkable long-term stability and can persist lifelong in infected individuals treated with suppressive antiretroviral therapy (ART). Using quantitative mass spectrometry-based proteomics, we showed that HIV-1 infection activated cellular survival programs that were governed by BIRC5, a molecular inhibitor of cell apoptosis that is frequently overexpressed in malignant cells. BIRC5 and its upstream regulator OX40 were upregulated in productively and latently infected CD4(+) T cells and were functionally involved in maintaining their viability. Moreover, OX40-expressing CD4(+) T cells from ART-treated patients were enriched for clonally expanded HIV-1 sequences, and pharmacological inhibition of BIRC5 resulted in a selective decrease of HIV-1-infected cells in vitro. Together, these findings suggest that BIRC5 supports long-term survival of HIV-1-infected cells and may lead to clinical strategies to reduce persisting viral reservoirs.	[Kuo, Hsiao-Hsuan; Lee, Guinevere Q.; Kim, Dhohyung; Tsibris, Athe; Yu, Xu G.; Lichterfeld, Mathias] Brigham & Womens Hosp, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA; [Kuo, Hsiao-Hsuan; Lee, Guinevere Q.; Gao, Ce; Chen, Hsiao-Rong; Ouyang, Zhengyu; Kim, Dhohyung; Yu, Xu G.; Lichterfeld, Mathias] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Ahmad, Rushdy; Szucs, Matthew J.; Carr, Steven A.; Lichterfeld, Mathias] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Chun, Tae-Wook] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Battivelli, Emilie; Verdin, Eric] Buck Inst Res Aging, Novato, CA 94945 USA; [Rosenberg, Eric S.] Massachusetts Gen Hosp, Infect Dis Div, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Buck Institute for Research on Aging; Harvard University; Massachusetts General Hospital	Lichterfeld, M (corresponding author), Brigham & Womens Hosp, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA.; Lichterfeld, M (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Lichterfeld, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02139 USA.	mlichterfeld@partners.org	Lee, Guinevere Q./D-4436-2017; KUO, HSIAOHSUAN/AAT-2100-2020; Chun, Tae-Wook/W-9187-2019; Verdin, Eric/AAB-7999-2019; Carr, Steven A./AAH-8366-2019; Chun, Tae-Wook/AAC-3101-2020; Lichterfeld, Mathias/B-2042-2008; Gao, Ce/ABD-2899-2021	Lee, Guinevere Q./0000-0002-9412-886X; KUO, HSIAOHSUAN/0000-0003-3754-3271; Chun, Tae-Wook/0000-0001-5153-7340; Lichterfeld, Mathias/0000-0001-9865-8350; 	NIH [AI130005, AI098487, AI117841, AI120008, AI124776, AI116228, AI078799, HL134539, AI125109]; Harvard University Center for AIDS Research (CFAR); NIH - NIAID [AI060354]; NIH - NCI [AI060354]; NIH - NIMH [AI060354]; NIH - NIDA [AI060354]; NIH - NHLBI [AI060354]; NIH - NCCAM [AI060354]; NIH Shared Instrumentation Grant [1S10OD012027-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106468, R21AI124776, R21AI116228, U01AI117841, R01AI120008, R56AI125109, P30AI060354, R01AI130005, R01AI078799, U01AI114235, R01AI098487, R33AI116228] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research (CFAR); NIH - NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH - NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH - NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH - NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH - NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.L. is supported by NIH grants AI130005, AI098487, AI117841, AI120008, and AI124776. X.G.Y. is supported by NIH grants AI116228, AI078799, HL134539, and AI125109. This work was supported in part by the Harvard University Center for AIDS Research (CFAR), an NIH-funded program (AI060354) that is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM. The authors gratefully acknowledge the support of the MGH sequencing core facility. The authors wish to thank Michael Waring and Nathalie Bonheur (Ragon Institute Imaging Core, part of the Harvard CFAR Advanced Technologies Core) for technical assistance with flow cytometry and cell sorting and Scott Mordecai (MGH Department of Pathology Flow and Image Cytometry Core, supported in part by an NIH Shared Instrumentation Grant 1S10OD012027-01A1) for support with the Amnis ISX MKII-based ImageStream analysis.	Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Andersson KME, 2015, ONCOTARGET, V6, P20043, DOI 10.18632/oncotarget.4994; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Badley AD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.248; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Clemens MR, 2015, BREAST CANCER RES TR, V149, P171, DOI 10.1007/s10549-014-3238-6; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Cummins NW, 2017, J VIROL, V91, DOI 10.1128/JVI.00012-17; Cummins NW, 2015, ONCOTARGET, V6, P23042, DOI 10.18632/oncotarget.5238; Dabrowska A, 2008, J IMMUNOL, V181, P8460, DOI 10.4049/jimmunol.181.12.8460; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Doitsh G, 2016, CELL HOST MICROBE, V19, P280, DOI 10.1016/j.chom.2016.02.012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng RP, 2013, BIOCHEM J, V450, P459, DOI 10.1042/BJ20120924; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Fukuda S, 2004, BLOOD, V103, P120, DOI 10.1182/blood-2003-05-1756; Gerold JM, 2017, 9 IAS C HIV SCI PAR; Greenwood E. J, 2016, ELIFE, V5, P5; Hogan LE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006856; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Huang SH, 2018, J CLIN INVEST, V128, P876, DOI [10.1172/jci97555, 10.1172/JCI97555]; Jaafoura S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6407; Kim YH, 2010, J ORAL PATHOL MED, V39, P368, DOI 10.1111/j.1600-0714.2009.00844.x; Kiselinova M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005472; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Linghu Bolan, 2013, Methods Mol Biol, V939, P215, DOI 10.1007/978-1-62703-107-3_14; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Munoz-Arias I, 2015, CELL HOST MICROBE, V18, P463, DOI 10.1016/j.chom.2015.09.010; Piekna-Przybylska D, 2017, CELL CYCLE, V16, P968, DOI 10.1080/15384101.2017.1312225; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodel F, 2012, CURR MED CHEM, V19, P3679, DOI 10.2174/092986712801661040; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Ruchaud S, 2007, CELL, V131, P230, DOI 10.1016/j.cell.2007.10.002; Ruggiero A, 2015, EBIOMEDICINE, V2, P1153, DOI 10.1016/j.ebiom.2015.07.025; Sainski AM, 2014, J CELL BIOL, V206, P867, DOI 10.1083/jcb.201405051; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shariat SF, 2009, CLIN CANCER RES, V15, P7012, DOI 10.1158/1078-0432.CCR-08-2554; Sharief MK, 2001, J NEUROIMMUNOL, V119, P358, DOI 10.1016/S0165-5728(01)00389-7; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Svinkina T, 2015, MOL CELL PROTEOMICS, V14, P2429, DOI 10.1074/mcp.O114.047555; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Xie YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep29794; Yoder AC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006226	62	71	72	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1183	+		10.1016/j.immuni.2018.04.004	http://dx.doi.org/10.1016/j.immuni.2018.04.004			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29802019	Green Accepted, Bronze			2022-12-18	WOS:000436456900017
J	Hauser, MA; Schaeuble, K; Kindinger, I; Impellizzieri, D; Krueger, WA; Hauck, CR; Boyman, O; Legler, DF				Hauser, Mark A.; Schaeuble, Karin; Kindinger, Ilona; Impellizzieri, Daniela; Krueger, Wolfgang A.; Hauck, Christof R.; Boyman, Onur; Legler, Daniel F.			Inflammation-Induced CCR7 Oligomers Form Scaffolds to Integrate Distinct Signaling Pathways for Efficient Cell Migration	IMMUNITY			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; CHEMOKINE GRADIENTS; DENDRITIC CELLS; LYMPH-NODE; ACTIVATION; LIGANDS; PHOSPHORYLATION; IMMUNITY; COMPLEX	Host defense depends on orchestrated cell migration guided by chemokines that elicit selective but biased signaling pathways to control chemotaxis. Here, we showed that different inflammatory stimuli provoked oligomerization of the chemokine receptor CCR7, enabling human dendritic cells and T cell subpopulations to process guidance cues not only through classical G protein-dependent signaling but also by integrating an oligomer-dependent Src kinase signaling pathway. Efficient CCR7-driven migration depends on a hydrophobic oligomerization interface near the conserved NPXXY motif of G proteincoupled receptors as shown by mutagenesis screen and a CCR7-SNP demonstrating super-oligomer characteristics leading to enhanced Src activity and superior chemotaxis. Furthermore, Src phosphorylates oligomeric CCR7, thereby creating a docking site for SH2-domain-bearing signaling molecules. Finally, we identified CCL21-biased signaling that involved the phosphatase SHP2 to control efficient cell migration. Collectively, our data showed that CCR7 oligomers serve as molecular hubs regulating distinct signaling pathways.	[Hauser, Mark A.; Schaeuble, Karin; Kindinger, Ilona; Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau BITg, CH-8280 Kreuzlingen, Switzerland; [Impellizzieri, Daniela; Boyman, Onur] Univ Zurich, Univ Zurich Hosp, Dept Immunol, CH-8044 Zurich, Switzerland; [Krueger, Wolfgang A.] Klinikum Konstanz, D-78464 Constance, Germany; [Hauck, Christof R.] Univ Konstanz, Chair Cell Biol, D-78464 Constance, Germany	University of Zurich; University Zurich Hospital; University of Konstanz	Legler, DF (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau BITg, CH-8280 Kreuzlingen, Switzerland.	daniel.legler@bitg.ch		Schauble, Karin/0000-0003-1826-0129; Boyman, Onur/0000-0001-8279-5545; Legler, Daniel F./0000-0001-8610-4764	Swiss National Science Foundation [SNF 31003A_143841]; Novartis Foundation for medical-biological research; Thurgauische Stiftung fur Wissenschaft und Forschung; Swiss State Secretariat for Education, Research and Innovation; Thurgauische Krebsliga	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for medical-biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Thurgauische Stiftung fur Wissenschaft und Forschung; Swiss State Secretariat for Education, Research and Innovation; Thurgauische Krebsliga	We gratefully acknowledge Hesso Farhan for numerous advice and critical reading of the manuscript and Michael Sixt and Marcus Groettrup for support. This study was supported by grants from the Swiss National Science Foundation (SNF 31003A_143841), the Novartis Foundation for medical-biological research, the Thurgauische Stiftung fur Wissenschaft und Forschung, the Swiss State Secretariat for Education, Research and Innovation, and the Thurgauische Krebsliga to D.F.L.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hayasaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117454; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mayya V, 2015, J IMMUNOL METHODS, V416, P84, DOI 10.1016/j.jim.2014.11.004; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mellado M, 1998, J IMMUNOL, V161, P805; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Prasanna X, 2014, BIOPHYS J, V106, P1290, DOI 10.1016/j.bpj.2014.02.002; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Schaeuble K, 2012, J CELL SCI, V125, P4463, DOI 10.1242/jcs.097519; Schaeuble K, 2011, J IMMUNOL, V187, P5645, DOI 10.4049/jimmunol.1101850; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	35	71	72	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					59	72		10.1016/j.immuni.2015.12.010	http://dx.doi.org/10.1016/j.immuni.2015.12.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789922	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000368347000013
J	Chang, SY; Song, JH; Guleng, B; Cotoner, CA; Arihiro, S; Zhao, Y; Chiang, HS; O'Keeffe, M; Liao, GX; Karp, CL; Kweon, MN; Sharpe, AH; Bhan, A; Terhorst, C; Reinecker, HC				Chang, Sun-Young; Song, Joo-Hye; Guleng, Bayasi; Cotoner, Carmen Alonso; Arihiro, Seiji; Zhao, Yun; Chiang, Hao-Sen; O'Keeffe, Michael; Liao, Gongxian; Karp, Christopher L.; Kweon, Mi-Na; Sharpe, Arlene H.; Bhan, Atul; Terhorst, Cox; Reinecker, Hans-Christian			Circulatory Antigen Processing by Mucosal Dendritic Cells Controls CD8(+) T Cell Activation	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL CAPILLARIES; ORAL TOLERANCE; LAMINA-PROPRIA; IN-VIVO; PERMEABILITY; HOMEOSTASIS; AUTOIMMUNE; TRANSPORT; RAT	Circulatory antigens transit through the small intestine via the fenestrated capillaries in the lamina propria prior to entering into the draining lymphatics. But whether or how this process controls mucosal immune responses remains unknown. Here we demonstrate that dendritic cells (DCs) of the lamina propria can sample and process both circulatory and lumina! antigens. Surprisingly, antigen cross-presentation by resident CX3CR1(+) DCs induced differentiation of precursor cells into CD8(+) T cells that expressed interleukin-10 (IL-10), IL-13, and IL-9 and could migrate into adjacent compartments. We conclude that lamina propria CX3CR1(+) DCs facilitate the surveillance of circulatory antigens and act as a conduit for the processing of self- and intestinally absorbed antigens, leading to the induction of CD8(+) T cells, that partake in the control of T cell activation during mucosal immune responses.	[Chang, Sun-Young; Song, Joo-Hye; Guleng, Bayasi; Cotoner, Carmen Alonso; Arihiro, Seiji; Zhao, Yun; Chiang, Hao-Sen; Reinecker, Hans-Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA; [Chang, Sun-Young; Song, Joo-Hye; Guleng, Bayasi; Cotoner, Carmen Alonso; Arihiro, Seiji; Zhao, Yun; Chiang, Hao-Sen; Reinecker, Hans-Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Bhan, Atul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA; [O'Keeffe, Michael; Liao, Gongxian] Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA; [O'Keeffe, Michael; Liao, Gongxian] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Karp, Christopher L.; Terhorst, Cox] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; [Kweon, Mi-Na] Int Vaccine Inst, Mucosal Immunol Sect, Seoul 151818, South Korea; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; International Vaccine Institute; Harvard University; Harvard Medical School	Reinecker, HC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA.	hans-christian_reinecker@hms.havard.edu	Alonso-Cotoner, Carmen/N-7057-2014; Chiang, Hao-Sen/K-7658-2019	Alonso-Cotoner, Carmen/0000-0002-3483-2919; Chiang, Hao-Sen/0000-0001-5041-9705; Karp, Christopher/0000-0002-0832-2659; Guleng, Bayasi/0000-0003-1106-5304	National Institutes of Health [DK-068181, DK-033506, AI093588, DK-043351, AI-057992, DK-52510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093588, R01AI057992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054427, R01DK052510, R01DK068181, P30DK043351, P01DK033506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Author contributions were as follows: S.Y.C., J.-H.S., B.G., C.A.C., S.A., Y.Z., H.-S.C., M.O., and G.L. carried out experiments; M.-N.K. and A.B. provided pathology advice in the assessments of colitis; C.L.K., A.H.S., and C.T. developed research tools and mice; and H.-C.R. directed the research. This work was supported by grants DK-068181 (H.-C.R.), DK-033506 (H.-C.R.), AI093588 (H.-C.R.), DK-043351 (H.-C.R., C.T.), AI-057992 (C.L.K.), and DK-52510 (C.T.) from the National Institutes of Health.	Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; CLEMENTI F, 1969, J CELL BIOL, V41, P33, DOI 10.1083/jcb.41.1.33; COLONY PC, 1985, GASTROENTEROLOGY, V89, P294, DOI 10.1016/0016-5085(85)90329-4; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Danese S, 2011, NAT REV GASTRO HEPAT, V8, P128, DOI 10.1038/nrgastro.2011.17; De Jong YP, 2000, GASTROENTEROLOGY, V119, P715, DOI 10.1053/gast.2000.16485; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; DOBBINS WO, 1970, J ULTRA MOL STRUCT R, V33, P29, DOI 10.1016/S0022-5320(70)90117-6; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Granger D N, 1980, Physiologist, V23, P47; GRANGER DN, 1980, AM J PHYSIOL, V238, pH457, DOI 10.1152/ajpheart.1980.238.4.H457; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; HEYMAN M, 1982, AM J PHYSIOL, V242, pG558, DOI 10.1152/ajpgi.1982.242.6.G558; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kimm MH, 1997, CAN J PHYSIOL PHARM, V75, P193, DOI 10.1139/cjpp-75-3-193; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Lee YH, 2008, J IMMUNOL, V180, P825, DOI 10.4049/jimmunol.180.2.825; LIN T, 1994, EUR J IMMUNOL, V24, P1080, DOI 10.1002/eji.1830240511; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Menager-Marcq I, 2006, GASTROENTEROLOGY, V131, P1775, DOI 10.1053/j.gastro.2006.09.008; MILICI AJ, 1982, AM J ANAT, V165, P165, DOI 10.1002/aja.1001650206; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Reynoso ED, 2009, J IMMUNOL, V182, P2102, DOI 10.4049/jimmunol.0802769; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; SIMIONESCU N, 1972, J CELL BIOL, V53, P365, DOI 10.1083/jcb.53.2.365; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Staton TL, 2006, NAT IMMUNOL, V7, P482, DOI 10.1038/ni1319; Strobel S, 2006, CURR OPIN ALLERGY CL, V6, P207, DOI 10.1097/01.all.0000225162.98391.81; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	46	71	74	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					153	165		10.1016/j.immuni.2012.09.018	http://dx.doi.org/10.1016/j.immuni.2012.09.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23246312	Bronze, Green Accepted			2022-12-18	WOS:000314195500017
J	Chen, Q; Wang, WC; Bruce, R; Li, H; Schleider, DM; Mulbury, MJ; Bain, MD; Wallace, PK; Baumann, H; Evans, SS				Chen, Q; Wang, WC; Bruce, R; Li, H; Schleider, DM; Mulbury, MJ; Bain, MD; Wallace, PK; Baumann, H; Evans, SS			Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress	IMMUNITY			English	Article							PROTEIN-KINASE KINASE; IN-VIVO; LEUKOCYTE RECRUITMENT; SOLUBLE RECEPTOR; HOMING RECEPTOR; HUMAN-MONOCYTES; INHIBITOR; ASSOCIATION; APOPTOSIS; RESPONSES	The physiological benefit of the febrile response is poorly understood. Here we show that fever-range thermal stress enhances the function of the L-selectin lymphocyte homing receptor through an interleukin-6 (IL-6)-dependent signaling mechanism. Thermal stimulation of L-selectin adhesion in vitro and in vivo is mediated by engagement of the gp130 signal-transducing chain by IL-6 and a soluble form of the IL-6 receptor-alpha (sIL-6Ralpha) binding subunit. Thermal control of adhesion is maintained in IL-6-deficient mice through a gp130-dependent compensatory mechanism mediated by IL-6-related cytokines (i.e., oncostatin M [OSM], leukemia inhibitory factor [LIF], and IL-11). Combined biochemical and pharmacological inhibitor (PD98059, U0126, SB203580, SP600125) approaches positioned MEK1/ERK1-2, but not p38 MAPK or JNK in the IL-6/sIL-6Ralpha signaling pathway upstream of activation of L-selectin/cytoskeletal interactions and L-selectin avidity/affinity. These results highlight a role for gp130-linked IL-6/sIL-6Ralpha transsignaling in amplifying lymphocyte trafficking during febrile inflammatory responses.	New York State Dept Hlth, Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; New York State Dept Hlth, Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; New York State Dept Hlth, Roswell Pk Canc Inst, Dept Pathol & Prevent Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Evans, SS (corresponding author), New York State Dept Hlth, Roswell Pk Canc Inst, Dept Immunol, Carlton & Elm St, Buffalo, NY 14263 USA.	sharon.evans@roswellpark.org	Wallace, PK/ABB-7704-2022	Wallace, PK/0000-0001-7823-9917	NCI NIH HHS [CA094045, CA79765, CA16056] Funding Source: Medline; NIDDK NIH HHS [DK33886] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056, P01CA094045, R01CA079765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033886] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Chen Y, 2003, CANCER RES, V63, P3619; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Evans SS, 2000, INT J HYPERTHER, V16, P45, DOI 10.1080/026567300285411; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; EVANS SS, 1993, J CELL BIOL, V123, P1889, DOI 10.1083/jcb.123.6.1889; Evans SS, 1999, J IMMUNOL, V162, P3615; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frey M, 1998, J IMMUNOL, V161, P400; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HEINRICH PC, 1990, CELL, V63, P1149; Hirano T, 1999, BIOCHEM BIOPH RES CO, V260, P303, DOI 10.1006/bbrc.1999.0609; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kim H, 1999, MOL CELL BIOL, V19, P5326; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Leid JG, 2001, J IMMUNOL, V166, P4899, DOI 10.4049/jimmunol.166.8.4899; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Mullin S, 1998, LAT TRADE, V6, P13; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Ndubuisi MI, 1998, J IMMUNOL, V160, P494; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Sehgal PB, 1996, P SOC EXP BIOL MED, V213, P238; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; SIMPSON GG, 1959, COLD SPRING HARB SYM, V24, P255, DOI 10.1101/SQB.1959.024.01.025; STEWART CC, 2001, CELL PREPARATION IDE; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Wang WC, 1998, J IMMUNOL, V160, P961; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu FH, 1998, BLOOD, V92, P241, DOI 10.1182/blood.V92.1.241.413k28_241_251; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738	46	71	76	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					59	70		10.1016/S1074-7613(03)00358-3	http://dx.doi.org/10.1016/S1074-7613(03)00358-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738765	Bronze			2022-12-18	WOS:000221442200007
J	Omori, M; Yamashita, M; Inami, M; Ukai-Tadenuma, M; Kimura, M; Nigo, Y; Hosokawa, H; Hasegawa, A; Taniguchi, M; Nakayama, T				Omori, M; Yamashita, M; Inami, M; Ukai-Tadenuma, M; Kimura, M; Nigo, Y; Hosokawa, H; Hasegawa, A; Taniguchi, M; Nakayama, T			CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; CYTOKINE GENES; IFN-GAMMA; MEDIATED ACTIVATION; DIFFERENTIATION; EXPRESSION; TH1; RECEPTOR; TYPE-2; ACETYLATION	Chromatin remodeling of type 2 cytokine gene loci occurs during differentiation of naive CD4 and CD8 T cells into type 2 helper (Th2) and cytotoxic (Tc2) T cells. IL-4 production and histone hyperacetylation in IL-4-associated nucleosomes in developing Tc2 cells were significantly lower than those of Th2 cells; however, cytokine production and histone hyperacetylation of IL-5 and IL-13 genes were equivalent. Developing Tc2 cells expressed lower GATA3 levels and dramatically increased levels of repressor of GATA (ROG). A ROG response element in the IL-13 gene exon 4 displayed Tc2-specific binding of ROG, HDAC1, and HDAC2 and exhibited repression of IL-4 gene activation. Thus, ROG may confer CD8 T cell-specific repression of histone hyperacetylation and activation of the IL-4 gene locus.	Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chuo Ku, Chiba 2608670, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan; Japan Sci & Technol Corp, PRESTO Project, Yokohama, Kanagawa 2300045, Japan	Chiba University; RIKEN; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		Nakayama, Toshinori/E-1067-2017; Taniguchi, Masaru/N-7932-2015	Nakayama, Toshinori/0000-0002-1434-2007; Taniguchi, Masaru/0000-0001-7821-7179; Hosokawa, Hiroyuki/0000-0002-9592-2889; Omori-Miyake, Miyuki/0000-0002-4643-4045				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Elser B, 2002, IMMUNITY, V17, P703, DOI 10.1016/S1074-7613(02)00471-5; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; FONG TAT, 1990, J IMMUNOL, V144, P1744; Fowler DH, 1996, J IMMUNOL, V157, P4811; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Kelso A, 1997, P NATL ACAD SCI USA, V94, P8070, DOI 10.1073/pnas.94.15.8070; Kemeny DM, 1998, CURR OPIN IMMUNOL, V10, P628, DOI 10.1016/S0952-7915(98)80080-0; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kubo M, 1999, J IMMUNOL, V163, P2432; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; SEDER RA, 1992, J IMMUNOL, V148, P1652; Shibata Y, 2002, J IMMUNOL, V169, P2134, DOI 10.4049/jimmunol.169.4.2134; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Vizler C, 2000, J IMMUNOL, V165, P6314, DOI 10.4049/jimmunol.165.11.6314; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	45	71	72	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					281	294		10.1016/S1074-7613(03)00210-3	http://dx.doi.org/10.1016/S1074-7613(03)00210-3			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932361	Bronze			2022-12-18	WOS:000184929000015
J	Wurzburg, BA; Garman, SC; Jardetzky, TS				Wurzburg, BA; Garman, SC; Jardetzky, TS			Structure of the human IgE-Fc C epsilon 3-C epsilon 4 reveals conformational flexibility in the antibody effector domains	IMMUNITY			English	Article							HIGH-AFFINITY RECEPTOR; HUMAN-IMMUNOGLOBULIN-E; EPSILON-RI; MONOCLONAL-ANTIBODY; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; BINDING-SITE; MURINE IGE; GLYCOSYLATION; FRAGMENT	IgE antibodies mediate antiparasitic immune responses and the inflammatory reactions of allergy and asthma. We have solved the crystal structure of the human IgE-Fc C epsilon 3-C epsilon 4 domains to 2.3 Angstrom resolution. The structure reveals a large rearrangement of the N-terminal C epsilon 3 domains when compared to related IgG-Fc structures and to the IgE-Fc bound to its high-affinity receptor, Fc epsilon RI. The IgE-Fc adopts a more compact, closed configuration that places the two C epsilon 3 domains in close proximity, decreases the size of the interdomain cavity, and obscures part of the FceRI binding site. IgE-Fc conformational flexibility may be required for interactions with two distinct IgE receptors, and the structure suggests strategies for the design of therapeutic compounds for the treatment of IgE-mediated diseases.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Jardetzky, TS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	tedj@northwestern.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU M, 1993, J BIOL CHEM, V268, P13118; BEAVIL AJ, 1995, BIOCHEMISTRY-US, V34, P14449, DOI 10.1021/bi00044a023; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEISENHOFER J, 1976, H-S Z PHYSIOL CHEM, V357, P1421, DOI 10.1515/bchm2.1976.357.2.1421; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; DELSENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361; DORRINGTON KJ, 1978, IMMUNOL REV, V41, P3, DOI 10.1111/j.1600-065X.1978.tb01458.x; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; GRANATO DA, 1987, MOL IMMUNOL, V24, P849, DOI 10.1016/0161-5890(87)90187-8; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1999, ADV IMMUNOL, V72, P191; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; Jardieu PM, 1999, INT ARCH ALLERGY IMM, V118, P112, DOI 10.1159/000024043; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keown MB, 1998, BIOCHEMISTRY-US, V37, P8863, DOI 10.1021/bi972354h; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUND J, 1990, MOL IMMUNOL, V27, P1145, DOI 10.1016/0161-5890(90)90103-7; MATSUDA H, 1990, MOL IMMUNOL, V27, P571, DOI 10.1016/0161-5890(90)90076-C; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Maurer D, 1998, J IMMUNOL, V161, P2731; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISSIM A, 1991, EMBO J, V10, P101, DOI 10.1002/j.1460-2075.1991.tb07925.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PEREZMONTFORT R, 1982, MOL IMMUNOL, V19, P1113, DOI 10.1016/0161-5890(82)90322-4; PRESTA L, 1994, J BIOL CHEM, V269, P26368; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; WEETALL M, 1990, J IMMUNOL, V145, P3849; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193; ZHENG Y, 1991, BIOCHEMISTRY-US, V30, P9125, DOI 10.1021/bi00102a002	50	71	78	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2000	13	3					375	385		10.1016/S1074-7613(00)00037-6	http://dx.doi.org/10.1016/S1074-7613(00)00037-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021535	Bronze			2022-12-18	WOS:000089616400010
J	Gourley, T; Roys, S; Lukacs, NW; Kunkel, SL; Flavell, RA; Chang, CH				Gourley, T; Roys, S; Lukacs, NW; Kunkel, SL; Flavell, RA; Chang, CH			A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production	IMMUNITY			English	Article							MHC CLASS-II; BARE LYMPHOCYTE SYNDROME; CD4(+) T-CELLS; PULMONARY GRANULOMA-FORMATION; TRANSCRIPTION FACTOR GATA-3; CYTOKINE GENE-EXPRESSION; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; TH2 CELLS; NF-AT	Class II transactivator (CIITA) is known as a coactivator for MHC class II gene expression in antigen-presenting cells. Surprisingly, when CIITA(-/-) CD4 T cells were stimulated in the presence of IL-12, they produced not only IFN gamma but also high levels of IL-4. The IL-4 production is due to the accumulation of IL-4 gene transcripts in Th1 cells. This transcriptional control is observed in T cells differentiating to the Th1 but not Th2 lineage, consistent with induction of expression of the CIITA gene in T cells by IFN gamma. Thus, in addition to its role in transactivation of genes involved in antigen presentation, CIITA plays a critical role during the T cell differentiation by negatively regulating the IL-4 gene transcription.	Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06510 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Yale University	Chang, CH (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	heechang@umich.edu	Lukacs, Nicholas W/ABH-5583-2020					Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Carter LL, 1996, CURR OPIN IMMUNOL, V8, P336, DOI 10.1016/S0952-7915(96)80122-1; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHENSUE SW, 1995, J IMMUNOL, V154, P5969; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Chensue SW, 1997, J IMMUNOL, V159, P3565; Chin KC, 1997, J IMMUNOL, V159, P2789; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; CHIN KC, 1994, IMMUNITY, V2, P533; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DAVYDOV IV, 1995, J IMMUNOL, V155, P5273; Dolganov G, 1996, BLOOD, V87, P3316, DOI 10.1182/blood.V87.8.3316.bloodjournal8783316; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; Fontes JD, 1996, J EXP MED, V183, P2517, DOI 10.1084/jem.183.6.2517; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; GOLLOB KJ, 1994, J IMMUNOL, V152, P5180; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HONG Z, 1995, IMMUNITY, V2, P545; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KleinHessling S, 1996, P NATL ACAD SCI USA, V93, P15311, DOI 10.1073/pnas.93.26.15311; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; LIWEBER M, 1994, J IMMUNOL, V153, P4122; LIWEBER M, 1993, J IMMUNOL, V151, P1371; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; MIN LW, 1992, J IMMUNOL, V148, P1913; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; Nakamura T, 1997, J IMMUNOL, V158, P1085; PAUL P, 1991, MICROW OPT TECHN LET, V4, P77, DOI 10.1002/mop.4650040207; PFEIFFER C, 1991, IMMUNOL REV, V123, P65, DOI 10.1111/j.1600-065X.1991.tb00606.x; PRIESCHL EE, 1995, J IMMUNOL, V154, P6112; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; SMITH MR, 1989, P NATL ACAD SCI USA, V86, P8526, DOI 10.1073/pnas.86.21.8526; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Thomas DB, 1996, J IMMUNOL, V157, P2386; TODD MD, 1993, J EXP MED, V177, P1663, DOI 10.1084/jem.177.6.1663; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Wright KL, 1998, P NATL ACAD SCI USA, V95, P6267, DOI 10.1073/pnas.95.11.6267; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	70	71	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1999	10	3					377	386		10.1016/S1074-7613(00)80037-0	http://dx.doi.org/10.1016/S1074-7613(00)80037-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204493	Bronze			2022-12-18	WOS:000079455700010
J	Cressman, DE; Chin, KC; Taxman, DJ; Ting, JPY				Cressman, DE; Chin, KC; Taxman, DJ; Ting, JPY			A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome	IMMUNITY			English	Article							GENE-EXPRESSION; TRANSACTIVATOR CIITA; COMPLEMENTATION GROUP; BINDING-PROTEIN; CELL-LINES; DEFICIENCY; COMPLEX; MUTATIONS; TRANSCRIPTION; IMMUNODEFICIENCY	The severe immunodeficiency type II bare lymphocyte syndrome (BLS) lacks class II MHC gene transcription. One defect from a complementation group A type II BLS patient is a 24 aa deletion in the MHC class II transactivator (CIITA). We show here that the molecular defect present in this protein is a failure of CIITA to undergo nuclear translocation. This defect was mapped to a position-dependent, novel nuclear localization sequence that cannot be functionally replaced by a classical NLS. Fusion of this 5 aa motif to an unrelated protein leads to nuclear translocation. Furthermore, this motif is not critical for transactivation function. This is a description of a genetic disease resulting from a novel defect in the subcellular localization of a transcriptional coactivator.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029564] Funding Source: NIH RePORTER; NCI NIH HHS [CA-09156] Funding Source: Medline; NIAID NIH HHS [AI41751, R01-AI29564-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDULKADIR SA, 1995, FASEB J, V9, P1429, DOI 10.1096/fasebj.9.14.7589984; ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; ARENS MQ, 1987, J INFECT DIS, V156, P837, DOI 10.1093/infdis/156.5.837; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Bontron S, 1997, HUM GENET, V99, P541, DOI 10.1007/s004390050403; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; Douhan J, 1996, J EXP MED, V183, P1063, DOI 10.1084/jem.183.3.1063; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; HAUBER I, 1995, J EXP MED, V181, P1411, DOI 10.1084/jem.181.4.1411; HUME CR, 1989, HUM IMMUNOL, V25, P1, DOI 10.1016/0198-8859(89)90065-7; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LISOWSKAGROSPIERRE B, 1985, J CLIN INVEST, V76, P381, DOI 10.1172/JCI111974; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; PEIJNENBURG A, 1995, IMMUNOGENETICS, V41, P287, DOI 10.1007/BF00172153; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Piskurich JF, 1998, J IMMUNOL, V160, P233; Prieve MG, 1998, MOL CELL BIOL, V18, P4819, DOI 10.1128/MCB.18.8.4819; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; REITH W, 1995, IMMUNOL TODAY, V16, P539, DOI 10.1016/0167-5699(95)80048-4; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Schlenstedt G, 1996, FEBS LETT, V389, P75, DOI 10.1016/0014-5793(96)00583-2; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; TOURAINE JL, 1981, HUM IMMUNOL, V2, P147, DOI 10.1016/0198-8859(81)90061-6; Westerheide SD, 1997, J IMMUNOL, V158, P4812; YANG Z, 1988, EMBO J, V7, P1965, DOI 10.1002/j.1460-2075.1988.tb03034.x; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	48	71	72	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					163	171		10.1016/S1074-7613(00)80017-5	http://dx.doi.org/10.1016/S1074-7613(00)80017-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072069	Green Published, Bronze			2022-12-18	WOS:000078972200004
J	Garboczi, DN; Biddison, WE				Garboczi, DN; Biddison, WE			Shapes of MHC restriction	IMMUNITY			English	Review							T-CELL RECEPTOR; ANTIGEN RECEPTOR; VIRAL PEPTIDES; ALPHA-BETA; NEGATIVE SELECTION; VIRUS TYPE-1; PROTEIN; SPECIFICITY; TCR; CRYSTALLIZATION		NIAID, Struct Biol Sect, NIH, Rockville, MD 20852 USA; NINDS, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Garboczi, DN (corresponding author), NIAID, Struct Biol Sect, NIH, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000835] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arden B, 1998, CURR OPIN IMMUNOL, V10, P74, DOI 10.1016/S0952-7915(98)80035-6; Bentley GA, 1996, ANNU REV IMMUNOL, V14, P563, DOI 10.1146/annurev.immunol.14.1.563; *CPP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; ENGEL I, 1988, CELL, V54, P473, DOI 10.1016/0092-8674(88)90068-2; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Janeway CA, 1997, CURR BIOL, V7, pR299, DOI 10.1016/S0960-9822(06)00142-4; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KATAYAMA CD, 1995, EMBO J, V14, P927, DOI 10.1002/j.1460-2075.1995.tb07074.x; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kostyu DD, 1997, HUM IMMUNOL, V57, P1, DOI 10.1016/S0198-8859(97)00175-4; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHIBATA K, 1992, P NATL ACAD SCI USA, V89, P3135, DOI 10.1073/pnas.89.7.3135; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	44	71	73	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1999	10	1					1	7		10.1016/S1074-7613(00)80001-1	http://dx.doi.org/10.1016/S1074-7613(00)80001-1			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023765	Bronze			2022-12-18	WOS:000078428700001
J	SHACHAR, I; ELLIOTT, EA; CHASNOFF, B; GREWAL, IS; FLAVELL, RA				SHACHAR, I; ELLIOTT, EA; CHASNOFF, B; GREWAL, IS; FLAVELL, RA			RECONSTITUTION OF INVARIANT CHAIN FUNCTION IN TRANSGENIC MICE IN-VIVO BY INDIVIDUAL P-31 AND P41 ISOFORMS	IMMUNITY			English	Article							MHC CLASS-II; HISTOCOMPATIBILITY COMPLEX-MOLECULES; HLA-DR MOLECULES; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; SURFACE EXPRESSION; INFLUENZA-VIRUS; PROTEIN; TRANSPORT; BINDING	MHC class II molecules associate with invariant chain (Ii) during biosynthesis. li facilitates folding of class II molecules, interferes with their association with peptides, and is involved in their transport. The murine ii gene encodes two chains, p31 and p41. The role of these isoforms has been studied in vitro only in inappropriate antigen-presenting cells. To circumvent this problem, we have generated invariant chain-deficient mice (Delta li), which express exclusively the p31 and p41 isoforms. Low level expression of p31 or p41 is not sufficient for rescuing high levels of cell surface class II expression. However, low levels of the typical compact dimer conformation indicative of tight peptide binding are observed. Thus, both isoforms participate in class II folding and assembly. Furthermore, p31 and p41 retrieve the CD4(+) T cell population, which is reduced in the (Delta li) mice. Moreover, the immune response to protein antigen is restored by both isoforms.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510	Howard Hughes Medical Institute; Yale University	SHACHAR, I (corresponding author), YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.			Grewal, Iqbal S/0000-0002-4775-055X				AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BONNEROT C, 1994, EMBO J, V13, P9034; CARDELL S, 1994, ADV IMMUNOL, V55, P423; Chan S H, 1994, Semin Immunol, V6, P241, DOI 10.1006/smim.1994.1031; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; HAMMERLING GJ, 1990, IMMUNOL TODAY, V11, P337; HARDING CV, 1990, CELL REGUL, V1, P499, DOI 10.1091/mbc.1.7.499; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LONG EO, 1994, J IMMUNOL, V153, P1487; LONG EO, 1989, IMMUNOL TODAY, V10, P232, DOI 10.1016/0167-5699(89)90259-4; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOUDGIL KD, 1993, J EXP MED, V178, P2131, DOI 10.1084/jem.178.6.2131; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; PIETERS J, 1993, J CELL SCI, V106, P831; QUI Y, 1994, J CELL BIOL, V125, P595, DOI DOI 10.1083/JCB.125.3.595; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; SCHAIFF WT, 1991, J IMMUNOL, V147, P603; SCHREIBER KL, 1994, INT IMMUNOL, V6, P101, DOI 10.1093/intimm/6.1.101; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; TEYTON L, 1992, NEW BIOL, V4, P441; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; van Meerwijk J P, 1994, Semin Immunol, V6, P231, DOI 10.1006/smim.1994.1030; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; YAMAMOTO K, 1985, J IMMUNOL, V134, P3461	52	71	73	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					373	383		10.1016/1074-7613(95)90121-3	http://dx.doi.org/10.1016/1074-7613(95)90121-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7553001	hybrid			2022-12-18	WOS:A1995RX64500011
J	FARBER, DL; LUQMAN, M; ACUTO, O; BOTTOMLY, K				FARBER, DL; LUQMAN, M; ACUTO, O; BOTTOMLY, K			CONTROL OF MEMORY CD4 T-CELL ACTIVATION - MHC CLASS-II MOLECULES ON APCS AND CD4 LIGATION INHIBIT MEMORY BUT NOT NAIVE CD4 T-CELLS	IMMUNITY			English	Article							MONOCLONAL ANTI-L3T4 ANTIBODIES; IMMUNOLOGICAL MEMORY; ADHESION MOLECULES; NEGATIVE SIGNAL; TYROSINE KINASE; FC-RECEPTORS; ANTIGEN; MOUSE; EXPRESSION; LYMPHOCYTES	Memory or antigen-experienced CD4 T cells differ from naive CD4 T cells both phenotypically by cell surface marker expression, and functionally by their dissimilar pattern of cytokine secretion and activation requirements through their T cell receptor (TCR). We show here that activation of memory CD4 T cells (CD45RB(lc) subset), but not naive CD4 T cells (CD45RB(hl) subset), is inhibited by MHC class II molecules on antigen-presenting cells and by CD4 ligation. We propose that the selective negative signal in memory cells is a direct result of the differences in signaling via CD4 and CD3, exemplified in the disparate pattern of tyrosine-phosphorylated proteins visible after activation of the two subsets. In vivo, this inhibitory signal may serve to prevent irrelevant interactions between memory CD4 T cells and bystander MHC class II+ cells, and may also be responsible for the defective functioning of memory CD4 T cells in AIDS.	INST PASTEUR, DEPT IMMUNOL, MOLEC IMMUNOL LAB, F-75724 PARIS 15, FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	FARBER, DL (corresponding author), YALE UNIV, SCH MED, HOWARD HUGHES MED INST, IMMUNOBIOL SECT, NEW HAVEN, CT 06510 USA.			Farber, Donna/0000-0001-8236-9183	NCI NIH HHS [CA-38350] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038350] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; BANK I, 1985, J EXP MED, V162, P1294, DOI 10.1084/jem.162.4.1294; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; BRADLEY LM, 1992, J IMMUNOL, V148, P324; BRADLEY LM, 1993, IMMUNOL TODAY, V14, P197, DOI 10.1016/0167-5699(93)90161-D; BUDD RC, 1987, J IMMUNOL, V138, P3120; BYRNE JA, 1988, J IMMUNOL, V141, P3249; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; CHUI D, 1994, EMBO J, V13, P798, DOI 10.1002/j.1460-2075.1994.tb06322.x; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; DIANZANI U, 1992, INT IMMUNOL, V4, P995, DOI 10.1093/intimm/4.9.995; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; HAQUE S, 1987, J IMMUNOL, V139, P3207; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; HELBERT MR, 1993, IMMUNOL TODAY, V14, P340, DOI 10.1016/0167-5699(93)90232-A; HORGAN KJ, 1990, EUR J IMMUNOL, V20, P1111, DOI 10.1002/eji.1830200525; HULI J, 1989, J IMMUNOL, V142, P800; JANEWAY CA, 1988, IMMUNOL REV, V101, P39, DOI 10.1111/j.1600-065X.1988.tb00732.x; JENKINS MK, 1992, FASEB J, V6, P2428, DOI 10.1096/fasebj.6.7.1563595; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; LANDAIS D, 1986, J IMMUNOL, V137, P3002; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEE WT, 1990, J IMMUNOL, V144, P3288; LEE WT, 1992, J EXP MED, V176, P575, DOI 10.1084/jem.176.2.575; LEE WT, 1991, CELL IMMUNOL, V132, P215, DOI 10.1016/0008-8749(91)90020-C; LIU Y, 1992, P NATL ACAD SCI USA, V89, P3845, DOI 10.1073/pnas.89.9.3845; LUQMAN M, 1992, J IMMUNOL, V149, P2300; MACKAY CR, 1991, IMMUNOL TODAY, V12, P189, DOI 10.1016/0167-5699(91)90051-T; MAZEROLLES F, 1990, EUR J IMMUNOL, V20, P637, DOI 10.1002/eji.1830200326; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MOEBIUS U, 1992, P NATL ACAD SCI USA, V89, P12008, DOI 10.1073/pnas.89.24.12008; NEWELL MK, 1990, NATURE, V347, P286, DOI 10.1038/347286a0; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; PECK AB, 1973, J IMMUNOL METHODS, V3, P147, DOI 10.1016/0022-1759(73)90030-6; PORTOLES P, 1989, J IMMUNOL, V142, P4169; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; ROSOFF PM, 1987, CELL, V49, P845, DOI 10.1016/0092-8674(87)90622-2; SALMON M, 1989, J IMMUNOL, V143, P907; SAMELSON LE, 1987, J IMMUNOL, V139, P2708; SANDERS ME, 1989, EUR J IMMUNOL, V19, P803, DOI 10.1002/eji.1830190504; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SMITH SH, 1986, IMMUNOLOGY, V58, P63; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TITE JP, 1986, J MOL CELL IMMUNOL, V2, P179; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WARNER NL, 1979, IMMUNOL REV, V48, P197, DOI 10.1111/j.1600-065X.1979.tb00304.x; WASSMER P, 1985, J IMMUNOL, V135, P2237	55	71	71	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1995	2	3					249	259		10.1016/1074-7613(95)90049-7	http://dx.doi.org/10.1016/1074-7613(95)90049-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7535181	hybrid			2022-12-18	WOS:A1995QP27600004
J	Sledzinska, A; de Mucha, MV; Bergerhoff, K; Hotblack, A; Demane, DF; Ghorani, E; Akarca, AU; Marzolini, MAV; Solomon, I; Vargas, FA; Pule, M; Ono, M; Seddon, B; Kassiotis, G; Ariyan, CE; Kom, T; Marafioti, T; Lord, GM; Stauss, H; Jenner, RG; Peggs, KS; Quezada, SA				Sledzinska, Anna; de Mucha, Maria Vila; Bergerhoff, Katharina; Hotblack, Alastair; Demane, Dafne Franz; Ghorani, Ehsan; Akarca, Ayse U.; Marzolini, Maria A., V; Solomon, Isabelle; Vargas, Frederick Arce; Pule, Martin; Ono, Masahiro; Seddon, Benedict; Kassiotis, George; Ariyan, Charlotte E.; Kom, Thomas; Marafioti, Teresa; Lord, Graham M.; Stauss, Hans; Jenner, Richard G.; Peggs, Karl S.; Quezada, Sergio A.			Regulatory T Cells Restrain Interleukin-2-and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4(+) T Cells	IMMUNITY			English	Article							GRANZYME-B; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; DIFFERENTIATION; EFFECTOR; BLIMP-1; CD8(+); BLOCKADE; PERFORIN; MEMORY	In addition to helper and regulatory potential, CD4(+) T cells also acquire cytotoxic activity marked by granzyme B (GzmB) expression and the ability to promote rejection of established tumors. Here, we examined the molecular and cellular mechanisms underpinning the differentiation of cytotoxic CD4(+) T cells following immunotherapy. CD4(+) transfer into lymphodepleted animals or regulatory T (Treg) cell depletion promoted GzmB expression by tumor-infiltrating CD4(+), and this was prevented by interleukin-2 (IL-2) neutralization. Transcriptional analysis revealed a polyfunctional helper and cytotoxic phenotype characterized by the expression of the transcription factors T-bet and Blimp-1. While T-bet ablation restricted interferon-gamma (IFN-gamma) production, loss of Blimp-1 prevented GzmB expression in response to IL-2, suggesting two independent programs required for polyfunctionality of tumor-reactive CD4(+) T cells. Our findings underscore the role of Treg cells, IL-2, and Blimp-1 in controlling the differentiation of cytotoxic CD4(+) T cells and offer a pathway to enhancement of anti-tumor activity through their manipulation.	[Sledzinska, Anna; de Mucha, Maria Vila; Bergerhoff, Katharina; Demane, Dafne Franz; Ghorani, Ehsan; Marzolini, Maria A., V; Solomon, Isabelle; Vargas, Frederick Arce; Peggs, Karl S.; Quezada, Sergio A.] UCL, UCL Canc Inst, Canc Immunol Unit, London WC1E 6DD, England; [Sledzinska, Anna; Bergerhoff, Katharina; Hotblack, Alastair; Demane, Dafne Franz; Ghorani, Ehsan; Marzolini, Maria A., V; Solomon, Isabelle; Vargas, Frederick Arce; Pule, Martin; Peggs, Karl S.; Quezada, Sergio A.] UCL, Canc Inst, Res Dept Haematol, London WC1E 6DD, England; [de Mucha, Maria Vila; Jenner, Richard G.] UCL, UCL Canc Inst, Regulatory Genom Res Grp, London WC1E 6DD, England; [Akarca, Ayse U.; Marafioti, Teresa] Univ Coll London Hosp, Dept Cellular Pathol, London NW1 2BU, England; [Ono, Masahiro] Imperial Coll London, Fac Nat Sci, Dept Life Sci, London SW7 2BB, England; [Seddon, Benedict; Stauss, Hans] Royal Free Hosp, Inst Immun & Transplantat, Dept Immunol, London NW3 2PF, England; [Kassiotis, George] Francis Crick Inst, Retroviral Immunol Lab, 1 Midland Rd, London NW1 1AT, England; [Ariyan, Charlotte E.] Mem Sloan Kettering Ctr, 1275 York Ave, New York, NY 10065 USA; [Kom, Thomas] Tech Univ Munich, Dept Expt Neuroimmunol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Lord, Graham M.] Univ Manchester, Fac Biol Med & Hlth, 46 Grafton St, Manchester M13 9NT, Lancs, England	University of London; University College London; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Francis Crick Institute; Memorial Sloan Kettering Cancer Center; Technical University of Munich; University of Manchester	Peggs, KS; Quezada, SA (corresponding author), UCL, UCL Canc Inst, Canc Immunol Unit, London WC1E 6DD, England.; Peggs, KS; Quezada, SA (corresponding author), UCL, Canc Inst, Res Dept Haematol, London WC1E 6DD, England.	k.peggs@ucl.ac.uk; s.quezada@ucl.ac.uk	Marafioti, Teresa/AAA-4652-2019; Quezada, Sergio/ABF-6466-2020; Jenner, Richard/J-8683-2012	Marafioti, Teresa/0000-0003-1223-6275; Quezada, Sergio/0000-0002-9763-1700; Jenner, Richard/0000-0002-2946-6811; Vila de Mucha, Maria/0000-0003-2085-7143; Lord, Graham/0000-0003-2069-4743	Cancer Research UK (CRUK) senior cancer research fellowship [C36463/A22246]; CRUK career development fellowship [536392/170773]; CRUK biotherapeutic program grant [C36463/A20764]; NIHR BTRU for Stem Cells and Immunotherapies [167097]; Cancer Research Institute investigator award; Worldwide Cancer Research grant; UCL/UCL Hospitals Biomedical Research Centre; CRUK-UCL Centre [C416/A18088]; Cancer Immunotherapy Accelerator Award (CITA-CRUK) [C33499/A20265]; Bloodwise [08022/P4664]; Department of Health; CRUK; MRC [MR/R001413/1]; ERC [CoG 647215]; MRC [MR/M003493/1] Funding Source: UKRI	Cancer Research UK (CRUK) senior cancer research fellowship; CRUK career development fellowship; CRUK biotherapeutic program grant; NIHR BTRU for Stem Cells and Immunotherapies; Cancer Research Institute investigator award; Worldwide Cancer Research grant; UCL/UCL Hospitals Biomedical Research Centre; CRUK-UCL Centre; Cancer Immunotherapy Accelerator Award (CITA-CRUK); Bloodwise; Department of Health; CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Georgiou, D. Zervas, J.Y. Henry, P. Levy, T. Clark, M. Werner Sunderland, E. Hatipoglu, and J. Clancy for technical expertise and W. Day for cell sorting. S.A.Q. is funded by a Cancer Research UK (CRUK) senior cancer research fellowship (C36463/A22246), a CRUK career development fellowship (536392/170773), and a CRUK biotherapeutic program grant (C36463/A20764). K.S.P. receives funding from the NIHR BTRU for Stem Cells and Immunotherapies (167097), of which he is the scientific director. This work was also supported by a Cancer Research Institute investigator award (S.A.Q.), a Worldwide Cancer Research grant (S.A.Q.), UCL/UCL Hospitals Biomedical Research Centre, the CRUK-UCL Centre (C416/A18088), the Cancer Immunotherapy Accelerator Award (CITA-CRUK) (C33499/A20265), Bloodwise (formerly Leukaemia and Lymphoma Research) (08022/P4664), the Department of Health, and CRUK funding schemes for NIHR BRC and Experimental Cancer Medicine Centres. M.V.M. was supported by a CRUK PhD studentship awarded to R.G.J. and S.A.Q. R.G.J and G.M.L were supported by an MRC grant (MR/R001413/1). T.K. was supported by the ERC (CoG 647215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Ariyan CE, 2018, CANCER IMMUNOL RES, V6, P189, DOI 10.1158/2326-6066.CIR-17-0356; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bankoti R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12171-3; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Castro I, 2012, J IMMUNOL, V189, P4321, DOI 10.4049/jimmunol.1202067; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Donnarumma T, 2016, CELL REP, V17, P1571, DOI 10.1016/j.celrep.2016.10.013; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Evans CM, 2013, BRIEF FUNCT GENOMICS, V12, P499, DOI 10.1093/bfgp/elt025; Fu SH, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0354-8; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Hannani D, 2015, CELL RES, V25, P399, DOI [10.1038/cr.2015.28, 10.1038/cr.2015.3]; Hotblack A, 2017, CHARACTERISING ROLE; Hotblack A, 2018, MOL THER, V26, P1471, DOI 10.1016/j.ymthe.2018.03.011; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Juno JA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00019; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kerkar SP, 2011, J IMMUNOTHER, V34, P343, DOI 10.1097/CJI.0b013e3182187600; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kitano S, 2013, CANCER IMMUNOL RES, V1, P235, DOI 10.1158/2326-6066.CIR-13-0068; Kurschus FC, 2004, FEBS LETT, V562, P87, DOI 10.1016/S0014-5793(04)00187-5; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Li QS, 2011, IMMUNITY, V34, P541, DOI 10.1016/j.immuni.2011.04.006; Marafioti T, 2003, BLOOD, V102, P2868, DOI 10.1182/blood-2003-03-0692; Marafioti T, 2008, BLOOD, V111, P3778, DOI 10.1182/blood-2007-10-117531; Marnik EA, 2017, CELL REP, V21, P208, DOI 10.1016/j.celrep.2017.09.036; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; McNamara MJ, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0028-y; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; MUSTAFA AS, 1987, CLIN EXP IMMUNOL, V69, P255; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schey R, 2016, MUCOSAL IMMUNOL, V9, P1205, DOI 10.1038/mi.2015.139; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Takeuchi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00194; Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x; Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Waight JD, 2018, CANCER CELL, V33, P1033, DOI 10.1016/j.ccell.2018.05.005; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Ye CX, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-017-0002-5; Zhou J, 2003, TOXICOL SCI, V73, P72, DOI 10.1093/toxsci/kfg047; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	67	70	73	4	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					151	+		10.1016/j.immuni.2019.12.007	http://dx.doi.org/10.1016/j.immuni.2019.12.007			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31924474	Green Published, hybrid			2022-12-18	WOS:000507384600015
J	Carty, M; Kearney, J; Shanahan, KA; Hams, E; Sugisawa, R; Connolly, D; Doran, CG; Munoz-Wolf, N; Gurtler, C; Fitzgerald, KA; Lavelle, EC; Fallon, PG; Bowie, AG				Carty, Michael; Kearney, Jay; Shanahan, Katharine A.; Hams, Emily; Sugisawa, Ryoichi; Connolly, Dympna; Doran, Ciara G.; Munoz-Wolf, Natalia; Gurtler, Claudia; Fitzgerald, Katherine A.; Lavelle, Ed C.; Fallon, Padraic G.; Bowie, Andrew G.			Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM	IMMUNITY			English	Article							GASDERMIN-D; NLRP3 INFLAMMASOME; PYROPTOSIS; RECEPTOR; PORE; CASPASE-11; SECRETION; MEMBRANE; GSDMD; MITOCHONDRIA	Assembly of inflammasomes after infection or injury leads to the release of interleukin-1 beta (IL-1 beta) and to pyroptosis. After inflammasome activation, cells either pyroptose or enter a hyperactivated state defined by IL-1 beta secretion without cell death, but what controls these different outcomes is unknown. Here, we show that removal of the Toll-IL-1R protein SARM from macrophages uncouples inflammasome-dependent cytokine release and pyroptosis, whereby cells displayed increased IL-1 beta production but reduced pyroptosis. Correspondingly, increasing SARM in cells caused less IL-1 beta release and more pyroptosis. SARM suppressed IL-1 beta by directly restraining the NLRP3 inflammasome and, hence, caspase-1 activation. Consistent with a role for SARM in pyroptosis, Sarm1(-/-) mice were protected from lipopolysaccharide (LPS)-stimulated sepsis. Pyroptosis-inducing, but not hyperactivating, NLRP3 stimulants caused SARM-dependent mitochondrial depolarization. Thus, SARM-dependent mitochondrial depolarization distinguishes NLRP3 activators that cause pyroptosis from those that do not, and SARM modulation represents a cell-intrinsic mechanism to regulate cell fate after inflammasome activation.	[Carty, Michael; Kearney, Jay; Shanahan, Katharine A.; Sugisawa, Ryoichi; Connolly, Dympna; Doran, Ciara G.; Munoz-Wolf, Natalia; Gurtler, Claudia; Lavelle, Ed C.; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Hams, Emily; Fallon, Padraic G.] Trinity Coll Dublin, Sch Med, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	Trinity College Dublin; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	agbowie@tcd.ie	Carty, Michael/AAG-1249-2022; Muñoz-Wolf, Natalia/AAQ-1677-2021; Fallon, Padraic/Y-2711-2019; Carty, Michael/AFK-2889-2022; Fitzgerald, Katherine/ABE-6317-2020	Muñoz-Wolf, Natalia/0000-0002-5173-4026; Fallon, Padraic/0000-0002-8401-7293; Hams, Emily/0000-0002-9745-3246; Sugisawa, Ryoichi/0000-0002-5912-5647; Carty, Michael/0000-0003-1588-7479; Fitzgerald, Kate/0000-0003-3175-609X; Doran, Ciara G/0000-0002-8493-143X; Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [11/PI/1056, 16/IA/4376, 10/IN.1/B3004]; Biotechnology and Biological Sciences Research Council-Science Foundation Ireland joint award (BBSRC-SFI) [BB/P020194/1]; BBSRC [BB/P006078/1, BB/P020194/1] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council-Science Foundation Ireland joint award (BBSRC-SFI)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Sarah Cannon for her assistance with genotyping of the Sarm1<SUP>-/-</SUP> mice. This work was supported by Science Foundation Ireland (11/PI/1056 and 16/IA/4376 to A.G.B.; 10/IN.1/B3004 to P.G.F.) and by a Biotechnology and Biological Sciences Research Council-Science Foundation Ireland joint award (BBSRC-SFI, BB/P020194/1 to A.G.B.).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Carty M, 2019, BIOCHEM PHARMACOL, V161, P52, DOI 10.1016/j.bcp.2019.01.005; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chinnakannan SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057063; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Conos SA, 2016, CELL DEATH DIFFER, V23, P1827, DOI 10.1038/cdd.2016.69; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gurtler C, 2014, J IMMUNOL, V192, P4821, DOI 10.4049/jimmunol.1302980; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Hou YJ, 2013, J IMMUNOL, V191, P875, DOI 10.4049/jimmunol.1300374; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Motani K, 2011, J BIOL CHEM, V286, P33963, DOI 10.1074/jbc.M111.286823; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Prochnicki T, 2017, CELL METAB, V26, P71, DOI 10.1016/j.cmet.2017.06.018; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; Shi H, 2016, BIO PROTOC, V6, pe1986; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Waldhuber A, 2016, J CLIN INVEST, V126, P2425, DOI 10.1172/JCI81916; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z	51	70	74	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1412	+		10.1016/j.immuni.2019.04.005	http://dx.doi.org/10.1016/j.immuni.2019.04.005			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31076360	Bronze			2022-12-18	WOS:000471876100013
J	Dmitrieva-Posocco, O; Dzutsev, A; Posocco, DF; Hou, V; Yuan, WX; Thovarai, V; Mufazalov, IA; Gunzer, M; Shilovskiy, IP; Khaitov, MR; Trinchieri, G; Waisman, A; Grivennikov, SI				Dmitrieva-Posocco, Oxana; Dzutsev, Amiran; Posocco, David F.; Hou, Vivianty; Yuan, Wuxing; Thovarai, Vishal; Mufazalov, Ilgiz A.; Gunzer, Matthias; Shilovskiy, Igor P.; Khaitov, Musa R.; Trinchieri, Giorgio; Waisman, Ari; Grivennikov, Sergei, I			Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; MOUSE MODEL; COLON-CANCER; T-CELLS; TUMORIGENESIS; IL-1-BETA; ACTIVATION; COLITIS; PROGRESSION; METASTASIS	Chronic inflammation drives the progression of colorectal cancer (CRC). Increased expression of interleukin (IL)-17A is associated with poor prognosis, and IL-17A blockade curbs tumor progression in preclinical models of CRC. Here we examined the impact of IL-1 signaling, a key regulator of the IL-17 pathway, in different cell types within the CRC microenvironment. Genetic deletion of the IL-1 receptor (IL-1R1) in epithelial cells alleviated tumorigenesis in the APC model of CRC, demonstrating a cell-autonomous role for IL-1 signaling in early tumor seed outgrowth. T cell specific ablation of IL-1R1 decreased tumor-elicited inflammation dependent on IL-17 and IL-22, thereby reducing CRC progression. The pro-tumorigenic roles of IL-1 were counteracted by its effects on myeloid cells, particularly neutrophils, where IL-1R1 ablation resulted in bacterial invasion into tumors, heightened inflammation and aggressive CRC progression. Thus, IL-1 signaling elicits cell-type-specific responses, which, in aggregate, set the inflammatory tone of the tumor microenvironment and determine the propensity for disease progression.	[Dmitrieva-Posocco, Oxana; Posocco, David F.; Hou, Vivianty; Grivennikov, Sergei, I] Fox Chase Canc Ctr, Canc Prevent & Control Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Dmitrieva-Posocco, Oxana; Shilovskiy, Igor P.; Khaitov, Musa R.] Natl Res Ctr, FMBA, Personalized Med & Mol Immunol, Inst Immunol, Moscow 115478, Russia; [Dzutsev, Amiran; Yuan, Wuxing; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Thovarai, Vishal] Frederick Natl Lab Canc Res, Basic Sci Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Mufazalov, Ilgiz A.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, D-55131 Mainz, Germany; [Gunzer, Matthias] Univ Duisburg Essen, Univ Hosp, Inst Expt Immunol & Imaging, D-45122 Essen, Germany	Fox Chase Cancer Center; NRC Institute of Immunology FMBA of Russia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johannes Gutenberg University of Mainz; University of Duisburg Essen	Grivennikov, SI (corresponding author), Fox Chase Canc Ctr, Canc Prevent & Control Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	sergey.grivennikov@fccc.edu	Trinchieri, Giorgio/F-9369-2015; Gunzer, Matthias/AAW-7026-2021; Mufazalov, Ilgiz/GLN-4021-2022; Khaitov, Musa/AAC-1516-2021; Grivennikov, Sergei/AAE-7365-2019; Igor, Shilovskiy P/N-7720-2016	Trinchieri, Giorgio/0000-0001-5892-7464; Gunzer, Matthias/0000-0002-5534-6055; Mufazalov, Ilgiz/0000-0001-9332-0131; Khaitov, Musa/0000-0003-4961-9640; Grivennikov, Sergei/0000-0003-2987-0555; Igor, Shilovskiy P/0000-0001-5343-4230	NIH [P30 CA-006927, R00 DK088589, R01CA227629]; DFG [CRC/TR 128 TPA03, TPA07]; RSF Grant [N14-15-00894]; Pew Scholar in Biomedical Sciences; AACR-Landon Innovator Awards; ACS-IRG [15-175-22]; PA DOH CURE grant; US-Israel BSF grant; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [R01CA227629, P30CA006927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); RSF Grant(Russian Science Foundation (RSF)); Pew Scholar in Biomedical Sciences; AACR-Landon Innovator Awards; ACS-IRG(American Cancer Society); PA DOH CURE grant; US-Israel BSF grant(US-Israel Binational Science Foundation); Frederick National Laboratory for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Balachandran and G. Rall (FCCC), D. Mucida (Rockefeller University) and R. Locke for critical comments, Dr. E. Koltsova (FCCC) for the help with confocal imaging and reading the manuscript, Aliia Fatkhullina (FCCC) for the help with graphical abstract, and E. Fearon (U Michigan) for CDX2Cre, CDX2ERT, and Apc<SUP>f/f</SUP> mice. We thank Histology laboratory of Department of Pathology at FCCC for tissue processing and slide preparation and LAF, Flow Cytometry, Cell Culture and Microscopy Facilities at FCCC. This work was supported by NIH P30 CA-006927 to FCCC, DFG grant CRC/TR 128 TPA03 and TPA07 to A.W., RSF Grant N14-15-00894 to M.R.K.; as well as by NIH R00 DK088589 and R01CA227629, Pew Scholar in Biomedical Sciences and AACR-Landon Innovator Awards, ACS-IRG #15-175-22, PA DOH CURE and US-Israel BSF grants to S.I.G. This project has been funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Dagenais M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1287247; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elkabets M, 2009, J IMMUNOL, V182, P4874, DOI 10.4049/jimmunol.0803916; Fatkhullina AR, 2018, IMMUNITY, V49, P943, DOI 10.1016/j.immuni.2018.09.011; Feng Y, 2013, AM J PATHOL, V183, P493, DOI 10.1016/j.ajpath.2013.04.013; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hickish T, 2017, LANCET ONCOL, V18, P192, DOI 10.1016/S1470-2045(17)30006-2; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Holen I, 2016, ONCOTARGET, V7, P75571, DOI 10.18632/oncotarget.12289; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kolb R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13007; Malik A, 2016, J CLIN INVEST, V126, P4469, DOI 10.1172/JCI88625; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	49	70	74	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					166	+		10.1016/j.immuni.2018.11.015	http://dx.doi.org/10.1016/j.immuni.2018.11.015			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650375	Green Accepted, Bronze			2022-12-18	WOS:000455661600018
J	Wang, MC; Zhang, SS; Zheng, GX; Huang, JJ; Zhou, SY; Zhao, XQ; Xin, L				Wang, Mingchao; Zhang, Shanshan; Zheng, Guoxing; Huang, Junjiu; Zhou Songyang; Zhao, Xueqiang; Xin Lin			Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A	IMMUNITY			English	Article							KAPPA-B ACTIVATION; INNATE IMMUNITY; MECHANISMS; DISEASE; MICE; AXIS; GENETICS; MODERATE; CARMA1; TARGET	Genetic mutations of CARD14 (encoding CARMA2) are observed in psoriasis patients. Here we showed that Card14(E138A/+) and Card14(Delta Q136/+) mice developed spontaneous psoriasis-like skin inflammation, which resulted from constitutively activated CARMA2 via self-aggregation leading to the enhanced activation of the IL-23-IL-17A cytokine axis. Card14(-/-) mice displayed attenuated skin inflammation in the imiquimod-induced psoriasis model due to impaired IL-17A signaling in keratinocytes. CARMA2, mainly expressed in keratinocytes, associates with the ACT1-TRAF6 signaling complex and mediates IL-17A-induced NF-kappa B and MAPK signaling pathway activation, which leads to expression of pro-inflammatory factors. Thus, CARMA2 serves as a key mediator of IL-17A signaling and its constitutive activation in keratinocytes leads to the onset of psoriasis, which indicates an important role of NF-kappa B activation in keratinocytes in psoriatic initiation.	[Wang, Mingchao; Zhang, Shanshan; Zheng, Guoxing; Zhao, Xueqiang; Xin Lin] Tsinghua Univ, Sch Med, Inst Immunol, Tsinghua Univ Peking Univ Jointed Ctr Life Sci, Beijing 100084, Peoples R China; [Huang, Junjiu; Zhou Songyang] Sun Yat Sen Univ, Inst Hlth Aging Res, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Tsinghua University; Sun Yat Sen University	Zhao, XQ; Xin, L (corresponding author), Tsinghua Univ, Sch Med, Inst Immunol, Tsinghua Univ Peking Univ Jointed Ctr Life Sci, Beijing 100084, Peoples R China.	zhaoxueqiang@tsinghua.edu.cn; linxin307@tsinghua.edu.cn			National Natural Science Foundation of China [81630058, 81570211, 91542107, 31670904]; Tsinghua University-Peking University Jointed Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University-Peking University Jointed Center for Life Sciences	We would like to thank Dr. Chen Dong for providing reagents. This work was partially supported by the grants (81630058, 81570211, and 91542107 to X.L., 31670904 to X.Z.) from National Natural Science Foundation of China, and a start-up fund from Tsinghua University-Peking University Jointed Center for Life Sciences. We thank Daniel C. Lin for editing and proofreading this manuscript.	Afonina IS, 2016, EMBO REP, V17, P914, DOI 10.15252/embr.201642109; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Crow JM, 2012, NATURE, V492, P558, DOI 10.1038/492S58a; Crow JM, 2012, NATURE, V492, P550; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Garber K, 2012, NATURE, V492, P556, DOI 10.1038/492S56a; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Howes A, 2016, BIOCHEM J, V473, P1759, DOI 10.1042/BCJ20160270; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kim J, 2017, ANNU REV MED, V68, P255, DOI 10.1146/annurev-med-042915-103905; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; Mease PJ, 2017, ANN RHEUM DIS, V76, P79, DOI 10.1136/annrheumdis-2016-209709; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; O'Rielly DD, 2014, BEST PRACT RES CL RH, V28, P673, DOI 10.1016/j.berh.2014.10.010; Page A, 2010, J INVEST DERMATOL, V130, P1598, DOI 10.1038/jid.2010.28; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Tanaka M, 2018, J IMMUNOL, V200, P71, DOI 10.4049/jimmunol.1700995; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van de Kerkhof PCM, 2016, J AM ACAD DERMATOL, V75, P83, DOI 10.1016/j.jaad.2016.03.024; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zhao XQ, 2017, NAT MED, V23, P337, DOI 10.1038/nm.4260	38	70	72	7	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					66	+		10.1016/j.immuni.2018.05.012	http://dx.doi.org/10.1016/j.immuni.2018.05.012			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29980436	Bronze			2022-12-18	WOS:000438949100012
J	Olenchock, BA; Rathmell, JC; Heiden, MGV				Olenchock, Benjamin A.; Rathmell, Jeffrey C.; Heiden, Matthew G. Vander			Biochemical Underpinnings of Immune Cell Metabolic Phenotypes	IMMUNITY			English	Review							ELECTRON-TRANSPORT CHAIN; CD8(+) T-CELLS; AEROBIC GLYCOLYSIS; MITOCHONDRIAL BIOGENESIS; TUMOR MICROENVIRONMENT; GLUCOSE-METABOLISM; EFFECTOR RESPONSES; ENERGY-METABOLISM; SKELETAL-MUSCLE; ATPASE ACTIVITY	The metabolism of immune cells affects their function and influences host immunity. This review explores how immune cell metabolic phenotypes reflect biochemical dependencies and highlights evidence that both the metabolic state of immune cells and nutrient availability can alter immune responses. The central importance of oxygen, energetics, and redox homeostasis in immune cell metabolism, and how these factors are reflected in different metabolic phenotypes, is also discussed. Linking immune cell metabolic phenotype to effector functions is important to understand how altering metabolism can impact the way in which immune cells meet their metabolic demands and affect the immune response in various disease contexts.	[Olenchock, Benjamin A.] Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, Boston, MA 02115 USA; [Olenchock, Benjamin A.] Harvard Med Sch, Boston, MA 02115 USA; [Rathmell, Jeffrey C.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Immunobiol, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Heiden, Matthew G. Vander] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Heiden, Matthew G. Vander] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Heiden, Matthew G. Vander] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Olenchock, BA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, Boston, MA 02115 USA.; Olenchock, BA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Heiden, MGV (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Heiden, MGV (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Heiden, MGV (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	bolenchock@bwh.harvard.edu; mvh@mit.edu			NIH [K08 HL119355, R01DK105550, R01CA168653, R01CA201276, SU2C]; Gilead Sciences Research Scholars Program in Cardiovascular Disease; Heart and Vascular Center Junior Faculty Award, Brigham and Women's Hospital; Ludwig Center at MIT; Lustgarten Foundation; HHMI Faculty Scholar award; Fulcrum Therapeutics; Peloton Therapeutics; Bristol-Myers Squibb; Incyte Corp.; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA201276, R01CA168653] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136664, K08HL119355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences Research Scholars Program in Cardiovascular Disease; Heart and Vascular Center Junior Faculty Award, Brigham and Women's Hospital; Ludwig Center at MIT; Lustgarten Foundation; HHMI Faculty Scholar award; Fulcrum Therapeutics; Peloton Therapeutics; Bristol-Myers Squibb(Bristol-Myers Squibb); Incyte Corp.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank William Kaelin (DFCI, HHMI), Sam McBrayer (DFCI), Abhishek Chakraborty (DFCI), Dan Schmidt (MIT), Lucas Sullivan (MIT), and David F. Wilson (University of Pennsylvania) for many helpful discussions and correspondences during the preparation of this manuscript. We also thank members of the Vander Heiden lab for thoughtful comments and give a special thanks to Brooke Bevis for generating the figures. B.A.O. acknowledges support from NIH K08 HL119355, the Gilead Sciences Research Scholars Program in Cardiovascular Disease, and the Heart and Vascular Center Junior Faculty Award, Brigham and Women's Hospital. J.C.R. is supported by NIH R01DK105550. M.G.V.H. acknowledges grant support from NIH R01CA168653, NIH R01CA201276, SU2C, the Ludwig Center at MIT, the Lustgarten Foundation, and an HHMI Faculty Scholar award. B.A.O. received consulting fees from Fulcrum Therapeutics, Peloton Therapeutics, and Bristol-Myers Squibb. J.C.R. receives funding from Incyte Corp. M.G.V.H. is a consultant and scientific advisory board member for Agios Pharmaceuticals and Aeglea Biotherapeutics.	Adams WC, 2016, CELL REP, V17, P3142, DOI 10.1016/j.celrep.2016.11.065; Angelin A., 2017, CELL METAB; Bambrick LL, 2011, BIOTECHNOL PROGR, V27, P1185, DOI 10.1002/btpr.622; Banh RS, 2016, NAT CELL BIOL, V18, P803, DOI 10.1038/ncb3376; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; BERENBAUM MC, 1970, NATURE, V225, P550, DOI 10.1038/225550a0; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; BROOME JD, 1963, J EXP MED, V118, P99, DOI 10.1084/jem.118.1.99; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Bulusu V, 2017, DEV CELL, V40, P331, DOI 10.1016/j.devcel.2017.01.015; Carmona-Fontaine C, 2017, P NATL ACAD SCI USA, V114, P2934, DOI 10.1073/pnas.1700600114; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chamoto K, 2017, P NATL ACAD SCI USA, V114, pE761, DOI 10.1073/pnas.1620433114; Chang C.-H., 2001, MEASURING BIOENERGET; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Connor H, 1982, Ciba Found Symp, V87, P214, DOI 10.1002/9780470720691.ch12; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Deussen A, 2012, J MOL CELL CARDIOL, V52, P794, DOI 10.1016/j.yjmcc.2011.10.001; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; El-Benna J, 2016, IMMUNOL REV, V273, P180, DOI 10.1111/imr.12447; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Flint TR, 2016, CELL METAB, V24, P672, DOI 10.1016/j.cmet.2016.10.010; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; GOLDFINE H, 1965, J GEN PHYSIOL, V49, P253, DOI 10.1085/jgp.49.1.253; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; James JH, 1999, AM J PHYSIOL-ENDOC M, V277, pE176, DOI 10.1152/ajpendo.1999.277.1.E176; Johnson MO, 2016, SEMIN IMMUNOL, V28, P505, DOI 10.1016/j.smim.2016.09.003; Jones RG, 2017, IMMUNITY, V46, P730, DOI 10.1016/j.immuni.2017.04.028; Joshi S, 2015, CELL REP, V13, P1895, DOI 10.1016/j.celrep.2015.10.059; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2016, JAMA-J AM MED ASSOC, V316, P1252, DOI 10.1001/jama.2016.12386; KIDD JG, 1953, J EXP MED, V98, P583, DOI 10.1084/jem.98.6.583; KIDD JG, 1953, J EXP MED, V98, P565, DOI 10.1084/jem.98.6.565; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koch CJ, 2015, SEMIN NUCL MED, V45, P163, DOI 10.1053/j.semnuclmed.2014.10.004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Magistretti PJ, 2016, P NATL ACAD SCI USA, V113, P7015, DOI 10.1073/pnas.1607423113; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; METZEN E, 1995, RESP PHYSIOL, V100, P101, DOI 10.1016/0034-5687(94)00125-J; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mik EG, 2009, J MOL CELL CARDIOL, V46, P943, DOI 10.1016/j.yjmcc.2009.02.002; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; O'Neill L.A., 2017, TRENDS IMMUNOL; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; OCONNOR RJ, 1952, NATURE, V169, P246, DOI 10.1038/169246a0; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Poole DC, 2013, EXP PHYSIOL, V98, P1645, DOI 10.1113/expphysiol.2013.073874; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SAGONE AL, 1974, CELL IMMUNOL, V14, P443, DOI 10.1016/0008-8749(74)90195-6; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Siska PJ, 2016, J IMMUNOL, V197, P2532, DOI 10.4049/jimmunol.1502464; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wilson DF, 2008, AM J PHYSIOL-HEART C, V294, pH11, DOI 10.1152/ajpheart.01293.2007; Wilson DF, 2015, AM J PHYSIOL-ENDOC M, V308, pE506, DOI 10.1152/ajpendo.00544.2014; WILSON DF, 1974, BIOCHEM J, V140, P57, DOI 10.1042/bj1400057; WOLFF M, 1993, AM J PHYSIOL, V265, pC1266, DOI 10.1152/ajpcell.1993.265.5.C1266; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	128	70	71	5	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					703	713		10.1016/j.immuni.2017.04.013	http://dx.doi.org/10.1016/j.immuni.2017.04.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514672	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000401316300001
J	Guo, XH; Liang, Y; Zhang, Y; Lasorella, A; Kee, BL; Fu, YX				Guo, Xiaohuan; Liang, Yong; Zhang, Yuan; Lasorella, Anna; Kee, Barbara L.; Fu, Yang-Xin			Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota	IMMUNITY			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; TISSUE INDUCER CELLS; HUMAN GUT MICROBIOTA; CITROBACTER-RODENTIUM; MUCOSAL INFECTION; TRANSCRIPTION; INTERLEUKIN-22; PROTEINS; NOTCH	Microbiota-mediated effects on the host immune response facilitate colonization resistance against pathogens. However, it is unclear whether and how the host immune response can regulate the microbiota to mediate colonization resistance. ID2, an essential transcriptional regulator for the development of innate lymphoid cell (ILC) progenitors, remains highly expressed in differentiated ILCs with unknown function. Using conditionally deficient mice in which ID2 is deleted from differentiated ILC3s, we observed that these mutant mice exhibited greatly impaired gut colonization resistance against Citrobacter rodentium. Utilizing gnotobiotic hosts, we showed that the ID2-dependent early colonization resistance was mediated by interleukin-22 (IL-22) regulation of the microbiota. In addition to regulating development, ID2 maintained homeostasis of ILC3s and controlled IL-22 production through an aryl hydrocarbon receptor (AhR) and IL-23 receptor pathway. Thus, ILC3s can mediate immune surveillance, which constantly maintains a proper microbiota, to facilitate early colonization resistance through an ID2-dependent regulation of IL-22.	[Guo, Xiaohuan; Liang, Yong; Zhang, Yuan; Kee, Barbara L.; Fu, Yang-Xin] Univ Chicago, Dept Pathol & Comm Immunol, Chicago, IL 60637 USA; [Guo, Xiaohuan] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Liang, Yong; Fu, Yang-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Liang, Yong; Fu, Yang-Xin] Chinese Acad Sci, Inst Biophys, Joint Grp Immunotherapy, Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, Dept Neurol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA	University of Chicago; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Columbia University; Columbia University	Guo, XH (corresponding author), Univ Chicago, Dept Pathol & Comm Immunol, Chicago, IL 60637 USA.	guoxiaohuan@biomed.tsinghua.edu.cn; yfu@uchicago.edu	Guo, Xiaohuan/I-3710-2017	Guo, Xiaohuan/0000-0001-5152-3010; fu, yang-xin/0000-0001-8441-6617; Zhang, Yuan/0000-0003-0022-1201	NIH [AI106352, DK080736, DK095962, DK100427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095962, R01DK080736, R01DK100427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to D. Littman (New York University) for Rorc cre mice, L. Zhou (Northwestern University) for the AhR plasmid, C.R. Nagler (The University of Chicago) for germ-free mice, A.T. Stefka (The University of Chicago) for the analysis of pyrosequencing with bacterial 16S rRNA genes, and W. Ouyang (Genentech) for anti-IL-22 antibody. The work was supported by NIH grants AI106352 (to B.L.K.) and DK080736, DK095962, and DK100427 (to Y.X.F.).	Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Austin M, 2014, AM J MED, V127, P479, DOI 10.1016/j.amjmed.2014.02.017; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Spahn TW, 2004, GASTROENTEROLOGY, V127, P1463, DOI 10.1053/j.gastro.2004.08.022; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang F, 2014, MUCOSAL IMMUNOL, V7, P521, DOI 10.1038/mi.2013.69; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	47	70	75	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					731	743		10.1016/j.immuni.2015.03.012	http://dx.doi.org/10.1016/j.immuni.2015.03.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902484	Bronze, Green Accepted			2022-12-18	WOS:000353347500018
J	Omilusik, K; Priatel, JJ; Chen, XX; Wang, YT; Xu, HJ; Choi, KB; Gopaul, R; McIntyre-Smith, A; Teh, HS; Tan, RS; Bech-Hansen, NT; Waterfield, D; Fedida, D; Hunt, SV; Jefferies, WA				Omilusik, Kyla; Priatel, John J.; Chen, Xiaoxi; Wang, Yiwen Teresa; Xu, Hongjian; Choi, Kyung Bok; Gopaul, Rayshad; McIntyre-Smith, Adam; Teh, Hung-Sia; Tan, Rusung; Bech-Hansen, N. Torben; Waterfield, Douglas; Fedida, David; Hunt, Simon V.; Jefferies, Wilfred A.			The Ca(v)1.4 Calcium Channel Is a Critical Regulator of T Cell Receptor Signaling and Naive T Cell Homeostasis	IMMUNITY			English	Article							MICE LACKING; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; CA2+ CHANNELS; MOUSE RETINA; ACTIVATION; LYMPHOCYTES; SUBUNIT; SELECTION	The transport of calcium ions (Ca2+) to the cytosol is essential for immunoreceptor signaling, regulating lymphocyte differentiation, activation, and effector function. Increases in cytosolic-free Ca2+ concentrations are thought to be mediated through two interconnected and complementary mechanisms: the release of endoplasmic reticulum Ca2+ "stores" and "store-operated" Ca2+ entry via plasma membrane channels. However, the identity of molecular components conducting Ca2+ currents within developing and mature T cells is unclear. Here, we have demonstrated that the L-type "voltage-dependent" Ca2+ channel Ca(v)1.4 plays a cell-intrinsic role in the function, development, and survival of naive T cells. Plasma membrane Ca(v)1.4 was found to be essential for modulation of intracellular Ca2+ stores and T cell receptor (TCR)-induced rises in cytosolic-free Ca2+, impacting activation of Ras-extracellular signal-regulated kinase (ERK) and nuclear factor of activated T cells (NFAT) pathways. Collectively, these studies revealed that Ca(v)1.4 functions in controlling naive T cell homeostasis and antigen-driven T cell immune responses.	[Omilusik, Kyla; Wang, Yiwen Teresa; Choi, Kyung Bok; Gopaul, Rayshad; McIntyre-Smith, Adam; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Omilusik, Kyla; Wang, Yiwen Teresa; Choi, Kyung Bok; Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; [Omilusik, Kyla; Chen, Xiaoxi; Wang, Yiwen Teresa; Choi, Kyung Bok; Gopaul, Rayshad; McIntyre-Smith, Adam; Teh, Hung-Sia; Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Priatel, John J.; Tan, Rusung] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; [Priatel, John J.; Tan, Rusung] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V6T 1Z3, Canada; [Xu, Hongjian; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Choi, Kyung Bok; Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z3, Canada; [Choi, Kyung Bok; Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Waterfield, Douglas] Univ British Columbia, Fac Dent, Dept Oral Biol, Vancouver, BC V6T 1Z3, Canada; [Bech-Hansen, N. Torben] Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Bech-Hansen, N. Torben] Univ Calgary, Fac Med, Dept Surg, Calgary, AB T2N 4N1, Canada; [Hunt, Simon V.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Calgary; University of Calgary; University of Oxford	Jefferies, WA (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wilf@brc.ubc.ca		Tan, Rusung/0000-0002-2204-2004; Omilusik, Kyla/0000-0003-3675-048X; Priatel, John/0000-0001-8794-6306	TRID-CIHR; CIHR; Foundation Fighting Blindness-Canada, Lions Sight Centre; Oxford University; Keble College; Canadian Institutes of Health Research (CIHR) [MOP-102698]	TRID-CIHR(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness-Canada, Lions Sight Centre; Oxford University; Keble College; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The authors thank A. Johnson and L. Xu for expert flow cytometry assistance; M. Gold, T. Snutch, and J. McRory for providing Abs; T. Pearson and J. Schrader for critical reading; T. Murakami for genotyping; and J. Lemmon, L. Munro, and C. Pfeifer for editorial assistance. K.O. is a holder of a TRID-CIHR scholarship award and a CIHR graduate scholarship. N.T.B.-H. is the Roy and Joan Allen Professor in Sight Research and acknowledges grant funding from the Foundation Fighting Blindness-Canada, Lions Sight Centre. S.V.H. received travel awards from Oxford University and Keble College. This work was supported by a grant to W.A.J. from the Canadian Institutes of Health Research (CIHR; MOP-102698).	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; David MD, 2005, J IMMUNOL, V175, P8236, DOI 10.4049/jimmunol.175.12.8236; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Grafton G, 2003, BIOCHEM PHARMACOL, V66, P2001, DOI 10.1016/j.bcp.2003.07.005; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Oh-hora M, 2009, IMMUNOL REV, V231, P210, DOI 10.1111/j.1600-065X.2009.00819.x; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Priatel JJ, 2007, J IMMUNOL, V179, P2143, DOI 10.4049/jimmunol.179.4.2143; Priatel JJ, 2006, J IMMUNOL, V177, P1470, DOI 10.4049/jimmunol.177.3.1470; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suzuki Y, 2008, BIOCHEM PHARMACOL, V75, P1492, DOI 10.1016/j.bcp.2007.12.006; Teixeiro E, 2010, FEBS J, V277, P30, DOI 10.1111/j.1742-4658.2009.07368.x; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Woodard GE, 2008, AM J PHYSIOL-CELL PH, V294, pC1323, DOI 10.1152/ajpcell.00071.2008	37	70	72	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					349	360		10.1016/j.immuni.2011.07.011	http://dx.doi.org/10.1016/j.immuni.2011.07.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21835646	Bronze			2022-12-18	WOS:000295748100007
J	Schnyder, T; Castello, A; Feest, C; Harwood, NE; Oellerich, T; Urlaub, H; Engelke, M; Wienands, J; Bruckbauer, A; Batista, FD				Schnyder, Tim; Castello, Angelo; Feest, Christoph; Harwood, Naomi E.; Oellerich, Thomas; Urlaub, Henning; Engelke, Michael; Wienands, Juergen; Bruckbauer, Andreas; Batista, Facundo D.			B Cell Receptor-Mediated Antigen Gathering Requires Ubiquitin Ligase Cbl and Adaptors Grb2 and Dok-3 to Recruit Dynein to the Signaling Microcluster	IMMUNITY			English	Article							NEGATIVE REGULATION; SYNAPSE FORMATION; TYROSINE KINASES; T-CELLS; ACTIVATION; PROTEIN; MICROTUBULE; LINKS; HDAC6; POLARIZATION	The B cell receptor (BCR) mediates B cell antigen gathering and acquisition for presentation to T cells. Although the amount of antigen presentation to T cells determines the extent of B cell activation, the molecular mechanisms underlying antigen gathering remain unexplored. Here, through a combination of high-resolution imaging, genetics and quantitative mass spectrometry, we demonstrate that adaptors Grb2 and Dok-3, and ubiquitin ligase Cbl in signaling BCR microclusters mediate association with the microtubule motor dynein. Furthermore, we visualize the localization and movement of these microclusters on the underlying microtubule network. Importantly, disruption of this network or diminished dynein recruitment in Grb2-, Dok-3-, or Cbl-deficient B cells, does not influence microcluster formation or actin-dependent spreading, but abrogates directed movement of microclusters and antigen accumulation. Thus we identify a surprising but pivotal role for dynein and the microtubule network alongside Grb2, Dok-3, and Cbl in antigen gathering during B cell activation.	[Schnyder, Tim; Castello, Angelo; Feest, Christoph; Harwood, Naomi E.; Bruckbauer, Andreas; Batista, Facundo D.] Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Oellerich, Thomas; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Gottingen, Univ Med Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Engelke, Michael; Wienands, Juergen] Univ Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany	Cancer Research UK; Max Planck Society; University of Gottingen; University of Gottingen	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	facundo.batista@cancer.org.uk	Feest, Christoph/C-7874-2013; Bruckbauer, Andreas/A-9598-2008; Engelke, Michael/A-6612-2013	Feest, Christoph/0000-0002-0772-7267; Bruckbauer, Andreas/0000-0003-1419-9674; 	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We would like to thank T. Kurosaki for providing DT40 B cell lines, L. Samelson for providing Cbl-YFP, M. Huse for contributing dynein and tubulin constructs, and R. Vallee for providing DYNC1H1 shRNA and dynamitin-GFP constructs. We thank U. Plessmann and M. Raabe for their excellent technical assistance in MS analyses. We would also like to thank the members of Lymphocyte Interaction Laboratory for critical reading of the manuscript. This work was funded by Cancer Research UK.	Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Jacob M, 2008, INT IMMUNOL, V20, P485, DOI 10.1093/intimm/dxn010; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Liu YC, 2002, TRENDS IMMUNOL, V23, P140, DOI 10.1016/S1471-4906(01)02157-3; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; McGrath JL, 2005, CURR BIOL, V15, pR970, DOI 10.1016/j.cub.2005.11.021; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Neumann K, 2009, IMMUNOL REV, V232, P135, DOI 10.1111/j.1600-065X.2009.00845.x; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Oellerich T, 2009, MOL CELL PROTEOMICS, V8, P1738, DOI 10.1074/mcp.M800567-MCP200; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Peters JD, 1996, J BIOL CHEM, V271, P4755; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Stork B, 2007, EMBO J, V26, P1140, DOI 10.1038/sj.emboj.7601557; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068	53	70	71	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 24	2011	34	6					905	918		10.1016/j.immuni.2011.06.001	http://dx.doi.org/10.1016/j.immuni.2011.06.001			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703542	Green Submitted, Bronze			2022-12-18	WOS:000292349700011
J	Wensveen, FM; van Gisbergen, KPJM; Derks, IAM; Gerlach, C; Schumacher, TN; van Lier, RAW; Eldering, E				Wensveen, Felix M.; van Gisbergen, Klaas P. J. M.; Derks, Ingrid A. M.; Gerlach, Carmen; Schumacher, Ton N.; van Lier, Rene A. W.; Eldering, Eric			Apoptosis Threshold Set by Noxa and Mcl-1 after T Cell Activation Regulates Competitive Selection of High-Affinity Clones	IMMUNITY			English	Article							FAMILY-MEMBER BIM; BCL-2 FAMILY; SIGNALING PATHWAYS; BH3-ONLY PROTEIN; IMMUNE-RESPONSE; DEFICIENT MICE; SURVIVAL; PUMA; EXPRESSION; CONTRIBUTES	The adaptive immune system generates protective T cell responses via a poorly understood selection mechanism that favors expansion of clones with optimal affinity for antigen. Here we showed that upon T cell activation, the proapoptotic molecule Noxa (encoded by Pmaip1) and its antagonist Mcl-1 were induced. During an acute immune response against influenza or ovalbumin, Pmaip1(-/-) effector T cells displayed decreased antigen affinity and functionality. Molecular analysis of influenza-specific T cells revealed persistence of many subdominant clones in the Pmaip1(-/-) effector pool. When competing for low-affinity antigen, Pmaip1(-/-) TCR transgenic T cells had a survival advantage in vitro, resulting in increased numbers of effector cells in vivo. Mcl-1 protein stability was controlled by T cell receptor (TCR) affinity-dependent interleukin-2 signaling. These results establish a role for apoptosis early during T cell expansion, based on antigen-driven competition and survival of the fittest T cells.	[Wensveen, Felix M.; van Gisbergen, Klaas P. J. M.; Derks, Ingrid A. M.; van Lier, Rene A. W.; Eldering, Eric] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Gerlach, Carmen; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	Eldering, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.eldering@amc.uva.nl	Schumacher, Ton/Y-2432-2019; Wensveen, Felix/O-3122-2018	Schumacher, Ton/0000-0003-0517-8804; Wensveen, Felix/0000-0002-1333-8882; Gerlach, Carmen/0000-0001-7889-2393; van Lier, Rene/0000-0002-3201-7144; van Gisbergen, Klaas/0000-0003-3623-7555	NWO	NWO(Netherlands Organization for Scientific Research (NWO))	We wish to thank A. Strasser for providing the Noxa-deficient mice, M. Breuer and T. Westphal (Netherlands Cancer Institute) for the p53<SUP>-/-</SUP> tissues, D. Zehn and M. Bevan (HHMI, Seattle, WA) for providing the Listens strains, and the staff of the AMC animal facility for excellent animal care. We are grateful to B. Hooibrink, S. Koch, E. Remmerswaal, R. Spijker, R. Van Olffen, and K. van der Sluijs for technical assistance, and we thank S. Florquin for the pathological analysis of the tissues. K. Oosterhuis helped with the DNA tattooing, and L. Boon generously provided antibodies. We would like to thank P. Klarenbeek and M. Nolte for encouraging discussions and critical reading of the manuscript. This study was partly funded by an NWO VICI grant to R.A.W.v.L.	Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Alves NL, 2007, TRENDS IMMUNOL, V28, P26, DOI 10.1016/j.it.2006.11.003; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Benczik M, 2004, IMMUNOL INVEST, V33, P109, DOI 10.1081/IMM-120030732; Bins AD, 2005, NAT MED, V11, P899, DOI 10.1038/nm1264; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Dessing MC, 2007, CLIN IMMUNOL, V125, P328, DOI 10.1016/j.clim.2007.08.001; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Fischer SF, 2008, P NATL ACAD SCI USA, V105, P3035, DOI 10.1073/pnas.0706913105; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Huntington ND, 2009, INT IMMUNOL, V21, P715, DOI 10.1093/intimm/dxp043; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kedzierska K, 2006, J IMMUNOL, V177, P6705, DOI 10.4049/jimmunol.177.10.6705; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; van Gisbergen KPJM, 2009, J IMMUNOL, V182, P5352, DOI 10.4049/jimmunol.0802809; Venturi V, 2007, J IMMUNOL METHODS, V321, P182, DOI 10.1016/j.jim.2007.01.019; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhong WM, 2004, INT IMMUNOL, V16, P1549, DOI 10.1093/intimm/dxh156	50	70	71	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					754	765		10.1016/j.immuni.2010.06.005	http://dx.doi.org/10.1016/j.immuni.2010.06.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620942	Bronze			2022-12-18	WOS:000279365800007
J	Pajerowski, AG; Nguyen, C; Aghajanian, H; Shapiro, MJ; Shapiro, VS				Pajerowski, Anthony G.; Nguyen, Chau; Aghajanian, Haig; Shapiro, Michael J.; Shapiro, Virginia Smith			NKAP Is a Transcriptional Repressor of Notch Signaling and Is Required for T Cell Development	IMMUNITY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; VULVAL DEVELOPMENT; ALPHA-BETA; PROTEIN; DIFFERENTIATION; EXPRESSION; RECEPTOR; PATHWAY; COMPLEX; COREPRESSOR	T cell development depends on the coordinated interplay between receptor signaling and transcriptional regulation. Through a genetic complementation screen a transcriptional repressor, NKAP, was identified. NKAP associated with the histone deacetylase HDAC3 and was shown to be part of a DNA-binding complex, as demonstrated by chromatin immunoprecipitation. NKAP also associated with the Notch corepressor complex. The expression of NKAP during T cell development inversely correlated with the expression of Notch target genes, implying that NKAP may modulate Notch-mediated transcription. To examine the function of NKAP in T cell development, we ablated NKAP by Lck(cre). Loss of NKAP blocked development of alpha beta but not gamma delta T cells, and Nkap(fl/o)Lck(cre) DP T cells expressed 8- to 20-fold higher amounts of Hes1, Deltex1, and CD25 mRNA. Thus, NKAP functions as a transcriptional repressor, acting on Notch target genes, and is required for alpha beta T cell development.	[Pajerowski, Anthony G.; Nguyen, Chau; Aghajanian, Haig; Shapiro, Michael J.; Shapiro, Virginia Smith] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Pajerowski, Anthony G.; Shapiro, Michael J.; Shapiro, Virginia Smith] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	University of Pennsylvania; Mayo Clinic	Shapiro, VS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	shapiro.virginia1@mayo.edu		Aghajanian, Haig/0000-0002-8317-0157	Arthritis Foundation Investigator Award [NIH R21]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069031] Funding Source: NIH RePORTER	Arthritis Foundation Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Pear, I. Mailliard, T. Kadesch, A. Bhandoola, D. Schultz, and M. Lazar for reagents and thoughtful discussions. We thank members of the Bhandoola and Allman laboratories for flow cytometry assistance and J. Richa for ES cell injection. This work was supported by an Arthritis Foundation Investigator Award and an NIH R21 grant to V.S.S.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Greene TA, 2003, IMMUNOL RES, V27, P513, DOI 10.1385/IR:27:2-3:513; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Michie AM, 2007, INT IMMUNOL, V19, P1421, DOI 10.1093/intimm/dxm113; Nguyen J, 2008, BIOTECHNIQUES, V44, P66, DOI 10.2144/000112681; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Perchonock CE, 2007, J IMMUNOL, V179, P1768, DOI 10.4049/jimmunol.179.3.1768; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Sundaram MV, 2004, CURR BIOL, V14, pR311, DOI 10.1016/j.cub.2004.03.052; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon T, 2008, SEMIN IMMUNOPATHOL, V30, P383, DOI 10.1007/s00281-008-0134-3; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Zhou SF, 2000, J VIROL, V74, P1939, DOI 10.1128/JVI.74.4.1939-1947.2000	35	70	75	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					696	707		10.1016/j.immuni.2009.02.011	http://dx.doi.org/10.1016/j.immuni.2009.02.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19409814	Green Accepted, Bronze			2022-12-18	WOS:000266356900012
J	Yewdell, JW; Del Val, M				Yewdell, JW; Del Val, M			Immunodominance in TCD8(+) responses to viruses: Cell biology, cellular immunology, and mathematical models	IMMUNITY			English	News Item								Highlights from a Fundacion Juan March Interdisciplinary Meeting. CD8(+) T cells (TCD8+) play a critical role in immunity to viruses. A central feature of antiviral TCD8+ responses is immunodominance: out of thousands of potential target peptides, only a handful generate measurable responses. A recent Fundacion Juan March Meeting brought together scientists working on the various steps in antigen presentation and T cell biology that contribute to immunodominance, whose understanding is key to rationally developing vaccines meant to elicit effective antiviral TCD8+ responses.	NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Inmunol Viral, E-28220 Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@nih.gov	Del Val, Margarita/E-4769-2010; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Del Val, Margarita/0000-0001-6769-4279; 				Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	1	70	77	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2004	21	2					149	153		10.1016/j.immuni.2004.06.015	http://dx.doi.org/10.1016/j.immuni.2004.06.015			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308096	Bronze			2022-12-18	WOS:000223441900004
J	Pu, Z; Lovitch, SB; Bikoff, EK; Unanue, ER				Pu, Z; Lovitch, SB; Bikoff, EK; Unanue, ER			T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM	IMMUNITY			English	Article							CLASS-II MOLECULES; HLA-DR MOLECULES; LIPOSOME-ENCAPSULATED ANTIGENS; CRYSTAL-STRUCTURE; INVARIANT CHAIN; HLA-DR4 DRA-ASTERISK-0101; CONFORMATIONAL-CHANGES; POSITIVE SELECTION; FLANKING RESIDUES; EARLY ENDOSOMES	The peptide spanning residues 48-61 of hen egg white lysozyme (HEL) presented by I-A(k) gives rise to two T cell populations, referred to as type A and B, that distinguish the complex generated intracellularly upon processing of HEL from that formed with exogenous peptide. Here, we ascribe this difference to recognition of distinct conformers of the complex and show that formation of the two complexes results from antigen processing in different intracellular compartments and is dependent upon H2-DM. While the type A complex preferentially formed in a lysosome-like late vesicle, the type B complex failed to form in this compartment; this distinction was abolished in antigen-presenting cells lacking DM. Experiments in vitro indicated that H2-DM acts directly on the complex to eliminate the type B conformation. We conclude that different antigen-processing pathways generate distinct MHC-peptide conformers, priming T cells with distinct specificity that may play unique roles in immunity.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Washington University (WUSTL); Harvard University	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	unanue@pathbox.wustl.edu		Lovitch, Scott/0000-0001-9013-0105				Accapezzato D, 1998, J IMMUNOL, V160, P5262; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; Anderson MW, 2003, J IMMUNOL, V171, P5683, DOI 10.4049/jimmunol.171.11.5683; Arnold PY, 2002, J IMMUNOL, V169, P739, DOI 10.4049/jimmunol.169.2.739; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Barlow AK, 1998, J EXP MED, V187, P1403, DOI 10.1084/jem.187.9.1403; Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Busch R, 2002, J IMMUNOL METHODS, V263, P111, DOI 10.1016/S0022-1759(02)00034-0; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; Chervonsky AV, 1998, P NATL ACAD SCI USA, V95, P10094, DOI 10.1073/pnas.95.17.10094; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Cirrito TP, 2001, J EXP MED, V194, P1165, DOI 10.1084/jem.194.8.1165; COLLINS DS, 1992, J IMMUNOL, V148, P3336; CONNOR J, 1984, P NATL ACAD SCI-BIOL, V81, P1715, DOI 10.1073/pnas.81.6.1715; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DAVIS WL, 1991, J CRAN GENET DEV BIO, V11, P105; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Fling SP, 1997, J EXP MED, V186, P1469, DOI 10.1084/jem.186.9.1469; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Griffin JP, 1997, J IMMUNOL, V158, P1523; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Huang JC, 2003, J IMMUNOL, V171, P2467, DOI 10.4049/jimmunol.171.5.2467; Hudson AW, 2002, EXP CELL RES, V272, P1, DOI 10.1006/excr.2001.5402; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Landsteiner K., 1945, SPECIFICITY SEROLOGI; Latek RR, 2000, P NATL ACAD SCI USA, V97, P11460, DOI 10.1073/pnas.210384197; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lindner R, 1996, EMBO J, V15, P6910, DOI 10.1002/j.1460-2075.1996.tb01083.x; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; Lovitch SB, 2003, J IMMUNOL, V170, P4155, DOI 10.4049/jimmunol.170.8.4155; MCCONAHEY P, 1980, IMMUNOCHEMICAL TEC A, V70, P210; Nelson CA, 1996, J IMMUNOL, V157, P755; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; PIERRES M, 1981, IMMUNOGENETICS, V14, P481, DOI 10.1007/BF00350120; Pinet VM, 1998, EUR J IMMUNOL, V28, P799, DOI 10.1002/(SICI)1521-4141(199803)28:03<799::AID-IMMU799>3.0.CO;2-5; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Pu Z, 2002, P NATL ACAD SCI USA, V99, P8844, DOI 10.1073/pnas.092260499; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; ROMAGNOLI P, 1995, J EXP MED, V182, P2027, DOI 10.1084/jem.182.6.2027; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Verreck FAW, 2001, EUR J IMMUNOL, V31, P1029, DOI 10.1002/1521-4141(200104)31:4<1029::AID-IMMU1029>3.0.CO;2-Q; VINER NJ, 1995, P NATL ACAD SCI USA, V92, P2214, DOI 10.1073/pnas.92.6.2214; Viner NJ, 1996, J IMMUNOL, V156, P2365; Viret C, 2003, P NATL ACAD SCI USA, V100, P5354, DOI 10.1073/pnas.0831129100; Viret C, 2001, P NATL ACAD SCI USA, V98, P9243, DOI 10.1073/pnas.161274698; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	73	70	71	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					467	476		10.1016/S1074-7613(04)00073-1	http://dx.doi.org/10.1016/S1074-7613(04)00073-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084275	Bronze			2022-12-18	WOS:000221442800012
J	Wang, XTZ; Stepp, SE; Brehm, MA; Chen, HD; Selin, LK; Welsh, RM				Wang, XTZ; Stepp, SE; Brehm, MA; Chen, HD; Selin, LK; Welsh, RM			Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; FAS LIGAND EXPRESSION; TRANSFORMING-GROWTH-FACTOR; ACUTE VIRAL-INFECTION; DOWN-REGULATION; IMMUNOLOGICAL MEMORY; IMMUNE-DEFICIENCY; CD95 FAS; IN-VIVO; ANTIGEN	CD8 T cells persist at high frequencies in peripheral organs after resolution of an immune response, and their presence in the periphery is important for resistance to secondary challenge. We show here that LCMV-specific T cells in peripheral tissue (peritoneal cavity, lung, fat pads) reacted much less with the apoptotic marker Annexin-V than those in spleen and lymph nodes. This was not due to a TCR-based selection. In comparison to lymphoid tissue, T cells in the periphery expressed lower levels of Fas and Fas ligand and were resistant to activation-induced cell death in vitro. This may contribute to the survival of nondividing peripheral memory T cells, enabling them to efficiently function without being driven into apoptosis.	Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Welsh, RM (corresponding author), Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA.			Brehm, Michael/0000-0001-6813-3262; Selin, Liisa/0000-0002-6993-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017672, R37AI017672, T32AI007272, T32AI007349, R01AI046578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-46578, AI07272, AI17672, AI07349] Funding Source: Medline; NIAMS NIH HHS [AR35506] Funding Source: Medline; NIDDK NIH HHS [DK32520] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Ayroldi E, 1998, BLOOD, V92, P4212, DOI 10.1182/blood.V92.11.4212.423k42_4212_4219; BROOME HE, 1995, J IMMUNOL, V155, P2311; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; DENG G, 1993, P NATL ACAD SCI USA, V90, P2189, DOI 10.1073/pnas.90.6.2189; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; Inaba M, 1999, J IMMUNOL, V163, P1315; JENNE DE, 1988, IMMUNOL REV, V103, P53, DOI 10.1111/j.1600-065X.1988.tb00749.x; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Liu ZX, 2001, J IMMUNOL, V166, P3035, DOI 10.4049/jimmunol.166.5.3035; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; Lohman BL, 1998, J VIROL, V72, P7815, DOI 10.1128/JVI.72.10.7815-7821.1998; MACKAY CR, 1992, EUR J IMMUNOL, V22, P887, DOI 10.1002/eji.1830220402; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mullbacher A, 1996, IMMUNOL REV, V150, P113, DOI 10.1111/j.1600-065X.1996.tb00698.x; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAZVI ES, 1995, J IMMUNOL, V154, P620; RAZVI ES, 1995, AM J PATHOL, V147, P79; RAZVI ES, 1993, J VIROL, V67, P5754, DOI 10.1128/JVI.67.10.5754-5765.1993; Reich A, 2000, EUR J IMMUNOL, V30, P678, DOI 10.1002/1521-4141(200002)30:2<678::AID-IMMU678>3.3.CO;2-H; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; WHITTON JL, 1988, J VIROL, V62, P687, DOI 10.1128/JVI.62.3.687-695.1988; Zimmermann C, 1996, EUR J IMMUNOL, V26, P2903, DOI 10.1002/eji.1830261215; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	50	70	72	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					631	642		10.1016/S1074-7613(03)00116-X	http://dx.doi.org/10.1016/S1074-7613(03)00116-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753740	Bronze			2022-12-18	WOS:000182962200008
J	Tanaka, Y; Bi, K; Kitamura, R; Hong, SJ; Altman, Y; Matsumoto, A; Tabata, H; Lebedeva, S; Bushway, PJ; Altman, A				Tanaka, Y; Bi, K; Kitamura, R; Hong, SJ; Altman, Y; Matsumoto, A; Tabata, H; Lebedeva, S; Bushway, PJ; Altman, A			SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSCRIPTION FACTOR GATA-3; ZAP-70 TYROSINE KINASE; ANTIGEN RECEPTOR; PKC-THETA; C-MAF; IL-4 PRODUCTION; MESSENGER-RNA; SYK FAMILY; IN-VIVO	We describe the isolation of a protein, SWAP-70-like adapter of T cells (SLAT), which is expressed at high levels in thymocytes and differentiated Th2 cells. SLAT expression was upregulated in differentiating Th2 cells and downregulated in Th1 cells. Ectopic SLAT expression exerted positive or negative effects on IL-4 versus IFNgamma induction, respectively. TCR signaling induced translocation of SLAT to the immunological synapse and its association with ZAP-70 kinase. SLAT reduced the association of ZAP-70 with TCR-zeta and interfered with ZAP-70 but not Lck signaling. Consistent with these results, pharmacological inhibition of ZAP-70 also induced Th2 skewing. Thus, SLAT is a protein which plays a role in Th2 development and/or activation, perhaps by interfering with ZAP-70 signaling.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	amnon@liai.org		Altman, Yoav/0000-0001-6075-1111; TANAKA, Yoshihiko/0000-0002-6458-5082	NCI NIH HHS [CA35299] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; AlRamadi BK, 1996, J IMMUNOL, V157, P4751; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Borggrefe T, 1999, EUR J IMMUNOL, V29, P1812, DOI 10.1002/(SICI)1521-4141(199906)29:06<1812::AID-IMMU1812>3.0.CO;2-J; Borggrefe T, 2001, EUR J IMMUNOL, V31, P2467, DOI 10.1002/1521-4141(200108)31:8<2467::AID-IMMU2467>3.0.CO;2-P; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DELPRETE GF, 1991, J CLIN INVEST, V88, P346, DOI 10.1172/JCI115300; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dong C, 2001, J CLIN IMMUNOL, V21, P253, DOI 10.1023/A:1010975124110; Dong C, 2001, CURR OPIN HEMATOL, V8, P47, DOI 10.1097/00062752-200101000-00009; Faith A, 1999, J IMMUNOL, V162, P1836; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110; Glimcher LH, 2000, GENE DEV, V14, P1693; Hannier S, 2002, J IMMUNOL, V169, P1904, DOI 10.4049/jimmunol.169.4.1904; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kaminuma O, 2002, FEBS LETT, V514, P153, DOI 10.1016/S0014-5793(02)02316-5; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; KAYE J, 1992, J IMMUNOL, V148, P3342; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KUMAR V, 1995, P NATL ACAD SCI USA, V92, P9510, DOI 10.1073/pnas.92.21.9510; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; OGARRA A, 1994, CURR OPIN IMMUNOL, V6, P458, DOI 10.1016/0952-7915(94)90128-7; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; Pesch J, 1996, J INTERF CYTOK RES, V16, P595, DOI 10.1089/jir.1996.16.595; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Singh RAK, 1999, J IMMUNOL, V163, P6393; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAMURA T, 1993, J IMMUNOL, V151, P6051; TAMURA T, 1995, J IMMUNOL, V155, P4692; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	64	70	80	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					403	414		10.1016/S1074-7613(03)00054-2	http://dx.doi.org/10.1016/S1074-7613(03)00054-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648457	Bronze			2022-12-18	WOS:000181713700010
J	Malarkannan, S; Horng, T; Eden, P; Gonzalez, F; Shih, P; Brouwenstijn, N; Klinge, H; Christianson, G; Roopenian, D; Shastri, N				Malarkannan, S; Horng, T; Eden, P; Gonzalez, F; Shih, P; Brouwenstijn, N; Klinge, H; Christianson, G; Roopenian, D; Shastri, N			Differences that matter: Major cytotoxic T cell-stimulating minor histocompatibility antigens	IMMUNITY			English	Article							CLASS-I COMPLEXES; EXPRESSION CLONING; H-Y; PEPTIDE; TRANSPLANTATION; IDENTIFICATION; ACTIVATION; INFECTION; DOMINANT; ASSAY	Despite thousands of genetic polymorphisms among MHC matched mouse strains, a few unknown histocompatibility antigens are targeted by the cytotoxic T cells specific for tissue grafts. We isolated the cDNA of a novel BALB.B antigen gene that defines the polymorphic H28 locus on chromosome 3 and yields the naturally processed ILENFPRL (IFL8) peptide for presentation by Kb MHC to C57BI/6 CTL. The CTL specific for the IFL8/K-b and our previously identified H60/K-b complexes represent a major fraction of the B6 anti-BALB.B immune response. The immunodominance of these antigens can be explained by their differential transcription in the donor versus the host strains and their expression in professional donor antigen-presenting cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University of California System; University of California Berkeley; Jackson Laboratory	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.		Malarkannan, Subra/AAQ-9617-2020; Malarkannan, Subramaniam/AAQ-3934-2020	Malarkannan, Subramaniam/0000-0002-7511-2731; Christianson, Gregory/0000-0001-5532-342X				Ausubel FM, 1994, CURRENT PROTOCOLS MO; BAILEY D, 1999, MINOR HISTOCOMPATIBI, P15; BAILEY DW, 1969, TRANSPLANTATION, V7, P394, DOI 10.1097/00007890-196905000-00009; BAILEY DW, 1975, IMMUNOGENETICS, V2, P249, DOI 10.1007/BF01572293; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; DIEFENBACH A, 2000, IN PRESS NAT IMMUNOL; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; Little C C, 1914, Science, V40, P904, DOI 10.1126/science.40.1042.904; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Mendoza LM, 1997, IMMUNITY, V7, P461, DOI 10.1016/S1074-7613(00)80368-4; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nevala WK, 1996, TRANSPLANTATION, V62, P283, DOI 10.1097/00007890-199607270-00022; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; ROTZSCHKE O, 1991, J EXP MED, V174, P1059, DOI 10.1084/jem.174.5.1059; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Shastri N, 1996, CURR OPIN IMMUNOL, V8, P271, DOI 10.1016/S0952-7915(96)80067-7; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; WALLNY HJ, 1990, NATURE, V343, P275, DOI 10.1038/343275a0; WOLPERT E, 1995, INT IMMUNOL, V7, P919, DOI 10.1093/intimm/7.6.919; Zuberi AR, 1998, IMMUNITY, V9, P687, DOI 10.1016/S1074-7613(00)80666-4	31	70	72	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					333	344		10.1016/S1074-7613(00)00033-9	http://dx.doi.org/10.1016/S1074-7613(00)00033-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021531	Bronze			2022-12-18	WOS:000089616400006
J	Thieblemont, N; Thieringer, R; Wright, SD				Thieblemont, N; Thieringer, R; Wright, SD			Innate immune recognition of bacterial lipopolysaccharide: Dependence on interactions with membrane lipids and endocytic movement	IMMUNITY			English	Article							LPS-BINDING-PROTEIN; SOLUBLE CD14; ENDOTOXIN; RESPONSES; CELLS; MACROPHAGES; SPHAEROIDES; ANTAGONISTS; NEUTROPHILS; MOLECULES	Lipopolysaccharide ([LPS], an endotoxin) from most bacterial species provokes a strong inflammatory response in naive animals. LPS from Rhodobacter sphaeroides (RsLPS) has a relatively small hydrophobic region and does not stimulate cells or animals but instead acts as antagonist of LPS action. Here, we show that the activity of RsLPS is transformed from antagonist to full agonist by the addition of chlorpromazine (CPZ) and other cationic membrane-active agents. In addition, while LPS is rapidly transported from the plasma membrane to an intracellular site, we find that RsLPS is not transported but instead remains in the cell periphery. Addition of CPZ also reverses this behavior, causing RsLPS to be transported to a perinuclear site. The data suggest that the interaction of LPS with membrane lipids is influenced by membrane-modifying agents such as CPZ, and these interactions dictate both its intracellular transport and its ability to stimulate cellular responses.	Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company	Wright, SD (corresponding author), Merck Res Labs, Rahway, NJ 07065 USA.	samuel_wright@merck.com	Thieblemont, Nathalie/P-1329-2017	Thieblemont, Nathalie/0000-0002-8898-9217				BARBER SA, 1995, J IMMUNOL, V155, P2303; Brandenburg K, 1996, J ENDOTOXIN RES, V3, P173, DOI 10.1177/096805199600300302; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; CHRIST WJ, 1994, J AM CHEM SOC, V116, P3637, DOI 10.1021/ja00087a075; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; De Costa B.R., 1994, SIGMA RECEPTORS, P45; deKruijff B, 1997, NATURE, V386, P129, DOI 10.1038/386129a0; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; Detmers PA, 1996, J IMMUNOL, V157, P5589; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FUSHITANI K, 1988, J BIOL CHEM, V263, P6502; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hailman E, 1996, J IMMUNOL, V156, P4384; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; JOSEPH CK, 1994, J BIOL CHEM, V269, P17606; KITCHENS RL, 1995, J BIOL CHEM, V270, P9904, DOI 10.1074/jbc.270.17.9904; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KOVACH NL, 1990, J EXP MED, V172, P77, DOI 10.1084/jem.172.1.77; KRZIWON C, 1995, INFECT IMMUN, V63, P2899, DOI 10.1128/IAI.63.8.2899-2905.1995; KUSUNOKI T, 1995, J EXP MED, V182, P1673, DOI 10.1084/jem.182.6.1673; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; Moebius FF, 1997, TRENDS PHARMACOL SCI, V18, P67, DOI 10.1016/S0165-6147(96)01037-1; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; QURESHI N, 1991, J BIOL CHEM, V266, P6532; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Thieblemont N, 1997, J EXP MED, V185, P2095, DOI 10.1084/jem.185.12.2095; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; Vasselon T, 1997, J IMMUNOL, V159, P4498; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Yu B, 1996, J BIOL CHEM, V271, P4100	36	70	70	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					771	777		10.1016/S1074-7613(00)80582-8	http://dx.doi.org/10.1016/S1074-7613(00)80582-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655491	Bronze			2022-12-18	WOS:000074396300013
J	Hostert, A; Tolaini, M; Roderick, K; Harker, N; Norton, T; Kioussis, D				Hostert, A; Tolaini, M; Roderick, K; Harker, N; Norton, T; Kioussis, D			A region in the CD8 gene locus that directs expression to the mature CD8 T cell subset in transgenic mice	IMMUNITY			English	Article							DOMINANT CONTROL REGION; BETA-CHAIN; KINASE P56LCK; BINDING-SITES; HIGH-LEVEL; IDENTIFICATION; MOUSE; LYT-2; TRANSCRIPTION; SELECTION	The coreceptors CD4 and CD8 play a crucial role during thymocyte development and T cell effector function, and their expression is developmentally regulated. To determine the underlying molecular mechanisms of CD8 gene regulation we cloned the murine CD8 gene locus from genomic libraries and analyzed this region for deoxyribonuclease (DNase I) hypersensitive sites (HSS). Here we report, using transgenic mice, deletion analysis of one of the identified clusters of DNase I hypersensitivity, consisting of three DNase I-HSS and located in the intergenic region between the CD8 alpha and CD8 beta genes. Our data show that at least two of the DNase I-HSS constituting this cluster are individually sufficient to direct CD8 alpha or heterologous transgene expression to the mature CD8 single-positive T cell subset and that this expression coincides temporally with the appearance of positively selected T cells.	NATL INST MED RES, DIV MOL IMMUNOL, LONDON NW7 1AA, ENGLAND	MRC National Institute for Medical Research				Harker, Nicola/0000-0003-3612-4366				Adlam M, 1997, INT IMMUNOL, V9, P877, DOI 10.1093/intimm/9.6.877; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BLUM MD, 1993, J EXP MED, V177, P1343, DOI 10.1084/jem.177.5.1343; CROOKS MEC, 1994, IMMUNITY, V1, P277; Donda A, 1996, EUR J IMMUNOL, V26, P493, DOI 10.1002/eji.1830260232; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gao MH, 1996, IMMUNOGENETICS, V45, P130, DOI 10.1007/s002510050180; GAO MH, 1993, J IMMUNOL, V150, P4376; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GODBOUT R, 1986, MOL CELL BIOL, V6, P477, DOI 10.1128/MCB.6.2.477; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GOTTLIEB PD, 1974, J EXP MED, V140, P1432, DOI 10.1084/jem.140.5.1432; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; HANKE JH, 1995, J MOL BIOL, V246, P63, DOI 10.1006/jmbi.1994.0066; Hostert A, 1997, J IMMUNOL, V158, P4270; ITAKURA K, 1972, TRANSPLANTATION, V13, P239, DOI 10.1097/00007890-197203000-00007; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JAY G, 1982, P NATL ACAD SCI-BIOL, V79, P2654, DOI 10.1073/pnas.79.8.2654; KAMOUN M, 1981, J EXP MED, V153, P207, DOI 10.1084/jem.153.1.207; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; LANG G, 1988, EMBO J, V7, P1675, DOI 10.1002/j.1460-2075.1988.tb02995.x; LANG G, 1991, NUCLEIC ACIDS RES, V19, P5851, DOI 10.1093/nar/19.21.5851; LEDBETTER JA, 1981, J EXP MED, V153, P1503, DOI 10.1084/jem.153.6.1503; LEDBETTER JA, 1982, IMMUNOL REV, V68, P197, DOI 10.1111/j.1600-065X.1982.tb01065.x; LEE WH, 1994, INT IMMUNOL, V6, P1307, DOI 10.1093/intimm/6.9.1307; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; PAILLARD F, 1990, EMBO J, V9, P1867, DOI 10.1002/j.1460-2075.1990.tb08312.x; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; PRUZINA S, 1991, NUCLEIC ACIDS RES, V19, P1413, DOI 10.1093/nar/19.7.1413; SALMON P, 1993, P NATL ACAD SCI USA, V90, P7739, DOI 10.1073/pnas.90.16.7739; Salmon P, 1996, J IMMUNOL, V156, P1873; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; Uematsu Y, 1997, INT IMMUNOL, V9, P179, DOI 10.1093/intimm/9.1.179; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0; ZHANG XL, 1994, GENET ANAL-BIOMOL E, V11, P129, DOI 10.1016/1050-3862(94)90033-7	49	70	70	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1997	7	4					525	536		10.1016/S1074-7613(00)80374-X	http://dx.doi.org/10.1016/S1074-7613(00)80374-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354473	Bronze			2022-12-18	WOS:A1997YD59300009
J	Wiest, DL; Ashe, JM; Howcroft, TK; Lee, HM; Kemper, DM; Negishi, I; Singer, DS; Singer, A; Abe, R				Wiest, DL; Ashe, JM; Howcroft, TK; Lee, HM; Kemper, DM; Negishi, I; Singer, DS; Singer, A; Abe, R			A spontaneously arising mutation in the DLAARN motif of murine ZAP-7O abrogates kinase activity and arrests thymocyte development	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; PROTEIN-TYROSINE KINASE; SEVERE COMBINED IMMUNODEFICIENCY; IMMATURE CD4+CD8+ THYMOCYTES; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODY; ZETA-CHAIN; PHOSPHOLIPASE C-GAMMA-1; NEGATIVE SELECTION; T-CELLS	Development of immature CD4(+)CD8(+) thymocytes into functionally mature CD4(+) and CD8(+) T cells is driven by selection events that require signals transduced through the T cell antigen receptor (TCR). Transduction of TCR signals in the thymus involves tyrosine phosphorylation of the protein tyrosine kinase ZAP-70 by p56(lck) and results in induction of ZAP-70 enzymatic activity. We have identified a novel, spontaneously arising point mutation within a highly conserved motif (DLAARN) in the kinase domain of murine ZAP-70 that uncouples tyrosine phosphorylation of ZAP-70 from induction of ZAP-70 kinase activity. Mice homozygous for this mutation are devoid of mature T cells because thymocyte development is arrested at the CD4(+)CD8(+) stage of differentiation. The developmental arrest is due to the inability of CD4(+)CD8(+) thymocytes to propagate TCR signals in the absence of ZAP-70 kinase activity despite tyrosine phosphorylation of TCR-associated ZAP-70 molecules.	NCI, EXPT IMMUNOL BRANCH, NIH, BETHESDA, MD 20892 USA; USN, MED RES INST, IMMUNE CELL BIOL DEPT, BETHESDA, MD 20889 USA; NIPPON ROCHE RES CTR, KAMAKURA, KANAGAWA 247, JAPAN; SCI UNIV TOKYO, RES INST BIOL SCI, DIV IMMUNOBIOL, TOKYO, CHIBA 278, JAPAN	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy; Roche Holding; Tokyo University of Science				Wiest, David/0000-0002-0792-3188				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; ASENSI V, 1989, IMMUNOLOGY, V68, P204; BOLEN JB, 1995, CURR OPIN IMMUNOL, V7, P306, DOI 10.1016/0952-7915(95)80103-0; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; GELFAND EW, 1995, J EXP MED, V182, P1057, DOI 10.1084/jem.182.4.1057; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Kong GH, 1996, MOL CELL BIOL, V16, P5026; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280; LITTMAN DR, 1994, ADV EXP MED BIOL, V365, P63; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WANGE RL, 1995, J BIOL CHEM, V270, P944, DOI 10.1074/jbc.270.2.944; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WATTS JD, 1994, J BIOL CHEM, V269, P29520; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	45	70	72	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1997	6	6					663	671		10.1016/S1074-7613(00)80442-2	http://dx.doi.org/10.1016/S1074-7613(00)80442-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208839	Bronze			2022-12-18	WOS:A1997XG57900002
J	Duncliffe, KN; Bert, AG; Vadas, MA; Cockerill, PN				Duncliffe, KN; Bert, AG; Vadas, MA; Cockerill, PN			A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; OCTAMER-BINDING-PROTEIN; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CYCLOSPORINE-A; NUCLEAR FACTOR; PROMOTER ELEMENTS; MOLECULAR-CLONING; IDENTIFICATION; FAMILY	Interleukin-3 (IL-3) is a cytokine that is expressed primarily in activated T cells. Here we identified an inducible T cell-specific enhancer 14 kb upstream of the IL-3 gene that responded to activation of T cell receptor signaling pathways. The IL-3 enhancer spanned an inducible cyclosporin A-sensitive DNase I-hypersensitive site found only in T cells. Four NFAT-like elements exist within the enhancer. The two most active NFAT-like elements were located at the center of the DNase I-hypersensitive site. One of these NFAT-like elements encompassed overlapping Oct- and NFATp/c-binding sites, which functioned in a highly synergistic manner. We suggest that the T cell-specific expression of the IL-3 gene is partly controlled through the enhancer by cooperation between Oct and NFAT family proteins.	INST MED & VET SCI,DIV HUMAN IMMUNOL,HANSON CTR CANC RES,ADELAIDE,SA 5000,AUSTRALIA	Institute Medical & Veterinary Science Australia			Vadas, Mathew/R-1378-2019	Bert, Andrew/0000-0003-3876-1537; Cockerill, Peter/0000-0002-4410-8174				BHARGAVA AK, 1993, P NATL ACAD SCI USA, V90, P10260, DOI 10.1073/pnas.90.21.10260; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; CAMERON S, 1994, BLOOD, V83, P2851, DOI 10.1182/blood.V83.10.2851.2851; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL GW, 1995, BLOOD, V86, P2689; Cockerill PN, 1996, CELL GROWTH DIFFER, V7, P917; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAVIES K, 1993, BLOOD, V81, P928; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; FITZPATRICK DR, 1995, J IMMUNOL, V155, P5140; FROLOVA EI, 1991, P NATL ACAD SCI USA, V88, P4821, DOI 10.1073/pnas.88.11.4821; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GOTTSCHALK LR, 1993, J EXP MED, V178, P1681, DOI 10.1084/jem.178.5.1681; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JONGSTRA J, 1984, NATURE, V307, P708, DOI 10.1038/307708a0; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099, DOI 10.1128/MCB.14.8.5099; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MASUDA ES, 1993, IMMUNOLOGIST, V1, P198; MATHEYPREVOT B, 1990, P NATL ACAD SCI USA, V87, P5046, DOI 10.1073/pnas.87.13.5046; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OSBORNE CS, 1995, J IMMUNOL, V155, P226; PARK JH, 1993, J BIOL CHEM, V268, P6299; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SHANNON MF, 1988, P NATL ACAD SCI USA, V85, P674, DOI 10.1073/pnas.85.3.674; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHOEMAKER SG, 1990, P NATL ACAD SCI USA, V87, P9650, DOI 10.1073/pnas.87.24.9650; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; TODD MD, 1993, J EXP MED, V177, P1663, DOI 10.1084/jem.177.6.1663; Tsuruta L, 1995, J ALLERGY CLIN IMMUN, V96, P1126, DOI 10.1016/S0091-6749(95)70197-4; YANG YC, 1988, BLOOD, V71, P958; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	55	70	72	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					175	185		10.1016/S1074-7613(00)80424-0	http://dx.doi.org/10.1016/S1074-7613(00)80424-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047239	Bronze			2022-12-18	WOS:A1997XC61600007
J	Sun, SQ; Cai, ZL; LangladeDemoyen, P; Kosaka, H; Brunmark, A; Jackson, MR; Peterson, PA; Sprent, J				Sun, SQ; Cai, ZL; LangladeDemoyen, P; Kosaka, H; Brunmark, A; Jackson, MR; Peterson, PA; Sprent, J			Dual function of Drosophila cells as APCs for naive CD8(+) T cells: Implications for tumor immunotherapy	IMMUNITY			English	Article							TOXIC LYMPHOCYTE-T; CLASS-I; MONOCLONAL-ANTIBODIES; CLONAL EXPANSION; ANTIGEN RECEPTOR; EXPRESSION; SUBSETS; CTLA-4; REJECTION; PROTEIN	With unseparated mouse spleen cells as responders, Drosophila cells expressing MHC class I (L(d)) molecules alone lead to peptide-specific responses of CD8(+) cells in the absence of exogenous cytokines. Under these conditions, DNA released from dying cells stimulates the B cells in spleen to up-regulate costimulatory molecules; these activated B cells then provide bystander costimulation for CD8(+) cells responding to class I-peptide complexes on the Drosophila APCs. By stimulating B cells and presenting antigen to T cells, Drosophila cells thus serve two different functions in promoting primary responses of CD8(+) cells in vitro. With this system, we show that L(d)-transfected Drosophila cells are able to induce autologous spleen cells to respond to a tumor-specific peptide in vitro and, after transfer, cause tumor rejection in vivo.			Sun, SQ (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, IMM4, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NCI NIH HHS [CA38355, CA25803] Funding Source: Medline; NIAID NIH HHS [AI21487] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA038355, R01CA038355, P01CA025803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BRUCE J, 1981, J IMMUNOL, V127, P2496; CAI ZL, 1994, J EXP MED, V179, P2005, DOI 10.1084/jem.179.6.2005; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DING L, 1994, EUR J IMMUNOL, V24, P859, DOI 10.1002/eji.1830240413; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Germain Ronald N., 1993, P629; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; LANE P, 1993, IMMUNOLOGY, V80, P56; LIU Y, 1992, P NATL ACAD SCI USA, V89, P3845, DOI 10.1073/pnas.89.9.3845; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; OZATO K, 1981, J IMMUNOL, V126, P317; Pisetsky DS, 1996, J IMMUNOL, V156, P421; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; SPRENT J, 1985, J EXP MED, V162, P2068, DOI 10.1084/jem.162.6.2068; STRAUSS WM, 1990, CURR PROT MOL BIOL, V1; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; WHITTON JL, 1989, J VIROL, V63, P4303, DOI 10.1128/JVI.63.10.4303-4310.1989	34	70	78	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1996	4	6					555	564		10.1016/S1074-7613(00)80482-3	http://dx.doi.org/10.1016/S1074-7613(00)80482-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673702	Bronze			2022-12-18	WOS:A1996UU44300004
J	Delacher, M; Imbusch, CD; Hotz-Wagenblatt, A; Mallm, JP; Bauer, K; Simon, M; Riegel, D; Rendeiro, AF; Bittner, S; Sanderink, L; Pant, A; Schmidleithner, L; Braband, KL; Echtenachter, B; Fischer, A; Giunchiglia, V; Hoffmann, P; Edinger, M; Bock, C; Rehli, M; Brors, B; Schmidl, C; Feuerer, M				Delacher, Michael; Imbusch, Charles D.; Hotz-Wagenblatt, Agnes; Mallm, Jan-Philipp; Bauer, Katharina; Simon, Malte; Riegel, Dania; Rendeiro, Andre F.; Bittner, Sebastian; Sanderink, Lieke; Pant, Asmita; Schmidleithner, Lisa; Braband, Kathrin L.; Echtenachter, Bernd; Fischer, Alexander; Giunchiglia, Valentina; Hoffmann, Petra; Edinger, Matthias; Bock, Christoph; Rehli, Michael; Brors, Benedikt; Schmidl, Christian; Feuerer, Markus			Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF	IMMUNITY			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; ACCUMULATION; AUTOIMMUNITY; POPULATION; ALIGNMENT; ELEMENTS; FATE	Specialized regulatory T (Treg) cells accumulate and perform homeostatic and regenerative functions in nonlymphoid tissues. Whether common precursors for nonlymphoid-tissue Treg cells exist and how they differentiate remain elusive. Using transcription factor nuclear factor, interleukin 3 regulated (Nfil3) reporter mice and single-cell RNA-sequencing (scRNA-seq), we identified two precursor stages of interleukin 33 (IL-33) receptor ST2-expressing non lymphoid tissue Treg cells, which resided in the spleen and lymph nodes. Global chromatin profiling of nonlymphoid tissue Treg cells and the two precursor stages revealed a stepwise acquisition of chromatin accessibility and reprogramming toward the nonlymphoid-tissue Treg cell phenotype. Mechanistically, we identified and validated the transcription factor Batf as the driver of the molecular tissue program in the precursors. Understanding this tissue development program will help to harness regenerative properties of tissue Treg cells for therapy.	[Delacher, Michael; Riegel, Dania; Bittner, Sebastian; Sanderink, Lieke; Pant, Asmita; Schmidleithner, Lisa; Echtenachter, Bernd; Hoffmann, Petra; Edinger, Matthias; Rehli, Michael; Schmidl, Christian; Feuerer, Markus] Regensburg Ctr Intervent Immunol RCI, Franz Josef Str Allee 11, D-93053 Regensburg, Germany; [Delacher, Michael; Bittner, Sebastian; Sanderink, Lieke; Pant, Asmita; Schmidleithner, Lisa; Echtenachter, Bernd; Feuerer, Markus] Regensburg Univ, Chair Immunol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany; [Delacher, Michael; Braband, Kathrin L.; Feuerer, Markus] German Canc Res Ctr, Tumor Immunol Program, Immune Tolerance Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Imbusch, Charles D.; Simon, Malte; Giunchiglia, Valentina] Heidelberg Univ, Fac Biosci, Neuenheimer Feld 234, D-69120 Heidelberg, Germany; [Imbusch, Charles D.; Simon, Malte; Giunchiglia, Valentina; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Genom & Prote Core Facil, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Mallm, Jan-Philipp; Bauer, Katharina] German Canc Res Ctr, Div Chromatin Networks, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Mallm, Jan-Philipp; Bauer, Katharina] German Canc Res Ctr, Single Cell Open Lab, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Rendeiro, Andre F.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14, A-1090 Vienna, Austria; [Fischer, Alexander; Hoffmann, Petra; Edinger, Matthias; Rehli, Michael] Univ Hosp Regensburg, Hematol & Oncol, Dept Internal Med 3, Franz Josef Str Allee 11, D-93053 Regensburg, Germany; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Spitalgasse 23, A-1090 Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, Saarland Informat Campus, D-66123 Saarbrucken, Germany; [Bock, Christoph] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Lazarettgasse 14, A-1090 Vienna, Austria; [Brors, Benedikt] Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, D-69120 Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, German Canc Consortium DKTK, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	University of Regensburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Regensburg; Medical University of Vienna; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Feuerer, M (corresponding author), Regensburg Ctr Intervent Immunol RCI, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.; Feuerer, M (corresponding author), Regensburg Univ, Chair Immunol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.; Feuerer, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Immune Tolerance Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	markus.feuerer@ukr.de	Bock, Christoph/AAE-7618-2019; Delacher, Michael/AAM-9710-2021; Schmidl, Christian/HDO-6299-2022; Brors, Benedikt/E-5620-2013; Rendeiro, Andre/C-1641-2009	Bock, Christoph/0000-0001-6091-3088; Schmidl, Christian/0000-0002-0522-202X; Brors, Benedikt/0000-0001-5940-3101; Mallm, Jan-Philipp/0000-0002-7059-4030; Giunchiglia, Valentina/0000-0002-2165-7840; Rendeiro, Andre/0000-0001-9362-5373	European Research Council (ERC-CoG) [648145]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [324392634-TRR 221]; University of Regensburg (ReForM C program); German-Israeli Helmholtz Research School in Cancer Biology; German Ministry of Research and Education (BMBF) [031L0076A, 01KU1216B]	European Research Council (ERC-CoG); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); University of Regensburg (ReForM C program); German-Israeli Helmholtz Research School in Cancer Biology; German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank A. Rudensky (Memorial Sloan Kettering Cancer Center) for providing mice and Gunter Kublbeck (DKFZ) for help with the BAC construct. We thank the DKFZ core facilities Preclinical Research, Flow Cytometry and Genomics & Proteomics for technical support. We thank Sabine Schmitt (DKFZ), Marina Wuttke, Brigitte Ruhland, Kathrin Schambeck, Veronika Hofmann, Brigitte Wild, Manuela Kovacs-Sauter, and David Dittmar (all RCI) for technical support. We thank the RCI flow cytometry core facility, the RCI NGS core facility, and Animal Facility Regensburg University for technical support. This work was supported by grants from the European Research Council (ERC-CoG, 648145 REGiREG) to M.F.; the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (Projektnummer 324392634-TRR 221) to M.F. (Project B08) and P.H., M.E., and M.R. (Project B07); and a faculty grant from the University of Regensburg (ReForM C program) to M.F. M.D. was supported by the German-Israeli Helmholtz Research School in Cancer Biology. B.B. received funding from the German Ministry of Research and Education (BMBF) (031L0076A and 01KU1216B).	Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bao K, 2016, J IMMUNOL, V197, P4371, DOI 10.4049/jimmunol.1601371; Bluestone JA, 2018, SCIENCE, V362, P154, DOI 10.1126/science.aau2688; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cossarizza A, 2019, EUR J IMMUNOL, V49, P1457, DOI 10.1002/eji.201970107; Delacher M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09276-w; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hasan Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15628; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmid C, 2018, J ALLERGY CLIN IMMUN, V142, P728, DOI [10.1016/j.jaci.2018.07.014, 10.1016/j.jaci..2018.07.014]; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Sullivan JM, 2019, J IMMUNOL, V202, P31, DOI 10.4049/jimmunol.1800917; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yamazaki S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17597-3; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	54	69	70	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					295	+		10.1016/j.immuni.2019.12.002	http://dx.doi.org/10.1016/j.immuni.2019.12.002			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	31924477	Green Published, hybrid			2022-12-18	WOS:000515082000012
J	Wang, TT; Fan, CG; Yao, AR; Xu, XW; Zheng, GX; You, Y; Jiang, CY; Zhao, XQ; Hou, YY; Hung, MC; Lin, X				Wang, Tingting; Fan, Chaogang; Yao, Anran; Xu, Xingwei; Zheng, Guoxing; You, Yun; Jiang, Changying; Zhao, Xueqiang; Hou, Yayi; Hung, Mien-Chie; Lin, Xin			The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; GUT MICROBIOTA; COLORECTAL-CANCER; CANDIDA-ALBICANS; IMMUNE-RESPONSES; INTESTINAL INFLAMMATION; ANTIFUNGAL IMMUNITY; INNATE IMMUNE; HOST-DEFENSE	The adaptor protein CARD9 links detection of fungi by surface receptors to the activation of the NF-kappa B pathway. Mice deficient in CARD9 exhibit dysbiosis and are more susceptible to colitis. Here we examined the impact of Card9 deficiency in the development of colitis-associated colon cancer (CAC). Treatment of Card9(-/-) ice with AOM-DSS resulted in increased tumor loads as compared to WT mice and in the accumulation of myeloid-derived suppressor cells (MDSCs) in tumor tissue. The impaired fungicidal functions of Card9(-/-) macrophages led to increased fungal loads and variation in the overall composition of the intestinal mycobiota, with a notable increase in C. tropicalis. Bone marrow cells incubated with C. tropicalis exhibited MDSC features and suppressive functions. Fluconazole treatment suppressed CAC in Card9(-/-) mice and was associated with decreased MDSC accumulation. The frequency of MDSCs in tumor tissues of colon cancer patients correlated positively with fungal burden, pointing to the relevance of this regulatory axis in human disease.	[Wang, Tingting; Yao, Anran; Hou, Yayi] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, State Key Lab Pharmaceut Biotechnol,Div Immunol, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Tingting; You, Yun; Jiang, Changying; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Fan, Chaogang; Xu, Xingwei] Nanjing Univ, Sch Med, Jinling Hosp, Gen Surg, Nanjing 210093, Jiangsu, Peoples R China; [Zheng, Guoxing; Zhao, Xueqiang; Lin, Xin] Tsinghua Univ, Inst Immunol, Sch Med, Beijing 100084, Peoples R China; [Zheng, Guoxing; Lin, Xin] Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing 100084, Peoples R China	Nanjing University; University of Texas System; UTMD Anderson Cancer Center; Nanjing University; Tsinghua University	Wang, TT (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, State Key Lab Pharmaceut Biotechnol,Div Immunol, Nanjing 210093, Jiangsu, Peoples R China.; Wang, TT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Lin, X (corresponding author), Tsinghua Univ, Inst Immunol, Sch Med, Beijing 100084, Peoples R China.; Lin, X (corresponding author), Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing 100084, Peoples R China.	wangtt@nju.edu.cn; linxin307@tsinghua.edu.cn	wang, tingting/AAK-2640-2020; Hung, Mien-Chie/ABD-5911-2021; Jiang, Changying/AAL-3711-2020	Hung, Mien-Chie/0000-0003-4317-4740; Jiang, Changying/0000-0003-3778-4438	National Natural Science Foundation of China [81572354, 81772542, 81630058, 91542107]; National Institutes of Health [AI116722]; Center for Inflammation and Cancer in MDACC; Natural Science Foundation of Jiangsu Province in China [BK20161400]; Top six talent project in Jiangsu Province [WSW-031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116722] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Inflammation and Cancer in MDACC; Natural Science Foundation of Jiangsu Province in China(Natural Science Foundation of Jiangsu Province); Top six talent project in Jiangsu Province; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Drs. Sarah Gaffen, Richard Bennett, Vishva Dixit, and Demin Wang for providing reagents. We thank Dr. Qing Ye in Nanjing University Affiliated Drum Tower Hospital for checking histology slides. Wealso thank Daniel C. Lin for editing and proofreading this manuscript. This work was partially supported by grants from National Natural Science Foundation of China (81572354 and 81772542 to T.W., 81630058 and 91542107 to X.L.), National Institutes of Health (AI116722 to M.-C.H.), a Scholar Award from the Center for Inflammation and Cancer in MDACC (to T.W.), Natural Science Foundation of Jiangsu Province in China (BK20161400 to T.W.), and Top six talent project in Jiangsu Province (WSW-031 to T.W.).	Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Arora M, 2010, MUCOSAL IMMUNOL, V3, P578, DOI 10.1038/mi.2010.41; Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bergmann H, 2017, EUR J IMMUNOL, V47, P1342, DOI 10.1002/eji.201646765; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2010, CELL HOST MICROBE, V7, P9, DOI 10.1016/j.chom.2009.12.005; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Geis AL, 2015, CANCER DISCOV, V5, P1098, DOI 10.1158/2159-8290.CD-15-0447; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hu Y, 2016, CARCINOGENESIS, V37, P366, DOI 10.1093/carcin/bgw019; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ilyas Mohammed Iyoob Mohammed, 2015, BMC Res Notes, V8, P32, DOI 10.1186/s13104-014-0962-2; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jia XM, 2014, J EXP MED, V211, P2307, DOI 10.1084/jem.20132349; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kang MS, 2017, SEMIN IMMUNOL, V32, P3, DOI 10.1016/j.smim.2017.04.003; Kargl J, 2013, J MOL MED, V91, P449, DOI 10.1007/s00109-012-0957-1; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Lasry A, 2016, NAT IMMUNOL, V17, P230, DOI 10.1038/ni.3384; Luan CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep07980; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Maruyama A, 2015, BIOCHEM BIOPH RES CO, V457, P445, DOI 10.1016/j.bbrc.2015.01.011; Mukherjee PK, 2015, NAT REV GASTRO HEPAT, V12, P77, DOI 10.1038/nrgastro.2014.188; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Neyrinck AM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060633; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Pindjakova J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01157; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rieber N, 2013, J IMMUNOL, V190, P1276, DOI 10.4049/jimmunol.1202144; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Santelmann H, 2005, EUR J GASTROEN HEPAT, V17, P21, DOI 10.1097/00042737-200501000-00005; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Sonda N, 2011, CURR OPIN IMMUNOL, V23, P279, DOI 10.1016/j.coi.2010.12.006; Stringer AM, 2009, EXP BIOL MED, V234, P430, DOI 10.3181/0810-RM-301; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang TT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005662; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhao XQ, 2014, J BIOL CHEM, V289, P30052, DOI 10.1074/jbc.M114.588574	59	69	81	6	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					504	+		10.1016/j.immuni.2018.08.018	http://dx.doi.org/10.1016/j.immuni.2018.08.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231984	Green Accepted, Bronze			2022-12-18	WOS:000444909600017
J	Sharma, MD; Rodriguez, PC; Koehn, BH; Baban, B; Cui, Y; Guo, G; Shimoda, M; Pacholczyk, R; Shi, HD; Lee, EJ; Xu, HY; Johnson, TS; He, YK; Mergoub, T; Venable, C; Bronte, V; Wolchok, JD; Blazar, BR; Munn, DH				Sharma, Madhav D.; Rodriguez, Paulo C.; Koehn, Brent H.; Baban, Babak; Cui, Yan; Guo, Gang; Shimoda, Michiko; Pacholczyk, Rafal; Shi, Huidong; Lee, Eun-Joon; Xu, Hongyan; Johnson, Theodore S.; He, Yukai; Mergoub, Taha; Venable, Christopher; Bronte, Vincenzo; Wolchok, Jedd D.; Blazar, Bruce R.; Munn, David H.			Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c(+)CD103(+) Monocytic Antigen-Presenting Cells in Tumors	IMMUNITY			English	Article							DENDRITIC CELLS; ANTICANCER CHEMOTHERAPY; SUPPRESSOR-CELLS; T-CELLS; EXPRESSION; RESPONSES; INACTIVATION; MACROPHAGES; TRAFFICKING; IMMUNITY	CD103(+) dendritic cells are critical for cross-presentation of tumor antigens. Here we have shown that during immunotherapy, large numbers of cells expressing CD103 arose inmurine tumors via direct differentiation of Ly6c(+) monocytic precursors. These Ly6c(+)CD103(+) cells could derive from bone-marrow monocytic progenitors (cMoPs) or from peripheral cells present within the myeloid-derived suppressor cell (MDSC) population. Differentiation was controlled by inflammation-induced activation of the transcription factor p53, which drove upregulation of Batf3 and acquisition of the Ly6c(+)CD103(+) phenotype. Mice with a targeted deletion of p53 in myeloid cells selectively lost the Ly6c(+)CD103(+) population and became unable to respond to multiple forms of immunotherapy and immunogenic chemotherapy. Conversely, increasing p53 expression using a p53-agonist drug caused a sustained increase in Ly6c(+)CD103(+) cells in tumors during immunotherapy, which markedly enhanced the efficacy and duration of response. Thus, p53-driven differentiation of Ly6c(+)CD103(+) monocytic cells represents a potent and previously unrecognized target for immunotherapy.	[Sharma, Madhav D.; Rodriguez, Paulo C.; Cui, Yan; Guo, Gang; Shimoda, Michiko; Pacholczyk, Rafal; Shi, Huidong; Lee, Eun-Joon; Xu, Hongyan; Johnson, Theodore S.; He, Yukai; Venable, Christopher; Munn, David H.] Augusta Univ, Georgia Canc Ctr, Med Coll Georgia, Augusta, GA 30912 USA; [Sharma, Madhav D.; Johnson, Theodore S.; Munn, David H.] Augusta Univ, Dept Pediat, Med Coll Georgia, Augusta, GA 30912 USA; [Cui, Yan; Guo, Gang; Shi, Huidong; Lee, Eun-Joon] Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA; [Xu, Hongyan] Augusta Univ, Dept Populat Hlth Sci, Med Coll Georgia, Augusta, GA 30912 USA; [Baban, Babak] Augusta Univ, Dent Coll Georgia, Augusta, GA 30912 USA; [Mergoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Center, Immunol Program & Ludwig Ctr, Dept Med, New York, NY 10065 USA; [Mergoub, Taha; Wolchok, Jedd D.] Weill Cornell Med Sch, New York, NY 10065 USA; [Koehn, Brent H.; Mergoub, Taha; Wolchok, Jedd D.] Grad Sch Biomed Sci, New York, NY 10065 USA; [Mergoub, Taha; Wolchok, Jedd D.] Ludwig Inst Canc Res, New York, NY 10065 USA; [Bronte, Vincenzo] Univ Verona, Univ Hosp, I-37134 Verona, Italy; [Bronte, Vincenzo] Univ Verona, Dept Med, I-37134 Verona, Italy; [Koehn, Brent H.; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Koehn, Brent H.; Blazar, Bruce R.] Univ Minnesota, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Rodriguez, Paulo C.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Ludwig Institute for Cancer Research; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; H Lee Moffitt Cancer Center & Research Institute	Munn, DH (corresponding author), Augusta Univ, Georgia Canc Ctr, Med Coll Georgia, Augusta, GA 30912 USA.; Munn, DH (corresponding author), Augusta Univ, Dept Pediat, Med Coll Georgia, Augusta, GA 30912 USA.	dmunn@augusta.edu	Merghoub, Taha/ABD-8362-2021; Rodríguez, Paulo/HDM-9539-2022; Bronte, Vincenzo/K-7902-2016	Bronte, Vincenzo/0000-0002-3741-5141; Rodriguez, Paulo/0000-0001-7480-6566; Munn, David/0000-0002-7711-2858; Cui, Yan/0000-0002-2800-6039; Shi, Huidong/0000-0003-1137-3390	NIH [R01 CA103320, CA211229]; NATIONAL CANCER INSTITUTE [R01CA103320, R01CA072669, R01CA169133, R01CA211229, P30CA008748, R01CA184185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Ron DePinho for Pten-flox mice; Dr. Miyuki Azuma for PD-L1 antibody clones; Dr. Tasuku Honjo and Hideo Agita for PD-1 and PD-L2 antibody clones; and Anita Sharma, Kimberly Smith, Joyce Wilson, Gabriela Pacholczyk, and Jeanene Pihkala for expert technical assistance. Supported by NIH R01 CA103320 and CA211229 to D.H.M.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Gamrekelashvili J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12597; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Goldszmid RS, 2014, CELL HOST MICROBE, V15, P295, DOI 10.1016/j.chom.2014.02.003; Guo G, 2013, CANCER RES, V73, P1668, DOI 10.1158/0008-5472.CAN-12-3810; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Koehn BH, 2015, BLOOD, V126, P1621, DOI 10.1182/blood-2015-03-634691; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lazzari E, 2014, CLIN IMMUNOL, V153, P343, DOI 10.1016/j.clim.2014.06.001; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Marigo I, 2016, CANCER CELL, V30, P377, DOI 10.1016/j.ccell.2016.08.004; Marino S, 2000, GENE DEV, V14, P994; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sharma MD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500845; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Slatter TL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1112941; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Tsushima F, 2003, EUR J IMMUNOL, V33, P2773, DOI 10.1002/eji.200324084; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang F, 2011, DRUG METAB DISPOS, V39, P15, DOI 10.1124/dmd.110.035915	46	69	70	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					91	+		10.1016/j.immuni.2017.12.014	http://dx.doi.org/10.1016/j.immuni.2017.12.014			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343444	Green Accepted, Bronze			2022-12-18	WOS:000422751600013
J	Di Cara, F; Sheshachalam, A; Braverman, NE; Rachubinski, RA; Simmonds, AJ				Di Cara, Francesca; Sheshachalam, Avinash; Braverman, Nancy E.; Rachubinski, Richard A.; Simmonds, Andrew J.			Peroxisome-Mediated Metabolism Is Required for Immune Response to Microbial Infection	IMMUNITY			English	Article							DROSOPHILA-MELANOGASTER; REACTIVE OXYGEN; INNATE IMMUNITY; HOST-DEFENSE; PHAGOCYTOSIS; DEGRADATION; RECOGNITION; MACROPHAGES; BIOGENESIS; PHYSIOLOGY	The innate immune response is critical for animal homeostasis and is conserved from invertebrates to vertebrates. This response depends on specialized cells that recognize, internalize, and destroy microbial invaders through phagocytosis. This is coupled to autonomous or non-autonomous cellular signaling via reactive oxygen species (ROS) and cytokine production. Lipids are known signaling factors in this process, as the acute phase response of macrophages is accompanied by systemic lipid changes that help resolve inflammation. We found that peroxisomes, membrane-enclosed organelles central to lipid metabolism and ROS turnover, were necessary for the engulfment of bacteria by Drosophila and mouse macrophages. Peroxisomes were also required for resolution of bacterial infection through canonical innate immune signaling. Reduced peroxisome function impaired the turnover of the oxidative burst necessary to fight infection. This impaired response to bacterial challenge affected cell and organism survival and revealed a previously unknown requirement for peroxisomes in phagocytosis and innate immunity.	[Di Cara, Francesca; Sheshachalam, Avinash; Rachubinski, Richard A.; Simmonds, Andrew J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Braverman, Nancy E.] McGill Univ, Childrens Hosp, Res Inst, Montreal, PQ H4A 3J1, Canada	University of Alberta; McGill University	Di Cara, F; Simmonds, AJ (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	dicara@ualberta.ca; andrew.simmonds@ualberta.ca		Simmonds, Andrew/0000-0001-7165-9302; Di cara, Francesca/0000-0002-6973-3232	Alberta Innovates Health Solutions; Canadian Institutes of Health Research (CIHR); CIHR Foundation; Alberta Innovates [201201150] Funding Source: researchfish	Alberta Innovates Health Solutions; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded by a Collaborative Research Innovation Opportunities grant from Alberta Innovates Health Solutions to R.A.R., A.J.S., and N.E.B.; an Operating Grant from the Canadian Institutes of Health Research (CIHR) to N.E.B., R.A.R., and A.J.S.; a CIHR Foundation Grant to R.A.R. Flow cytometry was performed at the University of Alberta, Faculty of Medicine & Dentistry Flow Cytometry Facility. We thank the Simmonds laboratory, Gary Eitzen, and Sarah Hughes for insightful comments, Christine Webber for assistance with mouse experiments, Neil Silverman and Pascal Meier for advice, Woo Jung Cho and Xuejun Sun for help with microscopy, Aja Rieger and Sabina Baghirova for training in flow cytometry, and Elena Savidov for technical help.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Baron MN, 2016, TRAFFIC, V17, P536, DOI 10.1111/tra.12384; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2010, MOL GENET METAB, V99, P408, DOI 10.1016/j.ymgme.2009.12.005; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Chakrabarti S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006089; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; EGUCHI M, 1979, AM J PATHOL, V95, P281; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Gonzalez EA, 2013, CURR BIOL, V23, P2319, DOI 10.1016/j.cub.2013.09.061; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Mast FD, 2011, DIS MODEL MECH, V4, P659, DOI 10.1242/dmm.007419; Moulding DA, 2013, IMMUNOL REV, V256, P282, DOI 10.1111/imr.12114; Muralidharan S, 2013, J LEUKOCYTE BIOL, V94, P1167, DOI 10.1189/jlb.0313153; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neyen C. D., 2014, MACROPHAGES LIPID IM; Neyen C, 2016, NAT IMMUNOL, V17, P1150, DOI 10.1038/ni.3536; Nguyen SD, 2008, BBA-MOL CELL BIOL L, V1781, P400, DOI 10.1016/j.bbalip.2008.06.004; Paschoal VA, 2013, LIPIDS, V48, P93, DOI 10.1007/s11745-012-3726-6; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	42	69	69	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					93	+		10.1016/j.immuni.2017.06.016	http://dx.doi.org/10.1016/j.immuni.2017.06.016			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723556	Bronze			2022-12-18	WOS:000405712800012
J	Martin, CE; Spasova, DS; Frimpong-Boateng, K; Kim, HO; Lee, M; Kim, KS; Surh, CD				Martin, Christopher E.; Spasova, Darina S.; Frimpong-Boateng, Kwesi; Kim, Hee-Ok; Lee, Minji; Kim, Kwang Soon; Surh, Charles D.			Interleukin-7 Availability Is Maintained by a Hematopoietic Cytokine Sink Comprising Innate Lymphoid Cells and T Cells	IMMUNITY			English	Article							HOMEOSTATIC PROLIFERATION; CUTTING EDGE; IN-VIVO; COMMENSAL BACTERIA; DECREASED CD127; NEONATAL MICE; BONE-MARROW; IL-7; NAIVE; EXPRESSION	Interleukin-7 (IL-7) availability determines the size and proliferative state of the resting T cell pool. However, the mechanisms that regulate steady-state IL-7 amounts are unclear. Using experimental lymphopenic mouse models and IL-7-induced homeostatic proliferation to measure IL-7 availability in vivo, we found that radioresistant cells were the source of IL-7 for both CD4(+) and CD8(+) T cells. Hematopoietic lineage cells, although irrelevant as a source of IL-7, were primarily responsible for limiting IL-7 availability via their expression of IL-7R. Unexpectedly, innate lymphoid cells were found to have a potent influence on IL-7 amounts in the primary and secondary lymphoid tissues. These results demonstrate that IL-7 homeostasis is achieved through consumption by multiple subsets of innate and adaptive immune cells.	[Martin, Christopher E.; Spasova, Darina S.; Frimpong-Boateng, Kwesi; Surh, Charles D.] Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA; [Martin, Christopher E.; Spasova, Darina S.; Frimpong-Boateng, Kwesi; Surh, Charles D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Martin, Christopher E.; Spasova, Darina S.; Frimpong-Boateng, Kwesi; Surh, Charles D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Spasova, Darina S.; Frimpong-Boateng, Kwesi; Kim, Hee-Ok; Lee, Minji; Kim, Kwang Soon; Surh, Charles D.] Acad Immunol & Microbiol, Inst Basic Sci, Pohang 790784, South Korea; [Lee, Minji; Kim, Kwang Soon; Surh, Charles D.] Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Scripps Research Institute; Scripps Research Institute; La Jolla Institute for Immunology; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH)	Surh, CD (corresponding author), Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA.; Surh, CD (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Surh, CD (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.; Surh, CD (corresponding author), Acad Immunol & Microbiol, Inst Basic Sci, Pohang 790784, South Korea.; Surh, CD (corresponding author), Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang 790784, South Korea.	csurh@ibs.re.kr			NIH; Institute for Basic Science of the Korean Ministry of Science, Information/Communication Technology, and Future Planning [IBS-R005-D1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Basic Science of the Korean Ministry of Science, Information/Communication Technology, and Future Planning	We thank T.K. Kim, J.W. Seo, M.O. Lee, and H.J. Woo for technical support and S.M. Hedrick for helpful discussions. This work was supported by NIH grants and by project IBS-R005-D1 from the Institute for Basic Science of the Korean Ministry of Science, Information/Communication Technology, and Future Planning.	Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Baccala R, 2005, J IMMUNOL, V174, P4606, DOI 10.4049/jimmunol.174.8.4606; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Bank U, 2016, J IMMUNOL, V196, P3532, DOI 10.4049/jimmunol.1501643; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cho JH, 2013, J IMMUNOL, V191, P5559, DOI 10.4049/jimmunol.1302293; Cinalli RM, 2005, EUR J IMMUNOL, V35, P786, DOI 10.1002/eji.200425729; Dai ZH, 2001, J IMMUNOL, V167, P6711, DOI 10.4049/jimmunol.167.12.6711; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Do JS, 2009, BLOOD, V113, P6361, DOI 10.1182/blood-2008-12-192997; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; French JD, 2005, P NATL ACAD SCI USA, V102, P14741, DOI 10.1073/pnas.0507520102; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hodge JN, 2011, BLOOD, V118, P3244, DOI 10.1182/blood-2010-12-323600; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Luther C, 2011, BLOOD, V117, P4012, DOI 10.1182/blood-2010-07-298901; Martin Christopher E, 2013, Methods Mol Biol, V979, P81, DOI 10.1007/978-1-62703-290-2_9; Martin CE, 2010, NAT IMMUNOL, V11, P547, DOI 10.1038/ni0710-547; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Osborne LC, 2011, J IMMUNOL, V186, P1981, DOI 10.4049/jimmunol.1002224; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; SAKATA T, 1990, J LEUKOCYTE BIOL, V48, P205, DOI 10.1002/jlb.48.3.205; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schuler T, 2004, J IMMUNOL, V172, P15, DOI 10.4049/jimmunol.172.1.15; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608	60	69	70	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					171	+		10.1016/j.immuni.2017.07.005	http://dx.doi.org/10.1016/j.immuni.2017.07.005			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723549	Bronze			2022-12-18	WOS:000405712800018
J	Lukens, JR; Gurung, P; Shaw, PJ; Barr, MJ; Zaki, MH; Brown, SA; Vogel, P; Chi, HB; Kanneganti, TD				Lukens, John R.; Gurung, Prajwal; Shaw, Patrick J.; Barr, Maggie J.; Zaki, Md. Hasan; Brown, Scott A.; Vogel, Peter; Chi, Hongbo; Kanneganti, Thirumala-Devi			The NLRP12 Sensor Negatively Regulates Autoinflammatory Disease by Modulating Interleukin-4 Production in T Cells	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY-BOWEL-DISEASE; IFN-GAMMA; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ULCERATIVE-COLITIS; COLON INFLAMMATION; OXAZOLONE COLITIS; INTERFERON-GAMMA; HOST-DEFENSE	Missense mutations in the nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain containing family of gene 12 (Nlrp12) are associated with periodic fever syndromes and atopic dermatitis in humans. Here, we have demonstrated a crucial role for NLRP12 in negatively regulating pathogenic T cell responses. Nlrp12(-/-) mice responded to antigen immunization with hyperinflammatory T cell responses. Furthermore, transfer of CD4(+)CD45RB(hi) Nlrp12(-/-) T cells into immunodeficient mice led to more severe colitis and atopic dermatitis. NLRP12 deficiency did not, however, cause exacerbated ascending paralysis during experimental autoimmune encephalomyelitis (EAE); instead, Nlrp12(-/-) mice developed atypical neuroinflammatory symptoms that were characterized by ataxia and loss of balance. Enhanced T-cell-mediated interleukin-4 (IL-4) production promotes the development of atypical EAE disease in Nlrp12(-/-) mice. These results define an unexpected role for NLRP12 as an intrinsic negative regulator of T-cell-mediated immunity and identify altered NF-kappa B regulation and IL-4 production as key mediators of NLRP12-associated disease.	[Lukens, John R.; Gurung, Prajwal; Shaw, Patrick J.; Barr, Maggie J.; Brown, Scott A.; Chi, Hongbo; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lukens, John R.] Univ Virginia, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA; [Zaki, Md. Hasan] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Chi, Hongbo/M-9397-2018; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Chi, Hongbo/0000-0002-9997-2496; Vogel, Peter/0000-0002-7535-0545; Gurung, Prajwal/0000-0002-7451-9433; Zaki, Hasan/0000-0001-9002-5399; Lukens, John/0000-0002-6795-0866	St. Jude Children's Research Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [AR056296]; National Cancer Institute, part of the NIH [CA163507]; National Institute of Allergy and Infectious Diseases, NIH [AI101935]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute, part of the NIH; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	P.G. is a postdoctoral fellow supported by Paul Barrett Endowed Fellowship from St. Jude Children's Research Hospital. This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the NIH, under Award Number AR056296 (T.-D.K.); the National Cancer Institute, part of the NIH, under Award Number CA163507 (T.-D.K.); the National Institute of Allergy and Infectious Diseases, part of the NIH, under Award Number AI101935 (T.-D.K.); and ALSAC.	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Bettelli E, 1998, J IMMUNOL, V161, P3299; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Davenport CM, 2002, INT IMMUNOPHARMACOL, V2, P653, DOI 10.1016/S1567-5769(01)00201-6; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Falcone M, 1998, J IMMUNOL, V160, P4822; Fort MM, 2001, J IMMUNOL, V166, P2793, DOI 10.4049/jimmunol.166.4.2793; Furlan R, 1998, HUM GENE THER, V9, P2605, DOI 10.1089/hum.1998.9.17-2605; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hohnoki K, 1998, J NEUROIMMUNOL, V87, P27, DOI 10.1016/S0165-5728(98)00053-8; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P1459, DOI 10.1002/art.30241; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kroenke MA, 2010, EUR J IMMUNOL, V40, P2340, DOI 10.1002/eji.201040489; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; LINK J, 1994, ANN NEUROL, V36, P379, DOI 10.1002/ana.410360309; Lukens JR, 2011, DISCOV MED, V11, P65; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Macaluso F, 2007, EXP DERMATOL, V16, P692, DOI 10.1111/j.1600-0625.2007.00589.x; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Schon MP, 1997, NAT MED, V3, P183, DOI 10.1038/nm0297-183; Shaw MK, 1997, J EXP MED, V185, P1711, DOI 10.1084/jem.185.9.1711; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Wensky A, 2001, J IMMUNOL, V167, P3074, DOI 10.4049/jimmunol.167.6.3074; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	46	69	72	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					654	664		10.1016/j.immuni.2015.03.006	http://dx.doi.org/10.1016/j.immuni.2015.03.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25888258	Bronze, Green Accepted			2022-12-18	WOS:000353347500012
J	Stelekati, E; Shin, H; Doering, TA; Dolfi, DV; Ziegler, CG; Beiting, DP; Dawson, L; Liboon, J; Wolski, D; Ali, MAA; Katsikis, PD; Shen, H; Roos, DS; Haining, WN; Lauer, GM; Wherry, EJ				Stelekati, Erietta; Shin, Haina; Doering, Travis A.; Dolfi, Douglas V.; Ziegler, Carly G.; Beiting, Daniel P.; Dawson, Lucas; Liboon, Jennifer; Wolski, David; Ali, Mohammed-Alkhatim A.; Katsikis, Peter D.; Shen, Hao; Roos, David S.; Haining, W. Nicholas; Lauer, Georg M.; Wherry, E. John			Bystander Chronic Infection Negatively Impacts Development of CD8(+) T Cell Memory	IMMUNITY			English	Article							HEPATITIS-C; VIRUS-INFECTION; IN-VITRO; EFFECTOR; EXPRESSION; IFN; HIV; REPLICATION; SUPPRESSION; VACCINATION	Epidemiological evidence suggests that chronic infections impair immune responses to unrelated pathogens and vaccines. The underlying mechanisms, however, are unclear and distinguishing effects on priming versus development of immunological memory has been challenging. We investigated whether bystander chronic infections impact differentiation of memory CD8(+) T cells, the hallmark of protective immunity against intracellular pathogens. Chronic bystander infections impaired development of memory CD8(+) T cells in several mouse models and humans. These effects were independent of initial priming and were associated with chronic inflammatory signatures. Chronic inflammation negatively impacted the number of bystander CD8(+) T cells and their memory development. Distinct underlying mechanisms of altered survival and differentiation were revealed with the latter regulated by the transcription factors T-bet and Blimp-1. Thus, exposure to prolonged bystander inflammation impairs the effector to memory transition. These data have relevance for immunity and vaccination during persisting infections and chronic inflammation.	[Stelekati, Erietta; Shin, Haina; Doering, Travis A.; Dolfi, Douglas V.; Ziegler, Carly G.; Dawson, Lucas; Liboon, Jennifer; Ali, Mohammed-Alkhatim A.; Shen, Hao; Wherry, E. John] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Stelekati, Erietta; Shin, Haina; Doering, Travis A.; Dolfi, Douglas V.; Ziegler, Carly G.; Dawson, Lucas; Ali, Mohammed-Alkhatim A.; Wherry, E. John] Univ Penn, Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Beiting, Daniel P.; Roos, David S.] Univ Penn, Sch Med, Dept Biol, Philadelphia, PA 19104 USA; [Wolski, David; Lauer, Georg M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Katsikis, Peter D.] Drexel Univ Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Massachusetts General Hospital; Drexel University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Wherry, EJ (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	shen, hao/HGF-0551-2022; Beiting, Daniel/AAG-6275-2019; Wherry, John/ABI-1280-2020; Lauer, Georg/J-1467-2018	Katsikis, Peter/0000-0001-7690-5218; Lauer, Georg/0000-0002-9792-4271; Roos, David Siker/0000-0001-6725-4089; Ziegler, Carly/0000-0002-8279-7150; Shin, Haina/0000-0002-1014-1451	NIH/NIAID [AI 083022, AI 082630]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, U19AI083022] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Penn Molecular Profiling Facility at the University of Pennsylvania for conducting the mouse microarray experiment. We thank D. Herbert (UCSF) for the H. polygyrus and members of the Wherry laboratory for comments and input. This work was supported by NIH/NIAID grants AI 083022 (to H.S. and E.J.W.) and AI 082630 (to W.N.H., G.M.L., and E.J.W.).	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bahgat MM, 2010, J INFECT DEV COUNTR, V4, P226, DOI 10.3855/jidc.522; Bahl K, 2006, J IMMUNOL, V176, P4284, DOI 10.4049/jimmunol.176.7.4284; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Dudani R, 2008, J IMMUNOL, V181, P1700, DOI 10.4049/jimmunol.181.3.1700; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; Gupta S, 2006, J CLIN IMMUNOL, V26, P193, DOI 10.1007/s10875-006-9019-1; Harcourt GC, 2005, AIDS, V19, P1135, DOI 10.1097/01.aids.0000176213.10367.05; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Hawkes M, 2010, MICROBES INFECT, V12, P864, DOI 10.1016/j.micinf.2010.05.013; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kamal SM, 2001, GASTROENTEROLOGY, V121, P646, DOI 10.1053/gast.2001.27024; Kim SK, 2004, J IMMUNOL, V172, P3139, DOI 10.4049/jimmunol.172.5.3139; Marshall HD, 2011, J VIROL, V85, P5929, DOI 10.1128/JVI.02516-10; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Moorman JP, 2011, VACCINE, V29, P3169, DOI 10.1016/j.vaccine.2011.02.052; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Co TR, 2007, CLIN EXP IMMUNOL, V147, P45, DOI 10.1111/j.1365-2249.2006.03247.x; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Vahidnia F, 2012, CLIN INFECT DIS, V55, P1012, DOI 10.1093/cid/cis589; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Wortzman ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068911; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	50	69	71	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					801	813		10.1016/j.immuni.2014.04.010	http://dx.doi.org/10.1016/j.immuni.2014.04.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837104	Green Accepted, Bronze			2022-12-18	WOS:000336026100017
J	O'Donnell, H; Pham, OH; Li, LX; Atif, SM; Lee, SJ; Ravesloot, MM; Stolfi, JL; Nuccio, SP; Broz, P; Monack, DM; Baumler, AJ; McSorley, SJ				O'Donnell, Hope; Pham, Oanh H.; Li, Lin-xi; Atif, Shaikh M.; Lee, Seung-Joo; Ravesloot, Marietta M.; Stolfi, Jessica L.; Nuccio, Sean-Paul; Broz, Petr; Monack, Denise M.; Baumler, Andreas J.; McSorley, Stephen J.			Toll-like Receptor and Inflammasome Signals Converge to Amplify the Innate Bactericidal Capacity of T Helper 1 Cells	IMMUNITY			English	Article							MEMORY CD8(+) T; IFN-GAMMA; CYTOKINE PRODUCTION; IN-VIVO; BYSTANDER ACTIVATION; DENDRITIC CELLS; FAMILY-MEMBERS; ANTIGEN; EFFECTOR; IL-12	T cell effector functions can be elicited by noncognate stimuli, but the mechanism and contribution of this pathway to the resolution of intracellular macrophage infections have not been defined. Here, we show that CD4(+) T helper 1 (Th1) cells could be rapidly stimulated by microbe-associated molecular patterns during active infection with Salmonella or Chlamydia. Further, maximal stimulation of Th1 cells by lipopolysaccharide (LPS) did not require T-cell-intrinsic expression of toll-like receptor 4 (TLR4), interleukin-1 receptor (IL-1R), or interferon-gamma receptor (IFN-gamma R) but instead required IL-18R, IL-33R, and adaptor protein MyD88. Innate stimulation of Th1 cells also required host expression of TLR4 and inflammasome components that together increased serum concentrations of IL-18. Finally, the elimination of noncognate Th1 cell stimulation hindered the resolution of primary Salmonella infection. Thus, the in vivo bactericidal capacity of Th1 cells is regulated by the response to noncognate stimuli elicited by multiple innate immune receptors.	[O'Donnell, Hope; Pham, Oanh H.; Li, Lin-xi; Atif, Shaikh M.; Lee, Seung-Joo; Ravesloot, Marietta M.; Stolfi, Jessica L.; McSorley, Stephen J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA; [O'Donnell, Hope] Univ Minnesota Med Sch Twin Cities, Microbiol Immunol & Canc Biol Grad Program, Minneapolis, MN 55455 USA; [Nuccio, Sean-Paul; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Broz, Petr; Monack, Denise M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; Stanford University	McSorley, SJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA.	sjmcsorley@ucdavis.edu	Baumler, Andreas J/H-2301-2011; Broz, Petr/AAC-7940-2019	Baumler, Andreas J/0000-0001-9152-7809; Broz, Petr/0000-0002-2334-7790; McSorley, Stephen/0000-0002-6363-3222; Li, Lin-Xi/0000-0002-5526-8966; Pham, Oanh/0000-0001-5307-6023; O'Donnell, Hope/0000-0001-6460-9016; Monack, Denise/0000-0003-3804-2209; Nuccio, Sean-Paul/0000-0002-9683-9278	National Institutes of Health (NIH) [AI055743, AI076278, AI056172, AI076246, AI095396, AI089722]; NIH [AI60555]; Vietnam Education Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076246, R01AI095396, R01AI076278, T32AI060555, R01AI055743, P01AI056172, R01AI089722] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vietnam Education Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) to S.J.M. (AI055743, AI076278, and AI056172), A.J.B. (AI076246), and D.M. (AI095396 and AI089722). H.O. was supported by an NIH T32 training grant (AI60555), and O.P. was supported by a Vietnam Education Foundation fellowship. The authors would like to thank Rebecca A. Elsner for her feedback on this manuscript and helpful discussions.	Beadling C, 2005, BLOOD, V105, P1179, DOI 10.1182/blood-2004-07-2833; Berg RE, 2002, EUR J IMMUNOL, V32, P2807, DOI 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Lee SJ, 2012, IMMUNOL LETT, V148, P138, DOI 10.1016/j.imlet.2012.10.009; Lee SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002499; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Mittrucker HW, 2002, INFECT IMMUN, V70, P199, DOI 10.1128/IAI.70.1.199-203.2002; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Pien GC, 2002, J IMMUNOL, V169, P5827, DOI 10.4049/jimmunol.169.10.5827; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Salazar-Gonzalez RM, 2007, J IMMUNOL, V179, P6169, DOI 10.4049/jimmunol.179.9.6169; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Srinivasan A, 2004, J IMMUNOL, V172, P6884, DOI 10.4049/jimmunol.172.11.6884; Srinivasan A, 2007, J IMMUNOL, V178, P6342, DOI 10.4049/jimmunol.178.10.6342; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	40	69	69	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					213	224		10.1016/j.immuni.2013.12.013	http://dx.doi.org/10.1016/j.immuni.2013.12.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24508233	Green Accepted, Bronze			2022-12-18	WOS:000331637600009
J	Jones-Mason, ME; Zhao, XD; Kappes, D; Lasorella, A; Iavarone, A; Zhuang, Y				Jones-Mason, Mary Elizabeth; Zhao, Xudong; Kappes, Dietmar; Lasorella, Anna; Iavarone, Antonio; Zhuang, Yuan			E Protein Transcription Factors Are Required for the Development of CD4(+) Lineage T Cells	IMMUNITY			English	Article							ZINC-FINGER; THYMOCYTE SELECTION; EXPRESSION; E2A; DIFFERENTIATION; GATA-3; THPOK; GENE; ID3; PROLIFERATION	The double-positive (DP) to single-positive (SP) transition during T cell development is initiated by downregulation of the E protein transcription factors HEB and E2A. Here, we have demonstrated that in addition to regulating the onset of this transition, HEB and E2A also play a separate role in CD4(+) lineage choice. Deletion of HEB and E2A in DP thymocytes specifically blocked the development of CD4(+) lineage T cells. Furthermore, deletion of the E protein inhibitors Id2 and Id3 allowed CD4(+) T cell development but blocked CD8(+) lineage development. Analysis of the CD4(+) lineage transcriptional regulators ThPOK and Gata3 placed HEB and E2A upstream of CD4(+) lineage specification. These studies identify an important role for E proteins in the activation of CD4(+) lineage differentiation as thymocytes undergo the DP to SP transition.	[Jones-Mason, Mary Elizabeth; Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Zhao, Xudong; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Kappes, Dietmar] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Duke University; Columbia University; Columbia University; Columbia University; Columbia University; Fox Chase Cancer Center	Zhuang, Y (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	yzhuang@duke.edu		zhao, zhao xu dong/0000-0001-9126-7365; Iavarone, Antonio/0000-0002-0683-4634; zhuang, yuan/0000-0002-2964-3654	NIH [R01GM059638]; NATIONAL CANCER INSTITUTE [R01CA153260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q.-J. Li and Y.-Y. Lin for critical reading of the manuscript; Y.-W. He for providing OT-II transgenic mice and constructs used to generate the Id2<SUP>hCD5</SUP> allele; R. Bosselut and Y. Xiong for technical advice on Gata3 intracellular staining; A. Singer for providing Cd4 transgenic mice; Q.-J. Li for providing Rag2<SUP>-/-</SUP> congenic mice; P. Zhang for assistance with Id3<SUP>RFP</SUP> genotyping; Y. Wan and Y. Wang for providing Gata3<SUP>f/+</SUP>Cd4cre samples; M. Dai for assistance with genotyping and i.v. injection; I. Belle for assistance with Id2<SUP>f/f</SUP>Id3<SUP>f/f</SUP>Cd4cre mice; M. Kondo and M. Krangel for advice and reagents; the Duke University transgenic facility for assistance with generating gene-targeted mice; the Duke Comprehensive Cancer Center Flow Cytometry facility for cell sorting; and the NIH tetramer facility for mouse CD1d tetramers. This work was supported by funding from NIH (R01GM059638) to Y.Z.	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Gregoire JM, 1999, J BIOL CHEM, V274, P6567, DOI 10.1074/jbc.274.10.6567; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lazorchak AS, 2006, J IMMUNOL, V177, P2495, DOI 10.4049/jimmunol.177.4.2495; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Schmitz I, 2003, INT IMMUNOL, V15, P1237, DOI 10.1093/intimm/dxg125; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; von Boehmer H, 2006, IMMUNOL REV, V209, P284, DOI 10.1111/j.0105-2896.2006.00346.x; Wang DC, 2006, J IMMUNOL, V177, P109, DOI 10.4049/jimmunol.177.1.109; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wikstrom I, 2008, MOL IMMUNOL, V45, P3302, DOI 10.1016/j.molimm.2008.02.012; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	44	69	72	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					348	361		10.1016/j.immuni.2012.02.010	http://dx.doi.org/10.1016/j.immuni.2012.02.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22425249	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000302048400008
J	Jiang, XX; Nguyen, Q; Chou, YC; Wang, T; Nandakumar, V; Yates, P; Jones, L; Wang, LF; Won, HJ; Lee, HR; Jung, JU; Muschen, M; Huang, XF; Chen, SY				Jiang, Xiao-Xia; Quan Nguyen; Chou, YuChia; Wang, Tao; Nandakumar, Vijayalakshmi; Yates, Peter; Jones, Lindsey; Wang, Lifeng; Won, Haejung; Lee, Hye-Ra; Jung, Jae U.; Mueschen, Markus; Huang, Xue F.; Chen, Si-Yi			Control of B Cell Development by the Histone H2A Deubiquitinase MYSM1	IMMUNITY			English	Article							TRANSCRIPTION FACTOR EBF; LINEAGE SPECIFICATION; LYMPHOID PROGENITORS; ANTIGEN PRESENTATION; HEMATOPOIETIC STEM; COMMITMENT; CHROMATIN; COMPLEX; UBIQUITYLATION; ACTIVATION	Epigenetic histone modifications play critical roles in the control of gene transcription. Recently, an increasing number of histone H2A deubiquitinases have been identified and characterized. However, the physiological functions for this entire group of histone H2A deubiquitinases remain unknown. In this study, we revealed that the histone H2A deubiquitinase MYSM1 plays an essential and intrinsic role in early B cell development. MYSM1 deficiency results in a block in early B cell commitment and a defect of B cell progenitors in expression of EBF1 and other B lymphoid genes. We further demonstrated that MYSM1 derepresses EBF1 transcription in B cell progenitors by orchestrating histone modifications and transcription factor recruitment to the EBF1 locus. Thus, this study not only uncovers the essential role for MYSM1 in gene transcription during early B cell development but also underscores the biological significance of reversible epigenetic histone H2A ubiquitination.	[Jiang, Xiao-Xia; Quan Nguyen; Chou, YuChia; Wang, Tao; Nandakumar, Vijayalakshmi; Yates, Peter; Jones, Lindsey; Wang, Lifeng; Won, Haejung; Lee, Hye-Ra; Jung, Jae U.; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Mueschen, Markus] Childrens Hosp, Leukemia Res Program, Los Angeles, CA 90027 USA	University of Southern California; Children's Hospital Los Angeles	Chen, SY (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	siyichen@usc.edu	Wang, Tao/ABB-7764-2021; Wang, Tao/AEN-3843-2022	Wang, Lifeng/0000-0001-5095-6842	National Institutes of Health [R01CA090427, AI084811, CA116677, AI068472, CA82057, CA31363, CA115284, AI073099, AI083025, CA100841, AI08185]; Leukemia & Lymphoma Society SCOR; NATIONAL CANCER INSTITUTE [R01CA137060, R01CA031363, R01CA082057, R01CA090427, R01CA100841, R01CA115284, R01CA116677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073099, R01AI084811, R01AI068472, U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society SCOR(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Hong, M. Chong, M. Gatzka, S.-H. Lee, and other members of the S.-Y.C. lab for valuable assistance and suggestions. We thank N. Wu, R. Maxson, O. Akbari, P. Wang, M. Kahn, J. Rice, M. Stallcup, P. Jones, and other colleagues at USC, S. Nutt, B. Zheng, H. Singh, and K. Medina for providing valuable reagents and help. This work was supported by grants from the National Institutes of Health (R01CA090427, AI084811, CA116677, and AI068472 to S.-Y.C.; CA82057, CA31363, CA115284, AI073099, and AI083025 to J.U.J.; and CA100841 and AI08185 to X.F.H.) and Leukemia & Lymphoma Society SCOR Award. X.-X.J. and Q.N. designed and performed experiments and analyzed data; T.W., Y.C., P.Y., L.W., L.J., V.N., H.-J.W., and X.F.H. performed experiments and analyzed data: H.-R.L. and J.U.J. performed yeast two-hybrid screening and provided reagents; M.M. provided reagents and analyzed data; S.-Y.C. designed experiments, supervised the research, and analyzed data; and S.-Y.C. and X.-X.J. wrote the manuscript.	Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Greig KT, 2010, BLOOD, V115, P2796, DOI 10.1182/blood-2009-08-239210; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Osipovich O, 2007, NAT IMMUNOL, V8, P809, DOI 10.1038/ni1481; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	44	69	73	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					883	896		10.1016/j.immuni.2011.11.010	http://dx.doi.org/10.1016/j.immuni.2011.11.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22169041	Bronze, Green Accepted			2022-12-18	WOS:000298777300008
J	Li, YL; Hofmann, M; Wang, Q; Teng, L; Chlewicki, LK; Pircher, H; Mariuzza, RA				Li, Yili; Hofmann, Maike; Wang, Qian; Teng, Leslie; Chlewicki, Lukasz K.; Pircher, Hanspeter; Mariuzza, Roy A.			Structure of Natural Killer Cell Receptor KLRG1 Bound to E-Cadherin Reveals Basis for MHC-Independent Missing Self Recognition	IMMUNITY			English	Article							C-TYPE LECTIN; CD8 T-CELLS; CRYSTAL-STRUCTURE; CUTTING EDGE; INHIBITORY RECEPTOR; MOUSE HOMOLOG; COMPLEX; EXPRESSION; ADHESION; LIGAND	The cytolytic activity of natural killer (NK) cells is regulated by inhibitory receptors that detect the absence of self molecules on target cells. Structural studies of missing self recognition have focused on NK receptors that bind MHC. However, NK cells also possess inhibitory receptors specific for non-MHC ligands, notably cadherins, which are downregulated in metastatic tumors. We determined the structure of killer cell lectin-like receptor G1 (KLRG1) in complex with E-cadherin. KLRG1 mediates missing self recognition by binding to a highly conserved site on classical cadherins, enabling it to monitor expression of several cadherins (E-, N-, and R-) on target cells. This site overlaps the site responsible for cell-cell adhesion but is distinct from the integrin alpha(E)beta(7) binding site. We propose that E-cadherin may coengage KLRG1 and alpha(E)beta(7) and that KLRG1 overcomes its exceptionally weak affinity for cadherins through multipoint attachment to target cells, resulting in inhibitory signaling.	[Li, Yili; Wang, Qian; Teng, Leslie; Mariuzza, Roy A.] Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Hofmann, Maike; Pircher, Hanspeter] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Immunol, D-79104 Freiburg, Germany; [Chlewicki, Lukasz K.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University System of Maryland; University of Maryland Baltimore; University of Freiburg; University of Chicago	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA.	mariuzza@carb.nist.gov	Hofmann, Maike/ABH-7388-2020		National Institutes of Health [A147990]; Deutche Forschungsgemeinschaft [SFB620 TP2]; US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutche Forschungsgemeinschaft(German Research Foundation (DFG)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (A147990 to R.A.M.) and by the Deutche Forschungsgemeinschaft (SFB620 TP2 to H.P.). We thank H. Robinson (Brookhaven National Synchrotron Light Source) for X-ray data collection. Support for beamline X29 comes from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy. We also thank W. Held (Ludwig Institute for Cancer Research, Lausanne) for critically reading this manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; BECKER KF, 1994, CANCER RES, V54, P3845; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Colonna M, 2006, J EXP MED, V203, P261, DOI 10.1084/jem.20052559; Corral L, 2000, EUR J IMMUNOL, V30, P920, DOI 10.1002/1521-4141(200003)30:3<920::AID-IMMU920>3.0.CO;2-P; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Deng L, 2006, SEMIN IMMUNOL, V18, P159, DOI 10.1016/j.smim.2006.03.004; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Grundemann C, 2006, J IMMUNOL, V176, P1311, DOI 10.4049/jimmunol.176.3.1311; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; GUTHMANN MD, 1995, P NATL ACAD SCI USA, V92, P9397, DOI 10.1073/pnas.92.20.9397; Hanke T, 1998, EUR J IMMUNOL, V28, P4409, DOI 10.1002/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO;2-3; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Lengyel CSE, 2007, J BIOL CHEM, V282, P30658, DOI 10.1074/jbc.M704513200; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marcolino I, 2004, EUR J IMMUNOL, V34, P2672, DOI 10.1002/eji.200425282; McNerney ME, 2005, MOL IMMUNOL, V42, P489, DOI 10.1016/j.molimm.2004.07.032; McNerney ME, 2005, BLOOD, V106, P1337, DOI 10.1182/blood-2005-01-0357; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Robbins SH, 2003, J IMMUNOL, V170, P5876, DOI 10.4049/jimmunol.170.12.5876; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Rosshart S, 2008, EUR J IMMUNOL, V38, P3354, DOI 10.1002/eji.200838690; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schwartzkopff S, 2007, J IMMUNOL, V179, P1022, DOI 10.4049/jimmunol.179.2.1022; SOTO EO, 1988, J IMMUNOL, V141, P4324; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Taraszka KS, 2000, J EXP MED, V191, P1555, DOI 10.1084/jem.191.9.1555; Tessmer MS, 2007, INT IMMUNOL, V19, P391, DOI 10.1093/intimm/dxm004; Thimme R, 2005, J VIROL, V79, P12112, DOI 10.1128/JVI.79.18.12112-12116.2005; Velikovsky CA, 2007, IMMUNITY, V27, P572, DOI 10.1016/j.immuni.2007.08.019; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	68	69	74	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					35	46		10.1016/j.immuni.2009.04.019	http://dx.doi.org/10.1016/j.immuni.2009.04.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604491	Green Accepted, Bronze			2022-12-18	WOS:000268219900010
J	Meixlsperger, S; Kohler, F; Wossning, T; Reppel, M; Muschen, M; Jumaa, H				Meixlsperger, Sonja; Koehler, Fabian; Wossning, Thomas; Reppel, Michael; Mueschen, Markus; Jumaa, Hassan			Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor	IMMUNITY			English	Article							PRE-B; RECOMBINASE ACTIVITY; TYROSINE KINASE; SH2 DOMAIN; BLNK; IMMUNOGLOBULIN; ACTIVATION; LAMBDA-5; PROTEIN; SURFACE	Signals from the B cell antigen receptor (BCR), consisting of R heavy chain ( MC) and conventional light chain (I-C), and its precursor the pre-BCR, consisting of mu HC and surrogate light chain (SLC), via the adaptor protein SLP-65 regulate the development and function of B cells. Here, we compare the effect of SLC and conventional LC expression on receptor-induced Ca2+, flux in B cells expressing an inducible form of SLP-65. We found that SLC expression strongly enhanced an autonomous ability of mu HC to induce Ca2+ flux irrespective of additional receptor crosslinking. In contrast, LC expression reduced this autonomous mu HC ability and resulted in antigen-dependent Ca2+, flux. These data indicate that autonomous ligand-independent signaling can be induced by receptor forms other than the pre-BCR. In addition, our data suggest that conventional LCs; play an important role in the inhibition of autonomous receptor signaling, thereby allowing further B cell differentiation.	Univ Freiburg, Inst Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; Univ Dusseldorf, Lab Mol Stem Cell Biol, D-40225 Dusseldorf, Germany	University of Freiburg; Max Planck Society; University of Cologne; Heinrich Heine University Dusseldorf	Jumaa, H (corresponding author), Univ Freiburg, Inst Biol 3, Stuebeweg 51, D-79108 Freiburg, Germany.	jumaa@immunbio.mpg.de						AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Galler GR, 2004, J EXP MED, V199, P1523, DOI 10.1084/jem.20031523; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; Karasuyama H, 1997, IMMUNOL CELL BIOL, V75, P209, DOI 10.1038/icb.1997.32; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Reppel M, 2005, J BIOL CHEM, V280, P36019, DOI 10.1074/jbc.M504750200; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schuh W, 2003, J IMMUNOL, V171, P3343, DOI 10.4049/jimmunol.171.7.3343; Sprangers M, 2006, ONCOGENE, V25, P5056, DOI 10.1038/sj.onc.1209510; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Su YW, 2003, J EXP MED, V198, P1699, DOI 10.1084/jem.20031428; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Taguchi T, 2004, IMMUNOLOGY, V112, P575, DOI 10.1111/j.1365-2567.2004.01918.x; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wossning T, 2004, IMMUNOL LETT, V92, P67, DOI 10.1016/j.imlet.2003.10.015; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397	48	69	70	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					323	333		10.1016/j.immuni.2007.01.012	http://dx.doi.org/10.1016/j.immuni.2007.01.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17331747	Bronze			2022-12-18	WOS:000245228100009
J	Bueno, C; Lemke, CD; Criado, G; Baroja, ML; Ferguson, SSG; Rahman, AKMNU; Tsoukas, CD; McCormick, JK; Madrenas, J				Bueno, Clara; Lemke, Caitlin D.; Criado, Gabriel; Baroja, Miren L.; Ferguson, Stephen S. G.; Rahman, A. K. M. Nur-Ur; Tsoukas, Constantine D.; McCormick, John K.; Madrenas, Joaquin			Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a G alpha 11-dependent, PLC-beta-mediated pathway	IMMUNITY			English	Article							SRC-FAMILY KINASES; ANTIGEN RECEPTOR; PROTEIN-KINASE; LIPID RAFTS; TYROSINE KINASES; ERK ACTIVATION; ENTEROTOXIN-B; TCR; CD4; LAT	The paradigm to explain antigen-dependent T cell receptor (TCR) signaling is based on the activation of the CD4 or CD8 coreceptor-associated kinase Lck. It is widely assumed that this paradigm is also applicable to signaling by bacterial superantigens. However, these bacterial toxins can activate human T cells lacking Lck, suggesting the existence of an additional pathway of TCR signaling. Here we showed that this alternative pathway operates in the absence of Lck-dependent tyrosine-phosphorylation events and was initiated by the TCR-dependent activation of raft-enriched heterotrimeric G alpha 11 proteins. This event, in turn, activated a phospholipase C-beta and protein kinase C-mediated cascade that turned on the mitogen-activated protein kinases ERK-1 and ERK-2, triggered Ca2+ influx, and translocated the transcription factors NF-AT and NF-kappa B to the nucleus, ultimately inducing the production of interleukin-2 in Lck-deficient T cells. The triggering of this alternative pathway by superantigens suggests that these toxins use a G protein-coupled receptor as a coreceptor on T cells.	Univ Western Ontario, FOCIS Ctr Clin Immunol & Immunotherapeut, London, ON N6A 5K8, Canada; Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; Lawson Hlth Res Inst, London, ON N6A 5K8, Canada; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); California State University System; San Diego State University	Madrenas, J (corresponding author), Univ Western Ontario, FOCIS Ctr Clin Immunol & Immunotherapeut, London, ON N6A 5K8, Canada.	madrenas@robarts.ca	Criado, Gabriel/J-1803-2019; Madrenas, Quim/P-5008-2019; McCormick, John/E-4232-2015	Criado, Gabriel/0000-0003-4824-0890; McCormick, John/0000-0003-3742-7289	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048848] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR048848] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; AlRamadi BK, 1996, J IMMUNOL, V157, P4751; BAVARI S, 1995, INFECT IMMUN, V63, P423, DOI 10.1128/IAI.63.2.423-429.1995; Boss V, 1996, J BIOL CHEM, V271, P10429, DOI 10.1074/jbc.271.18.10429; CHATTERJEE S, 1992, MOL CELL BIOCHEM, V113, P25; Chau LA, 1999, J IMMUNOL, V163, P1853; Chau LA, 1998, J EXP MED, V187, P1699, DOI 10.1084/jem.187.10.1699; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Coffield VM, 2004, J EXP MED, V200, P1315, DOI 10.1084/jem.20040944; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; Duchemin AM, 2002, J NEUROCHEM, V81, P696, DOI 10.1046/j.1471-4159.2002.00831.x; Filipp D, 2004, MOL IMMUNOL, V41, P645, DOI 10.1016/j.molimm.2004.04.011; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fuller CL, 1998, J IMMUNOL, V161, P5179; Gehring S, 1998, J IMMUNOL METHODS, V219, P85, DOI 10.1016/S0022-1759(98)00142-2; HAMEL ME, 1995, INT IMMUNOL, V7, P1065, DOI 10.1093/intimm/7.7.1065; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; Herrmann T, 1993, Semin Immunol, V5, P33, DOI 10.1006/smim.1993.1005; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Liu AMF, 2004, J BIOL CHEM, V279, P53196, DOI 10.1074/jbc.M410196200; Madrenas J, 2003, IMMUNITY, V18, P459, DOI 10.1016/S1074-7613(03)00089-X; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Martelli MP, 2000, BLOOD, V96, P2181; McCormick John K, 2003, Methods Mol Biol, V214, P33; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Miscia S, 1999, J HISTOCHEM CYTOCHEM, V47, P929, DOI 10.1177/002215549904700710; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nakagawa Y, 2003, J INFECT DIS, V188, P1284, DOI 10.1086/379036; OHMURA T, 1992, J EXP MED, V176, P887, DOI 10.1084/jem.176.3.887; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; OYAIZU N, 1992, P NATL ACAD SCI USA, V89, P8035, DOI 10.1073/pnas.89.17.8035; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Philip F, 2002, FEBS LETT, V531, P28, DOI 10.1016/S0014-5793(02)03411-7; Rapecki S, 2002, J PHARMACOL EXP THER, V303, P1325, DOI 10.1124/jpet.102.038380; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Singh KK, 2001, MITOCHONDRION, V1, P1, DOI 10.1016/S1567-7249(00)00003-9; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; WEBB SR, 1990, J EXP MED, V171, P953, DOI 10.1084/jem.171.3.953; Weil R, 1996, CURR TOP MICROBIOL, V205, P63; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Yablonski D, 2001, ADV IMMUNOL, V79, P93, DOI 10.1016/S0065-2776(01)79003-7; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yamasaki S, 1997, J BIOL CHEM, V272, P14787, DOI 10.1074/jbc.272.23.14787; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	59	69	73	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					67	78		10.1016/j.immuni.2006.04.012	http://dx.doi.org/10.1016/j.immuni.2006.04.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860758	Bronze			2022-12-18	WOS:000239713000011
J	Takabayshi, K; Corr, M; Hayashi, T; Redecke, V; Beck, L; Guiney, D; Sheppard, D; Raz, E				Takabayshi, K; Corr, M; Hayashi, T; Redecke, V; Beck, L; Guiney, D; Sheppard, D; Raz, E			RETRACTED: Induction of a homeostatic circuit in lung tissue by microbial compounds (Retracted Article. See vol 28, pg 724, 2008)	IMMUNITY			English	Article; Retracted Publication							TOLL-LIKE RECEPTORS; MONOCYTE-DERIVED MACROPHAGES; TGF-BETA ACTIVATION; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; ACTIN; INFLAMMATION; EXPRESSION; CYTOPATHOLOGY; MECHANISMS	TGF beta presented and activated by integrin alpha v beta 6 expressed on alveolar epithelial cells (AEC) continuously inhibits the functionality of alveolar macrophages (AM). Despite this inhibition, AM retain their ability to respond to inhaled microorganisms. Herein we describe a homeostatic circuit through which the effects of microbial products on macrophages transiently circumvent this inhibition by repressing alpha v beta 6 expression on AEC. Subsequent production of matrix metalloproteinases by activated AM activates latent TGF beta, reinduces alpha v beta 6 expression, and thereby reinstates tonic inhibition of AM function. Our results reveal how AM can be activated while minimizing their potential to inflict collateral damage to the adjacent lung tissue and indicate that tissue-specific microenvironmental factors shape organ-specific defense strategies against microbial invasion.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Francisco	Raz, E (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	eraz@ucsd.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL079449, R01HL064353, U01HL066600, R01HL053949, R01HL056365, R37HL053949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057709, U01AI056453, P01AI040682] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL79449, HL56365, HL64353, HL66600, HL53949] Funding Source: Medline; NIAID NIH HHS [AI56453, AI57709, AI40682] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bingisser RM, 2001, SWISS MED WKLY, V131, P171; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; CHEN CY, 1995, J BACTERIOL, V177, P5303, DOI 10.1128/jb.177.18.5303-5309.1995; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Fitzpatrick DR, 1999, TRENDS MICROBIOL, V7, P232, DOI 10.1016/S0966-842X(99)01498-5; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Huang XZ, 1998, AM J RESP CELL MOL, V19, P636, DOI 10.1165/ajrcmb.19.4.3293; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Kutsuna H, 2004, AM J PHYSIOL-CELL PH, V286, pC55, DOI 10.1152/ajpcell.00131.2003; Libby SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/j.1462-5822.2000.00030.x; Lipscomb Mary F., 1993, Regional Immunology, V5, P151; Martinez-Torres FJ, 2004, NEUROSCI LETT, V368, P274, DOI 10.1016/j.neulet.2004.06.064; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; O'Reilly PJ, 2003, AM J RESP CELL MOL, V28, P443, DOI 10.1165/rcmb.2002-0153OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THEPEN T, 1994, ANN NY ACAD SCI, V725, P200, DOI 10.1111/j.1749-6632.1994.tb39802.x; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Yu Q, 2000, GENE DEV, V14, P163; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	30	69	72	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2006	24	4					475	487		10.1016/j.immuni.2006.02.008	http://dx.doi.org/10.1016/j.immuni.2006.02.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618605	Bronze			2022-12-18	WOS:000237153000016
J	Medeiros, RB; Dickey, DM; Chung, H; Quale, AC; Nagarajan, LR; Billadeau, DD; Shimizu, Y				Medeiros, RB; Dickey, DM; Chung, H; Quale, AC; Nagarajan, LR; Billadeau, DD; Shimizu, Y			Protein kinase D1 and the beta 1 integrin cytoplasmic domain control beta 1 integrin function via regulation of Rap1 activation	IMMUNITY			English	Article							PROTEIN-KINASE-D; FUNCTION-ASSOCIATED ANTIGEN-1; T-CELL; INTEGRIN ACTIVATION; EXCHANGE FACTOR; BETA-SUBUNIT; ADHESION; BINDING; RECEPTOR; IDENTIFICATION	The functional activity of integrins is dynamically regulated by T cell receptor stimulation and by protein kinase C (PKC). We report a novel function for the PKC effector protein kinase D1 (PKD1) in integrin activation. Constitutively active and kinase-inactive PKD1 mutants lacking the PKD1 pleckstrin homology (PH) domain block phorbol ester and TCR-mediated activation and clustering of beta 1 integrins. The PH domain of PKD1 mediates the association of PKD1 with the GTPase Rap1 and is central to Rap1 activation and membrane translocation in T cells. Furthermore, PKD1 and Rap1 associate with beta 1 integrins in a manner that is dependent on the carboxy-terminal end of the beta 1 integrin subunit cytoplasmic domain. beta 1 integrin expression is required for Rapt activation and membrane localization of the PKD1-Rapt complex. Therefore, PKD1 promotes integrin activation in T cells by regulating Rapt activation and membrane translocation via interactions with the beta 1 integrin subunit cytoplasmic domain.	Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol,Canc Ctr, Minneapolis, MN 55455 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Shimizu, Y (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol,Canc Ctr, Minneapolis, MN 55455 USA.	shimi002@umn.edu		Shimizu, Yoji/0000-0001-9760-0288	NCI NIH HHS [T32 CA009138] Funding Source: Medline; NHLBI NIH HHS [T32 HL07741] Funding Source: Medline; NIAID NIH HHS [AI31126, AI38474] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031126, R56AI038474, R01AI038474, R01AI031126] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Cai DP, 1999, J IMMUNOL, V163, P2104; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Epler JA, 2000, J IMMUNOL, V165, P4941, DOI 10.4049/jimmunol.165.9.4941; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Gao XL, 2001, J BIOL CHEM, V276, P42219, DOI 10.1074/jbc.M105760200; Goda S, 2004, J IMMUNOL, V172, P5379, DOI 10.4049/jimmunol.172.9.5379; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Iwata S, 2000, J DERMATOL SCI, V23, P75, DOI 10.1016/S0923-1811(99)00096-1; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Liu L, 2002, J BIOL CHEM, V277, P40893, DOI 10.1074/jbc.M206208200; Liu SC, 2000, J CELL SCI, V113, P3563; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; MOBLEY JL, 1994, BLOOD, V83, P1039, DOI 10.1182/blood.V83.4.1039.bloodjournal8341039; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Romzek NC, 1998, MOL BIOL CELL, V9, P2715, DOI 10.1091/mbc.9.10.2715; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wood CD, 2005, J BIOL CHEM, V280, P6245, DOI 10.1074/jbc.M411564200; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232	55	69	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					213	226		10.1016/j.immuni.2005.07.006	http://dx.doi.org/10.1016/j.immuni.2005.07.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111639	Bronze			2022-12-18	WOS:000231721700011
J	Verkoczy, L; Ait-Azzouzene, D; Skog, P; Martensson, A; Lang, J; Duong, B; Nemazee, D				Verkoczy, L; Ait-Azzouzene, D; Skog, P; Martensson, A; Lang, J; Duong, B; Nemazee, D			A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes	IMMUNITY			English	Article							B-CELL DEVELOPMENT; MURINE RAG-2 PROMOTER; C-REL; T-CELLS; LYMPHOCYTE-PROLIFERATION; CHROMATIN STRUCTURE; RECEPTOR SELECTION; ESCAPE TOLERANCE; COMBINED ABSENCE; P50 SUBUNIT	In developing B cells, expression of surface immunoglobulin is an important signal to terminate recombinase activator gene (RAG) expression and V(D)J recombination. However, autoreactive antigen receptors instead promote continued gene rearrangement and receptor editing. The regulation by B cell receptor (BCR) signaling of RAG expression and editing is poorly understood. We report that in editing-competent cells BCR ligand-induced RAG mRNA expression is regulated at the level of RAG transcription, rather than mRNA stability. In immature B cells carrying innocuous receptors, RAG expression appears to be under rapidly reversible negative regulation. Studies involving transduction of a superrepressive (sr) I kappa B alpha protein indicate that NF-kappa B/Rel proteins promote RAG transcription. Interestingly, NF kappa B1-deficient cells overexpress RAG and undergo an exaggerated receptor editing response. Our data implicate NF kappa B transcription factors in the BCR-mediated regulation of RAG locus transcription. Rapidly activated NF kappa B pathways may facilitate prompt antigen receptor-regulated changes in RAG expression important for editing and haplotype exclusion.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Barbara Davis Ctr, Denver, CO 80262 USA; Scripps Res Inst, Doctoral Program Chem & Biol Sci, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	nemazee@scripps.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033608] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007195, T32HL07195] Funding Source: Medline; NIAID NIH HHS [R01AI33608, R01 AI033608] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Brown ST, 1997, J IMMUNOL, V158, P5071; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Fong IC, 2000, MOL IMMUNOL, V37, P391, DOI 10.1016/S0161-5890(00)00056-0; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; GROSS TM, 2000, DIABETES TECHNOL THE, V2, P19, DOI DOI 10.1089/15209150050214087; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Inlay M, 2003, CLIN IMMUNOL, V109, P29, DOI 10.1016/S1521-6616(03)00199-2; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; JUNG M, 1995, SCIENCE, V268, P1619, DOI 10.1126/science.7777860; Kabouridis PS, 2002, J IMMUNOL, V169, P2587, DOI 10.4049/jimmunol.169.5.2587; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kishi H, 2002, BLOOD, V99, P576, DOI 10.1182/blood.V99.2.576; Kishi H, 2000, BLOOD, V95, P3845; Kistler B, 1998, J IMMUNOL, V160, P2308; Kitagawa T, 1996, BLOOD, V88, P3785, DOI 10.1182/blood.V88.10.3785.bloodjournal88103785; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; Lauring J, 1999, MOL CELL BIOL, V19, P2601; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; MA A, 1992, EMBO J, V11, P2727, DOI 10.1002/j.1460-2075.1992.tb05338.x; Melamed D, 1997, J IMMUNOL, V159, P1233; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Miranda GA, 2002, MOL IMMUNOL, V38, P1151, DOI 10.1016/S0161-5890(02)00007-X; Monroe RJ, 1999, P NATL ACAD SCI USA, V96, P12713, DOI 10.1073/pnas.96.22.12713; NEALE GAM, 1992, MOL IMMUNOL, V29, P1457, DOI 10.1016/0161-5890(92)90219-N; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Scherer DC, 1996, IMMUNITY, V5, P563, DOI 10.1016/S1074-7613(00)80271-X; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Sheehy AM, 1999, J BIOL CHEM, V274, P8708, DOI 10.1074/jbc.274.13.8708; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; STORB U, 1987, ANNU REV IMMUNOL, V5, P151, DOI 10.1146/annurev.iy.05.040187.001055; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VERKOCZY LK, 1995, J IMMUNOL, V154, P5136; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; Weih F, 1996, J IMMUNOL, V157, P3974; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080; Zarrin AA, 1997, J IMMUNOL, V159, P4382; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	73	69	69	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					519	531		10.1016/j.immuni.2005.03.006	http://dx.doi.org/10.1016/j.immuni.2005.03.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845455	Bronze, Green Accepted			2022-12-18	WOS:000228909600012
J	Han, A; Saijo, K; Mecklenbrauker, I; Tarakhovsky, A; Nussenzweig, MC				Han, A; Saijo, K; Mecklenbrauker, I; Tarakhovsky, A; Nussenzweig, MC			Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival	IMMUNITY			English	Article							HEMATOPOIETIC PROGENITOR KINASE-1; NF-KAPPA-B; ANTIGEN-RECEPTOR; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-2; ADAPTER PROTEINS; SURFACE-IMMUNOGLOBULIN; LYMPHOCYTE DEVELOPMENT	Bam32 is an adaptor protein recruited to the plasma membrane upon B cell receptor (BCR) crosslinking in a phosphoinositol 3-kinase (PI3K)-dependent manner; however, its physiologic function is unclear. To determine its physiologic function, we produced Bam32-deficient mice. Bam32(-/-) B cells develop normally but have impaired T-independent antibody responses in vivo and diminished responses to BCR crosslinking in vitro. Biochemical analysis revealed that Bam32 acts in a novel pathway leading from the BCR to MAPK/ ERK Kinases (MEK1/2), MAPK/ERK Kinase Kinase-1 (MEKK1), extracellular signal-regulated kinase (ERK), and c-jun NH2-terminal kinase (JNK), but not p38 mitogen-activated protein kinase (p38). This pathway appears to be initiated by hematopoietic progenitor kinase-1 (HPK1), which interacts directly with Bam32, and differs from all previously characterized BCR signaling pathways in that it is required for normal BCR-mediated proliferation but not for B cell survival.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019					Anderson KE, 2000, CURR BIOL, V10, P1403, DOI 10.1016/S0960-9822(00)00794-6; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen TT, 1999, MAR BIOTECHNOL, V1, P1; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; Khan WN, 2001, IMMUNOL RES, V23, P147, DOI 10.1385/IR:23:2-3:147; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; King LB, 2000, IMMUNOL REV, V176, P86; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Maas A, 2001, Dev Immunol, V8, P171, DOI 10.1155/2001/28962; Marshall AJ, 2000, J EXP MED, V191, P1319, DOI 10.1084/jem.191.8.1319; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Meffre E, 2002, P NATL ACAD SCI USA, V99, P11334, DOI 10.1073/pnas.172369999; Niiro H, 2002, J EXP MED, V195, P143, DOI 10.1084/jem.20011524; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pogue SL, 2000, J IMMUNOL, V165, P1300, DOI 10.4049/jimmunol.165.3.1300; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rao VR, 1999, J BIOL CHEM, V274, P37893, DOI 10.1074/jbc.274.53.37893; Reth M, 2000, IMMUNOL REV, V176, P10; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	71	69	75	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					621	632		10.1016/S1074-7613(03)00275-9	http://dx.doi.org/10.1016/S1074-7613(03)00275-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563325	Bronze			2022-12-18	WOS:000186051900017
J	Marklund, U; Lightfoot, K; Cantrell, D				Marklund, U; Lightfoot, K; Cantrell, D			Intracellular location and cell context-dependent function of protein kinase D	IMMUNITY			English	Article							COUPLED RECEPTOR ACTIVATION; DEVELOPMENT IN-VIVO; ALLELIC EXCLUSION; TRANSGENIC MICE; THYMOCYTE DIFFERENTIATION; SIGNAL-TRANSDUCTION; IMMATURE THYMOCYTES; GENE REARRANGEMENT; MOLECULAR-CLONING; ANTIGEN RECEPTOR	Protein kinase D (PKD) is an antigen receptor-activated serine kinase localized at either the plasma membrane or the cytosol of lymphocytes. To probe PKD function at these different locations, transgenesis was used to target active PKD either to the membrane or cytosol of pre-T cells. In redombinase gene null pre-T cells, membrane and cytosolic active PKD both induced differentiation reminiscent of P selection: downregulation of CD25 and upregulation of CD2 and CD5. Active PKDs also induced pre-T cell proliferation, although this response was not universal to all thymocyte subsets. There were two striking differences between the actions of the differentially localized PKDs. Membrane but not cytosolic PKD could induce expression of CD8 and CD4 in recombinase null mice; cytosolic but not membrane PKD suppressed Vbeta to DJbeta rearrangements of the TCRbeta chain locus in wild-type T cells. PKD function is thus determined by its intracellular location and cell context.	Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Activat Lab, London WC2A 3PX, England	University of Dundee; Cancer Research UK	Cantrell, D (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk		Cantrell, Doreen/0000-0001-7525-3350				Aifantis I, 1999, J EXP MED, V190, P1093, DOI 10.1084/jem.190.8.1093; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Cantrell DA, 2002, IMMUNOLOGY, V105, P369, DOI 10.1046/j.1365-2567.2002.01391.x; Corre I, 2001, J EXP MED, V194, P903, DOI 10.1084/jem.194.7.903; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hurd C, 2003, BIOCHEM BIOPH RES CO, V302, P800, DOI 10.1016/S0006-291X(03)00268-7; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2003, J BIOL CHEM, V278, P9086, DOI 10.1074/jbc.M211295200; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Michie AM, 2001, P NATL ACAD SCI USA, V98, P609, DOI 10.1073/pnas.021288598; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Na SQ, 1999, ONCOGENE, V18, P7966, DOI 10.1038/sj.onc.1203122; Norment AM, 2003, J IMMUNOL, V170, P1141, DOI 10.4049/jimmunol.170.3.1141; PERLMUTTER RM, 1995, CANCER SURV, V22, P85; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Rey O, 2003, BIOCHEM BIOPH RES CO, V302, P817, DOI 10.1016/S0006-291X(03)00269-9; Rey O, 2001, BIOCHEM BIOPH RES CO, V287, P21, DOI 10.1006/bbrc.2001.5530; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2002, J BIOL CHEM, V277, P29431, DOI 10.1074/jbc.M200934200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	55	69	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					491	501		10.1016/S1074-7613(03)00260-7	http://dx.doi.org/10.1016/S1074-7613(03)00260-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563314	Bronze			2022-12-18	WOS:000186051900006
J	Riese, RJ; Shi, GP; Villadangos, J; Stetson, D; Driessen, C; Lennon-Dumenil, AM; CHu, CL; Naumov, Y; Behar, SM; Ploegh, H; Locksley, R; Chapman, HA				Riese, RJ; Shi, GP; Villadangos, J; Stetson, D; Driessen, C; Lennon-Dumenil, AM; CHu, CL; Naumov, Y; Behar, SM; Ploegh, H; Locksley, R; Chapman, HA			Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S	IMMUNITY			English	Article							COMPLEX CLASS-II; MHC CLASS-II; ANTIGEN-PRESENTING MOLECULES; INVARIANT CHAIN; DENDRITIC CELLS; MOUSE CD1; NKT CELLS; MICE; PEPTIDE; TRAFFICKING	NK1.1(+) T cells develop and function through interactions with cell surface CD1 complexes. In I-A(B) mice lacking the invariant chain (Ii) processing enzyme, cathepsin S, NK1.1(+) T cell selection and function are impaired. In vitro, thymic dendritic cells (DCs) from cathepsin S=/- mice exhibit defective presentation of the CD1restricted antigen, a-galactosylceramide (alpha -GalCer). CD1 dysfunction is secondary to defective trafficking of CD1, which colocalizes with Ii fragments and accumulates within endocytic compartments of cathepsin S-/- DCs. [-A(k), cathepsin S-/- mice do not accumulate class [II-associated Ii fragments and accordingly do not display CD1 abnormalities. Thus, function of CD1 is critically linked to processing of li, revealing MHC class II haplotype and cathepsin S activity as regulators of NK T cells.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94943 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Chapman, HA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94943 USA.		Lennon-Dumenil, Ana-Maria/I-6716-2016; Behar, Samuel M/C-3541-2009; Villadangos, Jose A/AAU-1404-2020; Driessen, C/F-7061-2016	Villadangos, Jose A/0000-0001-6771-8891; Driessen, C/0000-0002-1124-7303; Behar, Samuel/0000-0002-3374-6699; Chu, Ching-Liang/0000-0002-8463-526X	NHLBI NIH HHS [HL48716] Funding Source: Medline; NIAID NIH HHS [AI01555] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Behar SM, 1999, J IMMUNOL, V162, P161; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; Brossay L, 1998, J IMMUNOL, V160, P3681; Brossay L, 1998, IMMUNOL REV, V163, P139, DOI 10.1111/j.1600-065X.1998.tb01193.x; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Burdin N, 1999, CURR OPIN IMMUNOL, V11, P326, DOI 10.1016/S0952-7915(99)80052-1; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cresswell P, 1998, SCIENCE, V280, P394, DOI 10.1126/science.280.5362.394; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; HAYAKAWA K, 1992, J EXP MED, V176, P269, DOI 10.1084/jem.176.1.269; Honey K, 2001, J BIOL CHEM, V276, P22573, DOI 10.1074/jbc.M101851200; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Meara JP, 1996, J MED CHEM, V39, P3357, DOI 10.1021/jm950445b; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nordeng TW, 1999, J BIOL CHEM, V274, P21139, DOI 10.1074/jbc.274.30.21139; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shinkai K, 2000, J EXP MED, V191, P907, DOI 10.1084/jem.191.6.907; Taniguchi M, 1996, P NATL ACAD SCI USA, V93, P11025, DOI 10.1073/pnas.93.20.11025; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Wilson P, 1998, REV INT STUD, V24, P1, DOI 10.1017/S0260210598000011; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845	46	69	73	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					909	919		10.1016/S1074-7613(01)00247-3	http://dx.doi.org/10.1016/S1074-7613(01)00247-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754813	Bronze			2022-12-18	WOS:000172961400006
J	Savage, PA; Davis, MM				Savage, PA; Davis, MM			A kinetic window constricts the T cell receptor repertoire in the thymus	IMMUNITY			English	Article							POSITIVE SELECTION; ANTIGEN RECEPTOR; TRANSGENIC MICE; IN-VIVO; COMPLEX; ACTIVATION; THYMOCYTES; DIFFERENTIATION; RECOGNITION; EXPRESSION	To characterize the ligand binding properties of a naive T cell repertoire capable of responding to a foreign antigen, we analyzed T cell populations from T cell receptor (TCR) beta transgenic mice using a novel, single cell peptide/major histocompatibility complex (MHC) tetramer dissociation assay. The largely CD4(+)CD8(-/low) antigen-specific thymocyte repertoire exhibited a broad, bimodal distribution of tetramer binding half-lives (t(1/2)s), with a significant underrepresentation in the intermediate half-life range in which the majority of the peripheral repertoire lies. Thus, cells with the potential to bind foreign antigen with the lowest and highest stability are likely to be selectively removed from the repertoire prior to their establishment in the periphery. These studies provide direct evidence that thymic selection biases the naive peripheral T cell repertoire toward TCR-ligand interactions that fall within a moderate half-life "window.".	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Davis, Mark/0000-0001-6868-657X				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; Baldwin KK, 1999, J IMMUNOL, V163, P689; Baldwin KK, 1999, J EXP MED, V189, P13, DOI 10.1084/jem.189.1.13; Benoist C, 1997, CURR OPIN IMMUNOL, V9, P245, DOI 10.1016/S0952-7915(97)80143-4; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; CRISPE IN, 1987, J IMMUNOL, V138, P2013; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVIS MM, 1984, IMMUNOL REV, V81, P235, DOI 10.1111/j.1600-065X.1984.tb01113.x; FAZEKASDESTGROTH B, 1992, MOL MECH IMMUNOLOGIC, P123; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; HEDRICK SM, 1988, SCIENCE, V239, P1541, DOI 10.1126/science.2832942; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; REAY PA, 1994, J IMMUNOL, V152, P3946; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; ZINKERNAGEL RM, 1978, NATURE, V271, P251, DOI 10.1038/271251a0	42	69	69	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2001	14	3					243	252		10.1016/S1074-7613(01)00106-6	http://dx.doi.org/10.1016/S1074-7613(01)00106-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290334	Bronze			2022-12-18	WOS:000167959500004
J	Kang, J; Coles, M; Cado, D; Raulet, DH				Kang, J; Coles, M; Cado, D; Raulet, DH			The developmental fate of T cells is critically influenced by TCR gamma delta expression	IMMUNITY			English	Article							BETA-LINEAGE THYMOCYTES; RECEPTOR-ALPHA-GENE; REARRANGEMENT; MICE; COMMITMENT; SELECTION; PRECURSOR; ABSENCE	Differentiation of gamma delta and alpha beta T cells from a common precursor cell depends on productive rearrangement and expression of TCR gamma delta or TCR beta genes, but whether it is an instructive or a stochastic mechanism that is responsible for this process is unclear. We report that expression of the productively rearranged TCR gamma transgene competitively inhibits alpha beta thymocyte development under conditions where TCR beta gene rearrangement is limiting. The status of TCR delta gene rearrangements in the remaining alpha beta-lineage cells indicates that the effect is mediated by the intact gamma delta receptor. Paradoxically, in TCR beta(-/-) mice, gamma delta receptor expression can also drive differentiation of some up-lineage cells. To resolve this paradox, we provide evidence for a minor population of gamma delta-dependent alpha beta-lineage cells in normal mice. The results indicate that the T cell lineage commitment process is either error-prone or stochastic.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Div Immunol, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu		Raulet, David/0000-0002-1257-8649; kang, joonsoo/0000-0001-8419-7995	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031650] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI-31650] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BONNEVILLE M, 1989, NATURE, V342, P931, DOI 10.1038/342931a0; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Burtrum DB, 1996, J IMMUNOL, V157, P4293; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; KERSH GJ, 1995, J IMMUNOL, V154, P5706; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; LUCAS B, 1993, J IMMUNOL, V151, P4574; LYNCH F, 1993, INT IMMUNOL, V5, P991, DOI 10.1093/intimm/5.8.991; Mertsching E, 1996, EUR J IMMUNOL, V26, P804, DOI 10.1002/eji.1830260412; Mertsching E, 1997, EUR J IMMUNOL, V27, P389, DOI 10.1002/eji.1830270208; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PENIT C, 1995, J IMMUNOL, V154, P5103; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHORES EW, 1990, EUR J IMMUNOL, V20, P69, DOI 10.1002/eji.1830200111; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SIM GK, 1995, J IMMUNOL, V154, P5821; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vicari AP, 1996, EUR J IMMUNOL, V26, P1424, DOI 10.1002/eji.1830260704; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0	36	69	69	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					427	438		10.1016/S1074-7613(00)80548-8	http://dx.doi.org/10.1016/S1074-7613(00)80548-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586633	Bronze			2022-12-18	WOS:000073348000005
J	Reif, K; Cantrell, DA				Reif, K; Cantrell, DA			Networking Rho family GTPases in lymphocytes	IMMUNITY			English	Review							T-CELLS; EFFECTOR PATHWAYS; CDC42; RAC; THYMOCYTES; SELECTION; COMPLEXES; P21(RAS)		Imperial Canc Res Fund, Lymphocyte Activat Lab, London WC2A 3PX, England	Cancer Research UK	Reif, K (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	kreif@itsa.ucsf.edu	Reif, Karin/AAD-4692-2020	Reif, Karin/0000-0001-5490-8389				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Collins TL, 1997, IMMUNOL TODAY, V18, P221; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Cullen BR, 1996, CURR BIOL, V6, P1557, DOI 10.1016/S0960-9822(02)70770-7; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Galandrini R, 1997, IMMUNITY, V7, P163, DOI 10.1016/S1074-7613(00)80519-1; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Kirchhausen T, 1996, CURR BIOL, V6, P676, DOI 10.1016/S0960-9822(09)00447-3; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; LANG P, 1995, METHOD ENZYMOL, V256, P320; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nunes JA, 1996, J BIOL CHEM, V271, P1591, DOI 10.1074/jbc.271.3.1591; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Teramoto H, 1997, J BIOL CHEM, V272, P10751; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Turner H, 1997, J EXP MED, V185, P43, DOI 10.1084/jem.185.1.43; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Ward SG, 1996, IMMUNOL TODAY, V17, P187, DOI 10.1016/0167-5699(96)80618-9; Wu J, 1997, J EXP MED, V185, P1877, DOI 10.1084/jem.185.10.1877; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3	38	69	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1998	8	4					395	401		10.1016/S1074-7613(00)80545-2	http://dx.doi.org/10.1016/S1074-7613(00)80545-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586630	Bronze			2022-12-18	WOS:000073348000002
J	Afar, DEH; Han, LM; McLaughlin, J; Wong, S; Dhaka, A; Parmar, K; Rosenberg, N; Witte, ON; Colicelli, J				Afar, DEH; Han, LM; McLaughlin, J; Wong, S; Dhaka, A; Parmar, K; Rosenberg, N; Witte, ON; Colicelli, J			Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1	IMMUNITY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE-ACTIVITY; PHILADELPHIA-CHROMOSOME; C-ABL; HEMATOPOIETIC-CELLS; TRANSFORMING ABILITY; ADAPTER PROTEIN; MYELOID CELLS; GENE-PRODUCT; V-ABL	RIN1 was originally identified by its ability to physically bind to and interfere with activated Ras in yeast. Paradoxically, RIN1 potentiates the oncogenic activity of the BCR-ABL tyrosine kinase in hematopoietic cells and dramatically accelerates BCR-ABL-induced leukemias in mice. RIN1 rescues BCR-ABL mutants for transformation in a manner distinguishable from the cell cycle regulators c-Myc and cyclin D1 and the Ras connector She. These biological effects require tyrosine phosphorylation of RIN1 and binding of RIN1 to the Abl-SH2 and SH3 domains. RIN1 is tyrosine phosphorylated and is associated with BCR-ABL in human and murine leukemic cells. RIN1 exemplifies a new class of effector molecules dependent on the concerted action of the SH3, SH2, and catalytic domains of a cytoplasmic tyrosine kinase.	UNIV CALIF LOS ANGELES, DEPT MICROBIOL & MOL GENET, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, DEPT BIOL CHEM, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, INST MOL BIOL, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, HOWARD HUGHES MED INST, LOS ANGELES, CA 90095 USA; TUFTS UNIV, SCH MED, DEPT MOL BIOL & MICROBIOL, BOSTON, MA 02115 USA; TUFTS UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Tufts University; Tufts University					NATIONAL CANCER INSTITUTE [R01CA024220, R01CA056301, R35CA053867] Funding Source: NIH RePORTER; NCI NIH HHS [CA56301, R35CA53867, CA24220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AFAR DEH, 1995, P NATL ACAD SCI USA, V92, P9540, DOI 10.1073/pnas.92.21.9540; AFAR DEH, 1994, SCIENCE, V264, P424, DOI 10.1126/science.8153630; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; ELEFANTY AG, 1990, EMBO J, V9, P1069, DOI 10.1002/j.1460-2075.1990.tb08212.x; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; KAZLAUSKAS A, 1994, CURR OPIN GENET DEV, V4, P5, DOI 10.1016/0959-437X(94)90085-X; KELLIHER M, 1991, MOL CELL BIOL, V11, P4710, DOI 10.1128/MCB.11.9.4710; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Laneuville P, 1995, Semin Immunol, V7, P255, DOI 10.1006/smim.1995.0030; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; MANDANAS RA, 1993, BLOOD, V82, P1838; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MATSUGUCHI T, 1994, J BIOL CHEM, V269, P5016; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MCLAUGHLIN J, 1989, MOL CELL BIOL, V9, P1866, DOI 10.1128/MCB.9.5.1866; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; ODA T, 1994, J BIOL CHEM, V269, P22925; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/0092-8674(93)90689-N; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RENNICK D, 1987, BLOOD, V69, P682; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; ROSENBERG N, 1988, ADV VIRUS RES, V35, P39; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; SCOTT ML, 1991, P NATL ACAD SCI USA, V88, P6506, DOI 10.1073/pnas.88.15.6506; SOEKARMAN D, 1990, LEUKEMIA, V4, P397; TAUCHI T, 1994, J EXP MED, V179, P167, DOI 10.1084/jem.179.1.167; TENHOEVE J, 1994, CANCER RES, V54, P2563; TIMMONS MS, 1989, ONCOGENE, V4, P559; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3	63	69	76	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1997	6	6					773	782		10.1016/S1074-7613(00)80452-5	http://dx.doi.org/10.1016/S1074-7613(00)80452-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208849	Bronze			2022-12-18	WOS:A1997XG57900012
J	TUSSEY, LG; ROWLANDJONES, S; ZHENG, TS; ANDROLEWICZ, MJ; CRESSWELL, P; FRELINGER, JA; MCMICHAEL, AJ				TUSSEY, LG; ROWLANDJONES, S; ZHENG, TS; ANDROLEWICZ, MJ; CRESSWELL, P; FRELINGER, JA; MCMICHAEL, AJ			DIFFERENT MHC CLASS-I ALLELES COMPETE FOR PRESENTATION OF OVERLAPPING VIRAL EPITOPES	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOXIC LYMPHOCYTES-T; PROTEASOME-RELATED GENE; LINKED LMP GENE; PEPTIDE BINDING; ANTIGEN PRESENTATION; VACCINIA VIRUS; CELL EPITOPES; MOLECULES; RECOGNITION	We previously identified an HLA-B8(+) donor, NW, whose lymphoblastoid cells failed to present a B8-restricted epitope from the influenza A nucleoprotein following viral infection, although added peptide could still be presented. The failure to present through HLA-88 following viral infection appears to be specific for the NP epitope. Here, we report that donor NW makes an HLA-B2702-restricted influenza-specific CTL response to an epitope in the nucleoprotein that overlaps the B8-restricted epitope by 8 aa. Two mechanisms for the failure of this cell line to present the B8-restricted epitope following viral infection are investigated. One is that there is an antigen processing polymorphism specific to the NW cell line, so that there is either preferential generation or preferential transport of the B2702 epitope. The other is that B8 and B2702 compete for a common peptide fragment in the ER and this leads to suboptimal loading of HLA-B8.	UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; Yale University	TUSSEY, LG (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND.		Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020288, R01AI020288, R01AI029324] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 20288, AI 29324] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CHIMINI G, 1989, J EXP MED, V169, P297, DOI 10.1084/jem.169.1.297; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; COLBERT RA, 1993, P NATL ACAD SCI USA, V90, P6879, DOI 10.1073/pnas.90.14.6879; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; DENG HK, 1993, J EXP MED, V178, P1675, DOI 10.1084/jem.178.5.1675; DIBRINO M, 1994, J IMMUNOL, V152, P620; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; ELLIOTT T, 1993, CURR BIOL, V3, P854, DOI 10.1016/0960-9822(93)90219-E; ENGELHARD VH, 1994, CURR OPIN IMMUNOL, V6, P13, DOI 10.1016/0952-7915(94)90028-0; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; GAO XM, 1994, EUR J IMMUNOL, V24, P1665, DOI 10.1002/eji.1830240731; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; HAHN YS, 1991, J EXP MED, V174, P733, DOI 10.1084/jem.174.3.733; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JOHNSON RP, 1992, J EXP MED, V175, P961, DOI 10.1084/jem.175.4.961; JOYCE S, 1994, P NATL ACAD SCI USA, V91, P4145, DOI 10.1073/pnas.91.10.4145; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P2676, DOI 10.1073/pnas.90.7.2676; LOPEZ D, 1994, EUR J IMMUNOL, V24, P1194, DOI 10.1002/eji.1830240528; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MILLIGAN GN, 1990, J IMMUNOL, V145, P3188; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; NAVARRETE VO, 1991, NATURE, V353, P662; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; NIXON DF, 1992, IMMUNOLOGY, V76, P515; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PARKER KC, 1992, J IMMUNOL, V149, P3580; PAZMANY L, 1992, J EXP MED, V175, P361, DOI 10.1084/jem.175.2.361; RADKA SF, 1982, J IMMUNOL, V128, P2804; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; ROTZSCHKE O, 1991, J EXP MED, V174, P1059, DOI 10.1084/jem.174.5.1059; ROTZSCHKE O, 1991, IMMUNOL TODAY, V12, P447, DOI 10.1016/0167-5699(91)90018-O; ROWLANDJONES SL, 1993, EUR J IMMUNOL, V23, P1999, DOI 10.1002/eji.1830230841; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; SUTTON J, 1993, EUR J IMMUNOL, V23, P447, DOI 10.1002/eji.1830230222; SUTTON J, 1993, THESIS OXFORD U OXFO; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TUSSEY LG, 1994, J IMMUNOL, V152, P1213; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; WALLNY HJ, 1992, EUR J IMMUNOL, V22, P655, DOI 10.1002/eji.1830220307; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; YEWDELL J, 1994, J IMMUNOL, V152, P1163; ZHOU XZ, 1994, EUR J IMMUNOL, V24, P1863, DOI 10.1002/eji.1830240822	63	69	70	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					65	77		10.1016/1074-7613(95)90159-0	http://dx.doi.org/10.1016/1074-7613(95)90159-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7542549	hybrid, Green Published			2022-12-18	WOS:A1995RK86800008
J	Williams, JW; Huang, LH; Randolph, GJ				Williams, Jesse W.; Huang, Li-hao; Randolph, Gwendalyn J.			Cytokine Circuits in Cardiovascular Disease	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; ATHEROSCLEROTIC LESION DEVELOPMENT; DENSITY-LIPOPROTEIN TRANSCYTOSIS; VASCULAR ENDOTHELIAL-CELLS; COLONY-STIMULATING FACTOR; INTIMAL DENDRITIC CELLS; C-REACTIVE PROTEIN; NLRP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS	Arterial inflammation is a hallmark of atherosclerosis, and appropriate management of this inflammation represents a major unmet therapeutic need for cardiovascular disease patients. Here, we review the diverse contributions of immune cells to atherosclerosis, the mechanisms of immune cell activation in this context, and the cytokine circuits that underlie disease progression. We discuss the recent application of these insights in the form of immunotherapy to treat cardiovascular disease and highlight how studies on the cardiovascular co-morbidity that arises in autoimmunity might reveal additional roles for cytokines in atherosclerosis. Currently, data point to interleukin-1 beta (IL-1 beta), tumor necrosis factor (TNF), and IL-17 as cytokines that, at least in some settings, are effective targets to reduce cardiovascular disease progression.	[Williams, Jesse W.; Huang, Li-hao; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63139 USA	Washington University (WUSTL)	Randolph, GJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63139 USA.	gjrandolph@wustl.edu		Williams, Jesse/0000-0003-3815-0891	National Institutes of Health (NIH) [R37 A1049653, DP1DK109668]; Career Development Award from the American Heart Association; NIH [K99 HL138163]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL138163, K99HL138163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK109668] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the American Heart Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge Konstantin Zaitsev (Washington University PhD Program in Immunology) for help with generating the Monocle lineage analysis described as unpublished data and Dr. Bernd Zinselmeyer for assistance with illustrations. We are also grateful to Drs. Parrakal Deepak (Washington University) and Jaehoon Choi (Hanyang University) for scientific interactions and recent discussions that have helped to shape parts of this article. The authors are funded by National Institutes of Health (NIH) grants R37 A1049653 and DP1DK109668 to G.J.R., NIH grant K99 HL138163 to J.W.W., and a Career Development Award from the American Heart Association to L.H.	Aarestrup J., 2018, J CROHNS COLITIS; Afrasyab A, 2016, HEART VESSELS, V31, P1218, DOI 10.1007/s00380-015-0723-8; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Allam AH, 2009, JAMA-J AM MED ASSOC, V302, P2091, DOI 10.1001/jama.2009.1641; Aniwan S, 2018, CLIN GASTROENTEROL H, V16, P1607, DOI 10.1016/j.cgh.2018.04.031; [Anonymous], 2019, NY TIMES MAGAZINE; Anzai A, 2017, J EXP MED, V214, P3293, DOI 10.1084/jem.20170689; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; Bai YT, 2016, BBA-GEN SUBJECTS, V1860, P2863, DOI 10.1016/j.bbagen.2016.04.030; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Baldrighi M, 2017, ATHEROSCLEROSIS, V267, P127, DOI 10.1016/j.atherosclerosis.2017.10.027; Ballocca F, 2015, EUR J PREV CARDIOL, V22, P1435, DOI 10.1177/2047487314546826; BENDITT EP, 1974, CIRCULATION, V50, P650, DOI 10.1161/01.CIR.50.4.650; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bobryshev YV, 1998, CARDIOVASC RES, V37, P799, DOI 10.1016/S0008-6363(97)00229-0; BOBRYSHEV YV, 1995, ARCH HISTOL CYTOL, V58, P307, DOI 10.1679/aohc.58.307; BREMMELGAARD A, 1986, ARTERIOSCLEROSIS, V6, P442, DOI 10.1161/01.ATV.6.4.442; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; BUSSOLINO F, 1988, J BIOL CHEM, V263, P11856; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Cherepanova OA, 2016, NAT MED, V22, P657, DOI 10.1038/nm.4109; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DINARELLO CA, 1977, P NATL ACAD SCI USA, V74, P4624, DOI 10.1073/pnas.74.10.4624; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Du J, 2015, ANN EPIDEMIOL, V25, P575, DOI 10.1016/j.annepidem.2015.03.016; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Elnabawi Y. A., 2019, CARDIOVASC RES; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Erbel C, 2014, J IMMUNOL, V193, P4344, DOI 10.4049/jimmunol.1400181; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Evavold CL, 2019, IMMUNITY, V50, P15, DOI 10.1016/j.immuni.2018.12.032; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fatkhullina AR, 2018, IMMUNITY, V49, P943, DOI 10.1016/j.immuni.2018.09.011; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Folco EJ, 2014, CIRC RES, V115, P875, DOI 10.1161/CIRCRESAHA.115.304437; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; FURIE MB, 1989, J IMMUNOL, V143, P3309; Garshick M. S., 2019, ARTERIOSCLER THROMB, DOI [10.1161/ATVBAHA, DOI 10.1161/ATVBAHA]; Ge SW, 2013, CIRC RES, V113, P965, DOI 10.1161/CIRCRESAHA.113.301934; Ghaffari S, 2018, ARTERIOSCL THROM VAS, V38, P2283, DOI 10.1161/ATVBAHA.118.310792; Gistera A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006133; GOLDSTEIN JL, 1977, METABOLISM, V26, P1257, DOI 10.1016/0026-0495(77)90119-6; Gomez D, 2018, NAT MED, V24, P1418, DOI 10.1038/s41591-018-0124-5; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hu DS, 2015, IMMUNITY, V42, P1100, DOI 10.1016/j.immuni.2015.05.015; Hu S. C., 2017, INT J MOL SCI, V18, P18; Huang LH, 2019, CELL METAB, V29, P475, DOI 10.1016/j.cmet.2018.10.006; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Kim K, 2018, CIRC RES, V123, P1127, DOI 10.1161/CIRCRESAHA.118.312804; Kimura T, 2018, CIRCULATION, V138, P1130, DOI 10.1161/CIRCULATIONAHA.117.031420; Kimura T, 2015, AUTOIMMUNITY, V48, P152, DOI 10.3109/08916934.2014.1003641; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kojima Y, 2016, NATURE, V536, P86, DOI 10.1038/nature18935; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lee SE, 2018, JACC-CARDIOVASC IMAG, V11, P1475, DOI 10.1016/j.jcmg.2018.04.015; Lee SI, 2015, THER ADV CHRONIC DIS, V6, P347, DOI 10.1177/2040622315598502; Levy E, 2000, AM J CLIN NUTR, V71, P807, DOI 10.1093/ajcn/71.3.807; LIBBY P, 1986, AM J PATHOL, V124, P179; Libby P, 2015, EUR HEART J, V36, P2984, DOI 10.1093/eurheartj/ehv349; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Lim HY, 2018, IMMUNITY, V49, P1191, DOI 10.1016/j.immuni.2018.12.009; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Liu BN, 2010, EXP HEMATOL, V38, P877, DOI 10.1016/j.exphem.2010.06.004; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Millonig G, 2001, ARTERIOSCL THROM VAS, V21, P503, DOI 10.1161/01.ATV.21.4.503; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; MOSER R, 1989, J CLIN INVEST, V83, P444, DOI 10.1172/JCI113903; Mundi S, 2018, CARDIOVASC RES, V114, P35, DOI 10.1093/cvr/cvx226; Nasir K, 2005, ARTERIOSCL THROM VAS, V25, P1966, DOI 10.1161/01.ATV.0000175296.02550.e4; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nordlohne J, 2018, JACC-BASIC TRANSL SC, V3, P54, DOI 10.1016/j.jacbts.2017.08.005; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Paramel Varghese G, 2016, J AM HEART ASSOC, P5; Parsa R, 2016, J EXP MED, V213, P1537, DOI 10.1084/jem.20150577; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; POBER JS, 1986, J IMMUNOL, V137, P1893; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Romanato G, 2009, ALIMENT PHARM THER, V29, P298, DOI 10.1111/j.1365-2036.2008.03886.x; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; ROSS R, 1977, AM J PATHOL, V86, P675; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Roufaiel M, 2016, NAT IMMUNOL, V17, P1263, DOI 10.1038/ni.3564; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Sage A. P., 2018, NAT REV CARDIOL; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; Schwartz S. M., 2018, F1000RES, V7, P7; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; Sessa WC, 2018, ARTERIOSCL THROM VAS, V38, P2276, DOI 10.1161/ATVBAHA.118.311620; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi X, 2015, J STROKE CEREBROVASC, V24, P2455, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.024; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; SMALL DM, 1984, J CLIN INVEST, V73, P1590, DOI 10.1172/JCI111366; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Speeckaert R, 2016, BRIT J DERMATOL, V175, P892, DOI 10.1111/bjd.14703; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; STENDER S, 1984, J CLIN INVEST, V74, P1871, DOI 10.1172/JCI111606; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Subramanian S, 2018, ENDOCRIN METAB CLIN, V47, P65, DOI 10.1016/j.ecl.2017.10.012; Suntsova M, 2015, CELL MOL LIFE SCI, V72, P3653, DOI 10.1007/s00018-015-1947-6; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tokuyama M, 2018, P NATL ACAD SCI USA, V115, P12565, DOI 10.1073/pnas.1814589115; Treger RS, 2019, IMMUNITY, V50, P334, DOI 10.1016/j.immuni.2018.12.022; van Lammeren GW, 2014, CIRCULATION, V129, P2269, DOI 10.1161/CIRCULATIONAHA.113.007603; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; von Vietinghoff S, 2009, J IMMUNOL, V183, P865, DOI 10.4049/jimmunol.0804080; Waltner-Romen M, 1998, J HISTOCHEM CYTOCHEM, V46, P1347, DOI 10.1177/002215549804601202; Wan X, 2018, NATURE, V560, P107, DOI 10.1038/s41586-018-0341-6; Wang M, 2014, ARTERIOSCL THROM VAS, V34, P976, DOI 10.1161/ATVBAHA.113.303097; Williams JW, 2018, ARTERIOSCL THROM VAS, V38, P1702, DOI 10.1161/ATVBAHA.118.311319; Williams JW, 2017, CIRC RES, V121, P662, DOI 10.1161/CIRCRESAHA.117.311519; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Wolf D, 2019, CIRC RES, V124, P315, DOI 10.1161/CIRCRESAHA.118.313591; Wu J, 2014, CIRC RES, V114, P616, DOI 10.1161/CIRCRESAHA.114.302157; Wu P, 2017, EXP THER MED, V13, P395, DOI 10.3892/etm.2016.3966; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253; Yun TJ, 2016, CELL METAB, V23, P852, DOI 10.1016/j.cmet.2016.04.010; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang XB, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00130; Zheng F, 2013, HEART LUNG CIRC, V22, P746, DOI 10.1016/j.hlc.2013.01.012; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	163	68	74	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					941	954		10.1016/j.immuni.2019.03.007	http://dx.doi.org/10.1016/j.immuni.2019.03.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995508	Green Accepted, Bronze			2022-12-18	WOS:000464660800012
J	Snell, LM; MacLeod, BL; Law, JC; Osokine, I; Elsaesser, HJ; Hezaveh, K; Dickson, RJ; Gavin, MA; Guidos, CJ; McGaha, TL; Brooks, DG				Snell, Laura M.; MacLeod, Bethany L.; Law, Jaclyn C.; Osokine, Ivan; Elsaesser, Heidi J.; Hezaveh, Kebria; Dickson, Russell J.; Gavin, Marc A.; Guidos, Cynthia J.; McGaha, Tracy L.; Brooks, David G.			CD8(+) T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity	IMMUNITY			English	Article							EXPRESSION ANALYSIS; EXHAUSTION; BLOCKADE; INTERLEUKIN-21; LYMPHOCYTES; CYTOMETRY; DISEASE; IL-21	CD8(+) T cell exhaustion impedes control of chronic viral infection; yet how new T cell responses are mounted during chronic infection is unclear. Unlike T cells primed at the onset of infection that rapidly differentiate into effectors and exhaust, we demonstrate that virus-specific CD8(+) T cells primed after establishment of chronic LCMV infection preferentially generate memory-like transcription factor TCF1(+) cells that were transcriptionally and proteomically distinct, less exhausted, and more responsive to immunotherapy. Mechanistically, adaptations of antigen-presenting cells and diminished T cell signaling intensity promoted differentiation of the memory-like subset at the expense of rapid effector cell differentiation, which was now highly dependent on IL-21-mediated CD4(+) T cell help for its functional generation. Chronic viral infection similarly redirected de novo differentiation of tumor-specific CD8(+) T cells, ultimately preventing cancer control. Thus, targeting these T cell stimulatory pathways could enable strategies to control chronic infection, tumors, and enhance immunotherapeutic efficacy.	[Snell, Laura M.; MacLeod, Bethany L.; Law, Jaclyn C.; Elsaesser, Heidi J.; Hezaveh, Kebria; Dickson, Russell J.; McGaha, Tracy L.; Brooks, David G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Law, Jaclyn C.; Guidos, Cynthia J.; McGaha, Tracy L.; Brooks, David G.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Osokine, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Gavin, Marc A.] Benaroya Res Inst, Translat Res Program, Seattle, WA 98101 USA; [Guidos, Cynthia J.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada; [Osokine, Ivan] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Benaroya Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Francisco	Brooks, DG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Brooks, DG (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	dbrooks@uhnresearch.ca		McGaha, Tracy/0000-0003-4721-9301; Osokine, Ivan/0000-0002-8975-9341; Snell, Laura/0000-0001-9890-6588; Brooks, David/0000-0001-7763-8764	Canadian Institutes of Health Research (CIHR) Foundation Grant [FDN148386]; National Institutes of Health (NIH) [AI085043]; Scotiabank Research Chair; Fonds de la Recherche en Sante du Quebec; Medicine by Design Award [C1TPA-2016-20]	Canadian Institutes of Health Research (CIHR) Foundation Grant(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scotiabank Research Chair; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Medicine by Design Award	We thank past and present members of the Brooks laboratory for technical help and discussion. This work was supported by the Canadian Institutes of Health Research (CIHR) Foundation Grant FDN148386, the National Institutes of Health (NIH) grant AI085043, the Scotiabank Research Chair to D.G.B, a training grant from the Fonds de la Recherche en Sante du Quebec to L.M.S., and the Medicine by Design Award#C1TPA-2016-20 (D.G.B. and T.L.M.).	Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cunningham CR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005356; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Giordano M, 2015, EMBO J, V34, P2042, DOI 10.15252/embj.201490786; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishimura H, 2005, J IMMUNOL, V175, P4627, DOI 10.4049/jimmunol.175.7.4627; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Probst HC, 2005, J IMMUNOL, V174, P3920, DOI 10.4049/jimmunol.174.7.3920; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roney Kelly, 2013, Methods Mol Biol, V1031, P71, DOI 10.1007/978-1-62703-481-4_9; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Shin HM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006544; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhang M, 2015, ARTHRITIS RHEUMATOL, V67, P2723, DOI 10.1002/art.39233	47	68	68	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					378	+		10.1016/j.immuni.2018.08.002	http://dx.doi.org/10.1016/j.immuni.2018.08.002			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30314757	Green Accepted, Bronze			2022-12-18	WOS:000447386700014
J	Dulberger, CL; McMurtrey, CP; Holzemer, A; Neu, KE; Liu, V; Steinbach, AM; Garcia-Beltran, WF; Sulak, M; Jabri, B; Lynch, VJ; Altfeld, M; Hildebrand, WH; Adams, EJ				Dulberger, Charles L.; McMurtrey, Curtis P.; Hoelzemer, Angelique; Neu, Karlynn E.; Liu, Victor; Steinbach, Adriana M.; Garcia-Beltran, Wilfredo F.; Sulak, Michael; Jabri, Bana; Lynch, Vincent J.; Altfeld, Marcus; Hildebrand, William H.; Adams, Erin J.			Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors	IMMUNITY			English	Article							CLASS-I MOLECULES; HLA-E BINDS; HISTOCOMPATIBILITY ANTIGEN; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; INHIBITORY RECEPTOR; SURFACE EXPRESSION; OPEN CONFORMERS; COMPLEX; PROTEIN	Evidence ismountingthat themajor histocompatibility complex (MHC) molecule HLA-F (human leukocyte antigen F) regulates the immune systemin pregnancy, infection, and autoimmunity by signaling through NK cell receptors (NKRs). We present structural, biochemical, and evolutionary analyses demonstrating that HLA-F presents peptides of unconventional length dictated by a newly arisen mutation (R62W) that has produced an open-ended groove accommodating particularly long peptides. Compared to empty HLA-F open conformers (OCs), HLA-F tetramers bound with human-derived peptides differentially stained leukocytes, suggesting peptide-dependent engagement. Our in vitro studies confirm that NKRs differentiate between peptide-bound and peptide- free HLA-F. The complex structure of peptideloaded beta(2)m-HLA-F bound to the inhibitory LIR1 revealed similarities to high-affinity recognition of the viralMHC-I mimicUL18 and adockingstrategy that relies on contacts with HLA-F as well as beta(2)m, thus precluding binding to HLA-F OCs. These findings provide a biochemical framework to understand how HLA-F could regulate immunity via interactions with NKRs.	[Dulberger, Charles L.; Liu, Victor; Steinbach, Adriana M.; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [McMurtrey, Curtis P.; Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Hoelzemer, Angelique; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Hoelzemer, Angelique] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 1, Infect Dis Unit, D-20246 Hamburg, Germany; [Hoelzemer, Angelique] German Ctr Infect Res DZIF, D-20246 Hamburg, Germany; [Neu, Karlynn E.; Jabri, Bana] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Garcia-Beltran, Wilfredo F.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Sulak, Michael; Lynch, Vincent J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Oklahoma System; University of Oklahoma Health Sciences Center; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Chicago; University of Chicago	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	ejadams@uchicago.edu	Liu, Victor/B-2918-2017; Altfeld, Marcus/AAE-7306-2019	Liu, Victor/0000-0001-7811-3783; Altfeld, Marcus/0000-0001-5972-2997; Steinbach, Adriana/0000-0001-5073-7180	University of Chicago Molecular and Cellular Biology Training Grant [T32 GM007183]; NIH [R01 AI073922]; German Center for Infection Research (DZIF); German Center for Infection Research (DZIF) via Clinician Scientist Program of the Faculty of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115471, R01AI073922, F31AI116366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007183] Funding Source: NIH RePORTER	University of Chicago Molecular and Cellular Biology Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Center for Infection Research (DZIF); German Center for Infection Research (DZIF) via Clinician Scientist Program of the Faculty of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Chicago Molecular and Cellular Biology Training Grant (T32 GM007183) and NIH R01 AI073922 to E.J.A. A.H. was supported by the German Center for Infection Research (DZIF) through a MD/PhD Stipend and via the Clinician Scientist Program of the Faculty of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bergseng E, 2015, IMMUNOGENETICS, V67, P73, DOI 10.1007/s00251-014-0819-9; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Burrows CK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005858; Carter AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0070; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Coe CL, 2014, FRONT NEUROENDOCRIN, V35, P439, DOI 10.1016/j.yfrne.2014.03.004; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Conant GC, 2007, MOL PHYLOGENET EVOL, V42, P298, DOI 10.1016/j.ympev.2006.07.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; Favier B, 2010, FASEB J, V24, P689, DOI 10.1096/fj.09-135194; Ferreira LMR, 2017, TRENDS IMMUNOL, V38, P272, DOI 10.1016/j.it.2017.01.009; Fitzgerald I, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0125-0; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; GERAGHTY DE, 1990, J EXP MED, V171, P1, DOI 10.1084/jem.171.1.1; GODEAU F, 1992, J BIOL CHEM, V267, P24223; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Hackmon R, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12643; Jiang H, 2010, J CLIN INVEST, V120, P3641, DOI 10.1172/JCI43522; Korner C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00326; Kraemer T, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/346714; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee N, 1998, J IMMUNOL, V160, P4951; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMurtrey C, 2016, ELIFE, V5, DOI 10.7554/eLife.12556; Morgan CS, 1997, PROTEIN SCI, V6, P1771, DOI 10.1002/pro.5560060819; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; O'Callaghan CA, 1998, IMMUNOL REV, V163, P129, DOI 10.1111/j.1600-065X.1998.tb01192.x; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; O'Connor GM, 2013, CRIT REV IMMUNOL, V33, P203, DOI 10.1615/CritRevImmunol.2013007409; Raran-Kurussi S, 2015, PROTEIN EXPRES PURIF, V110, P159, DOI 10.1016/j.pep.2015.03.004; Romagnani C, 2002, P NATL ACAD SCI USA, V99, P11328, DOI 10.1073/pnas.172369799; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shobu T, 2006, J REPROD IMMUNOL, V72, P18, DOI 10.1016/j.jri.2006.02.001; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Trolle T, 2016, J IMMUNOL, V196, P1480, DOI 10.4049/jimmunol.1501721; Wainwright SD, 2000, J IMMUNOL, V164, P319, DOI 10.4049/jimmunol.164.1.319; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yaciuk JC, 2014, J VIROL, V88, P12992, DOI 10.1128/JVI.01914-14; Yang ZR, 2008, P NATL ACAD SCI USA, V105, P10095, DOI 10.1073/pnas.0804551105	60	68	72	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1018	+		10.1016/j.immuni.2017.06.002	http://dx.doi.org/10.1016/j.immuni.2017.06.002			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636952	Green Accepted, Bronze			2022-12-18	WOS:000403665900015
J	Zhang, ZD; Li, JJ; Zheng, WC; Zhao, G; Zhang, H; Wang, XF; Guo, YQ; Qin, C; Shi, Y				Zhang, Zongde; Li, Jianjian; Zheng, Wencheng; Zhao, Guang; Zhang, Hong; Wang, Xiaofei; Guo, Yaqian; Qin, Chuan; Shi, Yan			Peripheral Lymphoid Volume Expansion and Maintenance Are Controlled by Gut Microbiota via RALDH(+) Dendritic Cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; VITAMIN-A-DEFICIENCY; REGULATORY T-CELLS; GERM-FREE MICE; RETINOIC-ACID; IN-VIVO; COMMENSAL MICROBIOTA; PERMEABILITY CHANGES; VASCULAR ADDRESSIN; ORGAN DEVELOPMENT	Lymphocyte homing to draining lymph nodes is critical for the initiation of immune responses. Secondary lymphoid organs of germ-free mice are underdeveloped. How gut commensal microbes remotely regulate cellularity and volume of secondary lymphoid organs remains unknown. We report here that, driven by commensal fungi, a wave of CD45(+)CD103(+)RALDH(+) cells migrates to the peripheral lymph nodes after birth. The arrival of these cells introduces high amounts of retinoic acid, mediates the neonatal to adult addressin switch on endothelial cells, and directs the homing of lymphocytes to both gut-associated lymphoid tissues and peripheral lymph nodes. In adult mice, a small number of these RALDH(+) cells might serve to maintain the volume of secondary lymphoid organs. Homing deficiency of these cells was associated with lymph node attrition in vitamin-A-deficient mice, suggesting a perpetual dependence on retinoic acid signaling for structural and functional maintenance of peripheral immune organs.	[Zhang, Zongde; Li, Jianjian; Zheng, Wencheng; Zhao, Guang; Zhang, Hong; Wang, Xiaofei; Shi, Yan] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Inst Immunol,Dept Basic Med Sci, Beijing 100084, Peoples R China; [Guo, Yaqian; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Guo, Yaqian; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Beijing 100730, Peoples R China; [Shi, Yan] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Shi, Yan] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada	Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Calgary; University of Calgary	Shi, Y (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Inst Immunol,Dept Basic Med Sci, Beijing 100084, Peoples R China.; Shi, Y (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada.; Shi, Y (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada.	yanshi@biomed.tsinghua.edu.cn	Shi, Yan/Y-6642-2019	zhang, zongde/0000-0001-6488-3699	joint Peking-Tsinghua Center for Life Sciences; US NIH [R01AI098995]; Natural Sciences and Engineering Research Council of Canada [RGPIN-355350/396037]; Canadian Institutes for Health Research [MOP-119295]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098995] Funding Source: NIH RePORTER	joint Peking-Tsinghua Center for Life Sciences; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Hai Qi, Li Wu, Chen Dong, and Wei Jin of Tsinghua University for insightful comments and critiques, Shanghai and Chongqing animal facility and Drs. Chen Dong and Wei Jin for technical assistance, Libing Mu for the graphical abstract, and Tsinghua University Animal Facilities and Dr. Zai Chang for animal services. This work was supported by the joint Peking-Tsinghua Center for Life Sciences and by grants from the US NIH (R01AI098995), the Natural Sciences and Engineering Research Council of Canada (RGPIN-355350/396037) and the Canadian Institutes for Health Research (MOP-119295).	Aage S, 2015, ALLERGY, V70, P985, DOI 10.1111/all.12641; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; BAUER H, 1963, AM J PATHOL, V42, P471; BEACH RC, 1982, ARCH DIS CHILD, V57, P141, DOI 10.1136/adc.57.2.141; Benn CS, 2005, BMJ-BRIT MED J, V331, P1428, DOI 10.1136/bmj.38670.639340.55; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cuff CA, 1998, J IMMUNOL, V161, P6853; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eriksson M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00196; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; HUMPHREY JH, 1992, B WORLD HEALTH ORGAN, V70, P225; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Inagaki H, 1996, INFECT IMMUN, V64, P3280, DOI 10.1128/IAI.64.8.3280-3287.1996; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lund N, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-214; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Rector A, 2001, GENES IMMUN, V2, P323, DOI 10.1038/sj.gene.6363784; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Saba K, 2009, AM J PATHOL, V174, P144, DOI 10.2353/ajpath.2009.080235; SHEARER WT, 1995, CLIN DIAGN LAB IMMUN, V2, P281, DOI 10.1128/CDLI.2.3.281-285.1995; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sperandio M, 2006, FEBS J, V273, P4377, DOI 10.1111/j.1742-4658.2006.05437.x; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stephensen CB, 2004, J NUTR, V134, P2660, DOI 10.1093/jn/134.10.2660; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tung CH, 2004, CANCER RES, V64, P1579, DOI 10.1158/0008-5472.CAN-03-3226; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; van Zante A, 2003, J EXP MED, V198, P1289, DOI 10.1084/jem.20030057; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Wendland M, 2011, IMMUNITY, V35, P945, DOI 10.1016/j.immuni.2011.10.017; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	61	68	73	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					330	342		10.1016/j.immuni.2016.01.004	http://dx.doi.org/10.1016/j.immuni.2016.01.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885858	Green Accepted, Bronze			2022-12-18	WOS:000370294000015
J	Ucar, A; Ucar, O; Klug, P; Matt, S; Brunk, F; Hofmann, TG; Kyewski, B				Ucar, Ahmet; Ucar, Olga; Klug, Paula; Matt, Sonja; Brunk, Fabian; Hofmann, Thomas G.; Kyewski, Bruno			Adult Thymus Contains FoxN1(-) Epithelial Stem Cells that Are Bipotent for Medullary and Cortical Thymic Epithelial Lineages	IMMUNITY			English	Article							PROMISCUOUS GENE-EXPRESSION; PROGENITOR-CELL; MAMMARY-GLAND; IN-VITRO; AIRE; MICROENVIRONMENT; ORGANOGENESIS; POPULATION; GENERATION; MOUSE	Within the thymus, two major thymic epithelial cell (TEC) subsets-cortical and medullary TECs-provide unique structural and functional niches for T cell development and establishment of central tolerance. Both lineages are believed to originate from a common progenitor cell, yet the cellular and molecular identity of these bipotent TEC progenitors/stem cells remains ill defined. Here we identify rare stromal cells in the murine adult thymus, which under low-attachment conditions formed spheres (termed "thymospheres"). These thymosphere-forming cells (TSFCs) displayed the stemness features of being slow cycling, self-renewing, and bipotent. TSFCs could be significantly enriched based on their distinct surface antigen phenotype. The FoxN1 transcription factor was dispensable for TSFCs maintenance in situ and for commitment to the medullary and cortical TEC lineages. In summary, this study presents the characterization of the adult thymic epithelial stem cells and demonstrates the dispensability of FoxN1 function for their stemness.	[Ucar, Ahmet; Ucar, Olga; Klug, Paula; Brunk, Fabian; Kyewski, Bruno] German Canc Res Ctr, Div Dev Immunol, D-69120 Heidelberg, Germany; [Ucar, Ahmet; Matt, Sonja; Hofmann, Thomas G.] German Canc Res Ctr, ZMBH Alliance, Cellular Senescence Grp, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hofmann, TG (corresponding author), German Canc Res Ctr, ZMBH Alliance, Cellular Senescence Grp, D-69120 Heidelberg, Germany.	t.hofmann@dkfz.de; b.kyewski@dkfz.de		Ucar, Ahmet/0000-0002-6551-3486	DKFZ; EU consortium "Tolerage"; European Research Council; Baden-Wurttemberg Foundation; German Federal Ministry of Education and Research (BMBF GerontoSysII Program)	DKFZ(Helmholtz Association); EU consortium "Tolerage"; European Research Council(European Research Council (ERC)European Commission); Baden-Wurttemberg Foundation; German Federal Ministry of Education and Research (BMBF GerontoSysII Program)(Federal Ministry of Education & Research (BMBF))	We thank N. Manley, R. Sandhoff, E. Erikci, K. Chowdhury, S. Murata, P. Angel, and T. Barthlott for providing transgenic mice used in this study. We are grateful to the DKFZ Core Facilities Light Microscopy and Flow Cytometry for technical support. We are indebted to C. Sebening and S. Loukanova (Department of Cardiac Surgery, Medical School of the University of Heidelberg) for providing human thymic tissue. This study was supported by the DKFZ, the EU consortium "Tolerage" (B.K.), the European Research Council (ERC-2012-AdG to B.K.), the Baden-Wurttemberg Foundation (T.G.H.), and the German Federal Ministry of Education and Research (BMBF GerontoSysII Program to T.G.H.).	Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Heng TSP, 2010, CURR OPIN PHARMACOL, V10, P425, DOI 10.1016/j.coph.2010.04.006; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; Manley NR, 2010, PROG MOL BIOL TRANSL, V92, P103, DOI 10.1016/S1877-1173(10)92005-X; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Ohigashi I, 2013, P NATL ACAD SCI USA, V110, P9885, DOI 10.1073/pnas.1301799110; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018; Ucar O, 2013, EUR J IMMUNOL, V43, P1769, DOI 10.1002/eji.201343343; Wang XP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00019; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625	44	68	70	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					257	269		10.1016/j.immuni.2014.07.005	http://dx.doi.org/10.1016/j.immuni.2014.07.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148026	hybrid, Green Published			2022-12-18	WOS:000341455300013
J	Satoh, Y; Yokota, T; Sudo, T; Kondo, M; Lai, A; Kincade, PW; Kouro, T; Iida, R; Kokame, K; Miyata, T; Habuchi, Y; Matsui, K; Tanaka, H; Matsumura, I; Oritani, K; Kohwi-Shigematsu, T; Kanakura, Y				Satoh, Yusuke; Yokota, Takafumi; Sudo, Takao; Kondo, Motonari; Lai, Anne; Kincade, Paul W.; Kouro, Taku; Iida, Ryuji; Kokame, Koichi; Miyata, Toshiyuki; Habuchi, Yoko; Matsui, Keiko; Tanaka, Hirokazu; Matsumura, Itaru; Oritani, Kenji; Kohwi-Shigematsu, Terumi; Kanakura, Yuzuru			The Satb1 Protein Directs Hematopoietic Stem Cell Differentiation toward Lymphoid Lineages	IMMUNITY			English	Article							MAR-BINDING PROTEIN; RAG1 LOCUS; PROGENITORS; EXPRESSION; PROMOTE; IDENTIFICATION; SPECIFICATION; TRANSCRIPTION; ACTIVATION; GENES	How hematopoietic stem cells (HSCs) produce particular lineages is insufficiently understood. We searched for key factors that direct HSC to lymphopoiesis. Comparing gene expression profiles for HSCs and early lymphoid progenitors revealed that Satb1, a global chromatin regulator, was markedly induced with lymphoid lineage specification. HSCs from Satb1-deficient mice were defective in lymphopoietic activity in culture and failed to reconstitute T lymphopoiesis in wild-type recipients. Furthermore, Satb1 transduction of HSCs and embryonic stem cells robustly promoted their differentiation toward lymphocytes. Whereas genes that encode Ikaros, E2A, and Notch1 were unaffected, many genes involved in lineage decisions were regulated by Satb1. Satb1 expression was reduced in aged HSCs with compromised lymphopoietic potential, but forced Satb1 expression partly restored that potential. Thus, Satb1 governs the initiating process central to the replenishing of lymphoid lineages. Such activity in lymphoid cell generation may be of clinical importance and useful to overcome immunosenescence.	[Satoh, Yusuke; Yokota, Takafumi; Sudo, Takao; Habuchi, Yoko; Matsui, Keiko; Tanaka, Hirokazu; Matsumura, Itaru; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Kondo, Motonari; Lai, Anne] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Kincade, Paul W.; Iida, Ryuji] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Kouro, Taku; Iida, Ryuji] Natl Inst Biomed Innovat, Lab Immune Modulat, Ibaraki, Osaka 5670085, Japan; [Kokame, Koichi; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka 5658565, Japan; [Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	Osaka University; Duke University; Oklahoma Medical Research Foundation; National Institute of Health Sciences - Japan; National Cerebral & Cardiovascular Center - Japan; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Yokota, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan.	yokotat@bldon.med.osaka-u.ac.jp		Kouro, Taku/0000-0003-1526-575X; Kokame, Koichi/0000-0002-9654-6299	Mitsubishi Pharma Research Foundation; National Institutes of Health [AI020069, HL107138-03, R37 CA039681]; NATIONAL CANCER INSTITUTE [R37CA039681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020069, R37AI020069] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25293220] Funding Source: KAKEN	Mitsubishi Pharma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Nakano for discussion of the results. This work was supported in part by a grant from Mitsubishi Pharma Research Foundation and grants AI020069, HL107138-03, and R37 CA039681 from the National Institutes of Health.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lai AY, 2008, SEMIN IMMUNOL, V20, P207, DOI 10.1016/j.smim.2008.05.002; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Miller JP, 2005, SEMIN IMMUNOL, V17, P321, DOI 10.1016/j.smim.2005.05.003; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Satoh Y, 2008, J BIOL CHEM, V283, P30045, DOI 10.1074/jbc.M804768200; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Shimazu T, 2012, BLOOD, V119, P4889, DOI 10.1182/blood-2011-10-388736; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yokota T, 2003, J IMMUNOL, V171, P5091, DOI 10.4049/jimmunol.171.10.5091; Yokota T, 2003, IMMUNITY, V19, P365, DOI 10.1016/S1074-7613(03)00231-0; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	36	68	69	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1105	1115		10.1016/j.immuni.2013.05.014	http://dx.doi.org/10.1016/j.immuni.2013.05.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23791645	Bronze, Green Accepted			2022-12-18	WOS:000330947500007
J	Ali, SR; Timmer, AM; Bilgrami, S; Park, EJ; Eckmann, L; Nizet, V; Karin, M				Ali, Syed Raza; Timmer, Anjuli M.; Bilgrami, Sameera; Park, Eek Joong; Eckmann, Lars; Nizet, Victor; Karin, Michael			Anthrax Toxin Induces Macrophage Death by p38 MAPK Inhibition but Leads to Inflammasome Activation via ATP Leakage	IMMUNITY			English	Article							BACILLUS-ANTHRACIS; STAPHYLOCOCCUS-AUREUS; NEUTROPHIL RECRUITMENT; CASPASE-1 ACTIVATION; LETHAL FACTOR; IN-VIVO; RELEASE; CONNEXIN-43; PHOSPHORYLATION; CELLS	Detection of microbial constituents by membrane associated and cytoplasmic pattern recognition receptors is the essence of innate immunity, leading to activation of protective host responses. However, it is still unclear how immune cells specifically respond to pathogenic bacteria. Using virulent and nonvirulent strains of Bacillus anthracis, we have shown that secretion of ATP by infected macrophages and the sequential activation of the P2X7 purinergic receptor and nucleotide binding oligomerization domain (NOD)-like receptors are critical for IL-1-dependent host protection from virulent B. anthracis. Importantly, lethal toxin produced by virulent B. anthracis blocked activation of protein kinases, p38 MAPK and AKT, resulting in opening of a connexin ATP release channel and induction of macrophage death. Prevention of cell death or ATP release through constitutive p38 or AKT activation interfered with inflammasome activation and IL-1 beta production, thereby compromising antimicrobial immunity.	[Ali, Syed Raza; Park, Eek Joong; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Lab Signal Transduct, La Jolla, CA 92093 USA; [Ali, Syed Raza; Bilgrami, Sameera; Park, Eek Joong; Karin, Michael] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Timmer, Anjuli M.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Timmer, Anjuli M.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Nizet, Victor/AAF-3190-2019; ali, syed/J-6124-2014; Ali, Syed/M-7418-2013	Nizet, Victor/0000-0003-3847-0422	NIH; Philip Morris Foundation; A.P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris Foundation; A.P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants to M.K., V.N., and L.E. We thank R.A. Flavell and G. Cheng for various genetically targeted mouse strains. We also thank D.G. Guiney for B. anthracis strains. S.R.A. and A.M.T. were supported by postdoctoral fellowships from the Philip Morris and the A.P. Giannini Foundations, respectively. M.K. is an American Cancer Society Research Professor. We dedicate this paper to the memory of Jurg Tschopp, the discoverer of the inflammasome.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Clarke TC, 2009, EUR J PHARMACOL, V605, P9, DOI 10.1016/j.ejphar.2008.12.005; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Faigle M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002801; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Leykauf K, 2003, CELL TISSUE RES, V311, P23, DOI 10.1007/s00441-002-0645-5; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Spinella F, 2003, J BIOL CHEM, V278, P41294, DOI 10.1074/jbc.M304785200; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986	46	68	72	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 22	2011	35	1					34	44		10.1016/j.immuni.2011.04.015	http://dx.doi.org/10.1016/j.immuni.2011.04.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21683629	Green Accepted, Bronze			2022-12-18	WOS:000293107300008
J	Cemerski, S; Das, J; Locasale, J; Arnold, P; Giurisato, E; Markiewicz, MA; Fremont, D; Allen, PM; Chakraborty, AK; Shaw, AS				Cemerski, Saso; Das, Jayajit; Locasale, Jason; Arnold, Phoebe; Giurisato, Emanuele; Markiewicz, Mary A.; Fremont, Daved; Allen, Paul M.; Chakraborty, Arup K.; Shaw, Andrey S.			The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse	IMMUNITY			English	Article							ALTERED PEPTIDE LIGANDS; RECEPTOR MICROCLUSTERS; ZETA-PHOSPHORYLATION; TRANSGENIC MICE; ACTIVATION; TCR; KINETICS; BINDING; COSTIMULATION; RECOGNITION	T cell activation is predicated on the interaction between the T cell receptor and peptide-major histocompatibility (pMHC) ligands. The factors that determine the stimulatory potency of a pMHC molecule remain unclear. We describe results showing that a peptide exhibiting many hallmarks of a weak agonist stimulates T cells to proliferate more than the wild-type agonist ligand. An in silico approach suggested that the inability to form the central supramolecular activation cluster (cSMAC) could underlie the increased proliferation. This conclusion was supported by experiments that showed that enhancing cSMAC formation reduced stimulatory capacity of the weak peptide. Our studies highlight the fact that a complex interplay of factors determines the quality of a T cell antigen.	MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Washington University (WUSTL)	Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	arupc@mit.edu; ashaw@wustl.edu	Locasale, Jason W/ABE-6505-2020; Das, Jayajit/AAD-8502-2022; GIURISATO, EMANUELE/I-4904-2017; GIURISATO, EMANUELE/AAO-2352-2020; Das, Jayajit/E-2951-2011	Locasale, Jason W/0000-0002-7766-3502; Das, Jayajit/0000-0001-9649-4698; GIURISATO, EMANUELE/0000-0003-0598-6449; GIURISATO, EMANUELE/0000-0003-0598-6449; Markiewicz, Mary/0000-0001-5685-8573; Fremont, Daved/0000-0002-8544-2689	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [P01 AI071195-03, AI034094, R37 AI057966-05, AI071195-01, R37 AI057966, P01 AI071195, AI057966] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966, R01AI034094, P01AI071195] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Itoh Y, 1999, J IMMUNOL, V162, P2073; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; REAY PA, 1994, J IMMUNOL, V152, P3946; Rogers PR, 1998, J IMMUNOL, V160, P3698; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	40	68	70	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					345	355		10.1016/j.immuni.2007.01.013	http://dx.doi.org/10.1016/j.immuni.2007.01.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17346997	Bronze, Green Accepted			2022-12-18	WOS:000245228100011
J	Eubank, TD; Roberts, R; Galloway, M; Wang, YJ; Cohn, DE; Marsh, CB				Eubank, TD; Roberts, R; Galloway, M; Wang, YJ; Cohn, DE; Marsh, CB			GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice	IMMUNITY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; ACTIVATION; MIGRATION; FLT-1	GM-CSF promotes homeostasis of myeloid cells. We report that GM-CSF upregulates mRNA and protein production of the soluble form of membrane bound VEGF receptor-1 (sVEGFR-1) in human monocytes. This sVEGFR-1 was biologically active, as cell-free supematants from GM-CSF-stimulated monocytes blocked detection of endogenously expressed VEGF and inhibited endothelial cell migration and tube formation, even in the presence of exogenous rhVEGF. VEGF activity was recovered by neutralizing sVEGFR-1. To determine whether these events were important in vivo, Matrigel plugs were incubated with rhVEGF, rhGM-CSF, or rhGM-CSF/rhVEGF and injected into mice. Plugs containing GM-CSF or GM-CSFNEGF had less endothelial cell invasion than plugs containing rhVEGF and were similar to plugs incubated with PBS alone. Neutralizing antibodies specific for sVEGFR-1 injected in these plugs reversed the effects of GM-CSF or GMCSF/VEGF, while an isogenic antibody did not. Thus, GM-CSIF and monocytes play a vital role in angiogenesis through the regulation of VEGF and sVEGFR-1.	Ohio State Univ, Coll Med & Publ Hlth, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Marsh, CB (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	marsh.2@osu.edu	Roberts, Ryan D/D-2573-2013; Eubank, Tim/E-3043-2011	Roberts, Ryan D/0000-0001-5028-744X; Cohn, David/0000-0002-3036-6172; Eubank, Tim/0000-0002-8225-7824	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067176, R01HL063800, P01HL070294] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL63800, R01 HL063800, P01HL70294, R01 HL067176, R01HL67176, P01 HL070294, R01HL6108] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Cao YH, 1998, J CLIN INVEST, V101, P1055, DOI 10.1172/JCI1558; Clarijs R, 2003, INVEST OPHTH VIS SCI, V44, P1801, DOI 10.1167/iovs.02-0624; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; HEUSER LS, 1984, J SURG RES, V36, P244, DOI 10.1016/0022-4804(84)90094-5; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Nagata Y, 1997, BLOOD, V89, P2664, DOI 10.1182/blood.V89.8.2664; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roeckl W, 1998, EXP CELL RES, V241, P161, DOI 10.1006/excr.1998.4039; Scalerandi M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.218101; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; Terada K, 1997, J BIOL CHEM, V272, P4544, DOI 10.1074/jbc.272.7.4544; UCHIDA K, 1994, AM J PHYSIOL, V266, pF81, DOI 10.1152/ajprenal.1994.266.1.F81; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; WOGNUM AW, 1994, BLOOD, V84, P764; WOJCHOWSKI DM, 1993, STEM CELLS, V11, P381, DOI 10.1002/stem.5530110505; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200	28	68	72	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					831	842		10.1016/j.immuni.2004.10.011	http://dx.doi.org/10.1016/j.immuni.2004.10.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589171	Bronze, Green Accepted			2022-12-18	WOS:000225901600010
J	Mao, DL; Wu, XB; Deppong, C; Friend, LD; Dolecki, G; Nelson, DM; Molina, H				Mao, DL; Wu, XB; Deppong, C; Friend, LD; Dolecki, G; Nelson, DM; Molina, H			Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway	IMMUNITY			English	Article							DECAY-ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; REGULATORY PROTEINS; TROPHOBLAST CELLS; MESSENGER-RNA; FACTOR B; EXPRESSION; MOUSE; ACTIVATION; CD46	Factors involved in pregnancy failure due to abnormal fetomaternal tolerance are poorly understood. Here we describe distinct defects in placenta formation and subsequent pregnancy loss solely dependent on the activation of the complement alternative pathway and the effector mechanisms provided by the maternal C3. Surprisingly, this effect is independent of other complement activation pathways and of the effector mechanisms provided by other complement components. These findings provide significant insight into the role of the innate immune system in human pregnancy failure, a frequent clinical outcome.	Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Molina, H (corresponding author), Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA.	hmolina@imgate.wustl.edu			NIAID NIH HHS [R01 AI40576, R01 AI44912] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040576, R01AI044912] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 2000, CELLULAR MOL IMMUNOL, P316; Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; BILLINGTON WD, 1992, BAILLIERE CLIN OB GY, V6, P417, DOI 10.1016/S0950-3552(05)80004-5; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; CUNNINGHAM DS, 1995, CLIN IMMUNOL IMMUNOP, V74, P156, DOI 10.1006/clin.1995.1023; Fischer MB, 1996, J IMMUNOL, V157, P549; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; GEHA RS, 2001, IMMUNOBIOLOGY IMMUNE, P491; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; HILL JA, 1992, BAILLIERE CLIN OB GY, V6, P489, DOI 10.1016/S0950-3552(05)80007-0; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOLERS VM, 1992, IMMUNOL TODAY, V13, P231; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; HOLMES CH, 1992, EUR J IMMUNOL, V22, P1579, DOI 10.1002/eji.1830220635; HOLMES CH, 1992, BAILLIERE CLIN OB GY, V6, P439, DOI 10.1016/S0950-3552(05)80005-7; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; HSI BL, 1991, J REPROD IMMUNOL, V19, P209, DOI 10.1016/0165-0378(91)90036-P; Jelezarova E, 2000, BIOCHEM J, V349, P217, DOI 10.1042/0264-6021:3490217; KAUFMAN MH, 1998, ATLAS MOUSE DEV, P469; KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; LUBLIN DM, 1990, CURR TOP MICROBIOL, V153, P123; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MCINTYRE JA, 1992, AM J REPROD IMMUNOL, V28, P127, DOI 10.1111/j.1600-0897.1992.tb00773.x; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; MOLINA H, 1992, J EXP MED, V175, P121, DOI 10.1084/jem.175.1.121; NICHOLSONWELLER A, 1993, IMMUNOL RES, V12, P244, DOI 10.1007/BF02918256; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; ROONEY IA, 1993, IMMUNOL RES, V12, P276, DOI 10.1007/BF02918258; Rus HG, 2001, IMMUNOL REV, V180, P49, DOI 10.1034/j.1600-065X.2001.1800104.x; Schmidt BZ, 2000, IMMUNOL REV, V178, P166, DOI 10.1034/j.1600-065X.2000.17801.x; Sherer DM, 2001, PLACENTA, V22, P1, DOI 10.1053/plac.2000.0588; SHIBATA T, 1991, J IMMUNOL, V147, P3901; Tsujimura A, 2001, J BIOCHEM-TOKYO, V130, P841, DOI 10.1093/oxfordjournals.jbchem.a003056; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; Vince GS, 1995, HUM REPROD, V10, P107, DOI 10.1093/humrep/10.suppl_2.107; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498	43	68	69	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					813	822		10.1016/S1074-7613(03)00321-2	http://dx.doi.org/10.1016/S1074-7613(03)00321-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670299	Bronze			2022-12-18	WOS:000187230700007
J	McFarland, BJ; Strong, RK				McFarland, BJ; Strong, RK			Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: Not induced fit but rigid adaptation	IMMUNITY			English	Article							CELL-RECEPTOR RECOGNITION; LIGAND RECOGNITION; CUTTING EDGE; PEPTIDE-MHC; T-CELLS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING; PLASTICITY; MECHANISM	The homodimeric immunoreceptor NKG2D drives the activation of effector cells following engagement of diverse, conditionally expressed MHC class I-like protein ligands. NKG2D recognition is highly degenerate in that a single surface on receptor monomers binds pairs of distinct surfaces on each structurally divergent ligand, simultaneously accommodating multiple nonconservative ligand allelic or isoform substitutions. In contrast to TCR-pMHC and other NK receptor-ligand interactions, thermodynamic and kinetic analyses of four NKG2D-ligand pairs (MIC-A*001, MIC-B*005, ULBP1, and RAE-1beta) reported here show that the relative enthalpic and entropic terms, heat capacity, association rates, and activation energy barriers are comparable to typical, rigid protein-protein interactions. Rather than "induced-fit" binding, NKG2D degeneracy is achieved using distinct interaction mechanisms at each rigid interface.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Strong, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	rstrong@fhcrc.org			NIAID NIH HHS [AI48675] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048675] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Carayannopoulos LN, 2002, EUR J IMMUNOL, V32, P597, DOI 10.1002/1521-4141(200203)32:3<597::AID-IMMU597>3.3.CO;2-5; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Henriques DA, 2000, PROTEIN SCI, V9, P1975, DOI 10.1110/ps.9.10.1975; Holmes MA, 2002, J IMMUNOL, V169, P1395, DOI 10.4049/jimmunol.169.3.1395; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kasahara M, 2002, P NATL ACAD SCI USA, V99, P13687, DOI 10.1073/pnas.212375299; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; LONGSWORTH LG, 1954, J PHYS CHEM-US, V58, P770, DOI 10.1021/j150519a017; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; NIKULA TK, 1995, MOL IMMUNOL, V32, P865, DOI 10.1016/0161-5890(95)00052-G; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; Radaev S, 2002, J IMMUNOL, V169, P6279, DOI 10.4049/jimmunol.169.11.6279; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Strong RK, 2002, MOL IMMUNOL, V38, P1029, DOI 10.1016/S0161-5890(02)00032-9; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Sundberg EJ, 2000, STRUCTURE, V8, pR137, DOI 10.1016/S0969-2126(00)00167-2; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; YOO SH, 1995, BIOCHEMISTRY-US, V34, P632, DOI 10.1021/bi00002a030	51	68	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					803	812		10.1016/S1074-7613(03)00320-0	http://dx.doi.org/10.1016/S1074-7613(03)00320-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670298	Bronze			2022-12-18	WOS:000187230700006
J	Choi, EY; Christianson, GJ; Yoshimura, Y; Sproule, TJ; Jung, NJ; Joyce, S; Roopenian, DC				Choi, EY; Christianson, GJ; Yoshimura, Y; Sproule, TJ; Jung, NJ; Joyce, S; Roopenian, DC			Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide	IMMUNITY			English	Article							H-Y-ANTIGEN; CLASS-I MHC; IMMUNOGENETIC ANALYSIS; NKG2D RECEPTOR; COMPLEX; LIGANDS; NAIVE; LYMPHOCYTES; FREQUENCIES; RESPONSES	The H60 minor histocompatibility (H) antigen peptide is derived from a glycoprotein that serves as a ligand for the stimulatory NKG2D receptor. We show that this peptide is remarkably immunodominant in that it competes effectively with MHC alloantigens, is efficiently crosspresented by host antigen-presenting cells (APCs), and readily elicits naive CD8 T cell responses in vitro. H60 immunodominance is neither a consequence of NKG2D engagement nor competition among minor H antigens on APCs. Instead, H60 immunodominance is a consequence of an abnormally high naive precursor frequency of H60 peptide reactive CD8 T cells. Understanding why the H60 peptide is so immunogenic has important implications in tissue transplantation and vaccine design.	Jackson Lab, Bar Harbor, ME 04609 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Jackson Laboratory; Vanderbilt University	Roopenian, DC (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	dcr@jax.org	Yoshimura, Yoshitaka/F-9754-2012	Choi, Eun Young/0000-0002-2441-3374; Christianson, Gregory/0000-0001-5532-342X; JOYCE, Sebastian/0000-0002-3183-1451	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028802] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL65479, HL54977] Funding Source: Medline; NIAID NIH HHS [AI28802] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auchincloss H, 1996, CURR OPIN IMMUNOL, V8, P681, DOI 10.1016/S0952-7915(96)80086-0; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; BEVAN MJ, 1975, J EXP MED, V142, P1349, DOI 10.1084/jem.142.6.1349; Carayannopoulos LN, 2002, EUR J IMMUNOL, V32, P597, DOI 10.1002/1521-4141(200203)32:3<597::AID-IMMU597>3.3.CO;2-5; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2002, J IMMUNOL, V168, P3131, DOI 10.4049/jimmunol.168.7.3131; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Choi EY, 2001, J IMMUNOL, V166, P4370, DOI 10.4049/jimmunol.166.7.4370; CHOI EY, 2002, IN PRESS BLOOD; Correia-Neves M, 2001, EUR J IMMUNOL, V31, P2583, DOI 10.1002/1521-4141(200109)31:9<2583::AID-IMMU2583>3.0.CO;2-Z; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eden PA, 1999, J IMMUNOL, V162, P4502; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; GORDON RD, 1975, J EXP MED, V142, P1108, DOI 10.1084/jem.142.5.1108; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Grufman P, 1999, EUR J IMMUNOL, V29, P2197, DOI 10.1002/(SICI)1521-4141(199907)29:07<2197::AID-IMMU2197>3.0.CO;2-B; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; MACDONALD HR, 1980, IMMUNOL REV, V51, P93, DOI 10.1111/j.1600-065X.1980.tb00318.x; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; MARTIN S, 1993, NAT GENET, V5, P210, DOI 10.1038/ng1193-210a; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Mendoza LM, 1997, IMMUNITY, V7, P461, DOI 10.1016/S1074-7613(00)80368-4; Millrain M, 2001, J IMMUNOL, V167, P3756, DOI 10.4049/jimmunol.167.7.3756; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Nevala WK, 1996, IMMUNOGENETICS, V44, P400; Ono T, 1998, J IMMUNOL, V161, P5454; Perreault C, 1998, IMMUNOL TODAY, V19, P69, DOI 10.1016/S0167-5699(97)01185-7; PIMSLER M, 1978, J IMMUNOL, V121, P1302; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; ROOPENIAN DC, 1983, J IMMUNOL, V131, P2135; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Simpson E, 1997, CURR OPIN IMMUNOL, V9, P655, DOI 10.1016/S0952-7915(97)80045-3; TASWELL C, 1984, J IMMUNOL METHODS, V72, P29, DOI 10.1016/0022-1759(84)90430-7; TEH HS, 1982, EUR J IMMUNOL, V12, P887, DOI 10.1002/eji.1830121016; THEOBALD M, 1993, BLOOD, V82, P298, DOI 10.1182/blood.V82.1.298.bloodjournal821298; VANBLEEK GM, 1990, NATURE, V348, P213; VANDERBRUGGEN P, 2000, MOL B INT U, V8, P171; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	49	68	68	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2002	17	5					593	603		10.1016/S1074-7613(02)00428-4	http://dx.doi.org/10.1016/S1074-7613(02)00428-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433366	Bronze			2022-12-18	WOS:000179335100006
J	Broxmeyer, HE; Bruns, HA; Zhang, SM; Cooper, S; Hangoc, G; McKenzie, ANJ; Dent, AL; Schindler, U; Naeger, LK; Hoey, T; Kaplan, MH				Broxmeyer, HE; Bruns, HA; Zhang, SM; Cooper, S; Hangoc, G; McKenzie, ANJ; Dent, AL; Schindler, U; Naeger, LK; Hoey, T; Kaplan, MH			Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M	IMMUNITY			English	Article							SIGNAL TRANSDUCER; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; STAT PROTEINS; MICE; RESPONSES; IL-4; DIFFERENTIATION; ACTIVATOR; RECEPTOR	Regulation of hematopoietic progenitor cell homeostasis is crucial for maintenance of innate immunity and the ability of the body to respond to injury and infection, In this report, we demonstrate that progenitor cell numbers and cycling status in vivo are dramatically increased in mice deficient in Stat6 and decreased in mice deficient in Stat4, targeted mutations which also alter T helper cell polarization. Experiments using mice that have T cell restricted transgenic expression of Stat4 or Stat6 or have been in vivo depleted of T cell subsets demonstrate that CD4(+) T cells regulate progenitor cell activity. Injection of the Th1 cytokine Oncostatin M but not other cytokines into Stat4-deficient mice recovers progenitor cell activity to wild-type levels. Thus, T helper cells actively regulate hematopoietic progenitor cell homeostasis.	Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46208 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Tular GmbH, D-93053 Regensburg, Germany; Tularik Inc, San Francisco, CA 94080 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute; MRC Laboratory Molecular Biology	Kaplan, MH (corresponding author), Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.				NHLBI NIH HHS [HL67384, HL56416] Funding Source: Medline; NIAID NIH HHS [AI45515] Funding Source: Medline; NIDDK NIH HHS [DK53674] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067384, R01HL056416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045515, R56AI045515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053674] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BACON ER, 1983, EXP HEMATOL, V11, P747; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Boileau C, 2000, J IMMUNOL, V164, P5713, DOI 10.4049/jimmunol.164.11.5713; BONOMO AC, 1990, CELL IMMUNOL, V125, P210, DOI 10.1016/0008-8749(90)90075-3; BROXMEYER HE, 1988, J IMMUNOL, V141, P3852; Clegg CH, 1996, NATURE, V384, P261, DOI 10.1038/384261a0; Cooper S, 1991, J TISSUE CULTURE MET, V13, P77; Daniel C, 2000, J BIOL CHEM, V275, P14255, DOI 10.1074/jbc.C000129200; ENG VM, 1995, J EXP MED, V181, P193; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Glimcher LH, 2000, GENE DEV, V14, P1693; GREENBERGER JS, 1984, EXP HEMATOL, V12, P720; Guo LY, 2001, NAT IMMUNOL, V2, P461, DOI 10.1038/87778; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; JACOBSEN SE, 1993, J EXP MED, V1787, P413; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim CH, 1999, J EXP MED, V190, P681, DOI 10.1084/jem.190.5.681; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Lai YH, 1996, J IMMUNOL, V156, P3166; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MALIK N, 1995, MOL CELL BIOL, V15, P2349; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SONODA Y, 1990, BLOOD, V75, P1615; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tarleton RL, 2000, J IMMUNOL, V165, P1520, DOI 10.4049/jimmunol.165.3.1520; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Wallace PM, 1999, J IMMUNOL, V162, P5547; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Zhang SM, 2000, J IMMUNOL, V165, P10, DOI 10.4049/jimmunol.165.1.10; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	50	68	71	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					815	825		10.1016/S1074-7613(02)00319-9	http://dx.doi.org/10.1016/S1074-7613(02)00319-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121663	Bronze			2022-12-18	WOS:000176534000007
J	Fruci, D; Niedermann, G; Butler, RH; van Endert, PM				Fruci, D; Niedermann, G; Butler, RH; van Endert, PM			Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum	IMMUNITY			English	Article							HISTOCOMPATIBILITY CLASS-I; ANTIGEN PRESENTATION; PROCESSING PATHWAY; COMPLEX; MOLECULES; PROTEASOMES; PROTEIN; TRANSLOCATION; GENERATION; MECHANISM	MHC class I ligands are produced mainly by proteasomal proteolysis, in conjunction with an unknown extent of trimming by peptidases. Trimming of precursor peptides in the endoplasmic reticulum, a process postulated to be class I dependent, may substantially enhance the efficiency of antigen presentation. However, monitoring of luminal peptide processing has not so far been possible. Here we show that several precursor peptides with amino-terminal extensions are rapidly converted to HLA-A2 ligands by one or several highly efficient metallo-peptidases found on the outer surface of, but also within, microsomes. Surprisingly, luminal trimming is fully active in HLA class I- or TAP-deficient microsomes; and precedes peptide association with HLA class I molecules. Trimmed peptides are rapidly depleted from, and become undetectable in, microsomes lacking the restricting class I molecules.	INSERM, U25, F-75015 Paris, France; Rech Med Unite 25, F-75015 Paris, France; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; CNR, Inst Cell Biol, I-00016 Monterotondo, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Consiglio Nazionale delle Ricerche (CNR)	van Endert, PM (corresponding author), INSERM, U25, F-75015 Paris, France.		Fruci, Doriana/AAA-8218-2019; van Endert, Peter/R-4606-2017	Fruci, Doriana/0000-0003-3388-7296; van Endert, Peter/0000-0003-3782-0750				ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Barrett A. J, 2012, HDB PROTEOLYTIC ENZY; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Brooks P, 2000, BIOCHEM J, V352, P611, DOI 10.1042/0264-6021:3520611; BUCHLER M, 1994, EUR J BIOCHEM, V219, P627, DOI 10.1111/j.1432-1033.1994.tb19978.x; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Emmerich NPN, 2000, J BIOL CHEM, V275, P21140, DOI 10.1074/jbc.M000740200; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Hansen TH, 1997, ADV IMMUNOL, V64, P105, DOI 10.1016/S0065-2776(08)60888-3; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; JOYCE S, 1994, P NATL ACAD SCI USA, V91, P4145, DOI 10.1073/pnas.91.10.4145; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Lobigs M, 2000, EUR J IMMUNOL, V30, P1496, DOI 10.1002/(SICI)1521-4141(200005)30:5<1496::AID-IMMU1496>3.0.CO;2-6; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; NEISIG A, 1995, J IMMUNOL, V154, P1273; Niedermann G, 1999, IMMUNOL REV, V172, P29, DOI 10.1111/j.1600-065X.1999.tb01354.x; OJCIUS DM, 1994, J IMMUNOL, V152, P2798; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; Snyder HL, 1997, J EXP MED, V186, P1087, DOI 10.1084/jem.186.7.1087; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VANENDERT PM, 1995, J EXP MED, V182, P183; WANG J, 1996, ZINC METALLOPROTEASE, P131; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Yewdell JW, 1998, J IMMUNOTHER, V21, P127, DOI 10.1097/00002371-199803000-00006	33	68	68	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		467	476		10.1016/S1074-7613(01)00203-5	http://dx.doi.org/10.1016/S1074-7613(01)00203-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567636	Bronze			2022-12-18	WOS:000171211800013
J	Love, PE; Shores, EW				Love, PE; Shores, EW			ITAM multiplicity and thymocyte selection: How low can you go?	IMMUNITY			English	Review							T-CELL DEVELOPMENT; TCR-ZETA-CHAIN; EPSILON-RI-GAMMA; RECEPTOR SIGNAL-TRANSDUCTION; NEGATIVE SELECTION; POSITIVE SELECTION; ANTIGEN-RECEPTOR; MICE LACKING; CD4(+)CD8(+) THYMOCYTES; INTRAEPITHELIAL LYMPHOCYTES		US FDA, Div Therapeut Prot, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shores, EW (corresponding author), US FDA, Div Therapeut Prot, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alam A, 1997, J EXP MED, V186, P1503, DOI 10.1084/jem.186.9.1503; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Ashe JM, 1999, J EXP MED, V189, P1163, DOI 10.1084/jem.189.7.1163; CALNAN BJ, 1995, IMMUNITY, V3, P273; Carter JD, 1999, INT IMMUNOL, V11, P1999, DOI 10.1093/intimm/11.12.1999; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Clayton LK, 1997, EMBO J, V16, P2282, DOI 10.1093/emboj/16.9.2282; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; Gobel TWF, 1998, J IMMUNOL, V160, P1552; GOLD DP, 1987, P NATL ACAD SCI USA, V84, P7649, DOI 10.1073/pnas.84.21.7649; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Izquierdo M, 1999, EMBO J, V18, P156, DOI 10.1093/emboj/18.1.156; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kane LP, 1996, J IMMUNOL, V156, P4594; Kersh EN, 1999, J EXP MED, V190, P1627, DOI 10.1084/jem.190.11.1627; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; KUSTER H, 1990, J BIOL CHEM, V265, P6448; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LETOURNEUR F, 1989, IMMUNOGENETICS, V29, P265, DOI 10.1007/BF00717911; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mariathasan S, 1998, J IMMUNOL, V161, P6030; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Plas DR, 1999, J IMMUNOL, V162, P5680; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shao H, 1999, J IMMUNOL, V163, P603; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Shores E, 1997, J IMMUNOL, V159, P222; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smyth LA, 1998, P NATL ACAD SCI USA, V95, P8193, DOI 10.1073/pnas.95.14.8193; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; van Oers NSC, 1998, J IMMUNOL, V160, P163; VASQUEZ NJ, 1997, IMMUNOL TODAY, V6, P286; WANG CR, 1995, J EXP MED, V181, P927, DOI 10.1084/jem.181.3.927; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Zhang JY, 1999, J IMMUNOL, V163, P3012; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	76	68	68	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2000	12	6					591	597		10.1016/S1074-7613(00)80210-1	http://dx.doi.org/10.1016/S1074-7613(00)80210-1			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894159	Bronze			2022-12-18	WOS:000087937300001
J	Hernandez-Munain, C; Sleckman, BP; Krangel, MS				Hernandez-Munain, C; Sleckman, BP; Krangel, MS			A developmental switch from TCR delta enhancer to TCR alpha enhancer function during thymocyte maturation	IMMUNITY			English	Article							T-CELL-RECEPTOR; BETA-LINEAGE THYMOCYTES; GAMMA-DELTA; GENE REARRANGEMENT; ALPHA/DELTA LOCUS; V(D)J RECOMBINATION; C-MYB; REGULATORY SEQUENCES; MOUSE THYMOCYTES; IN-VITRO	V(D)J recombination and transcription within the TCR alpha/delta locus are regulated by three characterized cia-acting elements: the TCR delta enhancer (E delta), TCR alpha enhancer (E alpha), and T early alpha (TEA) promoter. Analysis of enhancer and promoter occupancy and function in developing thymocytes in vivo indicates E delta and E alpha to be developmental-stage-specific enhancers, with E delta "on" and E alpha "off" in double-negative III thymocytes and E delta "off" and E alpha "on" in double-positive thymocytes. E delta downregulation reflects a loss of occupancy. Surprisingly, E alpha and TEA are extensively occupied even prior to activation. TCR delta downregulation in double-positive thymocytes depends on two events, E delta inactivation and removal of TCR delta from the influence of E alpha by chromosomal excision.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Duke University; Washington University (WUSTL)	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	krang001@mc.duke.edu	de Munain, Cristina Hernandez Lopez/S-4389-2018	de Munain, Cristina Hernandez Lopez/0000-0002-6058-2458	NIGMS NIH HHS [GM41052] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041052] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Bernard M, 1998, INT IMMUNOL, V10, P1539, DOI 10.1093/intimm/10.10.1539; Birshtein BK, 1997, CURR TOP MICROBIOL, V224, P73; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Burtrum DB, 1996, J IMMUNOL, V157, P4293; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Capone M, 1998, P NATL ACAD SCI USA, V95, P12522, DOI 10.1073/pnas.95.21.12522; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; DECHASSEVAL R, 1993, EUR J IMMUNOL, V23, P1294, DOI 10.1002/eji.1830230616; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Habener JF, 1995, VITAM HORM, V51, P1, DOI 10.1016/S0083-6729(08)61037-7; Hedrick SM, 1998, IMMUNOL REV, V165, P95, DOI 10.1111/j.1600-065X.1998.tb01233.x; Hernandez-Munain C, 1998, MOL CELL BIOL, V18, P3223, DOI 10.1128/MCB.18.6.3223; HERNANDEZMUNAIN C, 1995, MOL CELL BIOL, V15, P3090; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; HernandezMunain C, 1996, J EXP MED, V183, P289, DOI 10.1084/jem.183.1.289; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; KERSH GJ, 1995, J IMMUNOL, V154, P5706; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Krangel MS, 1998, IMMUNOL REV, V165, P131, DOI 10.1111/j.1600-065X.1998.tb01236.x; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Lauzurica P, 1997, J EXP MED, V185, P1193, DOI 10.1084/jem.185.7.1193; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; Livak F, 1999, J IMMUNOL, V162, P2575; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; Livak F, 1996, MOL CELL BIOL, V16, P609; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; MacDonald HR, 1998, IMMUNOL REV, V165, P87, DOI 10.1111/j.1600-065X.1998.tb01232.x; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Monroe RJ, 1999, IMMUNITY, V10, P503, DOI 10.1016/S1074-7613(00)80050-3; MUELLER PR, 1992, CURRENT PROTOCOLS MO, P1; NAKAJIMA PB, 1995, IMMUNITY, V3, P609, DOI 10.1016/1074-7613(95)90132-9; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Roberts JL, 1997, J EXP MED, V185, P131, DOI 10.1084/jem.185.1.131; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; SHIMIZU T, 1993, INT IMMUNOL, V5, P155, DOI 10.1093/intimm/5.2.155; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219	70	68	69	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					723	733		10.1016/S1074-7613(00)80071-0	http://dx.doi.org/10.1016/S1074-7613(00)80071-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403647	Bronze			2022-12-18	WOS:000081209600010
J	Achour, A; Persson, K; Harris, RA; Sundback, J; Sentman, CL; Lindqvist, Y; Schneider, G; Karre, K				Achour, A; Persson, K; Harris, RA; Sundback, J; Sentman, CL; Lindqvist, Y; Schneider, G; Karre, K			The crystal structure of H-2D(d) MHC class I complexed with the HIV-1-derived peptide P18-I10 at 2.4 angstrom resolution: Implications for T cell and NK cell recognition	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL-KILLER-CELL; HIV-1 ENVELOPE PROTEIN; HLA-B MOLECULES; 3-DIMENSIONAL STRUCTURE; IMMUNODOMINANT DETERMINANT; ANTIGEN PRESENTATION; V3 LOOP; RECEPTOR; BINDING	The structure of H-2D(d) complexed with the HIV-derived peptide P18-I10 (RGPGRAFVTI) has been determined by X-ray crystallography at 2.4 Angstrom resolution. This MHC class I molecule has an unusual binding motif with four anchor residues in the peptide (G2, P3, R/K/H5, and I/L/F9 or 10). The cleft architecture of H-2Dd includes a deep narrow passage accomodating the N-terminal part of the peptide, explaining the obligatory G2P3 anchor motif. Toward the C-terminal half of the peptide, p5R to p8V form a type I' reverse turn; residues p6A to p9T, and in particular p7F, are readily exposed. The structure is discussed in relation to functional data available for T cell and natural killer cell recognition of the H-2D(d) molecule.	Karolinska Hosp, Ctr Microbiol & Tumor Biol, S-10401 Stockholm, Sweden; Karolinska Hosp, Dept Med Biochem & Biophys, S-10401 Stockholm, Sweden; Karolinska Hosp, Ctr Mol Med, S-10401 Stockholm, Sweden; Umea Univ, Umea Ctr Mol Pathogenesis, Umea, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Umea University	Karre, K (corresponding author), Karolinska Hosp, Ctr Microbiol & Tumor Biol, S-10401 Stockholm, Sweden.	klas.karre@mtc.ki.se	Lindqvist, Ylva/F-9009-2010	Harris, Robert/0000-0003-4990-509X; Achour, Adnane/0000-0003-0432-710X; Lindqvist, Ylva/0000-0003-3162-8661; Schneider, Gunter/0000-0003-0622-5713				ABASTADO JP, 1987, J EXP MED, V166, P327, DOI 10.1084/jem.166.2.327; ACHOUR A, 1998, IN PRESS ACTA CRYSAL; AlexanderMiller MA, 1996, INT IMMUNOL, V8, P641, DOI 10.1093/intimm/8.5.641; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; CORR M, 1993, J EXP MED, V178, P1877, DOI 10.1084/jem.178.6.1877; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; HASKINS K, 1984, ANNU REV IMMUNOL, V2, P51, DOI 10.1146/annurev.iy.02.040184.000411; Jones EY, 1997, CURR OPIN IMMUNOL, V9, P75, DOI 10.1016/S0952-7915(97)80162-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; KORBER B, 1997, HUMAN RETROVIRUSES A; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; Lu GA, 1996, PROTEIN DATA BANK Q, V78, P10; Luque I, 1996, EUR J IMMUNOL, V26, P1974, DOI 10.1002/eji.1830260845; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Matsumoto N, 1998, IMMUNITY, V8, P245, DOI 10.1016/S1074-7613(00)80476-8; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P55; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Ryan JC, 1997, IMMUNOL REV, V155, P79, DOI 10.1111/j.1600-065X.1997.tb00941.x; SENTMAN CL, 1994, J IMMUNOL, V153, P5482; Shirai M, 1997, J IMMUNOL, V158, P3181; SHIRAI M, 1992, J IMMUNOL, V148, P1657; Shirai M, 1996, J IMMUNOL, V157, P4399; SHIRAI M, 1993, J IMMUNOL, V151, P2283; Sundback J, 1998, J IMMUNOL, V160, P5971; TAKAHASHI H, 1989, SCIENCE, V246, P118, DOI 10.1126/science.2789433; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; TAKAHASHI H, 1992, SCIENCE, V255, P333, DOI 10.1126/science.1372448; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; TAKESHITA T, 1995, J IMMUNOL, V154, P1973; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WALDENSTROM M, 1998, IN PRESS EUR J IMMUN; WATTS S, 1989, IMMUNOGENETICS, V30, P390, DOI 10.1007/BF02425281; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	71	68	70	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					199	208		10.1016/S1074-7613(00)80602-0	http://dx.doi.org/10.1016/S1074-7613(00)80602-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729040	Bronze			2022-12-18	WOS:000075610300006
J	Oukka, M; ColucciGuyon, E; Tran, PL; CohenTannoudji, M; Babinet, C; Lotteau, V; Kosmatopoulos, K				Oukka, M; ColucciGuyon, E; Tran, PL; CohenTannoudji, M; Babinet, C; Lotteau, V; Kosmatopoulos, K			CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium	IMMUNITY			English	Article							BONE-MARROW CHIMERAS; CLONAL DELETION; SUPRALETHAL IRRADIATION; CYTOSOLIC ANTIGEN; ANERGY; INDUCTION; MHC; SELECTION	Thymic epithelium is involved in negative selection, but its precise role in selecting the CD4 T cell repertoire remains elusive. By using two transgenic mice, we have investigated how medullary thymic epithelium (mTE) and bone marrow (BM)-derived cells contribute to tolerance of CD4 T cells to nuclear beta-galactosidase (beta-gal). CD4 T cells were not tolerant when beta-gal was expressed in thymic BM-derived cells. In contrast, CD4 T cells of mice expressing beta-gal in mTE were tolerized. Tolerance resulted from presentation of endogenous beta-gal by mTE cells but not from cross-priming. mTE cells presented nuclear beta-gal to a Th clone in vitro, while thymic dendritic cells did not. The data indicate that mTE but not thymic BM-derived cells can use a MHC class II endogenous presentation pathway to induce tolerance to nuclear proteins.	INST PASTEUR,CNRS,URA 1960,UNITE BIOL DEV,F-75015 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INSERM U25,F-75743 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Oukka, M (corresponding author), INSERM U267,12 AVE PV COUTURIER,F-94807 VILLEJUIF,FRANCE.		lotteau, vincent/M-8143-2014	Lotteau, Vincent/0000-0003-0997-3282; Cohen-Tannoudji, Michel/0000-0002-6405-2657				BONOMO A, 1993, J EXP MED, V177, P1153, DOI 10.1084/jem.177.4.1153; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; BROOKS AG, 1993, J IMMUNOL, V150, P3690; BURKLY LC, 1993, J IMMUNOL, V151, P3954; COHENTANNOUDJI M, 1992, MOL REPROD DEV, V33, P149, DOI 10.1002/mrd.1080330206; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; HACKETT CJ, 1991, J IMMUNOL, V146, P2944; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HOFFMANN MW, 1995, P NATL ACAD SCI USA, V92, P9851, DOI 10.1073/pnas.92.21.9851; HOFFMANN MW, 1992, P NATL ACAD SCI USA, V89, P2526, DOI 10.1073/pnas.89.7.2526; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KOSAKA H, 1993, J EXP MED, V177, P367, DOI 10.1084/jem.177.2.367; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; MALNATI MS, 1993, J IMMUNOL, V151, P6751; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Oukka M, 1996, J IMMUNOL, V156, P968; PAGE DM, 1993, J IMMUNOL, V151, P1868; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; ROBERTS JL, 1990, J EXP MED, V171, P935, DOI 10.1084/jem.171.3.935; SALAUN J, 1992, P NATL ACAD SCI USA, V89, P10420, DOI 10.1073/pnas.89.21.10420; SCHONRICH G, 1992, EUR J IMMUNOL, V22, P1687, DOI 10.1002/eji.1830220704; SPEISER DE, 1992, J EXP MED, V175, P1277, DOI 10.1084/jem.175.5.1277; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; SPRENT J, 1993, IMMUNOL REV, V133, P151, DOI 10.1111/j.1600-065X.1993.tb01515.x; ULLMANN A, 1984, GENE, V29, P27, DOI 10.1016/0378-1119(84)90162-8; VONBOEHMER H, 1986, NATURE, V320, P626, DOI 10.1038/320626a0; WEBB SR, 1990, EUR J IMMUNOL, V20, P2525, DOI 10.1002/eji.1830201127; WEISS S, 1989, P NATL ACAD SCI USA, V86, P282, DOI 10.1073/pnas.86.1.282; WILD TF, 1992, J GEN VIROL, V73, P359, DOI 10.1099/0022-1317-73-2-359	35	68	68	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1996	4	6					545	553		10.1016/S1074-7613(00)80481-1	http://dx.doi.org/10.1016/S1074-7613(00)80481-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673701	Bronze			2022-12-18	WOS:A1996UU44300003
J	KALOFF, CR; HAAS, IG				KALOFF, CR; HAAS, IG			COORDINATION OF IMMUNOGLOBULIN CHAIN FOLDING AND IMMUNOGLOBULIN CHAIN ASSEMBLY IS ESSENTIAL FOR THE FORMATION OF FUNCTIONAL IGG	IMMUNITY			English	Article							BINDING-PROTEIN; HEAVY-CHAIN; ENDOPLASMIC-RETICULUM; NP ANTIBODIES; LIGHT CHAIN; VARIABLE DOMAINS; DISULFIDE BONDS; CELL-FUSION; INVITRO; MICE	The first constant domain (C(H)1) of immunoglobulin heavy (H) chains is essential for BiP-mediated retention of unassembled H chains in the endoplasmic reticulum (ER). Here, we demonstrated that both wild-type and a mutant gamma chain lacking the C(H)1 domain bind BiP when they are reduced in vivo. However, only oxidized mutant H chain dimers are released from BiP interaction, whereas oxidized wild-type gamma chain dimers still bind Sip. In light (L) chain-producing cells, some of the mutant H chains accumulate with L chains in ER-derived vesicles and some are secreted as IgG. Furthermore, only half of the secreted antibodies bind antigen. We found the same with a mutant gamma chain, in which the CHI domain was replaced by a C(H)3 domain. Therefore, we propose that Sip interaction with incompletely folded C(H)1 domains is required to mediate correct assembly of H and L chains.			KALOFF, CR (corresponding author), UNIV HEIDELBERG, INST BIOCHEM 1, NEUENHEIMER FELD 328, D-69120 HEIDELBERG, GERMANY.							ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BAZIN H, 1984, J IMMUNOL METHODS, V66, P261, DOI 10.1016/0022-1759(84)90337-5; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CREMER A, 1994, 44 C MOSB 1993 GLYC, P171; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; DESILVA AM, 1990, J CELL BIOL, V111, P857, DOI 10.1083/jcb.111.3.857; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; GOTO Y, 1982, J MOL BIOL, V156, P911, DOI 10.1016/0022-2836(82)90147-4; HAAS IG, 1991, CURR TOP MICROBIOL, V167, P71; HAAS IG, 1984, P NATL ACAD SCI-BIOL, V81, P7185, DOI 10.1073/pnas.81.22.7185; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAAS IG, 1988, P NATL ACAD SCI USA, V85, P2250, DOI 10.1073/pnas.85.7.2250; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; HOCHMAN J, 1973, BIOCHEMISTRY-US, V12, P1130, DOI 10.1021/bi00730a018; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; IGARASHI T, 1990, BIOCHEMISTRY-US, V29, P5727, DOI 10.1021/bi00476a013; KEYNA U, 1995, IN PRESS ANN NY ACAD; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KNITTLER MR, 1995, P NATL ACAD SCI USA, V92, P1764, DOI 10.1073/pnas.92.5.1764; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; MASAT L, 1994, P NATL ACAD SCI USA, V91, P893, DOI 10.1073/pnas.91.3.893; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216; SECHER DS, 1977, IMMUNOL REV, V36, P51, DOI 10.1111/j.1600-065X.1977.tb00382.x; SHULMAN MJ, 1982, MOL CELL BIOL, V2, P1033, DOI 10.1128/MCB.2.9.1033; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983	34	68	69	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1995	2	6					629	637		10.1016/1074-7613(95)90007-1	http://dx.doi.org/10.1016/1074-7613(95)90007-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796296	Bronze			2022-12-18	WOS:A1995RE53800008
J	Bonavita, E; Bromley, CP; Jonsson, G; Pelly, VS; Sahoo, S; Walwyn-Brown, K; Mensurado, S; Moeini, A; Flanagan, E; Bell, CR; Chiang, SC; Chikkanna-Gowda, CP; Rogers, N; Silva-Santos, B; Jaillon, S; Mantovani, A; Sousa, CRE; Guerra, N; Davis, DM; Zelenay, S				Bonavita, Eduardo; Bromley, Christian P.; Jonsson, Gustav; Pelly, Victoria S.; Sahoo, Sudhakar; Walwyn-Brown, Katherine; Mensurado, Sofia; Moeini, Agrin; Flanagan, Eimear; Bell, Charlotte R.; Chiang, Shih-Chieh; Chikkanna-Gowda, C. P.; Rogers, Neil; Silva-Santos, Bruno; Jaillon, Sebastien; Mantovani, Alberto; Sousa, Caetano Reis E.; Guerra, Nadia; Davis, Daniel M.; Zelenay, Santiago			Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CLINICAL-RESPONSE; CTLA-4 BLOCKADE; DENDRITIC CELLS; PD-1 BLOCKADE; CANCER; LANDSCAPE; SENSITIVITY; CONTEXTURE; BIOMARKERS	Inflammation can support or restrain cancer progression and the response to therapy. Here, we searched for primary regulators of cancer-inhibitory inflammation through deep profiling of inflammatory tumor microenvironments (TMEs) linked to immune-dependent control in mice. We found that early intratumoral accumulation of interferon gamma (IFN-gamma)-producing natural killer (NK) cells induced a profound remodeling of the TME and unleashed cytotoxic T cell (CTL)-mediated tumor eradication. Mechanistically, tumor-derived prostaglandin E2 (PGE2) acted selectively on EP2 and EP4 receptors on NK cells, hampered the TME switch, and enabled immune evasion. Analysis of patient datasets across human cancers revealed distinct inflammatory TME phenotypes resembling those associated with cancer immune control versus escape in mice. This allowed us to generate a gene-expression signature that integrated opposing inflammatory factors and predicted patient survival and response to immune checkpoint blockade. Our findings identify features of the tumor inflammatory milieu associated with immune control of cancer and establish a strategy to predict immunotherapy outcomes.	[Bonavita, Eduardo; Bromley, Christian P.; Pelly, Victoria S.; Sahoo, Sudhakar; Moeini, Agrin; Flanagan, Eimear; Bell, Charlotte R.; Chiang, Shih-Chieh; Chikkanna-Gowda, C. P.; Zelenay, Santiago] Univ Manchester, Canc Res UK Manchester Inst, Alderley Pk, Manchester, Lancs, England; [Jonsson, Gustav; Guerra, Nadia] Imperial Coll London, Dept Life Sci, London, England; [Walwyn-Brown, Katherine; Davis, Daniel M.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Lydia Becker Inst Immunol & Inflammat, Manchester, Lancs, England; [Mensurado, Sofia; Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Rogers, Neil; Sousa, Caetano Reis E.] Francis Crick Inst, London, England; [Jaillon, Sebastien; Mantovani, Alberto] Humanitas Univ, IRCCS, Humanitas Clin & Res Ctr, Dept Biomed Sci, Milan, Italy	Cancer Research UK; University of Manchester; Imperial College London; University of Manchester; Universidade de Lisboa; Francis Crick Institute; Humanitas University	Zelenay, S (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Alderley Pk, Manchester, Lancs, England.	santiago.zelenay@cruk.manchester.ac.uk	JAILLON, Sebastien/A-7537-2015; Mantovani, Alberto/HCI-7449-2022; Bonavita, Eduardo/P-4370-2014	JAILLON, Sebastien/0000-0002-5600-855X; Mantovani, Alberto/0000-0001-5578-236X; Bonavita, Eduardo/0000-0003-2335-5827; Pelly, Victoria S/0000-0001-7323-4105; Rogers, Neil/0000-0001-8977-7585; Zelenay, Santiago/0000-0002-6865-3978; Jonsson, Gustav/0000-0001-6692-8395; Mensurado, Sofia/0000-0002-5157-0033; Bell, Charlotte/0000-0001-8653-2291	Cancer Research UK Institute Award [A19258]; EMBO long-term fellowship [ALTF-69-2016]; EMBO advanced fellowship [aALTF-638-2018]; National Institute for Health Research Manchester Biomedical Research Centre; Society of Swedish Engineers in Great Britain; Medical Research Council; Cancer Research UK [FC001136]; UK Medical Research Council [FC001136]; Wellcome Trust [FC001136]; ERC Advanced Investigator grant [AdG 268670]; Wellcome Investigator Award [WT106973MA]; Imperial Confidence in Concept Scheme [RSRO_P71752]; Wellcome Trust Investigator Award [110091/Z/15/Z]; Francis Crick Institute	Cancer Research UK Institute Award; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); EMBO advanced fellowship; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Society of Swedish Engineers in Great Britain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); ERC Advanced Investigator grant; Wellcome Investigator Award; Imperial Confidence in Concept Scheme; Wellcome Trust Investigator Award(Wellcome Trust); Francis Crick Institute	This work was supported by a Cancer Research UK Institute Award (A19258) to S.Z. We thank colleagues at CRUK Manchester Institute core facilities, in particular, Biological Resource Unit, Transgenic Breeding, Molecular Biology, Histology, and Flow Cytometry. E.B. was supported by an EMBO long-term fellowship (ALTF-69-2016) and an EMBO advanced fellowship (aALTF-638-2018). C.P.B. was funded by the National Institute for Health Research Manchester Biomedical Research Centre. G.J. was supported by a scholarship from The Society of Swedish Engineers in Great Britain. K.W.-B. was supported by a doctoral studentship from the Medical Research Council. C.R.e.S. was supported by The Francis Crick Institute, which receives core funding from Cancer Research UK (FC001136), the UK Medical Research Council (FC001136), and the Wellcome Trust (FC001136), by an ERC Advanced Investigator grant (AdG 268670), by a Wellcome Investigator Award (WT106973MA), and by a prize from the Louis-Jeantet Foundation. N.G. was supported by an Imperial Confidence in Concept Scheme (RSRO_P71752). D.M.D. was supported by a Wellcome Trust Investigator Award (110091/Z/15/Z). We acknowledge Richard Meyer (Vanderbilt University Medical Center), David Baltimore (California Institute of Technology), and Susan M Kaech (Yale University School of Medicine) for generously providing and permitting use of GPP mice. We also thank all investigators and organizations, such as Genentech/gRED for making publicly available or generously sharing patient datasets.	Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Barrow AD, 2018, CELL, V172, P534, DOI 10.1016/j.cell.2017.11.037; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Danaher P, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0367-1; Danaher P, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0215-8; Dangaj D, 2019, CANCER CELL, V35, P885, DOI 10.1016/j.ccell.2019.05.004; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hoekstra ME, 2020, NAT CANCER, V1, P291, DOI 10.1038/s43018-020-0036-4; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim ST, 2018, NAT MED, V24, P1449, DOI 10.1038/s41591-018-0101-z; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Molgora M, 2017, NATURE, V551, P110, DOI 10.1038/nature24293; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Nicolai CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz2738; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Salmon H, 2019, NAT REV CANCER, V19, P215, DOI 10.1038/s41568-019-0125-9; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Shalapour S, 2019, IMMUNITY, V51, P15, DOI 10.1016/j.immuni.2019.06.021; Snyder A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002309; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Thibaut R, 2020, NAT CANCER, V1, P302, DOI 10.1038/s43018-020-0038-2; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wculek S.K., 2020, NAT REV IMMUNOL, V20, P7, DOI DOI 10.1038/S41577-019-0210-Z; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zelenay S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1123370; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	68	67	70	5	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1215	+		10.1016/j.immuni.2020.10.020	http://dx.doi.org/10.1016/j.immuni.2020.10.020			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33220234	hybrid, Green Published			2022-12-18	WOS:000599363300011
J	Tran, S; Baba, I; Poupel, L; Dussau, S; Moreau, M; Gelineau, A; Marcelin, G; Magreau-Davy, E; Ouhachi, M; Lesnik, P; Boissonnas, A; Le Goff, W; Clausen, BE; Yvan-Charvet, L; Sennlaub, F; Huby, T; Gautier, EL				Tran, Sophie; Baba, Ines; Poupel, Lucie; Dussau, Sebastien; Moreau, Martine; Gelineau, Adelaide; Marcelin, Genevieve; Magreau-Davy, Elissa; Ouhachi, Melissa; Lesnik, Philippe; Boissonnas, Alexandre; Le Goff, Wilfried; Clausen, Bjorn E.; Yvan-Charvet, Laurent; Sennlaub, Florian; Huby, Thierry; Gautier, Emmanuel L.			Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis	IMMUNITY			English	Article							MONOCYTE-DERIVED MACROPHAGES; INFLAMMATION; APOPTOSIS; HOMEOSTASIS; EXPRESSION; DIVERSITY	Kupffer cells (KCs) are liver-resident macrophages that self-renew by proliferation in the adult independently from monocytes. However, how they are maintained during non-alcoholic steatohepatitis (NASH) remains ill defined. We found that a fraction of KCs derived from Ly-6C(+) monocytes during NASH, underlying impaired KC self-renewal. Monocyte-derived KCs (MoKCs) gradually seeded the KC pool as disease progressed in a response to embryo-derived KC (EmKC) death. Those MoKCs were partly immature and exhibited a pro-inflammatory status compared to EmKCs. Yet, they engrafted the KC pool for the long term as they remained following disease regression while acquiring mature EmKC markers. While KCs as a whole favored hepatic triglyceride storage during NASH, EmKCs promoted it more efficiently than MoKCs, and the latter exacerbated liver damage, highlighting functional differences among KCs with different origins. Overall, our data reveal that KC homeostasis is impaired during NASH, altering the liver response to lipids, as well as KC ontogeny.	[Tran, Sophie; Baba, Ines; Poupel, Lucie; Dussau, Sebastien; Moreau, Martine; Marcelin, Genevieve; Magreau-Davy, Elissa; Ouhachi, Melissa; Lesnik, Philippe; Le Goff, Wilfried; Huby, Thierry; Gautier, Emmanuel L.] Sorbonne Univ, Inst Natl Sante & Rech Med Inserm, Hop Pitie Salpetriere, UMR S 1166, Paris, France; [Gelineau, Adelaide] Sorbonne Univ, Inst Natl Sante & Rech Med Inserm, Hop Pitie Salpetriere, UMR S 1269, Paris, France; [Boissonnas, Alexandre] Sorbonne Univ, Ctr Natl Rech Sci CNRS, Ctr Immunol & Malad Infect CIMI, ERL8255,Inst Natl Sante & Rech Med Inserm,UMR1135, Paris, France; [Clausen, Bjorn E.] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Yvan-Charvet, Laurent] Univ Cote Azur, Federat Hosp Univ FHU Oncoage, Ctr Mediterraneen Med Mol C3M, Atip Avenir,Inst Natl Sante & Rech Med Inserm,U10, Nice, France; [Sennlaub, Florian] Sorbonne Univ, Ctr Natl Rech Sci CNRS, Inst Natl Sante & Rech Med Inserm, Inst Vis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Johannes Gutenberg University of Mainz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gautier, EL (corresponding author), Sorbonne Univ, Inst Natl Sante & Rech Med Inserm, Hop Pitie Salpetriere, UMR S 1166, Paris, France.	emmanuel-laurent.gautier@inserm.fr	CLAUSEN, Björn Erik/A-8229-2010; Boissonnas, Alexandre/A-2801-2016; Sennlaub, Florian/F-2756-2017; Gautier, Emmanuel L./E-2259-2017; Lesnik, Philippe/AAD-7393-2020; Le Goff, Wilfried/N-6326-2017; Le Goff, Wilfried/N-7593-2019; HUBY, Thierry/N-4820-2019	CLAUSEN, Björn Erik/0000-0002-2484-7842; Boissonnas, Alexandre/0000-0002-7770-7210; Sennlaub, Florian/0000-0003-4412-1341; Gautier, Emmanuel L./0000-0003-2976-7566; Lesnik, Philippe/0000-0002-6909-7715; Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; HUBY, Thierry/0000-0001-6634-551X; Dussaud, Sebastien/0000-0002-5365-8338; Poupel, Lucie/0000-0001-7015-8450; marcelin, genevieve/0000-0002-9779-5529	Agence Nationale de la Recherche [ANR-15-CE14-0015-02, ANR-17-CE14-0009-02, ANR-17CE14-0023-01]; city of Paris (Emergence(s) program); Nouvelle Societe Francaise d'Atherosclerose (NSFA)	Agence Nationale de la Recherche(French National Research Agency (ANR)); city of Paris (Emergence(s) program)(Region Ile-de-France); Nouvelle Societe Francaise d'Atherosclerose (NSFA)	This work was supported by grants to E.L.G. from the Agence Nationale de la Recherche (ANR-15-CE14-0015-02, ANR-17-CE14-0009-02, and ANR-17CE14-0023-01) and from the city of Paris (Emergence(s) program). S.T. and M.O. both received a one-year doctoral fellowship from the Nouvelle Societe Francaise d'Atherosclerose (NSFA).	Beattie L, 2016, J HEPATOL, V65, P758, DOI 10.1016/j.jhep.2016.05.037; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Bouchareychas L, 2015, CARDIOVASC RES, V108, P111, DOI 10.1093/cvr/cvv177; Devisscher L, 2017, CELL IMMUNOL, V322, P74, DOI 10.1016/j.cellimm.2017.10.006; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jourdren L, 2012, BIOINFORMATICS, V28, P1542, DOI 10.1093/bioinformatics/bts165; Kanda T, 2018, WORLD J GASTROENTERO, V24, P2661, DOI 10.3748/wjg.v24.i25.2661; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Morgantini C, 2019, NAT METAB, V1, P445, DOI 10.1038/s42255-019-0044-9; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Reid DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159524; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Surewaard BGJ, 2016, J EXP MED, V213, P1141, DOI 10.1084/jem.20160334; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880; Zeng ZT, 2016, CELL HOST MICROBE, V20, P99, DOI 10.1016/j.chom.2016.06.002; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	35	67	68	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					627	+		10.1016/j.immuni.2020.06.003	http://dx.doi.org/10.1016/j.immuni.2020.06.003			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32562600	Green Published, Bronze			2022-12-18	WOS:000569806100017
J	Kumagai, S; Togashi, Y; Sakai, C; Kawazoe, A; Kawazu, M; Ueno, T; Sato, E; Kuwata, T; Kinoshita, T; Yamamoto, M; Nomura, S; Tsukamoto, T; Mano, H; Shitara, K; Nishikawa, H				Kumagai, Shogo; Togashi, Yosuke; Sakai, Chika; Kawazoe, Akihito; Kawazu, Masahito; Ueno, Toshihide; Sato, Eiichi; Kuwata, Takeshi; Kinoshita, Takahiro; Yamamoto, Masami; Nomura, Sachiyo; Tsukamoto, Tetsuya; Mano, Hiroyuki; Shitara, Kohei; Nishikawa, Hiroyoshi			An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells	IMMUNITY			English	Article							FATTY-ACID SYNTHASE; FOXP3 EXPRESSION; ANTITUMOR-ACTIVITY; ADVANCED MELANOMA; PD-1 BLOCKADE; PI3K PATHWAY; OPEN-LABEL; CANCER; GENE; P110-DELTA	Only a small percentage of patients afflicted with gastric cancer (GC) respond to immune checkpoint blockade (ICB). To study the mechanisms underlying this resistance, we examined the immune landscape of GC. A subset of these tumors was characterized by high frequencies of regulatory T (Treg) cells and low numbers of effector T cells. Genomic analyses revealed that these tumors bore mutations in RHOA that are known to drive tumor progression. RHOA mutations in cancer cells activated the PI3K-AKT-mTOR signaling pathway, increasing production of free fatty acids that are more effectively consumed by Treg cells than effector T cells. RHOA mutant tumors were resistant to PD-1 blockade but responded to combination of PD-1 blockade with inhibitors of the PI3K pathway or therapies targeting Treg cells. We propose that the metabolic advantage conferred by RHOA mutations enables Treg cell accumulation within GC tumors, generating an immunosuppressive TME that underlies resistance to ICB.	[Kumagai, Shogo; Togashi, Yosuke; Sakai, Chika; Nishikawa, Hiroyoshi] Natl Canc Ctr, Res Inst, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr EPOC, Tokyo, Japan; [Kumagai, Shogo; Nishikawa, Hiroyoshi] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi, Japan; [Kawazoe, Akihito; Shitara, Kohei] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Chiba, Japan; [Kawazu, Masahito; Ueno, Toshihide; Mano, Hiroyuki] Natl Canc Ctr, Div Cellular Signaling, Grp Canc Dev & Progress, Res Inst, Tokyo, Japan; [Sato, Eiichi] Tokyo Med Univ, Inst Med Sci, Dept Pathol, Tokyo, Japan; [Kuwata, Takeshi] Natl Canc Ctr Hosp East, Dept Pathol & Clin Labs, Chiba, Japan; [Kinoshita, Takahiro] Natl Canc Ctr Hosp East, Dept Gastr Surg, Chiba, Japan; [Yamamoto, Masami] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Appl Sci, Div Physiol Pathol, Tokyo, Japan; [Nomura, Sachiyo] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan; [Tsukamoto, Tetsuya] Fujita Hlth Univ, Grad Sch Med, Dept Pathol, Toyoake, Aichi, Japan	National Cancer Center - Japan; Nagoya University; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical University; National Cancer Center - Japan; National Cancer Center - Japan; Nippon Veterinary & Life Science University; University of Tokyo; Fujita Health University	Togashi, Y; Nishikawa, H (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr EPOC, Tokyo, Japan.; Nishikawa, H (corresponding author), Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi, Japan.	ytogashi1584@gmail.com; hnishika@ncc.go.jp	Tsukamoto, Tetsuya/ABD-4397-2020; Shitara, Kohei/AAA-3877-2021; Kawazu, Masahito/AAE-6143-2022	Tsukamoto, Tetsuya/0000-0002-7502-8724; Kawazu, Masahito/0000-0003-4146-3629; Yamamoto, Masami/0000-0003-2071-7730; Nomura, Sachiyo/0000-0003-4293-6205; Ueno, Toshihide/0000-0002-7408-7298	Ministry of Education, Culture, Sports, Science and Technology of Japan [18J21551, 17H06162, 16K15551, 17J09900]; Projects for Cancer Research by Therapeutic Evolution (P-CREATE) [16cm0106301h0001, 18cm0106502s0403, 18cm0106340h0001]; Development of Technology for Patient Stratification Biomarker Discovery grant [19ae0101074s0401]; Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED) [18am0001001h9905]; National Cancer Center Research and Development Fund [28-A-7, 31-A-7]; Naito Foundation; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Novartis Research Grant; Bristol-Myers Squibb Research Grant; SGH Foundation; Ono Pharmaceutical	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Projects for Cancer Research by Therapeutic Evolution (P-CREATE); Development of Technology for Patient Stratification Biomarker Discovery grant; Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Novartis Research Grant; Bristol-Myers Squibb Research Grant(Bristol-Myers Squibb); SGH Foundation; Ono Pharmaceutical	We thank Drs. Kota Itahashi, Takuma Irie, Eri Sugiyama, Ms. Tomoka Takaku, Miyuki Nakai, Konomi Onagawa, Megumi Takemura, Chie Haijima, Megumi Hoshino, Kumiko Yoshida, Yumi Osada, and Miho Ozawa for their technical assistance. This study was supported by Grants-in-Aid for Scientific Research (S grant no. 17H06162 [H.N.], Challenging Exploratory Research Grant no. 16K15551 [H.N.], Young Scientists no. 17J09900 [Y.T.], and JSPS Research Fellowship no. 18J21551 [S.K.]) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by the Projects for Cancer Research by Therapeutic Evolution (P-CREATE, no. 16cm0106301h0001 [H.N.], no. 16cm0106301h0001 [H.M.], no. 18cm0106502s0403 [M.K.], and no. 18cm0106340h0001 [Y.T.]), by the Development of Technology for Patient Stratification Biomarker Discovery grant (no.19ae0101074s0401 [H.N.]), by Leading Advanced Projects for Medical Innovation (LEAP; no. 18am0001001h9905 [H.M.]) from the Japan Agency for Medical Research and Development (AMED), by the National Cancer Center Research and Development Fund (no. 28-A-7 and 31-A-7 [H.N.]), by the Naito Foundation (Y.T. and H.N.), by the Takeda Science Foundation (Y.T.), by the Kobayashi Foundation for Cancer Research (Y.T.), by the Novartis Research Grant (Y.T.), by the Bristol-Myers Squibb Research Grant (Y.T.), and by the SGH Foundation (Y.T.). This study was executed in part as a research program supported by Ono Pharmaceutical.	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fan MY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00069; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gorbachev AV, 2007, J IMMUNOL, V178, P2278, DOI 10.4049/jimmunol.178.4.2278; Gouw AM, 2017, P NATL ACAD SCI USA, V114, P4300, DOI 10.1073/pnas.1617709114; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hensbergen PJ, 2005, J IMMUNOTHER, V28, P343, DOI 10.1097/01.cji.0000165355.26795.27; Ho PC, 2017, CURR OPIN IMMUNOL, V46, P38, DOI 10.1016/j.coi.2017.04.003; Hoelzinger DB, 2010, J IMMUNOL, V184, P6833, DOI 10.4049/jimmunol.0904084; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Muraoka D, 2010, J IMMUNOL, V185, P3768, DOI 10.4049/jimmunol.0903649; Muroski ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05556-x; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Ozguroglu M., 2018, LANCET, V392, P123; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schachter J, 2017, LANCET, V390, P1853, DOI 10.1016/S0140-6736(17)31601-X; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama E, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav3937; Tada Y, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0403-1; Takeuchi Y, 2018, INT IMMUNOL, V30, P13, DOI 10.1093/intimm/dxx073; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang HP, 2017, TRENDS CANCER, V3, P583, DOI 10.1016/j.trecan.2017.06.005; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Wiig H, 2003, AM J PHYSIOL-HEART C, V284, pH416, DOI 10.1152/ajpheart.00327.2002; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Yamamoto M, 2018, CANCER SCI, V109, P1480, DOI 10.1111/cas.13569; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Zumwalt TJ, 2015, ONCOTARGET, V6, P2981, DOI 10.18632/oncotarget.3205	86	67	67	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					187	+		10.1016/j.immuni.2020.06.016	http://dx.doi.org/10.1016/j.immuni.2020.06.016			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32640259	Bronze			2022-12-18	WOS:000551116800019
J	Plum, T; Wang, X; Rettel, M; Krijgsveld, J; Feyerabend, TB; Rodewald, HR				Plum, Thomas; Wang, Xi; Rettel, Mandy; Krijgsveld, Jeroen; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer			Human Mast Cell Proteome Reveals Unique Lineage, Putative Functions, and Structural Basis for Cell Ablation	IMMUNITY			English	Article							NEURITE OUTGROWTH; IMMUNOGLOBULIN-E; HOST-DEFENSE; IDENTIFICATION; DEGRANULATION; TRANSPORTERS; ACTIVATION; RECEPTORS; ROLES; VENOM	Mast cells are rare tissue-resident cells of importance to human allergies. To understand the structural basis of principle mast cell functions, we analyzed the proteome of primary human and mouse mast cells by quantitative mass spectrometry. We identified a mast-cell-specific proteome signature, indicative of a unique lineage, only distantly related to other immune cell types, including innate immune cells. Proteome comparison between human and mouse suggested evolutionary conservation of core mast cell functions. In addition to specific proteases and proteins associated with degranulation and proteoglycan biosynthesis, mast cells expressed proteins potentially involved in interactions with neurons and neurotransmitter metabolism, including cell adhesion molecules, ion channels, and G protein coupled receptors. Toward targeted cell ablation in severe allergic diseases, we used MRGPRX2 for mast cell depletion in human skin biopsies. These proteome analyses suggest a unique role of mast cells in the immune system, probably intertwined with the nervous system.	[Plum, Thomas; Wang, Xi; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Plum, Thomas] Heidelberg Univ, Fac Biosci, Neuenheimer Feld 234, D-69120 Heidelberg, Germany; [Wang, Xi] German Canc Res Ctr, Div Theoret Syst Biol, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Rettel, Mandy] European Mol Biol Lab, Prote Core Facil, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Krijgsveld, Jeroen] German Canc Res Ctr, Div Prote Stem Cells & Canc, Neuenheimer Feld 581, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de	Wang, Xi/N-9527-2014	Wang, Xi/0000-0002-7572-6354; Plum, Thomas/0000-0002-7811-4476	Helmholtz Graduate School of Cancer Research; HGF Project Immunology Inflammation [ZT-0027]; Leibniz program of the Deutsche Forschungsgemeinschaft;  [CRC156/TRR156]	Helmholtz Graduate School of Cancer Research; HGF Project Immunology Inflammation; Leibniz program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	The authors are grateful to the tissue donors and A. Altinay, R. Uebing, A. Dalpke, K. Schakel, and S. Meuer for kindly making human tissues available. We thank B. Fischer and S. Fohr for expert contributions to initial bioinformatic analysis and S. Schafer for technical assistance. We thank the Flow Cytometry Facility team at the German Cancer Research Centre (DKFZ) for their support with sorting of human cells. This work was supported by the Helmholtz Graduate School of Cancer Research to T.P., CRC156/TRR156 project A7 to T.B.F. and H.-R.R., and HGF Project Immunology & Inflammation (ZT-0027) and the Leibniz program of the Deutsche Forschungsgemeinschaft to H.-R.R.	Abebayehu D, 2016, J IMMUNOL, V197, P2909, DOI 10.4049/jimmunol.1600651; Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Albert-Bayo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020135; Anghel SI, 2012, PIGM CELL MELANOMA R, V25, P482, DOI 10.1111/j.1755-148X.2012.01018.x; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Baccari GC, 2011, INT REV CEL MOL BIO, V290, P1, DOI 10.1016/B978-0-12-386037-8.00006-5; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Bradding P, 2009, THORAX, V64, P278, DOI 10.1136/thx.2008.106427; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Cavalcante MCM, 2002, J STRUCT BIOL, V137, P313, DOI 10.1016/S1047-8477(02)00007-2; Chen S, 2011, J BIOL CHEM, V286, P10201, DOI 10.1074/jbc.M110.175273; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Church MK, 2018, IMMUNOL REV, V282, P232, DOI 10.1111/imr.12632; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Collo G, 1996, J NEUROSCI, V16, P2495; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crivellato E, 2015, METHODS MOL BIOL, V1220, P11, DOI 10.1007/978-1-4939-1568-2_2; de Barros C.M., 2007, J BIOL CHEM, V282, P1615; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; ENERBACK L, 1987, INT ARCH ALLER A IMM, V82, P249, DOI 10.1159/000234199; Feyerabend TB, 2016, CELL METAB, V24, P1, DOI 10.1016/j.cmet.2016.06.019; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Fleming TJ, 1997, J EXP MED, V186, P1307, DOI 10.1084/jem.186.8.1307; Forsythe P, 2019, TRENDS NEUROSCI, V42, P43, DOI 10.1016/j.tins.2018.09.006; Freitas EG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163904; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Galli SJ, 2016, AM J PATHOL, V186, P212, DOI 10.1016/j.ajpath.2015.07.025; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; GENTILINI G, 1995, BRIT J PHARMACOL, V115, P389, DOI 10.1111/j.1476-5381.1995.tb16345.x; Gil OD, 1998, J NEUROSCI, V18, P9312; Gorelik A, 2018, FEBS J, V285, P2481, DOI 10.1111/febs.14489; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Gschwandtner M, 2017, ALLERGY, V72, P85, DOI 10.1111/all.12919; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Gutierrez DA, 2015, CELL METAB, V21, P678, DOI 10.1016/j.cmet.2015.04.013; Gutierrez DA, 2014, DIABETES, V63, P3827, DOI 10.2337/db14-0372; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Joulia R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7174; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; Kitamura Y, 2002, INT ARCH ALLERGY IMM, V127, P106, DOI 10.1159/000048178; Kraft S, 2013, J IMMUNOL, V191, P2871, DOI 10.4049/jimmunol.1202323; Kulka Marianna, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0725s90; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; Lonnstedt I, 2002, STAT SINICA, V12, P31; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Loyd DR, 2013, SEMIN CELL DEV BIOL, V24, P51, DOI 10.1016/j.semcdb.2012.09.002; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Marshall JS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174241; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Pakhale S, 2011, CLIN MED INSIGHTS-CI, V5, P37, DOI 10.4137/CCRPM.S5535; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Le QT, 2019, J EXP MED, V216, P2348, DOI 10.1084/jem.20190701; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; ROTHENBERG ME, 1989, ANN NY ACAD SCI, V556, P233; Saleh SM, 2013, J IMMUNOL, V191, P2796, DOI 10.4049/jimmunol.1300601; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Schubert N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01870; Serra-Batlles J, 1998, EUR RESPIR J, V12, P1322, DOI 10.1183/09031936.98.12061322; SHANAHAN F, 1984, CAN J PHYSIOL PHARM, V62, P734, DOI 10.1139/y84-121; Shubin NJ, 2017, J ALLERGY CLIN IMMUN, V139, P323, DOI 10.1016/j.jaci.2016.03.051; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Stoitzner P, 2014, EXP DERMATOL, V23, P909, DOI 10.1111/exd.12573; Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Undem BJ, 2014, J ALLERGY CLIN IMMUN, V133, P1521, DOI 10.1016/j.jaci.2013.11.027; Van Acker HH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00892; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wong MX, 2002, J IMMUNOL, V168, P6455, DOI 10.4049/jimmunol.168.12.6455; Zhang D, 2012, PHYSIOL RES, V61, P113, DOI 10.33549/physiolres.932053; Zhang Y, 2019, J MOL CELL BIOL, V11, P1, DOI 10.1093/jmcb/mjy052	101	67	68	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					404	+		10.1016/j.immuni.2020.01.012	http://dx.doi.org/10.1016/j.immuni.2020.01.012			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32049054	Bronze			2022-12-18	WOS:000515082000019
J	Finkin, S; Hartweger, H; Oliveira, TY; Kara, EE; Nussenzweig, MC				Finkin, Shlomo; Hartweger, Harald; Oliveira, Thiago Y.; Kara, Ervin E.; Nussenzweig, Michel C.			Protein Amounts of the MYC Transcription Factor Determine Germinal Center B Cell Division Capacity	IMMUNITY			English	Article							C-MYC; AFFINITY MATURATION; T-CELLS; ANTIBODY-RESPONSES; CLONAL SELECTION; CENTER LIGHT; CENTER DARK; GENE; CYCLE; RECEPTOR	High-affinity B cell selection in the germinal center (GC) is governed by signals delivered by follicular helper T (Tfh) cells to B cells. Selected B cells undergo clonal expansion and affinity maturation in the GC dark zone in direct proportion to the amount of antigen they capture and present to Tfh cells in the light zone. Here, we examined the mechanisms whereby Tfh cells program the number of GC B cell divisions. Gene expression analysis revealed that Tfh cells induce Myc expression in light-zone B cells in direct proportion to antigen capture. Conditional Myc haplo-insufficiency or overexpression combined with cell division tracking showed that MYC expression produces a metabolic reservoir in selected light-zone B cells that is proportional to the number of cell divisions in the dark zone. Thus, MYC constitutes the GC B cell division timer that when deregulated leads to emergence of B cell lymphoma.	[Finkin, Shlomo; Hartweger, Harald; Oliveira, Thiago Y.; Kara, Ervin E.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, HHMI, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, HHMI, New York, NY 10065 USA.	nussen@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/ABF-5186-2020	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Hartweger, Harald/0000-0002-1118-1818	NIH [5R37 AI037526-24, UM1-AI100663]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R37AI037526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Miyawaki, T. Kurosaki, J.M. Sedivy, and F.J. Gonzalez for mice; T. Eisenreich for help with mouse colony management; K. Yao for technical help; A. Gazumyan and D. Yost for protein production; A. Gitlin and M. Biton for advice; B. Zhang and C. Zhao at The Rockefeller University Genomics Resource Center for assistance with high-throughput sequencing; K. Gordon for assistance with cell sorting, S. Semova and S. Mazel at The Rockefeller University Flow Cytometry Resource Center for assistance with ImageStream analysis; and all members of the Nussenzweig laboratory for discussion. This work was supported by NIH grants 5R37 AI037526-24 and UM1-AI100663 to M.C.N. H.H. is a Cancer Research Institute Irvington fellow. E.E.K. is a National Health and Medical Research Council C.J. Martin Overseas Biomedical fellow. M.C.N. is an HHMI investigator.	ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Pasqual G, 2015, METHODS MOL BIOL, V1291, P125, DOI 10.1007/978-1-4939-2498-1_10; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stewart I, 2018, IMMUNITY, V49, P477, DOI 10.1016/j.immuni.2018.08.025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wiesner SM, 2005, BLOOD, V106, P1054, DOI 10.1182/blood-2004-08-3306	59	67	67	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					324	+		10.1016/j.immuni.2019.06.013	http://dx.doi.org/10.1016/j.immuni.2019.06.013			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31350178	Green Accepted, Bronze			2022-12-18	WOS:000482088500015
J	Daniel, B; Nagy, G; Czimmerer, Z; Horvath, A; Hammers, DW; Cuaranta-Monroy, I; Poliska, S; Tzerpos, P; Kolostyak, Z; Hays, TT; Patsalos, A; Houtman, R; Sauer, S; Francois-Deleuze, J; Rastinejad, F; Balint, BL; Sweeney, HL; Nagy, L				Daniel, Bence; Nagy, Gergely; Czimmerer, Zsolt; Horvath, Attila; Hammers, David W.; Cuaranta-Monroy, Ixchelt; Poliska, Szilard; Tzerpos, Petros; Kolostyak, Zsuzsanna; Hays, Tristan T.; Patsalos, Andreas; Houtman, Rene; Sauer, Sascha; Francois-Deleuze, Jean; Rastinejad, Fraydoon; Balint, Balint L.; Sweeney, H. Lee; Nagy, Laszlo			The Nuclear Receptor PPAR gamma Controls Progressive Macrophage Polarization as a Ligand-Insensitive Epigenomic Ratchet of Transcriptional Memory	IMMUNITY			English	Article							RETINOID-X-RECEPTOR; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; DENDRITIC CELLS; MUSCLE INJURY; ENHANCERS; CHROMATIN; BINDING; RXR; DNA	Macrophages polarize into distinct phenotypes in response to complex environmental cues. We found that the nuclear receptor PPAR gamma drove robust phenotypic changes in macrophages upon repeated stimulation with interleukin (IL)-4. The functions of PPARy on macrophage polarization in this setting were independent of ligand binding. Ligand-insensitive PPAR gamma bound DNA and recruited the coactivator P300 and the architectural protein RAD21. This established a permissive chromatin environment that conferred transcriptional memory by facilitating the binding of the transcriptional regulator STAT6 and RNA polymerase II, leading to robust production of enhancer and mRNAs upon IL-4 re-stimulation. Ligand-insensitive PPAR gamma binding controlled the expression of an extracellular matrix remodeling related gene network in macrophages. Expression of these genes increased during muscle regeneration in a mouse model of injury, and this increase coincided with the detection of IL-4 and PPAR gamma in the affected tissue. Thus, a predominantly ligand-insensitive PPAR gamma:RXR cistrome regulates progressive and/or reinforcing macrophage polarization.	[Daniel, Bence; Hays, Tristan T.; Patsalos, Andreas; Rastinejad, Fraydoon; Nagy, Laszlo] Sanford Burnham Prebys Med Discovery Inst, Orlando, FL 32827 USA; [Nagy, Gergely; Czimmerer, Zsolt; Horvath, Attila; Cuaranta-Monroy, Ixchelt; Poliska, Szilard; Tzerpos, Petros; Kolostyak, Zsuzsanna; Balint, Balint L.; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary; [Sauer, Sascha; Sweeney, H. Lee] Max Planck Inst Mol Genet, Otto Warburg Lab, Berlin, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, Wurzburg, Germany; [Sauer, Sascha] Max Delbruck Ctr Mol Med, BISMB, Berlin, Germany; [Sauer, Sascha] Max Delbruck Ctr Mol Med, BIH, Berlin, Germany; [Francois-Deleuze, Jean] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Nagy, Laszlo] Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, Debrecen, Hungary; [Hammers, David W.; Sweeney, H. Lee] Univ Florida, Coll Med, Myol Inst, Gainesville, FL USA; [Hammers, David W.; Sweeney, H. Lee] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Houtman, Rene] PamGene Int BV S Hertogenbosch, Shertogenbosch, Netherlands; [Hays, Tristan T.; Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Johns Hopkins All Childrens Hosp, Dept Med, St Petersburg, FL 33701 USA; [Hays, Tristan T.; Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Johns Hopkins All Childrens Hosp, Dept Biol Chem, St Petersburg, FL 33701 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Debrecen; Max Planck Society; University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Berlin Institute of Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Debrecen; State University System of Florida; University of Florida; State University System of Florida; University of Florida; PamGene International BV; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Nagy, L (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Orlando, FL 32827 USA.; Nagy, L (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary.; Nagy, L (corresponding author), Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, Debrecen, Hungary.; Nagy, L (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins All Childrens Hosp, Dept Med, St Petersburg, FL 33701 USA.; Nagy, L (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins All Childrens Hosp, Dept Biol Chem, St Petersburg, FL 33701 USA.	lnagy@jhmi.edu	Nagy, Laszlo/A-3814-2008; Patsalos, Andreas/L-8957-2019; Horvath, Attila/AAA-9075-2020; Patsalos, Andreas/GQY-7136-2022; Nagy, Gergely/F-7670-2017	Nagy, Laszlo/0000-0001-6653-2155; Patsalos, Andreas/0000-0002-9022-4985; Patsalos, Andreas/0000-0002-9022-4985; Horvath, Attila/0000-0002-6127-8925; Nagy, Gergely/0000-0002-3273-731X; Houtman, Rene/0000-0001-7639-6310; Balint, Balint/0000-0002-6163-7190	NIH [R01DK115924]; Hungarian Scientific Research Fund [OTKA K124298, K126885, K116855, OTKA PD124843]; SBP; European Sequencing and Genotyping Infrastructure - European Commission, as part of the ADIPOMACTX transnational access program [26205]; American Heart Association (AHA) [17POST33660450]; Wellstone Muscular Dystrophy Cooperative Center grant from the NIH [U54-AR-052646]; Muscular Dystrophy Association [MDA549004]; European Union; European Regional Development Fund;  [GINOP-2.3.2-15-2016-00006]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); SBP; European Sequencing and Genotyping Infrastructure - European Commission, as part of the ADIPOMACTX transnational access program; American Heart Association (AHA)(American Heart Association); Wellstone Muscular Dystrophy Cooperative Center grant from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); European Union(European Commission); European Regional Development Fund(European Commission); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to acknowledge Dr. T. Osborne and members of the Nagy laboratory for discussions and comments on the manuscript. We thank Ms. T. Cseh and Ms. M. Beladi for technical assistance. This work is supported by grants from the NIH R01DK115924 to L.N. and the Hungarian Scientific Research Fund (OTKA K124298, K126885, and K116855 to L.N.) and (OTKA PD124843 to G.N.) and by SBP. Library preparation and bioinformatics analysis was performed at the Center of Clinical Genomics and Personalized Medicine of the University of Debrecen. Next-generation sequencing was performed at the Centre National de Genotypage (CNG) Evry, by Steven McGinn, Anne Boland, Doris Lechner, and Marie Therese Bihoreau and supported by the European Sequencing and Genotyping Infrastructure (funded by the European Commission, FP7/2007-2013) under grant agreement no. 26205 (ESGI), as part of the ADIPOMACTX transnational access program and also at the Analytical Genomics Core Facility at the SBP. B.D. is supported by the American Heart Association (AHA) postdoctoral fellowship (17POST33660450). H.L.S. is funded by a Wellstone Muscular Dystrophy Cooperative Center grant (U54-AR-052646) from the NIH, and D.W.H. is funded by a grant from the Muscular Dystrophy Association (MDA549004). L.N. and Z.C. is supported by the GINOP-2.3.2-15-2016-00006 project. The project is co-financed by the European Union and the European Regional Development Fund.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Brazda P, 2014, MOL CELL BIOL, V34, P1234, DOI 10.1128/MCB.01097-13; Broekema MF, 2018, ENDOCRINOLOGY, V159, P2397, DOI 10.1210/en.2018-00149; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Daniel B, 2018, NUCLEIC ACIDS RES, V46, P4425, DOI 10.1093/nar/gky157; Daniel B, 2014, METHODS MOL BIOL, V1204, P15, DOI 10.1007/978-1-4939-1346-6_2; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Patsalos A, 2017, J PHYSIOL-LONDON, V595, P5815, DOI 10.1113/JP274361; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Soccio RE, 2017, J CLIN INVEST, V127, P1451, DOI 10.1172/JCI91211; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Varga T, 2016, IMMUNITY, V45, P1038, DOI 10.1016/j.immuni.2016.10.016; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100	41	67	69	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					615	+		10.1016/j.immuni.2018.09.005	http://dx.doi.org/10.1016/j.immuni.2018.09.005			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332629	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000447386700009
J	Goto, A; Okado, K; Martins, N; Cai, H; Barbier, V; Lamiable, O; Troxler, L; Santiago, E; Kuhn, L; Paik, D; Silverman, N; Holleufer, A; Hartmann, R; Liu, JY; Peng, T; Hoffmann, JA; Meignin, C; Daeffler, L; Imler, JL				Goto, Akira; Okado, Kiyoshi; Martins, Nelson; Cai, Hua; Barbier, Vincent; Lamiable, Olivier; Troxler, Laurent; Santiago, Estelle; Kuhn, Lauriane; Paik, Donggi; Silverman, Neal; Holleufer, Andreas; Hartmann, Rune; Liu, Jiyong; Peng, Tao; Hoffmann, Jules A.; Meignin, Carine; Daeffler, Laurent; Imler, Jean-Luc			The Kinase IKK beta Regulates a STING- and NF-kappa B-Dependent Antiviral Response Pathway in Drosophila	IMMUNITY			English	Article							INNATE IMMUNE-RESPONSE; CYTOSOLIC DNA SENSOR; HOST-DEFENSE; IMD PATHWAY; VIRUS; GENES; CGAS; SPECIFICITY; RECOGNITION; ACTIVATION	Antiviral immunity in Drosophila involves RNA interference and poorly characterized inducible responses. Here, we showed that two components of the IMD pathway, the kinase dIKK beta and the transcription factor Relish, were required to control infection by two picorna-like viruses. We identified a set of genes induced by viral infection and regulated by dIKK beta and Relish, which included an ortholog of STING. We showed that dSTING participated in the control of infection by picorna-like viruses, acting upstream of dIKK beta to regulate expression of Nazo, an antiviral factor. Our data reveal an antiviral function for STING in an animal model devoid of interferons and suggest an evolutionarily ancient role for this molecule in antiviral immunity.	[Goto, Akira; Okado, Kiyoshi; Martins, Nelson; Cai, Hua; Barbier, Vincent; Lamiable, Olivier; Troxler, Laurent; Santiago, Estelle; Hoffmann, Jules A.; Meignin, Carine; Daeffler, Laurent; Imler, Jean-Luc] Univ Strasbourg, CNRS, Insect Models Innate Immun M3I, UPR9022, F-67084 Strasbourg, France; [Kuhn, Lauriane] Univ Strasbourg, CNRS, Plateforme Prote Strasbourg Esplanade, F-67000 Strasbourg, France; [Goto, Akira; Martins, Nelson; Cai, Hua; Liu, Jiyong; Peng, Tao; Hoffmann, Jules A.; Imler, Jean-Luc] Guangzhou Med Univ, Sino French Hoffmann Inst, Sch Basic Med Sci, Guangzhou 511436, Guangdong, Peoples R China; [Paik, Donggi; Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Holleufer, Andreas; Hartmann, Rune] Aarhus Univ, Struct Biol Ctr, DK-8000 Aarhus C, Denmark; [Hoffmann, Jules A.] Univ Strasbourg, Inst Adv Study, F-67000 Strasbourg, France; [Okado, Kiyoshi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Guangzhou Medical University; University of Massachusetts System; University of Massachusetts Worcester; Aarhus University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Obihiro University of Agriculture & Veterinary Medicine	Goto, A; Imler, JL (corresponding author), Univ Strasbourg, CNRS, Insect Models Innate Immun M3I, UPR9022, F-67084 Strasbourg, France.; Goto, A; Imler, JL (corresponding author), Guangzhou Med Univ, Sino French Hoffmann Inst, Sch Basic Med Sci, Guangzhou 511436, Guangdong, Peoples R China.	goto@unistra.fr; jl.imler@unistra.fr	Martins, Nelson/L-7143-2013; GOTO, Akira/V-7847-2017; Daeffler, Laurent/M-8914-2017; Imler, Jean-Luc/GXH-4323-2022; Daeffler, Laurent/S-6395-2019	Martins, Nelson/0000-0002-3923-2998; GOTO, Akira/0000-0003-3395-484X; Peng, Tao/0000-0001-5260-7128; OKADO, Kiyoshi/0000-0002-2898-465X; Paik, Donggi/0000-0003-1031-0371; Meignin, Carine/0000-0002-6588-9045; Holleufer, Andreas/0000-0002-1313-2016; Hartmann, Rune/0000-0003-1159-066X; Daeffler, laurent/0000-0001-5871-5082; Kuhn, Lauriane/0000-0002-2637-1024; Lamiable, Olivier/0000-0001-7571-9253	National Institutes of Health [PO1 AI070167]; Agence Nationale de la Recherche [ANR-13-BSV3-0009, ANR-17-CE15-0014]; Balzan Foundation; Investissement d'Avenir Programs [ANR-10-LABX-0036, ANR-11-EQPX-0022]; Sino-French Hoffmann Institute; CNRS; INSERM; Marie Sklodowska Curie fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167, R01AI060025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Balzan Foundation; Investissement d'Avenir Programs(French National Research Agency (ANR)); Sino-French Hoffmann Institute; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Marie Sklodowska Curie fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Ms. A. Courtin for excellent technical assistance, P. Hamman and J. Chicher for dSTING proteomic approach, and L. Coquet and T. Jouenne for Edman degradation sequencing. Microarray analyses were performed by the IGBMC Microarray and Sequencing platform, a member of the "France Genomique'' consortium (ANR-10-INBS-0009). This work was supported by the National Institutes of Health (PO1 AI070167), the Agence Nationale de la Recherche (ANR-13-BSV3-0009 and ANR-17-CE15-0014), the Balzan Foundation (to J.A.H.), the Investissement d'Avenir Programs (ANR-10-LABX-0036 and ANR-11-EQPX-0022), the Sino-French Hoffmann Institute, CNRS, and INSERM. N.M. was supported by a Marie Sklodowska Curie fellowship.	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Balasov M, 2009, P NATL ACAD SCI USA, V106, P10672, DOI 10.1073/pnas.0902670106; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chtarbanova S, 2014, J VIROL, V88, P14057, DOI 10.1128/JVI.02320-14; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Franz KM, 2018, P NATL ACAD SCI USA, V115, pE2058, DOI 10.1073/pnas.1716937115; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ji YB, 2016, J IMMUNOL, V197, P2382, DOI 10.4049/jimmunol.1600994; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kim CH, 2014, J BIOL CHEM, V289, P20092, DOI 10.1074/jbc.M113.544841; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Lamiable O, 2016, P NATL ACAD SCI USA, V113, P698, DOI 10.1073/pnas.1516122113; Lamiable O, 2014, CURR OPIN MICROBIOL, V20, P62, DOI 10.1016/j.mib.2014.05.006; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Marques JT, 2016, CURR OPIN MICROBIOL, V32, P71, DOI 10.1016/j.mib.2016.05.002; Merkling SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12758; Merkling SH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004692; Morris O, 2016, CELL HOST MICROBE, V20, P283, DOI 10.1016/j.chom.2016.08.003; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paro S, 2015, CURR OPIN IMMUNOL, V32, P106, DOI 10.1016/j.coi.2015.01.009; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; tenOever BR, 2016, CELL HOST MICROBE, V19, P142, DOI 10.1016/j.chom.2016.01.006; Tusco R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01287-9; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu XM, 2014, NUCLEIC ACIDS RES, V42, P8243, DOI 10.1093/nar/gku569; Xu J, 2012, CELL HOST MICROBE, V12, P531, DOI 10.1016/j.chom.2012.08.011; Zaghloul HAH, 2017, J VIROL, V91, DOI [10.1128/JVI.00874-17, 10.1128/jvi.00874-17]; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	58	67	76	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					225	+		10.1016/j.immuni.2018.07.013	http://dx.doi.org/10.1016/j.immuni.2018.07.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30119996	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000442354500009
J	Manda, P; Feng, YJ; Lyons, JD; Berger, SB; Otani, S; DeLaney, A; Tharp, GK; Maner-Smith, K; Burd, EM; Schaeffer, M; Hoffman, S; Capriotti, C; Roback, L; Young, CB; Liang, Z; Ortlund, EA; DiPaolo, NC; Bosinger, S; Bertin, J; Gough, PJ; Brodsky, IE; Coopersmith, CM; Shayakhmetov, DM; Mocarski, ES				Manda, Pratyusha; Feng, Yanjun; Lyons, John D.; Berger, Scott B.; Otani, Shunsuke; DeLaney, Alexandra; Tharp, Gregory K.; Maner-Smith, Kristal; Burd, Eileen M.; Schaeffer, Michelle; Hoffman, Sandra; Capriotti, Carol; Roback, Linda; Young, Cedrick B.; Liang, Zhe; Ortlund, Eric A.; DiPaolo, Nelson C.; Bosinger, Steven; Bertin, John; Gough, Peter J.; Brodsky, Igor E.; Coopersmith, Craig M.; Shayakhmetov, Dmitry M.; Mocarski, Edward S.			Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic Shock	IMMUNITY			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; APOPTOTIC CELL-DEATH; I INTERFERONS; MOUSE MODELS; RIPK3; ROLES; EXPRESSION; RECEPTORS; NECROSIS; PROMOTES	The execution of shock following high dose E. coli lipopolysaccharide (LPS) or bacterial sepsis in mice required pro-apoptotic caspase-8 in addition to pro-pyroptotic caspase-11 and gasdermin D. Hematopoietic cells produced MyD88- and TRIF-dependent inflammatory cytokines sufficient to initiate shock without any contribution from cas pase-8 or caspase-11. Both proteases had to be present to support tumor necrosis factor- and interferon-beta-dependent tissue injury first observed in the small intestine and later in spleen and thymus. Caspase-11 enhanced the activation of caspase-8 and extrinsic cell death machinery within the lower small intestine. Neither caspase-8 nor caspase-11 was individually sufficient for shock. Both caspases collaborated to amplify inflammatory signals associated with tissue damage. Therefore, combined pyroptotic and apoptotic signaling mediated endotoxemia independently of RIPK1 kinase activity and RIPK3 function. These observations bring to light the relevance of tissue compartmentalization to disease processes in vivo where cytokines act in parallel to execute diverse cell death pathways.	[Manda, Pratyusha; Feng, Yanjun; Roback, Linda; Mocarski, Edward S.] Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Lyons, John D.; Otani, Shunsuke; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Emory Crit Care Ctr, Atlanta, GA 30322 USA; [Berger, Scott B.; Schaeffer, Michelle; Hoffman, Sandra; Bertin, John; Gough, Peter J.] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA 19426 USA; [Berger, Scott B.; Hoffman, Sandra; Capriotti, Carol; Gough, Peter J.] GlaxoSmithKline, Host Def Discovery Performance Unit, Infect Dis Therapeut Area, Collegeville, PA 19426 USA; [DeLaney, Alexandra; Brodsky, Igor E.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Tharp, Gregory K.; Bosinger, Steven] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Maner-Smith, Kristal; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Burd, Eileen M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Young, Cedrick B.; DiPaolo, Nelson C.; Shayakhmetov, Dmitry M.] Emory Univ, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; GlaxoSmithKline; GlaxoSmithKline; University of Pennsylvania; Emory University; Emory University; Emory University; Emory University	Mocarski, ES (corresponding author), Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA.	pmanda2@emory.edu; mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020; Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Maner-Smith, Kristal/0000-0002-2274-4284	NIH (PHS) [R01 GM112547, R01 AI118853, RO1 GM072808, T32 GM095442, F32 GM117895, R01 AI065429, R01 AI107960, R01 AI123126]; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126816, R01AI020211, R01AI128530, R01AI118853, R01AI065429, R01AI107960, R01AI123126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, F32GM117895, T32GM095442, R01GM112547] Funding Source: NIH RePORTER	NIH (PHS)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this manuscript to the memory of Stanley Falkow, who, as the father of pathogen-host interactions, enriched the scientific lives of everyone with whom he interacted. We thank Vishva Dixit and Kim Newton (Genentech, LLC) for helpful discussions and for providing Ripk3<SUP>-/-</SUP>, Casp11<SUP>-/-</SUP> and Asc<SUP>-/-</SUP> mice, as well as Alan Aderem (Institute for Systems Biology) for Irf3<SUP>-/-</SUP> mice and Michael Diamond (Washington University) for Ifnar1<SUP>-/-</SUP> mice. We thank Nobuhiko Kayagaki (Genentech, LLC) for bones from Gsdmd<SUP>-/-</SUP> mice. At Emory University, we thank Samuel Speck for Ifnar1<SUP>-/-</SUP> and Ifngr<SUP>-/-</SUP> mice and Bali Pulendran for Myd88<SUP>-/-</SUP> and Trif<SUP>-/-</SUP> mice. At the Yerkes National Primate Research Center, we thank Evan Dessasau and AnaPatricia Garcia for histopathology as well as Tershel Batchelor and Nirav Patel for processing RNA from tissues. Supported by NIH (PHS grants R01 GM112547 and R01 AI118853 to E.S.M., RO1 GM072808 to C.M.C., T32 GM095442 and F32 GM117895 to J.D.L., R01 AI065429 and R01 AI107960 to D.M.S. and R01 AI123126 to N.C.D.P.) and by GlaxoSmithKline (S.B.B., M.S., S.H., C.C., P.J.G. and J.B.).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570; Berger S. B., 2015, CELL DEATH DIS, V1, P15001; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Daley-Bauer LP, 2012, IMMUNITY, V37, P122, DOI 10.1016/j.immuni.2012.04.014; Filliol A, 2017, J HEPATOL, V66, P1205, DOI 10.1016/j.jhep.2017.01.005; Gomez-Hurtado I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023037; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hurley JC, 2015, J CLIN MICROBIOL, V53, P1183, DOI 10.1128/JCM.03531-14; Itoi S, 2009, J APPL MICROBIOL, V107, P867, DOI 10.1111/j.1365-2672.2009.04266.x; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101828; Linkermann A, 2016, KIDNEY INT, V89, P46, DOI 10.1016/j.kint.2015.10.008; Man SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45126; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; O'Flaherty BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135719; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Peterson LW, 2017, J EXP MED, V214, P3171, DOI 10.1084/jem.20170347; Philip NH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005910; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Saleh D, 2017, CURR TOP MICROBIOL, V403, P37, DOI 10.1007/82_2015_449; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Vanden Berghe T, 2014, AM J RESP CRIT CARE, V189, P282, DOI 10.1164/rccm.201308-1535OC; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoseph BP, 2016, SHOCK, V46, P52, DOI 10.1097/SHK.0000000000000565	67	67	69	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					42	+		10.1016/j.immuni.2018.06.011	http://dx.doi.org/10.1016/j.immuni.2018.06.011			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021146	Green Accepted, Bronze			2022-12-18	WOS:000438949100010
J	Martinez-Murillo, P; Tran, K; Guenaga, J; Lindgren, G; Adori, M; Feng, Y; Phad, GE; Bernat, NV; Bale, S; Ingale, J; Dubrovskaya, V; O'Dell, S; Pramanik, L; Spangberg, M; Corcoran, M; Lore, K; Mascola, JR; Wyatt, RT; Hedestam, GBK				Martinez-Murillo, Paola; Tran, Karen; Guenaga, Javier; Lindgren, Gustaf; Adori, Monika; Feng, Yu; Phad, Ganesh E.; Bernat, Nestor Vazquez; Bale, Shridhar; Ingale, Jidnyasa; Dubrovskaya, Viktoriya; O'Dell, Sijy; Pramanik, Lotta; Spangberg, Mats; Corcoran, Martin; Lore, Karin; Mascola, John R.; Wyatt, Richard T.; Hedestam, Gunilla B. Karlsson			Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach	IMMUNITY			English	Article							IG KNOCKIN MICE; BINDING-SITE; VACCINE DESIGN; B-CELLS; ENVELOPE; IMMUNIZATION; RESPONSES; RECEPTOR; REDESIGN; FEATURES	The development of soluble envelope glycoprotein (Env) mimetics displaying ordered trimeric symmetry has ushered in a new era in HIV-1 vaccination. The recently reported native, flexibly linked (NFL) design allows the generation of native-like trimers from clinical isolates at high yields and homogeneity. As the majority of infections world-wide are of the clade C subtype, we examined responses in non-human primates to well-ordered subtype C 16055 trimers administered in soluble or high-density liposomal formats. We detected superior germinal center formation and enhanced autologous neutralizing antibodies against the neutralization-resistant (tier 2) 16055 virus following inoculation of liposome-arrayed trimers. Epitope mapping of the neutralizing monoclonal antibodies (mAbs) indicated major contacts with the V2 apex, and 3D electron microscopy reconstructions of Fab-trimer complexes revealed a horizontal binding angle to the Env spike. These vaccine-elicited mAbs target the V2 cap, demonstrating a means to accomplish tier 2 virus neutralization by penetrating the dense N-glycan shield.	[Martinez-Murillo, Paola; Adori, Monika; Phad, Ganesh E.; Bernat, Nestor Vazquez; Pramanik, Lotta; Corcoran, Martin; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Tran, Karen; Guenaga, Javier; Feng, Yu; Bale, Shridhar; Ingale, Jidnyasa; Dubrovskaya, Viktoriya; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbiol, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Lindgren, Gustaf; Lore, Karin] Karolinska Inst, Dept Med, Immunol & Allergy Unit, S-17177 Solna, Sweden; [O'Dell, Sijy; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Spangberg, Mats] Karolinska Inst, Astrid Fagraeus Lab, Comparat Med, SE-17177 Stockholm, Sweden	Karolinska Institutet; International AIDS Vaccine Initiative; Scripps Research Institute; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet	Hedestam, GBK (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden.; Wyatt, RT (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.	wyatt@scripps.edu; gunilla.karlsson.hedestam@ki.se	Mascola, John/AAI-7193-2021; Hedestam, Gunilla Karlsson/AAN-9616-2021	Martinez Murillo, Paola Andrea/0000-0003-0888-3867	NIH [AI104722]; intramural research program of the Vaccine Research Center, NIAID, NIH; Scripps CHAVI-ID grant [AI100663]; IAVI Neutralizing Antibody Consortium; Bill and Melinda Gates Foundation CAVD; USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI104722, UM1AI100663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural research program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Scripps CHAVI-ID grant; IAVI Neutralizing Antibody Consortium; Bill and Melinda Gates Foundation CAVD; USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Bengt Eriksson and all personnel at Astrid Fagraeus laboratory for expert assistance with rhesus macaques and Richard Wilson and Barbara Lemaire for assistance with protein production. We also thank Novavax, AB, for making the Matrix-M adjuvant available and Christina Corbaci for help with the graphical abstract. EM analysis of the trimer-conjugated liposomes was performed at the TSRI Microscopy Core with assistance from Malcom Wood and Theresa Fassel. EM imaging of Fab:trimer complexes and 3D reconstructions were performed by NanoImaging Services. This work was funded by an NIH P01 grant AI104722 (HIVRAD), the intramural research program of the Vaccine Research Center, NIAID, NIH, the Scripps CHAVI-ID grant AI100663 (R.T.W.), grants for doctoral education to P.M.-M., G.L., and G.E.P., and from the IAVI Neutralizing Antibody Consortium (R.T.W. and G.K.H.) and its generous donors, including the Bill and Melinda Gates Foundation CAVD and USAID. The full list of IAVI donors can be found at www.iavi.org.	Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Guenaga J, 2017, IMMUNITY, V46, P792, DOI 10.1016/j.immuni.2017.04.014; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hedestam GBK, 2017, IMMUNOL REV, V275, P183, DOI 10.1111/imr.12515; Ingale J, 2016, CELL REP, V15, P1986, DOI 10.1016/j.celrep.2016.04.078; Ingale J, 2014, J VIROL, V88, P14002, DOI 10.1128/JVI.02614-14; Jiang XQ, 2016, J VIROL, V90, P11007, DOI 10.1128/JVI.01409-16; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Klausen MS, 2015, NUCLEIC ACIDS RES, V43, pW349, DOI 10.1093/nar/gkv535; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Navis M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004337; Phad GE, 2015, J IMMUNOL, V194, P5903, DOI 10.4049/jimmunol.1500122; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Sundling C., 2012, SCI TRANSL MED, V4; Sundling C, 2012, J IMMUNOL METHODS, V386, P85, DOI 10.1016/j.jim.2012.09.003; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	48	67	69	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					804	+		10.1016/j.immuni.2017.04.021	http://dx.doi.org/10.1016/j.immuni.2017.04.021			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514687	Green Accepted, Bronze			2022-12-18	WOS:000401316300016
J	Yang, HY; Barbi, J; Wu, CY; Zheng, Y; Vignali, PDA; Wu, XM; Tao, JH; Park, BV; Bandara, S; Novack, L; Ni, XH; Yang, XP; Chang, KY; Wu, RC; Zhang, JR; Yang, CW; Pardoll, DM; Li, HB; Pan, F				Yang, Huang-Yu; Barbi, Joseph; Wu, Chao-Yi; Zheng, Ying; Vignali, Paolo D. A.; Wu, Xingmei; Tao, Jin-Hui; Park, Benjamin V.; Bandara, Shashika; Novack, Lewis; Ni, Xuhao; Yang, Xiaoping; Chang, Kwang-Yu; Wu, Ren-Chin; Zhang, Junran; Yang, Chih-Wei; Pardoll, Drew M.; Li, Huabin; Pan, Fan			MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor	IMMUNITY			English	Article							TGF-BETA; CUTTING EDGE; MALIGNANT-LYMPHOMA; TH1 RESPONSES; IMMUNE-SYSTEM; EXPRESSION; IL-6; DIFFERENTIATION; PLASTICITY; T(H)17	Regulatory T (Treg) cells are important in maintaining self-tolerance and immune homeostasis. The Treg cell transcription factor Foxp3 works in concert with other co-regulatory molecules, including Eos, to determine the transcriptional signature and characteristic suppressive phenotype of Treg cells. Here, we report that the inflammatory cytokine interleukin-6 (IL-6) actively repressed Eos expression through microRNA-17 (miR-17). miR-17 expression increased in Treg cells in the presence of IL-6, and its expression negatively correlated with that of Eos. Treg cell suppressive activity was diminished upon overexpression of miR-17 in vitro and in vivo, which was mitigated upon co-expression of an Eos mutant lacking miR-17 target sites. Also, RNAi of miR-17 resulted in enhanced suppressive activity. Ectopic expression of miR-17 imparted effector-T-cell-like characteristics to Treg cells via the derepression of genes encoding effector cytokines. Thus, miR-17 provides a potent layer of Treg cell control through targeting Eos and additional Foxp3 co-regulators.	[Yang, Huang-Yu; Barbi, Joseph; Wu, Chao-Yi; Zheng, Ying; Vignali, Paolo D. A.; Wu, Xingmei; Tao, Jin-Hui; Park, Benjamin V.; Bandara, Shashika; Novack, Lewis; Ni, Xuhao; Yang, Xiaoping; Chang, Kwang-Yu; Pardoll, Drew M.; Pan, Fan] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr,Dept Oncol, Bloomberg Kimmel Inst,Immunol & Hematopoiesis Div, Baltimore, MD 21287 USA; [Yang, Huang-Yu; Yang, Chih-Wei] Chang Gung Univ, Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Kidney Res Ctr,Dept Nephrol,Coll Med, Taoyuan 333, Taiwan; [Barbi, Joseph] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Wu, Chao-Yi] Chang Gung Univ, Chang Gung Mem Hosp, Div Allergy Asthma & Rheumatol, Dept Pediat,Coll Med, Taoyuan 333, Taiwan; [Zheng, Ying; Wu, Xingmei; Li, Huabin] Shanghai Jiao Tong Univ, Shanghai Key Lab Translat Med Ear & Nose Dis, Dept Otolaryngol, Xinhua Hosp,Sch Med, Shanghai 200092, Peoples R China; [Chang, Kwang-Yu] Natl Inst Canc Res, NIH, Tainan 70456, Taiwan; [Wu, Ren-Chin] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pathol, Taoyuan 333, Taiwan; [Zhang, Junran] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins Medicine; Chang Gung Memorial Hospital; Chang Gung University; Roswell Park Cancer Institute; Chang Gung Memorial Hospital; Chang Gung University; Shanghai Jiao Tong University; Chang Gung Memorial Hospital; Chang Gung University; Case Western Reserve University	Pan, F (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr,Dept Oncol, Bloomberg Kimmel Inst,Immunol & Hematopoiesis Div, Baltimore, MD 21287 USA.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Translat Med Ear & Nose Dis, Dept Otolaryngol, Xinhua Hosp,Sch Med, Shanghai 200092, Peoples R China.	allergyli@163.com; fpan1@jhmi.edu	tao, jinhui/AAA-8818-2020	Novack, Lewis/0000-0001-7508-1720; Bandara, Shashika/0000-0002-1698-138X; Ni, Xuhao/0000-0003-1550-8408; YANG, HUANG-YU/0000-0001-6826-9717; Wu, Ren-Chin/0000-0003-1439-0874; Vignali, Paolo/0000-0002-0214-8629	Bloomberg-Kimmel Institute; Melanoma Research Alliance; NIH [RO1AI099300, RO1AI089830, P30CA006873]; National Natural Science Foundations of China [81271054, 81470673]; Shanghai Committee of Science and Technology [14DZ2260300]; Chang Gung Memorial Hospital [CMRPG3D0551]; Ministry of Science and Technology in Taiwan [104-2314-B-182A-110]; "Kelly's Dream" Foundation; Janey Fund; Seraph Foundation; CCFA Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA154625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089830, R01AI099300, T32AI007247] Funding Source: NIH RePORTER	Bloomberg-Kimmel Institute; Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); "Kelly's Dream" Foundation; Janey Fund; Seraph Foundation; CCFA Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Our research was supported by grants from the Bloomberg-Kimmel Institute, the Melanoma Research Alliance, the NIH (RO1AI099300, RO1AI089830, and P30CA006873), the National Natural Science Foundations of China (81271054 and 81470673), the Shanghai Committee of Science and Technology (14DZ2260300), Chang Gung Memorial Hospital (CMRPG3D0551), the Ministry of Science and Technology in Taiwan (104-2314-B-182A-110), "Kelly's Dream" Foundation, the Janey Fund, the Seraph Foundation, and gifts from Bill and Betty Topecer and Dorothy Needle. F.P. is a Stewart Trust Scholar, and J.B. was supported by a CCFA Research Fellowship. We are grateful to Dr. Yu, Alice Lin-Tsing, Dr. Ya-Hui Wang, and Dr. Chun-Yen Lin (Chang Gung Memorial Hospital) for contributing reagents and mice.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gao ZM, 2012, INT J CLIN EXP PATHO, V5, P626; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kretschmer Karsten, 2008, V94, P8, DOI 10.1159/000154846; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lindberg RLP, 2010, EUR J IMMUNOL, V40, P888, DOI 10.1002/eji.200940032; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wu YX, 2015, BLOOD, V126, P1314, DOI 10.1182/blood-2015-02-627356; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	53	67	72	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					83	93		10.1016/j.immuni.2016.06.022	http://dx.doi.org/10.1016/j.immuni.2016.06.022			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438767	Green Accepted, Bronze			2022-12-18	WOS:000380749000012
J	Lee, MS; Glassman, CR; Deshpande, NR; Badgandi, HB; Parrish, HL; Uttamapinant, C; Stawski, PS; Ting, AY; Kuhns, MS				Lee, Mark S.; Glassman, Caleb R.; Deshpande, Neha R.; Badgandi, Hemant B.; Parrish, Heather L.; Uttamapinant, Chayasith; Stawski, Philipp S.; Ting, Alice Y.; Kuhns, Michael S.			A Mechanical Switch Couples T Cell Receptor Triggering to the Cytoplasmic Juxtamembrane Regions of CD3 zeta zeta	IMMUNITY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ERYTHROPOIETIN RECEPTOR; ANTIGEN RECEPTOR; SURFACE EXPRESSION; MEMBRANE-BINDING; LIVING CELLS; TCR; ACTIVATION; COMPLEX; DOMAIN	The eight-subunit T cell receptor (TCR)-CD3 complex is the primary determinant for T cell fate decisions. Yet how it relays ligand-specific information across the cell membrane for conversion to chemical signals remains unresolved. We hypothesized that TCR engagement triggers a change in the spatial relationship between the associated CD3 zeta zeta subunits at the junction where they emerge from the membrane into the cytoplasm. Using three in situ proximity assays based on ID-PRIME, FRET, and EPOR activity, we determined that the cytosolic juxtamembrane regions of the CD3 zeta zeta subunits are spread apart upon assembly into the TCR-CD3 complex. TCR engagement then triggered their apposition. This mechanical switch resides upstream of the CD3 zeta zeta intracellular motifs that initiate chemical signaling, as well as the polybasic stretches that regulate signal potentiation. These findings provide a framework from which to examine triggering events for activating immune receptors and other complex molecular machines.	[Lee, Mark S.; Glassman, Caleb R.; Deshpande, Neha R.; Badgandi, Hemant B.; Parrish, Heather L.; Kuhns, Michael S.] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA; [Deshpande, Neha R.; Kuhns, Michael S.] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85724 USA; [Uttamapinant, Chayasith; Stawski, Philipp S.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02138 USA; [Kuhns, Michael S.] Univ Arizona, Coll Med, Inst BIO5, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Massachusetts Institute of Technology (MIT); University of Arizona	Kuhns, MS (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA.	mkuhns@u.arizona.edu		Badgandi, Hemant/0000-0001-6181-4241; Erdmann, Philipp/0000-0001-8289-9133	Pew Charitable Trusts; NIH [5R01CA186568]; University of Arizona College of Medicine; Bio5 Institute; NIH/NIAID [1R01AI101053]; NATIONAL CANCER INSTITUTE [R01CA186568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101053] Funding Source: NIH RePORTER	Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona College of Medicine; Bio5 Institute; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jackson Egen, Felicia Goodrum, Matthew Krummel, Evan Newell, and Dominik Schenten for critical feedback on the manuscript, as well as Mark M. Davis, Yueh-Hsiu Chien, and K. Christopher Garcia for thoughtful comments and valuable reagents. We also thank Bentley Fane, Jeff Frelinger, Kurt Griffin, Anita Koshy, Lonnie Lybarger, Maggie So, and members of the Frelinger, M.S.K., and Wu labs for feedback. M.S.K. is a Pew Scholar in Biomedical Sciences, supported by The Pew Charitable Trusts. This work was also supported by NIH 5R01CA186568 (A.Y.T.), The University of Arizona College of Medicine (M.S.K.), the Bio5 Institute (M.S.K.), and NIH/NIAID 1R01AI101053 (M.S.K.).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9; Fernandes RA, 2012, J BIOL CHEM, V287, P13324, DOI 10.1074/jbc.M111.332783; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Guy CS, 2009, IMMUNOL REV, V232, P7, DOI 10.1111/j.1600-065X.2009.00843.x; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Lauritsen JPH, 1998, J IMMUNOL, V161, P260; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Slavoff SA, 2011, J AM CHEM SOC, V133, P19769, DOI 10.1021/ja206435e; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Uttamapinant C, 2013, NAT PROTOC, V8, P1620, DOI 10.1038/nprot.2013.096; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Yang MM, 1997, BIOTECHNOLOGY, V3, P1; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zal T, 2004, CURR OPIN IMMUNOL, V16, P418, DOI 10.1016/j.coi.2004.05.019; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	47	67	68	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					227	239		10.1016/j.immuni.2015.06.018	http://dx.doi.org/10.1016/j.immuni.2015.06.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26231119	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000360101200007
J	Kwak, HJ; Liu, P; Bajrami, B; Xu, YF; Park, SY; Nombela-Arrieta, C; Mondal, S; Sun, Y; Zhu, HY; Chai, L; Silberstein, LE; Cheng, T; Luo, HR				Kwak, Hyun-Jeong; Liu, Peng; Bajrami, Besnik; Xu, Yuanfu; Park, Shin-Young; Nombela-Arrieta, Cesar; Mondal, Subhanjan; Sun, Yan; Zhu, Haiyan; Chai, Li; Silberstein, Leslie E.; Cheng, Tao; Luo, Hongbo R.			Myeloid Cell-Derived Reactive Oxygen Species Externally Regulate the Proliferation of Myeloid Progenitors in Emergency Granulopoiesis	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR PTEN; G-CSF; T-CELL; GM-CSF; REDOX REGULATION; MICE LACKING; B-CELL; INACTIVATION; INFLAMMATION	The cellular mechanisms controlling infection-induced emergency granulopoiesis are poorly defined. Here we found that reactive oxygen species (ROS) concentrations in the bone marrow (BM) were elevated during acute infection in a phagocytic NADPH oxidase-dependent manner in myeloid cells. Gr1(+) myeloid cells were uniformly distributed in the BM, and all c-kit(+) progenitor cells were adjacent to Gr1(+) myeloid cells. Inflammation-induced ROS production in the BM played a critical role in myeloid progenitor expansion during emergency granulopoiesis. ROS elicited oxidation and deactivation of phosphatase and tensin homolog (PTEN), resulting in upregulation of PtdIns(3,4,5)P3 signaling in BM myeloid progenitors. We further revealed that BM myeloid cell-produced ROS stimulated proliferation of myeloid progenitors via a paracrine mechanism. Taken together, our results establish that phagocytic NADPH oxidase-mediated ROS production by BM myeloid cells plays a critical role in mediating emergency granulopoiesis during acute infection.	[Kwak, Hyun-Jeong; Bajrami, Besnik; Park, Shin-Young; Mondal, Subhanjan; Sun, Yan; Silberstein, Leslie E.; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol,Dept Lab Med, Childrens Hosp Boston,Dana Farber Harvard Cancer, Boston, MA 02115 USA; [Liu, Peng; Xu, Yuanfu; Zhu, Haiyan; Cheng, Tao] Chinese Acad Med Sci, Blood Dis Hosp, Ctr Stem Cell Med, Inst Hematol,State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Liu, Peng; Xu, Yuanfu; Zhu, Haiyan; Cheng, Tao] Chinese Acad Med Sci, Blood Dis Hosp, Ctr Stem Cell Med, Tianjin 300020, Peoples R China; [Liu, Peng; Xu, Yuanfu; Zhu, Haiyan; Cheng, Tao] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Nombela-Arrieta, Cesar] Univ Zurich Hosp, Dept Expt Hematol, CH-8091 Zurich, Switzerland; [Chai, Li] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Joint Program Transfus Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Zurich; University Zurich Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Luo, HR (corresponding author), Harvard Univ, Sch Med, Dept Pathol,Dept Lab Med, Childrens Hosp Boston,Dana Farber Harvard Cancer, Boston, MA 02115 USA.	hongbo.luo@childrens.harvard.edu	zhu, xueqiong/U-1320-2019	Cheng, Tao/0000-0002-5925-2769; Chai, Li/0000-0003-1937-4750; Nombela-Arrieta, Cesar/0000-0003-0415-259X; Park, Shin-Young/0000-0001-6385-4132	Ministry of Science and Technology of China [2011CB964801]; Nature Science Foundation of China [81090411, 81421002]; National Basic Research Program of China [2012CB966403]; Chinese National Natural Sciences Foundation [31271484, 31471116]; Tianjin Natural Science Foundation [12JCZDJC24600]; NIH [R01AI103142, R01HL092020, P01 HL095489]; FAMRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092020, P01HL095489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103142] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank J. Lucky and J. Manis for helpful discussions. T. C. is supported by the grants from the Ministry of Science and Technology of China (2011CB964801) and from the Nature Science Foundation of China (81090411 and 81421002). Y.X. is supported by the grants from National Basic Research Program of China (2012CB966403) and Chinese National Natural Sciences Foundation (31271484 and 31471116) and Tianjin Natural Science Foundation (12JCZDJC24600). H. R. L. is supported by NIH grants R01AI103142, R01HL092020, and P01 HL095489 and a grant from the FAMRI.	Basu S, 2000, BLOOD, V95, P3725; Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778; Boettcher S, 2014, BLOOD, V124, P1393, DOI 10.1182/blood-2014-04-570762; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; CARACCIOLO D, 1989, BLOOD, V73, P666; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Covey TM, 2007, ONCOGENE, V26, P5784, DOI 10.1038/sj.onc.1210391; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; DONAHUE RE, 1988, SCIENCE, V241, P1820, DOI 10.1126/science.3051378; Gupta R, 2006, BLOOD, V107, P1837, DOI 10.1182/blood-2005-03-1180; Haneline LS, 2008, ANTIOXID REDOX SIGN, V10, P1849, DOI 10.1089/ars.2008.2141; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Henderson LM, 1996, BBA-BIOENERGETICS, V1273, P87, DOI 10.1016/0005-2728(95)00140-9; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hibbs ML, 2007, J IMMUNOL, V178, P6435, DOI 10.4049/jimmunol.178.10.6435; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; KOIKE K, 1986, BLOOD, V67, P859; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nishinakamura R, 1996, BLOOD, V88, P2458, DOI 10.1182/blood.V88.7.2458.bloodjournal8872458; Okkenhaug K, 2003, BIOCHEM SOC T, V31, P270, DOI 10.1042/bst0310270; Okkenhaug K, 2002, SCIENCE, V297, P1031; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Subramanian K.K., 2009, GRANULOCYTES CLASSIF; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Tesio M, 2013, J EXP MED, V210, P2337, DOI 10.1084/jem.20122768; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Walker F, 2008, BLOOD, V111, P3978, DOI 10.1182/blood-2007-10-119636; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612	57	67	71	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					159	171		10.1016/j.immuni.2014.12.017	http://dx.doi.org/10.1016/j.immuni.2014.12.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25579427	Green Accepted, Bronze			2022-12-18	WOS:000348197500019
J	Eckert, JK; Kim, YJ; Kim, JI; Gurtler, K; Oh, DY; Sur, S; Lundvall, L; Hamann, L; van der Ploeg, A; Pickkers, P; Giamarellos-Bourboulis, E; Kubarenko, AV; Weber, AN; Kabesch, M; Kumpf, O; An, HJ; Lee, JO; Schumann, RR				Eckert, Jana K.; Kim, Young J.; Kim, Jung I.; Guertler, Kathleen; Oh, Djin-Ye; Sur, Saubashya; Lundvall, Linn; Hamann, Lutz; van der Ploeg, Anke; Pickkers, Peter; Giamarellos-Bourboulis, Evangelos; Kubarenko, Andriy V.; Weber, Alexander N.; Kabesch, Michael; Kumpf, Oliver; An, Hyun-Jung; Lee, Jie-Oh; Schumann, Ralf R.			The Crystal Structure of Lipopolysaccharide Binding Protein Reveals the Location of a Frequent Mutation that Impairs Innate Immunity	IMMUNITY			English	Article							BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; (LPS)-BINDING PROTEIN; CELL ACTIVATION; GENE POLYMORPHISMS; SEVERE SEPSIS; IN-VIVO; LPS; PHASE; MICE; RECOGNITION	Lipopolysaccharide (LPS) binding protein (LBP) is an acute-phase protein that initiates an immune response after recognition of bacterial LPS. Here, we report the crystal structure of murine LBP at 2.9 angstrom resolution. Several structural differences were observed between LBP and the related bactericidal/permeability-increasing protein (BPI), and the LBP C-terminal domain contained a negatively charged groove and a hydrophobic "phenylalanine core." A frequent human LBP SNP (allelic frequency 0.08) affected this region, potentially generating a proteinase cleavage site. The mutant protein had a reduced binding capacity for LPS and lipopeptides. SNP carriers displayed a reduced cytokine response after in vivo LPS exposure and lower cytokine concentrations in pneumonia. In a retrospective trial, the LBP SNP was associated with increased mortality rates during sepsis and pneumonia. Thus, the structural integrity of LBP may be crucial for fighting infections efficiently, and future patient stratification might help to develop better therapeutic strategies.	[Eckert, Jana K.; Guertler, Kathleen; Oh, Djin-Ye; Sur, Saubashya; Lundvall, Linn; Hamann, Lutz; Schumann, Ralf R.] Charite, Inst Microbiol & Hyg, D-10117 Berlin, Germany; [Kim, Young J.; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [van der Ploeg, Anke] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HC Nijmegen, Netherlands; [Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6500 HC Nijmegen, Netherlands; [Giamarellos-Bourboulis, Evangelos] Univ Athens, Sch Med, Dept Internal Med 4, Athens 12462, Greece; [Kubarenko, Andriy V.; Weber, Alexander N.] German Canc Res Ctr, Jr Grp TLRs & Canc, D-69120 Heidelberg, Germany; [Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, D-93042 Regensburg, Germany; [Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Kumpf, Oliver] Charite Univ Med Berlin, Dept Anesthesiol & Intens Care Med, Berlin, Germany; [An, Hyun-Jung] Chungnam Natl Univ, Coll Biosci & Biotechnol, Daedeok R&D Innopolis Bio Brain Ctr BK21, Dept Biol, Taejon 305764, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Korea Advanced Institute of Science & Technology (KAIST); Radboud University Nijmegen; Radboud University Nijmegen; Athens Medical School; National & Kapodistrian University of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr; ralf.schumann@charite.de	Lee, Jie-Oh/C-1581-2011; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Kabesch, Michael/GZM-1583-2022; Kumpf, Oliver/CAF-5792-2022; Pickkers, P./H-8080-2014; Lee, Jie-Oh/AAG-4302-2020; Kabesch, Michael/AAB-5701-2020	Pickkers, P./0000-0002-1104-4303; Weber, Alexander/0000-0002-8627-7056; Kumpf, Oliver/0000-0001-7891-8872; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; Lee, Jie-Oh/0000-0001-6519-6049; Oh, Djin-Ye/0000-0003-0541-6155; Lundvall, Linn/0000-0001-8332-0293; kim, youngjin/0000-0001-6505-9212; Hamann, Lutz/0000-0003-4719-2583	NRF; Center for Membrane Receptor Research [2008-0060543]; Korean government; Deutsche Forschungsgemeinschaft (DFG) [Schr 726/1-1, Schr 726/1-2, Schr 726/1-3, Sonderforschungsbereich (SFB) 633]; International Graduate School (IRTG) [GRK1673]	NRF; Center for Membrane Receptor Research; Korean government(Korean Government); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Graduate School (IRTG)	We thank the staff of the BL41XU beam line of SPring-8 and the 4A beam line of Pohang Accelerator Laboratory, Korea, for help with data collection. We thank Franzi Creutzburg and Diana Woellner (Institute for Microbiology), and Ina Wendler (Robert-Rossle-Klinik), Charite-Universitatsmedizin Berlin, Germany, for excellent technical assistance throughout this project. This work was supported by a NRF grant, Center for Membrane Receptor Research (2008-0060543), funded by the Korean government, and by grants from the Deutsche Forschungsgemeinschaft (DFG) as part of the priority program "Innate Immunity'' (Schr 726/1-1, through 1-3), by the Sonderforschungsbereich (SFB) 633, Teilprojekt A7, and by the International Graduate School (IRTG) GRK1673 (both to R.R.S.).	Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Branger J, 2004, INT IMMUNOL, V16, P1605, DOI 10.1093/intimm/dxh161; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Canny G, 2008, TRENDS IMMUNOL, V29, P541, DOI 10.1016/j.it.2008.07.012; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Flores C, 2009, CRIT CARE MED, V37, P2759, DOI 10.1097/CCM.0b013e3181a57b90; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hamann L, 2005, INFECT IMMUN, V73, P193, DOI 10.1128/IAI.73.1.193-200.2005; HAN JH, 1994, J BIOL CHEM, V269, P8172; Hemmila MR, 2006, J TRAUMA, V61, P598, DOI 10.1097/01.ta.0000233763.18853.5b; Hubacek JA, 2001, CRIT CARE MED, V29, P557, DOI 10.1097/00003246-200103000-00015; Hubacek JA, 2002, CLIN CHEM LAB MED, V40, P1097, DOI 10.1515/CCLM.2002.191; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knapp S, 2006, J IMMUNOL, V176, P3189, DOI 10.4049/jimmunol.176.5.3189; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lamping N, 1996, J IMMUNOL, V157, P4648; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Roy D, 1999, J IMMUNOL, V162, P7454; Lee BY, 2011, GENOMICS, V97, P101, DOI 10.1016/j.ygeno.2010.11.001; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mueller M, 2006, J BIOL CHEM, V281, P31448, DOI 10.1074/jbc.M605966200; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39; Schedel M, 2008, AM J RESP CRIT CARE, V177, P613, DOI 10.1164/rccm.200703-373OC; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Schumann RR, 1997, J IMMUNOL, V159, P5599; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Takeuchi F, 2007, BIOCHEM BIOPH RES CO, V357, P1100, DOI 10.1016/j.bbrc.2007.04.063; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; Tsukamoto H, 2010, INT IMMUNOL, V22, P271, DOI 10.1093/intimm/dxq005; Vollmer T, 2009, CLIN BIOCHEM, V42, P1413, DOI 10.1016/j.clinbiochem.2009.06.010; Vreugdenhil ACE, 2003, J IMMUNOL, V170, P1399, DOI 10.4049/jimmunol.170.3.1399; WEISS J, 1978, J BIOL CHEM, V253, P2664; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475; Zhan Q, 2012, J THROMB THROMBOLYS, V34, P260, DOI 10.1007/s11239-012-0701-2; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	47	67	70	2	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					647	660		10.1016/j.immuni.2013.09.005	http://dx.doi.org/10.1016/j.immuni.2013.09.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24120359	Bronze			2022-12-18	WOS:000330950000007
J	Schenk, M; Belisle, JT; Modlin, RL				Schenk, Mirjam; Belisle, John T.; Modlin, Robert L.			TLR2 Looks at Lipoproteins	IMMUNITY			English	Editorial Material							MICROBIAL LIPOPROTEINS; ACTIVATION	Toll-like receptors (TLRs) have evolved to recognize lipoproteins from diverse species of bacteria. In this issue of Immunity, Kang et al. (2009) provide insight into the mechanisms by which TLR2-TLR6 heterodimers recognize diacylated liporoteins, whereas TLR2-TLR1 heterodimers recognize triacylated lipopeptides.	[Schenk, Mirjam; Modlin, Robert L.] Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90025 USA; [Modlin, Robert L.] Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA; [Belisle, John T.; Modlin, Robert L.] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90025 USA; [Belisle, John T.] Colorado State Univ, Coll Veterinarian Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Colorado State University	Modlin, RL (corresponding author), Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90025 USA.		Belisle, John T/B-8944-2017; Modlin, Robert L/M-7941-2014	Belisle, John T/0000-0002-2539-2798; Modlin, Robert L/0000-0003-4720-031X; Schenk, Mirjam/0000-0002-1637-0730				Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10	10	67	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					847	849		10.1016/j.immuni.2009.11.008	http://dx.doi.org/10.1016/j.immuni.2009.11.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064441	Bronze			2022-12-18	WOS:000273616400002
J	Sullivan, LC; Clements, CS; Beddoe, T; Johnson, D; Hoare, HL; Lin, J; Huyton, T; Hopkins, EJ; Reid, HH; Wilce, MCJ; Kabat, J; Borrego, F; Coligan, JE; Rossjohn, J; Brooks, AG				Sullivan, Lucy C.; Clements, Craig S.; Beddoe, Travis; Johnson, Darryl; Hoare, Hilary L.; Lin, Jie; Huyton, Trevor; Hopkins, Emma J.; Reid, Hugh H.; Wilce, Mafthew C. J.; Kabat, Juraj; Borrego, Francisco; Coligan, John E.; Rossjohn, Jamie; Brooks, Andrew G.			The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition	IMMUNITY			English	Article							KILLER-CELL RECEPTOR; CLASS-I RECOGNITION; HLA-E; CRYSTAL-STRUCTURE; IMMUNORECEPTOR NKG2D; INHIBITORY RECEPTOR; CD94/NKG2 RECEPTORS; STRUCTURAL BASIS; COMPLEX; CD94	The CD94-NKG2 receptor family that regulates NK and T cells; is unique among the lectin-like receptors encoded within the natural killer cell complex. The function of the CD94-NKG2 receptors is dictated by the pairing of the invariant CD94 polypeptide with specific NKG2 isoforms to form a family of functionally distinct heterodimeric receptors. However, the structural basis for this selective pairing and how they interact with their ligand, HLA-E, is unknown. We describe the 2.5 angstrom resolution crystal structure of CD94-NKG2A in which the mode of dimerization contrasts with that of other homodimeric NK receptors. Despite structural homology between the CD94 and NKG2A subunits, the dimer interface is asymmetric, thereby providing a structural basis for the preferred heterodimeric assembly. Structure-based sequence comparisons of other CD94-NKG2 family members, combined with extensive mutagenesis studies on HLA-E and CD94-NKG2A, allows a model of the interaction between CD94-NKG2A and HLA-E to be established, in which the invariant CD94 chain plays a more dominant role in interacting with HLA-E in comparison to the variable NKG2 chain.	[Clements, Craig S.; Beddoe, Travis; Hoare, Hilary L.; Huyton, Trevor; Hopkins, Emma J.; Reid, Hugh H.; Wilce, Mafthew C. J.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol,Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Sullivan, Lucy C.; Johnson, Darryl; Lin, Jie; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Kabat, Juraj; Borrego, Francisco; Coligan, John E.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	Monash University; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol,Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au; agbrooks@unimelb.edu.au	Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013	Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Borrego, Francisco/0000-0002-3105-981X; Brooks, Andrew/0000-0002-4085-9683; Petrie, Emma/0000-0002-9827-3378; Sullivan, Lucy/0000-0003-2907-4989	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000963, ZIAAI000963] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellon T, 1999, J IMMUNOL, V162, P3996; Bland FA, 2003, J BIOL CHEM, V278, P33747, DOI 10.1074/jbc.M305593200; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1999, J IMMUNOL, V162, P305; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Brostjan C, 2002, J IMMUNOL METHODS, V264, P109, DOI 10.1016/S0022-1759(02)00084-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; Cella M, 2000, CURR TOP MICROBIOL, V251, P161; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Kaiser BK, 2005, J IMMUNOL, V174, P2878, DOI 10.4049/jimmunol.174.5.2878; Kim JH, 2004, MACROMOL RES, V12, P53, DOI 10.1007/BF03218995; Kogelberg H, 2001, CURR OPIN STRUC BIOL, V11, P635, DOI 10.1016/S0959-440X(00)00259-1; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; Lieto LD, 2006, GENES IMMUN, V7, P36, DOI 10.1038/sj.gene.6364268; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Sawicki MW, 2001, IMMUNOL REV, V181, P52, DOI 10.1034/j.1600-065X.2001.1810104.x; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Wada H, 2004, EUR J IMMUNOL, V34, P81, DOI 10.1002/eji.200324432; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	43	67	74	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					900	911		10.1016/j.immuni.2007.10.013	http://dx.doi.org/10.1016/j.immuni.2007.10.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18083576	Bronze			2022-12-18	WOS:000251907300010
J	Krosl, J; Beslu, N; Mayotte, N; Humphries, RK; Sauvageau, G				Krosl, J; Beslu, N; Mayotte, N; Humphries, RK; Sauvageau, G			The competitive nature of HOXB4-transduced HSC is limited by PBX1: The generation of ultra-competitive stem cells retaining full differentiation potential	IMMUNITY			English	Article							HUMAN HEMATOPOIETIC-CELLS; EXPANSION IN-VITRO; BONE-MARROW CELLS; CELLULAR PROLIFERATION; QUANTITATIVE ASSAY; HOMEOBOX GENES; C-MYC; HOXB4; EXPRESSION; PROTEINS	We previously showed that HOXB4 is a potent stimulator of hematopoietic stem cell (HSC) proliferation in vivo and ex vivo. As a result, HOXB4 overexpressing HSCs are 20- to 50-times more competitive than untransduced cells when transplanted into mice. By knocking down the expression of PBX1 (PBX1(K.D.)) in HOXB4 overexpressing cells, we now present the possibility of generating HSCs that are >20-times more competitive than those that overexpress HOXB4. The differentiation activity of these cells appears intact, since they competitively contributed to the reconstitution of normal myeloid and lymphoid compartments in vivo. We also show that the in vivo expansion of HOXB4-PBX1(K.D.)-expressing HSCs regenerated normal stem cell pools and did not lead to HSC levels above those detected in unmanipulated mice. The vigorous competitive nature of these cells in vivo compared to HOXB4-transduced HSCs suggests the existence of a distinct, non-cell autonomous mechanism that limits the expansion of HOXB4-transduced hemopoietic stem cells in mice.	Clin Res Inst Montreal, Lab Mol Genet Hemopoiet Stem Cells, Montreal, PQ H2W 1R7, Canada; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ Montreal, Hop Maison Neuve Rosemont, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; British Columbia Cancer Agency; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Clin Res Inst Montreal, Lab Mol Genet Hemopoiet Stem Cells, Montreal, PQ H2W 1R7, Canada.			Sauvageau, Guy/0000-0002-4333-7266; Humphries, Richard/0000-0003-0540-7005	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065430] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL65430-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Buske C, 2000, INT J HEMATOL, V71, P301; Buske C, 2002, BLOOD, V100, P862, DOI 10.1182/blood-2002-01-0220; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; El-Kadi ASM, 2002, MECH DEVELOP, V113, P131, DOI 10.1016/S0925-4773(02)00047-3; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Krosl J, 2000, ONCOGENE, V19, P5134, DOI 10.1038/sj.onc.1203897; Krosl J, 1998, ONCOGENE, V16, P3403, DOI 10.1038/sj.onc.1201883; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Pan Q, 2001, J ENDOCRINOL, V169, P153, DOI 10.1677/joe.0.1690153; Pan QT, 1999, J BIOL CHEM, V274, P8437, DOI 10.1074/jbc.274.13.8437; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Thorsteinsdottir U, 1999, BLOOD, V94, P2605, DOI 10.1182/blood.V94.8.2605.420k19_2605_2612; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390	26	67	72	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					561	571		10.1016/S1074-7613(03)00090-6	http://dx.doi.org/10.1016/S1074-7613(03)00090-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705858	Bronze			2022-12-18	WOS:000182353900011
J	Michael, N; Martin, TE; Nicolae, D; Kim, N; Padjen, K; Zhan, P; Nguyen, H; Pinkert, C; Storb, U				Michael, N; Martin, TE; Nicolae, D; Kim, N; Padjen, K; Zhan, P; Nguyen, H; Pinkert, C; Storb, U			Effects of sequence and structure on the hypermutability of immunoglobulin genes	IMMUNITY			English	Article							DOUBLE-STRAND BREAKS; CENTER B-CELLS; SOMATIC HYPERMUTATION; V-GENES; DNA; IG; TRANSCRIPTION; MUTATIONS; DINUCLEOTIDE; MUTAGENESIS	Somatic hypermutation (SHM) is investigated in related immunoglobulin transgenes that differ in a short artificial sequence designed to vary the content of hotspot motifs and the potential to form RNA or DNA secondary structures. Mutability depends on hotspots, not secondary structure. Hotspot motifs predict about 50% of the mutations; the rest are in neutral and coldspots. Clusters of mutations and the sequential addition of mutations found in cell pedigrees suggest epigenetic attributes of SHM. Sometime in SHM, an essential factor seems to become limiting. Particular error-prone DNA polymerases appear to create mutations in hotspots on the top and bottom DNA strands throughout the target and the SHM process. One transgene is superhypermutable in all regions, suggesting the presence of a cis-element that enhances SHM.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Rochester	Storb, U (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.			Nicolae, Dan/0000-0002-0918-4630; Pinkert, Carl/0000-0001-7460-3881	NIAID NIH HHS [AI47380] Funding Source: Medline; NICHD NIH HHS [N01-HD-5-3229] Funding Source: Medline; NIGMS NIH HHS [GM07183, GM38649, 5 T32 GM07281] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD053229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047380, R56AI047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038649, T32GM007183, T32GM007281] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachl J, 1997, EUR J IMMUNOL, V27, P3398, DOI 10.1002/eji.1830271239; Bertocci B, 1998, IMMUNITY, V9, P257, DOI 10.1016/S1074-7613(00)80608-1; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BOTH GW, 1990, MOL CELL BIOL, V10, P5187, DOI 10.1128/MCB.10.10.5187; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Diaz M, 1998, P NATL ACAD SCI USA, V95, P14343, DOI 10.1073/pnas.95.24.14343; Foster SJ, 1999, EUR J IMMUNOL, V29, P4011, DOI 10.1002/(SICI)1521-4141(199912)29:12<4011::AID-IMMU4011>3.0.CO;2-W; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Gearhart P. J., 1991, Somatic hypermutation in V-regions., P29; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; KELSOE G, 1995, IMMUNOL TODAY, V16, P324, DOI 10.1016/0167-5699(95)80146-4; Klotz EL, 1998, J IMMUNOL, V161, P782; Kong QZ, 2001, GENETICS, V158, P369; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peng HZ, 1999, BLOOD, V93, P2167, DOI 10.1182/blood.V93.7.2167.407a35_2167_2172; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; RADA C, 1994, EUR J IMMUNOL, V24, P1453, DOI 10.1002/eji.1830240632; Rice J. A., 1995, MATH STAT DATA ANAL; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Shapiro GS, 1999, J IMMUNOL, V163, P259; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Smith DS, 1996, J IMMUNOL, V156, P2642; Spencer J, 1999, J IMMUNOL, V162, P6596; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689; Storb U, 1998, CURR TOP MICROBIOL, V229, P11; Storb U, 2001, NAT IMMUNOL, V2, P484, DOI 10.1038/88673; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; ZUCKER M, 1989, SCIENCE, V244, P48	44	67	67	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					123	134		10.1016/S1074-7613(02)00261-3	http://dx.doi.org/10.1016/S1074-7613(02)00261-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825571	Bronze			2022-12-18	WOS:000173575700012
J	Utku, N; Heinemann, T; Tullius, SG; Bulwin, GC; Beinke, S; Blumberg, RS; Beato, F; Randall, J; Kojima, R; Busconi, L; Robertson, ES; Schulein, R; Volk, HD; Milford, EL; Gullans, SR				Utku, N; Heinemann, T; Tullius, SG; Bulwin, GC; Beinke, S; Blumberg, RS; Beato, F; Randall, J; Kojima, R; Busconi, L; Robertson, ES; Schulein, R; Volk, HD; Milford, EL; Gullans, SR			Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein	IMMUNITY			English	Article							VACUOLAR PROTON PUMP; 116-KDA POLYPEPTIDE; ACTIVATION; CD28; COSTIMULATION; SUBUNIT; CTLA-4; ATPASE; LYMPHOCYTES; MECHANISM	A novel 75 kDa membrane protein, TIRC7, is described that exhibits a central role in T cell activation in vitro and in vivo. Modulation of TIRC7-mediated signals with specific anti-TIRC7 antibodies in vitro efficiently prevents human T cell proliferation and IL-2 secretion. Moreover, anti-TIRC7 antibodies specifically inhibit type 1 subset specific IFN-gamma expression but spare the type 2 cytokine IL-4. Diminished proliferation but not lFN-gamma secretion is reversible by exogenous rIL-2. An anti-TIRC7 antibody that cross-reacts with the 75 kDa rat homolog exhibits inhibition of rat alloimmune response in vitro and significantly prolongs kidney allograft survival in vivo. Targeting of TIRC7 may provide a novel therapeutic approach for modulation of the immune response.	Humboldt Univ, Charite, Inst Med Immunol, D-10098 Berlin, Germany; Humboldt Univ, Charite, Chirurg Klin, D-10098 Berlin, Germany; Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Forschungsinst Mol Pharmakol, D-10315 Berlin, Germany; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Inst Med, Boston, MA 02115 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Utku, N (corresponding author), Humboldt Univ, Charite, Inst Med Immunol, Campus Mitte, D-10098 Berlin, Germany.	nalan.utku@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036031] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK36031] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Blazar BR, 1996, J IMMUNOL, V157, P3250; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; COSIMI AB, 1981, TRANSPLANTATION, V32, P535, DOI 10.1097/00007890-198112000-00018; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kojima R, 1996, J BIOL CHEM, V271, P12327, DOI 10.1074/jbc.271.21.12327; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; LEE CK, 1990, MOL IMMUNOL, V27, P1137; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; MANOLSON MF, 1992, J EXP BIOL, V172, P105; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Oksche A, 1998, FEBS LETT, V424, P57, DOI 10.1016/S0014-5793(98)00140-9; PENG SB, 1994, J BIOL CHEM, V269, P17262; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PLATZER C, 1994, TRANSPLANTATION, V58, P264, DOI 10.1097/00007890-199407270-00025; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schulein R, 1996, J BIOL CHEM, V271, P28844, DOI 10.1074/jbc.271.46.28844; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SOLIOZ M, 1994, J BIOL CHEM, V269, P9453; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	33	67	84	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					509	518		10.1016/S1074-7613(00)80634-2	http://dx.doi.org/10.1016/S1074-7613(00)80634-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806637	Bronze			2022-12-18	WOS:000076680700009
J	ROCHE, PA				ROCHE, PA			HLA-DM - AN IN-VIVO FACILITATOR OF MHC CLASS-II PEPTIDE LOADING	IMMUNITY			English	Article							ANTIGEN-PROCESSING MUTANT; INVARIANT CHAIN PEPTIDES; DR MOLECULES; COMPARTMENTS; TRANSPORT; BINDING	Initiation of cell-mediated immune responses requires processing of intracellular pathogens into peptide fragments and presentation of these fragments to effector T cells. In the past few years, considerable progress has been made in understanding the molecular mechanisms underlying antigen processing and presentation. In particular, recent work has led to an understanding of the function of HLA-DM (DM), a key player in antigen presentation, whose importance was first appreciated only 1 year ago.			ROCHE, PA (corresponding author), NCI,EXPTL IMMUNOL BRANCH,BLDG 10,BETHESDA,MD 20892, USA.			Roche, Paul/0000-0002-8949-9172				BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BROOKS AG, 1994, J IMMUNOL, V153, P5382; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; MARKS MS, 1995, IN PRESS J CELL BIOL; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NIJMAN HW, 1995, J EXP MED, V182, P163, DOI 10.1084/jem.182.1.163; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHERMAN MA, 1995, IMMUNITY, V3; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E	24	67	67	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					259	262		10.1016/1074-7613(95)90111-6	http://dx.doi.org/10.1016/1074-7613(95)90111-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552991	Bronze			2022-12-18	WOS:A1995RX64500001
J	MULLBACHER, A; LOBIGS, M				MULLBACHER, A; LOBIGS, M			UP-REGULATION OF MHC CLASS-I BY FLAVIVIRUS-INDUCED PEPTIDE TRANSLOCATION INTO THE ENDOPLASMIC-RETICULUM	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOTOXIC LYMPHOCYTES-T; RMA-S CELLS; ANTIGEN PRESENTATION; VIRAL-ANTIGEN; SURFACE EXPRESSION; GAMMA-INTERFERON; WEST-NILE; MOLECULES; VIRUS	Flavivirus infection of mammalian cells increases the cell surface expression of major histocompatibility complex (MHC) class I molecules, the recognition elements for cytotoxic T cells. Here, we show that the mechanism for flavivirus-induced up-regulation of class I MHC involves an increase in peptide supply to the endoplasmic reticulum. Flavivirus-mediated peptide supply for MHC class I assembly is independent of the peptide transporters for class I antigen presentation, since infection of class I MHC peptide transport-deficient cell lines with flaviviruses results in the cell surface expression of biologically functional class I MHC peptide complexes, The flavivirus-induced supply of antigenic peptides to the endoplasmic reticulum is not restricted to flavivirus-encoded peptides and independent of interferon. The data imply that peptide availability regulates surface expression of class I MHC restriction elements and suggests a mechanism for flavivirus-induced immunopathology.			MULLBACHER, A (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV CELL BIOL,CANBERRA,ACT 2601,AUSTRALIA.		lobigs, mario/ABC-5711-2020					ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BLANDEN RV, 1987, IMMUNOL REV, V98, P75, DOI 10.1111/j.1600-065X.1987.tb00520.x; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; ELVIN J, 1991, EUR J IMMUNOL, V21, P2025, DOI 10.1002/eji.1830210909; ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163; FRANKSSON L, 1993, EUR J IMMUNOL, V23, P2606, DOI 10.1002/eji.1830231034; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GOODING LR, 1992, CELL, V71, P5; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILL AB, 1993, VIRUSES CELLULAR IMM, P389; Holmes K. V., 1990, VIROLOGY, V1, P841; HOSKEN NA, 1992, J EXP MED, V175, P719, DOI 10.1084/jem.175.3.719; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; JACKSON MR, 1993, ANNU REV CELL BIOL, V9, P207, DOI 10.1146/annurev.cb.09.110193.001231; KESSON AM, 1988, IMMUNOL CELL BIOL, V66, P23, DOI 10.1038/icb.1988.3; KING NJC, 1988, J GEN VIROL, V69, P2535, DOI 10.1099/0022-1317-69-10-2535; KING NJC, 1989, P NATL ACAD SCI USA, V86, P911, DOI 10.1073/pnas.86.3.911; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; LANGLADEDEMOYEN P, 1994, INT IMMUNOL, V6, P1759, DOI 10.1093/intimm/6.11.1759; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; LIU Y, 1989, J NEUROIMMUNOL, V21, P187; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LOBIGS M, 1995, IMMUNOL CELL BIOL, V73, P181, DOI 10.1038/icb.1995.29; LOBIGS M, 1994, VIROLOGY, V202, P195, DOI 10.1006/viro.1994.1335; LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P2676, DOI 10.1073/pnas.90.7.2676; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; LOBIGS M, 1995, IN PRESS IMMUNOGENET; MASSA PT, 1987, P NATL ACAD SCI USA, V84, P7242, DOI 10.1073/pnas.84.20.7242; MAUDSLEY DJ, 1991, IMMUNOL TODAY, V12, P429, DOI 10.1016/0167-5699(91)90013-J; MONACO JJ, 1992, CURR OPIN IMMUNOL, V4, P70, DOI 10.1016/0952-7915(92)90128-2; Monath T.P., 1990, VIROLOGY, P763; MULLBACHER A, 1991, J IMMUNOL, V147, P1765; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; STORKUS WJ, 1993, J IMMUNOL, V151, P3719; SUZUMURA A, 1986, SCIENCE, V232, P991, DOI 10.1126/science.3010460; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4; ZHOU XZ, 1993, EUR J IMMUNOL, V23, P1796, DOI 10.1002/eji.1830230810; ZHOU XZ, 1993, EUR J IMMUNOL, V23, P1802, DOI 10.1002/eji.1830230811; ZWEERINK HJ, 1993, J IMMUNOL, V150, P1763	46	67	71	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					207	214		10.1016/1074-7613(95)90090-X	http://dx.doi.org/10.1016/1074-7613(95)90090-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7544229	Bronze			2022-12-18	WOS:A1995RR33900006
J	Jarjour, NN; Masopust, D; Jameson, SC				Jarjour, Nicholas N.; Masopust, David; Jameson, Stephen C.			T Cell Memory: Understanding COVID-19	IMMUNITY			English	Editorial Material								As the SARS-CoV-2 pandemic has progressed, increasing attention has focused on establishing natural and vaccine-induced immunity against this coronavirus and the disease, COVID-19, that it causes. In this Primer, we explain the fundamental features of T cell memory and their potential relevance for effective immunity to SARS-CoV-2.	[Jarjour, Nicholas N.; Masopust, David; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Jarjour, Nicholas N.; Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.; Jameson, SC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Jarjour, Nicholas/0000-0001-9400-4448	NIH [AI38903]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Carolyn King (Basel University) and Marc Jenkins (University of Minnesota) for valuable discussions. We apologize to many colleagues whose important work on this topic could not be included due to space limitations. This work was supported by NIH award AI38903 to S.C.J.	Behar SM, 2020, NATURE, V577, P31, DOI 10.1038/d41586-019-03597-y; Canete PF, 2020, CELL, V183, P13, DOI 10.1016/j.cell.2020.09.013; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; DiPiazza A.T., 2020, BIOCH BIOPHYS RES CO; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Iwasaki A, 2016, ANNU REV IMMUNOL, V34, P575, DOI 10.1146/annurev-immunol-032414-112315; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lipsitch M, 2020, NAT REV IMMUNOL, V20, P709, DOI 10.1038/s41577-020-00460-4; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820	15	66	67	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					14	18		10.1016/j.immuni.2020.12.009	http://dx.doi.org/10.1016/j.immuni.2020.12.009		JAN 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33406391	Bronze, Green Published			2022-12-18	WOS:000607814000006
J	Kwok, I; Becht, E; Xia, Y; Ng, M; Teh, YC; Tan, L; Evrard, M; Li, JLY; Tran, HTN; Tan, YR; Liu, DH; Mishra, A; Liong, KH; Leong, K; Zhang, YN; Olsson, A; Mantri, CK; Shyamsunder, P; Liu, ZY; Piot, C; Dutertre, CA; Cheng, H; Bari, S; Ang, N; Biswas, SK; Koeffler, HP; Tey, HL; Larbi, A; Su, IH; Lee, B; John, AS; Chan, JKY; Hwang, WYK; Chen, JM; Salomonis, N; Chong, SZ; Grimes, HL; Liu, B; Hidalgo, A; Newell, EW; Cheng, T; Ginhoux, F; Ng, LG				Kwok, Immanuel; Becht, Etienne; Xia, Yu; Ng, Melissa; Teh, Ye Chean; Tan, Leonard; Evrard, Maximilien; Li, Jackson L. Y.; Tran, Hoa T. N.; Tan, Yingrou; Liu, Dehua; Mishra, Archita; Liong, Ka Hang; Leong, Keith; Zhang, Yuning; Olsson, Andre; Mantri, Chinmay Kumar; Shyamsunder, Pavithra; Liu, Zhaoyuan; Piot, Cecile; Dutertre, Charles-Antoine; Cheng, Hui; Bari, Sudipto; Ang, Nicholas; Biswas, Subhra K.; Koeffler, H. Philip; Tey, Hong Liang; Larbi, Anis; Su, I-Hsin; Lee, Bernett; John, Ashley St.; Chan, Jerry K. Y.; Hwang, William Y. K.; Chen, Jinmiao; Salomonis, Nathan; Chong, Shu Zhen; Grimes, H. Leighton; Liu, Bing; Hidalgo, Andres; Newell, Evan W.; Cheng, Tao; Ginhoux, Florent; Ng, Lai Guan			Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor	IMMUNITY			English	Article							MYELOID PROGENITOR; GENE-EXPRESSION; LINEAGE; DISTINCT; FATE; DIFFERENTIATION; DYNAMICS; PRODUCE; SEPSIS	Granulocyte-monocyte progenitors (GMPs) have been previously defined for their potential to generate various myeloid progenies such as neutrophils and monocytes. Although studies have proposed lineage heterogeneity within GMPs, it is unclear if committed progenitors already exist among these progenitors and how they may behave differently during inflammation. By combining single-cell transcriptomic and proteomic analyses, we identified the early committed progenitor within the GMPs responsible for the strict production of neutrophils, which we designate as proNeu1. Our dissection of the GMP hierarchy led us to further identify a previously unknown intermediate proNeu2 population. Similar populations could be detected in human samples. proNeu1s, but not proNeu2s, selectively expanded during the early phase of sepsis at the expense of monocytes. Collectively, our findings help shape the neutrophil maturation trajectory roadmap and challenge the current definition of GMPs.	[Kwok, Immanuel; Becht, Etienne; Xia, Yu; Ng, Melissa; Teh, Ye Chean; Tan, Leonard; Evrard, Maximilien; Li, Jackson L. Y.; Tran, Hoa T. N.; Tan, Yingrou; Liu, Dehua; Mishra, Archita; Liong, Ka Hang; Leong, Keith; Zhang, Yuning; Piot, Cecile; Dutertre, Charles-Antoine; Ang, Nicholas; Biswas, Subhra K.; Larbi, Anis; Lee, Bernett; Chen, Jinmiao; Chong, Shu Zhen; Newell, Evan W.; Ginhoux, Florent; Ng, Lai Guan] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Kwok, Immanuel; Su, I-Hsin; Ng, Lai Guan] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Xia, Yu] Shanghai Jiao Tong Univ, Zhiyuan Coll, Shanghai 200240, Peoples R China; [Teh, Ye Chean] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117558, Singapore; [Tan, Leonard; John, Ashley St.; Ng, Lai Guan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117545, Singapore; [Tan, Yingrou; Tey, Hong Liang] Natl Skin Ctr, 1 Mandalay Rd, Singapore 308205, Singapore; [Olsson, Andre; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Olsson, Andre; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Mantri, Chinmay Kumar; John, Ashley St.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore 169857, Singapore; [Shyamsunder, Pavithra; Koeffler, H. Philip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Shyamsunder, Pavithra; Hwang, William Y. K.] Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore 169857, Singapore; [Liu, Zhaoyuan; Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China; [Cheng, Hui; Cheng, Tao; Ng, Lai Guan] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Cheng, Hui; Cheng, Tao] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin 300020, Peoples R China; [Cheng, Hui; Cheng, Tao] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Cheng, Hui; Cheng, Tao] Chinese Acad Med Sci, Ctr Stem Cell Med, Tianjin 300020, Peoples R China; [Cheng, Hui; Cheng, Tao] Peking Union Med Coll, Dept Stem Cell & Regenerat Med, Tianjin 300020, Peoples R China; [Bari, Sudipto; Hwang, William Y. K.; Ng, Lai Guan] Natl Canc Ctr Singapore, Singapore 169610, Singapore; [Koeffler, H. Philip] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Koeffler, H. Philip] Natl Univ Singapore Hosp, Natl Univ Canc Inst Singapore, Dept Hematol Oncol, Singapore 119074, Singapore; [John, Ashley St.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [John, Ashley St.] SingHealth Duke Natl Univ Singapore, Global Hlth Inst, Singapore 168753, Singapore; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Singapore 119228, Singapore; [Hwang, William Y. K.] Singapore Gen Hosp, Dept Hematol, Singapore 169608, Singapore; [Salomonis, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Liu, Bing] Acad Mil Med Sci, Acad Mil Sci, State Key Lab Prote, Beijing 100071, Peoples R China; [Liu, Bing] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Expt Hematol, Med Ctr 5, Beijing 100071, Peoples R China; [Liu, Bing] Jinan Univ, Inst Hematol, Sch Med, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Peoples R China; [Hidalgo, Andres] Ctr Nacl Invest Cardiovasc Carlos III, Area Cell & Dev Biol, Madrid 28029, Spain; [Ginhoux, Florent] SingHealth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Shanghai Jiao Tong University; National University of Singapore; National University of Singapore; National Skin Centre; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; National University of Singapore; National University of Singapore; National University of Singapore; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Cancer Centre Singapore (NCCS); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; Duke University; KK Women's & Children's Hospital; National University of Singapore; Singapore General Hospital; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Jinan University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Kwok, I; Ng, LG (corresponding author), ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore 138648, Singapore.; Kwok, I; Ng, LG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.; Ng, LG (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117545, Singapore.; Ng, LG (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China.; Ng, LG (corresponding author), Natl Canc Ctr Singapore, Singapore 169610, Singapore.	immanuel_kwok@immunol.a-star.edu.sg; ng_lai_guan@immunol.a-star.edu.sg	Hidalgo, Andrés/L-5643-2014; Tey, Hong Liang/GON-9676-2022; Larbi, Anis/ABE-5868-2020; Mishra, Archita/GWC-7822-2022; Tan, Leonard/GXG-9931-2022; Kwok, Immanuel/GXH-0537-2022; Mantri, Chinmay Kumar Kumar/AAX-6509-2021; Teh, Ye Chean/GXG-9981-2022; StJohn, Ashley/AAE-4378-2021; Hwang, William/AAX-8452-2021; Newell, Evan W/F-9711-2012; Hwang, William/AAT-3079-2021; Chen, Jinmiao/ABE-5601-2021	Hidalgo, Andrés/0000-0001-5513-555X; Kwok, Immanuel/0000-0003-1523-1621; StJohn, Ashley/0000-0001-5098-1044; Newell, Evan W/0000-0002-2889-243X; Hwang, William/0000-0003-0143-6263; Becht, Etienne/0000-0003-1859-9202; Li, Jackson LiangYao/0000-0001-5197-193X; Dutertre, Charles-Antoine/0000-0001-7950-3652; Grimes, H. Leighton/0000-0001-8162-6758; Evrard, Maximilien/0000-0002-2105-1160; Cheng, Tao/0000-0002-5925-2769; Tan, Leonard/0000-0002-6923-1021	Singapore Immunology Network (SIgN); A*STAR, Singapore; Singapore Ministry of Health's National Medical Research Council under its Open Fund -Young Investigator Research Grant [OFYIRG17may036]; Singapore National Research Foundation Investigatorship (NRFI) [NRF2016NRF-NRFI001-02]; SIgN core funding; National Research Foundation (NRF) Singapore [NRF2017_SISFP09]	Singapore Immunology Network (SIgN)(Agency for Science Technology & Research (A*STAR)); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health's National Medical Research Council under its Open Fund -Young Investigator Research Grant; Singapore National Research Foundation Investigatorship (NRFI); SIgN core funding; National Research Foundation (NRF) Singapore(National Research Foundation, Singapore)	We thank all members of L.G.N. laboratory, the SIgN flow cytometry team, the SIgN functional genomics team for their assistance with transcriptomics, and the SIgN mouse core facility for their technical help and support. This research was funded by Singapore Immunology Network (SIgN) core funding and A*STAR, Singapore. S.Z.C. is supported by Singapore Ministry of Health's National Medical Research Council under its Open Fund -Young Investigator Research Grant (OFYIRG17may036). F.G. is an EMBO YIP awardee and is supported by SIgN core funding and by Singapore National Research Foundation Investigatorship (NRFI) (NRF2016NRF-NRFI001-02). L.G.N. is supported by SIgN core funding. SIgN Flow Cytometry facility is supported by National Research Foundation (NRF) Singapore under Shared Infrastructure Support (SIS) (NRF2017_SISFP09).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kyme P, 2012, J CLIN INVEST, V122, P3316, DOI 10.1172/JCI62070; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Lawrence SM, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00057-17; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Paul F, 2016, CELL, V164, P325, DOI 10.1016/j.cell.2015.12.046; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubinstein MP, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-75; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Serwas NK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00588; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vassen L., 2011, BLOOD, V118, P3217; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yanez A, 2015, BLOOD, V125, P1452, DOI 10.1182/blood-2014-09-600833	45	66	67	6	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					303	+		10.1016/j.immuni.2020.06.005	http://dx.doi.org/10.1016/j.immuni.2020.06.005			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32579887	Bronze			2022-12-18	WOS:000561190600011
J	Li, XH; Gong, W; Wang, H; Li, TL; Attri, KS; Lewis, RE; Kalil, AC; Bhinderwala, F; Powers, R; Yin, GW; Herring, LE; Asara, JM; Lei, YL; Yang, XY; Rodriguez, DA; Yang, M; Green, DR; Singh, PK; Wen, HT				Li, Xinghui; Gong, Wei; Wang, Hao; Li, Tianliang; Attri, Kuldeep S.; Lewis, Robert E.; Kalil, Andre C.; Bhinderwala, Fatema; Powers, Robert; Yin, Guowei; Herring, Laura E.; Asara, John M.; Lei, Yu L.; Yang, Xiaoyong; Rodriguez, Diego A.; Yang, Mao; Green, Douglas R.; Singh, Pankaj K.; Wen, Haitao			O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3	IMMUNITY			English	Article							PSEUDOKINASE MLKL; RIP1 KINASE; CELL; GLCNACYLATION; PHOSPHORYLATION; NECROSIS; COMPLEX; TRANSCRIPTION; ACTIVATION; MECHANISMS	Elevated glucose metabolism in immune cells represents a hallmark feature of many inflammatory diseases, such as sepsis. However, the role of individual glucose metabolic pathways during immune cell activation and inflammation remains incompletely understood. Here, we demonstrate a previously unrecognized anti-inflammatory function of the O-linked beta-N-acetylglucosamine (O-GlcNAc) signaling associated with the hexosamine biosynthesis pathway (HBP). Despite elevated activities of glycolysis and the pentose phosphate pathway, activation of macrophages with lipopolysaccharide (LPS) resulted in attenuated HBP activity and protein O-GlcNAcylation. Deletion of O-GlcNAc transferase (OGT), a key enzyme for protein O-GlcNAcylation, led to enhanced innate immune activation and exacerbated septic inflammation. Mechanistically, OGT-mediated O-GlcNAcylation of the serine-threonine kinase RIPK3 on threonine 467 (T467) prevented RIPK3-RIPK1 hetero- and RIPK3-RIPK3 homo-interaction and inhibited downstream innate immunity and necroptosis signaling. Thus, our study identifies an immuno-metabolic crosstalk essential for finetuning innate immune cell activation and highlights the importance of glucose metabolism in septic inflammation.	[Li, Xinghui; Li, Tianliang; Wen, Haitao] Ohio State Univ, Comprehens Canc Ctr, Infect Dis Inst, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Gong, Wei] Shandong Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg & Liver Transplantat, Jinan, Shandong, Peoples R China; [Wang, Hao] Shandong Univ, Dept Crit Care Med, Qilu Hosp, Jinan, Shandong, Peoples R China; [Attri, Kuldeep S.; Lewis, Robert E.; Singh, Pankaj K.] Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Kalil, Andre C.] Univ Nebraska Med Ctr, Dept Internal Med, Div Infect Dis, Omaha, NE 68198 USA; [Bhinderwala, Fatema; Powers, Robert] Univ Nebraska, Nebraska Ctr Integrated Biomol Commun, Dept Chem, Lincoln, NE 68588 USA; [Yin, Guowei] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Herring, Laura E.] Univ N Carolina, Prote Core Facil, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Asara, John M.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Asara, John M.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Lei, Yu L.] Univ Michigan, Rogel Canc Ctr, Dept Periodont & Oral Med, Sch Dent, Ann Arbor, MI 48105 USA; [Yang, Xiaoyong] Yale Univ, Sch Med, Dept Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Rodriguez, Diego A.; Yang, Mao; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Yale University; St Jude Children's Research Hospital	Wen, HT (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Infect Dis Inst, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	haitao.wen@osumc.edu	Wang, Hao/AGS-5901-2022; Lei, Yu Leo/ABF-1293-2020; Wen, Haitao/AAJ-7621-2020; Powers, Robert/AAK-3431-2020; , Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022; Attri, Kuldeep S/S-9840-2019	Wang, Hao/0000-0003-4493-3147; Lei, Yu Leo/0000-0002-9868-9824; Powers, Robert/0000-0001-9948-6837; Rodriguez, Diego/0000-0003-4771-0221; Bhinderwala, Fatema/0000-0002-3033-8438	National Institutes of Health (NIH) [R01GM120496, 5P01CA120964, 5P30CA006516, P30CA016086, R01CA163649, R01CA210439, R01CA216853, P30GM103335, P20GM113126, R00DE024173, R01DE026728, R01DK102648, R37AI044828, R35CA231620]; NIH [RR015468-01]; NATIONAL CANCER INSTITUTE [R35CA231620, R01CA210439, R01CA169291, R01CA163649, R01CA216853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026728, R00DE024173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120496] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A.S. Baldwin for the NF-kappa B-driven luciferase reporter construct and the expression plasmids for IKK1, IKK2, and RELA; F.K. Chan for the RIPK3 WT and mutant expression plasmids; H.K. Lin for the TRAF6 expression plasmid; X. Yu for the OGT expression plasmid; E.S. Mocarski for Rip<SUP>K3K51A</SUP> bone marrow cells; V.M. Dixit for Ripk3<SUP>-/-</SUP> mice; J.M. Murphy for Mlkl<SUP>-/-</SUP> mice; and M. Yuan for the metabolomics assay. This work was supported by National Institutes of Health (NIH) grants R01GM120496 to H.W.; 5P01CA120964 and 5P30CA006516 to J.M.A.; P30CA016086 to the UNC Lineberger Comprehensive Cancer Center; R01CA163649, R01CA210439, and R01CA216853 to P.K.S.; P30GM103335 and P20GM113126 to R.P.; R00DE024173 and R01DE026728 to Y.L.L.; R01DK102648 to X.Y.; and R37AI044828 and R35CA231620 to D.R.G. Metabolic tracer experiments were performed in facilities renovated under NIH grant RR015468-01.	Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Galluzzi L, 2017, ANNU REV PATHOL-MECH, V12, P103, DOI 10.1146/annurev-pathol-052016-100247; Gunda V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154416; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Johnson BA, 2018, METHODS MOL BIOL, V1688, P257, DOI 10.1007/978-1-4939-7386-6_13; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li TL, 2018, CELL HOST MICROBE, V24, P791, DOI 10.1016/j.chom.2018.11.001; Li XH, 2017, J EXP MED, V214, P1093, DOI 10.1084/jem.20161105; Lin J, 2016, NATURE, V540, P124, DOI 10.1038/nature20558; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; McQuade T, 2013, BIOCHEM J, V456, P409, DOI 10.1042/BJ20130860; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mompean M, 2018, CELL, V173, P1244, DOI 10.1016/j.cell.2018.03.032; Moriwaki K, 2017, CELL REP, V18, P2441, DOI 10.1016/j.celrep.2017.02.015; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang Y, 2015, MOL CELL, V58, P47, DOI 10.1016/j.molcel.2015.01.038; Yang YR, 2015, ONCOTARGET, V6, P12529, DOI 10.18632/oncotarget.3725	55	66	69	7	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					576	+		10.1016/j.immuni.2019.01.007	http://dx.doi.org/10.1016/j.immuni.2019.01.007			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30770249	Green Accepted, Bronze			2022-12-18	WOS:000461660500010
J	Mamedov, MR; Scholzen, A; Nair, RV; Cumnock, K; Kenkel, JA; Oliveira, JHM; Trujillo, DL; Saligrama, N; Zhang, Y; Rubelt, F; Schneider, DS; Chien, YH; Sauerwein, RW; Davis, MM				Mamedov, Murad R.; Scholzen, Anja; Nair, Ramesh V.; Cumnock, Katherine; Kenkel, Justin A.; Oliveira, Jose Henrique M.; Trujillo, Damian L.; Saligrama, Naresha; Zhang, Yue; Rubelt, Florian; Schneider, David S.; Chien, Yueh-hsiu; Sauerwein, Robert W.; Davis, Mark M.			A Macrophage Colony-Stimulating-Factor-Producing gamma delta T Cell Subset Prevents Malarial Parasitemic Recurrence	IMMUNITY			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ALPHA-BETA; IMMUNE-RESPONSE; RECEPTOR REPERTOIRE; CHABAUDI-CHABAUDI; ANTIGEN RECEPTOR; INTERFERON-GAMMA; DEFICIENT MICE; HOST-DEFENSE; BLOOD-STAGE	Despite evidence that gamma delta T cells play an important role during malaria, their precise role remains unclear. During murine malaria induced by Plasmodium chabaudi infection and in human P. falciparum infection, we found that gamma delta T cells expanded rapidly after resolution of acute parasitemia, in contrast to alpha beta T cells that expanded at the acute stage and then declined. Single-cell sequencing showed that TRAV15N-1 (Vd6.3) gamma delta T cells were clonally expanded in mice and had convergent complementaritydetermining region 3 sequences. These gamma delta T cells expressed specific cytokines, M-CSF, CCL5, CCL3, which are known to act on myeloid cells, indicating that this gamma delta T cell subset might have distinct functions. Both gamma delta T cells and M-CSF were necessary for preventing parasitemic recurrence. These findings point to an M-CSF-producing gamma delta T cell subset that fulfills a specialized protective role in the later stage of malaria infection when alpha beta T cells have declined.	[Mamedov, Murad R.; Chien, Yueh-hsiu] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Mamedov, Murad R.; Rubelt, Florian; Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Scholzen, Anja; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Scholzen, Anja] Innatoss Labs BV, NL-5349 AB Oss, Netherlands; [Nair, Ramesh V.; Zhang, Yue] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cumnock, Katherine; Oliveira, Jose Henrique M.; Trujillo, Damian L.; Saligrama, Naresha; Rubelt, Florian; Schneider, David S.; Chien, Yueh-hsiu; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Kenkel, Justin A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Oliveira, Jose Henrique M.] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, BR-88040900 Florianopolis, SC, Brazil; [Trujillo, Damian L.] Aduro Biotech Inc, Berkeley, CA 94710 USA; [Zhang, Yue] Stanford Univ, Genet Bioinformat Serv Ctr, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Radboud University Nijmegen; Stanford University; Stanford University; Stanford University; Universidade Federal de Santa Catarina (UFSC); Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Scholzen, Anja/D-1046-2013; Sauerwein, Robert/C-8519-2013	Scholzen, Anja/0000-0001-6481-6090; Davis, Mark/0000-0001-6868-657X; Saligrama, Naresha/0000-0003-2526-7150; /0000-0001-7593-5511	NIH [T32AI729029]; US National Institutes of Health [5U19AI057229]; Stanford University School of Medicine (Discovery Innovation Fund); Howard Hughes Medical Institute; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, T32AI007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University School of Medicine (Discovery Innovation Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Davis and Chien laboratories, A. Han, C. Tato, and K. Yadava for helpful discussion and advice; A. Nau, X. Ji, V. Shokoohi for experimental help; volunteers in the CHMI study; Stanford Shared FACS Facility and Functional Genomics Facility for equipment and services. M.R.M. was supported under an NIH Training Grant (T32AI729029). Work was supported by US National Institutes of Health (5U19AI057229 to M.M.D.) and the Stanford University School of Medicine (Discovery Innovation Fund to Y.-h.C.). M.M.D. is supported by the Howard Hughes Medical Institute and the Bill & Melinda Gates Foundation.	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; ARDEN B, 1985, NATURE, V316, P783, DOI 10.1038/316783a0; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bettina A, 2016, J IMMUNOL, V196, P5047, DOI 10.4049/jimmunol.1600306; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BORN W, 1990, SCIENCE, V249, P67, DOI 10.1126/science.1695022; Born WK, 2003, SCAND J IMMUNOL, V58, P374, DOI 10.1046/j.1365-3083.2003.01315.x; Brugat T, 2014, CELL MICROBIOL, V16, P687, DOI 10.1111/cmi.12212; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cady CT, 2000, J IMMUNOL, V165, P1790, DOI 10.4049/jimmunol.165.4.1790; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; CARDING SR, 1990, J EXP MED, V172, P1225, DOI 10.1084/jem.172.4.1225; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontana MF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006046; FU YX, 1993, P NATL ACAD SCI USA, V90, P322, DOI 10.1073/pnas.90.1.322; GOODIER MR, 1995, PARASITE IMMUNOL, V17, P413, DOI 10.1111/j.1365-3024.1995.tb00909.x; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; HAPP MP, 1989, NATURE, V342, P696, DOI 10.1038/342696a0; HO M, 1994, INFECT IMMUN, V62, P855, DOI 10.1128/IAI.62.3.855-862.1994; Hviid L, 2001, INFECT IMMUN, V69, P3190, DOI 10.1128/IAI.69.5.3190-3196.2001; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; LANGHORNE J, 1995, INT IMMUNOL, V7, P1005, DOI 10.1093/intimm/7.6.1005; LANGHORNE J, 1993, SCAND J IMMUNOL, V38, P521, DOI 10.1111/j.1365-3083.1993.tb03235.x; Lee SH, 1997, THROMB HAEMOSTASIS, V77, P289; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; OBRIEN RL, 1992, P NATL ACAD SCI USA, V89, P4348, DOI 10.1073/pnas.89.10.4348; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROUSSILHON C, 1994, CLIN EXP IMMUNOL, V95, P91, DOI 10.1111/j.1365-2249.1994.tb06020.x; Schats R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124243; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Seixas E, 2002, PARASITE IMMUNOL, V24, P131, DOI 10.1046/j.1365-3024.2002.00446.x; Seixas EMG, 1999, J IMMUNOL, V162, P2837; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Skeen MJ, 2004, J LEUKOCYTE BIOL, V76, P104, DOI 10.1189/jlb.1103574; Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231; Spence PJ, 2011, NAT PROTOC, V6, P553, DOI 10.1038/nprot.2011.313; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stanley E. R., 2014, COLD SPRING HARB PER, V6, P6; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Tsuji M, 1996, INT IMMUNOL, V8, P359, DOI 10.1093/intimm/8.3.359; VANDERHEYDE HC, 1993, EUR J IMMUNOL, V23, P1846, DOI 10.1002/eji.1830230817; VILLEVAL JL, 1990, EXP PARASITOL, V71, P375, DOI 10.1016/0014-4894(90)90063-I; Wei YL, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00118; Weidanz WP, 1999, J IMMUNOL, V162, P7383; Welte T, 2011, FEMS IMMUNOL MED MIC, V63, P183, DOI 10.1111/j.1574-695X.2011.00840.x; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zachariadis O, 2006, INFECT IMMUN, V74, P1837, DOI 10.1128/IAI.74.3.1837-1845.2006	61	66	68	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					350	+		10.1016/j.immuni.2018.01.009	http://dx.doi.org/10.1016/j.immuni.2018.01.009			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29426701	Green Accepted, Bronze			2022-12-18	WOS:000425507800019
J	Liew, PX; Lee, WY; Kubes, P				Liew, Pei Xiong; Lee, Woo-Yong; Kubes, Paul			iNKT Cells Orchestrate a Switch from Inflammation to Resolution of Sterile Liver Injury	IMMUNITY			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; MICROBIAL ANTIGENS; WOUND CONTRACTION; DIVERSE ROLES; MOUSE MODEL; ACTIVATION; ALPHA; INNATE; FIBROSIS	After traumatic injury, some cells function as detectors to sense injury and to modulate the local immune response toward a restitution phase by affecting the local cytokine milieu. Using intravital microscopy, we observed that patrolling invariant natural killer T (iNKT) cells were initially excluded from a site of hepatic injury but subsequently were strategically arrested first via self-antigens and then by cytokines, circumscribing the injured site at exactly the location where monocytes co-localized and hepatocytes proliferated. Activation of iNKT cells by self-antigens resulted in the production of interleukin-4 (IL-4) but not interferon-gamma (IFN-gamma). This promoted increased hepatocyte proliferation, monocyte transition (from Ly6C(hi) to Ly6C(lo)), and improved healing where IL-4 from iNKT cells was critical for these processes. Disruption of any of these mechanisms led to delayed wound healing. We have shown that self-antigen- driven iNKT cells function as sensors and orchestrators of the transformation from inflammation to tissue restitution for essential timely wound repair.	[Liew, Pei Xiong; Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary	Liew, PX (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada.	pkubes@ucalgary.ca	Liew, Pei X/M-4653-2018	Liew, Pei X/0000-0002-6065-0684	Canadian Institutes for Health Research operating grant [FDN-143248]; Alberta Innovates Health Solutions studentship [201100494]	Canadian Institutes for Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions studentship	We thank the Flow Cytometry Facility (L. Kennedy and Y. Liu) and Live Cell Imaging Facility for their assistance and T. Nussbaumer and M. Wilson for excellent technical support. The NIH Tetramer Core Facility provided PBS57-loaded CD1d tetramer for iNKT cell identification in flow cytometry. Albert Bendelac generated and donated flox CD1d/VECad-Cre mice. Robert Strieter provided anti-CXCR3 serum. Cxcr6 <SUP>Gfp/Gfp</SUP> and Cx3Cr1 <SUP>Gfp/Gfp</SUP> mice were provided by Dan Littman. Ccr2 <SUP>Rfp/Rfp</SUP> mice were provided by Richard Ransohoff and Israel Charo. This work was supported by a Canadian Institutes for Health Research operating grant (FDN-143248); P.K. is an Alberta Innovates Health Solutions Scientist and the Snyder Chair in Critical Care Medicine, and P.X.L. is supported by an Alberta Innovates Health Solutions studentship (201100494).	Adams EJ, 2011, IMMUNITY, V34, P281, DOI 10.1016/j.immuni.2011.03.006; Ajuebor MN, 2007, AM J PHYSIOL-GASTR L, V293, pG651, DOI 10.1152/ajpgi.00298.2007; Attallah Abdelfattah M, 2016, J Immunoassay Immunochem, V37, P597, DOI 10.1080/15321819.2016.1179646; Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Bajt ML, 2003, J PHARMACOL EXP THER, V307, P67, DOI 10.1124/jpet.103.052506; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2014, NAT REV IMMUNOL, V14, P640, DOI 10.1038/nri3725; Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Choi HJ, 2008, J LEUKOCYTE BIOL, V84, P1462, DOI 10.1189/jlb.0108038; Chuang YH, 2008, HEPATOLOGY, V47, P571, DOI 10.1002/hep.22052; Cox Guy, 2006, V319, P15; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; DeAngelis RA, 2012, J IMMUNOL, V188, P641, DOI 10.4049/jimmunol.1101925; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Gapin L, 2013, CURR OPIN IMMUNOL, V25, P168, DOI 10.1016/j.coi.2013.01.002; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kimura K, 2009, HEPATOL RES, V39, P93, DOI 10.1111/j.1872-034X.2008.00409.x; Knight B, 2007, J HEPATOL, V47, P826, DOI 10.1016/j.jhep.2007.06.022; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kuboki S, 2009, AM J PHYSIOL-GASTR L, V296, pG1054, DOI 10.1152/ajpgi.90464.2008; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Liew PX, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00240; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Mallevaey T, 2012, IMMUNOLOGY, V136, P273, DOI 10.1111/j.1365-2567.2012.03580.x; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Racine-Samson L, 1997, J BIOL CHEM, V272, P30911, DOI 10.1074/jbc.272.49.30911; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Shen H, 2013, J IMMUNOL, V191, P2857, DOI 10.4049/jimmunol.1301539; Shimamura K, 2005, CELL IMMUNOL, V234, P31, DOI 10.1016/j.cellimm.2005.04.022; Slaba I, 2015, HEPATOLOGY, V62, P1593, DOI 10.1002/hep.28003; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Toyabe S, 1997, J IMMUNOL, V159, P1537; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413, DOI 10.4049/jimmunol.167.3.1413; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; Van Kaer L, 2013, TRENDS IMMUNOL, V34, P50, DOI 10.1016/j.it.2012.08.009; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wang XH, 2012, J EXP MED, V209, P987, DOI 10.1084/jem.20111024; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	58	66	68	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					752	+		10.1016/j.immuni.2017.09.016	http://dx.doi.org/10.1016/j.immuni.2017.09.016			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045904	Bronze			2022-12-18	WOS:000413091600018
J	Kieback, E; Hilgenberg, E; Stervbo, U; Lampropoulou, V; Shen, P; Bunse, M; Jaimes, Y; Boudinot, P; Radbruch, A; Klemm, U; Kuhl, AA; Liblau, R; Hoevelmeyer, N; Anderton, SM; Uckert, W; Fillatreau, S				Kieback, Elisa; Hilgenberg, Ellen; Stervbo, Ulrik; Lampropoulou, Vicky; Shen, Ping; Bunse, Mario; Jaimes, Yarua; Boudinot, Pierre; Radbruch, Andreas; Klemm, Uwe; Kuehl, Anja A.; Liblau, Roland; Hoevelmeyer, Nadine; Anderton, Stephen M.; Uckert, Wolfgang; Fillatreau, Simon			Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RETROVIRAL VECTORS; SIGNAL STRENGTH; EFFECTOR-CELLS; HIGH-LEVEL; RECEPTOR; FOXP3(+); TCR; EXPRESSION; DISEASE	Regulatory T (Treg) cells expressing Foxp3 transcripton factor are essential for immune homeostasis. They arise in the thymus as a separate lineage from conventional CD4(+)Foxp3(-) T (Tconv) cells. Here, we show that the thymic development of Treg cells depends on the expression of their endogenous cognate self-antigen. The formation of these cells was impaired in mice lacking this self-antigen, while Tconv cell development was not negatively affected. Thymus-derived Treg cells were selected by self-antigens in a specific manner, while autoreactive Tconv cells were produced through degenerate recognition of distinct antigens. These distinct modes of development were associated with the expression of T cell receptor of higher functional avidity for self-antigen by Treg cells than Tconv cells, a difference subsequently essential for the control of autoimmunity. Our study documents how self-antigens define the repertoire of thymus-derived Treg cells to subsequently endow this cell type with the capacity to undermine autoimmune attack.	[Kieback, Elisa; Uckert, Wolfgang] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Kieback, Elisa; Bunse, Mario; Uckert, Wolfgang] Helmholtz Assoc, Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany; [Hilgenberg, Ellen; Stervbo, Ulrik; Lampropoulou, Vicky; Shen, Ping; Jaimes, Yarua; Radbruch, Andreas; Fillatreau, Simon] Deutsch Rheuma Forschungszentrum, D-10117 Berlin, Germany; [Boudinot, Pierre] INRA, Unite Virol & Immunol Mol, F-78352 Jouy En Josas, France; [Klemm, Uwe] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Kuehl, Anja A.] Charite, Inst Pathol RCIS, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Liblau, Roland] Univ Toulouse 3, CNRS UMR 5282, CPTP, INSERM UMR 1043, Toulouse, France; [Hoevelmeyer, Nadine] Johannes Gutenberg Univ Mainz, Inst Mol Med, D-55131 Mainz, Germany; Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [Fillatreau, Simon] INEM, CNRS UMR 8253, INSERM U1151, Paris, France; [Fillatreau, Simon] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Fillatreau, Simon] Hop Necker Enfants Malad, AP HP, F-75730 Paris, France	Humboldt University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Deutsches Rheuma-Forschungszentrum (DRFZ); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Johannes Gutenberg University of Mainz; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Fillatreau, S (corresponding author), Deutsch Rheuma Forschungszentrum, D-10117 Berlin, Germany.; Fillatreau, S (corresponding author), INEM, CNRS UMR 8253, INSERM U1151, Paris, France.; Fillatreau, S (corresponding author), Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France.; Fillatreau, S (corresponding author), Hop Necker Enfants Malad, AP HP, F-75730 Paris, France.	simon.fillatreau@inserm.fr	Stervbo, Ulrik/AAV-1561-2020; Liblau, Roland/J-3530-2014; boudinot, pierre/L-4246-2016	Stervbo, Ulrik/0000-0002-2831-8868; Kuhl, Anja/0000-0003-2293-5387; Radbruch, Andreas/0000-0001-5753-0000; Hovelmeyer, Nadine/0000-0002-1807-4556; boudinot, pierre/0000-0002-7490-9677; LIBLAU, Roland/0000-0001-5477-5475; Bunse, Mario/0000-0002-7554-2520; Fillatreau, Simon/0000-0002-7730-9917; Shen, Ping/0000-0003-3046-3818	Deutsche Forschungsgemeinschaft [SFB-TR-36, SFB-650]; MRC [G0901697, G0801924] Funding Source: UKRI; Medical Research Council [G0801924, G0901697] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Carolin Genehr, Martina Kalupa, Christin Hesse, and Mareen Kamarys for technical help, Bernard Malissen for T.54 zeta 17 cells, Dimitris Kioussis (NIMR, UK) for the CD2 minigene expression system, and the NIH Tetramer Facility for the tetramers. This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TR-36 and SFB-650).	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Anderton SM, 2002, NAT REV IMMUNOL, V2, P487, DOI 10.1038/nri842; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Bunse M, 2014, MOL THER, V22, P1983, DOI 10.1038/mt.2014.142; Chinen T, 2010, J EXP MED, V207, P2323, DOI 10.1084/jem.20101235; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Fazilleau N, 2006, EUR J IMMUNOL, V36, P533, DOI 10.1002/eji.200535021; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Hood JD, 2015, J IMMUNOL, V195, P4162, DOI 10.4049/jimmunol.1501464; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kieback E, 2014, METHODS MOL BIOL, V1193, P117, DOI 10.1007/978-1-4939-1212-4_12; Kroger CJ, 2007, J IMMUNOL, V179, P748, DOI 10.4049/jimmunol.179.2.748; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Saetrom P, 2006, OLIGONUCLEOTIDES, V16, P115, DOI 10.1089/oli.2006.16.115; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Theil A, 2015, CYTOTHERAPY, V17, P473, DOI 10.1016/j.jcyt.2014.11.005; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van den Elzen P, 2004, AUTOIMMUN REV, V3, P524, DOI 10.1016/j.autrev.2004.07.008; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Verhagen J, 2009, P NATL ACAD SCI USA, V106, P3306, DOI 10.1073/pnas.0803186106; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	51	66	66	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1114	1126		10.1016/j.immuni.2016.04.018	http://dx.doi.org/10.1016/j.immuni.2016.04.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192577	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000376478500016
J	Henderson, JG; Opejin, A; Jones, A; Gross, C; Hawiger, D				Henderson, Jacob G.; Opejin, Adeleye; Jones, Andrew; Gross, Cindy; Hawiger, Daniel			CD5 Instructs Extrathymic Regulatory T Cell Development in Response to Self and Tolerizing Antigens	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VIVO; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSES; DEFICIENT MICE; REG CELLS; MTOR; SELECTION; RECEPTOR	Self-reactive T cells can escape thymic deletion and therefore some of these potentially autoaggressive T cells need to convert into regulatory T (Treg) cells to help control responses against self. However, it remains unknown how peripheral self-reactive T cells are specifically instructed to become Treg cells. We report that CD5, whose expression is upregulated in T cells by self and tolerizing antigens in the thymus and periphery, governed extrathymic Treg cell development. CD5 modified effector cell-differentiating signals that inhibit Treg cell induction. Treg cell conversion of Cd5(-/-) and CD5(lo) T cells was inhibited by even small amounts of interleukin-4 (IL-4), IL-6, and interferon-gamma (IFN-gamma) produced by bystander lymphocytes, while CD5(hi) T cells resisted this inhibition of Treg cell induction. Our findings further revealed that CD5 promoted Treg cell induction by blocking mechanistic target of rapamycin (mTOR) activation. Therefore CD5 instructs extrathymic Treg cell development in response to self and tolerizing antigens.	[Henderson, Jacob G.; Opejin, Adeleye; Jones, Andrew; Gross, Cindy; Hawiger, Daniel] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University	Hawiger, D (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	dhawiger@slu.edu		Opejin, Adeleye/0000-0002-0023-3192	National Multiple Sclerosis Society [TA 3024A]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113903] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Dr. Richard Flavell (Yale University) for providing some of the experimental mice, Joy Eslick and Sherri L. Koehm (Saint Louis University) for expert help with flow cytometry, and Ziva Misulovin (Saint Louis University) for help with immunoblots. This work was supported in part by National Multiple Sclerosis Society career transition fellowship (TA 3024A) and internal funds provided by the Saint Louis University (all to D.H.).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Axtell RC, 2006, J IMMUNOL, V177, P8542, DOI 10.4049/jimmunol.177.12.8542; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G; Brown MH, 2010, J IMMUNOL, V185, P6068, DOI 10.4049/jimmunol.0903823; Cardoso B, 2009, LEUKEMIA, V23, P206, DOI 10.1038/leu.2008.178; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dasu T, 2008, IMMUNOL LETT, V119, P103, DOI 10.1016/j.imlet.2008.05.008; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Fang P, 2006, EXP CELL RES, V312, P1229, DOI 10.1016/j.yexcr.2005.12.011; Fenutria R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084895; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Hadjur S, 2009, IMMUNOL LETT, V122, P37, DOI 10.1016/j.imlet.2008.11.001; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kim HY, 2014, J GASTROENTEROL, V49, P1264, DOI 10.1007/s00535-013-0891-1; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; McGuire DJ, 2014, EUR J IMMUNOL, V44, P1137, DOI 10.1002/eji.201343998; Ordonez-Rueda D, 2009, EUR J IMMUNOL, V39, P2233, DOI 10.1002/eji.200839053; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Sestero CM, 2012, J IMMUNOL, V189, P2918, DOI 10.4049/jimmunol.1200065; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Stamou P, 2003, J IMMUNOL, V171, P1278, DOI 10.4049/jimmunol.171.3.1278; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhao CF, 2010, J EXP MED, V207, P2883, DOI 10.1084/jem.20100598; Zheng MK, 2014, IMMUNOL INVEST, V43, P705, DOI 10.3109/08820139.2014.917096; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	58	66	68	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					471	483		10.1016/j.immuni.2015.02.010	http://dx.doi.org/10.1016/j.immuni.2015.02.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786177	Bronze			2022-12-18	WOS:000351301900012
J	Hawkins, RD; Larjo, A; Tripathi, SK; Wagner, U; Luu, Y; Lonnberg, T; Raghav, SK; Lee, LK; Lund, R; Ren, B; Lahdesmaki, H; Lahesmaa, R				Hawkins, R. David; Larjo, Antti; Tripathi, Subhash K.; Wagner, Ulrich; Luu, Ying; Lonnberg, Tapio; Raghav, Sunil K.; Lee, Leonard K.; Lund, Riikka; Ren, Bing; Lahdesmaki, Harri; Lahesmaa, Riitta			Global Chromatin State Analysis Reveals Lineage-Specific Enhancers during the Initiation of Human T helper 1 and T helper 2 Cell Polarization	IMMUNITY			English	Article							GENOME-WIDE ASSOCIATION; IFNG GENE-EXPRESSION; CD4(+) T-CELLS; LARGE-SCALE; HISTONE MODIFICATIONS; REGULATORY SEQUENCES; FATE DETERMINATION; INTERFERON-GAMMA; LEUKOTRIENE C-4; RISK LOCI	Naive CD4(+) T cells can differentiate into specific helper and regulatory T cell lineages in order to combat infection and disease. The correct response to cytokines and a controlled balance of these populations is critical for the immune system and the avoidance of autoimmune disorders. To investigate how early cell-fate commitment is regulated, we generated the first human genome-wide maps of histone modifications that reveal enhancer elements after 72 hr of in vitro polarization toward T helper 1 (Th1) and T helper 2 (Th2) cell lineages. Our analysis indicated that even at this very early time point, cell-specific gene regulation and enhancers were at work directing lineage commitment. Further examination of lineage-specific enhancers identified transcription factors (TFs) with known and unknown T cell roles as putative drivers of lineage-specific gene expression. Lastly, an integrative analysis of immunopathogenic-associated SNPs suggests a role for distal regulatory elements in disease etiology.	[Hawkins, R. David] Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Hawkins, R. David] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Larjo, Antti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Hawkins, R. David; Tripathi, Subhash K.; Lonnberg, Tapio; Raghav, Sunil K.; Lund, Riikka; Lahdesmaki, Harri; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Hawkins, R. David; Tripathi, Subhash K.; Lonnberg, Tapio; Raghav, Sunil K.; Lund, Riikka; Lahdesmaki, Harri; Lahesmaa, Riitta] Abo Akad Univ, FIN-20520 Turku, Finland; [Tripathi, Subhash K.] Natl Doctoral Programme Informat & Struct Biol, Turku 20520, Finland; [Larjo, Antti; Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, FI-00076 Aalto, Finland; [Wagner, Ulrich; Luu, Ying; Lee, Leonard K.; Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Wagner, Ulrich; Luu, Ying; Lee, Leonard K.; Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Wagner, Ulrich; Luu, Ying; Lee, Leonard K.; Ren, Bing] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tampere University; University of Turku; Abo Akademi University; Aalto University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hawkins, RD (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	rdhawk@uw.edu; harri.lahdesmaki@aalto.fi; riitta.lahesmaa@btk.fi	Lund, Riikka/AAW-7853-2020; Lund, Riikka J/F-7320-2014; Raghav, Sunil/AAL-1121-2021; Lund, Riikka/K-2441-2019; Tripathi, Subhash Kumar/AAW-4285-2020; Lönnberg, Tapio/Q-7245-2016	Lund, Riikka/0000-0002-1068-5918; Tripathi, Subhash Kumar/0000-0003-0669-9636; Lönnberg, Tapio/0000-0003-4484-5657	Academy of Finland [20122017, 140019, 256355]; European Commission [EC-FP7-SYBILLA-201106]; Sigrid Juselius Foundation; Turku University Hospital Grant; Biocenter Finland; TISE Graduate School; NIH [U01 ES017166]; Ludwig Institute for Cancer Research; WA State Life Sciences Discover Fund [265508]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital Grant; Biocenter Finland; TISE Graduate School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; WA State Life Sciences Discover Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank all voluntary blood donors and the personnel of Turku University Hospital Department of Obstetrics and Gynaecology, Maternity Ward (Hospital District of Southwest Finland) for the cord blood collection. We thank Sanna Edelman and Soile Tuomela for suggestions and discussion. We thank Marjo Hakkarainen, Sarita Heinonen, Paivi Junni, Elina Pietila, and the Finnish Microarray and Sequencing Center for technical assistance. This study was supported by the Academy of Finland (R. L., H. L.: Centre of Excellence in Molecular Systems Immunology and Physiology Research, 20122017; R. L. grants 140019 and 256355); the European Commission Seventh Framework grant EC-FP7-SYBILLA-201106 (R. L., H. L.); The Sigrid Juselius Foundation (R. L., H. L.); Turku University Hospital Grant (R. L.); Biocenter Finland (R. L., R. D. H.); TISE Graduate School (H. L.); NIH U01 ES017166 (B. R.) and Ludwig Institute for Cancer Research (B. R.); WA State Life Sciences Discover Fund/(265508) Northwest Institute for Genomic Medicine (R. D. H.).	Aday AW, 2011, DEV BIOL, V357, P450, DOI 10.1016/j.ydbio.2011.03.007; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aijo T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-572; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filen S, 2010, J IMMUNOL, V184, P4990, DOI 10.4049/jimmunol.0903106; Frossi B, 2007, J IMMUNOL, V178, P2549, DOI 10.4049/jimmunol.178.4.2549; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Horiuchi S, 2011, J IMMUNOL, V186, P6378, DOI 10.4049/jimmunol.1100179; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lund R, 2005, EUR J IMMUNOL, V35, P3307, DOI 10.1002/eji.200526079; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Scoggan KA, 1997, J BIOL CHEM, V272, P10182; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sjostrom M, 2001, EUR J BIOCHEM, V268, P2578, DOI 10.1046/j.1432-1327.2001.02142.x; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	65	66	67	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1271	1284		10.1016/j.immuni.2013.05.011	http://dx.doi.org/10.1016/j.immuni.2013.05.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23791644	Green Accepted, Bronze			2022-12-18	WOS:000330947500021
J	Schuster, M; Glauben, R; Plaza-Sirvent, C; Schreiber, L; Annemann, M; Floess, S; Kuhl, AA; Clayton, LK; Sparwasser, T; Schulze-Osthoff, K; Pfeffer, K; Huehn, J; Siegmund, B; Schmitz, I				Schuster, Marc; Glauben, Rainer; Plaza-Sirvent, Carlos; Schreiber, Lisa; Annemann, Michaela; Floess, Stefan; Kuehl, Anja A.; Clayton, Linda K.; Sparwasser, Tim; Schulze-Osthoff, Klaus; Pfeffer, Klaus; Huehn, Jochen; Siegmund, Britta; Schmitz, Ingo			I kappa B-NS Protein Mediates Regulatory T Cell Development via Induction of the Foxp3 Transcription Factor	IMMUNITY			English	Article							THYMIC DEVELOPMENT; C-REL; GENE; EXPRESSION; RECEPTOR; CARMA1; SELF; ACTIVATION; SELECTION; GOVERN	Forkhead box P3 positive (Foxp3(+)) regulatory T (Treg) cells suppress immune responses and regulate peripheral tolerance. Here we show that the atypical inhibitor of NF kappa B (I kappa B) I kappa B-NS drives Foxp3 expression via association with the promoter and the conserved noncoding sequence 3 (CNS3) of the Foxp3 locus. Consequently, I kappa B-NS deficiency leads to a substantial reduction of Foxp3+ Treg cells in vivo and impaired Foxp3 induction upon transforming growth factor-beta (TGF-13) treatment in vitro. Moreover, fewer Foxp3+ Treg cells developed from I kappa B-NS-deficient CD25(-)CD4(+) T cells adoptively transferred into immunodeficient recipients. Importantly, I kappa B-NS was required for the transition of immature GITR(+)CD25(+) Foxp3(-) thymic Treg cell precursors into Foxp3(+) cells. In contrast to mice lacking c-Rel or Carmal, I kappa B-NS-deficient mice do not show reduced Treg precursor cells. Our results demonstrate that IkBNs critically regulates Treg cell development in the thymus and during gut inflammation, indicating that strategies targeting IkBNs could modulate the Treg cell compartment.	[Schreiber, Lisa; Floess, Stefan; Huehn, Jochen; Schmitz, Ingo] Helmholtz Ctr Infect Res, Det Expt Immunol, D-38124 Braunschweig, Germany; [Schuster, Marc; Plaza-Sirvent, Carlos; Annemann, Michaela; Schmitz, Ingo] Univ Magdeburg, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany; [Kuehl, Anja A.] Charite, Inst Pathol, D-12203 Berlin, Germany; [Glauben, Rainer; Siegmund, Britta] Charite, Med Klin 1, D-12203 Berlin, Germany; [Clayton, Linda K.] Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Clayton, Linda K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Sparwasser, Tim] TWINCORE, Inst Infect Immunol, D-30625 Hannover, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Pfeffer, Klaus] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Schmitz, I (corresponding author), Helmholtz Ctr Infect Res, Det Expt Immunol, D-38124 Braunschweig, Germany.	ingo.schmitz@helmholtz-hzi.de	Siegmund, Britta/E-6929-2018; Sparwasser, Tim/AAF-7085-2019; Schmitz, Ingo/G-2093-2013; Schulze-Osthoff, Klaus/N-9025-2013; Sparwasser, Tim D/AAA-4306-2022	Siegmund, Britta/0000-0002-0055-958X; Sparwasser, Tim/0000-0001-5645-902X; Schmitz, Ingo/0000-0002-5360-0419; Schulze-Osthoff, Klaus/0000-0003-1443-2720; Kuhl, Anja/0000-0003-2293-5387; Pfeffer, Klaus/0000-0002-5652-6330; Plaza-Sirvent, Carlos/0000-0003-2767-0402	Deutsche Forschungsgemeinschaft [SI 749/5-3]; SFB [738/C-6, 685/B-7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF))	We thank Sabrina Schumann, Dominique Gollasch, Stephanie Grosch, and Inka Freise for their excellent technical assistance, Ralf Hocker for help with apoptosis experiments, and Alisha Walker for critically reading the manuscript. We are grateful to David Dettbarn and colleagues for excellent mouse husbandry. Rag1<SUP>-/-</SUP> mice were a kind gift from Thomas Blankenstein and Charite Berlin. DNA methylation experiments were developed and performed by Udo Baron and Sven Olek at Epiontis GmbH. We thank the Forschungs-kommission of the Heinrich-Heine University Dusseldorf for initial funding. Further support was provided by the Deutsche Forschungsgemeinschaft (SI 749/5-3) and the SFB 738/C-6 and SFB 685/B-7.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grigoriadis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026851; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Hsieh CS, 2009, IMMUNITY, V31, P852, DOI 10.1016/j.immuni.2009.11.006; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Touma M, 2007, J IMMUNOL, V179, P1681, DOI 10.4049/jimmunol.179.3.1681; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	42	66	66	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					998	1008		10.1016/j.immuni.2012.08.023	http://dx.doi.org/10.1016/j.immuni.2012.08.023			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23200824	Green Submitted, Bronze			2022-12-18	WOS:000312575000009
J	Kosan, C; Saba, I; Godmann, M; Herold, S; Herkert, B; Eilers, M; Moroy, T				Kosan, Christian; Saba, Ingrid; Godmann, Maren; Herold, Stefanie; Herkert, Barbara; Eilers, Martin; Moeroey, Tarik			Transcription Factor Miz-1 Is Required to Regulate Interleukin-7 Receptor Signaling at Early Commitment Stages of B Cell Differentiation	IMMUNITY			English	Article							COMMON LYMPHOID PROGENITORS; HEMATOPOIETIC STEM-CELLS; TRANSGENIC MICE; BONE-MARROW; MYC; FETAL; LYMPHOPOIESIS; EXPRESSION; LACKING; IL-7	B cell development requires the coordinated action of transcription factors and cytokines, in particular interleukin-7 (IL-7). We report that mice lacking the POZ (Poxvirus and zinc finger) domain of the transcription factor Miz-1 (Zbtb17(Delta POZ/Delta POZ)) almost entirely lacked follicular B cells, as shown by the fact that their progenitors failed to activate the Jak-Stat5 pathway and to upregulate the antiapoptotic gene Bcl2 upon IL-7 stimulation. We show that Miz-1 exerted a dual role in the interleukin-7 receptor (IL-7R) pathway by directly repressing the Janus kinase (Jak) inhibitor suppressor of cytokine signaling 1 (Socs1) and by activating Bcl2 expression. Zbtb17(Delta POZ/Delta POZ) (Miz-1-deficient) B cell progenitors had low expression of early B cell genes as transcription factor 3 (Tcf3) and early B cell factor 1 (Ebf1) and showed a propensity for apoptosis. Only the combined re-expression of Bcl2 and Ebf1 could reconstitute the ability of Miz-1-deficient precursors to develop into CD19(+) B cells.	[Kosan, Christian; Saba, Ingrid; Moeroey, Tarik] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Saba, Ingrid; Moeroey, Tarik] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Godmann, Maren] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Herold, Stefanie; Herkert, Barbara; Eilers, Martin] Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; [Moeroey, Tarik] Univ Duisburg Essen, ZMB, D-45117 Essen, Germany	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; University of Wurzburg; University of Duisburg Essen	Moroy, T (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	tarik.moroy@ircm.qc.ca	Kosan, Christian/C-1213-2017; Moroy, Tarik/D-9923-2011; Godmann, Maren/B-5899-2016	Kosan, Christian/0000-0002-8387-3653; Godmann, Maren/0000-0002-0214-8012; Eilers, Martin/0000-0002-0376-6533	IRCM; Canadian Foundation for Innovation (CFI); CIHR [84526]; Canada Research Chair (Tier1)	IRCM; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier1)(Canada Research Chairs)	We thank H. Singh (University of Chicago) for the EBF retroviral construct and H.M. Jaeck (Erlangen, Germany) for the VHT-KI mice. This work was supported by the IRCM, the Canadian Foundation for Innovation (CFI), the CIHR operating grant 84526, and a Canada Research Chair (Tier1) to T.M.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Borghesi L, 2005, J EXP MED, V202, P1669, DOI 10.1084/jem.20051190; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Domen Jos, 1998, Blood, V91, P2272; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hesslein DGT, 2006, MOL IMMUNOL, V43, P326, DOI 10.1016/j.molimm.2005.02.010; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Patel JH, 2007, J BIOL CHEM, V282, P5, DOI 10.1074/jbc.M609138200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Singh H, 2007, ADV EXP MED BIOL, V596, P57; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145	47	66	66	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					917	928		10.1016/j.immuni.2010.11.028	http://dx.doi.org/10.1016/j.immuni.2010.11.028			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21167753	Bronze			2022-12-18	WOS:000286293900012
J	Kioussis, D; Pachnis, V				Kioussis, Dimitris; Pachnis, Vassilis			Immune and Nervous Systems: More Than Just a Superficial Similarity?	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTORS; RANBPM; DIFFERENTIATION; NEURONS; BRAIN; PLASTICITY; CELLS; INNERVATION; ACTIVATION	Strong evidence is emerging that the nervous and immune systems share mechanisms of gene regulation signaling, cell communication, and supracellular organization. This brings to the fore many questions, not least of which is the developmental and evolutionary origin of the commonalities between the two systems. By providing answers to these questions, immunologists and neurobiologists increasingly expose the mechanistic and conceptual affinities of their respective fields and facilitate the understanding of fundamental principles that govern the organization of complex cellular systems. The current essay and reviews in Immunity and Neuron attempt to communicate to the wider scientific community a series of examples relating to commonalities between the immune and nervous system and enhance the dialog and exchange of ideas between the two fields.	[Kioussis, Dimitris] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Pachnis, Vassilis] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England.	dkioussis@nimr.mrc.ac.uk		Pachnis, Vassilis/0000-0001-9733-7686	MRC [MC_U117512796, MC_U117537087] Funding Source: UKRI; Medical Research Council [MC_U117537087, MC_U117512796] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agoston DV, 2007, J NEUROCHEM, V102, P1805, DOI 10.1111/j.1471-4159.2007.04653.x; Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Allen ND, 2008, PHILOS T R SOC B, V363, P23, DOI 10.1098/rstb.2006.2010; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Camacho-Arroyo I, 2009, NEUROIMMUNOMODULAT, V16, P1, DOI 10.1159/000179661; Cedar H, 2008, CURR OPIN IMMUNOL, V20, P308, DOI 10.1016/j.coi.2008.02.002; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Crepaldi L, 2009, EPIGENETICS-US, V4, P23, DOI 10.4161/epi.4.1.7604; Daneman R, 2009, IMMUNITY, V31, P722, DOI 10.1016/j.immuni.2009.09.012; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kerschensteiner M, 2009, NEUROSCIENCE, V158, P1122, DOI 10.1016/j.neuroscience.2008.09.009; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; LANDIS SC, 1988, DEV BIOL, V126, P129, DOI 10.1016/0012-1606(88)90246-1; Le Douarin NM, 1999, NEURAL CREST; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Ma Y, 2007, CELL CYCLE, V6, P2859, DOI 10.4161/cc.6.23.5018; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rothenberg EV, 2004, SEMIN IMMUNOL, V16, P227, DOI 10.1016/j.smim.2004.08.002; Selmeczy Z, 2008, NEUROCHEM INT, V52, P52, DOI 10.1016/j.neuint.2007.06.001; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shaw AS, 2001, NAT IMMUNOL, V2, P575, DOI 10.1038/89712; Sloan EK, 2008, BRAIN BEHAV IMMUN, V22, P15, DOI 10.1016/j.bbi.2007.06.011; Stockinger B, 2009, EUR J IMMUNOL, V39, P652, DOI 10.1002/eji.200839134; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wheway J, 2007, CURR TOP MED CHEM, V7, P1743, DOI 10.2174/156802607782341046; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wolfe EA, 2008, STUD AM INDIAN LIT, V20, P1, DOI 10.1353/ail.0.0045; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	49	66	68	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 20	2009	31	5					705	710		10.1016/j.immuni.2009.09.009	http://dx.doi.org/10.1016/j.immuni.2009.09.009			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19836266	Bronze			2022-12-18	WOS:000272097900006
J	Feng, JM; Hu, YHK; Xie, LH; Colwell, CS; Shao, XSM; Sun, XP; Chen, BM; Tang, HZ; Campagnoni, AT				Feng, Ji-Ming; Hu, Yanhong K.; Xie, Lai-Hua; Colwell, Christopher S.; Shao, Xuesi M.; Sun, Xiao-Ping; Chen, Boming; Tang, Hezhen; Campagnoni, Anthony T.			Golli protein negatively regulates store depletion-induced calcium influx in T cells	IMMUNITY			English	Article							AUTOIMMUNE ENCEPHALOMYELITIS; CA2+ SENSOR; ACTIVATION; GENE; MECHANISMS; EXPRESSION; RECEPTOR; ENTRY; MBP; PRODUCTS	Calcium influx is crucial for T cell activation and differentiation. The detailed regulation of this process remains unclear. We report here that golli protein, an alternatively spliced product of the myelin basic protein gene, plays a critical role in regulating calcium influx in T cells. Golli-deficient T cells were hyperproliferative and showed enhanced calcium entry upon T cell receptor stimulation. We further found that golli regulates calcium influx in T cells through the inhibition of the store depletion-induced calcium influx. Mutation of the myristoylation site on golli disrupted its association with the plasma membrane and reversed its inhibitory action on Ca2+ influx, indicating that membrane association of golli was essential for its inhibitory action. These results indicate that golli functions in a unique way to regulate T cell activation through a mechanism involving the modulation of the calcium homeostasis.	Univ Calif Los Angeles, Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Geffen Sch Med, Dept Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Feng, JM (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Semel Inst Neurosci & Human Behav, 635 Charles Young Dr, Los Angeles, CA 90095 USA.	jfeng@mednet.ucla.edu; acampagnoni@mednet.ucla.edu	Colwell, Chris/AAM-6111-2020	Colwell, Christopher/0000-0002-1059-184X; Feng, Ji-Ming/0000-0001-7956-2126	NINDS NIH HHS [NS33091, NS23022] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033091, R01NS023022] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Campagnoni A, 2001, BRAIN PATHOL, V11, P74; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feng JM, 2000, J IMMUNOL, V165, P5443, DOI 10.4049/jimmunol.165.10.5443; Feng JM, 2004, J NEUROIMMUNOL, V152, P57, DOI 10.1016/j.jneuroim.2004.03.021; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Jacobs EC, 2005, J NEUROSCI, V25, P7004, DOI 10.1523/JNEUROSCI.0288-05.2005; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Landry CF, 1996, J NEUROSCI, V16, P2452; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Paget WJ, 1999, SOZ PRAVENTIV MED, V44, P1, DOI 10.1007/BF01624804; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; PREMACK BA, 1994, J IMMUNOL, V152, P5226; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 2001, J CELL SCI, V114, P2223; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SMITH BH, 1989, J INSECT BEHAV, V2, P397, DOI 10.1007/BF01068064; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Voskuhl RR, 2003, J NEUROIMMUNOL, V139, P44, DOI 10.1016/S0165-5728(03)00161-9; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	42	66	68	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					717	727		10.1016/j.immuni.2006.04.007	http://dx.doi.org/10.1016/j.immuni.2006.04.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782028	Bronze			2022-12-18	WOS:000238592200010
J	Hostert, A; Garefalaki, A; Mavria, G; Tolaini, M; Roderick, K; Norton, T; Mee, PJ; Tybulewicz, VLJ; Coles, M; Kioussis, D				Hostert, A; Garefalaki, A; Mavria, G; Tolaini, M; Roderick, K; Norton, T; Mee, PJ; Tybulewicz, VLJ; Coles, M; Kioussis, D			Hierarchical interactions of control elements determine CD8 alpha gene expression in subsets of thymocytes and peripheral T cells	IMMUNITY			English	Article							TRANSGENIC MICE; CD4 GENE; INTRAEPITHELIAL LYMPHOCYTES; MOUSE LYT-2; SELECTION; ENHANCER; RECEPTOR; DIFFERENTIATION; EPITHELIUM; DISRUPTION	CD4 and CD8 are crucial for the development and function of T cells. An intergenic deoxyribonuclease I hypersensitive site region (cluster CIII) directs expression in mature CD8 T cells only. Here, we show that two further independent regions from the CD8 gene locus in conjunction with cluster CIII restore transgene expression in appropriate immature thymocytes. Deletion of two of the intergenic cluster CIII DNasel-HSS in homozygous mutant mice affects expression of CD8 alpha alpha homodimers on intraepithelial T cells (IEL), particularly on the gamma delta TCR+ subset. Surprisingly, none of the thymocyte or peripheral alpha beta TCR T cell subsets are affected by this mutation, indicating hierarchical activation of these elements within the different T cell subsets.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, Div Mol Immunol, Ridgeway,Mill Hill, London NW7 1AA, England.	d-kiouss@nimr.mrc.ac.uk		Tybulewicz, Victor/0000-0003-2439-0798				Adlam M, 1997, INT IMMUNOL, V9, P877, DOI 10.1093/intimm/9.6.877; BLUMBERG MR, 1993, SECOND SOURCE BIOMED, V4, P4; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GU JJ, 1992, IMMUNOGENETICS, V36, P283; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Hamerman JA, 1997, J IMMUNOL, V159, P1240; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; HOSTERT A, 1998, THESIS U LONDON LOND; HWANG I, 1993, IMMUNOGENETICS, V37, P129; JAY G, 1982, P NATL ACAD SCI-BIOL, V79, P2654, DOI 10.1073/pnas.79.8.2654; Kieffer LJ, 1997, J IMMUNOL, V159, P4907; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; LEDBETTER JA, 1981, J EXP MED, V153, P1503, DOI 10.1084/jem.153.6.1503; LEDBETTER JA, 1982, IMMUNOL REV, V68, P197, DOI 10.1111/j.1600-065X.1982.tb01065.x; LEE WH, 1994, INT IMMUNOL, V6, P1307, DOI 10.1093/intimm/6.9.1307; MALOY KJ, 1991, IMMUNOLOGY, V72, P555; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROCHA B, 1992, IMMUNOL TODAY, V13, P449, DOI 10.1016/0167-5699(92)90074-H; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Salmon P, 1996, J IMMUNOL, V156, P1873; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Uematsu Y, 1997, INT IMMUNOL, V9, P179, DOI 10.1093/intimm/9.1.179; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7	39	66	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					497	508		10.1016/S1074-7613(00)80633-0	http://dx.doi.org/10.1016/S1074-7613(00)80633-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806636	Bronze			2022-12-18	WOS:000076680700008
J	Cerutti, A; Schaffer, A; Shah, S; Zan, H; Liou, HC; Goodwin, RG; Casali, P				Cerutti, A; Schaffer, A; Shah, S; Zan, H; Liou, HC; Goodwin, RG; Casali, P			CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells	IMMUNITY			English	Article							NF-KAPPA-B; TRAF-INTERACTING PROTEIN; REED-STERNBERG CELLS; ACTIVATED T-CELLS; CD40 LIGAND; HODGKINS-DISEASE; RECEPTOR; EXPRESSION; DIFFERENTIATION; TNF	We used our monoclonal model of germinal center maturation, CL-01 B cells, to investigate the role of CD30 in human B cell differentiation. CL-01 cells are IgM(+)IgD(+)CD30(+) and switch to IgG, IgA, and IgE when exposed to CD40L and IL-4. Switching is hampered by CD30 coengagement, possibly through interference with the CD40-mediated NF-kappa B-dependent transcriptional activation of downstream C-H genes. The physiological relevance of this phenomenon is emphasized by similar CD30-mediated effects in naive B cells. Expression of CD30 by these cells is induced by CD40L but is inhibited by B cell receptor coengagement and/or exposure to IL-6 and IL-12. Our data suggest that CD30 critically regulates the CD40-mediated differentiation of non-antigen-selected human B cells.	Cornell Univ, Coll Med, Dept Pathol, Div Mol Immunol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Coll Med, Dept Med, Div Immunol, New York, NY 10021 USA; Immunex Corp, Seattle, WA 98101 USA	Cornell University; Cornell University; Cornell University; Immunex Corporation	Casali, P (corresponding author), Cornell Univ, Coll Med, Dept Pathol, Div Mol Immunol, New York, NY 10021 USA.	pcasali@mail.med.cornell.edu	Casali, Paolo/F-6579-2010	Cerutti, Andrea/0000-0003-3026-4704	NCI NIH HHS [CA 68541] Funding Source: Medline; NIAMS NIH HHS [AR 40908, R01 AR040908] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040908] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ansieau S, 1996, P NATL ACAD SCI USA, V93, P14053, DOI 10.1073/pnas.93.24.14053; ARMITAGE RJ, 1992, EUR J IMMUNOL, V22, P2071, DOI 10.1002/eji.1830220817; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Cerutti A, 1998, J IMMUNOL, V160, P2145; Choe JS, 1996, J IMMUNOL, V157, P1006; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; DELPRETE G, 1995, J EXP MED, V182, P1655, DOI 10.1084/jem.182.6.1655; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; GRUSS HJ, 1995, EUR J IMMUNOL, V25, P2083, DOI 10.1002/eji.1830250742; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Jacquot S, 1997, J IMMUNOL, V159, P2652; JUMPER MD, 1995, J IMMUNOL, V155, P2369; JUMPER MD, 1994, J IMMUNOL, V152, P438; Jumper MD, 1996, MOL IMMUNOL, V33, P965, DOI 10.1016/S0161-5890(96)00045-4; Kehry MR, 1996, J IMMUNOL, V156, P2345; Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; ORourke L, 1997, CURR OPIN IMMUNOL, V9, P324, DOI 10.1016/S0952-7915(97)80077-5; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Schaffer A, 1998, FASEB J, V12, pA1058; SCHATTNER EJ, 1995, J EXP MED, V182, P1557, DOI 10.1084/jem.182.5.1557; SCHWARTING R, 1989, BLOOD, V74, P1678; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; STEIN H, 1982, INT J CANCER, V30, P445, DOI 10.1002/ijc.2910300411; STEIN H, 1985, BLOOD, V66, P848; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VanKooten C, 1996, ADV IMMUNOL, V61, P1; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zan H, 1998, FASEB J, V12, pA1057; ZAN H, IN PRESS J IMMUNOL	46	66	66	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1998	9	2					247	256		10.1016/S1074-7613(00)80607-X	http://dx.doi.org/10.1016/S1074-7613(00)80607-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729045	Green Accepted, hybrid			2022-12-18	WOS:000075610300011
J	Ohto, U; Ishida, H; Shibata, T; Sato, R; Miyake, K; Shimizu, T				Ohto, Umeharu; Ishida, Hanako; Shibata, Takuma; Sato, Ryota; Miyake, Kensuke; Shimizu, Toshiyuki			Toll-like Receptor 9 Contains Two DNA Binding Sites that Function Cooperatively to Promote Receptor Dimerization and Activation	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; NUCLEIC-ACID RECOGNITION; SINGLE-STRANDED RNA; RESPONSES; CPG	Toll-like receptor 9 (TLR9) recognizes DNA containing CpG motifs derived from bacteria and viruses and activates the innate immune response to eliminate them. TLR9 is known to bind to CpG DNA, and here, we identified another DNA binding site in TLR9 that binds DNA containing cytosine at the second position from the 5' end (5'-xCx DNA). 5'-xCx DNAs bound to TLR9 in the presence of CpG DNA and cooperatively promoted dimerization and activation of TLR9. Binding at both sites was important for efficient activation of TLR9. The 5'-xCx DNA bound the site corresponding to the nucleoside binding site in TLR7 and TLR8 as revealed by the structural analysis. This study revealed that TLR9 recognizes two types of DNA through its two binding sites for efficient activation. This information may contribute to the development of drugs that control the activity of TLR9.	[Ohto, Umeharu; Ishida, Hanako; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shibata, Takuma; Sato, Ryota; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Innate Immun, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo	Ohto, U; Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	umeji@mol.f.u-tokyo.ac.jp; shimizu@mol.f.u-tokyo.ac.jp	Shibata, Takuma/M-8196-2019		Japanese Ministry of Education, Culture, Sports, Science, and Technology [26711002, 16K08827, 16H06388, 16H02494]; CREST, JST; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Naito Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation)	We thank the Beamline staff members at SPring-8 for their assistance with data collection. This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 26711002 (U.O.), 16K08827 (T. Shibata), 16H06388 (K.M.) and 16H02494 (T. Shimizu); CREST, JST (T. Shibata and T. Shimizu); the Takeda Science Foundation (U.O. and T. Shimizu); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.); the Daiichi Sankyo Foundation of Life Science (U.O.); the Uehara Memorial Foundation (T. Shimizu); and the Naito Foundation (U.O. and T. Shimizu).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hipp MM, 2013, IMMUNITY, V39, P711, DOI 10.1016/j.immuni.2013.09.004; Ishii N, 2014, J IMMUNOL, V193, P5118, DOI 10.4049/jimmunol.1401375; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li XD, 2012, ELIFE, V1, DOI 10.7554/eLife.00102; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Miyake K, 2017, J LEUKOCYTE BIOL, V101, P135, DOI 10.1189/jlb.4MR0316-108R; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Ohto U, 2014, MICROBES INFECT, V16, P273, DOI 10.1016/j.micinf.2014.01.007; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pohar J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15363; Pohar J, 2017, J IMMUNOL, V198, P2093, DOI 10.4049/jimmunol.1600757; Pohar J, 2015, J IMMUNOL, V195, P4396, DOI 10.4049/jimmunol.1500600; Pohar J, 2015, J IMMUNOL, V194, P3901, DOI 10.4049/jimmunol.1402755; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011	39	65	67	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					649	+		10.1016/j.immuni.2018.03.013	http://dx.doi.org/10.1016/j.immuni.2018.03.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29625894	Bronze			2022-12-18	WOS:000430198900013
J	Snijder, J; Ortego, MS; Weidle, C; Stuart, AB; Gray, MD; McElrath, MJ; Pancera, M; Veesler, D; McGuire, AT				Snijder, Joost; Ortego, Michael S.; Weidle, Connor; Stuart, Andrew B.; Gray, Matthew D.; McElrath, M. Juliana; Pancera, Marie; Veesler, David; McGuire, Andrew T.			An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; EPHRIN RECEPTOR A2; EPITHELIAL-CELLS; B-CELLS; CRYSTAL-STRUCTURE; GLYCOPROTEINS GH; DENSITY MAPS; VACCINE; BINDING; GH/GL	Epstein-Barr virus (EBV) is a causative agent of infectious mononucleosis and is associated with 200,000 new cases of cancer and 140,000 deaths annually. Subunit vaccines against this pathogen have focused on the gp350 glycoprotein and remain unsuccessful. We isolated human antibodies recognizing the EBV fusion machinery (gH/gL and gB) from rare memory B cells. One anti-gH/gL antibody, AMMO1, potently neutralized infection of B cells and epithelial cells, the two major cell types targeted by EBV. We determined a cryo-electron microscopy reconstruction of the gH/gL-gp42-AMMO1 complex and demonstrated that AMMO1 bound to a discontinuous epitope formed by both gH and gL at the Domain-I/Domain-II interface. Integrating structural, biochemical, and infectivity data, we propose that AMMO1 inhibits fusion of the viral and cellular membranes. This work identifies a crucial epitope that may aid in the design of next-generation subunit vaccines against this major public health burden.	[Snijder, Joost; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ortego, Michael S.; Weidle, Connor; Stuart, Andrew B.; Gray, Matthew D.; McElrath, M. Juliana; Pancera, Marie; Veesler, David; McGuire, Andrew T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N POB 19024, Seattle, WA 98109 USA; [McGuire, Andrew T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Veesler, D; McGuire, AT (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N POB 19024, Seattle, WA 98109 USA.; McGuire, AT (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	dveesler@uw.edu; amcguire@fredhutch.org	Veesler, David/HCH-3986-2022	McGuire, Andrew/0000-0003-1841-6859	Vaccine and Infectious Disease Division Faculty Initiative Grant "EBV Vaccine Discovery'' through the Fred Hutchinson Cancer Research Center (ATM); National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R01GM120553]; Seattle Structural and Genomics Center for Infectious Disease from the National Institute of Allergy and Infectious Diseases [HHSN272201700059C]; Pew Biomedical Scholars Award; Netherlands Organization for Scientific Research (NWO) [Rubicon 019.2015.2.310.006]; European Molecular Biology Organisation (EMBO) [ALTF 933-2015]; NIH [1U24GM116792, 1S10RR23057, 1S10OD018111]; NSF [DBI-1338135]; CNSI at UCLA; National Institutes of Health, National Institute of General Medical Sciences; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; University of Washington's Proteomics Resource [UWPR95794]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120553, U24GM116792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER	Vaccine and Infectious Disease Division Faculty Initiative Grant "EBV Vaccine Discovery'' through the Fred Hutchinson Cancer Research Center (ATM); National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Seattle Structural and Genomics Center for Infectious Disease from the National Institute of Allergy and Infectious Diseases; Pew Biomedical Scholars Award; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CNSI at UCLA; National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); University of Washington's Proteomics Resource; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are particularly grateful to Leonidas Stamatatos for use of laboratory space, equipment, and for helpful discussions. This research was supported by a Vaccine and Infectious Disease Division Faculty Initiative Grant "EBV Vaccine Discovery'' through the Fred Hutchinson Cancer Research Center (ATM) and the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award Number R01GM120553 (D.V.), the Seattle Structural and Genomics Center for Infectious Disease from the National Institute of Allergy and Infectious Diseases under contract number HHSN272201700059C (D.V.), a Pew Biomedical Scholars Award (D.V.), the Netherlands Organization for Scientific Research (NWO, Rubicon 019.2015.2.310.006; J.S.), and the European Molecular Biology Organisation (EMBO, ALTF 933-2015; J.S.). The authors acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by NIH (1U24GM116792, 1S10RR23057, and 1S10OD018111), NSF (DBI-1338135), and CNSI at UCLA. We thank the James B. Pendleton Charitable Trust for its generous support of Formulatrix robotic instruments. We thank Dr. Anna Wald for serum samples for the EBV seronegative donor (P); Drs. J. Agirre and Y. Yang for helpful discussion on analysis and representation of N-linked glycosylation by MS; Stephen P. Voght for careful technical editing of the manuscript; and Ashley R. Clayton and Abigail Wall for assistance with figure preparation. X-ray diffraction data were collected at the Berkeley Center for Structural Biology beamlines 5.0.1 and 5.0.2, which are supported in part by the National Institutes of Health, National Institute of General Medical Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This work was also partly supported by the University of Washington's Proteomics Resource (UWPR95794).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALACHANDRAN N, 1987, J VIROL, V61, P1125, DOI 10.1128/JVI.61.4.1125-1135.1987; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Borza CM, 2004, J VIROL, V78, P5007, DOI 10.1128/JVI.78.10.5007-5014.2004; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chandramouli S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan1457; Chen J, 2018, NAT MICROBIOL, V3, P172, DOI 10.1038/s41564-017-0081-7; Chen J, 2013, J VIROL, V87, P3620, DOI 10.1128/JVI.03245-12; Chen J, 2012, MBIO, V3, DOI 10.1128/mBio.00290-11; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Ciferri C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005230; Cohen J. I., 2011, VACCINE S2, V3; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Cui XL, 2016, VACCINE, V34, P4050, DOI 10.1016/j.vaccine.2016.06.021; DeLano W. L, 2002, PYMOL MOL GENETICS G; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/NMETH.3286, 10.1038/nmeth.3286]; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Easterhoff D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006182; EDSON CM, 1981, J VIROL, V39, P172, DOI 10.1128/JVI.39.1.172-184.1981; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frese CK, 2013, J PROTEOME RES, V12, P1520, DOI 10.1021/pr301130k; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haan KM, 2000, J VIROL, V74, P2451, DOI 10.1128/JVI.74.5.2451-2454.2000; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; Hague T, 2006, J INFECT DIS, V194, P584, DOI 10.1086/505912; Herrman M, 2016, J VIROL, V90, P1222, DOI 10.1128/JVI.02531-15; HOFFMAN GJ, 1980, P NATL ACAD SCI-BIOL, V77, P2979, DOI 10.1073/pnas.77.5.2979; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kirschner AN, 2007, J VIROL, V81, P9216, DOI 10.1128/JVI.00575-07; Kirschner AN, 2006, J VIROL, V80, P9444, DOI 10.1128/JVI.00572-06; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LI QX, 1995, J VIROL, V69, P3987, DOI 10.1128/JVI.69.7.3987-3994.1995; LI QX, 1992, NATURE, V356, P347, DOI 10.1038/356347a0; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McShane Marisa P, 2005, Methods Mol Biol, V292, P187; MILLER G, 1972, J INFECT DIS, V125, P403, DOI 10.1093/infdis/125.4.403; MILLER N, 1992, J VIROL, V66, P3409, DOI 10.1128/JVI.66.6.3409-3414.1992; Mohl BS, 2016, MOL CELLS, V39, P286, DOI 10.14348/molcells.2016.0066; Mohl BS, 2014, J VIROL, V88, P13570, DOI 10.1128/JVI.02272-14; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; MOSS DJ, 1972, J GEN VIROL, V17, P233, DOI 10.1099/0022-1317-17-2-233; Moutschen M, 2007, VACCINE, V25, P4697, DOI 10.1016/j.vaccine.2007.04.008; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Omerovic J, 2005, J VIROL, V79, P12408, DOI 10.1128/JVI.79.19.12408-12415.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plate AE, 2011, VIROLOGY, V413, P26, DOI 10.1016/j.virol.2010.12.006; Plate AE, 2009, J VIROL, V83, P7678, DOI 10.1128/JVI.00457-09; Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960; Rickinson AB, 2014, TRENDS IMMUNOL, V35, P159, DOI 10.1016/j.it.2014.01.003; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sashihara J, 2009, VIROLOGY, V391, P249, DOI 10.1016/j.virol.2009.06.013; Sathiyamoorthy K, 2017, P NATL ACAD SCI USA, V114, pE8703, DOI 10.1073/pnas.1704661114; Sathiyamoorthy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13557; Sathiyamoorthy K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004309; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Snijder J, 2017, J STRUCT BIOL, V198, P38, DOI 10.1016/j.jsb.2017.02.008; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Stampfer SD, 2013, CURR OPIN VIROL, V3, P13, DOI 10.1016/j.coviro.2012.10.005; STRNAD BC, 1982, J VIROL, V41, P258, DOI 10.1128/JVI.41.1.258-264.1982; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tangye SG, 2017, J EXP MED, V214, P269, DOI 10.1084/jem.20161846; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Taylor GS, 2015, ANNU REV IMMUNOL, V33, P787, DOI 10.1146/annurev-immunol-032414-112326; Taylor JJ, 2012, J EXP MED, V209, P2065, DOI 10.1084/jem.20112272; THORLEYLAWSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P5307, DOI 10.1073/pnas.77.9.5307; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu LG, 2005, J VIROL, V79, P10923, DOI 10.1128/JVI.79.17.10923-10930.2005; Xing Y, 2015, P NATL ACAD SCI USA, V112, P6056, DOI 10.1073/pnas.1501176112; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang H, 2018, NAT MICROBIOL, V3, P164, DOI 10.1038/s41564-017-0080-8; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	98	65	66	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					799	+		10.1016/j.immuni.2018.03.026	http://dx.doi.org/10.1016/j.immuni.2018.03.026			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669253	Bronze, Green Accepted			2022-12-18	WOS:000430198900024
J	McFarland, AP; Luo, S; Ahmed-Qadri, F; Zuck, M; Thayer, EF; Goo, YA; Hybiske, K; Tong, L; Woodward, JJ				McFarland, Adelle P.; Luo, Shukun; Ahmed-Qadri, Fariha; Zuck, Meghan; Thayer, Elizabeth F.; Goo, Young Ah; Hybiske, Kevin; Tong, Liang; Woodward, Joshua J.			Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promotes NF-kappa B Activation and Shapes a Proinflammatory Antibacterial State	IMMUNITY			English	Article							C-DI-AMP; TOLL-LIKE RECEPTOR; CYTOSOLIC SURVEILLANCE PATHWAY; SITE-DIRECTED MUTAGENESIS; NITRIC-OXIDE SYNTHASE; ALDO-KETO REDUCTASES; IMMUNE DNA SENSOR; LISTERIA-MONOCYTOGENES; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON RESPONSE	Bacterial and host cyclic dinucleotides (cdNs) mediate cytosolic immune responses through the STING signaling pathway, although evidence suggests that alternative pathways exist. We used cdN-conjugated beads to biochemically isolate host receptors for bacterial cdNs, and we identified the oxidoreductase RECON. High-affinity cdN binding inhibited RECON enzyme activity by simultaneously blocking the substrate and cosubstrate sites, as revealed by structural analyses. During bacterial infection of macrophages, RECON antagonized STING activation by acting as a molecular sink for cdNs. Bacterial infection of hepatocytes, which do not express STING, revealed that RECON negatively regulates NF-kappa B activation. Loss of RECON activity, via genetic ablation or inhibition by cdNs, increased NF-kappa B activation and reduced bacterial survival, suggesting that cdN inhibition of RECON promotes a proinflammatory, antibacterial state that is distinct from the antiviral state associated with STING activation. Thus, RECON functions as a cytosolic sensor for bacterial cdNs, shaping inflammatory gene activation via its effects on STING and NF-kappa B.	[McFarland, Adelle P.; Ahmed-Qadri, Fariha; Thayer, Elizabeth F.; Woodward, Joshua J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [McFarland, Adelle P.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Luo, Shukun; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Zuck, Meghan; Hybiske, Kevin] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Zuck, Meghan] Univ Calif Berkeley, Sch Publ Hlth, Program Infect Dis, Berkeley, CA 94720 USA; [Goo, Young Ah] Northwestern Univ, Prote Ctr Excellence, Chicago, IL 60611 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; Northwestern University	Woodward, JJ (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jjwoodwa@uw.edu	Luo, Shukun/A-8371-2017; Luo, Shukun/AAT-8195-2021	Luo, Shukun/0000-0002-2766-3125; Luo, Shukun/0000-0002-2766-3125; Tong, Liang/0000-0002-0563-6468; McFarland, Adelle/0000-0001-7534-1158	National Science Foundation [DGE-1256082]; National Institutes of Health [AI116669, AI108698]; Pew Scholars Program in the Biomedical Sciences; NIH [S10OD012018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116669, R56AI108698] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to Dan Stetson and Michael Gale, Jr. (U. of Washington) for murine bone marrow, Ram Savan (U. of Washington) for help with real-time qPCR experiments, Kamakshi Sureka for helpful discussions, Alex Pollock for feedback on the preparation of the manuscript, and TuAnh Ngoc Huynh for technical help with pull-down experiments. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program (to A.P.M.) under grant no. DGE-1256082 and by National Institutes of Health grants AI116669 (to J.J.W. and L.T.), AI108698 (to J.J.W.), and the Pew Scholars Program in the Biomedical Sciences (to J.J.W.). The in-house instrument for X-ray diffraction screening was supported by an NIH grant to L.T. (S10OD012018).	Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bruhn KW, 2007, MICROBES INFECT, V9, P1226, DOI 10.1016/j.micinf.2007.05.010; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cole C, 2012, IMMUNITY, V36, P807, DOI 10.1016/j.immuni.2012.03.011; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Crimmins GT, 2008, P NATL ACAD SCI USA, V105, P10191, DOI 10.1073/pnas.0804170105; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Di Costanzo L, 2009, CHEM-BIOL INTERACT, V178, P127, DOI 10.1016/j.cbi.2008.10.046; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Endo S, 2007, ARCH BIOCHEM BIOPHYS, V467, P76, DOI 10.1016/j.abb.2007.08.011; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Ikeda S, 1999, FEBS LETT, V459, P433, DOI 10.1016/S0014-5793(99)01243-0; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jacobs AT, 2003, NITRIC OXIDE-BIOL CH, V8, P222, DOI 10.1016/S1089-8603(03)00027-2; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kellenberger CA, 2015, P NATL ACAD SCI USA, V112, P5383, DOI 10.1073/pnas.1419328112; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Martin HJO, 2006, DRUG METAB DISPOS, V34, P464, DOI 10.1124/dmd; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Mosa A, 2009, INFECT IMMUN, V77, P2908, DOI 10.1128/IAI.01068-08; Murphy PM, 2000, PHARMACOL REV, V52, P145; Penning TM, 2009, ANN NY ACAD SCI, V1155, P33, DOI 10.1111/j.1749-6632.2009.03700.x; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shimizu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21093; Skrnjug I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095728; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Thomsen MK, 2016, HEPATOLOGY, V64, P746, DOI 10.1002/hep.28685; Vergnes L, 2003, J LIPID RES, V44, P503, DOI 10.1194/jlr.M200399-JLR200; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Yang X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006074; Yi GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077846; Yun HY, 2015, ONCOTARGET, V6, P11600, DOI 10.18632/oncotarget.3417; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	54	65	69	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					433	445		10.1016/j.immuni.2017.02.014	http://dx.doi.org/10.1016/j.immuni.2017.02.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329705	Bronze, Green Accepted			2022-12-18	WOS:000396818100015
J	Barouch, DH; Thomas, SJ; Michael, NL				Barouch, Dan H.; Thomas, Stephen J.; Michael, Nelson L.			Prospects for a Zika Virus Vaccine	IMMUNITY			English	Review							ANTIBODY-DEPENDENT ENHANCEMENT; BORNE ENCEPHALITIS-VIRUS; GUILLAIN-BARRE-SYNDROME; TETRAVALENT DENGUE VACCINE; JAPANESE ENCEPHALITIS; PROTECTIVE EFFICACY; CROSS-REACTIVITY; STRUCTURAL BASIS; BIRTH-DEFECTS; INFECTION	A recent unprecedented outbreak of Zika virus (ZIKV) in the Americas has been associated with microcephaly and other congenital malformations in infants as well as Guillain-Barre syndrome in adults. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Promising data from preclinical vaccine studies in mice and monkeys suggest that an effective vaccine will likely be possible, but important scientific challenges remain. Here we review the current state of ZIKV vaccine development. We discuss different vaccination strategies and we highlight challenges facing clinical evaluation of ZIKV vaccine candidates.	[Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Harvard Med Sch, Boston, MA 02215 USA; [Barouch, Dan H.] Ragon Inst MGH MIT Harvard, Cambridge, MA 02139 USA; [Thomas, Stephen J.] State Univ New York, Upstate Med Univ, Syracuse, NY 13210 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Community College; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Harvard Med Sch, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019	Thomas, Stephen/0000-0002-8368-7682	U.S. Military Research and Materiel Command; U.S. Military HIV Research Program [W81XWH-11-2-0174]; NIH [AI095985, AI096040, AI100663, AI124377]; Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096040, UM1AI124377, UM1AI126603, UM1AI100663, U19AI095985] Funding Source: NIH RePORTER	U.S. Military Research and Materiel Command; U.S. Military HIV Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge support from the U.S. Military Research and Materiel Command and the U.S. Military HIV Research Program (W81XWH-11-2-0174), the NIH (AI095985, AI096040, AI100663, AI124377), and the Ragon Institute of MGH, MIT, and Harvard. The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Charles A.S., 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620, DOI 10.1371/CURRENTS.OUTBREAKS.4AB8BC87C945EB41CD8A49E127082620]; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24; Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x; Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pardi N., 2017, NATURE; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020; Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; SPECTOR S, 1968, APPL MICROBIOL, V16, P1770, DOI 10.1128/AEM.16.11.1770-1775.1968; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2; Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Venturi G, 2006, J VIROL METHODS, V134, P136, DOI 10.1016/j.jviromet.2005.12.010; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; WHO, 2016, VACCINE, V34, P302, DOI 10.1016/j.vaccine.2015.07.057; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	78	65	69	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					176	182		10.1016/j.immuni.2017.02.005	http://dx.doi.org/10.1016/j.immuni.2017.02.005			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228277	Green Accepted, Bronze			2022-12-18	WOS:000396410900007
J	Ito, A; Hong, C; Oka, K; Salazar, JV; Diehl, C; Witztum, JL; Diaz, M; Castrillo, A; Bensinger, SJ; Chan, L; Tontonoz, P				Ito, Ayaka; Hong, Cynthia; Oka, Kazuhiro; Salazar, Jon V.; Diehl, Cody; Witztum, Joseph L.; Diaz, Mercedes; Castrillo, Antonio; Bensinger, Steven J.; Chan, Lawrence; Tontonoz, Peter			Cholesterol Accumulation in CD11c(+) Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease	IMMUNITY			English	Article							LIVER-X-RECEPTORS; APOLIPOPROTEIN-A-I; SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL; RHEUMATOID-ARTHRITIS; MICE LACKING; LXR-ALPHA; HEMATOPOIETIC STEM; LIPID-METABOLISM; ATHEROSCLEROSIS	Liver X receptors (LXRs) are regulators of cholesterol metabolism that also modulate immune responses. Inactivation of LXR alpha and beta in mice leads to autoimmunity; however, how the regulation of cholesterol metabolism contributes to autoimmunity is unclear. Here we found that cholesterol loading of CD11c(+) cells triggered the development of autoimmunity, whereas preventing excess lipid accumulation by promoting cholesterol efflux was therapeutic. LXR beta-deficient mice crossed to the hyperlipidemic ApoE-deficient background or challenged with a high-cholesterol diet developed autoantibodies. Cholesterol accumulation in lymphoid organs promoted T cell priming and stimulated the production of the B cell growth factors Baff and April. Conversely, B cell expansion and the development of autoantibodies in ApoE/LXR-beta-deficient mice was reversed by ApoA-I expression. These findings implicate cholesterol imbalance as a contributor to immune dysfunction and suggest that stimulating HDL-dependent reverse cholesterol transport could be beneficial in the setting of autoimmune disease.	[Ito, Ayaka; Hong, Cynthia; Salazar, Jon V.; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Diaz, Mercedes; Castrillo, Antonio] Univ Las Palmas Gran Canaria, IUIBS, Inst Invest Biomeed Alberto Sols Madrid,CSIC, Consejo Super Invest Cient Unidad Biomed,Unidad A, Las Palmas Gran Canaria, Spain; [Diehl, Cody; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, San Diego, CA 92037 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Med, 1 Baylor Plaza, Houston, TX 77030 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Biochem, 1 Baylor Plaza, Houston, TX 77030 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Las Palmas de Gran Canaria; University of California System; University of California San Diego; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu			NIH grants [HL030568, DK063491, AI093768]; Ministerio de Economia y Competitividad (MINECO) grant [SAF2014-56819-R]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL030568, R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad (MINECO) grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Johan Auwerx and the Institut Clinique de la Souris for the LXR beta-floxed mice. We thank members of the P.T. laboratory for helpful discussion and technical advice. This work was supported by NIH grants HL030568, DK063491, and DK063491 to P.T. and AI093768 to S.J.B. and Ministerio de Economia y Competitividad (MINECO) grant SAF2014-56819-R to A.C. J.L.W. has patents and patent applications for the use of oxidation specific antibodies, which are held by the University of California, San Diego.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Baldan A, 2014, J IMMUNOL, V193, P5637, DOI 10.4049/jimmunol.1400606; Belalcazar LM, 2003, CIRCULATION, V107, P2726, DOI 10.1161/01.CIR.0000066913.69844.B2; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Charles-Schoeman C, 2012, ANN RHEUM DIS, V71, P1157, DOI 10.1136/annrheumdis-2011-200493; Fessler MB, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0548-7; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hong C, 2012, J LIPID RES, V53, P1126, DOI 10.1194/jlr.M022061; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; McMahon M, 2006, ARTHRITIS RHEUM, V54, P2541, DOI 10.1002/art.21976; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Ronda N, 2014, ANN RHEUM DIS, V73, P609, DOI 10.1136/annrheumdis-2012-202914; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Smith JD, 2010, CURR OPIN INVEST DR, V11, P989; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Torocsik D, 2010, J IMMUNOL, V184, P5456, DOI 10.4049/jimmunol.0902399; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Wang SH, 2012, ATHEROSCLEROSIS, V225, P105, DOI 10.1016/j.atherosclerosis.2012.07.029; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	47	65	66	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1311	1326		10.1016/j.immuni.2016.11.008	http://dx.doi.org/10.1016/j.immuni.2016.11.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002731	Bronze, Green Accepted			2022-12-18	WOS:000392918100016
J	Guo, CS; Xie, SJ; Chi, ZX; Zhang, JH; Liu, YY; Zhang, L; Zheng, MZ; Zhang, X; Xia, DJ; Ke, YH; Lu, LR; Wang, D				Guo, Chuansheng; Xie, Shujun; Chi, Zhexu; Zhang, Jinhua; Liu, Yangyang; Zhang, Li; Zheng, Mingzhu; Zhang, Xue; Xia, Dajing; Ke, Yuehai; Lu, Linrong; Wang, Di			Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome (vol 45, pg 802, 2016)	IMMUNITY			English	Correction												diwang@zju.edu.cn	Xie, Shujun/HGU-6058-2022	Xie, Shujun/0000-0002-1582-9175; Lu, Linrong/0000-0002-0171-4115				Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008	1	65	69	4	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					944	944		10.1016/j.immuni.2016.10.009	http://dx.doi.org/10.1016/j.immuni.2016.10.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760343	Bronze			2022-12-18	WOS:000389473200023
J	Woytschak, J; Keller, N; Krieg, C; Impellizzieri, D; Thompson, RW; Wynn, TA; Zinkernagel, AS; Boyman, O				Woytschak, Janine; Keller, Nadia; Krieg, Carsten; Impellizzieri, Daniela; Thompson, Robert W.; Wynn, Thomas A.; Zinkernagel, Annelies S.; Boyman, Onur			Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation	IMMUNITY			English	Article							ATOPIC-DERMATITIS; IN-VIVO; ALLERGIC INFLAMMATION; ANTIBODY COMPLEXES; IMMUNE-RESPONSES; MYELOID CELLS; IL-4; ACTIVATION; INNATE; MECHANISMS	Neutrophils are the first immune cells recruited to sites of inflammation and infection. However, patients with allergic disorders such as atopic dermatitis show a paucity of skin neutrophils and are prone to bacterial skin infections, suggesting that allergic inflammation curtails neutrophil responses. Here we have shown that the type 2 cell signature cytokine interleukin-4 (IL-4) hampers neutrophil expansion and migration by antagonizing granulocyte colony-stimulating factor (G-CSF) and chemokine receptor-mediated signals. Cutaneous bacterial infection in mice was exacerbated by IL-4 signaling and improved with IL-4 inhibition, each outcome inversely correlating with neutrophil migration to skin. Likewise, systemic bacterial infection was worsened by heightened IL-4 activity, with IL-4 restricting G-CSF-induced neutrophil expansion and migration to tissues by affecting CXCR2-CXCR4 chemokine signaling in neutrophils. These effects were dependent on IL-4 acting through type 2 IL-4 receptors on neutrophils. Thus, targeting IL-4 might be beneficial in neutropenic conditions with increased susceptibility to bacterial infections.	[Woytschak, Janine; Impellizzieri, Daniela; Boyman, Onur] Univ Zurich, Univ Zurich Hosp, Dept Immunol, CH-8091 Zurich, Switzerland; [Keller, Nadia; Zinkernagel, Annelies S.] Univ Zurich, Univ Zurich Hosp, Dept Infect Dis, CH-8091 Zurich, Switzerland; [Krieg, Carsten] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Thompson, Robert W.; Wynn, Thomas A.] NIAID, Immunopathogenesis Sect, Program Barrier Immun & Repair, Lab Parasit Dis,NIH, Bethesda, MD 20892 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Boyman, O (corresponding author), Univ Zurich, Univ Zurich Hosp, Dept Immunol, CH-8091 Zurich, Switzerland.	onur.boyman@uzh.ch	Krieg, Carsten/ABA-6734-2020; Zinkernagel, Annelies S/F-1780-2017; Wynn, Thomas A/AAO-3523-2021	Krieg, Carsten/0000-0002-5145-7591; Zinkernagel, Annelies S/0000-0003-4700-1118; Wynn, Thomas A/0000-0002-7244-8731; Boyman, Onur/0000-0001-8279-5545	Swiss National Science Foundation [PP00P3-128421, PP00P3-150751, 310030-146295]; University of Zurich; Candoc fellowship of University of Zurich; Hochspezialisierte Medizin Schwerpunkt Immunologie (HSM-2-Immunologie); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; Candoc fellowship of University of Zurich; Hochspezialisierte Medizin Schwerpunkt Immunologie (HSM-2-Immunologie); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Daniel Legler and the members of the O.B. laboratory for helpful discussions and critical reading of the manuscript. We thank Emerita Ammann Meier for excellent technical assistance and Sandra Seyfferth for help with typing the manuscript. This study was funded by Swiss National Science Foundation grants PP00P3-128421, PP00P3-150751 (both to O.B.), and 310030-146295 (to A.S.Z.), a grant of University of Zurich (to O.B.), a Candoc fellowship of University of Zurich (to J.W.), and by Hochspezialisierte Medizin Schwerpunkt Immunologie (HSM-2-Immunologie; to O.B.).	Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bennett CL, 2013, NEW ENGL J MED, V368, P1131, DOI 10.1056/NEJMct1210890; Bober LA, 2000, ARTHRITIS RHEUM, V43, P2660, DOI 10.1002/1529-0131(200012)43:12<2660::AID-ANR5>3.0.CO;2-4; BOBER LA, 1995, CLIN EXP IMMUNOL, V99, P129; BOEY H, 1989, J ALLERGY CLIN IMMUN, V83, P978, DOI 10.1016/0091-6749(89)90115-2; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Bouchaud G, 2013, J EXP MED, V210, P2105, DOI 10.1084/jem.20130291; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fine JS, 2003, INFLAMMATION, V27, P161, DOI 10.1023/A:1025076111950; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Hale KK, 1999, J IMMUNOL, V162, P4246; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hemmerle T, 2014, P NATL ACAD SCI USA, V111, P12008, DOI 10.1073/pnas.1402783111; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Knudsen E, 2011, EUR J HAEMATOL, V87, P302, DOI 10.1111/j.1600-0609.2011.01658.x; Kohler A, 2011, BLOOD, V117, P4349, DOI 10.1182/blood-2010-09-308387; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PERRETTI M, 1995, BRIT J PHARMACOL, V116, P2251, DOI 10.1111/j.1476-5381.1995.tb15061.x; POWRIE F, 1993, EUR J IMMUNOL, V23, P2223, DOI 10.1002/eji.1830230926; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Ratthe C, 2007, J LEUKOCYTE BIOL, V81, P1287, DOI 10.1189/jlb.0306209; Ratti M, 2015, EXPERT REV CLIN PHAR, V8, P15, DOI 10.1586/17512433.2015.984688; Rubinstein MP, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-75; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Seki T, 2012, INFECT IMMUN, V80, P159, DOI 10.1128/IAI.05581-11; Wang H, 2013, HEPATOLOGY, V58, P1474, DOI 10.1002/hep.26471; Wermeling F, 2013, P NATL ACAD SCI USA, V110, P13487, DOI 10.1073/pnas.1312525110; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	52	65	66	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					172	184		10.1016/j.immuni.2016.06.025	http://dx.doi.org/10.1016/j.immuni.2016.06.025			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438770	Bronze			2022-12-18	WOS:000380749000019
J	Leventhal, DS; Gilmore, DC; Berger, JM; Nishi, S; Lee, V; Malchow, S; Kline, DE; Kline, J; Griend, DJV; Huang, HC; Socci, ND; Savage, PA				Leventhal, Daniel S.; Gilmore, Dana C.; Berger, Julian M.; Nishi, Saki; Lee, Victoria; Malchow, Sven; Kline, Douglas E.; Kline, Justin; Griend, Donald J. Vander; Huang, Haochu; Socci, Nicholas D.; Savage, Peter A.			Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells	IMMUNITY			English	Article							ANTIGEN-PRESENTING-CELL; THYMIC B-CELLS; SELF-ANTIGENS; AUTOIMMUNE-DISEASE; POSITIVE SELECTION; TOLERANCE; AIRE; ACTIVATION; GENERATION; THYMOCYTES	Although antigen recognition mediated by the T cell receptor (TCR) influences many facets of Foxp3(+) regulatory T (Treg) cell biology, including development and function, the cell types that present antigen to Treg cells in vivo remain largely undefined. By tracking a clonal population of Aire-dependent, prostate-specific Treg cells in mice, we demonstrated an essential role for dendritic cells (DCs) in regulating organ-specific Treg cell biology. We have shown that the thymic development of prostate-specific Treg cells required antigen presentation by DCs. Moreover, Batf3-dependent CD8 alpha(+) DCs were dispensable for the development of this clonotype and had negligible impact on the polyclonal Treg cell repertoire. In the periphery, CCR7-dependent migratory DCs coordinated the activation of organ-specific Treg cells in the prostate-draining lymph nodes. Our results demonstrate that the development and peripheral regulation of organ-specific Treg cells are dependent on antigen presentation by DCs, implicating DCs as key mediators of organ-specific immune tolerance.	[Leventhal, Daniel S.; Gilmore, Dana C.; Berger, Julian M.; Nishi, Saki; Lee, Victoria; Malchow, Sven; Savage, Peter A.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kline, Douglas E.; Kline, Justin] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Griend, Donald J. Vander] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Huang, Haochu] Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center	Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	psavage@bsd.uchicago.edu	Griend, Donald J Vander/H-7532-2019	Griend, Donald J Vander/0000-0003-4421-5698	R01 [R01CA160371, R01AI110507, R01CA166770]; Cancer Research Institute Investigator Award; University of Chicago Comprehensive Cancer Center; NIH/NCI F31 predoctoral fellowship [CA183357]; MSKCC Comprehensive Cancer Center [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA160371, R01CA166770, F31CA183357, T32CA009594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090, R01AI110507] Funding Source: NIH RePORTER	R01; Cancer Research Institute Investigator Award; University of Chicago Comprehensive Cancer Center; NIH/NCI F31 predoctoral fellowship; MSKCC Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Bana Jabri for critical reading of the manuscript. We thank Hannah Brechka, Jacob Kach, Yi Cai, and Zheng Zhong for technical assistance. We thank Dengping Yin and the University of Chicago Microsurgery Core Facility for their assistance with intrathymic injections. This work was funded by the following sources (to P.A.S.): R01 (R01CA160371), R01 (R01AI110507), a Cancer Research Institute Investigator Award, and the University of Chicago Comprehensive Cancer Center. J.K. was supported by R01 (R01CA166770). D.S.L. was supported by an NIH/NCI F31 predoctoral fellowship (CA183357). N.D.S. was supported by MSKCC Comprehensive Cancer Center (Support Grant #P30 CA008748).	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Guerri L, 2013, J IMMUNOL, V190, P2102, DOI 10.4049/jimmunol.1202883; Haniffa M, 2013, ADV IMMUNOL, V120, P1, DOI 10.1016/B978-0-12-417028-5.00001-6; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Isaacs J. T., 1987, CONTROL CELL PROLIFE; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Magurran A.E, 1988, ECOLOGICAL DIVERSITY; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; MARKOWITZ JS, 1993, P NATL ACAD SCI USA, V90, P2779, DOI 10.1073/pnas.90.7.2779; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Setiady YY, 2006, BLOOD, V107, P1056, DOI 10.1182/blood-2005-08-3088; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Wheeler KM, 2009, J IMMUNOL, V183, P7635, DOI 10.4049/jimmunol.0804251; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013	45	65	67	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					847	859		10.1016/j.immuni.2016.01.025	http://dx.doi.org/10.1016/j.immuni.2016.01.025			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27037189	Green Accepted, Bronze			2022-12-18	WOS:000374444300016
J	Boller, S; Ramamoorthy, S; Akbas, D; Nechanitzky, R; Burger, L; Murr, R; Schubeler, D; Grosschedl, R				Boller, Soeren; Ramamoorthy, Senthilkumar; Akbas, Duygu; Nechanitzky, Robert; Burger, Lukas; Murr, Rabih; Schuebeler, Dirk; Grosschedl, Rudolf			Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming	IMMUNITY			English	Article							TRANSCRIPTION FACTOR EBF1; ENHANCER REPERTOIRES; LYMPHOID PROGENITORS; PRECEDES COMMITMENT; FATE COMMITMENT; LINEAGE; ACTIVATION; DIFFERENTIATION; NETWORK; IDENTIFICATION	Lymphopoiesis requires the activation of lineage-specific genes embedded in naive, inaccessible chromatin or in primed, accessible chromatin. The mechanisms responsible for de novo gain of chromatin accessibility, known as "pioneer" function, remain poorly defined. Here, we showed that the EBF1 C-terminal domain (CTD) is required for the regulation of a specific gene set involved in B cell fate decision and differentiation, independently of activation and repression functions. Using genomewide analysis of DNaseI hypersensitivity and DNA methylation in multipotent Ebf1(-/-) progenitors and derivative EBF1wt- or EBF1DC-expressing cells, we found that the CTD promoted chromatin accessibility and DNA demethylation in previously naive chromatin. The CTD allowed EBF1 to bind at inaccessible genomic regions that offer limited co-occupancy by other transcription factors, whereas the CTD was dispensable for EBF1 binding at regions that are occupied by multiple transcription factors. Thus, the CTD enables EBF1 to confer permissive lineage-specific changes in progenitor chromatin landscape.	[Boller, Soeren; Ramamoorthy, Senthilkumar; Akbas, Duygu; Nechanitzky, Robert; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Burger, Lukas; Murr, Rabih; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Burger, Lukas] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland	Max Planck Society; Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.	grosschedl@ie-freiburg.mpg.de	Ramamoorthy, Senthilkumar/E-9325-2017; Ramamoorthy, Senthilkumar/AAT-1088-2021	Ramamoorthy, Senthilkumar/0000-0003-3468-4247; Nechanitzky, Robert/0000-0002-0429-0688	Max Planck Society; German Research Foundation	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	We are grateful to S. Mullerke and I. Falk for technical help. We thank members of the R.G. lab for discussions, Dr. I. Gyory for providing A-MuLV-transformed Ebf1<SUP>fl/fl</SUP> RERT<SUP>Cre</SUP> cells, Dr. E. Trompouki for critically reading the manuscript, and M. Rott for assistance with the manuscript preparation. Research in the R.G. lab is supported by funds from the Max Planck Society and German Research Foundation.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Banerjee A, 2013, IMMUNITY, V38, P930, DOI 10.1016/j.immuni.2013.01.014; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Feldmann A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003994; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Guilhamon P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3166; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Luyten A, 2014, GENE DEV, V28, P1827, DOI 10.1101/gad.240101.114; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu W, 2011, J BIOL CHEM, V286, P41153, DOI 10.1074/jbc.M111.273755; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	46	65	67	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					527	541		10.1016/j.immuni.2016.02.021	http://dx.doi.org/10.1016/j.immuni.2016.02.021			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982363	Green Accepted, Bronze			2022-12-18	WOS:000372784200012
J	Irimia, A; Sarkar, A; Stanfield, RL; Wilson, IA				Irimia, Adriana; Sarkar, Anita; Stanfield, Robyn L.; Wilson, Ian A.			Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODIES; GP41 ECTODOMAIN; PHOSPHOLIPASE-D; MEMBRANE; 2F5; ENVELOPE; RECOGNITION; BINDING	Numerous studies of the anti-HIV-1 envelope glycoprotein 41 (gp41) broadly neutralizing antibody 4E10 suggest that 4E10 also interacts with membrane lipids, but the antibody regions contacting lipids and its orientation with respect to the viral membrane are unknown. Vaccine immunogens capable of re-eliciting these membrane proximal external region (MPER)-like antibodies may require a lipid component to be successful. We performed a systematic crystallographic study of lipid binding to 4E10 to identify lipids bound by the antibody and the lipid-interacting regions. We identified phosphatidic acid, phosphatidylglycerol, and glycerol phosphate as specific ligands for 4E10 in the crystal structures. 4E10 used its CDRH1 loop to bind the lipid head groups, while its CDRH3 interacted with the hydrophobic lipid tails. Identification of the lipid binding sites on 4E10 may aid design of immunogens for vaccines that include a lipid component in addition to the MPER on gp41 for generation of broadly neutralizing antibodies.	[Irimia, Adriana; Sarkar, Anita; Stanfield, Robyn L.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Collaborat AIDS Vaccine Discovery CAVD, Int AIDS Vaccine Initiat,Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Irimia, Adriana; Sarkar, Anita; Stanfield, Robyn L.; Wilson, Ian A.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, Collaborat AIDS Vaccine Discovery CAVD, Int AIDS Vaccine Initiat,Neutralizing Antibody Ct, La Jolla, CA 92037 USA.	wilson@scripps.edu	Stanfield, Robyn/AAH-3190-2019	Sarkar, Anita/0000-0001-5602-8406	NIH [R01 AI084817]; Scripps CHAVI-ID [UM1 AI100663]; IAVI; USAID; Ministry of Foreign Affairs of the Netherlands; Bill & Melinda Gates Foundation; U.S. Department of Energy; DOE Office of Biological and Environmental Research; NIH NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R56AI084817, R01AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scripps CHAVI-ID; IAVI; USAID(United States Agency for International Development (USAID)); Ministry of Foreign Affairs of the Netherlands; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Department of Energy(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Stephen Connelly and Marc Elsliger for discussions, Dr. Marc Deller and Henry Tien for technical support with crystallization robots, and Drs. Jean-Philippe Julien and Leopold Kong for kindly providing crystals of PGT135 and PGT145 antibodies for control experiments. This work was supported by NIH grants R01 AI084817 to I.A.W. and Scripps CHAVI-ID (UM1 AI100663), and partially funded by IAVI with the generous support of USAID, Ministry of Foreign Affairs of the Netherlands, and the Bill & Melinda Gates Foundation; a full list of IAVI donors is available at www.iavi.org. Use of the 23-ID sector at Advanced Photon Source was supported by the U.S. Department of Energy. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory, and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by NIH NIGMS, (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NIAID, NIH, USAID or the US Government. This is publication 29027 from The Scripps Research Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; [Anonymous], PYMOL MOL GRAPHICS S; Asherson RA, 2003, ANN RHEUM DIS, V62, P388, DOI 10.1136/ard.62.5.388; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chen Y, 2013, J IMMUNOL, V191, P1260, DOI 10.4049/jimmunol.1300770; Chien MP, 2008, FASEB J, V22, P1179, DOI 10.1096/fj.07-9576com; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finton KAK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003639; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Ingale S, 2010, J PEPT SCI, V16, P716, DOI 10.1002/psc.1325; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Morita SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11737; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Paruch S, 2007, FASEB J, V21, P4038, DOI 10.1096/fj.06-7325com; Rathinakumar R, 2012, J VIROL, V86, P1820, DOI 10.1128/JVI.05489-11; Rout AK, 2014, J BIOL CHEM, V289, P35111, DOI 10.1074/jbc.M114.609446; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Sene D, 2009, REV MED INTERNE, V30, P135, DOI 10.1016/j.revmed.2008.05.020; Serrano S, 2014, J BIOL CHEM, V289, P6565, DOI 10.1074/jbc.M113.527747; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vcelar B, 2007, AIDS, V21, P2161, DOI 10.1097/QAD.0b013e328285da15; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	55	65	66	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					21	31		10.1016/j.immuni.2015.12.001	http://dx.doi.org/10.1016/j.immuni.2015.12.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26777395	Bronze, Green Accepted			2022-12-18	WOS:000368347000010
J	Daley-Bauer, LP; Wynn, GM; Mocarski, ES				Daley-Bauer, Lisa P.; Wynn, Grace M.; Mocarski, Edward S.			Cytomegalovirus Impairs Antiviral CD8(+) T Cell Immunity by Recruiting Inflammatory Monocytes	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MURINE CYTOMEGALOVIRUS; SUPPRESSOR-CELLS; IMMUNOSUPPRESSIVE ACTIVITY; CHEMOKINE HOMOLOG; SALIVARY-GLANDS; BONE-MARROW; INFECTION; DETERMINANT; SUBSETS	Inflammatory monocytes are key early responders to infection that contribute to pathogen-host interactions in diverse ways. Here, we report that the murine cytomegalovirus-encoded CC chemokine, MCK2, enhanced CCR2-dependent recruitment of these cells to modulate antiviral immunity, impairing virus-specific CD8(+) T cell expansion and differentiation into effector cytotoxic T lymphocytes, thus reducing the capacity to eliminate viral antigen-bearing cells and slowing viral clearance. Adoptive transfer of inflammatory monocytes into Ccr2(-/-)Ccl2(-/-) mice impaired virus antigen-specific clearance. Cytomegalovirus therefore enhances a natural CCR2-dependent immune regulatory network to modulate adaptive immunity via nitric oxide production, reminiscent of the monocytic subtype of myeloid-derived suppressor cells primarily implicated in cancer immunomodulation.	[Daley-Bauer, Lisa P.; Wynn, Grace M.; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Mocarski, ES (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020	Daley-Bauer, Lisa/0000-0002-3377-7989	Public Health Service Grants [R01 AI20211, AI030363]; Flow Cytometry Core Facility of Emory University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020211, R21AI030363, R56AI030363, R01AI030363] Funding Source: NIH RePORTER	Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); Flow Cytometry Core Facility of Emory University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Upton and L. Roback for technical assistance, S. Speck for reagents, and R. Ahmed, J. Altman, M. Ford, and the Mocarski laboratory members for critical comments on the manuscript. This work was supported by Public Health Service Grants R01 AI20211 and AI030363 and in part by the Flow Cytometry Core Facility of the Emory University School of Medicine.	Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Babic M, 2011, TRENDS MOL MED, V17, P677, DOI 10.1016/j.molmed.2011.07.003; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bowen JL, 2009, J IMMUNOL, V183, P6971, DOI 10.4049/jimmunol.0902193; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Doom CM, 2008, MED MICROBIOL IMMUN, V197, P191, DOI 10.1007/s00430-008-0089-y; Fleming P, 1999, J VIROL, V73, P6800, DOI 10.1128/JVI.73.8.6800-6809.1999; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hengel H, 1999, IMMUNOL REV, V168, P167, DOI 10.1111/j.1600-065X.1999.tb01291.x; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; KLEMOLA E, 1965, BMJ-BRIT MED J, V2, P1099, DOI 10.1136/bmj.2.5470.1099; KOSZINOWSKI UH, 1990, CURR TOP MICROBIOL, V154, P189; LAGENAUR LA, 1994, J VIROL, V68, P7717, DOI 10.1128/JVI.68.12.7717-7727.1994; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; MANNING WC, 1992, J VIROL, V66, P3794, DOI 10.1128/JVI.66.6.3794-3802.1992; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mencacci A, 2002, J IMMUNOL, V169, P3180, DOI 10.4049/jimmunol.169.6.3180; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagendra S, 2004, CYTOM PART A, V58A, P195, DOI 10.1002/cyto.a.20007; Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Presti RM, 2001, J EXP MED, V193, P483, DOI 10.1084/jem.193.4.483; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Saederup N, 1999, P NATL ACAD SCI USA, V96, P10881, DOI 10.1073/pnas.96.19.10881; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Samardzic T, 2001, CYTOKINE, V13, P179, DOI 10.1006/cyto.2000.0785; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SISSONS JGP, 1991, KIDNEY INT, V40, pS8; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Zhang M, 2007, INVEST OPHTH VIS SCI, V48, P285, DOI 10.1167/iovs.06-0792	52	65	65	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					122	133		10.1016/j.immuni.2012.04.014	http://dx.doi.org/10.1016/j.immuni.2012.04.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840843	Green Accepted, Bronze			2022-12-18	WOS:000307133200015
J	Austenaa, L; Barozzi, I; Chronowska, A; Termanini, A; Ostuni, R; Prosperini, E; Stewart, AF; Testa, G; Natoli, G				Austenaa, Liv; Barozzi, Iros; Chronowska, Agnieszka; Termanini, Alberto; Ostuni, Renato; Prosperini, Elena; Stewart, A. Francis; Testa, Giuseppe; Natoli, Gioacchino			The Histone Methyltransferase Wbp7 Controls Macrophage Function through GPI Glycolipid Anchor Synthesis	IMMUNITY			English	Article							DEVELOPMENTAL REGULATORS; LIPOPOLYSACCHARIDE LPS; BINDING PROTEIN; GENE-EXPRESSION; METHYLATION; POLYCOMB; CD14; H3; RECOGNITION; COMPLEXES	Histone methyltransferases catalyze site-specific deposition of methyl groups, enabling recruitment of transcriptional regulators. In mammals, trimethylation of lysine 4 in histone H3, a modification localized at the transcription start sites of active genes, is catalyzed by six enzymes (SET1a and SET1b, MLL1-MLL4) whose specific functions are largely unknown. By using a genomic approach, we found that in macrophages, MLL4 (also known as Wbp7) was required for the expression of Pigp, an essential component of the GPI-GlcNAc transferase, the enzyme catalyzing the first step of glycosylphosphatidylinositol (GPI) anchor synthesis. Impaired Pigp expression in Wbp7(-/-) macrophages abolished GPI anchor-dependent loading of proteins on the cell membrane. Consistently, loss of GPI-anchored CD14, the coreceptor for lipopolysaccharide (LPS) and other bacterial molecules, markedly attenuated LPS-triggered intracellular signals and gene expression changes. These data link a histone-modifying enzyme to a biosynthetic pathway and indicate a specialized biological role for Wbp7 in macrophage function and antimicrobial response.	[Austenaa, Liv; Barozzi, Iros; Chronowska, Agnieszka; Termanini, Alberto; Ostuni, Renato; Prosperini, Elena; Testa, Giuseppe; Natoli, Gioacchino] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Stewart, A. Francis] Tech Univ Dresden, BiolnnovatZentrum, D-01307 Dresden, Germany	IRCCS European Institute of Oncology (IEO); Technische Universitat Dresden	Natoli, G (corresponding author), European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	gioacchino.natoli@ifom-ieo-campus.it	Barozzi, Iros/GLQ-8907-2022; Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020; Ostuni, Renato/AAB-8832-2022; PROSPERINI, ELENA/AAB-1952-2021; Stewart, A. Francis/E-7789-2010; Termanini, Alberto/AAB-9934-2019; Testa, Giuseppe/J-4572-2012	Barozzi, Iros/0000-0003-0690-3473; Ostuni, Renato/0000-0003-0460-3426; Termanini, Alberto/0000-0002-9697-906X; Natoli, Gioacchino/0000-0003-0711-2411; Testa, Giuseppe/0000-0002-9104-0918	European Community; Italian Association for Research on Cancer, AIRC; European Research Council (ERC); Italian Health Ministry	European Community(European Commission); Italian Association for Research on Cancer, AIRC(Fondazione AIRC per la ricerca sul cancro); European Research Council (ERC)(European Research Council (ERC)European Commission); Italian Health Ministry(Ministry of Health, Italy)	We thank B. Amati for critically reading this manuscript; N. Sidenius (IFOM, Milan) and J. Kagan (Harvard Medical School, Boston, MA) for antibodies; and G. Bucci (Cogentech, Milan) for initial microarray data analysis. This work was supported by the FP6 program of the European Community (Marie Curie Excellence Grant Trans-Tar to G.N.), the Italian Association for Research on Cancer, AIRC (G.N. and G.T.), the European Research Council (ERC, project NORM;G.N.), and the Italian Health Ministry (G.T.).	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brodsky RA, 2000, AM J CLIN PATHOL, V114, P459, DOI 10.1093/ajcp/114.3.459; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	63	65	67	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					572	585		10.1016/j.immuni.2012.02.016	http://dx.doi.org/10.1016/j.immuni.2012.02.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22483804	Bronze			2022-12-18	WOS:000303223900010
J	Zhang, L; Reynolds, TL; Shan, XC; Desiderio, S				Zhang, Li; Reynolds, Taylor L.; Shan, Xiaochuan; Desiderio, Stephen			Coupling of V(D)J Recombination to the Cell Cycle Suppresses Genomic Instability and Lymphoid Tumorigenesis	IMMUNITY			English	Article							STRAND BREAK REPAIR; RAG PROTEINS; DNA-REPAIR; CHROMOSOMAL TRANSLOCATIONS; HISTONE H2AX; B-CELLS; ACCUMULATION; COMPLEXES; MICE; DEGRADATION	V(D)J gene segment recombination is linked to the cell cycle by the periodic phosphorylation and destruction of the RAG-2 protein at the G1 -to-S cell cycle transition. To examine the function of this coupling, we constructed mice in which the phosphorylation site at threonine 490 of RAG-2 was mutated to alanine. The RAG-2(T490A) mutation uncoupled DNA cleavage from cell cycle and promoted aberrant recombination. Similar aberrant recombination products were observed in mice deficient in the Skp2 ubiquitin ligase subunit, which is required for periodic destruction of RAG-2. On a p53-deficient background, the RAG-2(T490A) mutation induced lymphoid malignancies characterized by clonal chromosomal translocations involving antigen receptor genes. Taken together, these observations provide a direct link between the periodic destruction of RAG-2 and lymphoid tumorigenesis. We infer that cell cycle control of the V(D)J recombinase limits the potential genomic damage that could otherwise result from RAG-mediated DNA cleavage.	[Zhang, Li; Reynolds, Taylor L.; Shan, Xiaochuan; Desiderio, Stephen] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zhang, Li; Reynolds, Taylor L.; Shan, Xiaochuan; Desiderio, Stephen] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu			National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to C. Greider and F. Alt for the gift of BAC clones and to K. Nakayama for Skp2-deficient mice. We thank M. Strong for advice, A. Tam for cell sorting, and D. Dordai and N. Platek for expert technical assistance. This work was supported by a grant from the National Cancer Institute and by a gift to the Institute for Cell Engineering.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Candeias S, 1996, J EXP MED, V184, P1919, DOI 10.1084/jem.184.5.1919; CARROLL AM, 1993, J IMMUNOL, V150, P2222; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Curry JD, 2008, NUCLEIC ACIDS RES, V36, P5750, DOI 10.1093/nar/gkn553; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang H, 2004, J BIOL CHEM, V279, P8478, DOI 10.1074/jbc.M311219200; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McMahan CJ, 1997, MOL CELL BIOL, V17, P4544, DOI 10.1128/MCB.17.8.4544; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Ross AE, 2003, MOL CELL BIOL, V23, P5308, DOI 10.1128/MCB.23.15.5308-5319.2003; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Touvrey C, 2006, IMMUNOBIOLOGY, V211, P741, DOI 10.1016/j.imbio.2006.04.001; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	53	65	66	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					163	174		10.1016/j.immuni.2011.02.003	http://dx.doi.org/10.1016/j.immuni.2011.02.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349429	Green Accepted, Bronze			2022-12-18	WOS:000287989500007
J	Strober, W				Strober, Warren			The Multifaceted Influence of the Mucosal Microflora on Mucosal Dendritic Cell Responses	IMMUNITY			English	Review							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; INVASIVE ESCHERICHIA-COLI; REGULATORY T-CELLS; ENTERIC BACTERIAL-ANTIGENS; NEONATAL FC-RECEPTOR; ILEAL CROHNS-DISEASE; TOLL-LIKE RECEPTORS; IMMUNE-RESPONSES; NEGATIVE REGULATOR	Over the last decade, it has become apparent that the complex interactions between components of the mucosal microflora and the mucosal immune system can involve either direct contact with dendritic cells in the lamina propria or, alternatively, contact with epithelial cells lining the mucosa that then influence the function of dendritic cells. Although in some cases these interactions involve signaling specific to particular organisms and in others, to classes of organisms, a common theme is that signaling is invariably channeled through receptors that address many organisms or all organisms such as the pattern-recognition receptors TLR and NLR. Here, I review this information with the intention of identifying how the mucosal microflora influences specific functions of the mucosal immune system such the production of particular cytokines as well as broader functions such as the maintenance of mucosal immune homeostasis and host defense.	NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000354] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Baker K, 2009, SEMIN IMMUNOPATHOL, V31, P223, DOI 10.1007/s00281-009-0160-9; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Beckwith J, 2005, GASTROENTEROLOGY, V129, P1473, DOI 10.1053/j.gastro.2005.07.057; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boirivant M, 2008, GASTROENTEROLOGY, V135, P1612, DOI 10.1053/j.gastro.2008.07.028; Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brandwein SL, 1997, J IMMUNOL, V159, P44; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Winter H, 2002, GASTROENTEROLOGY, V122, P1829, DOI 10.1053/gast.2002.33655; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; ILIEV ID, 2009, GUT IN PRESS, DOI DOI 10.1136/GUT.2008.175166; Iliev ID, 2007, J EXP MED, V204, P2253, DOI 10.1084/jem.20062535; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; KOBAYASHI K, 2009, GASTROENTER IN PRESS, DOI DOI 10.1053/J.GASTRO.2009.07.059; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Kyd JM, 2008, VACCINE, V26, P6221, DOI 10.1016/j.vaccine.2008.09.061; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Manocha M, 2009, J IMMUNOL, V183, P270, DOI 10.4049/jimmunol.0802424; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; NIESS JH, 2009, MUCOSAL IMMUNOL S1, V2, P81; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Roesler J, 2005, J PEDIATR GASTR NUTR, V41, P27, DOI 10.1097/01.MPG.0000165017.00562.27; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang ZQ, 2007, GASTROENTEROLOGY, V133, P1510, DOI 10.1053/j.gastro.2007.07.025; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821	83	65	70	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					377	388		10.1016/j.immuni.2009.09.001	http://dx.doi.org/10.1016/j.immuni.2009.09.001			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766081	Bronze			2022-12-18	WOS:000270525900004
J	Wildbaum, G; Nahir, MA; Karin, N				Wildbaum, G; Nahir, MA; Karin, N			Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity	IMMUNITY			English	Article							ONGOING ADJUVANT ARTHRITIS; NEONATAL TOLERANCE; RHEUMATOID-ARTHRITIS; MOLECULAR MIMICRY; DNA VACCINATION; MICE LACKING; ADULT LIFE; TNF-ALPHA; T-CELLS; ENCEPHALOMYELITIS	Therapies that neutralize the function of TNF-alpha suppress rheumatoid arthritis (RA) but not osteoarthritis (OA). We show that patients suffering from RA but not OA have significant levels of autoantibodies directed to TNF-alpha. Thus, the immune system can selectively generate autoimmunity to proinflammatory mediators when such a response is beneficial for the host. A well-defined model of RA was used to elaborate the contribution of beneficial autoimmunity to the regulation of disease. We show that during the disease autoantibody production is elicited against few inflammatory, but not regulatory, mediators. Selective amplification of these beneficial antibodies by targeted DNA vaccines provided protective immunity. Epitope mapping revealed that anti-TNF-alpha immunity is highly restricted and excretes no crossreactivity to other known gene products. Its selective exclusion substantially exacerbated the disease. Administration of anti-TNF-alpha antibodies could then override this aggravation. This substantiates the significance of beneficial autoimmunity in restraining self-destructive immunity.	Bruce Rappaport Fac Med, Dept Immunol, IL-31096 Haifa, Israel; Rambam Med Ctr, B Shine Dept Rheumatol, IL-31096 Haifa, Israel; Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Karin, N (corresponding author), Bruce Rappaport Fac Med, Dept Immunol, IL-31096 Haifa, Israel.							AREND WP, 1994, J IMMUNOL, V153, P4766; BACHA P, 1992, EUR J IMMUNOL, V22, P1673, DOI 10.1002/eji.1830220702; Choy EHS, 2002, RHEUMATOLOGY, V41, P1133, DOI 10.1093/rheumatology/41.10.1133; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Feldmann M, 1997, ADV IMMUNOL, V64, P283, DOI 10.1016/S0065-2776(08)60891-3; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; GAMMON G, 1986, NATURE, V319, P413, DOI 10.1038/319413a0; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Grabie N, 1999, INT IMMUNOL, V11, P899, DOI 10.1093/intimm/11.6.899; Grabie N, 1999, INT IMMUNOL, V11, P907, DOI 10.1093/intimm/11.6.907; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Mor G, 1996, J CLIN INVEST, V98, P2700, DOI 10.1172/JCI119094; PEARSON CM, 1956, P SOC EXP BIOL MED, V91, P95, DOI 10.3181/00379727-91-22179; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Salomon I, 2002, J IMMUNOL, V169, P2685, DOI 10.4049/jimmunol.169.5.2685; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Singh RR, 1996, J EXP MED, V183, P1613, DOI 10.1084/jem.183.4.1613; STEINMAN L, 1995, CELL, V80, P7, DOI 10.1016/0092-8674(95)90443-3; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; WALLACH D, 1984, J IMMUNOL, V132, P2464; WEKERLE H, 1994, ANN NEUROL, V36, P47; WENMING C, 2000, CELL, V103, P909; Wildbaum G, 2000, J CLIN INVEST, V106, P671, DOI 10.1172/JCI8759; Wildbaum G, 1999, GENE THER, V6, P1128, DOI 10.1038/sj.gt.3300915; Wildbaum G, 2002, J IMMUNOL, V168, P5885, DOI 10.4049/jimmunol.168.11.5885; Wildbaum G, 2002, J CLIN INVEST, V110, P701, DOI 10.1172/JCI200215176; Wildbaum G, 2000, J IMMUNOL, V165, P5860, DOI 10.4049/jimmunol.165.10.5860; Wildbaum G, 1998, J IMMUNOL, V161, P6368; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Youssef S, 1998, J IMMUNOL, V161, P3870; Youssef S, 2000, J CLIN INVEST, V106, P361, DOI 10.1172/JCI9109	41	65	69	2	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					679	688		10.1016/S1074-7613(03)00291-7	http://dx.doi.org/10.1016/S1074-7613(03)00291-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614855	Bronze			2022-12-18	WOS:000186672200008
J	Yokota, T; Kouro, T; Hirose, J; Igarashi, H; Garrett, KP; Gregory, SC; Sakaguchi, N; Owen, JJT; Kincade, PW				Yokota, T; Kouro, T; Hirose, J; Igarashi, H; Garrett, KP; Gregory, SC; Sakaguchi, N; Owen, JJT; Kincade, PW			Unique properties of fetal lymphoid progenitors identified according to RAG1 gene expression	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; B-LYMPHOPOIESIS; PRECURSORS; LIVER; LINEAGE; MOUSE; RECEPTOR; TRANSCRIPTION; PURIFICATION	RAG1/GFP knockin mice were exploited to isolate and characterize fetal lymphoid progenitors. CD11b and IL-7Ralpha are expressed in a developmental stage-dependent fashion, revealing how substantial numbers of early lymphoid progenitors were discarded or neglected in previous studies. The myeloerythroid potential of fetal progenitors in clonal assays declined in synchrony with activation of the RAG1 locus but was not completely extinguished. Lymphoid differentiation corresponded to patterns of gene expression previously found for adult marrow, but no fraction of fetal liver was enriched with respect to B + T progenitors. Also, unlike adults, fetal lymphoid progenitors transiently expressed endothelial cell markers. These findings help to reconcile discrepancies in previous reports and suggest that the fetal immune system arises via unique mechanisms.	Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; Kumamoto Univ, Sch Med, Dept Immunol, Kumamoto 8600811, Japan	Oklahoma Medical Research Foundation; Kumamoto University	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.			Kouro, Taku/0000-0003-1526-575X	NIAID NIH HHS [AI 45864, AI 20069] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069, P01AI045864] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Crompton T, 1998, EUR J IMMUNOL, V28, P1859, DOI 10.1002/(SICI)1521-4141(199806)28:06<1859::AID-IMMU1859>3.0.CO;2-A; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; Douagi I, 2002, BLOOD, V99, P463, DOI 10.1182/blood.V99.2.463; Dzierzak E, 2002, IMMUNOL REV, V187, P126, DOI 10.1034/j.1600-065X.2002.18711.x; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Godin I, 1995, Semin Immunol, V7, P131, DOI 10.1016/1044-5323(95)90041-1; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; Kincade PW, 2002, SEMIN IMMUNOL, V14, P385, DOI 10.1016/S1044532302000738; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2002, BLOOD, V100, P3672, DOI 10.1182/blood-2002-02-0653; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Kuwata N, 1999, J IMMUNOL, V163, P6355; MANZ MG, 2001, ANN NY ACAD SCI, V937, P167; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Ogawa M, 2002, EXP HEMATOL, V30, P3, DOI 10.1016/S0301-472X(01)00770-6; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Sagara S, 1997, J IMMUNOL, V158, P666; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Spangrude GJ, 2002, IMMUNOL REV, V187, P40, DOI 10.1034/j.1600-065X.2002.18704.x; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Suniara RK, 1999, EUR J IMMUNOL, V29, P75, DOI 10.1002/(SICI)1521-4141(199901)29:01<75::AID-IMMU75>3.3.CO;2-3; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	45	65	65	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					365	375		10.1016/S1074-7613(03)00231-0	http://dx.doi.org/10.1016/S1074-7613(03)00231-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499112	Bronze			2022-12-18	WOS:000185499800008
J	Hayashi, K; Yamamoto, M; Nojima, T; Goitsuka, R; Kitamura, D				Hayashi, K; Yamamoto, M; Nojima, T; Goitsuka, R; Kitamura, D			Distinct signaling requirements for D mu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors	IMMUNITY			English	Article							SURROGATE LIGHT-CHAIN; IMMUNOGLOBULIN GENE REARRANGEMENT; TYROSINE KINASE SYK; MOUSE BONE-MARROW; ANTIGEN RECEPTOR; TARGETED DISRUPTION; LINKER PROTEIN; HEAVY-CHAINS; LYMPHOCYTE DEVELOPMENT; MEDIATED ACTIVATION	The pre-B cell receptor triggers expansion and differentiation of pre-B cells (the pre-B cell transition), as well as inhibition Of V-H to DJ(H) recombination (allelic exclusion). The latter also accounts for counter-selection of pro-B cells expressing Dmu protein (Dmu selection). However, the signaling pathways responsible for these events remain poorly defined. Here we show complete arrest of B cell development at the pre-B cell transition in BASH/CD19 double mutant mice, indicating partial redundancy of the two B cell-specific adaptors. Allelic exclusion remained intact in the double mutant mice, whereas Dmu, selection was abolished in BASH mutant mice. Thus, distinct signals are required for these events. In addition, both mutant mice succumbed to pre-B cell leukemia, indicating that BASH and CD19 contribute to tumor suppression.	Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Biol, Chiba 2780022, Japan	Tokyo University of Science	Kitamura, D (corresponding author), Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Biol, Yamazaki 2669, Chiba 2780022, Japan.	kitamura@rs.noda.tus.ac.jp						ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Conley M E, 2000, Rev Immunogenet, V2, P231; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Gong SC, 1996, J EXP MED, V184, P2079, DOI 10.1084/jem.184.6.2079; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; Goodman PA, 2001, ONCOGENE, V20, P3969, DOI 10.1038/sj.onc.1204515; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; HAASNER D, 1994, INT IMMUNOL, V6, P21, DOI 10.1093/intimm/6.1.21; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Horne MC, 1996, IMMUNITY, V4, P145, DOI 10.1016/S1074-7613(00)80679-2; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; IGLESIAS A, 1991, EMBO J, V10, P2147, DOI 10.1002/j.1460-2075.1991.tb07749.x; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; Malynn BA, 2002, MOL IMMUNOL, V38, P547, DOI 10.1016/S0161-5890(01)00085-2; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Papavasiliou F, 1996, J EXP MED, V184, P2025, DOI 10.1084/jem.184.5.2025; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; ten Boekel E, 1998, IMMUNITY, V8, P199; Thevenin C, 1998, J EXP MED, V188, P735, DOI 10.1084/jem.188.4.735; Tornberg UC, 1998, J EXP MED, V187, P703, DOI 10.1084/jem.187.5.703; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TSUBATA T, 1991, EUR J IMMUNOL, V21, P1359, DOI 10.1002/eji.1830210605; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; Xu SL, 2000, J IMMUNOL, V165, P4153, DOI 10.4049/jimmunol.165.8.4153	70	65	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2003	18	6					825	836		10.1016/S1074-7613(03)00142-0	http://dx.doi.org/10.1016/S1074-7613(03)00142-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818163	Bronze			2022-12-18	WOS:000183767700012
J	Liu, JQ; Na, SQ; Glasebrook, A; Fox, N; Solenberg, PJ; Zhang, Q; Song, HY; Yang, DD				Liu, JQ; Na, SQ; Glasebrook, A; Fox, N; Solenberg, PJ; Zhang, Q; Song, HY; Yang, DD			Enhanced CD4(+) T cell proliferation and Th2 cytokine production in DR6-deficient mice	IMMUNITY			English	Article							NECROSIS-FACTOR RECEPTOR; MEDIATED-IMMUNITY; FAMILY MEMBERS; NF-ATC; ACTIVATION; RESPONSES; CTLA-4; TUMOR; DIFFERENTIATION; ABSENCE	We have found that DR6,a member of the TNF receptor family, is highly expressed in resting T cells and downregulated in activated T cells. DR6-targeted mutant mice were generated and showed normal development. However, DR6(-/-) CD4(+) T cells hyperproliferated in response to TCR-mediated stimulation and protein antigen challenge. Activated DR6(-/-) CD4(+) T cells exhibited upregulated CD25 expression and enhanced proliferation in response to exogenous IL-2 stimulation. In addition, increased CD28 and reduced CTLA-4 expression were observed in these cells. Enhanced Th2 cytokine production by activated DR6(/-) CD4(+) T cells was associated with the increased transcription factor NF-ATc in nuclei. DR6, therefore, functions as a regulatory receptor for mediating CD4(+) T cell activation and maintaining proper immune responses.	Eli Lilly & Co, Dept Biores Technol & Prot, Indianapolis, IN 46285 USA	Eli Lilly	Na, SQ (corresponding author), Eli Lilly & Co, Dept Biores Technol & Prot, Indianapolis, IN 46285 USA.	na_songqing@lilly.com; yang_derek_di@lilly.com						Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Flavell RA, 1999, IMMUNOL RES, V19, P159, DOI 10.1007/BF02786484; Fraser JH, 1999, EUR J IMMUNOL, V29, P838; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Gravestein LA, 1998, SEMIN IMMUNOL, V10, P423, DOI 10.1006/smim.1998.0144; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Kato T, 2000, J IMMUNOL, V164, P3554, DOI 10.4049/jimmunol.164.7.3554; Khattri R, 1999, J IMMUNOL, V162, P5784; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Liu JQ, 1997, MOL CELL BIOL, V17, P5275, DOI 10.1128/MCB.17.9.5275; MADELBROT DA, 1999, J EXP MED, V189, P435; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Nakaseko C, 1999, J EXP MED, V190, P765, DOI 10.1084/jem.190.6.765; Olsson C, 1999, J BIOL CHEM, V274, P14400, DOI 10.1074/jbc.274.20.14400; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Tamada K, 2000, NAT MED, V6, P283; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	36	65	74	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					23	34		10.1016/S1074-7613(01)00162-5	http://dx.doi.org/10.1016/S1074-7613(01)00162-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485735	Bronze			2022-12-18	WOS:000170153300004
J	Xu, XN; Purbhoo, MA; Chen, N; Mongkolsapaya, J; Cox, JH; Meier, UC; Tafuro, S; Dunbar, PR; Sewell, AK; Hourigan, CS; Appay, V; Cerundolo, V; Burrows, SR; McMichael, AJ; Screaton, GR				Xu, XN; Purbhoo, MA; Chen, N; Mongkolsapaya, J; Cox, JH; Meier, UC; Tafuro, S; Dunbar, PR; Sewell, AK; Hourigan, CS; Appay, V; Cerundolo, V; Burrows, SR; McMichael, AJ; Screaton, GR			A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha 3 domain mutants of MHC class I/peptide complex	IMMUNITY			English	Article							CYTOTOXIC T-LYMPHOCYTES; FAS-LIGAND; CELLS; APOPTOSIS; CD8; IMMUNOPATHOLOGY; EXPRESSION; REPERTOIRE; TOLERANCE; REQUIRES	In this study, we have compared the effector functions and fate of a number of human CTL clones in vitro or ex vivo following contact with variant peptides presented either on the cell surface or in a soluble multimeric format. In the presence of CD8 coreceptor binding, there is a good correlation between TCR signaling, killing of the targets, and Fast-mediated CTL apoptosis. Blocking CD8 binding using (alpha3 domain mutants of MHC class I results in much reduced signaling and reduced killing of the targets. Surprisingly, however, Fast expression is induced to a similar degree on these CTLs, and apoptosis of CTL is unaffected. The ability to divorce these events may allow the deletion of antigen-specific and pathological CTL populations without the deleterious effects induced by full CTL activation.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX 3 9DS, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Clin Med, Oxford OX 3 9DS, England; Queensland Inst Med Res, Div Infect Dis & Immunol, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute	Xu, XN (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX 3 9DS, England.		Hourigan, Christopher S/C-7588-2012; Burrows, Scott/G-2050-2011; Meier, Ute Christiane/N-6891-2018; Appay, Victor/AAM-7701-2021; Appay, Victor/M-4830-2017; Dunbar, Rod/C-2570-2012; Sewell, Andrew/GPT-4220-2022	Hourigan, Christopher S/0000-0002-6189-8067; Burrows, Scott/0000-0002-1430-0472; Meier, Ute Christiane/0000-0002-8838-5464; Dunbar, Rod/0000-0001-9626-2600; Sewell, Andrew/0000-0003-3194-3135; Screaton, Gavin/0000-0002-3549-4309; Appay, Victor/0000-0001-5434-3963; Southcombe, Jennifer/0000-0003-0699-650X; Cerundolo, Vincenzo/0000-0003-0040-3793				Aichele P, 1996, IMMUNOL REV, V152, P21, DOI 10.1111/j.1600-065X.1996.tb00909.x; Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; Combadiere B, 1998, J EXP MED, V187, P349, DOI 10.1084/jem.187.3.349; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dunbar PR, 1998, CURR BIOL, V8, P413, DOI 10.1016/S0960-9822(98)70161-7; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kiener PA, 1997, J IMMUNOL, V159, P1594; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lowin B, 1996, INT IMMUNOL, V8, P57, DOI 10.1093/intimm/8.1.57; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pestano GA, 1999, SCIENCE, V284, P1187, DOI 10.1126/science.284.5417.1187; Purbhoo MA, 1998, P NATL ACAD SCI USA, V95, P4527, DOI 10.1073/pnas.95.8.4527; ROBBINS PA, 1991, J EXP MED, V173, P221, DOI 10.1084/jem.173.1.221; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Sewell AK, 1997, EUR J IMMUNOL, V27, P2323, DOI 10.1002/eji.1830270929; Tafuro S, 2001, EUR J IMMUNOL, V31, P440, DOI 10.1002/1521-4141(200102)31:2<440::AID-IMMU440>3.0.CO;2-0; Tan RS, 1999, BLOOD, V93, P1506, DOI 10.1182/blood.V93.5.1506.405a38_1506_1510; Van Parijs L, 1998, SCIENCE, V280, P243; Whelan JA, 1999, J IMMUNOL, V163, P4342	32	65	66	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2001	14	5					591	602		10.1016/S1074-7613(01)00133-9	http://dx.doi.org/10.1016/S1074-7613(01)00133-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371361	Bronze			2022-12-18	WOS:000168880900011
J	Yamagami, T; ten Boekel, E; Andersson, J; Rolink, A; Melchers, F				Yamagami, T; ten Boekel, E; Andersson, J; Rolink, A; Melchers, F			Frequencies of multiple IgL chain gene rearrangements in single normal or kappa L chain-deficient B lineage cells	IMMUNITY			English	Article							LIGHT-CHAIN; BONE-MARROW; MOUSE IMMUNOGLOBULIN; ALLELIC EXCLUSION; EXCISION PRODUCTS; LOCUS; LYMPHOCYTES; EXPRESSION; TOLERANCE; MODEL	PCR analyses of the kappa L chain locus in single B-lineage cells of wild-type, C kappa-, or JC kappa-deficient homozygous or heterozygous mice often detect multiple in- and out-of-frame rearrangements at the kappa L and lambda L loci. They are most frequent in small pre-BII cells and equally so in wild-type and kappa L chain-deficient cells. Hence, kappa L chain production appears not to inhibit secondary rearrangements. Around 20% of all small preBII cells express IgL chains in their cytoplasm. Cells with a first productive rearrangement on one allele are favored to enter the immature B cell compartment. Thus, allelic exclusion might be secured by control of accessibility of IgL chain loci for rearrangement and by rapid selection of cells with a fitting over those with a nonfitting IgL chain.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Melchers, F (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.							Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; GHIA P, 1995, EUR J IMMUNOL, V25, P3108, DOI 10.1002/eji.1830251118; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hertz M, 1998, NATURE, V394, P292, DOI 10.1038/28419; Kirschbaum T, 1996, EUR J IMMUNOL, V26, P1613, DOI 10.1002/eji.1830260731; KOFLER R, 1992, IMMUNOL REV, V128, P5, DOI 10.1111/j.1600-065X.1992.tb00830.x; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LANGMAN RE, 1992, 47 FOR IMM PAR I PAS, P803; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; ROLINK A, 1993, BLOOD, V81, P2290; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; SELSING E, 1995, IMMUNOGLOBULIN GENES, P193; SELSING E, 1984, NUCLEIC ACIDS RES, V15, P2699; SHAPIRO MA, 1987, J IMMUNOL, V139, P3834; SHAPIRO MA, 1987, MOL CELL BIOL, V7, P4130, DOI 10.1128/MCB.7.11.4130; SHIMIZU T, 1991, J EXP MED, V173, P1065, DOI 10.1084/jem.173.5.1065; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; YELTON DE, 1981, HYBRIDOMA, V1, P5, DOI 10.1089/hyb.1.1981.1.5; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	38	65	65	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					317	327		10.1016/S1074-7613(00)80107-7	http://dx.doi.org/10.1016/S1074-7613(00)80107-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514010	Bronze			2022-12-18	WOS:000082918500007
J	Goldrath, AW; Hogquist, KA; Bevan, MJ				Goldrath, AW; Hogquist, KA; Bevan, MJ			CD8 lineage commitment in the absence of CD8	IMMUNITY			English	Article							T-CELL RECEPTOR; MHC CLASS-I; POSITIVE SELECTION; CORECEPTOR MOLECULES; IMMATURE THYMOCYTES; NEGATIVE SELECTION; CD4-DEFICIENT MICE; THYMIC MATURATION; ALPHA-3 DOMAIN; BETA-CHAIN	The absence of cytotoxic T lymphocyte activity and the failure of MHC class I-restricted T cell receptor (TCR) transgenic thymocytes to mature in CD8 alpha-deficient mice suggest that CD8 may be essential for CD8 lineage commitment. We report that variants of the antigenic peptide that delete TCR transgenic thymocytes from CD8 wild-type but not CD8 alpha-deficient mice can restore positive selection of CD8 lineage cells in the absence of CD8. The positively selected cells down-regulate CD4, up-regulate TCR, respond to the antigenic peptide, and express CD8 beta mRNA. Interestingly, there was no enhanced selection of CD4(+) T cells, implying that the TCR-MHC interaction, even in the absence of CD8, provided instructive signaling for commitment to the CD8 lineage. Our results are discussed in terms of recent models of T cell lineage commitment.	UNIV WASHINGTON, DEPT IMMUNOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA; UNIV MINNESOTA, SCH MED, DEPT PATHOL & LAB MED, MINNEAPOLIS, MN 55455 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities				Hogquist, Kristin/0000-0001-9963-5687	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009537-13, T32 CA009537, P32CA09537] Funding Source: Medline; NIAID NIH HHS [R01 AI029802-11, R01 AI029802] Funding Source: Medline; PHS HHS [A1-39560, A1-29802] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029802] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; BACHMANN MF, 1995, J IMMUNOL, V155, P3727; BARNDEN MJ, 1994, EUR J IMMUNOL, V24, P2452, DOI 10.1002/eji.1830241029; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; CROOKS MEC, 1994, IMMUNITY, V1, P277; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P212, DOI 10.1002/eji.1830230133; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KNALL C, 1994, MOL IMMUNOL, V31, P875, DOI 10.1016/0161-5890(94)90007-8; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MULLER KP, 1993, EUR J IMMUNOL, V23, P1661, DOI 10.1002/eji.1830230740; MULLER KP, 1995, EUR J IMMUNOL, V25, P896, DOI 10.1002/eji.1830250406; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; POTTER TA, 1987, J EXP MED, V166, P956, DOI 10.1084/jem.166.4.956; RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; Renard V, 1996, J EXP MED, V184, P2439, DOI 10.1084/jem.184.6.2439; RUDD C, 1989, BIOCHEM CELL BIOL, V67, P581, DOI 10.1139/o89-090; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SUN JR, 1995, J EXP MED, V182, P1275, DOI 10.1084/jem.182.5.1275; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; TEH HS, 1991, NATURE, V349, P241, DOI 10.1038/349241a0; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2	46	65	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1997	6	5					633	642		10.1016/S1074-7613(00)80351-9	http://dx.doi.org/10.1016/S1074-7613(00)80351-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175841	Green Accepted, Bronze			2022-12-18	WOS:A1997XB81900014
J	Androlewicz, MJ; Cresswell, P				Androlewicz, MJ; Cresswell, P			How selective is the transporter associated with antigen processing?	IMMUNITY			English	Article							CLASS-I MOLECULES; HLA-B ANTIGENS; PEPTIDE-BINDING; ENDOPLASMIC-RETICULUM; P-GLYCOPROTEIN; RMA-S; MHC; CELLS; GENE; TRANSLOCATION		UNIV S FLORIDA,COLL MED,DEPT BIOCHEM & MOL BIOL,TAMPA,FL 33612; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	State University System of Florida; University of South Florida; Howard Hughes Medical Institute; Yale University	Androlewicz, MJ (corresponding author), UNIV S FLORIDA,COLL MED,H LEE MOFFITT CANC CTR & RES INST,PROGRAM IMMUNOL,TAMPA,FL 33612, USA.							ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LJUNGGREN HG, 1989, J IMMUNOL, V142, P2911; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Momburg F, 1996, J IMMUNOL, V156, P1756; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEISIG A, 1995, J IMMUNOL, V154, P1273; Nijenhuis M, 1996, J IMMUNOL, V156, P2186; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; RIORDAN JR, 1989, SCIENCE, V245, P1066; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4	40	65	65	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					1	5		10.1016/S1074-7613(00)80304-0	http://dx.doi.org/10.1016/S1074-7613(00)80304-0			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758889	hybrid			2022-12-18	WOS:A1996UZ45400001
J	KEARSE, KP; ROBERTS, JL; SINGER, A				KEARSE, KP; ROBERTS, JL; SINGER, A			TCR-ALPHA-CD3-DELTA-EPSILON ASSOCIATION IS THE INITIAL STEP IN ALPHA-BETA DIMER FORMATION IN MURINE T-CELLS AND IS LIMITING IN IMMATURE CD4(+)CD8(+) THYMOCYTES	IMMUNITY			English	Article							ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODY; ENDOPLASMIC-RETICULUM; CD3 COMPLEX; DELTA-CHAIN; DEGRADATION; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; EXPRESSION	The present study has examined the molecular events leading to formation of up dimers in normal murine thymocytes and mature T cells. We demonstrate that TCR assembly proceeds by initial association of TCR alpha with CD3 delta epsilon proteins and by association of ICRP with CD3 gamma epsilon proteins to form alpha delta epsilon and beta gamma epsilon trimers; these trimers then associate to form alpha delta epsilon-beta gamma epsilon complexes, within which alpha-beta disulfide bond formation occurs. We also show that TCR-associated protein (TRAP) associates uniquely with CD3 gamma epsilon pairs and that formation of beta gamma epsilon trimers occurs subsequent to TRAP dissociation. Importantly, we document that the assembly step that is quantitatively limiting in CD4(+)CD8(+) thymocytes is the initial association of TCR alpha with CD3 delta epsilon chains, which appears necessary to protect nascent TCR alpha proteins from accelerated degradation within the ER of immature thymocytes.			KEARSE, KP (corresponding author), NCI,EXPTL IMMUNOL BRANCH,BLDG 10,BETHESDA,MD 20892, USA.							ALARCON B, 1988, J BIOL CHEM, V263, P2953; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; BECKER MLB, 1989, CELL, V58, P911, DOI 10.1016/0092-8674(89)90943-4; BONIFACINO JS, 1988, J BIOL CHEM, V263, P8965; BONIFACINO JS, 1990, NATURE, V344, P247, DOI 10.1038/344247a0; BONIFACINO JS, 1988, P NATL ACAD SCI USA, V35, P6929; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; COULIE PG, 1991, EUR J IMMUNOL, V21, P1703, DOI 10.1002/eji.1830210718; GREEN NM, 1991, NATURE, V351, P349, DOI 10.1038/351349a0; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; KEARSE KP, 1993, P NATL ACAD SCI USA, V90, P2438, DOI 10.1073/pnas.90.6.2438; KEARSE KP, 1994, J IMMUNOL METHODS, V167, P75, DOI 10.1016/0022-1759(94)90076-0; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KONING F, 1988, J IMMUNOL, V140, P3126; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIPPINCOTTSCHWA.J, 1988, CELL, V54, P209; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; PETTEY CL, 1987, J BIOL CHEM, V262, P4854; SAMELSON LE, 1986, J IMMUNOL, V137, P3254; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973	26	65	65	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					391	399						9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719941				2022-12-18	WOS:A1995QU61600009
J	Willcox, CR; Vantourout, P; Salim, M; Zlatareva, I; Melandri, D; Zanardo, L; George, R; Kjaer, S; Jeeves, M; Mohammed, F; Hayday, AC; Willcox, BE				Willcox, Carrie R.; Vantourout, Pierre; Salim, Mahboob; Zlatareva, Iva; Melandri, Daisy; Zanardo, Leonor; George, Roger; Kjaer, Svend; Jeeves, Mark; Mohammed, Fiyaz; Hayday, Adrian C.; Willcox, Benjamin E.			Butyrophilin-like 3 Directly Binds a Human V gamma 4(+) T Cell Receptor Using a Modality Distinct from Clonally-Restricted Antigen	IMMUNITY			English	Article							RECOGNITION; MOLECULES; SKINT-1; PROTEIN; PHOSPHOANTIGENS; MODULATION; EXPRESSION; DIVERSITY; INFECTION; EXPANSION	Butyrophilin (BTN) and butyrophilin-like (BTNL/Btnl) heteromers are major regulators of human and mouse gamma delta T cell subsets, but considerable contention surrounds whether they represent direct gamma delta T cell receptor (TCR) ligands. We demonstrate that the BTNL3 IgV domain binds directly and specifically to a human V gamma 4(+) TCR, "LES'' with an affinity (similar to 15-25 mu M) comparable to many alpha beta TCR-peptide major histocompatibility complex interactions. Mutations in germline-encoded V gamma 4 CDR2 and HV4 loops, but not in somatically recombined CDR3 loops, drastically diminished binding and T cell responsiveness to BTNL3-BTNL8-expressing cells. Conversely, CDR3 gamma and CDR3 delta loops mediated LES TCR binding to endothelial protein C receptor, a clonally restricted autoantigen, with minimal CDR1, CDR2, or HV4 contributions. Thus, the gamma delta TCR can employ two discrete binding modalities: a non-clonotypic, superantigen-like interaction mediating subset-specific regulation by BTNL/BTN molecules and CDR3-dependent, anti-body-like interactions mediating adaptive gamma delta T cell biology. How these findings might broadly apply to gamma delta T cell regulation is also examined.	[Willcox, Carrie R.; Salim, Mahboob; Zanardo, Leonor; Mohammed, Fiyaz; Willcox, Benjamin E.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Willcox, Carrie R.; Salim, Mahboob; Zanardo, Leonor; Mohammed, Fiyaz; Willcox, Benjamin E.] Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England; [Vantourout, Pierre; Zlatareva, Iva; Melandri, Daisy; Hayday, Adrian C.] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Vantourout, Pierre; Zlatareva, Iva; Melandri, Daisy; Hayday, Adrian C.] Francis Crick Inst, Immunosurveillance Lab, London, England; [Zanardo, Leonor] Univ Tours, Fac Med, Tours, France; [George, Roger; Kjaer, Svend] Francis Crick Inst, Struct Biol Team, London, England; [Jeeves, Mark] Univ Birmingham, Inst Canc & Genom Sci, Henry Wellcome Bldg NMR, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of London; King's College London; Francis Crick Institute; Universite de Tours; Francis Crick Institute; University of Birmingham	Willcox, BE (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.; Willcox, BE (corresponding author), Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England.; Hayday, AC (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England.; Hayday, AC (corresponding author), Francis Crick Inst, Immunosurveillance Lab, London, England.	adrian.hayday@kcl.ac.uk; b.willcox@bham.ac.uk		Zlatareva, Iva/0000-0001-8027-8042; HAYDAY, ADRIAN/0000-0002-9495-5793; Jeeves, Mark/0000-0001-9736-0990	Wellcome Trust [208400/Z/17/Z, 099266/Z/12/Z, FC001093]; Wellcome Trust Investigator Award [106292/Z/14/Z]; Francis Crick Institute - Cancer Research UK (CRUK) [FC001093]; UK Medical Research Council [FC001093]; King's Bioscience Institute; Guy's and St Thomas' Charity Prize PhD program in Biomedical and Translational Science; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Investigator Award(Wellcome Trust); Francis Crick Institute - Cancer Research UK (CRUK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's Bioscience Institute; Guy's and St Thomas' Charity Prize PhD program in Biomedical and Translational Science; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London	We thank the University of Birmingham Protein Expression Facility for use of their equipment, P. Bates and R. Chaleil (the Francis Crick Institute) for advice, and O. Polyakova and O. Nussbaumer (GammaDelta Therapeutics) for V gamma 4V delta 1 sTCR reagents. This work was supported in part by the Wellcome Trust (grant 208400/Z/17/Z to University of Birmingham), and we thank HWB-NMR staff at the University of Birmingham for providing open access to their Wellcome Trust-funded 800/900 MHz spectrometers. This work was supported by the Wellcome Trust (grant 099266/Z/12/Z to B.E.W. supporting C.R.W., M.S., and F.M.); a Wellcome Trust Investigator Award (grant 106292/Z/14/Z to A.C.H.); the Francis Crick Institute, which receives its core funding from Cancer Research UK (CRUK) (grant FC001093), the UK Medical Research Council (grant FC001093), and the Wellcome Trust (grant FC001093); studentships from King's Bioscience Institute and Guy's and St Thomas' Charity Prize PhD program in Biomedical and Translational Science (to D.M.); and the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London (to I.Z.).	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Bukowski JF, 1998, J IMMUNOL, V161, P286; Dalessandri T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12080; Davey MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04076-0; Davey MS, 2018, TRENDS IMMUNOL, V39, P446, DOI 10.1016/j.it.2018.03.003; Davey MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14760; DELFAU MH, 1992, EUR J IMMUNOL, V22, P2437, DOI 10.1002/eji.1830220937; Edelblum KL, 2015, GASTROENTEROLOGY, V148, P1417, DOI 10.1053/j.gastro.2015.02.053; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; He S, 2019, NATURE, V566, P115, DOI 10.1038/s41586-018-0849-9; Hsiao CHC, 2014, CHEM BIOL, V21, P945, DOI 10.1016/j.chembiol.2014.06.006; Hunter S, 2018, J HEPATOL, V69, P654, DOI 10.1016/j.jhep.2018.05.007; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Krishnan S, 2018, P NATL ACAD SCI USA, V115, P10738, DOI 10.1073/pnas.1802320115; Lafarge X, 2005, EUR J IMMUNOL, V35, P1896, DOI 10.1002/eji.200425837; Lebrero-Fernandez C, 2016, IMMUN INFLAMM DIS, V4, P191, DOI 10.1002/iid3.105; Lebrero-Fernandez C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00001; Mayassi T, 2019, CELL, V176, P967, DOI 10.1016/j.cell.2018.12.039; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Mitropoulou AN, 2018, P NATL ACAD SCI USA, V115, pE8707, DOI 10.1073/pnas.1806840115; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Salim M, 2016, J BIOL CHEM, V291, P9310, DOI 10.1074/jbc.M116.722066; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; van Konijnenburg DPH, 2017, CELL, V171, P783, DOI 10.1016/j.cell.2017.08.046; Vantourout P, 2018, P NATL ACAD SCI USA, V115, P1039, DOI 10.1073/pnas.1701237115; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Willcox BE, 2019, NAT IMMUNOL, V20, P121, DOI 10.1038/s41590-018-0304-y; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004	55	64	67	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					813	+		10.1016/j.immuni.2019.09.006	http://dx.doi.org/10.1016/j.immuni.2019.09.006			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31628053	hybrid, Green Published			2022-12-18	WOS:000497811300007
J	Munoz, LE; Boeltz, S; Bilyy, R; Schauer, C; Mahajan, A; Widulin, N; Gruneboom, A; Herrmann, I; Boada, E; Rauh, M; Krenn, V; Biermann, MHC; Podolska, MJ; Hahn, J; Knopf, J; Maueroder, C; Paryzhak, S; Dumych, T; Zhao, Y; Neurath, MF; Hoffmann, MH; Fuchs, TA; Leppkes, M; Schett, G; Herrmann, M				Munoz, Luis E.; Boeltz, Sebastian; Bilyy, Rostyslav; Schauer, Christine; Mahajan, Aparna; Widulin, Navena; Grueneboom, Anika; Herrmann, Irmgard; Boada, Edgyda; Rauh, Manfred; Krenn, Veit; Biermann, Mona H. C.; Podolska, Malgorzata J.; Hahn, Jonas; Knopf, Jasmin; Maueroeder, Christian; Paryzhak, Solomiya; Dumych, Tetiana; Zhao, Yi; Neurath, Markus F.; Hoffmann, Markus H.; Fuchs, Tobias A.; Leppkes, Moritz; Schett, Georg; Herrmann, Martin			Neutrophil Extracellular Traps Initiate Gallstone Formation	IMMUNITY			English	Article							ACTIVATION; CRYSTALS; BILE; HOMEOSTASIS; ARTHRITIS; CALCIUM; BINDING; MICE	The presence of gallstones (cholelithiasis) is a highly prevalent and severe disease and one of the leading causes of hospital admissions worldwide. Due to its substantial health impact, we investigated the biological mechanisms that lead to the formation and growth of gallstones. We show that gallstone assembly essentially requires neutrophil extracellular traps (NETs). We found consistent evidence for the presence of NETs in human and murine gallstones and describe an immune-mediated process requiring activation of the innate immune system for the formation and growth of gallstones. Targeting NET formation via inhibition of peptidyl arginine deiminase type 4 or abrogation of reactive oxygen species (ROS) production, as well as damping of neutrophils by metoprolol, effectively inhibit gallstone formation in vivo. Our results show that after the physicochemical process of crystal formation, NETs foster their assembly into larger aggregates and finally gallstones. These insights provide a feasible therapeutic concept to prevent cholelithiasis in patients at risk.	[Munoz, Luis E.; Boeltz, Sebastian; Bilyy, Rostyslav; Schauer, Christine; Mahajan, Aparna; Grueneboom, Anika; Herrmann, Irmgard; Boada, Edgyda; Biermann, Mona H. C.; Podolska, Malgorzata J.; Hahn, Jonas; Knopf, Jasmin; Maueroeder, Christian; Hoffmann, Markus H.; Schett, Georg; Herrmann, Martin] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol 3, D-90154 Erlangen, Germany; [Bilyy, Rostyslav; Paryzhak, Solomiya; Dumych, Tetiana] Danylo Halytsky Lviv Natl Med Univ, UA-79010 Lvov, Ukraine; [Widulin, Navena] Berlin Museum Med Hist Charite, D-10117 Berlin, Germany; [Boada, Edgyda] Hassberg Clin, Dept Gen Surg, Hassfurt, Germany; [Rauh, Manfred] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Pediat, D-91054 Erlangen, Germany; [Krenn, Veit] Univ Trier, Dept Pathol, D-54296 Trier, Germany; [Zhao, Yi] Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, Chengdu 610041, Sichuan, Peoples R China; [Neurath, Markus F.; Leppkes, Moritz] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Internal Med Gastroenterol Pneumol & Endocri, D-91054 Erlangen, Germany; [Fuchs, Tobias A.] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Lab Mol Inflammat, D-20251 Hamburg, Germany	University of Erlangen Nuremberg; Danylo Halytsky Lviv National Medical University; University of Erlangen Nuremberg; Universitat Trier; Sichuan University; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Herrmann, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol 3, D-90154 Erlangen, Germany.	martin.hermiann@uk-erlangen.de	Bilyy, Rostyslav/A-9777-2010; Leppkes, Moritz/ABG-7617-2020; Knopf, Jasmin/AAS-4377-2020; Munoz, Luis E/E-7725-2010; Boeltz, Sebastian/H-3594-2014; herrmann, martin/AAT-9836-2020; Leppkes, Moritz/N-2932-2017; Herrmann, Martin/A-9597-2013; Maueroder, Christian/H-7412-2016	Bilyy, Rostyslav/0000-0002-2344-1349; Leppkes, Moritz/0000-0003-2311-090X; Knopf, Jasmin/0000-0003-2922-9370; Munoz, Luis E/0000-0002-5395-804X; Boeltz, Sebastian/0000-0001-5227-8707; Herrmann, Martin/0000-0002-0258-2484; Gruneboom, Anika/0000-0002-7928-5613; Hoffmann, Markus/0000-0001-9698-9922; Maueroder, Christian/0000-0002-7563-883X; Hahn, Jonas/0000-0003-3944-2108	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); German Research Foundation (DFG) [SCHA 2040/1-1, SCHE1583714-1, CRC1181, KFO257, KFO 306, FU742/4-1, FOR 2886]; EU( H2020-MSCE-RISE-2015) [690836 PANG]; Volkswagen-Stiftung [90361]; MSD Sharp Dohme; Interdisciplinary Center for Clinical Research (IZKF); ELAN of the FAU; Ministry of Health of Ukraine [0119U101338]; RECOOP HST RCSS grant; Ardea Biosciences; Optical Imaging Center Erlangen (OICE); EU (ERC-Synergy 4D Nanoscope)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); German Research Foundation (DFG)(German Research Foundation (DFG)); EU( H2020-MSCE-RISE-2015); Volkswagen-Stiftung(Volkswagen); MSD Sharp Dohme; Interdisciplinary Center for Clinical Research (IZKF); ELAN of the FAU; Ministry of Health of Ukraine; RECOOP HST RCSS grant; Ardea Biosciences; Optical Imaging Center Erlangen (OICE); EU (ERC-Synergy 4D Nanoscope)	The present work was performed in (partial) fulfillment of the requirements for obtaining the degree Dr. med./Dr. rer. biol. hum. to S.B. The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding program Open Access Publishing and by the Optical Imaging Center Erlangen (OICE). The authors thank Prof. M.D. Lootsik for his assistance and suggestions. This work was partially supported by the German Research Foundation (DFG) (SCHA 2040/1-1; SCHE1583714-1; CRC1181 projects: C03, A01, B02, and Z02; KFO257, KFO 306, and FU742/4-1; FOR 2886 projects: A03, B03, and B04), the EU (H2020-MSCE-RISE-2015 project 690836 PANG; ERC-Synergy 4D Nanoscope), Volkswagen-Stiftung (90361), MSD Sharp & Dohme (research scholarship), local funds from the Interdisciplinary Center for Clinical Research (IZKF), and ELAN of the FAU to C.S., the Ministry of Health of Ukraine (0119U101338), a RECOOP HST RCSS grant to R.B., and Ardea Biosciences.	ADMIRAND WH, 1968, J CLIN INVEST, V47, P1043, DOI 10.1172/JCI105794; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; BEEN JM, 1979, GASTROENTEROLOGY, V76, P548; Bicker KL, 2012, ACS MED CHEM LETT, V3, P1081, DOI 10.1021/ml300288d; Biermann MHC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00557; CAREY MC, 1978, J LIPID RES, V19, P945; CAREY MC, 1978, J CLIN INVEST, V61, P998, DOI 10.1172/JCI109025; Desai J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15106-0; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Garcia-Prieto J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14780; HEUMAN DM, 1989, J LIPID RES, V30, P719; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Kanlaya R, 2013, CELL BIOCHEM BIOPHYS, V67, P1171, DOI 10.1007/s12013-013-9630-8; Leppkes M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10973; Lin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30215; Maueroder C, 2015, J MOL MED, V93, P727, DOI 10.1007/s00109-015-1295-x; MOORE EW, 1984, HEPATOLOGY, V4, pS228, DOI 10.1002/hep.1840040842; Munoz LE, 2016, P NATL ACAD SCI USA, V113, pE5856, DOI 10.1073/pnas.1602230113; Niyonzima N, 2017, MOL IMMUNOL, V84, P43, DOI 10.1016/j.molimm.2016.09.019; Reinwald C, 2016, NAT MED, V22, P1384, DOI 10.1038/nm.4217; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Takeuchi K, 2008, CHEM SENSES, V33, P425, DOI 10.1093/chemse/bjn009; Thomas MP, 2014, J IMMUNOL, V192, P5390, DOI 10.4049/jimmunol.1303296	29	64	69	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					443	+		10.1016/j.immuni.2019.07.002	http://dx.doi.org/10.1016/j.immuni.2019.07.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31422870	Bronze, Green Submitted			2022-12-18	WOS:000486184600008
J	Bu, W; Joyce, MG; Nguyen, H; Banh, DV; Aguilar, F; Tariq, Z; Yap, ML; Tsujimura, Y; Gillespie, RA; Tsybovsky, Y; Andrews, SF; Narpala, SR; McDermott, AB; Rossmann, MG; Yasutomi, Y; Nabel, GJ; Kanekiyo, M; Cohen, JI				Bu, Wei; Joyce, M. Gordon; Hanh Nguyen; Banh, Dalton V.; Aguilar, Fiona; Tariq, Zeshan; Yap, Moh Lan; Tsujimura, Yusuke; Gillespie, Rebecca A.; Tsybovsky, Yaroslav; Andrews, Sarah F.; Narpala, Sandeep R.; McDermott, Adrian B.; Rossmann, Michael G.; Yasutomi, Yasuhiro; Nabel, Gary J.; Kanekiyo, Masaru; Cohen, Jeffrey I.			Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells	IMMUNITY			English	Article							RECEPTOR-BINDING; GLYCOPROTEIN-B; INFECTION; GH; EXPRESSION; ANTIGEN; EBV; ALPHA-V-BETA-6; LYMPHOCYTES; PROTEINS	Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with epithelial-cell cancers and B cell lymphomas. An effective EBV vaccine is not available. We found that antibodies to the EBV glycoprotein gH/gL complex were the principal components in human plasma that neutralized infection of epithelial cells and that antibodies to gH/gL and gp42 contributed to B cell neutralization. Immunization of mice and nonhuman primates with nanoparticle vaccines that displayed components of the viral-fusion machinery EBV gH/gL or gH/gL/gp42 elicited antibodies that potently neutralized both epithelial-cell and B cell infection. Immune serum from nonhuman primates inhibited EBV-glycoprotein-mediated fusion of epithelial cells and B cells and targeted an epitope critical for virus-cell fusion. Therefore, unlike the leading EBV gp350 vaccine candidate, which only protects B cells from infection, these EBV nanoparticle vaccines elicit antibodies that inhibit the virus-fusion apparatus and provide cell-type-independent protection from virus infection.	[Bu, Wei; Hanh Nguyen; Banh, Dalton V.; Aguilar, Fiona; Tariq, Zeshan; Cohen, Jeffrey I.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Joyce, M. Gordon; Gillespie, Rebecca A.; Andrews, Sarah F.; Narpala, Sandeep R.; McDermott, Adrian B.; Nabel, Gary J.; Kanekiyo, Masaru] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Joyce, M. Gordon] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Yap, Moh Lan; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Yap, Moh Lan] Univ Tunku Abdul Rahman, Fac Sci, Dept Biol Sci, Kampar 31900, Perak, Malaysia; [Tsujimura, Yusuke; Yasutomi, Yasuhiro] Natl Inst Biomed Innovat Hlth & Nutr, Tsukuba Primate Res Ctr, Lab Immunoregulat & Vaccine Res, Tsukuba, Ibaraki 3050843, Japan; [Tsybovsky, Yaroslav] Leidos Biomed Res Inc, Electron Microscopy Lab, Adv Res Technol Facil, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Nabel, Gary J.] Sanofi, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universiti Tunku Abdul Rahman (UTAR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanofi-Aventis	Cohen, JI (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov	Kanekiyo, Masaru/Y-9820-2018; McDermott, Adrian B/E-7306-2011	Kanekiyo, Masaru/0000-0001-5767-1532; McDermott, Adrian/0000-0003-0616-9117; Aguilar, Fiona/0000-0002-0596-7486; Banh, Dalton/0000-0001-8167-9358	intramural research program of the National Institute of Allergy and Infectious Diseases; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]	intramural research program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Frederick National Laboratory for Cancer Research, National Institutes of Health	We thank Jing Qin for statistical analyses; Sundar Ganesan and Juraj Kabat for help with microscopy; Bernard Moss for plasmids and vaccinia viruses; Lindsey Hutt-Fletcher for mAbs E1D1, F-2-1, and CL40 and Akata BX1 and SVKCR2 cells; Henri-Jacques Delecluse and Bill Sugden for 293/2089 cells; Shannon Kenney for AGS cells; Richard Longnecker for plasmids encoding EBV gH, gL, gB, gp42, and T7 luciferase and for 293 T14 and Daudi cells; Andrew McGuire for AMMO1 antibody; Jeffrey Boyington and Peter Kwong for help with DLS experiments; and David Ambrozak and the VRC Flow Cytometry Core for help with B cell sorting. This research was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases and in part with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E.	BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chen J, 2018, NAT MICROBIOL, V3, P172, DOI 10.1038/s41564-017-0081-7; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Coghill AE, 2016, CLIN CANCER RES, V22, P3451, DOI 10.1158/1078-0432.CCR-15-2299; Cohen JI, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2014.27; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DINTZIS RZ, 1982, P NATL ACAD SCI-BIOL, V79, P884, DOI 10.1073/pnas.79.3.884; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; HOFFMAN GJ, 1980, P NATL ACAD SCI-BIOL, V77, P2979, DOI 10.1073/pnas.77.5.2979; Kanekiyo M, 2015, CELL, V162, P1090, DOI 10.1016/j.cell.2015.07.043; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kirschner AN, 2007, J VIROL, V81, P9216, DOI 10.1128/JVI.00575-07; LI QX, 1995, J VIROL, V69, P3987, DOI 10.1128/JVI.69.7.3987-3994.1995; Li QX, 1997, J VIROL, V71, P4657, DOI 10.1128/JVI.71.6.4657-4662.1997; LI QX, 1992, NATURE, V356, P347, DOI 10.1038/356347a0; McShane MP, 2004, P NATL ACAD SCI USA, V101, P17474, DOI 10.1073/pnas.0404535101; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Sashihara J, 2009, VIROLOGY, V391, P249, DOI 10.1016/j.virol.2009.06.013; Sathiyamoorthy K, 2017, P NATL ACAD SCI USA, V114, pE8703, DOI 10.1073/pnas.1704661114; Sathiyamoorthy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13557; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Silva AL, 2004, J VIROL, V78, P5946, DOI 10.1128/JVI.78.11.5946-5956.2004; Snijder J, 2018, IMMUNITY, V48, P799, DOI 10.1016/j.immuni.2018.03.026; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Sorem J, 2009, J GEN VIROL, V90, P591, DOI 10.1099/vir.0.007237-0; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wu LG, 2007, VIROLOGY, V363, P148, DOI 10.1016/j.virol.2007.01.025; Yap ML, 2017, P NATL ACAD SCI USA, V114, P13703, DOI 10.1073/pnas.1713166114; Yoshiyama H, 1997, J VIROL, V71, P5688, DOI 10.1128/JVI.71.7.5688-5691.1997; Zhang HL, 2018, SPRBRIEF ELECT, P1, DOI 10.1007/978-3-319-60469-5_1; 2006, J VIROL, V80, P9444, DOI DOI 10.1128/JVI.00572-06; 2005, J VIROL, V79, P1240, DOI DOI 10.1128/JVI.79.19.12408-12415.2005	45	64	67	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1305	+		10.1016/j.immuni.2019.03.010	http://dx.doi.org/10.1016/j.immuni.2019.03.010			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	30979688	Green Accepted, Bronze			2022-12-18	WOS:000468429500019
J	Brown, JA; Singh, G; Acklin, JA; Lee, S; Duehr, JE; Chokola, AN; Frere, JJ; Hoffman, KW; Foster, GA; Krysztof, D; Cadagan, R; Jacobs, AR; Stramer, SL; Krammer, F; Garcia-Sastre, A; Lim, JK				Brown, Julia A.; Singh, Gursewak; Acklin, Joshua A.; Lee, Silviana; Duehr, James E.; Chokola, Anupa N.; Frere, Justin J.; Hoffman, Kevin W.; Foster, Gregory A.; Krysztof, David; Cadagan, Richard; Jacobs, Adam R.; Stramer, Susan L.; Krammer, Florian; Garcia-Sastre, Adolfo; Lim, Jean K.			Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy	IMMUNITY			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN PLACENTAL TROPHOBLASTS; CROSS-REACTIVITY; BIRTH-DEFECTS; INFECTION; DISEASE; PATHOGENESIS; PROTECTION; CELLS; INFANTS	Zika virus (ZIKV) has recently been associated with birth defects and pregnancy loss after maternal infection. Because dengue virus (DENV) and ZIKV co-circulate, understanding the role of antibody-dependent enhancement in the context of pregnancy is critical. Here, we showed that the presence of DENV-specific antibodies in ZIKV-infected pregnant mice significantly increased placental damage, fetal growth restriction, and fetal resorption. This was associated with enhanced viral replication in the placenta that coincided with an increased frequency of infected trophoblasts. ZIKV-infected human placental tissues also showed increased replication in the presence of DENV antibodies, which was reversed by FcyR blocking antibodies. Furthermore, ZIKV-mediated fetal pathogenesis was enhanced in mice in the presence of a DENV-reactive monoclonal antibody, but not in the presence of the LALA variant, indicating a dependence on FcyR engagement. Our data suggest a possible mechanism for the recent increase in severe pregnancy outcomes after ZIKV infection in DENV-endemic areas.	[Brown, Julia A.; Singh, Gursewak; Acklin, Joshua A.; Lee, Silviana; Duehr, James E.; Chokola, Anupa N.; Frere, Justin J.; Hoffman, Kevin W.; Cadagan, Richard; Krammer, Florian; Garcia-Sastre, Adolfo; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Brown, Julia A.; Acklin, Joshua A.; Lee, Silviana; Duehr, James E.; Chokola, Anupa N.; Hoffman, Kevin W.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Cadagan, Richard; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Foster, Gregory A.; Krysztof, David; Stramer, Susan L.] Amer Red Cross, Gaithersburg, MD USA; [Jacobs, Adam R.] Icahn Sch Med Mt Sinai, Dept Obstet & Gynecol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; American Red Cross; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Lim, JK (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	jean.lim@mssm.edu	Krammer, Florian/H-3237-2019; amsalu, ribka/G-8780-2019	Krammer, Florian/0000-0003-4121-776X; Duehr, James/0000-0003-2077-6685; Chokola, Anupa/0000-0003-4225-7640; Acklin, Joshua/0000-0002-4203-2428; Frere, Justin/0000-0002-7514-8873; Lee, Silviana/0000-0002-5847-5725	NIAID [R21AI130299, R21AI129486, R21AI139593, R21AI127955, U19AI118610]; NIAID training grant [T32AI007647]; NIH, as part of the WRCEVA program: Dengue Virus Type 4 [PR 06-65-740, NR-49757]; NIH, as part of the WRCEVA program: Dengue Virus Type 1 [BC89/94, NR-3787]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, R21AI129486, R21AI130299, U19AI118610, R21AI127955, R21AI139593] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID training grant; NIH, as part of the WRCEVA program: Dengue Virus Type 4(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, as part of the WRCEVA program: Dengue Virus Type 1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Matthew J. Evan and Marion Sourisseau for providing the RNA standards for ZIKV quantification, Dr. Christian Schindler for providing the original Stat2<SUP>-/-</SUP> mice, and Dr. Domenico Tortorella for providing the NS3 antibody. We also thank David Sachs for assistance with R and Justin Taft for assistance with CellProfiler software. We are grateful to Drs. Dusan Bogunovic and Christopher J. Obara for invaluable evaluation of our manuscript. We thank Dr. Michael Donovan, Olha Fedoryshyn, Anastasiya Dzhun, and Josefa Lopez from the Biorepository and Pathology CoRE at the Mount Sinai Health System. Microscopy and image analysis were performed at the Microscopy CoRE at the Icahn School of Medicine at Mount Sinai. This work was supported by NIAID grants R21AI130299, R21AI129486, R21AI139593, and R21AI127955; NIAID training grant T32AI007647; and a supplement to NIAID grant U19AI118610. The following reagents were obtained through BEI Resources, NIAID, and NIH, as part of the WRCEVA program: Dengue Virus Type 4, PR 06-65-740, NR-49757; Dengue Virus Type 1, BC89/94, NR-3787. Zika virus strain PRVABC59 was obtained through ATCC (VR-1843).	Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389; Aguado LC, 2015, CELL HOST MICROBE, V18, P714, DOI 10.1016/j.chom.2015.11.003; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957; Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5; El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296; Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849; Gil-Sanchez Alfonso, 2011, Frontiers in Genetics, V2, P57, DOI 10.3389/fgene.2011.00057; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lozano NA, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12972; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Pacheco O., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037]; Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674; Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72; Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]; Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16; Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1; Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114; Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14; Tomashek KM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005025; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11; Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z; Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031; Woods L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00308-x; Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680; Yougbare I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00269-1; Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120; Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008	65	64	65	5	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					751	+		10.1016/j.immuni.2019.01.005	http://dx.doi.org/10.1016/j.immuni.2019.01.005			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30737148	Green Accepted, Bronze			2022-12-18	WOS:000461660500023
J	Campbell, C; Dikiy, S; Bhattarai, SK; Chinen, T; Matheis, F; Calafiore, M; Hoyos, B; Hanash, A; Mucida, D; Bucci, V; Rudensky, AY				Campbell, Clarissa; Dikiy, Stanislav; Bhattarai, Shakti K.; Chinen, Takatoshi; Matheis, Fanny; Calafiore, Marco; Hoyos, Beatrice; Hanash, Alan; Mucida, Daniel; Bucci, Vanni; Rudensky, Alexander Y.			Extrathymically Generated Regulatory T Cells Establish a Niche for Intestinal Border-Dwelling Bacteria and Affect Physiologic Metabolite Balance	IMMUNITY			English	Article							ALTERED SCHAEDLER FLORA; INNATE LYMPHOID-CELLS; GUT MICROBIOTA; COMMENSAL BACTERIA; ANTIGENS; GENE; DIFFERENTIATION; IMMUNITY	The mammalian gut microbiota provides essential metabolites to the host and promotes the differentiation and accumulation of extrathymically generated regulatory T (pTreg) cells. To explore the impact of these cells on intestinal microbial communities, we assessed the composition of the microbiota in pTreg cell-deficient and -sufficient mice. pTreg cell deficiency led to heightened type 2 immune responses triggered by microbial exposure, which disrupted the niche of border-dwelling bacteria early during colonization. Moreover, impaired pTreg cell generation led to pervasive changes in metabolite profiles, altered features of the intestinal epithelium, and reduced body weight in the presence of commensal microbes. Absence of a single species of bacteria depleted in pTreg cell-deficient animals, Mucispirillum schaedleri, partially accounted for the sequelae of pTreg cell deficiency. These observations suggest that pTreg cells modulate the metabolic function of the intestinal microbiota by restraining immune defense mechanisms that may disrupt a particular bacterial niche.	[Campbell, Clarissa; Dikiy, Stanislav; Chinen, Takatoshi; Hoyos, Beatrice; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10065 USA; [Campbell, Clarissa; Dikiy, Stanislav; Chinen, Takatoshi; Hoyos, Beatrice; Rudensky, Alexander Y.] Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA; [Campbell, Clarissa; Dikiy, Stanislav; Chinen, Takatoshi; Hoyos, Beatrice; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Campbell, Clarissa; Dikiy, Stanislav; Rudensky, Alexander Y.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA; [Bhattarai, Shakti K.; Bucci, Vanni] Univ Massachusetts, Program Biotechnol & Biomed Engn, Dept Biol, Dartmouth, MA 02747 USA; [Bhattarai, Shakti K.] Univ Massachusetts, Dept Biol, Program Engn & Appl Sci, Dartmouth, MA 02747 USA; [Matheis, Fanny; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Calafiore, Marco; Hanash, Alan] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hanash, Alan] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Massachusetts System; University Massachusetts Dartmouth; University of Massachusetts System; University Massachusetts Dartmouth; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University	Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA.	rudenska@mskcc.org	Dikiy, Stanislav/GWR-2104-2022; Bucci, Vanni/B-4558-2011	Dikiy, Stanislav/0000-0002-8287-6561; Campbell, Clarissa/0000-0002-1918-0318	NIH/NCI Cancer Center Support Grant (CCSG) [P30CA008748]; NIH [R37AI034206]; Ludwig Center at Memorial Sloan Kettering; Hilton-Ludwig Cancer Prevention Initiative; National Institute of Allergy and Infectious Disease [R15-AI112985-01A1]; National Science Foundation [1458347]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R15AI112985] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1458347] Funding Source: National Science Foundation	NIH/NCI Cancer Center Support Grant (CCSG); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at Memorial Sloan Kettering; Hilton-Ludwig Cancer Prevention Initiative; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Drs. Alessandra Piersigilli (MSKCC) and Piper Treuting (University of Washington) for pathological assessment of histological specimens, Aneta Rogoz (Rockefeller University) for re-derivation of GF mouse strains, Dr. Michael Wannemuehler (Iowa State University) for ASF bacterial strains, Eric Pamer (MSKCC) for assistance with anaerobic bacterial culture, and all the members of the Rudensky lab for technical support and discussion. This work was supported by NIH/NCI Cancer Center Support Grant (CCSG) P30CA008748, NIH grant R37AI034206, the Ludwig Center at Memorial Sloan Kettering, and the Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation and Ludwig Cancer Research). A.Y.R. is an investigator with the Howard Hughes Medical Institute. V.B. acknowledges support by the National Institute of Allergy and Infectious Disease grant R15-AI112985-01A1 and the National Science Foundation grant 1458347.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Biggs MB, 2017, ISME J, V11, P426, DOI 10.1038/ismej.2016.130; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Chinen T, 2010, J EXP MED, V207, P2323, DOI 10.1084/jem.20101235; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Forman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042248; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gasteiger G, 2013, J EXP MED, V210, P1167, DOI 10.1084/jem.20122462; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hrvatin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089459; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loy A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00171-16; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; R Development Core Team, 2011, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scholz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084019; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tsuji S, 2010, BRIT J CANCER, V103, P517, DOI 10.1038/sj.bjc.6605786; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Xiao YJ, 2015, INT J BIOCHEM CELL B, V67, P158, DOI 10.1016/j.biocel.2015.06.015; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Zhang HS, 2015, ISME J, V9, P770, DOI 10.1038/ismej.2014.165; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	65	64	66	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1245	+		10.1016/j.immuni.2018.04.013	http://dx.doi.org/10.1016/j.immuni.2018.04.013			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29858010	Bronze, Green Accepted			2022-12-18	WOS:000436456900022
J	Volmering, S; Block, H; Boras, M; Lowell, CA; Zarbock, A				Volmering, Stephanie; Block, Helena; Boras, Mark; Lowell, Clifford A.; Zarbock, Alexander			The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation	IMMUNITY			English	Article							SRC-FAMILY KINASES; BRUTONS TYROSINE KINASE; SH3 DOMAIN; RECRUITMENT; RESPONSES; HCK; TRANSDUCTION; DEFICIENT; MIGRATION; PATHWAYS	Neutrophils are recruited from the blood to sites of sterile inflammation, where they are involved in wound healing but can also cause tissue damage. During sterile inflammation, necrotic cells release pro-inflammatory molecules including formylated peptides. However, the signaling pathway triggered by formylated peptides to integrin activation and leukocyte recruitment is unknown. By using spinning-disk confocal intravital microscopy, we examined the molecular mechanisms of leukocyte recruitment to sites of focal hepatic necrosis in vivo. We demonstrated that the Bruton's tyrosine kinase (Btk) was required for multiple Mac-1 activation events involved in neutrophil recruitment and functions during sterile inflammation triggered by fMLF. The Src family kinase Hck, Wiskott-Aldrich-syndrome protein, and phospholipase C gamma 2 were also involved in this pathway required for fMLF-triggered Mac-1 activation and neutrophil recruitment. Thus, we have identified a neutrophil Btk signalosome that is involved in a signaling pathway triggered by formylated peptides leading to the selective activation of Mac-1 and neutrophil recruitment during sterile inflammation.	[Volmering, Stephanie; Block, Helena; Boras, Mark; Zarbock, Alexander] Univ Munster, Dept Anesthesiol Intens Care & Pain Med, D-48149 Munster, Germany; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Program Immunol, San Francisco, CA 94143 USA	University of Munster; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zarbock, A (corresponding author), Univ Munster, Dept Anesthesiol Intens Care & Pain Med, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	zarbock@uni-muenster.de			Deutsche Forschungsgemeinschaft [ZA428/6-1, SFB1009_A5, BL-1292/1]; IZKF Munster [Za2/001/14]; Cells-in-Motion Cluster of Excellence (University of Munster, Germany) [EXC 1003-CiM]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065495, R01AI068150, R01AI113272] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Munster; Cells-in-Motion Cluster of Excellence (University of Munster, Germany); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Stefan Volkery for expert technical support. This work was supported by the Deutsche Forschungsgemeinschaft (ZA428/6-1 and SFB1009_A5 to A.Z. and BL-1292/1 to H.B.), IZKF Munster (Za2/001/14 to A.Z.), and Cells-in-Motion Cluster of Excellence EXC 1003-CiM (University of Munster, Germany; to A.Z.).	Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; Afar DEH, 1996, MOL CELL BIOL, V16, P3465; Block H, 2012, INT REV IMMUNOL, V31, P104, DOI 10.3109/08830185.2012.668982; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Gilbert C, 2003, J IMMUNOL, V170, P5235, DOI 10.4049/jimmunol.170.10.5235; Grommes J, 2014, J INNATE IMMUN, V6, P111, DOI 10.1159/000353229; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; Herter JM, 2013, BLOOD, V121, P2301, DOI 10.1182/blood-2012-09-457085; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kuehn HS, 2010, J CELL SCI, V123, P2576, DOI 10.1242/jcs.071043; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Liao HR, 2015, CHEM-BIOL INTERACT, V236, P90, DOI 10.1016/j.cbi.2015.05.004; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; McDonald B, 2012, TOXICOL PATHOL, V40, P157, DOI 10.1177/0192623311427570; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Rossaint J, 2014, BLOOD, V123, P2573, DOI 10.1182/blood-2013-07-516484; Sakuma C, 2015, MOL IMMUNOL, V63, P328, DOI 10.1016/j.molimm.2014.08.004; Sakuma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030351; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009; Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	33	64	66	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					73	87		10.1016/j.immuni.2015.11.011	http://dx.doi.org/10.1016/j.immuni.2015.11.011			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26777396	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000368347000014
J	Mehta, A; Zhao, JL; Sinha, N; Marinov, GK; Mann, M; Kowalczyk, MS; Galimidi, RP; Du, XM; Erikci, E; Regev, A; Chowdhury, K; Baltimore, D				Mehta, Arnav; Zhao, Jimmy L.; Sinha, Nikita; Marinov, Georgi K.; Mann, Mati; Kowalczyk, Monika S.; Galimidi, Rachel P.; Du, Xiaomi; Erikci, Erdem; Regev, Aviv; Chowdhury, Kamal; Baltimore, David			The MicroRNA-132 and MicroRNA-212 Cluster Regulates Hematopoietic Stem Cell Maintenance and Survival with Age by Buffering FOXO3 Expression	IMMUNITY			English	Article							GENE-EXPRESSION; SELF-RENEWAL; AUTOPHAGY; DIFFERENTIATION; TARGETS; MIR-132; STRESS	MicroRNAs are critical post-transcriptional regulators of hematopoietic cell-fate decisions, though little remains known about their role in aging hematopoietic stem cells (HSCs). We found that the microRNA-212/132 cluster (Mirc19) is enriched in HSCs and is upregulated during aging. Both overexpression and deletion of microRNAs in this cluster leads to inappropriate hematopoiesis with age. Enforced expression of miR-132 in the bone marrow of mice led to rapid HSC cycling and depletion. A genetic deletion of Mirc19 in mice resulted in HSCs that had altered cycling, function, and survival in response to growth factor starvation. We found that miR-132 exerted its effect on aging HSCs by targeting the transcription factor FOXO3, a known aging associated gene. Our data demonstrate that Mirc19 plays a role in maintaining balanced hematopoietic output by buffering FOXO3 expression. We have thus identified it as a potential target that might play a role in age-related hematopoietic defects.	[Mehta, Arnav; Zhao, Jimmy L.; Sinha, Nikita; Marinov, Georgi K.; Mann, Mati; Galimidi, Rachel P.; Du, Xiaomi; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Mehta, Arnav; Zhao, Jimmy L.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kowalczyk, Monika S.; Regev, Aviv] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Erikci, Erdem; Chowdhury, Kamal] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Max Planck Society	Baltimore, D (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	baltimo@caltech.edu		Sinha, Nikita/0000-0003-4703-3937; Mehta, Arnav/0000-0002-0313-2848	NIH [RO1AI079243]; National Research Service Award [CA183220, HL110691]; UCLA/Caltech Medical Scientist Training Program; Human Frontiers Science Foundation; Broad Institute; NATIONAL CANCER INSTITUTE [F30CA183220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL110691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA/Caltech Medical Scientist Training Program; Human Frontiers Science Foundation; Broad Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Diana Perez at the Caltech Flow Cytometry core facility, and Igor Antoshechkin and Vijaya Kumar at the Caltech Genetics and Genomics Laboratory for their assistance. We also thank Michael T. Bethune for helpful discussions throughout the preparation of this manuscript. This work was supported by an NIH RO1AI079243 (D.B.), National Research Service Award CA183220 (A.M.), HL110691 (J.L.Z.), the UCLA/Caltech Medical Scientist Training Program (A.M. and J.L.Z.), the Human Frontiers Science Foundation (M.M.), and the Broad Institute (M.S.K. and A.R.).	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Chaudhuri AA, 2012, P NATL ACAD SCI USA, V109, P4233, DOI 10.1073/pnas.1200677109; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Frasca D, 2011, J CLIN IMMUNOL, V31, P430, DOI 10.1007/s10875-010-9501-7; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Henry CJ, 2011, AGING-US, V3, P643, DOI 10.18632/aging.100351; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Ni B, 2014, J IMMUNOL, V193, P4537, DOI 10.4049/jimmunol.1400124; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Strovas TJ, 2014, ACS SYNTH BIOL, V3, P324, DOI 10.1021/sb4001867; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537	38	64	68	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1021	1032		10.1016/j.immuni.2015.05.017	http://dx.doi.org/10.1016/j.immuni.2015.05.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084022	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000356362800009
J	Hong, M; Yoon, SI; Wilson, IA				Hong, Minsun; Yoon, Sung-il; Wilson, Ian A.			Structure and Functional Characterization of the RNA-Binding Element of the NLRX1 Innate Immune Modulator	IMMUNITY			English	Article							LEUCINE-RICH REPEAT; NF-KAPPA-B; NOD-LIKE RECEPTORS; CRYSTAL-STRUCTURE; LRR PROTEINS; RIBONUCLEASE INHIBITOR; CRITICAL RESIDUES; RECOGNITION; COMPLEX; FAMILY	Mitochondrial NLRX1 is a member of the family of nucleotide-binding domain and leucine-rich-repeat-containing proteins (NLRs) that mediate host innate immunity as intracellular surveillance sensors against common molecular patterns of invading pathogens. NLRX1 functions in antiviral immunity, but the molecular mechanism of its ligand-induced activation is largely unknown. The crystal structure of the C-terminal fragment (residues 629-975) of human NLRX1 (cNLRX1) at 2.65 angstrom resolution reveals that cNLRX1 consists of an N-terminal helical (LRRNT) domain, central leucine-rich repeat modules (LRRM), and a C-terminal three-helix bundle (LRRCT). cNLRX1 assembles into a compact hexameric architecture that is stabilized by intersubunit and interdomain interactions of LRRNT and LRRCT in the trimer and dimer components of the hexamer, respectively. Furthermore, we find that cNLRX1 interacts directly with RNA and supports a role for NLRX1 in recognition of intracellular viral RNA in antiviral immunity.	[Hong, Minsun; Yoon, Sung-il; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu			NIH [AI042266]; Skaggs Institute for Chemical Biology; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; National Institute of General Medical Sciences; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI042266 (I.A.W.) and the Skaggs Institute for Chemical Biology. X-ray diffraction data sets were collected at SSRL beamline 11-1 and APS beamline 23ID-B. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The APS beamline 23ID-B has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and National Institute of General Medical Sciences (Y1-GM-1104). We thank H. Tien and D. Marciano (Robotics Core of the Joint Center for Structural Genomics) for automated crystal screening, X. Dai and M.A. Elsliger (The Scripps Research Institute) for expert crystallographic and computational support, and R. Stanfield (The Scripps Research Institute) and K.J. Newberry (The University of Texas M. D. Anderson Cancer Center) for helpful discussions. We also thank A. Bobkov (protein production analysis facility, Sanford-Burnham Medical Research Institute) for the analytical ultracentrifugation analysis and O. Kurnasov (Sanford-Burnham Medical Research Institute), A.C.M. Ferreon (The Scripps Research Institute), and S. Hedrick and Y. Song (The Salk Institute) for generously sharing their instruments. This is manuscript no. 20843 from The Scripps Research Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; DeLano W. L, 2002, PYMOL MOL GENETICS G; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dieude P, 2011, ANN RHEUM DIS, V70, P668, DOI 10.1136/ard.2010.131243; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2000, METH MOL B, V160, P201; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lu WG, 2010, WORLD J GASTROENTERO, V16, P4348, DOI 10.3748/wjg.v16.i34.4348; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Molnar T, 2007, DIGEST LIVER DIS, V39, P1064, DOI 10.1016/j.dld.2007.09.003; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	50	64	69	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					337	347		10.1016/j.immuni.2011.12.018	http://dx.doi.org/10.1016/j.immuni.2011.12.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22386589	Bronze, Green Accepted			2022-12-18	WOS:000302048400007
J	Mrass, P; Kinjyo, I; Ng, LG; Reiner, SL; Pure, E; Weninger, W				Mrass, Paulus; Kinjyo, Ichiko; Ng, Lai Guan; Reiner, Steven L.; Pure, Ellen; Weninger, Wolfgang			CD44 Mediates Successful Interstitial Navigation by Killer T Cells and Enables Efficient Antitumor Immunity	IMMUNITY			English	Article							HYALURONIC-ACID BINDING; IMMUNOLOGICAL SYNAPSE; EXTRACELLULAR-MATRIX; CYTOPLASMIC DOMAIN; ERM PROTEINS; MIGRATION; ACTIVATION; MOTILITY; LESSONS; POLARIZATION	Although T lymphocytes are constitutively nonadherent cells, they undergo facultative polarity during migration and upon interaction with cells presenting cognate antigen, suggesting that cell polarity might be critical for target cell destruction. Using two-photon imaging of tumor-infiltrating T lymphocytes, we found that CD44, a receptor for extracellular matrix proteins and glycosaminoglycans, was crucial for interstitial T cell navigation and, consequently, efficient tumor cell screening. CD44 functioned as a critical regulator of intratumoral movement by stabilizing cell polarity in migrating T cells, but not during target cell interactions. Stable anterior-posterior asymmetry was maintained by CD44 independently of its extracellular domain. Instead, migratory polarity depended on the recruitment of ezrin, radixin, moesin (ERM) proteins by the intracellular domain of CD44 to the posterior cellular protrusion. Our results formally demonstrate that CD44-dependent T lymphocyte locomotion within target sites represents an essential immunologic checkpoint that determines the potency of T cell effector functions.	[Mrass, Paulus; Ng, Lai Guan; Pure, Ellen; Weninger, Wolfgang] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Kinjyo, Ichiko; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Kinjyo, Ichiko; Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Ng, Lai Guan; Weninger, Wolfgang] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia; [Pure, Ellen] Ludwig Inst Canc Res, Philadelphia, PA 19104 USA; [Weninger, Wolfgang] Univ Sydney, Discipline Dermatol, Camperdown, NSW 2050, Australia	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Sydney; Centenary Institute; Ludwig Institute for Cancer Research; University of Sydney	Weninger, W (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	w.weninger@centenary.org.au	Ng, Lai Guan/E-5673-2011; Ng, Lai Guan/N-6980-2019	Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Weninger, Wolfgang/0000-0003-3133-8699; Kinjyo, Ichiko/0000-0001-7051-3790	National Institutes of Health; National Health and Medical Research Council [512265]; New South Wales government; Cancer Research Institute fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076458, R01AI061699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New South Wales government; Cancer Research Institute fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Fukunaga-Kalabis and A. Iparraguirre-Wolf for helpful discussion and E.J. Wherry and M. Herlyn (all at the Wistar Institute) for providing reagents. S.L.R. and E.P. were supported by grants from the National Institutes of Health. W.W. was supported by National Health and Medical Research Council grant 512265 and a Life Sciences Award from the New South Wales government. P.M. is the recipient of a Cancer Research Institute fellowship.	Alstergren P, 2004, CELL IMMUNOL, V231, P146, DOI 10.1016/j.cellimm.2005.01.007; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cichy J, 2004, FEBS LETT, V556, P69, DOI 10.1016/S0014-5793(03)01370-X; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Jacobelli J, 2004, CURR OPIN IMMUNOL, V16, P345, DOI 10.1016/j.coi.2004.03.008; Knudson W, 1996, AM J PATHOL, V148, P1721; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Mrass P, 2006, IMMUNOL REV, V213, P195, DOI 10.1111/j.1600-065X.2006.00433.x; Ng LG, 2008, IMMUNOL REV, V221, P147, DOI 10.1111/j.1600-065X.2008.00596.x; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; SCHOR SL, 1983, J CELL BIOL, V96, P1089, DOI 10.1083/jcb.96.4.1089; Shaw AS, 2005, IMMUNOL RES, V32, P247, DOI 10.1385/IR:32:1-3:247; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stinchcombe JC, 2003, SEMIN IMMUNOL, V15, P301, DOI 10.1016/j.smim.2003.09.003; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zalatnai A, 2006, CURR MOL MED, V6, P685, DOI 10.2174/156652406778195053	43	64	66	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					971	985		10.1016/j.immuni.2008.10.015	http://dx.doi.org/10.1016/j.immuni.2008.10.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100702	Bronze, Green Accepted			2022-12-18	WOS:000262012400016
J	Naito, T; Arco, PGD; Williams, CJ; Georgopoulos, K				Naito, Taku; Arco, Pablo Gomez-Del; Williams, Christine J.; Georgopoulos, Katia			Antagonistic interactions between lkaros and the chromatin remodeler Mi-2 beta determine silencer activity and Cd4 gene expression	IMMUNITY			English	Article							T-LYMPHOCYTE DEVELOPMENT; DNA-BINDING PROTEINS; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; RUNX PROTEINS; CELL DIFFERENTIATION; IKAROS FAMILY; NURD COMPLEX; N-COR; THYMOCYTES	Lineage commitment is induced by changes in gene expression dictated by the intimate interaction between transcription factors and chromatin regulators. Here, we revealed the antagonistic interplay between Ilkaros and its associate the chromatin remodeler Mi-2 beta during T cell development, as exemplified by the regulation of Cd4 expression. Loss of lkaros or Mi-2 beta led to activation or repression, respectively, of the Cd4 locus at inappropriate stages of development. Their combined mutation reverted to normal CD4 expression. In double-negative thymocytes, lkaros binding to the Cd4 silencer contributed to its repressive activity. In double-positive thymocytes, concomitant binding of Mi-2 beta with lkaros to the Cd4 silencer caused silencer inactivation, thereby allowing for CD4 expression. Mi-2 beta facilitated recruitment of histone acetyl transferases to the silencer. This recruitment possibly antagonized Ikaros and associated repressive activities. Thus, concomitant interactions between functionally opposing chromatin-regulating machineries are an important mode of gene regulation during lineage determination.	Univ Autonoma Madrid, Cardiovasc Res Ctr, E-28029 Madrid, Spain; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Harvard University; Massachusetts General Hospital	Georgopoulos, K (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Arco, Pablo Gomez-del/ABG-3417-2020; Gomez-del Arco, Pablo/L-2728-2013	Gomez-del Arco, Pablo/0000-0001-6748-7157	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042254, R01AI038342] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042254, R01 AI038342, AI380342] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Jiang HM, 2005, MOL CELL BIOL, V25, P10675, DOI 10.1128/MCB.25.24.10675-10683.2005; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kioussis D, 2007, SCIENCE, V317, P620, DOI 10.1126/science.1143777; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Pelletier N, 2002, ONCOGENE, V21, P2729, DOI 10.1038/sj.onc.1205367; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Shimono Y, 2003, J BIOL CHEM, V278, P51638, DOI 10.1074/jbc.M309198200; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Willcox N, 2004, ARTHROSCOPY, V20, P20, DOI 10.1016/j.arthro.2004.04.018; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	46	64	65	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	2007	27	5					723	734		10.1016/j.immuni.2007.09.008	http://dx.doi.org/10.1016/j.immuni.2007.09.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	17980631	Bronze			2022-12-18	WOS:000251269000007
J	Huang, AYC; Qi, H; Germain, RN				Huang, AYC; Qi, H; Germain, RN			Illuminating the landscape of in vivo immunity: Insights from dynamic in situ imaging of secondary lymphoid tissues	IMMUNITY			English	Review							CD4 T-CELLS; EPIDERMAL LANGERHANS CELLS; MATURING DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; EXTRACELLULAR-MATRIX; ANTIGEN PRESENTATION; 2-PHOTON MICROSCOPY; NODE CORTEX; B-CELLS; NAIVE	A central feature of the immune system is the migratory behavior of its cellular components. Thus, fully understanding the generation and maintenance of immune responses must include consideration of how hematopoietic cells home to, interact within, and exit from secondary lymphoid organs as well as peripheral tissues. Recent advances in in situ imaging techniques now permit direct observation of these events in their physiologic settings with high spatiotemporal resolution. This review summarizes progress in this area of investigation from a lymphocentric perspective. We highlight controversies, point out key unanswered questions, and briefly outline what we believe are some of the near-term directions that in situ microscopic analysis of the immune system will take.	NIAID, Immunol Lab, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Immunol Lab, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov	Qi, Hai/A-3955-2009; Huang, Alex Y./ABG-8182-2021; Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Huang, Alex Y./0000-0002-5701-4521; Qi, Hai/0000-0001-5475-3989	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000545, ZIAAI000545] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Choy Garry, 2003, Mol Imaging, V2, P303, DOI 10.1162/153535003322750646; Cyster JG, 2000, CURR BIOL, V10, pR30, DOI 10.1016/S0960-9822(99)00253-5; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dickinson ME, 2003, J BIOMED OPT, V8, P329, DOI 10.1117/1.1583734; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; FORD WL, 1969, SEMIN HEMATOL, V6, P67; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Friedl P, 2001, TRENDS IMMUNOL, V22, P187, DOI 10.1016/S1471-4906(01)01869-5; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hardy J, 2001, EXP HEMATOL, V29, P1353, DOI 10.1016/S0301-472X(01)00756-1; Herschman HR, 2003, CURR OPIN IMMUNOL, V15, P378, DOI 10.1016/S0952-7915(03)00066-9; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kalb J, 2004, BIOCHEM BIOPH RES CO, V316, P341, DOI 10.1016/j.bbrc.2004.02.047; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kircher MF, 2003, CANCER RES, V63, P6838; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MACPHEE PJ, 1992, AM J PHYSIOL, V263, pG17, DOI 10.1152/ajpgi.1992.263.1.G17; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Nagorsen D, 2004, CYTOKINE, V25, P31, DOI 10.1016/j.cyto.2003.08.012; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Siegel R. M., 2000, SCI STKE, V2000, ppl1; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; STINGL G, 1978, J IMMUNOL, V121, P2005; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; TEUNISSEN MBM, 1994, J IMMUNOL, V152, P3400; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Weinlich G, 1998, J INVEST DERMATOL, V110, P441, DOI 10.1046/j.1523-1747.1998.00161.x; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wetzel SA, 2002, J IMMUNOL, V169, P6092, DOI 10.4049/jimmunol.169.11.6092; YAMASHITA U, 1978, J EXP MED, V148, P1171, DOI 10.1084/jem.148.5.1171; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	70	64	66	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					331	339		10.1016/S1074-7613(04)00235-3	http://dx.doi.org/10.1016/S1074-7613(04)00235-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357944	Bronze			2022-12-18	WOS:000224034900004
J	Andrade, F; Bull, HG; Thornberry, NA; Ketner, GW; Casciola-Rosen, LA; Rosen, A				Andrade, F; Bull, HG; Thornberry, NA; Ketner, GW; Casciola-Rosen, LA; Rosen, A			Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death	IMMUNITY			English	Article							CYTOKINE RESPONSE MODIFIER; L4 100-KILODALTON PROTEIN; CASPASE ACTIVATION; INDUCED APOPTOSIS; TARGET-CELLS; IN-VITRO; CYTOTOXIC LYMPHOCYTES; CYTOLYTIC LEUKOCYTES; EFFECTOR MOLECULES; VIRUS-INFECTIONS	Cytotoxic lymphocytes kill virus-infected target cells and play a critical role in host recovery from viral infections. Granzyme B (GrB) is a cytotoxic lymphocyte granule protease that plays a critical role in mediating cytotoxicity. In these studies, we demonstrate that the adenovirus assembly protein L4-100K (100K) is a GrB substrate that prevents cytotoxic lymphocyte granule-induced apoptosis in infected target cells by potently inhibiting GrB. This inhibition is absolutely dependent on Asp-48 in 100K, found within a classic GrB consensus motif. 100K is the first viral protein described that exclusively targets the GrB pathway. It represents a novel class of viral protease inhibitor, in which an essential, multifunctional viral protein, which is vulnerable to specific proteolysis by GrB, expresses inhibitory function against that protease.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Merck & Company; Johns Hopkins University	Rosen, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.				NHLBI NIH HHS [HL56091, P01 HL056091] Funding Source: Medline; NIAMS NIH HHS [R01 AR044684, AR44684] Funding Source: Medline; NIDCR NIH HHS [DE12354] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AIELLO L, 1979, VIROLOGY, V94, P460, DOI 10.1016/0042-6822(79)90476-8; Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Anel A, 1997, J IMMUNOL, V158, P1999; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; CEPKO CL, 1982, CELL, V31, P407, DOI 10.1016/0092-8674(82)90134-9; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V227, P658, DOI 10.1006/bbrc.1996.1565; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hardwick JM, 1998, SEMIN CELL DEV BIOL, V9, P339, DOI 10.1006/scdb.1998.0243; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; HAYES BW, 1990, J VIROL, V64, P2732, DOI 10.1128/JVI.64.6.2732-2742.1990; HAYES MP, 1989, J EXP MED, V170, P933, DOI 10.1084/jem.170.3.933; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P282; KAGI D, 1995, IMMUNOL REV, V146, P95, DOI 10.1111/j.1600-065X.1995.tb00686.x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEVY JA, 1968, NATURE, V217, P744, DOI 10.1038/217744a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Macen JL, 1996, P NATL ACAD SCI USA, V93, P9108, DOI 10.1073/pnas.93.17.9108; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Perez D, 1998, J CELL BIOL, V141, P1255, DOI 10.1083/jcb.141.5.1255; Pinkoski MJ, 1998, BLOOD, V92, P1044; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; RILEY D, 1993, J VIROL, V67, P3586, DOI 10.1128/JVI.67.6.3586-3595.1993; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Shenk Thomas, 1996, P979; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Tay CH, 1998, CURR TOP MICROBIOL, V230, P193; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tollefson AE, 1998, NATURE, V392, P726, DOI 10.1038/33712; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Trapani JA, 1999, IMMUNOL TODAY, V20, P351, DOI 10.1016/S0167-5699(99)01488-7; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Turner PC, 1999, J VIROL, V73, P6394, DOI 10.1128/JVI.73.8.6394-6404.1999; White E, 1998, SEMIN VIROL, V8, P505, DOI 10.1006/smvy.1998.0155; Wold WSM, 1999, CURR OPIN IMMUNOL, V11, P380, DOI 10.1016/S0952-7915(99)80064-8	59	64	65	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					751	761		10.1016/S1074-7613(01)00149-2	http://dx.doi.org/10.1016/S1074-7613(01)00149-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420045	Bronze			2022-12-18	WOS:000169495100011
J	Kinoshita, K; Tashiro, J; Tomita, S; Lee, CG; Honjo, T				Kinoshita, K; Tashiro, J; Tomita, S; Lee, CG; Honjo, T			Target specificity of immunoglobulin class switch recombination is not determined by nucleotide sequences of S regions	IMMUNITY			English	Article							HEAVY-CHAIN SWITCH; CIRCULAR DNA; B-CELLS; GENE; TRANSCRIPTS; EXPRESSION; ISOTYPE; DELETION; REARRANGEMENT; ORGANIZATION	We describe a model system for class switch recombination (CSR) using CH12F3-2 cells transfected with a DNA construct containing two S sequences transcribed by different promoters and separated by a viral thymidine kinase (TK) gene. Recombination observed using this system shares key properties with physiological CSR: deletion of DNA between two S regions, requirement for cytokine stimulation, and nonhomologous and no consensus breakpoint sequences. Studies on transfectants with variants of this construct led us to the following conclusions: (1) two S sequences are required for CSR; (2) isotype specificity of recombination is not determined by nucleotide sequences of S regions; (3) S sequences are not strand-specific; and (4) induction of recombination activity requires cytokine stimulation.	Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp						ARAKAWA H, 1993, J BIOL CHEM, V268, P4651; Ballantyne J, 1998, J IMMUNOL, V161, P1336; Ballantyne J, 1997, INT IMMUNOL, V9, P963, DOI 10.1093/intimm/9.7.963; BALTIMORE D, 1996, J IMMUNOL, V156, P183; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625; Du J, 1997, NUCLEIC ACIDS RES, V25, P3066, DOI 10.1093/nar/25.15.3066; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Harriman GR, 1996, J CLIN INVEST, V97, P477, DOI 10.1172/JCI118438; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919; Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8; Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9; LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151; LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154; Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; OTT DE, 1987, EMBO J, V6, P577, DOI 10.1002/j.1460-2075.1987.tb04793.x; PURKERSON JM, 1992, J EXP MED, V175, P973, DOI 10.1084/jem.175.4.973; QIU G, 1999, IN PRESS INT IMMUNOL; RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SEVERINSON E, 1990, EUR J IMMUNOL, V20, P1079, DOI 10.1002/eji.1830200520; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; WAKATSUKI Y, 1993, J EXP MED, V178, P129, DOI 10.1084/jem.178.1.129; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; ZELAZOWSKI P, 1995, J IMMUNOL, V154, P1223; ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235	52	64	64	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1998	9	6					849	858		10.1016/S1074-7613(00)80650-0	http://dx.doi.org/10.1016/S1074-7613(00)80650-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881975	Green Submitted, Bronze			2022-12-18	WOS:000077836600010
J	Yoon, DW; Lee, H; Seol, W; DeMaria, M; Rosenzweig, M; Jung, JU				Yoon, DW; Lee, H; Seol, W; DeMaria, M; Rosenzweig, M; Jung, JU			Tap: A novel cellular protein that interacts with Tip of herpesvirus saimiri and induces lymphocyte aggregation	IMMUNITY			English	Article							INVITRO IMMORTALIZATION; GROWTH TRANSFORMATION; SIGNAL-TRANSDUCTION; RECEPTOR FAMILY; IDENTIFICATION; INFECTION; CELLS; TRANSMEMBRANE; PHENOTYPE; TERMINUS	Tip of herpesvirus saimiri associates with Lck and down-regulates Lck-mediated activation. We identified a novel cellular Tip-associated protein (Tap) by a yeast two-hybrid screen. Tap associated with Tip following transient expression in COS-1 cells and stable expression in human Jurkat-T cells. Expression of Tip and Tap in Jurkat-T cells induced dramatic cell aggregation. Aggregation was likely caused by the upregulated surface expression of adhesion molecules including integrin alpha, L-selectin, ICAM-3, and H-CAM. Furthermore, NF-kappa B transcriptional factor of aggregated cells had approximately 40-fold higher activity than that of parental cells. Thus, Tap is likely to be an important cellular mediator of Tip function in T cell transformation by herpesvirus saimiri.	HARVARD UNIV,SCH MED,NEW ENGLAND REG PRIMATE RES CTR,DEPT IMMUNOL,SOUTHBOROUGH,MA 01772; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT BIOL MOL,BOSTON,MA 02114	Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yoon, DW (corresponding author), HARVARD UNIV,SCH MED,NEW ENGLAND REG PRIMATE RES CTR,DEPT MOL GENET & MICROBIOL,SOUTHBOROUGH,MA 01772, USA.				NCI NIH HHS [CA31363] Funding Source: Medline; NCRR NIH HHS [RR00168] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA031363] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AHUJA SK, 1993, J BIOL CHEM, V268, P20691; ALBRECHT JC, 1992, VIROLOGY, V190, P527, DOI 10.1016/0042-6822(92)91247-R; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEREND KR, 1993, J VIROL, V67, P6317, DOI 10.1128/JVI.67.10.6317-6321.1993; BIESINGER B, 1990, VIROLOGY, V176, P505, DOI 10.1016/0042-6822(90)90020-R; BIESINGER B, 1995, J BIOL CHEM, V270, P4729, DOI 10.1074/jbc.270.9.4729; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; BROKER BM, 1993, J IMMUNOL, V151, P1184; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Choi HS, 1996, J STEROID BIOCHEM, V56, P23, DOI 10.1016/0960-0760(95)00220-0; COLGAN J, 1995, MOL CELL BIOL, V15, P2311; DESROSIERS RC, 1982, J VIROL, V43, P352, DOI 10.1128/JVI.43.1.352-356.1982; DESROSIERS RC, 1986, J VIROL, V57, P701, DOI 10.1128/JVI.57.2.701-705.1986; DESROSIERS RC, 1985, SCIENCE, V49, P343; FIELD J, 1990, SCIENCE, V247, P464, DOI 10.1126/science.2405488; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; JUNG JU, 1995, J VIROL, V69, P7814, DOI 10.1128/JVI.69.12.7814-7822.1995; JUNG JU, 1994, MOL CELL BIOL, V14, P7235, DOI 10.1128/MCB.14.11.7235; JUNG JU, 1995, J BIOL CHEM, V270, P20660, DOI 10.1074/jbc.270.35.20660; JUNG JU, 1995, MOL CELL BIOL, V15, P6506; JUNG JU, 1991, P NATL ACAD SCI USA, V88, P7051, DOI 10.1073/pnas.88.16.7051; JUNG JU, 1994, ENCY VIROLOGY, P614; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LONGNECKER R, 1993, J VIROL, V67, P2006, DOI 10.1128/JVI.67.4.2006-2013.1993; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MEDVECZKY P, 1984, J VIROL, V52, P938, DOI 10.1128/JVI.52.3.938-944.1984; MITTRUCKER HW, 1995, J EXP MED, V176, P900; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; NICHOLAS J, 1992, NATURE, V355, P362, DOI 10.1038/355362a0; OHSUMI T, 1993, BIOCHEM J, V294, P465, DOI 10.1042/bj2940465; Rosales C, 1996, CANCER RES, V56, P2302; ROTHER RP, 1994, J VIROL, V68, P730, DOI 10.1128/JVI.68.2.730-737.1994; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SZOMOLANYI E, 1987, J VIROL, V61, P3485, DOI 10.1128/JVI.61.11.3485-3490.1987; THOMSON BJ, 1991, NATURE, V351, P530, DOI 10.1038/351530a0; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yao ZB, 1996, J IMMUNOL, V156, P3260	47	64	69	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					571	582		10.1016/S1074-7613(00)80345-3	http://dx.doi.org/10.1016/S1074-7613(00)80345-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175835	Bronze			2022-12-18	WOS:A1997XB81900008
J	LEVELT, CN; MOMBAERTS, P; WANG, BP; KOHLER, H; TONEGAWA, S; EICHMANN, K; TERHORST, C				LEVELT, CN; MOMBAERTS, P; WANG, BP; KOHLER, H; TONEGAWA, S; EICHMANN, K; TERHORST, C			REGULATION OF THYMOCYTE DEVELOPMENT THROUGH CD3 - FUNCTIONAL DISSOCIATION BETWEEN P56(LCK) AND CD3-ZETA IN EARLY THYMIC SELECTION	IMMUNITY			English	Article							T-CELL-RECEPTOR; ANTIGEN RECEPTOR; MICE LACKING; BETA-CHAIN; SURFACE EXPRESSION; CD4+8+ THYMOCYTES; MUTANT MICE; ZETA-CHAIN; CD3-EPSILON; REARRANGEMENT	We studied the extent of functional linkage between CD3 zeta and p56(lck) in pre-TCR-dependent thymocyte development. Differentiation of DN to DP cells was examined by treatment of RAG2/CD3 zeta and RAG1/p56(lck) double-deficient mice with anti-CD3 epsilon antibodies. The results suggest that CD3 zeta has no specific role in this maturation step, but may be important for amplification of signaling through the pre-TCR. In contrast, p56(lck) is the main protein tyrosine kinase associated with signaling through the pre-TCR-CD3 complex. In DP thymocytes, the Ca2+ response to anti-CDSE was totally abolished in CD3 zeta(-/-) but only reduced in p56(lck-/-) mice, and in vivo responses to anti-CD3 epsilon differed from one another. Thus, CD3 zeta and p56(lck) are functionally not tightly associated and their deficiencies cause distinct developmental defects.	MIT,CTR CANC RES,HOWARD HUGHES MED INST,DEPT BIOL,CAMBRIDGE,MA 02139; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,BOSTON,MA 02115	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	LEVELT, CN (corresponding author), MAX PLANCK INST IMMUNBIOL,STUBEWEG 51,D-79108 FREIBURG,GERMANY.				NIAID NIH HHS [AI-28046, AI-17879, AI-15066] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI028046, R01AI017879, R01AI015066, R56AI015066, R37AI017879] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON SJ, 1993, NATURE, V356, P552; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; EICHMANN K, 1995, IMMUNOL LETT, V44, P87, DOI 10.1016/0165-2478(94)00197-Y; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; HAVRAN WL, 1987, NATURE, V330, P1523; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; LEVELT CN, 1993, J EXP MED, V178, P1867, DOI 10.1084/jem.178.6.1867; LEVELT CN, 1993, IMMUNOLOGIST, V1, P151; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; PUNT JA, 1991, J EXP MED, V174, P775, DOI 10.1084/jem.174.4.775; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; ROTHENBERG EV, 1994, CURR OPIN IMMUNOL, V6, P257, DOI 10.1016/0952-7915(94)90099-X; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SPITS H, 1994, CURR OPIN IMMUNOL, V6, P212, DOI 10.1016/0952-7915(94)90094-9; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WANG BP, 1995, INT IMMUNOL, V7, P435, DOI 10.1093/intimm/7.3.435; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; WIEST DL, 1994, J EXP MED, V180, P1375, DOI 10.1084/jem.180.4.1375; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	43	64	64	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					215	222		10.1016/1074-7613(95)90091-8	http://dx.doi.org/10.1016/1074-7613(95)90091-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648394	Bronze			2022-12-18	WOS:A1995RR33900007
J	SCHAFER, PH; PIERCE, SK				SCHAFER, PH; PIERCE, SK			EVIDENCE FOR DIMERS OF MHC CLASS-II MOLECULES IN B-LYMPHOCYTES AND THEIR ROLE IN LOW-AFFINITY T-CELL RESPONSES	IMMUNITY			English	Article							ALPHA-BETA-HETERODIMERS; HLA-DR MOLECULES; INVARIANT-CHAIN; SURFACE EXPRESSION; MONOCLONAL-ANTIBODIES; ANTIGEN-BINDING; MICE LACKING; COMPLEX; PEPTIDE; TRANSPORT	The crystallographic structure of the MHC class II molecule showed that the ap heterodimer can itself dimerize to form a four chain (alpha beta)(2) complex of 120 kDa. Here we provide evidence for the existence of a 120 kDa (alpha beta)(2) complex of the class II I-E(k) molecules in mouse B cells. Both a 60 kDa and a 120 kDa form of I-E(k) are detected by Western blotting and by immunoprecipitation under conditions in which class II alpha beta heterodimers are stable. The 120 kDa I-E(k) complex does not contain ii and, upon warming, dissociates into free alpha and beta chains. The 120 kDa I-E(k) complex is expressed at the cell surface, is active in antigen presentation, and appears to play a significant role in T cell responses to low affinity but not to high affinity antigens, possibly by facilitating cross-linking of the T cell receptors.			SCHAFER, PH (corresponding author), NORTHWESTERN UNIV,DEPT BIOCHEM MOLEC BIOL & CELL BIOL,2153 SHERIDAN RD,EVANSTON,IL 60208, USA.				NIAID NIH HHS [AI27957, AI18939] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027957, R01AI018939, R37AI018939] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Brautigan D L, 1978, Methods Enzymol, V53, P128; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CASTEN LA, 1985, P NATL ACAD SCI USA, V82, P5890, DOI 10.1073/pnas.82.17.5890; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GILLIS S, 1978, J IMMUNOL, V120, P2027; HARDING CV, 1993, J IMMUNOL, V151, P3988; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; LAKEY EK, 1986, J IMMUNOL, V136, P3933; LAMB CA, 1992, J IMMUNOL, V148, P3478; LERNER EA, 1980, J EXP MED, V152, P1085, DOI 10.1084/jem.152.4.1085; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MATHIS DJ, 1983, CELL, V32, P745, DOI 10.1016/0092-8674(83)90060-0; MENGLEGAW L, 1983, P NATL ACAD SCI-BIOL, V80, P7621, DOI 10.1073/pnas.80.24.7621; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; OZATO K, 1980, J IMMUNOL, V124, P533; PENNELL CA, 1985, P NATL ACAD SCI USA, V82, P3799, DOI 10.1073/pnas.82.11.3799; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; QUILL H, 1986, J IMMUNOL, V136, P3351; RESKE K, 1985, EUR J IMMUNOL, V15, P1229, DOI 10.1002/eji.1830151216; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SADEGHNASSERI S, 1992, IMMUNOL TODAY, V13, P43, DOI 10.1016/0167-5699(92)90131-P; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SHACKELFORD DA, 1981, J IMMUNOL, V127, P1403; SPRINGER TA, 1977, J BIOL CHEM, V252, P6201; SRINIVASAN M, 1990, P NATL ACAD SCI USA, V87, P919, DOI 10.1073/pnas.87.3.919; SRINIVASAN M, 1993, EUR J IMMUNOL, V23, P1011, DOI 10.1002/eji.1830230504; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	43	64	65	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1994	1	8					699	707		10.1016/1074-7613(94)90040-X	http://dx.doi.org/10.1016/1074-7613(94)90040-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7600295				2022-12-18	WOS:A1994PT93000007
J	ITANO, A; CADO, D; CHAN, FKM; ROBEY, E				ITANO, A; CADO, D; CHAN, FKM; ROBEY, E			A ROLE FOR THE CYTOPLASMIC TAIL OF THE BETA-CHAIN OF CD8 IN THYMIC SELECTION	IMMUNITY			English	Article								The CD8 coreceptor plays a critical role in the recognition of foreign antigens by mature T cells and in the development of class I-restricted T cells. CD8 can be expressed on the surface of T cells as either a heterodimer composed of an alpha and beta chain, or as a homodimer composed of two alpha chains. In this report, we show that a CD8 beta transgene that lacks a cytoplasmic domain can suppress expression of wild-type endogenous CD8 beta and act as a dominant negative mutation. We show that this dominant negative CD8 beta transgene interferes with the development of mature CD8 T cells to different extents depending on the individual class I-restricted TCR. These data suggest CD8 beta plays a role in thymic development, and that different class I-restricted TCRs differ in their dependence on the cytoplasmic tail of CD8 beta.			ITANO, A (corresponding author), UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, 229 STANLEY HALL, BERKELEY, CA 94720 USA.		Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Itano, Andrea/0000-0002-4766-6876				CROOKS MEC, 1994, IMMUNITY, V1, P277; DEMBIC Z, 1987, NATURE, V326, P510, DOI 10.1038/326510a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; KIALELOW P, 1988, NATURE, V333, P742; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.iy.05.040187.003021; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PARNES JR, 1989, ADV IMMUNOL, V44, P265; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; YOUN HJ, 1988, IMMUNOGENETICS, V28, P353, DOI 10.1007/BF00364234	20	64	64	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1994	1	4					287	290		10.1016/1074-7613(94)90080-9	http://dx.doi.org/10.1016/1074-7613(94)90080-9			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889416				2022-12-18	WOS:A1994PK16600006
J	Xu, SA; Chaudhary, O; Rodriguez-Morales, P; Sun, XL; Chen, D; Zappasodi, R; Xu, ZY; Pinto, AFM; Williams, A; Schulze, I; Farsakoglu, Y; Varanasi, SK; Low, JS; Tang, WX; Wang, HP; McDonald, B; Tripple, V; Downes, M; Evans, RM; Abumrad, NA; Merghoub, T; Wolchok, JD; Shokhirev, MN; Ho, PC; Witztum, JL; Emu, B; Cui, GL; Kaech, SM				Xu, Shihao; Chaudhary, Omkar; Rodriguez-Morales, Patricia; Sun, Xiaoli; Chen, Dan; Zappasodi, Roberta; Xu, Ziyan; Pinto, Antonio F. M.; Williams, April; Schulze, Isabell; Farsakoglu, Yagmur; Varanasi, Siva Karthik; Low, Jun Siong; Tang, Wenxi; Wang, Haiping; McDonald, Bryan; Tripple, Victoria; Downes, Michael; Evans, Ronald M.; Abumrad, Nada A.; Merghoub, Taha; Wolchok, Jedd D.; Shokhirev, Maxim N.; Ho, Ping-Chih; Witztum, Joseph L.; Emu, Brinda; Cui, Guoliang; Kaech, Susan M.			Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors	IMMUNITY			English	Article							LOW-DENSITY-LIPOPROTEIN; FATTY-ACID TRANSPORT; OXIDATIVE STRESS; METABOLIC ADAPTATION; EFFECTOR FUNCTION; GENE-EXPRESSION; CANCER; FERROPTOSIS; MELANOMA; LDL	A common metabolic alteration in the tumor microenvironment (TME) is lipid accumulation, a feature associated with immune dysfunction. Here, we examined how CD8(+) tumor infiltrating lymphocytes (TILs) respond to lipids within the TME. We found elevated concentrations of several classes of lipids in the TME and accumulation of these in CD8(+) TILs. Lipid accumulation was associated with increased expression of CD36, a scavenger receptor for oxidized lipids, on CD8(+) TILs, which also correlated with progressive T cell dysfunction. Cd36(-/-) T cells retained effector functions in the TME, as compared to WT counterparts. Mechanistically, CD36 promoted uptake of oxidized low-density lipoproteins (OxLDL) into T cells, and this induced lipid peroxidation and downstream activation of p38 kinase. Inhibition of p38 restored effector T cell functions in vitro, and resolution of lipid peroxidation by overexpression of glutathione peroxidase 4 restored functionalities in CD8(+) TILs in vivo. Thus, an oxidized lipid-CD36 axis promotes intratumoral CD8(+) T cell dysfunction and serves as a therapeutic avenue for immunotherapies.	[Xu, Shihao; Rodriguez-Morales, Patricia; Chen, Dan; Xu, Ziyan; Farsakoglu, Yagmur; Varanasi, Siva Karthik; McDonald, Bryan; Tripple, Victoria; Kaech, Susan M.] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Chaudhary, Omkar; Emu, Brinda] Yale Sch Med, Sect Infect Dis, New Haven, CT 06510 USA; [Sun, Xiaoli; Tang, Wenxi; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zappasodi, Roberta; Schulze, Isabell; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat & Swim Amer Lab, New York, NY 10065 USA; [Xu, Ziyan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Pinto, Antonio F. M.] Salk Inst Biol Studies, Mass Spectrometry Core Prote & Metabol, La Jolla, CA 92037 USA; [Williams, April; Shokhirev, Maxim N.] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core F, La Jolla, CA 92037 USA; [Low, Jun Siong] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Low, Jun Siong] Fdn Ist Ric Biomed, Bellinzona, Switzerland; [Wang, Haiping; Ho, Ping-Chih] Univ Lausanne, Dept Fundamental Oncol, Ludwig Inst Canc Res, Lausanne, Switzerland; [Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Abumrad, Nada A.] Washington Univ, Dept Med, Div Geriatr & Nutr Sci, Sch Med, St Louis, MO 63110 USA; [Zappasodi, Roberta; Schulze, Isabell; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA; [Zappasodi, Roberta; Schulze, Isabell; Merghoub, Taha; Wolchok, Jedd D.] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Cui, Guoliang] German Canc Res Ctr, T Cell Metab Grp D140, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Cui, Guoliang] Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany	Salk Institute; Yale University; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; Salk Institute; Salk Institute; Yale University; Ludwig Institute for Cancer Research; University of Lausanne; Salk Institute; Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kaech, SM (corresponding author), Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA.; Cui, GL (corresponding author), German Canc Res Ctr, T Cell Metab Grp D140, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.; Cui, GL (corresponding author), Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany.	g.cui@dkfz-heidelberg.de; skaech@salk.edu	Merghoub, Taha/ABD-8362-2021		NCI [P30 CA030199]; NIH-NCI [CCSG P30 014195]; Chapman Foundation; Helmsley Charitable Trust; NIH/NGMS [R01 GM102491-07]; NIH/NCI [CCSG P30 014195, P30 CA014195-46]; NIA/NMG [1RF1AG064049-01]; Helmsley Trust; Helmsley Center for Genomic Medicine; NIH [1S10OD021815-01, K99HL148504, DK057978, HL105278, ES010337, CA014195, R01CA240909, R01 CA206483, R01HL148188]; NCI Cancer Center Support Grant (CCSG) [P30CA23100]; Parker Institute for Cancer Immunotherapy Bridge Scholar award; Lustgarten Foundation; Don and Lorraine Freeberg Foundation; Helmholtz Young Investigator Award (Helmholtz Gemeinschaft) [VH-NG1113]; German Research Foundation (Deutsche Forschungsgemeinschaft) [CU375/7-1]; Melanoma Research Alliance; Genentech Foundation fellowship; Salk innovation grant	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chapman Foundation; Helmsley Charitable Trust; NIH/NGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA/NMG; Helmsley Trust; Helmsley Center for Genomic Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Parker Institute for Cancer Immunotherapy Bridge Scholar award; Lustgarten Foundation; Don and Lorraine Freeberg Foundation; Helmholtz Young Investigator Award (Helmholtz Gemeinschaft); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Melanoma Research Alliance; Genentech Foundation fellowship; Salk innovation grant	We thank Dr. Marcus W. Bosenberg for discussions; Dr. Annelise G. Snyder for graphics assistance; Dr. Anna-Maria Globig for assistance with RNA-seq; Dr. Hubert Tseng for grant applications; Drs. Thomas H. Mann and Heather M. McGee for manuscript review; Dr. Xuchu Que for technical assistance with preparation of oxidized LDL; Dr. Yao-cheng Li for assistance with cloning; C. O'Connor, Lara Boggeman, and C. Fitzpatrick at the Salk FACS core; Nasun Hah and Tzu-Wen Wang at the Salk Sequencing core; the UCSD FACS core for cell sorting; Dr. M. Valeria Estrada at the UCSD Histology core; and Faye McDonald for administrative assistance. We thank Dr. Yoav Altman from the Sanford Burnham Prebys Flow Cytometry Core, NCI grant P30 CA030199, and the James B. Pendleton Charitable Trust (which helped purchase the Amnis) for Amnis analysis. The NGS Core Facility of the Salk Institute is supported by funding from NIH-NCI CCSG P30 014195, the Chapman Foundation, and the Helmsley Charitable Trust. The Razavi Newman Integrative Genomics and Bioinformatics Core is supported by NIH/NGMS R01 GM102491-07, NIH/NCI P30 CA014195-46, NIA/NMG 1RF1AG064049-01, and the Helmsley Trust. The Mass Spectrometry Core of the Salk Institute is supported by funding from NIH-NCI CCSG P30 014195 and the Helmsley Center for Genomic Medicine. The MS data described here were gathered on a ThermoFisher Q Exactive Hybrid Quadrupole Orbitrap mass spectrometer funded by NIH grant 1S10OD021815-01. The Tissue Technology Shared Resource is supported by a NCI Cancer Center Support Grant (CCSG; P30CA23100). R.Z. is supported by the Parker Institute for Cancer Immunotherapy Bridge Scholar award. X.S. is supported by NIH grant K99HL148504. R.M.E is an investigator of the Howard Hughes Medical Institute and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute and supported by the NIH (DK057978, HL105278, and ES010337), the Cancer Center (CA014195), a NOMIS Foundation Distinguished Scientist and Scholar Award, the Lustgarten Foundation, and the Don and Lorraine Freeberg Foundation. G.C. is supported by a Helmholtz Young Investigator Award (Helmholtz Gemeinschaft, VH-NG1113) and the German Research Foundation (Deutsche Forschungsgemeinschaft, CU375/7-1). This work was supported by the NIH (R01CA240909 to S.M.K, R01 CA206483 to S.M.K and B.E., R01 CA206483 supplemental to P.R.M, and R01HL148188 to X.S. and J.L.W.), the Melanoma Research Alliance (to S.M.K.), a Genentech Foundation fellowship (to S.X.), and a Salk innovation grant (to S.M.K. and R.M.E.).	Abumrad N, 1998, J LIPID RES, V39, P2309; Al-Khami AA, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1344804; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Di Gioia M, 2020, NAT IMMUNOL, V21, P42, DOI 10.1038/s41590-019-0539-2; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gurusamy D, 2020, CANCER CELL, V37, P818, DOI 10.1016/j.ccell.2020.05.004; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hale JS, 2014, STEM CELLS, V32, P1746, DOI 10.1002/stem.1716; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Jay AG, 2015, J BIOL CHEM, V290, P4590, DOI 10.1074/jbc.M114.627026; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kita T, 2000, ANN NY ACAD SCI, V902, P95; Kuda O, 2013, J BIOL CHEM, V288, P15547, DOI 10.1074/jbc.M113.473298; Ma XZ, 2021, CELL METAB, V33, P1001, DOI 10.1016/j.cmet.2021.02.015; Ma XZ, 2019, CELL METAB, V30, P143, DOI 10.1016/j.cmet.2019.04.002; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miller YI, 2017, TRENDS ENDOCRIN MET, V28, P143, DOI 10.1016/j.tem.2016.11.002; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Pacella I, 2018, P NATL ACAD SCI USA, V115, pE6546, DOI 10.1073/pnas.1720113115; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Staveley-O'Carroll K, 2003, J IMMUNOL, V171, P697, DOI 10.4049/jimmunol.171.2.697; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su P, 2020, CANCER RES, V80, P1438, DOI 10.1158/0008-5472.CAN-19-2994; Sullivan MR, 2019, ELIFE, V8, DOI 10.7554/eLife.44235; Sun XL, 2020, CELL METAB, V31, P189, DOI 10.1016/j.cmet.2019.10.014; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Veglia F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02186-9; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Yan DH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01399; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Ye HB, 2016, CELL STEM CELL, V19, P23, DOI 10.1016/j.stem.2016.06.001; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004	86	63	63	8	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1561	+		10.1016/j.immuni.2021.05.003	http://dx.doi.org/10.1016/j.immuni.2021.05.003		JUL 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW		Bronze, Green Accepted			2022-12-18	WOS:000672812100018
J	Ji, LL; Zhao, XB; Zhang, B; Kang, L; Song, WX; Zhao, BH; Xie, W; Chen, LG; Hu, XY				Ji, Liangliang; Zhao, Xinbin; Zhang, Bin; Kang, Lan; Song, Wenxin; Zhao, Baohong; Xie, Wei; Chen, Ligong; Hu, Xiaoyu			Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses	IMMUNITY			English	Article							IMMUNE-RESPONSES; NITRIC-OXIDE; TRANSCRIPTION; TRANSPORTER; ACTIVATION; METABOLISM; CELLS; HOMEOSTASIS; MECHANISM; PATHWAYS	Macrophage polarization is accompanied by drastic changes in L-arginine metabolism. Two L-arginine catalytic enzymes, iNOS and arginase 1, are well-characterized hallmark molecules of classically and alternatively activated macrophages, respectively. The third metabolic fate of L-arginine is the generation of creatine that acts as a key source of cellular energy reserve, yet little is known about the role of creatine in the immune system. Here, genetic, genomic, metabolic, and immunological analyses revealed that creatine reprogrammed macrophage polarization by suppressing M(interferon-gamma [IFN-gamma]) yet promoting M(interleukin-4 [IL-4]) effector functions. Mechanistically, creatine inhibited the induction of immune effector molecules, including iNOS, by suppressing IFN-gamma-JAK-STAT1 transcription-factor signaling while supporting IL-4-STATE-activated arginase 1 expression by promoting chromatin remodeling. Depletion of intracellular creatine by ablation of the creatine transporter Slc6a8 altered macrophage-mediated immune responses in vivo. These results uncover a previously uncharacterized role for creatine in macrophage polarization by modulating cellular responses to cytokines such as IFN-gamma and IL-4.	[Ji, Liangliang; Zhang, Bin; Kang, Lan; Hu, Xiaoyu] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Ji, Liangliang; Zhang, Bin; Kang, Lan; Hu, Xiaoyu] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ji, Liangliang; Xie, Wei] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Ji, Liangliang; Zhang, Bin; Kang, Lan; Hu, Xiaoyu] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China; [Zhao, Xinbin; Song, Wenxin; Chen, Ligong] Tsinghua Univ, Minist Educ, Sch Pharmaceut Sci, Beijing Adv Innovat Ctr Struct Biol,Key Lab Bioor, Beijing 100084, Peoples R China; [Zhao, Baohong] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Zhao, Baohong] Hosp Special Surg, Res Div, 535 E 70th St, New York, NY 10021 USA; [Zhao, Baohong] Hosp Special Surg, David Z Rosensweig Genom Ctr, 535 E 70th St, New York, NY 10021 USA; [Xie, Wei] Tsinghua Univ, Ctr Stem Cell Biol & Regenerat Med, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Chen, Ligong] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy & Canc Ctr,West China Me, Chengdu 610041, Sichuan, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Cornell University; Tsinghua University; Sichuan University	Hu, XY (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Hu, XY (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Hu, XY (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.; Chen, LG (corresponding author), Tsinghua Univ, Minist Educ, Sch Pharmaceut Sci, Beijing Adv Innovat Ctr Struct Biol,Key Lab Bioor, Beijing 100084, Peoples R China.; Chen, LG (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy & Canc Ctr,West China Me, Chengdu 610041, Sichuan, Peoples R China.	ligongchen@tsinghua.edu.cn; xiaoyuhu@tsinghua.edu.cn	Hu, Xiaoyu/D-5403-2017; song, wenxin/GOE-3530-2022; Chen, Ligong/AAE-8536-2020	Hu, Xiaoyu/0000-0002-4289-6998; Chen, Ligong/0000-0002-7893-7173; Ji, Liangliang/0000-0001-8572-315X; zhang, bin/0000-0001-6232-6768; Kang, Lan/0000-0002-8643-9174; song, wenxin/0000-0002-6568-4461	Ministry of Science and Technology of China National Key RD Programs [2015CB943201, 2018YFA0506903]; National Natural Science Foundation of China [31821003, 31725010, 81571580, 91642115, 81661130161, 91857108, 81470839]; Nation Science and Technology Major Projects for Major New Drugs Innovation and Development [2018ZX09711003004-002]; Tsinghua University Initiative Scientific Research Program [20161080086]; Tsinghua-Peking Center for Life Sciences; Institute for Immunology at Tsinghua University	Ministry of Science and Technology of China National Key RD Programs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Science and Technology Major Projects for Major New Drugs Innovation and Development; Tsinghua University Initiative Scientific Research Program; Tsinghua-Peking Center for Life Sciences; Institute for Immunology at Tsinghua University	We thank Chen Dong for providing the Listeria monocytogenes strain, Xin Lin for providing Candida albicans with GFP, Jingyi Wu and Bofeng Liu from the Xie laboratory for assistance with ATAC-seq experiments, and all members of the Hu laboratory for discussion and assistance. We are thankful for the service provided by the Laboratory Animal Research Center, the Genomics Core Facility, and the Metabolomics Facility at Tsinghua University. This research was supported by the Ministry of Science and Technology of China National Key R&D Programs (2015CB943201 to X.H. and 2018YFA0506903 to L.C.), the National Natural Science Foundation of China (grants 31821003, 31725010, 81571580, 91642115, and 81661130161 to X.H. and grants 91857108 and 81470839 to L.C.), Nation Science and Technology Major Projects for Major New Drugs Innovation and Development (2018ZX09711003004-002 to L.C.), the Tsinghua University Initiative Scientific Research Program (20161080086 to L.C.), and funds from the Tsinghua-Peking Center for Life Sciences and the Institute for Immunology at Tsinghua University (to X.H.).	Abplanalp J, 2013, HUM MOL GENET, V22, P3218, DOI 10.1093/hmg/ddt175; Ardon O, 2010, AM J MED GENET A, V152A, P1979, DOI 10.1002/ajmg.a.33551; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Candow DG, 2011, BIOGERONTOLOGY, V12, P273, DOI 10.1007/s10522-011-9327-6; Cooper R, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-33; Curt MJC, 2015, BIOCHIMIE, V119, P146, DOI 10.1016/j.biochi.2015.10.022; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GUIMBAL C, 1993, J BIOL CHEM, V268, P8418; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kurosawa Y, 2012, J CLIN INVEST, V122, P2837, DOI 10.1172/JCI59373; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Liu J, 2016, CELL MOL IMMUNOL, V13, P711, DOI 10.1038/cmi.2016.58; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Munder M, 1998, J IMMUNOL, V160, P5347; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Schwartz Daniella M, 2017, Nat Rev Drug Discov, V17, P78, DOI 10.1038/nrd.2017.267; Shang YL, 2016, NAT IMMUNOL, V17, P930, DOI 10.1038/ni.3486; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; SHOUBRIDGE EA, 1985, BIOCHEM J, V232, P125, DOI 10.1042/bj2320125; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Skelton MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016187; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stienstra R, 2017, CELL METAB, V26, P142, DOI 10.1016/j.cmet.2017.06.001; Tokunaga R, 2018, CANCER TREAT REV, V63, P40, DOI 10.1016/j.ctrv.2017.11.007; Turer E, 2017, P NATL ACAD SCI USA, V114, pE1273, DOI 10.1073/pnas.1621400114; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	45	63	67	4	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					272	+		10.1016/j.immuni.2019.06.007	http://dx.doi.org/10.1016/j.immuni.2019.06.007			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31399282	Bronze			2022-12-18	WOS:000482088500011
J	Yang, YY; Li, LP; Yuan, LJ; Zhou, XY; Duan, JX; Xiao, HY; Cai, NN; Han, S; Ma, XQ; Liu, WD; Chen, CC; Wang, LL; Li, X; Chen, JH; Kang, N; Chen, J; Shen, ZX; Malwal, SR; Liu, WL; Shi, Y; Oldfield, E; Guo, RT; Zhang, YH				Yang, Yunyun; Li, Liping; Yuan, Linjie; Zhou, Xiaoying; Duan, Jianxin; Xiao, Hongying; Cai, Ningning; Han, Shuai; Ma, Xianqiang; Liu, Weidong; Chen, Chun-Chi; Wang, Lingle; Li, Xin; Chen, Jiahuan; Kang, Ning; Chen, Jing; Shen, Zhixun; Malwal, Satish R.; Liu, Wanli; Shi, Yan; Oldfield, Eric; Guo, Rey-Ting; Zhang, Yonghui			A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated V gamma 9V delta 2 T Cell Activation	IMMUNITY			English	Article							PRENYL PYROPHOSPHATE STIMULATION; SYNAPSE FORMATION; 3A1; BTN3A1; DOMAIN; MODULATION; ANTIGENS	Human V gamma 9V delta 2 T cells respond to microbial infections and malignancy by sensing diphosphate-containing metabolites called phosphoantigens, which bind to the intracellular domain of butyrophilin 3A1, triggering extracellular interactions with the V gamma 9V delta 2 T cell receptor (TCR). Here, we examined the molecular basis of this "inside-out" triggering mechanism. Crystal structures of intracellular butyrophilin 3A proteins alone or in complex with the potent microbial phosphoantigen HMBPP or a synthetic analog revealed key features of phosphoantigens and butyrophilins required for gamma delta T cell activation. Analyses with chemical probes and molecular dynamic simulations demonstrated that dimerized intracellular proteins cooperate in sensing HMBPP to enhance the efficiency of gamma delta T cell activation. HMBPP binding to butyrophilin doubled the binding force between a gamma delta T cell and a target cell during "outside" signaling, as measured by single-cell force microscopy. Our findings provide insight into the "inside-out" triggering of V gamma 9V delta 2 T cell activation by phosphoantigen-bound butyrophilin, facilitating immunotherapeutic drug design.	[Yang, Yunyun; Li, Liping; Yuan, Linjie; Zhou, Xiaoying; Xiao, Hongying; Han, Shuai; Ma, Xianqiang; Li, Xin; Zhang, Yonghui] Tsinghua Univ, Sch Pharmaceut Sci, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China; [Duan, Jianxin] Schrodinger GmbH, Q7 23, D-68161 Mannheim, Germany; [Xiao, Hongying; Li, Xin] Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China; [Cai, Ningning] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Cai, Ningning] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Liu, Weidong; Chen, Chun-Chi; Guo, Rey-Ting] Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Hubei, Peoples R China; [Wang, Lingle] Schrodinger Inc, 120 West 45th St, New York, NY 10036 USA; [Chen, Jiahuan; Kang, Ning; Chen, Jing; Shen, Zhixun; Liu, Wanli; Shi, Yan] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Malwal, Satish R.; Oldfield, Eric] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Tsinghua University; National Institute of Biological Sciences, Beijing; Tsinghua University; Sichuan University; Hubei University; Tsinghua University; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, YH (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.; Guo, RT (corresponding author), Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Hubei, Peoples R China.; Oldfield, E (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	eoldfiel@illinois.edu; guoreyting@gmail.com; zhangyonghui@tsinghua.edu.cn	Malwal, Satish/M-5168-2019; Malwal, Satish R./ABA-4890-2020; Shi, Yan/Y-6642-2019	Malwal, Satish/0000-0001-7606-1932; Malwal, Satish R./0000-0001-7606-1932; , Yonghui/0000-0002-9842-3049; Guo, Rey-Ting/0000-0003-2942-7246	National Key R&D Program of China [2017YFA1014000, 2017YFA1014001]; National Natural Science Foundation of China [81573270]; Beijing Advanced Innovation Center for Structural Biology; Tsinghua-Peking Center for Life Sciences; 1000 Young Talents Program; United States Public Health Service [GM065307]; National Science Council	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Advanced Innovation Center for Structural Biology; Tsinghua-Peking Center for Life Sciences; 1000 Young Talents Program(Chinese Academy of Sciences); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Council(Ministry of Science and Technology, Taiwan)	We thank Erin J. Adams (University of Chicago, USA) for providing us with the BTN3A1 B30.2 domain plasmid, Xinquan Wang (Tsinghua University) for helping to analyze the BTN3A3 data, and Brian Kent Kobilka (Standford University School of Medicine) and Ye Xiang and Wenqi Li (Tsinghua University) for helpful discussions. We thank Peter Schuck (National Institute of Biomedical Imaging and Bioengineering) for helping to analyze SV-AUC data. This work was funded by grants to Y.Z. from the National Key R&D Program of China (2017YFA1014000 and 2017YFA1014001), the National Natural Science Foundation of China (81573270), the Beijing Advanced Innovation Center for Structural Biology, the Tsinghua-Peking Center for Life Sciences, and the 1000 Young Talents Program. It was also funded in part by the United States Public Health Service (GM065307) to E.O. Synchrotron data were collected at the National Synchrotron Radiation Research Center, Taiwan, supported by the National Science Council, and at the Shanghai Synchrotron Radiation Facility.	Arnett HA, 2014, NAT REV IMMUNOL, V14, P559, DOI 10.1038/nri3715; Chen JH, 2017, J EXP MED, V214, P327, DOI 10.1084/jem.20160620; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Davey MS, 2014, J IMMUNOL, V193, P3704, DOI 10.4049/jimmunol.1401018; Deng W, 2015, BIOPOLYMERS, V104, P317, DOI 10.1002/bip.22651; Favier B, 2003, J IMMUNOL, V171, P5027, DOI 10.4049/jimmunol.171.10.5027; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Gu Siyi, 2014, Front Immunol, V5, P688, DOI 10.3389/fimmu.2014.00688; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Hsiao CHC, 2014, CHEM BIOL, V21, P945, DOI 10.1016/j.chembiol.2014.06.006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kabelitz D, 2017, F1000RESEARCH, V6, P1000; Lentini NA, 2018, J MED CHEM, V61, P8658, DOI 10.1021/acs.jmedchem.8b00655; Lim TS, 2011, J IMMUNOL, V187, P258, DOI 10.4049/jimmunol.1100267; Matsushita H., 2016, IMMUNOTHERAPY CANC, P99; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Peigne CM, 2017, J IMMUNOL, V198, P4228, DOI 10.4049/jimmunol.1601910; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rhodes DA, 2015, J IMMUNOL, V194, P2390, DOI 10.4049/jimmunol.1401064; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sebestyen Z, 2016, CELL REP, V15, P1973, DOI 10.1016/j.celrep.2016.04.081; Shippy RR, 2017, J MED CHEM, V60, P2373, DOI 10.1021/acs.jmedchem.6b00965; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Vantourout P, 2018, P NATL ACAD SCI USA, V115, P1039, DOI 10.1073/pnas.1701237115; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wang H, 2015, J IMMUNOL, V195, P4583, DOI 10.4049/jimmunol.1500314; Wang H, 2013, J IMMUNOL, V191, P1029, DOI 10.4049/jimmunol.1300658; Zhang YH, 2010, ANGEW CHEM INT EDIT, V49, P1136, DOI 10.1002/anie.200905933; Zhao H., 2013, CURR PROTOC PROTEIN; Zhou Xiaoying, 2017, Front Immunol, V8, P1381, DOI 10.3389/fimmu.2017.01381	38	63	64	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1043	+		10.1016/j.immuni.2019.02.016	http://dx.doi.org/10.1016/j.immuni.2019.02.016			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30902636	Bronze			2022-12-18	WOS:000464660800021
J	Martinez-Navio, JM; Fuchs, SP; Pantry, SN; Lauer, WA; Duggan, NN; Keele, BF; Rakasz, EG; Gao, GP; Lifson, JD; Desrosiers, RC				Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Pantry, Shara N.; Lauer, William A.; Duggan, Natasha N.; Keele, Brandon F.; Rakasz, Eva G.; Gao, Guangping; Lifson, Jeffrey D.; Desrosiers, Ronald C.			Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; NEUTRALIZING ANTIBODIES; NONHUMAN-PRIMATES; GENE-EXPRESSION; RECOMBINANT AAV; BROAD; PROTECTION; IDENTIFICATION; REPLICATION	Long-term delivery of anti-HIV monoclonal antibodies (mAbs) using adeno-associated virus (AAV) vectors holds promise for the prevention and treatment of HIV infection. We describe a therapy trial in which four rhesus monkeys were infected with SHIV-AD8 for 86 weeks before receiving the AAV-encoded mAbs 3BNC117, 10-1074, and 10E8. Although anti-drug antibody (ADA) responses restricted mAb delivery, one monkey successfully maintained 50-150 mu g/mL of 3BNC117 and 10-1074 for over 2 years. Delivery of these two mAbs to this monkey resulted in an abrupt decline in plasma viremia, which remained undetectable for 38 successive measurements over 3 years. We generated two more examples of virologic suppression using AAV delivery of a cocktail of four mAbs in a 12-monkey study. Our results provide proof of concept for AAV-delivered mAbs to produce a "functional cure." However, they also serve as a warning that ADAs may be a problem for practical application of this approach in humans.	[Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Pantry, Shara N.; Lauer, William A.; Duggan, Natasha N.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Keele, Brandon F.; Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Rakasz, Eva G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Gao, Guangping] Univ Massachusetts, Gene Therapy Ctr, Med Sch, Worcester, MA 01605 USA	University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Worcester	Desrosiers, RC (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	r.desrosiers@med.miami.edu		Duggan, Natasha/0000-0002-1938-9170; Martinez-Navio, Jose/0000-0003-0560-5407	National Institutes of Health (NIH) [P01 AI100263, R01 AI098446, U19 AI0595985]; P51 base grant (Wisconsin National Primate Research Center) from the NIH [RR000167]; Miami Center for AIDS Research; University of Miami Miller School of Medicine from the NIH [P30AI073961]; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UG3HL147367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098446, P01AI100263, P30AI073961] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P51 base grant (Wisconsin National Primate Research Center) from the NIH; Miami Center for AIDS Research; University of Miami Miller School of Medicine from the NIH; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Sonia Pedreno-Lopez, Pratibha D. Selvakumar, Desiree E. Mendes, and Kimberly L. Weisgrau for technical assistance; Jun Xie, Qin Su, Ran He, and Shaoyong Li of the Gene Therapy Core at the University of Massachusetts Medical School for excellent AAV vector preparation and supportive advice; the Wisconsin National Primate Research Center veterinary staff for professional animal care; Nancy Schultz-Darken, Wendy Newton, and Eric Alexander for animal experiment planning and conduct; and William J. Bosche, Randy Fast, Michael Hull, Kelli Oswald, and Rebecca Shoemaker of the Quantitative Molecular Virology Core and members of the Viral Evolution Core in the AIDS and Cancer Virus Program of the Frederick National Laboratory for Cancer Research for expert technical assistance with viral quantitation and sequencing. We also thank Dennis R. Burton (The Scripps Research Institute), Michel C. Nussenzweig (The Rockefeller University), and Mark Connors (NIAID) for providing antibody sequences and Malcolm A. Martin (NIAID) for providing the SHIV-AD8 sequence. The authors wish to also acknowledge Michael Farzan, Mario Stevenson, David I. Watkins, and Mauricio A. Martins for their insightful comments and critical reading of the manuscript. This project was supported by National Institutes of Health (NIH) grants P01 AI100263, R01 AI098446, and U19 AI0595985 (to R.C.D) and by P51 base grant RR000167 (Wisconsin National Primate Research Center) from the NIH. We also acknowledge support from the Miami Center for AIDS Research (to J.M.M.-N.) at the University of Miami Miller School of Medicine funded by grant P30AI073961 from the NIH. This project has been funded in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E (B.F.K. and J.D.L.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Alexander L, 1997, J VIROL, V71, P6094, DOI 10.1128/JVI.71.8.6094-6099.1997; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; amfAR, 2017, COUNTD CUR AIDS; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boisgerault F, 2013, HUM GENE THER, V24, P393, DOI 10.1089/hum.2012.208; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; BURNS DPW, 1991, J VIROL, V65, P1843, DOI 10.1128/JVI.65.4.1843-1854.1991; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Calvas P, 1999, SCAND J IMMUNOL, V49, P595; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Corbyn Z, 2012, LANCET, V380, P203, DOI 10.1016/S0140-6736(12)61199-4; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Fuchs SP, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.68; Fuchs SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158009; Fuchs SP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005090; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Greig JA, 2016, VACCINE, V34, P6323, DOI 10.1016/j.vaccine.2016.10.053; Hansen SG, 2017, NATURE, V547, P123, DOI 10.1038/nature22984; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jefferys R, 2018, HIV VACCINE UPDATE M; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Lechtzier V, 2002, J IMMUNOL METHODS, V270, P19, DOI 10.1016/S0022-1759(02)00214-4; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Majowicz A, 2013, J GENE MED, V15, P219, DOI 10.1002/jgm.2712; Martinez-Navio JM, 2016, MOL THER, V24, P76, DOI 10.1038/mt.2015.191; Mays LE, 2014, MOL THER, V22, P28, DOI 10.1038/mt.2013.134; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mueller C., 2012, CURR PROTOC MICROBIO, V14, P1; Mueller C, 2017, MOL THER, V25, P1387, DOI 10.1016/j.ymthe.2017.03.029; National Institute of Allergy and Infectious Diseases, 2016, NIH EXP INV HIV CUR; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; Saunders KO, 2015, J VIROL, V89, P8334, DOI 10.1128/JVI.00908-15; Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schnepp BC, 2016, HUM GENE THER, V27, P32, DOI 10.1089/hum.2015.136; Scinicariello F, 2004, IMMUNOLOGY, V111, P66, DOI 10.1111/j.1365-2567.2004.01767.x; Sharland A, 2010, DISCOV MED, V9, P519; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wilkinson DA, 1998, J INFECT DIS, V178, P1163, DOI 10.1086/515675; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	65	63	63	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					567	+		10.1016/j.immuni.2019.02.005	http://dx.doi.org/10.1016/j.immuni.2019.02.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30850342	Green Accepted, Bronze			2022-12-18	WOS:000461660500009
J	Chen, LX; Youssef, Y; Robinson, C; Ernst, GF; Carson, MY; Young, KA; Scoville, SD; Zhang, XL; Harris, R; Sekhri, P; Mansour, AG; Chan, WK; Nalin, AP; Mao, HYC; Hughes, T; Mace, EM; Pan, YH; Rustagi, N; Chatterjee, SS; Gunaratne, PH; Behbehani, GK; Mundy-Bosse, BL; Caligiuri, MA; Freud, AG				Chen, Luxi; Youssef, Youssef; Robinson, Cameron; Ernst, Gabrielle F.; Carson, Mary Y.; Young, Karen A.; Scoville, Steven D.; Zhang, Xiaoli; Harris, Regine; Sekhri, Palak; Mansour, Anthony G.; Chan, Wing K.; Nalin, Ansel P.; Mao, Hsiaoyin C.; Hughes, Tiffany; Mace, Emily M.; Pan, Yinghong; Rustagi, Navin; Chatterjee, Sujash S.; Gunaratne, Preethi H.; Behbehani, Gregory K.; Mundy-Bosse, Bethany L.; Caligiuri, Michael A.; Freud, Aharon G.			CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway	IMMUNITY			English	Article							MASS CYTOMETRY; DIFFERENTIATION; IDENTIFICATION; PROGENITOR; SUBSET; HETEROGENEITY; PRECURSORS; GENERATION; RESPONSES; RECEPTOR	According to the established model of murine innate lymphoid cell (ILC) development, helper ILCs develop separately from natural killer (NK) cells. However, it is unclear how helper ILCs and NK cells develop in humans. Here we elucidated key steps of NK cell, ILC2, and ILC3 development within human tonsils using ex vivo molecular and functional profiling and lineage differentiation assays. We demonstrated that while tonsillar NK cells, ILC2s, and ILC3s originated from a common CD34(+)CD117(+) ILC precursor pool, final steps of ILC2 development deviated independently and became mutually exclusive from those of NK cells and ILC3s, whose developmental pathways overlapped. Moreover, we identified a CD34(-)CD117(+) ILC precursor population that expressed CD56 and gave rise to NK cells and ILC3s but not to ILC2s. These data support a model of human ILC development distinct from the mouse, whereby human NK cells and ILC3s share a common developmental pathway separate from ILC2s.	[Chen, Luxi; Scoville, Steven D.; Nalin, Ansel P.] Ohio State Univ, James Canc Hosp, Med Scientist Training Program, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Chen, Luxi; Robinson, Cameron; Ernst, Gabrielle F.; Carson, Mary Y.; Scoville, Steven D.; Harris, Regine; Sekhri, Palak; Mansour, Anthony G.; Chan, Wing K.; Nalin, Ansel P.; Mao, Hsiaoyin C.; Hughes, Tiffany; Behbehani, Gregory K.; Mundy-Bosse, Bethany L.] Ohio State Univ, James Canc Hosp, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Youssef, Youssef; Young, Karen A.; Freud, Aharon G.] Ohio State Univ, James Canc Hosp, Dept Pathol, Columbus, OH 43210 USA; [Zhang, Xiaoli] Ohio State Univ, James Canc Hosp, Ctr Biostat, Columbus, OH 43210 USA; [Chan, Wing K.; Behbehani, Gregory K.; Mundy-Bosse, Bethany L.; Freud, Aharon G.] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH 43210 USA; Ohio State Univ, James Canc Hosp, Solove Res Inst, Columbus, OH 43210 USA; [Mace, Emily M.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Pan, Yinghong; Rustagi, Navin; Chatterjee, Sujash S.; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Caligiuri, Michael A.] City Hope Natl Med Ctr, Duarte, CA 91010 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Columbia University; University of Houston System; University of Houston; City of Hope	Freud, AG (corresponding author), Ohio State Univ, James Canc Hosp, Dept Pathol, Columbus, OH 43210 USA.; Freud, AG (corresponding author), Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Caligiuri, MA (corresponding author), City Hope Natl Med Ctr, Duarte, CA 91010 USA.	mcaligiuri@coh.org; aharon.freud@osumc.edu	Sekhri, Palak/AAF-3636-2021	Sekhri, Palak/0000-0001-8178-8562; Chen, Luxi/0000-0002-8880-3347; Pan, Yinghong/0000-0001-7334-1787; Mansour, Anthony/0000-0002-6986-6203	National Institutes of Health/National Cancer Institute [CA095426, CA210087, CA163205, CA16058, CA068458, CA199447, CA208353]; AACR [17-20-46-MUND]; UH Division of Research; UH College of Natural Sciences and Mathematics; Department of Biology AMP; Biochemistry, NRUF MINOR CORE 17 Grant; UH Small Core Equipment Program Grant; Pelotonia Graduate Student Fellowship; NATIONAL CANCER INSTITUTE [R35CA210087, R01CA208353, P01CA163205, P01CA095426, R01CA068458, P30CA016058, R37CA068458] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AACR; UH Division of Research; UH College of Natural Sciences and Mathematics; Department of Biology AMP; Biochemistry, NRUF MINOR CORE 17 Grant; UH Small Core Equipment Program Grant; Pelotonia Graduate Student Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health/National Cancer Institute (CA095426, CA210087, CA163205, CA16058, and CA068458 to M.A.C. and CA199447 and CA208353 to A.G.F.), AACR 17-20-46-MUND to B.L.M., UH Division of Research, UH College of Natural Sciences and Mathematics, and Department of Biology & Biochemistry, NRUF MINOR CORE 17 Grant to P.H.G., UH Small Core Equipment Program Grant to P.H.G., and a Pelotonia Graduate Student Fellowship to L.C. We thank the Cooperative Human Tissue Network of Nationwide Children's Hospital for providing us with human pediatric tonsil samples and the Analytic Cytometry, Genomics, and Biostatistics Shared Resources of The Ohio State University Comprehensive Cancer Center. We would also like to thank Dr.J.C. Zuniga-Pflucker (University of Toronto) for kindly providing the OP9-DL1 cell line and Dr. David Clever (Washington University) for technical assistance with experiments.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Behbehani GK, 2015, CANCER DISCOV, V5, P988, DOI 10.1158/2159-8290.CD-15-0298; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2016, CELL REP, V16, P379, DOI 10.1016/j.celrep.2016.05.095; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hughes T, 2014, CELL REP, V8, P150, DOI 10.1016/j.celrep.2014.05.042; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mace EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12171; MATOS ME, 1993, J EXP MED, V178, P1079, DOI 10.1084/jem.178.3.1079; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Scoville SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00360; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Scoville SD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12490; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	51	63	64	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					464	+		10.1016/j.immuni.2018.08.010	http://dx.doi.org/10.1016/j.immuni.2018.08.010			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30193847	Green Accepted, Bronze			2022-12-18	WOS:000444909600014
J	Kotas, ME; Locksley, RM				Kotas, Maya E.; Locksley, Richard M.			Why Innate Lymphoid Cells?	IMMUNITY			English	Review							TYPE-2 IMMUNITY; PPAR-GAMMA; STEM-CELLS; T-CELLS; DIFFERENTIATION; ACTIVATION; PLASTICITY; PROMOTES; PATHWAY; FATE	Innate lymphoid cells (ILCs) are positioned in tissues perinatally, constitutively express receptors responsive to their organ microenvironments, and perform an arsenal of effector functions that overlap those of adaptive CD4(+) T cells. Based on knowledge regarding subsets of invariant-like lymphocytes (e. g., natural killer T [NKT] cells, gd T cells, mucosal-associated invariant T [MAIT] cells, etc.) and fetally derived macrophages, we hypothesize that immune cells established during the perinatal period-including, but not limited to, ILCsserve intimate roles in tissue that go beyond classical understanding of the immune system in microbial host defense. In this Perspective, we propose mechanisms by which the establishment of ILCs and the tissue lymphoid niche during early development may have consequences much later in life. Although definitive answers require better tools, efforts to achieve deeper understanding of ILC biology across the mammalian lifespan have the potential to lift the veil on the unknown breadth of immune cell functions.	[Kotas, Maya E.; Locksley, Richard M.] UCSF, HHMI, 513 Parnassus Ave,S1032B, San Francisco, CA 94143 USA; [Kotas, Maya E.; Locksley, Richard M.] UCSF, Dept Med, 513 Parnassus Ave,S1032B, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kotas, ME; Locksley, RM (corresponding author), UCSF, HHMI, 513 Parnassus Ave,S1032B, San Francisco, CA 94143 USA.; Kotas, ME; Locksley, RM (corresponding author), UCSF, Dept Med, 513 Parnassus Ave,S1032B, San Francisco, CA 94143 USA.	maya.kotas@ucsf.edu; richard.locksley@ucsf.edu			NIH [4 R01 AI26918, 5 P01 HL128903, 5 NIH R01 HL122593, 1 F32 HL140868-01]; HHMI; SABRE Center at UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122593, R01HL128903, F32HL140868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); SABRE Center at UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors appreciated spirited input from Locksley lab members and support from the NIH grant numbers 4 R01 AI26918, 5 P01 HL128903, 5 NIH R01 HL122593, 1 F32 HL140868-01, HHMI, and the SABRE Center at UCSF.	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Buckley KM, 2017, ELIFE, V6, DOI 10.7554/eLife.23481; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Chen CC, 2017, NATURE, V542, P43, DOI 10.1038/nature20818; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Gadani SP, 2017, J EXP MED, V214, P285, DOI 10.1084/jem.20161982; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Han QF, 2015, J IMMUNOL, V195, P5440, DOI 10.4049/jimmunol.1500892; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hernandez P, 2018, EUR J IMMUNOL, V48, P15, DOI 10.1002/eji.201747183; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hu D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01571-8; Huang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132802; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Juelke K, 2016, CURR OPIN IMMUNOL, V38, P75, DOI 10.1016/j.coi.2015.11.005; Keyes BE, 2018, J CELL BIOL, V217, P79, DOI 10.1083/jcb.201708099; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li J, 2018, MUCOSAL IMMUNOL, V11, P581, DOI 10.1038/mi.2017.97; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Secombes CJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00209; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; van de Pavert SA, 2016, INT IMMUNOL, V28, P35, DOI 10.1093/intimm/dxv052; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wang TH, 2016, ONCOTARGET, V7, P10917, DOI 10.18632/oncotarget.7295; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yamaguchi Takuya, 2015, Biology-Basel, V4, P814, DOI 10.3390/biology4040814; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	84	63	63	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1081	1090		10.1016/j.immuni.2018.06.002	http://dx.doi.org/10.1016/j.immuni.2018.06.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924974	Green Accepted, Bronze			2022-12-18	WOS:000436456900009
J	Xu, M; Lu, HP; Lee, YH; Wu, YL; Liu, KW; Shi, YL; An, HR; Zhang, JR; Wang, XH; Lai, YP; Dong, C				Xu, Miao; Lu, Huiping; Lee, Young-Hee; Wu, Yelin; Liu, Kewei; Shi, Yuling; An, Haoran; Zhang, Jingren; Wang, Xiaohu; Lai, Yuping; Dong, Chen			An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation	IMMUNITY			English	Article							STAPHYLOCOCCUS-AUREUS; IL-25; EXPRESSION; IL-17; DIFFERENTIATION; INDUCTION; EXPANSION; RESPONSES; CYTOKINE; PROMOTES	Psoriasis is a chronic autoinflammatory skin disease. Although interleukin-17, derived from lymphocytes, has been shown to be critical in psoriasis, the initiation and maintenance of chronic skin inflammation has not been well understood. IL-25 (also called IL-17E), another IL-17 family cytokine, is well known to regulate allergic responses and type 2 immunity. Here we have shown that IL-25, also highly expressed in the lesional skin of psoriasis patients, was regulated by IL-17 in murine skin of a imiquimod (IMQ)-induced psoriasis model. IL-25 injection induced skin inflammation, whereas germline or keratinocyte-specific deletion of IL-25 caused resistance to IMQ-induced psoriasis. Via IL-17RB expression in keratinocytes, IL-25 stimulated the proliferation of keratinocytes and induced the production of inflammatory cytokines and chemokines, via activation of the STAT3 transcription factor. Thus, our data demonstrate that an IL-17-induced autoregulatory circuit in keratinocytes is mediated by IL-25 and suggest that this circuit could be targeted in the treatment of psoriasis patients.	[Xu, Miao; Lu, Huiping; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Xu, Miao; Lu, Huiping; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wu, Yelin; Liu, Kewei; Lai, Yuping] East China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Shi, Yuling] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Dermatol, Shanghai 200072, Peoples R China; [An, Haoran; Zhang, Jingren] Tsinghua Univ, Ctr Infect Dis, Sch Med, Beijing 100084, Peoples R China; [Xu, Miao] Peking Univ, Tsinghua Univ, Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Lee, Young-Hee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Lee, Young-Hee] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA; [Dong, Chen] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; East China Normal University; Tongji University; Tsinghua University; Peking University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Shi, Yuling/0000-0002-1273-7881	Ministry of Science and Technology [2016YFC0906200]; National Natural Science Foundation of China [31630022, 31570884]; Beijing Natural Science Foundation [5172017]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	We thank Dr. Xiao Yang in the Academy for Military Medical Sciences for providing the K5-cre mice. This work was supported by grants from Ministry of Science and Technology (2016YFC0906200 to C.D.), National Natural Science Foundation of China (31630022 to C.D. and 31570884 to X.W.), and Beijing Natural Science Foundation (5172017 to X.W.). C.D. is a Bayer Chair Professor at Tsinghua University.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Albanesi C, 1999, J IMMUNOL, V162, P494; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Archer NK, 2013, INFECT IMMUN, V81, P2070, DOI 10.1128/IAI.00084-13; Bata-Csorgo Z., 1998, IMMUNOL TODAY, V101, P1509; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cho SH, 2001, J INVEST DERMATOL, V116, P658, DOI 10.1046/j.0022-202x.2001.01331.x; D'Souza SJA, 2001, J BIOL CHEM, V276, P23531, DOI 10.1074/jbc.M100780200; Ding X, 2016, CELL REP, V16, P1055, DOI 10.1016/j.celrep.2016.06.056; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Kaiser S, 1998, J INVEST DERMATOL, V111, P1145, DOI 10.1046/j.1523-1747.1998.00407.x; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kim MR, 2002, BLOOD, V100, P2330, DOI 10.1182/blood-2002-01-0012; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Mchenga SSS, 2008, CELL MOL IMMUNOL, V5, P425, DOI 10.1038/cmi.2008.53; Monteleone G, 2011, CLIN SCI, V120, P1, DOI 10.1042/CS20100163; Morita Hideaki, 2013, Arerugi, V62, P924; Muromoto R, 2016, INT IMMUNOL, V28, P443, DOI 10.1093/intimm/dxw011; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; Purwar R, 2006, J IMMUNOL, V177, P4444, DOI 10.4049/jimmunol.177.7.4444; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Robinson KM, 2014, J INFECT DIS, V209, P865, DOI 10.1093/infdis/jit527; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sharkhuu T, 2006, CLIN EXP ALLERGY, V36, P1575, DOI 10.1111/j.1365-2222.2006.02595.x; Shiao YM, 2013, J INVEST DERMATOL, V133, P1375, DOI 10.1038/jid.2012.484; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Wu L, 2015, J IMMUNOL, V194, P4528, DOI 10.4049/jimmunol.1402760; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	56	63	65	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					787	+		10.1016/j.immuni.2018.03.019	http://dx.doi.org/10.1016/j.immuni.2018.03.019			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29653697	Bronze			2022-12-18	WOS:000430198900023
J	Zhang, ZY; Meng, P; Han, YJ; Shen, CB; Li, BW; Hakim, MA; Zhang, XG; Lu, QM; Rong, MQ; Lai, R				Zhang, Zhiye; Meng, Ping; Han, Yajun; Shen, Chuanbin; Li, Bowen; Hakim, Md Abdul; Zhang, Xuguang; Lu, Qiumin; Rong, Mingqiang; Lai, Ren			Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic Recognition	IMMUNITY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; PLASMACYTOID DENDRITIC CELLS; ANTIMICROBIAL PEPTIDE; INFLAMMATORY RESPONSES; ENDOTHELIAL-CELLS; DNA; MICE; STREPTOCOCCUS; DEGRADATION; IMMUNITY	Atherosclerosis is a chronic inflammatory disease of arterial wall. Mitochondrial DNA (mtDNA) and human antimicrobial peptide LL-37 (Cramp in mice) are involved in atherosclerosis. Recently, mtDNA has been found to escape from autophagy and cause inflammation. Normally, mtDNA as an inflammato-genic factor cannot escape from autophagy and degradation by DNase II. In this study, we found elevated amounts of LL37-mtDNA complex in atherosclerotic plasmaandplaques. The complex was resistant to DNase II degradation and escaped from autophagic recognition, leading to activation of Toll-like receptor 9 (TLR9)-mediated inflammatory responses. Mouse model studies indicated that Cramp-mtDNA complex aggravated atherosclerotic lesion formation in apolipoprotein E-deficient mice and antibody treatment against the complex alleviated the lesion. These findings suggest that the LL-37-mtDNA complex acts as a key mediator of atherosclerosis formation, and thus represents a promising therapeutic target.	[Zhang, Zhiye; Shen, Chuanbin; Li, Bowen; Hakim, Md Abdul; Lu, Qiumin; Rong, Mingqiang; Lai, Ren] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Meng, Ping; Han, Yajun; Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Zhiye; Shen, Chuanbin; Li, Bowen; Hakim, Md Abdul] Univ Chinese Acad Sci, Beijing 100009, Peoples R China; [Zhang, Xuguang] Kunming Yanan Hosp, Major Cardiovasc Surg, Kunming 650051, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lai, R (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn	HAKIM, ABDUL/AAF-9864-2021; Lu, Qiumin/AAB-4791-2022	HAKIM, ABDUL/0000-0002-6183-7950; Shen, Chuanbin/0000-0002-4635-5160; Zhang, Zhiye/0000-0002-1661-2277	MOST [2013CB911300]; NSFC [U1132601, 31200590]; CAS [XDB13000000, KSZD-EW-Z-007, XDA12040209]; Yunnan Province [2012BC009]	MOST; NSFC(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Yunnan Province	We thank Professor Hong Tang of Wuhan Institute of Virology, Chinese Academy of Sciences, for kindly providing Tlr9 knockout mouse. This work was supported by MOST (2013CB911300), NSFC (U1132601, 31200590), CAS (XDB13000000, KSZD-EW-Z-007, XDA12040209), and Yunnan Province (2012BC009).	Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Ciornei Cristina D, 2006, BMC Cardiovasc Disord, V6, P49, DOI 10.1186/1471-2261-6-49; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Cooper PR, 2013, PERIODONTOL 2000, V63, P165, DOI 10.1111/prd.12025; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koyanagi M, 2000, CIRCULATION, V102, P2243; Kwon GP, 2008, CIRCULATION, V117, P2919, DOI 10.1161/CIRCULATIONAHA.107.754614; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang YZ, 2014, J MOL CELL CARDIOL, V72, P85, DOI 10.1016/j.yjmcc.2014.02.012	40	63	66	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1137	1147		10.1016/j.immuni.2015.10.018	http://dx.doi.org/10.1016/j.immuni.2015.10.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26680206	Bronze			2022-12-18	WOS:000366846600017
J	Bekiaris, V; Sedy, JR; Macauley, MG; Rhode-Kurnow, A; Ware, CF				Bekiaris, Vasileios; Sedy, John R.; Macauley, Matthew G.; Rhode-Kurnow, Antje; Ware, Carl F.			The Inhibitory Receptor BTLA Controls gamma delta T Cell Homeostasis and Inflammatory Responses	IMMUNITY			English	Article							SECONDARY LYMPHOID-TISSUE; INTERLEUKIN-7 RECEPTOR; INDUCER CELLS; B-LYMPHOCYTE; NK CELLS; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSE; NKP46(+) CELLS; CELIAC-DISEASE; DIFFERENTIATION	gamma delta T cells rapidly secrete inflammatory cytokines at barrier sites that aid in protection from pathogens, but mechanisms limiting inflammatory damage remain unclear. We found that retinoid-related orphan receptor gamma-t (ROR gamma t) and interleukin-7 (IL-7) influence gamma delta T cell homeostasis and function by regulating expression of the inhibitory receptor, B and T lymphocyte attenuator (BTLA). The transcription factor ROR gamma t, via its activating function-2 domain, repressed Btla transcription, whereas IL-7 increased BTLA levels on the cell surface. BTLA expression limited gamma delta T cell numbers and sustained normal gamma delta T cell subset frequencies by restricting IL-7 responsiveness and expansion of the CD27(-)ROR gamma t(+) population. BTLA also negatively regulated IL-17 and TNF production in CD27(-) gamma delta T cells. Consequently, BTLA-deficient mice exhibit enhanced disease in a gamma delta T cell-dependent model of dermatitis, whereas BTLA agonism reduced inflammation. Therefore, by coordinating expression of BTLA, ROR gamma t and IL-7 balance suppressive and activation stimuli to regulate gamma delta T cell homeostasis and inflammatory responses.	[Bekiaris, Vasileios; Sedy, John R.; Macauley, Matthew G.; Rhode-Kurnow, Antje; Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Ware, CF (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cware@sanfordburnham.org		Sedy, John/0000-0002-6428-1054; Bekiaris, Vasileios/0000-0002-4051-4327	US National Institutes of Health [R37AI33068, AI48073, AI067890, CA164679]; NATIONAL CANCER INSTITUTE [R01CA164679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R37AI033068, R01AI067890] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Cortez and Y. Altman for assistance with flow cytometry, S. Villareal and B. Charbono for assistance with animal work, and R. Newlin and G. Garcia for assistance with histology. This study was supported by grants from the US National Institutes of Health (R37AI33068, AI48073, AI067890, CA164679 to C. F. W.) and a gift from the Jean Perkins Family Foundation.	Baccala R, 2005, J IMMUNOL, V174, P4606, DOI 10.4049/jimmunol.174.8.4606; Bekiaris V, 2008, J IMMUNOL, V180, P6768, DOI 10.4049/jimmunol.180.10.6768; Bekiaris V, 2009, EUR J IMMUNOL, V39, P2800, DOI 10.1002/eji.200939508; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Germain RN, 2012, NAT IMMUNOL, V13, P902, DOI 10.1038/ni.2404; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hurchla MA, 2005, J IMMUNOL, V174, P3377, DOI 10.4049/jimmunol.174.6.3377; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Kobayashi Y, 2013, P NATL ACAD SCI USA, V110, P5121, DOI 10.1073/pnas.1222093110; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Malissen M, 1997, J EXP MED, V186, P1277, DOI 10.1084/jem.186.8.1277; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Withers DR, 2012, J IMMUNOL, V189, P2094, DOI 10.4049/jimmunol.1201639; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	54	63	66	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1082	1094		10.1016/j.immuni.2013.10.017	http://dx.doi.org/10.1016/j.immuni.2013.10.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24315996	Bronze, Green Accepted			2022-12-18	WOS:000330951000014
J	Castagnaro, L; Lenti, E; Maruzzelli, S; Spinardi, L; Migliori, E; Farinello, D; Sitia, G; Harrelson, Z; Evans, SM; Guidotti, LG; Harvey, RP; Brendolan, A				Castagnaro, Laura; Lenti, Elisa; Maruzzelli, Sara; Spinardi, Laura; Migliori, Edoardo; Farinello, Diego; Sitia, Giovanni; Harrelson, Zachary; Evans, Sylvia M.; Guidotti, Luca G.; Harvey, Richard P.; Brendolan, Andrea			Nkx2-5(+)Islet1(+) Mesenchymal Precursors Generate Distinct Spleen Stromal Cell Subsets and Participate in Restoring Stromal Network Integrity	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; FIBROBLASTIC RETICULAR CELLS; TISSUE-INDUCER CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SPLENIC WHITE PULP; LYMPH-NODE; STEM-CELLS; RESIDENT; SYSTEM; HEART	Secondary lymphoid organ stromal cells comprise different subsets whose origins remain unknown. Herein, we exploit a genetic lineage-tracing approach to show that splenic fibroblastic reticular cells (FRCs), follicular dendritic cells (FDCs), marginal reticular cells (MRCs), and mural cells, but not endothelial cells, originate from embryonic mesenchymal progenitors of the Nkx2-5(+)Islet1(+) lineage. This lineage include embryonic mesenchymal cells with lymphoid tissue organizer (LTo) activity capable also of supporting ectopic lymphoid-like structures and a subset of resident spleen stromal cells that proliferate and regenerate the splenic stromal microenvironment following resolution of a viral infection. These findings identify progenitor cells that generate stromal diversity in spleen development and repair and suggest the existence of multipotent stromal progenitors in the adult spleen with regenerative capacity.	[Castagnaro, Laura; Lenti, Elisa; Maruzzelli, Sara; Migliori, Edoardo; Farinello, Diego; Brendolan, Andrea] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy; [Sitia, Giovanni; Guidotti, Luca G.] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Spinardi, Laura] Ca Granda Osped Maggiore Policlin, Fdn IRCCS, I-20122 Milan, Italy; [Harrelson, Zachary; Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA; [Harrelson, Zachary; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Guidotti, Luca G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Harvey, Richard P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Harvey, Richard P.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Brendolan, A (corresponding author), Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy.	brendolan.andrea@hsr.it	Sitia, Giovanni/K-1036-2016; Evans, Sylvia/G-1980-2015; Sitia, Giovanni/U-2114-2019; Andrea, Brendolan/ABG-3387-2020; Spinardi, Laura/I-6925-2015; Guidotti, Luca G. G/I-8542-2018; Lenti, Elisa/ABG-5312-2020; Castagnaro, Laura/AAN-1895-2020	Sitia, Giovanni/0000-0003-1024-9128; Sitia, Giovanni/0000-0003-1024-9128; Spinardi, Laura/0000-0002-4619-853X; Guidotti, Luca G. G/0000-0002-0205-2678; Castagnaro, Laura/0000-0003-4387-9919; Brendolan, Andrea/0000-0003-0109-6879; Migliori, Edoardo/0000-0003-2804-1552; Harvey, Richard/0000-0002-9950-9792	Associazione Italiana Ricerca sul Cancro (AIRC) [4780, 9965]; Marie Curie Foundation (IRG) [208932]; Italian Ministry of Health [GR08.17]; National Institutes of Health (NIH) [R01-AI40696]; National Health and Medical Research Council, Australia [573705, 573703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040696] Funding Source: NIH RePORTER	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Marie Curie Foundation (IRG); Italian Ministry of Health(Ministry of Health, Italy); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to R. Aiolfi for technical assistance and A. Mondino, K. Pilipow, I. Harel, and R. Mazzucchelli for helpful suggestions and reagents. We are thankful to J. Caamano, M. Bajenoff, R. Mebius, S. van der Pavert, D. Talarico, G. Tonon, and F. Caligaris-Cappio for comments on the manuscript. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) (Start-Up Grant #4780 to A. B. and Special Program Molecular Clinical Oncology-5 per mille #9965); Marie Curie Foundation (IRG-2007 #208932 to A. B); Italian Ministry of Health (GR08.17 to G. S); National Institutes of Health (NIH) (R01-AI40696 to L. G. G), National Health and Medical Research Council, Australia (573705, 573703 to R. P. H). S. M. E. acknowledges funding from NIH. L. C., E. L., L. S., S. M., E. M., D. F., Z. H., G. S., L. G. G., and A. B. performed the experiments and analyzed data, S. E., L. G. G., and R. P. H. provided mouse lines and reagents, A. B. wrote the manuscript with the contribution of L. G. G. and R. P. H., and A. B. directed the study.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cyster JG, 2000, IMMUNOL REV, V176, P181; DEAR TN, 1995, DEVELOPMENT, V121, P2909; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Glanville SH, 2009, EUR J IMMUNOL, V39, P280, DOI 10.1002/eji.200838724; Hecksher-Sorensen J, 2004, DEVELOPMENT, V131, P4665, DOI 10.1242/dev.01364; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Koning JJ, 2012, TRENDS IMMUNOL, V33, P264, DOI 10.1016/j.it.2011.10.006; Koss M, 2012, DEV CELL, V22, P913, DOI 10.1016/j.devcel.2012.02.009; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mabbott NA, 2011, IMMUNOLOGY, V133, P482, DOI 10.1111/j.1365-2567.2011.03461.x; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Onder L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00050; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; SCHNIZLEIN CT, 1985, J IMMUNOL, V134, P1360; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MFR, 2008, J LEUKOCYTE BIOL, V84, P152, DOI 10.1189/jlb.0907659; Withers DR, 2007, EUR J IMMUNOL, V37, P3240, DOI 10.1002/eji.200737541; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322	44	63	64	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					782	791		10.1016/j.immuni.2012.12.005	http://dx.doi.org/10.1016/j.immuni.2012.12.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601687	Green Accepted, Bronze			2022-12-18	WOS:000330942100019
J	Murphy, MP; Siegel, RM				Murphy, Michael P.; Siegel, Richard M.			Mitochondrial ROS Fire Up T Cell Activation	IMMUNITY			English	Editorial Material							SIGNAL-TRANSDUCTION	Metabolic reprogramming has emerged as an important feature of immune cell activation. Two new studies, including Sena et al. (2013) in this issue of Immunity, identify mitochondrial reactive oxygen species (ROS) arising from metabolic reprogramming as signaling molecules in T cell activation.	[Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Siegel, Richard M.] NIAMSD, Immunoregulat Sect, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Siegel, RM (corresponding author), NIAMSD, Immunoregulat Sect, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.	rsiegel@nih.gov	Murphy, Michael P/C-2120-2009	Murphy, Michael P/0000-0003-1115-9618	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041175, ZIAAR041133] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025	9	63	66	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					201	202		10.1016/j.immuni.2013.02.005	http://dx.doi.org/10.1016/j.immuni.2013.02.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438817	Bronze			2022-12-18	WOS:000330940800001
J	Liu, DF; Peterson, ME; Long, EO				Liu, Dongfang; Peterson, Mary E.; Long, Eric O.			The Adaptor Protein Crk Controls Activation and Inhibition of Natural Killer Cells	IMMUNITY			English	Article							MHC CLASS-I; CHRONIC VIRAL-INFECTION; COMPLEX CLASS-I; IMMUNE SYNAPSES; ACTIN CYTOSKELETON; TYROSINE PHOSPHORYLATION; LIVING CELLS; T-CELLS; RECEPTORS; REORGANIZATION	Natural killer (NK) cell inhibitory receptors recruit tyrosine phosphatases to prevent activation, induce phosphorylation and dissociation of the small adaptor Crk from cytoskeleton scaffold complexes, and maintain NK cells in a state of responsiveness to subsequent activation events. How Crk contributes to inhibition is unknown. We imaged primary NK cells over lipid bilayers carrying IgG1 Fc to stimulate CD16 and human leukocyte antigen (HLA)-E to inhibit through receptor CD94-NKG2A. HLA-E alone induced Crk phosphorylation in NKG2A(+) NK cells. At activating synapses with Fc alone, Crk was required for the movement of Fc microclusters and their ability to trigger activation signals. At inhibitory synapses, HLA-E promoted central accumulation of both Fc and phosphorylated Crk and blocked the Fc-induced buildup of F-actin. We propose a unified model for inhibitory receptor function: Crk phosphorylation prevents essential Crk-dependent activation signals and blocks F-actin network formation, thereby reducing constraints on subsequent engagement of activation receptors.	[Liu, Dongfang; Peterson, Mary E.; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Long, EO (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	elong@nih.gov	Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728; Liu, Dongfang/0000-0002-7295-8088	National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001117] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Brzostowski, S. Rajagopalan, and P. Sun for advice and help, D. Geraghty and M. Robertson for cell lines, and Y. Ohba for the CrkL biosensor. This work has been supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Abeyweera TP, 2011, J CELL BIOL, V192, P675, DOI 10.1083/jcb.201009135; Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; CICCONE E, 1992, J EXP MED, V176, P963, DOI 10.1084/jem.176.4.963; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Guerra N, 2002, BLOOD, V100, P2874, DOI 10.1182/blood-2002-02-0643; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; Gupta N, 1997, J EXP MED, V186, P473, DOI 10.1084/jem.186.3.473; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; March ME, 2011, J IMMUNOL, V186, P2998, DOI 10.4049/jimmunol.1002438; Masilamani M, 2006, J IMMUNOL, V177, P3590, DOI 10.4049/jimmunol.177.6.3590; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Mizutani T, 2010, CLIN CANCER RES, V16, P3964, DOI 10.1158/1078-0432.CCR-10-0548; Nakashima N, 1999, J BIOL CHEM, V274, P3001, DOI 10.1074/jbc.274.5.3001; Olcese L, 1996, J IMMUNOL, V156, P4531; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Schleinitz N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003278; Segovis CM, 2009, J IMMUNOL, V182, P6933, DOI 10.4049/jimmunol.0803840; Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x	51	63	64	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					600	611		10.1016/j.immuni.2012.03.007	http://dx.doi.org/10.1016/j.immuni.2012.03.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22464172	Green Accepted, Bronze			2022-12-18	WOS:000303223900012
J	Yin, L; Huseby, E; Scott-Browne, J; Rubtsova, K; Pinilla, C; Crawford, F; Marrack, P; Dai, SD; Kappler, JW				Yin, Lei; Huseby, Eric; Scott-Browne, James; Rubtsova, Kira; Pinilla, Clamencia; Crawford, Frances; Marrack, Philippa; Dai, Shaodong; Kappler, John W.			A Single T Cell Receptor Bound to Major Histocompatibility Complex Class I and Class II Glycoproteins Reveals Switchable TCR Conformers	IMMUNITY			English	Article							STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURE; SELF-PEPTIDE; AMINO-ACIDS; CRYSTAL-STRUCTURE; MHC RESTRICTION; RECOGNITION; ANTIGEN; BINDING; SPECIFICITY	Major histocompatibility complex class I (MHCI) and MHCII proteins differ in structure and sequence. To understand how T cell receptors (TCRs) can use the same set of variable regions to bind both proteins, we have presented a comparison of a single TCR bound to both MHCI and MHCII ligands. The TCR adopts similar orientations on both ligands with TCR amino acids thought to be evolutionarily conserved for MHC interaction occupying similar positions on the MHCI and MHCII helices. However, the TCR antigen-binding loops use different conformations when interacting with each ligand. Most importantly, we observed alternate TCR core conformations. When bound to MHCI, but not MHCII, V alpha disengages from the J alpha beta strand, switching V alpha's position relative to V beta. In several other structures, either V alpha or V beta undergoes this same modification. Thus, both TCR V-domains can switch among alternate conformations, perhaps extending their ability to react with different MHC-peptide ligands.	[Yin, Lei; Huseby, Eric; Scott-Browne, James; Rubtsova, Kira; Crawford, Frances; Marrack, Philippa; Dai, Shaodong; Kappler, John W.] Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Denver, CO 80206 USA; [Yin, Lei; Huseby, Eric; Scott-Browne, James; Rubtsova, Kira; Crawford, Frances; Marrack, Philippa; Dai, Shaodong; Kappler, John W.] Integrated Dept Immunol, Denver, CO 80206 USA; [Pinilla, Clamencia] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Marrack, Philippa] Univ Colorado Denver, Dept Biochem & Mol Genet, Sch Med, Aurora, CO 80045 USA; [Kappler, John W.] Univ Colorado Denver, Program Struct Biol & Biophys, Sch Med, Aurora, CO 80045 USA	Howard Hughes Medical Institute; National Jewish Health; Torrey Pines Institute for Molecular Studies, California; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kappler, JW (corresponding author), Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Denver, CO 80206 USA.	kapplerj@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; yin, lei/0000-0001-5203-2766	USPHS [AI-18785, AI-22295]; National Jewish Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, T32AI007405, R56AI018785, R01AI018785, R37AI018785, P01AI022295] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Jewish Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank L. Gapin for thoughtful discussions and the staff of the Advanced Light Source synchrotron facility (BL 8.2.2) for help in the x-ray data collection. This work was supported by USPHS grants AI-18785 and AI-22295. Also we thank the Zuckerman Family/Canyon Ranch and Allen Lapporte for support of the Structural Facility at National Jewish Health.	Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bjorkman PJ, 1997, CELL, V89, P167, DOI 10.1016/S0092-8674(00)80195-6; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Gagnon SJ, 2006, J MOL BIOL, V363, P228, DOI 10.1016/j.jmb.2006.08.045; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Huseby ES, 1999, J IMMUNOL, V163, P1115; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Logunova NN, 2005, J EXP MED, V202, P73, DOI 10.1084/jem.20050198; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; PINILLA C, 1992, BIOTECHNIQUES, V13, P901; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rubtsova K, 2009, P NATL ACAD SCI USA, V106, P7951, DOI 10.1073/pnas.0902728106; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	45	63	65	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					23	33		10.1016/j.immuni.2011.04.017	http://dx.doi.org/10.1016/j.immuni.2011.04.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21683626	Green Accepted, Bronze			2022-12-18	WOS:000293107300007
J	Flach, H; Rosenbaum, M; Duchniewicz, M; Kim, S; Zhang, SL; Cahalan, MD; Mittler, G; Grosschel, R				Flach, Henrik; Rosenbaum, Marc; Duchniewicz, Marlena; Kim, Sola; Zhang, Shenyuan L.; Cahalan, Michael D.; Mittler, Gerhard; Grosschel, Rudolf			Mzb1 Protein Regulates Calcium Homeostasis, Antibody Secretion, and Integrin Activation in Innate-like B Cells	IMMUNITY			English	Article							ENDOPLASMIC-RETICULUM; MARGINAL ZONE; B-1 CELLS; OXIDOREDUCTASE ERP57; SIGNAL-TRANSDUCTION; QUALITY-CONTROL; RESPONSES; DIFFERENTIATION; IMMUNOGLOBULIN; CHAPERONES	Marginal zone (MZ) B cells of the spleen and B1 cells, termed innate-like B cells, differ from follicular B cells by their attenuated Ca2+ mobilization, fast antibody secretion, and increased cell adhesion. We identified and characterized Mzb1 as an endoplasmic reticulum-localized and B cell-specific protein that was most abundantly expressed in MZ B and B1 cells. Knockdown of Mzb1 in MZ B cells increased Ca2+ mobilization and nuclear NFAT transcription factor localization, but reduced lipopolysaccharide-induced antibody secretion and integrin-mediated cell adhesion. Conversely, ectopic expression of an Lck-Mzb1 transgene in peripheral T cells resulted in attenuated Ca2+ mobilization and augmented integrin-mediated cell adhesion. In addition to its interaction with the substrate-specific chaperone Grp94, Mzb1 augmented the function of the oxidoreductase ERp57 in favoring the expression of integrins in their activated conformation. Thus, Mzb1 helps to diversify peripheral B cell functions by regulating Ca2+ stores, antibody secretion, and integrin activation.	[Flach, Henrik; Rosenbaum, Marc; Duchniewicz, Marlena; Mittler, Gerhard; Grosschel, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Kim, Sola] Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany; [Zhang, Shenyuan L.; Cahalan, Michael D.] Univ Calif Irvine, Inst Immunol, Dept Physiol & Biophys, Irvine, CA 92697 USA	Max Planck Society; University of Munich; University of California System; University of California Irvine	Grosschel, R (corresponding author), Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de		Rosenbaum, Marc/0000-0001-6834-385X	Danish Graduate Student Fellowship; Max-Planck-Research-Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER	Danish Graduate Student Fellowship; Max-Planck-Research-Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Falk for expert technical help, A. Travis for the initial screening of the cDNA library, B. Schreiber and M. Pink for their help in generating the siRNA knockdown cells, K. Rattay for help in establishing the isomerization assay and E. Kremmer (GSF, Munich) for producing Mzb1 monoclonal antibodies. We thank M. Digman and E. Gratton for assistance with the fluorescence lifetime imaging measurements. We are grateful to R. Faessler, S. Rospert, A. Spang, H.P. Hauri, W. Schamel and M. Reth for discussions and advice. We thank R. Faessler, U. Hart and E. Mandel for comments on the manuscript. S.K. was supported by a Danish Graduate Student Fellowship. This work was supported by funds of the Max-Planck-Research-Society.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Biswas C, 2007, BIOCHEM J, V405, P233, DOI 10.1042/BJ20061867; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dal Porto JM, 2004, IMMUNITY, V21, P443, DOI 10.1016/j.immuni.2004.07.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Ghadially H, 2005, J IMMUNOL, V174, P5620, DOI 10.4049/jimmunol.174.9.5620; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KOLB JP, 1990, J IMMUNOL, V145, P429; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Muller G, 2001, BIOL CHEM, V382, P1387, DOI 10.1515/BC.2001.171; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimizu Y, 2009, P NATL ACAD SCI USA, V106, P17013, DOI 10.1073/pnas.0811591106; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; van Anken E, 2009, P NATL ACAD SCI USA, V106, P17019, DOI 10.1073/pnas.0903036106; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; Yang Y, 2005, MOL CELLS, V20, P173	50	63	67	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					723	735		10.1016/j.immuni.2010.11.013	http://dx.doi.org/10.1016/j.immuni.2010.11.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093319	Green Accepted, Bronze			2022-12-18	WOS:000286082600011
J	Wu, Z; Jia, X; de la Cruz, L; Su, XC; Marzolf, B; Troisch, P; Zak, D; Hamilton, A; Whittle, B; Yu, D; Sheahan, D; Bertram, E; Aderem, A; Otting, G; Goodnow, CC; Hoyne, GF				Wu, Zuopeng; Jia, Xinying; de la Cruz, Laura; Su, Xun-Cheng; Marzolf, Bruz; Troisch, Pamela; Zak, Daniel; Hamilton, Adam; Whittle, Belinda; Yu, Di; Sheahan, Daniel; Bertram, Edward; Aderem, Alan; Otting, Gottfried; Goodnow, Christopher C.; Hoyne, Gerard F.			Memory T Cell RNA Rearrangement Programmed by Heterogeneous Nuclear Ribonucleoprotein hnRNPLL	IMMUNITY			English	Article							PRE-MESSENGER-RNA; MOLECULAR-CLONING; CD45; DIFFERENTIATION; ACTIVATION; GENERATION; EXPRESSION; RESPONSES; IDENTIFICATION; SPECIFICATION	Differentiation of memory cells involves DNA-sequence changes in B lymphocytes but is less clearly defined in T cells. RNA rearrangement is identified here as a key event in memory T cell differentiation by analysis of a mouse mutation that altered the proportions of naive and memory T cells and crippled the process of Ptprc exon silencing needed to generate CD45RO in memory T cells. A single substitution in a memory-induced RNA-binding protein, hnRNPLL, destabilized an RNA-recognition domain that bound with micromolar affinity to RNA containing the Ptprc exon-silencing sequence. Hnrpll mutation selectively diminished T cell accumulation in peripheral lymphoid tissues but not proliferation. Exon-array analysis of Hnrpll mutant naive and memory T cells revealed an extensive program of alternative mRNA splicing in memory T cells, coordinated by hnRNPLL. A remarkable overlap with alternative splicing in neural tissues may reflect a co-opted strategy for diversifying memory T cells.	[Jia, Xinying; de la Cruz, Laura; Su, Xun-Cheng; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia; [Marzolf, Bruz; Troisch, Pamela; Zak, Daniel; Aderem, Alan] Inst Syst Biol, Seattle, WA 98103 USA	Australian National University; Institute for Systems Biology (ISB)		chris.goodnow@anu.edu.au	Jia, Xinying/B-8949-2016; Goodnow, Christopher C/V-8108-2018; Hoyne, Gerard/M-5406-2013; Otting, Gottfried/H-8413-2014; Yu, Di/C-2163-2009; Su, Xun-Cheng/A-3182-2014	Jia, Xinying/0000-0003-0133-8321; Goodnow, Christopher C/0000-0001-5296-6155; Hoyne, Gerard/0000-0002-7370-9139; Otting, Gottfried/0000-0002-0563-0146; Yu, Di/0000-0003-1721-8922; , Xun-Cheng/0000-0003-3051-0047; Wu, Zuopeng/0000-0002-2005-3279	Australian Research Council Federation Fellowships; Australian Partnership for Advanced Computing supercomputer; National Health and Medical Research Council Program [316956]; National Institutes of Health (NIH) [RO1-AI52127, BAA NIAID-DAIT-07-35]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025032, U54AI054523, R01AI032972, R01AI052127] Funding Source: NIH RePORTER	Australian Research Council Federation Fellowships(Australian Research Council); Australian Partnership for Advanced Computing supercomputer; National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the Australian Research Council Federation Fellowships (C.C.G. and G.O.) by an Australian Partnership for Advanced Computing supercomputer grant, by National Health and Medical Research Council Program grant 316956 (C.C.G.), and by National Institutes of Health (NIH) grant RO1-AI52127 (C.C.G.) and NIH contract BAA NIAID-DAIT-07-35 (A.A., E.B., and C.C.G.).	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Beverley PCL, 2004, SEMIN IMMUNOL, V16, P315, DOI 10.1016/j.smim.2004.08.012; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Charych EI, 2006, J NEUROCHEM, V97, P884, DOI 10.1111/j.1471-4159.2006.03795.x; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kondo M, 1998, INT J CANCER, V75, P559, DOI 10.1002/(SICI)1097-0215(19980209)75:4<559::AID-IJC11>3.0.CO;2-4; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Neuberger MS, 2000, PHILOS T ROY SOC B, V355, P357, DOI 10.1098/rstb.2000.0573; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Robertson JM, 2006, IMMUNOL REV, V211, P49, DOI 10.1111/j.0105-2896.2006.00383.x; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; ROTHSTEIN DM, 1992, J BIOL CHEM, V267, P7139; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sakurai H, 1998, BIOCHEM BIOPH RES CO, V243, P545, DOI 10.1006/bbrc.1998.8124; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Tsyba L, 2004, GENOMICS, V84, P106, DOI 10.1016/j.ygeno.2004.02.005; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu PSC, 2006, J BIOMOL NMR, V34, P13, DOI 10.1007/s10858-005-5021-9; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	51	63	65	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 19	2008	29	6					863	875		10.1016/j.immuni.2008.11.004	http://dx.doi.org/10.1016/j.immuni.2008.11.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100700	Green Accepted, Bronze			2022-12-18	WOS:000262012400007
J	Scheinecker, C; Redlich, K; Smolen, JS				Scheinecker, Clemens; Redlich, Kurt; Smolen, Josef S.			Cytokines as therapeutic targets: Advances and limitations	IMMUNITY			English	Editorial Material							ACTIVE RHEUMATOID-ARTHRITIS; ANTITUMOR-NECROSIS-FACTOR; DOUBLE-BLIND; T-CELLS; PLACEBO; METHOTREXATE; INHIBITOR; DISEASE; SAFETY; TOCILIZUMAB	Biological therapies targeting cytokines, T cells, or B cells have improved outcomes of inflammatory diseases. However, many issues remain open: What is the best target? How well can response be predicted? How can cure be achieved?.	[Scheinecker, Clemens; Redlich, Kurt; Smolen, Josef S.] Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria	Medical University of Vienna	Smolen, JS (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	josef.smolen@meduniwien.at						Bluml S, 2007, ANN RHEUM DIS, V66, P120; Breedveld FC, 2007, ANN RHEUM DIS, V66, P441; BRENNAN FM, 1989, LANCET, V2, P244; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Charles P, 1999, J IMMUNOL, V163, P1521; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Holtmann MH, 2004, CURR MOL MED, V4, P439, DOI 10.2174/1566524043360636; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P1592, DOI 10.1053/gast.2002.33426; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; SMOLEN JS, 2005, ARTHRITIS RLHEU, V2, P1030; van der Heijde D, 2007, ANN RHEUM DIS, V66, P89; Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	25	63	66	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					440	444		10.1016/j.immuni.2008.03.005	http://dx.doi.org/10.1016/j.immuni.2008.03.005			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400186	Bronze			2022-12-18	WOS:000254939400002
J	Newbrough, SA; Mocsai, A; Clemens, RA; Wu, JN; Silverman, MA; Singer, AL; Lowell, CA; Koretzky, GA				Newbrough, SA; Mocsai, A; Clemens, RA; Wu, JN; Silverman, MA; Singer, AL; Lowell, CA; Koretzky, GA			SLP-76 regulates Fc gamma receptor and integrin signaling in neutrophils	IMMUNITY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACTIVATED PROTEIN-KINASE; ADHERENT HUMAN NEUTROPHILS; CELL ANTIGEN RECEPTOR; SHC ADAPTER PROTEIN; T-CELL; IMMUNE-COMPLEXES; TYROSINE KINASE; MAST-CELLS; DIFFERENTIAL REQUIREMENT	While the contribution of intracellular adaptor proteins to lymphocyte activation has been well studied, the function of these molecules in innate immune effector cells such as neutrophils has not been extensively addressed. Here we demonstrate a critical role for the adaptor molecule SH2 domain-containing leukoctye-specific phosphoprotein of 76 kDa (SLP-76) in FcgammaR and integrin signaling. Stimulation of these receptors induces tyrosine phosphorylation and cytoplasmic relocalization of SLP-76 in freshly isolated murine neutrophils. Neutrophils lacking SLP-76 demonstrate decreased FcgammaR-induced calcium flux and reactive oxygen intermediate (ROI) production in response to immune complex stimulation. More dramatically, SLP76(-/-) neutrophils fail to produce ROI, spread, or activate critical downstream regulators in response to integrin ligation. These results provide genetic evidence for a critical role of SLP-76 in the regulation of neutrophil function.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Med Scientist Training Program, Philadelphia, PA 19104 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of California System; University of California San Francisco; University of Pennsylvania	Koretzky, GA (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Mocsai, Attila/B-2792-2008; Koretzky, Gary/AAU-5381-2021	Mocsai, Attila/0000-0002-0512-1157				Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Bonilla FA, 2000, P NATL ACAD SCI USA, V97, P1725, DOI 10.1073/pnas.040543597; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Clements JL, 1998, J IMMUNOL, V161, P3880; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dalpiaz A., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P33, DOI 10.2174/1568008033340333; DAVIES EV, 1994, IMMUNOLOGY, V82, P57; de Koning JP, 1998, BLOOD, V91, P1924, DOI 10.1182/blood.V91.6.1924.1924_1924_1933; del Pozo MA, 2003, J IMMUNOL, V170, P41, DOI 10.4049/jimmunol.170.1.41; DELLABIANCA V, 1993, BIOCHEM BIOPH RES CO, V196, P1233, DOI 10.1006/bbrc.1993.2384; Detmers PA, 1998, J IMMUNOL, V161, P1921; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Fang N, 1996, J IMMUNOL, V157, P3769; Fernandez R, 1998, J IMMUNOL, V160, P5154; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; GORDAN MS, 2003, NAT IMMUNOL, V4, P110; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; Judd BA, 2002, J EXP MED, V195, P705, DOI 10.1084/jem.20011583; Kettner A, 2003, MOL CELL BIOL, V23, P2395, DOI 10.1128/MCB.23.7.2395-2406.2003; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; LIU P, 1995, SHOCK, V3, P56, DOI 10.1097/00024382-199501000-00010; Lofgren R, 1999, BBA-MOL CELL RES, V1452, P46, DOI 10.1016/S0167-4889(99)00112-3; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; NICHOLS GL, 1994, BLOOD, V84, P2912; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; ODA T, 1994, J BIOL CHEM, V269, P22925; Panaro MA, 1999, IMMUNOPHARM IMMUNOT, V21, P397, DOI 10.3109/08923979909007117; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perskvist N, 2000, J IMMUNOL, V164, P959, DOI 10.4049/jimmunol.164.2.959; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; RYAN TC, 1990, J IMMUNOL METHODS, V130, P223, DOI 10.1016/0022-1759(90)90052-W; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Walzog B, 1999, AM J PHYSIOL-GASTR L, V276, pG1125, DOI 10.1152/ajpgi.1999.276.5.G1125; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Watson F, 1998, BIOCHEM BIOPH RES CO, V247, P819, DOI 10.1006/bbrc.1998.8524; Williams MA, 1999, J LEUKOCYTE BIOL, V65, P725, DOI 10.1002/jlb.65.6.725; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wonerow P, 2002, BIOCHEM J, V364, P755, DOI 10.1042/BJ20020128; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yablonski D, 2001, ADV IMMUNOL, V79, P93, DOI 10.1016/S0065-2776(01)79003-7; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yokozeki T, 2003, J IMMUNOL, V171, P1328, DOI 10.4049/jimmunol.171.3.1328; Zheng LM, 1996, P NATL ACAD SCI USA, V93, P8431, DOI 10.1073/pnas.93.16.8431; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	71	63	64	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					759	769						11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY					2022-12-18	WOS:000186672200015
J	Qin, XB; Krumrei, N; Grubissich, L; Dobarro, M; Aktas, H; Perez, G; Halperin, JA				Qin, XB; Krumrei, N; Grubissich, L; Dobarro, M; Aktas, H; Perez, G; Halperin, JA			Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility	IMMUNITY			English	Article							DECAY-ACCELERATING FACTOR; MEMBRANE ATTACK COMPLEX; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MOLECULAR-BASIS; INAB PHENOTYPE; CD59; RELEASE; C5B-9; CELLS; GENE	Basal complement activity presents a potential danger for "self" cells that are tightly protected by complement regulators including CD59. Mice express two Cd59 genes (mCd59a and mCd59b); mCd59b has approximately a 6-fold higher specific activity than mCd59a. Consistently, mCd59b knockout mice present a strong phenotype characterized by hemolytic anemia with increased reticulocytes, anisopoikilocytosis, echinocytosis, schistocytosis, free hemoglobin in plasma, hemoglobinuria with hemosiderinuria and platelet activation. Remarkably, mCd59b(-/-) males express a progressive loss of fertility associated with immobile dysmorphic and fewer sperm cells after 5 months of age. This work indicates that mCd59b is a key complement regulator in mice and that CD59 is critical in protecting self cells; it also provides a novel model to study complement regulation in human diseases.	Brigham & Womens Hosp, Dept Med, Div Hematol & Oncol, Boston, MA 02115 USA; Harvard Med Sch, Lab Translat Res, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Halperin, JA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol & Oncol, 75 Francis St, Boston, MA 02115 USA.	jose_halperin@hms.harvard.edu			NIDDK NIH HHS [DK60979, DK52855, DK062994] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052855, R01DK060979, R01DK062994] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450; Acosta JA, 1996, MOL MED, V2, P755, DOI 10.1007/BF03401659; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; BLAKNEY GB, 1975, CLIN BIOCHEM, V8, P96, DOI 10.1016/S0009-9120(75)91005-X; Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; DAVITZ MA, 1986, J EXP MED, V163, P1150, DOI 10.1084/jem.163.5.1150; Fisicaro N, 2000, TRANSPLANTATION, V70, P963, DOI 10.1097/00007890-200009270-00014; Forlow SB, 2000, BLOOD, V95, P1317, DOI 10.1182/blood.V95.4.1317.004k30_1317_1323; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; FUKUOKA Y, 1982, TOHOKU J EXP MED, V137, P79, DOI 10.1620/tjem.137.79; GRALNICK HR, 1995, BRIT J HAEMATOL, V91, P697, DOI 10.1111/j.1365-2141.1995.tb05371.x; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; HALPERIN JA, 1993, BLOOD, V81, P200; Ham TH, 1937, NEW ENGL J MED, V217, P915, DOI 10.1056/NEJM193712022172307; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Hugel B, 1999, BLOOD, V93, P3451, DOI 10.1182/blood.V93.10.3451.410k27_3451_3456; Kilgore KS, 1997, AM J PATHOL, V150, P2019; KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151; LIN RC, 1988, TRANSFUSION, V28, P427, DOI 10.1046/j.1537-2995.1988.28588337329.x; MATSUO S, 1994, KIDNEY INT, V46, P191, DOI 10.1038/ki.1994.259; Mayer M M, 1984, Complement, V1, P2; MEDOF ME, 1987, P NATL ACAD SCI USA, V84, P2007, DOI 10.1073/pnas.84.7.2007; Miwa T, 2002, BLOOD, V99, P3707, DOI 10.1182/blood.V99.10.3707; Mizuno M, 1997, ARTHRITIS RHEUM, V40, P527, DOI 10.1002/art.1780400319; MORGAN BP, 1995, IMMUNOL TODAY, V16, P257, DOI 10.1016/0167-5699(95)80175-8; NICHOLSONWELLER A, 1985, BLOOD, V65, P1237; NICHOLSONWELLER A, 1993, IMMUNOL RES, V12, P244, DOI 10.1007/BF02918256; Parker CJ, 1996, STEM CELLS, V14, P396, DOI 10.1002/stem.140396; Qian YM, 2000, J IMMUNOL, V165, P2528, DOI 10.4049/jimmunol.165.5.2528; Qin XB, 2001, MAMM GENOME, V12, P582, DOI 10.1007/s00335-001-2060-8; REID ME, 1991, BLOOD, V78, P3291; Roitt I., 2001, IMMUNOLOGY, V6th; ROONEY IA, 1992, IMMUNOLOGY, V75, P499; ROONEY IA, 1993, J EXP MED, V177, P1409, DOI 10.1084/jem.177.5.1409; SEIFERT PS, 1988, ATHEROSCLEROSIS, V73, P91, DOI 10.1016/0021-9150(88)90030-5; Shankland SJ, 1999, KIDNEY INT, V56, P538, DOI 10.1046/j.1523-1755.1999.00560.x; SHEN Y, 1995, BRAIN RES, V671, P282, DOI 10.1016/0006-8993(94)01264-I; Stenberg PE, 1998, BLOOD, V91, P1599, DOI 10.1182/blood.V91.5.1599.1599_1599_1608; Suny XJ, 1999, P NATL ACAD SCI USA, V96, P628, DOI 10.1073/pnas.96.2.628; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; TELEN MJ, 1989, BLOOD, V74, P437; TORBOHM I, 1990, KIDNEY INT, V37, P1098, DOI 10.1038/ki.1990.91; Torzewski J, 1996, ARTERIOSCL THROM VAS, V16, P673, DOI 10.1161/01.ATV.16.5.673; UEDA E, 1992, INT IMMUNOL, V4, P1263, DOI 10.1093/intimm/4.11.1263; VANDIJK H, 1980, J IMMUNOL METHODS, V39, P257; Vyas P, 1999, BLOOD, V93, P2867; WIEDMER T, 1993, BLOOD, V82, P1192, DOI 10.1182/blood.V82.4.1192.bloodjournal8241192; Wirth-Dzieciolowska E, 2000, BIOGERONTOLOGY, V1, P171, DOI 10.1023/A:1010087729037; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707; Yang LB, 2000, J NEUROSCI, V20, P7505	53	63	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2003	18	2					217	227		10.1016/S1074-7613(03)00022-0	http://dx.doi.org/10.1016/S1074-7613(03)00022-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594949	Bronze			2022-12-18	WOS:000181138100006
J	Kreuwel, HTC; Aung, S; Silao, C; Sherman, LA				Kreuwel, HTC; Aung, S; Silao, C; Sherman, LA			Memory CD8(+) T cells undergo peripheral tolerance	IMMUNITY			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CROSS-PRESENTATION; DENDRITIC CELLS; SELF-ANTIGENS; AVIDITY MATURATION; TRANSGENIC MICE; VIRUS-INFECTION; DELETION; NAIVE; PEPTIDE	Memory T cells differ from naive T cells in that they respond more rapidly and in greater numbers. In addition, memory T cells are generally believed to be less susceptible to tolerance induction than naive T cells. In this study, we show that this is not the case. Using two different methods of tolerance induction, peptide-induced tolerance and crosstolerance, we present evidence that memory CD8(+) T cells are as susceptible to tolerance as naive cells. These results have a direct impact on manipulating T cell responses to self-antigens in order to improve immunotherapy of cancer and autoimmune diseases.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sherman, LA (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lsherman@scripps.edu		Sherman, Linda/0000-0001-6422-7069	NCI NIH HHS [CA57855] Funding Source: Medline; NIDDK NIH HHS [DK50824] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050824] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bercovici N, 2000, J IMMUNOL, V165, P202, DOI 10.4049/jimmunol.165.1.202; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; BUDD RC, 1987, J IMMUNOL, V138, P3120; Cerwenka A, 1998, J IMMUNOL, V161, P97; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Chung Y, 1999, J IMMUNOL, V163, P3692; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; de Visser KE, 2000, EUR J IMMUNOL, V30, P1458, DOI 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Hernandez J, 2000, J IMMUNOL, V164, P596, DOI 10.4049/jimmunol.164.2.596; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kedl RM, 1998, J IMMUNOL, V161, P674; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Koniaras C, 1997, INT IMMUNOL, V9, P1601, DOI 10.1093/intimm/9.10.1601; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; Marzo AL, 1999, J IMMUNOL, V162, P5838; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mirshahidi S, 2001, J EXP MED, V194, P719, DOI 10.1084/jem.194.6.719; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Morgan DJ, 1999, J IMMUNOL, V163, P723; Morgan DJ, 1996, J IMMUNOL, V157, P978; Nugent CT, 2000, J IMMUNOL, V164, P191, DOI 10.4049/jimmunol.164.1.191; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Quinn A, 2001, J IMMUNOL, V167, P1748, DOI 10.4049/jimmunol.167.3.1748; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; WALUNAS TL, 1995, J IMMUNOL, V155, P1873; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	52	63	66	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2002	17	1					73	81		10.1016/S1074-7613(02)00337-0	http://dx.doi.org/10.1016/S1074-7613(02)00337-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150893	Bronze			2022-12-18	WOS:000177187500008
J	Leitenberg, D; Boutin, Y; Lu, DD; Bottomly, K				Leitenberg, D; Boutin, Y; Lu, DD; Bottomly, K			Biochemical association of CD45 with the T cell receptor complex: Regulation by CD45 isoform and during T cell activation	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PHOSPHOTYROSINE PHOSPHATASE; KINASE-ACTIVITY; MONOCLONAL-ANTIBODY; FUNCTIONAL COMPLEX; MEMBRANE DOMAINS; EXPRESSION; ANTIGEN; MURINE; LCK	CD45 is the predominant transmembrane tyrosine phosphatase in lymphocytes and is required for the efficient induction of T cell receptor signaling and activation. However, the regulation of CD45 activity and substrate specificity are poorly understood. In the present study, we demonstrate a basal biochemical association of CD45 with the T cell receptor complex that is regulated in part by CD45 isoform expression. Further, maintenance of CD45/TCR association is differentially regulated following TCR ligation with peptide: a partial agonist peptide induces CD45/TCR dissociation while an agonist peptide promotes sustained association in a CD4-dependent manner. These data suggest that T cell receptor signaling pathways may be modulated by altering access of CD45 to TCR-associated substrates involved in T cell activation.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Yale University; Yale University	Bottomly, K (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA.			Leitenberg, David/0000-0002-0622-9522				AKBAR AN, 1988, J IMMUNOL, V140, P2171; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; Boutin Y, 1997, J IMMUNOL, V159, P5802; BURNS CM, 1994, J BIOL CHEM, V269, P13594; COLLINS TL, 1993, P NATL ACAD SCI USA, V90, P11885, DOI 10.1073/pnas.90.24.11885; Doro U, 1996, MOL CELL BIOL, V16, P4996; Duplay P, 1996, J BIOL CHEM, V271, P17896, DOI 10.1074/jbc.271.30.17896; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; GUTTINGER M, 1992, INT IMMUNOL, V4, P1325, DOI 10.1093/intimm/4.11.1325; HATHCOCK KS, 1992, J IMMUNOL, V148, P19; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KORETZKY GA, 1993, J BIOL CHEM, V268, P8958; LEE WT, 1990, J IMMUNOL, V144, P3288; LEFRANCOIS L, 1987, J IMMUNOL, V139, P3718; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; Leitenberg D, 1998, J IMMUNOL, V161, P1194; LUQMAN M, 1991, EUR J IMMUNOL, V21, P17, DOI 10.1002/eji.1830210104; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; Matsuda A, 1998, J EXP MED, V187, P1863, DOI 10.1084/jem.187.11.1863; MCCALL MN, 1992, IMMUNOLOGY, V76, P310; MCFARLAND EDC, 1995, J BIOL CHEM, V270, P28103; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MCKENNEY DW, 1995, J BIOL CHEM, V270, P24949, DOI 10.1074/jbc.270.42.24949; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MUSTELIN T, 1995, EUR J IMMUNOL, V25, P942, DOI 10.1002/eji.1830250413; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; ROGERS PR, 1992, J IMMUNOL, V148, P4054; ROSS SE, 1994, BIOCHEM BIOPH RES CO, V198, P88, DOI 10.1006/bbrc.1994.1013; SCHRAVEN B, 1991, EUR J IMMUNOL, V21, P2469, DOI 10.1002/eji.1830211025; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Sperling AI, 1998, J IMMUNOL, V161, P6459; Tao X, 1997, J IMMUNOL, V158, P4237; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N	41	63	66	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					701	711		10.1016/S1074-7613(00)80069-2	http://dx.doi.org/10.1016/S1074-7613(00)80069-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403645	Bronze			2022-12-18	WOS:000081209600008
J	Andersen, PS; Lavoie, PM; Sekaly, RP; Churchill, H; Kranz, DM; Schlievert, PM; Karjalainen, K; Mariuzza, RA				Andersen, PS; Lavoie, PM; Sekaly, RP; Churchill, H; Kranz, DM; Schlievert, PM; Karjalainen, K; Mariuzza, RA			Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes	IMMUNITY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; TOXIC SHOCK SYNDROME; BETA-CHAIN; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ANTIGEN RECEPTOR; BINDING-SITES; BACTERIAL SUPERANTIGENS; PROTEIN HLA-DR1; PEPTIDE	Superantigens (SAGs) activate T cells by simultaneously binding the VB domain of the TCR and MHC class II molecules on antigen-presenting cells. The preferential expression of certain Va regions among SAG-reactive T cells has suggested that the TCR alpha chain may modulate the level of activation through an interaction with MHC. We demonstrate that the TCR alpha chain is required for maximum stabilization of the TCR-SAG-MHC complex and that the alpha chain increases the half-life of the complex to match those of TCR-peptide/MHC complexes. The site on the TCR alpha chain responsible for these effects is CDR2. Thus, the overall stability of the TCR-SAG-MHC complex is determined by the combination of three distinct interactions: TCR-SAG, SAG-MHC, and MHC-TCR.	Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Inst Rech Clin Montreal, Immunol Lab, Montreal, PQ H2W 1R7, Canada; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Basel Inst Immunol, CH-4005 Basel, Switzerland	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities	Mariuzza, RA (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	mariuzza@indigo2.carb.nist.gov	Karjalainen, Klaus/A-2206-2011	Lavoie, Pascal/0000-0002-2205-0362; Schlievert, Patrick/0000-0001-8314-9369	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL036611, R01HL036611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036900, R37AI036900] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36611] Funding Source: Medline; NIAID NIH HHS [AI36900, AI42937] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Arden Bernhard, 1995, Immunogenetics, V42, P455; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; Blackman MA, 1996, IMMUNOL RES, V15, P98, DOI 10.1007/BF02918500; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BOHACH GA, 1997, SUPERANTIGENS MOL BI, P167; BORRERO H, 1995, J IMMUNOL, V154, P4247; Clark Stephen P., 1995, Immunogenetics, V42, P531; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DALY K, 1995, J IMMUNOL, V155, P27; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; DECKHUT AM, 1994, J EXP MED, V180, P1931, DOI 10.1084/jem.180.5.1931; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Donson D, 1997, J IMMUNOL, V158, P5229; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GASCOIGNE NRJ, 1991, P NATL ACAD SCI USA, V88, P613, DOI 10.1073/pnas.88.2.613; HOFF SJ, 1994, PROG PEDIATR CARDIOL, V3, P62, DOI 10.1016/1058-9813(94)90026-4; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; HOVDE CJ, 1990, MOL GEN GENET, V220, P329; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; KIRKBERG J, 1994, J EXP MED, V180, P25; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; KUBO RT, 1989, J IMMUNOL, V142, P2736; LABRECQUE N, 1994, J EXP MED, V180, P1921, DOI 10.1084/jem.180.5.1921; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Margulies DH, 1996, CURR OPIN IMMUNOL, V8, P262, DOI 10.1016/S0952-7915(96)80066-5; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; NATARAJAN SK, 1999, IN PRESS J IMMUNOL; Proft T, 1998, J EXP MED, V187, P819, DOI 10.1084/jem.187.6.819; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Tiedemann RE, 1995, P NATL ACAD SCI USA, V92, P12156, DOI 10.1073/pnas.92.26.12156; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WALLNY HJ, 1995, EUR J IMMUNOL, V25, P1262, DOI 10.1002/eji.1830250520; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; WEBB SR, 1994, CURR OPIN IMMUNOL, V6, P467, DOI 10.1016/0952-7915(94)90129-5; WOODLAND DL, 1993, IMMUNOL TODAY, V14, P208, DOI 10.1016/0167-5699(93)90164-G	62	63	66	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1999	10	4					473	483		10.1016/S1074-7613(00)80047-3	http://dx.doi.org/10.1016/S1074-7613(00)80047-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229190	Bronze			2022-12-18	WOS:000079989600008
J	Rohm, TV; Meier, DT; Olefsky, JM; Donath, MY				Rohm, Theresa, V; Meier, Daniel T.; Olefsky, Jerrold M.; Donath, Marc Y.			Inflammation in obesity, diabetes, and related disorders	IMMUNITY			English	Review							NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; INNATE LYMPHOID-CELLS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; ISLET-ASSOCIATED MACROPHAGES; SKELETAL-MUSCLE; NLRP3 INFLAMMASOME; FATTY-ACID	Obesity leads to chronic, systemic inflammation and can lead to insulin resistance (IR), b-cell dysfunction, and ultimately type 2 diabetes (T2D). This chronic inflammatory state contributes to long-term complications of diabetes, including non-alcoholic fatty liver disease (NAFLD), retinopathy, cardiovascular disease, and nephropathy, and may underlie the association of type 2 diabetes with other conditions such as Alzheimer's disease, polycystic ovarian syndrome, gout, and rheumatoid arthritis. Here, we review the current understanding of the mechanisms underlying inflammation in obesity, T2D, and related disorders. We discuss how chronic tissue inflammation results in IR, impaired insulin secretion, glucose intolerance, and T2D and review the effect of inflammation on diabetic complications and on the relationship between T2D and other pathologies. In this context, we discuss current therapeutic options for the treatment of metabolic disease, advances in the clinic and the potential of immune-modulatory approaches.	[Rohm, Theresa, V; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Meier, Daniel T.; Donath, Marc Y.] Univ Hosp Basel, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland; [Meier, Daniel T.; Donath, Marc Y.] Univ Basel, Univ Hosp Basel, Dept Biomed DBM, CH-4031 Basel, Switzerland	University of California System; University of California San Diego; University of Basel; University of Basel	Donath, MY (corresponding author), Univ Hosp Basel, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland.; Donath, MY (corresponding author), Univ Basel, Univ Hosp Basel, Dept Biomed DBM, CH-4031 Basel, Switzerland.	marc.donath@usb.ch		Donath, Marc/0000-0002-3143-5045; Zeman-Meier, Daniel/0000-0003-3348-4657; Olefsky, Jerrold/0000-0003-0392-1705	Swiss National Foun-dation (SNF) Early Postdoc Mobility grant [P2BSP3_200177]; U.S. National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK063491, DK101395]	Swiss National Foun-dation (SNF) Early Postdoc Mobility grant; U.S. National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ACKNOWLEGMENTS Funding supporting the work in this review was from the Swiss National Foun-dation (SNF) Early Postdoc Mobility grant (P2BSP3_200177 to T.R.) and by the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK063491 and DK101395 to J.M.O.) .	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2015, AM J CARDIOL, V115, P288, DOI 10.1016/j.amjcard.2014.11.003; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Abrams GA, 2004, HEPATOLOGY, V40, P475, DOI 10.1002/hep.20323; Adam TCM, 2004, PHYSIOL BEHAV, V83, P459, DOI 10.1016/j.physbeh.2004.08.035; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00338; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; [Anonymous], 2000, ENDOTEXT; Antohe JL, 2012, ARTHRIT CARE RES, V64, P215, DOI 10.1002/acr.20657; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; BATAILLARD A, 1992, AM J PHYSIOL, V263, pR840, DOI 10.1152/ajpregu.1992.263.4.R840; Bennett H, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.609618; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; Bigornia SJ, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.3; Bonhof GJ, 2019, ENDOCR REV, V40, P153, DOI 10.1210/er.2018-00107; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Boni-Schnetzler M, 2019, SEMIN IMMUNOPATHOL, V41, P501, DOI 10.1007/s00281-019-00745-4; Boni-Schnetzler M, 2018, CELL REP, V22, P1774, DOI 10.1016/j.celrep.2018.01.063; Boon MR, 2015, CLIN SCI, V128, P143, DOI 10.1042/CS20140179; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Butcher MJ, 2014, DIABETOLOGIA, V57, P491, DOI 10.1007/s00125-013-3116-5; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cao XC, 2014, INT J BIOCHEM CELL B, V53, P372, DOI 10.1016/j.biocel.2014.06.003; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Cavelti-Weder Claudia, 2011, Diabetes Care, V34, pe158, DOI 10.2337/dc11-1196; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042971, 10.1371/journal.pone.0037149]; Choi BSY, 2020, INT J OBESITY, V44, P1818, DOI 10.1038/s41366-020-0618-3; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Cook DG, 2000, ATHEROSCLEROSIS, V149, P139, DOI 10.1016/S0021-9150(99)00312-3; Cox N, 2021, SCIENCE, V373, DOI 10.1126/science.abe9383; Dagdeviren S, 2016, MOL CELL BIOL, V36, P2956, DOI 10.1128/MCB.00181-16; Dalmas E, 2017, IMMUNITY, V47, P928, DOI 10.1016/j.immuni.2017.10.015; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dang SY, 2019, INT J BIOL SCI, V15, P351, DOI 10.7150/ijbs.28522; Dani M, 2018, BRAIN, V141, P2740, DOI 10.1093/brain/awy188; DASH PK, 1995, BIOCHEM BIOPH RES CO, V208, P542, DOI 10.1006/bbrc.1995.1372; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; DELBO R, 1995, NEUROSCI LETT, V188, P70, DOI 10.1016/0304-3940(95)11384-9; Desai HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07923-0; Di Meo S, 2017, J ENDOCRINOL, V233, pR15, DOI 10.1530/JOE-16-0598; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dong N, 2013, MOL VIS, V19, P1734; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ebrahimi F, 2018, J CLIN ENDOCR METAB, V103, P3466, DOI 10.1210/jc.2018-00739; Ebstein W, 1876, BERLINER KLIN WOCHEN, V13, P337; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Escobar-Morreale HF, 2018, NAT REV ENDOCRINOL, V14, P270, DOI 10.1038/nrendo.2018.24; Everett BM, 2019, CIRCULATION, V139, P1289, DOI 10.1161/CIRCULATIONAHA.118.038010; Everett BM, 2018, J AM COLL CARDIOL, V71, P2392, DOI 10.1016/j.jacc.2018.03.002; Faghihimani E, 2013, ACTA DIABETOL, V50, P537, DOI 10.1007/s00592-011-0329-2; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Febbraio MA, 2021, CELL METAB, V33, P2316, DOI 10.1016/j.cmet.2021.09.004; Febbraio MA, 2019, CELL METAB, V29, P18, DOI 10.1016/j.cmet.2018.10.012; Febbraio MA, 2014, TRENDS ENDOCRIN MET, V25, P312, DOI 10.1016/j.tem.2014.02.004; FEINGOLD KR, 1989, J CLIN INVEST, V83, P1116, DOI 10.1172/JCI113991; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Findeisen M, 2019, NATURE, V574, P63, DOI 10.1038/s41586-019-1601-9; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Finucane OM, 2015, DIABETES, V64, P2116, DOI 10.2337/db14-1098; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Fuchs A, 2021, GASTROENTEROLOGY, V161, P968, DOI 10.1053/j.gastro.2021.05.008; Gardner SE, 2015, ARTERIOSCL THROM VAS, V35, P1963, DOI 10.1161/ATVBAHA.115.305896; Geng K, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.653940; GERRITY RG, 1981, AM J PATHOL, V103, P181; Ghazarian M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7616; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Goldfine AB, 2013, DIABETOLOGIA, V56, P714, DOI 10.1007/s00125-012-2819-3; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Goncalves MD, 2019, SCIENCE, V363, P1345, DOI 10.1126/science.aat8515; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Guay C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0097-7; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Hajmrle C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86055; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hayes A, 2002, NEUROSCI LETT, V331, P171, DOI 10.1016/S0304-3940(02)00888-1; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hepprich M, 2020, CELL METAB, V31, P699, DOI 10.1016/j.cmet.2020.02.013; Herder C, 2019, TRENDS ENDOCRIN MET, V30, P286, DOI 10.1016/j.tem.2019.02.007; Herder C, 2018, DIABETES, V67, P2434, DOI 10.2337/db18-0060; Herder C, 2017, DIABETES CARE, V40, P569, DOI 10.2337/dc16-2259; Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382; Herder C, 2009, DIABETES CARE, V32, P680, DOI 10.2337/dc08-2011; Herman MA, 2021, CELL METAB, V33, P2329, DOI 10.1016/j.cmet.2021.09.010; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hildreth AD, 2021, NAT IMMUNOL, V22, P639, DOI 10.1038/s41590-021-00922-4; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holm JG, 2019, PSORIASIS-TARGETS TH, V9, P1, DOI 10.2147/PTT.S159163; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hong CP, 2017, GASTROENTEROLOGY, V152, P1998, DOI 10.1053/j.gastro.2017.02.016; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huvers FC, 2007, ANN RHEUM DIS, V66, P558, DOI 10.1136/ard.2006.062323; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jang C, 2020, NAT METAB, V2, P586, DOI 10.1038/s42255-020-0222-9; Javeed N, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109613; Ji YD, 2021, NAT METAB, V3, P1163, DOI 10.1038/s42255-021-00444-1; Jialal I, 2014, J DIABETES COMPLICAT, V28, P755, DOI 10.1016/j.jdiacomp.2014.07.003; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jiang FJ, 2020, J HEPATOL, V72, P156, DOI 10.1016/j.jhep.2019.09.014; Johnson AMF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122195; JONES TH, 1993, CYTOKINE, V5, P531, DOI 10.1016/S1043-4666(05)80001-8; Jonsson T, 2013, NEW ENGL J MED, V369, P1568, DOI 10.1056/NEJMc1306509; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kamata K, 2014, AMYLOID, V21, P191, DOI 10.3109/13506129.2014.937857; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kane H, 2019, TRENDS IMMUNOL, V40, P857, DOI 10.1016/j.it.2019.07.006; Kataria Y, 2019, SEMIN IMMUNOPATHOL, V41, P413, DOI 10.1007/s00281-019-00743-6; Kawano Y, 2016, CELL METAB, V24, P295, DOI 10.1016/j.cmet.2016.07.009; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan IM, 2015, INT J OBESITY, V39, P1607, DOI 10.1038/ijo.2015.104; Khan S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22727-7; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Kita S, 2019, J CLIN INVEST, V129, P4041, DOI 10.1172/JCI129193; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Klover P, 2003, DIABETES, V52, pA290; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Kluck V, 2020, LANCET RHEUMATOL, V2, pE270, DOI [10.1016/S2665-9913(20)30065-5, 10.1016/s2665-9913(20)30065-5]; Kocahan S, 2017, CLIN PSYCHOPHARM NEU, V15, P1, DOI 10.9758/cpn.2017.15.1.1; Kol S, 1999, MOL CELL ENDOCRINOL, V149, P115, DOI 10.1016/S0303-7207(98)00260-3; Koska J, 2009, DIABETOLOGIA, V52, P385, DOI 10.1007/s00125-008-1239-x; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Kranendonk MEG, 2014, OBESITY, V22, P2216, DOI 10.1002/oby.20847; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lakhter AJ, 2018, DIABETOLOGIA, V61, P1124, DOI 10.1007/s00125-018-4559-5; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lawler HM, 2016, J CLIN ENDOCR METAB, V101, P1422, DOI 10.1210/jc.2015-4125; Lee AH, 2020, IMMUNITY, V53, P510, DOI 10.1016/j.immuni.2020.08.013; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lee YS, 2021, GENE DEV, V35, P307, DOI [10.1101/gad.346312, 10.1101/gad.346312.120]; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Lehrskov LL, 2018, MOL METAB, V12, P107, DOI 10.1016/j.molmet.2018.04.001; Leng FD, 2021, NAT REV NEUROL, V17, P157, DOI 10.1038/s41582-020-00435-y; Li CR, 2020, IMMUNOL REV, V295, P114, DOI 10.1111/imr.12850; Li PP, 2016, CELL, V167, P973, DOI 10.1016/j.cell.2016.10.025; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; LIBBY P, 1985, ARTERIOSCLEROSIS, V5, P186, DOI 10.1161/01.ATV.5.2.186; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Liu XY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00008; Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015; Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685; Luck H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11370-y; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097985; Ma J, 2014, INT J CLIN EXP PATHO, V7, P481; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Marra M, 2007, INT J IMMUNOPATH PH, V20, P731, DOI 10.1177/039463200702000408; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Martino L, 2015, DIABETOLOGIA, V58, P2554, DOI 10.1007/s00125-015-3734-1; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mayerl C, 2006, VIRCHOWS ARCH, V449, P96, DOI 10.1007/s00428-006-0176-7; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Meier DT, 2014, DIABETOLOGIA, V57, P1884, DOI 10.1007/s00125-014-3304-y; Mesquida M, 2014, CLIN EXP IMMUNOL, V176, P301, DOI 10.1111/cei.12295; Mesquida M, 2019, SEMIN IMMUNOPATHOL, V41, P427, DOI 10.1007/s00281-019-00750-7; Monteiro-Sepulveda M, 2015, CELL METAB, V22, P113, DOI 10.1016/j.cmet.2015.05.020; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2010-1221, 10.3233/JAD-2009-1221]; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagineni CN, 2012, J CELL PHYSIOL, V227, P116, DOI 10.1002/jcp.22708; NAITO M, 1989, J LEUKOCYTE BIOL, V46, P1; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nakano Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003364; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen-Lefebvre Anh Thu, 2015, J Enzymol Metab, V1; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nordmann TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06731-w; Nott A, 2019, SCIENCE, V366, P1134, DOI 10.1126/science.aay0793; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Okla M, 2018, INFLAMMATION, V41, P626, DOI 10.1007/s10753-017-0718-y; Ong JP, 2005, OBES SURG, V15, P310, DOI 10.1381/0960892053576820; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Paik S, 2021, CELL MOL IMMUNOL, V18, P1141, DOI 10.1038/s41423-021-00670-3; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Paquot N, 2000, J CLIN ENDOCR METAB, V85, P1316, DOI 10.1210/jc.85.3.1316; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014; Popovic M, 2019, SEMIN IMMUNOPATHOL, V41, P447, DOI 10.1007/s00281-019-00737-4; Povero D, 2015, CELL MOL GASTROENTER, V1, P646, DOI 10.1016/j.jcmgh.2015.07.007; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ramos-Zavala MG, 2011, DIABETES CARE, V34, P1591, DOI 10.2337/dc11-0357; Rao PM, 2013, NAT REV ENDOCRINOL, V9, P479, DOI 10.1038/nrendo.2013.122; Rehman K, 2017, CRIT REV EUKAR GENE, V27, P229, DOI 10.1615/CritRevEukaryotGeneExpr.2017019712; Richardson SJ, 2009, DIABETOLOGIA, V52, P1686, DOI 10.1007/s00125-009-1410-z; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2021, LANCET, V397, P2060, DOI 10.1016/S0140-6736(21)00520-1; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Rissanen A, 2012, DIABETES OBES METAB, V14, P1088, DOI 10.1111/j.1463-1326.2012.01637.x; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Rohm T, 2017, DIABETES, V66, pA546; Rohm TV, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.668654; Rohm TV, 2018, DIABETES, V67, DOI 10.2337/db18-283-OR; Romano M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01625; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Rubsam A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040942; Ruscitti P, 2015, CLIN EXP IMMUNOL, V182, P35, DOI 10.1111/cei.12667; Ruscitti P, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002901; Ruscitti P, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014587; Ruscitti P, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007896; Ruscitti P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181203; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178; Sarafidis PA, 2016, NEW ENGL J MED, V374, P1092, DOI 10.1056/NEJMc1600827; Sasaki T, 2019, CELL REP, V28, P202, DOI 10.1016/j.celrep.2019.06.016; Sauter NS, 2015, DIABETES, V64, P1273, DOI 10.2337/db14-1282; Schlesinger S, 2019, DIABETES CARE, V42, P240, DOI 10.2337/dc18-1842; Schodel J, 2019, NAT REV NEPHROL, V15, P641, DOI 10.1038/s41581-019-0182-z; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Seo JB, 2019, NAT METAB, V1, P86, DOI 10.1038/s42255-018-0003-x; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Shahzad K, 2016, J AM SOC NEPHROL, V27, P2270, DOI 10.1681/ASN.2015060676; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Simo-Servat O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/872978; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Smith GI, 2019, J CLIN INVEST, V129, P3978, DOI 10.1172/JCI129186; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stagg AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02883; Stahel M, 2016, RETINA-J RET VIT DIS, V36, P385, DOI 10.1097/IAE.0000000000000701; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Takikawa A, 2016, DIABETES, V65, P3649, DOI 10.2337/db16-0012; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tang SCW, 2020, NAT REV NEPHROL, V16, P206, DOI 10.1038/s41581-019-0234-4; Taylor SR, 2021, NATURE, V597, P263, DOI [10.1038/s41586-021-03827-2, https://doi.org/10.1038/d41586-021-02195-1]; Tesch GH, 2017, CLIN SCI, V131, P2183, DOI 10.1042/CS20160636; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Nguyen TT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093165; Timper K, 2013, DIABETES CARE, V36, pE90, DOI 10.2337/dc13-0199; Todoric J, 2020, NAT METAB, V2, P1034, DOI 10.1038/s42255-020-0261-2; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Toubal A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17307-0; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Traub S, 2017, CELL REP, V18, P3192, DOI 10.1016/j.celrep.2017.03.005; Tschop M, 2006, NAT MED, V12, P1359, DOI 10.1038/nm1206-1359; van Asseldonk EJP, 2015, CLIN IMMUNOL, V160, P155, DOI 10.1016/j.clim.2015.06.003; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; van Poppel PCM, 2014, DIABETES OBES METAB, V16, P1269, DOI 10.1111/dom.12357; Van Tassell BW, 2018, CLIN CARDIOL, V41, P1004, DOI 10.1002/clc.22988; Van Tassell BW, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004373; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Varelias A, 2018, J CLIN INVEST, V128, P1919, DOI 10.1172/JCI91646; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Vitale A, 2015, CLIN RHEUMATOL, V34, P981, DOI 10.1007/s10067-014-2601-7; Wang HD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11270-1; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wanschel A, 2013, ARTERIOSCL THROM VAS, V33, P886, DOI 10.1161/ATVBAHA.112.300941; Wedell-Neergaard AS, 2019, CELL METAB, V29, P844, DOI 10.1016/j.cmet.2018.12.007; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wohlford GF, 2021, J CARDIOVASC PHARM, V77, P49, DOI 10.1097/FJC.0000000000000931; Wojtaszewski JFP, 2000, DIABETES, V49, P325, DOI 10.2337/diabetes.49.3.325; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yates SL, 2000, J NEUROCHEM, V74, P1017, DOI 10.1046/j.1471-4159.2000.0741017.x; Yazdani-Biuki B, 2004, EUR J CLIN INVEST, V34, P641, DOI 10.1111/j.1365-2362.2004.01390.x; Yazdani-Biuki B, 2006, DIABETES CARE, V29, P1712, DOI 10.2337/dc06-0636; Ying W, 2021, CELL METAB, V33, P781, DOI 10.1016/j.cmet.2020.12.019; Ying W, 2019, CELL METAB, V29, P457, DOI 10.1016/j.cmet.2018.12.003; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zamarron BF, 2017, DIABETES, V66, P392, DOI 10.2337/db16-0500; Zatterale F, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01607; Zhao S, 2020, NATURE, V579, P586, DOI 10.1038/s41586-020-2101-7; Zheng C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.54; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	410	62	62	116	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					31	55		10.1016/j.immuni.2021.12.013	http://dx.doi.org/10.1016/j.immuni.2021.12.013			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021057				2022-12-18	WOS:000743523600007
J	Golebski, K; Layhadi, JA; Sahiner, U; Steveling-Klein, EH; Lenormand, MM; Li, RCY; Bal, SM; Heesters, BA; Vila-Nadal, G; Hunewald, O; Montamat, G; He, FQ; Ollert, M; Fedina, O; Lao-Araya, M; Vijverberg, SJH; Maitland-van der Zee, AH; van Drunen, CM; Fokkens, WJ; Durham, SR; Spits, H; Shamji, MH				Golebski, Korneliusz; Layhadi, Janice A.; Sahiner, Umit; Steveling-Klein, Esther H.; Lenormand, Madison M.; Li, Rachael C. Y.; Bal, Suzanne M.; Heesters, Balthasar A.; Vila-Nadal, Gemma; Hunewald, Oliver; Montamat, Guillem; He, Feng Q.; Ollert, Markus; Fedina, Oleksandra; Lao-Araya, Mongkol; Vijverberg, Susanne J. H.; Maitland-van der Zee, Anke-Hilse; van Drunen, Cornelis M.; Fokkens, Wytske J.; Durham, Stephen R.; Spits, Hergen; Shamji, Mohamed H.			Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response	IMMUNITY			English	Article							GRASS-POLLEN IMMUNOTHERAPY; REGULATORY B-CELLS; SUBLINGUAL IMMUNOTHERAPY; T-CELLS; BARRIER DYSFUNCTION; EFFICACY; IL-10; TOLERANCE; INCREASES; MUCOSAL	The role of innate immune cells in allergen immunotherapy that confers immune tolerance to the sensitizing allergen is unclear. Here, we report a role of interleukin-10-producing type 2 innate lymphoid cells (IL-10(+) ILC2s) in modulating grass-pollen allergy. We demonstrate that KLRG1(+) but not KLRG1(-) ILC2 produced IL-10 upon activation with IL-33 and retinoic acid. These cells attenuated Th responses and maintained epithelial cell integrity. IL-10(+) KLRG1(+) ILC2s were lower in patients with grass-pollen allergy when compared to healthy subjects. In a prospective, double-blind, placebo-controlled trial, we demonstrated that the competence of ILC2 to produce IL-10 was restored in patients who received grass-pollen sublingual immunotherapy. The underpinning mechanisms were associated with the modification of retinol metabolic pathway, cytokine-cytokine receptor interaction, and JAK-STAT signaling pathways in the ILCs. Altogether, our findings underscore the contribution of IL-10(+) ILC2s in the disease-modifying effect by allergen immunotherapy.	[Golebski, Korneliusz; Bal, Suzanne M.; Heesters, Balthasar A.; Spits, Hergen] Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands; [Golebski, Korneliusz; Vijverberg, Susanne J. H.; Maitland-van der Zee, Anke-Hilse] Univ Amsterdam, Dept Resp Med, Amsterdam UMC, Amsterdam, Netherlands; [Layhadi, Janice A.; Sahiner, Umit; Steveling-Klein, Esther H.; Lenormand, Madison M.; Li, Rachael C. Y.; Vila-Nadal, Gemma; Fedina, Oleksandra; Lao-Araya, Mongkol; Durham, Stephen R.; Shamji, Mohamed H.] Imperial Coll London, Dept Natl Heart & Lung Inst, Allergy & Clin Immunol, Immunomodulat & Tolerance Grp, London, England; [Layhadi, Janice A.; Lenormand, Madison M.; Li, Rachael C. Y.; Durham, Stephen R.; Shamji, Mohamed H.] Imperial Coll London, Asthma UK Ctr Allerg Mech Asthma, NIHR Biomed Res Ctr, London, England; [Steveling-Klein, Esther H.] Univ Hosp Basel, Dept Dermatol, Allergy Unit, Basel, Switzerland; [Hunewald, Oliver; Montamat, Guillem; He, Feng Q.; Ollert, Markus] Luxembourg Inst Hlth LIH, Dept Infect & Immun, 29 Rue Henri Koch, L-4354 Esch Sur Alzette, Luxembourg; [Montamat, Guillem] Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark; [He, Feng Q.] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, D-45122 Essen, Germany; [Ollert, Markus] Univ Southern Denmark, Odense Res Ctr Anaphylaxis ORCA, Dept Dermatol, Odense, Denmark; [Ollert, Markus] Univ Southern Denmark, Odense Res Ctr Anaphylaxis ORCA, Allergy Ctr, Odense, Denmark; [van Drunen, Cornelis M.; Fokkens, Wytske J.] Univ Amsterdam, Dept Otorhinolaryngol, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Imperial College London; Imperial College London; University of London; King's College London; University of Basel; Luxembourg Institute of Health; University of Southern Denmark; University of Duisburg Essen; University of Southern Denmark; University of Southern Denmark; University of Amsterdam	Spits, H (corresponding author), Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands.; Shamji, MH (corresponding author), Imperial Coll London, Dept Natl Heart & Lung Inst, Allergy & Clin Immunol, Immunomodulat & Tolerance Grp, London, England.; Shamji, MH (corresponding author), Imperial Coll London, Asthma UK Ctr Allerg Mech Asthma, NIHR Biomed Res Ctr, London, England.	hergen.spits@amsterdamumc.nl; m.shamji@imperial.ac.uk	Heesters, Balthasar/ABA-7594-2021; HeFeng, Feng/HGC-3025-2022; Maitland-van der Zee, Anke/I-9572-2016	Heesters, Balthasar/0000-0002-2909-8481; HeFeng, Feng/0000-0003-2657-7361; Maitland-van der Zee, Anke/0000-0002-0414-3442; Lao-araya, Mongkol/0000-0002-6679-4152; Hunewald, Oliver/0000-0001-5402-5084; Shamji, Mohamed/0000-0003-3425-3463; Ollert, Markus W./0000-0002-8055-0103; Li, Rachael/0000-0001-6263-5149; Layhadi, Janice/0000-0002-5242-1806; van Drunen, Cornelis M/0000-0001-5503-066X	Imperial College Trust; NIHR Imperial Biomedical Research Centre; ERC [341038]; Luxembourg National Research Fund (FNR) [AFR-RIKEN/11228353/TregBAR, PRIDE/10907093/CRITICS, PRIDE/11012546/NEXTIMMUNE]	Imperial College Trust; NIHR Imperial Biomedical Research Centre; ERC(European Research Council (ERC)European Commission); Luxembourg National Research Fund (FNR)(Luxembourg National Research Fund)	We would like to acknowledge Jane Srivastava and Radhika Patel for help with cell sorting, Susanne Reinartz for help with experimental design, Danielle van Egmond, Esther de Groot, and Maryse Tempert for samples acquisition and experimental work, and colleagues from flow cytometry core facility Amsterdam UMC for help with flow cytometry. The Imperial BRC Genomics Facility provided resources and support that contributed to results reported within this paper. This study was supported by the Imperial College Trust and the NIHR Imperial Biomedical Research Centre. H.S. was supported by an advanced grant of the ERC, #341038. F.Q.H, O.H., M.O., and G.M. were supported by Luxembourg National Research Fund (FNR) grants AFR-RIKEN/11228353/TregBAR (F.Q.H. and M.O.), PRIDE/11012546/NEXTIMMUNE (G.M., F.Q.H., and M.O.), and PRIDE/10907093/CRITICS (F.Q.H.).	Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Asaka D, 2012, INT ARCH ALLERGY IMM, V158, P47, DOI 10.1159/000337764; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bando JK, 2020, J EXP MED, V217, DOI 10.1084/jem.20191520; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coomes SM, 2017, MUCOSAL IMMUNOL, V10, P150, DOI 10.1038/mi.2016.47; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Demoly P, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-015-0109-6; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; Didier A, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0057-8; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Doherty TA, 2014, J ALLERGY CLIN IMMUN, V133, P1203, DOI 10.1016/j.jaci.2013.12.1086; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; Golebski K, 2013, ALLERGY, V68, P152, DOI 10.1111/all.12080; Golebski K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09883-7; Golebski K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152808; Golebski K, 2015, MOL IMMUNOL, V65, P43, DOI 10.1016/j.molimm.2014.12.011; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Krohn IK, 2018, ALLERGY, V73, P837, DOI 10.1111/all.13340; Krohn IK, 2018, CURR OPIN PULM MED, V24, P11, DOI 10.1097/MCP.0000000000000435; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lao-Araya M, 2014, J ALLERGY CLIN IMMUN, V134, P1193, DOI 10.1016/j.jaci.2014.07.029; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lombardi V, 2016, J ALLERGY CLIN IMMUN, V138, P305, DOI 10.1016/j.jaci.2015.12.1325; Mielle J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00961; Mitthamsiri W, 2018, ALLERGY ASTHMA IMMUN, V10, P662, DOI 10.4168/aair.2018.10.6.662; Morita H, 2019, J ALLERGY CLIN IMMUN, V143, P2190, DOI 10.1016/j.jaci.2018.12.1018; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Ott H, 2009, ALLERGY, V64, P1394, DOI [10.1111/j.1398-9995.2008.01875.x, 10.1111/j.1398-9995.2009.02194.x]; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Renand A, 2018, J ALLERGY CLIN IMMUN, V141, P1750, DOI 10.1016/j.jaci.2017.09.041; Rolland JM, 2010, CURR OPIN ALLERGY CL, V10, P559, DOI 10.1097/ACI.0b013e32833ff2b2; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Schleimer RP, 2017, J ALLERGY CLIN IMMUN, V139, P1752, DOI 10.1016/j.jaci.2017.04.010; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Shamji MH, 2019, J ALLERGY CLIN IMMUN, V143, P1131, DOI 10.1016/j.jaci.2018.06.041; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Sharif H, 2019, J ALLERGY CLIN IMMUN, V144, P738, DOI 10.1016/j.jaci.2019.02.023; Stadhouders R, 2018, J ALLERGY CLIN IMMUN, V142, P1793, DOI 10.1016/j.jaci.2017.12.1006; Steveling EH, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0087-2; Sugita K, 2018, J ALLERGY CLIN IMMUN, V141, P300, DOI 10.1016/j.jaci.2017.02.038; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taylor A, 2007, J ALLERGY CLIN IMMUN, V120, P76, DOI 10.1016/j.jaci.2007.04.004; Tyurin YA, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/3054217; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P654, DOI 10.1016/j.jaci.2016.07.006; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Vroling AB, 2008, AM J RESP CELL MOL, V38, P293, DOI 10.1165/rcmb.2007-0278OC; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; WALKER SM, 1995, ALLERGY, V50, P405, DOI 10.1111/j.1398-9995.1995.tb01170.x; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996	64	62	62	7	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					291	+		10.1016/j.immuni.2020.12.013	http://dx.doi.org/10.1016/j.immuni.2020.12.013		FEB 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33450188	Green Submitted, Bronze			2022-12-18	WOS:000627407700013
J	Dubrovskaya, V; Tran, K; Ozorowski, G; Guenaga, J; Wilson, R; Bale, S; Cottrell, CA; Turner, HL; Seabright, G; O'Dell, S; Torres, JL; Yang, LF; Feng, Y; Leaman, DP; Bernat, NV; Liban, T; Louder, M; McKee, K; Bailer, RT; Movsesyan, A; Doria-Rose, NA; Pancera, M; Hedestam, GBK; Zwick, MB; Crispin, M; Mascola, JR; Ward, AB; Wyatt, RT				Dubrovskaya, Viktoriya; Tran, Karen; Ozorowski, Gabriel; Guenaga, Javier; Wilson, Richard; Bale, Shridhar; Cottrell, Christopher A.; Turner, Hannah L.; Seabright, Gemma; O'Dell, Sijy; Torres, Jonathan L.; Yang, Lifei; Feng, Yu; Leaman, Daniel P.; Bernat, Nestor Vazquez; Liban, Tyler; Louder, Mark; McKee, Krisha; Bailer, Robert T.; Movsesyan, Arlette; Doria-Rose, Nicole A.; Pancera, Marie; Hedestam, Gunilla B. Karlsson; Zwick, Michael B.; Crispin, Max; Mascola, John R.; Ward, Andrew B.; Wyatt, Richard T.			Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability	IMMUNITY			English	Article							CRYO-EM STRUCTURE; ENV TRIMERS; MATURATION PATHWAY; SILENT FACE; BINDING; MODEL; GLYCOSYLATION; RECOGNITION; DISPLAY; SHIELD	The elicitation of broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) trimer remains a major vaccine challenge. Most cross-conserved protein determinants are occluded by self-N-glycan shielding, limiting B cell recognition of the underlying polypeptide surface. The exceptions to the contiguous glycan shield include the conserved receptor CD4 binding site (CD4bs) and glycoprotein (gp)41 elements proximal to the furin cleavage site. Accordingly, we performed heterologous trimer-liposome prime:boosting in rabbits to driveBcells specific for cross-conserved sites. To preferentially expose the CD4bs to B cells, we eliminated proximal N-glycans while maintaining the native-like state of the cleavage-independent NFL trimers, followed by gradual N-glycan restoration coupled with heterologous boosting. This approach successfully elicited CD4bs-directed, cross-neutralizing Abs, including one targeting a unique glycanprotein epitope and a bNAb (87% breadth) directed to the gp120:gp41 interface, both resolved by highresolution cryoelectron microscopy. This study provides proof-of-principle immunogenicity toward eliciting bNAbs by vaccination.	[Dubrovskaya, Viktoriya; Wilson, Richard; Bale, Shridhar; Yang, Lifei; Leaman, Daniel P.; Movsesyan, Arlette; Zwick, Michael B.; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Tran, Karen; Guenaga, Javier; Feng, Yu; Ward, Andrew B.; Wyatt, Richard T.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Cottrell, Christopher A.; Turner, Hannah L.; Torres, Jonathan L.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Seabright, Gemma; Crispin, Max] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [O'Dell, Sijy; Louder, Mark; McKee, Krisha; Bailer, Robert T.; Doria-Rose, Nicole A.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bernat, Nestor Vazquez; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Liban, Tyler; Pancera, Marie] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Ward, Andrew B.; Wyatt, Richard T.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of Southampton; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; Fred Hutchinson Cancer Center; Scripps Research Institute	Wyatt, RT (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Wyatt, RT (corresponding author), Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA.; Wyatt, RT (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.	wyatt@scripps.edu	Ward, Andrew/ABD-7728-2021; Ozorowski, Gabriel/HCH-0634-2022; Cottrell, Christopher A/P-3514-2015; Crispin, Max/AAG-4098-2020; Mascola, John/AAI-7193-2021; Hedestam, Gunilla Karlsson/AAN-9616-2021	Ward, Andrew/0000-0001-7153-3769; Cottrell, Christopher A/0000-0002-3364-3083; Crispin, Max/0000-0002-1072-2694; Torres, Jonathan/0000-0003-0137-8497	James B. Pendleton Charitable Trust; NIH [P01 AI104722, R01 AI136621]; Scripps CHAVI-ID grant [UM1 AI100663]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery grants [OPP1115782, OPP1084519]; Vaccine Research Center, NIAID, NIH; IAVI; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI131873, R01AI136621, UM1AI100663, P01AI104722] Funding Source: NIH RePORTER	James B. Pendleton Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scripps CHAVI-ID grant; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery grants; Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IAVI; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Elise Landais for providing molecular clones of select pseudovirus constructs for initial neutralization screening and Theresa Fassel at the TSRI Microscopy Core for assistance with imaging the trimer-conjugated liposomes. We thank the James B. Pendleton Charitable Trust for its generous support of Formulatrix robotic instruments. This work was supported by NIH grants P01 AI104722 and R01 AI136621; the Scripps CHAVI-ID grant UM1 AI100663; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery grants OPP1115782 and OPP1084519; the intramural research program of the Vaccine Research Center, NIAID, NIH; and IAVI and its generous donors, including USAID. The full list of IAVI donors is available at https://www.iavi.org/. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. The contents of the study do not necessarily reflect the views of USAID or the United States government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bale S, 2017, J VIROL, V91, DOI 10.1128/JVI.00443-17; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/nmeth.3541, 10.1038/NMETH.3541]; Behrens AJ, 2018, J PROTEOME RES, V17, P987, DOI 10.1021/acs.jproteome.7b00639; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Bianchi M, 2018, IMMUNITY, V49, P288, DOI 10.1016/j.immuni.2018.07.009; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Cao LW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06121-4; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Crooks ET, 2017, VIROLOGY, V505, P193, DOI 10.1016/j.virol.2017.02.024; de la Pena AT, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0445-y; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; Dubrovskaya V, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006614; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escolano A, 2019, NATURE, V570, P468, DOI 10.1038/s41586-019-1250-z; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Guenaga J, 2017, IMMUNITY, V46, P792, DOI 10.1016/j.immuni.2017.04.014; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Hedestam GBK, 2017, IMMUNOL REV, V275, P183, DOI 10.1111/imr.12515; Ingale J, 2016, CELL REP, V15, P1986, DOI 10.1016/j.celrep.2016.04.078; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klasse PJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006913; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Kong R, 2019, CELL, V178, P567, DOI 10.1016/j.cell.2019.06.030; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lavinder JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101322; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Martinez-Murillo P, 2017, IMMUNITY, V46, P804, DOI 10.1016/j.immuni.2017.04.021; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pauthner MG, 2019, IMMUNITY, V50, P241, DOI 10.1016/j.immuni.2018.11.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ringe RP, 2019, J VIROL, V93, DOI 10.1128/JVI.01656-18; Rujas E, 2018, J VIROL, V92, DOI 10.1128/JVI.02249-17; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sarkar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04272-y; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schoofs T, 2019, IMMUNITY, V50, P1513, DOI 10.1016/j.immuni.2019.04.014; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Struwe WB, 2018, CELL REP, V24, P1958, DOI 10.1016/j.celrep.2018.07.080; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu K, 2018, NAT MED, V24, P857, DOI 10.1038/s41591-018-0042-6; Yang LF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01631; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhou TQ, 2018, IMMUNITY, V48, P500, DOI 10.1016/j.immuni.2018.02.013; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012	63	62	62	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					915	+		10.1016/j.immuni.2019.10.008	http://dx.doi.org/10.1016/j.immuni.2019.10.008			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31732167	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-18	WOS:000497811300014
J	Rivas, MN; Wakita, D; Franklin, MK; Carvalho, TT; Abolhesn, A; Gomez, AC; Fishbein, MC; Chen, S; Lehman, TJ; Sato, K; Shibuya, A; Fasano, A; Kiyono, H; Abe, M; Tatsumoto, N; Yamashita, M; Crother, TR; Shimada, K; Arditi, M				Rivas, Magali Noval; Wakita, Daiko; Franklin, Michael K.; Carvalho, Thacyana T.; Abolhesn, Amanda; Gomez, Angela C.; Fishbein, Michael C.; Chen, Shuang; Lehman, Thomas J.; Sato, Kazuki; Shibuya, Akira; Fasano, Alessio; Kiyono, Hiroshi; Abe, Masanori; Tatsumoto, Narihito; Yamashita, Michifumi; Crother, Timothy R.; Shimada, Kenichi; Arditi, Moshe			Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation	IMMUNITY			English	Article							MANNOSE-BINDING LECTIN; INTERLEUKIN-1 RECEPTOR ANTAGONIST; KAWASAKI-DISEASE; CORONARY ARTERITIS; MOUSE MODEL; CELIAC-DISEASE; SECRETORY IGA; KIDNEY AXIS; GENOME-WIDE; BARRIER	Recent experimental data and clinical, genetic, and transcriptome evidence from patients converge to suggest a key role of interleukin-1 beta (IL-1 beta) in the pathogenesis of Kawasaki disease (KD). However, the molecular mechanisms involved in the development of cardiovascular lesions during KD vasculitis are still unknown. Here, we investigated intestinal barrier function in KD vasculitis and observed evidence of intestinal permeability and elevated circulating secretory immunoglobulin A (sIgA) in KD patients, as well as elevated sIgA and IgA deposition in vascular tissues in a mouse model of KD vasculitis. Targeting intestinal permeability corrected gut permeability, prevented IgA deposition and ameliorated cardiovascular pathology in the mouse model. Using genetic and pharmacologic inhibition of IL-1 beta signaling, we demonstrate that IL-1 beta lies upstream of disrupted intestinal barrier function, subsequent IgA vasculitis development, and cardiac inflammation. Targeting mucosal barrier dysfunction and the IL-1 beta pathway may also be applicable to other IgA-related diseases, including IgA vasculitis and IgA nephropathy.	[Rivas, Magali Noval; Wakita, Daiko; Franklin, Michael K.; Carvalho, Thacyana T.; Abolhesn, Amanda; Gomez, Angela C.; Chen, Shuang; Abe, Masanori; Crother, Timothy R.; Shimada, Kenichi; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Dept Biomed Sci Infect & Immunol Dis Res Ctr IIDR, Los Angeles, CA 90048 USA; [Rivas, Magali Noval; Chen, Shuang; Crother, Timothy R.; Shimada, Kenichi; Arditi, Moshe] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Rivas, Magali Noval; Chen, Shuang; Crother, Timothy R.; Shimada, Kenichi; Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Fishbein, Michael C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lehman, Thomas J.] Cornell Univ, Hosp Special Surg, New York, NY 10021 USA; [Lehman, Thomas J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Sato, Kazuki; Shibuya, Akira] Univ Tsukuba, Life Sci Ctr Survival Dynam, Dept Immunol, Fac Med,TARA, Tsukuba, Ibaraki, Japan; [Fasano, Alessio] Massachusetts Gen Hosp, Ctr Celiac Res, Mucosal Immunol & Biol Res Ctr, Boston, MA 02114 USA; [Fasano, Alessio] Massachusetts Gen Hosp, Div Pediat Gastroenterol & Nutr, Boston, MA 02114 USA; [Kiyono, Hiroshi] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Tokyo, Japan; [Kiyono, Hiroshi] Univ Calif San Diego, Dept Med, CU UCSD Ctr Mucosal Immunol Allergy & Vaccines, Div Gastroenterol, San Diego, CA 92103 USA; [Tatsumoto, Narihito; Yamashita, Michifumi] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Tatsumoto, Narihito; Yamashita, Michifumi] Cedars Sinai Med Ctr, Dept Lab Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; Cornell University; University of Tsukuba; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Tokyo; University of California System; University of California San Diego; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Rivas, MN; Arditi, M (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Dept Biomed Sci Infect & Immunol Dis Res Ctr IIDR, Los Angeles, CA 90048 USA.; Rivas, MN; Arditi, M (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA.; Rivas, MN; Arditi, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	magali.novalrivas@csmc.edu; moshe.arditi@cshs.org	Fasano, Alessio/K-5486-2016; YAMASHITA, Michifumi/AFT-3479-2022; de Carvalho, Thacyana Teixeira/AAJ-7187-2020; Crother, Timothy R/E-2879-2010; Kiyono, Hiroshi/AAC-6735-2022; Noval Rivas, Magali/R-4987-2016	Fasano, Alessio/0000-0002-2134-0261; de Carvalho, Thacyana Teixeira/0000-0002-8580-6200; Crother, Timothy R/0000-0001-8465-6127; Franklin, Michael/0000-0003-4993-0164; Sato, Kazuki/0000-0001-8516-292X; Gomez, Angela/0000-0001-7019-9607; Noval Rivas, Magali/0000-0001-5570-8928; Abe, Masanori/0000-0002-5641-4996	NIH [R01 AI072726, R01 HL139766]; AHA [17SDG33671141]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa de Doutorado Sanduiche no Exterior (CAPES-PDSE) [88881.133324/2016-01]; Cedars-Sinai CTSI Clinical Scholar Grant; NCATS UCLA CTSI KL2 [KL2TR001882]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001882] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072726] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa de Doutorado Sanduiche no Exterior (CAPES-PDSE); Cedars-Sinai CTSI Clinical Scholar Grant; NCATS UCLA CTSI KL2; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Ganghua Huang, Wenxuan Zhang, Malcolm Lane, and Debbie Moreira for their technical support and the lab members for their helpful discussions. We thank the EUCOMM consortium for providing the ESCs and the Cedars-Sinai Genomic core for generating the II1r1<SUP>fl/fl</SUP> mice. We thank Dr. Fukata for giving us the Igha<SUP>-/-</SUP>mice, Dr. Rowley, Dr. Shulman, and Dr. Fukazawa for kindly sharing human serum samples. We would like to thank Dr. Waters at CSMC for the histological analysis of the murine intestinal sections and Daniel N. Leal, BS, CEMT for assistance in electron microscopy study. Research was supported by NIH R01 AI072726 to M. Arditi and NIH R01 HL139766 and AHA 17SDG33671141 to M.N.R.T.T.C. was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa de Doutorado Sanduiche no Exterior (CAPES-PDSE) (88881.133324/2016-01). M. Y. is supported by NCATS UCLA CTSI KL2 (KL2TR001882) and Cedars-Sinai CTSI Clinical Scholar Grant.	Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Asachi S, 1989, J JPN COLL ANGIOL, V29, P453; ATKINS RC, 1995, KIDNEY INT, V48, P576, DOI 10.1038/ki.1995.330; AUKRUST P, 1994, BLOOD, V84, P2136; Besbas N, 1997, SCAND J RHEUMATOL, V26, P456, DOI 10.3109/03009749709065719; Biezeveld MH, 2003, LANCET, V361, P1268, DOI 10.1016/S0140-6736(03)12985-6; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bloom JL, 2018, PEDIATR RHEUMATOL, V16, DOI 10.1186/s12969-018-0270-9; Boyer EM, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-21; BRUN JG, 1992, J RHEUMATOL, V19, P859; Burns JC, 2017, ARTHRITIS RHEUMATOL, V69, P268, DOI 10.1002/art.39975; Chun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24667; Coppo R, 2018, SEMIN NEPHROL, V38, P504, DOI 10.1016/j.semnephrol.2018.05.020; Coppo R, 2018, PEDIATR NEPHROL, V33, P53, DOI 10.1007/s00467-017-3652-1; DESOUZA VR, 1995, EUR J IMMUNOL, V25, P1267, DOI 10.1002/eji.1830250521; Eriguchi M, 2018, AM J PHYSIOL-RENAL, V314, pF531, DOI 10.1152/ajprenal.00523.2017; Fabi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202658; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Ferrier L, 2003, GASTROENTEROLOGY, V125, P795, DOI 10.1016/S0016-5085(03)01057-6; Floege J, 2016, NAT REV NEPHROL, V12, P147, DOI 10.1038/nrneph.2015.208; Fury W, 2010, HUM IMMUNOL, V71, P865, DOI 10.1016/j.humimm.2010.06.008; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gupta M, 2002, CARDIOLOGY, V97, P180, DOI 10.1159/000063118; IWATA M, 1987, INFECT IMMUN, V55, P547, DOI 10.1128/IAI.55.3.547-554.1987; Jordan SC, 2017, NEW ENGL J MED, V377, P442, DOI 10.1056/NEJMoa1612567; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kalla R, 2016, AM J GASTROENTEROL, V111, P1796, DOI 10.1038/ajg.2016.342; Kanarek N, 2014, P NATL ACAD SCI USA, V111, pE702, DOI 10.1073/pnas.1322691111; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; KOHSAKA T, 1994, J ALLERGY CLIN IMMUN, V93, P520, DOI 10.1016/0091-6749(94)90362-X; Lamm ME, 2008, AM J PATHOL, V172, P31, DOI 10.2353/ajpath.2008.070131; Lee Y, 2015, ARTERIOSCL THROM VAS, V35, P2605, DOI 10.1161/ATVBAHA.115.306475; Lee Y, 2012, CIRCULATION, V125, P1542, DOI 10.1161/CIRCULATIONAHA.111.072769; LEHMAN TJA, 1985, ARTHRITIS RHEUM, V28, P652, DOI 10.1002/art.1780280609; LEUNG DYM, 1989, LANCET, V2, P1298; Lutz HU, 2005, CLIN REV ALLERG IMMU, V29, P207, DOI 10.1385/CRIAI:29:3:207; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Moja P, 1998, CLIN IMMUNOL IMMUNOP, V86, P290, DOI 10.1006/clin.1997.4493; Myones BL, 1995, INT CONGR SER, V1093, P252; NAGATA S, 1993, PEDIATR RES, V33, P557, DOI 10.1203/00006450-199306000-00004; Nakamura A, 2014, CLIN IMMUNOL, V153, P64, DOI 10.1016/j.clim.2014.03.019; Nishimura S, 2003, J PEDIATR-US, V143, P357, DOI 10.1067/S0022-3476(03)00330-5; OHSHIO G, 1987, MICROBIOL IMMUNOL, V31, P891, DOI 10.1111/j.1348-0421.1987.tb03150.x; Oortwijn BD, 2006, KIDNEY INT, V69, P1131, DOI 10.1038/sj.ki.5000074; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Paterson BM, 2007, ALIMENT PHARM THER, V26, P757, DOI 10.1111/j.1365-2036.2007.03413.x; Quan CP, 1997, INFECT IMMUN, V65, P3997, DOI 10.1128/IAI.65.10.3997-4004.1997; Rivas MN, 2017, ARTHRITIS RHEUMATOL, V69, P410, DOI 10.1002/art.39939; Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; Rowley AH, 2018, INT J RHEUM DIS, V21, P20, DOI 10.1111/1756-185X.13213; Sato S, 2009, INT J RHEUM DIS, V12, P307, DOI 10.1111/j.1756-185X.2009.01428.x; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spadoni I, 2015, SCIENCE, V350, P830, DOI 10.1126/science.aad0135; Stagi S, 2006, RHEUMATOLOGY, V45, P847, DOI 10.1093/rheumatology/kel007; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Takeshita S, 2002, PEDIATR INT, V44, P5, DOI 10.1046/j.1442-200X.2002.01506.x; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wakita D, 2016, ARTERIOSCL THROM VAS, V36, P886, DOI 10.1161/ATVBAHA.115.307072; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Watanabe Toru, 2018, World J Clin Pediatr, V7, P83, DOI 10.5409/wjcp.v7.i3.83; Yoon HJ, 2003, J MED GENET, V40, P104, DOI 10.1136/jmg.40.2.104; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	67	62	62	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					508	+		10.1016/j.immuni.2019.05.021	http://dx.doi.org/10.1016/j.immuni.2019.05.021			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31471109	Green Accepted, Bronze			2022-12-18	WOS:000486184600013
J	Landais, E; Murrell, B; Briney, B; Murrell, S; Rantalainen, K; Berndsen, ZT; Ramos, A; Wickramasinghe, L; Smith, ML; Eren, K; de Val, N; Wu, MY; Cappelletti, A; Umotoy, J; Lie, Y; Wrin, T; Algate, P; Chan-Hui, PY; Karita, E; Ward, AB; Wilson, IA; Burton, DR; Smith, D; Pond, SLK; Poignard, P				Landais, Elise; Murrell, Ben; Briney, Bryan; Murrell, Sasha; Rantalainen, Kimmo; Berndsen, Zachary T.; Ramos, Alejandra; Wickramasinghe, Lalinda; Smith, Melissa Laird; Eren, Kemal; de Val, Natalia; Wu, Mengyu; Cappelletti, Audrey; Umotoy, Jeffrey; Lie, Yolanda; Wrin, Terri; Algate, Paul; Chan-Hui, Po-Ying; Karita, Etienne; Ward, Andrew B.; Wilson, Ian A.; Burton, Dennis R.; Smith, Davey; Pond, Sergei L. Kosakovsky; Poignard, Pascal		IAVI Protocol C Investigators; IAVI African HIV Res Network	HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage	IMMUNITY			English	Article							CRYSTAL-STRUCTURE; POTENT; ENV; GERMLINE; REVEAL; MODEL; IMMUNIZATION; PREVALENCE; INDUCTION; RESPONSES	Understanding how broadly neutralizing antibodies (bnAbs) to HIV envelope (Env) develop during natural infection can help guide the rational design of an HIV vaccine. Here, we described a bnAb lineage targeting the Env V2 apex and the Ab-Env co-evolution that led to development of neutralization breadth. The lineage Abs bore an anionic heavy chain complementarity-determining region 3 (CDRH3) of 25 amino acids, among the shortest known for this class of Abs, and achieved breadth with only 10% nucleotide somatic hypermutation and no insertions or deletions. The data suggested a role for Env glycoform heterogeneity in the activation of the lineage germline B cell. Finally, we showed that localized diversity at key V2 epitope residues drove bnAb maturation toward breadth, mirroring the Env evolution pattern described for another donor who developed V2-apex targeting bnAbs. Overall, these findings suggest potential strategies for vaccine approaches based on germline-targeting and serial immunogen design.	[Landais, Elise; Ramos, Alejandra; Wickramasinghe, Lalinda; de Val, Natalia; Cappelletti, Audrey; Umotoy, Jeffrey; Ward, Andrew B.; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Landais, Elise; Briney, Bryan; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Murrell, Sasha; Rantalainen, Kimmo; Berndsen, Zachary T.; de Val, Natalia; Wu, Mengyu; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Briney, Bryan; Murrell, Sasha; Rantalainen, Kimmo; Berndsen, Zachary T.; de Val, Natalia; Ward, Andrew B.; Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Murrell, Ben; Smith, Davey; Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Eren, Kemal] Univ Calif San Diego, Biomed Informat, San Diego, CA 92103 USA; [Eren, Kemal] Univ Calif San Diego, Bioinformat & Syst Biol, San Diego, CA 92103 USA; [Smith, Melissa Laird] Icahn Sch Med, New York, NY 10029 USA; [Smith, Melissa Laird] Icahn Inst Genom & Multiscale Biol Mt Sinai, New York, NY 10029 USA; [Lie, Yolanda; Wrin, Terri] Monogram Biosci Inc, Lab Corp America Holdings, San Francisco, CA 94080 USA; [Algate, Paul; Chan-Hui, Po-Ying] Theraclone Sci Inc, Seattle, WA 98104 USA; [Karita, Etienne] Project San Francisco, Rwanda Zambia HIV Res Grp, Kigali, Rwanda; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA; [Smith, Davey] Vet Affairs Healthcare Syst, San Diego, CA 92161 USA; [Landais, Elise; Wickramasinghe, Lalinda; Umotoy, Jeffrey; Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Poignard, Pascal] Univ Grenoble Alpes, Commissariat Energie Atom, CNRS, Inst Biol Struct, F-38044 Grenoble, France; [Poignard, Pascal] Ctr Hosp Univ Grenoble Alpes, F-38044 Grenoble, France; [de Val, Natalia] NCI, Ctr Mol Microscopy, NIH, Leidos Biomed Inc, Bethesda, MD 20892 USA; [Pond, Sergei L. Kosakovsky] Temple Univ, Philadelphia, PA 19122 USA; [Algate, Paul; Chan-Hui, Po-Ying] OncoResponse Inc, Seattle, WA 98104 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Landais, E; Poignard, P (corresponding author), Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.; Landais, E; Poignard, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Landais, E; Poignard, P (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.; Poignard, P (corresponding author), Univ Grenoble Alpes, Commissariat Energie Atom, CNRS, Inst Biol Struct, F-38044 Grenoble, France.; Poignard, P (corresponding author), Ctr Hosp Univ Grenoble Alpes, F-38044 Grenoble, France.	elandais@iavi.org; pascal.poignard@ibs.fr	poignard, pascal/N-6678-2013; Pond, Sergei LK/G-9830-2012; poignard, pascal/AAB-4613-2020; Smith, David/GQQ-8257-2022; Murrell, Ben/AAM-1188-2021; de Val, Natalia/AAF-4822-2019; Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Pond, Sergei LK/0000-0003-4817-4029; Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Smith, Davey/0000-0003-3603-1733; Rantalainen, Kimmo/0000-0002-3158-9183; Poignard, Pascal/0000-0002-0021-7192; Umotoy, Jeffrey/0000-0003-0687-5820; Murrell, Ben/0000-0002-0393-4445	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); American people through USAID; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant [UM1AI100663]; National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R00AI120851]; National Library of Medicine [T15LM007092]; NIH/NIGMS [U01GM110749]; DOE Office of Science [DE-AC02-06CH11357]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grant [OPP1084519, OPP1115782];  [U19AI090970]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI120851, U19AI090970, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110749] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; World Bank(The World Bank India); Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); American people through USAID(United States Agency for International Development (USAID)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant; National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grant; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan in partnership with The World Bank; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. This study is made possible by the generous support of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery and the American people through USAID. The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. This study was supported by Awards Number U19AI090970, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663, and in part by R00AI120851 from the National Institute of Allergy and Infectious Diseases (NIH/NIAID). K.E. was supported by T15LM007092 from the National Library of Medicine. Sequence analysis was performed on a cluster supported by U01GM110749 (NIH/NIGMS). This research also used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This work was also supported by the International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grants OPP1084519 and OPP1115782. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH, NIAID, NLM, or NIGMS. This is manuscript number 29605 from The Scripps Research Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Briney B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23901; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006148; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan ZC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07331; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sheng ZZ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004940; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith ML, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew018; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	71	62	63	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					990	+		10.1016/j.immuni.2017.11.002	http://dx.doi.org/10.1016/j.immuni.2017.11.002			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166592	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000416483700020
J	Nguyen, TA; Smith, BRC; Tate, MD; Belz, GT; Barrios, MH; Elgass, KD; Weisman, AS; Baker, PJ; Preston, SP; Whitehead, L; Garnham, A; Lundie, RJ; Smyth, GK; Pellegrini, M; O'Keeffe, M; Wicks, IP; Masters, SL; Hunter, CP; Pang, KC				Nguyen, Tan A.; Smith, Blake R. C.; Tate, Michelle D.; Belz, Gabrielle T.; Barrios, Marilou H.; Elgass, Kirstin D.; Weisman, Alexandra S.; Baker, Paul J.; Preston, Simon P.; Whitehead, Lachlan; Garnham, Alexandra; Lundie, Rachel J.; Smyth, Gordon K.; Pellegrini, Marc; O'Keeffe, Meredith; Wicks, Ian P.; Masters, Seth L.; Hunter, Craig P.; Pang, Ken C.			SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL SIGNALING PROTEIN; INDUCIBLE GENE-I; DENDRITIC CELLS; RIG-I; IDENTIFICATION; PLATFORM; MOUSE; TLR3; INTERFERENCE	Double-stranded RNA (dsRNA) is a common by-product of viral infections and acts as a potent trigger of antiviral immunity. In the nematode C. elegans, sid-1 encodes a dsRNA transporter that is highly conserved throughout animal evolution, but the physiological role of SID-1 and its orthologs remains unclear. Here, we show that the mammalian SID-1 ortholog, SIDT2, is required to transport internalized extracellular dsRNA from endocytic compartments into the cytoplasm for immune activation. Sidt2-deficient mice exposed to extracellular dsRNA, encephalomyocarditis virus (EMCV), and herpes simplex virus 1 (HSV-1) show impaired production of antiviral cytokines and-in the case of EMCV and HSV-1-reduced survival. Thus, SIDT2 has retained the dsRNA transport activity of its C. elegans ortholog, and this transport is important for antiviral immunity.	[Nguyen, Tan A.; Smith, Blake R. C.; Belz, Gabrielle T.; Barrios, Marilou H.; Baker, Paul J.; Preston, Simon P.; Whitehead, Lachlan; Garnham, Alexandra; Smyth, Gordon K.; Pellegrini, Marc; Wicks, Ian P.; Masters, Seth L.; Pang, Ken C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Nguyen, Tan A.; Belz, Gabrielle T.; Barrios, Marilou H.; Baker, Paul J.; Preston, Simon P.; Whitehead, Lachlan; Garnham, Alexandra; Pellegrini, Marc; Wicks, Ian P.; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Tate, Michelle D.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Tate, Michelle D.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Elgass, Kirstin D.] Monash Univ, Monash Micro Imaging, Clayton, Vic, Australia; [Weisman, Alexandra S.; Hunter, Craig P.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Lundie, Rachel J.; O'Keeffe, Meredith] Burnet Inst, Melbourne, Vic, Australia; [Lundie, Rachel J.; O'Keeffe, Meredith] Monash Univ, Dept Biochem Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Smyth, Gordon K.] Univ Melbourne, Sch Math & Stat, Parkville, Vic, Australia; [Pang, Ken C.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Pang, Ken C.] Univ Melbourne, Dept Pediat, Parkville, Vic, Australia; [Pang, Ken C.] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Hudson Institute of Medical Research; Monash University; Monash University; Harvard University; Burnet Institute; Monash University; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Pang, KC (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Pang, KC (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Pang, KC (corresponding author), Univ Melbourne, Dept Pediat, Parkville, Vic, Australia.; Pang, KC (corresponding author), Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia.	pang.k@wehi.edu.au	Masters, Seth L/N-2886-2013; Belz, Gabrielle T/C-9350-2013; O'Keeffe, Meredith/U-9347-2017	Masters, Seth L/0000-0003-4763-576X; Belz, Gabrielle T/0000-0002-9660-9587; O'Keeffe, Meredith/0000-0002-0779-4654; Preston, Simon/0000-0001-8969-8297; Nguyen, Tan/0000-0003-2696-9170; Tate, Michelle/0000-0002-0587-5514; Pellegrini, Marc/0000-0003-3627-3126; Baker, Paul J./0000-0002-3642-2366; Pang, Ken/0000-0002-6881-775X	Australian NHMRC [520574, 1064591, 1123319, 1006592, 1045549, 1065626]; Royal Australasian College of Physicians; Menzies Foundation; CASS Foundation [SM13-4846, SM14-5566]; Reid Family Trust; Sylvia & Charles Viertel Senior Medical Research Fellowship; Victorian State Government; Independent Research Institutes Infrastructure Support Scheme (NHMRC); GlaxoSmithKline; US NIH [1R01GM089795, U19CA179513]; NATIONAL CANCER INSTITUTE [U19CA179513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089795] Funding Source: NIH RePORTER	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians(General Electric); Menzies Foundation; CASS Foundation; Reid Family Trust; Sylvia & Charles Viertel Senior Medical Research Fellowship; Victorian State Government; Independent Research Institutes Infrastructure Support Scheme (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); GlaxoSmithKline(GlaxoSmithKline); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank C. Jones and A. Moseman for gifts of HSV-1 and VSV, respectively, L. Attardi, T. Okamoto, D. Huang, A. Irving, P. Gleeson, A. Janic, and J. Bernardini for gifts of plasmids, as well as J. Botros, F. Song, N. Nakatsuka, L. Mackiewicz, R. Crawley, L. Scott, C. Hay, and L. Inglis for technical assistance. We also wish to thank W. Chen, M. Zhao, N. Hacohen, N. Chevrier, M. Fleming, A. Lew, D. Miller, K. Rodgers, D. Segal, and all members of the Hunter, Masters, and Wicks laboratories for helpful discussions and comments. K.C.P., T.A.N., B.R.C.S., and M.H.B. are supported by the Australian NHMRC (ID 520574 and 1064591), Royal Australasian College of Physicians, Menzies Foundation, CASS Foundation (SM13-4846 and SM14-5566), and Reid Family Trust. M.D.T. was supported by the Australian NHMRC (Fellowship #1123319). M.P. was supported by Australian NHMRC (Grants 1006592, 1045549, and 1065626), The Sylvia & Charles Viertel Senior Medical Research Fellowship, the Victorian State Government Operational Infrastructure Support, and the Independent Research Institutes Infrastructure Support Scheme (NHMRC). S.L.M. receives funding from GlaxoSmithKline. A.S.W. and C.P.H. are supported by the US NIH (1R01GM089795 and U19CA179513).	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Buschow SI, 2012, J PROTEOMICS, V75, P1547, DOI 10.1016/j.jprot.2011.11.024; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; Davidson S, 2015, J INTERF CYTOK RES, V35, P252, DOI 10.1089/jir.2014.0227; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Khoo D, 2002, J VIROL, V76, P11971, DOI 10.1128/JVI.76.23.11971-11981.2002; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Leslie M, 2013, SCIENCE, V341, P947, DOI 10.1126/science.341.6149.947; Leung DW, 2012, TRENDS MICROBIOL, V20, P139, DOI 10.1016/j.tim.2011.12.005; Li WQ, 2015, J BIOL CHEM, V290, P18904, DOI 10.1074/jbc.M115.658864; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811; McEwan DL, 2012, MOL CELL, V47, P746, DOI 10.1016/j.molcel.2012.07.014; Melchjorsen J, 2009, VIRUSES-BASEL, V1, P737, DOI 10.3390/v1030737; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miyazaki D, 2011, INVEST OPHTH VIS SCI, V52, P4282, DOI 10.1167/iovs.10-6911; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Nellimarla S, 2014, J INTERF CYTOK RES, V34, P419, DOI 10.1089/jir.2014.0002; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Perrot I, 2010, J IMMUNOL, V185, P2080, DOI 10.4049/jimmunol.1000532; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Ren RW, 2011, DEV COMP IMMUNOL, V35, P692, DOI 10.1016/j.dci.2011.02.003; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Russell TA, 2015, J VIROL METHODS, V213, P18, DOI 10.1016/j.jviromet.2014.11.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Sjolinder M, 2012, INFECT IMMUN, V80, P4027, DOI 10.1128/IAI.00456-12; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sugiyama T, 2008, INT IMMUNOL, V20, P1, DOI 10.1093/intimm/dxm112; Sun Hong, 2007, V383, P311, DOI 10.1007/978-1-59745-335-6_20; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Watanabe A, 2011, J BIOL CHEM, V286, P10702, DOI 10.1074/jbc.M110.185793; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xing JJ, 2012, J VIROL, V86, P3528, DOI 10.1128/JVI.06713-11; Yen JH, 2009, BLOOD, V114, P1344, DOI 10.1182/blood-2008-12-196592	72	62	62	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					498	+		10.1016/j.immuni.2017.08.007	http://dx.doi.org/10.1016/j.immuni.2017.08.007			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28916264	Bronze, Green Accepted			2022-12-18	WOS:000411128200014
J	Iborra, S; Martinez-Lopez, M; Cueto, FJ; Conde-Garrosa, R; Del Fresno, C; Izquierdo, HM; Abram, CL; Mori, D; Campos-Martin, Y; Reguera, RM; Kemp, B; Yamasaki, S; Robinson, MJ; Soto, M; Lowell, CA; Sancho, D				Iborra, Salvador; Martinez-Lopez, Maria; Cueto, Francisco J.; Conde-Garrosa, Ruth; Del Fresno, Carlos; Izquierdo, Helena M.; Abram, Clare L.; Mori, Daiki; Campos-Martin, Yolanda; Maria Reguera, Rosa; Kemp, Benjamin; Yamasaki, Sho; Robinson, Matthew J.; Soto, Manuel; Lowell, Clifford A.; Sancho, David			Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection	IMMUNITY			English	Article							C-TYPE LECTIN; FCR-GAMMA; MAJOR INFECTION; ACTIVATING RECEPTOR; PATHOGENIC FUNGUS; IDENTIFICATION; MCL; INFLAMMATION; RECOGNITION; EXPRESSION	C-type lectin receptors sense a diversity of endogenous and exogenous ligands that may trigger differential responses. Here, we have found that human and mouse Mincle bind to a ligand released by Leishmania, a eukaryote parasite that evades an effective immune response. Mincle-deficient mice had milder dermal pathology and a tenth of the parasite burden compared to wild-type mice after Leishmania major intradermal ear infection. Mincle deficiency enhanced adaptive immunity against the parasite, correlating with increased activation, migration, and priming by Mincle-deficient dendritic cells ( DCs). Leishmania triggered a Mincle-dependent inhibitory axis characterized by SHP1 coupling to the FcRg chain. Selective loss of SHP1 in CD11c(+) cells phenocopies enhanced adaptive immunity to Leishmania. In conclusion, Leishmania shifts Mincle to an inhibitory ITAM ( ITAMi) configuration that impairs DC activation. Thus, ITAMi can be exploited for immune evasion by a pathogen and may represent a paradigm for ITAM-coupled receptors sensing self and non-self.	[Iborra, Salvador; Martinez-Lopez, Maria; Cueto, Francisco J.; Conde-Garrosa, Ruth; Del Fresno, Carlos; Izquierdo, Helena M.; Sancho, David] Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Immunobiol Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Iborra, Salvador; Soto, Manuel] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa CSIC UAM, Nicolas Cabrera 1, E-28049 Madrid, Spain; [Cueto, Francisco J.] Univ Autonoma Madrid, Fac Med, Dept Biochem, Calle Arzobispo Morcillo 4, E-28029 Madrid, Spain; [Abram, Clare L.; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Mori, Daiki; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan; [Campos-Martin, Yolanda] Hosp Virgen de la Salud, Serv Anat Patol, Ave Barber 30, Toledo 45004, Spain; [Maria Reguera, Rosa] Univ Leon, Dept Ciencias Biomed, Fac Vet, Campus Vegazana S-N, E-24071 Leon, Spain; [Kemp, Benjamin; Robinson, Matthew J.] Medimmune, Granta Pk, Cambridge CB21 6GH, England	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of California System; University of California San Francisco; Kyushu University; Complejo Hospitalario de Toledo; Universidad de Leon; AstraZeneca; Medimmune	Iborra, S; Sancho, D (corresponding author), Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Immunobiol Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain.; Iborra, S (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa CSIC UAM, Nicolas Cabrera 1, E-28049 Madrid, Spain.	siborra@cnic.es; dsancho@cnic.es	Del Fresno Sánchez, CArlos/AAY-1525-2021; Iborra, Salvador/J-2863-2015; Reguera, Rosa M/K-6027-2017; Sancho, David/D-3433-2009; Cueto, Francisco J/AGN-4489-2022; Campos-MArtín, Yolanda/R-2630-2017; Álvarez, Manuel Soto/Q-5234-2018; Del Fresno, Carlos/ABD-7766-2020; Martinez Lopez, Maria/HGA-6834-2022; Izquierdo, Helena/Q-2841-2018	Iborra, Salvador/0000-0002-1607-1749; Reguera, Rosa M/0000-0001-9148-2997; Sancho, David/0000-0003-2890-3984; Cueto, Francisco J/0000-0002-7457-9583; Campos-MArtín, Yolanda/0000-0001-9686-7036; Álvarez, Manuel Soto/0000-0001-6825-841X; Del Fresno, Carlos/0000-0003-1771-7254; MORI, Daiki/0000-0002-3596-0840; Martinez Lopez, Maria/0000-0002-1995-0642; Izquierdo, Helena/0000-0002-1301-3287	CNIC; Spanish Ministry of Economy and Competitiveness (MINECO) [SAF-2013-42920R]; European Commission [635122-PROCROP H2020]; European Research Council [ERC-2010-StG 260414]; MINECO; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award) [SEV-2015-0505];  [SAF2015-74561-JIN]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065495, R01AI113272] Funding Source: NIH RePORTER	CNIC; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); MINECO(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award)(Spanish Government); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to C. Reis e Sousa, C. Ardavin, A. Corbi, A. Hidalgo, and members of the D.S. laboratory for discussions and critical reading of the manuscript. We thank the CNIC facilities, personnel, and S. Bartlett for editorial assistance. We are indebted to G. Brown, J. Willment, A. Corbi, J. Yewdell, N. Shastri, C. Wells, R. Ashman, H. Miyoshi, RIKEN BRC, and the Scripps Research Institute for providing reagents. S. I. is funded by grant SAF2015-74561-JIN. Work in the D.S. laboratory is funded by the CNIC and grants from the Spanish Ministry of Economy and Competitiveness (MINECO, SAF-2013-42920R), the European Commission (635122-PROCROP H2020), and the European Research Council (ERC-2010-StG 260414). The CNIC is supported by the MINECO and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). M.J.R. and B.K. are employees of MedImmune and shareholders in the parent company Astrazeneca.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Aloulou M, 2012, BLOOD, V119, P3084, DOI 10.1182/blood-2011-08-376046; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Ben Mkaddem S, 2014, J CLIN INVEST, V124, P3945, DOI 10.1172/JCI74572; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kerscher B, 2016, EUR J IMMUNOL, V46, P381, DOI 10.1002/eji.201545858; Lefevre L, 2013, IMMUNITY, V38, P1038, DOI 10.1016/j.immuni.2013.04.010; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; Martinez-Lopez M, 2015, EUR J IMMUNOL, V45, P119, DOI 10.1002/eji.201444651; Masumoto M, 1999, J IMMUNOL, V163, P5039; Miyake Y, 2015, J IMMUNOL, V194, P5366, DOI 10.4049/jimmunol.1402429; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Pagan AJ, 2013, EUR J IMMUNOL, V43, P427, DOI 10.1002/eji.201242715; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Ribeiro-Gomes FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002536; Sancho D, 2013, CURR OPIN IMMUNOL, V25, P46, DOI 10.1016/j.coi.2012.12.007; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Walker PS, 1999, P NATL ACAD SCI USA, V96, P6970, DOI 10.1073/pnas.96.12.6970; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wevers BA, 2014, CELL HOST MICROBE, V15, P494, DOI 10.1016/j.chom.2014.03.008; Woelbing F, 2006, J EXP MED, V203, P177, DOI 10.1084/jem.20052288; Wuthrich M, 2015, EUR J IMMUNOL, V45, P2542, DOI 10.1002/eji.201545591; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yazdanbakhsh M, 2010, NAT REV IMMUNOL, V10, P80, DOI 10.1038/nri2673	44	62	65	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					788	801		10.1016/j.immuni.2016.09.012	http://dx.doi.org/10.1016/j.immuni.2016.09.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27742545	Green Accepted, Bronze			2022-12-18	WOS:000389473200012
J	McDonald, BD; Bunker, JJ; Ishizuka, IE; Jabri, B; Bendelac, A				McDonald, Benjamin D.; Bunker, Jeffrey J.; Ishizuka, Isabel E.; Jabri, Bana; Bendelac, Albert			Elevated T Cell Receptor Signaling Identifies a Thymic Precursor to the TCR alpha beta(+)CD4(-)CD8 beta(-) Intraepithelial Lymphocyte Lineage	IMMUNITY			English	Article							COMPLEX CLASS-I; AUTOREACTIVE THYMOCYTES; NEGATIVE SELECTION; DELTA; EXPRESSION; MOUSE; GUT; ANTIGEN; FATE; MICE	The origin and developmental pathway of intestinal T cell receptor alpha beta(+) CD4(-)CD8 beta(-) intraepithelial lymphocytes (unconventional iIELs), a major population of innate-like resident cytolytic T cells, have remained elusive. By cloning and expressing several TCRs isolated from unconventional iIELs, we identified immature CD4(lo)CD8(lo)(DPlo)CD69(hi)PD-1(hi) thymocytes as the earliest postsignaling precursors for these cells. Although these precursors displayed multiple signs of elevated TCR signaling, a sizeable fraction of them escaped deletion to selectively engage in unconventional iIEL differentiation. Conversely, TCRs cloned from DP(lo)CD69(hi)PD-1(hi) thymocytes, a population enriched in autoreactive thymocytes, selectively gave rise to unconventional iIELs upon transgenic expression. Thus, the unconventional iIEL precursor overlaps with the DPlo population undergoing negative selection, indicating that, concomitant with the downregulation of both CD4 and CD8 coreceptors, a balance between apoptosis and survival signals results in outcomes as divergent as clonal deletion and differentiation to the unconventional iIEL lineage.	[McDonald, Benjamin D.; Bunker, Jeffrey J.; Ishizuka, Isabel E.; Jabri, Bana; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [McDonald, Benjamin D.; Bunker, Jeffrey J.; Ishizuka, Isabel E.; Bendelac, Albert] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu		Bunker, Jeffrey/0000-0002-9351-7003	NIH Medical Scientist Training Program [T32GM007281]; NIH [R01AI038339, RO1 DK067180]; HHMI; Digestive Diseases Research Center of Excellence [P30DK42086]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R01DK067180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Digestive Diseases Research Center of Excellence; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Savage for discussion and advice; P. Verhoef for assistance with intrathymic injection; R. Brink, D. Mathis, and K. Hogquist for providing plasmids for TCR expression; R. Locksley for an IRES-thy1.1 plasmid; D. Leclerc, J. Cao, M. Olsen, and R. Duggan for cell sorting; and L. Degenstein for production of mice. B.D.M. and J.J.B. were supported by an NIH Medical Scientist Training Program grant T32GM007281. This work was supported by NIH grant R01AI038339 and by HHMI (A.B.), by NIH grant RO1 DK067180 (B.J.), and by Digestive Diseases Research Center of Excellence P30DK42086.	Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Das G, 1999, J EXP MED, V190, P881, DOI 10.1084/jem.190.6.881; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Fritsch M, 1998, EUR J IMMUNOL, V28, P828, DOI 10.1002/(SICI)1521-4141(199803)28:03&lt;828::AID-IMMU828&gt;3.0.CO;2-X; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gapin L, 1999, J IMMUNOL, V163, P4100; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; GUYGRAND D, 1992, EUR J IMMUNOL, V22, P505, DOI 10.1002/eji.1830220232; GuyGrand D, 1996, EUR J IMMUNOL, V26, P2248, DOI 10.1002/eji.1830260942; Hendricks DW, 2009, J IMMUNOL, V182, P4267, DOI 10.4049/jimmunol.0804180; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Kreslavsky T, 2013, J EXP MED, V210, P1911, DOI 10.1084/jem.20130876; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Levelt CN, 1999, P NATL ACAD SCI USA, V96, P5628, DOI 10.1073/pnas.96.10.5628; Lin TS, 1999, J CLIN INVEST, V104, P1297, DOI 10.1172/JCI7437; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; Regnault A, 1996, EUR J IMMUNOL, V26, P914, DOI 10.1002/eji.1830260429; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Turner VM, 2010, J IMMUNOL METHODS, V360, P162, DOI 10.1016/j.jim.2010.06.007; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070	53	62	65	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					219	229		10.1016/j.immuni.2014.07.008	http://dx.doi.org/10.1016/j.immuni.2014.07.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25131532	Bronze, Green Accepted			2022-12-18	WOS:000341455300010
J	Raue, HP; Beadling, C; Haun, J; Slifka, MK				Raue, Hans-Peter; Beadling, Carol; Haun, Jennifer; Slifka, Mark K.			Cytokine-Mediated Programmed Proliferation of Virus-Specific CD8(+) Memory T Cells	IMMUNITY			English	Article							IFN-GAMMA; IN-VIVO; BYSTANDER ACTIVATION; CUTTING EDGE; CD40 LIGAND; DIFFERENTIATION; EFFECTOR; IL-12; STIMULATION; EXPANSION	During infection, CD8(+) T cells not only respond to antigenic signals through their T cell receptor (TCR) but also incorporate inflammatory signals from cytokines produced in the local infected microenvironnnent. Transient TCR-mediated stimulation will result in programmed proliferation that continues despite removal of the antigenic stimulus, but it remains unclear whether brief exposure to specific cytokines will elicit similar effects. Here, we have demonstrated that brief stimulation of memory T cells with interleukin-12 (IL-12) and interleukin-18 (IL-18) results in tightly regulated programmed proliferation, in addition to acquisition of enhanced virus-specific cytokine production and cytolytic activity. CD8(+) T cells briefly exposed to IL-12 and IL-18 in vitro showed improved antiviral activity in vivo, as demonstrated by increased proliferation and reduced viremia. These results indicate that even transitory exposure to inflammatory cytokines can provide a selective advantage to infiltrating CD8(+) T cells by triggering a developmental program that is initiated prior to direct contact with virus-infected cells.	[Raue, Hans-Peter; Haun, Jennifer; Slifka, Mark K.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Beadling, Carol] Oregon Hlth & Sci Univ, Div Hematol & Oncol, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	slifkam@ohsu.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1 AI082196 U54, RO1 AI054458, ONPRC 8P51OD011092-53]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054458, U01AI082196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Ian Amanna for assistance with in vivo experiments and Bailey Freeman for helpful scientific discussions. This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health grants UO1 AI082196 U54 (to M.K.S.), RO1 AI054458 (to M.K.S.), and ONPRC 8P51OD011092-53 (to M.K.S.). H-2L<SUP>d</SUP> NP118 tetramers were prepared by the National Institute of Health Tetramer Core Facility (Atlanta, GA, USA).	Andreasen SO, 2000, J IMMUNOL, V164, P3689, DOI 10.4049/jimmunol.164.7.3689; Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; Beadling C, 2005, BLOOD, V105, P1179, DOI 10.1182/blood-2004-07-2833; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Berg RE, 2002, EUR J IMMUNOL, V32, P2807, DOI 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Carroll HP, 2008, RHEUMATOLOGY, V47, P1269, DOI 10.1093/rheumatology/ken257; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Kim SK, 2002, J IMMUNOL, V169, P90, DOI 10.4049/jimmunol.169.1.90; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nguyen KB, 1999, J IMMUNOL, V162, P5238; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Spierings DCJ, 2006, EUR J IMMUNOL, V36, P1707, DOI 10.1002/eji.200635929; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Verdeil G, 2006, EUR J IMMUNOL, V36, P3090, DOI 10.1002/eji.200636347; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Wong P, 2004, J IMMUNOL, V172, P2171, DOI 10.4049/jimmunol.172.4.2171; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194	51	62	68	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					131	139		10.1016/j.immuni.2012.09.019	http://dx.doi.org/10.1016/j.immuni.2012.09.019			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23260193	Green Accepted, Bronze			2022-12-18	WOS:000314195500015
J	Iwasaki, A				Iwasaki, Akiko			Innate Immune Recognition of HIV-1	IMMUNITY			English	Review							PLASMACYTOID DENDRITIC CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; RESTRICTION FACTOR SAMHD1; SINGLE-STRANDED RNA; PRODUCTIVE INFECTION; INTERFERON-ALPHA; DC-SIGN; PROTEIN; SURFACE; TRIM5	In contrast to the extraordinary body of knowledge gained over the past three decades on the virology, pathogenesis, and immunology of HIV-1 infection, innate sensors that detect HIV-1 had remained elusive until recently. By virtue of integration, retroviridae makes up a substantial portion of our genome. Thus, immune strategies that deal with endogenous retroviruses are, by necessity, those of self-preservation and not of virus elimination. Some of the principles of such strategies may also apply for defense against exogenous retroviruses including HIV-1. Here, I highlight several sensors that have recently been revealed to be capable of recognizing distinct features of HIV-1 infection, while taking into account the host-retrovirus relationship that converges on avoiding pathogenic inflammatory consequences.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	National Institutes of Health (NIH) [AI081884, AI054359, AI062428, AI064705]; NIH/NIAID [U54AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI062428, R01AI062428, U54AI057160, R01AI081884, R01AI064705, R01AI054359] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I wish to thank R. Medzhitov for critical discussion and reading of the manuscript and National Institutes of Health (NIH) for its support of research in my laboratory (AI081884, AI054359, AI062428, and AI064705). Research in my laboratory is supported in part by the NIH/NIAID under Award Number U54AI057160 to the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MRCE).	Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benecke A, 2012, CURR OPIN HIV AIDS, V7, P79, DOI 10.1097/COH.0b013e32834dde31; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fitzgerald-Bocarsly P, 2010, J LEUKOCYTE BIOL, V87, P609, DOI 10.1189/jlb.0909635; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Grutter MG, 2012, CURR OPIN VIROL, V2, P142, DOI 10.1016/j.coviro.2012.02.003; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; Jolly C, 2011, VIROLOGY, V411, P251, DOI 10.1016/j.virol.2010.12.031; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Machmach K, 2012, J VIROL, V86, P4245, DOI 10.1128/JVI.07114-11; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; O'Brien M, 2011, J CLIN INVEST, V121, P1088, DOI 10.1172/JCI44960; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Ylinen LMJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001062; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836; Zhou DJ, 2012, J INFECT DIS, V205, P1258, DOI 10.1093/infdis/jis187	76	62	65	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					389	398		10.1016/j.immuni.2012.08.011	http://dx.doi.org/10.1016/j.immuni.2012.08.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999945	Green Accepted, Bronze			2022-12-18	WOS:000309199000002
J	Tsuji, Y; Watanabe, T; Kudo, M; Arai, H; Strober, W; Chiba, T				Tsuji, Yoshihisa; Watanabe, Tomohiro; Kudo, Masatoshi; Arai, Hidenori; Strober, Warren; Chiba, Tsutomu			Sensing of Commensal Organisms by the Intracellular Sensor NOD1 Mediates Experimental Pancreatitis	IMMUNITY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACINAR-CELLS; BACTERIAL PEPTIDOGLYCAN; INTESTINAL HOMEOSTASIS; SIGNAL TRANSDUCER; T-CELLS; ACTIVATION; MICE; INFLAMMATION; RECOGNITION	The intracellular sensor NOD1 has important host-defense functions relating to a variety of pathogens. Here, we showed that this molecule also participates in the induction of a noninfectious pancreatitis via its response to commensal organisms. Pancreatitis induced by high-dose cerulein (a cholecystokinin receptor agonist) administration depends on NOD1 stimulation by gut microflora. To analyze this NOD1 activity, we induced pancreatitis by simultaneous administration of a low dose of cerulein (that does not itself induce pancreatitis) and FK156, an activator of NOD1 that mimics the effect of gut bacteria that have breached the mucosal barrier. The pancreatitis was dependent on acinar cell production of the chemokine MCP-1 and the intrapancreatic influx of CCR2(+) inflammatory cells. Moreover, MCP-1 production involved activation of the transcription factors NF-kappa B and STAT3, each requiring complementary NOD1 and cerulein signaling. These studies indicate that gut commensals enable noninfectious pancreatic inflammation via NOD1 signaling in pancreatic acinar cells.	[Tsuji, Yoshihisa; Watanabe, Tomohiro; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan; [Watanabe, Tomohiro] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto 6068507, Japan; [Arai, Hidenori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto 6068507, Japan; [Watanabe, Tomohiro; Strober, Warren] NIAID, Mucosal Immun Sect, Lab Host Def, NIH, Bethesda, MD 20852 USA; [Kudo, Masatoshi] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 5898511, Japan	Kyoto University; Kyoto University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kindai University (Kinki University)	Watanabe, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan.	tmhrwtnb@kuhp.kyoto-u.ac.jp	Yoshihisa, Tsuji/AAW-2327-2021; Watanabe, Tomohiro/ABA-4712-2021; Kudo, Masatoshi/AAA-9744-2019; Arai, Hidenori/P-9816-2017	Kudo, Masatoshi/0000-0002-4102-3474; Arai, Hidenori/0000-0002-9000-6849	Japan Society for the Promotion of Science [21590532, 21229009, 24229005, 24659363]; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Foundation; Cell Science Research Foundation; Kato Memorial Trust for Nambyo Research; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001159, ZIAAI000354] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant-in-Aid for Scientific Research (21590532, 21229009, 24229005, and 24659363) from Japan Society for the Promotion of Science, Takeda Science Foundation, Astellas Foundation for Research on Metabolic Disorders, Yakult Bioscience Foundation, Cell Science Research Foundation, Kato Memorial Trust for Nambyo Research, Uehara Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Intramural Research Program of the National Institutes of Health. We would like to thank N. Asano for critical reading of this manuscript and S. Ueno for thoughtful support of our experiments.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Bhatia M, 2005, AM J PHYSIOL-GASTR L, V288, pG1259, DOI 10.1152/ajpgi.00435.2004; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Ferrand A, 2005, J BIOL CHEM, V280, P10710, DOI 10.1074/jbc.M413309200; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gao HK, 2007, PANCREAS, V34, P295, DOI 10.1097/mpa.0b013e318032674a; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Ji BA, 2011, GASTROENTEROLOGY, V141, P1972, DOI 10.1053/j.gastro.2011.10.021; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Regner S, 2008, PANCREATOLOGY, V8, P42, DOI 10.1159/000114866; Rychter JW, 2009, SURGERY, V145, P157, DOI 10.1016/j.surg.2008.09.011; Sharif R, 2009, GUT, V58, P813, DOI 10.1136/gut.2008.170423; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takagi Y, 2009, HUM IMMUNOL, V70, P200, DOI 10.1016/j.humimm.2009.01.006; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Werts C, 2011, J LEUKOCYTE BIOL, V90, P471, DOI 10.1189/jlb.0411183; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yoshida M, 2001, INT IMMUNOL, V13, P1561, DOI 10.1093/intimm/13.12.1561; Yu JH, 2005, INT J BIOCHEM CELL B, V37, P1458, DOI 10.1016/j.biocel.2005.02.004; Zhao HF, 2005, GUT, V54, P1759, DOI 10.1136/gut.2004.049403	35	62	66	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					326	338		10.1016/j.immuni.2012.05.024	http://dx.doi.org/10.1016/j.immuni.2012.05.024			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22902233	Green Accepted, Bronze			2022-12-18	WOS:000308261800016
J	Stadinski, BD; Trenh, P; Smith, RL; Bautista, B; Huseby, PG; Li, GQ; Stern, LJ; Huseby, ES				Stadinski, Brian D.; Trenh, Peter; Smith, Rebecca L.; Bautista, Bianca; Huseby, Priya G.; Li, Guoqi; Stern, Lawrence J.; Huseby, Eric S.			A Role for Differential Variable Gene Pairing in Creating T Cell Receptors Specific for Unique Major Histocompatibility Ligands	IMMUNITY			English	Article							ANTIGEN RECEPTOR; AMINO-ACIDS; MHC RESTRICTION; PEPTIDE-MHC; CLASS-I; RECOGNITION; REPERTOIRE; SELECTION; COMPLEX; BETA	A limited set of T cell receptor (TCR) variable (V) gene segments are used to create a repertoire of TCRs that recognize all major histocompatibility complex (MHC) ligands within a species. How individual alpha beta TCRs are constructed to specifically recognize a limited set of MHC ligands is unclear. Here we have identified a role for the differential pairing of particular V gene segments in creating TCRs that recognized MHC class II ligands exclusively, or cross-reacted with classical and nonclassical MHC class I ligands. Biophysical and structural experiments indicated that TCR specificity for MHC ligands is not driven by germline-encoded pairwise interactions. Rather, identical TCR beta chains can have altered peptide-MHC (pMHC) binding modes when paired with different TCR alpha chains. The ability of TCR chain pairing to modify how V region residues interact with pMHC helps to explain how the same V genes are used to create TCRs specific for unique MHC ligands.	[Stadinski, Brian D.; Trenh, Peter; Smith, Rebecca L.; Bautista, Bianca; Huseby, Priya G.; Li, Guoqi; Stern, Lawrence J.; Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Huseby, ES (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	eric.huseby@umassmed.edu			Searle Scholars Award; NIH [RAI088495A, RC1 DK086474, R01-AI-38996, U19-AI-5T32, AI 0073497391]; UMass DERC [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, R21AI088495, R01AI038996, R37AI038996, T32AI007349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086474, P30DK032520] Funding Source: NIH RePORTER	Searle Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMass DERC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank A. Bean, M. Paczosa, and V. Vanguri for assistance with some experiments and helpful discussions. This work was supported by a Searle Scholars Award to E.S.H., NIH grants to E.S.H. (RAI088495A and RC1 DK086474 NIH/NIDDK, PI Kang), NIH grants to L.J.S. (R01-AI-38996 and U19-AI-57391, PI Rothman), and a NIH training grant to B.D.S. (T32 AI 007349). E.S.H. is a member of the UMass DERC (grant DK32520). The tetramer and biotinylated monomer CD1d-PBS57 was obtained through the NIH Tetramer Facility.	Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; Arden Bernhard, 1995, Immunogenetics, V42, P501; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Behar SM, 1999, J IMMUNOL, V162, P161; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeLano W. L, 2002, PYMOL MOL GENETICS G; DERSIMONIAN H, 1991, J EXP MED, V174, P639, DOI 10.1084/jem.174.3.639; DILLON SR, 1994, J IMMUNOL, V152, P1790; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; GARMAN RD, 1986, P NATL ACAD SCI USA, V83, P3987, DOI 10.1073/pnas.83.11.3987; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JAMESON SC, 1990, J IMMUNOL, V145, P1324; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; Valkenburg SA, 2010, EUR J IMMUNOL, V40, P2470, DOI 10.1002/eji.201040473; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; Wucherpfennig KW, 2009, CURR OPIN IMMUNOL, V21, P590, DOI 10.1016/j.coi.2009.07.008; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; Zhong WM, 2007, J MOL BIOL, V372, P535, DOI 10.1016/j.jmb.2007.06.057; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	53	62	63	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					694	704		10.1016/j.immuni.2011.10.012	http://dx.doi.org/10.1016/j.immuni.2011.10.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22101158	Bronze, Green Accepted			2022-12-18	WOS:000297390800010
J	Li, W; Sofi, MH; Rietdijk, S; Wang, N; Terhorst, C; Chang, CH				Li, Wei; Sofi, M. Hanief; Rietdijk, Svend; Wang, Ninghai; Terhorst, Cox; Chang, Cheong-Hee			The SLAM-Associated protein signaling pathway is required for development of CD4(+) T cells selected by homotypic thymocyte interaction	IMMUNITY			English	Article							KINASE-C-THETA; BONE-MARROW-TRANSPLANTATION; KAPPA-B ACTIVATION; NATURAL-KILLER; CUTTING EDGE; POSITIVE SELECTION; HUMORAL IMMUNITY; SH2 DOMAIN; PKC-THETA; SAP	MHC class II-expressing double-positive thymocytes induce progression of CD4(+) T cell development as efficiently as cortical thymic epithelial cells do. Because double-positive thymocytes expressing CD1d select natural killer T (NKT) cells, we investigated whether thymocyte-selected CD4(+) (T-CD4) T cells require the same signaling components as NKT cells. Using bone-marrow chimeras, we found that the signaling molecules SAP, Fyn, and PKC theta were essential for T-CD4 T cell generation, whereas mutations in the Ly108 receptor, interleukin-15 receptor alpha, or the transcription factor T-bet had a marginal effect. Furthermore, SAP was critical for IL-4 production by T-CD4 T cells, but the PKC theta deficiency did not alter the ability of T-CD4 T cells to produce cytokines. T-bet was necessary to produce the maximum amount of IFN-gamma for CD4(+) T cells regardless of the selection pathway. Thus, in contrast to epithelial cell-selected CD4(+) T cells, the two distinct lineages of T cells selected by thymocytes-i.e., T-CD4 and NKT cells-both utilize the SAP-Fyn-PKC theta pathway for their development and function.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Li, W (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	wll@iupui.edu; heechang@umich.edu	Rietdijk, Svend/AAH-7519-2021		NIAID NIH HHS [R01 AI045811, R01 AI045811-06] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045811] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Eberl G, 1999, J IMMUNOL, V163, P4091; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Godthelp BC, 2000, HUM IMMUNOL, V61, P898, DOI 10.1016/S0198-8859(00)00156-7; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Jordan MA, 2007, J IMMUNOL, V178, P1618, DOI 10.4049/jimmunol.178.3.1618; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KLEIN C, 1995, BLOOD, V85, P580; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; LEWIS DB, 1991, J EXP MED, V173, P89, DOI 10.1084/jem.173.1.89; Li W, 2007, J EXP MED, V204, P2145, DOI 10.1084/jem.20070321; Li WL, 2005, MICROSYST TECHNOL, V11, P23, DOI 10.1007/s00542-004-0462-8; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Manicassamy S, 2006, J IMMUNOL, V176, P6709, DOI 10.4049/jimmunol.176.11.6709; Marinova Ts., 2001, Archives of Physiology and Biochemistry, V109, P74, DOI 10.1076/apab.109.1.74.4281; Markert ML, 2004, BLOOD, V104, P2574, DOI 10.1182/blood-2003-08-2984; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Matsuda JL, 2005, CURR OPIN IMMUNOL, V17, P122, DOI 10.1016/j.coi.2005.01.002; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Ohteki T, 1997, J IMMUNOL, V159, P5931; PARK SH, 1992, HUM IMMUNOL, V33, P294; Park WS, 2004, INT IMMUNOL, V16, P1355, DOI 10.1093/intimm/dxh132; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Patel DR, 2005, CELL IMMUNOL, V233, P30, DOI 10.1016/j.cellimm.2005.03.006; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Thulesen S, 1999, EXP CLIN IMMUNOGENET, V16, P226, DOI 10.1159/000019114; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	52	62	63	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					763	774		10.1016/j.immuni.2007.10.008	http://dx.doi.org/10.1016/j.immuni.2007.10.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031696	Green Accepted, Bronze			2022-12-18	WOS:000251269000010
J	Rubtsov, A; Strauch, P; DiGiacomo, A; Hu, JC; Pelanda, R; Torres, RM				Rubtsov, A; Strauch, P; DiGiacomo, A; Hu, JC; Pelanda, R; Torres, RM			Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response	IMMUNITY			English	Article							HETEROTRIMERIC G-PROTEINS; SPHINGOSINE 1-PHOSPHATE; IMMUNE-RESPONSES; P115 RHOGEF; EXCHANGE FACTORS; LYMPHOID ORGANS; IN-VIVO; ACTIVATION; MICE; RHOA	The humoral immune response to protein antigens is composed of a rapid low-affinity IgM antibody response followed by an IgG response exhibiting higher affinity. Here, we demonstrate that Lsc, a protein that regulates G protein-coupled-receptor signaling and RhoA activation, is required by B lymphocytes for the antigen-specific IgM antibody response to a protein antigen. We further show that in lsc(-/-) mice, MZB cells are selectively affected such that naive and in vivo-activated MZB cells migrate toward sphingosine-1 -phosphate at increased proportions but release inefficiently from integrin ligands. Consequently, lsc(-/-) MZB cells do not traffick appropriately in an immune response and do not contribute to the TD antibody response. These data demonstrate that Lsc regulates the migration and adhesion of MZB cells, and this regulation appears to be required for these cells to contribute to the antibody response to TD antigens.	Univ Colorado, Hlth Sci Ctr, Denver, CO 80207 USA; Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80207 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Torres, RM (corresponding author), Univ Colorado, Hlth Sci Ctr, Denver, CO 80207 USA.	torresr@njc.org	Di Giacomo, Anna Maria/AAY-5625-2020; Hu, Jiancheng/ABE-8133-2021	Hu, Jiancheng/0000-0003-1615-0030	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052310, R01AI052310, R01AI052157] Funding Source: NIH RePORTER; NIAID NIH HHS [AI052310, R01 AI052310, R01 AI052157, AI052157] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aasheim HC, 1997, ONCOGENE, V14, P1747, DOI 10.1038/sj.onc.1200994; Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; Casamayor-Palleja M, 2002, BLOOD, V99, P1913, DOI 10.1182/blood.V99.6.1913; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; GROENEVELD PHP, 1985, IMMUNOBIOLOGY, V170, P402, DOI 10.1016/S0171-2985(85)80064-4; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hasan M, 2002, EUR J IMMUNOL, V32, P3463, DOI 10.1002/1521-4141(200212)32:12<3463::AID-IMMU3463>3.0.CO;2-B; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Liu L, 2002, J IMMUNOL, V169, P2330, DOI 10.4049/jimmunol.169.5.2330; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Whitehead IP, 1996, J BIOL CHEM, V271, P18643, DOI 10.1074/jbc.271.31.18643; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Wright N, 2002, J IMMUNOL, V168, P5268, DOI 10.4049/jimmunol.168.10.5268; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	58	62	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					527	538		10.1016/j.immuni.2005.09.018	http://dx.doi.org/10.1016/j.immuni.2005.09.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286020	Bronze			2022-12-18	WOS:000233660700009
J	Guo, LY; Hu-Li, J; Paul, WE				Guo, LY; Hu-Li, J; Paul, WE			Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13	IMMUNITY			English	Article							ASYNCHRONOUS REPLICATION; COORDINATE REGULATOR; ALLELIC EXCLUSION; GENE; INTERLEUKIN-13; ACCESSIBILITY; DELETION; CLUSTER	II4 and II13, closely linked genes, are expressed monoallelically in TH2 cells. Four different approaches (RNA FISH, cultures from II13T-II4/II13-G4 mice, cultures from heterozygous II13-II4 double knockout mice, and a highly selected set of BABL/c*CAST/Ei clones displaying strong II4 allelic bias) were utilized to study monoallelic expression of II4 and coexpression of II4 and II13 on the same chromosome. There was a random probability for expression of one or two II4 and one or two II13 alleles; coexpression of cis and trans II4 and II13 alleles was equally probable. Histone H3 acetylation of CNS1, located in the II13-II4 intergenic region, was permissive for expression of IL-4 and IL-13 but did not determine the degree of their expression. Thus, monoallelism at the II4 locus is a complex process; expression is linked to opening CNS1 but probability of expression is controlled at other sites. Based on these probabilities, individual cells randomly express II4 and II13 alleles.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Guo, LY (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	lguo@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000493, ZIAAI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bergman Y, 1999, SEMIN IMMUNOL, V11, P319, DOI 10.1006/smim.1999.0188; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; BOULAY JL, 1992, CURR OPIN IMMUNOL, V4, P294, DOI 10.1016/0952-7915(92)90079-T; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Hudson TJ, 2003, NAT GENET, V33, P439, DOI 10.1038/ng0403-439; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lee CC, 2003, PHOTOCH PHOTOBIO SCI, V2, P145, DOI 10.1039/b207598a; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; PAUL P, 1991, MICROW OPT TECHN LET, V4, P77, DOI 10.1002/mop.4650040207; PAUL WE, 1993, ADV IMMUNOL, V53, P1, DOI 10.1016/S0065-2776(08)60496-4; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	34	62	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					89	99		10.1016/j.immuni.2005.05.008	http://dx.doi.org/10.1016/j.immuni.2005.05.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039582	Bronze			2022-12-18	WOS:000231024800011
J	Chen, CZ; Li, L; Li, M; Lodish, HF				Chen, CZ; Li, L; Li, M; Lodish, HF			The Endoglin(positive) Sca-1(Positive) Rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells	IMMUNITY			English	Article							ADULT BONE-MARROW; IN-VIVO; COMPETITIVE REPOPULATION; MOUSE; IDENTIFICATION; ENDOGLIN; NUMBERS; ASSAY; MICE	Endoglin, an ancillary TGF-beta receptor, is differentially expressed in long-term repopulating hematopoietic stem cells (LTR-HSC). Here, we describe simple and highly efficient purification schemes for mouse bone marrow LTR-HSCs using Endoglin as a marker. The Endoglin positive and Sca-1 positive (Endo(Pos) Sca-1(Pos)) population, which contains about 36% of "Side Population" (SP) cells, is highly enriched for LTR-HSCs. In long-term competitive reconstitution assays, 100 such cells reconstituted all lethally irradiated recipients. Interestingly, the Endo(Pos) Sca-1(Pos) population contains comparable LTR-HSC activity in both SP and non-SP fractions, indicating that many HSCs are not captured by the SP phenotype. Furthermore, LTR-HSCs are exclusively found in the End(Pos) Sca-1(Pos) Lin(Neg/Low) (lineage negative/low), but not in the Endo(Neg) Sca-1(Pos) Lin(Neg/Low) population, suggesting that the Endo(Pos) population may contain all LTR-HSCs in mouse bone marrow. Finally, we demonstrated that the Endo(Pos) Sca-1(Pos) Rh-Low (Rhodamine-123 low) phenotype, without using CD34, c-Kit, or Lineage markers, defines a nearly homogenous population of LTR-HSCs.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Li, Ling/A-2008-2010	Chen, Chang-Zheng/0000-0002-1620-242X				ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Azuma Hiroyuki, 2000, Journal of Medical Investigation, V47, P81; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Ortiz M, 1999, IMMUNITY, V10, P173, DOI 10.1016/S1074-7613(00)80018-7; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pierelli L, 1998, BRIT J HAEMATOL, V102, P1139, DOI 10.1046/j.1365-2141.1998.00885.x; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rebel VI, 1996, EXP HEMATOL, V24, P638; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Szilvassy SJ, 2003, EXP HEMATOL, V31, P331, DOI 10.1016/S0301-472X(03)00005-5; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Zhong RK, 1996, J IMMUNOL, V157, P138; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999	22	62	66	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					525	533		10.1016/S1074-7613(03)00265-6	http://dx.doi.org/10.1016/S1074-7613(03)00265-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563317	Bronze			2022-12-18	WOS:000186051900009
J	Matza, D; Kerem, A; Medvedovsky, H; Lantner, F; Shachar, I				Matza, D; Kerem, A; Medvedovsky, H; Lantner, F; Shachar, I			Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain	IMMUNITY			English	Article							MHC CLASS-II; ENDOPLASMIC-RETICULUM; HLA-DR; MATURATION; MOLECULES; TRANSPORT; CONTAINS; COMPLEX; PROTEIN; SIGNAL	Immature B cells differentiate in the spleen into mature B cells, a process that is essential for their participation in the immune response. Previously, we showed that the MHC class II chaperone, invariant chain (h), controls this differentiation to the mature stage. Ii cytosolic domain-induced B cell maturation involves activation of transcription mediated by the NF-kappaB p65/ RelA homodimer and requires the B cell enriched coactivator, TAF(\\)105. In this study we show that the cytosolic region of Ii is cleaved within the plane of the membrane to generate a cytosolic fragment, which is essential for NF-kappaB activation and B cell differentiation. Our results suggest that Ii functions as a membrane-bound inactive inducer of NF-kappaB transcription that is activated by intramembrane proteolytic cleavage.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shachar, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	idit.shachar@weizmann.ac.uk	Shaked, Helena/M-9682-2014					Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; ERICKSON AH, 1979, J BIOL CHEM, V254, P1771; Flaishon L, 2000, J EXP MED, V192, P1381, DOI 10.1084/jem.192.9.1381; Frauwirth K, 2001, CELL IMMUNOL, V209, P97, DOI 10.1006/cimm.2001.1796; Hammond C, 1998, J IMMUNOL, V161, P3282; HARDING CV, 1990, CELL REGUL, V1, P499, DOI 10.1091/mbc.1.7.499; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Kenty G, 1998, J IMMUNOL, V160, P606; Kenty G, 1999, J IMMUNOL, V163, P232; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LIPP J, 1986, CELL, V46, P1103, DOI 10.1016/0092-8674(86)90710-5; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; LONG EO, 1989, IMMUNOL TODAY, V10, P232, DOI 10.1016/0167-5699(89)90259-4; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; Matza D, 2002, P NATL ACAD SCI USA, V99, P3018, DOI 10.1073/pnas.052703299; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; PIETERS J, 1993, J CELL SCI, V106, P831; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Stang E, 1997, EXP CELL RES, V235, P79, DOI 10.1006/excr.1997.3617; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	41	62	66	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2002	17	5					549	560		10.1016/S1074-7613(02)00455-7	http://dx.doi.org/10.1016/S1074-7613(02)00455-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433362	Bronze			2022-12-18	WOS:000179335100002
J	Gold, ES; Morrissette, NS; Underhill, DM; Guo, J; Bassetti, M; Aderem, A				Gold, ES; Morrissette, NS; Underhill, DM; Guo, J; Bassetti, M; Aderem, A			Amphiphysin IIm, a novel amphiphysin II isoform, is required for macrophage phagocytosis	IMMUNITY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; COATED VESICLE FORMATION; SH3 DOMAIN; NERVE-TERMINALS; SPLICE VARIANTS; DYNAMIN; BINDING; MUTATIONS; PROTEINS; FAMILY	Phagocytosis of pathogens by macrophages initiates the innate immune response, which in turn orchestrates the adaptive immune response. Amphiphysin II participates in receptor-mediated endocytosis, in part, by recruiting the GTPase dynamin to the nascent endosome. We demonstrate here that a novel isoform of amphiphysin II associates with early phagosomes in macrophages. We have ablated the dynamin-binding site of this protein and shown that this mutant form of amphiphysin II inhibits phagocytosis at the stage of membrane extension around the bound particles. We define a signaling cascade in which PI3K is required to recruit amphiphysin II to the phagosome, and amphiphysin II in turn recruits dynamin. Thus, amphiphysin II facilitates a critical initial step in host response to infection.	Univ Washington, Dept Immunol, Seattle, WA 98159 USA; Univ Washington, Div Cardiol, Seattle, WA 98159 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Aderem, A (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98159 USA.	aaderem@u.washington.edu	Bassetti, Matteo/L-3081-2019; UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X	NIAID NIH HHS [AI-R37-25032, AI-R01-32972] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032972, R37AI025032] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ADEREM AA, 1984, J CELL BIOL, V99, P1235, DOI 10.1083/jcb.99.4.1235; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Balguerie A, 1999, J CELL SCI, V112, P2529; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Moffat FL, 1996, J CELL PHYSIOL, V168, P638, DOI 10.1002/(SICI)1097-4652(199609)168:3<638::AID-JCP16>3.0.CO;2-V; Morrissette NS, 1999, J CELL SCI, V112, P4705; Mundigl O, 1998, J NEUROSCI, V18, P93; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; Ramjaun AR, 1999, J BIOL CHEM, V274, P19785, DOI 10.1074/jbc.274.28.19785; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsutsui K, 1997, BIOCHEM BIOPH RES CO, V236, P178, DOI 10.1006/bbrc.1997.6927; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5	50	62	63	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					285	292		10.1016/S1074-7613(00)80181-8	http://dx.doi.org/10.1016/S1074-7613(00)80181-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755615	Bronze			2022-12-18	WOS:000086292100006
J	Reiner, SL; Seder, RA				Reiner, SL; Seder, RA			Dealing from the evolutionary pawnshop: How lymphocytes make decisions	IMMUNITY			English	Review							CD4(+) T-CELLS; POSITION-EFFECT VARIEGATION; INTERFERON-GAMMA PRODUCTION; TRANSCRIPTION FACTOR GATA-3; IFN-GAMMA; CENTROMERIC HETEROCHROMATIN; ERYTHROPOIETIN RECEPTOR; PHENOTYPE DEVELOPMENT; IL-4-PRODUCING CELLS; GENE-EXPRESSION		Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Dept Med, Comm Immunol & Dev Biol, Chicago, IL 60637 USA; NIAID, Clin Immunol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Reiner, SL (corresponding author), Univ Penn, 421 Curie Blvd,4th Floor, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu						ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; BERTON MT, 1990, J EXP MED, V172, P375, DOI 10.1084/jem.172.1.375; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; BURGER C, 1990, EUR J IMMUNOL, V20, P2285, DOI 10.1002/eji.1830201018; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DEMEURE CE, 1995, EUR J IMMUNOL, V25, P2722, DOI 10.1002/eji.1830250950; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Grakoui A, 1999, J IMMUNOL, V162, P1923; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huang H, 1997, J IMMUNOL, V159, P3731; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KALINSKI P, 1995, J IMMUNOL, V154, P3753; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; KELSO A, 1995, EUR J IMMUNOL, V25, P1168, DOI 10.1002/eji.1830250506; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; KING CL, 1995, EUR J IMMUNOL, V25, P587, DOI 10.1002/eji.1830250242; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; LEBMAN DA, 1988, J EXP MED, V168, P853, DOI 10.1084/jem.168.3.853; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; MELVIN AJ, 1995, EUR J IMMUNOL, V25, P426, DOI 10.1002/eji.1830250218; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Morris SC, 1998, J IMMUNOL, V160, P3299; Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Nichogiannopoulou A, 1998, SEMIN IMMUNOL, V10, P119, DOI 10.1006/smim.1998.0113; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schmitz J, 1989, Int Immunol, V1, P570, DOI 10.1093/intimm/1.6.570; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEINTRAUB H, 1977, COLD SPRING HARB SYM, V42, P401, DOI 10.1101/SQB.1978.042.01.042; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; YOUNG HA, 1994, J IMMUNOL, V153, P3603; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; [No title captured]	100	62	62	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1999	11	1					1	10		10.1016/S1074-7613(00)80076-X	http://dx.doi.org/10.1016/S1074-7613(00)80076-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435574	Bronze			2022-12-18	WOS:000081671300001
J	LEIBSON, PJ				LEIBSON, PJ			MHC-RECOGNIZING RECEPTORS - THEYRE NOT JUST FOR T-CELLS ANYMORE	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CLASS-I; RECOGNITION; REJECTION; MICE; SPECIFICITY; MARROW; SELF				LEIBSON, PJ (corresponding author), MAYO CLIN & MAYO FDN, DEPT IMMUNOL, 200 1ST ST SW, ROCHESTER, MN 55905 USA.							BENNETT M, 1995, IN PRESS SEM IMMUNOL; BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; BOTTINO C, 1994, EUR J IMMUNOL, V24, P2527, DOI 10.1002/eji.1830241040; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; CUDKOWICZ G, 1964, IMMUNOLOGY, V7, P291; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KAUFMAN DS, 1993, J IMMUNOL, V150, P1429; KAUFMAN DS, 1992, P NATL ACAD SCI USA, V89, P8337, DOI 10.1073/pnas.89.17.8337; KAUFMAN DS, 1995, IN PRESS P NATL ACAD; KIESSLING R, 1977, EUR J IMMUNOL, V7, P655, DOI 10.1002/eji.1830070915; LITWIN V, 1993, J EXP MED, V178, P1321, DOI 10.1084/jem.178.4.1321; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MASON LH, 1994, J LEUKOCYTE BIOL, V55, P362, DOI 10.1002/jlb.55.3.362; MASON LH, 1995, IN PRESS J EXP MED; MELERO I, 1994, J IMMUNOL, V152, P1662; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; MORETTA L, 1994, ADV IMMUNOL, V55, P341; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; ROLSTAD B, 1994, NATURAL IMMUNITY NOR, P99; SNELL GD, 1958, JNCI-J NATL CANCER I, V21, P843; STORKUS WJ, 1992, J IMMUNOL, V149, P1185; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	36	62	63	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1995	3	1					5	8		10.1016/1074-7613(95)90153-1	http://dx.doi.org/10.1016/1074-7613(95)90153-1			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621077	Bronze			2022-12-18	WOS:A1995RK86800002
J	Lu, Q; Liu, J; Zhao, S; Castro, MFG; Laurent-Rolle, M; Dong, JB; Ran, XJ; Damani-Yokota, P; Tang, HZ; Karakousi, T; Son, J; Kaczmarek, ME; Zhang, Z; Yeung, ST; McCune, BT; Chen, RE; Tang, F; Ren, XW; Chen, XF; Hsu, JCC; Teplova, M; Huang, B; Deng, HJ; Long, ZL; Mudianto, T; Jin, SM; Lin, P; Du, JP; Zang, RC; Su, TT; Herrera, A; Zhou, M; Yan, RH; Cui, J; Zhu, J; Zhou, Q; Wang, T; Ma, JZ; Koralov, SB; Zhang, ZM; Aifantis, I; Segal, LN; Diamond, MS; Khanna, KM; Stapleford, KA; Cresswell, P; Liu, Y; Ding, SY; Xie, Q; Wang, J				Lu, Qiao; Liu, Jia; Zhao, Shuai; Castro, Maria Florencia Gomez; Laurent-Rolle, Maudry; Dong, Jianbo; Ran, Xiaojuan; Damani-Yokota, Payal; Tang, Hongzhen; Karakousi, Triantafyllia; Son, Juhee; Kaczmarek, Maria E.; Zhang, Ze; Yeung, Stephen T.; McCune, Broc T.; Chen, Rita E.; Tang, Fei; Ren, Xianwen; Chen, Xufeng; Hsu, Jack C. C.; Teplova, Marianna; Huang, Betty; Deng, Haijing; Long, Zhilin; Mudianto, Tenny; Jin, Shumin; Lin, Peng; Du, Jasper; Zang, Ruochen; Su, Tina Tianjiao; Herrera, Alberto; Zhou, Ming; Yan, Renhong; Cui, Jia; Zhu, James; Zhou, Qiang; Wang, Tao; Ma, Jianzhu; Koralov, Sergei B.; Zhang, Zemin; Aifantis, Iannis; Segal, Leopoldo N.; Diamond, Michael S.; Khanna, Kamal M.; Stapleford, Kenneth A.; Cresswell, Peter; Liu, Yue; Ding, Siyuan; Xie, Qi; Wang, Jun			SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2	IMMUNITY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; DC-SIGN; DENDRITIC CELLS; VIRUS; INFECTION; PROTEIN; REPLICATION; EXPRESSION; ANTIBODIES; INDUCTION	Despite mounting evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) engagement with immune cells, most express little, if any, of the canonical receptor of SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2). Here, using a myeloid cell receptor-focused ectopic expression screen, we identified several C-type lectins (DC-SIGN, L-SIGN, LSECtin, ASGR1, and CLEC10A) and Tweety family member 2 (TTYH2) as glycan-dependent binding partners of the SARS-CoV-2 spike. Except for TTYH2, these molecules primarily interacted with spike via regions outside of the receptor-binding domain. Single-cell RNA sequencing analysis of pulmonary cells from individuals with coronavirus disease 2019 (COVID-19) indicated predominant expression of these molecules on myeloid cells. Although these receptors do not support active replication of SARS-CoV-2, their engagement with the virus induced robust proinflammatory responses in myeloid cells that correlated with COVID-19 severity. We also generated a bispecific anti-spike nanobody that not only blocked ACE2-mediated infection but also the myeloid receptor-mediated proinflammatory responses. Our findings suggest that SARS-CoV-2-myeloid receptor interactions promote immune hyperactivation, which represents potential targets for COVID-19 therapy.	[Lu, Qiao; Liu, Jia; Karakousi, Triantafyllia; Zhang, Ze; Chen, Xufeng; Teplova, Marianna; Mudianto, Tenny; Du, Jasper; Herrera, Alberto; Koralov, Sergei B.; Aifantis, Iannis; Wang, Jun] NYU, Grossman Sch Med, Dept Pathol, New York, NY 10016 USA; [Lu, Qiao; Liu, Jia; Karakousi, Triantafyllia; Zhang, Ze; Teplova, Marianna; Khanna, Kamal M.; Wang, Jun] New York Univ Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Zhao, Shuai; Ran, Xiaojuan; Tang, Hongzhen; Deng, Haijing; Long, Zhilin; Jin, Shumin; Lin, Peng; Zhou, Ming; Xie, Qi] Westlake Univ, Ctr Infect Dis Res, Sch Life Sci,Key Lab Growth Regulat & Translat Re, Westlake Lab Life Sci & Biomed,Zhejiang Prov Lab, Hangzhou 310024, Zhejiang, Peoples R China; [Zhao, Shuai; Ran, Xiaojuan; Tang, Hongzhen; Deng, Haijing; Long, Zhilin; Jin, Shumin; Lin, Peng; Zhou, Ming; Xie, Qi] Westlake Univ, Sch Life Sci, Inst Basics Med Sci, Westlake Inst Adv Study, Hangzhou 310024, Zhejiang, Peoples R China; [Castro, Maria Florencia Gomez; Son, Juhee; Zang, Ruochen; Diamond, Michael S.; Ding, Siyuan] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Laurent-Rolle, Maudry; Hsu, Jack C. C.; Su, Tina Tianjiao; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Dong, Jianbo; Huang, Betty; Liu, Yue] Ab Studio Inc, Hayward, CA 94545 USA; [Damani-Yokota, Payal; Kaczmarek, Maria E.; Yeung, Stephen T.; Khanna, Kamal M.; Stapleford, Kenneth A.] NYU, Grossman Sch Med, Dept Microbiol, New York, NY 10016 USA; [McCune, Broc T.; Chen, Rita E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [McCune, Broc T.; Chen, Rita E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Tang, Fei; Ren, Xianwen; Zhang, Zemin] Peking Univ, Beijing Adv Innovat Ctr Genom, Sch Life Sci, BIOPIC, Beijing 100871, Peoples R China; [Yan, Renhong; Zhou, Qiang] Westlake Univ, Joint Res Ctr Hangzhou First Hosp Grp & Westlake, Ctr Infect Dis Res, Sch Life Sci,Key Lab Struct Biol Zhejiang Prov,Zh, Hangzhou 310024, Zhejiang, Peoples R China; [Cui, Jia] Kactus Biosyst Co Ltd, Shanghai 201114, Peoples R China; [Zhu, James; Wang, Tao] Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Ma, Jianzhu] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Segal, Leopoldo N.] NYU, Sch Med, Div Pulm & Crit Care Med, New York, NY 10016 USA	New York University; New York University; Westlake University; Westlake University; Washington University (WUSTL); Yale University; New York University; Washington University (WUSTL); Washington University (WUSTL); Peking University; Westlake University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Purdue University System; Purdue University; Purdue University West Lafayette Campus; New York University	Wang, J (corresponding author), NYU, Grossman Sch Med, Dept Pathol, New York, NY 10016 USA.; Wang, J (corresponding author), New York Univ Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Xie, Q (corresponding author), Westlake Univ, Ctr Infect Dis Res, Sch Life Sci,Key Lab Growth Regulat & Translat Re, Westlake Lab Life Sci & Biomed,Zhejiang Prov Lab, Hangzhou 310024, Zhejiang, Peoples R China.; Xie, Q (corresponding author), Westlake Univ, Sch Life Sci, Inst Basics Med Sci, Westlake Inst Adv Study, Hangzhou 310024, Zhejiang, Peoples R China.; Ding, SY (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	siyuan.ding@wustl.edu; xieqi@westlake.edu.cn; jun.wang@nyulangone.org		Wang, Jun/0000-0002-6346-2929; Ding, Siyuan/0000-0002-5338-260X; Tang, Hongzhen/0000-0003-2146-7868; Segal, Leopoldo/0000-0003-3559-9431; Zhao, Shuai/0000-0002-1488-2601; Hsu, Chun Chieh/0000-0003-4380-8723; Lu, Qiao/0000-0002-5930-3132; Koralov, Sergei/0000-0002-4843-3791; Xie, Qi/0000-0002-2370-2078; Liu, Jia/0000-0003-3612-6089; Stapleford, Kenneth/0000-0002-7796-2254; Son, Juhee/0000-0001-9605-7017; deng, haijing/0000-0003-2464-5252	Office of Science Research (OSR); Department of Pathology of New York University Grossman School of Medicine; Westlake Education Foundation; Tencent Foundation [XHTX202001008]; Hangzhou Science and Technology Development Foundation [20202013A05]; National Institutes of Health (NIH) DDRCC [P30 DK052574]; NIH [R01-AI059167, R00 AI135031, R01 AI150796, R01 AI157155, R01 AI143861, AI143861S1]; Cancer Research Institute Irvington postdoctoral fellowship	Office of Science Research (OSR); Department of Pathology of New York University Grossman School of Medicine; Westlake Education Foundation; Tencent Foundation; Hangzhou Science and Technology Development Foundation; National Institutes of Health (NIH) DDRCC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Irvington postdoctoral fellowship	We thank Dr. Pratip Chattopadhyay and Dr. Nathaniel Landau from New York University Grossman School of Medicine for providing human PBMCs from healthy donors and help with the anti-ACE2 blocking antibody, respectively; Dr. Peihui Wang from Shandong University for providing the pcDNA6BFLAG-ACE2 plasmid; Dr. Lu Lu from Fudan University for providing the SARS-CoV-2 pseudovirus plasmids; and members of the laboratories of New York University Grossman School of Medicine and Ab Studio for helpful discussions and technical assistance. This work is supported by internal funds provided by the Office of Science & Research (OSR) and the Department of Pathology of New York University Grossman School of Medicine (to J.W.); the Westlake Education Foundation, the Tencent Foundation (XHTX202001008), and the Hangzhou Science and Technology Development Foundation (20202013A05) (to Q.X.); National Institutes of Health (NIH) DDRCC grant P30 DK052574, NIH grants R00 AI135031 and R01 AI150796, and COVID19 Fast Grants funding (to S.D.); NIH grants R01 AI157155 (to M.S.D.); NIH grants R01 AI143861 and AI143861S1 (to K.M.K.); NIH grants R01-AI059167 (to P.C.); and a Cancer Research Institute Irvington postdoctoral fellowship (to J.H.).	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; [Anonymous], 2020, CANCER DISCOV, DOI [DOI 10.1038/S41379-019-0362-1, DOI 10.1038/S41421-020-0168-9]; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Brudner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060838; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; da Silva RC, 2011, HUM IMMUNOL, V72, P305, DOI 10.1016/j.humimm.2011.01.012; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dong JB, 2020, EMERG MICROBES INFEC, V9, P1034, DOI 10.1080/22221751.2020.1768806; Feng Z., 2020, MEDRXIV, p2020.03.27.20045427, DOI 10.1101/2020.03.27.20045427; Gai JW, 2021, MEDCOMM, V2, P101, DOI 10.1002/mco2.60; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gong J, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05681-5; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Han DP, 2007, J VIROL, V81, P12029, DOI 10.1128/JVI.00315-07; Harcourt J, 2020, EMERG INFECT DIS, V26, P1266, DOI 10.3201/eid2606.200516; Heger L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00744; Hillaire MLB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056164; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kanemaru K, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax6908; Konieczna P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120261; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Li X., 2020, SARS COV 2 SPIKE PRO, DOI [10.1101/2020.05.10.087288, DOI 10.1101/2020.05.10.087288]; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Lu Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05556-z; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6; Mehta P, 2020, LANCET RESP MED, V8, P822, DOI 10.1016/S2213-2600(20)30267-8; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Morniroli D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01480; Nambulli Sham, 2021, bioRxiv, DOI 10.1101/2021.02.23.432569; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Ren XW, 2021, CELL, V184, P1895, DOI 10.1016/j.cell.2021.01.053; Seethamraju H., 2020, DISRUPTION CCL5 RANT; Shajahan Asif, 2020, Glycobiology, V30, P981, DOI 10.1093/glycob/cwaa042; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Tang L, 2009, GASTROENTEROLOGY, V137, P1498, DOI 10.1053/j.gastro.2009.07.051; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Wang K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00426-x; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Xia S, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0184-0; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yang J, 2010, ARCH VIROL, V155, P881, DOI 10.1007/s00705-010-0657-5; Yu YRA, 2016, AM J RESP CELL MOL, V54, P13, DOI 10.1165/rcmb.2015-0146OC; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zhang L, 2016, J MED VIROL, V88, P2186, DOI 10.1002/jmv.24570; Zhang X, 2011, ARCH VIROL, V156, P637, DOI 10.1007/s00705-010-0903-x; Zhao DY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005487; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504; Zhou Peng, 2020, Nature (London), V588, DOI 10.1038/s41586-020-2951-z; Zhou T, 2020, J EXP MED, V217, DOI 10.1084/jem.20200674; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zhu James, 2020, bioRxiv, DOI 10.1101/2020.02.08.939553	93	61	62	5	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1304	+		10.1016/j.immuni.2021.05.006	http://dx.doi.org/10.1016/j.immuni.2021.05.006		JUN 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34048708	Bronze, Green Published			2022-12-18	WOS:000659882900019
J	Heming, M; Li, XL; Rauber, S; Mausberg, AK; Borsch, AL; Hartlehnert, M; Singhal, A; Lu, IN; Fleischer, M; Szepanowski, F; Witzke, O; Brenner, T; Dittmer, U; Yosef, N; Kleinschnitz, C; Wiendl, H; Stettner, M; zu Horste, GM				Heming, Michael; Li, Xiaolin; Raeuber, Saskia; Mausberg, Anne K.; Boersch, Anna-Lena; Hartlehnert, Maike; Singhal, Arpita; Lu, I-Na; Fleischer, Michael; Szepanowski, Fabian; Witzke, Oliver; Brenner, Thorsten; Dittmer, Ulf; Yosef, Nir; Kleinschnitz, Christoph; Wiendl, Heinz; Stettner, Mark; zu Hoerste, Gerd Meyer			Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid	IMMUNITY			English	Article							MULTIPLE-SCLEROSIS; IMMUNE; DYSFUNCTION	Patients suffering from Coronavirus disease 2019 (COVID-19) can develop neurological sequelae, such as headache and neuroinflammatory or cerebrovascular disease. These conditions termed here as Neuro-COVID are more frequent in patients with severe COVID-19. To understand the etiology of these neurological sequelae, we utilized single-cell sequencing and examined the immune cell profiles from the cerebrospinal fluid (CSF) of Neuro-COVID patients compared with patients with non-inflammatory and auto-immune neurological diseases or with viral encephalitis. The CSF of Neuro-COVID patients exhibited an expansion of dedifferentiated monocytes and of exhausted CD4(+) T cells. Neuro-COVID CSF leukocytes featured an enriched interferon signature; however, this was less pronounced than in viral encephalitis. Repertoire analysis revealed broad clonal T cell expansion and curtailed interferon response in severe compared with mild Neuro-COVID patients. Collectively, our findings document the CSF immune compartment in Neuro-COVID patients and suggest compromised antiviral responses in this setting.	[Heming, Michael; Li, Xiaolin; Raeuber, Saskia; Boersch, Anna-Lena; Hartlehnert, Maike; Lu, I-Na; Wiendl, Heinz; zu Hoerste, Gerd Meyer] Univ Hosp Munster, Inst Translat Neurol, Dept Neurol, Munster, Germany; [Mausberg, Anne K.; Fleischer, Michael; Szepanowski, Fabian; Kleinschnitz, Christoph; Stettner, Mark] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Singhal, Arpita; Yosef, Nir] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Singhal, Arpita; Yosef, Nir] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Witzke, Oliver] Univ Duisburg Essen, West German Ctr Infect Dis, Dept Infect Dis, Duisburg, Germany; [Brenner, Thorsten] Univ Duisburg Essen, Univ Hosp Essen, Dept Anesthesiol & Intens Care Med, Essen, Germany; [Dittmer, Ulf] Univ Hosp Essen, Inst Virol, Essen, Germany; [Yosef, Nir] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA; [Yosef, Nir] Chan Zuckerberg Biohub, San Francisco, CA USA	University of Munster; University of Duisburg Essen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	zu Horste, GM (corresponding author), Univ Hosp Munster, Inst Translat Neurol, Dept Neurol, Munster, Germany.; Stettner, M (corresponding author), Univ Hosp Essen, Dept Neurol, Essen, Germany.	mark.stettner@uk-essen.de; gerd.meyerzuhoerste@ukmuenster.de	Stettner, Mark/GQY-7516-2022; FLeischer, Michael/GRY-2134-2022; Wiendl, Heinz/AAX-6041-2021; LI, Xiaolin/GXH-0388-2022; Horste, Gerd Meyer zu/O-9549-2016	LI, Xiaolin/0000-0003-1524-051X; Horste, Gerd Meyer zu/0000-0002-4341-4719; Fleischer, Michael/0000-0002-5720-8393; Heming, Michael/0000-0002-9568-2790; Singhal, Arpita/0000-0002-6515-6474; Kleinschnitz, Christoph/0000-0002-1650-8875	Deutsche Forschungsgemeinschaft (DFG) [ME4050/4-1]; DFG [ME4050/8-1]; Ministerium fur Innovation, Wissenschaft und Forschung (MIWF) des Landes Nordrhein-Westfalen; DFG through Sonderforschungsbereich Collaborative Research Center Transregio (CRC-TR) 128; Foundation University Hospital Essen; Biogen; Rudolf-Ackermann-Stiftung (Stiftung fur Klinische Infektiologie)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Ministerium fur Innovation, Wissenschaft und Forschung (MIWF) des Landes Nordrhein-Westfalen; DFG through Sonderforschungsbereich Collaborative Research Center Transregio (CRC-TR) 128(German Research Foundation (DFG)); Foundation University Hospital Essen; Biogen(Biogen); Rudolf-Ackermann-Stiftung (Stiftung fur Klinische Infektiologie)	We are deeply indebted to the patients for their participation. We thank Carolin Lewe and Marc Hennies for excellent technical assistance and Dr. Chenling Xu for help with data analysis. G.M.z.H. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; grant number ME4050/4-1) and DFG grant ME4050/8-1, under the frame of E-Rare-3, the ERA-Net for Research on Rare Diseases; and from the Ministerium fur Innovation, Wissenschaft und Forschung (MIWF) des Landes Nordrhein-Westfalen. This study was supported by the DFG through Sonderforschungsbereich Collaborative Research Center Transregio (CRC-TR) 128, projects A09 (to H.W.) and B03 (to G.M.z.H.). The study was also supported by the Foundation University Hospital Essen (M.S.). H.W. received project-related research support from Biogen. O.W. was supported by an unrestricted grant of the Rudolf-Ackermann-Stiftung (Stiftung f_ur Klinische Infektiologie). The graphical abstract contains images from Servier Medical Art (https://smart.servier.com, licensed under a Create Commons Attribution 3.0 Unported License).	Alexopoulos H, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000893; Alsoussi WB, 2020, J IMMUNOL, V205, P915, DOI 10.4049/jimmunol.2000583; Bellon M, 2021, CLIN INFECT DIS, V73, pE3102, DOI 10.1093/cid/ciaa1165; Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Borcherding Nicholas, 2020, F1000Res, V9, P47, DOI 10.12688/f1000research.22139.1; Buonsenso D, 2021, LANCET INFECT DIS, V21, P22, DOI [10.1016/S1473-3099(20)30396-0, 10.1016/s14733099(20)303960]; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Corrie BD, 2018, IMMUNOL REV, V284, P24, DOI 10.1111/imr.12666; De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4; Destras G, 2020, LANCET MICROBE, V1, pE149, DOI 10.1016/S2666-5247(20)30066-5; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Esaulova E, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000732; Espindola OD, 2020, INT J INFECT DIS, V96, P567, DOI 10.1016/j.ijid.2020.05.123; Fan X., 2020, 20101238 MEDRXIV; Farhadian SF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121718; Filippi M, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/s41572-018-0041-4, 10.1038/s41572-018-0046-z]; Fotuhi M, 2020, J ALZHEIMERS DIS, V76, P3, DOI 10.3233/JAD-200581; Franke C, 2021, BRAIN BEHAV IMMUN, V93, P415, DOI 10.1016/j.bbi.2020.12.022; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Fu Rui, 2020, F1000Res, V9, P223, DOI 10.12688/f1000research.22969.1; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Han S, 2014, J IMMUNOL, V192, P2551, DOI 10.4049/jimmunol.1302884; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hillje R, 2020, BIOINFORMATICS, V36, P2311, DOI 10.1093/bioinformatics/btz877; Horste GMZ, 2020, TRENDS IMMUNOL, V41, P341, DOI 10.1016/j.it.2020.02.005; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang L, 2020, BLOOD SINGLE CELL IM, DOI 10.1101/2020.03.15.20033472; Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kilpatrick GJ, 2020, BIORXIV, DOI [10.1101/2020.05.20.106294v1, DOI 10.1101/2020.05.20.106294, 10.1101/2020.05.20.106294]; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kowarik MC, 2014, J NEUROL, V261, P130, DOI 10.1007/s00415-013-7145-2; Kremer S, 2020, RADIOLOGY, V297, pE242, DOI [10.1148/radiol.2020202222, 10.1148/radiol.202020222]; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Mamedov IZ, 2020, LONGITUDINAL HIGH TH, DOI DOI 10.1101/2020.05.18.100545; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Mollan SP, 2019, EYE, V33, P478, DOI 10.1038/s41433-018-0238-5; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Neumann B, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117090; Nielsen S.C.A., 2020, RES SQ, DOI DOI 10.1016/J.CHOM.2020.09.002; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664; Pezzini A, 2020, NAT REV NEUROL, V16, P636, DOI 10.1038/s41582-020-0398-3; Ramesh A, 2020, P NATL ACAD SCI USA, V117, P22932, DOI 10.1073/pnas.2008523117; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Robert C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17670-y; Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937; Rutigliano JA, 2014, J VIROL, V88, P1636, DOI 10.1128/JVI.02851-13; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Schafflick D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14118-w; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Schultheiss C, 2020, IMMUNITY, V53, P442, DOI 10.1016/j.immuni.2020.06.024; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Song Eric, 2020, bioRxiv, DOI 10.1101/2020.09.11.293464; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Tian WM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19706-9; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; VARATHARAJ A, 2020, LANCET PSYCHIAT, V7, P875, DOI [DOI 10.1016/S2215-0366(20)30287-X, 10.1016/S2215-0366(20)30287-X]; Wang TY, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2599-6; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wolbert J, 2020, P NATL ACAD SCI USA, V117, P9466, DOI 10.1073/pnas.1912139117; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Xiong WX, 2020, NEUROLOGY, V95, pE1479, DOI 10.1212/WNL.0000000000010034; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu LN, 2020, IMMUNITY, V53, P685, DOI 10.1016/j.immuni.2020.07.009	85	61	61	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					164	+		10.1016/j.immuni.2020.12.011	http://dx.doi.org/10.1016/j.immuni.2020.12.011		JAN 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33382973	Green Published, Bronze			2022-12-18	WOS:000607814000017
J	Kato, Y; Abbott, RK; Freeman, BL; Haupt, S; Groschel, B; Silva, M; Menis, S; Irvine, DJ; Schief, WR; Crotty, S				Kato, Yu; Abbott, Robert K.; Freeman, Brian L.; Haupt, Sonya; Groschel, Bettina; Silva, Murillo; Menis, Sergey; Irvine, Darrell J.; Schief, William R.; Crotty, Shane			Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo	IMMUNITY			English	Article							ELICITS NEUTRALIZING ANTIBODIES; PRIMARY IMMUNE-RESPONSE; GERMINAL-CENTERS; PLASMA-CELL; VIRUS; HIV-1; VACCINE; MEMORY; IMMUNIZATION; ACTIVATION	How antigen valency affects B cells in vivo during immune responses is not well understood. Here, using HIV immunogens with defined valencies ranging from 1 to 60, we investigated the role of antigen valency during different phases of B cell responses in vivo. Highly multimerized immunogens preferentially rapidly activated cognate B cells, with little affinity discrimination. This led to strong early induction of the transcription factors IRF4 (interferon regulatory factor 4) and Bcl6, driving both early extrafollicular plasma cell and germinal center responses, in a CD4 (+) T-cell-dependent manner, involving B cells with a broad range of affinities. Low-valency antigens induced smaller effector B cell responses, with preferential recruitment of high-affinity B cells. Thus, antigen valency has multifaceted effects on B cell responses and can dictate affinity thresholds and competitive landscapes for B cells in vivo, with implications for vaccine design.	[Kato, Yu; Abbott, Robert K.; Freeman, Brian L.; Haupt, Sonya; Crotty, Shane] La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA; [Kato, Yu; Abbott, Robert K.; Groschel, Bettina; Silva, Murillo; Menis, Sergey; Irvine, Darrell J.; Schief, William R.; Crotty, Shane] Scripps Consortium HIV AIDS Vaccine Dev CHAVD, La Jolla, CA 92037 USA; [Haupt, Sonya; Crotty, Shane] Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA; [Groschel, Bettina; Menis, Sergey; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Groschel, Bettina; Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Silva, Murillo; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Irvine, Darrell J.; Schief, William R.] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Irvine, Darrell J.; Schief, William R.] Harvard Univ, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute	Crotty, S (corresponding author), La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA.; Schief, WR; Crotty, S (corresponding author), Scripps Consortium HIV AIDS Vaccine Dev CHAVD, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Schief, WR (corresponding author), Harvard Univ, Cambridge, MA 02139 USA.	schief@scripps.edu; shane@lji.org	Schief, William/ABF-3645-2020; Silva, Murillo/I-4863-2017	Schief, William/0000-0002-1120-0150; Kato, Yu/0000-0003-4743-1775; Freeman, Brian/0000-0002-9496-9001; Silva, Murillo/0000-0003-4668-6290	NIH NIAID [Al100663, UM1 AI144462]; NIAID [AI048240]; US Department of Defense [W911NF-18-2-0048]; Ragon Institute of MGH, MIT and Harvard; NIH [S10OD021831, K99 AI145762]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Defense(United States Department of Defense); Ragon Institute of MGH, MIT and Harvard; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank members of the LJI Microscopy, Histology, FACS, and DLAC Core Facilities for outstanding expertise. This work was funded by the NIH NIAID under awards Al100663 (Scripps CHAVI-ID) and UM1 AI144462 (Scripps CHAVD) (to S.C. and W.R.S.). This work was additionally supported in part by the NIAID under award AI048240 (W.R.S.); the US Department of Defense under award W911NF-18-2-0048 (W.R.S.); the Ragon Institute of MGH, MIT and Harvard (W.R.S.); and NIH grant K99 AI145762 (R.K.A). Zeiss LSM880 was supported by NIH grant S10OD021831.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bachmann MF, 1996, IMMUNOL TODAY, V17, P553, DOI 10.1016/S0167-5699(96)10066-9; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BRUNSWICK M, 1989, J IMMUNOL, V143, P1414; Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Coleman CM, 2014, VACCINE, V32, P3169, DOI 10.1016/j.vaccine.2014.04.016; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Deng YQ, 2006, STRUCTURE, V14, P247, DOI 10.1016/j.str.2005.10.010; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Dosenovic P, 2018, P NATL ACAD SCI USA, V115, P4743, DOI 10.1073/pnas.1803457115; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; FELDMANN M, 1971, J EXP MED, V134, P103, DOI 10.1084/jem.134.1.103; Fink K, 2007, J IMMUNOL, V179, P5877, DOI 10.4049/jimmunol.179.9.5877; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Ingale J, 2016, CELL REP, V15, P1986, DOI 10.1016/j.celrep.2016.04.078; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Kanekiyo M, 2019, NAT IMMUNOL, V20, P362, DOI 10.1038/s41590-018-0305-x; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046; Martinez-Murillo P, 2017, IMMUNITY, V46, P804, DOI 10.1016/j.immuni.2017.04.021; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mohsen MO, 2017, SEMIN IMMUNOL, V34, P123, DOI 10.1016/j.smim.2017.08.014; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moyer TJ, 2020, NAT MED, V26, P430, DOI 10.1038/s41591-020-0753-3; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pape KA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029116; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Piot P, 2019, NATURE, V575, P119, DOI 10.1038/s41586-019-1656-7; Plotkin S, 2017, PLOTKINS VACCINES; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shlomchik MJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029405; Steichen JM, 2019, SCIENCE, V366, P1216, DOI 10.1126/science.aax4380; Szmuness W., 1980, NEW ENGL J MED, V303, P833; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Tokatlian T, 2019, SCIENCE, V363, P649, DOI 10.1126/science.aat9120; Turner JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15072; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x; Zarnitsyna VI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005692; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	70	61	62	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					548	+		10.1016/j.immuni.2020.08.001	http://dx.doi.org/10.1016/j.immuni.2020.08.001			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32857950	Bronze, Green Published			2022-12-18	WOS:000569806100013
J	Walker, JA; Clark, PA; Crisp, A; Barlow, JL; Szeto, A; Ferreira, ACF; Rana, BMJ; Jolin, HE; Rodriguez-Rodriguez, N; Sivasubramaniam, M; Pannell, R; Cruickshank, J; Daly, M; Haim-Vilmovsky, L; Teichmann, SA; McKenzie, ANJ				Walker, Jennifer A.; Clark, Paula A.; Crisp, Alastair; Barlow, Jillian L.; Szeto, Aydan; Ferreira, Ana C. F.; Rana, Batika M. J.; Jolin, Helen E.; Rodriguez-Rodriguez, Noe; Sivasubramaniam, Meera; Pannell, Richard; Cruickshank, James; Daly, Maria; Haim-Vilmovsky, Liora; Teichmann, Sarah A.; McKenzie, Andrew N. J.			Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow	IMMUNITY			English	Article							ROR-GAMMA-T; TRANSCRIPTION FACTOR BCL11B; RNA-SEQ; FACTOR GATA3; DIFFERENTIATION; QUANTIFICATION; EXPRESSION; GENERATION; PLASTICITY; INSIGHTS	Innate lymphoid cells (ILCs) play strategic roles in tissue homeostasis and immunity. ILCs arise from lymphoid progenitors undergoing lineage restriction and the development of specialized ILC subsets. We generated "5x polychromILC'' transcription factor reporter mice to delineate ILC precursor states by revealing the multifaceted expression of key ILC-associated transcription factors (Id2, Bcl11b, Gata3, ROR gamma t, and ROR alpha) during ILC development in the bone marrow. This approach allowed previously unattained enrichment of rare progenitor subsets and revealed hitherto unappreciated ILC precursor heterogeneity. In vivo and in vitro assays identified precursors with potential to generate all ILC subsets and natural killer (NK) cells, and also permitted discrimination of elusive ILC3 bone marrow antecedents. Single-cell gene expression analysis identified a discrete ILC2-committed population and delineated transition states between early progenitors and a highly heterogeneous ILC1, ILC3, and NK precursor cell cluster. This diversity might facilitate greater lineage potential upon progenitor recruitment to peripheral tissues.	[Walker, Jennifer A.; Clark, Paula A.; Crisp, Alastair; Barlow, Jillian L.; Szeto, Aydan; Ferreira, Ana C. F.; Rana, Batika M. J.; Jolin, Helen E.; Rodriguez-Rodriguez, Noe; Sivasubramaniam, Meera; Pannell, Richard; Cruickshank, James; Daly, Maria; McKenzie, Andrew N. J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Haim-Vilmovsky, Liora; Teichmann, Sarah A.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Teichmann, Sarah A.] Univ Cambridge, Theory Condensed Matter, Cavendish Lab, Dept Phys, Cambridge, England; [Teichmann, Sarah A.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Genome Campus, Hinxton, England	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL)	McKenzie, ANJ (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	anm@mrc-lmb.cam.ac.uk		Rodriguez-Rodriguez, Noe/0000-0001-7825-5634; Crisp, Alastair/0000-0001-8069-2294; Barlow, Jillian Lynne/0000-0002-8680-3589; Vilmovsky, Liora/0000-0001-9342-749X	UK Medical Research Council [U105178805]; Wellcome Trust [100963/Z/13/Z]; H2020 Marie Sklodowska Curie Actions; MRC [MC_EX_MR/S300001/1, MC_U105178805] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); H2020 Marie Sklodowska Curie Actions; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Ares staff, genotyping facility and flow cytometry core for their technical assistance. We are grateful to Pentao Liu for providing the Bcl11b-tdTomato mice. This study was supported by grants from the UK Medical Research Council (U105178805) and Wellcome Trust (100963/Z/13/Z). L.H-V held an EMBL Interdisciplinary Postdoctoral fellowship, supported by H2020 Marie Sk1odowska Curie Actions.	Allan DSJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03256-0; Burt BM, 2008, J LEUKOCYTE BIOL, V84, P1039, DOI 10.1189/jlb.0408256; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Chea S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/368427; Chen LX, 2018, IMMUNITY, V49, P464, DOI 10.1016/j.immuni.2018.08.010; Cherrier DE, 2018, IMMUNITY, V48, P1091, DOI 10.1016/j.immuni.2018.05.010; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Frechette I, 2010, FEBS J, V277, P4241, DOI 10.1111/j.1742-4658.2010.07813.x; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Krabbendam L, 2018, IMMUNOL REV, V286, P74, DOI 10.1111/imr.12708; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lun Aaron T L, 2016, F1000Res, V5, P2122; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Ng KKH, 2018, ELIFE, V7, DOI 10.7554/eLife.37851; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Zhu JF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01571	52	61	61	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					104	+		10.1016/j.immuni.2019.05.002	http://dx.doi.org/10.1016/j.immuni.2019.05.002			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31128961	Green Published, hybrid			2022-12-18	WOS:000475561000014
J	Sokol, CL; Camire, RB; Jones, MC; Luster, AD				Sokol, Caroline L.; Camire, Ryan B.; Jones, Michael C.; Luster, Andrew D.			The Chemokine Receptor CCR8 Promotes the Migration of Dendritic Cells into the Lymph Node Parenchyma to Initiate the Allergic Immune Response	IMMUNITY			English	Article							ADAPTIVE IMMUNITY; T-CELLS; IN-VIVO; INFLAMMATION; RECRUITMENT; INNATE; MOBILIZATION; MACROPHAGES; TRAFFICKING; EXPRESSION	The migration of mature dendritic cells (DCs) into the draining lymph node (dLN) is thought to depend solely on the chemokine receptor CCR7. CD301b(+) DCs migrate into the dLN after cutaneous allergen exposure and are required for T helper 2 (Th2) differentiation. We found that CD301b(+) DCs poorly upregulated CCR7 expression after allergen exposure and required a second chemokine signal, mediated by CCR8 on CD301b(+) DCs and its ligand CCL8, to exit the subcapsular sinus (SCS) and enter the lymph node (LN) parenchyma. After allergen exposure, CD169(+)SIGN-R1(+) macrophages in interfollicular regions produced CCL8, which synergized with CCL21 in a Src-kinase-dependent manner to promote CD301b(+) DC migration. In CCR8-deficient mice, CD301b(+) DCs remained in the SCS and were unable to enter the LN parenchyma, resulting in defective Th2 differentiation. We have defined a CCR8-dependent stepwise mechanism of DC-subset-specific migration through which LN CD169(+) SIGN-R1(+) macrophages control the polarization of the adaptive immune response.	[Sokol, Caroline L.; Camire, Ryan B.; Jones, Michael C.; Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Sokol, Caroline L.; Camire, Ryan B.; Jones, Michael C.; Luster, Andrew D.] Harvard Med Sch, Boston, MA 02114 USA; [Jones, Michael C.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Luster, AD (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.; Luster, AD (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912; Jones, Michael/0000-0002-5986-5426	NIH [R37AI040618, K08AI121421, T32HL116275, 1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]; Asthma and Allergy Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020936] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040618, R37AI040618, K08AI121421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016372, S10OD012027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asthma and Allergy Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work was supported by NIH grants R37AI040618 (to A.D.L) and K08AI121421 (to C.L.S.). C.L.S. was supported by NIH grant T32HL116275 and the Asthma and Allergy Foundation of America. Flow cytometry was performed in the Department of Pathology Flow and Image Cytometry Research Core at Massachusetts General Hospital with support from the NIH Shared Instrumentation Program (1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1). We thank Drs. Sergio Lira, Israel Charo, and Osami Kanagawa for providing breeding pairs of Ccr8<SUP>-/-</SUP>, Ccl8<SUP>-/-</SUP>Ccl12<SUP>-/-</SUP>, and Kaede transgenic mice, respectively. We thank Drs. Robert Anthony and Joseph F. Urban for providing Nippostrongylus brasiliensis.	Asano K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8802; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Chung CD, 2003, J IMMUNOL, V170, P581, DOI 10.4049/jimmunol.170.1.581; Das S, 2013, J EXP MED, V210, P1509, DOI 10.1084/jem.20111627; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Goya I, 2003, J IMMUNOL, V170, P2138, DOI 10.4049/jimmunol.170.4.2138; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kumamoto Y, 2016, ELIFE, V5, DOI 10.7554/eLife.17979; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Lian J, 2015, CURR OPIN CELL BIOL, V36, P1, DOI 10.1016/j.ceb.2015.05.003; MILLER MD, 1992, P NATL ACAD SCI USA, V89, P2950, DOI 10.1073/pnas.89.7.2950; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Woodruff MC, 2014, J EXP MED, V211, P1611, DOI 10.1084/jem.20132327; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116; Yabe R, 2015, INT IMMUNOL, V27, P169, DOI 10.1093/intimm/dxu098	46	61	61	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					449	+		10.1016/j.immuni.2018.07.012	http://dx.doi.org/10.1016/j.immuni.2018.07.012			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30170811	Bronze, Green Accepted			2022-12-18	WOS:000444909600013
J	Adams, NM; Lau, CM; Fan, XY; Rapp, M; Geary, CD; Weizman, OE; Diaz-Salazar, C; Sun, JC				Adams, Nicholas M.; Lau, Colleen M.; Fan, Xiying; Rapp, Moritz; Geary, Clair D.; Weizman, Orr-El; Diaz-Salazar, Carlos; Sun, Joseph C.			Transcription Factor IRF8 Orchestrates the Adaptive Natural Killer Cell Response	IMMUNITY			English	Article							SEQUENCE-BINDING PROTEIN; NK CELLS; IN-VIVO; T-CELLS; IMMUNE-RESPONSES; LYMPHOID-CELLS; CYTOMEGALOVIRUS; ICSBP; INFECTION; ACTIVATION	Natural killer (NK) cells are innate lymphocytes that display features of adaptive immunity during viral infection. Biallelic mutations in IRF8 have been reported to cause familial NK cell deficiency and susceptibility to severe viral infection in humans; however, the precise role of this transcription factor in regulating NK cell function remains unknown. Here, we show that cell-intrinsic IRF8 was required for NK-cell-mediated protection against mouse cytomegalovirus infection. During viral exposure, NK cells upregulated IRF8 through interleukin-12 (IL-12) signaling and the transcription factor STAT4, which promoted epigenetic remodeling of the Irf8 locus. Moreover, IRF8 facilitated the proliferative burst of virus-specific NK cells by promoting expression of cell-cycle genes and directly controlling Zbtb32, a master regulator of virus-driven NK cell proliferation. These findings identify the function and cell-type-specific regulation of IRF8 in NK-cellmediated antiviral immunity and provide a mechanistic understanding of viral susceptibility in patients with IRF8 mutations.	[Adams, Nicholas M.; Lau, Colleen M.; Fan, Xiying; Rapp, Moritz; Geary, Clair D.; Weizman, Orr-El; Diaz-Salazar, Carlos; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA.; Sun, JC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	sunj@mskcc.org		Rapp, Moritz/0000-0001-5104-7683; Fan, Xiying/0000-0003-3090-381X; Adams, Nicholas/0000-0001-5751-0480	Medical Scientist Training Program grant from the NIH National Institute of General Medical Sciences [T32GM007739]; F30 Predoctoral Fellowships from the NIH National Institute of Allergy and Infectious Diseases [F30 AI136239-01A1, F30 AI122721-01]; T32 award from the NIH [CA009149]; German Academic Exchange Service (DAAD); Ludwig Center for Cancer Immunotherapy; American Cancer Society; Burroughs Wellcome Fund; NIH [AI100874, AI130043, P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI136239, F30AI122721, R01AI100874, R01AI130043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Medical Scientist Training Program grant from the NIH National Institute of General Medical Sciences; F30 Predoctoral Fellowships from the NIH National Institute of Allergy and Infectious Diseases; T32 award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ludwig Center for Cancer Immunotherapy; American Cancer Society(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sun lab for technical support and experimental assistance and Alexander Rudensky, Ming Li, David Artis, and members of the Sun lab for comments and discussions. Eric Vivier, Toshinori Nakayama, Mark Kaplan, Silvia Vidal, Sandeep Tripathy, and Ken Murphy provided mice critical to this study. N.M.A. and X.F. were supported by a Medical Scientist Training Program grant from the NIH National Institute of General Medical Sciences (T32GM007739 to the Weill Cornell, Rockefeller, and Sloan Kettering Tri-Institutional MD-PhD Program) and F30 Predoctoral Fellowships from the NIH National Institute of Allergy and Infectious Diseases (F30 AI136239-01A1 to N.M.A. and F30 AI122721-01 to X.F.). C.M.L. was supported by a T32 award from the NIH (CA009149). M.R. was supported by a fellowship from the German Academic Exchange Service (DAAD). J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy, the American Cancer Society, the Burroughs Wellcome Fund, and the NIH (AI100874, AI130043, and P30CA008748).	Adams NM, 2016, J IMMUNOL, V197, P2963, DOI 10.4049/jimmunol.1600973; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Etzioni A, 2005, J PEDIATR-US, V146, P423, DOI 10.1016/j.jpeds.2004.11.022; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Herzig Y, 2017, NAT IMMUNOL, V18, P161, DOI 10.1038/ni.3638; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Johnson LR, 2016, CELL REP, V17, P636, DOI 10.1016/j.celrep.2016.09.019; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Mace EM, 2017, J CLIN INVEST, V127, P306, DOI 10.1172/JCI86276; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Mancino A, 2015, GENE DEV, V29, P394, DOI 10.1101/gad.257592.114; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Russ B.E, 2014, IMMUNITY, V41, P853; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shin DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027384; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2011, J EXP MED, V208, P357, DOI 10.1084/jem.20100479; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tamura T, 2015, INT J HEMATOL, V101, P342, DOI 10.1007/s12185-015-1761-9; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	71	61	62	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1172	+		10.1016/j.immuni.2018.04.018	http://dx.doi.org/10.1016/j.immuni.2018.04.018			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29858012	Bronze, Green Accepted			2022-12-18	WOS:000436456900016
J	Mendoza, JL; Schneider, WM; Hoffmann, HH; Vercauteren, K; Jude, KM; Xiong, AM; Moraga, I; Horton, TM; Glenn, JS; de Jong, YP; Rice, CM; Garcia, KC				Mendoza, Juan L.; Schneider, William M.; Hoffmann, Hans-Heinrich; Vercauteren, Koen; Jude, Kevin M.; Xiong, Anming; Moraga, Ignacio; Horton, Tim M.; Glenn, Jeffrey S.; de Jong, Ype P.; Rice, Charles M.; Garcia, K. Christopher			The IFN-lambda-IFN-lambda R1-IL-10R beta Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity	IMMUNITY			English	Article							MURINE NOROVIRUS INFECTION; RANDOMIZED PHASE 2B; CHRONIC HEPATITIS-C; INTERFERON-LAMBDA; PEGINTERFERON LAMBDA-1A; CRYSTAL-STRUCTURE; ANTITUMOR-ACTIVITY; HUMAN HEPATOCYTES; RECEPTOR COMPLEX; IL-10R2 BINDING	Type III interferons (IFN-lambda s) signal through a heterodimeric receptor complex composed of the IFN-lambda R1 subunit, specific for IFN-lambda s, and interleukin-10Rb (IL-10Rb), which is shared by multiple cytokines in the IL-10 superfamily. Low affinity of IL-10Rb for cytokines has impeded efforts aimed at crystallizing cytokine-receptor complexes. Weused yeast surface display to engineer a higher-affinity IFN-lambda variant, H11, which enabled crystallization of the ternary complex. The structure revealed that IL-10Rb uses a network of tyrosine residues as hydrophobic anchor points to engage IL-10 family cytokines that present complementary hydrophobic binding patches, explaining its role as both a cross-reactive but cytokine-specific receptor. H11 elicited increased antiproliferative and antiviral activities in vitro and in vivo. In contrast, engineered higher-affinity type I IFNs did not increase antiviral potency over wild-type type I IFNs. Our findings provide insight into cytokine recognition by the IL-10R family and highlight the plasticity of type III interferon signaling and its therapeutic potential.	[Mendoza, Juan L.; Jude, Kevin M.; Moraga, Ignacio; Horton, Tim M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Mendoza, Juan L.; Jude, Kevin M.; Moraga, Ignacio; Horton, Tim M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Schneider, William M.; Hoffmann, Hans-Heinrich; Vercauteren, Koen; de Jong, Ype P.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Xiong, Anming; Glenn, Jeffrey S.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Div Gastroenterol & Hepatol,Dept Med, Stanford, CA 94305 USA; [Xiong, Anming; Glenn, Jeffrey S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [de Jong, Ype P.] Weill Cornell Med, Div Gastroenterol & Hepatol, Ctr Study Hepatitis C, New York, NY 10065 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Rockefeller University; Stanford University; Stanford University; Cornell University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Moraga, Ignacio/0000-0001-9909-0701; Vercauteren, Koen O.A./0000-0003-1472-9938; Jude, Kevin/0000-0002-3675-5136	NIH [1U19AI109662, RO1-AI51321, AI091707, K01CA175127, DK095666, K08DK090576, R01HL131093]; Greenberg Medical Research Institute; Starr Foundation; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [K01CA175127] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321, R01AI091707, U19AI109662, R37AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095666, K08DK090576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Menashe Elazar for work on preliminary in vivo studies, Wu Di for help with protein expression, and Deepa Waghray and Susan Fischer for technical assistance. This work was supported by NIH grants 1U19AI109662 (to K.C.G. and J.G.) NIH RO1-AI51321 (to K.C.G.), AI091707 (to C.M.R.). K.C.G. is an investigator of the Howard Hughes Medical Institute. J.L.M. is supported by NIH award K01CA175127, W.M.S. by DK095666, and Y.P.J. by K08DK090576 and R01HL131093. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation, and several generous donors (to C.M.R.). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Structure factors and coordinates have been deposited in the Protein Data Bank with identification number PDB: 5T5W. Diffraction images have been deposited in the SBGrid Data Bank (http://dx.doi.org/10.15785/SBGRID/416).	Andrus L, 2011, HEPATOLOGY, V54, P1901, DOI 10.1002/hep.24557; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Billerbeck E, 2016, J HEPATOL, V65, P334, DOI 10.1016/j.jhep.2016.04.022; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Bleicher L, 2008, FEBS LETT, V582, P2985, DOI 10.1016/j.febslet.2008.07.046; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Brideau-Andersen AD, 2007, P NATL ACAD SCI USA, V104, P8269, DOI 10.1073/pnas.0609001104; Chan HLY, 2016, J HEPATOL, V64, P1011, DOI 10.1016/j.jhep.2015.12.018; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; Ciancio A, 2014, NAT REV GASTRO HEPAT, V11, P68, DOI 10.1038/nrgastro.2013.164; de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Hruska M, 2015, J CLIN PHARMACOL, V55, P73, DOI 10.1002/jcph.361; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Jones BC, 2008, ACTA CRYSTALLOGR F, V64, P266, DOI 10.1107/S1744309108004752; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Logsdon NJ, 2004, J MOL BIOL, V342, P503, DOI 10.1016/j.jmb.2004.07.069; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Miknis ZJ, 2010, J MOL BIOL, V404, P650, DOI 10.1016/j.jmb.2010.09.068; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shlomai A, 2014, P NATL ACAD SCI USA, V111, P12193, DOI 10.1073/pnas.1412631111; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Steen HC, 2010, J INTERF CYTOK RES, V30, P597, DOI 10.1089/jir.2010.0058; TAN JC, 1993, J BIOL CHEM, V268, P21053; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang XD, 2015, J CLIN PHARMACOL, V55, P63, DOI 10.1002/jcph.363; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wu PW, 2008, J MOL BIOL, V382, P1168, DOI 10.1016/j.jmb.2008.07.046; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	58	61	68	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					379	392		10.1016/j.immuni.2017.02.017	http://dx.doi.org/10.1016/j.immuni.2017.02.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329704	Green Accepted, Bronze			2022-12-18	WOS:000396818100011
J	Chou, C; Verbaro, DJ; Tonc, E; Holmgren, M; Cella, M; Colonna, M; Bhattacharya, D; Egawa, T				Chou, Chun; Verbaro, Daniel J.; Tonc, Elena; Holmgren, Melanie; Cella, Marina; Colonna, Marco; Bhattacharya, Deepta; Egawa, Takeshi			The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses	IMMUNITY			English	Article							C-MYC; NEUTRALIZING ANTIBODIES; CLONAL SELECTION; MEMORY B; CD40-DEFICIENT MICE; AFFINITY MATURATION; IMMUNE-RESPONSES; DEFICIENT; DIFFERENTIATION; PROLIFERATION	B cells diversify and affinity mature their antigen receptor repertoire in germinal centers (GCs). GC B cells receive help signals during transient interaction with T cells, yet it remains unknown how these transient T-B interactions in the light zone sustain the subsequent proliferative program of selected B cells that occurs in the anatomically distant dark zone. Here, we show that the transcription factor AP4 was required for sustained GC B cell proliferation and subsequent establishment of a diverse and protective antibody repertoire. AP4 was induced by c-MYC during the T-B interactions, was maintained by T-cell-derived interleukin-21 (IL-21), and promoted repeated rounds of divisions of selected GC B cells. B-cell-specific deletion of AP4 resulted in reduced GC sizes and reduced somatic hypermutation coupled with a failure to control chronic viral infection. These results indicate that AP4 integrates T-cell-mediated selection and sustained expansion of GC B cells for humoral immunity.	[Chou, Chun; Verbaro, Daniel J.; Tonc, Elena; Holmgren, Melanie; Cella, Marina; Colonna, Marco; Bhattacharya, Deepta; Egawa, Takeshi] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Egawa, T (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	tegawa@wustl.edu	Cella, Marina/ABA-8564-2020	Cella, Marina/0000-0003-1230-1313; Colonna, Marco/0000-0001-5222-4987; Egawa, Takeshi/0000-0001-7489-1051; Holmgren, Melanie/0000-0002-2541-4854	Lucille P. Markey Pathway Program; NIH [P30 AR048335, R01 AI097244, R56 AI114593, R01 AI099108, UL1 TR000448, P30 CA91842]; Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244, R56AI114593, R01AI099108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	Lucille P. Markey Pathway Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B.P. Sleckman for c-MYC-GFP mice; F.W. Alt for Myc<SUP>F</SUP> mice; E. Oltz for Cd79a<SUP>icre/+</SUP> mice; J.M. White for ES cell microinjection; S. Hsiung, Y. Wang, R. Wong, and S. Faragasan for technical support; and C.-S. Hsieh, K.M. Murphy, and E. Oltz for discussion. This study was supported by the Lucille P. Markey Pathway Program (C.C.), the NIH (P30 AR048335 to the Rheumatic Diseases Core Center; R01 AI097244 and R56 AI114593 to T.E.; R01 AI099108 to D.B.; UL1 TR000448 to the Washington University Institute of Clinical and Translational Sciences; P30 CA91842 to the Siteman Cancer Center), and the Edward Mallinckrodt Jr. Foundation (T.E.). D.B. is a New York Stem Cell Foundation-Robertson Investigator.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Chou C, 2014, NAT IMMUNOL, V15, P884, DOI 10.1038/ni.2943; Corcoran LM, 2016, CURR OPIN IMMUNOL, V39, P59, DOI 10.1016/j.coi.2015.12.008; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Johnson DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037337; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; McHeyzer-Williams Louise J, 2004, Methods Mol Biol, V271, P173; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Seiler P, 1998, J VIROL, V72, P2253, DOI 10.1128/JVI.72.3.2253-2258.1998; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	55	61	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					570	582		10.1016/j.immuni.2016.07.023	http://dx.doi.org/10.1016/j.immuni.2016.07.023			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27566940	Green Accepted, Bronze			2022-12-18	WOS:000388454300014
J	Ban, T; Sato, GR; Nishiyama, A; Akiyama, A; Takasuna, M; Umehara, M; Suzuki, S; Ichino, M; Matsunaga, S; Kimura, A; Kimura, Y; Yanai, H; Miyashita, S; Kuromitsu, J; Tsukahara, K; Yoshimatsu, K; Endo, I; Yamamoto, T; Hirano, H; Ryo, A; Taniguchi, T; Tamura, T				Ban, Tatsuma; Sato, Go R.; Nishiyama, Akira; Akiyama, Ai; Takasuna, Marie; Umehara, Marina; Suzuki, Shinsuke; Ichino, Motohide; Matsunaga, Satoko; Kimura, Ayuko; Kimura, Yayoi; Yanai, Hideyuki; Miyashita, Sadakazu; Kuromitsu, Junro; Tsukahara, Kappei; Yoshimatsu, Kentaro; Endo, Itaru; Yamamoto, Tadashi; Hirano, Hisashi; Ryo, Akihide; Taniguchi, Tadatsugu; Tamura, Tomohiko			Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity	IMMUNITY			English	Article							INTERFERON REGULATORY FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; B-CELLS; I INTERFERON; IRF5(-/-) MICE; DISEASE; PATHOGENESIS; EXPRESSION	Interferon regulatory factor-5 (IRF5), a transcription factor critical for the induction of innate immune responses, contributes to the pathogenesis of the autoimmune disease systemic lupus erythematosus (SLE) in humans and mice. Lyn, a Src family kinase, is also implicated in human SLE, and Lyn-deficient mice develop an SLE-like disease. Here, we found that Lyn physically interacted with IRF5 to inhibit ubiquitination and phosphorylation of IRF5 in the TLR-MyD88 pathway, thereby suppressing the transcriptional activity of IRF5 in a manner independent of Lyn's kinase activity. Conversely, Lyn did not inhibit NF-kappa B signaling, another major branch downstream of MyD88. Monoallelic deletion of Irf5 alleviated the hyperproduction of cytokines in TLR-stimulated Lyn(-/-) dendritic cells and the development of SLE-like symptoms in Lyn(-/-) mice. Our results reveal a role for Lyn as a specific suppressor of the TLR-MyD88-IRF5 pathway and illustrate the importance of fine-tuning IRF5 activity for the maintenance of immune homeostasis.	[Ban, Tatsuma; Sato, Go R.; Nishiyama, Akira; Akiyama, Ai; Takasuna, Marie; Umehara, Marina; Suzuki, Shinsuke; Ichino, Motohide; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan; [Suzuki, Shinsuke; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol Surg, Yokohama, Kanagawa 2360004, Japan; [Matsunaga, Satoko; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Dept Microbiol, Yokohama, Kanagawa 2360004, Japan; [Kimura, Ayuko; Kimura, Yayoi; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; [Yanai, Hideyuki; Taniguchi, Tadatsugu] Univ Tokyo, Inst Ind Sci, Dept Mol Immunol, Tokyo 1538505, Japan; [Miyashita, Sadakazu; Kuromitsu, Junro; Tsukahara, Kappei; Yoshimatsu, Kentaro] Eisai & Co Ltd, Tsukuba Res Labs, Ibaraki 3002635, Japan; [Yamamoto, Tadashi] Grad Univ, Okinawa Inst Sci & Technol, Cell Signal Unit, Okinawa 9040495, Japan	Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; University of Tokyo; Eisai Co Ltd; Okinawa Institute of Science & Technology Graduate University	Tamura, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan.	tamurat@yokohama-cu.ac.jp	Yanai, Hideyuki/AGK-5933-2022	Yanai, Hideyuki/0000-0002-0115-9000	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Science and Technology Agency; Eisai Co., Ltd.; MEXT/Japan Society for the Promotion of Science (KAKENHI) [24390246, 24118002, 25860368]; Grant for Strategic Research Promotion from Yokohama City University; Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Science and Technology Agency(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eisai Co., Ltd.(Eisai Co Ltd); MEXT/Japan Society for the Promotion of Science (KAKENHI); Grant for Strategic Research Promotion from Yokohama City University; Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program	We thank Ms. Ayako Nomura, Dr. Masatoshi Nakazawa, Ms. Rei Konya, and Mr. Masahiro Yoshinari at Yokohama City University and Dr. Miho Ohsugi at the University of Tokyo for their help with experiments. This work was supported by the Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Science and Technology Agency to T. Tamura, which accompanies a matching fund from Eisai Co., Ltd.; Grants-in-Aid (KAKENHI) from the MEXT/Japan Society for the Promotion of Science (nos. 24390246 and 24118002 to T. Tamura and 25860368 to T.B.); and a Grant for Strategic Research Promotion from Yokohama City University to T. Tamura. S. Miyashita, J.K., K.T., and K.Y. are employees of Eisai Co., Ltd.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Eames HL, 2016, TRANSL RES, V167, P167, DOI 10.1016/j.trsl.2015.06.018; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fang CM, 2012, GENES IMMUN, V13, P421, DOI 10.1038/gene.2012.10; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Gutierrez T, 2010, EUR J IMMUNOL, V40, P1897, DOI 10.1002/eji.200940043; Hayden MS, 2014, P NATL ACAD SCI USA, V111, P17348, DOI 10.1073/pnas.1419689111; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hua ZL, 2014, J IMMUNOL, V192, P875, DOI 10.4049/jimmunol.1300683; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Kono DH, 2013, CURR OPIN IMMUNOL, V25, P720, DOI 10.1016/j.coi.2013.10.006; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lamagna C, 2014, J IMMUNOL, V192, P919, DOI 10.4049/jimmunol.1301979; Lamagna C, 2013, P NATL ACAD SCI USA, V110, pE3311, DOI 10.1073/pnas.1300617110; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Silver KL, 2007, EUR J IMMUNOL, V37, P2734, DOI 10.1002/eji.200737293; Steinhagen F, 2013, EUR J IMMUNOL, V43, P1896, DOI 10.1002/eji.201242792; Stone RC, 2012, ARTHRITIS RHEUM-US, V64, P788, DOI 10.1002/art.33395; Tadokoro D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.65; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Verhagen AM, 2009, J IMMUNOL, V182, P2020, DOI 10.4049/jimmunol.0803127; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Watkins AA, 2015, J IMMUNOL, V194, P1467, DOI 10.4049/jimmunol.1402807; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Xu Y, 2012, J IMMUNOL, V188, P4113, DOI 10.4049/jimmunol.1103113; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yang LS, 2012, J IMMUNOL, V189, P3741, DOI 10.4049/jimmunol.1201162; Yasuda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103478; Yasuda K, 2013, INT IMMUNOL, V25, P295, DOI 10.1093/intimm/dxs114	50	61	63	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					319	332		10.1016/j.immuni.2016.07.015	http://dx.doi.org/10.1016/j.immuni.2016.07.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27521268	Bronze			2022-12-18	WOS:000382267300014
J	Schuster, C; Gerold, KD; Schober, K; Probst, L; Boerner, K; Kim, MJ; Ruckdeschel, A; Serwold, T; Kissler, S				Schuster, Cornelia; Gerold, Kay D.; Schober, Kilian; Probst, Lilli; Boerner, Kevin; Kim, Mi-Jeong; Ruckdeschel, Anna; Serwold, Thomas; Kissler, Stephan			The Autoimmunity-Associated Gene CLEC16A Modulates Thymic Epithelial Cell Autophagy and Alters T Cell Selection	IMMUNITY			English	Article							MHC CLASS-II; PROTEIN; SUSCEPTIBILITY; COMPLEX; ANTIGEN; IDENTIFICATION; COMPARTMENTS; MOLECULES; DELETION; VARIANTS	CLEC16A variation has been associated with multiple immune-mediated diseases, including type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, celiac disease, Crohn's disease, Addison's disease, primary biliary cirrhosis, rheumatoid arthritis, juvenile idiopathic arthritis, and alopecia areata. Despite strong genetic evidence implicating CLEC16A in autoimmunity, this gene's broad association with disease remains unexplained. We generated Clec16a knock-down (KD) mice in the nonobese diabetic (NOD) model for type 1 diabetes and found that Clec16a silencing protected against autoimmunity. Disease protection was attributable to T cell hyporeactivity, which was secondary to changes in thymic epithelial cell (TEC) stimuli that drive thymocyte selection. Our data indicate that T cell selection and reactivity were impacted by Clec16a variation in thymic epithelium owing to Clec16a's role in TEC autophagy. These findings provide a functional link between human CLEC16A variation and the immune dysregulation that underlies the risk of autoimmunity.	[Schuster, Cornelia; Schober, Kilian; Boerner, Kevin; Kim, Mi-Jeong; Ruckdeschel, Anna; Serwold, Thomas; Kissler, Stephan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Gerold, Kay D.; Probst, Lilli; Kissler, Stephan] Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; German Research Foundation (DFG); University of Wurzburg	Kissler, S (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	stephan.kissler@joslin.harvard.edu		/0000-0003-3062-7800	NIH [P30DK036836]; Deutsche Forschungsgemeinschaft [DFG FZ82]; JDRF [2-2010-383]; Mary K. Iacocca Fellowship by Iacocca Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); JDRF(Juvenile Diabetes Research Foundation); Mary K. Iacocca Fellowship by Iacocca Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Nicole Hain for technical assistance, Daniela Blassfeld for help with the initial cloning and validation of lentiviral vectors, Jennifer Hollister-Lock for advice with islet purification and insulin measurements, and the Joslin DRC (NIH Award Number P30DK036836) Flow Cytometry Core facility for help with cell sorting. This work was supported in part by funding from the Deutsche Forschungsgemeinschaft to the Rudolf Virchow Center (DFG FZ82), by a Career Development Award from JDRF to S.K. (2-2010-383), and by a Mary K. Iacocca Fellowship provided by the Iacocca Foundation to C.S.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Berge T, 2013, INT J MOL SCI, V14, P4476, DOI 10.3390/ijms14034476; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; Hirschfield GM, 2012, GENES IMMUN, V13, P328, DOI 10.1038/gene.2011.89; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hu XL, 2012, CURR OPIN IMMUNOL, V24, P571, DOI 10.1016/j.coi.2012.09.001; Jagielska D, 2012, J INVEST DERMATOL, V132, P2192, DOI 10.1038/jid.2012.129; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Keir ME, 2005, J IMMUNOL, V175, P7372, DOI 10.4049/jimmunol.175.11.7372; Kim S, 2012, P NATL ACAD SCI USA, V109, pE1072, DOI 10.1073/pnas.1120320109; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Marquez A, 2009, EUR J HUM GENET, V17, P1304, DOI 10.1038/ejhg.2009.50; Martinez A, 2010, ANN RHEUM DIS, V69, P309, DOI 10.1136/ard.2008.098376; Mero IL, 2011, GENES IMMUN, V12, P191, DOI 10.1038/gene.2010.59; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Plesa G, 2012, BLOOD, V119, P3420, DOI 10.1182/blood-2011-09-377051; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Skinningsrud B, 2010, ANN RHEUM DIS, V69, P1471, DOI 10.1136/ard.2009.114934; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Sukseree S, 2013, BIOCHEM BIOPH RES CO, V430, P689, DOI 10.1016/j.bbrc.2012.11.090; Sukseree S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038933; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	40	61	63	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					942	952		10.1016/j.immuni.2015.04.011	http://dx.doi.org/10.1016/j.immuni.2015.04.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25979422	Bronze, Green Accepted			2022-12-18	WOS:000354827400019
J	Laky, K; Evans, S; Perez-Diez, A; Fowlkes, BJ				Laky, Karen; Evans, Sharron; Perez-Diez, Ainhoa; Fowlkes, B. J.			Notch Signaling Regulates Antigen Sensitivity of Naive CD4(+) T Cells by Tuning Co-stimulation	IMMUNITY			English	Article							TRANSFERRIN RECEPTOR; LYMPHOCYTES-T; ACTIVATION; INTERLEUKIN-2; EXPRESSION; DIFFERENTIATION; RESPONSES; PROLIFERATION; PATHWAY; LIGAND	Adaptive immune responses begin when naive CD4(+) T cells engage peptide+major histocompatibility complex class II and co-stimulatory molecules on antigen-presenting cells (APCs). Notch signaling can influence effector functions in differentiated CD4(+) T helper and T regulatory cells. Whether and how ligand-induced Notch signaling influences the initial priming of CD4(+) T cells has not been addressed. We have found that Delta Like Ligand 4 (DLL4)-induced Notch signaling potentiates phosphatidylinositol 3-OH kinase (PI3K)-dependent signaling downstream of the T cell receptor+CD28, allowing naive CD4(+) T cells to respond to lower doses of antigen. In vitro, DLL4-deficient APCs were less efficient stimulators of CD4(+) T cell activation, metabolism, proliferation, and cytokine secretion. With deletion of DLL4 from CD11c(+) APCs in vivo, these deficits translated to an impaired ability to mount an effective CD4(+)-dependent anti-tumor response. These data implicate Notch signaling as an important regulator of adaptive immune responses.	[Laky, Karen; Evans, Sharron; Fowlkes, B. J.] NIAID, T Cell Dev Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Perez-Diez, Ainhoa] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fowlkes, BJ (corresponding author), NIAID, T Cell Dev Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	bfowlkes@nih.gov	Perez-Diez, Ainhoa/AAR-1630-2020	Perez-Diez, Ainhoa/0000-0001-8948-554X	Intramural Research Program of the NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000486] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Singh, R. Varma, E. Shevach, F. Ramsdell, L. Lefrancois, and P. Schwartzberg for their valuable suggestions regarding experimental design, interpretation of the data, and/or writing of the manuscript; R. Germain, T. Honjo, and S. Habu for critical reagents; T. Moyer and C. Eigsti of the NIAID Flow Cytometry Core Facility for sorting; and S. Friend and R. DeMarco of Amnis/EMD Millipore and D. Stephany of the NIAID Flow Cytometry Core Facility for assistance with the Imagestream analyses. This research was supported by the Intramural Research Program of the NIAID, NIH.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Auderset F, 2013, J IMMUNOL, V191, P2344, DOI 10.4049/jimmunol.1300643; Bayer AL, 1998, J LEUKOCYTE BIOL, V64, P19, DOI 10.1002/jlb.64.1.19; BREKELMANS P, 1994, EUR J IMMUNOL, V24, P2896, DOI 10.1002/eji.1830241147; BREKELMANS P, 1994, CELL IMMUNOL, V159, P331, DOI 10.1006/cimm.1994.1319; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng PY, 2010, IMMUNOL REV, V234, P105, DOI 10.1111/j.0105-2896.2009.00871.x; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; COTNER T, 1983, J EXP MED, V157, P461, DOI 10.1084/jem.157.2.461; Dongre A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00054; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Helbig C, 2012, P NATL ACAD SCI USA, V109, P9041, DOI 10.1073/pnas.1206044109; INABA K, 1984, J EXP MED, V160, P1717, DOI 10.1084/jem.160.6.1717; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P8224, DOI 10.1167/iovs.11-7756; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jehn BM, 1999, J IMMUNOL, V162, P635; Jelley-Gibbs DM, 2008, IMMUNOL CELL BIOL, V86, P343, DOI 10.1038/icb.2008.13; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Khwaja SS, 2010, J CLIN INVEST, V120, P2537, DOI 10.1172/JCI41277; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Minter LM, 2012, CURR TOP MICROBIOL, V360, P99, DOI 10.1007/82_2012_233; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Riha Pavel, 2010, Self Nonself, V1, P231, DOI 10.4161/self.1.3.12968; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Takeichi N, 2010, INT IMMUNOL, V22, P729, DOI 10.1093/intimm/dxq059; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Teh HS, 1997, CELL IMMUNOL, V179, P74, DOI 10.1006/cimm.1997.1137; Tran IT, 2013, J CLIN INVEST, V123, P1590, DOI 10.1172/JCI65477; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Weber J, 2011, CLIN CANCER RES, V17, P1664, DOI 10.1158/1078-0432.CCR-10-2272; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751	57	61	66	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					80	94		10.1016/j.immuni.2014.12.027	http://dx.doi.org/10.1016/j.immuni.2014.12.027			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607460	Green Accepted, Bronze			2022-12-18	WOS:000348197500013
J	Soudja, SM; Chandrabos, C; Yakob, E; Veenstra, M; Palliser, D; Lauvau, G				Soudja, Saidi M'Homa; Chandrabos, Ceena; Yakob, Ernest; Veenstra, Mike; Palliser, Deborah; Lauvau, Gregoire			Memory-T-Cell-Derived Interferon-gamma Instructs Potent Innate Cell Activation for Protective Immunity	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; CD8(+) T; LISTERIA-MONOCYTOGENES; IFN-GAMMA; RESPONSES; EFFECTOR; INFECTION; MICE; INFLAMMATION	Cells of the innate immune system are essential for host defenses against primary microbial pathogen infections, yet their involvement in effective memory responses of vaccinated individuals has been poorly investigated. Here we show that memory T cells instruct innate cells to become potent effector cells in a systemic and a mucosal model of infection. Memory T cells controlled phagocyte, dendritic cell, and NK or NK T cell mobilization and induction of a strong program of differentiation, which included their expression of effector cytokines and microbicidal pathways, all of which were delayed in nonvaccinated hosts. Disruption of IFN-gamma signaling in Ly6C(+) monocytes, dendritic cells, and macrophages impaired these processes and the control of pathogen growth. These results reveal how memory T cells, through rapid secretion of IFN-gamma, orchestrate extensive modifications of host innate immune responses that are essential for effective protection of vaccinated hosts.	[Soudja, Saidi M'Homa; Chandrabos, Ceena; Yakob, Ernest; Veenstra, Mike; Palliser, Deborah; Lauvau, Gregoire] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Lauvau, G (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	gregoire.lauvau@einstein.yu.edu			NIH [AI095835, AI103338, AI099567, GM007288]; Einstein Cancer Center [2P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095835, R01AI103338, R01AI099567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H2-K<SUP>d</SUP>/LLO<INF>91-99</INF> tetramers came from the NIH Tetramer Facility. We are grateful to M. Levy (AECOM) for privileged access to the FACS Aria III and thank the AECOM FACS and genomic core facilities. We thank S. Porcelli (AECOM), J. Daily (AECOM), and laboratory members L. Chorro and E. Spaulding for critical comments. Supported by the NIH (grants AI095835, AI103338, and Einstein DRC pilot to G. L.; AI099567 to D. P.; GM007288 to E.Y.). Core resources for FACS were supported by the Einstein Cancer Center (NCI cancer center support grant 2P30CA013330).	Bajenoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011524; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lee SH, 2013, J IMMUNOL, V191, P4223, DOI 10.4049/jimmunol.1300910; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Narni-Mancinelli E, 2007, J EXP MED, V204, P2075, DOI 10.1084/jem.20070204; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; Neighbors M, 2001, J EXP MED, V194, P343, DOI 10.1084/jem.194.3.343; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; OZMEN L, 1994, J EXP MED, V180, P907, DOI 10.1084/jem.180.3.907; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; ZANETTI G, 1992, J IMMUNOL, V148, P1890; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	44	61	63	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					974	988		10.1016/j.immuni.2014.05.005	http://dx.doi.org/10.1016/j.immuni.2014.05.005			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24931122	Bronze, Green Accepted			2022-12-18	WOS:000341440200018
J	Fraser, KA; Schenkel, JM; Jameson, SC; Vezys, V; Masopust, D				Fraser, Kathryn A.; Schenkel, Jason M.; Jameson, Stephen C.; Vezys, Vaiva; Masopust, David			Preexisting High Frequencies of Memory CD8(+) T Cells Favor Rapid Memory Differentiation and Preservation of Proliferative Potential upon Boosting	IMMUNITY			English	Article							SPARE RESPIRATORY CAPACITY; IN-VIVO; TERMINAL DIFFERENTIATION; TELOMERASE ACTIVITY; OXIDATIVE STRESS; VIRAL-INFECTION; CUTTING EDGE; EFFECTOR; EXPRESSION; NAIVE	Memory CD8(+) T cell quantity and quality determine protective efficacy against reinfection. Heterologous prime boost vaccination minimizes contraction of anamnestic effectors and maximizes memory CD8(+) T cell quantity but reportedly erodes proliferative potential and protective efficacy. This study exploited heterologous prime boost vaccination to discover parameters regulating effector CD8(+) T cell contraction and memory differentiation. When abundant memory T cells were established, boosting induced only 5-8 cell divisions, unusually rapid memory T cell differentiation as measured by phenotype and mitochondrial bioenergetic function, long-lived survival of 50% of effector T cells, and preservation of proliferative potential. Conversely, boosting in situations of low memory CD8(+) T cell frequencies induced many cell divisions, increased contraction of effector cells, and caused senescence, low mitochondrial membrane potential, and poorly protective memory. Thus, anamnestic memory T cell differentiation is flexible, and abundant quantity can be achieved while maximizing protective efficacy and preserving proliferative potential.	[Fraser, Kathryn A.; Schenkel, Jason M.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Fraser, Kathryn A.; Schenkel, Jason M.; Jameson, Stephen C.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008; Schenkel, Jason/AAV-8184-2020; Jameson, Stephen C/D-9892-2013; Vezys, Vaiva/N-3144-2013	Schenkel, Jason/0000-0003-4641-6872; Jameson, Stephen C/0000-0001-9137-1146; Vezys, Vaiva/0000-0002-2520-809X	National Institutes of Health [DP2-OD-006467, T32AI007313]; Ruth L. Kirschstein NRSA award [AI084622];  [P30 CA77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI084622, T32AI007313] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health Director's New Innovator Award Program DP2-OD-006467 (D. M.), Ruth L. Kirschstein NRSA award AI084622 (KAF) and NIH T32AI007313 (J.M.S.). The authors acknowledge Jon Yewdell and Hao Shen for sharing recombinant pathogens and the assistance of the Flow Cytometry Core Facility of the Masonic Cancer Center, a comprehensive cancer center designated by the National Cancer Institute, supported in part by P30 CA77598.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Earl P. L., 2001, CURR PROTOC PROTEIN, P12; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hathcock KS, 2003, J IMMUNOL, V170, P147, DOI 10.4049/jimmunol.170.1.147; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Martin MD, 2012, J IMMUNOL, V188, P1255, DOI 10.4049/jimmunol.1101579; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Welsh R. M., 2008, CURR PROTOC MICROBIO, P11; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; YEWDELL JW, 1986, J EXP MED, V163, P1529, DOI 10.1084/jem.163.6.1529; Zehn D, 2012, CELL MOL LIFE SCI, V69, P1565, DOI 10.1007/s00018-012-0965-x; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	58	61	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					171	183		10.1016/j.immuni.2013.07.003	http://dx.doi.org/10.1016/j.immuni.2013.07.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890070	Green Accepted, Bronze			2022-12-18	WOS:000330948300017
J	Kreslavsky, T; Gleimer, M; Miyazaki, M; Choi, Y; Gagnon, E; Murre, C; Sicinski, P; von Boehmer, H				Kreslavsky, Taras; Gleimer, Michael; Miyazaki, Masaki; Choi, Yoon; Gagnon, Etienne; Murre, Cornelis; Sicinski, Piotr; von Boehmer, Harald			beta-Selection-Induced Proliferation Is Required for alpha beta T Cell Differentiation	IMMUNITY			English	Article							PRE-TCR; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; IN-VIVO; C-MYC; NOTCH; PROMOTES; KINASE; GAMMA; SURVIVAL	Proliferation and differentiation are tightly coordinated to produce an appropriate number of differentiated cells and often exhibit an antagonistic relationship. Developing T cells, which arise in the thymus from a minute number of bone-marrow-derived progenitors, undergo a major expansion upon pre-T cell receptor (TCR) expression. The burst of proliferation coincides with differentiation toward the alpha beta T cell lineage-but the two processes were previously thought to be independent from one another, although both were driven by signaling from pre-TCR and Notch receptors. Here we report that proliferation at this step was not only absolutely required for differentiation but also that its ectopic activation was sufficient to substantially rescue differentiation in the absence of Notch signaling. Consistently, pharmacological inhibition of the cell cycle machinery also blocked differentiation in vivo. Thus the proliferation step is strictly required prior to differentiation of immature thymocytes.	[Kreslavsky, Taras; Gleimer, Michael; von Boehmer, Harald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Choi, Yoon; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Miyazaki, Masaki; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Gagnon, Etienne] Univ Montreal, Dept Microbiol & Immunol, Inst Rech Immunol & Cancerol, Montreal, PQ H3T1J4, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Diego; Universite de Montreal	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu		Kreslavsky, Taras/0000-0002-6672-1914	National Institutes of Health [R01 A145846, R01 A151378]; NATIONAL CANCER INSTITUTE [R01CA108420, R01CA108950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045846, R01AI051378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank J.C. Zuniga-Pflucker J.M. Adams, M. Dose, F. Gounari, H. Cantor, and A. Capobianco for providing reagents and mice and G. Turchinovich, D. Gray, M. Herold, H.-J. Kim, C. Daniel, and S. Schlenner for helpful discussions. The authors are grateful to V. Schmidt and G. Singh for technical assistance. These studies were supported by National Institutes of Health Grants R01 A145846 and R01 A151378.	Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Barndt R, 1999, J IMMUNOL, V163, P3331; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Braunstein M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/678705; Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Hu MG, 2011, BLOOD, V117, P6120, DOI 10.1182/blood-2010-08-300517; Hu MG, 2009, CANCER RES, V69, P810, DOI 10.1158/0008-5472.CAN-08-2473; Kreslavsky T, 2010, IMMUNOL REV, V238, P169, DOI 10.1111/j.1600-065X.2010.00947.x; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Petrie HT, 2000, J IMMUNOL, V165, P3094, DOI 10.4049/jimmunol.165.6.3094; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tussiwand R, 2011, EUR J IMMUNOL, V41, P3371, DOI 10.1002/eji.201141824; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	34	61	62	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					840	853		10.1016/j.immuni.2012.08.020	http://dx.doi.org/10.1016/j.immuni.2012.08.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159226	Green Accepted, Bronze			2022-12-18	WOS:000311460000011
J	Santamaria, P				Santamaria, Pere			The Long and Winding Road to Understanding and Conquering Type 1 Diabetes	IMMUNITY			English	Article							CD8(+) T-CELLS; ANTI-CD3 MONOCLONAL-ANTIBODY; COMPLEX-LINKED RESISTANCE; NOD MICE; DENDRITIC CELLS; AVIDITY MATURATION; ISLET ANTIGENS; B-LYMPHOCYTES; IN-SITU; TOLERANCE	Autoimmune diseases with high population prevalence such as type 1 diabetes (T1D) develop as a result of ill-defined interactions between putative environmental triggers and a constellation of genetic elements scattered throughout the genome. In T1D, these interactions somehow trigger a loss of tolerance to pancreatic p cells, manifested in the form of a chronic autoimmune response that mobilizes virtually every cell type of the immune system and progressively erodes the host's 1 cell mass. The five accompanying review articles focus on key areas of T1D research, ranging from genetics and pathogenesis to prediction and therapy. Here, I attempt to integrate and bring into focus the most salient points of these reviews in the context of other findings, with an emphasis on identifying knowledge gaps and research opportunities.	[Santamaria, Pere] Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Santamaria, Pere] Univ Calgary, Fac Med, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Santamaria, P (corresponding author), Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Dept Microbiol & Infect Dis, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Santamaria, Pere/ABF-6823-2021		Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Juvenile Diabetes Research Foundation; Diabetes Association (Foothills)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Association (Foothills)	I acknowledge funding from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Juvenile Diabetes Research Foundation P S is a Scientist of Alberta Innovates-Health Solutions (formerly AHFMR) and a JDRF Scholar I gratefully acknowledge the many scientific and intellectual contributions of past and present laboratory members and collaborators I apologize to those authors whose publications could not be cited owing to space constraints The JMDRC is supported by the Diabetes Association (Foothills)	Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Atabani SF, 2005, EUR J IMMUNOL, V35, P2157, DOI 10.1002/eji.200526168; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Carrillo J, 2005, DIABETES, V54, P69, DOI 10.2337/diabetes.54.1.69; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Hamilton-Williams EE, 2001, P NATL ACAD SCI USA, V98, P11533, DOI 10.1073/pnas.191383798; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Husebye ES, 2010, IMMUNITY, V32, P479, DOI 10.1016/j.immuni.2010.03.016; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Kamanaka M, 2009, P NATL ACAD SCI USA, V106, P11236, DOI 10.1073/pnas.0904780106; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Maier LM, 2005, CURR OPIN IMMUNOL, V17, P601, DOI 10.1016/j.coi.2005.09.013; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McGuire HM, 2009, P NATL ACAD SCI USA, V106, P19438, DOI 10.1073/pnas.0903561106; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; MILLER SD, 1979, J EXP MED, V149, P758, DOI 10.1084/jem.149.3.758; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Novak J, 2007, INT REV IMMUNOL, V26, P49, DOI 10.1080/08830180601070229; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Phillips B, 2008, DIABETES, V57, P1544, DOI 10.2337/db07-0507; Phillips JM, 2007, DIABETES, V56, P634, DOI 10.2337/db06-0832; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Puertas MC, 2007, J IMMUNOL, V178, P6533, DOI 10.4049/jimmunol.178.10.6533; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Schmidt D, 1999, J IMMUNOL, V162, P4627; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Sgouroudis E, 2008, J IMMUNOL, V181, P6283, DOI 10.4049/jimmunol.181.9.6283; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Stratmann T, 2000, J IMMUNOL, V165, P3214, DOI 10.4049/jimmunol.165.6.3214; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Thiessen S, 2002, DIABETES, V51, P325, DOI 10.2337/diabetes.51.2.325; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Tsui H, 2008, DIABETES, V57, P918, DOI 10.2337/db07-0226; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Wucherpfennig KW, 2009, CURR OPIN IMMUNOL, V21, P590, DOI 10.1016/j.coi.2009.07.008; Yamanouchi J, 2003, J IMMUNOL, V171, P6900, DOI 10.4049/jimmunol.171.12.6900; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yamanouchi J, 2010, DIABETES, V59, P272, DOI 10.2337/db09-0648; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	97	61	67	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					437	445		10.1016/j.immuni.2010.04.003	http://dx.doi.org/10.1016/j.immuni.2010.04.003			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412754	Bronze			2022-12-18	WOS:000277171900001
J	Ren, M; Feng, H; Fu, Y; Land, M; Rubin, CS				Ren, Min; Feng, Hui; Fu, Ya; Land, Marianne; Rubin, Charles S.			Protein Kinase D Is an Essential Regulator of C. elegans Innate Immunity	IMMUNITY			English	Article							CAENORHABDITIS-ELEGANS; GOLGI-COMPLEX; IN-VIVO; EXPRESSION; STRESS; GENE; PHOSPHORYLATION; ACTIVATION; RESISTANCE; INFECTION	Protein kinase D (PKD) mediates signal transduction downstream from phospholipase C and diacylglycerol (DAG). PKDs are activated by hormones and stress in cell lines, but little is known about PKD functions and regulation in vivo. Here, we show that DKF-2, a C. elegans PKD, regulates innate immunity. Animals lacking DKF-2 were hypersensitive to killing by bacteria that are pathogens of C. elegans and humans. DKF-2 induced 85 mRNAs, which encode antimicrobial peptides and proteins that sustain intestinal epithelium. Induction of immune effector mRNAs by DKF-2 proceeded via PMK-1 (p38 Mapkinase)-dependent and -independent pathways. TPA-1, a PKC delta homolog, regulated activation and functions of DKF-2 in vivo. Therefore, DKF-2 provides a molecular link that couples DAG signaling to regulation of immunity. This intersection between DAG-TPA-1-DKF-2 and PMK-1 pathways enables integrated immune responses to multiple stimuli. Thus, a PKD mobilizes activation of host immune defenses against pathogens by previously unappreciated signaling pathways and mechanisms.	[Ren, Min; Feng, Hui; Fu, Ya; Land, Marianne; Rubin, Charles S.] Albert Einstein Coll Med, Atran Labs, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rubin, CS (corresponding author), Albert Einstein Coll Med, Atran Labs, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rubin@aecom.yu.edu	Fu, Ya/G-9846-2011		NIH [GM080615]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM080615 (C.S.R.).	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Crane JK, 1997, INFECT IMMUN, V65, P3277, DOI 10.1128/IAI.65.8.3277-3285.1997; Feng H, 2007, J BIOL CHEM, V282, P31273, DOI 10.1074/jbc.M701532200; Feng H, 2006, J BIOL CHEM, V281, P17801, DOI 10.1074/jbc.M511899200; Feng H, 2006, J BIOL CHEM, V281, P17815, DOI 10.1074/jbc.M511898200; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gecz J, 2003, GENE, V320, P137, DOI 10.1016/S0378-1119(03)00819-9; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; IslasTrejo A, 1997, J BIOL CHEM, V272, P6629, DOI 10.1074/jbc.272.10.6629; Ivison SM, 2007, J IMMUNOL, V178, P5735, DOI 10.4049/jimmunol.178.9.5735; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LAND M, 1994, J BIOL CHEM, V269, P9234; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Liu P, 2007, FEBS LETT, V581, P1377, DOI 10.1016/j.febslet.2007.02.055; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; REEVES JE, 1995, MOL MEMBR BIOL, V12, P201, DOI 10.3109/09687689509027508; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; TABUSE Y, 1995, BIOCHEM J, V312, P69, DOI 10.1042/bj3120069; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	34	61	65	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					521	532		10.1016/j.immuni.2009.03.007	http://dx.doi.org/10.1016/j.immuni.2009.03.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19371715	Bronze, Green Accepted			2022-12-18	WOS:000265319000009
J	Zarebski, A; Velu, CS; Baktula, AM; Bourdeau, T; Horman, SR; Basu, S; Bertolone, SJ; Horwitz, M; Hildeman, DA; Trent, JO; Grimes, HL				Zarebski, Adrian; Velu, Chinavenmeni S.; Baktula, Avinash M.; Bourdeau, Tristan; Horman, Shane R.; Basu, Sudeep; Bertolone, Salvatore J.; Horwitz, Marshal; Hildeman, David A.; Trent, John O.; Grimes, H. Leighton			Mutations in growth factor independent-1 associated with human neutropenia mock murine granulopoiesis through colony stimulating factor-1	IMMUNITY			English	Article							SEVERE CONGENITAL NEUTROPENIA; ZINC-FINGER PROTEIN; HEMATOPOIETIC STEM-CELLS; TRANSCRIPTIONAL REPRESSOR; MICE LACKING; GFI-1; DEFICIENCY; EXPRESSION; ELASTASE; MOUSE	Severe congenital neutropenia (SCN) is characterized by a deficiency of mature neutrophils, leading to recurrent bacterial and fungal infections. Although mutations in Elastase-2, neutrophil (ELA2) predominate in human SCN, mutation of Ela2 in mice does not recapitulate SCN. The growth factor independent-1 (GFI1) transcription factor regulates ELA2. Mutations in GFI1 are associated with human SCN, and genetic deletion of GO results in murine neutropenia. We examined whether human SCN-associated GFI1 N382S mutant proteins are causal in SCN and found that GFI1 functions as a rate-limiting granulopoietic molecular switch. The N382S mutation inhibited GFI1 DNA binding and resulted in a dominant-negative block to murine granulopoiesis. Moreover, Gfil N382S selectively derepressed the monopoietic cytokine CSF1 and its receptor. Gfi1 N382S-expressing Csf1(-/-) cells formed neutrophils. These results reveal a common transcriptional program that underlies both human and murine myelopoiesis, and that is central to the pathogenesis of SCN associated with mutations in GFI1. This shared transcriptional pathway may provide new avenues for understanding SCN caused by mutations in other genes and for clinical intervention into human neutropenias.	[Zarebski, Adrian; Velu, Chinavenmeni S.; Baktula, Avinash M.; Bourdeau, Tristan; Horman, Shane R.; Hildeman, David A.; Grimes, H. Leighton] Cincinnati Childrens Hosp, Med Ctr, Div Immunbiol, Cincinnati, OH 45229 USA; [Basu, Sudeep; Bertolone, Salvatore J.; Trent, John O.] Univ Louisville, Louisville, KY 40202 USA; [Horwitz, Marshal] Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA	Cincinnati Children's Hospital Medical Center; University of Louisville; University of Washington; University of Washington Seattle	Grimes, HL (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Immunbiol, Cincinnati, OH 45229 USA.	lee.grimes@cchmc.org	Hildeman, David/I-4884-2015; Hildeman, David/AAA-1757-2020	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; Horwitz, Marshall/0000-0002-1683-1680; Grimes, H. Leighton/0000-0001-8162-6758; Horman, Shane/0000-0002-4291-2126; trent, John/0000-0002-7346-4231	NCI NIH HHS [R01 CA105152, R01 CA105152-05, CA105152] Funding Source: Medline; NHLBI NIH HHS [R01 HL079574, R01 HL079574-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079574] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Donini M, 2007, BLOOD, V109, P4716, DOI 10.1182/blood-2006-09-045427; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; Grenda DS, 2002, BLOOD, V100, P3221, DOI 10.1182/blood-2002-05-1372; Grimes HL, 1996, P NATL ACAD SCI USA, V93, P14569, DOI 10.1073/pnas.93.25.14569; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; HAWLEY RG, 1994, ANN NY ACAD SCI, V716, P327, DOI 10.1111/j.1749-6632.1994.tb21724.x; Heyd F, 2006, NAT IMMUNOL, V7, P859, DOI 10.1038/ni1361; HIRSCH S, 1983, IMMUNOGENETICS, V18, P229, DOI 10.1007/BF00952962; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Khanna-Gupta A, 2007, BLOOD, V109, P4181, DOI 10.1182/blood-2005-05-022004; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Marteijn JAF, 2007, BLOOD, V109, P100, DOI 10.1182/blood-2006-02-003590; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; Trent JO, 2001, METHOD ENZYMOL, V340, P290; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhuang DZ, 2006, J BIOL CHEM, V281, P10745, DOI 10.1074/jbc.M510924200; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	37	61	62	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					370	380		10.1016/j.immuni.2007.12.020	http://dx.doi.org/10.1016/j.immuni.2007.12.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18328744	Bronze, Green Accepted			2022-12-18	WOS:000254142500014
J	Feng, JW; Garrity, D; Call, ME; Moffett, H; Wucherpfennig, KW				Feng, JW; Garrity, D; Call, ME; Moffett, H; Wucherpfennig, KW			Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; NATURAL-KILLER-CELLS; HUMAN FC RECEPTOR; COLLAGEN RECEPTOR; GLYCOPROTEIN VI; COMPLEX; ASSOCIATION; TRANSMEMBRANE; RECOGNITION; EXPRESSION	Activating receptors in cells of hematopoetic origin include members of two unrelated protein families, the immunoglobulin (Ig) and C type lectins, which differ even in the orientation of the transmembrane (TM) domains. We examined assembly of four receptors with diverse function: the NK receptors KIR2DS and NKG2C/CD94, the Fc receptor for IgA, and the GPVI collagen receptor. For each of the four different receptors studied here, assembly results in the formation of a three-helix interface in the membrane involving two acidic TM residues from the signaling dimer and a basic TM residue from the ligand recognition module, an arrangement remarkably similar to the T cell receptor (TCR)-CD3 complex. The fact that the TM domains of Ig family and C type lectins adopt opposite orientations proves that these receptor families independently evolved toward the same structural arrangement of the interacting TM helices. This assembly mechanism is thus widely utilized by receptors in cells of hematopoetic origin.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Program Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu		Moffett, Howell/0000-0002-7799-1688; Call, Matthew/0000-0001-5846-6469	NIAID NIH HHS [R01 AI054520, R01 AI54520] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Blery M, 2000, HUM IMMUNOL, V61, P51, DOI 10.1016/S0198-8859(99)00157-3; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hebert DN, 1998, BIOCHEM CELL BIOL, V76, P867, DOI 10.1139/bcb-76-5-867; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; KUSTER H, 1990, J BIOL CHEM, V265, P6448; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Natarajan K, 2002, MOL IMMUNOL, V38, P1023, DOI 10.1016/S0161-5890(02)00031-7; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Smith KM, 1998, J IMMUNOL, V161, P7; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	33	61	64	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					427	438		10.1016/j.immuni.2005.02.005	http://dx.doi.org/10.1016/j.immuni.2005.02.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845448	Green Accepted, Bronze			2022-12-18	WOS:000228909600005
J	SERAFINI, AT; LEWIS, RS; CLIPSTONE, NA; BRAM, RJ; FANGER, C; FIERING, S; HERZENBERG, LA; CRABTREE, GR				SERAFINI, AT; LEWIS, RS; CLIPSTONE, NA; BRAM, RJ; FANGER, C; FIERING, S; HERZENBERG, LA; CRABTREE, GR			ISOLATION OF MUTANT T-LYMPHOCYTES WITH DEFECTS IN CAPACITATIVE CALCIUM-ENTRY	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; INTRACELLULAR CA2+ STORES; SIGNAL-TRANSDUCTION; CYCLOSPORINE-A; NUCLEAR FACTOR; PHORBOL ESTER; MUSCARINIC RECEPTOR; TUMOR PROMOTER; NF-AT; ACTIVATION	Calcium and calcium-binding proteins play important roles in the signaling cascade leading from the initial engagement of TCRs on T cells to the fully activated state. To undertake a molecular dissection of this cascade, we first isolated a Jurkat T cell line derivative containing the NF-AT promoter element driving transcription of the diphtheria toxin A chain gene (dipA), resulting in rapid cell death. Selecting viable cells that fail to activate NF-AT-dependent transcription, we isolated two independent cell lines possessing defects in capacitative Ca2+ entry. NF-AT-dependent transcription can be restored in these cells by expression of a constitutively active calcineurin, but not by overexpression of the Ca2+ regulatory protein CAML, which can normally replace the Ca2+ signal. The defect in these cell lines probably lies between CAML and calcineurin in the T cell activation cascade.	STANFORD UNIV, SCH MED, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, DEPT DEV BIOL, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, DEPT PATHOL, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA; ST JUDE CHILDRENS RES HOSP, DEPT EXPTL ONCOL, MEMPHIS, TN 38101 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; St Jude Children's Research Hospital	SERAFINI, AT (corresponding author), STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA.			Fanger, Christopher/0000-0002-8268-9053	NIGMS NIH HHS [R01 GM045374, GM47354] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ALBERTI S, 1987, CYTOMETRY, V8, P114, DOI 10.1002/cyto.990080203; Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DESAI DM, 1990, INT IMMUNOL, V2, P615, DOI 10.1093/intimm/2.7.615; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FANGER CM, 1995, IN PRESS J CELL BIOL; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GELFAND EW, 1988, EUR J IMMUNOL, V18, P917, DOI 10.1002/eji.1830180613; GOLDSMITH MA, 1988, P NATL ACAD SCI USA, V85, P8613, DOI 10.1073/pnas.85.22.8613; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HIVROZBURGAUD C, 1991, EUR J IMMUNOL, V21, P2811, DOI 10.1002/eji.1830211124; HO SN, 1995, IN PRESS J BIOL CHEM; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, J IMMUNOL, V151, P837; KAO FT, 1969, J CELL PHYSIOL, V74, P245, DOI 10.1002/jcp.1040740305; KINCAID R, 1993, ADV SEC MESS PHOSPH, V27, P1; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; LIU CM, 1978, J BIOL CHEM, V253, P5892; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MASON MJ, 1991, J BIOL CHEM, V266, P10872; MASON MJ, 1993, BIOCHEM J, V296, P33, DOI 10.1042/bj2960033; MASTRO AM, 1983, J CELL PHYSIOL, V116, P51, DOI 10.1002/jcp.1041160109; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MCDONALD TV, 1993, J BIOL CHEM, V268, P3889; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; NAKANISHI T, 1988, J BIOL CHEM, V263, P6384; NISBETBROWN E, 1985, NATURE, V316, P545, DOI 10.1038/316545a0; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PREMACK BA, 1994, J IMMUNOL, V152, P5226; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SARKADI B, 1991, J MEMBRANE BIOL, V123, P9, DOI 10.1007/BF01993958; SERAFINI AT, 1994, THESIS STANFORD U ST; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WEINERT TA, 1992, RADIAT RES, V132, P141, DOI 10.2307/3578518; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WEISS MJ, 1984, P NATL ACAD SCI-BIOL, V81, P6836, DOI 10.1073/pnas.81.21.6836; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	75	61	61	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					239	250		10.1016/1074-7613(95)90093-4	http://dx.doi.org/10.1016/1074-7613(95)90093-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648396	Bronze			2022-12-18	WOS:A1995RR33900009
J	Satoh-Takayama, N; Kato, T; Motomura, Y; Kageyama, T; Taguchi-Atarashi, N; Kinoshita-Daitoku, R; Kuroda, E; Di Santo, JP; Mimuro, H; Moro, K; Ohno, H				Satoh-Takayama, Naoko; Kato, Tamotsu; Motomura, Yasutaka; Kageyama, Tomoko; Taguchi-Atarashi, Naoko; Kinoshita-Daitoku, Ryo; Kuroda, Eisuke; Di Santo, James P.; Mimuro, Hitomi; Moro, Kazuyo; Ohno, Hiroshi			Bacteria-Induced Group 2 Innate Lymphoid Cells in the Stomach Provide Immune Protection through Induction of IgA	IMMUNITY			English	Article							HELICOBACTER-PYLORI INFECTION; GASTRIC-MUCOSA; MESSENGER-RNA; TUFT CELLS; RESPONSES; MICE; DIVERSIFICATION; COLONIZATION; INFLAMMATION; POPULATIONS	The intestinal microbiota shapes and directs immune development locally and systemically, but little is known about whether commensal microbes in the stomach can impact their immunological microenvironment. Here, we report that group 2 innate lymphoid cells (ILC2s) were the predominant ILC subset in the stomach and show that their homeostasis and effector functions were regulated by local commensal communities. Microbes elicited interleukin-7 (IL-7) and IL-33 production in the stomach, which in turn triggered the propagation and activation of ILC2. Stomach ILC2s were also rapidly induced following infection with Helicobacter pylori. ILC2-derived IL-5 resulted in the production of IgA, which coated stomach bacteria in both specific pathogen-free (SPF) and H. pylori-infected mice. Our study thus identifies ILC2-dependent IgA response that is regulated by the commensal microbiota, which is implicated in stomach protection by eliminating IgA-coated bacteria including pathogenic H. pylori.	[Satoh-Takayama, Naoko; Kato, Tamotsu; Kageyama, Tomoko; Taguchi-Atarashi, Naoko; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Satoh-Takayama, Naoko; Kato, Tamotsu; Taguchi-Atarashi, Naoko; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, Yokohama, Kanagawa 2300045, Japan; [Motomura, Yasutaka; Moro, Kazuyo] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Innate Immune Syst, Suita, Osaka 5650871, Japan; [Motomura, Yasutaka; Moro, Kazuyo] RIKEN, Ctr Integrat Med Sci, Lab Innate Immune Syst, Yokohama, Kanagawa 2300045, Japan; [Kinoshita-Daitoku, Ryo; Kuroda, Eisuke; Mimuro, Hitomi] Osaka Univ, Res Inst Microbial Dis, Dept Infect Microbiol, Suita, Osaka 5650871, Japan; [Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75015 Paris, France; [Di Santo, James P.] INSERM, U1223, F-75013 Paris, France; [Ohno, Hiroshi] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Ebina, Kanagawa 2430435, Japan	RIKEN; Yokohama City University; Osaka University; RIKEN; Osaka University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Satoh-Takayama, N; Ohno, H (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan.; Satoh-Takayama, N; Ohno, H (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, Yokohama, Kanagawa 2300045, Japan.; Ohno, H (corresponding author), Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Ebina, Kanagawa 2430435, Japan.	naoko.satoh@riken.jp; hiroshi.ohno@riken.jp	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862; Kato, Tamotsu/0000-0002-8407-4327; Moro, Kazuyo/0000-0002-7377-1303	Japan Society for the Promotion of Science KAKENHI [15H06866, 16H05207, 26293110, 17K19551]; Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology [JP18gm0710009]; Takeda Science Foundation; Mochida Memorial Foundation; Naito Foundation; Institut Pasteur, INSERM; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [695467 - ILC_REACTIVITY]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Institut Pasteur, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	We would like to thank Drs. S. Nakae (U. Tokyo), B. Malissen (INSERM), and S. Koyasu (RIKEN) for providing mice lines; Dr. M.R. Amieva for providing the H. pylori PMSS1 strain; Dr. T. Endo for supporting RNA-seq analysis; Dr. H. Kiyono for helpful discussions; and Drs. K.M. Maslowski and P. Burrows for English proofreading. We also thank Ms. N. Tachibana and members of the animal facility, especially Mr. S. Oonawa, and the FACS platform for technical support. This work was supported by the Japan Society for the Promotion of Science KAKENHI (15H06866 to N.S.-T., 16H05207 to H.O., 26293110 to K.M., and 17K19551 to H.M.), Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (JP18gm0710009 to H.O.), Takeda Science Foundation (to N.S.-T), Mochida Memorial Foundation (to N.S.-T.), and The Naito Foundation (to H.M.). J.P.D. receives support from the Institut Pasteur, INSERM, and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (695467 - ILC_REACTIVITY).	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gonzalez DG, 2018, J IMMUNOL, V201, P3569, DOI 10.4049/jimmunol.1500497; Harder A, 2003, INT J ANTIMICROB AG, V22, P318, DOI 10.1016/S0924-8579(03)00219-X; HARRIMAN GR, 1988, J IMMUNOL, V140, P3033; Herbert DR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092276; Hirayama F, 1996, J GASTROENTEROL, V31, P24; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Horikawa K, 2001, J IMMUNOL, V167, P5018, DOI 10.4049/jimmunol.167.9.5018; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kiga K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5497; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kuo CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101290; Leach ST, 2008, CAN J GASTROENTEROL, V22, P461, DOI 10.1155/2008/308942; Li R, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4927964; Longstreth GF, 2014, CLIN GASTROENTEROL H, V12, P1763, DOI 10.1016/j.cgh.2014.03.024; Lv YP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0493-1; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; Martin CE, 2017, IMMUNITY, V47, P171, DOI 10.1016/j.immuni.2017.07.005; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moyat M, 2014, WORLD J GASTROENTERO, V20, P5583, DOI 10.3748/wjg.v20.i19.5583; Muller A, 2011, HELICOBACTER, V16, P26, DOI 10.1111/j.1523-5378.2011.00877.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohne Y, 2016, NAT IMMUNOL, V17, P1005, DOI 10.1038/ni0816-1005a; Parikh SS, 2003, INFECT IMMUN, V71, P6582, DOI 10.1128/IAI.71.11.6582-6590.2003; Park AM, 2018, BIOTECHNIQUES, V65, P227, DOI 10.2144/btn-2018-0017; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Sahasakul Y, 2014, BRIT J NUTR, V112, P408, DOI 10.1017/S0007114514000968; SAKATA T, 1990, J LEUKOCYTE BIOL, V48, P205, DOI 10.1002/jlb.48.3.205; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2016, INT IMMUNOL, V28, P29, DOI 10.1093/intimm/dxv054; Satoh-Takayama N, 2011, EUR J IMMUNOL, V41, P780, DOI 10.1002/eji.201040851; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074; Yamaoka Y, 1995, SCAND J GASTROENTERO, V30, P1153, DOI 10.3109/00365529509101624; Yang J, 2018, J EXP MED, V215, P1069, DOI 10.1084/jem.20170518	62	60	62	6	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					635	+		10.1016/j.immuni.2020.03.002	http://dx.doi.org/10.1016/j.immuni.2020.03.002			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32240600	Bronze			2022-12-18	WOS:000526782600009
J	Mathur, AN; Zirak, B; Boothby, IC; Tan, M; Cohen, JN; Mauro, TM; Mehta, P; Lowe, MM; Abbas, AK; Ali, N; Rosenblum, MD				Mathur, Anubhav N.; Zirak, Bahar; Boothby, Ian C.; Tan, Madge; Cohen, Jarish N.; Mauro, Thea M.; Mehta, Pooja; Lowe, Margaret M.; Abbas, Abul K.; Ali, Niwa; Rosenblum, Michael D.			Treg-Cell Control of a CXCL5-IL-17 Inflammatory Axis Promotes Hair-Follicle-Stem-Cell Differentiation During Skin-Barrier Repair	IMMUNITY			English	Article							REGULATORY T-CELLS; IMMUNE DYSREGULATION; NICHE; POLYENDOCRINOPATHY; ENTEROPATHY; CXCL5; MAINTENANCE; RECRUITMENT; HOMEOSTASIS; CONTRIBUTE	Restoration of barrier-tissue integrity after injury is dependent on the function of immune cells and stem cells (SCs) residing in the tissue. In response to skin injury, hair-follicle stem cells (HFSCs), normally poised for hair generation, are recruited to the site of injury and differentiate into cells that repair damaged epithelium. We used a SC fate-mapping approach to examine the contribution of regulatory T (Treg) cells to epidermal-barrier repair after injury. Depletion of Treg cells impaired skin-barrier regeneration and was associated with a Th17 inflammatory response and failed HFSC differentiation. In this setting, damaged epithelial cells preferentially expressed the neutrophil chemoattractant CXCL5, and blockade of CXCL5 or neutrophil depletion restored barrier function and SC differentiation after epidermal injury. Thus, Treg-cell regulation of localized inflammation enables HFSC differentiation and, thereby, skin-barrier regeneration, with implications for the maintenance and repair of other barrier tissues.	[Mathur, Anubhav N.; Zirak, Bahar; Boothby, Ian C.; Tan, Madge; Cohen, Jarish N.; Mauro, Thea M.; Mehta, Pooja; Lowe, Margaret M.; Ali, Niwa; Rosenblum, Michael D.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Abbas, Abul K.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosenblum, MD (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	michael.rosenblum@ucsf.edu		Boothby, Ian/0000-0002-1112-2834	Diabetes Research Center (DRC) [NIH P30 DK063720]; NIH [5P30CA082103-15, K08 AR070910, R01AR071944, DP2-AR068130, R21-AR066821]; Dermatology Foundation Career Development Award; Burroughs Wellcome Fund [CAMS-1010934]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071944] Funding Source: NIH RePORTER	Diabetes Research Center (DRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation Career Development Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Jason Cyster and Mark Kaplan for their critical review of the manuscript, Ophir Klein for providing Lgr5-tdTom mice, and Carlos Benetiz for assistance with animal husbandry. Flow cytometry data were generated in the UCSF Parnassus Flow Cytometry Core, which is supported by the Diabetes Research Center (DRC) grant NIH P30 DK063720. Histology was performed with assistance from the UCSF Mouse Pathology Core, which is supported by NIH 5P30CA082103-15. A.N.M. is supported by a Dermatology Foundation Career Development Award and NIH K08 AR070910. This work was primarily funded by M.D.R.'s grants: NIH R01AR071944, NIH DP2-AR068130, Burroughs Wellcome Fund CAMS-1010934, and NIH R21-AR066821.	Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Balamayooran G, 2012, AM J RESP CELL MOL, V47, P104, DOI 10.1165/rcmb.2011-0260OC; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Castiglioni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128094; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Gratz IK, 2014, J IMMUNOL, V192, P1351, DOI 10.4049/jimmunol.1301777; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Halabi-Tawil M, 2009, BRIT J DERMATOL, V160, P645, DOI 10.1111/j.1365-2133.2008.08835.x; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2008, J INVEST DERMATOL, V128, P1059, DOI 10.1038/jid.2008.86; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jia HP, 2016, J IMMUNOL, V197, P859, DOI 10.4049/jimmunol.1600618; Jin HL, 2009, J CLIN INVEST, V119, P47, DOI 10.1172/JCI32310; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martin-Santiago A, 2013, PEDIATR DERMATOL, V30, pE221, DOI 10.1111/pde.12126; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nieves DS, 2004, ARCH DERMATOL, V140, P466, DOI 10.1001/archderm.140.4.466; Panduro M, 2018, P NATL ACAD SCI USA, V115, pE2585, DOI 10.1073/pnas.1800618115; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Scharschmidt TC, 2017, CELL HOST MICROBE, V21, P467, DOI 10.1016/j.chom.2017.03.001; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Spence A, 2015, CURR OPIN IMMUNOL, V37, P11, DOI 10.1016/j.coi.2015.09.002; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Wilson CH, 2014, ONCOGENE, V33, P4877, DOI 10.1038/onc.2014.78	56	60	62	13	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					655	+		10.1016/j.immuni.2019.02.013	http://dx.doi.org/10.1016/j.immuni.2019.02.013			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893588	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000461660500016
J	Pelka, K; Bertheloot, D; Reimer, E; Phulphagar, K; Schmidt, SV; Christ, A; Stahl, R; Watson, N; Miyake, K; Hacohen, N; Haas, A; Brinkmann, MM; Marshak-Rothstein, A; Meissner, F; Latz, E				Pelka, Karin; Bertheloot, Damien; Reimer, Elisa; Phulphagar, Kshiti; Schmidt, Susanne V.; Christ, Anette; Stahl, Rainer; Watson, Nicki; Miyake, Kensuke; Hacohen, Nir; Haas, Albert; Brinkmann, Melanie M.; Marshak-Rothstein, Ann; Meissner, Felix; Latz, Eicke			The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport	IMMUNITY			English	Article							DENDRITIC CELLS; PROTEIN UNC93B; NUCLEIC-ACID; LOCALIZATION; RECOGNITION; EXPRESSION; RESPONSES; ROLES	Unc-93 homolog B1 (UNC93B1) is a key regulator of nucleic acid (NA)-sensing Toll-like receptors (TLRs). Loss of NA-sensing TLR responses in UNC93B1-deficient patients facilitates Herpes simplex virus type 1 (HSV-1) encephalitis. UNC93B1 is thought to guide NA-sensing TLRs from the endoplasmic reticulum (ER) to their respective endosomal signaling compartments and to guide the flagellin receptor TLR5 to the cell surface, raising the question of how UNC93B1 mediates differential TLR trafficking. Here, we report that UNC93B1 regulates a step upstream of the differential TLR trafficking process. We discovered that UNC93B1 deficiency resulted in near-complete loss of TLR3 and TLR7 proteins in primary splenic mouse dendritic cells and macrophages, showing that UNC93B1 is critical for maintaining TLR expression. Notably, expression of an ER-retained UNC93B1 version was sufficient to stabilize TLRs and largely restore endosomal TLR trafficking and activity. These data are critical for an understanding of how UNC93B1 can regulate the function of a broad subset of TLRs.	[Pelka, Karin; Bertheloot, Damien; Phulphagar, Kshiti; Schmidt, Susanne V.; Christ, Anette; Stahl, Rainer; Latz, Eicke] Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Pelka, Karin; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bertheloot, Damien] IFM Therapeut GmbH, D-53127 Bonn, Germany; [Reimer, Elisa; Brinkmann, Melanie M.] Helmholtz Ctr Infect Res, Viral Immune Modulat Res Grp, D-38124 Braunschweig, Germany; [Phulphagar, Kshiti; Meissner, Felix] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Marshak-Rothstein, Ann; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Watson, Nicki] Whitehead Inst, WM Keck Microscopy Facil, Cambridge, MA 02142 USA; [Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun, Tokyo 1088639, Japan; [Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Innate Immun, Tokyo 1088639, Japan; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Haas, Albert] Univ Bonn, Cell Biol Inst, D-53121 Bonn, Germany; [Latz, Eicke] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany	University of Bonn; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Max Planck Society; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Tokyo; University of Tokyo; Harvard University; Massachusetts General Hospital; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Latz, E (corresponding author), Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany.; Latz, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.; Latz, E (corresponding author), German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany.	eicke.latz@uni-bonn.de	Bertheloot, Damien/AAF-9235-2021; Latz, Eicke/H-3951-2014; Schmidt, Susanne/AAU-6827-2021; Meissner, Felix/C-8767-2015	Bertheloot, Damien/0000-0002-9495-706X; Latz, Eicke/0000-0003-1488-5666; Meissner, Felix/0000-0003-1000-7989	NCRR-NIH; NIH [1R01AR066808-01A1]; German Research Foundation (DFG) [EXC1023, SFB670, SFB1123, TRR83, TRR57, GRK21687, SPP1923, SFB900, BR 3432/3-1]; Initiative and Networking Fund of the Helmholtz Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066808] Funding Source: NIH RePORTER	NCRR-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); Initiative and Networking Fund of the Helmholtz Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Heat-killed GBS was kindly provided by Dr. G. Teti, and the TLR7-stimulatory RNA ligand was provided by Idera Pharmaceuticals. EBV-immortalized UNC93B1-deficient B cells were kindly provided by Dr. Jean-Laurent Casanova. The Unc93b1<SUP>-/-</SUP> mouse strain used for this research project was created from ES cell clone 10049A-G9, obtained from the NCRR-NIH supported KOMP Repository (www.komp.org) and generated by Regeneron Pharmaceuticals. This work was supported by NIH grant 1R01AR066808-01A1 (to A.M.R. and E.L.), German Research Foundation (DFG) grants EXC1023 (Excellence Cluster ImmunoSensation), SFB670, SFB1123, TRR83, TRR57, GRK21687, and SPP1923 (to E.L.) and SFB900 and BR 3432/3-1 (to M.M.B.), and the Initiative and Networking Fund of the Helmholtz Association (to M.M.B.). We thank G. Engels for technical support and Dr. F. Adolf, Dr. F. Wieland, Dr. T. Espevik, and the Latz Lab for helpful discussions.	Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies JC, 2015, CURR OPIN PULM MED, V21, P579, DOI 10.1097/MCP.0000000000000211; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Guo H, 2015, J IMMUNOL, V194, P4737, DOI 10.4049/jimmunol.1402312; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Huh JW, 2014, P NATL ACAD SCI USA, V111, P7072, DOI 10.1073/pnas.1322838111; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Kanno A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7119; Kanno A, 2013, INT IMMUNOL, V25, P413, DOI 10.1093/intimm/dxt007; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Meunier E, 2015, JOVE-J VIS EXP, DOI 10.3791/52960; Murakami Y, 2014, J IMMUNOL, V193, P5208, DOI 10.4049/jimmunol.1400386; Nakano S, 2010, RHEUMATOLOGY, V49, P876, DOI 10.1093/rheumatology/keq001; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Panchanathan R, 2013, INT IMMUNOL, V25, P521, DOI 10.1093/intimm/dxt015; Pelka K, 2014, J IMMUNOL, V193, P3257, DOI 10.4049/jimmunol.1301886; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Scheltema RA, 2014, MOL CELL PROTEOMICS, V13, P3698, DOI 10.1074/mcp.M114.043489; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Signorino G, 2014, INFECT IMMUN, V82, P5013, DOI 10.1128/IAI.02282-14; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	42	60	62	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					911	+		10.1016/j.immuni.2018.04.011	http://dx.doi.org/10.1016/j.immuni.2018.04.011			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768176	Bronze, Green Accepted			2022-12-18	WOS:000432488600012
J	Baratin, M; Simon, L; Jorquera, A; Ghigo, C; Dembele, D; Nowak, J; Gentek, R; Wienert, S; Klauschen, F; Malissen, B; Dalod, M; Bajenoff, M				Baratin, Myriam; Simon, Lea; Jorquera, Audrey; Ghigo, Clement; Dembele, Doulaye; Nowak, Jonathan; Gentek, Rebecca; Wienert, Stephan; Klauschen, Frederick; Malissen, Bernard; Dalod, Marc; Bajenoff, Marc			T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node	IMMUNITY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; PAROTID SECRETORY PROTEIN; TINGIBLE BODY MACROPHAGES; DENDRITIC CELLS; FLUORESCENT PROTEIN; TISSUE MACROPHAGES; EXPRESSION; MONOCYTES; MOUSE; RECEPTOR	In lymph nodes (LNs), dendritic cells (DCs) are thought to dispose of apoptotic cells, a function pertaining to macrophages in other tissues. We found that a population of CX3CR1(+) MERTK+ cells located in the T cell zone of LNs, previously identified as DCs, are efferocytic macrophages. Lineage-tracing experiments and shield chimeras indicated that these T zone macrophages (TZM) are long-lived macrophages seeded in utero and slowly replaced by blood monocytes after birth. Imaging the LNs of mice in which TZM and DCs express different fluorescent proteins revealed that TZM-and not DCs-act as the only professional scavengers, clearing apoptotic cells in the LN T cell zone in a CX3CR1-dependent manner. Furthermore, similar to other macrophages, TZM appear inefficient in priming CD4 T cells. Thus, efferocytosis and T cell activation in the LN are uncoupled processes designated to macrophages and DCs, respectively, with implications to the maintenance of immune homeostasis.	[Baratin, Myriam; Nowak, Jonathan; Wienert, Stephan; Malissen, Bernard] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Ghigo, Clement; Nowak, Jonathan; Wienert, Stephan; Malissen, Bernard; Dalod, Marc] Charite, Inst Pathol, D-10117 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Baratin, M (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.	baratin@ciml.univ-mrs.fr; bajenoff@ciml.univ-mrs.fr	Klauschen, Frederick/C-5637-2015; Dalod, Marc/AAK-6163-2020; Dembélé, Doulaye/O-6513-2017; Malissen, Bernard/AAK-4659-2020	Klauschen, Frederick/0000-0002-9131-2389; Dalod, Marc/0000-0002-6436-7966; Dembélé, Doulaye/0000-0003-3879-6940; Gentek, Rebecca/0000-0001-6574-7242; Malissen, Bernard/0000-0003-1340-9342	Agence National pour la Recherche [ANR-STROMA, ANR-10-INBS-04-01 France Bio Imaging]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [647257- STROMA]; INSERM; CNRS; Aix-Marseille University	Agence National pour la Recherche(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University	We thank Emilie Narni-Mancinelli and Sandrine Henri for the critical reading of the manuscript and the CIML cytometry, and mouse house core facilities. We also thank Caetano Reis e Sousa for providing the clec9a<SUP>Cre</SUP> mice. This study was funded by grants from the Agence National pour la Recherche (ANR-STROMA, and ANR-10-INBS-04-01 France Bio Imaging). This work was supported by a grant from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme grant agreement No 647257- STROMA. This work was supported by institutional grants from INSERM, CNRS, and Aix-Marseille University to the CIML. This work benefited from data assembled by the ImmGen Consortium.	Abdolhosseini M, 2012, MOL CELL BIOCHEM, V359, P1, DOI 10.1007/s11010-011-0991-2; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Carpentier S, 2016, J IMMUNOL METHODS, V432, P35, DOI 10.1016/j.jim.2016.02.023; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Dasoveanu DC, 2016, TRENDS IMMUNOL, V37, P764, DOI 10.1016/j.it.2016.08.013; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Divangahi M, 2015, ONCOTARGET, V6, P14721, DOI 10.18632/oncotarget.4402; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Geetha C, 2003, BIOCHEM SOC T, V31, P815, DOI 10.1042/bst0310815; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00406; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x; Kumar V, 2015, IMMUNITY, V42, P719, DOI 10.1016/j.immuni.2015.03.015; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martin CJ, 2014, CURR OPIN MICROBIOL, V17, P17, DOI 10.1016/j.mib.2013.10.007; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MEBIUS RE, 1991, IMMUNOBIOLOGY, V182, P277, DOI 10.1016/S0171-2985(11)80663-7; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Novkovic M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002515; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Rahman ZSM, 2010, J IMMUNOL, V185, P5859, DOI 10.4049/jimmunol.1001187; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; Manh TPV, 2016, METHODS MOL BIOL, V1423, P211, DOI 10.1007/978-1-4939-3606-9_16; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Villablanca EJ, 2008, EUR J IMMUNOL, V38, P2975, DOI 10.1002/eji.200838919; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880	66	60	62	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					349	+		10.1016/j.immuni.2017.07.019	http://dx.doi.org/10.1016/j.immuni.2017.07.019			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28801233	Bronze			2022-12-18	WOS:000407788300019
J	Holthausen, DJ; Lee, SH; Kumar, VTV; Bouvier, NM; Krammer, F; Ellebedy, AH; Wrammert, J; Lowen, AC; George, S; Pillai, MR; Jacob, J				Holthausen, David J.; Lee, Song Hee; Kumar, Vineeth T. V.; Bouvier, Nicole M.; Krammer, Florian; Ellebedy, Ali H.; Wrammert, Jens; Lowen, Anice C.; George, Sanil; Pillai, Madhavan Radhakrishna; Jacob, Joshy			An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses	IMMUNITY			English	Article							HERPES-SIMPLEX-VIRUS; ANTIMICROBIAL PEPTIDES; THERAPEUTIC APPLICATIONS; ANTIVIRAL ACTIVITY; ANTIBODIES; SKIN; INACTIVATION; MECHANISM; PROSPECTS; VACCINES	Although vaccines confer protection against influenza A viruses, antiviral treatment becomes the first line of defense during pandemics because there is insufficient time to produce vaccines. Current antiviral drugs are susceptible to drug resistance, and developing new antivirals is essential. We studied host defense peptides from the skin of the South Indian frog and demonstrated that one of these, which we named "urumin," is virucidal for H1 hemagglutinin-bearing human influenza A viruses. This peptide specifically targeted the conserved stalk region of H1 hemagglutinin and was effective against drug-resistant H1 influenza viruses. Using electron microscopy, we showed that this peptide physically destroyed influenza virions. It also protected naive mice from lethal influenza infection. Urumin represents a unique class of anti-influenza virucide that specifically targets the hemagglutinin stalk region, similar to targeting of antibodies induced by universal influenza vaccines. Urumin therefore has the potential to contribute to first-line anti-viral treatments during influenza outbreaks.	[Holthausen, David J.; Lee, Song Hee; Ellebedy, Ali H.; Wrammert, Jens; Lowen, Anice C.; Jacob, Joshy] Emory Univ, Yerkes Natl Primate Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA; [Kumar, Vineeth T. V.; George, Sanil; Pillai, Madhavan Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India; [Bouvier, Nicole M.; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, One Gustave L Levy Pl,Box 1124, New York, NY 10029 USA	Emory University; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Icahn School of Medicine at Mount Sinai	Jacob, J (corresponding author), Emory Univ, Yerkes Natl Primate Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	joshy.jacob@emory.edu	Krammer, Florian/H-3237-2019; T.V, Vineeth/AAF-4607-2020	Krammer, Florian/0000-0003-4121-776X; George, Sanil/0000-0001-6542-2931; kumar, vineeth/0000-0002-2683-034X	Kerala State Council for Science, Technology and Environment [006/SRSLS/2011/CSTE]	Kerala State Council for Science, Technology and Environment	We gratefully acknowledge Dr. Caitlin Bohannon and Gordon Dale for helpful discussions, Dr. Brian Evavold and Laurel Ann Lawrence for peptide synthesis, Hong Yi for electron microscopy, Dr. Rafi Ahmed for anti-HA mAbs, Dr. William Shafer for critically reading the manuscript and suggesting the L vs. D enantiomer peptide experiment, and Mrs. Leela Thomas for mouse colony management. S.G. is grateful to Kerala State Council for Science, Technology and Environment for grant no. 006/SRSLS/2011/CSTE.	Belaid A, 2002, J MED VIROL, V66, P229, DOI 10.1002/jmv.2134; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Bouvier NM, 2012, J VIROL, V86, P7268, DOI 10.1128/JVI.07242-12; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; GIOVANNINI MG, 1987, BIOCHEM J, V243, P113, DOI 10.1042/bj2430113; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Koday MT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005409; Krammer F, 2015, CURR TOP MICROBIOL, V386, P301, DOI 10.1007/82_2014_408; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Kumar TVV, 2016, ACTA BIOL HUNG, V67, P121, DOI 10.1556/018.67.2016.1.10; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Lorin C, 2005, VIROLOGY, V334, P264, DOI 10.1016/j.virol.2005.02.002; Luke CJ, 2006, EMERG INFECT DIS, V12, P66, DOI 10.3201/eid1201.051147; Matanic VCA, 2004, INT J ANTIMICROB AG, V23, P382, DOI 10.1016/j.ijantimicag.2003.07.022; Mulder KCL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00321; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Seibert CW, 2012, J VIROL, V86, P5386, DOI 10.1128/JVI.00151-12; Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276; Shyla G., 2017, CHEM BIOL DRUG DES; Skalickova S, 2015, VIRUSES-BASEL, V7, P5428, DOI 10.3390/v7102883; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	44	60	67	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					587	595		10.1016/j.immuni.2017.03.018	http://dx.doi.org/10.1016/j.immuni.2017.03.018			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423338	Bronze			2022-12-18	WOS:000399451100012
J	Das, A; Heesters, BA; Bialas, A; O'Flynn, J; Rifkin, IR; Ochando, J; Mittereder, N; Carlesso, G; Herbst, R; Carroll, MC				Das, Abhishek; Heesters, Balthasar A.; Bialas, Allison; O'Flynn, Joseph; Rifkin, Ian R.; Ochando, Jordi; Mittereder, Nanette; Carlesso, Gianluca; Herbst, Ronald; Carroll, Michael C.			Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; I INTERFERON; AUTOANTIBODY PRODUCTION; IMMUNE-COMPLEXES; GERMINAL-CENTERS; MOUSE MODEL; LUPUS; COMPLEMENT; ANTIBODIES; TOLERANCE	A hallmark of autoimmunity inmurinemodels of lupus is the formation of germinal centers (GCs) in lymphoid tissues where self-reactive B cells expand and differentiate. In the host response to foreign antigens, follicular dendritic cells (FDCs) maintain GCs through the uptake and cycling of complement-opsonized immune complexes. Here, we examined whether FDCs retain self-antigens and the impact of this process in autoantibody secretion in lupus. We found that FDCs took up and retained self-immune complexes composed of ribonucleotide proteins, autoantibody, and complement. This uptake, mediated through CD21, triggered endosomal TLR7 and led to the secretion of interferon (IFN) alpha via an IRF5-dependent pathway. Blocking of FDC secretion of IFN-alpha restored B cell tolerance and reduced the amount of GCs and pathogenic autoantibody. Thus, FDCs are a critical source of the IFN-a driving autoimmunity in this lupus model. This pathway is conserved in humans, suggesting that it may be a viable therapeutic target in systemic lupus erythematosus.	[Das, Abhishek; Heesters, Balthasar A.; Bialas, Allison; O'Flynn, Joseph; Carroll, Michael C.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Carroll, Michael C.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Rifkin, Ian R.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ochando, Jordi] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10129 USA; [Mittereder, Nanette; Carlesso, Gianluca] MedImmune LLC, Dept Resp Inflammat & Autoimmun RIA, Gaithersburg, MD 20878 USA; [Herbst, Ronald] MedImmune LLC, Dept Canc Biol, Gaithersburg, MD 20878 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Boston University; Icahn School of Medicine at Mount Sinai; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Carroll, MC (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Carroll, MC (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	michael.carroll@childrens.harvard.edu	Ochando, Jordi/B-6219-2008; Ochando, jordi/ABE-2358-2020; Heesters, Balthasar/ABA-7594-2021	Ochando, Jordi/0000-0001-7037-1681; Ochando, jordi/0000-0001-7037-1681; Heesters, Balthasar/0000-0002-2909-8481	NIH [AI039246]; MedImmune LLC	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MedImmune LLC(AstraZenecaMedimmune)	The authors thank all members of the M.C.C. lab for suggestions and help with experiments and reading of the manuscript. We acknowledge the valuable assistance of Elisabeth M. Carroll and the editorial assistance from Dr. Christina Usher. The authors thank Drs. T. Taniguchi and T. Mak for access to Irf5<SUP>-/-</SUP> and Irf7<SUP>-/-</SUP> mice. This work was supported by grants from NIH (AI039246) to M.C.C. and from MedImmune LLC. R.H., N.M., and G.C. are employees of MedImmune, LLC.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; [Anonymous], 2017, IMMUNITY, V46, P106; Baccala R, 2012, J IMMUNOL, V189, P5976, DOI 10.4049/jimmunol.1201477; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chatterjee P, 2013, EUR J IMMUNOL, V43, P2441, DOI 10.1002/eji.201343412; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; COTRAN RS, 1994, PATHOLOGIC BASIS DIS; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Crow MK, 2010, RHEUM DIS CLIN N AM, V36, P173, DOI 10.1016/j.rdc.2009.12.008; Davison LM, 2015, ARTHRITIS RHEUMATOL, V67, P1012, DOI 10.1002/art.38989; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; Green NM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383000; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Han JH, 2014, EUR J IMMUNOL, V44, P215, DOI 10.1002/eji.201343714; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Heesters BA, 2014, MOL IMMUNOL, V62, P283, DOI 10.1016/j.molimm.2014.02.010; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Krieg AM, 2007, IMMUNITY, V27, P695, DOI 10.1016/j.immuni.2007.11.001; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; STEINER LA, 1967, J EXP MED, V126, P1161, DOI 10.1084/jem.126.6.1161; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thibault DL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2771; Umiker BR, 2014, EUR J IMMUNOL, V44, P1503, DOI 10.1002/eji.201344283; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Victoratos P, 2009, IMMUNITY, V30, P130, DOI 10.1016/j.immuni.2008.10.019; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Watkins AA, 2015, J IMMUNOL, V194, P1467, DOI 10.4049/jimmunol.1402807; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yasuda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103478; Yasuda K, 2013, INT IMMUNOL, V25, P295, DOI 10.1093/intimm/dxs114; Yau IW, 2013, J IMMUNOL, V191, P1082, DOI 10.4049/jimmunol.1201569; Zagury D, 2009, P NATL ACAD SCI USA, V106, P5294, DOI 10.1073/pnas.0900615106	71	60	63	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					106	119		10.1016/j.immuni.2016.12.014	http://dx.doi.org/10.1016/j.immuni.2016.12.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099860	Bronze, Green Accepted			2022-12-18	WOS:000392918300014
J	Hasan, M; Fermaintt, CS; Gao, NG; Sakai, T; Miyazaki, T; Jiang, SX; Li, QZ; Atkinson, JP; Morse, HC; Lehman, MA; Yan, N				Hasan, Maroof; Fermaintt, Charles S.; Gao, Ningguo; Sakai, Tomomi; Miyazaki, Takuya; Jiang, Sixin; Li, Quan-Zhen; Atkinson, John P.; Morse, Herbert C., III; Lehman, Mark A.; Yan, Nan			Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation	IMMUNITY			English	Article							DNA EXONUCLEASE TREX1; DOUBLE-STRANDED DNA; DOMINANT MUTATIONS; ACLACINOMYCIN-A; LUPUS; GENE; RECOGNITION; DEGRADATION; REVEALS	TREX1 is an endoplasmic reticulum (ER)-associated negative regulator of innate immunity. TREX1 mutations are associated with autoimmune and autoinflammatory diseases. Biallelic mutations abrogating DNase activity cause autoimmunity by allowing immunogenic self-DNA to accumulate, but it is unknown how dominant frameshift (fs) mutations that encode DNase-active but mislocalized proteins cause disease. We found that the TREX1 C terminus suppressed immune activation by interacting with the ER oligosaccharyltransferase (OST) complex and stabilizing its catalytic integrity. C-terminal truncation of TREX1 by fs mutations dysregulated the OST complex, leading to free glycan release from dolichol carriers, as well as immune activation and autoantibody production. A connection between OST dysregulation and immune disorders was demonstrated in Trex1(-/-) mice, TREX1-V235fs patient lymphoblasts, and TREX1-V235fs knock-in mice. Inhibiting OST with aclacinomycin corrects the glycan and immune defects associated with Trex1 deficiency or fs mutation. This function of the TREX1 C terminus suggests a potential therapeutic option for TREX1-fs mutant-associated diseases.	[Hasan, Maroof; Fermaintt, Charles S.; Yan, Nan] Univ Texas SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Hasan, Maroof; Fermaintt, Charles S.; Yan, Nan] Univ Texas SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; [Gao, Ningguo; Jiang, Sixin; Lehman, Mark A.] Univ Texas SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Sakai, Tomomi; Miyazaki, Takuya; Morse, Herbert C., III] Natl Inst Allergy & Infect Dis, NIH, Lab Immunogenet, Virol & Cellular Immunol Sect, Rockville, MD 20852 USA; [Li, Quan-Zhen] Univ Texas SW Med Ctr, Dept Immunol, Dallas, TX 75390 USA; [Atkinson, John P.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; Xbiotech, Austin, TX 78744 USA; [Hasan, Maroof; Miyazaki, Takuya] Yokohama City Univ, Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 23600004, Japan; [Gao, Ningguo; Jiang, Sixin] Albany Med Coll, Albany, NY 12208 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Novartis; Yokohama City University; Albany Medical College	Lehman, MA (corresponding author), Univ Texas SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	mark.lehrman@utsouthwestern.edu; nan.yan@utsouthwestern.edu		Atkinson, John/0000-0002-2514-3441; /0000-0001-8140-5461	Washington University Protein Production and Purification Core Facility of the Rheumatic Disease Core Center [P30 AR048335]; UT Southwestern; Biomedical Science from UT Southwestern; US NIH [AI098569, AR067135, GM038545, AR048335]; Alliance for Lupus Foundation; Welch Foundation; NSF; Cure CRV Research, Energy 4 A Cure Foundation; Clayco Corporation; Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335, R01AR067135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM038545, R01GM038545] Funding Source: NIH RePORTER	Washington University Protein Production and Purification Core Facility of the Rheumatic Disease Core Center; UT Southwestern; Biomedical Science from UT Southwestern; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Foundation; Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); Cure CRV Research, Energy 4 A Cure Foundation; Clayco Corporation; Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Min-Ae Lee-Kirsch (TU Dreston, Germany) for TREX1 patient cells, Zhijian James Chen for cGAS/mice, Russell Vance (UC Berkley) for Stinggt/gt mice, Rolf Brekken (UTSW) for Tbk1D/D mice, Michael White (UTSW) for Compound II, Shizuo Akira (Osaka U) for the MRX-ibsr retroviral vector, James Koch for technical assistance, experimental support from Washington University Protein Production and Purification Core Facility of the Rheumatic Disease Core Center (P30 AR048335), and members of the N.Y. lab, M.A.L. lab, and H.C.M. lab for discussions. Supported by the Rita C. and William P. Clements, Jr. Endowed Scholar Award from UT Southwestern to N.Y., The John P. Perkins, Ph.D. Distinguished Professorship in Biomedical Science from UT Southwestern to M.A.L., the US NIH (AI098569 and AR067135 to N.Y., GM038545 to M.A.L., AR048335 to J.P.A.), Alliance for Lupus Foundation (N.Y.), Welch Foundation (N.Y.), NSF graduate student fellowship (C.S.F.), private donations from Cure CRV Research, Energy 4 A Cure Foundation, and the Robert G. Clark family and Clayco Corporation (J.P.A.), and in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (H.C.M.).	Bennett DC, 2013, TRANSL ONCOL, V6, P382, DOI 10.1593/tlo.13232; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cline A, 2012, MOL BIOL CELL, V23, P4175, DOI 10.1091/mbc.E12-05-0411; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Holm CK, 2013, CURR OPIN IMMUNOL, V25, P13, DOI 10.1016/j.coi.2012.12.006; Kawasaki T, 2013, CELL HOST MICROBE, V14, P148, DOI 10.1016/j.chom.2013.07.011; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Lindahl T, 2009, BIOCHEM SOC T, V37, P535, DOI 10.1042/BST0370535; MAJIMA H, 1987, BIOMED PHARMACOTHER, V41, P233; MORIN MJ, 1984, CANCER RES, V44, P2807; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Taylor KL, 2008, J INTERF CYTOK RES, V28, P733, DOI 10.1089/jir.2008.0030; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	30	60	62	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					463	474		10.1016/j.immuni.2015.07.022	http://dx.doi.org/10.1016/j.immuni.2015.07.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26320659	Bronze, Green Accepted			2022-12-18	WOS:000361575300014
J	Kurashima, Y; Amiya, T; Fujisawa, K; Shibata, N; Suzuki, Y; Kogure, Y; Hashimoto, E; Otsuka, A; Kabashima, K; Sato, S; Sato, T; Kubo, M; Akira, S; Miyake, K; Kunisawa, J; Kiyono, H				Kurashima, Yosuke; Amiya, Takeaki; Fujisawa, Kumiko; Shibata, Naoko; Suzuki, Yuji; Kogure, Yuta; Hashimoto, Eri; Otsuka, Atsushi; Kabashima, Kenji; Sato, Shintaro; Sato, Takeshi; Kubo, Masato; Akira, Shizuo; Miyake, Kensuke; Kunisawa, Jun; Kiyono, Hiroshi			The Enzyme Cyp26b1 Mediates Inhibition of Mast Cell Activation by Fibroblasts to Maintain Skin-Barrier Homeostasis	IMMUNITY			English	Article							CD8(+) T-CELLS; CONNECTIVE-TISSUE; RETINOIC ACID; INFLAMMATION; RESPONSES; KERATINOCYTES; VITAMIN-D-3; MECHANISMS; ABLATION; BINDING	Mast cells (MCs) mature locally, thus possessing tissue-dependent phenotypes for their critical roles in both protective immunity against pathogens and the development of allergy or inflammation. We previously reported that MCs highly express P2X7, a receptor for extracellular ATP, in the colon but not in the skin. The ATP-P2X7 pathway induces MC activation and consequently exacerbates the inflammation. Here, we identified the mechanisms by which P2X7 expression on MCs is reduced by fibroblasts in the skin, but not in the other tissues. The retinoic-acid-degrading enzyme Cyp26b1 is highly expressed in skin fibroblasts, and its inhibition resulted in the upregulation of P2X7 on MCs. We also noted the increased expression of P2X7 on skin MCs and consequent P2X7- and MC-dependent dermatitis (so-called retinoid dermatitis) in the presence of excessive amounts of retinoic acid. These results demonstrate a unique skin-barrier homeostatic network operating through Cyp26b1-mediated inhibition of ATP-dependent MC activation by fibroblasts.	[Kurashima, Yosuke; Amiya, Takeaki; Fujisawa, Kumiko; Shibata, Naoko; Suzuki, Yuji; Kogure, Yuta; Sato, Shintaro; Sato, Takeshi; Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan; [Kurashima, Yosuke; Amiya, Takeaki; Fujisawa, Kumiko; Shibata, Naoko; Sato, Shintaro; Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Kurashima, Yosuke; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun, Tokyo 1088639, Japan; [Kurashima, Yosuke; Amiya, Takeaki; Shibata, Naoko; Kogure, Yuta; Hashimoto, Eri; Sato, Takeshi; Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka 5670085, Japan; [Amiya, Takeaki; Shibata, Naoko; Kogure, Yuta; Sato, Takeshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778561, Japan; [Otsuka, Atsushi; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068501, Japan; [Kubo, Masato] Yokohama Inst, RIKEN, Res Ctr Integrat Med Sci, Lab Cytokine Regulat, Kanagawa 2300045, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba 2780022, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka 5650871, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo 1088639, Japan; [Kunisawa, Jun] Kobe Univ, Sch Med, Dept Microbiol & Immunol, Kobe, Hyogo 6500017, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; National Institute of Health Sciences - Japan; University of Tokyo; Kyoto University; RIKEN; Tokyo University of Science; Osaka University; University of Tokyo; Kobe University	Kunisawa, J (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan.	kunisawa@nibio.go.jp; kiyono@ims.u-tokyo.ac.jp	Kubo, Masato/A-5918-2016; Kiyono, Hiroshi/AAC-6735-2022; Akira, Shizuo/C-3134-2009; Kabashima, Kenji/G-2521-2014	Otsuka, Atsushi/0000-0001-7365-947X; Sato, Shintaro/0000-0001-5156-3354; Kabashima, Kenji/0000-0002-0773-0554	Ministry of Education, Science, Sports, and Technology of Japan; Ministry of Education, Science, Sports, and Technology of Japan grant from Leading-edge Research Infrastructure Program; Young Researcher Overseas Visits Program for Vitalizing Brain Circulation (Japan Society for the Promotion of Science); Ministry of Health and Welfare of Japan; Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Kowa Life Science Foundation; Kishimoto Foundation Research Grant; Yakult Bioscience Foundation	Ministry of Education, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, Sports, and Technology of Japan grant from Leading-edge Research Infrastructure Program; Young Researcher Overseas Visits Program for Vitalizing Brain Circulation (Japan Society for the Promotion of Science); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Kowa Life Science Foundation; Kishimoto Foundation Research Grant; Yakult Bioscience Foundation	We thank H. Suto (Atopy Research Center, Juntendo University, Tokyo) for providing Kit<SUP>W-sh/W-sh</SUP> mice, and S. Nakae (University of Tokyo) for advice on analyzing Kit<SUP>W-sh/W-sh</SUP> mice. We also thank Y. Yokota (School of Medicine, University of Fukui, Fukui) for providing Id2<SUP>-/-</SUP> mice. This work was supported by grants from the Ministry of Education, Science, Sports, and Technology of Japan (Grant-in Aid for Scientific Research S [H. K.] for Scientific Research on Innovative Areas [J.K.]; grant from the Leading-edge Research Infrastructure Program [to J.K., H. K.]); from the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation (Japan Society for the Promotion of Science, J.K., H. K., Y. K.); for Japan Society for the Promotion of Science Fellows (Y. K., T. A., N.S.); from the Ministry of Health and Welfare of Japan (J.K., H. K.); from the Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine (H. K.); from the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (to J.K.); and Kowa Life Science Foundation (J.K.); Kishimoto Foundation Research Grant (J.K.); and from the Yakult Bioscience Foundation (J.K.).	Biggs L, 2010, J EXP MED, V207, P455, DOI 10.1084/jem.20091725; Cetin ED, 2009, AM J DERMATOPATH, V31, P53, DOI 10.1097/DAD.0b013e318185a66e; DeCoster R, 1996, J STEROID BIOCHEM, V56, P133, DOI 10.1016/0960-0760(95)00230-8; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Duncan FJ, 2013, J INVEST DERMATOL, V133, P334, DOI 10.1038/jid.2012.344; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Garcia-Serrano L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023825; Geria AN, 2008, CURR OPIN INVEST DR, V9, P1228; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kawamura T, 2012, J CLIN INVEST, V122, P722, DOI 10.1172/JCI58618; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Kurashima Y, 2007, J IMMUNOL, V179, P1577, DOI 10.4049/jimmunol.179.3.1577; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Morizane S, 2010, J INVEST DERMATOL, V130, P1297, DOI 10.1038/jid.2009.435; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Schirmer C, 2010, BLOOD, V116, P1715, DOI 10.1182/blood-2010-01-263509; Sudo N, 1996, J IMMUNOL, V156, P3970; Takahashi T, 2013, J INVEST DERMATOL, V133, P2407, DOI 10.1038/jid.2013.163; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Varani J, 2003, ARCH DERMATOL RES, V295, P255, DOI 10.1007/s00403-003-0416-5; Wang ZP, 2012, J IMMUNOL, V189, P1551, DOI 10.4049/jimmunol.1200471; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	50	60	61	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					530	541		10.1016/j.immuni.2014.01.014	http://dx.doi.org/10.1016/j.immuni.2014.01.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24726878	Bronze			2022-12-18	WOS:000334849400011
J	Hipp, MM; Shepherd, D; Gileadi, U; Aichinger, MC; Kessler, BM; Edelmann, MJ; Essalmani, R; Seidah, NG; Sousa, CRE; Cerundolo, V				Hipp, Madeleine M.; Shepherd, Dawn; Gileadi, Uzi; Aichinger, Michael C.; Kessler, Benedikt M.; Edelmann, Mariola J.; Essalmani, Rachid; Seidah, Nabil G.; Reis e Sousa, Caetano; Cerundolo, Vincenzo			Processing of Human Toll-like Receptor 7 by Furin-like Proprotein Convertases Is Required for Its Accumulation and Activity in Endosomes	IMMUNITY			English	Article							NUCLEIC-ACID RECOGNITION; PATHOGEN RECOGNITION; IN-VITRO; ACTIVATION; CELLS; IDENTIFICATION; INHIBITION; EXPRESSION; CLEAVAGE; MUTATION	Toll-like receptor 7 (TLR7) triggers antiviral immune responses by recognizing viral single-stranded RNA in endosomes, but the biosynthetic pathway of human TLR7 (hTLR7) remains unclear. Here, we show that hTLR7 is proteolytically processed and that the C-terminal fragment selectively accumulates in endocytic compartments. hTLR7 processing occurred at neutral pH and was dependent on furin-like proprotein convertases (PCs). Furthermore, TLR7 processing was required for its functional response to TLR7 agonists such as R837 or influenza virus. Notably, proinflammatory and differentiation stimuli increased the expression of furin-like PCs in immune cells, suggesting a positive feedback mechanism for TLR7 processing during infection. Because self-RNA can under certain conditions activate TLR7 and trigger autoimmunity, our results identify furin-like PCs as a possible target to attenuate TLR7-dependent autoimmunity and other immune pathologies.	[Hipp, Madeleine M.; Shepherd, Dawn; Gileadi, Uzi; Aichinger, Michael C.; Cerundolo, Vincenzo] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DU, England; [Kessler, Benedikt M.; Edelmann, Mariola J.] Churchill Hosp, Ctr Cellular & Mol Physiol, Nuffield Dept Med, Oxford OX3 7BN, England; [Essalmani, Rachid; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Reis e Sousa, Caetano] London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3LY, England	University of Oxford; University of Oxford; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Cancer Research UK	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3LY, England.	caetano@cancer.org.uk; vincenzo.cerundolo@imm.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Reis e Sousa, Caetano/O-1657-2014; Seidah, Nabil/I-3596-2013; Reis e Sousa, Caetano/ABD-7322-2021	Kessler, Benedikt/0000-0002-8160-2446; Reis e Sousa, Caetano/0000-0001-7392-2119; Seidah, Nabil/0000-0001-6503-9342; Reis e Sousa, Caetano/0000-0001-7392-2119; Shepherd, Dawn/0000-0003-1304-6051; Cerundolo, Vincenzo/0000-0003-0040-3793; Gileadi, Uzi/0000-0001-7348-9204; Edelmann, Mariola/0000-0003-0459-7716	Medical Research Council, UK; CRUK [C399/A2291]; Wellcome Trust [084923]; DC-THERA; European Commission Sixth Framework Programme [512074]; Harry Mahon Cancer Research Trust, UK; CIHR [MOP 44363]; Canada Chair [216684]; Biomedical Research Centre (NIHR), Oxford, UK; Cancer Research UK [15689, 11331] Funding Source: researchfish; Medical Research Council [MC_UU_12010/1, G0501068] Funding Source: researchfish; MRC [MC_UU_12010/1, G0501068] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); DC-THERA; European Commission Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Harry Mahon Cancer Research Trust, UK; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Chair; Biomedical Research Centre (NIHR), Oxford, UK(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank C. De Santo for generous practical and advisory input, S. Booth for practical and G. Napolitani for advisory input, and M. Johnson for critical reading and editing of the manuscript (all MRC Human Immunology Unit, University of Oxford, Oxford, UK). We thank G. Ball (Micron Oxford, Advanced Bioimaging Unit) for helping with the Fiji analysis and L. Chaperot as well as J. Plumas (Universite Joseph Fourier, Grenoble, France) for experimental help. This work was supported by the Medical Research Council, UK, CRUK (Programme Grant # C399/A2291 to V. C. and LRI core support to C. R. S.), the Wellcome Trust (084923 to V. C.), DC-THERA, European Commission Sixth Framework Programme (Project Number 512074), the Harry Mahon Cancer Research Trust, UK, CIHR grant # MOP 44363, and a Canada Chair # 216684 (to N.G.S.). B. M. K. is supported by the Biomedical Research Centre (NIHR), Oxford, UK.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALEXANDER B, 1962, AM J MED, V33, P679, DOI 10.1016/0002-9343(62)90246-2; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; Kanno A, 2013, INT IMMUNOL, V25, P413, DOI 10.1093/intimm/dxt007; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Komiyama T, 2009, J BIOL CHEM, V284, P15729, DOI 10.1074/jbc.M901540200; Krug Anne, 2008, V183, P129; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Maschalidi S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002841; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nie GY, 2003, BIOL REPROD, V68, P439, DOI 10.1095/biolreprod.102.006676; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Salvas A, 2005, FEBS LETT, V579, P5621, DOI 10.1016/j.febslet.2005.09.029; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Zarkik S, 1997, FEBS LETT, V406, P205, DOI 10.1016/S0014-5793(97)00275-5; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	42	60	61	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					711	721		10.1016/j.immuni.2013.09.004	http://dx.doi.org/10.1016/j.immuni.2013.09.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138882	Bronze, Green Accepted			2022-12-18	WOS:000330950000012
J	Hess, I; Boehm, T				Hess, Isabel; Boehm, Thomas			Intravital Imaging of Thymopoiesis Reveals Dynamic Lympho-Epithelial Interactions	IMMUNITY			English	Article							T-CELL DEVELOPMENT; THYMOCYTE MIGRATION; FUNCTIONAL THYMUS; GENETIC-EVIDENCE; ZEBRAFISH; HEMATOPOIESIS; SELECTION; ADULT; MOUSE; MICE	T cell development occurs in the thymus. The thymic microenvironment attracts hematopoietic progenitors, specifies them toward the T cell lineage, and orchestrates their differentiation and egress into the periphery. The anatomical location of the thymus and the intrauterine development of mouse embryos have so far precluded a direct visualization of the initial steps of thymopoiesis. Here, we describe transgenic zebrafish lines enabling the in vivo observation of thymopoiesis. The cell-autonomous proliferation of thymic epithelial cells, their morphological transformation into a reticular meshwork upon contact with hematopoietic cells, and the multiple migration routes of thymus-settling cells could be directly visualized. The unexpectedly dynamic thymus homing process is chemokine driven and independent of blood circulation. Thymocyte development appears to be completed in less than 4 days. Our work establishes a versatile model for the in vivo observation and manipulation of thymopoiesis.	[Hess, Isabel; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de			Max-Planck Society; Deutsche Forschungsgemeinschaft	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Schorpp, P. Kindle, D. Diekhoff, and A. Haas-Assenbaum for help during various stages of the project; U. Nienhaus, J. Wiedenmann, B. Appel, J. Shin, T. Carney, M. Hammerschmidt, D. Bela, and D. Stainier for constructs and reagents; and the Max-Planck Society and the Deutsche Forschungsgemeinschaft for financial support.	Anderson G, 2009, EUR J IMMUNOL, V39, P1694, DOI 10.1002/eji.200939379; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2009, CURR OPIN HEMATOL, V16, P243, DOI 10.1097/MOH.0b013e32832c05e4; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Chen JN, 1996, DEVELOPMENT, V123, P293; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Desanti GE, 2011, J IMMUNOL, V186, P5227, DOI 10.4049/jimmunol.1002686; DeWaal EJ, 1997, MICROSC RES TECHNIQ, V38, P227, DOI 10.1002/(SICI)1097-0029(19970801)38:3<227::AID-JEMT4>3.0.CO;2-J; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Iwanami N, 2011, J IMMUNOL, V186, P7060, DOI 10.4049/jimmunol.1003907; Jenkinson WE, 2007, EUR J IMMUNOL, V37, P2090, DOI 10.1002/eji.200737212; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Li J, 2007, J IMMUNOL, V179, P1605, DOI 10.4049/jimmunol.179.3.1605; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Nitta T, 2011, CURR OPIN IMMUNOL, V23, P190, DOI 10.1016/j.coi.2010.12.002; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Phee H, 2010, NAT IMMUNOL, V11, P503, DOI 10.1038/ni.1868; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Roberts NA, 2009, EUR J IMMUNOL, V39, P2395, DOI 10.1002/eji.200939501; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Sanos SL, 2011, J IMMUNOL, V186, P2835, DOI 10.4049/jimmunol.1003563; Schorpp M, 2002, MECH DEVELOP, V118, P179, DOI 10.1016/S0925-4773(02)00241-1; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	49	60	61	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					298	309		10.1016/j.immuni.2011.12.016	http://dx.doi.org/10.1016/j.immuni.2011.12.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22342843	Bronze			2022-12-18	WOS:000300812400017
J	de Vries, VC; Pino-Lagos, K; Nowak, EC; Bennett, KA; Oliva, C; Noelle, RJ				de Vries, Victor C.; Pino-Lagos, Karina; Nowak, Elizabeth C.; Bennett, Kathy A.; Oliva, Carla; Noelle, Randolph J.			Mast Cells Condition Dendritic Cells to Mediate Allograft Tolerance	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; CD8(+) T-CELLS; FC-EPSILON-RI; GM-CSF; MATURATION; APOPTOSIS; ACTIVATION; MECHANISMS; EXPRESSION	Peripheral tolerance orchestrated by regulatory T cells, dendritic cells (DCs), and mast cells (MCs) has been studied in several models including skin allograft tolerance. We now define a role for MCs in controlling DC behavior ("conditioning") to facilitate tolerance. Under tolerant conditions, we show that MCs mediated a marked increase in tumor necrosis factor (TNF alpha)-dependent accumulation of graft-derived DCs in the dLN compared to nontolerant conditions. This increase of DCs in the dLN is due to the local production of granulocyte macrophage colony-stimulating factor (GM-CSF) by MCs that induces a survival advantage of graft-derived DCs. DCs that migrated to the dLN from the tolerant allograft were tolerogenic; i.e., they dominantly suppress T cell responses and control regional immunity. This study underscores the importance of MCs in conditioning DCs to mediate peripheral tolerance and shows a functional impact of peripherally produced TNF alpha and GM-CSF on the migration and function of tolerogenic DCs.	[de Vries, Victor C.; Pino-Lagos, Karina; Nowak, Elizabeth C.; Bennett, Kathy A.; Noelle, Randolph J.] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [de Vries, Victor C.; Pino-Lagos, Karina; Nowak, Elizabeth C.; Bennett, Kathy A.; Noelle, Randolph J.] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [de Vries, Victor C.] ASTAR, Singapore Immunol Network SIgN, Lab Allergy & Inflammat, Singapore 138648, Singapore; [Oliva, Carla; Noelle, Randolph J.] Kings Coll London, MRC, Ctr Transplantat, Guys Hosp, London SE1 9RT, England	Dartmouth College; Norris Cotton Cancer Center; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Noelle, RJ (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.	randolph.noelle@kcl.ac.uk	Pino-Lagos, Karina/C-9583-2017; Pino-Lagos, Karina/H-7581-2013	Pino-Lagos, Karina/0000-0002-4070-6169; Pino-Lagos, Karina/0000-0002-4070-6169	National Institutes of Health (United States) [R01AT005382, AI048667]; Wellcome Trust; MRC Centre for Transplantation (United Kingdom); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy's and St Thomas' NHS Foundation Trust and King's College London; Agency of Science, Technology and Research (A*STAR, Singapore); National Multiple Sclerosis Society; BECAS Chile; Medical Research Council [G0802651, G0600698B] Funding Source: researchfish; MRC [G0802651] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048667] Funding Source: NIH RePORTER	National Institutes of Health (United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); MRC Centre for Transplantation (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy's and St Thomas' NHS Foundation Trust and King's College London(National Institute for Health Research (NIHR)); Agency of Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); BECAS Chile; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge support of National Institutes of Health grant (R01AT005382, AI048667, United States), "The Wellcome Trust," MRC Centre for Transplantation (United Kingdom), National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy's and St Thomas' NHS Foundation Trust and King's College London and the Agency of Science, Technology and Research (A*STAR, Singapore). E.C.N. is supported by a postdoctoral fellowship from National Multiple Sclerosis Society. C.O. is recipient of a postdoctoral fellowship from BECAS Chile.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435, DOI 10.1002/jlb.59.3.435; Bischoff SC, 2007, IMMUNOL REV, V217, P329, DOI 10.1111/j.1600-065X.2007.00523.x; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Carvalho MA, 2000, BIOL CELL, V92, P605, DOI 10.1016/S0248-4900(01)01113-3; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dudeck A, 2011, EUR J IMMUNOL, V41, P1883, DOI 10.1002/eji.201040994; Faderl S, 2003, BLOOD, V102, P630, DOI 10.1182/blood-2002-06-1890; Gondek DC, 2008, J IMMUNOL, V181, P4752, DOI 10.4049/jimmunol.181.7.4752; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; KOCH F, 1990, J EXP MED, V171, P159, DOI 10.1084/jem.171.1.159; Leverkus M, 2000, BLOOD, V96, P2628; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; LUDEWIG B, 1995, EUR J IMMUNOL, V25, P1943, DOI 10.1002/eji.1830250722; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Metz M, 2008, IMMUNOBIOLOGY, V213, P251, DOI 10.1016/j.imbio.2007.10.017; Modrowski D, 1998, J CELL PHYSIOL, V177, P187, DOI 10.1002/(SICI)1097-4652(199810)177:1<187::AID-JCP19>3.0.CO;2-A; Moldenhauer LM, 2010, J IMMUNOL, V185, P7085, DOI 10.4049/jimmunol.1001374; Ni K, 2001, Dev Immunol, V8, P133, DOI 10.1155/2001/68024; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Quezada SA, 2005, J IMMUNOL, V175, P771, DOI 10.4049/jimmunol.175.2.771; Quezada SA, 2003, BLOOD, V102, P1920, DOI 10.1182/blood-2003-02-0586; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Welker P, 2001, ARCH DERMATOL RES, V293, P249, DOI 10.1007/s004030100225	32	60	60	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					550	561		10.1016/j.immuni.2011.09.012	http://dx.doi.org/10.1016/j.immuni.2011.09.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035846	Green Accepted, Bronze			2022-12-18	WOS:000296657700014
J	Germain, RN				Germain, Ronald N.			Vaccines and the Future of Human Immunology	IMMUNITY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SPECTROMETRY-BASED PROTEOMICS; CYTOPLASMIC FREE CALCIUM; YELLOW-FEVER VACCINE; MEMORY B-CELLS; T-CELLS; MASS-SPECTROMETRY; PRIMARY IMMUNODEFICIENCIES; INFECTIOUS-DISEASES; MOLECULAR-CLONING	In this issue of Immunity, a collection of detailed reviews summarizes needs, opportunities, and roadblocks to the development of new vaccines, all in the context of our current knowledge and understanding of key aspects of immune function and microbial interactions with the host This Perspective is designed to provide a broad overview that discusses our present limitations in designing effective novel vaccines for diseases that do not typically induce robust resistance in infected individuals and how the addition of a systems-level, multiplexed approach to the analysis of the human immune system can complement traditional highly focused research efforts to accelerate our progress toward this goal and the improvement of human health	[Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIAID, Program Syst Immunol & Infect Dis Modeling, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NIAID NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000974] Funding Source: NIH RePORTER	NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I would like to especially thank my colleagues in the CHI for their efforts to develop a new way to gain understanding of the human immune system in health and disease and for their comments on a draft article that was used in part to prepare this Perspective I also would like to thank A Hayday B Pulendran M Davis C Benoist J Banchereau D Chaussabel and others for discussions that have helped formulate the ideas expressed here about a new beginning in the systematic analysis of human immunity This work was supported by the Intramural Research Program of NIAID NIH	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; Casanova JL, 2008, J INTERN MED, V264, P115, DOI 10.1111/j.1365-2796.2008.01971.x; Chandran A, 2005, EXPERT REV VACCINES, V4, P819, DOI 10.1586/14760584.4.6.819; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Chun HJ, 2001, ADV EXP MED BIOL, V490, P49; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Ehl S, 1997, EUR J IMMUNOL, V27, P3404, DOI 10.1002/eji.1830271240; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gross C P, 1998, Int J Infect Dis, V3, P54; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Henderson DA, 1999, VACCINE, V17, pS53, DOI 10.1016/S0264-410X(99)00293-5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; IMBODEN JB, 1985, J IMMUNOL, V134, P663; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Letvin NL, 2005, ANNU REV MED, V56, P213, DOI 10.1146/annurev.med.54.101601.152349; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; MILLER JFAP, 1972, INT REV CYTOL, V33, P77, DOI 10.1016/S0074-7696(08)61449-7; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Picard C, 2007, IMMUNOL RES, V38, P347, DOI 10.1007/s12026-007-0006-2; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; PRINCE GA, 1985, VIRUS RES, V3, P193, DOI 10.1016/0168-1702(85)90045-0; PRINCE GA, 1985, J VIROL, V55, P517, DOI 10.1128/JVI.55.3.517-520.1985; PRINCE GA, 1985, J INFECT DIS, V151, P634, DOI 10.1093/infdis/151.4.634; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Rappuoli R, 2001, VACCINE, V19, P2319, DOI 10.1016/S0264-410X(00)00552-1; Ravanfar P, 2009, DERMATOL THER, V22, P110, DOI 10.1111/j.1529-8019.2009.01224.x; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; REINHERZ EL, 1982, PHARMACOL REV, V34, P17; RERKS NS, 2009, NEW ENGL J MED, V361, P2209; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; SCHULZ KR, 2007, CURR PROTOC IMMUNOL, P8; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; SILVERSTEIN AM, 1999, HIST IMMUNOLOGY FUND, P19; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trimble CL, 2009, LANCET ONCOL, V10, P975, DOI 10.1016/S1470-2045(09)70227-X; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; Weiss A, 1991, Semin Immunol, V3, P313; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, IMMUNOL REV, V42, P224, DOI 10.1111/j.1600-065X.1978.tb00264.x; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	89	60	62	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					441	450		10.1016/j.immuni.2010.09.014	http://dx.doi.org/10.1016/j.immuni.2010.09.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029956	Bronze			2022-12-18	WOS:000284300200002
J	Hermann-Kleiter, N; Gruber, T; Lutz-Nicoladoni, C; Thuille, N; Fresser, F; Labi, V; Schiefermeier, N; Warnecke, M; Huber, L; Villunger, A; Eichele, G; Kaminski, S; Baier, G				Hermann-Kleiter, Natascha; Gruber, Thomas; Lutz-Nicoladoni, Christina; Thuille, Nikolaus; Fresser, Friedrich; Labi, Verena; Schiefermeier, Natalia; Warnecke, Marei; Huber, Lukas; Villunger, Andreas; Eichele, Gregor; Kaminski, Sandra; Baier, Gottfried			The nuclear orphan receptor NR2176 suppresses lymphocyte activation and T helper 17-dependent autoimmunity	IMMUNITY			English	Article							PROTEIN-KINASE-C; ROR-GAMMA-T; PKC-THETA; CELL-ACTIVATION; COUP-TFII; KAPPA-B; MICE; GENE; DIFFERENTIATION; TRANSCRIPTION	The protein kinase C (PKC) family of serine-threonine kinases; plays a central role in T lymphocyte activation. Here, we identify NR2F6, a nuclear zinc-finger orphan receptor, as a critical PKC substrate and essential regulator of CD4(+) T cell activation responses. NR2F6 potently antagonized the ability of T helper 0 (Th0) and Th17 CD4+ T cells to induce expression of key cytokine genes such as interleukin-2 (IL-2) and IL-17. Mechanistically, NR2F6 directly interfered with the DNA binding of nuclear factor of activated T cells (NF-AT):activator protein 1 (AP-1) but not nuclear factor kappa B (NF-kappa B) and, subsequently, transcriptional activity of the NF-AT-dependent IL-17A cytokine promoter. Consistent with our model, Nr2f6-deficient mice had hyperreactive lymphocytes, developed a late-onset immunopathology, and were hypersusceptible to Th17-dependent experimental autoimmune encephalomyelitis. Our study establishes NR2F6 as a transcriptional repressor of IL-17 expression in Th17-differentiated CD4(+) T cells in vitro and in vivo.	[Hermann-Kleiter, Natascha; Gruber, Thomas; Lutz-Nicoladoni, Christina; Thuille, Nikolaus; Fresser, Friedrich; Kaminski, Sandra; Baier, Gottfried] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Labi, Verena; Schiefermeier, Natalia; Huber, Lukas; Villunger, Andreas] Med Univ Innsbruck, Bioctr, A-6020 Innsbruck, Austria; [Warnecke, Marei; Eichele, Gregor] MPI Biophys Chem, D-37077 Gottingen, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Max Planck Society	Baier, G (corresponding author), Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria.		Kaminski, Sandra/AAM-6134-2021; Labi, Verena/V-2766-2019; Huber, Lukas Alfons/AAM-3499-2021; Schiefermeier-Mach, Natalia/AAW-6428-2021; Kleiter, Natascha/I-5101-2018; Baier, Gottfried/E-8755-2012	Labi, Verena/0000-0001-7538-1520; Schiefermeier-Mach, Natalia/0000-0001-6638-5298; Kleiter, Natascha/0000-0003-4389-9813; Gruber, Thomas/0000-0002-5796-7090; Huber, Lukas Alfons/0000-0003-1116-2120; Thuille, Nikolaus/0000-0002-2253-3946; Baier, Gottfried/0000-0002-2085-8325	FWF Austrian Science Fund [SFB-021, P19505-B05]; Foundation pour la Recherche Medicale	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We are grateful to H. Dietrich, N. Krumbock, C. Mayerl, M. Hermann, and G. Bock (all from Innsbruck) for animal care, expert technical assistance, and FACS analysis. This work was supported by a grant from the FWF Austrian Science Fund (SFB-021 and P19505-B05) and the Foundation pour la Recherche Medicale (S.K.).	Altman A, 2004, EUR J IMMUNOL, V34, P2001, DOI 10.1002/eji.200324625; Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; [Anonymous], 2002, INTRO STAT R; Auwerx J, 1999, CELL, V97, P161; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chaudhary D, 2006, CURR OPIN INVEST DR, V7, P432; Cheng K, 2007, PROG NAT SCI, V17, P19; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Everitt BS, 2001, ANAL MED DATA USING; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Harant H, 2004, NUCLEIC ACIDS RES, V32, P5280, DOI 10.1093/nar/gkh856; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu XB, 2003, CIRC RES, V92, P1033, DOI 10.1161/01.RES.0000071355.82009.43; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pfeifhofer C, 2006, J IMMUNOL, V176, P6004, DOI 10.4049/jimmunol.176.10.6004; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Schmidt CS, 2005, J IMMUNOL, V175, P2286, DOI 10.4049/jimmunol.175.4.2286; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundrud MS, 2008, IMMUNITY, V28, P5, DOI 10.1016/j.immuni.2007.12.006; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhang Y, 2004, VITAM HORM, V68, P1	47	60	63	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 15	2008	29	2					205	216		10.1016/j.immuni.2008.06.008	http://dx.doi.org/10.1016/j.immuni.2008.06.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701084	Bronze, Green Accepted			2022-12-18	WOS:000258610800009
J	Moore, CB; Ting, JPY				Moore, Chris B.; Ting, Jenny P-Y.			Regulation of mitochondrial antiviral signaling pathways	IMMUNITY			English	Review							NEGATIVE REGULATION; UBIQUITIN LIGASE; ADAPTER PROTEIN; INTERFERON; INHIBITION; NLRX1; DNA	Mitochondrial antiviral immunity involves the detection of viral RNA by intracellular pattern-recognition receptors (PRRs) belonging to the RIG-I-like helicase family. The convergence of these and other signaling molecules to the outer mitochondrial membrane results in the rapid induction of antiviral cytokines including type-1 interferon. Here, we discuss recent studies describing new molecules implicated in the regulation of this antiviral response.	[Moore, Chris B.; Ting, Jenny P-Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Moore, CB (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	cbmoore2@med.unc.edu; jenny_ting@med.unc.edu						Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; SUN Q, 1989, IMMUNITY, V24, P633; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 2008, ADV DRUG DELIVER REV, V60, P841, DOI 10.1016/j.addr.2007.12.001	27	60	62	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2008	28	6					735	739		10.1016/j.immuni.2008.05.005	http://dx.doi.org/10.1016/j.immuni.2008.05.005			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549796	Green Submitted, Bronze			2022-12-18	WOS:000256760200005
J	Zhang, XR; Wang, HS; Claudio, E; Brown, K; Siebenlist, U				Zhang, Xiaoren; Wang, Hongshan; Claudio, Estefania; Brown, Keith; Siebenlist, Ulrich			A role for the I kappa B family member bcl-3 in the control of central immunologic tolerance	IMMUNITY			English	Article							REGULATORY T-CELLS; LYMPHOTOXIN BETA-RECEPTOR; GERMINAL CENTER REACTIONS; THYMIC EPITHELIAL-CELLS; SELF-TOLERANCE; SPLENIC MICROARCHITECTURE; SIGNALING PATHWAY; ONCOPROTEIN BCL-3; MICE DEFICIENT; P50 HOMODIMERS	Bcl-3 is a member of the family of I kappa B inhibitors. Unlike the classical, cytoplasmic I kappa Bs, Bcl-3 does not inhibit ReIA- or c-Rel-containing NF-kappa B transcription factor dimers. Instead, Bcl-3 can enter the nucleus and modulate NF-kappa B activity, although the underlying mechanism and physiologic function remain largely unknown. Here we identified Bcl-3 as a regulator of immunologic tolerance to self. In parallel with NF-kappa B2, Bcl-3 functions within stroma to generate medullary thymic epithelial cells, which are essential for negative selection of autoreactive T cells. Loss of both NF-kappa B2 and Bcl-3, but not either one alone, led to a profound breakdown in central tolerance resulting in rapid and fatal multiorgan inflammation. These data reveal extensive utilization of the NF-kappa B system to promote central tolerance in the thymus, in apparent contrast with the well-known roles of NF-kappa B to promote inflammation and autoimmunity in the periphery.	NIAID, NIH, Immunoregulat Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), NIAID, NIH, Immunoregulat Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	us3n@nih.gov		zhang, xiaoren/0000-0003-4080-433X	Intramural NIH HHS [Z01 AI000723-13, Z01 AI000722-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000723, Z01AI000722] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; BOURNE S, 1993, SIGHT SOUND, V3, P72; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Claudio E, 2006, CELL DEATH DIFFER, V13, P697, DOI 10.1038/sj.cdd.4401894; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Elewaut D, 2003, J EXP MED, V197, P1623, DOI 10.1084/jem.20030141; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Ge BS, 2003, J IMMUNOL, V171, P4210, DOI 10.4049/jimmunol.171.8.4210; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Martin E, 2003, IMMUNITY, V18, P155, DOI 10.1016/S1074-7613(02)00503-4; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P114, DOI 10.1111/j.1749-6632.2002.tb05946.x; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Paxian S, 2002, GASTROENTEROLOGY, V122, P1853, DOI 10.1053/gast.2002.33651; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; VANVLIET E, 1985, EUR J IMMUNOL, V15, P675, DOI 10.1002/eji.1830150707; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Zhang BC, 2006, J BIOL CHEM, V281, P38617, DOI 10.1074/jbc.M606705200; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	54	60	63	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					438	452		10.1016/j.immuni.2007.07.017	http://dx.doi.org/10.1016/j.immuni.2007.07.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17869136	Green Accepted, Bronze			2022-12-18	WOS:000249843400011
J	Spits, H; Lanier, LL				Spits, Hergen; Lanier, Lewis L.			Natural killer or dendritic: What's in a name?	IMMUNITY			English	Article							T-CELL-ACTIVATION; HUMAN NK CELLS; MYELOID PROGENITOR; IFN-GAMMA; RECEPTOR; INNATE; SUBSET; LINK; IPC	Accumulating data suggest a potential for substantial overlap in phenotypic and functional characteristics between natural killer and dendritic cells. Thus, their identification, lineage commitment, and in vivo relevance may need a closer look.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spits, H (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	hspits@gene.com; lewis.lanier@ucsf.edu	Spits, Hergen/N-2581-2019; Lanier, Lewis L/E-2139-2014	Spits, Hergen/0000-0003-3269-8338; Lanier, Lewis L/0000-0003-1308-3952				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; AULT KA, 1981, J IMMUNOL, V126, P359; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chicha L, 2004, J EXP MED, V200, P1519, DOI 10.1084/jem.20040809; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Homann D, 2002, IMMUNITY, V16, P403, DOI 10.1016/S1074-7613(02)00290-X; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; Josien R, 1997, J EXP MED, V186, P467, DOI 10.1084/jem.186.3.467; LANIER LL, 1986, J IMMUNOL, V137, P2735; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; NAGLER A, 1989, J IMMUNOL, V143, P3183; PHILLIPS JH, 1984, J EXP MED, V159, P993, DOI 10.1084/jem.159.4.993; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Puzanov IJ, 1996, J IMMUNOL, V157, P4282; RONCAROLO MG, 1991, J IMMUNOL, V147, P781; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Trinite B, 2000, J IMMUNOL, V165, P4202, DOI 10.4049/jimmunol.165.8.4202; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716	33	60	64	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					11	16		10.1016/j.immuni.2007.01.004	http://dx.doi.org/10.1016/j.immuni.2007.01.004			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17241957	Bronze			2022-12-18	WOS:000243959000005
J	Ibiza, S; Victor, VM; Bosca, I; Ortega, A; Urzainqui, A; O'Connor, J; Sanchez-Madrid, F; Esplugues, JV; Serrador, JM				Ibiza, Sales; Victor, Victor M.; Bosca, Irene; Ortega, Angel; Urzainqui, Ana; O'Connor, Jose.; Sanchez-Madrid, Francisco; Esplugues, Juan V.; Serrador, Juan M.			Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse	IMMUNITY			English	Article							FLUORESCENT INDICATORS; GOLGI-APPARATUS; ENTEROTOXIN-B; IFN-GAMMA; ACTIVATION; LYMPHOCYTES; INHIBITION; EXPRESSION; RAS; AKT	The role of nitric oxide (NO) in T cells remains controversial, and the origin and localization of endogenous NO and whether it regulates lymphocyte activation are unclear. We show here that, within minutes of binding to antigen, T cells produce NO via endothelial nitric oxide synthase (eNOS). This process required increased intracellular Ca2+ and phosphoinositide3-kinase activity. Ely using an eNOS-green fluorescent fusion protein and fluorescent probes to detect NO, we show that eNOS translocates with the Golgi apparatus to the immune synapse of T helper cells engaged with antigen-presenting cells (APC), where it was fully activated. Overexpression of eNOS prevented the central coalescence of CD3 at the T cell-APC contact site, which was accompanied by increased phosphorylation of CD3 chain, ZAP-70, and extracellular signal-regulated kinases and increased IFN-gamma synthesis, but reduced production of IL-2. Therefore, eNOS-derived NO selectively potentiates T cell receptor signaling to antigen at the immunological synapse.	Univ Valencia, CNIC, Unidad Mixta, E-46010 Valencia, Spain; Univ Valencia, Unidad Cent Invest, E-46010 Valencia, Spain; Univ Autonoma Madrid, Hosp La Princesa, Serv Inmunol, E-28006 Madrid, Spain; Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, E-46010 Valencia, Spain; Univ Valencia, Fac Med, Dept Farmacol, E-46010 Valencia, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Valencia; University of Valencia; Autonomous University of Madrid; Hospital de La Princesa; University of Valencia; University of Valencia	Serrador, JM (corresponding author), Univ Valencia, CNIC, Unidad Mixta, Ave Blasco Ibanez 15-17, E-46010 Valencia, Spain.	jmserrador@cnic.es	Serrador, Juan M/K-2718-2014; Ortega, Angel L./A-4113-2014; Urzainqui, Ana/AAB-4466-2020; Urzainqui, Ana/HDN-9549-2022; Sanchez-Madrid, Francisco/M-7889-2016; victor, victor/Q-4843-2019; Esplugues, Juan/ABC-1488-2021; VICTOR, VICTOR M/I-3270-2015	Serrador, Juan M/0000-0003-4710-3077; Ortega, Angel L./0000-0002-9901-3383; Urzainqui, Ana/0000-0001-9326-6112; Urzainqui, Ana/0000-0001-9326-6112; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Esplugues Mota, Juan Vicente/0000-0001-8205-021X; VICTOR, VICTOR/0000-0002-3027-3945; Ibiza, Sales/0000-0002-5748-382X; Ibiza, Sales/0000-0002-0132-2971				Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Fiorucci S, 2004, J IMMUNOL, V173, P874, DOI 10.4049/jimmunol.173.2.874; Fischer TA, 2001, J BIOL CHEM, V276, P5967, DOI 10.1074/jbc.M009781200; FLORQUIN S, 1995, EUR J IMMUNOL, V25, P1148, DOI 10.1002/eji.1830250503; FRA AM, 1994, J BIOL CHEM, V269, P30745; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; FURFINE ES, 1993, BIOCHEMISTRY-US, V32, P8512, DOI 10.1021/bi00084a017; Handy RLC, 1996, BRIT J PHARMACOL, V119, P423, DOI 10.1111/j.1476-5381.1996.tb16003.x; Harrison Stephen A, 2002, Semin Gastrointest Dis, V13, P3; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Koh KP, 2004, J CLIN INVEST, V114, P846, DOI 10.1172/JCI200421767; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; KUPFER A, 1986, P NATL ACAD SCI USA, V83, P6080, DOI 10.1073/pnas.83.16.6080; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mori N, 1999, BLOOD, V94, P2862, DOI 10.1182/blood.V94.8.2862.420k24_2862_2870; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Reiling N, 1996, EUR J IMMUNOL, V26, P511, DOI 10.1002/eji.1830260302; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Schade AE, 2004, J IMMUNOL, V172, P5828, DOI 10.4049/jimmunol.172.10.5828; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Sriskandan S, 1996, J IMMUNOL, V156, P2430; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225	41	60	64	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2006	24	6					753	765		10.1016/j.immuni.2006.04.006	http://dx.doi.org/10.1016/j.immuni.2006.04.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782031	Bronze			2022-12-18	WOS:000238592200013
J	Hovanessian, AG; Briand, JP; Said, EA; Svab, J; Ferris, S; Dali, H; Muller, S; Desgranges, C; Krust, B				Hovanessian, AG; Briand, JP; Said, EA; Svab, J; Ferris, S; Dali, H; Muller, S; Desgranges, C; Krust, B			The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEMBRANE RAFT MICRODOMAINS; PLASMA-MEMBRANE; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; PERMISSIVE CELLS; LIPID RAFTS; FUSION; PEPTIDE; PSEUDOPEPTIDE	Caveolin-1 is a scaffolding protein that organizes and concentrates specific ligands within the caveolae membranes. We identified a conserved caveolin-1 binding motif in the HIV-1 transmembrane envelope glycoprotein gp41 and designed several synthetic peptides, referred to as CBD1, corresponding to the consensus caveolin-1 binding domain in gp41. In rabbits, these peptides elicit the production of antibodies that inhibit infection of primary CD4+ T lymphocytes by various primary HIV-1 isolates. Interestingly, gp41 exists as a stable complex with caveolin-1 in HIV-infected cells. Anti-CBD1 peptide antibodies, therefore, might be functional by inhibiting the potential interaction of gp41 with caveolin-1. Because of their capacity to elicit antibodies that inhibit the different clades of HIV-1, CBD1-based peptides may represent a novel synthetic universal B cell epitope vaccine candidate for HIV/ AIDS. Moreover, such peptides could also have an application as a therapeutic vaccine since CBD1-specific antibodies are rare in HIV-infected individuals from several geographic origins.	CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France; INSERM, EMI 03 34, Inst Mol Genet, Hop St Louis, F-75010 Paris, France; Inst Pasteur, URA 1930, CNRS, Unit Virol & Immunol Cellulaire, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Hovanessian, AG (corresponding author), Univ Paris 05, CNRS, UFR Biomed Saints Peres, UPR 2228, 45 Rue Saints Peres, F-75270 Paris 6, France.	ara.hovanessian@univ-paris5.fr	Said, Elias/AAY-5557-2020; Muller, Sylviane/J-5319-2014	Said, Elias/0000-0003-4224-6351				Belliard G, 2003, VACCINE, V21, P3186, DOI 10.1016/S0264-410X(03)00233-0; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Desgranges C, 1998, AIDS, V12, P1563, DOI 10.1097/00002030-199812000-00027; Dong XN, 2001, IMMUNOL LETT, V75, P215, DOI 10.1016/S0165-2478(00)00302-3; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Du APC, 2002, J MOL BIOL, V323, P503, DOI 10.1016/S0022-2836(02)00701-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; HOVANESSIAN AG, 1988, IMMUNOL TODAY, V9, P161, DOI 10.1016/0167-5699(88)91288-1; KATSUMOTO T, 1990, J ELECTRON MICROSC, V39, P33; LAURENTCRAWFORD AG, 1993, J GEN VIROL, V74, P2619, DOI 10.1099/0022-1317-74-12-2619; LAURENTCRAWFORD AG, 1993, AIDS RES HUM RETROV, V9, P761, DOI 10.1089/aid.1993.9.761; Legastelois I, 2000, J VIROL, V74, P5712, DOI 10.1128/JVI.74.12.5712-5715.2000; LLANO M, 2002, J BIOL CHEM, V277, P41295; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Moore JP, 2001, J VIROL, V75, P5721, DOI 10.1128/JVI.75.13.5721-5729.2001; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; NEIMARK J, 1993, PEPTIDE RES, V6, P219; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Nisole S, 2002, EXP CELL RES, V276, P155, DOI 10.1006/excr.2002.5522; Nisole S, 2000, AIDS RES HUM RETROV, V16, P237, DOI 10.1089/088922200309331; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sattentau QJ, 1999, IMMUNOL LETT, V66, P143, DOI 10.1016/S0165-2478(98)00174-6; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shu W, 2000, J BIOL CHEM, V275, P1839, DOI 10.1074/jbc.275.3.1839; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Valenzuela A, 1997, J VIROL, V71, P8289, DOI 10.1128/JVI.71.11.8289-8298.1997; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000	45	60	66	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2004	21	5					617	627		10.1016/j.immuni.2004.08.015	http://dx.doi.org/10.1016/j.immuni.2004.08.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539149	Bronze			2022-12-18	WOS:000225365000004
J	Brakebusch, C; Fillatreau, S; Potocnik, AJ; Bungartz, G; Wilhelm, P; Svensson, M; Kearney, P; Korner, H; Gray, D; Fassler, R				Brakebusch, C; Fillatreau, S; Potocnik, AJ; Bungartz, G; Wilhelm, P; Svensson, M; Kearney, P; Korner, H; Gray, D; Fassler, R			beta 1 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; BONE-MARROW; ADHESION MOLECULES; IN-VIVO; INTEGRIN ALPHA-4-BETA-1; CD29 MOLECULE; STEM-CELLS; FIBRONECTIN; ACTIVATION; PROLIFERATION	Several experimental evidences suggested that beta1 integrin-mediated adhesion of hematopoietic stem cells (HSC) is important for their function in the bone marrow (BM). Using induced deletion of the beta1 integrin gene restricted to the hematopoietic system, we show that beta1 integrin is not essential for HSC retention in the BM, hematopoiesis, and trafficking of lymphocytes. However, immunization with a T cell-dependent antigen resulted in virtually no IgM production and an increased secretion of IgG in mutant mice, while the response to a T cell-independent type 2 antigen showed decreases in both IgM and IgG. These data suggest that beta1 integrins are necessary for the primary IgM antibody response.	Lund Univ, S-22185 Lund, Sweden; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; Basel Inst Immunol, CH-4005 Basel, Switzerland; Nikolaus Fiebiger Zentrum Mol Med, D-91054 Erlangen, Germany; Act Biotech, S-22007 Lund, Sweden	Lund University; Max Planck Society; University of Edinburgh	Brakebusch, C (corresponding author), Lund Univ, S-22185 Lund, Sweden.	brakebus@biochem.mpg.de	Gray, David/L-8295-2013; Korner, Heinrich/D-9970-2014	Gray, David/0000-0003-3785-4934; Korner, Heinrich/0000-0003-4610-2814; Potocnik, Alexandre/0000-0002-4730-8593; Kearney, Phil/0000-0001-7408-1067; Brakebusch, Cord/0000-0002-9342-1634; Fillatreau, Simon/0000-0002-7730-9917; Svensson-Frej, Marcus/0000-0002-3934-464X				Agenes F, 2000, CURR TOP MICROBIOL, V252, P67; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Arroyo AG, 2000, J IMMUNOL, V165, P4667, DOI 10.4049/jimmunol.165.8.4667; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Coligan J, 1995, CURRENT PROTOCOLS IM; Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215; DAMLE NK, 1991, P NATL ACAD SCI USA, V88, P6403, DOI 10.1073/pnas.88.15.6403; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Friedl P, 2000, Dev Immunol, V7, P249, DOI 10.1155/2000/56473; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389; GROUX H, 1989, NATURE, V339, P152, DOI 10.1038/339152a0; Gulbranson-Judge A, 1999, EUR J IMMUNOL, V29, P477, DOI 10.1002/(SICI)1521-4141(199902)29:02&lt;477::AID-IMMU477&gt;3.0.CO;2-V; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Korner H, 2000, J EXP MED, V191, P89, DOI 10.1084/jem.191.1.89; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUPIECWEGLINSKI JW, 1991, IMMUNOLOGY, V72, P312; Lehnert K, 1998, EUR J IMMUNOL, V28, P3605, DOI 10.1002/(SICI)1521-4141(199811)28:11<3605::AID-IMMU3605>3.3.CO;2-A; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; OOSTENDORP RAJ, 1995, BRIT J HAEMATOL, V91, P275, DOI 10.1111/j.1365-2141.1995.tb05290.x; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Prosper F, 2001, J LEUKOCYTE BIOL, V69, P307; RUIZ P, 1995, EUR J IMMUNOL, V25, P2034, DOI 10.1002/eji.1830250735; SALOMON DR, 1994, J EXP MED, V179, P1573, DOI 10.1084/jem.179.5.1573; Schmitz H, 1997, PHILOS RUNDSCH, V44, P90; Schofield KP, 1998, BLOOD, V91, P3230, DOI 10.1182/blood.V91.9.3230.3230_3230_3238; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; TICCHIONI M, 1993, J IMMUNOL, V151, P119; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; VERFAILLIE CM, 1994, BLOOD, V84, P1802; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Voura EB, 1997, EXP HEMATOL, V25, P1172; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wang MWJ, 1998, CELL GROWTH DIFFER, V9, P105; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; YAMADA A, 1991, EUR J IMMUNOL, V21, P319, DOI 10.1002/eji.1830210212; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Yokota T, 1998, BLOOD, V91, P3263, DOI 10.1182/blood.V91.9.3263.3263_3263_3272	58	60	63	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					465	477		10.1016/S1074-7613(02)00281-9	http://dx.doi.org/10.1016/S1074-7613(02)00281-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911830	Bronze			2022-12-18	WOS:000174572800014
J	Swat, W; Fujikawa, K; Ganiatsas, S; Yang, D; Xavier, RJ; Harris, NL; Davidson, L; Ferrini, R; Davis, RJ; Labow, MA; Flavell, RA; Zon, LI; Alt, FW				Swat, W; Fujikawa, K; Ganiatsas, S; Yang, D; Xavier, RJ; Harris, NL; Davidson, L; Ferrini, R; Davis, RJ; Labow, MA; Flavell, RA; Zon, LI; Alt, FW			SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; LYN-DEFICIENT MICE; AUTOIMMUNE-DISEASE; TRANSGENIC MICE; CELL-DEATH; T-CELLS; C-JUN; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; CASTLEMANS DISEASE	SAPK is a member of the group of evolutionary conserved stress-activated kinases that mediate control of cellular death and proliferation. In lymphocytes, the SAPK pathway has been implicated in signaling from antigen, costimulatory, and death receptors; SEK1, which directly activates SAPK, is required for early embryonic development and has also been reported to be essential for normal lymphocyte development. In contrast to the latter findings, we have used RAG-2-deficient blastocyst complementation to show that SEK1-deficient embryonic stem cells support unimpaired T and B lymphocyte development. Moreover, mature SEK1-deficient lymphocytes are capable of SAPK activation. Surprisingly, however, aging SEK1-deficient chimeric mice frequently develop lymphadenopathy and polyclonal B and T cell expansions. Thus, SEK1 is not required for lymphocyte development, but is required for maintaining peripheral lymphoid homeostasis.	Harvard Univ, Sch Med, Ctr Blood Res, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Hoffmann La Roche Inc, Nutley, NJ 07110 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Yale University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Roche Holding	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL59561, HL32262] Funding Source: Medline; NIAID NIH HHS [AI20047] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; BRANDT SJ, 1990, J CLIN INVEST, V86, P592, DOI 10.1172/JCI114749; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chauhan D, 1997, BLOOD, V89, P227, DOI 10.1182/blood.V89.1.227.227_227_234; CHEN J, 1994, TRANSGENESIS TARGETE, P35; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cosulich S, 1996, CURR BIOL, V6, P1586, DOI 10.1016/S0960-9822(02)70779-3; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; FISHER AG, 1993, LEUKEMIA, V7, pS66; GANIATSAS S, 1998, IN PRESS P NATL ACAD; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; Graves JD, 1996, P NATL ACAD SCI USA, V93, P13814, DOI 10.1073/pnas.93.24.13814; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; Kiefer F, 1997, BIOCHEM SOC T, V25, P491, DOI 10.1042/bst0250491; KOYASU S, 1994, EMBO J, V13, P784, DOI 10.1002/j.1460-2075.1994.tb06321.x; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCDONNELL TJ, 1990, MOL CELL BIOL, V10, P1901, DOI 10.1128/MCB.10.5.1901; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NAGATA S, 1994, ADV IMMUNOL, V57, P129, DOI 10.1016/S0065-2776(08)60672-0; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OHNO H, 1994, EMBO J, V13, P1157, DOI 10.1002/j.1460-2075.1994.tb06365.x; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; YOSHIZAKI K, 1989, BLOOD, V74, P1360; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	66	60	64	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					625	634		10.1016/S1074-7613(00)80567-1	http://dx.doi.org/10.1016/S1074-7613(00)80567-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620683	Bronze			2022-12-18	WOS:000073885400010
J	Tolosa, E; King, LB; Ashwell, JD				Tolosa, E; King, LB; Ashwell, JD			Thymocyte glucocorticoid resistance alters positive selection and inhibits autoimmunity and lymphoproliferative disease in MRL-lpr/lpr mice	IMMUNITY			English	Article							T-CELL RECEPTOR; NEGATIVE SELECTION; LPR MICE; INDUCED APOPTOSIS; TRANSGENIC MICE; GENE-PRODUCTS; IPR GENE; ANTIGEN; REPERTOIRE; ACTIVATION	Thymus-derived glucocorticoids antagonize 7 cell receptor (TCR)-induced thymocyte apoptosis, allowing the survival (positive selection) of cells bearing TCRs that recognize self antigens with low-to-moderate avidity. Here we demonstrate that expression of an antisense glucocorticoid receptor transgene in thymocytes of spontaneously autoimmune MRL-lpr/lpr mice causes the loss of specific TCR V beta-bearing T cells that are normally positively selected in this strain. These transgenic mice had lower autoantibody production and milder symptoms of autoimmune disease than MRL-/pr/lpr controls and had markedly reduced accumulation of the TCR(+)Thy-1(+)CD4(-)CD8(-)B220(+) T cells that are the hallmark of the lpr mutation. Thus, decreased glucocorticoid signaling in thymocytes alters the T cell repertoire and greatly diminishes autoimmunity in MRL-lpr/lpr autoimmune mice.	NCI, Lab Immune Cell Biol, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, Div Basic Sci, NIH, Bethesda, MD 20892 USA.		Tolosa, Eva/S-3454-2016					AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Altman A, 1994, Semin Immunol, V6, P9, DOI 10.1006/smim.1994.1003; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Balomenos D, 1997, J IMMUNOL, V159, P2265; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0; BOSSU P, 1993, J IMMUNOL, V151, P7233; BUDD RC, 1995, IMMUNOL TODAY, V16, P428, DOI 10.1016/0167-5699(95)80019-0; COHEN JJ, 1984, J IMMUNOL, V132, P38; COHEN PL, 1986, CLIN IMMUNOL IMMUNOP, V40, P485, DOI 10.1016/0090-1229(86)90193-5; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CRISPE IN, 1994, CURR OPIN IMMUNOL, V6, P438, DOI 10.1016/0952-7915(94)90124-4; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; HERRON LR, 1993, J IMMUNOL, V151, P3450; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; ISENBERG DA, 1987, ANN RHEUM DIS, V46, P448, DOI 10.1136/ard.46.6.448; IWATA M, 1991, EUR J IMMUNOL, V21, P643, DOI 10.1002/eji.1830210316; IZUI S, 1993, ANN RHEUM DIS, V52, pS48, DOI 10.1136/ard.52.Suppl_1.S48; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; KELLY KA, 1993, EUR J IMMUNOL, V23, P1922, DOI 10.1002/eji.1830230829; KING LB, 1995, IMMUNITY, V3, P647, DOI 10.1016/1074-7613(95)90135-3; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; MOUNTZ JD, 1990, J EXP MED, V172, P1805, DOI 10.1084/jem.172.6.1805; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Peng SL, 1996, J IMMUNOL, V157, P5225; Perkins DL, 1996, J IMMUNOL, V156, P4961; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; RAVECHE ES, 1982, J IMMUNOL, V129, P1219; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; SPRENT J, 1988, IMMUNOL REV, V101, P172; SWIGER RR, 1995, BIOTECHNIQUES, V18, P952; SY MS, 1988, CELL IMMUNOL, V113, P82, DOI 10.1016/0008-8749(88)90008-1; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; TOMONARI K, 1993, IMMUNOL REV, V131, P131, DOI 10.1111/j.1600-065X.1993.tb01534.x; TOMONARI K, 1992, IMMUNOGENETICS, V35, P9, DOI 10.1007/BF00216621; TOMONARI K, 1992, INT IMMUNOL, V4, P1195, DOI 10.1093/intimm/4.10.1195; TOMONARI K, 1992, IMMUNOGENETICS, V36, P230, DOI 10.1007/BF00215053; TUCKER JD, 1994, CELL BIOL LAB HDB, P450; Vacchio MS, 1997, J EXP MED, V185, P2033, DOI 10.1084/jem.185.11.2033; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; WARREN RW, 1984, CLIN IMMUNOL IMMUNOP, V31, P65, DOI 10.1016/0090-1229(84)90190-9; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WESTON KM, 1988, J IMMUNOL, V141, P1941; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; ZACHARCHUK C M, 1992, Current Biology, V2, P246, DOI 10.1016/0960-9822(92)90363-F; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; ZHOU T, 1993, J IMMUNOL, V150, P3651	60	60	60	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					67	76		10.1016/S1074-7613(00)80459-8	http://dx.doi.org/10.1016/S1074-7613(00)80459-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462512	Bronze			2022-12-18	WOS:000071765700007
J	OHMEN, JD; BARNES, PF; GRISSO, CL; BLOOM, BR; MODLIN, RL				OHMEN, JD; BARNES, PF; GRISSO, CL; BLOOM, BR; MODLIN, RL			EVIDENCE FOR A SUPERANTIGEN IN HUMAN TUBERCULOSIS	IMMUNITY			English	Article							STAPHYLOCOCCAL ENTEROTOXIN-A; TOXIC SHOCK SYNDROME; DELTA T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL SUPERANTIGENS; SELECTIVE EXPANSION; RECEPTOR REPERTOIRE; ANTIGEN RECEPTOR; CROHNS-DISEASE; GENE USAGE	T cells are not only required far resistance to tuberculosis, but they likely contribute to the tissue damage characteristic of the disease. To define better the T cell populations that contribute to the immunopathogenesis of human tuberculosis, we investigated the T cell receptor (TCR) beta chain repertoire expressed in patients with tuberculous pleuritis. Analysis by polymerase chain reaction and flow cytometry indicated an expansion of V beta 8(+) T cells at the site of disease in some donors, suggesting the possibility that Mycobacterium tuberculosis contains a superantigen. M. tuberculosis induced strong T cell proliferative responses in tuberculin-negative healthy donors in vitro, with preferential expansion of V beta 8(+) T cells, independent of the CDR3 region. T cell stimulation was MHC class II-dependent and did not require antigen processing by the antigen-presenting cells. These findings are consistent with the presence of a superantigen in M. tuberculosis, aspects of which may contribute to the immunopathology of tuberculosis and to the adjuvant properties of M. tuberculosis.	UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90024; UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033; YESHIVA UNIV ALBERT EINSTEIN COLL MED,HOWARD HUGHES MED INST,BRONX,NY 10461	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	OHMEN, JD (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DIV DERMATOL,LOS ANGELES,CA 90024, USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022553, R22AI022553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 22553, AI 08558] Funding Source: Medline; NIAMS NIH HHS [AR 40312] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE J, 1993, J EXP MED, V177, P791, DOI 10.1084/jem.177.3.791; BARNES PF, 1990, J IMMUNOL, V145, P149; BOWNESS P, 1992, J EXP MED, V176, P893, DOI 10.1084/jem.176.3.893; BRAUNSTEIN NS, 1992, J EXP MED, V175, P1301, DOI 10.1084/jem.175.5.1301; CARLSSON R, 1988, J IMMUNOL, V140, P2484; CASANOVA JL, 1993, J EXP MED, V177, P811, DOI 10.1084/jem.177.3.811; CHOI YW, 1990, J EXP MED, V172, P981, DOI 10.1084/jem.172.3.981; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; DERSIMONIAN H, 1991, J EXP MED, V174, P639, DOI 10.1084/jem.174.3.639; FINK PJ, 1990, J EXP MED, V172, P139, DOI 10.1084/jem.172.1.139; GORONZY JJ, 1992, J IMMUNOL, V148, P604; GULWANIAKOLKAR B, 1991, J EXP MED, V174, P1139, DOI 10.1084/jem.174.5.1139; HAVLIR DV, 1991, J CLIN INVEST, V87, P729, DOI 10.1172/JCI115053; HERMAN A, 1990, J EXP MED, V172, P709, DOI 10.1084/jem.172.3.709; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; IGNATOWICZ L, 1992, J EXP MED, V175, P917, DOI 10.1084/jem.175.4.917; KABELITZ D, 1990, J EXP MED, V171, P667, DOI 10.1084/jem.171.3.667; KABELITZ D, 1991, J EXP MED, V173, P1331, DOI 10.1084/jem.173.6.1331; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KARP DR, 1992, J EXP MED, V175, P415, DOI 10.1084/jem.175.2.415; KARP DR, 1990, NATURE, V346, P474, DOI 10.1038/346474a0; MAILLARD J, 1972, J EXP MED, V136, P185, DOI 10.1084/jem.136.1.185; MALHOTRA U, 1992, J IMMUNOL, V149, P1802; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; MITCHELL IC, 1992, LANCET, V339, P1015, DOI 10.1016/0140-6736(92)90536-C; MOLLER DR, 1988, J CLIN INVEST, V82, P1183, DOI 10.1172/JCI113715; MOLLICK JA, 1993, J EXP MED, V177, P283, DOI 10.1084/jem.177.2.283; OHMEN JD, 1991, J IMMUNOL, V147, P3353; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; PANINABORDIGNON P, 1992, J EXP MED, V176, P1779, DOI 10.1084/jem.176.6.1779; POSNETT DN, 1990, J CLIN INVEST, V85, P1770, DOI 10.1172/JCI114634; RUSSELL JK, 1991, P NATL ACAD SCI USA, V88, P7228, DOI 10.1073/pnas.88.16.7228; SABOOR SA, 1992, LANCET, V339, P1012, DOI 10.1016/0140-6736(92)90535-B; SANDERSON JD, 1992, GUT, V33, P890, DOI 10.1136/gut.33.7.890; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT DE, 1993, J IMMUNOL, V150, P664; SIELING PA, 1993, J IMMUNOL, V150, P5501; SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635; TAMURA N, 1990, J EXP MED, V172, P169, DOI 10.1084/jem.172.1.169; TAUB DD, 1992, CELL IMMUNOL, V141, P263, DOI 10.1016/0008-8749(92)90147-H; UYEMURA K, 1993, J IMMUNOL, V151, P7095; WANG XH, 1993, J IMMUNOL, V151, P7105; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; YAN XJ, 1993, J IMMUNOL, V150, P3873	48	60	62	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1994	1	1					35	43		10.1016/1074-7613(94)90007-8	http://dx.doi.org/10.1016/1074-7613(94)90007-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889397				2022-12-18	WOS:A1994PK15400005
J	Morrissey, MA; Kern, N; Vale, RD				Morrissey, Meghan A.; Kern, Nadja; Vale, Ronald D.			CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; REGULATORY PROTEIN; FC-GAMMA; TUMOR-CELLS; SIGNAL; MACROPHAGES; SEGREGATION; SHPS-1; PHOSPHATIDYLSERINE; BLOCKADE	CD47 acts as a "don't eat me" signal that protects cells from phagocytosis by binding and activating its receptor SIPRA on macrophages. CD47 suppresses multiple different pro-engulfment "eat me" signals, including immunoglobulin G (IgG), complement, and calreticulin, on distinct target cells. This complexity has limited understanding of how the "don't eat me" signal is transduced biochemically. Here, we utilized a reconstituted system with a defined set of signals to interrogate the mechanism of SIRPA activation and its downstream targets. CD47 ligation altered SIRPA localization, positioning SIRPA for activation at the phagocytic synapse. At the phagocytic synapse, SIRPA inhibited integrin activation to limit macrophage spreading across the surface of the engulfment target. Chemical reactivation of integrin bypassed CD47-mediated inhibition and rescued engulfment, similar to the effect of a CD47 function-blocking antibody. Thus, the CD47-SIRPA axis suppresses phagocytosis by inhibiting inside-out activation of integrin signaling in the macrophage, with implications to cancer immunotherapy applications.	[Morrissey, Meghan A.; Kern, Nadja; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Morrissey, Meghan A.; Kern, Nadja; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	valer@janelia.hhmi.org			National Institute of General Medical Sciences of the National Institutes of Health [F32GM120990]; Howard Hughes Medical Institute	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank R. Dong for providing the SNAP-DNA used in our DNA-based adhesion system, N. Stuurman for developing the image randomizer plug-in for blinding our analysis, and K. McKinley and O. Klein for providing mouse long bones as a source for hematopoietic stem cells. We thank members of the Vale lab for critical feedback on this manuscript. M.A.M. was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number F32GM120990. This work was funded by the Howard Hughes Medical Institute to R.D.V.	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Bakalar MH, 2018, CELL, V174, P131, DOI 10.1016/j.cell.2018.05.059; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Campbell H, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216648; Carbone CB, 2017, P NATL ACAD SCI USA, V114, pE9338, DOI 10.1073/pnas.1710358114; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Cham LB, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.058; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen J, 2017, NATURE, V544, P493, DOI 10.1038/nature22076; Chow C. W., 2004, CURRENT PROTOCOLS CE, V22; Dheilly E, 2017, MOL THER, V25, P523, DOI 10.1016/j.ymthe.2016.11.006; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Edelstein A.D., 2014, J BIOL METHODS, V1, pe10; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; FADOK VA, 1992, J IMMUNOL, V148, P2207; Farlow J, 2013, NAT METHODS, V10, P1203, DOI [10.1038/NMETH.2682, 10.1038/nmeth.2682]; Freeman SA, 2016, CELL, V164, P128, DOI 10.1016/j.cell.2015.11.048; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardner B, 1991, Transfus Med, V1, P77, DOI 10.1111/j.1365-3148.1991.tb00013.x; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gholamin S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf2968; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jacobs SA, 2012, PROTEIN ENG DES SEL, V25, P107, DOI 10.1093/protein/gzr064; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kojima Y, 2016, NATURE, V536, P86, DOI 10.1038/nature18935; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Lin J, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0143-2; Liu DQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003291; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Matlung HL, 2018, CELL REP, V23, P3946, DOI 10.1016/j.celrep.2018.05.082; Michaels AD, 2018, CLIN CANCER RES, V24, P1415, DOI 10.1158/1078-0432.CCR-17-2283; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Noguchi T, 1996, J BIOL CHEM, V271, P27652, DOI 10.1074/jbc.271.44.27652; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Panni RZ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9240; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid EM, 2016, NAT PHYS, V12, P704, DOI [10.1038/NPHYS3678, 10.1038/nphys3678]; Schmid MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07387-4; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Swaminathan V, 2017, P NATL ACAD SCI USA, V114, P10648, DOI 10.1073/pnas.1701136114; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; UTSUGI T, 1991, CANCER RES, V51, P3062; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wong HS, 2016, CELL REP, V14, P2859, DOI 10.1016/j.celrep.2016.02.071; Wu JX, 2018, P NATL ACAD SCI USA, V115, P6786, DOI 10.1073/pnas.1805542115; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	78	59	59	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					290	+		10.1016/j.immuni.2020.07.008	http://dx.doi.org/10.1016/j.immuni.2020.07.008			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32768386	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000561190600010
J	Rivadeneira, DB; DePeaux, K; Wang, YY; Kulkarni, A; Tabib, T; Menk, AV; Sampath, P; Lafyatis, R; Ferris, RL; Sarkar, SN; Thorne, SH; Delgoffe, GM				Rivadeneira, Dayana B.; DePeaux, Kristin; Wang, Yiyang; Kulkarni, Aditi; Tabib, Tracy; Menk, Ashley, V; Sampath, Padmavathi; Lafyatis, Robert; Ferris, Robert L.; Sarkar, Saumendra N.; Thorne, Stephen H.; Delgoffe, Greg M.			Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance	IMMUNITY			English	Article							SKELETAL-MUSCLE; ACTIVATION; VACCINIA; PROLIFERATION; CHECKPOINT; INDUCTION; KINETICS; OBESE; LINK; FAT	Immunotherapy can reinvigorate dormant responses to cancer, but response rates remain low. Oncolytic viruses, which replicate in cancer cells, induce tumor lysis and immune priming, but their immune consequences are unclear. We profiled the infiltrate of aggressive melanomas induced by oncolytic Vaccinia virus using RNA sequencing and found substantial remodeling of the tumor microenvironment, dominated by effector T cell influx. However, responses to oncolytic viruses were incomplete due to metabolic insufficiencies induced by the tumor microenvironment. We identified the adipokine leptin as a potent metabolic reprogramming agent that supported antitumor responses. Leptin metabolically reprogrammed T cells in vitro, and melanoma cells expressing leptin were immunologically controlled in mice. Engineering oncolytic viruses to express leptin in tumor cells induced complete responses in tumor-bearing mice and supported memory development in the tumor infiltrate. Thus, leptin can provide metabolic support to tumor immunity, and oncolytic viruses represent a platform to deliver metabolic therapy.	[Rivadeneira, Dayana B.; DePeaux, Kristin; Wang, Yiyang; Menk, Ashley, V; Ferris, Robert L.; Delgoffe, Greg M.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Rivadeneira, Dayana B.; DePeaux, Kristin; Wang, Yiyang; Menk, Ashley, V; Sampath, Padmavathi; Ferris, Robert L.; Sarkar, Saumendra N.; Thorne, Stephen H.; Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Tabib, Tracy; Lafyatis, Robert] Univ Pittsburgh, Sch Med, Div Rheumatol, Pittsburgh, PA USA; [Kulkarni, Aditi; Ferris, Robert L.; Delgoffe, Greg M.] Univ Pittsburgh, Head & Neck Canc SPORE, Pittsburgh, PA 15260 USA; [Wang, Yiyang] Tsinghua Univ, Sch Med, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University	Delgoffe, GM (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Delgoffe, GM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.; Delgoffe, GM (corresponding author), Univ Pittsburgh, Head & Neck Canc SPORE, Pittsburgh, PA 15260 USA.	delgoffeg@upmc.edu	Sarkar, Saumendra N/B-5038-2011; Delgoffe, Greg M./HCH-2805-2022	Sarkar, Saumendra N/0000-0002-2850-6121; Delgoffe, Greg M./0000-0002-2957-8135; DePeaux, Kristin/0000-0001-8460-727X	Stand Up to Cancer Innovative Research Grant [SU2C-AACR-IRG-04-16]; NIH Director's New Innovator Award [DP2AI136598]; UPMC Hillman Cancer Center Melanoma and Skin Cancer SPORE [P50CA121973-09]; Sy Holzer Endowed Immunotherapy Fund; Head and Neck Cancer SPORE [P50CA097190]; Alliance for Cancer Gene Therapy/Swim Across America; NATIONAL CANCER INSTITUTE [P50CA097190, P30CA047904, P50CA121973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI136598, R21AI135367] Funding Source: NIH RePORTER	Stand Up to Cancer Innovative Research Grant; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPMC Hillman Cancer Center Melanoma and Skin Cancer SPORE; Sy Holzer Endowed Immunotherapy Fund; Head and Neck Cancer SPORE; Alliance for Cancer Gene Therapy/Swim Across America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Nicole Scharping for technical and mentoring assistance and Dr. Chandranath Roy for assistance with virus production. This work was primarily supported by a Stand Up to Cancer Innovative Research Grant (SU2C-AACR-IRG-04-16) and was additionally supported by the NIH Director's New Innovator Award (DP2AI136598) to G.M.D., the UPMC Hillman Cancer Center Melanoma and Skin Cancer SPORE (P50CA121973-09) to G.M.D., the Head and Neck Cancer SPORE (P50CA097190) to R.L.F. and G.M.D., the Alliance for Cancer Gene Therapy/Swim Across America to G.M.D., and the Sy Holzer Endowed Immunotherapy Fund to G.M.D.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Barve M, 2008, J CLIN ONCOL, V26, P4418, DOI 10.1200/JCO.2008.16.6462; Brown MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan4220; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Delgoffe GM, 2009, MOL IMMUNOL, V46, P2694, DOI 10.1016/j.molimm.2009.05.185; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Friedman GK, 2012, TRANSL ONCOL, V5, P200, DOI 10.1593/tlo.12115; Gerriets VA, 2016, EUR J IMMUNOL, V46, P1970, DOI 10.1002/eji.201545861; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hiley CT, 2010, GENE THER, V17, P281, DOI 10.1038/gt.2009.132; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Hsu WH, 2015, INT J OBESITY, V39, P1750, DOI 10.1038/ijo.2015.120; Justus CR, 2015, INT J MOL SCI, V16, P11055, DOI 10.3390/ijms160511055; Kanerva A, 2013, CLIN CANCER RES, V19, P2734, DOI 10.1158/1078-0432.CCR-12-2546; Kirn DH, 2007, PLOS MED, V4, P2001, DOI 10.1371/journal.pmed.0040353; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; La-Beck NM, 2015, PHARMACOTHERAPY, V35, P963, DOI 10.1002/phar.1643; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Menk AV, 2018, J EXP MED, V215, P1091, DOI 10.1084/jem.20171068; Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199; Najjar YG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124989; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Papathanassoglou E, 2006, J IMMUNOL, V176, P7745, DOI 10.4049/jimmunol.176.12.7745; Perez-Perez A, 2017, CYTOKINE GROWTH F R, V35, P71, DOI 10.1016/j.cytogfr.2017.03.001; Pipiya T, 2005, GENE THER, V12, P911, DOI 10.1038/sj.gt.3302459; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Puhlmann M, 2000, CANCER GENE THER, V7, P66, DOI 10.1038/sj.cgt.7700075; Ricca JM, 2018, MOL THER, V26, P1008, DOI 10.1016/j.ymthe.2018.01.019; Rivadeneira DB, 2018, CLIN CANCER RES, V24, P2473, DOI 10.1158/1078-0432.CCR-17-0894; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Roman EAFR, 2010, MOL CELL ENDOCRINOL, V314, P62, DOI 10.1016/j.mce.2009.08.007; Russell SJ, 2018, CANCER CELL, V33, P599, DOI 10.1016/j.ccell.2018.03.011; Sanchez-Margalet V, 2001, CELL IMMUNOL, V211, P30, DOI 10.1006/cimm.2001.1815; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Scharping NE, 2017, CANCER IMMUNOL RES, V5, P9, DOI 10.1158/2326-6066.CIR-16-0103; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Siska PJ, 2015, TRENDS IMMUNOL, V36, P257, DOI 10.1016/j.it.2015.02.007; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; WHITMAN ED, 1994, SURGERY, V116, P183; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zamarin D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14340; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	63	59	62	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					548	+		10.1016/j.immuni.2019.07.003	http://dx.doi.org/10.1016/j.immuni.2019.07.003			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31471106	Green Accepted, Bronze			2022-12-18	WOS:000486184600016
J	Shi, H; Liu, CH; Tan, HY; Li, YX; Nguyen, TLM; Dhungana, Y; Guy, C; Vogel, P; Neale, G; Rankin, S; Feng, YQ; Peng, JM; Tao, WF; Chi, HB				Shi, Hao; Liu, Chaohong; Tan, Haiyan; Li, Yuxin; Nguyen, Thanh-Long M.; Dhungana, Yogesh; Guy, Cliff; Vogel, Peter; Neale, Geoffrey; Rankin, Sherri; Feng, Yongqiang; Peng, Junmin; Tao, Wufan; Chi, Hongbo			Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity	IMMUNITY			English	Article							IL-2 RECEPTOR; HOMEOSTATIC CONTROL; RESPONSES; EFFECTOR; INTERLEUKIN-2; MECHANISMS; TOLERANCE; STABILITY; PATHWAY; GTPASES	Interleukin-2 (IL-2) and downstream transcription factor STAT5 are important for maintaining regulatory T (Treg) cell homeostasis and function. Treg cells can respond to low IL-2 levels, but the mechanisms of STAT5 activation during partial IL-2 deficiency remain uncertain. We identified the serine-threonine kinase Mst1 as a signal-dependent amplifier of IL-2-STAT5 activity in Treg cells. High Mst1 and Mst2 (Mst1-Mst2) activity in Treg cells was crucial to prevent tumor resistance and autoimmunity. Mechanistically, Mst1-Mst2 sensed IL-2 signals to promote the STAT5 activation necessary for Treg cell homeostasis and lineage stability and to maintain the highly suppressive phosphorylated-STAT5 + Treg cell subpopulation. Unbiased quantitative proteomics revealed association of Mst1 with the cytoskeletal DOCK8-LRCHs module. Mst1 deficiency limited Treg cell migration and access to IL-2 and activity of the small GTPase Rac, which mediated downstream STAT5 activation. Collectively, IL-2-STAT5 signaling depends upon Mst1-Mst2 functions to maintain a stable Treg cell pool and immune tolerance.	[Shi, Hao; Tao, Wufan] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shi, Hao; Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Shi, Hao; Liu, Chaohong; Nguyen, Thanh-Long M.; Dhungana, Yogesh; Guy, Cliff; Rankin, Sherri; Feng, Yongqiang; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Peng, Junmin] St Jude Childrens Res Hosp, Prote Facil, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tao, Wufan] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Fudan University	Tao, WF (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.; Tao, WF (corresponding author), Fudan Univ, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China.; Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Tao, WF (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	wufan_tao@fudan.edu.cn; hongbo.chi@stjude.org	li, yu/HGL-9518-2022; Li, yuxin/GSD-1668-2022; SHI, HAO/ABE-4662-2020; Feng, Yongqiang/AAR-7719-2021; Chi, Hongbo/M-9397-2018; Peng, Junmin/N-2614-2018; Vogel, Peter/N-2490-2018; li, Yu/HCI-9086-2022	SHI, HAO/0000-0002-2796-629X; Feng, Yongqiang/0000-0002-2320-5063; Chi, Hongbo/0000-0002-9997-2496; Peng, Junmin/0000-0003-0472-7648; Vogel, Peter/0000-0002-7535-0545; Dhungana, Yogesh/0000-0002-4021-0075	National Institutes of Health (NIH) [AI105887, AI101407, AI140761, CA176624, CA221290]; National Key Research and Development Program of China [2016YFC1000504]; NATIONAL CANCER INSTITUTE [R01CA176624, R01CA221290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105887, R01AI101407, R37AI105887, R01AI140761] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Research and Development Program of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge A. Rudensky for Foxp3<SUP>YFP-Cre</SUP> mice (Chinen et al., 2016), E. Olson for Yap1<SUP>f/f</SUP> and Wwtr1<SUP>f/f</SUP> mice (Xin et al., 2013), Y. Wang for help with immunological assays and editing the manuscript, J. Wei for initial analysis of Foxp3<SUP>Cre</SUP> Yap1<SUP>f/f</SUP> Wwtr1<SUP>f/f</SUP> mice, H. Zeng and N. Chapman for helpful discussions and editing the manuscript, M. Hendren and A. KC for animal colony management, and St. Jude Immunology FACS core facility for cell sorting. This work was supported by National Institutes of Health (NIH) grants AI105887, AI101407, AI140761, CA176624, and CA221290 to H.C., and National Key Research and Development Program of China grant 2016YFC1000504 to W.T.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grassart A, 2008, EMBO REP, V9, P356, DOI 10.1038/embor.2008.28; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Janssen E, 2016, J CLIN INVEST, V126, P3837, DOI 10.1172/JCI85774; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu C, 2016, FEBS J, V283, P2731, DOI 10.1111/febs.13656; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xu XY, 2017, J EXP MED, V214, P209, DOI 10.1084/jem.20160068; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	35	59	64	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					899	+		10.1016/j.immuni.2018.10.010	http://dx.doi.org/10.1016/j.immuni.2018.10.010			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30413360	Green Accepted, Bronze			2022-12-18	WOS:000450752200015
J	Duan, HY; Chen, XJ; Boyington, JC; Cheng, C; Zhang, Y; Jafari, AJ; Stephens, T; Tsybovsky, Y; Kalyuzhniy, O; Zhao, P; Menis, S; Nason, MC; Normandin, E; Mukhamedova, M; DeKosky, BJ; Wells, L; Schief, WR; Tian, M; Alt, FW; Kwong, PD; Mascola, JR				Duan, Hongying; Chen, Xuejun; Boyington, Jeffrey C.; Cheng, Cheng; Zhang, Yi; Jafari, Alexander J.; Stephens, Tyler; Tsybovsky, Yaroslav; Kalyuzhniy, Oleksandr; Zhao, Peng; Menis, Sergey; Nason, Martha C.; Normandin, Erica; Mukhamedova, Maryam; DeKosky, Brandon J.; Wells, Lance; Schief, William R.; Tian, Ming; Alt, Frederick W.; Kwong, Peter D.; Mascola, John R.			Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODY; X-SER/THR SEQUON; ANTIGENIC DETERMINANTS; STRUCTURAL BASIS; AMINO-ACID; VACCINE DESIGN; BINDING-SITE; VIRUS; GP120; IMMUNOGENICITY	An important class of HIV-1 broadly neutralizing antibodies, termed the VRC01 class, targets the conserved CD4-binding site (CD4bs) of the envelope glycoprotein (Env). An engineered Env outer domain (OD) eOD-GT8 60-mer nanoparticle has been developed as a priming immunogen for eliciting VRC01class precursors and is planned for clinical trials. However, a substantial portion of eOD-GT8-elicited antibodies target non-CD4bs epitopes, potentially limiting its efficacy. We introduced N-linked glycans into non-CD4bs surfaces of eOD-GT8 to mask irrelevant epitopes and evaluated these mutants in a mouse model that expressed diverse immunoglobulin heavy chains containing human IGHV1-2*02, the germline VRC01 V-H segment. Compared to the parental eOD-GT8, a mutant with five added glycans stimulated significantly higher proportions of CD4bs-specific serum responses and CD4bs-specific immunoglobulin G(+) B cells including VRC01-class precursors. These results demonstrate that glycan masking can limit elicitation of off-target antibodies and focus immune responses to the CD4bs, a major target of HIV-1 vaccine design.	[Duan, Hongying; Chen, Xuejun; Boyington, Jeffrey C.; Cheng, Cheng; Zhang, Yi; Jafari, Alexander J.; Normandin, Erica; Mukhamedova, Maryam; DeKosky, Brandon J.; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Stephens, Tyler; Tsybovsky, Yaroslav] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Electron Microscopy Lab, Canc Res Technol Program, Frederick, MD 21701 USA; [Kalyuzhniy, Oleksandr; Menis, Sergey; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Kalyuzhniy, Oleksandr; Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Rockville, MD 20852 USA; [DeKosky, Brandon J.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA; [DeKosky, Brandon J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Zhao, Peng; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Tian, Ming; Alt, Frederick W.] Boston Childrens Hosp, Boston, MA 02115 USA; [Tian, Ming; Alt, Frederick W.] Harvard Med Sch, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kansas; University of Kansas; University System of Georgia; University of Georgia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@nih.gov	Schief, William/ABF-3645-2020; Mascola, John/AAI-7193-2021; Cheng, Cheng/AAE-8255-2019	Schief, William/0000-0002-1120-0150; Zhao, Peng/0000-0002-9296-5293; Wells, Lance/0000-0003-4956-5363; Nason, Martha/0000-0002-0110-881X; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	Vaccine Research Center, NIAID, NIH; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NIAID [UM1AI100663]; NIGMS [P41GM103490]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium; United States Agency for International Development; Ministry of Foreign Affairs of the Netherlands; Bill AMP; Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, ZIAAI005024, ZIAAI005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Frederick National Laboratory for Cancer Research, National Institutes of Health; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); International AIDS Vaccine Initiative Neutralizing Antibody Consortium; United States Agency for International Development(United States Agency for International Development (USAID)); Ministry of Foreign Affairs of the Netherlands; Bill AMP; Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Nguyen and Ambrozak David for assistance in single-cell sorting, Marlon Dillon and Salbador Gloria for animal care and maintenance, Sam Darko for assistance with data analysis, and members of the Structural Biology Section of the Vaccine Research Center for helpful discussions. This work was supported by the intramural research program of the Vaccine Research Center, NIAID, NIH. Support for this work was also provided by federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E to Leidos Biomedical Research, Inc. (T.S., Y.T.). The work was also supported by NIAID UM1AI100663 (CHAVI-ID) (W.R.S.), NIGMS P41GM103490 (L.W.) and the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center with support from the United States Agency for International Development, the Ministry of Foreign Affairs of the Netherlands, and the Bill & Melinda Gates Foundation; a full list of IAVI donors is available at http://www.iavi.org (W.R.S.).	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Ahmed FK, 2012, VACCINE, V30, P922, DOI 10.1016/j.vaccine.2011.11.089; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cheng C, 2016, J VIROL, V90, P2740, DOI 10.1128/JVI.02380-15; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Forsell MNE, 2013, J IMMUNOL, V191, P44, DOI 10.4049/jimmunol.1203087; Garrity RR, 1997, J IMMUNOL, V159, P279; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; He LL, 2015, CURR OPIN VIROL, V11, P103, DOI 10.1016/j.coviro.2015.03.013; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Ingale J, 2014, J VIROL, V88, P14002, DOI 10.1128/JVI.02614-14; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julg B., 2017, J VIROL, V91, P91; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lin SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092822; Marshall R D, 1974, Biochem Soc Symp, P17; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Sampath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003420; Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	61	59	63	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					301	+		10.1016/j.immuni.2018.07.005	http://dx.doi.org/10.1016/j.immuni.2018.07.005			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30076101	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000442354500015
J	Poissonnier, A; Sanseau, D; Le Gallo, M; Malleter, M; Levoin, N; Viel, R; Morere, L; Penna, A; Blanco, P; Dupuy, A; Poizeau, F; Fautrel, A; Seneschal, J; Jouan, F; Ritz, J; Forcade, E; Rioux, N; Contin-Bordes, C; Ducret, T; Vacher, AM; Barrow, PA; Flynn, RJ; Vacher, P; Legembre, P				Poissonnier, Amanda; Sanseau, Doriane; Le Gallo, Matthieu; Malleter, Marine; Levoin, Nicolas; Viel, Roselyne; Morere, Lucie; Penna, Aubin; Blanco, Patrick; Dupuy, Alain; Poizeau, Florence; Fautrel, Alain; Seneschal, Julien; Jouan, Florence; Ritz, Jerome; Forcade, Edouard; Rioux, Nathalie; Contin-Bordes, Cecile; Ducret, Thomas; Vacher, Anne-Marie; Barrow, Paul A.; Flynn, Robin J.; Vacher, Pierre; Legembre, Patrick			CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice	IMMUNITY			English	Article							FAS GENE-MUTATIONS; LYMPHOPROLIFERATIVE SYNDROME; SH3 DOMAIN; PROTEIN; APOPTOSIS; CD95; LIGAND; DEATH; ASSOCIATION; EXPRESSION	CD95 ligand (CD95L) is expressed by immune cells and triggers apoptotic death. Metalloprotease-cleaved CD95L (cl-CD95L) is released into the bloodstream but does not trigger apoptotic signaling. Hence, the pathophysiological role of cl-CD95L remains unclear. We observed that skin-derived endothelial cells from systemic lupus erythematosus (SLE) patients expressed CD95L and that after cleavage, cl-CD95L promoted T helper 17 (Th17) lymphocyte transmigration across the endothelial barrier at the expense of T regulatory cells. T cell migration relied on a direct interaction between the CD95 domain called calcium-inducing domain (CID) and the Src homology 3 domain of phospholipase C gamma 1. Th17 cells stimulated with cl-CD95L produced sphingosine-1-phosphate (S1P), which promoted endothelial transmigration by activating the S1P receptor 3. We generated a cell-penetrating CID peptide that prevented Th17 cell transmigration and alleviated clinical symptoms in lupus mice. Therefore, neutralizing the CD95 non-apoptotic signaling pathway could be an attractive therapeutic approach for SLE treatment.	[Poissonnier, Amanda; Sanseau, Doriane; Le Gallo, Matthieu; Malleter, Marine; Morere, Lucie; Poizeau, Florence; Jouan, Florence; Legembre, Patrick] Ctr Eugene Marquis, Rue Bataille Flandres Dunkerque, F-35042 Rennes, France; [Poissonnier, Amanda; Sanseau, Doriane; Le Gallo, Matthieu; Malleter, Marine; Morere, Lucie; Poizeau, Florence; Jouan, Florence; Legembre, Patrick] INSERM, ERL440 OSS, Equipe Labellisee, F-35042 Rennes, France; [Poissonnier, Amanda; Sanseau, Doriane; Le Gallo, Matthieu; Malleter, Marine; Viel, Roselyne; Morere, Lucie; Penna, Aubin; Dupuy, Alain; Fautrel, Alain; Jouan, Florence; Rioux, Nathalie; Legembre, Patrick] Univ Rennes 1, 2 Ave Prof Leon Bernard, F-35043 Rennes, France; [Levoin, Nicolas] Bioprojet Biotech, Rue Chesnay Beauregard, F-35760 St Gregoire, France; [Malleter, Marine; Viel, Roselyne; Fautrel, Alain; Legembre, Patrick] Biosit, Plateforme H2P2, Biogenouest, 2 Ave Prof Leon Bernard, F-35043 Rennes, France; [Penna, Aubin; Rioux, Nathalie] INSERM, U1085, 2 Ave Prof Leon Bernard, F-35043 Rennes, France; [Blanco, Patrick; Seneschal, Julien; Forcade, Edouard; Contin-Bordes, Cecile; Ducret, Thomas; Vacher, Anne-Marie; Vacher, Pierre] Univ Bordeaux, CHU Bordeaux, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Blanco, Patrick; Forcade, Edouard; Contin-Bordes, Cecile] CNRS, UMR 5164, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Dupuy, Alain; Poizeau, Florence] Ctr Hosp Univ Rennes, 2 Rue Henri Le Guilloux, F-35022 Rennes, France; [Seneschal, Julien; Rioux, Nathalie] INSERM, U1035, 146 Rue Le Saignat, F-33076 Bordeaux, France; [Ritz, Jerome; Forcade, Edouard] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Ritz, Jerome; Forcade, Edouard] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ducret, Thomas] INSERM, U1045, 146 Rue Le Saignat, F-33076 Bordeaux, France; [Vacher, Anne-Marie; Vacher, Pierre] INSERM, U1218, Inst Bergonie, F-33076 Bordeaux, France; [Barrow, Paul A.; Flynn, Robin J.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England	UNICANCER; Centre Eugene Marquis; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; University of Nottingham	Legembre, P (corresponding author), Ctr Eugene Marquis, Rue Bataille Flandres Dunkerque, F-35042 Rennes, France.; Legembre, P (corresponding author), INSERM, ERL440 OSS, Equipe Labellisee, F-35042 Rennes, France.; Legembre, P (corresponding author), Univ Rennes 1, 2 Ave Prof Leon Bernard, F-35043 Rennes, France.	patrick.legembre@inserm.fr	Legembre, Patrick/U-1882-2019; Flynn, Robin/H-7387-2019; PENNA, aubin/E-2208-2018; Fautrel, Alain/AAL-7391-2020; Ritz, Jerome/C-7929-2009; Le Gallo, Matthieu/T-4181-2019; Dupuy, Alain/AFU-6822-2022; Le Gallo, Matthieu/F-7188-2012; penna, aubin/AAD-2550-2019; legembre, patrick/L-3475-2016; Vacher, Pierre/N-2243-2018	Legembre, Patrick/0000-0001-6649-8049; Flynn, Robin/0000-0001-5304-3088; PENNA, aubin/0000-0002-1070-5990; Ritz, Jerome/0000-0001-5526-4669; Le Gallo, Matthieu/0000-0001-9085-8155; penna, aubin/0000-0002-1070-5990; legembre, patrick/0000-0001-6649-8049; Seneschal, Julien/0000-0003-1139-0908; VACHER, Pierre/0000-0003-3503-7981; FAUTREL, Alain/0000-0002-3449-0779; levoin, nicolas/0000-0002-7731-736X; Ducret, Thomas/0000-0002-5146-6869	INCa PLBIO; Ligue Contre le Cancer; INSERM Transfert; Fondation ARC; Region Bretagne; Rennes Metropole; University of Nottingham Faculty of Medicine; Biotechnology and Biological Sciences Research Council [BB/M018369/1]; ANR [ANR-12-JSV2-0004-001]; BBSRC [BB/M018369/1] Funding Source: UKRI	INCa PLBIO; Ligue Contre le Cancer(Ligue nationale contre le cancer); INSERM Transfert; Fondation ARC; Region Bretagne(Region Bretagne); Rennes Metropole(Region Bretagne); University of Nottingham Faculty of Medicine; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ANR(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to the H2P2 facility of Biosit (Rennes) for its technical assistance. This work was supported by INCa PLBIO, Ligue Contre le Cancer, INSERM Transfert, Fondation ARC, Region Bretagne, Rennes Metropole. We would like to thank the University of Nottingham Faculty of Medicine for funding of BSU pump priming. R.J.F. was supported by the Biotechnology and Biological Sciences Research Council award BB/M018369/1. AP was supported by ANR (ANR-12-JSV2-0004-001).	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Deng L, 2005, J MOL BIOL, V352, P1, DOI 10.1016/j.jmb.2005.06.072; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fouque A, 2014, BBA-REV CANCER, V1846, P130, DOI 10.1016/j.bbcan.2014.04.007; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Khadra N, 2011, P NATL ACAD SCI USA, V108, P19072, DOI 10.1073/pnas.1116946108; Kikawada E, 2003, J IMMUNOL, V170, P3915, DOI 10.4049/jimmunol.170.7.3915; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kuhtrelber WM, 2003, J MOL ENDOCRINOL, V31, P373, DOI 10.1677/jme.0.0310373; Legembre P, 2004, EMBO REP, V5, P1084, DOI 10.1038/sj.embor.7400280; Li C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0286-8; Malleter M, 2013, CANCER RES, V73, P6711, DOI 10.1158/0008-5472.CAN-13-1794; Motz GT, 2014, NAT MED, V20, P607, DOI 10.1038/nm.3541; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Orlinick JR, 1997, J BIOL CHEM, V272, P32221, DOI 10.1074/jbc.272.51.32221; Peter ME, 2015, CELL DEATH DIFFER, V22, P549, DOI 10.1038/cdd.2015.3; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Tauzin S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001090; Tuettenberg J, 2012, INT IMMUNOPHARMACOL, V13, P93, DOI 10.1016/j.intimp.2012.03.004; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200	38	59	61	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					209	223		10.1016/j.immuni.2016.06.028	http://dx.doi.org/10.1016/j.immuni.2016.06.028			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438772	Green Published, hybrid			2022-12-18	WOS:000380749000022
J	Kong, L; Ju, B; Chen, YJ; He, LL; Ren, L; Liu, JD; Hong, KX; Su, B; Wang, Z; Ozorowski, G; Ji, XL; Hua, YZ; Chen, YL; Deller, MC; Hao, YL; Feng, Y; Garces, F; Wilson, R; Dai, KF; O'Dell, S; McKee, K; Mascola, JR; Ward, AB; Wyatt, RT; Li, YX; Wilson, IA; Zhu, J; Shao, YM				Kong, Leopold; Ju, Bin; Chen, Yajing; He, Linling; Ren, Li; Liu, Jiandong; Hong, Kunxue; Su, Bin; Wang, Zheng; Ozorowski, Gabriel; Ji, Xiaolin; Hua, Yuanzi; Chen, Yanli; Deller, Marc C.; Hao, Yanling; Feng, Yi; Garces, Fernando; Wilson, Richard; Dai, Kaifan; O'Dell, Sijy; McKee, Krisha; Mascola, John R.; Ward, Andrew B.; Wyatt, Richard T.; Li, Yuxing; Wilson, Ian A.; Zhu, Jiang; Shao, Yiming			Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HIV-1 ENVELOPE; HIV-1-NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; SITE; GLYCOPROTEINS; VACCINE; IDENTIFICATION; VULNERABILITY	VRC01-class antibodies neutralize diverse HIV-1 strains by targeting the conserved CD4-binding site. Despite extensive investigations, crucial events in the early stage of VRC01 development remain elusive. We demonstrated how VRC01-class antibodies emerged in a Chinese donor by antigen-specific single B cell sorting, structural and functional studies, and longitudinal antibody and virus repertoire analyses. A monoclonal antibody DRVIA7 with modest neutralizing breadth was isolated that displayed a subset of VRC01 signatures. X-ray and EM structures revealed a VRC01-like angle of approach, but less favorable interactions between the DRVIA7 light-chain CDR1 and the N terminus with N276 and V5 glycans of gp120. Although the DRVIA7 lineage was unable to acquire broad neutralization, longitudinal analysis revealed a repertoire-encoded VRC01 light-chain CDR3 signature and VRC01-like neutralizing heavy-chain precursors that rapidly matured within 2 years. Thus, light chain accommodation of the glycan shield should be taken into account in vaccine design targeting this conserved site of vulnerability.	[Kong, Leopold; Ozorowski, Gabriel; Hua, Yuanzi; Garces, Fernando; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ju, Bin; Ren, Li; Liu, Jiandong; Hong, Kunxue; Wang, Zheng; Ji, Xiaolin; Chen, Yanli; Hao, Yanling; Feng, Yi; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China; [Ju, Bin; Ren, Li; Liu, Jiandong; Hong, Kunxue; Wang, Zheng; Ji, Xiaolin; Chen, Yanli; Hao, Yanling; Feng, Yi; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing 102206, Peoples R China; [Kong, Leopold; Ozorowski, Gabriel; Hua, Yuanzi; Garces, Fernando; Ward, Andrew B.; Wyatt, Richard T.; Wilson, Ian A.; Zhu, Jiang] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Chen, Yajing; He, Linling; Dai, Kaifan; Wyatt, Richard T.; Zhu, Jiang] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Deller, Marc C.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kong, Leopold; Ozorowski, Gabriel; Hua, Yuanzi; Garces, Fernando; Wilson, Richard; Ward, Andrew B.; Wyatt, Richard T.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Kong, Leopold; Ozorowski, Gabriel; Hua, Yuanzi; Garces, Fernando; Wilson, Richard; Ward, Andrew B.; Wyatt, Richard T.; Wilson, Ian A.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Su, Bin] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [O'Dell, Sijy; McKee, Krisha; Mascola, John R.] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA; [Li, Yuxing] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Shao, Yiming] Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Shao, Yiming] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Scripps Research Institute; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Jiangsu Provincial Center for Disease Control & Prevention; National Institutes of Health (NIH) - USA; Peking University; Nankai University	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China.; Shao, YM (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing 102206, Peoples R China.; Zhu, J (corresponding author), Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA.; Zhu, J (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Shao, YM (corresponding author), Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China.; Shao, YM (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	jiang@scripps.edu; yshao@bjmu.edu.cn	Mascola, John/AAI-7193-2021; Ward, Andrew B/F-9203-2014; Ozorowski, Gabriel/HCH-0634-2022; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Deller, Marc/0000-0001-8070-6502; Kong, Leopold/0000-0001-7456-1773	US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; International AIDS Vaccine Initiative Neutralizing Antibody Center; CAVD; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [UM1 AI100663]; HIV Vaccine Research and Design (HIVRAD) program [P01 AI110657]; Joint Center of Structural Genomics (JCSG) - NIH NIGMS, Protein Structure Initiative [U54 GM094586]; SKLID Development grant [2012SKLID103]; NIH NIAID [R01 AI102766, AI084817]; NIH NIAID development grant from the Center for AIDS Research at the University of California, San Diego [P30AI36214]; NIH CIPRA grant [U19AI51915]; American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R56AI084817, P30AI036214, P01AI110657, P01AI104722, U19AI051915, R01AI102766, R01AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Major projects for Infectious Diseases Control and Prevention; International AIDS Vaccine Initiative Neutralizing Antibody Center; CAVD; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); HIV Vaccine Research and Design (HIVRAD) program; Joint Center of Structural Genomics (JCSG) - NIH NIGMS, Protein Structure Initiative; SKLID Development grant; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NIAID development grant from the Center for AIDS Research at the University of California, San Diego; NIH CIPRA grant; American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to R. Stanfield for helpful discussions; M. Elsliger for computer support; H. Tien for crystallization screening; A. Eroshkin for help with calculating N-linked glycosylation frequencies; J. Hou, P. Li, and M. Zhu for help with antibody binding assays; D. Li, H. Liang, and H. Peng for help with measuring patient CD4<SUP>+</SUP> T cell counts; Q. Zhao for help with viral load assays; J. Wu and X. Ding for help with patient blood sample collection; and J. P. Verenini for manuscript formatting. X-ray data sets were collected at the Advanced Photon Source (APS) beamline 23ID-B. Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. Electron microscopy data were collected at the Scripps Research Institute EM Facility. This work was supported by the National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008) (Y. S.), by the International AIDS Vaccine Initiative Neutralizing Antibody Center and CAVD, by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID UM1 AI100663) (A. B. W., I. A. W., J. Z.), by the HIV Vaccine Research and Design (HIVRAD) program (P01 AI110657) (A. B. W., I. A. W.), by the Joint Center of Structural Genomics (JCSG) funded by the NIH NIGMS, Protein Structure Initiative (U54 GM094586) (I. A. W.), by the SKLID Development grant (2012SKLID103) (Y. S.), by NIH NIAID grants R01 AI102766 (Y. L.) and AI084817 (I. A. W., A. B. W.), and by an NIH NIAID development grant from the Center for AIDS Research at the University of California, San Diego (P30AI36214) (Y. L., J. Z.). A portion of this work was supported by the NIH CIPRA grant (U19AI51915) (Y. S.) and by an American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research (L. K.). Y. S. is grateful to Dennis Burton for hosting his stay at The Scripps Research Institute to initiate this collaborative study.	Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Freund NT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005238; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; He LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06778; Hu XT, 2012, J GEN VIROL, V93, P2267, DOI 10.1099/vir.0.043802-0; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Ma Y, 1990, ZHONGHUA LIU XING BI, V11, P184; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wang WB, 2015, JAIDS-J ACQ IMM DEF, V69, P270, DOI 10.1097/QAI.0000000000000595; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2013, P NATL ACAD SCI USA, V110, pE4088, DOI 10.1073/pnas.1306262110	41	59	68	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					939	950		10.1016/j.immuni.2016.03.006	http://dx.doi.org/10.1016/j.immuni.2016.03.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27067056	Green Accepted, Bronze			2022-12-18	WOS:000374444300023
J	Balasubramani, A; Shibata, Y; Crawford, GE; Baldwin, AS; Hatton, RD; Weaver, CT				Balasubramani, Anand; Shibata, Yoichiro; Crawford, Gregory E.; Baldwin, Albert S.; Hatton, Robin D.; Weaver, Casey T.			Modular Utilization of Distal cis-Regulatory Elements Controls Ifng Gene Expression in T Cells Activated by Distinct Stimuli	IMMUNITY			English	Article							NF-KAPPA-B; INTERFERON-GAMMA PRODUCTION; TRANSCRIPTION FACTOR; C-REL; LYMPHOCYTE-PROLIFERATION; FATE DETERMINATION; OPPOSING ROLES; NUCLEAR-FACTOR; MICE LACKING; ROR-GAMMA	Distal cis-regulatory elements play essential roles in the T lineage-specific expression of cytokine genes. We have mapped interactions of three trans-acting factors-NF-kappa B, STAT4, and T-bet-with cis elements in the Ifng locus. We find that RelA is critical for optimal Ifng expression and is differentially recruited to multiple elements contingent upon T cell receptor (TCR) or interleukin-12 (IL-12) plus IL-18 signaling. RelA recruitment to at least four elements is dependent on T-bet-dependent remodeling of the Ifng locus and corecruitment of STAT4. STAT4 and NF-kappa B therefore cooperate at multiple cis elements to enable NF-kappa B-dependent enhancement of Ifng expression. RelA recruitment to distal elements was similar in T helper 1 (Th1) and effector CD8(+) T (Tc1) cells, although T-bet was dispensable in CD8 effectors. These results support a model of Ifng regulation in which distal cis-regulatory elements differentially recruit key transcription factors in a modular fashion to initiate gene transcription induced by distinct activation signals.	[Balasubramani, Anand; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Balasubramani, Anand; Weaver, Casey T.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Shibata, Yoichiro; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Baldwin, Albert S.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hatton, RD (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	rdzialo@uab.edu; cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793; Hatton, Robin/0000-0002-4797-9899	National Institutes of Health [AI35783, AI77574, AI35098, K22HG003169]; Crohn's and Colitis Foundation of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG003169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098, R21AI035783, R01AI035098, R01AI077574, R01AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to L. Harrington and members of the Weaver laboratory for their helpful comments and suggestions. We gratefully acknowledge T. Gilmore for advice and reagents for study of NF-kappa B and B. Weaver for development of DNAse-chip and ChIP-chip data analysis scripts. We also thank J. Oliver, C. Song, M. Blake, B.J. Parsons, and S. Sinclair for expert technical assistance, G. Gaskins for editorial assistance, and the UAB Digestive Diseases Research Developmental Center (DDRDC) and Epitope Recognition and Immunoreagent Core Facility for generation and genotyping of gene-targeted mice and for antibody preparations, respectively. This work was supported by grants from the National Institutes of Health (AI35783 to C.T.W., AI77574 to C.T.W. and R.D.H., AI35098 to A.S.B., and K22HG003169 to G.E.C.) and the Crohn's and Colitis Foundation of America (to C.T.W.).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Berenson LS, 2006, J IMMUNOL, V177, P5195, DOI 10.4049/jimmunol.177.8.5195; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Chang SJ, 2008, J IMMUNOL, V181, P8372, DOI 10.4049/jimmunol.181.12.8372; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Levanon D, 2007, NAT IMMUNOL, V8, P145; Lewis MD, 2007, MOL CELL BIOL, V27, P8510, DOI 10.1128/MCB.01615-07; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Soutto M, 2002, J IMMUNOL, V169, P6664, DOI 10.4049/jimmunol.169.12.6664; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Tato CM, 2006, INT IMMUNOL, V18, P505, DOI 10.1093/intimm/dxh391; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	62	59	60	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					35	47		10.1016/j.immuni.2010.07.004	http://dx.doi.org/10.1016/j.immuni.2010.07.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643337	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000280418100008
J	Guo, LY; Hu-Li, J; Paul, WE				Guo, LY; Hu-Li, J; Paul, WE			Probabilistic regulation of IL-4 production in Th2 cells: Accessibility at the Il4 locus	IMMUNITY			English	Article							CYTOKINE GENE-EXPRESSION; T-CELLS; COORDINATE REGULATOR; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; LINEAGE COMMITMENT; IMMUNE-SYSTEM; CUTTING EDGE; C-MAF; DIFFERENTIATION	IL-4 secreting and nonsecreting cells from Th2 cultures have a similar probability of producing IL-4 upon subsequent stimulation, implying that there is stochastic element in IL-4 production by stimulated Th2 cells. Purified IL-4 producers and nonproducers have similar Gata3 and c-maf mRNA expression. 114 gene accessibility, analyzed by restriction enzyme accessibility (REA) at sites in the promoter, in the second intron (DNase I hypersensitivity sites HSII and HSIII) and in CNS-1 in the two populations was also similar. However, upon TCR stimulation, site V-A, which is 5 kB 3' of exon 4, displayed a striking increase in accessibility but REA was 2- to 3-fold greater in producers than nonproducers. Cyclosporin A treatment inhibited VA opening, implying the involvement of NFAT in increased VA accessibility. Induction of VA accessibility is sensitive to cycloheximide, suggesting an additional factor(s) is needed. Thus, opening of V-A is a probabilistic event determining which Th2 cells transcribe II4.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	wepaul@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; HENKEL G, 1992, J IMMUNOL, V149, P3239; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	32	59	62	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					193	203		10.1016/S1074-7613(04)00025-1	http://dx.doi.org/10.1016/S1074-7613(04)00025-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975241	Bronze			2022-12-18	WOS:000221442400008
J	de Fougerolles, AR; Chi-Rosso, G; Bajardi, A; Gotwals, P; Green, CD; Koteliansky, VE				de Fougerolles, AR; Chi-Rosso, G; Bajardi, A; Gotwals, P; Green, CD; Koteliansky, VE			Global expression analysis of extracellular matrix-integrin interactions in monocytes	IMMUNITY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ATHEROSCLEROTIC LESIONS; PROTEIN-KINASE; MESSENGER-RNA; CELLS; MACROPHAGE; INDUCTION; COLLAGEN	Central to immune and inflammatory responses are the integrin-mediated adhesive interactions of cells with their extracellular matrix (ECM)-rich environment. Using a comprehensive and quantitative mRNA profiling technique, we analyzed the effect of ECM-induced attachment on monocyte gene expression, its regulation by growth factors, and the integrin specificity of this event. Adhesion of cells to fibronectin resulted in increased expression of a large number of genes, which was strongly potentiated by the presence of growth factors. Adhesion activated both the NF-kappaB and Jak/STAT pathways of gene transcription and increased expression of genes involved in inflammatory and immune responses, revealing the importance of ECM-integrin interactions in these processes.	Biogen Inc, Cambridge, MA 02142 USA; CuraGen Corp, New Haven, CT 06511 USA	Biogen	de Fougerolles, AR (corresponding author), Biogen Inc, 12 Cambridge Ctr, Cambridge, MA 02142 USA.							BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Brizzi MF, 1999, MOL BIOL CELL, V10, P3463, DOI 10.1091/mbc.10.10.3463; Brumell JH, 1999, J IMMUNOL, V163, P3388; COHN ZA, 1983, HARVEY LECT, V77, P63; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; ENGLISH BK, 1993, J EXP MED, V178, P1017, DOI 10.1084/jem.178.3.1017; FAN ST, 1995, J IMMUNOL, V154, P3266; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Garcia-Velasco JA, 1999, MOL HUM REPROD, V5, P1135, DOI 10.1093/molehr/5.12.1135; Gingras MC, 2000, EXP HEMATOL, V28, P65, DOI 10.1016/S0301-472X(99)00126-5; Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; HASKILL S, 1988, J IMMUNOL, V140, P1690; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kahn J, 2000, AM J PATHOL, V156, P1887, DOI 10.1016/S0002-9440(10)65062-6; KAPLAN G, 1982, J EXP MED, V156, P1101, DOI 10.1084/jem.156.4.1101; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KLESLINGER M, 2000, GENE DEV, V14, P232; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Lilly M, 1997, CANCER RES, V57, P5348; LIN TH, 1994, J CELL BIOL, V126, P1585, DOI 10.1083/jcb.126.6.1585; Marra F, 1997, FEBS LETT, V414, P221, DOI 10.1016/S0014-5793(97)01004-1; McGilvray ID, 1997, J BIOL CHEM, V272, P10287; Meredith JE, 1996, ENDOCR REV, V17, P207, DOI 10.1210/er.17.3.207; Ohneda O, 2000, IMMUNITY, V12, P141, DOI 10.1016/S1074-7613(00)80167-3; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Pang JHS, 1996, J CLIN INVEST, V97, P2204, DOI 10.1172/JCI118661; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; Renz M, 2000, J BIOL CHEM, V275, P10429, DOI 10.1074/jbc.275.14.10429; Rosales C, 1996, CANCER RES, V56, P2302; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shimkets RA, 1999, NAT BIOTECHNOL, V17, P798, DOI 10.1038/11743; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; VAN AD, 1996, SCIENCE, V274, P787; Wang XK, 1999, FEBS LETT, V462, P145, DOI 10.1016/S0014-5793(99)01521-5; WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984; WERB Z, 1987, BASIC CLIN IMMUNOL, P96; Wesley RB, 1998, ARTERIOSCL THROM VAS, V18, P432, DOI 10.1161/01.ATV.18.3.432; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034	55	59	62	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6					749	758		10.1016/S1074-7613(00)00073-X	http://dx.doi.org/10.1016/S1074-7613(00)00073-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163191	Bronze			2022-12-18	WOS:000166142300001
J	Ortiz, M; Wine, JW; Lohrey, N; Ruscetti, FW; Spence, SE; Keller, JR				Ortiz, M; Wine, JW; Lohrey, N; Ruscetti, FW; Spence, SE; Keller, JR			Functional characterization of a novel hematopoietic stem cell and its place in the c-kit maturation pathway in bone marrow cell development	IMMUNITY			English	Article							COLONY-FORMING CELLS; CFU-S; PROGENITOR CELLS; MOUSE; SPLEEN; RECONSTITUTION; SEPARATION; EXPRESSION; TRANSPLANTATION; ENRICHMENT	While the majority of purified pluripotential hematopoietic stem cells (PHSC) express c-Kit, the receptor for steel factor, we have phenotypically and functionally separated a distinct class of PHSC that does not express c-Kit. In contrast to c-Kit-postive (c-Kit(pos)) PHSC, the c-Kit-negative (C-Kit(neg)) PHSC do not proliferate in response to multiple hematopoietic growth factors in vitro and do not radioprotect or form macroscopic spleen colonies (CFU-s) when transplanted into lethally irradiated recipients. However, the C-Kit(neg) PHSC show delayed or slow reconstitution kinetics when cotransplanted with radioprotective bone marrow cells. c-Kit(neg) PHSCs cells can give rise to c-Kit(pos) cells with CFU-s activity, radioprotective activity, and PHSC activity. Thus, constituitive hematopoiesis is maintained by c-Kit(pos) PHSCS cells that are recruited from a more primitive quiescent c-Kit(neg) PHSC population, which represents a critical developmental stage in definitive hematopoiesis.	SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA; NCI, Frederick Canc Res & Dev Ctr, Lab Leukocyte Biol, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Keller, JR (corresponding author), SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA.	kellerj@mail.ncifcrf.gov	Keller, Jonathan R./O-6677-2018		NATIONAL CANCER INSTITUTE [Z01BC010001] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-56000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERTONCELLO I, 1985, EXP HEMATOL, V13, P999; BLOUIN R, 1993, CLIN DISORDERS EXPT, P157; BODINE DM, 1995, BLOOD, V84, P3991; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; CHUNG LL, 1995, BLOOD, V85, P1472; Doi H, 1997, P NATL ACAD SCI USA, V94, P2513, DOI 10.1073/pnas.94.6.2513; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; KATAYAMA N, 1993, BLOOD, V82, P2353; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OGAWA M, 1993, DEVELOPMENT, V117, P1089; OKADA S, 1993, BLOOD, V81, P1720; OKADA S, 1991, BLOOD, V78, P1706; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PHILLIPS RL, 1992, P NATL ACAD SCI USA, V89, P11607, DOI 10.1073/pnas.89.23.11607; PLOEMACHER RE, 1988, J CELL PHYSIOL, V136, P531, DOI 10.1002/jcp.1041360320; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; PLOEMACHER RE, 1988, EXP HEMATOL, V16, P21; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SCOTT MA, 1995, BRIT J HAEMATOL, V90, P738, DOI 10.1111/j.1365-2141.1995.tb05190.x; Silver W. K., 1979, COAT COLORS MICE MOD, P243; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; VISSER JWM, 1988, BLOOD CELLS, V14, P369; VISSER JWM, 1984, J EXP MED, V59, P1576; WOLF NS, 1993, EXP HEMATOL, V21, P614	33	59	60	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					173	182		10.1016/S1074-7613(00)80018-7	http://dx.doi.org/10.1016/S1074-7613(00)80018-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072070	Bronze			2022-12-18	WOS:000078972200005
J	SMITH, TJ; DUCHARME, LA; SHAW, SK; PARKER, CM; BRENNER, MB; KILSHAW, PJ; WEIS, JH				SMITH, TJ; DUCHARME, LA; SHAW, SK; PARKER, CM; BRENNER, MB; KILSHAW, PJ; WEIS, JH			MURINE M290 INTEGRIN EXPRESSION MODULATED BY MAST-CELL ACTIVATION	IMMUNITY			English	Article							GROWTH-FACTOR ACTIVITY; C-KIT LIGAND; BETA-7 SUBUNIT; ALPHA-CHAIN; T-CELLS; BIOLOGIC PROPERTIES; CROSS-LINKAGE; FC-EPSILON; MOUSE; INTERLEUKIN-3	Intraepithelial T lymphocytes possess a (TGF beta)-inducible integrin complex that consists of the beta 7 integrin chain in association with a novel alpha chain, murine alpha M290. Using antibodies directed against the murine alpha M290 chain, IL-3-dependent murine bone marrow-derived mast cells demonstrated positive staining after induction with TGF beta. Sequence information from the human intraepithelial T lymphocyte-alpha E gene sequence was used to clone the murine homolog from a TGF beta-induced T cell library. The murine alpha E homolog gene encodes a protein recognized by antibodies to alpha M290. Expression of this gene by bone marrow-derived mast cells was found to be induced by TGF beta or IgE-mediated cross-linking of Fc epsilon R1. Furthermore, exposure of murine TK-1 cells to supernatants from activated mast cells induces the expression of the alpha M290 gene, indicating that a mast cell mediator(s) can act in a paracrine manner to induce expression of this integrin complex by other cells.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED, DEPT RHEUMATOL IMMUNOL,LYMPHOCYTE BIOL SECT, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED, DEPT RHEUMATOL IMMUNOL,DIV MED SCI, BOSTON, MA 02115 USA; AFRC, BABRAHAM INST, DEPT IMMUNOL, CAMBRIDGE CB2 4AT, ENGLAND	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	SMITH, TJ (corresponding author), UNIV UTAH, SCH MED, DEPT PATHOL, DIV CELL BIOL & IMMUNOL, SALT LAKE CITY, UT 84132 USA.			Shaw, Sunil/0000-0001-9701-6065	NCI NIH HHS [CA-42014] Funding Source: Medline; NIAID NIH HHS [AI-32958, AI-24158] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024158, R01AI032958] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; BEFUS AD, 1982, J IMMUNOL, V128, P2475; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BOWLIN TL, 1984, J IMMUNOL, V133, P2001; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; CEPEK KL, 1993, J IMMUNOL, V150, P3459; CERFBENSUSSAN N, 1992, EUR J IMMUNOL, V22, P273, DOI 10.1002/eji.1830220140; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DUCHARME LA, 1992, EUR J IMMUNOL, V22, P2603, DOI 10.1002/eji.1830221020; Enerback L., 1981, MONOGR ALLERGY, V17, P222; GALLI SJ, 1984, PROG ALLERGY, V34, P1; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; GURISH MF, 1992, J IMMUNOL, V149, P1964; HARLOW E, 1988, ANTIBODIES LABORATOR; HAVRY M, 1993, EUR J IMMUNOL, V23, P313; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; IHLE JN, 1983, J IMMUNOL, V131, P282; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; KSANDER GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1831, DOI 10.1177/38.12.2254647; LUI FT, 1980, J IMMUNOL, V124, P2728; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; METCALF D, 1986, BLOOD, V68, P46; MICKLEM KJ, 1991, AM J PATHOL, V139, P1297; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; PICCINNI MP, 1991, P NATL ACAD SCI USA, V88, P8656, DOI 10.1073/pnas.88.19.8656; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1991, J IMMUNOL, V146, P981; ROBERTS K, 1993, EUR J IMMUNOL, V23, P1630, DOI 10.1002/eji.1830230735; ROMAGNANI S, 1992, IMMUNOL TODAY, V13, P379, DOI 10.1016/0167-5699(92)90083-J; SHAW SK, 1994, J BIOL CHEM, V269, P6016; SMINIA T, 1989, CRIT REV IMMUNOL, V9, P119; SMITH TJ, 1994, EUR J IMMUNOL, V24, P822, DOI 10.1002/eji.1830240408; Tan S S, 1992, PCR Methods Appl, V2, P137; TERTIAN G, 1981, J IMMUNOL, V127, P788; THOMPSON NL, 1989, J CELL BIOL, V108, P661, DOI 10.1083/jcb.108.2.661; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; WAKEFIELD LM, 1988, ANN NY ACAD SCI, V551, P290, DOI 10.1111/j.1749-6632.1988.tb22355.x; WEIS JH, 1992, TRENDS GENET, V8, P263, DOI 10.1016/0168-9525(92)90242-V; WILKES LK, 1992, IMMUNOLOGY, V75, P535; YUAN Q, 1992, J BIOL CHEM, V267, P7352	49	59	61	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1994	1	5					393	403		10.1016/1074-7613(94)90070-1	http://dx.doi.org/10.1016/1074-7613(94)90070-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882170				2022-12-18	WOS:A1994PK16800008
J	CHEN, JZ; STEWART, V; SPYROU, G; HILBERG, F; WAGNER, EF; ALT, FW				CHEN, JZ; STEWART, V; SPYROU, G; HILBERG, F; WAGNER, EF; ALT, FW			GENERATION OF NORMAL T-LYMPHOCYTES AND B-LYMPHOCYTES BY C-JUN DEFICIENT EMBRYONIC STEM-CELLS	IMMUNITY			English	Article							ANTIGEN RECEPTOR; TRANSGENIC MICE; CYCLOSPORINE-A; NUCLEAR FACTOR; NULL MUTATION; ES CELLS; INTERLEUKIN-2; FOS; TRANSCRIPTION; PROTEIN	To determine the potential roles of c-jun in lymphocyte development, we generated somatic chimeric mice by injecting homozygous c-jun mutant embryonic stem (ES) cells into blastocysts from recombination activating gene-2 (RAG-2)-deficient mice. Chimeric mice had poor restoration of thymocytes, but contained substantial numbers of mature T and a lymphocytes in the periphery. Stimulation of c-jun(-/-) 8 cells resulted in normal levels of proliferation and immunoglobulin secretion. Likewise, stimulation of c-jun(-/-) T cells resulted in essentially normal levels of IL-2R alpha expression, IL-2 secretion, and proliferation. We further showed that the relatively normal activation responses of the c-jun(-/-) T cells probably results from the fact that other members of the Jun family contribute to the bulk of the activator protein-1 (AP-1) complexes in normal T cells and, as a result, AP-1 complexes are found at relatively normal levels in c-jun(-/-) T cells.	HARVARD UNIV,SCH MED,CTR BLOOD RES,BOSTON,MA 02115; RES INST MOLEC PATHOL,A-1030 VIENNA,AUSTRIA; KAROLINSKA INST,MED NOBLE INST,BIOCHEM LAB,INST MED BIOCHEM & BIOPHYS,S-17177 STOCKHOLM,SWEDEN	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Karolinska Institutet	CHEN, JZ (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115, USA.			Wagner, Erwin F/0000-0001-7872-0196	NATIONAL CANCER INSTITUTE [R01CA042335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, R01AI020047, R37AI020047] Funding Source: NIH RePORTER; NCI NIH HHS [CA42335] Funding Source: Medline; NIAID NIH HHS [U01 AI31541, AI20047] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BOHM S, 1993, J BIOL CHEM, V268, P3952; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; CASTIGLI E, 1993, J IMMUNOL, V150, P3284; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHEN JZ, 1993, CURR BIOL, V3, P405, DOI 10.1016/0960-9822(93)90347-Q; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FUJITA K, 1993, INT IMMUNOL, V5, P227, DOI 10.1093/intimm/5.2.227; HILBERG F, 1992, ONCOGENE, V7, P2371; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JAIN J, 1994, IN PRESS MOL CELL BI; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; OKADA S, 1994, IN PRESS MOL CELL BI; Robertson E. J., 1987, TERATOCARCINOMAS EMB; RUTHER U, 1988, CELL, V53, P847, DOI 10.1016/S0092-8674(88)90289-9; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SMITH KA, 1992, CURR OPIN IMMUNOL, V4, P271, DOI 10.1016/0952-7915(92)90076-Q; TAKAO S, 1991, INT IMMUNOL, V3, P369, DOI 10.1093/intimm/3.4.369; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	35	59	59	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1994	1	1					65	72		10.1016/1074-7613(94)90010-8	http://dx.doi.org/10.1016/1074-7613(94)90010-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889400				2022-12-18	WOS:A1994PK15400008
J	VASQUEZ, NJ; KANE, LP; HEDRICK, SM				VASQUEZ, NJ; KANE, LP; HEDRICK, SM			INTRACELLULAR SIGNALS THAT MEDIATE THYMIC NEGATIVE SELECTION	IMMUNITY			English	Article							PROTEIN-KINASE-C; MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL ACTIVATION; PHORBOL-MYRISTATE ACETATE; ANTIGEN-PRESENTING CELLS; INVITRO CLONAL DELETION; CD4+8+ THYMOCYTES; TRANSGENIC MICE; CYCLOSPORINE-A; 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE H-7	Antigenic stimulation of CD4/CD8 double positive (DP) thymocytes results in programmed cell death, while the identical stimulation of mature T cells results in proliferation and lymphokine secretion. Using thymocytes from transgenic mice expressing pigeon cytochrome c-specific T cell receptors, we previously demonstrated that major histocompatibility complex class Il-transfected L cells were capable of presenting peptide antigen and inducing programmed cell death in DP thymocytes, as well as proliferation and lymphokine secretion in mature CD4 single positive (SP)T cells. We therefore were interested in utilizing this system to compare antigen-induced signal transduction events in DP thymocytes and mature SP T cells. In this report, we demonstrate that significant distinctions between thymocytes and mature T cells are seen upon examination of antigen sensitivity and the phosphatidylinositol signaling cascade.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR CANC, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego			Hedrick, Stephen M/E-9171-2010	Kane, Lawrence/0000-0001-5198-516X; Hedrick, Stephen/0000-0002-6345-8751	NIAID NIH HHS [AI21372-10] Funding Source: Medline; NIGMS NIH HHS [GM 07313] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021372, R01AI021372] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACRES RB, 1986, J BIOL CHEM, V261, P6210; ASAOKA Y, 1991, P NATL ACAD SCI USA, V88, P8681, DOI 10.1073/pnas.88.19.8681; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRY N, 1990, P NATL ACAD SCI USA, V87, P2294, DOI 10.1073/pnas.87.6.2294; BERRY N, 1989, J IMMUNOL, V143, P1407; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BHAYANI H, 1989, J EXP MED, V170, P1609, DOI 10.1084/jem.170.5.1609; BISHOP WR, 1990, BIOCHEM J, V269, P465, DOI 10.1042/bj2690465; BLUE ML, 1987, J IMMUNOL, V139, P3949; CARNEY DH, 1985, CELL, V42, P479, DOI 10.1016/0092-8674(85)90105-9; CHOW SC, 1990, IMMUNOLOGY, V70, P106; DAVIS MM, 1993, CURR OPIN IMMUNOL, V5, P45, DOI 10.1016/0952-7915(93)90079-8; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FINKEL TH, 1987, NATURE, V330, P179, DOI 10.1038/330179a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FOX BS, 1987, J IMMUNOL, V139, P1578; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; FUJITA I, 1986, BIOCHEM PHARMACOL, V35, P4555, DOI 10.1016/0006-2952(86)90778-1; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; HANSBURG D, 1981, J IMMUNOL, V127, P1844; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; IMBODEN JB, 1985, J IMMUNOL, V134, P663; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IWABUCHI K, 1992, P NATL ACAD SCI USA, V89, P9000, DOI 10.1073/pnas.89.19.9000; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KIZAKI H, 1989, J IMMUNOL, V143, P1790; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; NAKAYAMA K, 1992, SCIENCE, V257, P94, DOI 10.1126/science.1621101; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OETTGEN HC, 1985, CELL, V40, P583, DOI 10.1016/0092-8674(85)90206-5; PAGE DM, 1993, J IMMUNOL, V151, P1868; PAGE DM, 1994, IN PRESS P NATL ACAD; PIRCHER H, 1993, EUR J IMMUNOL, V23, P669, DOI 10.1002/eji.1830230315; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RANSOM JT, 1988, J IMMUNOL, V140, P3150; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; RONCHESE F, 1987, NATURE, V329, P254, DOI 10.1038/329254a0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SLECKMAN BP, 1989, J IMMUNOL, V142, P1457; SORGER SB, 1990, J IMMUNOL, V144, P1127; SPRENT J, 1978, J EXP MED, V147, P1142, DOI 10.1084/jem.147.4.1142; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; TADAKUMA T, 1990, EUR J IMMUNOL, V20, P779, DOI 10.1002/eji.1830200411; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TAMAOKI T, 1990, ADV SEC MESS PHOSPH, V24, P497; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; WANG PTH, 1987, J IMMUNOL, V139, P2157; YAMAMOTO Y, 1985, EUR J IMMUNOL, V15, P1204, DOI 10.1002/eji.1830151212; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	71	59	59	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1994	1	1					45	56		10.1016/1074-7613(94)90008-6	http://dx.doi.org/10.1016/1074-7613(94)90008-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889398				2022-12-18	WOS:A1994PK15400006
J	Xian, HX; Liu, Y; Nilsson, AR; Gatchalian, R; Crother, TR; Tourtellotte, WG; Zhang, Y; Aleman-Muench, GR; Lewis, G; Chen, WX; Kang, S; Luevanos, M; Trudler, D; Lipton, SA; Soroosh, P; Teijaro, J; de la Torre, JC; Arditi, M; Karin, M; Sanchez-Lopez, E				Xian, Hongxu; Liu, Yuan; Nilsson, Alexandra Rundberg; Gatchalian, Raphaella; Crother, Timothy R.; Tourtellotte, Warren G.; Zhang, Yi; Aleman-Muench, German R.; Lewis, Gavin; Chen, Weixuan; Kang, Sarah; Luevanos, Melissa; Trudler, Dorit; Lipton, Stuart A.; Soroosh, Pejman; Teijaro, John; de la Torre, Juan Carlos; Arditi, Moshe; Karin, Michael; Sanchez-Lopez, Elsa			Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation	IMMUNITY			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; MORTALITY; EXPRESSION; COVID-19; PHOSPHORYLATION; IL-1-BETA; COMPLEX; NF-IL6; IL-10	Acute respiratory distress syndrome (ARDS), an inflammatory condition with high mortality rates, is common in severe COVID-19, whose risk is reduced by metformin rather than other anti-diabetic medications. Detecting of inflammasome assembly in post-mortem COVID-19 lungs, we asked whether and how metformin inhibits inflammasome activation while exerting its anti-inflammatory effect. We show that metformin inhibited NLRP3 inflammasome activation and interleukin (IL)-1 beta production in cultured and alveolar macrophages along with inflammasome-independent IL-6 secretion, thus attenuating lipopolysaccharide (LPS)- and SARS-CoV-2-induced ARDS. By targeting electron transport chain complex 1 and independently of AMP-activated protein kinase (AMPK) or NF-kappa B, metformin blocked LPS-induced and ATP-dependent mitochondrial (mt) DNA synthesis and generation of oxidized mtDNA, an NLRP3 ligand. Myeloid-specific ablation of LPS-induced cytidine monophosphate kinase 2 (CMPK2), which is rate limiting for mtDNA synthesis, reduced ARDS severity without a direct effect on IL-6. Thus, inhibition of ATP and mtDNA synthesis is sufficient for ARDS amelioration.	[Xian, Hongxu; Liu, Yuan; Nilsson, Alexandra Rundberg; Gatchalian, Raphaella; Kang, Sarah; Karin, Michael; Sanchez-Lopez, Elsa] UCSD, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, Sch Med, La Jolla, CA 92093 USA; [Crother, Timothy R.; Tourtellotte, Warren G.; Zhang, Yi; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Los Angeles, CA 90048 USA; [Tourtellotte, Warren G.; Zhang, Yi] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Tourtellotte, Warren G.; Zhang, Yi] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Tourtellotte, Warren G.; Zhang, Yi] Cedars Sinai Med Ctr, Dept Neurol Surg, Los Angeles, CA 90048 USA; [Tourtellotte, Warren G.] Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA; [Aleman-Muench, German R.; Lewis, Gavin; Soroosh, Pejman] Janssen Res & Dev, Immunometab, CVM Discovery, San Diego, CA 92121 USA; [Chen, Weixuan] Janssen Res & Dev LLC, San Diego, CA USA; [Luevanos, Melissa; Trudler, Dorit; Lipton, Stuart A.] Scripps Res Inst, Neurodegenerat New Med Ctr, La Jolla, CA 92037 USA; [Luevanos, Melissa; Trudler, Dorit; Lipton, Stuart A.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Lipton, Stuart A.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Teijaro, John; de la Torre, Juan Carlos] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Sanchez-Lopez, Elsa] UCSD, Dept Orthoped Surg, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego	Karin, M (corresponding author), UCSD, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, Sch Med, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Crother, Timothy R/E-2879-2010; Sanchez-Lopez, Elsa/K-3987-2015	Crother, Timothy R/0000-0001-8465-6127; Lipton, Stuart/0000-0002-3490-1259; Sanchez-Lopez, Elsa/0000-0002-4236-1985; Chen, Weixuan/0000-0002-2294-7049; Xian, Hongxu/0000-0002-8610-2029	NCI Cancer Center Support Grant [CCSG P30CA23100]; NIH [R01AI072726, R01NS095894, U54CA260591, R01A1043477, P42ES010337]; NIAMS [K01AR077111]; Resource-based Center for the study of the joint microenvironment in rheumatology UCSD [P30AR073761]	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Resource-based Center for the study of the joint microenvironment in rheumatology UCSD	We thank eBioscience, Cell Signaling Technologies, Santa Cruz Technologies, Thermo Fisher, and Promega for gifts of reagents, and the UCSD TTSR supported by an NCI Cancer Center Support Grant (CCSG P30CA23100). We also thank T.N. Ngo for technical assistance; J.D. Rabinowitz and L. Yang for Ndsuf4~/~ mouse bones; and R. Liu-Bryan for Ampka1~/~ mice. M.A. (R01AI072726) and W.G.T. (R01NS095894) were supported by the NIH. E.S.-L. was supported by NIAMS (K01AR077111) and Resource-based Center for the study of the joint microenvironment in rheumatology UCSD (P30AR073761). Research was supported by NIH grant awards to M.K., M.A. and W.G.T. (U54CA260591), and M.K. (R01A1043477, P42ES010337), who is an American Cancer Research Society Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469; Bramante CT, 2021, LANCET HEALTH LONGEV, V2, pE34, DOI 10.1016/S2666-7568(20)30033-7; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; Campbell JM, 2018, J ALZHEIMERS DIS, V65, P1225, DOI 10.3233/JAD-180263; Cauchois R, 2020, P NATL ACAD SCI USA, V117, P18951, DOI 10.1073/pnas.2009017117; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Cheng X, 2020, CELL METAB, V32, P537, DOI 10.1016/j.cmet.2020.08.013; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Crouse AB, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.600439; Day CW, 2009, VIROLOGY, V395, P210, DOI 10.1016/j.virol.2009.09.023; Dick IE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10370; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Dosch SF, 2009, VIRUS RES, V142, P19, DOI 10.1016/j.virusres.2009.01.005; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0; Freeman TL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01518; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Gao F, 2021, J GASTROEN HEPATOL, V36, P204, DOI 10.1111/jgh.15112; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gupta S, 2021, JAMA INTERN MED, V181, P41, DOI 10.1001/jamainternmed.2020.6252; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jupelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077447; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Li AY, 2016, MOL CELL ENDOCRINOL, V434, P36, DOI 10.1016/j.mce.2016.06.008; Li JH, 2020, ENDOCR PRACT, V26, P1166, DOI 10.4158/EP-2020-0466; Li X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02911-9; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo P, 2020, AM J TROP MED HYG, V103, P69, DOI 10.4269/ajtmh.20-0375; Luo Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00604; Marcucci F, 2020, TRENDS PHARMACOL SCI, V41, P162, DOI 10.1016/j.tips.2020.01.003; Markowicz-Piasecka M, 2017, PHARM RES-DORDR, V34, P2614, DOI 10.1007/s11095-017-2199-y; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; McElroy GS, 2020, CELL METAB, V32, P301, DOI 10.1016/j.cmet.2020.06.003; Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Park MJ, 2019, J IMMUNOL, V203, P127, DOI 10.4049/jimmunol.1800006; Pollak M, 2017, DIABETOLOGIA, V60, P1662, DOI 10.1007/s00125-017-4352-x; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Roschewski M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd0110; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi Q, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024954; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Singh S, 2020, GASTROENTEROLOGY, V159, P768, DOI 10.1053/j.gastro.2020.04.064; Soberanes S, 2019, CELL METAB, V29, P335, DOI [10.1016/j.cmet.2018.09.019, 10.1016/j.cmet.2018.12.001]; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vaez H, 2016, INT IMMUNOPHARMACOL, V40, P501, DOI 10.1016/j.intimp.2016.10.002; Valencia WM, 2017, DIABETOLOGIA, V60, P1630, DOI 10.1007/s00125-017-4349-5; Verma N, 2021, GASTROENTEROLOGY, V160, P1893, DOI 10.1053/j.gastro.2020.05.090; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Yang LF, 2020, CELL METAB, V31, P809, DOI 10.1016/j.cmet.2020.02.017; Yu LL, 2018, EUR REV MED PHARMACO, V22, P5355, DOI 10.26355/eurrev_201808_15737; Zhang XJ, 2020, CELL METAB, V32, P176, DOI 10.1016/j.cmet.2020.06.015; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu J.H., 2020, CIRCULATING MITOCHON	94	58	59	18	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1463	+		10.1016/j.immuni.2021.05.004	http://dx.doi.org/10.1016/j.immuni.2021.05.004		JUL 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34115964	Bronze, Green Published			2022-12-18	WOS:000672812100012
J	Perner, C; Flayer, CH; Zhu, XP; Aderhold, PA; Dewan, ZNA; Voisin, T; Camire, RB; Chow, OA; Chiu, IM; Sokol, CL				Perner, Caroline; Flayer, Cameron H.; Zhu, Xueping; Aderhold, Pamela A.; Dewan, Zaynah N. A.; Voisin, Tiphaine; Camire, Ryan B.; Chow, Ohn A.; Chiu, Isaac M.; Sokol, Caroline L.			Substance P Release by Sensory Neurons Triggers Dendritic Cell Migration and Initiates the Type-2 Immune Response to Allergens	IMMUNITY			English	Article							PROTEIN-COUPLED RECEPTORS; MAST-CELLS; IN-VIVO; CYSTEINE PROTEASES; ADAPTIVE IMMUNITY; C-KIT; EXPRESSION; SKIN; INFLAMMATION; CYTOKINE	Dendritic cells (DCs) of the cDC2 lineage initiate allergic immunity and in the dermis are marked by their expression of CD301b. CD301b(+) dermal DCs respond to allergens encountered in vivo, but not in vitro. This suggests that another cell in the dermis may sense allergens and relay that information to activate and induce the migration of CD301b(+) DCs to the draining lymph node (dLN). Using a model of cutaneous allergen exposure, we show that allergens directly activated TRPV1(+) sensory neurons leading to itch and pain behaviors. Allergen-activated sensory neurons released the neuropeptide Substance P, which stimulated proximally located CD301b(+) DCs through the Mas-related G-protein coupled receptor member A1 (MRGPRA1). Substance P induced CD301b(+) DC migration to the dLN where they initiated T helper-2 cell differentiation. Thus, sensory neurons act as primary sensors of allergens, linking exposure to activation of allergic-skewing DCs and the initiation of an allergic immune response.	[Perner, Caroline; Flayer, Cameron H.; Zhu, Xueping; Aderhold, Pamela A.; Dewan, Zaynah N. A.; Camire, Ryan B.; Chow, Ohn A.; Sokol, Caroline L.] Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Voisin, Tiphaine; Camire, Ryan B.; Chiu, Isaac M.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sokol, CL (corresponding author), Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.	clsokol@mgh.harvard.edu		Perner, Caroline/0000-0002-0851-1759; Flayer, Cameron/0000-0002-3001-9058	NIH Shared Instrumentation Program [1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]; NIH [K08AI121421, DP2AT009499, R01AI130019, T32HL116275, DFG PE2864/3-1, DK043351]; Massachusetts General Hospital Transformative Scholar Award; AAAAI Foundation; Food Allergy Science Initiative; Chan Zuckerberg Initiative; Burroughs Wellcome Fund; Harvard Stem Cell Institute; Allergan Pharmaceuticals	NIH Shared Instrumentation Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Transformative Scholar Award; AAAAI Foundation; Food Allergy Science Initiative; Chan Zuckerberg Initiative; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Stem Cell Institute; Allergan Pharmaceuticals(AbbVieAllergan)	We thank N. Andrew (MGH) for technical advice, M. Hoon (NIH) for providing Trpv1<SUP>DTR</SUP> mice, K. Blake and S. Sannajust (Harvard) for breeding Tac1<SUP>-/-</SUP>, Nav1.8<SUP>cre</SUP>, and tdTomato<SUP>loxSTOPlox</SUP> mice, and X. Dong (Johns Hopkins) for providing Mrgpra1<SUP>-/-</SUP> bone marrow. BioRender.com was used to produce the graphical abstract. Cytometric findings reported here were performed in the MGH Department of Pathology Flow and Image Cytometry Research Core, with support from the NIH Shared Instrumentation Program (1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1). This work was supported by NIH K08AI121421 (to C.L.S), DP2AT009499 and R01AI130019 (to I.M.C.), T32HL116275 (to C.H.F.), DFG PE2864/3-1 (to C.P.), Center for the Study of Inflammatory Bowel Disease Pilot Feasibility Study Award (DK043351 to C.L.S.), Massachusetts General Hospital Transformative Scholar Award (to C.L.S.), AAAAI Foundation and Dr. Donald Y. M. Leung/JACI Editors Faculty Development Award (to C.L.S.), and Food Allergy Science Initiative (to C.L.S. and I.M.C.). I.M.C. receives additional support from the Chan Zuckerberg Initiative, Burroughs Wellcome Fund, Harvard Stem Cell Institute, GlaxoSmithKline (GSK), and Allergan Pharmaceuticals.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Azimi E, 2017, J ALLERGY CLIN IMMUN, V140, P447, DOI 10.1016/j.jaci.2016.12.980; Azimi E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89362; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chen J, 2010, PROG NEUROBIOL, V92, P151, DOI 10.1016/j.pneurobio.2010.06.006; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Choi HW, 2018, SCIENCE, V362, P656, DOI 10.1126/science.aao0666; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Dawicki W, 2010, J IMMUNOL, V184, P2116, DOI 10.4049/jimmunol.0803894; Deckers J, 2017, J ALLERGY CLIN IMMUN, V140, P1364, DOI 10.1016/j.jaci.2016.12.970; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Guzman M, 2018, MUCOSAL IMMUNOL, V11, P1441, DOI 10.1038/s41385-018-0040-5; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HIRATA T, 1993, DEVELOPMENT, V119, P49; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Iida H, 2014, ALLERGOL INT, V63, P219, DOI 10.2332/allergolint.13-OA-0621; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Janelsins BM, 2013, BLOOD, V121, P2923, DOI 10.1182/blood-2012-07-446054; Janelsins BM, 2009, BLOOD, V113, P3017, DOI 10.1182/blood-2008-06-163121; Joost S, 2020, CELL STEM CELL, V26, P441, DOI 10.1016/j.stem.2020.01.012; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Lin YP, 2018, MOL CELL, V70, P228, DOI 10.1016/j.molcel.2018.03.025; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Mathers AR, 2007, J IMMUNOL, V178, P7006, DOI 10.4049/jimmunol.178.11.7006; Mazzoni A, 2006, J IMMUNOL, V177, P3577, DOI 10.4049/jimmunol.177.6.3577; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Meixiong J, 2019, ELIFE, V8, DOI 10.7554/eLife.44116; Migueres M, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-16; Milenkovic N, 2007, NEURON, V56, P893, DOI 10.1016/j.neuron.2007.10.040; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Pogorzala LA, 2013, J NEUROSCI, V33, P5533, DOI 10.1523/JNEUROSCI.5788-12.2013; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Reddy VB, 2010, BRIT J DERMATOL, V163, P532, DOI 10.1111/j.1365-2133.2010.09862.x; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2018, IMMUNITY, V49, P449, DOI 10.1016/j.immuni.2018.07.012; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Takagi K, 2008, NEUROSCIENCE, V153, P1278, DOI 10.1016/j.neuroscience.2008.02.073; Talbot S, 2016, ANNU REV IMMUNOL, V34, P421, DOI 10.1146/annurev-immunol-041015-055340; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Trier AM, 2019, J IMMUNOL, V202, P2829, DOI 10.4049/jimmunol.1801473; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Van Dyken SJ, 2018, J ALLERGY CLIN IMMUN, V142, P364, DOI 10.1016/j.jaci.2018.06.017; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Xu JJ, 2020, IMMUNITY, V53, P371, DOI 10.1016/j.immuni.2020.06.023; Yosipovitch G, 2018, J AM ACAD DERMATOL, V78, P882, DOI 10.1016/j.jaad.2018.02.030; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	76	58	60	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1063	+		10.1016/j.immuni.2020.10.001	http://dx.doi.org/10.1016/j.immuni.2020.10.001			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33098765	Bronze, Green Accepted			2022-12-18	WOS:000599348200016
J	Hoyer, FF; Naxerova, K; Schloss, MJ; Hulsmans, M; Nair, AV; Dutta, P; Calcagno, DM; Herisson, F; Anzai, A; Sun, Y; Wojtkiewicz, G; Rohde, D; Frodermann, V; Vandoorne, K; Courties, G; Iwamoto, Y; Garris, CS; Williams, DL; Breton, S; Brown, D; Whalen, M; Libby, P; Pittet, MJ; King, KR; Weissleder, R; Swirski, FK; Nahrendorf, M				Hoyer, Friedrich Felix; Naxerova, Kamila; Schloss, Maximilian J.; Hulsmans, Maarten; Nair, Anil V.; Dutta, Partha; Calcagno, David M.; Herisson, Fanny; Anzai, Atsushi; Sun, Yuan; Wojtkiewicz, Gregory; Rohde, David; Frodermann, Vanessa; Vandoorne, Katrien; Courties, Gabriel; Iwamoto, Yoshiko; Garris, Christopher S.; Williams, David L.; Breton, Sylvie; Brown, Dennis; Whalen, Michael; Libby, Peter; Pittet, Mikael J.; King, Kevin R.; Weissleder, Ralph; Swirski, Filip K.; Nahrendorf, Matthias			Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge	IMMUNITY			English	Article							CARDIAC MACROPHAGES; STEADY-STATE; ACTIVATION; MECHANISMS; STROKE; GAMMA; CELL; EXPRESSION; MICROGLIA; MONOCYTES	Myocardial infarction, stroke, and sepsis trigger systemic inflammation and organism-wide complications that are difficult to manage. Here, we examined the contribution of macrophages residing in vital organs to the systemic response after these injuries. We generated a comprehensive catalog of changes in macrophage number, origin, and gene expression in the heart, brain, liver, kidney, and lung of mice with myocardial infarction, stroke, or sepsis. Predominantly fueled by heightened local proliferation, tissue macrophage numbers increased systemically. Macrophages in the same organ responded similarly to different injuries by altering expression of tissue-specific gene sets. Preceding myocardial infarction improved survival of subsequent pneumonia due to enhanced bacterial clearance, which was caused by IFN gamma priming of alveolar macrophages. Conversely, EGF receptor signaling in macrophages exacerbated inflammatory lung injury. Our data suggest that local injury activates macrophages in remote organs and that targeting macrophages could improve resilience against systemic complications following myocardial infarction, stroke, and sepsis.	[Hoyer, Friedrich Felix; Naxerova, Kamila; Schloss, Maximilian J.; Hulsmans, Maarten; Nair, Anil V.; Herisson, Fanny; Anzai, Atsushi; Sun, Yuan; Wojtkiewicz, Gregory; Rohde, David; Frodermann, Vanessa; Vandoorne, Katrien; Courties, Gabriel; Iwamoto, Yoshiko; Garris, Christopher S.; Breton, Sylvie; Brown, Dennis; Pittet, Mikael J.; Weissleder, Ralph; Swirski, Filip K.; Nahrendorf, Matthias] Massachusetts Gen Hosp, Dept Radiol, Ctr Syst Biol, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA; [Hoyer, Friedrich Felix; Naxerova, Kamila; Schloss, Maximilian J.; Hulsmans, Maarten; Nair, Anil V.; Herisson, Fanny; Anzai, Atsushi; Sun, Yuan; Wojtkiewicz, Gregory; Rohde, David; Frodermann, Vanessa; Vandoorne, Katrien; Courties, Gabriel; Iwamoto, Yoshiko; Garris, Christopher S.; Breton, Sylvie; Brown, Dennis; Pittet, Mikael J.; Weissleder, Ralph; Swirski, Filip K.; Nahrendorf, Matthias] Harvard Med Sch, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA; [Nair, Anil V.; Breton, Sylvie; Brown, Dennis] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA; [Nair, Anil V.; Breton, Sylvie; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Dutta, Partha] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh Heart Lung Blood & Vasc Med Inst,Div C, BST 1720-1,200 Lothrop St, Pittsburgh, PA 15213 USA; [Dutta, Partha] Univ Pittsburgh, Med Ctr, BST 1720-1,200 Lothrop St, Pittsburgh, PA 15213 USA; [Calcagno, David M.; King, Kevin R.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Williams, David L.] East Tennessee State Univ, Dept Surg, 178 Maple Ave, Johnson City, TN 37614 USA; [Williams, David L.] East Tennessee State Univ, Ctr Excellence Inflammat Infect Dis & Immun, 178 Maple Ave, Johnson City, TN 37614 USA; [Whalen, Michael] Massachusetts Gen Hosp, Ctr Neurosci, 55 Fruit St, Boston, MA 02114 USA; [Whalen, Michael] Massachusetts Gen Hosp, Dept Pediat, 55 Fruit St, Boston, MA 02114 USA; [Whalen, Michael] Harvard Med Sch, 55 Fruit St, Boston, MA 02114 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Libby, Peter] Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA; [King, Kevin R.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St, Boston, MA 02114 USA; [Nahrendorf, Matthias] Harvard Med Sch, 185 Cambridge St, Boston, MA 02114 USA; [Nahrendorf, Matthias] Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; East Tennessee State University; East Tennessee State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Wurzburg	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Ctr Syst Biol, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, 185 Cambridge St, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany.	mnahrendorf@mgh.harvard.edu	Libby, Peter/AAY-6404-2021; Pittet, Mikael/ABD-6300-2021; Hoyer, Friedrich/AAC-8097-2022; Wojtkiewicz, Gregory/L-3660-2018	Libby, Peter/0000-0002-1502-502X; Wojtkiewicz, Gregory/0000-0002-3148-8411; Swirski, Filip/0000-0002-3163-9152; Vandoorne, Katrien/0000-0002-8132-8280; Naxerova, Kamila/0000-0001-7744-5110	National Institutes of Health [HL139598, HL125428, NS084863, HL128264, HL129168, DP2AR075321, UL1TR001442, CA225655, GM53522, GM083016, GM119197, T32HL076136, DK57521, DK43351]; American Heart Association [AHA 17IRG33410543]; European Union's Horizon 2020 program [667837]; MGH Research Scholar Program; Cure Alzheimer's Fund; German Research Foundation [HO5279/1-2, RO5071/1-1]; German Heart Foundation; Jung Foundation for Science and Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001442] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL142494, T32HL076136, R00HL129168, R35HL139598, R01HL125428, K99HL129168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP2AR075321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); European Union's Horizon 2020 program; MGH Research Scholar Program; Cure Alzheimer's Fund; German Research Foundation(German Research Foundation (DFG)); German Heart Foundation; Jung Foundation for Science and Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health (HL139598, HL125428, NS084863, HL128264, HL129168, DP2AR075321, UL1TR001442, CA225655, GM53522, GM083016, GM119197, T32HL076136, DK57521, DK43351), the American Heart Association (AHA 17IRG33410543), the European Union's Horizon 2020 program 667837, the MGH Research Scholar Program, and the Cure Alzheimer's Fund. F.F.H. was supported by the German Research Foundation HO5279/1-2, German Heart Foundation, and the Jung Foundation for Science and Research. D.R. was supported by the German Research Foundation RO5071/1-1.	Alp Emine, 2004, Ann Clin Microbiol Antimicrob, V3, P17, DOI 10.1186/1476-0711-3-17; Case J, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/479730; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hardbower DM, 2016, J CLIN INVEST, V126, P3296, DOI 10.1172/JCI83585; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hilbi H, 1997, PARASITOLOGY, V115, pS79, DOI 10.1017/S0031182097001790; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kallmunzer B, 2012, STROKE, V43, P2892, DOI 10.1161/STROKEAHA.112.664318; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; McNamara RL, 2016, J AM COLL CARDIOL, V68, P626, DOI 10.1016/j.jacc.2016.05.049; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Swirski FK, 2018, NAT REV IMMUNOL, V18, P733, DOI 10.1038/s41577-018-0065-8; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Truffa AAM, 2012, JACC-CARDIOVASC INTE, V5, P769, DOI 10.1016/j.jcin.2012.03.018; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Yasumoto M, 1994, J Anesth, V8, P269, DOI 10.1007/BF02514648; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	45	58	58	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					899	+		10.1016/j.immuni.2019.10.010	http://dx.doi.org/10.1016/j.immuni.2019.10.010			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31732166	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000497811300013
J	Spencer, SP; Fragiadakis, GK; Sonnenburg, JL				Spencer, Sean P.; Fragiadakis, Gabriela K.; Sonnenburg, Justin L.			Pursuing Human-Relevant Gut Microbiota-Immune Interactions	IMMUNITY			English	Review							SEGMENTED FILAMENTOUS BACTERIA; REGULATORY T-CELLS; DIETARY FIBER INTAKE; SPATIAL-ORGANIZATION; COMMENSAL BACTERIA; HUNTER-GATHERERS; METABOLITES; HOST; RECEPTOR; COLITIS	The gut microbiota is a complex and plastic network of diverse organisms intricately connected with human physiology. Recent advances in profiling approaches of both the microbiota and the immune system now enable a deeper exploration of immunity-microbiota connections. An important next step is to elucidate a human-relevant "map" of microbial-immune wiring while focusing on animal studies to probe a prioritized subset of interactions. Here, we provide an overview of this field's current status and discuss two approaches for establishing priorities for detailed investigation: (1) longitudinal intervention studies in humans probing the dynamics of both the microbiota and the immune system and (2) the study of traditional populations to assess lost features of human microbial identity whose absence may be contributing to the rise of immunological disorders. These human-centered approaches offer a judicious path forward to understand the impact of the microbiota in immune development and function.	[Spencer, Sean P.; Fragiadakis, Gabriela K.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Sonnenburg, Justin L.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Sonnenburg, Justin L.] Stanford Univ, Ctr Human Microbiome Studies, Stanford, CA 94305 USA	Stanford University; Stanford University	Fragiadakis, GK; Sonnenburg, JL (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Sonnenburg, JL (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Sonnenburg, JL (corresponding author), Stanford Univ, Ctr Human Microbiome Studies, Stanford, CA 94305 USA.	gabif@stanford.edu; jsonnenburg@stanford.edu		Spencer, Sean/0000-0002-7328-5399	National Science Foundation [1648230]; NIH [R01-DK085025, DP1-AT00989201]; Stanford School of Medicine Dean's Fellowship;  [NIH 4T32AI7328-29];  [NIH 5T32DK007056-44]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007056, R01DK085025] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford School of Medicine Dean's Fellowship; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	LWe would like to thank members of the Sonnenburg lab for helpful discussions, National Science Foundation for their funding support (grant number 1648230), and the NIH (R01-DK085025 and DP1-AT00989201 to J.L.S.). J.L.S. is a Chan Zuckerberg Biohub Investigator. G.K.F. is supported by postdoctoral training grant (NIH 4T32AI7328-29) and Stanford School of Medicine Dean's Fellowship. S.P.S. is supported by postdoctoral training grant (NIH 5T32DK007056-44).	Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ayeni FA, 2018, CELL REP, V23, P3056, DOI 10.1016/j.celrep.2018.05.018; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Bashiardes S, 2018, CURR OPIN BIOTECH, V51, P57, DOI 10.1016/j.copbio.2017.11.013; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bhattarai Y, 2018, CELL HOST MICROBE, V23, P775, DOI 10.1016/j.chom.2018.05.004; Bilen M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0485-5; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Britton GJ, 2019, IMMUNITY, V50, P212, DOI 10.1016/j.immuni.2018.12.015; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; BURKITT DP, 1972, LANCET, V1, P1408; Bushman FD, 2019, AM J OBSTET GYNECOL, V220, P213, DOI 10.1016/j.ajog.2018.11.1093; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Chen B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01403; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cleophas MCP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37246-7; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Cohen LJ, 2015, P NATL ACAD SCI USA, V112, pE4825, DOI 10.1073/pnas.1508737112; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davis MM, 2018, ANNU REV IMMUNOL, V36, P843, DOI 10.1146/annurev-immunol-042617-053206; De Filippis F, 2019, CELL HOST MICROBE, V25, P444, DOI 10.1016/j.chom.2019.01.004; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Debelius J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1086-x; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Dianda L, 1997, AM J PATHOL, V150, P91; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ericsson AC, 2014, COMPARATIVE MED, V64, P90; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Fragiadakis GK, 2019, GUT MICROBES, V10, P216, DOI 10.1080/19490976.2018.1494103; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gehrig JL, 2019, SCIENCE, V365, P139, DOI 10.1126/science.aau4732; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Gong J, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0225-x; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Hryckowian AJ, 2018, NAT MICROBIOL, V3, P662, DOI 10.1038/s41564-018-0150-6; Hugenholtz P, 1996, TRENDS BIOTECHNOL, V14, P190, DOI 10.1016/0167-7799(96)10025-1; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jha AR, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005396; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; King DE, 2012, J ACAD NUTR DIET, V112, P642, DOI 10.1016/j.jand.2012.01.019; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024; Laforest-Lapointe I., 2018, MSYSTEMS, V3; Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]; Landhuis E, 2018, NATURE, V557, P595, DOI 10.1038/d41586-018-05214-w; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee TS, 2017, ENABLING AGRI-ENTREPRENEURSHIP AND INNOVATION: EMPIRICAL EVIDENCE AND SOLUTIONS FOR CONFLICT REGIONS AND TRANSITIONING ECONOMIES, P89, DOI 10.1079/9781780647753.0089; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lewis JD, 2017, INFLAMM BOWEL DIS, V23, P181, DOI 10.1097/MIB.0000000000001009; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Magurran A.E, 1988, ECOLOGICAL DIVERSITY; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; McKenzie C, 2017, IMMUNOL REV, V278, P277, DOI 10.1111/imr.12556; Miller ET, 2018, TRENDS ECOL EVOL, V33, P926, DOI 10.1016/j.tree.2018.09.002; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Morton ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005658; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Olsen LR, 2019, IMMUNITY, V50, P535, DOI 10.1016/j.immuni.2019.02.015; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Paun A, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8125; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Plunkett CH, 2017, J IMMUNOL, V198, P581, DOI 10.4049/jimmunol.1601266; Pontzer H, 2018, OBES REV, V19, P24, DOI 10.1111/obr.12785; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Raman R, 2019, SCIENCE, V363, P1051, DOI 10.1126/science.aaw3611; Reese AT, 2018, MBIO, V9, DOI 10.1128/mBio.01294-18; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Schirmer M, 2018, CELL HOST MICROBE, V24, P600, DOI 10.1016/j.chom.2018.09.009; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Schulfer AF, 2018, NAT MICROBIOL, V3, P234, DOI 10.1038/s41564-017-0075-5; Shao TY, 2019, CELL HOST MICROBE, V25, P404, DOI 10.1016/j.chom.2019.02.004; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Shepherd ES, 2018, NATURE, V557, P434, DOI 10.1038/s41586-018-0092-4; Sheth RU, 2019, NAT BIOTECHNOL, V37, P877, DOI 10.1038/s41587-019-0183-2; Skelly AN, 2019, NAT REV IMMUNOL, V19, P305, DOI 10.1038/s41577-019-0144-5; Smillie CS, 2018, CELL HOST MICROBE, V23, P229, DOI 10.1016/j.chom.2018.01.003; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Sprockett D, 2018, NAT REV GASTRO HEPAT, V15, P197, DOI 10.1038/nrgastro.2017.173; Staley C, 2016, MBIO, V7, DOI 10.1128/mBio.01965-16; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Suzuki TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1037; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Thomas S, 2015, CLIN IMMUNOL, V157, P277, DOI 10.1016/j.clim.2014.12.004; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tropini C, 2017, CELL HOST MICROBE, V21, P433, DOI 10.1016/j.chom.2017.03.010; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vangay P, 2018, CELL, V175, P962, DOI 10.1016/j.cell.2018.10.029; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144; Virtue AT, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1892; Wagner M, 2012, CURR OPIN BIOTECH, V23, P96, DOI 10.1016/j.copbio.2011.10.010; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin YS, 2013, ISME J, V7, P615, DOI 10.1038/ismej.2012.128; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05001; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7; Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	194	58	60	4	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					225	239		10.1016/j.immuni.2019.08.002	http://dx.doi.org/10.1016/j.immuni.2019.08.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433970	Green Accepted, Bronze			2022-12-18	WOS:000482088500008
J	Pai, CCS; Huang, JT; Lu, XQ; Simons, DM; Park, C; Chang, A; Tamaki, W; Liu, E; Roybal, KT; Seagal, J; Chen, MY; Hagihara, K; Wei, XX; DuPage, M; Kwek, SS; Oh, DY; Daud, A; Tsai, KK; Wu, C; Zhang, L; Fasso, M; Sachidanandam, R; Jayaprakash, A; Lin, I; Casbon, AJ; Kinsbury, GA; Fong, L				Pai, Chien-Chun Steven; Huang, John T.; Lu, Xiaoqing; Simons, Donald M.; Park, Chanhyuk; Chang, Anthony; Tamaki, Whitney; Liu, Eric; Roybal, Kole T.; Seagal, Jane; Chen, Mingyi; Hagihara, Katsunobu; Wei, Xiao X.; DuPage, Michel; Kwek, Serena S.; Oh, David Y.; Daud, Adil; Tsai, Katy K.; Wu, Clint; Zhang, Li; Fasso, Marcella; Sachidanandam, Ravi; Jayaprakash, Anitha; Lin, Ingrid; Casbon, Amy-Jo; Kinsbury, Gillian A.; Fong, Lawrence			Clonal Deletion of Tumor-Specific T Cells by Interferon-gamma Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade	IMMUNITY			English	Article							PD-1 BLOCKADE; IFN-GAMMA; ACQUIRED-RESISTANCE; COMBINED NIVOLUMAB; SOLID TUMORS; CANCER; IPILIMUMAB; IMMUNOTHERAPY; ANTI-CTLA-4; RESPONSES	Resistance to checkpoint-blockade treatments is a challenge in the clinic. We found that although treatment with combined anti-CTLA-4 and anti-PD-1 improved control of established tumors, this combination compromised anti-tumor immunity in the low tumor burden (LTB) state in pre-clinical models as well as in melanoma patients. Activated tumor-specific T cells expressed higher amounts of interferon-gamma (IFN-gamma) receptor and were more susceptible to apoptosis than naive T cells. Combination treatment induced deletion of tumor-specific T cells and altered the T cell repertoire landscape, skewing the distribution of T cells toward lower-frequency clonotypes. Additionally, combination therapy induced higher IFN-gamma production in the LTB state than in the high tumor burden (HTB) state on a per-cell basis, reflecting a less exhausted immune status in the LTB state. Thus, elevated IFN-gamma secretion in the LTB state contributes to the development of an immuneintrinsic mechanism of resistance to combination checkpoint blockade, highlighting the importance of achieving the optimal magnitude of immune stimulation for successful combination immunotherapy strategies.	[Pai, Chien-Chun Steven; Huang, John T.; Park, Chanhyuk; Chang, Anthony; Tamaki, Whitney; Liu, Eric; Hagihara, Katsunobu; Wei, Xiao X.; Kwek, Serena S.; Oh, David Y.; Daud, Adil; Tsai, Katy K.; Wu, Clint; Zhang, Li; Fasso, Marcella; Lin, Ingrid; Casbon, Amy-Jo; Fong, Lawrence] Univ Calif San Francisco, Dept Hematol & Oncol, San Francisco, CA 94143 USA; [Pai, Chien-Chun Steven; Roybal, Kole T.; Hagihara, Katsunobu; Wei, Xiao X.; DuPage, Michel; Kwek, Serena S.; Oh, David Y.; Daud, Adil; Tsai, Katy K.; Wu, Clint; Zhang, Li; Lin, Ingrid; Fong, Lawrence] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Lu, Xiaoqing; Simons, Donald M.; Seagal, Jane; Kinsbury, Gillian A.] AbbVie Biores Ctr, 100 Res Dr, Worcester, MA 01605 USA; [Chen, Mingyi] Univ Texas Southwestern Med Ctr Dallas, Sch Med, Dept Hematopathol, Dallas, TX 75390 USA; [Sachidanandam, Ravi; Jayaprakash, Anitha] Girihlet, 355 30th St, Oakland, CA 94609 USA; [Wei, Xiao X.] Harvard Med Sch, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA; [Fasso, Marcella] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Casbon, Amy-Jo] Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA; [Kinsbury, Gillian A.] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; AbbVie; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Roche Holding; Genentech; Amgen; Agios Pharmaceuticals	Fong, L (corresponding author), Univ Calif San Francisco, Dept Hematol & Oncol, San Francisco, CA 94143 USA.; Fong, L (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	lawrence.fong@ucsf.edu	sachidanandam, ravi/Q-6916-2019; Daud, Adil/T-3079-2019	sachidanandam, ravi/0000-0001-9844-4459; Daud, Adil/0000-0002-6617-8421; Liu, Eric/0000-0003-2286-0856; Zhang, Li/0000-0002-3617-2627	National Cancer Institute [R01CA163012, R01CA194511, U01CA233100]; Prostate Cancer Foundation Challenge Award; AbbVie Inc.; Girihlet Inc.; NATIONAL CANCER INSTITUTE [U01CA233100, R01CA194511, R01CA223484] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation Challenge Award; AbbVie Inc.(AbbVie); Girihlet Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the UCSF Flow Cytometry Core for technical help and the NIH Tetramer Core for the generation of Spas-1 and Spas-2 tetramers. This work was supported by National Cancer Institute grants R01CA163012, R01CA194511, and U01CA233100 and a Prostate Cancer Foundation Challenge Award. This study was also supported by research funding from AbbVie Inc. and Girihlet Inc.	Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Berner V, 2007, NAT MED, V13, P354, DOI 10.1038/nm1554; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Champiat S, 2017, CLIN CANCER RES, V23, P1920, DOI 10.1158/1078-0432.CCR-16-1741; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; Gallegos AM, 2016, NAT IMMUNOL, V17, P379, DOI 10.1038/ni.3386; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Guirnalda P, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25752; Hellmann MD, 2018, CANCER CELL, V33, P843, DOI 10.1016/j.ccell.2018.03.018; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kammertoens T, 2017, NATURE, V545, P98, DOI 10.1038/nature22311; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Kwon E. D., 2014, CA184 043 INVESTIGAT; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Messenheimer DJ, 2017, CLIN CANCER RES, V23, P6165, DOI 10.1158/1078-0432.CCR-16-2677; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Petrelli F, 2015, ACTA ONCOL, V54, P961, DOI 10.3109/0284186X.2015.1043026; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Sharma A., 2018, CLIN CANC RES; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wen XS, 2010, J INTERF CYTOK RES, V30, P653, DOI 10.1089/jir.2009.0119; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1544-9	57	58	60	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					477	+		10.1016/j.immuni.2019.01.006	http://dx.doi.org/10.1016/j.immuni.2019.01.006			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30737146	Bronze, Green Accepted			2022-12-18	WOS:000459006700020
J	Schultze, JL; Mass, E; Schlitzer, A				Schultze, Joachim L.; Mass, Elvira; Schlitzer, Andreas			Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; RESIDENT CARDIAC MACROPHAGES; ACUTE MYOCARDIAL-INFARCTION; CLASSICAL DENDRITIC CELLS; LUNG-CARCINOMA TUMORS; BONE-MARROW; CLONAL HEMATOPOIESIS; SUPPRESSOR-CELLS; TISSUE MACROPHAGES; ANALYSIS REVEALS	Myelopoiesis ensures the steady state of the myeloid cell compartment. Technological advances in fate mapping and genetic engineering, as well as the advent of single cell RNA-sequencing, have highlighted the heterogeneity of the hematopoietic system and revealed new concepts in myeloid cell ontogeny. These technologies are also shedding light on mechanisms of myelopoiesis at homeostasis and at different phases of infection and inflammation, illustrating important feedback loops between affected tissues and the bone marrow. We review these findings here and revisit principles in myelopoiesis in light of the evolving understanding of myeloid cell ontogeny and heterogeneity. We argue for the importance of system-wide evaluation of changes in myelopoiesis and discuss how even after the resolution of inflammation, long-lasting alterations in myelopoiesis may play a role in innate immune memory or trained immunity.	[Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, D-53175 Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, D-53175 Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany; [Mass, Elvira] Univ Bonn, LIMES Inst, Dev Biol Innate Immune Syst, D-53115 Bonn, Germany; [Schlitzer, Andreas] Univ Bonn, LIMES Inst, Myeloid Cell Biol, D-53115 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; University of Bonn; University of Bonn	Schultze, JL (corresponding author), German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, D-53175 Bonn, Germany.; Schultze, JL (corresponding author), Univ Bonn, D-53175 Bonn, Germany.; Schultze, JL (corresponding author), Univ Bonn, LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany.; Mass, E (corresponding author), Univ Bonn, LIMES Inst, Dev Biol Innate Immune Syst, D-53115 Bonn, Germany.; Schlitzer, A (corresponding author), Univ Bonn, LIMES Inst, Myeloid Cell Biol, D-53115 Bonn, Germany.	j.schultze@uni-bonn.de; emass@uni-bonn.de; andreas.schlitzer@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020; Mass, Elvira/AAH-3805-2019	Schultze, Joachim L./0000-0003-2812-9853; Mass, Elvira/0000-0003-2318-2356	German Research Foundation [EXC1023]; European Union's Horizon 2020 research and innovation program [733100]; Fritz Thyssen Foundation; German Research Foundation (Emmy Noether research grant) [SCHL2116/1]	German Research Foundation(German Research Foundation (DFG)); European Union's Horizon 2020 research and innovation program; Fritz Thyssen Foundation; German Research Foundation (Emmy Noether research grant)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (EXC1023 ImmunoSensation to J.L.S., E.M., A.S., and an Emmy Noether research grant SCHL2116/1 to A.S. A.S. and J.L.S. are members of the DFG Excellence Cluster ImmunoSensation<SUP>2</SUP>. J.L.S. has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 733100. E.M. is supported by the Fritz Thyssen Foundation.	Al Sayed MF, 2019, CANCER RES, V79, P346, DOI 10.1158/0008-5472.CAN-17-3026; Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Alemany A, 2018, NATURE, V556, P108, DOI 10.1038/nature25969; Alvarez R, 2018, SEMIN ONCOL, V45, P84, DOI 10.1053/j.seminoncol.2018.05.001; Arora N, 2014, DEV CELL, V29, P621, DOI 10.1016/j.devcel.2014.04.013; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Avital G, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1340-x; Bain CC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00658-6; Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Basilico P, 2016, AM J RESP CELL MOL, V54, P424, DOI 10.1165/rcmb.2015-0017OC; Bassler K, 2019, ANNU REV IMMUNOL, V37, P269, DOI 10.1146/annurev-immunol-042718-041728; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bodi V, 2008, AM HEART J, V156, P1065, DOI 10.1016/j.ahj.2008.07.008; Boettcher S, 2016, CURR OPIN HEMATOL, V23, P5, DOI 10.1097/MOH.0000000000000201; Boisset JC, 2018, NAT METHODS, V15, P547, DOI 10.1038/s41592-018-0009-z; Buechler MB, 2016, J IMMUNOL, V197, P2577, DOI 10.4049/jimmunol.1600813; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Chapman TJ, 2013, J IMMUNOL METHODS, V400, P122, DOI 10.1016/j.jim.2013.10.010; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; Cornwell WD, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0664-y; Courties G, 2015, CIRC RES, V116, P407, DOI 10.1161/CIRCRESAHA.116.305207; Davis MM, 2017, NAT IMMUNOL, V18, P725, DOI 10.1038/ni.3768; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dress RJ, 2018, IMMUNOL CELL BIOL, V96, P463, DOI 10.1111/imcb.12028; Dutta P, 2016, ARTERIOSCL THROM VAS, V36, P1802, DOI 10.1161/ATVBAHA.116.307519; Dutta P, 2015, CELL STEM CELL, V16, P477, DOI 10.1016/j.stem.2015.04.008; Eguiluz-Gracia I, 2016, THORAX, V71, P1006, DOI 10.1136/thoraxjnl-2016-208292; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Garhyan J, 2015, AM J PATHOL, V185, P1924, DOI 10.1016/j.ajpath.2015.03.028; Geissmann F, 2015, SEMIN IMMUNOL, V27, P353, DOI 10.1016/j.smim.2016.03.016; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Kandalla PK, 2016, J EXP MED, V213, P2269, DOI 10.1084/jem.20151975; Kanitakis J, 2011, EXP DERMATOL, V20, P145, DOI 10.1111/j.1600-0625.2010.01146.x; Karmaus PWF, 2017, J EXP MED, V214, P2629, DOI 10.1084/jem.20161855; Kathirvel M, 2016, EPIGENOMICS-UK, V8, P537, DOI 10.2217/epi.16.1; Kato H, 2018, NAT IMMUNOL, V19, P1059, DOI 10.1038/s41590-018-0202-3; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kebschull JM, 2018, NAT METHODS, V15, P871, DOI 10.1038/s41592-018-0185-x; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kim EK, 2014, CANCER RES, V74, P6705, DOI 10.1158/0008-5472.CAN-14-1482; Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; Lund H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07295-7; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Mass E, 2018, INT IMMUNOL, V30, P493, DOI 10.1093/intimm/dxy044; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Mitroulis I, 2018, J INNATE IMMUN, V10, P365, DOI 10.1159/000489406; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nayak DK, 2016, AM J TRANSPLANT, V16, P2300, DOI 10.1111/ajt.13819; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nicaise P, 1998, SCAND J IMMUNOL, V48, P585; Norris BA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007154; OLSSON I, 1990, LEUKEMIA RES, V14, P715, DOI 10.1016/0145-2126(90)90100-N; Osorio FG, 2018, CELL REP, V25, P2308, DOI 10.1016/j.celrep.2018.11.014; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; PARWARESCH MR, 1984, CELL TISSUE KINET, V17, P25, DOI 10.1111/j.1365-2184.1984.tb00565.x; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Saelens W, 2018, BIORXIV, DOI [10.1101/276907, DOI 10.1101/276907]; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schmid MA, 2011, BLOOD, V118, P4829, DOI 10.1182/blood-2011-03-344960; Schultze JL, 2019, NAT IMMUNOL, V20, P7, DOI 10.1038/s41590-018-0277-x; Schultze JL, 2019, SEMIN CELL DEV BIOL, V86, P15, DOI 10.1016/j.semcdb.2018.02.017; Schultze JL, 2016, IMMUNITY, V44, P18, DOI 10.1016/j.immuni.2015.12.019; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; See P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02425; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Su YC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02530; Swirski FK, 2018, NAT REV IMMUNOL, V18, P733, DOI 10.1038/s41577-018-0065-8; Swirski FK, 2018, NAT REV CARDIOL, V15, P208, DOI 10.1038/nrcardio.2017.208; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tada T, 1996, CELL IMMUNOL, V173, P155, DOI 10.1006/cimm.1996.0261; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tcyganov E, 2018, CURR OPIN IMMUNOL, V51, P76, DOI 10.1016/j.coi.2018.03.009; Thomas GD, 2016, IMMUNITY, V45, P975, DOI 10.1016/j.immuni.2016.10.011; Tornack J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169119; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02345; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Weaver L. K, 2019, JCI INSIGHT, V4, P4; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Wolf D, 2015, CIRC RES, V116, P389, DOI 10.1161/CIRCRESAHA.114.305678; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; YOUNG MRI, 1992, CANCER RES, V52, P6335; YOUNG MRI, 1990, INT J CANCER, V46, P245, DOI 10.1002/ijc.2910460217; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhao JL, 2015, CURR OPIN HEMATOL, V22, P286, DOI 10.1097/MOH.0000000000000149; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	182	58	60	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					288	301		10.1016/j.immuni.2019.01.019	http://dx.doi.org/10.1016/j.immuni.2019.01.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784577	Bronze			2022-12-18	WOS:000459006700007
J	Wang, ZZ; Yin, WJ; Zhu, LZ; Li, J; Yao, YK; Chen, FF; Sun, MM; Zhang, JY; Shen, N; Song, Y; Chang, X				Wang, Zhizhang; Yin, Weijie; Zhu, Lizhen; Li, Jia; Yao, Yikun; Chen, Feifei; Sun, Mengmeng; Zhang, Jiayuan; Shen, Nan; Song, Yan; Chang, Xing			Iron Drives T Helper Cell Pathogenicity by Promoting RNA-Binding Protein PCBP1-Mediated Proinflammatory Cytokine Production	IMMUNITY			English	Article							FACTOR MESSENGER-RNA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; IN-VIVO; B-CELL; POSTTRANSCRIPTIONAL CONTROL; SELECTIVE-INHIBITION; GM-CSF; MACROPHAGE; IDENTIFICATION; INFLAMMATION	Iron deposition is frequently observed in human autoinflammatory diseases, but its functional significance is largely unknown. Here we showed that iron promoted proinflammatory cytokine expression in T cells, including GM-CSF and IL-2, via regulating the stability of an RNA-binding protein PCBP1. Iron depletion or Pcbp1 deficiency in T cells inhibited GM-CSF production by attenuating Csf2 3' untranslated region (UTR) activity and messenger RNA stability. Pcbp1 deficiency or iron uptake blockade in autoreactive T cells abolished their capacity to induce experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis. Mechanistically, intracellular iron protected PCBP1 protein from caspase-mediated proteolysis, and PCBP1 promoted messenger RNA stability of Csf2 and Il2 by recognizing UC-rich elements in the 3' UTRs. Our study suggests that iron accumulation can precipitate autoimmune diseases by promoting proinflammatory cytokine production. RNA-binding protein-mediated iron sensing may represent a simple yet effective means to adjust the inflammatory response to tissue homeostatic alterations.	[Wang, Zhizhang; Yin, Weijie; Zhu, Lizhen; Li, Jia; Yao, Yikun; Chen, Feifei; Sun, Mengmeng; Zhang, Jiayuan; Shen, Nan; Chang, Xing] SJTUSM, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Wang, Zhizhang; Yin, Weijie; Zhu, Lizhen; Li, Jia; Yao, Yikun; Chen, Feifei; Sun, Mengmeng; Zhang, Jiayuan; Shen, Nan; Chang, Xing] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Song, Yan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego	Chang, X (corresponding author), SJTUSM, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200031, Peoples R China.; Chang, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	changxing@sibs.ac.cn	Shen, Nan/AGK-6807-2022; Yao, Yikun/AAH-9197-2021	Yao, Yikun/0000-0002-8890-2409; Chang, Xing/0000-0002-5072-9225; Wang, Zhizhang/0000-0002-4699-953X	MOST [2014CB943600]; NSFC [31370858, 81671552]; SMSTC [13PJ1409300]	MOST; NSFC(National Natural Science Foundation of China (NSFC)); SMSTC	We would like to thank Drs. Yang Sun, Liang Zhang, Yanan Zhang, and Jiansheng Liu for sharing reagents and advice. This work was supported by 2014CB943600 from MOST, 31370858 and 81671552 from NSFC, and 13PJ1409300 from SMSTC.	ANDERS S, 2010, GENOME BIOL, V11; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Baker JF, 2009, RHEUMATOLOGY, V48, P1339, DOI 10.1093/rheumatology/kep221; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Campbell IK, 1998, J IMMUNOL, V161, P3639; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang X, 2015, P NATL ACAD SCI USA, V112, pE1888, DOI 10.1073/pnas.1422490112; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Cho SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071724; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; CRAELIUS W, 1982, ARCH PATHOL LAB MED, V106, P397; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Grant SM, 2003, J NUTR, V133, P2635, DOI 10.1093/jn/133.8.2635; Haider L, 2014, J NEUROL NEUROSUR PS, V85, P1386, DOI 10.1136/jnnp-2014-307712; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho JJD, 2013, MOL CELL BIOL, V33, P2029, DOI 10.1128/MCB.01257-12; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; IWAI Y, 1991, J BIOL CHEM, V266, P17959; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Ji XJ, 2013, MOL CELL BIOL, V33, P2560, DOI 10.1128/MCB.01380-12; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; KEMP JD, 1987, J IMMUNOL, V138, P2422; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; LeVine SM, 2004, ANN NY ACAD SCI, V1012, P252, DOI 10.1196/annals.1306.021; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lynch SG, 2000, CELL MOL BIOL, V46, P865; Martin M., 2011, EMBNET J, V17, P5, DOI 10.14806/ej.17.1.200; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; MUNRO HN, 1990, J CELL BIOCHEM, V44, P107, DOI 10.1002/jcb.240440205; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ned RM, 2003, BLOOD, V102, P3711, DOI 10.1182/blood-2003-04-1086; Pedchenko TV, 1998, J NEUROIMMUNOL, V84, P188, DOI 10.1016/S0165-5728(97)00256-7; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Ryu MS, 2017, J CLIN INVEST, V127, P1786, DOI 10.1172/JCI90519; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sargent PJ, 2005, CURR MED CHEM, V12, P2683, DOI 10.2174/092986705774462969; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Tani H, 2012, RNA BIOL, V9, P1233, DOI 10.4161/rna.22036; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Weigel KJ, 2014, ASN NEURO, V6, P43, DOI 10.1042/AN20130037; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhou X, 2012, CELL RES, V22, P717, DOI 10.1038/cr.2011.184	66	58	61	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					80	+		10.1016/j.immuni.2018.05.008	http://dx.doi.org/10.1016/j.immuni.2018.05.008			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958803	Bronze			2022-12-18	WOS:000438949100013
J	Cuadrado, E; van den Biggelaar, M; de Kivit, S; Chen, YY; Slot, M; Doubal, I; Meijer, A; van Lier, RAW; Borst, J; Amsen, D				Cuadrado, Eloy; van den Biggelaar, Maartje; de Kivit, Sander; Chen, Yi-yen; Slot, Manon; Doubal, Ihsane; Meijer, Alexander; van Lier, Rene A. W.; Borst, Jannie; Amsen, Derk			Proteomic Analyses of Human Regulatory T Cells Reveal Adaptations in Signaling Pathways that Protect Cellular Identity	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; SUPPRESSIVE ACTIVITY; NEGATIVE REGULATOR; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; INFLAMMATION; ACTIVATION; COMPLEX	To obtain a molecular definition of regulatory T (Treg) cell identity, we performed proteomics and transcriptomics on various populations of human regulatory and conventional CD4(+) T (Tconv) cells. A protein expression signature was identified that defines all Treg cells, and another signature that defines effector Treg cells. These signatures could not be extrapolated from transcriptome data. Unique cellbiological and metabolic features in Treg cells were defined, as well as specific adaptations in cytokine, TCR, and costimulatory receptor signaling pathways. One such adaptation-selective STAT4 deficiency-prevented destabilization of Treg cell identity and function by inflammatory cytokines, while these signals could still induce critical transcription factors and homing receptors via other pathways. Furthermore, our study revealed surface markers that identify FOXP3(+)CD4(+) T cells with distinct functional properties. Our findings suggest that adaptation in signaling pathways protect Treg cell identity and present a resource for further research into Treg cell biology.	[Cuadrado, Eloy; Slot, Manon; Doubal, Ihsane; van Lier, Rene A. W.; Amsen, Derk] Univ Amsterdam, Acad Med Ctr, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [van den Biggelaar, Maartje; Meijer, Alexander] Univ Amsterdam, Acad Med Ctr, Dept Plasma Prot, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [de Kivit, Sander; Chen, Yi-yen; Borst, Jannie] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Tumor Biol & Immunol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	Cuadrado, E; Amsen, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	eloycua@gmail.com; d.amsen@sanquin.nl	de Kivit, Sander/AAQ-3038-2021	de Kivit, Sander/0000-0003-0148-7802; Borst, Jannie/0000-0002-8043-5009	ZonMW-TOP grant [40-00812-98-13071]; Institute for Chemical Immunology [ICI-00014]; LSBR (Landsteiner Foundation for Blood Transfusion Research) [1430]	ZonMW-TOP grant; Institute for Chemical Immunology; LSBR (Landsteiner Foundation for Blood Transfusion Research)	We thank Jelle ten Hoeve and Ran Elkon for assistance with bioinformatics, Evert de Vries for help with biochemistry, Floris van Alphen for help in processing MS samples, Simon Tol and Erik Mul for help with FACS sorting, and Celia Berkers for insightful discussions. This work was supported by a ZonMW-TOP grant 40-00812-98-13071 to R.A.W.v.L. and J.B., grant ICI-00014 from the Institute for Chemical Immunology to J.B., and grant 1430 from the LSBR (Landsteiner Foundation for Blood Transfusion Research) to D.A.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Campbell DJ, 2015, J IMMUNOL, V195, P2507, DOI 10.4049/jimmunol.1500801; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Gao YY, 2015, P NATL ACAD SCI USA, V112, pE3246, DOI 10.1073/pnas.1421463112; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hwang SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10789; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Li P, 2014, IMMUNOL REV, V261, P141, DOI 10.1111/imr.12199; Li XD, 2015, TRENDS IMMUNOL, V36, P344, DOI 10.1016/j.it.2015.04.006; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Overacre-Delgoffe AE, 2017, CELL, V169; Pandiyan P, 2015, CYTOKINE, V76, P13, DOI 10.1016/j.cyto.2015.07.005; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Pellerin L, 2014, IMMUNOL RES, V58, P358, DOI 10.1007/s12026-014-8512-5; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Rogge L, 1998, J IMMUNOL, V161, P6567; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan TG, 2016, P NATL ACAD SCI USA, V113, P14103, DOI 10.1073/pnas.1616710113; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15876; Xiao X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9266; Xu JN, 2011, J IMMUNOL, V186, P6597, DOI 10.4049/jimmunol.1004074; Yan DP, 2015, P NATL ACAD SCI USA, V112, P14942, DOI 10.1073/pnas.1520393112; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zaragoza B, 2016, NAT MED, V22, P16, DOI 10.1038/nm.4019; Zhuo CH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-153	72	58	58	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					1046	+		10.1016/j.immuni.2018.04.008	http://dx.doi.org/10.1016/j.immuni.2018.04.008			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29752063	Bronze			2022-12-18	WOS:000432488600022
J	Grajkowska, LT; Ceribelli, M; Lau, CM; Warren, ME; Tiniakou, I; Higa, SN; Bunin, A; Haecker, H; Mimy, LA; Staudt, LM; Reizis, B				Grajkowska, Lucja T.; Ceribelli, Michele; Lau, Colleen M.; Warren, Margaret E.; Tiniakou, Ioanna; Higa, Sandra Nakandakari; Bunin, Anna; Haecker, Hans; Mimy, Leonid A.; Staudt, Louis M.; Reizis, Boris			Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification	IMMUNITY			English	Article							TRANSCRIPTION FACTOR E2-2; GERMINAL CENTER; CLONOGENIC PROGENITOR; REPRESSING ID2; STEADY-STATE; B-CELL; SUBSETS; CD8-ALPHA(+); MAINTAINS; ONTOGENY	The cell fate decision between interferon-producing plasmacytoid DC (pDC) and antigen-presenting classicalDC( cDC) is controlled by the E protein transcription factor TCF4 (E2-2). We report that TCF4 comprises two transcriptional isoforms, both of which are required for optimal pDC development in vitro. The long Tcf4 isoform is expressed specifically in pDCs, and its deletion in mice impaired pDCs development and led to the expansion of non-canonical CD8 + cDCs. The expression of Tcf4 commenced in progenitors and was further upregulated in pDCs, correlating with stage-specific activity of multiple enhancer elements. A conserved enhancer downstream of Tcf4 was required for its upregulation during pDC differentiation, revealing a positive feedback loop. The expression of Tcf4 and the resulting pDC differentiation were selectively sensitive to the inhibition of enhancer-binding BET protein activity. Thus, lineage-specifying function of E proteins is facilitated by lineage-specific isoform expression and by BET-dependent feedback regulation through distal regulatory elements.	[Grajkowska, Lucja T.; Lau, Colleen M.; Warren, Margaret E.; Tiniakou, Ioanna; Higa, Sandra Nakandakari; Reizis, Boris] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; [Grajkowska, Lucja T.; Bunin, Anna; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Ceribelli, Michele; Staudt, Louis M.] NCI, Lymphoid Malignancies Branch, NIH, Bethesda, MD 20892 USA; [Ceribelli, Michele] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Warren, Margaret E.] Columbia Univ, Med Ctr, Grad Program Genet & Dev, New York, NY 10032 USA; [Haecker, Hans] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Mimy, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Reizis, Boris] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	New York University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Columbia University; St Jude Children's Research Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Reizis, B (corresponding author), NYU, Dept Pathol, Sch Med, New York, NY 10016 USA.; Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	boris.reizis@nyumc.org	Mirny, Leonid/ABE-8083-2020; Staudt, Louis/AAC-5324-2019	Mirny, Leonid/0000-0002-0785-5410; Reizis, Boris/0000-0003-1140-7853; Tiniakou, Ioanna/0000-0002-8429-7045	NIH [AI072571, AI100853, AI124661]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI124661, R01AI072571, T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224, T32GM007088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kellner for help with cloning sgRNA constructs, N. De Silva and N. Heise for advice, and Y. Zhuang for the Id2 reporter strain. Supported by the NIH grants AI072571 (B.R.), AI100853 (C.M.L.), and AI124661 (M.E.W.).	Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Braunstein M, 2010, EUR J IMMUNOL, V40, P3173, DOI 10.1002/eji.201040360; Ceribelli M, 2016, CANCER CELL, V30, P764, DOI 10.1016/j.ccell.2016.10.002; Chen WY, 2013, GENE DEV, V27, P1596, DOI 10.1101/gad.216192.113; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gloury R, 2016, J EXP MED, V213, P1095, DOI 10.1084/jem.20152003; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Ippolito GC, 2014, P NATL ACAD SCI USA, V111, pE998, DOI 10.1073/pnas.1319228111; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Kamogawa-Schifter Y, 2005, BLOOD, V105, P2787, DOI 10.1182/blood-2004-09-3388; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lau CM, 2016, J EXP MED, V213, P415, DOI 10.1084/jem.20150642; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Omilusik KD, 2013, CURR OPIN IMMUNOL, V25, P660, DOI 10.1016/j.coi.2013.09.004; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/NMETH.2510, 10.1038/nmeth.2510]; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Schraml BU, 2015, CURR OPIN IMMUNOL, V32, P13, DOI 10.1016/j.coi.2014.11.001; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Sepp M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022138; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shortman K, 2013, ADV IMMUNOL, V120, P105, DOI 10.1016/B978-0-12-417028-5.00004-1; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Toyama-Sorimachi N, 2005, J IMMUNOL, V174, P4621, DOI 10.4049/jimmunol.174.8.4621; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang DC, 2010, J IMMUNOL, V185, P4109, DOI 10.4049/jimmunol.0901783; Wohner M, 2016, J EXP MED, V213, P1201, DOI 10.1084/jem.20152002	50	58	58	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					65	77		10.1016/j.immuni.2016.11.006	http://dx.doi.org/10.1016/j.immuni.2016.11.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	27986456	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000392918300011
J	Gieseck, RL; Ramalingam, TR; Hart, KM; Vannella, KM; Cantu, DA; Lu, WY; Ferreira-Gonzalez, S; Forbes, SJ; Vallier, L; Wynn, TA				Gieseck, Richard L., III; Ramalingam, Thirumalai R.; Hart, Kevin M.; Vannella, Kevin M.; Cantu, David A.; Lu, Wei-Yu; Ferreira-Gonzalez, Sofia; Forbes, Stuart J.; Vallier, Ludovic; Wynn, Thomas A.			Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis	IMMUNITY			English	Article							SEVERE ATOPIC-DERMATITIS; HEPATIC STELLATE CELLS; STEM-CELLS; EPITHELIAL INJURY; PROGENITOR CELLS; GROWTH-FACTOR; DOUBLE-BLIND; LIVER; IL-13; MICE	Fibroproliferative diseases are driven by dysregulated tissue repair responses and are a major cause of morbidity and mortality because they affect nearly every organ system. Type 2 cytokine responses are critically involved in tissue repair; however, the mechanisms that regulate beneficial regeneration versus pathological fibrosis are not well understood. Here, we have shown that the type 2 effector cytokine interleukin-13 simultaneously, yet independently, directed hepatic fibrosis and the compensatory proliferation of hepatocytes and biliary cells in progressive models of liver disease induced by interleukin-13 overexpression or after infection with Schistosoma mansoni. Using transgenic mice with interleukin-13 signaling genetically disrupted in hepatocytes, cholangiocytes, or resident tissue fibroblasts, we have revealed direct and distinct roles for interleukin-13 in fibrosis, steatosis, cholestasis, and ductular reaction. Together, these studies show that these mechanisms are simultaneously controlled but distinctly regulated by interleukin-13 signaling. Thus, it may be possible to promote interleukin-13-dependent hepatobiliary expansion without generating pathological fibrosis.	[Gieseck, Richard L., III; Ramalingam, Thirumalai R.; Hart, Kevin M.; Vannella, Kevin M.; Cantu, David A.; Wynn, Thomas A.] NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20852 USA; [Gieseck, Richard L., III; Vallier, Ludovic] Univ Cambridge, Dept Surg, Anne McLaren Lab, MRC,Wellcome Trust,Stem Cell Inst, Cambridge CB2 0SZ, England; [Lu, Wei-Yu; Ferreira-Gonzalez, Sofia; Forbes, Stuart J.] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge; Wellcome Trust Sanger Institute; University of Edinburgh; Wellcome Trust Sanger Institute	Wynn, TA (corresponding author), NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20852 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021; Ferreira-Gonzalez, Sofia/AAL-9189-2021; Lu, Wei-Yu/N-5884-2019	Wynn, Thomas A/0000-0002-7244-8731; Ferreira-Gonzalez, Sofia/0000-0001-7776-287X; Lu, Wei-Yu/0000-0002-0419-0257; Vallier, Ludovic/0000-0002-3848-2602; Forbes, Stuart/0000-0003-3715-2561; Gieseck, Richard/0000-0003-0200-581X	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Disease; ERC; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; UKRMP Hub; Medical Research Council; MRC [MR/K026666/1, MR/K017047/1] Funding Source: UKRI; Medical Research Council [MC_PC_12009, MR/K026666/1, MR/K017047/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019, ZIAAI000829] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Disease; ERC(European Research Council (ERC)European Commission); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; UKRMP Hub; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Disease. L.V. is funded by the ERC starting grant Relieve IMDs and the Cambridge Hospitals National Institute for Health Research Biomedical Research Center. S.J.F. is funded by the UKRMP Hub and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Frank Brombacher for sharing the IL-4R alpha-floxed mice.	Alison MR, 2005, CELL PROLIFERAT, V38, P407, DOI 10.1111/j.1365-2184.2005.00354.x; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Borthwick LA, 2016, MUCOSAL IMMUNOL, V9, P38, DOI 10.1038/mi.2015.34; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Chandriani S, 2014, J IMMUNOL, V193, P111, DOI 10.4049/jimmunol.1301761; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Danese S, 2015, GUT, V64, P243, DOI 10.1136/gutjnl-2014-308004; FARBER E, 1956, CANCER RES, V16, P142; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Hamilton JD, 2014, J ALLERGY CLIN IMMUN, V134, P1293, DOI 10.1016/j.jaci.2014.10.013; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Jors S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585; Karimian N, 2013, J HEPATOL, V58, P1065, DOI 10.1016/j.jhep.2013.02.023; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Landi A, 2014, J INTERF CYTOK RES, V34, P204, DOI 10.1089/jir.2013.0075; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Li J, 2011, J CLIN INVEST, V121, P4244, DOI 10.1172/JCI57728; Lin J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655353; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Metwally Shereen S, 2004, Egypt J Immunol, V11, P171; Murray LA, 2014, AM J RESP CELL MOL, V50, P985, DOI 10.1165/rcmb.2013-0342OC; Park YN, 2007, CANCER-AM CANCER SOC, V109, P915, DOI 10.1002/cncr.22460; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Scheerens H, 2014, CLIN EXP ALLERGY, V44, P38, DOI 10.1111/cea.12220; Shimamura T, 2008, J IMMUNOL, V181, P4656, DOI 10.4049/jimmunol.181.7.4656; Sorrentino P, 2010, J GASTROENTEROL, V45, P1053, DOI 10.1007/s00535-010-0249-x; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003	53	58	61	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					145	158		10.1016/j.immuni.2016.06.009	http://dx.doi.org/10.1016/j.immuni.2016.06.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27421703	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000380749000017
J	Komarowska, I; Coe, D; Wang, GS; Haas, R; Mauro, C; Kishore, M; Cooper, D; Nadkarni, S; Fu, HM; Steinbruchel, DA; Pitzalis, C; Anderson, G; Bucy, P; Lombardi, G; Breckenridge, R; Marelli-Berg, FM				Komarowska, Izabela; Coe, David; Wang, Guosu; Haas, Robert; Mauro, Claudio; Kishore, Madhav; Cooper, Dianne; Nadkarni, Suchita; Fu, Hongmei; Steinbruchel, Daniel A.; Pitzalis, Costantino; Anderson, Graham; Bucy, Pat; Lombardi, Giovanna; Breckenridge, Ross; Marelli-Berg, Federica M.			Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release	IMMUNITY			English	Article							DENDRITIC CELLS; IN-VIVO; REJECTION; LYMPHOCYTES; ACTIVATION; EXPRESSION; MODEL; MICE; REGENERATION; RECRUITMENT	Effector-T-cell-mediated immunity depends on the efficient localization of antigen-primed lymphocytes to antigen-rich non-lymphoid tissue, which is facilitated by the expression of a unique set of "homing'' receptors acquired by memory T cells. We report that engagement of the hepatocyte growth factor (HGF) receptor c-Met by heart-produced HGF during priming in the lymph nodes instructs T cell cardiotropism, which was associated with a specialized homing "`signature'' (c-Met(+)CCR4(+)CXCR3(+)). c-Met signals facilitated T cell recruitment to the heart via the chemokine receptor CCR5 by inducing autocrine CCR5 ligand release. c-Met triggering was sufficient to support cardiotropic T cell recirculation, while CCR4 and CXCR3 sustained recruitment during heart inflammation. Transient pharmacological blockade of c-Met during T cell priming led to enhanced survival of heart, but not skin, allografts associated with impaired localization of alloreactive T cells to heart grafts. These findings suggest c-Met as a target for development of organ-selective immunosuppressive therapies.	[Komarowska, Izabela; Coe, David; Wang, Guosu; Haas, Robert; Mauro, Claudio; Kishore, Madhav; Cooper, Dianne; Nadkarni, Suchita; Fu, Hongmei; Pitzalis, Costantino; Marelli-Berg, Federica M.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Steinbruchel, Daniel A.] Copenhagen Univ Hosp, Dept Thorac Surg, DK-2100 Copenhagen, Denmark; [Anderson, Graham] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Bucy, Pat] Univ Alabama Birmingham, Birmingham, AL 35233 USA; [Lombardi, Giovanna] Kings Coll London, MRC, Ctr Transplantat, London SE1 1UL, England; [Breckenridge, Ross] UCL, Div Med, BHF Labs, London WC1E 6JJ, England	University of London; Queen Mary University London; University of Copenhagen; University of Birmingham; University of Alabama System; University of Alabama Birmingham; University of London; King's College London; University of London; University College London	Marelli-Berg, FM (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	f.marelli-berg@qmul.ac.uk	Mauro, Claudio/AAN-1848-2021	Mauro, Claudio/0000-0002-3736-0099; Coe, David/0000-0001-8167-600X; Haas, Robert/0000-0003-4826-2379; Pitzalis, Costantino/0000-0003-1326-5051; anderson, graham/0000-0002-2917-4085	British Heart Foundation [RG/09/002/2642]; Medical Research Council of UK [G0901084]; Wellcome Trust [101604/Z/13/Z]; National Institute of Health Research; MRC [G1000213, G0901084, G0800648] Funding Source: UKRI; British Heart Foundation [RG/14/2/30616, PG/14/84/31136, FS/12/38/29640, RG/09/002/26425] Funding Source: researchfish; Medical Research Council [1263270, G0901084, G1000213, G0800648, MR/J006742/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council of UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Andrew McKenzie for generously providing the CCR4KO mice and to Mauro Perretti for critical review of the manuscript. This study was funded by the British Heart Foundation (RG/09/002/2642 to F.M.M.-B.) and the Medical Research Council of the UK (G0901084 to F.M.M.-B.). ImageStream X was funded by the Wellcome Trust (101604/Z/13/Z). This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research.	ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Garrood T, 2009, RHEUMATOLOGY, V48, P926, DOI 10.1093/rheumatology/kep117; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hartmann G, 1998, CURR BIOL, V8, P125, DOI 10.1016/S0960-9822(98)70059-4; Honjo K, 2004, AM J TRANSPLANT, V4, P1762, DOI 10.1046/j.1600-6143.2004.00596.x; Huser N, 2005, EUR J IMMUNOL, V35, P128, DOI 10.1002/eji.200324745; Kaibori M, 2006, J SURG RES, V130, P88, DOI 10.1016/j.jss.2005.09.025; Khabbazi S, 2013, CELL BIOCHEM FUNCT, V31, P312, DOI 10.1002/cbf.2901; Kitamura K, 1998, BIOCHEM BIOPH RES CO, V244, P551, DOI 10.1006/bbrc.1998.8310; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Matsuda-Hashii Y, 2004, EXP HEMATOL, V32, P955, DOI 10.1016/j.exphem.2004.06.012; McCully ML, 2012, BLOOD, V120, P4591, DOI 10.1182/blood-2012-05-433037; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Okada Y, 1998, BONE, V22, P361, DOI 10.1016/S8756-3282(97)00296-2; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Rodig SJ, 2010, CURR OPIN INVEST DR, V11, P1477; Santiago B, 2012, ARTHRITIS RHEUM-US, V64, P409, DOI 10.1002/art.33345; Schnickel GT, 2008, J IMMUNOL, V180, P4714, DOI 10.4049/jimmunol.180.7.4714; Sebastiani S, 2005, EUR J IMMUNOL, V35, P746, DOI 10.1002/eji.200525800; Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961; Tanaka Y, 1998, CANCER RES, V58, P4138; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; Tu HJ, 2009, ONKOLOGIE, V32, P331, DOI 10.1159/000216352; Vischer HF, 2011, BRIT J PHARMACOL, V163, P246, DOI 10.1111/j.1476-5381.2011.01229.x; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	34	58	60	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1087	1099		10.1016/j.immuni.2015.05.014	http://dx.doi.org/10.1016/j.immuni.2015.05.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26070483	Green Published, hybrid			2022-12-18	WOS:000356362800014
J	Vrisekoop, N; Monteiro, JP; Mandl, JN; Germain, RN				Vrisekoop, Nienke; Monteiro, Joao P.; Mandl, Judith N.; Germain, Ronald N.			Revisiting Thymic Positive Selection and the Mature T Cell Repertoire for Antigen	IMMUNITY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; NEGATIVE SELECTION; CROSS-REACTIVITY; RECEPTOR REPERTOIRE; MHC RESTRICTION; MOLECULAR-BASIS; GERMLINE BIAS; HIGH-AFFINITY; NAIVE CD4(+); CLASS-I	To support effective host defense, the T cell repertoire must balance breadth of recognition with sensitivity for antigen. The concept that T lymphocytes are positively selected in the thymus is well established, but how this selection achieves such a repertoire has not been resolved. Here we suggest that it is direct linkage between self and foreign antigen recognition that produces the necessary blend of TCR diversity and specificity in the mature peripheral repertoire, enabling responses to a broad universe of unpredictable antigens while maintaining an adequate number of highly sensitive T cells in a population of limited size. Our analysis also helps to explain how diversity and frequency of antigen-reactive cells in a T cell repertoire are adjusted in animals of vastly different size scale to enable effective antipathogen responses and suggests a possible binary architecture in the TCR repertoire that is divided between germline-related optimal binding and diverse recognition.	[Vrisekoop, Nienke] Univ Med Ctr Utrecht, Dept Resp Med, Lab Translat Immunol, NL-3584 CT Utrecht, Netherlands; [Monteiro, Joao P.; Mandl, Judith N.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	Utrecht University; Utrecht University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mandl, JN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	mandlj@niaid.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020		Intramural Research Program of NIAID at the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000403] Funding Source: NIH RePORTER	Intramural Research Program of NIAID at the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to D. van Baarle, C. Kesmir, K. Hogquist, and N. Singh for reading earlier versions of this manuscript and providing critical feedback. We would also like to thank J. Textor for immensely valuable discussions. This work was supported by the Intramural Research Program of NIAID at the NIH.	ALLISON JP, 1982, J IMMUNOL, V129, P2293; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borghans JAM, 1998, IMMUNOL TODAY, V19, P428, DOI 10.1016/S0167-5699(98)01317-6; Boyton RJ, 2002, TRENDS IMMUNOL, V23, P526, DOI 10.1016/S1471-4906(02)02319-0; Boyton RJ, 2002, J IMMUNOL, V168, P1018, DOI 10.4049/jimmunol.168.3.1018; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cabaniols JP, 2001, J EXP MED, V194, P1385, DOI 10.1084/jem.194.9.1385; Calis JJA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002412; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Corse E, 2011, J IMMUNOL, V186, P5039, DOI 10.4049/jimmunol.1003650; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Detours V, 2000, J IMMUNOL, V164, P121, DOI 10.4049/jimmunol.164.1.121; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Edwards LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00086; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; FORSDYKE DR, 1975, J THEOR BIOL, V52, P187, DOI 10.1016/0022-5193(75)90050-8; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; GILFILLAN S, 1995, EUR J IMMUNOL, V25, P3115, DOI 10.1002/eji.1830251119; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Hemmer B, 1998, IMMUNOL TODAY, V19, P163, DOI 10.1016/S0167-5699(97)01217-6; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; KAPPLER J, 1983, CELL, V35, P295, DOI 10.1016/0092-8674(83)90232-5; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; Kim C, 2013, IMMUNITY, V39, P508, DOI 10.1016/j.immuni.2013.08.033; Knudson KM, 2013, CELL REP, V4, P554, DOI 10.1016/j.celrep.2013.07.008; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; LANGMAN RE, 1987, MOL IMMUNOL, V24, P675, DOI 10.1016/0161-5890(87)90050-2; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Lucas B, 1996, CURR BIOL, V6, P783, DOI 10.1016/S0960-9822(02)00594-8; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Martin B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3209; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Murugan A, 2012, P NATL ACAD SCI USA, V109, P16161, DOI 10.1073/pnas.1212755109; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Piepenbrink KH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2948; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Scott-Browne JP, 2011, IMMUNITY, V35, P526, DOI 10.1016/j.immuni.2011.09.005; Sim BC, 1998, IMMUNOL TODAY, V19, P276, DOI 10.1016/S0167-5699(98)01257-2; Singh NJ, 2012, IMMUNITY, V37, P735, DOI 10.1016/j.immuni.2012.08.008; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Viret C, 2011, J EXP MED, V208, P3, DOI 10.1084/jem.20100027; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wiegel FW, 2004, IMMUNOL CELL BIOL, V82, P127, DOI 10.1046/j.0818-9641.2004.01229.x; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; Yassai M, 2000, J IMMUNOL, V165, P3706, DOI 10.4049/jimmunol.165.7.3706; Yassai M, 2002, J IMMUNOL, V168, P3801, DOI 10.4049/jimmunol.168.8.3801; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Zarnitsyna VI, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00485; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; ZINKERNAGEL RM, 1978, NATURE, V271, P251, DOI 10.1038/271251a0	108	58	58	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					181	190		10.1016/j.immuni.2014.07.007	http://dx.doi.org/10.1016/j.immuni.2014.07.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148022	Green Accepted, Bronze			2022-12-18	WOS:000341455300007
J	Puhar, A; Tronchere, H; Payrastre, B; Nhieu, GTV; Sansonetti, PJ				Puhar, Andrea; Tronchere, Helene; Payrastre, Bernard; Guy Tran Van Nhieu; Sansonetti, Philippe J.			A Shigella Effector Dampens Inflammation by Regulating Epithelial Release of Danger Signal ATP through Production of the Lipid Mediator PtdIns5P	IMMUNITY			English	Article							GAP-JUNCTION CHANNELS; CONNEXIN HEMICHANNELS; EXTRACELLULAR ATP; HELA-CELLS; FLEXNERI; SECRETION; PROTEIN; IPGD; ACTIVATION; RECEPTORS	Upon infection with Shigella flexneri, epithelial cells release ATP through connexin hemichannels. However, the pathophysiological consequence and the regulation of this process are unclear. Here we showed that in intestinal epithelial cell ATP release was an early alert response to infection with enteric pathogens that eventually promoted inflammation of the gut. Shigella evolved to escape this inflammatory reaction by its type III secretion effector IpgD, which blocked hemichannels via the production of the lipid PtdIns5P. Infection with an ipgD mutant resulted in rapid hemichannel-dependent accumulation of extracellular ATP in vitro and in vivo, which preceded the onset of inflammation. At later stages of infection, ipgD-deficient Shigella caused strong intestinal inflammation owing to extracellular ATP. We therefore describe a new paradigm of host-pathogen interaction based on endogenous danger signaling and identify extracellular ATP as key regulator of mucosal inflammation during infection. Our data provide new angles of attack for the development of anti-inflammatory molecules.	[Puhar, Andrea; Sansonetti, Philippe J.] Inserm U786, F-75724 Paris 15, France; [Puhar, Andrea; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; [Tronchere, Helene; Payrastre, Bernard] Inserm U1048, F-31432 Toulouse 4, France; [Tronchere, Helene; Payrastre, Bernard] Univ Toulouse 3, I2MC, F-31432 Toulouse 4, France; [Payrastre, Bernard] CHU Toulouse, Hematol Lab, F-31432 Toulouse 4, France; [Guy Tran Van Nhieu] Inserm U1050, F-75231 Paris 5, France; [Guy Tran Van Nhieu] CNRS UMR7241, F-75231 Paris 5, France; [Guy Tran Van Nhieu] CIRB, Equipe Commun Intercellulaire & Infect Microbienn, Coll France, F-75231 Paris 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Puhar, A (corresponding author), Inserm U786, F-75724 Paris 15, France.	andrea.puhar@pasteur.fr; philippe.sansonetti@pasteur.fr	TRONCHERE, Helene/M-5631-2014; Payrastre, Bernard/M-5295-2014; Van Nhieu, Guy Tran/Y-6359-2018	Van Nhieu, Guy Tran/0000-0002-3901-2186; , Bernard/0000-0002-8693-0190; Puhar, Andrea/0000-0002-9915-002X	EMBO Long-Term Fellowship; EMBO Marie Curie Intra-European Fellowship; ANR [2010 MIDI 007 01]; ERC Advanced Grant HOMEOEPITH	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); EMBO Marie Curie Intra-European Fellowship; ANR(French National Research Agency (ANR)); ERC Advanced Grant HOMEOEPITH	We thank Huot Khun for suggestions concerning histology, Pamela Schnupf for sharing RT-PCR primers, and PMM members for critical reading. A. P. thanks Cesare Montecucco for introducing her to lipids. A. P. performed and analyzed all experiments, except PtdIns5P mass assays and in vivo infections, which were carried out with the help of H. T. and P.J.S., respectively. B. P. contributed tools and discussion. A. P., G.T.V.N., and P.J.S. designed research. A. P. wrote the manuscript. All authors corrected and approved the manuscript. A. P. was a recipient of subsequent EMBO Long-Term and Marie Curie Intra-European Fellowships. P.J.S. is an HHMI Investigator. This project was supported by ANR grant 2010 MIDI 007 01 to A. P. and P.J.S. and ERC Advanced Grant HOMEOEPITH to P.J.S.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36; Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; ALLAOUI A, 1992, MOL MICROBIOL, V6, P1605, DOI 10.1111/j.1365-2958.1992.tb00885.x; ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; ALLAOUI A, 1993, INFECT IMMUN, V61, P1707, DOI 10.1128/IAI.61.5.1707-1714.1993; Arondel J, 1999, INFECT IMMUN, V67, P6056, DOI 10.1128/IAI.67.11.6056-6066.1999; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Clair C, 2008, EXP CELL RES, V314, P1250, DOI 10.1016/j.yexcr.2007.12.021; CLERC P, 1987, INFECT IMMUN, V55, P2681, DOI 10.1128/IAI.55.11.2681-2688.1987; Coronas S, 2007, BIOCHEM SOC SYMP, V74, P117, DOI 10.1042/BSS2007c11; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Humphreys D, 2009, CELL HOST MICROBE, V5, P225, DOI 10.1016/j.chom.2009.01.010; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jun HK, 2012, IMMUNITY, V36, P755, DOI 10.1016/j.immuni.2012.05.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keune WJ, 2011, ADV ENZYME REGUL, V51, P91, DOI 10.1016/j.advenzreg.2010.09.009; Konradt C, 2011, CELL HOST MICROBE, V9, P263, DOI 10.1016/j.chom.2011.03.010; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Pettengill MA, 2012, INFECT IMMUN, V80, P4232, DOI 10.1128/IAI.00441-12; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Ramel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001619; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Robertson J, 2010, BIOCHEM J, V432, P133, DOI 10.1042/BJ20091753; Romero S, 2011, CELL HOST MICROBE, V9, P508, DOI 10.1016/j.chom.2011.05.005; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Save S, 2010, INFECT IMMUN, V78, P3609, DOI 10.1128/IAI.00074-10; Schnupf P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036446; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	51	58	59	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1121	1131		10.1016/j.immuni.2013.11.013	http://dx.doi.org/10.1016/j.immuni.2013.11.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332032	Bronze			2022-12-18	WOS:000330951000017
J	Zou, J; Kawai, T; Tsuchida, T; Kozaki, T; Tanaka, H; Shin, KS; Kumar, H; Akira, S				Zou, Jian; Kawai, Taro; Tsuchida, Tetsuo; Kozaki, Tatsuya; Tanaka, Hiroki; Shin, Kyung-Sue; Kumar, Himanshu; Akira, Shizuo			Poly IC Triggers a Cathepsin D- and IPS-1-Dependent Pathway to Enhance Cytokine Production and Mediate Dendritic Cell Necroptosis	IMMUNITY			English	Article							INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; POLYINOSINIC-POLYCYTIDYLIC ACID; MOBILITY GROUP BOX-1; PROGRAMMED NECROSIS; NALP3 INFLAMMASOME; TYROSINE KINASE; DEATH PATHWAYS; CASPASE-8	RIG-I-like receptors (RLRs) sense virus-derived RNA or polyinosinic-polycytidylic acid (poly IC) to exert antiviral immune responses. Here, we examine the mechanisms underlying the adjuvant effects of poly IC. Poly IC was taken up by dendritic cells (DCs), and it induced lysosomal destabilization, which, in turn, activated an RLR-dependent signaling pathway. Upon poly IC stimulation, cathepsin D was released into the cytoplasm from the lysosome to interact with IPS-1, an adaptor molecule for RLRs. This interaction facilitated cathepsin D cleavage of caspase 8 and the activation of the transcription factor NF-kappa B, resulting in enhanced cytokine production. Further recruitment of the kinase RIP-1 to this complex initiated the necroptosis of a small number of DCs. HMGB1 released by dying cells enhanced IFN-beta production in concert with poly IC. Collectively, these findings suggest that cathepsin D-triggered, IPS-1-dependent necroptosis is a mechanism that propagates the adjuvant efficacy of poly IC.	[Zou, Jian; Kawai, Taro; Tsuchida, Tetsuo; Kozaki, Tatsuya; Tanaka, Hiroki; Shin, Kyung-Sue; Kumar, Himanshu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka 5650871, Japan; [Zou, Jian; Kawai, Taro; Tsuchida, Tetsuo; Kozaki, Tatsuya; Tanaka, Hiroki; Shin, Kyung-Sue; Kumar, Himanshu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; [Tsuchida, Tetsuo] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 9909585, Japan; [Shin, Kyung-Sue] Jeju Natl Univ, Sch Med, Dept Pediat, Cheju 690756, South Korea; [Kumar, Himanshu] Indian Inst Sci Educ & Res, Dept Biol Sci, Immunol Lab, Bhopal 460023, India	Osaka University; Osaka University; Yamagata University; Jeju National University; Indian Institute of Science Education & Research (IISER) - Bhopal	Kawai, T (corresponding author), Nara Inst Sci & Technol, NAIST, Grad Sch Biol Sci, Lab Mol Immunobiol, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	tkawai@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Kumar, Himanshu/J-4494-2012	Kumar, Himanshu/0000-0001-5246-2694; Kawai, Taro/0000-0001-7510-4662	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science;  [23689030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Kamada and M. Kageyama for secretarial assistance and C. Funamoto and M. Nishino for technical assistance. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and a Grant-in-Aid for Young Scientists (A) (23689030).	Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Conus S, 2012, J BIOL CHEM, V287, P21142, DOI 10.1074/jbc.M111.306399; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Creasy BM, 2011, CELL IMMUNOL, V267, P56, DOI 10.1016/j.cellimm.2010.11.004; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Jiang WW, 2007, J IMMUNOL, V178, P6495, DOI 10.4049/jimmunol.178.10.6495; Jiang WW, 2006, J IMMUNOL, V177, P3337, DOI 10.4049/jimmunol.177.5.3337; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rintahaka J, 2011, J IMMUNOL, V186, P3085, DOI 10.4049/jimmunol.1002051; Roth S, 2011, IMMUNITY, V34, P283, DOI 10.1016/j.immuni.2011.03.011; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tohyama Y, 2009, J BIOCHEM, V145, P267, DOI 10.1093/jb/mvp001; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Watanabe A, 2011, J BIOL CHEM, V286, P10702, DOI 10.1074/jbc.M110.185793; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yatim N, 2011, IMMUNITY, V35, P478, DOI 10.1016/j.immuni.2011.10.010; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001	67	58	60	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					717	728		10.1016/j.immuni.2012.12.007	http://dx.doi.org/10.1016/j.immuni.2012.12.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601685	Bronze			2022-12-18	WOS:000330942100014
J	Husebye, ES; Anderson, MS				Husebye, Eystein S.; Anderson, Mark S.			Autoimmune Polyendocrine Syndromes: Clues to Type 1 Diabetes Pathogenesis	IMMUNITY			English	Review							REGULATORY T-CELLS; CANDIDIASIS-ECTODERMAL DYSTROPHY; X-LINKED SYNDROME; THYMIC EPITHELIAL-CELLS; SYNDROME TYPE-I; CHRONIC MUCOCUTANEOUS CANDIDIASIS; DEFECTIVE SUPPRESSOR FUNCTION; BONE-MARROW-TRANSPLANTATION; IMMUNE DYSREGULATION; ADDISONS-DISEASE	Autoimmune diseases such as type 1 diabetes are complex in their pathogenesis. One approach to improving our understanding of type 1 diabetes is the study of diseases that represent more extreme examples of autoimmunity. Autoimmune polyendocrine syndromes (APS) are relatively rare diseases that often include type 1 diabetes as part of the disease phenotype. Recently, there has been tremendous progress in unraveling some of the underlying mechanisms of APS. Here, we highlight the APS disorders with the perspective of the clues they can offer to the pathogenesis and treatment of type 1 diabetes.	[Husebye, Eystein S.] Univ Bergen, Inst Med, N-5021 Bergen, Norway; [Husebye, Eystein S.] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of Bergen; University of Bergen; Haukeland University Hospital; University of California System; University of California San Francisco	Husebye, ES (corresponding author), Univ Bergen, Inst Med, N-5021 Bergen, Norway.				National Institutes of Health; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; Helmsley Foundation; NATIONAL EYE INSTITUTE [R01EY016408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Helmsley Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank U Fan for her help with the figure M S A is supported by the National Institutes of Health, the Burroughs Wellcome Fund, the Juvenile Diabetes Research Foundation, and the Helmsley Foundation	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Adamson KA, 2007, INT J IMMUNOGENET, V34, P17, DOI 10.1111/j.1744-313X.2006.00643.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Alimohammadi M, 2008, NEW ENGL J MED, V358, P1018, DOI 10.1056/NEJMoa0706487; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Anderson MS, 2008, J CLIN ENDOCR METAB, V93, P3663, DOI 10.1210/jc.2008-1251; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, CURR OPIN IMMUNOL, V14, P760, DOI 10.1016/S0952-7915(02)00405-3; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Barker JM, 2006, J CLIN ENDOCR METAB, V91, P1210, DOI 10.1210/jc.2005-1679; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bratland E, 2009, J CLIN ENDOCR METAB, V94, P5117, DOI 10.1210/jc.2009-1115; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; De Benedetti F, 2006, CLIN GASTROENTEROL H, V4, P653, DOI 10.1016/j.cgh.2005.12.014; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Di Nunzio S, 2009, BLOOD, V114, P4138, DOI 10.1182/blood-2009-04-214593; DUNNOVICBELLO I, 2010, GENES IMMUN, V11, P188; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Ekwall O, 1999, LANCET, V354, P568, DOI 10.1016/S0140-6736(99)01989-3; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gylling M, 2000, J CLIN ENDOCR METAB, V85, P4434, DOI 10.1210/jc.85.12.4434; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Howson JMM, 2007, DIABETOLOGIA, V50, P741, DOI 10.1007/s00125-007-0603-6; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Ikegami H, 2006, J CLIN ENDOCR METAB, V91, P1087, DOI 10.1210/jc.2005-1407; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kahaly GJ, 2009, EUR J ENDOCRINOL, V161, P11, DOI 10.1530/EJE-09-0044; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Mazzolari E, 2005, BONE MARROW TRANSPL, V35, P1033, DOI 10.1038/sj.bmt.1704954; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Moraes-Vasconcelos D, 2008, J CLIN IMMUNOL, V28, pS11, DOI 10.1007/s10875-008-9176-5; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ochs HD, 2007, IMMUNOL RES, V38, P112, DOI 10.1007/s12026-007-0022-2; Owen CJ, 2003, J CLIN ENDOCR METAB, V88, P6034, DOI 10.1210/jc.2003-031080; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Rao A, 2007, BLOOD, V109, P383, DOI 10.1182/blood-2006-05-025072; Rubio-Cabezas O, 2009, DIABETES CARE, V32, P111, DOI 10.2337/dc08-1188; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Ulinski T, 2006, J CLIN ENDOCR METAB, V91, P192, DOI 10.1210/jc.2005-1538; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Vendrame F, 2006, J CLIN ENDOCR METAB, V91, P5064, DOI 10.1210/jc.2006-1358; Ward L, 1999, J CLIN ENDOCR METAB, V84, P844, DOI 10.1210/jc.84.3.844; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wolff ASB, 2008, GENES IMMUN, V9, P130, DOI 10.1038/sj.gene.6364457; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Yu LP, 1999, J CLIN ENDOCR METAB, V84, P328, DOI 10.1210/jc.84.1.328; Zhan H, 2008, PEDIATRICS, V121, pE998, DOI 10.1542/peds.2007-1863; Zhang L, 2007, CLIN IMMUNOL, V125, P131, DOI 10.1016/j.clim.2007.07.015; Zuber J, 2007, GASTROENTEROLOGY, V132, P1694, DOI 10.1053/j.gastro.2007.02.034; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	87	58	60	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					479	487		10.1016/j.immuni.2010.03.016	http://dx.doi.org/10.1016/j.immuni.2010.03.016			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412758	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000277171900005
J	Odegard, VH; Kim, ST; Anderson, SM; Shlomchik, MJ; Schatz, DG				Odegard, VH; Kim, ST; Anderson, SM; Shlomchik, MJ; Schatz, DG			Histone modifications associated with somatic hypermutation	IMMUNITY			English	Article							DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; ACTIVATION-INDUCED DEAMINASE; IMMUNOGLOBULIN GENES; B-CELLS; STERILE-20 KINASE; REGION CHROMATIN; DNA DEAMINATION; AID; TRANSCRIPTION	A number of modified histones, including acetylated H3 and H4 and phosphorylated H2AX (gamma H2AX), are associated with V(D)J recombination and class switch recombination (CSR). In contrast, little is known concerning the chromatin modifications associated with somatic hypermutation (SHM) in vivo. Here, we report that several modifications-including histone acetylation and H3-lysine 4 methylation-fail to demarcate an actively hypermutating immunoglobulin (Ig) locus or to correlate spatially with SHM within Ig loci. Furthermore, no obvious association between SHM and gamma H2AX could be detected. Instead, we find that the phosphorylated form of histone H2B (H2B(Ser14P)) correlates tightly with SHM and CSR. Phosphorylation of H2B within Ig variable and switch regions requires AID and may be mediated by the histone kinase Mst1. These findings indicate that SHM and CSR trigger distinct DNA damage responses and identify a novel histone modification pattern for SHM consisting of H2B(Ser14P) in the absence of gamma H2AX.	Yale Univ, Immunol Sect, Sch Med, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, Sch Med, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Schatz, DG (corresponding author), Yale Univ, Immunol Sect, Sch Med, Box 208011, New Haven, CT 06520 USA.	david.schatz@yale.edu	Shlomchik, Mark J./AAN-6189-2020; Schatz, David/A-6748-2013	Shlomchik, Mark J./0000-0002-2152-0959; Schatz, David/0000-0002-5669-1176	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43603] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Bassing CH, 2004, CELL CYCLE, V3, P149; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; BURGER C, 1990, EUR J IMMUNOL, V20, P2285, DOI 10.1002/eji.1830201018; BURGER C, 1992, MOL IMMUNOL, V29, P1105, DOI 10.1016/0161-5890(92)90043-W; Catalan N, 2003, J IMMUNOL, V171, P2504, DOI 10.4049/jimmunol.171.5.2504; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Haber JE, 2001, NAT IMMUNOL, V2, P902, DOI 10.1038/ni1001-902; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Inlay M, 2003, CLIN IMMUNOL, V109, P29, DOI 10.1016/S1521-6616(03)00199-2; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; Kong QZ, 2001, GENETICS, V158, P369; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Li ZQ, 2004, P NATL ACAD SCI USA, V101, P15428, DOI 10.1073/pnas.0406827101; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Storb U, 1998, IMMUNOL REV, V162, P153; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1	47	58	70	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					101	110		10.1016/j.immuni.2005.05.007	http://dx.doi.org/10.1016/j.immuni.2005.05.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039583	Bronze			2022-12-18	WOS:000231024800012
J	Raptis, SZ; Shapiro, SD; Simmons, PM; Cheng, AM; Pham, CTN				Raptis, SZ; Shapiro, SD; Simmons, PM; Cheng, AM; Pham, CTN			Serine protease cathepsin G regulates adhesion-dependent neutrophil effector functions by modulating integrin clustering	IMMUNITY			English	Article							ALPHA-1-PROTEINASE INHIBITOR; ACTIVATED RECEPTOR-2; CATALYTIC-ACTIVITY; CELL-ADHESION; FC-RECEPTORS; HOST-DEFENSE; IN-VIVO; ELASTASE; CHEMOKINES; MECHANISMS	The polymorphonuclear leukocyte (PMN)-derived serine proteases play a key role in immune complex (IC)-mediated inflammation. However, the mechanisms by which these proteases regulate inflammatory response remain largely undefined. Here, we show that IC-activated cathepsin G- and neutrophil elastase-deficient (CG/NE) PMNs adhered normally to IC-coated surfaces but did not undergo CD11b clustering and failed to initiate cytoskeletal reorganization and cell spreading. As a result, CG/NE-deficient PMNs exhibited severe defects in MIP-2 secretion and reactive oxygen intermediates production. Exogenously added CG, but not proteolytically inactive CG, was sufficient to restore these defects. These findings identify an important role for CG in integrin-dependent PMN effector functions that are separate from and downstream of integrin-dependent adhesion.	Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pham, CTN (corresponding author), Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA.	cpham@wustl.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049261, R01AI049261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54853] Funding Source: Medline; NIAID NIH HHS [R01 AI049261, AI49261] Funding Source: Medline; NIAMS NIH HHS [P30AR48335] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BERMAN ME, 1995, J IMMUNOL, V154, P299; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carden DL, 1996, AM J PHYSIOL-HEART C, V271, pH1947, DOI 10.1152/ajpheart.1996.271.5.H1947; Carney DF, 1998, J LEUKOCYTE BIOL, V63, P75, DOI 10.1002/jlb.63.1.75; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; FEARON DT, 1977, P NATL ACAD SCI USA, V74, P1683, DOI 10.1073/pnas.74.4.1683; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Howells GL, 1997, J CELL SCI, V110, P881; HUBER AR, 1989, J CLIN INVEST, V83, P1122, DOI 10.1172/JCI113992; Jin TQ, 2002, J BIOL CHEM, V277, P32963, DOI 10.1074/jbc.M201525200; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Kessel JM, 1998, J IMMUNOL, V160, P5579; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Mackarel AJ, 1999, AM J RESP CELL MOL, V20, P1209; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Moffatt JD, 2002, AM J RESP CELL MOL, V26, P680, DOI 10.1165/ajrcmb.26.6.4693; Mylonas C, 1999, IN VIVO, V13, P295; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; OWEN CA, 1995, J IMMUNOL, V155, P5803; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; SHAPPELL SB, 1990, J IMMUNOL, V144, P2702; Si-Tahar M, 1997, J BIOL CHEM, V272, P11636; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; WOODMAN RC, 1993, BLOOD, V82, P2188; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	52	58	63	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					679	691		10.1016/j.immuni.2005.03.015	http://dx.doi.org/10.1016/j.immuni.2005.03.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963783	Bronze			2022-12-18	WOS:000230180300006
J	Buch, T; Rieux-Laucat, F; Forster, I; Rajewsky, K				Buch, T; Rieux-Laucat, F; Forster, I; Rajewsky, K			Failure of HY-specific thymocytes to escape negative selection by receptor editing	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; GERM-LINE TRANSCRIPTION; DEVELOPING T-CELLS; J-ALPHA-LOCUS; TRANSGENIC MICE; TCR-ALPHA; POSITIVE SELECTION; V-ALPHA; B-LYMPHOCYTES; GENE SEGMENTS	Editing of autoreactive antigen receptors by secondary V(D)J recombination efficiently rescues B lymphocyte precursors from apoptosis induced by negative selection, but its role has not been rigorously assessed in T cell development. We therefore generated a transgenic mouse model in which self-reactive thymocytes could edit their TCR by secondary recombination at the TCRalpha locus. For this purpose, the ValphaJalpha exon of a male-specific TCR was inserted into the TCRalpha. locus followed by Cre-IoxP-mediated deletion of the TCRdelta locus. In this model, only few thymocytes escaped negative selection by change of specificity, probably through recombination before encounter of autoantigen. In the absence of the restricting MHC element, however, developing thymocytes replaced the inserted TCRa exon efficiently.	Univ Cologne, Genet Inst, D-50931 Cologne, Germany; Hop Necker Enfants Malad, INSERM U429, F-75015 Paris, France; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	University of Cologne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.		Förster, Irmgard/P-8545-2016; Buch, Thorsten/P-1659-2019; Rieux-Laucat, Frédéric/A-7916-2017	Förster, Irmgard/0000-0002-7644-5642; Buch, Thorsten/0000-0002-2236-9074; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Rajewsky, Klaus/0000-0002-6633-6370				Arden Bernhard, 1995, Immunogenetics, V42, P501; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Braun U, 2000, P NATL ACAD SCI USA, V97, P7429, DOI 10.1073/pnas.050578497; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Davodeau F, 2001, EMBO J, V20, P4717, DOI 10.1093/emboj/20.17.4717; Fink PJ, 2000, IMMUNOL TODAY, V21, P561, DOI 10.1016/S0167-5699(00)01734-5; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Hertz M, 1998, NATURE, V394, P292, DOI 10.1038/28419; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Hozumi K, 1998, EUR J IMMUNOL, V28, P1368, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1368::AID-IMMU1368&gt;3.0.CO;2-B; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KILLEEN N, 1992, J EXP MED, V176, P89, DOI 10.1084/jem.176.1.89; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kouskoff V, 2000, P NATL ACAD SCI USA, V97, P7435, DOI 10.1073/pnas.130182597; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; MAROLLEAU JP, 1988, CELL, V55, P291, DOI 10.1016/0092-8674(88)90052-9; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; OKASAKI K, 1988, EMBO J, V7, P1669; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; Riegert P, 1999, J IMMUNOL, V162, P3471; RIEUXLAUCAT F, 1993, EUR J IMMUNOL, V23, P928, DOI 10.1002/eji.1830230425; ROTH ME, 1991, J IMMUNOL, V147, P1075; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHORTMAN K, 1988, CELL IMMUNOL, V113, P462, DOI 10.1016/0008-8749(88)90042-1; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; UEMATSU Y, 1992, EUR J IMMUNOL, V22, P603, DOI 10.1002/eji.1830220247; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834	55	58	60	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2002	16	5					707	718		10.1016/S1074-7613(02)00312-6	http://dx.doi.org/10.1016/S1074-7613(02)00312-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049722	Bronze			2022-12-18	WOS:000175820400009
J	Hackenmiller, R; Kim, J; Feldman, RA; Simon, MC				Hackenmiller, R; Kim, J; Feldman, RA; Simon, MC			Abnormal stat activation, hematopoietic homeostasis, and innate immunity in c-fes(-/-) mice	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; PROTEIN-TYROSINE KINASE; FES-RELATED PROTEIN; C-FOS PROMOTER; MYELOID DIFFERENTIATION; PROTOONCOGENE PRODUCT; SIGNAL-TRANSDUCTION; BINDING PROTEINS; CELL-POPULATIONS; TRANSGENIC MICE	The c-fes protooncogene encodes a nonreceptor tyrosine kinase (Fes) implicated in cytokine receptor signal transduction, neutrophil survival, and myeloid differentiation. To determine the role of Fes in embryonic development and hematopoiesis, we engineered a null mutation of the murine c-fes locus. c-fes(-/-) mice are viable but not born in the expected Mendelian ratios. Live born c-fes(-/-) mice exhibit lymphoid/myeloid homeostasis defects, compromised innate immunity, and increased Stat activation in response to GM-CSF and IL-6 signaling. Therefore, increased cytokine responsiveness in the absence of Fes leads to abnormal myeloid proliferation and functional defects in the macrophage lineage.	Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago; University System of Maryland; University of Maryland Baltimore	Simon, MC (corresponding author), Univ Chicago, Comm Genet, Chicago, IL 60637 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021	Feldman, Ricardo A./0000-0001-6090-0439	PHS HHS [52094, 55293] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brizzi MF, 1996, J BIOL CHEM, V271, P3562; Brown CR, 1999, INFECT IMMUN, V67, P1967; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DORSHKIND K, 1991, J IMMUNOL, V146, P4204; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; FELDMAN RA, 1990, ONCOGENE RES, V5, P187; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; FERRARI S, 1992, ANN NY ACAD SCI, V660, P11, DOI 10.1111/j.1749-6632.1992.tb21053.x; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V140, P908, DOI 10.1016/0006-291X(86)90721-7; GREER P, 1994, MOL CELL BIOL, V14, P6755, DOI 10.1128/MCB.14.10.6755; HANAZONO Y, 1993, BLOOD, V81, P3193; HANAZONO Y, 1993, EMBO J, V12, P1641, DOI 10.1002/j.1460-2075.1993.tb05809.x; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; Jucker M, 1997, J BIOL CHEM, V272, P2104; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Kieslinger M, 2000, GENE DEV, V14, P232; KIM L, 1995, MOL CELL BIOL, V15, P4553; LEE MY, 1993, BLOOD, V82, P2062; Li JZ, 1996, J BIOL CHEM, V271, P32930, DOI 10.1074/jbc.271.51.32930; LIEBERMANN DA, 1989, ONCOGENE, V4, P583; LINNEKIN D, 1995, J BIOL CHEM, V270, P4950, DOI 10.1074/jbc.270.9.4950; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; MANFREDINI R, 1993, J EXP MED, V178, P381, DOI 10.1084/jem.178.2.381; Manfredini R, 1997, BLOOD, V89, P135, DOI 10.1182/blood.V89.1.135.135_135_145; MATSUDA T, 1995, J BIOL CHEM, V270, P11037, DOI 10.1074/jbc.270.19.11037; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; METCALF D, 1995, BLOOD, V85, P2364, DOI 10.1182/blood.V85.9.2364.bloodjournal8592364; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Nelson KL, 1998, J BIOL CHEM, V273, P7072, DOI 10.1074/jbc.273.12.7072; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; PALLARD C, 1995, J BIOL CHEM, V270, P15942, DOI 10.1074/jbc.270.27.15942; Park WY, 1998, CANCER LETT, V129, P29, DOI 10.1016/S0304-3835(98)00077-9; Rajotte D, 1996, BLOOD, V88, P2906, DOI 10.1182/blood.V88.8.2906.bloodjournal8882906; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Senis Y, 1999, MOL CELL BIOL, V19, P7436; SMITH RL, 1988, CHEST, V93, P60, DOI 10.1378/chest.93.1.60; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SPORN SA, 1990, J IMMUNOL, V144, P4434; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WILKS AF, 1988, ONCOGENE, V3, P289; YU G, 1988, MOL PHARMACOL, V33, P384; YU G, 1989, J BIOL CHEM, V264, P10276; YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034	59	58	58	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2000	13	3					397	407		10.1016/S1074-7613(00)00039-X	http://dx.doi.org/10.1016/S1074-7613(00)00039-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021537	Bronze			2022-12-18	WOS:000089616400012
J	Scherer, DC; Brockman, JA; Bendall, HH; Zhang, GM; Ballard, DW; Oltz, EM				Scherer, DC; Brockman, JA; Bendall, HH; Zhang, GM; Ballard, DW; Oltz, EM			Corepression of RelA and c-Rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes	IMMUNITY			English	Article							CHAIN INTRON ENHANCER; V(D)J RECOMBINATION; CELL DIFFERENTIATION; HEAVY-CHAIN; FUNCTIONAL-CHARACTERIZATION; BINDING-PROTEINS; DNA-BINDING; FETAL LIVER; EXPRESSION; ACTIVATION	Multiple members of the NF-kappa B/Rel protein family are induced during B cell differentiation and have been implicated in transcriptional activation of the immunoglobulin kappa (Ig kappa) locus. Despite these findings, normal numbers of Ig kappa(+) B lymphocytes are produced by mice bearing targeted mutations in individual NF-kappa B/Rel genes. In the present study, precursor B lymphocytes were engineered to express a trans-dominant form of I kappa B alpha that simultaneously impairs the c-Rel and RelA transactivating subunits of NF-kappa B. This dual block in NF-kappa B/Rel signaling led to potent inhibition of germline Igh transcription and rearrangement, whereas recombinase activity was unaffected. These findings suggest that c-Rel and RelA serve compensatory functional roles in the developmental mechanisms that govern Ig kappa gene assembly.	VANDERBILT UNIV,SCH MED,HOWARD HUGHES MED INST,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,NASHVILLE,TN 37232	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI036944, R01AI033839, R01AI036944] Funding Source: NIH RePORTER; NIAID NIH HHS [AI01412, AI33839, AI36944] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BALLARD D W, 1989, New Biologist, V1, P83; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; BOOTHBY M, 1989, J IMMUNOL, V142, P1005; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FULTON R, 1993, NUCLEIC ACIDS RES, V21, P4941, DOI 10.1093/nar/21.21.4941; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; GHOSH S, 1995, IMMUNOLOGIST, V3, P168; GILLY M, 1992, J IMMUNOL, V148, P3275; HARTMAN SC, 1988, P NATL ACAD SCI USA, V85, P8047, DOI 10.1073/pnas.85.21.8047; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LANSFORD R, 1996, MOL IMMUNOL, P1; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LENNON GG, 1990, J IMMUNOL, V144, P1983; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; MARTIN DJ, 1990, MOL CELL BIOL, V10, P1950, DOI 10.1128/MCB.10.5.1950; MEYER KB, 1994, NUCLEIC ACIDS RES, V22, P1576, DOI 10.1093/nar/22.9.1576; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OLTZ EM, 1993, MOL CELL BIOL, V13, P6223, DOI 10.1128/MCB.13.10.6223; PAIGE CJ, 1978, J IMMUNOL, V121, P641; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	60	58	58	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					563	574		10.1016/S1074-7613(00)80271-X	http://dx.doi.org/10.1016/S1074-7613(00)80271-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986716	Bronze			2022-12-18	WOS:A1996WA65100007
J	Dyer, DP; Medina-Ruiz, L; Bartolini, R; Schuette, F; Hughes, CE; Pallas, K; Vidler, F; Macleod, MKL; Kelly, CJ; Lee, KM; Hansell, CAH; Graham, GJ				Dyer, Douglas P.; Medina-Ruiz, Laura; Bartolini, Robin; Schuette, Fabian; Hughes, Catherine E.; Pallas, Kenneth; Vidler, Francesca; Macleod, Megan K. L.; Kelly, Christopher J.; Lee, Kit Ming; Hansell, Christopher A. H.; Graham, Gerard J.			Chemokine Receptor Redundancy and Specificity Are Context Dependent	IMMUNITY			English	Article							HOST-DEFENSE; NEUTROPHIL MIGRATION; MONOCYTE SUBSETS; BONE-MARROW; CELLS; RECRUITMENT; EXPRESSION; TISSUE; ROLES; CCR2	Currently, we lack an understanding of the individual and combinatorial roles for chemokine receptors in the inflammatory process. We report studies on mice with a compound deletion of Ccr1, Ccr2, Ccr3, and Ccr5, which together control monocytic and eosinophilic recruitment to resting and inflamed sites. Analysis of resting tissues from these mice, and mice deficient in each individual receptor, provides clear evidence for redundant use of these receptors in establishing tissue-resident monocytic cell populations. In contrast, analysis of cellular recruitment to inflamed sites provides evidence of specificity of receptor use for distinct leukocyte subtypes and no indication of comprehensive redundancy. We find no evidence of involvement of any of these receptors in the recruitment of neutrophils or lymphocytes to resting or acutely inflamed tissues. Our data shed important light on combinatorial inflammatory chemokine receptor function and highlight Ccr2 as the primary driver of myelomonocytic cell recruitment in acutely inflamed contexts.	[Dyer, Douglas P.; Medina-Ruiz, Laura; Bartolini, Robin; Schuette, Fabian; Hughes, Catherine E.; Pallas, Kenneth; Vidler, Francesca; Macleod, Megan K. L.; Kelly, Christopher J.; Lee, Kit Ming; Hansell, Christopher A. H.; Graham, Gerard J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Chemokine Res Grp, Glasgow G12 8TT, Lanark, Scotland; [Dyer, Douglas P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res,Lydia Becker Inst Im, Manchester, Lancs, England	University of Glasgow; University of Manchester	Graham, GJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Chemokine Res Grp, Glasgow G12 8TT, Lanark, Scotland.	gerard.graham@glasgow.ac.uk	LEE, KIT/GZM-4116-2022; Ruiz, Laura/GXV-2578-2022; Medina-Ruiz, Laura/AAF-4440-2021; Dyer, Douglas/J-2675-2015	Medina-Ruiz, Laura/0000-0002-2934-534X; Kelly, Christopher/0000-0001-7557-4568; Schuette, Fabian/0000-0001-5959-952X; Dyer, Douglas/0000-0001-5567-6241; Bartolini, Robin/0000-0001-6875-6734; Lee, Kit Ming/0000-0002-0475-3865	Wellcome Trust Senior Investigator Award [099251/Z/12/Z]; MRC Programme Grant [MR/M019764/1]; Wolfson Royal Society Merit Award; MRC [MR/M019764/1] Funding Source: UKRI	Wellcome Trust Senior Investigator Award(Wellcome Trust); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wolfson Royal Society Merit Award(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge the help of John Cole and Graham Hamilton with the analysis of the RNA sequencing data. We also acknowledge the assistance of the Institute of Infection, Immunity, and Inflammation Flow Core Facility at the University of Glasgow. Work in G.J.G.'s laboratory is funded by a Wellcome Trust Senior Investigator Award (099251/Z/12/Z) and an MRC Programme Grant (MR/M019764/1). G.J.G is recipient of a Wolfson Royal Society Merit Award.	Bachelerie F, 2014, NAT IMMUNOL, V15, P207, DOI 10.1038/ni.2812; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dyer DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42681; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Lionakis MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002865; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Nomiyama H, 2011, DEV COMP IMMUNOL, V35, P705, DOI 10.1016/j.dci.2011.01.019; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Reichel CA, 2006, J LEUKOCYTE BIOL, V79, P114, DOI 10.1189/jlb.0605337; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2013, J IMMUNOL, V190, P6450, DOI 10.4049/jimmunol.1201429; Sandblad KG, 2015, CLIN IMMUNOL, V161, P348, DOI 10.1016/j.clim.2015.09.012; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schaller MA, 2008, AM J PATHOL, V172, P386, DOI 10.2353/ajpath.2008.070537; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soehnlein O, 2013, EMBO MOL MED, V5, P471, DOI 10.1002/emmm.201201717; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	57	57	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					378	+		10.1016/j.immuni.2019.01.009	http://dx.doi.org/10.1016/j.immuni.2019.01.009			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784579	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000459006700013
J	Hosokawa, H; Ungerback, J; Wang, X; Matsumoto, M; Nakayama, KI; Cohen, SM; Tanaka, T; Rothenberg, EV				Hosokawa, Hiroyuki; Ungerback, Jonas; Wang, Xun; Matsumoto, Masaki; Nakayama, Keiichi I.; Cohen, Sarah M.; Tanaka, Tomoaki; Rothenberg, Ellen V.			Transcription Factor PU. 1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding	IMMUNITY			English	Article							LINEAGE COMMITMENT; NATURAL-KILLER; B-CELLS; RUNX1; HAPLOINSUFFICIENCY; EBF1; DIFFERENTIATION; CHROMATIN; NETWORKS; FATE	Transcription factors normally regulate gene expression through their action at sites where they bind to DNA. However, the balance of activating and repressive functions that a transcription factor can mediate is not completely understood. Here, we showed that the transcription factor PU. 1 regulated gene expression in early T cell development both by recruiting partner transcription factors to its own binding sites and by depleting them from the binding sites that they preferred when PU. 1 was absent. The removal of partner factors Satb1 and Runx1 occurred primarily from sites where PU. 1 itself did not bind. Genes linked to sites of partner factor "theft'' were enriched for genes that PU. 1 represses despite lack of binding, both in a model cell line system and in normal T cell development. Thus, system-level competitive recruitment dynamics permit PU. 1 to affect gene expression both through its own target sites and through action at a distance.	[Hosokawa, Hiroyuki; Ungerback, Jonas; Wang, Xun; Cohen, Sarah M.; Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ungerback, Jonas] Lund Univ, Div Mol Hematol, Lund, Sweden; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka, Fukuoka, Japan; [Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Tanaka, Tomoaki] Japan Agcy Med Res & Dev, AMED, AMED CREST, Tokyo, Japan	California Institute of Technology; Lund University; Kyushu University; Chiba University	Rothenberg, EV (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Matsumoto, Masaki/0000-0002-6987-0288; Rothenberg, Ellen/0000-0002-3901-347X; Hosokawa, Hiroyuki/0000-0002-9592-2889; Cohen, Sarah/0000-0003-4469-2670	Manpei Suzuki Diabetes Foundation; Swedish Research Council; USPHS [R01HD076915, R01AI95943]; Takeda Science Foundation; SENSHINE Medical Research Foundation; L.A. Garfinkle Memorial Laboratory Fund; Al Sherman Foundation; Provost and Division of Biology & Biological Engineering of the California Institute of Technology; Albert Billings Ruddock Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095943] Funding Source: NIH RePORTER	Manpei Suzuki Diabetes Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHINE Medical Research Foundation; L.A. Garfinkle Memorial Laboratory Fund; Al Sherman Foundation; Provost and Division of Biology & Biological Engineering of the California Institute of Technology; Albert Billings Ruddock Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Diana Perez, Jaime Tijerina, and Rochelle Diamond for cell sorting and advice, Ingrid Soto for mouse colony care, Vijaya Kumar for library preparation and sequencing, Henry Amrhein and Diane Trout for computational help, Igor Antoshechkin for sequencing management, and members of the Rothenberg group for valuable discussion and reagents. Fellowships from the Manpei Suzuki Diabetes Foundation (to H.H.) and from the Swedish Research Council (to J.U.) are gratefully acknowledged. This work was supported by grants from the USPHS to E.V.R. (R01HD076915 and R01AI95943) and Grants-in-Aid for Advanced Research and Development Programs for Medical Innovation, the Takeda Science Foundation, and SENSHINE Medical Research Foundation to T.T. This work was partly performed in the Collaborative Research Project Program of the Medical Institute of Bioregulation, Kyushu University, and was also supported by the L.A. Garfinkle Memorial Laboratory Fund and the Al Sherman Foundation, by funds from the Provost and Division of Biology & Biological Engineering of the California Institute of Technology, and by the Albert Billings Ruddock Professorship to E.V.R.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Alvarez JD, 2000, GENE DEV, V14, P521; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Champhekar A, 2015, GENE DEV, V29, P832, DOI 10.1101/gad.259879.115; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Dionne CJ, 2005, DEV BIOL, V280, P448, DOI 10.1016/j.ydbio.2005.01.027; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jacobs PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069083; Kamath MB, 2008, LEUKEMIA, V22, P1214, DOI 10.1038/leu.2008.67; Kawazu M, 2005, J IMMUNOL, V174, P3526, DOI 10.4049/jimmunol.174.6.3526; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krishnakumar R, 2016, CELL STEM CELL, V18, P104, DOI 10.1016/j.stem.2015.10.003; Lacaud G, 2004, BLOOD, V103, P886, DOI 10.1182/blood-2003-06-2149; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukin K, 2010, P NATL ACAD SCI USA, V107, P7869, DOI 10.1073/pnas.1003525107; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Prasad MAJ, 2015, BLOOD, V125, P4052, DOI 10.1182/blood-2014-12-617282; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Respuela P, 2016, CELL STEM CELL, V18, P118, DOI 10.1016/j.stem.2015.09.010; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Rothenberg EV, 2016, ADV IMMUNOL, V129, P109, DOI 10.1016/bs.ai.2015.09.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Talebian L, 2007, BLOOD, V109, P11, DOI 10.1182/blood-2006-05-021188; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Ungerback J, 2018, BIORXIV, DOI [10.1101/331710, DOI 10.1101/331710.]; van Oevelen C, 2013, CURR OPIN GENET DEV, V23, P562, DOI 10.1016/j.gde.2013.07.003; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong WF, 2010, IMMUNOLOGY, V130, P243, DOI 10.1111/j.1365-2567.2009.03230.x; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhao F, 2003, MOL CELL BIOL, V23, P3837, DOI 10.1128/MCB.23.11.3837-3846.2003	72	57	57	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1119	+		10.1016/j.immuni.2018.04.024	http://dx.doi.org/10.1016/j.immuni.2018.04.024			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924977	Green Accepted, Bronze			2022-12-18	WOS:000436456900012
J	Guenaga, J; Garces, F; de Val, N; Stanfield, RL; Dubrovskaya, V; Higgins, B; Carrette, B; Ward, AB; Wilson, IA; Wyatt, RT				Guenaga, Javier; Garces, Fernando; de Val, Natalia; Stanfield, Robyn L.; Dubrovskaya, Viktoriya; Higgins, Brett; Carrette, Barbara; Ward, Andrew B.; Wilson, Ian A.; Wyatt, Richard T.			Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CRYO-EM STRUCTURE; NEUTRALIZATION; ANTIBODY; TRIMERS; RECOGNITION; COMPLEX; FUSION; REGION; GP120	Advances in HIV-1 envelope glycoprotein (Env) design generate native-like trimers and high-resolution clade A, B, and G structures and elicit neutralizing antibodies. However, a high-resolution clade C structure is critical, as this subtype accounts for the majority of HIV infections worldwide, but well-ordered clade C Env trimers are more challenging to produce due to their instability. Based on targeted glycine substitutions in the Env fusion machinery, we defined a general approach that disfavors helical transitions leading to post-fusion conformations, thereby favoring the pre-fusion state. We generated a stabilized, soluble clade C Env (16055 NFL) and determined its crystal structure at 3.9 angstrom. Its overall conformation is similar to SOSIP.664 and native Env trimers but includes a covalent linker between gp120 and gp41, an engineered 201-433 disulfide bond, and density corresponding to 22 N-glycans. Env-structure-guided design strategies resulted in multiple homogeneous cross-clade immunogens with the potential to advance HIV vaccine development.	[Guenaga, Javier; Stanfield, Robyn L.; Carrette, Barbara; Ward, Andrew B.; Wilson, Ian A.; Wyatt, Richard T.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Garces, Fernando; de Val, Natalia; Stanfield, Robyn L.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Dubrovskaya, Viktoriya; Higgins, Brett; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Ward, Andrew B.; Wilson, Ian A.; Wyatt, Richard T.] Scripps Ctr HIV AIDS Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wilson, IA; Wyatt, RT (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wyatt, RT (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Wilson, IA; Wyatt, RT (corresponding author), Scripps Ctr HIV AIDS Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu; wyatt@scripps.edu	Stanfield, Robyn/AAH-3190-2019; Ward, Andrew B/F-9203-2014; de Val, Natalia/AAF-4822-2019; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769	International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery [CAVD OPP1084519]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [UM1 AI00663]; NIH [P01 HIVRAD AI104722, R56 AI084817]; Joint Center of Structural Genomics (JCSG) - NIH NIGMS Protein Structure Initiative [U54 GM094586]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084817, UM1AI100663, P01AI104722, R01AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center of Structural Genomics (JCSG) - NIH NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD OPP1084519) (J.G., I.A.W., A.B.W., and R.T.W.). IAVI's work is made possible by generous support from many donors, including the following: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. We are very grateful to H. Tien for crystallization screening. X-ray data sets were collected at the GM/CA@APS-23ID-D beamline, which has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This work was supported by the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) UM1 AI00663 (A.B.W., I.A.W., and R.T.W.), by NIH P01 HIVRAD AI104722 (R.T.W.), by NIH R56 AI084817 (I.A.W.) and by the Joint Center of Structural Genomics (JCSG) funded by the NIH NIGMS Protein Structure Initiative U54 GM094586 (I.A.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERGER EA, 1991, P NATL ACAD SCI USA, V88, P8082, DOI 10.1073/pnas.88.18.8082; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Cuenaga J., 2015, PLOS PATHOG, V11; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Martinez-Murillo P, 2017, IMMUNITY, V46, P804, DOI 10.1016/j.immuni.2017.04.021; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907	49	57	69	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					792	+		10.1016/j.immuni.2017.04.014	http://dx.doi.org/10.1016/j.immuni.2017.04.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514686	Green Published, hybrid			2022-12-18	WOS:000401316300015
J	Miyazaki, M; Miyazaki, K; Chen, KN; Jin, Y; Turner, J; Moore, AJ; Saito, R; Yoshida, K; Ogawa, S; Rodewald, HR; Lin, YC; Kawamoto, H; Murre, C				Miyazaki, Masaki; Miyazaki, Kazuko; Chen, Kenian; Jin, Yi; Turner, Jacob; Moore, Amanda J.; Saito, Rintaro; Yoshida, Kenichi; Ogawa, Seishi; Rodewald, Hans-Reimer; Lin, Yin C.; Kawamoto, Hiroshi; Murre, Cornelis			The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development	IMMUNITY			English	Article							DNA-BINDING PROTEINS; B-CELL; TRANSCRIPTION FACTORS; LINEAGE SPECIFICATION; GENE-EXPRESSION; E2A PROTEINS; DIFFERENTIATION; NOTCH; ACQUISITION; PROGENITORS	Innate and adaptive lymphoid development is orchestrated by the activities of E proteins and their antagonist Id proteins, but how these factors regulate early T cell progenitor (ETP) and innate lymphoid cell (ILC) development remains unclear. Using multiple genetic strategies, we demonstrated that E proteins E2A and HEB acted in synergy in the thymus to establish T cell identity and to suppress the aberrant development of ILCs, including ILC2s and lymphoidtissue-inducer-like cells. E2A and HEB orchestrated T cell fate and suppressed the ILC transcription signature by activating the expression of genes associated with Notch receptors, T cell receptor (TCR) assembly, and TCR-mediated signaling. E2A and HEB acted in ETPs to establish and maintain a T-cell-lineage-specific enhancer repertoire, including regulatory elements associated with the Notch1, Rag1, and Rag2 loci. On the basis of these and previous observations, we propose that the E-Id protein axis specifies innate and adaptive lymphoid cell fate.	[Miyazaki, Masaki; Miyazaki, Kazuko; Kawamoto, Hiroshi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Immunol, Kyoto 6068507, Japan; [Miyazaki, Masaki; Miyazaki, Kazuko; Moore, Amanda J.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Chen, Kenian; Jin, Yi; Turner, Jacob; Lin, Yin C.] Baylor Inst Immunol Res, Baylor Res Inst, Dallas, TX 75246 USA; [Saito, Rintaro] Univ Calif San Diego, Inst Metabol Med, La Jolla, CA 92093 USA; [Saito, Rintaro] Univ Calif San Diego, Ctr Renal Translat Med, La Jolla, CA 92093 USA; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto 6068507, Japan; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Neuenheimer Field 280, D-69120 Heidelberg, Germany	Kyoto University; University of California System; University of California San Diego; Baylor Scott & White Health; Baylor University Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyoto University; Helmholtz Association; German Cancer Research Center (DKFZ)	Miyazaki, M (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Immunol, Kyoto 6068507, Japan.; Miyazaki, M; Murre, C (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	mmiyazaki@infront.kyoto-u.ac.jp; murre@biomail.ucsd.edu	Ogawa, Seishi/AAE-7088-2019; CHEN, KENIAN/L-8899-2019; CHEN, KENIAN/F-8240-2019	CHEN, KENIAN/0000-0002-4083-841X; Miyazaki, Kazuko/0000-0001-9754-698X; Lin, Yin/0000-0003-4925-5453; Yoshida, Kenichi/0000-0003-4612-2778	Baylor Institute for Immunology Research; Baylor Charles A. Sammons Cancer Center; NIH [AI102853]; KAKENHI from the MEXT of Japan [16H05205, 15H06330]; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102853] Funding Source: NIH RePORTER	Baylor Institute for Immunology Research; Baylor Charles A. Sammons Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KAKENHI from the MEXT of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Naito Foundation(Naito Memorial Foundation); Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Itoi and K. Hozumi for helpful discussion; T. Ikawa, K. Hozumi, S. Sawa, and Y. Motomura for technical advice; K. Masuda for mouse transfer, and N. Okada for mouse observation and care. We thank G. Kondoh and members of the Laboratory of Animal Experiments for Regeneration in Kyoto University for their kind help with the transfer of mice and generating mutant mice. We thank A. Goldrath (University of California, San Diego) for Id2-YFP mice, Yuan Zhuang (Duke University) for Tcf3<SUP>fl/fl</SUP>, Tcf12<SUP>fl/fl</SUP>, and Tcf3<SUP>E2A-GFP/E2A-GFP</SUP> mice, and A. Lasorella (Columbia University) for Id2<SUP>fl/fl</SUP> mice. This work was partly supported by funding from the Baylor Institute for Immunology Research and Baylor Charles A. Sammons Cancer Center (to K.C., Y.J., J.T., and Y.C.L.), the NIH (AI102853 to C.M.), the KAKENHI (Grant-in-Aid for Scientific Research) from the MEXT of Japan (16H05205 and 15H06330), the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Naito Foundation, the Daiichi Sankyo Foundation of Life Science, and the Uehara Memorial Foundation (to M.M and K.M.).	Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; Barndt R, 1999, J IMMUNOL, V163, P3331; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Belle I, 2014, CURR TOP DEV BIOL, V110, P153, DOI [10.1016/B978-0-12-405943-6.00003-4-X, 10.1016/B978-0-12-405943-6.00004-X]; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; de Sousa AP, 2012, J IMMUNOL, V189, P3822, DOI 10.4049/jimmunol.1103723; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Miyazaki K, 2014, TRENDS IMMUNOL, V35, P205, DOI 10.1016/j.it.2014.02.009; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Welinder E, 2011, P NATL ACAD SCI USA, V108, P17402, DOI 10.1073/pnas.1111766108; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 2004, MOL IMMUNOL, V40, P1165, DOI 10.1016/j.molimm.2003.11.031; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	57	57	57	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					818	+		10.1016/j.immuni.2017.04.022	http://dx.doi.org/10.1016/j.immuni.2017.04.022			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514688	Bronze, Green Accepted			2022-12-18	WOS:000401316300017
J	Watanabe, M; Moon, KD; Vacchio, MS; Hathcock, KS; Hodes, RJ				Watanabe, Masashi; Moon, Kyung Duk; Vacchio, Melanie S.; Hathcock, Karen S.; Hodes, Richard J.			Downmodulation of Tumor Suppressor p53 by T Cell Receptor Signaling Is Critical for Antigen-Specific CD4(+) T Cell Responses	IMMUNITY			English	Article							IN-VIVO ACTIVATION; CANCER-THERAPY; IMMUNE-SYSTEM; IL-2 RECEPTOR; CHAIN GENE; MICE; MEMORY; MDM2; INTERLEUKIN-2; TUMORIGENESIS	Antigen specificity is critical in immune response and requires integration of antigen-specific signals with antigen-nonspecific signals such as those provided by cytokines. The mechanism integrating these pathways is incompletely understood. We report here that antigen-specific proliferative responses of CD4(+) T cells required downmodulation of tumor suppressor p53. In the absence of T cell receptor (TCR) signal, IL-2 induced sustained increase in p53 protein, which prevented proliferative responses despite strong signaling through the IL-2 receptor. In contrast, TCR signaling resulted in early termination of p53 protein expression by decreasing p53 mRNA as well as strong transcriptional induction of the p53-regulating protein Mdm2. Downmodulation of p53 in response to antigen stimulation was in fact critical for antigenspecific T cell proliferation, and preventing p53 degradation by inhibiting Mdm2 resulted in sustained p53 protein and prevented antigen-specific T cell proliferation. It is thus termination of p53 by TCR signaling that allows proliferative responses, enforcing antigen specificity.	[Watanabe, Masashi; Moon, Kyung Duk; Vacchio, Melanie S.; Hathcock, Karen S.; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hodes, RJ (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	hodesr@31.nia.nih.gov	Hodes, Rebecca/T-3266-2018	Watanabe, Masashi/0000-0003-1741-8748	Intramural Research Program of the NIH; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [ZIABC009281, ZIABC009405] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Singer, C. Harris, and M. Perry for critical reading of the manuscript and insightful comments during the course of these studies. This work was supported by the Intramural Research Program of the NIH. M.W. was supported by the Uehara Memorial Foundation.	Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Grayson JM, 2001, J IMMUNOL, V167, P1333, DOI 10.4049/jimmunol.167.3.1333; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Ohkusu-Tsukada K, 1999, J IMMUNOL, V163, P1966; Okuda Y, 2003, J NEUROIMMUNOL, V135, P29, DOI 10.1016/S0165-5728(02)00428-9; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Simelyte E, 2005, ARTHRITIS RHEUM-US, V52, P1876, DOI 10.1002/ART.21099; Singh N, 2010, EUR J IMMUNOL, V40, P559, DOI 10.1002/eji.200939736; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Warner K, 2013, CURR HEMATOL MALIG R, V8, P163, DOI 10.1007/s11899-013-0165-2; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Zdzalik M, 2010, CELL CYCLE, V9, P4584, DOI 10.4161/cc.9.22.13871; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423	39	57	58	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					681	691		10.1016/j.immuni.2014.04.006	http://dx.doi.org/10.1016/j.immuni.2014.04.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24792911	Green Accepted, Bronze			2022-12-18	WOS:000336026100008
J	Griffith, AV; Fallahi, M; Nakase, H; Gosink, M; Young, B; Petrie, HT				Griffith, Ann V.; Fallahi, Mohammad; Nakase, Hiroshi; Gosink, Mark; Young, Brandon; Petrie, Howard T.			Spatial Mapping of Thymic Stromal Microenvironments Reveals Unique Features Influencing T Lymphoid Differentiation	IMMUNITY			English	Article							RECEPTOR-BETA CHAIN; IMMATURE THYMOCYTES; CELL PROGENITORS; EPITHELIAL-CELLS; GENE-EXPRESSION; ALPHA-BETA; MIGRATION; MICE; EXPANSION; MOUSE	Interaction of hematopoietic progenitors with the thymic microenvironment induces them to proliferate, adopt the T lineage fate, and asymmetrically diverge into multiple functional lineages. Progenitors at various developmental stages are stratified within the thymus, implying that the corresponding microenvironments provide distinct sets of signals to progenitors migrating between them. These differences remain largely undefined. Here we used physical and computational approaches to generate a comprehensive spatial map of stromal gene expression in the thymus. Although most stromal regions were characterized by a unique gene expression signature, the central cortex lacked distinctive features. Instead, a key function of this region appears to be the sequestration of unique microenvironments found at the cortical extremities, thus modulating the relative proximity of progenitors moving between them. Our findings compel reexamination of how cell migration, lineage specification, and proliferation are controlled by thymic architecture and provide an in-depth resource for global characterization of this control.	[Griffith, Ann V.; Fallahi, Mohammad; Nakase, Hiroshi; Young, Brandon; Petrie, Howard T.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Gosink, Mark] Scripps Res Inst, Dept Bioinformat, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Petrie, HT (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.		Griffith, Ann/N-5624-2016	Griffith, Ann/0000-0001-5345-0222; Gosink, Mark/0000-0003-3009-3941	PHS [AI033940, AI067453, AG031576]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067453, R01AI033940, R56AI033940, R29AI033940, R21AI033940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031576, R01AG034876] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by PHS grants AI033940, AI067453, and AG031576 (to H T P)	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Gosink MM, 2007, BIOINFORMATICS, V23, P3328, DOI 10.1093/bioinformatics/btm508; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Li J, 2007, J IMMUNOL, V179, P1605, DOI 10.4049/jimmunol.179.3.1605; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P649, DOI 10.1002/eji.1830190412; PENIT C, 1988, J HISTOCHEM CYTOCHEM, V36, P473, DOI 10.1177/36.5.2895787; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; PETRIE HT, 1990, EUR J IMMUNOL, V20, P2813, DOI 10.1002/eji.1830201243; Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Prockop SE, 2002, J IMMUNOL, V169, P4354, DOI 10.4049/jimmunol.169.8.4354; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Shortman K, 1990, Semin Immunol, V2, P3; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; WALLIS VJ, 1975, TRANSPLANTATION, V19, P2, DOI 10.1097/00007890-197501000-00002; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yang D, 2003, BLOOD, V102, P3396, DOI 10.1182/blood-2003-01-0151; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882; Zlotoff DA, 2008, SEMIN IMMUNOPATHOL, V30, P371, DOI 10.1007/s00281-008-0133-4	60	57	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					999	1009		10.1016/j.immuni.2009.09.024	http://dx.doi.org/10.1016/j.immuni.2009.09.024			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064453	Green Accepted, Bronze			2022-12-18	WOS:000273616400019
J	Layer, K; Lin, GS; Nencioni, A; Hu, W; Schmucker, A; Antov, AN; Li, XY; Takamatsu, S; Chevassut, T; Dower, NA; Stang, SL; Beier, D; Buhlmann, J; Bronson, RT; Elkon, KB; Stone, JC; Van Parijs, L; Lim, B				Layer, K; Lin, GS; Nencioni, A; Hu, W; Schmucker, A; Antov, AN; Li, XY; Takamatsu, S; Chevassut, T; Dower, NA; Stang, SL; Beier, D; Buhlmann, J; Bronson, RT; Elkon, KB; Stone, JC; Van Parijs, L; Lim, B			Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1	IMMUNITY			English	Article							T-CELL DEVELOPMENT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GTP-BINDING PROTEINS; NEGATIVE SELECTION; ANTIGEN-RECEPTOR; IN-VIVO; THYMOCYTE DIFFERENTIATION; POSITIVE SELECTION; TCR SIGNALS; B-CELLS	A mouse strain was identified with a recessive genetic lesion, which spontaneously developed a lymphoproliferative autoimmune syndrome exhibiting features of systemic lupus erythematosus. Positional mapping of the disease-associated locus revealed a lesion in Rasgrp1 that prevented the translation of the RasGRP1 protein. T cells from these mice failed to activate Ras or proliferate vigorously following antigen encounter and showed defects in positive selection. Peripheral RasGRP1(lag) T cells spontaneously adopted a memory phenotype and were able to transfer disease to lymphopenic recipient mice. CD4(+) T cells accumulated in the lymphoid tissues of older RasGRP1(lag) mice and were resistant to activation-induced cell death. RasGRP1(lag) B cells were functionally normal, but activated B cells were detected in older mice, as were autoantibodies directed against self-antigens. Our findings indicate that Ras signaling pathways are required to maintain T cell tolerance and to prevent autoimmune disease.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cnc Biol Program, Boston, MA 02115 USA; Univ Washington, Dept Med & Immunol, Seattle, WA 98195 USA; Univ Alberta, Dept Pediat, Edmonton, AB T6G 2G7, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2G7, Canada; Brigham & Womens Hosp, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Immunol, Boston, MA 02115 USA; Heidelberg Univ, Dept Biol, D-69117 Heidelberg, Germany; Genome Inst Singapore, Singapore 117528, Singapore; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; University of Alberta; University of Alberta; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Ruprecht Karls University Heidelberg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Harvard Medical School	Van Parijs, L (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lukvp@mit.edu; blim@caregroup.harvard.edu	Takamatsu, Satoshi/AAW-5197-2020; Nencioni, Alessio/K-3692-2018	Takamatsu, Satoshi/0000-0001-5620-6196; NENCIONI, ALESSIO/0000-0001-5068-8884	NIDDK NIH HHS [DK47636] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Bullard DC, 1997, J IMMUNOL, V159, P2058; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; del Rincon I, 2000, J IMMUNOL, V165, P7011, DOI 10.4049/jimmunol.165.12.7011; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; ELKON KB, 1990, J IMMUNOL, V145, P636; Erb KJ, 1997, J EXP MED, V185, P329, DOI 10.1084/jem.185.2.329; Foote LC, 1996, J IMMUNOL, V157, P2749; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Mehal WZ, 1998, J IMMUNOL, V161, P1686; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Paget WJ, 1999, SOZ PRAVENTIV MED, V44, P1, DOI 10.1007/BF01624804; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Puente LG, 2000, J IMMUNOL, V165, P6865, DOI 10.4049/jimmunol.165.12.6865; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Roose J, 2000, NAT IMMUNOL, V1, P275, DOI 10.1038/79713; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Tan E.M., 1989, ADV IMMUNOL, V44, P151, DOI [10.1016/S0065-2776(08)60641-0, DOI 10.1016/S0065-2776(08)60641-0]; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Van Parijs L, 1998, SCIENCE, V280, P243; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Yin L, 1997, MOL IMMUNOL, V34, P481, DOI 10.1016/S0161-5890(97)00053-9; Yun TJ, 2001, NAT IMMUNOL, V2, P13, DOI 10.1038/83118; [No title captured]	65	57	59	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					243	255		10.1016/S1074-7613(03)00209-7	http://dx.doi.org/10.1016/S1074-7613(03)00209-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932358	Bronze			2022-12-18	WOS:000184929000012
